PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Finger, JD; Tylleskar, T; Lampert, T; Mensink, GBM				Finger, Jonas D.; Tylleskar, Thorkild; Lampert, Thomas; Mensink, Gert B. M.			Dietary Behaviour and Socioeconomic Position: The Role of Physical Activity Patterns	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; NUTRITION SURVEY; NATIONAL-HEALTH; HEART-DISEASE; UNITED-STATES; SOCIAL-CLASS; ADULTS; WOMEN; CONSUMPTION; VALIDATION	Background: The positive association between education level and health outcomes can be partly explained by dietary behaviour. We investigated the associations between education and several indices of food intake and potential influencing factors, placing special emphasis on physical-activity patterns, using a representative sample of the German adult population. Methods: The German National Health Interview and Examination Survey 1998 (GNHIES98) involved 7,124 participants aged between 18 and 79. Complete information on the exposure (education) and outcome (nutrition) variables was available for 6,767 persons. The associations between 'education' and indices of 'sugar-rich food', 'fat-rich food', 'fruit-and-vegetable' and 'alcohol' intake were analysed separately for men and women using multivariate logistic regression analysis. Odds ratios (OR) of education level on nutrition outcomes were calculated and adjusted for age, region (former East/West Germany), occupation, income and other influencing factors such as physical activity indicators. Results: Men and women with only a primary education had a more frequent intake of sugar-rich and fat-rich foods and a less frequent intake of fruit and vegetables and alcohol than people with a tertiary education. 'Physical work activity' partly explained the associations between education and sugar-rich food intake. The interference with physical work activity was stronger among men than women. No significant associations between education and energy-dense food intake were observed in the retirement-age group of persons aged 65+ and among persons with low energy expenditure. Conclusions: In Germany, adults with a low level of education report that they consume energy-dense foods more frequently - and fruit and vegetables and alcohol less frequently - than adults with a high education level. High levels of physical work activity among adults with a low education level may partly explain why they consume more energy-dense foods.	[Finger, Jonas D.; Lampert, Thomas; Mensink, Gert B. M.] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway	Robert Koch Institute; University of Bergen	Finger, JD (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.	FingerJ@rki.de	Mensink, Gert B/B-2447-2009; Tylleskär, Thorkild/S-5529-2017	Mensink, Gert B/0000-0001-6268-5998; Tylleskär, Thorkild/0000-0003-4801-4324; Finger, Jonas David/0000-0003-3697-6649	German Federal Ministry of Health	German Federal Ministry of Health	The study was financed by the German Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Amine E, 2011, DIET NUTR PREV CHRON; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bellach B M, 1998, Gesundheitswesen, V60 Suppl 2, pS59; Blundell JE, 2003, P NUTR SOC, V62, P651, DOI 10.1079/PNS2003286; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; de Vries H, 2008, PREV MED, V46, P203, DOI 10.1016/j.ypmed.2007.08.005; Erkkila AT, 1999, EUR J CLIN NUTR, V53, P662, DOI 10.1038/sj.ejcn.1600829; FEHILY AM, 1984, AM J CLIN NUTR, V40, P827, DOI 10.1093/ajcn/40.4.827; Finger JD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1079; Fransson EIM, 2003, SCAND J PUBLIC HEALT, V31, P324, DOI 10.1080/14034940210165055; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Gillman MW, 2001, PREV MED, V32, P295, DOI 10.1006/pmed.2000.0812; Girois SB, 2001, AM J PUBLIC HEALTH, V91, P418, DOI 10.2105/AJPH.91.3.418; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Haftenberger M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-36; Hoffmeyer-Zlotnik J.H., 2003, ZUMA NACHRICHTEN, V27, P125; Howley ET, 2001, MED SCI SPORT EXER, V33, pS364, DOI 10.1097/00005768-200106001-00005; Hulshof KFAM, 2003, EUR J CLIN NUTR, V57, P128, DOI 10.1038/sj.ejcn.1601503; King NA, 1997, MED SCI SPORT EXER, V29, P1076, DOI 10.1097/00005768-199708000-00014; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Lallukka T, 2007, EUR J CLIN NUTR, V61, P701, DOI 10.1038/sj.ejcn.1602583; Lu N, 2002, J HEALTH CARE POOR U, V13, P241; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Marks GC, 2006, J NUTR, V136, P459, DOI 10.1093/jn/136.2.459; Martikainen P, 2003, SOC SCI MED, V56, P1397, DOI 10.1016/S0277-9536(02)00137-5; Mensink GBM, 2004, EUR J CLIN NUTR, V58, P1000, DOI 10.1038/sj.ejcn.1601923; Mishra G, 2011, EUROPEAN J CLIN NUTR, V56, P687; Mullie P, 2010, EUR J CLIN NUTR, V64, P231, DOI 10.1038/ejcn.2009.145; Murakami K, 2009, NUTR RES, V29, P164, DOI 10.1016/j.nutres.2009.02.002; OECD, 2011, OECD PROJ INC DISTR; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; Popkin BM, 1996, NEW ENGL J MED, V335, P716, DOI 10.1056/NEJM199609053351006; Schroedter JH, 2006, ZUMA METHODENBERICHT, V12, P1; SMITH AM, 1992, J EPIDEMIOL COMMUN H, V46, P409, DOI 10.1136/jech.46.4.409; Sternfeld B, 1999, PREV MED, V28, P313, DOI 10.1006/pmed.1998.0470; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; US Department of Health and Human Services & US Department of Agriculture, 2010, DIET GUID AM 2010; Van Domelen DR, 2011, AM J PREV MED, V41, P136, DOI 10.1016/j.amepre.2011.03.019	42	27	27	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78390	10.1371/journal.pone.0078390	http://dx.doi.org/10.1371/journal.pone.0078390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223150	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200042
J	Garzon-Ospina, D; Lopez, C; Cadavid, LF; Patarroyo, ME; Patarroyo, MA				Garzon-Ospina, Diego; Lopez, Carolina; Cadavid, Luis F.; Patarroyo, Manuel E.; Patarroyo, Manuel A.			Identification and Diversity of Killer Cell Ig-Like Receptors in Aotus vociferans, a New World Monkey	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; RAPID EVOLUTION; KIR GENES; MHC; RECOGNITION; DNA; RECOMBINATION; SUBSTITUTIONS; MECHANISM; EXPANSION	Previous BAC clone analysis of the Platyrrhini owl monkey KIRs have shown an unusual genetic structure in some loci. Therefore, cDNAs encoding KIR molecules from eleven Aotus vociferans monkeys were characterized here; ten putative KIR loci were found, some of which encoded atypical proteins such as KIR4DL and transcripts predicted to encode a D0+D1 configuration (AOTVOKIR2DL1*01v1) which appear to be unique in the Aotus genus. Furthermore, alternative splicing was found as a likely mechanism for producing activator receptors in A. vociferans species. KIR proteins from New World monkeys may be split into three new lineages according to domain by domain phylogenetic analysis. Although the A. vociferans KIR family displayed a high divergence among paralogous genes, individual loci were limited in their genetic polymorphism. Selection analysis showed that both constrained and rapid evolution may operate within the AvKIR family. The frequent alternative splicing (as a likely mechanism generating activator receptors), the presence of KIR4DL and KIR2DL1 (D0+D1) molecules and other data reported here suggest that the KIR family in Aotus has had a rapid evolution, independent from its Catarrhini counterparts.	[Garzon-Ospina, Diego; Lopez, Carolina; Patarroyo, Manuel E.; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Garzon-Ospina, Diego; Lopez, Carolina; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Cadavid, Luis F.] Univ Nacl Colombia, Inst Genet, Bogota, Colombia; [Cadavid, Luis F.] Univ Nacl Colombia, Dept Biol, Bogota, Colombia	Universidad del Rosario; Universidad Nacional de Colombia; Universidad Nacional de Colombia	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia.	mapatarr.fidic@gmail.com	Patarroyo, Manuel A/I-8046-2016; Garzón-Ospina, Diego/AFS-7704-2022; Garzón-Ospina, Diego/L-8585-2016; López-Santana, Carolina/L-8580-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017	Patarroyo, Manuel A/0000-0002-4751-2500; Garzón-Ospina, Diego/0000-0003-3829-6719; López-Santana, Carolina/0000-0003-1313-7607; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Cadavid, Luis F./0000-0002-6778-7958				Bimber BN, 2008, J IMMUNOL, V181, P6301, DOI 10.4049/jimmunol.181.9.6301; Boyington JC, 2002, MOL IMMUNOL, V38, P1007, DOI 10.1016/S0161-5890(02)00030-5; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; Cadavid LF, 2009, IMMUNOGENETICS, V61, P27, DOI 10.1007/s00251-008-0342-y; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Chwae YJ, 1999, IMMUNOL LETT, V68, P267, DOI 10.1016/S0165-2478(99)00062-0; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Goodridge JP, 2007, EUR J IMMUNOL, V37, P199, DOI 10.1002/eji.200636316; Guethlein LA, 2002, J IMMUNOL, V169, P220, DOI 10.4049/jimmunol.169.1.220; Guethlein LA, 2007, J IMMUNOL, V179, P491, DOI 10.4049/jimmunol.179.1.491; Hao L, 2005, GENE, V347, P149, DOI 10.1016/j.gene.2004.12.012; Hershberger KL, 2005, EUR J IMMUNOL, V35, P922, DOI 10.1002/eji.200425408; Hershberger KL, 2001, J IMMUNOL, V166, P4380, DOI 10.4049/jimmunol.166.7.4380; Hughes AL, 2002, MOL PHYLOGENET EVOL, V25, P330, DOI 10.1016/S1055-7903(02)00255-5; Isakov N, 1997, J LEUKOCYTE BIOL, V61, P6, DOI 10.1002/jlb.61.1.6; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mager DL, 2001, CURR BIOL, V11, P626, DOI 10.1016/S0960-9822(01)00148-8; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; Menezes AN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-248; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Palacios C, 2011, GENE, V474, P39, DOI 10.1016/j.gene.2010.12.006; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Rajalingam R, 2004, J IMMUNOL, V172, P356, DOI 10.4049/jimmunol.172.1.356; Rajalingam Raja, 2011, Korean J Hematol, V46, P216, DOI 10.5045/kjh.2011.46.4.216; Robinson J, 2010, NUCLEIC ACIDS RES, V38, pD863, DOI 10.1093/nar/gkp879; Sambrook JG, 2005, GENOME RES, V15, P25, DOI 10.1101/gr.2381205; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	47	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79731	10.1371/journal.pone.0079731	http://dx.doi.org/10.1371/journal.pone.0079731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223188	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200081
J	Xu, JL; Yin, ZQ; Shen, H; Gao, W; Qian, YY; Pei, D; Liu, LX; Shu, YQ				Xu, Jiali; Yin, Zhiqiang; Shen, Hong; Gao, Wen; Qian, Yingying; Pei, Dong; Liu, Lingxiang; Shu, Yongqian			A Genetic Polymorphism in pre-miR-27a Confers Clinical Outcome of Non-Small Cell Lung Cancer in a Chinese Population	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ONCOGENIC MICRORNA-27A; METFORMIN; EXPRESSION; SURVIVAL; SUSCEPTIBILITY; CHEMOTHERAPY; METAANALYSIS; MECHANISM; IMPACT	Background: Recent evidence indicates that microRNAs (miRNAs) can function as tumor suppressors and oncogenes. Single nucleotide polymorphisms (SNPs) at miRNA genes can influence the maturation of miRNAs or miRNA-mediated transcriptional regulation. Our objective was to investigate the association of SNPs in deregulated miRNAs with clinical outcome in patients with non-small cell lung cancer (NSCLC) in a Chinese population. Methods: Deregulated miRNAs in NSCLC and their SNPs were identified through public databases. A single SNP, rs895819 in pre-miR-27a, was found suitable for selection. TaqMan assays were performed for genotyping and to assess the effect on the overall survival (OS) and chemotherapy response in 576 NSCLC patients. Results: Log-rank test and Cox regression analysis indicated that the G allele of rs895819 was associated with shorter survival and increased risk of death in NSCLC [dominant model: 22.0 vs. 46.0 months, P<0.001; adjusted hazard ratio (HR) = 1.71, 95% confidential interval (CI): 1.12-2.26]. Further stepwise regression analysis suggested that this SNP was an independently unfavorable factor for the prognosis of NSCLC and the effect remained significant in subgroup analysis stratified by clinical parameters and treatment status. Moreover, multivariate logistic regression analysis showed that the subjects with AG/GG genotypes of rs895819 had significantly decreased response rate to platinum-based chemotherapy compared to those with the AA genotype. Conclusion: Our results suggest that the pre-miR-27a rs895819 polymorphism may influence NSCLC patients' clinical outcome. Further large sample studies should be used to validate our findings.	[Xu, Jiali; Shen, Hong; Gao, Wen; Qian, Yingying; Pei, Dong; Liu, Lingxiang; Shu, Yongqian] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Yin, Zhiqiang] Nanjing Med Univ, Dept Dermatol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Shu, YQ (corresponding author), Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	shuyongqian@csco.org.cn	Liu, Lingxiang/I-7538-2016; Shu, Yongqian/ABD-5698-2021	Liu, Lingxiang/0000-0001-8689-1788; 	National Natural Science Foundation of China [81172140, 81272532]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (81172140, 81272532) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bahl A, 2001, BRIT J CANCER, V84, P1143, DOI 10.1054/bjoc.2000.1740; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guo ZJ, 2012, INT J CANCER, V131, P1318, DOI 10.1002/ijc.27352; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hatlen P, 2011, J THORAC ONCOL, V6, P1810, DOI 10.1097/JTO.0b013e31822a75be; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hong MJ, 2013, J THORAC ONCOL, V8, P703, DOI 10.1097/JTO.0b013e318288dc0a; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Huang LN, 2013, MOL BIOL REP, V40, P917, DOI 10.1007/s11033-012-2132-8; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jiang Y, 2013, INT J CANC; Kao S, 2012, NUCLEIC ACIDS RES, V40, pD972, DOI 10.1093/nar/gkr1183; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Shi DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046566; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Sun QM, 2009, ONCOL REP, V22, P563, DOI 10.3892/or_00000472; Sweeney C, 2003, CANCER EPIDEM BIOMAR, V12, P527; Tan BX, 2011, CANCER-AM CANCER SOC, V117, P5103, DOI 10.1002/cncr.26151; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Xu L, 2013, ANTICANCER AGENTS ME; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yang Q, 2012, ONCOGENE; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhang HW, 2010, DIGEST DIS SCI, V55, P2545, DOI 10.1007/s10620-009-1051-6; Zhong SL, 2013, MOL BIOL REP, V40, P3181, DOI 10.1007/s11033-012-2392-3; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhu LJ, 2012, DNA CELL BIOL, V31, P349, DOI 10.1089/dna.2011.1348	56	19	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79135	10.1371/journal.pone.0079135	http://dx.doi.org/10.1371/journal.pone.0079135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223174	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200066
J	Lee, DE; Kim, SY; Lim, JH; Park, SY; Ryu, HM				Lee, Da Eun; Kim, Shin Young; Lim, Ji Hyae; Park, So Yeon; Ryu, Hyun Mee			Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma	PLOS ONE			English	Article							CELL-FREE DNA; FETAL DNA; SERUM; DIAGNOSIS; ORIGIN; MASPIN; WOMEN; GENE	Background: Quantification of cell-free fetal DNA by methylation-based DNA discrimination has been used in non-invasive prenatal testing of fetal chromosomal aneuploidy. The maspin (Serpin peptidase inhibitor, clade B (ovalbumin), member 5; SERPINB5) gene, located on chromosome 18q21.33, is hypomethylated in the placenta and completely methylated in maternal blood cells. The objective of this study was to evaluate the accuracy of non-invasive detection of fetal trisomy 18 using the unmethylated-maspin (U-maspin) gene as a cell-free fetal DNA marker and the methylated-maspin (M-maspin) gene as a cell-free total DNA marker in the first trimester of pregnancy. Methodology/Principal Findings: A nested case-control study was conducted using maternal plasma collected from 66 pregnant women, 11 carrying fetuses with trisomy 18 and 55 carrying normal fetuses. Median U-maspin concentrations were significantly elevated in women with trisomy 18 fetuses compared with controls (27.2 vs. 6.7 copies/mL; P<0.001). Median M-maspin concentrations were also significantly higher in women with trisomy 18 fetuses than in controls (96.9 vs. 19.5 copies/mL, P<0.001). The specificities of U-maspin and M-maspin concentrations for non-invasive fetal trisomy 18 detection were 96.4% and 74.5%, respectively, with a sensitivity of 90.9%. Conclusions: Our results suggest that U-maspin and M-maspin concentrations may be useful as potential biomarkers for non-invasive detection of fetal trisomy 18 in the first trimester of pregnancy, irrespective of the sex and genetic variations of the fetus.	[Lee, Da Eun; Kim, Shin Young; Lim, Ji Hyae; Park, So Yeon; Ryu, Hyun Mee] Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea; [Lee, Da Eun; Kim, Shin Young; Lim, Ji Hyae; Park, So Yeon; Ryu, Hyun Mee] Womens Healthcare Ctr, Seoul, South Korea; [Ryu, Hyun Mee] Cheil Gen Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Ryu, Hyun Mee] Kwandong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea	Catholic Kwandong University	Ryu, HM (corresponding author), Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea.	hmryu@yahoo.com	Lim, Ji Hyae/N-4634-2013	Lim, Ji Hyae/0000-0002-1105-7235	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111550]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This project was supported by the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Bianchi DW, 2012, OBSTET GYNECOLOGY, V119, P1; Brojer E, 2005, TRANSFUSION, V45, P1473, DOI 10.1111/j.1537-2995.2005.00559.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cereda A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-81; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dokras A, 2002, PLACENTA, V23, P274, DOI 10.1053/plac.2001.0784; Farina A, 2005, AM J OBSTET GYNECOL, V193, P421, DOI 10.1016/j.ajog.2004.12.023; Herman JG, 1996, CANCER RES, V56, P722; Leung TN, 2001, CLIN CHEM, V47, P137; Lim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056787; Lim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027709; Lim JH, 2011, J ASSIST REPROD GEN, V28, P167, DOI 10.1007/s10815-010-9489-1; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 2012, ANNU REV GENOM HUM G, V13, P285, DOI 10.1146/annurev-genom-090711-163806; Lui YNYN, 2002, CLIN CHEM, V48, P421; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; PALOMAKI GE, 1995, PRENATAL DIAG, V15, P713, DOI 10.1002/pd.1970150806; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Spencer K, 2003, PRENATAL DIAG, V23, P580, DOI 10.1002/pd.647; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tsui DWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015069; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273; Zhong XY, 2006, PRENATAL DIAG, V26, P1272, DOI 10.1002/pd	27	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78136	10.1371/journal.pone.0078136	http://dx.doi.org/10.1371/journal.pone.0078136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223769	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300025
J	Slodka, A; Wiktorska, M; Brzezinska-Blaszczyk, E				Slodka, Aleksandra; Wiktorska, Magdalena; Brzezinska-Blaszczyk, Ewa			IgE by Itself Affects Mature Rat Mast Cell Preformed and De Novo-Synthesized Mediator Release and Amplifies Mast Cell Migratory Response	PLOS ONE			English	Article							FC-EPSILON-RI; SERUM IGE; HISTAMINE SYNTHESIS; IMMUNOGLOBULIN-E; SURVIVAL; ACTIVATION; MECHANISMS; ELEVATION; PATHWAYS; ANTIGEN	Background: findings have revealed that IgE by itself may regulate various aspects of mast cell biology, however, detailed data is still limited. Methodology/Findings: Here, we have examined the influence of IgE alone, used at different concentrations, on mast cell activity and releasability. For the study we have employed in vivo differentiated mature tissue mast cells isolated from rat peritoneal cavity. Mast cells were exposed to IgE alone and then the release of preformed and de novo-synthesized mediators, surface Fc epsilon RI expression and mast cell migratory response were assessed. IgE by itself was found to up-regulate FceRI expression and activate mast cells to degranulation, as well as de novo synthesis and release of cysteinyl leukotrienes and TNF. We have provided evidence that IgE alone also amplified spontaneous and CCL5- or TNF-induced migration of mast cells. Importantly, IgE was effective only at concentrations >= 3 mu g/mL. A molecular basis investigation using an array of specific inhibitors showed that Src kinases, PLC/PLA(2), MAP kinases (ERK and p38) and PI3K were entirely or partially involved in IgE-induced mast cell response. Furthermore, IgE alone stimulated the phosphorylation of MAP kinases and PI3K in rat mast cells. Conclusion: Our results clearly demonstrated that IgE by itself, at higher concentrations, influences mast cell activity and releasability. As there are different conditions when the IgE level is raised it might be supposed that in vivo IgE is one of the important factors modulating mast cell biology within tissues.	[Slodka, Aleksandra; Brzezinska-Blaszczyk, Ewa] Med Univ Lodz, Dept Expt Immunol, Lodz, Poland; [Wiktorska, Magdalena] Med Univ Lodz, Dept Mol & Med Biophys, Lodz, Poland	Medical University Lodz; Medical University Lodz	Brzezinska-Blaszczyk, E (corresponding author), Med Univ Lodz, Dept Expt Immunol, Lodz, Poland.	ewab@csk.umed.lodz.pl		Slodka, Aleksandra/0000-0002-9598-2347; Brzezinska-Blaszczyk, Ewa/0000-0002-1466-4321; Wiktorska, Magdalena/0000-0001-7346-0380	Medical University of Lodz [502-03/6-164-01/502-64-037]	Medical University of Lodz	This work was supported by grant number 502-03/6-164-01/502-64-037, funded by the Medical University of Lodz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; BORISH L, 1993, J ALLERGY CLIN IMMUN, V92, P123, DOI 10.1016/0091-6749(93)90046-I; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; Brzezinska-Blaszczyk E, 2007, J INTERF CYTOK RES, V27, P911, DOI 10.1089/jir.2006.0158; CHANG C C, 1991, Pediatric Asthma Allergy and Immunology, V5, P253, DOI 10.1089/pai.1991.5.253; Cruse G, 2005, EUR RESPIR J, V25, P858, DOI 10.1183/09031936.05.00091704; Cruse G, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-2; Ellis Anne K, 2009, Allergy Asthma Clin Immunol, V5, P12, DOI 10.1186/1710-1492-5-12; Freeman AF, 2008, IMMUNOL ALLERGY CLIN, V28, P277, DOI 10.1016/j.iac.2008.01.005; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Heimall J, 2010, CLIN REV ALLERG IMMU, V38, P32, DOI 10.1007/s12016-009-8134-1; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Ishizuka T, 2001, J IMMUNOL, V167, P2298, DOI 10.4049/jimmunol.167.4.2298; Iwata Y, 2008, ARCH DERMATOL, V144, P41, DOI 10.1001/archdermatol.2007.9; Juremalm M, 2002, BIOCHEM BIOPH RES CO, V297, P480, DOI 10.1016/S0006-291X(02)02244-1; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kitaura J, 2005, BLOOD, V105, P3222, DOI 10.1182/blood-2004-11-4205; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kohno M, 2005, BLOOD, V105, P2059, DOI 10.1182/blood-2004-07-2639; Koutsonikolis A, 1997, ANN ALLERG ASTHMA IM, V78, P27, DOI 10.1016/S1081-1206(10)63366-2; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubo S, 2001, J IMMUNOL, V167, P3427, DOI 10.4049/jimmunol.167.6.3427; Lam V, 2003, BLOOD, V102, P1405, DOI 10.1182/blood-2002-10-3176; Marone G, 2000, CRIT REV IMMUNOL, V20, P477; Matsuda K, 2005, J ALLERGY CLIN IMMUN, V116, P1357, DOI 10.1016/j.jaci.2005.08.042; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Misiak-Tloczek A, 2009, APMIS, V117, P558, DOI 10.1111/j.1600-0463.2009.02518.x; Neuber K, 1996, DERMATOLOGY, V192, P110, DOI 10.1159/000246332; Ovcina-Kurtovic Nermina, 2010, Med Arh, V64, P28; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023; Roth K, 2008, ARCH IMMUNOL THER EX, V56, P385, DOI 10.1007/s00005-008-0041-2; Schuerwegh AJM, 2010, P NATL ACAD SCI USA, V107, P2586, DOI 10.1073/pnas.0913054107; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Suurmond J, 2011, ANN RHEUM DIS, V70, pI55, DOI 10.1136/ard.2010.138032; Tanaka S, 2002, J EXP MED, V196, P229, DOI 10.1084/jem.20012037; Tanaka S, 2005, EUR J IMMUNOL, V35, P460, DOI 10.1002/eji.200425622; Vasudev M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032556; Watanabe N, 2005, TRENDS PARASITOL, V21, P175, DOI 10.1016/j.pt.2005.02.010; Weller CL, 2011, CLIN SCI, V120, P473, DOI 10.1042/CS20100459; Wierzbicki M, 2009, MICROBIOL IMMUNOL, V53, P694, DOI 10.1111/j.1348-0421.2009.00174.x; WRIGHT DN, 1990, J ALLERGY CLIN IMMUN, V85, P445, DOI 10.1016/0091-6749(90)90154-V; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Zar HJ, 2002, PEDIATR ALLERGY IMMU, V13, P328, DOI 10.1034/j.1399-3038.2002.02019.x	45	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79286	10.1371/journal.pone.0079286	http://dx.doi.org/10.1371/journal.pone.0079286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205379	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500148
J	Liao, BL; Wang, ZH; Lin, SW; Xu, Y; Yi, JQ; Xu, M; Huang, ZX; Zhou, Y; Zhang, FC; Hou, JL				Liao, Baolin; Wang, Zhanhui; Lin, Siwei; Xu, Ying; Yi, Junqing; Xu, Min; Huang, Zuxiong; Zhou, Ying; Zhang, Fuchun; Hou, Jinlin			Significant Fibrosis Is Not Rare in Chinese Chronic Hepatitis B Patients with Persistent Normal ALT	PLOS ONE			English	Article							HBV-DNA LEVELS; ALANINE AMINOTRANSFERASE LEVELS; VIRUS-INFECTION; LIVER HISTOLOGY; CARRIERS; ANTIGEN; DISEASE; LAMIVUDINE; BIOPSY; GENOTYPE	Background: Limited studies have been done on chronic hepatitis B (CHB) patients defined according to the latest Asian-Pacific Association for the Study of the Liver guideline with liver histology by a large sample size. Methods: We retrospectively evaluated liver histological characteristics on a cohort of consecutive treatment-naive CHB patients with persistent normal alanine aminotransferase (PNALT) or elevated ALT from May 2005 to October 2011. Histological assessment was based on the Metavir scoring system, significant abnormality was defined as necroinflammation grade >= A2 and/or fibrosis stage >= F2. Results: A total of 675 CHB patients were recruited, including 516 HBeAg-positive and 159 HBeAg-negative patients. In HBeAg-positive patients, significant fibrosis was found 49.4% (42/85) in PNALT, 69.8% (88/126) in ALT 1-2xupper limit normal (ULN) and 81.6% (249/305) in ALT>2xULN group, respectively. In HBeAg-negative patients, significant fibrosis was found 30.9% (17/55) in PNALT, 73.3% (33/45) in ALT 1-2xULN and 94.9% (56/59) in ALT>2xULN group, respectively. HBeAg-positive patients with PNALT over 30 years old had a higher frequency of significant fibrosis than those under 30 years old (87.5% vs. 45.5%, P = 0.058). Multivariate logistic regression analysis indicated increasing age (P = 0.012), higher aspartate aminotransferase (AST) (P < 0.001) and lower HBV DNA (P < 0.001) were associated with significant necroinflammation, while higher AST (P < 0.001), lower albumin (P = 0.027) and HBV DNA (P = 0.004) were associated with significant fibrosis in HBeAg-positive patients with elevated ALT. Higher AST was associated with significant necroinflammation in HBeAg-negative patients with elevated ALT (P = 0.009). Conclusions: Significant fibrosis is not rare in Chinese CHB patients with PNALT, especially HBeAg-positive patients over 30 years old.	[Liao, Baolin; Wang, Zhanhui; Xu, Ying; Huang, Zuxiong; Hou, Jinlin] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China; [Liao, Baolin; Wang, Zhanhui; Xu, Ying; Huang, Zuxiong; Hou, Jinlin] Southern Med Univ, Nanfang Hosp, Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Liao, Baolin; Yi, Junqing; Xu, Min; Zhou, Ying; Zhang, Fuchun] Guangzhou Med Univ, Dept Hepatol, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China; [Lin, Siwei] Yuexiu Dist Tradit Chinese Med Hosp, Dept Internal Med 3, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou Medical University	Zhang, FC (corresponding author), Guangzhou Med Univ, Dept Hepatol, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.	gz8hzfc@126.com; jlhousmu@163.com	Shen, Jianzhong/AAH-8184-2019		National Science and Technology Major Project of China [2012ZX10002003]	National Science and Technology Major Project of China	This study was supported by grants from National Science and Technology Major Project of China (2012ZX10002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Assy N, 2009, WORLD J GASTROENTERO, V15, P3025, DOI 10.3748/wjg.15.3025; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Chan HLY, 2002, AM J GASTROENTEROL, V97, P406; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Fung J, 2011, HEPATOL INT, V5, P868, DOI 10.1007/s12072-011-9288-5; Han KH, 2008, HEPATOL INT, V2, P185, DOI 10.1007/s12072-008-9068-z; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Lesmana CRA, 2011, J DIGEST DIS, V12, P476, DOI 10.1111/j.1751-2980.2011.00540.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mani H, 2009, HEPATOLOGY, V49, pS61, DOI 10.1002/hep.22930; Martinot-Peignoux M, 2002, J HEPATOL, V36, P543, DOI 10.1016/S0168-8278(02)00004-1; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2008, HEPATOLOGY, V48, P1451, DOI 10.1002/hep.22518; Papatheodoridis GV, 2012, J HEPATOL, V57, P196, DOI 10.1016/j.jhep.2011.11.030; Park JY, 2008, J VIRAL HEPATITIS, V15, P615, DOI 10.1111/j.1365-2893.2008.00989.x; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; Shao J, 2007, WORLD J GASTROENTERO, V13, P2104, DOI 10.3748/wjg.v13.i14.2104; Tai DI, 2009, HEPATOLOGY, V49, P1859, DOI 10.1002/hep.22878; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Wong GLH, 2009, CLIN GASTROENTEROL H, V7, P227, DOI 10.1016/j.cgh.2008.10.023; Wong GLH, 2008, AM J GASTROENTEROL, V103, P3071, DOI 10.1111/j.1572-0241.2008.02157.x; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zacharakis G, 2008, J HEPATOL, V49, P884, DOI 10.1016/j.jhep.2008.06.009; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	39	43	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78672	10.1371/journal.pone.0078672	http://dx.doi.org/10.1371/journal.pone.0078672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205292	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400096
J	Marson, KG; Tapia, K; Kohler, P; McGrath, CJ; John-Stewart, GC; Richardson, BA; Njoroge, JW; Kiarie, JN; Sakr, SR; Chung, MH				Marson, Kara G.; Tapia, Kenneth; Kohler, Pamela; McGrath, Christine J.; John-Stewart, Grace C.; Richardson, Barbra A.; Njoroge, Julia W.; Kiarie, James N.; Sakr, Samah R.; Chung, Michael H.			Male, Mobile, and Moneyed: Loss to Follow-Up vs. Transfer of Care in an Urban African Antiretroviral Treatment Clinic	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; THERAPY PROGRAMS; PUBLIC-SECTOR; RETROSPECTIVE ANALYSIS; MORTALITY; MALAWI; RETENTION	Objectives: The purpose of this study was to analyze characteristics, reasons for transferring, and reasons for discontinuing care among patients defined as lost to follow-up (LTFU) from an antiretroviral therapy (ART) clinic in Nairobi, Kenya. Design: The study used a prospective cohort of patients who participated in a randomized, controlled ART adherence trial between 2006 and 2008. Methods: Participants were followed from pre-ART clinic enrollment to 18 months after ART initiation, and were defined as LTFU if they failed to return to clinic 4 weeks after their last scheduled visit. Reasons for loss were captured through phone call or home visit. Characteristics of LTFU who transferred care and LTFU who did not transfer were compared to those who remained in clinic using log-binomial regression to estimate risk ratios. Results: Of 393 enrolled participants, total attrition was 83 (21%), of whom 75 (90%) were successfully traced. Thirty-seven (49%) were alive at tracing and 22 (59%) of these reported having transferred their antiretroviral care. In the final model, transfers were more likely to have salaried employment [Risk Ratio (RR), 2.7; 95% confidence interval (CI), 1.2-6.1; p=0.020)] and pay a higher monthly rent (RR, 5.8; 95% CI, 1.3-25.0; p=0.018) compared to those retained in clinic. LTFU who did not transfer care were three times as likely to be men (RR, 3.1; 95% CI, 1.1-8.1; p=0.028) and nearly 4 times as likely to have a primary education or less (RR, 3.8; 95% CI, 1.3-10.6; p=0.013). Overall, the most common reason for LTFU was moving residence, predominantly due to job loss or change in employment. Conclusion: A broad definition of LTFU may include those who have transferred their antiretroviral care and thereby overestimate negative effects on ART continuation. Interventions targeting men and considering mobility due to employment may improve retention in urban African ART clinics.	[Marson, Kara G.; Tapia, Kenneth; Kohler, Pamela; McGrath, Christine J.; John-Stewart, Grace C.; Njoroge, Julia W.; Chung, Michael H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Med, Seattle, WA USA; [John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Richardson, Barbra A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Kiarie, James N.] Univ Nairobi, Nairobi, Kenya; [Sakr, Samah R.] Copt Hosp, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Nairobi	Marson, KG (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	marsonk@uw.edu	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019; Kohler, Pamela/GYE-0155-2022	Kohler, Pamela/0000-0001-6176-6374; John-Stewart, Grace/0000-0002-4301-1573; kiarie, james/0000-0003-4180-7858	K23 grant from the National Institutes of Health [K23AI065222-04]; University of Washington Center for AIDS Research (CFAR), an NIH [P30 AI027757]; NIAID; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; President's Emergency Plan for AIDS Relief (PEPFAR) from the US Centers for Disease Control and Prevention (CDC) [U62/CCU024512-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065222, P30AI027757] Funding Source: NIH RePORTER	K23 grant from the National Institutes of Health; University of Washington Center for AIDS Research (CFAR), an NIH; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); President's Emergency Plan for AIDS Relief (PEPFAR) from the US Centers for Disease Control and Prevention (CDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a K23 grant from the National Institutes of Health (K23AI065222-04) and the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA). The Coptic Hope Center for Infectious Diseases is supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through a cooperative agreement (U62/CCU024512-04) from the US Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Ahonkhai AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032993; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bajunirwe Francis, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P139, DOI 10.1177/1545109709332470; Balcha Taye T, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P119, DOI 10.1177/1545109710387674; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bigsten A, 1996, J Afr Econ, V5, P1, DOI 10.1093/oxfordjournals.jae.a020893; Brennan AT, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-49; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Chung MH, 2010, JAIDS-J ACQ IMM DEF, V53, P422, DOI 10.1097/QAI.0b013e3181b32bd6; Dahab M, 2011, AIDS PATIENT CARE ST, V25, P53, DOI 10.1089/apc.2010.0140; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gerver SM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-29; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Myer L, 2004, SAMJ S AFR MED J, V94, P273; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Ogutu Z A, 1993, GeoJournal, V30, P409, DOI 10.1007/BF00807222; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Program NASC, 2011, GUID ANT THER KEN; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Pyne-Mercier LD, 2011, AIDS CARE, V23, P562, DOI 10.1080/09540121.2010.525615; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2010, TROP MED INT HEALTH, V15, P98, DOI 10.1111/j.1365-3156.2010.02512.x; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Scuteri A, 2009, NUTR METAB CARDIOVAS, V19, P532, DOI 10.1016/j.numecd.2008.11.004; Tayler-Smith K, 2011, TROP MED INT HEALTH, V16, P579, DOI 10.1111/j.1365-3156.2011.02740.x; Todaro MP, 1996, INT LABOUR REV, V135, P421; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	46	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78900	10.1371/journal.pone.0078900	http://dx.doi.org/10.1371/journal.pone.0078900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205345	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300085
J	Zulian, A; Cancello, R; Ruocco, C; Gentilini, D; Di Blasio, AM; Danelli, P; Micheletto, G; Cesana, E; Invitti, C				Zulian, Alessandra; Cancello, Raffaella; Ruocco, Chiara; Gentilini, Davide; Di Blasio, Anna Maria; Danelli, Piergiorgio; Micheletto, Giancarlo; Cesana, Elisabetta; Invitti, Cecilia			Differences in Visceral Fat and Fat Bacterial Colonization between Ulcerative Colitis and Crohn's Disease. An In Vivo and In Vitro Study	PLOS ONE			English	Article							ADIPOSE-TISSUE; TRANSLOCATION; OBESITY	Crohn's disease (CD) is notably characterized by the expansion of visceral fat with small adipocytes expressing a high proportion of anti-inflammatory genes. Conversely, visceral fat depots in ulcerative colitis (UC) patients have never been characterized. Our study aims were a) to compare adipocyte morphology and gene expression profile and bacterial translocation in omental (OM) and mesenteric (MES) adipose tissue of patients with UC and CD, and b) to investigate the effect of bacterial infection on adipocyte proliferation in vitro. Specimens of OM and MES were collected from 11 UC and 11 CD patients, processed and examined by light microscopy. Gene expression profiles were evaluated in adipocytes isolated from visceral adipose tissue using microarray and RTqPCR validations. Bacteria within adipose tissue were immuno-detected by confocal scanning laser microscopy. Adipocytes were incubated with Enterococcus faecalis and cells counted after 24h. Morphology and molecular profile of OM and MES revealed that UC adipose tissue is less inflamed than CD adipose tissue. Genes linked to inflammation, bacterial response, chemotaxis and angiogenesis were down-regulated in adipocytes from UC compared to CD, whereas genes related to metallothioneins, apoptosis pathways and growth factor binding were up-regulated. A dense perinuclear positivity for Enterococcus faecalis was detected in visceral adipocytes from CD, whereas positivity was weak in UC. In vitro bacterial infection was associated with a five-fold increase in the proliferation rate of OM preadipocytes. Compared to UC, visceral adipose tissue from CD is more inflamed and more colonized by intestinal bacteria, which increase adipocyte proliferation. The influence of bacteria stored within adipocytes on the clinical course of IBD warrants further investigations.	[Zulian, Alessandra; Ruocco, Chiara] Ist Auxol Italiano, Diabet Res Lab, Milan, Italy; [Cancello, Raffaella; Gentilini, Davide; Di Blasio, Anna Maria] Ist Auxol Italiano, Mol Biol Lab, Milan, Italy; [Danelli, Piergiorgio] Univ Milan, Luigi Sacco Hosp, Dept Clin Sci, Milan, Italy; [Micheletto, Giancarlo] Univ Milan, Dept Med & Surg Pathophysiol & Transplants, Milan, Italy; [Cesana, Elisabetta] Ist Auxol Italiano, Microbiol Lab, Milan, Italy; [Invitti, Cecilia] Ist Auxol Italiano, Dept Med Sci & Rehabil, Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Invitti, C (corresponding author), Ist Auxol Italiano, Dept Med Sci & Rehabil, Milan, Italy.	invitti@auxologico.it	Gentilini, Davide/AAB-2567-2019; Danelli, Piergiorgio/AAB-1698-2021; Danelli, Piergiorgio/R-5992-2017	Danelli, Piergiorgio/0000-0003-1461-9835; Danelli, Piergiorgio/0000-0003-1461-9835; Gentilini, Davide/0000-0002-8391-0725; Ruocco, Chiara/0000-0002-6544-2067; micheletto, giancarlo/0000-0003-3687-1126	Istituto Auxologico Italiano	Istituto Auxologico Italiano	This study was supported by Istituto Auxologico Italiano. Istituto Auxologico Italiano, funder of this study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Bamias G, 2011, CLIN GASTROENT-SER, P41, DOI 10.1007/978-1-60327-433-3_4; Bechah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008547; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Goossens GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039930; Goossens H, 1999, CURR OPIN INFECT DIS, V12, P537, DOI 10.1097/00001432-199912000-00002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Khan KJ, 2011, AM J GASTROENTEROL, V106, P661, DOI 10.1038/ajg.2011.72; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Zulian A, 2012, GUT, V61, P86, DOI 10.1136/gutjnl-2011-300391	15	40	42	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78495	10.1371/journal.pone.0078495	http://dx.doi.org/10.1371/journal.pone.0078495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205244	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300064
J	Bee, C; Abdiche, YN; Pons, J; Rajpal, A				Bee, Christine; Abdiche, Yasmina N.; Pons, Jaume; Rajpal, Arvind			Determining the Binding Affinity of Therapeutic Monoclonal Antibodies towards Their Native Unpurified Antigens in Human Serum	PLOS ONE			English	Article							PROTEIN; EQUILIBRIUM; PROGRANULIN; CHOLESTEROL	Monoclonal antibodies (mAbs) are a growing segment of therapeutics, yet their in vitro characterization remains challenging. While it is essential that a therapeutic mAb recognizes the native, physiologically occurring epitope, the generation and selection of mAbs often rely on the use of purified recombinant versions of the antigen that may display non-native epitopes. Here, we present a method to measure both, the binding affinity of a therapeutic mAb towards its native unpurified antigen in human serum, and the antigen's endogenous concentration, by combining the kinetic exclusion assay and Biacore's calibration free concentration analysis. To illustrate the broad utility of our method, we studied a panel of mAbs raised against three disparate soluble antigens that are abundant in the serum of healthy donors: proprotein convertase subtilisin/kexin type 9 (PCSK9), progranulin (PGRN), and fatty acid binding protein (FABP4). We also determined the affinity of each mAb towards its purified recombinant antigen and assessed whether the interactions were pH-dependent. Of the six mAbs studied, three did not appear to discriminate between the serum and recombinant forms of the antigen; one mAb bound serum antigen with a higher affinity than recombinant antigen; and two mAbs displayed a different affinity for serum antigen that could be explained by a pH-dependent interaction. Our results highlight the importance of taking pH into account when measuring the affinities of mAbs towards their serum antigens, since the pH of serum samples becomes increasingly alkaline upon aerobic handling.	[Bee, Christine; Abdiche, Yasmina N.; Pons, Jaume; Rajpal, Arvind] Pfizer Inc, Rinat, San Francisco, CA USA	Pfizer	Abdiche, YN (corresponding author), Pfizer Inc, Rinat, San Francisco, CA USA.	Yasmina.Abdiche@pfizer.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	All research was funded by Pfizer Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2011, ANAL BIOCHEM, V411, P139, DOI 10.1016/j.ab.2010.12.020; Bee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036261; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Cui Q, 2010, ATHEROSCLEROSIS, V213, P632, DOI 10.1016/j.atherosclerosis.2010.09.027; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Day YSN, 2002, PROTEIN SCI, V11, P1017, DOI 10.1110/ps.4330102; Drake AW, 2012, ANAL BIOCHEM, V429, P58, DOI 10.1016/j.ab.2012.06.024; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Myszka D G, 2003, J Biomol Tech, V14, P247; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Rathanaswami P, 2011, ANAL BIOCHEM, V414, P7, DOI 10.1016/j.ab.2011.02.034; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; Tkaczuk KR, 2011, BREAST CANCER-BASIC, V5, P155, DOI 10.4137/BCBCR.S7224	15	22	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80501	10.1371/journal.pone.0080501	http://dx.doi.org/10.1371/journal.pone.0080501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223227	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200120
J	Gustafsson, K; Aronsson, G; Marklund, S; Wikman, A; Floderus, B				Gustafsson, Klas; Aronsson, Gunnar; Marklund, Staffan; Wikman, Anders; Floderus, Birgitta			Does Social Isolation and Low Societal Participation Predict Disability Pension? A Population Based Study	PLOS ONE			English	Article							SELF-RATED HEALTH; FOLLOW-UP; MENTAL-DISORDERS; JOB STRAIN; DEPRESSION; WOMEN; RISK; DETERMINANTS; UNEMPLOYMENT; LONELINESS	Purpose: The aim was to examine the potential influence of social isolation and low societal participation on the future risk of receiving disability pension among individuals in Sweden. A specific aim was to describe differences depending on disability pension diagnoses, and how the results were modified by sex and age. Method: The study comprised representative samples of Swedish women and men, who had been interviewed in any of the annual Swedish Surveys of Living Conditions between 1990 and 2007. Information on disability pension and diagnoses was added from the Swedish Social Insurance Agency's database (1991-2011). The mean number of years of follow-up for the 53920 women and men was twelve years (SD 5.5), and the study base was restricted to the ages 20 to 64 years of age. The predictors were related to disability pension by Cox's proportional hazards regression. Results: Social isolation and low societal participation were associated with future disability pension also after control for age, year of interview, socio demographic conditions and self reported longstanding illness. Lone individuals were at increased risk of disability pension, and the effect of living without children was modified by sex and age. An increase in risk was particularly noticeable among younger women who reported that they had sparse contacts with others, and no close friend. Both women and men who reported that they did not participate in political discussions and who could not appeal on a decision by a public authority were also at increased risk. The effects of social isolation were mainly attributed to disability pension with mental diagnoses, and to younger individuals. Conclusions: The study suggests that social isolation and low societal participation are predictors of future disability pension. Social isolation and low societal participation increased particularly the risk of future disability pension in mental diagnoses among younger individuals.	[Gustafsson, Klas; Marklund, Staffan; Wikman, Anders; Floderus, Birgitta] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Aronsson, Gunnar] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Gustafsson, K (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden.	klas.gustafsson@ki.se	Aronsson, Gunnar/ABE-7189-2020; Aronsson, Gunnar/ABF-3405-2020	Aronsson, Gunnar/0000-0003-3664-1814	Swedish Council for Working Life and Social research, Sweden [2012-0664]	Swedish Council for Working Life and Social research, Sweden(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The study was financed by the Swedish Council for Working Life and Social research, Sweden (Dnr: 2012-0664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen K, 2007, SCAND J PUBLIC HEALT, V35, P78, DOI 10.1080/14034940600858474; Benyamini Y, 2011, PSYCHOL HEALTH, V26, P1407, DOI 10.1080/08870446.2011.621703; Bjorngaard J. H., 2009, Norsk Epidemiologi, V19, P103; Brage S, 2007, SPINE, V32, P269, DOI 10.1097/01.brs.0000251883.20205.26; Canivet C, 2013, INT ARCH OCC ENV HEA, V86, P307, DOI 10.1007/s00420-012-0766-4; de Jong Gierveld J, 2004, CAN J AGING, V23, P109, DOI [10.1353/cja.2004.0021, DOI 10.1353/CJA.2004.0021.PUBMED:15334811]; Eden L, 1999, EXP AGING RES, V25, P471, DOI 10.1080/036107399243959; EU, 2010, HOUS STAT EUR UN 201; Floderus B, 2009, OCCUP ENVIRON MED, V66, P704, DOI 10.1136/oem.2008.044883; Floderus B, 2008, WOMEN HEALTH, V47, P63, DOI 10.1080/03630240802092308; Floderus B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000840; Gallie D, 2003, EUR SOC, V5, P1, DOI 10.1080/1461669032000057668; Gravseth HM, 2007, EUR J EPIDEMIOL, V22, P533, DOI 10.1007/s10654-007-9139-9; Gustafsson K, 2013, INT J BEHAV MED, DOI [10.1007/s12529-012-9287-5, DOI 10.1007/S12529-012-9287-5.PUBMED:23307701]; Haukenes I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-406; Hultin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035614; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kieselbach T, 2003, AM J COMMUN PSYCHOL, V32, P69, DOI 10.1023/A:1025694823396; Knudsen AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042567; Knudsen AK, 2010, J PSYCHOSOM RES, V69, P59, DOI 10.1016/j.jpsychores.2010.03.007; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Labriola Merete, 2007, Work, V29, P233; Mansson NO, 2001, EUR J EPIDEMIOL, V17, P65, DOI 10.1023/A:1010906402079; Mantyniemi A, 2012, OCCUP ENVIRON MED, V69, P574, DOI 10.1136/oemed-2011-100411; Mykletun A, 2006, AM J PSYCHIAT, V163, P1412, DOI 10.1176/appi.ajp.163.8.1412; Olsson Ingrid, 2006, Clin Pract Epidemiol Ment Health, V2, P21, DOI 10.1186/1745-0179-2-21; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Osterberg T, 2006, SOC SCI MED, V63, P805, DOI 10.1016/j.socscimed.2006.02.009; Overland S, 2007, PSYCHIAT SERV, V58, P1479, DOI 10.1176/appi.ps.58.11.1479; Rai D, 2012, J EPIDEMIOL COMMUN H, V66, P586, DOI 10.1136/jech.2010.119644; Reine I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-159; SCB, 2011, 120 SCB; SCB, 1980, 18 SCB; SCB, 1997, LIV COND IN SWED 20; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Sinokki M, 2010, J OCCUP ENVIRON MED, V52, P733, DOI 10.1097/JOM.0b013e3181e79525; Stattin M, 2005, OCCUP ENVIRON MED, V62, P135, DOI 10.1136/oem.2004.015669; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stordal E, 2003, SCAND J PRIM HEALTH, V21, P136, DOI 10.1080/02813430310002030; Swedish Social Insurance Agency, 2012, SOC INS FIG; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Thorlacius S, 2010, J MENT HEALTH, V19, P176, DOI 10.3109/09638230902968316; THORSLUND M, 1985, SOC INDIC RES, V16, P77, DOI 10.1007/BF00317661; Vogel J, 2003, 101 SCB; *WHO, 1997, INT STAT CLASS DIS R; WIKMAN A, 1990, SOC INDIC RES, V22, P199, DOI 10.1007/BF00354840; Wikman A, 2006, SOC INDIC RES, V78, P85, DOI 10.1007/s11205-005-5372-3	47	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80655	10.1371/journal.pone.0080655	http://dx.doi.org/10.1371/journal.pone.0080655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223229	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200122
J	Siami, S; Polito, A; Porcher, R; Hissem, T; Blanchard, A; Boucly, C; Carlier, R; Annane, D; Haymann, JP; Sharshar, T				Siami, Shidasp; Polito, Andrea; Porcher, Raphael; Hissem, Tarik; Blanchard, Anne; Boucly, Catherine; Carlier, Robert; Annane, Djillali; Haymann, Jean-Philippe; Sharshar, Tarek			Thirst Perception and Osmoregulation of Vasopressin Secretion Are Altered During Recovery From Septic Shock	PLOS ONE			English	Article							ANTIDIURETIC-HORMONE; RELEASE; PNEUMONIA; EXCRETION; FAILURE; NEURONS; HUMANS; BRAIN; SCORE; RATS	Objective: Vasopressin (AVP) secretion during an osmotic challenge is frequently altered in the immediate post-acute phase of septic shock. We sought to determine if this response is still altered in patients recovering from septic shock. Design: Prospective interventional study Setting: Intensive care unit (ICU) at Raymond Poincare and Etampes Hospitals. Patients: Normonatremic patients at least 5 days post discontinuation of catecholamines given for a septic shock. Intervention: Osmotic challenge involved infusing 500 mL of hypertonic saline solution (with cumulative amount of sodium not exceeding 24 g) over 120 minutes. Measurements and main results: Plasma AVP levels were measured 15 minutes before the infusion and then every 30 minutes for two hours. Non-responders were defined as those with a slope of the relation between AVP and plasma sodium levels less than < 0.5 ng/mEq. Among the 30 included patients, 18 (60%) were non-responders. Blood pressure and plasma sodium and brain natriuretic peptide levels were similar in both responders and non-responders during the course of the test. Critical illness severity, hemodynamic alteration, electrolyte disturbances, treatment and outcome did not differ between the two groups. Responders had more severe gas exchange abnormality. Thirst perception was significantly diminished in non-responders. The osmotic challenge was repeated in 4 non-responders several months after discharge and the abnormal response persisted. Conclusion: More than half of patients recovering from septic shock have an alteration of osmoregulation characterised by a dramatic decrease in vasopressin secretion and thirst perception during osmotic challenge. The mechanisms of this alteration but also of the relationship between haematosis and normal response remain to be elucidated.	[Siami, Shidasp; Hissem, Tarik] Sud Essonne Hosp, Dept Intens Care Med, Etampes, France; [Polito, Andrea; Annane, Djillali; Sharshar, Tarek] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Garches, France; [Porcher, Raphael] St Louis Teaching Hosp, Biostat & Med Comp Sci Dept, Paris, France; [Blanchard, Anne] Univ Paris 05, European Georges Pompidou Teaching Hosp, AP HP, Clin Invest Ctr, Paris, France; [Blanchard, Anne] INSERM, CIC9201, Paris, France; [Boucly, Catherine] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Dept Biochem, Garches, France; [Carlier, Robert] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Dept Radiol, Garches, France; [Haymann, Jean-Philippe] Univ Paris 06, Tenon Teaching Hosp, AP HP, Dept Funct Invest, Paris, France; [Haymann, Jean-Philippe] INSERM, U702, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sharshar, T (corresponding author), Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Garches, France.	tarek.sharshar@rpc.aphp.fr	Sharshar, Tarek/ABF-4117-2021; Annane, Djillali/R-7947-2019	BLANCHARD, Anne/0000-0002-0815-0586; Porcher, Raphael/0000-0002-5277-4679	Programme Hospitalier de Recherche Clinique [AOR 05047]	Programme Hospitalier de Recherche Clinique	The study was supported, in part, by Grant AOR 05047 from the Programme Hospitalier de Recherche Clinique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; [Anonymous], 2009, CHEST; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; BAERTSCHI AJ, 1981, J PHYSIOL-LONDON, V315, P217, DOI 10.1113/jphysiol.1981.sp013743; BAYLIS PH, 1987, AM J PHYSIOL, V253, pR671, DOI 10.1152/ajpregu.1987.253.5.R671; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; CAILLENS H, 1982, ANN PHARM FR, V40, P113; Carlson SH, 1997, AM J PHYSIOL-REG I, V272, pR750, DOI 10.1152/ajpregu.1997.272.3.R750; Darmon M, 2010, NEPHROL DIAL TRANSPL, V25, P2510, DOI 10.1093/ndt/gfq067; DREYFUSS D, 1988, AM REV RESPIR DIS, V138, P583, DOI 10.1164/ajrccm/138.3.583; Giltinan, 1995, MONOGRAPHS STAT APPL; Harrison-Bernard LM, 2009, ADV PHYSIOL EDUC, V33, P270, DOI 10.1152/advan.00049.2009; Hussy N, 1997, J PHYSIOL-LONDON, V502, P609, DOI 10.1111/j.1469-7793.1997.609bj.x; Ishikawa S, 1996, ENDOCR J, V43, P101, DOI 10.1507/endocrj.43.101; Landry DW, 1997, CIRCULATION, V95, P1122; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MCCABE WR, 1962, ARCH INTERN MED, V110, P845; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; PHILLIPS PA, 1985, AM J PHYSIOL, V248, pR645, DOI 10.1152/ajpregu.1985.248.6.R645; Pinheiro J, 2001, MIXED EFFECTS MODELS; PRUSZCZYNSKI W, 1984, CLIN SCI, V67, P307, DOI 10.1042/cs0670307; Richard D, 1996, J NEUROSCI, V16, P7526; ROSENOW EC, 1972, MAYO CLIN PROC, V47, P169; SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321, DOI 10.1152/ajprenal.1979.236.4.F321; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sharshar T, 2003, CRIT CARE MED, V31, P1752, DOI 10.1097/01.CCM.0000063046.82359.4A; Sharshar T, 2002, CRIT CARE MED, V30, P497, DOI 10.1097/00003246-200203000-00001; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Sharshar T, 2008, BEST PRACT RES-CLIN, V22, P265, DOI 10.1016/j.bpa.2008.02.005; Siami S, 2010, CRIT CARE MED, V38, P1962, DOI 10.1097/CCM.0b013e3181eb9acf; THIBONNIER M, 1984, KIDNEY INT, V25, P411, DOI 10.1038/ki.1984.32; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wilson Y, 2002, P NATL ACAD SCI USA, V99, P3252, DOI 10.1073/pnas.042701199	33	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80190	10.1371/journal.pone.0080190	http://dx.doi.org/10.1371/journal.pone.0080190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223220	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200113
J	Trombetta-eSilva, J; Eadie, EP; Zhang, YH; Norris, RA; Borg, TK; Bradshaw, AD				Trombetta-eSilva, Jessica; Eadie, Erik P.; Zhang, Yuhua; Norris, Russell A.; Borg, Thomas K.; Bradshaw, Amy D.			The Effects of Age and the Expression of SPARC on Extracellular Matrix Production by Cardiac Fibroblasts in 3-D Cultures	PLOS ONE			English	Article							FIBRILLAR COLLAGEN CONTENT; DIASTOLIC FUNCTION ROLE; CONNECTIVE-TISSUE; IN-VITRO; NETWORK; HEART; BIOLOGY; MUSCLE; TENDON	Fibrillar collagen is the primary component of the cardiac interstitial extracellular matrix. This extracellular matrix undergoes dramatic changes from birth to adulthood and then into advanced age. As evidence, fibrillar collagen content was compared in sections from neonates, adult, and old hearts and was found to increase at each respective age. Cardiac fibroblasts are the principle cell type that produce and control fibrillar collagen content. To determine whether fibroblast production, processing, and deposition of collagen differed with age, primary cardiac fibroblasts from neonate, adult, and old mice were isolated and cultured in 3-dimensional (3D) fibrin gels. Fibroblasts from each age aligned in fibrin gels along points of tension and deposited extracellular matrix. By confocal microscopy, wild-type neonate fibroblasts appeared to deposit less collagen into fibrillar structures than fibroblasts from adults. However, by immunoblot analysis, differences in procollagen production and processing of collagen I were not detected in neonate versus adult fibroblasts. In contrast, fibroblasts from old mice demonstrated increased efficiency of procollagen processing coupled with decreased production of total collagen. SPARC is a collagen-binding protein previously shown to affect cardiac collagen deposition. Accordingly, in the absence of SPARC, less collagen appeared to be associated with fibroblasts of each age grown in fibrin gels. In addition, the increased efficiency of procollagen alpha 1(I) processing in old wild-type fibroblasts was not detected in old SPARC-null fibroblasts. Increased levels of fibronectin were detected in wild-type neonate fibroblasts over that of adult and old fibroblasts but not in SPARC-null neonate fibroblasts versus older ages. Immunostaining of SPARC overlapped with that of collagen I but not to that of fibronectin in 3D cultures. Hence, whereas increases in procollagen processing, influenced by SPARC expression, plausibly contribute to increased collagen deposition in old hearts, other cellular mechanisms likely affect differential collagen deposition by neonate fibroblasts.	[Trombetta-eSilva, Jessica; Bradshaw, Amy D.] Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Eadie, Erik P.; Norris, Russell A.; Borg, Thomas K.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Zhang, Yuhua; Bradshaw, Amy D.] Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Bradshaw, Amy D.] Vet Affairs Med Ctr, Ralph H Johnson Dept, Charleston, SC 29403 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Bradshaw, AD (corresponding author), Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA.	bradshad@musc.edu			Research Service of the Department of Veterans Affairs [1I01BX001385-01A1]; National Heart, Lung, and Blood Institute [HL085847]; National Institute of Dental and Craniofacial Research [DE023009-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023009] Funding Source: NIH RePORTER	Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Research Service of the Department of Veterans Affairs (Dr. Bradshaw: 1I01BX001385-01A1) and grants from the National Heart, Lung, and Blood Institute (Dr. Borg: HL085847) and the National Institute of Dental and Craniofacial Research (Ms Trombetta-eSilva: DE023009-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; BORG TK, 1982, SCAN ELECTRON MICROS, P1775; BORG TK, 1982, AM J ANAT, V165, P435, DOI 10.1002/aja.1001650407; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; CAULFIELD JB, 1979, LAB INVEST, V40, P364; EGHBALI M, 1989, CARDIOVASC RES, V23, P723, DOI 10.1093/cvr/23.8.723; Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; Kalson NS, 2010, MATRIX BIOL, V29, P678, DOI 10.1016/j.matbio.2010.08.009; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; Moxham B J, 1995, Connect Tissue Res, V33, P31, DOI 10.3109/03008209509016978; Nehls V, 1998, CELL TISSUE RES, V293, P479, DOI 10.1007/s004410051140; Ngo P, 2006, METH MOL B, V341, P103; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Robinson PS, 2008, TISSUE ENG PT A, V14, P83, DOI 10.1089/ten.a.2007.0148; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341	22	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79715	10.1371/journal.pone.0079715	http://dx.doi.org/10.1371/journal.pone.0079715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223185	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200078
J	Xing, L; Niu, MJ; Zhao, X; Kleiman, L				Xing, Li; Niu, Meijuan; Zhao, Xia; Kleiman, Lawrence			Roles of the Linker Region of RNA Helicase A in HIV-1 RNA Metabolism	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TAT PROTEIN; VIRAL-RNA; IN-VITRO; BINDING; TRANSCRIPTION; REPLICATION; EXPRESSION; CELLS; REQUIREMENT	RNA helicase A (RHA) promotes multiple steps in HIV-1 production including transcription and translation of viral RNA, annealing of primer tRNA(Lys3) to viral RNA, and elevating the ratio of unspliced to spliced viral RNA. At its amino terminus are two double-stranded RNA binding domains (dsRBDs) that are essential for RHA-viral RNA interaction. Linking the dsRBDs to the core helicase domain is a linker region containing 6 predicted helices. Working in vitro with purified mutant RHAs containing deletions of individual helices reveals that this region may regulate the enzyme's helicase activity, since deletion of helix 2 or 3 reduces the rate of unwinding RNA by RHA. The biological significance of this finding was then examined during HIV-1 production. Deletions in the linker region do not significantly affect either RHA-HIV-1 RNA interaction in vivo or the incorporation of mutant RHAs into progeny virions. While the partial reduction in helicase activity of mutant RHA containing a deletion of helices 2 or 3 does not reduce the ability of RHA to stimulate viral RNA synthesis, the promotion of tRNA(Lys3) annealing to viral RNA is blocked. In contrast, deletion of helices 4 or 5 does not affect the ability of RHA to promote tRNA(Lys3) annealing, but reduces its ability to stimulate viral RNA synthesis. Additionally, RHA stimulation of viral RNA synthesis results in an increased ratio of unspliced to spliced viral RNA, and this increase is not inhibited by deletions in the linker region, nor is the pattern of splicing changed within the similar to 4.0 kb or similar to 1.8 kb HIV-1 RNA classes, suggesting that RHA's effect on suppressing splicing is confined mainly to the first 5'-splice donor site. Overall, the differential responses to the mutations in the linker region of RHA reveal that RHA participates in HIV-1 RNA metabolism by multiple distinct mechanisms.	[Xing, Li; Niu, Meijuan; Zhao, Xia; Kleiman, Lawrence] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Xing, Li; Niu, Meijuan; Zhao, Xia; Kleiman, Lawrence] Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ, Canada; [Xing, Li; Niu, Meijuan; Zhao, Xia; Kleiman, Lawrence] McGill Univ, Dept Med, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Xing, L (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.	xingli107@gmail.com; lawrence.kleiman@mcgill.ca	Xing, Li/ABH-3898-2020	Xing, Li/0000-0002-1405-3459	Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratani S, 2001, MOL CELL BIOL, V21, P4460, DOI 10.1128/MCB.21.14.4460-4469.2001; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; CACHIANES G, 1993, BIOTECHNIQUES, V15, P255; CHURCHER MJ, 1993, J MOL BIOL, V230, P90, DOI 10.1006/jmbi.1993.1128; Cordin O, 2012, RNA BIOL, P10; Das AT, 2011, J VIROL, V85, P9506, DOI 10.1128/JVI.00650-11; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; Fujii R, 2001, J BIOL CHEM, V276, P5445, DOI 10.1074/jbc.M006892200; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P2552, DOI 10.1093/nar/22.13.2552; Guo F, 2009, J VIROL, V83, P8099, DOI 10.1128/JVI.00488-09; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Jeang KT, 2006, NUCLEIC ACIDS RES, V34, P4198, DOI 10.1093/nar/gkl398; Kameoka M, 2002, J VIROL, V76, P3637, DOI 10.1128/JVI.76.8.3637-3645.2002; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Kuciak M, 2008, NUCLEIC ACIDS RES, V36, P3389, DOI 10.1093/nar/gkn177; LEE CG, 1992, J BIOL CHEM, V267, P4398; Li JZ, 1999, P NATL ACAD SCI USA, V96, P709, DOI 10.1073/pnas.96.2.709; Ma J, 2008, VIROLOGY, V375, P253, DOI 10.1016/j.virol.2008.01.025; Mandal D, 2010, J VIROL, V84, P12790, DOI 10.1128/JVI.01257-10; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; NEUMANN M, 1994, AIDS RES HUM RETROV, V10, P1531, DOI 10.1089/aid.1994.10.1531; Pham PL, 2006, MOL BIOTECHNOL, V34, P225, DOI 10.1385/MB:34:2:225; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; Schneider S, 2001, J BIOL CHEM, V276, P21184, DOI 10.1074/jbc.M101964200; Schutz P, 2010, J MOL BIOL, V400, P768, DOI 10.1016/j.jmb.2010.05.046; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; TERWILLIGER EF, 1989, P NATL ACAD SCI USA, V86, P5163, DOI 10.1073/pnas.86.13.5163; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Xing L, 2012, J VIROL, V86, P13272, DOI 10.1128/JVI.01993-12; Xing L, 2011, J VIROL, V85, P8929, DOI 10.1128/JVI.00336-11; Xing L, 2011, J VIROL, V85, P1847, DOI 10.1128/JVI.02010-10; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhang SS, 1997, J BIOL CHEM, V272, P11487	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78596	10.1371/journal.pone.0078596	http://dx.doi.org/10.1371/journal.pone.0078596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223160	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200052
J	Zotev, V; Phillips, R; Young, KD; Drevets, WC; Bodurka, J				Zotev, Vadim; Phillips, Raquel; Young, Kymberly D.; Drevets, Wayne C.; Bodurka, Jerzy			Prefrontal Control of the Amygdala during Real-Time fMRI Neurofeedback Training of Emotion Regulation	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; GRANGER CAUSALITY ANALYSIS; EFFECTIVE CONNECTIVITY; VOLUNTARY SUPPRESSION; NEGATIVE AFFECT; METAANALYSIS; VISUALIZATION; MODULATION; ATTENTION; COGNITION	We observed in a previous study (PLoS ONE 6:e24522) that the self-regulation of amygdala activity via real-time fMRI neurofeedback (rtfMRI-nf) with positive emotion induction was associated, in healthy participants, with an enhancement in the functional connectivity between the left amygdala (LA) and six regions of the prefrontal cortex. These regions included the left rostral anterior cingulate cortex (rACC), bilateral dorsomedial prefrontal cortex (DMPFC), bilateral superior frontal gyrus (SFG), and right medial frontopolar cortex (MFPC). Together with the LA, these six prefrontal regions thus formed the functional neuroanatomical network engaged during the rtfMRI-nf procedure. Here we perform a structural vector autoregression (SVAR) analysis of the effective connectivity for this network. The SVAR analysis demonstrates that the left rACC plays an important role during the rtfMRI-nf training, modulating the LA and the other network regions. According to the analysis, the rtfMRI-nf training leads to a significant enhancement in the time-lagged effect of the left rACC on the LA, potentially consistent with the ipsilateral distribution of the monosynaptic projections between these regions. The training is also accompanied by significant increases in the instantaneous (contemporaneous) effects of the left rACC on four other regions - the bilateral DMPFC, the right MFPC, and the left SFG. The instantaneous effects of the LA on the bilateral DMPFC are also significantly enhanced. Our results are consistent with a broad literature supporting the role of the rACC in emotion processing and regulation. Our exploratory analysis provides, for the first time, insights into the causal relationships within the network of regions engaged during the rtfMRI-nf procedure targeting the amygdala. It suggests that the rACC may constitute a promising target for rtfMRI-nf training along with the amygdala in patients with affective disorders, particularly posttraumatic stress disorder (PTSD).	[Zotev, Vadim; Phillips, Raquel; Young, Kymberly D.; Drevets, Wayne C.; Bodurka, Jerzy] Laureate Inst Brain Res, Tulsa, OK USA; [Drevets, Wayne C.] Johnson & Johnson Inc, Janssen Pharmaceut LLC, Titusville, NJ USA; [Bodurka, Jerzy] Univ Oklahoma, Coll Engn, Norman, OK 73019 USA	Laureate Institute for Brain Research, Inc.; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA; University of Oklahoma System; University of Oklahoma - Norman	Zotev, V (corresponding author), Laureate Inst Brain Res, Tulsa, OK USA.	vzotev@laureateinstitute.org; jbodurka@laureateinstitute.org	Young, Kymberly/AAV-5407-2021	Zotev, Vadim/0000-0002-5784-2562; Young, Kymberly/0000-0001-5133-2142	Laureate Institute for Brain Research; The William K. Warren Foundation	Laureate Institute for Brain Research; The William K. Warren Foundation	This research was supported by the Laureate Institute for Brain Research, and The William K. Warren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WCD is currently an employee of Johnson & Johnson, Inc., and has consulted for Myriad/Rules Based Medicine and for Eisai, Inc.	Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Chen G, 2011, COMPUT BIOL MED, V41, P1142, DOI 10.1016/j.compbiomed.2011.09.004; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Hampson M, 2012, JOVE-J VIS EXP, DOI 10.3791/3535; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Johnston S, 2011, COGN AFFECT BEHAV NE, V11, P44, DOI 10.3758/s13415-010-0010-1; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; Kim KR, 2012, NEUROSCI LETT, V521, P152, DOI 10.1016/j.neulet.2012.05.075; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Koush Y, 2013, NEUROIMAGE, V81, P422, DOI 10.1016/j.neuroimage.2013.05.010; Lee H, 2012, NEUROIMAGE, V62, P1575, DOI 10.1016/j.neuroimage.2012.05.044; Lee JH, 2012, NEUROSCI RES, V72, P347, DOI 10.1016/j.neures.2012.01.002; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Stoeckel LE, 2009, BRAIN RES BULL, V79, P388, DOI 10.1016/j.brainresbull.2009.05.016; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Talairach J., 1988, COPLANAR STEREOTAXIC; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Zotev V, 2014, NEUROIMAGE, V85, P985, DOI 10.1016/j.neuroimage.2013.04.126; Zotev V, 2012, NEUROIMAGE, V63, P698, DOI 10.1016/j.neuroimage.2012.07.031; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	60	96	100	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79184	10.1371/journal.pone.0079184	http://dx.doi.org/10.1371/journal.pone.0079184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223175	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200067
J	Featherstone, CR; Morrison, CM; Waterman, MG; MacGregor, LJ				Featherstone, Cara R.; Morrison, Catriona M.; Waterman, Mitch G.; MacGregor, Lucy J.			Semantics, Syntax or Neither? A Case for Resolution in the Interpretation of N500 and P600 Responses to Harmonic Incongruities	PLOS ONE			English	Article							ELECTRIC BRAIN RESPONSES; FUNCTIONAL-ANATOMY; MUSIC PERCEPTION; LANGUAGE AREAS; POTENTIALS; MELODIES; TENSION; TIME	The processing of notes and chords which are harmonically incongruous with their context has been shown to elicit two distinct late ERP effects. These effects strongly resemble two effects associated with the processing of linguistic incongruities: a P600, resembling a typical response to syntactic incongruities in language, and an N500, evocative of the N400, which is typically elicited in response to semantic incongruities in language. Despite the robustness of these two patterns in the musical incongruity literature, no consensus has yet been reached as to the reasons for the existence of two distinct responses to harmonic incongruities. This study was the first to use behavioural and ERP data to test two possible explanations for the existence of these two patterns: the musicianship of listeners, and the resolved or unresolved nature of the harmonic incongruities. Results showed that harmonically incongruous notes and chords elicited a late positivity similar to the P600 when they were embedded within sequences which started and ended in the same key (harmonically resolved). The notes and chords which indicated that there would be no return to the original key (leaving the piece harmonically unresolved) were associated with a further P600 in musicians, but with a negativity resembling the N500 in non-musicians. We suggest that the late positivity reflects the conscious perception of a specific element as being incongruous with its context and the efforts of musicians to integrate the harmonic incongruity into its local context as a result of their analytic listening style, while the late negativity reflects the detection of the absence of resolution in non-musicians as a result of their holistic listening style.	[Featherstone, Cara R.; Morrison, Catriona M.; Waterman, Mitch G.] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [MacGregor, Lucy J.] Cognit & Brain Sci Unit, Med Res Council, Cambridge, England	University of Leeds; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Featherstone, CR (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	c.r.featherstone@leeds.ac.uk		Waterman, Mitch/0000-0003-0168-0426; MacGregor, Lucy/0000-0002-1062-9529	Economic and Social Research Council	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by an Economic and Social Research Council +3 Open Competition Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSON M, 1994, NEUROSCI LETT, V168, P101, DOI 10.1016/0304-3940(94)90426-X; Besson M, 1998, CAH PSYCHOL COGN, V17, P921; BESSON M, 1987, PSYCHOPHYSIOLOGY, V24, P14, DOI 10.1111/j.1469-8986.1987.tb01853.x; Besson M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00094; Bidelman GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060676; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Conway CM, 2009, CURR DIR PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-8721.2009.01651.x; Ducreux D, 2003, J NEURORADIOLOGY, V30, P18; Featherstone CR, 2012, BEHAV RES METHODS, V44, P81, DOI 10.3758/s13428-011-0137-1; Hantz EC, 1997, MUSIC PERCEPT, V15, P69; Jentschke S, 2005, ANN NY ACAD SCI, V1060, P231, DOI 10.1196/annals.1360.016; Jongsma MLA, 2004, BIOL PSYCHOL, V66, P129, DOI 10.1016/j.biopsycho.2003.10.002; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; Koelsch S, 2003, NEUROREPORT, V14, P709, DOI 10.1097/00001756-200304150-00010; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Koelsch S, 2011, PHYS LIFE REV, V8, P89, DOI 10.1016/j.plrev.2011.04.004; Koelsch S, 2010, J COGNITIVE NEUROSCI, V22, P2251, DOI 10.1162/jocn.2009.21338; Kreutz G, 2008, MUSIC PERCEPT, V26, P57, DOI 10.1525/MP.2008.26.1.57; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Levitin DJ, 2005, MUSIC PERCEPT, V22, P563, DOI 10.1525/mp.2005.22.3.563; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Lovelock W, 1957, RUDIMENTS MUSIC; Meyer L., 1956, EMOTION MEANING MUSI; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Mirz F, 1999, SCAND AUDIOL, V28, P161, DOI 10.1080/010503999424734; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; PALLER KA, 1992, PSYCHOPHYSIOLOGY, V29, P202, DOI 10.1111/j.1469-8986.1992.tb01686.x; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Piston W., 1978, HARMONY; Poulin-Charronnat B, 2005, COGNITION, V94, pB67, DOI 10.1016/j.cognition.2004.05.003; Regnault P, 1998, CAH PSYCHOL COGN, V17, P1069; Rogalsky C, 2011, J NEUROSCI, V31, P3843, DOI 10.1523/JNEUROSCI.4515-10.2011; Schmithorst VJ, 2005, NEUROIMAGE, V25, P444, DOI 10.1016/j.neuroimage.2004.12.006; Slevc LR, 2009, PSYCHON B REV, V16, P374, DOI 10.3758/16.2.374; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Stoesz BM, 2007, MUSIC PERCEPT, V25, P153, DOI 10.1525/MP.2007.25.2.153; Tillmann B, 2012, TOP COGN SCI, V4, P568, DOI 10.1111/j.1756-8765.2012.01209.x; Vuust P, 2006, NEUROIMAGE, V31, P832, DOI 10.1016/j.neuroimage.2005.12.037	45	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e76600	10.1371/journal.pone.0076600	http://dx.doi.org/10.1371/journal.pone.0076600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223704	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400003
J	Fujiki, Y; Yokota, S; Okada, Y; Oku, Y; Tamura, Y; Ishiguro, M; Miwakeichi, F				Fujiki, Yasuhisa; Yokota, Shigefumi; Okada, Yasumasa; Oku, Yoshitaka; Tamura, Yoshiyasu; Ishiguro, Makio; Miwakeichi, Fumikazu			Standardization of Size, Shape and Internal Structure of Spinal Cord Images: Comparison of Three Transformation Methods	PLOS ONE			English	Article							RESPIRATORY NEURONAL NETWORK; SPATIAL NORMALIZATION; TEMPLATE IMAGES; REGISTRATION; DISTURBANCE; VALIDATION	Functional fluorescence imaging has been widely applied to analyze spatio-temporal patterns of cellular dynamics in the brain and spinal cord. However, it is difficult to integrate spatial information obtained from imaging data in specific regions of interest across multiple samples, due to large variability in the size, shape and internal structure of samples. To solve this problem, we attempted to standardize transversely sectioned spinal cord images focusing on the laminar structure in the gray matter. We employed three standardization methods, the affine transformation (AT), the angle-dependent transformation (ADT) and the combination of these two methods (AT+ADT). The ADT is a novel non-linear transformation method developed in this study to adjust an individual image onto the template image in the polar coordinate system. We next compared the accuracy of these three standardization methods. We evaluated two indices, i.e., the spatial distribution of pixels that are not categorized to any layer and the error ratio by the leave-one-out cross validation method. In this study, we used neuron-specific marker (NeuN)-stained histological images of transversely sectioned cervical spinal cord slices (21 images obtained from 4 rats) to create the standard atlas and also to serve for benchmark tests. We found that the AT+ADT outperformed other two methods, though the accuracy of each method varied depending on the layer. This novel image standardization technique would be applicable to optical recording such as voltage-sensitive dye imaging, and will enable statistical evaluations of neural activation across multiple samples.	[Fujiki, Yasuhisa; Tamura, Yoshiyasu; Ishiguro, Makio; Miwakeichi, Fumikazu] Grad Univ Adv Studies, Sch Multidisciplinary Sci, Dept Stat Sci, Tachikawa, Tokyo, Japan; [Yokota, Shigefumi] Shimane Univ, Sch Med, Dept Anat & Morphol Neurosci, Izumo, Shimane, Japan; [Okada, Yasumasa] Murayama Med Ctr, Dept Internal Med, Musashimurayama, Tokyo, Japan; [Oku, Yoshitaka] Hyogo Coll Med, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan; [Tamura, Yoshiyasu; Ishiguro, Makio; Miwakeichi, Fumikazu] Inst Stat Math, Dept Data Sci, Tachikawa, Tokyo, Japan	Graduate University for Advanced Studies - Japan; Shimane University; Hyogo College of Medicine; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Fujiki, Y (corresponding author), Grad Univ Adv Studies, Sch Multidisciplinary Sci, Dept Stat Sci, Tachikawa, Tokyo, Japan.	yasfujiki@gmail.com			Japan Society for the Promotion of Science (JSPS) [19200021, 24300108, 24500365]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Science Research (Nos. 19200021, 24300108 and 24500365) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Aoyama R, 2011, PAIN, V152, P2085, DOI 10.1016/j.pain.2011.05.014; Black KJ, 2001, NEUROIMAGE, V14, P736, DOI 10.1006/nimg.2001.0752; Black KJ, 2001, NEUROIMAGE, V14, P744, DOI 10.1006/nimg.2001.0871; Cachier P, 2001, LNCS, V2208, P734; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Davatzikos C, 1997, COMPUT VIS IMAGE UND, V66, P207, DOI 10.1006/cviu.1997.0605; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fukuda K, 2006, NEUROSCIENCE, V140, P1453, DOI 10.1016/j.neuroscience.2006.03.034; Gaens T, 1998, LECT NOTES COMPUT SC, V1496, P1099, DOI 10.1007/BFb0056299; Hartkens T., 2002, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2002. 5th International Conference. Proceedings, Part II (Lecture Notes in Computer Science Vol.2489), P565; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kawai S, 2009, NEUROSCI RES, V63, P165, DOI 10.1016/j.neures.2008.11.008; Krucker JF, 2000, ULTRASOUND MED BIOL, V26, P1475, DOI 10.1016/S0301-5629(00)00286-6; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Miwakeichi F, 2011, IEEE T MED IMAGING, V30, P859, DOI 10.1109/TMI.2011.2104419; Okada Y, 2007, EUR J NEUROSCI, V26, P2834, DOI 10.1111/j.1460-9568.2007.05891.x; Oku Y, 2008, RESP PHYSIOL NEUROBI, V161, P281, DOI 10.1016/j.resp.2008.03.002; Oku Y, 2007, J PHYSIOL-LONDON, V585, P175, DOI 10.1113/jphysiol.2007.138180; Roland P E, 1994, Hum Brain Mapp, V1, P173, DOI 10.1002/hbm.460010303; Schnabel JA, 2003, IEEE T MED IMAGING, V22, P238, DOI 10.1109/TMI.2002.808367; Schnabel JA., 2001, LECT NOTES COMPUTER, P573, DOI DOI 10.1007/3-540-45468-3_69; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Shekhar R, 2002, IEEE T MED IMAGING, V21, P9, DOI 10.1109/42.981230; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Sugiura M, 1999, J NUCL MED, V40, P317; Yoshida H, 2003, J NEUROTRAUM, V20, P1365, DOI 10.1089/089771503322686157	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e76415	10.1371/journal.pone.0076415	http://dx.doi.org/10.1371/journal.pone.0076415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223702	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400001
J	Wang, LL; Hatem, A; Catalyurek, UV; Morrison, M; Yu, ZT				Wang, Lingling; Hatem, Ayat; Catalyurek, Umit V.; Morrison, Mark; Yu, Zhongtang			Metagenomic Insights into the Carbohydrate-Active Enzymes Carried by the Microorganisms Adhering to Solid Digesta in the Rumen of Cows	PLOS ONE			English	Article							HERBIVORE GASTROINTESTINAL-TRACT; RNA GENE-SEQUENCES; REAL-TIME PCR; BOVINE RUMEN; CELLULOLYTIC BACTERIA; DIVERSITY; PREVOTELLA; BIOMASS; ADAPTATION; ABUNDANCE	The ruminal microbial community is a unique source of enzymes that underpin the conversion of cellulosic biomass. In this study, the microbial consortia adherent on solid digesta in the rumen of Jersey cattle were subjected to an activity-based metagenomic study to explore the genetic diversity of carbohydrolytic enzymes in Jersey cows, with a particular focus on cellulases and xylanases. Pyrosequencing and bioinformatic analyses of 120 carbohydrate-active fosmids identified genes encoding 575 putative Carbohydrate-Active Enzymes (CAZymes) and proteins putatively related to transcriptional regulation, transporters, and signal transduction coupled with polysaccharide degradation and metabolism. Most of these genes shared little similarity to sequences archived in databases. Genes that were predicted to encode glycoside hydrolases (GH) involved in xylan and cellulose hydrolysis (e. g., GH3, 5, 9, 10, 39 and 43) were well represented. A new subfamily (S-8) of GH5 was identified from contigs assigned to Firmicutes. These subfamilies of GH5 proteins also showed significant phylum-dependent distribution. A number of polysaccharide utilization loci (PULs) were found, and two of them contained genes encoding Sus-like proteins and cellulases that have not been reported in previous metagenomic studies of samples from the rumens of cows or other herbivores. Comparison with the large metagenomic datasets previously reported of other ruminant species (or cattle breeds) and wallabies showed that the rumen microbiome of Jersey cows might contain differing CAZymes. Future studies are needed to further explore how host genetics and diets affect the diversity and distribution of CAZymes and utilization of plant cell wall materials.	[Wang, Lingling; Morrison, Mark; Yu, Zhongtang] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Hatem, Ayat; Catalyurek, Umit V.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Hatem, Ayat; Catalyurek, Umit V.] Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA; [Morrison, Mark] CSIRO Livestock Ind, St Lucia, Qld, Australia	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Yu, ZT (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	yu.226@osu.edu	Yu, Zhongtang/B-3987-2012; Morrison, Mark/C-9707-2013; Catalyurek, Umit/A-2454-2008	Yu, Zhongtang/0000-0002-6165-8522; Morrison, Mark/0000-0001-9257-9133; Catalyurek, Umit/0000-0002-5625-3758				An DD, 2005, ANAEROBE, V11, P207, DOI 10.1016/j.anaerobe.2005.02.001; Ballouz S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000672; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Del Pozo MV, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-73; Doyle J. J., 1987, PHYTOCHEM B, P11; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Firkins J. L., 2006, P19; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kittelmann S, 2011, FEMS MICROBIOL ECOL, V75, P468, DOI 10.1111/j.1574-6941.2010.01022.x; KWON KS, 1994, APPL ENVIRON MICROB, V60, P4584, DOI 10.1128/AEM.60.12.4584-4586.1994; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Mackenzie AK, 2012, APPL ENVIRON MICROB, V78, P5935, DOI 10.1128/AEM.01164-12; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Michalet-Doreau B, 2001, REPROD NUTR DEV, V41, P187, DOI 10.1051/rnd:2001122; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pope PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038571; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Sambrook J., 2001, MOL CLONING LAB MANU; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Weimer PJ, 1996, J DAIRY SCI, V79, P1496, DOI 10.3168/jds.S0022-0302(96)76509-8; Wood J, 1998, APPL ENVIRON MICROB, V64, P3683; Yang SL, 2010, MOL BIOL REP, V37, P2063, DOI 10.1007/s11033-009-9664-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	40	77	79	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78507	10.1371/journal.pone.0078507	http://dx.doi.org/10.1371/journal.pone.0078507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223817	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400031
J	Hsu, HC; Chiou, JF; Wang, YH; Chen, CH; Mau, SY; Ho, CT; Chang, PJ; Liu, TZ; Chen, CH				Hsu, Hung-Chih; Chiou, Jeng-Fong; Wang, Yu-Huei; Chen, Chia-Hui; Mau, Shin-Yi; Ho, Chun-Te; Chang, Pey-Jium; Liu, Tsan-Zon; Chen, Ching-Hsein			Folate Deficiency Triggers an Oxidative-Nitrosative Stress-Mediated Apoptotic Cell Death and Impedes Insulin Biosynthesis in RINm5F Pancreatic Islet beta-Cells: Relevant to the Pathogenesis of Diabetes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ENZYME GENE-EXPRESSION; CASPASE-3 ACTIVATION; REDUCED GLUTATHIONE; HYDROGEN-PEROXIDE; DEFENSE STATUS; MOUSE-TISSUES; NITRIC-OXIDE; RESISTANCE; ALLOXAN	It has been postulated that folic acid (folate) deficiency (FD) may be a risk factor for the pathogenesis of a variety of oxidative stress-triggered chronic degenerative diseases including diabetes, however, the direct evidence to lend support to this hypothesis is scanty. For this reason, we set out to study if FD can trigger the apoptotic events in an insulin-producing pancreatic RINm5F islet beta cells. When these cells were cultivated under FD condition, a time-dependent growth impediment was observed and the demise of these cells was demonstrated to be apoptotic in nature proceeding through a mitochondria-dependent pathway. In addition to evoke oxidative stress, FD condition could also trigger nitrosative stress through a NF-kappa B-dependent iNOS-mediated overproduction of nitric oxide (NO). The latter compound could then trigger depletion of endoplasmic reticulum (ER) calcium (Ca2+) store leading to cytosolic Ca2+ overload and caused ER stress as evidence by the activation of CHOP expression. Furthermore, FD-induced apoptosis of RINm5F cells was found to be correlated with a time-dependent depletion of intracellular gluthathione (GSH) and a severe down-regulation of Bcl-2 expression. Along the same vein, we also demonstrated that FD could severely impede RINm5F cells to synthesize insulin and their abilities to secret insulin in response to glucose stimulation were appreciably hampered. Even more importantly, we found that folate replenishment could not restore the ability of RINm5F cells to resynthesize insulin. Taken together, our data provide strong evidence to support the hypothesis that FD is a legitimate risk factor for the pathogenesis of diabetes.	[Hsu, Hung-Chih; Chang, Pey-Jium] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Hsu, Hung-Chih] Chia Yi Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Hsu, Hung-Chih] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Chiou, Jeng-Fong] Taipei Med Univ & Hosp, Ctr Canc, Taipei, Taiwan; [Chiou, Jeng-Fong] Taipei Med Univ & Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Wang, Yu-Huei; Chen, Chia-Hui; Mau, Shin-Yi; Ho, Chun-Te; Liu, Tsan-Zon] Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Chen, Ching-Hsein] Natl Chiayi Univ, Collage Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Chiayi University	Liu, TZ (corresponding author), Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan.	tzliu@tmuh.org.tw; chench@mail.ncyu.edu.tw		Chang, Pey-Jium/0000-0002-6492-0346	National Science Council, Taiwan [NSC 99-2314-B-038-026-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Taiwan (NSC 99-2314-B-038-026-MY3; National Science Council's Web site: http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari MY, 2012, NUTRITION, V28, P23; Chen NC, 2010, FASEB J, V24, P2804, DOI 10.1096/fj.09-143651; Chen Y. H., 2001, J BIOMED LAB SCI, V13, P52; Chern CL, 2001, BIOMED PHARMACOTHER, V55, P434, DOI 10.1016/S0753-3322(01)00095-6; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Honda T, 2004, CANCER GENE THER, V11, P249, DOI 10.1038/sj.cgt.7700684; Huang RFS, 2001, LIFE SCI, V68, P2799, DOI 10.1016/S0024-3205(01)01066-9; Kikumoto Y, 2010, BBA-MOL BASIS DIS, V1802, P240, DOI 10.1016/j.bbadis.2009.10.009; Kim JS, 2011, BIOCHEM BIOPH RES CO, V413, P105, DOI 10.1016/j.bbrc.2011.08.063; Kim SJ, 2007, J NEUROSCI RES, V85, P139, DOI 10.1002/jnr.21106; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Lee DH, 2009, ENVIRON HEALTH PERSP, V117, P1799, DOI 10.1289/ehp.0900741; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Mathews CE, 1999, FREE RADICAL BIO MED, V27, P449, DOI 10.1016/S0891-5849(99)00084-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Park JH, 2008, FOOD CHEM TOXICOL, V46, P3684, DOI 10.1016/j.fct.2008.09.056; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Scullion SMJ, 2012, J ENDOCRINOL, V214, P233, DOI 10.1530/JOE-11-0461; Setola E, 2004, EUR J ENDOCRINOL, V151, P483, DOI 10.1530/eje.0.1510483; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shils ME, 2006, MODERN NUTR HLTH DIS, P550; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200; Watson D, 2009, BRIT J BIOMED SCI, V66, P208, DOI 10.1080/09674845.2009.11730278; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444; Woltjer RL, 2005, J NEUROCHEM, V93, P1047, DOI 10.1111/j.1471-4159.2005.03109.x; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200	35	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77931	10.1371/journal.pone.0077931	http://dx.doi.org/10.1371/journal.pone.0077931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223745	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400024
J	Pampel, H; Vierkant, P; Scholze, F; Bertelmann, R; Kindling, M; Klump, J; Goebelbecker, HJ; Gundlach, J; Schirmbacher, P; Dierolf, U				Pampel, Heinz; Vierkant, Paul; Scholze, Frank; Bertelmann, Roland; Kindling, Maxi; Klump, Jens; Goebelbecker, Hans-Juergen; Gundlach, Jens; Schirmbacher, Peter; Dierolf, Uwe			Making Research Data Repositories Visible: The re3data.org Registry	PLOS ONE			English	Article								Researchers require infrastructures that ensure a maximum of accessibility, stability and reliability to facilitate working with and sharing of research data. Such infrastructures are being increasingly summarized under the term Research Data Repositories (RDR). The project re3data.org-Registry of Research Data Repositories-has begun to index research data repositories in 2012 and offers researchers, funding organizations, libraries and publishers an overview of the heterogeneous research data repository landscape. In July 2013 re3data.org lists 400 research data repositories and counting. 288 of these are described in detail using the re3data.org vocabulary. Information icons help researchers to easily identify an adequate repository for the storage and reuse of their data. This article describes the heterogeneous RDR landscape and presents a typology of institutional, disciplinary, multidisciplinary and project-specific RDR. Further the article outlines the features of re3data.org, and shows how this registry helps to identify appropriate repositories for storage and search of research data.	[Pampel, Heinz; Bertelmann, Roland; Klump, Jens] Deutsch GeoForschungsZentrum GFZ, Lib & Informat Serv, Potsdam, Germany; [Vierkant, Paul; Kindling, Maxi; Schirmbacher, Peter] Humboldt Univ, Berlin Sch Lib & Informat Sci, D-10099 Berlin, Germany; [Scholze, Frank; Goebelbecker, Hans-Juergen; Gundlach, Jens; Dierolf, Uwe] Karlsruhe Inst Technol, KIT Lib, D-76021 Karlsruhe, Germany	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Humboldt University of Berlin; Helmholtz Association; Karlsruhe Institute of Technology	Pampel, H (corresponding author), Deutsch GeoForschungsZentrum GFZ, Lib & Informat Serv, Potsdam, Germany.	heinz.pampel@gfz-potsdam.de	Vierkant, Paul/J-2739-2017; Klump, Jens/Q-5947-2019; Vierkant, Paul/V-5573-2019; Bertelmann, Roland/C-4211-2012; scholze, frank/A-8173-2014; Pampel, Heinz/J-5635-2014	Vierkant, Paul/0000-0003-4448-3844; Klump, Jens/0000-0001-5911-6022; Vierkant, Paul/0000-0003-4448-3844; Bertelmann, Roland/0000-0002-5588-0290; scholze, frank/0000-0003-3404-1452; Pampel, Heinz/0000-0003-3334-2771; Goebelbecker, Hans-Jurgen/0000-0003-4512-0367; Kindling, Maxi/0000-0002-0167-0466	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The writing of this paper was supported by a grant from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NAT BIOTECHNOL, V27, P579, DOI 10.1038/nbt0709-579; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berlin Declaration, 2003, BERL DECL OP ACC KNO; Braun K, 2011, DINI CERTIGICATE DOC; Chavan V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-S2; Consultative Committee for Space Data Systems (CCSDS), 2011, 6520M1 CCSDS; Cravedi K, 2008, GENBANK CLEBRATES 25; Dallmeier-Tiessen S, 2012, SUMMARY STUDIES THEM; Dallmeier-Tiessen S, 2009, POSITIONSPAPIER FORS; Data Seal of Approval, 2010, DAT SEAL APPR GUID V; Deutsche Forschungsgemeinschaft, 2012, PROP PREP INSTR DFG; Diepenbroek M, 1999, USE PROXIES PALEOCEA, P715; ELIXIR, DRAFT REP WORKP 2; ESF & EUROHORCs, 2011, BAS REQ RES INFR EUR; European Commission, 2012, COMM COMM EUR PARLL; European Commission, 2009, COM2009108 EUR COMM; European Commission, 2012, C20124890 EUR COMM, VC, P4890; European Strategy Forum on Research Infrastructures, 2006, EUR ROADM RES INFR; Fenner M, 2012, FIGSHARE INERVIEW MA; Fernandez-Suarez XM, 2012, NUCLEIC ACIDS RES, P1; Graaf M van der, 2011, SURFBOARD RIDING WAV; High Level Expert Group on Scientific Data, 2010, RID WAV EUR CAN GAIN; ICSU World Data System (WDS), 2011, CERT WORLD DAT SYST; Kindling M, 2013, INFORM-WISS PRAX, V64, P127, DOI 10.1515/iwp-2013-0017; Klump J., 2006, DATA SCI J, V5, P79, DOI DOI 10.2481/DSJ.5.79; Klump J, 2007, SCI DRILL, V4, P30, DOI 10.5194/sd-4-30-2007; Kroes N, 2012, SPEECH12258; Kroes N, 2012, SPEECH12392; Kuipers T, 2009, INSIGHT DIGITAL PRES; LabArchives, EL NOT SOFTW LAB NOT; Lagoze C., 2001, P 1 ACMIEEE CS JOINT, P54, DOI DOI 10.1145/379437.379449; Marcial LH, 2010, J AM SOC INF SCI TEC, V61, P2029, DOI 10.1002/asi.21339; National Science Foundation, 2011, PROP AW POL PROC GUI; OECD, 2007, PRINC GUID ACC RES D; Office of Science and Technology Policy, 2013, INCR ACC RES FED FUN; Pampel H, OPENING SCI EVOLVING; Pampel H, 2012, VERNETZTES WISSEN DA, P61; Pampel H, 2011, HDB FORSCHUNGSDATENM, P49; PANGAEA, IMPR; Pfeiffenberger H, 2012, REPORT STRATEY ANNOT; Rice R, 2009, DISC UK DATASHARE; Schaaf I, 2011, FORSCHUNGSDATEN NETZ; Schallehn V, 2010, OPEN DATA LMU; Schindler U, 2012, GEOPH RES ABSTR, V14; Suber P., 2012, KNOWLEDGE UNBOUND, DOI 10.1080/00049670.2013.811775; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; The Royal Society, 2012, 0112 ROYAL SOC SCI P; Vierkant P, 2012, VOCABULARY REGISTRAT, DOI DOI 10.2312/RE3.001; Woutersen-Windhouwer S, 2009, ENHANCED PUBLICATION	50	72	73	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78080	10.1371/journal.pone.0078080	http://dx.doi.org/10.1371/journal.pone.0078080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223762	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400033
J	Souza, MFVR; Ferreira, RL				Villela Rezende Souza, Maysa Fernanda; Ferreira, Rodrigo Lopes			Two New Species of the Enigmatic Leptokoenenia (Eukoeneniidae: Palpigradi) from Brazil: First Record of the Genus Outside Intertidal Environments	PLOS ONE			English	Article							CAVES; ARACHNIDA	Two new species of Leptokoenenia Conde 1965 (Eukoeneniidae: Palpigradi), Leptokoenenia pelada sp. nov. and Leptokoenenia thalassophobica sp. nov., are described based on both male and female specimens collected in iron ore caves from the Brazilian Amazon. This is the first record of the genus for the Americas. Furthermore, a new combination is stated for Eukoenenia gallii based on its morphology.	[Villela Rezende Souza, Maysa Fernanda] Univ Fed Lavras, Programa Posgrad Ecol Aplicada, Lavras, MG, Brazil; [Villela Rezende Souza, Maysa Fernanda; Ferreira, Rodrigo Lopes] Univ Fed Lavras, Dept Biol, Setor Zool, Lab Ecol Subterranea, Lavras, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras	Ferreira, RL (corresponding author), Univ Fed Lavras, Dept Biol, Setor Zool, Lab Ecol Subterranea, Lavras, MG, Brazil.	drops@dbi.ufla.br	Ferreira, RL/L-8419-2014	Ferreira, RL/0000-0003-3288-4405	Conselho Nacional do desenvolvimento Cientifico e Tecnologico (CNPq) [301061/2011-4]	Conselho Nacional do desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Conselho Nacional do desenvolvimento Cientifico e Tecnologico (CNPq grant 301061/2011-4), (http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barranco P, 2007, J ARACHNOL, V35, P318, DOI 10.1636/H05-23.1; Christian E, 2010, REV SUISSE ZOOL, V117, P829; Christian E, 2009, ZOOTAXA, P59, DOI 10.11646/zootaxa.2136.1.5; CONDE B, 1993, REV SUISSE ZOOL, V100, P279, DOI 10.5962/bhl.part.79861; CONDE B, 1965, CR HEBD ACAD SCI, V261, P1898; Conde B, 1955, NOTES BIOSPELEOL, V9, P145; Conde B., 1990, B SOC EUROPEENNE ARA, V1, P64; Conde B, 1998, INTRO STUDY MEIOFAUN, p425 ; Enghoff H, 2013, J NAT HIST, V47, P1613, DOI 10.1080/00222933.2012.759289; Ferreira RL, 2011, J ARACHNOL, V39, P409, DOI 10.1636/Ha11-03.1; Hansen HJ, 1901, ENTOMOL TIDSKR, V22, P193; Harvey M.S, 2003, CATALOGUE SMALLER AR; Krantz G., 2009, MANUAL ACAROLOGY; Mello-Lietao C. de, 1935, Ann Acad Bras Sci Rio T, V7, P339; Monniot F., 1966, Rev Ecol Biol Sci, V3, P41; ROWLAND JM, 1980, J ARACHNOL, V8, P69; Rucker A, 1901, AM NAT, V35, P615, DOI 10.1086/277979; Silvestri F, 1913, B LAB ZOOL GEN AGR P, V7, P211; Souza MFVR, 2012, ZOOTAXA, P59, DOI 10.11646/zootaxa.3295.1.3; Souza MFVR, 2011, ZOOTAXA, P31, DOI 10.11646/zootaxa.2886.1.3; Souza MFVR, 2012, J ARACHNOL, V40, P151, DOI 10.1636/Ha11-26.1; Souza MFVR, 2011, J ARACHNOL, V39, P185, DOI 10.1636/Ha10-43.1; Souza MFVR, 2010, J ARACHNOL, V38, P415, DOI 10.1636/Ha09-112.1; van der Hammen L., 1982, ZOOL VERH, V196, P1	24	10	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77840	10.1371/journal.pone.0077840	http://dx.doi.org/10.1371/journal.pone.0077840			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223731	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400017
J	Wang, B; Zhao, BF; North, P; Kong, A; Huang, J; Miao, QR				Wang, Bei; Zhao, Baofeng; North, Paula; Kong, Amanda; Huang, Jian; Miao, Qing Robert			Expression of NgBR Is Highly Associated with Estrogen Receptor Alpha and Survivin in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; NOGO-B; PROTEIN EXPRESSION; APOPTOSIS; CELLS; INHIBITOR; CARCINOMAS; SUBTYPES; CLASSIFICATION	NgBR is a type I receptor with a single transmembrane domain and was identified as a specific receptor for Nogo-B. Our recent findings demonstrated that NgBR binds farnesylated Ras and recruits Ras to the plasma membrane, which is a critical step required for the activation of Ras signaling in human breast cancer cells and tumorigenesis. Here, we first use immunohistochemistry and real-time PCR approaches to examine the expression patterns of Nogo-B and NgBR in both normal and breast tumor tissues. Then, we examine the relationship between NgBR expression and molecular subtypes of breast cancer, and the roles of NgBR in estrogen-dependent survivin signaling pathway. Results showed that NgBR and Nogo-B protein were detected in both normal and breast tumor tissues. However, the expression of Nogo-B and NgBR in breast tumor tissue was much stronger than in normal breast tissue. The statistical analysis demonstrated that NgBR is highly associated with ER-positive/HER2-negative breast cancer. We also found that the expression of NgBR has a strong correlation with the expression of survivin, which is a well-known apoptosis inhibitor. The correlation between NgBR and survivin gene expression was further confirmed by real-time PCR. In vitro results also demonstrated that estradiol induces the expression of survivin in ER-positive T47D breast tumor cells but not in ER-negative MDA-MB-468 breast tumor cells. NgBR knockdown with siRNA abolishes estradiol-induced survivin expression in ER-positive T47D cells but not in ERnegative MDA-MB-468 cells. In addition, estradiol increases the expression of survivin and cell growth in ER-positive MCF-7 and T47D cells whereas knockdown of NgBR with siRNA reduces estradiol-induced survivin expression and cell growth. In summary, these results indicate that NgBR is a new molecular marker for breast cancer. The data suggest that the expression of NgBR may be essential in promoting ER-positive tumor cell proliferation via survivin induction in breast cancer.	[Wang, Bei] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China; [Wang, Bei; Zhao, Baofeng; Miao, Qing Robert] Med Coll Wisconsin, Childrens Res Inst, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Wang, Bei; Zhao, Baofeng; North, Paula; Miao, Qing Robert] Med Coll Wisconsin, Childrens Res Inst, Dept Pathol, Div Pediat Pathol, Milwaukee, WI 53226 USA; [Kong, Amanda] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Huang, Jian] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Huang, Jian] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	China-Japan Friendship Hospital; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Baylor College of Medicine	Huang, J (corresponding author), Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.	jihuang@mcw.edu; qmiao@mcw.edu	Miao, Qing/K-3186-2019	Miao, Qing/0000-0002-3125-1238	Division of Pediatric Surgery, Medical College of Wisconsin (MCW); Division of Pediatric Pathology, Medical College of Wisconsin (MCW); Advancing a Healthier Wisconsin endowment; American Cancer Society; MCW Cancer Center pilot grant; NIH [R01HL108938]; Wisconsin Breast Cancer Showhouse (WBCS); Independent Seed Grant for Breast Cancer Research in the Cancer Center at MCW; Women's Health Research Program (WHRP) at MCW; Falk Medical Research; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108938] Funding Source: NIH RePORTER	Division of Pediatric Surgery, Medical College of Wisconsin (MCW); Division of Pediatric Pathology, Medical College of Wisconsin (MCW); Advancing a Healthier Wisconsin endowment; American Cancer Society(American Cancer Society); MCW Cancer Center pilot grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Breast Cancer Showhouse (WBCS); Independent Seed Grant for Breast Cancer Research in the Cancer Center at MCW; Women's Health Research Program (WHRP) at MCW; Falk Medical Research; AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by start-up funds from Division of Pediatric Surgery and Division of Pediatric Pathology, Medical College of Wisconsin (MCW) and Advancing a Healthier Wisconsin endowment to MCW, the American Cancer Society and MCW Cancer Center pilot grant, and NIH R01HL108938 to R.Q.M., and the Wisconsin Breast Cancer Showhouse (WBCS) to R.Q.M and J.H., the Independent Seed Grant for Breast Cancer Research in the Cancer Center at MCW to J.H., the Women's Health Research Program (WHRP) at MCW and the Falk Medical Research to J.H., AHA postdoctoral fellowship to B.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Asanuma K, 2000, JPN J CANCER RES, V91, P1204, DOI 10.1111/j.1349-7006.2000.tb00906.x; Bombonati A, 2011, J PATHOL, V223, P307, DOI 10.1002/path.2808; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheung HH, 2006, CLIN CANCER RES, V12, P3238, DOI 10.1158/1078-0432.CCR-06-0817; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Grandpre T, 2001, NEUROSCIENTIST, V7, P377, DOI 10.1177/107385840100700507; Ho TF, 2009, TOXICOL APPL PHARM, V235, P253, DOI 10.1016/j.taap.2008.12.009; Huber AB, 2002, J NEUROSCI, V22, P3553; Jha K, 2012, SURG ONCOL, V21, P125, DOI 10.1016/j.suronc.2011.01.001; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; KASSIS JA, 1981, J BIOL CHEM, V256, P7378; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kuang E, 2006, EXP CELL RES, V312, P1983, DOI 10.1016/j.yexcr.2006.02.024; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li Q, 2001, ONCOGENE, V20, P3929, DOI 10.1038/sj.onc.1204536; Ma Jian, 2009, Zhonghua Zhongliu Zazhi, V31, P250, DOI 10.3760/cma.j.issn.0253-3766.2009.04.003; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Oertle T, 2003, ONCOGENE, V22, P1390, DOI 10.1038/sj.onc.1206278; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Reilly CE, 2000, J NEUROL, V247, P239; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh M, 2004, APPL IMMUNOHISTO M M, V12, P296, DOI 10.1097/00129039-200412000-00003; Song J, 2013, TUMOR BIOL, V34, P2053, DOI 10.1007/s13277-013-0848-2; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Tanaka K, 2000, CLIN CANCER RES, V6, P127; TAVASSOLI FA, 2003, WHO CLASSIFICATION T, P9; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weigelt B, 2010, MOL ONCOL, V4, P192, DOI 10.1016/j.molonc.2010.04.004; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Xiong HH, 2007, J HUAZHONG UNIV SCI, V27, P65, DOI 10.1007/s11596-007-0119-9; Zhao BF, 2010, BLOOD, V116, P5423, DOI 10.1182/blood-2010-02-271577	44	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78083	10.1371/journal.pone.0078083	http://dx.doi.org/10.1371/journal.pone.0078083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223763	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400034
J	Wearn, OR; Rowcliffe, JM; Carbone, C; Bernard, H; Ewers, RM				Wearn, Oliver R.; Rowcliffe, J. Marcus; Carbone, Chris; Bernard, Henry; Ewers, Robert M.			Assessing the Status of Wild Felids in a Highly-Disturbed Commercial Forest Reserve in Borneo and the Implications for Camera Trap Survey Design	PLOS ONE			English	Article							LEOPARD NEOFELIS-DIARDI; SMALL CARNIVORES; TROPICAL FOREST; CATOPUMA-BADIA; SABAH; DIVERSITY; CONSERVATION; LOCALITY; DENSITY; MAMMALS	The proliferation of camera-trapping studies has led to a spate of extensions in the known distributions of many wild cat species, not least in Borneo. However, we still do not have a clear picture of the spatial patterns of felid abundance in Southeast Asia, particularly with respect to the large areas of highly-disturbed habitat. An important obstacle to increasing the usefulness of camera trap data is the widespread practice of setting cameras at non-random locations. Non-random deployment interacts with non-random space-use by animals, causing biases in our inferences about relative abundance from detection frequencies alone. This may be a particular problem if surveys do not adequately sample the full range of habitat features present in a study region. Using camera-trapping records and incidental sightings from the Kalabakan Forest Reserve, Sabah, Malaysian Borneo, we aimed to assess the relative abundance of felid species in highly-disturbed forest, as well as investigate felid space-use and the potential for biases resulting from non-random sampling. Although the area has been intensively logged over three decades, it was found to still retain the full complement of Bornean felids, including the bay cat Pardofelis badia, a poorly known Bornean endemic. Camera-trapping using strictly random locations detected four of the five Bornean felid species and revealed inter-and intra-specific differences in space-use. We compare our results with an extensive dataset of >1,200 felid records from previous camera-trapping studies and show that the relative abundance of the bay cat, in particular, may have previously been underestimated due to the use of non-random survey locations. Further surveys for this species using random locations will be crucial in determining its conservation status. We advocate the more wide-spread use of random survey locations in future camera-trapping surveys in order to increase the robustness and generality of inferences that can be made.	[Wearn, Oliver R.; Ewers, Robert M.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Wearn, Oliver R.; Rowcliffe, J. Marcus; Carbone, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England; [Bernard, Henry] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia	Imperial College London; Zoological Society of London; Universiti Malaysia Sabah	Wearn, OR (corresponding author), Imperial Coll London, Dept Life Sci, Ascot, Berks, England.	oliver.wearn08@imperial.ac.uk	Rowcliffe, Marcus/G-3713-2018	Rowcliffe, Marcus/0000-0002-4286-6887; Wearn, Oliver/0000-0001-8258-3534	Sime Darby Foundation	Sime Darby Foundation	This work was funded by the Sime Darby Foundation (http://www.yayasansimedarby.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; [Anonymous], 2012, BORNEO POST     1121; [Anonymous], 2011, BORNEO POST     0104; [Anonymous], 2011, BORNEO POST     0826; Azlan JM, 2006, ORYX, V40, P36, DOI 10.1017/S0030605306000147; Bashir T., 2011, NeBIO, V2, P1; Bernard Henry, 2012, Cat News, V56, P4; Brodie Jedediah, 2012, Cat News, V56, P8; Brodie J, 2012, ORYX, V46, P427, DOI 10.1017/S0030605312000087; Brodie Jedediah, 2011, Small Carnivore Conservation, V44, P1; Cheyne SM, 2011, ORYX, V45, P119, DOI 10.1017/S003060531000133X; Cochran WG., 1963, SAMPLING TECHNIQUES; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Didham RK, 2011, BIOTROPICA, V43, P393, DOI 10.1111/j.1744-7429.2011.00790.x; Ewers RM, 2011, PHILOS T R SOC B, V366, P3292, DOI 10.1098/rstb.2011.0049; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Harmsen BJ, 2011, POPUL ECOL, V53, P253, DOI 10.1007/s10144-010-0211-z; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hearn A, 2008, IUCN 2012 IUCN RED L; Hearn AJ, 2009, FLAT HEADED CAT PHOT; Hunter L, 2011, CARNIVORES WORLD; IUCN and UNEP, 2012, WORLD DAT PROT AR WD; Johnson A, 2009, ORYX, V43, P626, DOI 10.1017/S0030605309990238; Karanth KU, 1998, ECOLOGY, V79, P2852; Kays Roland, 2011, International Journal of Research and Reviews in Wireless Sensor Networks, V1, P19; Kitchener AC, 2004, MAMM BIOL, V69, P349, DOI 10.1078/1616-5047-00154; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Lhota S, 2012, AM J PRIMATOL, V74, P193, DOI 10.1002/ajp.21983; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; Maffei L, 2004, J ZOOL, V262, P295, DOI 10.1017/S0952836903004655; Mathai John, 2010, Small Carnivore Conservation, V42, P1; Matsubayashi Hisashi, 2011, Small Carnivore Conservation, V45, P18; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Meek P, 2012, INTRO CAMERA TRAPPIN; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mohamed A, 2009, CAT NEWS, V51, P12; Mohd-Azlan J, 2007, ORYX, V41, P394, DOI 10.1017/S0030605307000516; Olsen AR, 1999, ENVIRON MONIT ASSESS, V54, P1, DOI 10.1023/A:1005823911258; Osseweijer M., 2008, REFLECTIONS HEART BO; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pinard M. A., 2000, International Forestry Review, V2, P33; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Rowcliffe JM, 2011, METHODS ECOL EVOL, V2, P464, DOI 10.1111/j.2041-210X.2011.00094.x; Rustam, 2012, MAMM STUDY, V37, P299, DOI 10.3106/041.037.0404; Samejima Hiromitsu, 2012, Small Carnivore Conservation, V46, P1; Samejima H, 2012, FOREST ECOL MANAG, V270, P248, DOI 10.1016/j.foreco.2012.01.013; Scott DM, 2004, CAN HUMAN MODIFIED L; Sunquist ME, 2002, WILD CATS WORLD; Thompson W.L., 1998, MONITORING VERTEBRAT; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilting A, 2010, WILDLIFE SURVEYS SEG; Wilting A, 2012, ORYX, V46, P423, DOI 10.1017/S0030605311001694; Wilting Andreas, 2010, Small Carnivore Conservation, V42, P10; Wilting A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009612; Wilting Andreas, 2006, BMC Ecology, V6, P16, DOI 10.1186/1472-6785-6-16; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; WWF, 2012, HEART BORN NAT PRIOR; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	62	61	68	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77598	10.1371/journal.pone.0077598	http://dx.doi.org/10.1371/journal.pone.0077598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223717	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400011
J	Lyn, RK; Hope, G; Sherratt, AR; McLauchlan, J; Pezacki, JP				Lyn, Rodney K.; Hope, Graham; Sherratt, Allison R.; McLauchlan, John; Pezacki, John Paul			Bidirectional Lipid Droplet Velocities Are Controlled by Differential Binding Strengths of HCV Core DII Protein	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SIGNAL PEPTIDE PEPTIDASE; TUG-OF-WAR; CARS MICROSCOPY; IN-VIVO; INFECTIOUS VIRUS; MOLECULAR MOTORS; TRANSPORT; DYNEIN; REPLICATION	Host cell lipid droplets (LD) are essential in the hepatitis C virus (HCV) life cycle and are targeted by the viral capsid core protein. Core-coated LDs accumulate in the perinuclear region and facilitate viral particle assembly, but it is unclear how mobility of these LDs is directed by core. Herein we used two-photon fluorescence, differential interference contrast imaging, and coherent anti-Stokes Raman scattering microscopies, to reveal novel core-mediated changes to LD dynamics. Expression of core protein's lipid binding domain II (DII-core) induced slower LD speeds, but did not affect directionality of movement on microtubules. Modulating the LD binding strength of DII-core further impacted LD mobility, revealing the temporal effects of LD-bound DII-core. These results for DII-core coated LDs support a model for core-mediated LD localization that involves core slowing down the rate of movement of LDs until localization at the perinuclear region is accomplished where LD movement ceases. The guided localization of LDs by HCV core protein not only is essential to the viral life cycle but also poses an interesting target for the development of antiviral strategies against HCV.	[Lyn, Rodney K.; Sherratt, Allison R.; Pezacki, John Paul] Natl Res Council Canada, Ottawa, ON, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Hope, Graham; McLauchlan, John] Univ Glasgow, Ctr Virus Res, Med Res Council, Glasgow, Lanark, Scotland	National Research Council Canada; University of Ottawa; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow	McLauchlan, J (corresponding author), Univ Glasgow, Ctr Virus Res, Med Res Council, Glasgow, Lanark, Scotland.	john.mclauchlan@glasgow.ac.uk; john.pezacki@nrc-cnrc.gc.ca			National Research Council of Canada; Canadian Institutes for Health Research (CIHR); Ontario Graduate Scholarship; Medical Research Council [MC_UU_12014/1] Funding Source: researchfish; MRC [MC_UU_12014/1] Funding Source: UKRI	National Research Council of Canada; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the National Research Council of Canada and a grant from the Canadian Institutes for Health Research (CIHR). R. K. L. was the recipient of an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Alsaleh K, 2010, J VIROL, V84, P12515, DOI 10.1128/JVI.01393-10; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Clement S, 2007, J HEPATOL, V46, P985, DOI 10.1016/j.jhep.2007.03.005; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Erhardt A, 2002, VIROLOGY, V292, P272, DOI 10.1006/viro.2001.1227; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Hayashi J, 2000, HEPATOLOGY, V32, P958, DOI 10.1053/jhep.2000.19343; Henry T, 2006, CELL MICROBIOL, V8, P23, DOI 10.1111/j.1462-5822.2005.00649.x; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09; Kulic IM, 2008, P NATL ACAD SCI USA, V105, P10011, DOI 10.1073/pnas.0800031105; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lai CK, 2010, J VIROL, V84, P11590, DOI 10.1128/JVI.00587-10; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mazumder N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066738; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Pegoraro AF, 2009, OPT EXPRESS, V17, P20700, DOI 10.1364/OE.17.020700; Pegoraro AF, 2009, OPT EXPRESS, V17, P2984, DOI 10.1364/OE.17.002984; Perez-Berna AJ, 2008, J VIRAL HEPATITIS, V15, P346, DOI 10.1111/j.1365-2893.2007.00948.x; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pezacki JP, 2010, MOL BIOSYST, V6, P1131, DOI 10.1039/b924668c; Roingeard P, 2011, BIOL CELL, V103, P223, DOI 10.1042/BC20100119; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tang HL, 2009, CLIN SCI, V117, P49, DOI 10.1042/CS20080631; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836	77	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78065	10.1371/journal.pone.0078065	http://dx.doi.org/10.1371/journal.pone.0078065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223760	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300020
J	Pathak, SK; Tavares, R; de Klerk, N; Spetz, AL; Jonsson, AB				Pathak, Sushil Kumar; Tavares, Raquel; de Klerk, Nele; Spetz, Anna-Lena; Jonsson, Ann-Beth			Helicobacter pylori Protein JHP0290 Binds to Multiple Cell Types and Induces Macrophage Apoptosis via Tumor Necrosis Factor (TNF)-Dependent and Independent Pathways	PLOS ONE			English	Article							KAPPA-B ACTIVATION; FACTOR-ALPHA; GASTRIC-CANCER; INCREASED RISK; INFECTION; RELEASE; TNF; INTERLEUKIN-1-BETA; EXPRESSION; INDUCTION	Activated macrophages at the sub-mucosal space play a major role in generating innate immune responses during H. pylori infection. Final disease outcome largely depends on how H. pylori and bacterium-derived products modulate macrophage responses. Here, we report that JHP0290, a functionally unknown protein from H. pylori, regulates macrophage functions. Recombinant purified JHP0290 (rJHP0290) had the ability to bind to several cell types including macrophages, human gastric epithelial cell lines, human monocyte-derived dendritic cells (MoDC) and human neutrophils. Exposure to rJHP0290 induced apoptosis in macrophages concurrent with release of proinflammatory cytokine tumor necrosis factor (TNF). A mutant strain of H. pylori disrupted in the jhp0290 gene was significantly impaired in its ability to induce apoptosis and TNF in macrophages confirming the role of endogenous protein in regulating macrophage responses. Intracellular signaling involving Src family of tyrosine kinases (SFKs) and ERK MAPK were required for rJHP0290-induced TNF release and apoptosis in macrophages. Furthermore, rJHP0290-induced TNF release was partly dependent on activation of nuclear transcription factor-kappa B (NF-kappa B). Neutralizing antibodies against TNF partially blocked rJHP0290-induced macrophage apoptosis indicating TNF-independent pathways were also involved. These results provide mechanistic insight into the potential role of the protein JHP0290 during H. pylori-associated disease development. By virtue of its ability to induce TNF, an acid suppressive proinflammatory cytokine and induction of macrophage apoptosis, JHP0290 possibly helps in persistent survival of the bacterium inside the stomach.	[Pathak, Sushil Kumar; Tavares, Raquel; de Klerk, Nele; Jonsson, Ann-Beth] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Spetz, Anna-Lena] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Karolinska University Hospital	Pathak, SK (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	sushil.pathak@su.se; ann-beth.jonsson@su.se	Spetz, Anna-Lena/C-3543-2016	Spetz, Anna-Lena/0000-0003-3964-9512	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Swedish Research Council (www.vr.se) and the Swedish Cancer Society (www.cancerfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alvi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022530; Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Bhattacharyya A, 2002, BIOCHEM J, V368, P121, DOI 10.1042/BJ20020555; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Catrina AI, 2005, ARTHRITIS RHEUM-US, V52, P61, DOI 10.1002/art.20764; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Epplein M, 2012, CANCER EPIDEM BIOMAR, V21, P2185, DOI 10.1158/1055-9965.EPI-12-0792-T; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Haas G, 2002, PROTEOMICS, V2, P313, DOI 10.1002/1615-9861(200203)2:3<313::AID-PROT313>3.0.CO;2-7; Harris PR, 1998, J INFECT DIS, V178, P1516, DOI 10.1086/314426; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Kim N, 2002, J BACTERIOL, V184, P6155, DOI 10.1128/JB.184.22.6155-6162.2002; Li X, 2009, TOXICOL MECH METHOD, V19, P51, DOI 10.1080/15376510802354201; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; Parker H, 2012, MICROBES INFECT, V14, P9, DOI 10.1016/j.micinf.2011.08.007; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Ramarao N, 2001, INFECT IMMUN, V69, P2604, DOI 10.1128/IAI.69.4.2604-2611.2001; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; Schwartz JT, 2006, J LEUKOCYTE BIOL, V79, P1214, DOI 10.1189/jlb.0106030; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamauchi K, 2008, J IMMUNOL, V180, P1207, DOI 10.4049/jimmunol.180.2.1207	43	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77872	10.1371/journal.pone.0077872	http://dx.doi.org/10.1371/journal.pone.0077872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223737	gold, Green Submitted, Green Published			2022-12-27	WOS:000326499300012
J	Poon, AFY; Walker, LW; Murray, H; McCloskey, RM; Harrigan, PR; Liang, RH				Poon, Art F. Y.; Walker, Lorne W.; Murray, Heather; McCloskey, Rosemary M.; Harrigan, P. Richard; Liang, Richard H.			Mapping the Shapes of Phylogenetic Trees from Human and Zoonotic RNA Viruses	PLOS ONE			English	Article							EVOLUTIONARY; DIVERSIFICATION; PERFORMANCE; PYTHON	A phylogeny is a tree-based model of common ancestry that is an indispensable tool for studying biological variation. Phylogenies play a special role in the study of rapidly evolving populations such as viruses, where the proliferation of lineages is constantly being shaped by the mode of virus transmission, by adaptation to immune systems, and by patterns of human migration and contact. These processes may leave an imprint on the shapes of virus phylogenies that can be extracted for comparative study; however, tree shapes are intrinsically difficult to quantify. Here we present a comprehensive study of phylogenies reconstructed from 38 different RNA viruses from 12 taxonomic families that are associated with human pathologies. To accomplish this, we have developed a new procedure for studying phylogenetic tree shapes based on the 'kernel trick', a technique that maps complex objects into a statistically convenient space. We show that our kernel method outperforms nine different tree balance statistics at correctly classifying phylogenies that were simulated under different evolutionary scenarios. Using the kernel method, we observe patterns in the distribution of RNA virus phylogenies in this space that reflect modes of transmission and pathogenesis. For example, viruses that can establish persistent chronic infections (such as HIV and hepatitis C virus) form a distinct cluster. Although the visibly 'star-like' shape characteristic of trees from these viruses has been well-documented, we show that established methods for quantifying tree shape fail to distinguish these trees from those of other viruses. The kernel approach presented here potentially represents an important new tool for characterizing the evolution and epidemiology of RNA viruses.	[Poon, Art F. Y.; Murray, Heather; McCloskey, Rosemary M.; Harrigan, P. Richard; Liang, Richard H.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Poon, Art F. Y.; Harrigan, P. Richard] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Walker, Lorne W.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Diego	Poon, AFY (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	apoon@cfenet.ubc.ca	Poon, Art/W-9811-2019; Murray, Heather/GQY-8016-2022	Poon, Art/0000-0003-3779-154X; Walker, Lorne/0000-0002-2500-0504	Canadian Institutes of Health Research (CIHR) [HOP-111406]; Michael Smith Foundation for Health Research (MSFHR)/St. similar toPaul's Hospital Foundation-Providence Health Care Research Institute (SPHF-PHCRI); CIHR HIV Vaccine Initiative (CHVI) for Vaccine Discovery and Social Research; Simon Fraser University; University of British Columbia; CIHR/GSK Research Chair in Clinical Virology	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)/St. similar toPaul's Hospital Foundation-Providence Health Care Research Institute (SPHF-PHCRI); CIHR HIV Vaccine Initiative (CHVI) for Vaccine Discovery and Social Research(Canadian Institutes of Health Research (CIHR)); Simon Fraser University; University of British Columbia; CIHR/GSK Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institutes of Health Research (CIHR) operating grant (HOP-111406) awarded to AFYP. AFYP is supported by a Scholar Award from the Michael Smith Foundation for Health Research (MSFHR)/St. similar to Paul's Hospital Foundation-Providence Health Care Research Institute (SPHF-PHCRI) Career Investigator program, and by a New Investigator Award from the CIHR HIV Vaccine Initiative (CHVI) for Vaccine Discovery and Social Research. RMM was supported by a Vice President Research Undergraduate Student Research Award (VPR-USRA) from Simon Fraser University. HM was supported by a Centre for Blood Research Summer Studentship from the University of British Columbia. PRH is supported by a CIHR/GSK Research Chair in Clinical Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Aizerman A., 1964, AUTOMAT REM CONTR, V25, P821, DOI DOI 10.1234/12345678; Bernhard S., 2004, KERNEL METHODS COMPU, P35; Blum MGB, 2005, MATH BIOSCI, V195, P141, DOI 10.1016/j.mbs.2005.03.003; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Collins M., 2002, ADV NEURAL INFORM PR, V14; Dalcin L, 2008, J PARALLEL DISTR COM, V68, P655, DOI 10.1016/j.jpdc.2007.09.005; Drake JW, 1998, GENETICS, V148, P1667; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; Frost SDW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0208; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Karatzoglou A., 2004, R J STAT SOFTW, V11, P1; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Moschitti A., 2006, P 11 C EUR CHAPT ASS, P113; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Pompei S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044849; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Purvis A, 2002, J THEOR BIOL, V214, P99, DOI 10.1006/jtbi.2001.2443; Ratmann O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002835; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; Scholkopf B, 2000, NEURAL COMPUTATION, V12, P1207; Sharp PM, 2002, CELL, V108, P305, DOI 10.1016/S0092-8674(02)00639-6; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talevich E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-209; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weston J, 2003, ANN I STAT MATH, V55, P391, DOI 10.1023/A:1026338322729; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107	42	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78122	10.1371/journal.pone.0078122	http://dx.doi.org/10.1371/journal.pone.0078122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223766	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300023
J	Schulz, PJ; Hartung, U; Riva, S				Schulz, Peter J.; Hartung, Uwe; Riva, Silvia			Causes, Coping, and Culture: A Comparative Survey Study on Representation of Back Pain in Three Swiss Language Regions	PLOS ONE			English	Article							ILLNESS REPRESENTATIONS; PRIMARY-CARE; ATTRIBUTIONS; PERCEPTIONS; OUTCOMES; HEALTH; SWITZERLAND; ADJUSTMENT; DEPRESSION; PREDICTOR	Introduction: This study intends to contribute to a research tradition that asks how causal attributions of illnesses affect coping behavior. Causal attributions are understood as the most important element of illness representations and coping as a means to preserve quality of life. The issue is applied to a condition so far often neglected in research on illness representations-back pain-and a third concept is added to the picture: culture. Aim: The aim of this study is (a) to explore the causal factors to which persons with back pain attribute the further course of their illness, (b) to find out whether the attributed causes are predictors of coping maxims, and (c) to find out whether cultural factors affect attributions and coping and moderate the relationship between the two. Methods: A total of 1259 gainfully employed or self-employed persons with recent episodes of back pain were recruited in the three language regions of Switzerland. They were asked to complete a structured online interview, measuring among many other variables attributed causes, coping maxims, and affiliation to one of the Swiss micro-cultures (German-, French- or Italian-speaking). Results: Attributed causes of the illness that can be influenced by a patient go along with more active coping styles. Cultural affiliation impacts on coping maxims independently, but culture moderates the relationship of attributed causes and coping maxims only in two of twenty possible cases. Implications: The results show that cultural differences can be analytically incorporated in the models of illness representations. Results may help to improve healthcare providers' communication with patients and plan public health campaigns. The approach to micro-cultural differences and the substantive relationships between alterability of causes and activity in coping may help the further development of models of illness representations.	[Schulz, Peter J.; Hartung, Uwe; Riva, Silvia] Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland	Universita della Svizzera Italiana	Schulz, PJ (corresponding author), Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland.	schulzp@usi.ch	Schulz, Peter/AAM-9816-2020; Riva, Silvia/M-3163-2013; Schulz, Peter/GQQ-1290-2022; , Silvia/H-8838-2019	Schulz, Peter/0000-0003-4281-489X; Riva, Silvia/0000-0003-2153-0169; Schulz, Peter/0000-0003-4281-489X; 	SUVA - a Swiss insurance company	SUVA - a Swiss insurance company	The authors received funding from SUVA - a Swiss insurance company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhan JH, 1998, PERS SOC PSYCHOL B, V24, P1006, DOI 10.1177/0146167298249008; Baum A., 2012, HDB HLTH PSYCHOL, V2nd, P3; BHUGRA D, 1998, BRIT J PSYCHOTHERAPY, V14, P310, DOI DOI 10.1111/J.1752-0118.1998.TB00385.X; Billari F.C., 2001, INT J POPULATION GEO, V7, P339, DOI DOI 10.1002/IJPG.231; Carroll LJ, 2004, PAIN, V107, P134, DOI 10.1016/j.pain.2003.10.009; Chen SL, 2009, J CLIN NURS, V18, P2234, DOI 10.1111/j.1365-2702.2008.02706.x; Confino Alon, 1997, NATION LOCAL METAPHO; Dalal AK, 1992, PSYCHOL HEALTH, V6, P193; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; FOLKMAN S, 1992, PERSONAL COPING THEO, P31, DOI DOI 10.1037/0022-3514.50.5.992; Foster NE, 2008, PAIN, V136, P177, DOI 10.1016/j.pain.2007.12.007; Foster NE, 2010, PAIN, V148, P398, DOI 10.1016/j.pain.2009.11.002; Glattacker M, 2012, PATIENT EDUC COUNS, V86, P378, DOI 10.1016/j.pec.2011.05.028; Groarke AM, 2005, PSYCHOL HEALTH, V20, P597, DOI 10.1080/14768320500094177; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Heijmans M, 1998, J BEHAV MED, V21, P485, DOI 10.1023/A:1018788427100; Heijmans MJWM, 1998, J PSYCHOSOM RES, V45, P39, DOI 10.1016/S0022-3999(97)00265-1; Hoth KF, 2011, J PSYCHOSOM RES, V70, P465, DOI 10.1016/j.jpsychores.2010.10.005; Hurt CS, 2012, INT J GERIATR PSYCH, V27, P394, DOI 10.1002/gps.2731; Jessop DC, 2003, PSYCHOL HEALTH, V18, P595, DOI 10.1080/0887044031000097009; Kelly MAR, 2007, BRIT J CLIN PSYCHOL, V46, P315, DOI 10.1348/014466506X173070; Kim Y, 2012, NEPHROL NURS J, V39, P39; Koehler M, 2009, CRIT REV ONCOL HEMAT, V69, P237, DOI 10.1016/j.critrevonc.2008.09.014; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LAWSON K, 1990, PAIN, V43, P195, DOI 10.1016/0304-3959(90)91073-R; Lazarus R.S., 1984, EMOTION ADAPTATION; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; Pluss-Suard C, 2011, J HOSP INFECT, V79, P166, DOI 10.1016/j.jhin.2011.05.028; Reynolds NR, 2009, AIDS BEHAV, V13, P258, DOI 10.1007/s10461-007-9297-5; Reynolds N, 2013, J ADOLESCENT HEALTH, V52, P559, DOI 10.1016/j.jadohealth.2012.09.007; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; Schulz PJ, 2006, PATIENT EDUC COUNS, V64, P294, DOI 10.1016/j.pec.2006.03.009; Stuifbergen AK, 2006, WOMEN HEALTH ISS, V16, P353, DOI 10.1016/j.whi.2006.05.003; Tennen H, 2000, AM PSYCHOL, V55, P626, DOI 10.1037//0003-066X.55.6.626; Torriani R, 2002, J CONTEMP HIST, V37, P559, DOI 10.1177/00220094020370040401; Utsey S., 2000, J BLACK PSYCHOL, V26, P194, DOI DOI 10.1177/0095798400026002005; Utsey SO, 2007, J BLACK PSYCHOL, V33, P75, DOI 10.1177/0095798406295094; vanTulder MW, 1997, SPINE, V22, P2128, DOI 10.1097/00007632-199709150-00012; Wright LJ, 2010, J PAIN, V11, P628, DOI 10.1016/j.jpain.2009.10.004	41	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78029	10.1371/journal.pone.0078029	http://dx.doi.org/10.1371/journal.pone.0078029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245XZ	24223756	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300019
J	Blaskovich, MA; Yendluri, V; Lawrence, HR; Lawrence, NJ; Sebti, SM; Springett, GM				Blaskovich, Michelle A.; Yendluri, Vimala; Lawrence, Harshani R.; Lawrence, Nicholas J.; Sebti, Said M.; Springett, Gregory M.			Lysophosphatidic Acid Acyltransferase Beta Regulates mTOR Signaling	PLOS ONE			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; CELL-CYCLE PROGRESSION; PROTEIN-KINASE-C; PHOSPHATIDIC-ACID; MAMMALIAN TARGET; TUMOR-CELLS; COMPLEX; IDENTIFICATION; ACTIVATION; APOPTOSIS	Lysophosphatidic acid acyltransferase (LPAAT-beta) is a phosphatidic acid (PA) generating enzyme that plays an essential role in triglyceride synthesis. However, LPAAT-beta is now being studied as an important regulator of cell growth and differentiation and as a potential therapeutic target in cancer since PA is necessary for the activity of key proteins such as Raf, PKC-zeta and mTOR. In this report we determine the effect of LPAAT-beta silencing with siRNA in pancreatic adenocarcinoma cell lines. We show for the first time that LPAAT-beta knockdown inhibits proliferation and anchorage-independent growth of pancreatic cancer cells. This is associated with inhibition of signaling by mTOR as determined by levels of mTORC1- and mTORC2-specific phosphorylation sites on 4E-BP1, S6K and Akt. Since PA regulates the activity of mTOR by modulating its binding to FKBP38, we explored the possibility that LPAAT-beta might regulate mTOR by affecting its association with FKBP38. Coimmunoprecipitation studies of FKBP38 with mTOR show increased levels of FKBP38 associated with mTOR when LPAAT-beta protein levels are knocked down. Furthermore, depletion of LPAAT-beta results in increased Lipin 1 nuclear localization which is associated with increased nuclear eccentricity, a nuclear shape change that is dependent on mTOR, further confirming the ability of LPAAT-beta to regulate mTOR function. Our results provide support for the hypothesis that PA generated by LPAAT-beta regulates mTOR signaling. We discuss the implications of these findings for using LPAAT-beta as a therapeutic target.	[Blaskovich, Michelle A.; Yendluri, Vimala; Springett, Gregory M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL 33612 USA; [Lawrence, Harshani R.; Lawrence, Nicholas J.; Sebti, Said M.; Springett, Gregory M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Springett, Gregory M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA; [Lawrence, Harshani R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Chem Biol Core, Tampa, FL 33612 USA; [Lawrence, Harshani R.; Lawrence, Nicholas J.; Sebti, Said M.] Univ S Florida, Dept Oncol Sci, Tampa, FL USA; [Sebti, Said M.] Univ S Florida, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Blaskovich, MA (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL 33612 USA.	michelle.blaskovich@moffitt.org			National Institutes of Health (NIH) [RO1CA131400-01A2]; American Cancer Society [93-032-10]; Shirley E. Noland Foundation, Melbourne, FL; National Cancer Institute [P30-CA076292]; NATIONAL CANCER INSTITUTE [R01CA131400, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Shirley E. Noland Foundation, Melbourne, FL; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health (NIH) RO1CA131400-01A2, Institutional Research Grant number 93-032-10 from the American Cancer Society, and the Shirley E. Noland Foundation, Melbourne, FL. The H. Lee Moffitt Cancer Center Chemical Biology and Analytical Microscopy Cores are supported by the National Cancer Institute Award number P30-CA076292 as a Cancer Center Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, TRENDS ENDOCRIN MET, V14, P214, DOI 10.1016/S1043-2760(03)00078-X; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Bonham L, 2003, EXPERT OPIN THER TAR, V7, P643; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Coon M, 2003, MOL CANCER THER, V2, P1067; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fleming JB, 2005, MOL CANCER RES, V3, P413, DOI 10.1158/1541-7786.MCR-04-0206; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Hideshima T, 2003, CANCER RES, V63, P8428; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; La Rosee P, 2006, CLIN CANCER RES, V12, P6540, DOI 10.1158/1078-0432.CCR-06-0140; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Li D, 2003, J HUM GENET, V48, P438, DOI 10.1007/s10038-003-0045-z; Li HS, 2003, BMC CELL BIOL, V4, P1, DOI 10.1186/1471-2121-4-13; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Litosch I, 2003, BIOCHEMISTRY-US, V42, P1618, DOI 10.1021/bi026414h; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Pagel JM, 2005, CLIN CANCER RES, V11, P4857, DOI 10.1158/1078-0432.CCR-04-2352; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Springett GM, 2005, CANCER RES, V65, P9415, DOI 10.1158/0008-5472.CAN-05-0516; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Tang WW, 2006, J BIOCHEM MOL BIOL, V39, P626; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	38	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78632	10.1371/journal.pone.0078632	http://dx.doi.org/10.1371/journal.pone.0078632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205284	Green Submitted, gold, Green Published			2022-12-27	WOS:000326373800021
J	Poutahidis, T; Kearney, SM; Levkovich, T; Qi, PM; Varian, BJ; Lakritz, JR; Ibrahim, YM; Chatzigiagkos, A; Alm, EJ; Erdman, SE				Poutahidis, Theofilos; Kearney, Sean M.; Levkovich, Tatiana; Qi, Peimin; Varian, Bernard J.; Lakritz, Jessica R.; Ibrahim, Yassin M.; Chatzigiagkos, Antonis; Alm, Eric J.; Erdman, Susan E.			Microbial Symbionts Accelerate Wound Healing via the Neuropeptide Hormone Oxytocin	PLOS ONE			English	Article							REGULATORY T-CELLS; GUT MICROBIOTA; IMMUNE-SYSTEM; VAGUS NERVE; INTESTINAL MICROBIOTA; INFLAMMATORY RESPONSE; SOCIAL-BEHAVIOR; MICE; LYMPHOCYTES; VASOPRESSIN	Wound healing capability is inextricably linked with diverse aspects of physical fitness ranging from recovery after minor injuries and surgery to diabetes and some types of cancer. Impact of the microbiome upon the mammalian wound healing process is poorly understood. We discover that supplementing the gut microbiome with lactic acid microbes in drinking water accelerates the wound-healing process to occur in half the time required for matched control animals. Further, we find that Lactobacillus reuteri enhances wound-healing properties through up-regulation of the neuropeptide hormone oxytocin, a factor integral in social bonding and reproduction, by a vagus nerve-mediated pathway. Bacteria-triggered oxytocin serves to activate host CD4+Foxp3+CD25+ immune T regulatory cells conveying transplantable wound healing capacity to naive Rag2-deficient animals. This study determined oxytocin to be a novel component of a multi-directional gut microbe-brain-immune axis, with wound-healing capability as a previously unrecognized output of this axis. We also provide experimental evidence to support long-standing medical traditions associating diet, social practices, and the immune system with efficient recovery after injury, sustained good health, and longevity.	[Poutahidis, Theofilos; Kearney, Sean M.; Levkovich, Tatiana; Qi, Peimin; Varian, Bernard J.; Lakritz, Jessica R.; Ibrahim, Yassin M.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos; Chatzigiagkos, Antonis] Aristotle Univ Thessaloniki, Fac Vet Med, Pathol Lab, GR-54006 Thessaloniki, Greece; [Kearney, Sean M.; Alm, Eric J.] MIT, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Erdman, SE (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	serdman@mit.edu		Lakritz, Jessica/0000-0003-2510-3869	National Institutes of Health [P30-ES002109, U01 CA164337, RO1CA108854]; NATIONAL CANCER INSTITUTE [U01CA164337, R01CA108854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants P30-ES002109 (pilot project award to SEE and EJA), U01 CA164337 (to SEE and EJA), and RO1CA108854 (to SEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber C, 2011, J INVEST DERMATOL, V131, P278, DOI 10.1038/jid.2010.409; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Barnard A, 2008, NEUROIMMUNOMODULAT, V15, P7, DOI 10.1159/000135619; Belkaid Y, 2010, CLIN EXP IMMUNOL, V160, P35, DOI 10.1111/j.1365-2249.2010.04131.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Chow J, 2009, CELL HOST MICROBE, V5, P8, DOI 10.1016/j.chom.2008.12.006; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Costa RA, 2011, WOUND REPAIR REGEN, V19, P487, DOI 10.1111/j.1524-475X.2011.00700.x; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cukjati D, 2001, MED BIOL ENG COMPUT, V39, P263, DOI 10.1007/BF02344811; Davari S, 2013, NEUROSCIENCE; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Detillion CE, 2004, PSYCHONEUROENDOCRINO, V29, P1004, DOI 10.1016/j.psyneuen.2003.10.003; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; DREIFUSS JJ, 1988, BRAIN RES BULL, V20, P765, DOI 10.1016/0361-9230(88)90089-5; DVORAK AM, 1986, NEW ENGL J MED, V315, P969; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2003, CANCER RES, V63, P6042; Erdman SE, 2001, GASTROENTEROLOGY, V120, pA524, DOI 10.1016/S0016-5085(08)82601-7; Erdman SE, 2009, P NATL ACAD SCI US; Erdman SE, 2010, INT J CANCER, V126, P1651, DOI 10.1002/ijc.24923; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Floch MH, 2011, J CLIN GASTROENTEROL, V45, pS168, DOI 10.1097/MCG.0b013e318230928b; Frank S, 2003, METH MOLEC MED, V78, P3; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Gajendrareddy PK, 2013, BRAIN BEHAV IMMUN, V28, P44, DOI 10.1016/j.bbi.2012.10.016; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Grose R, 2004, MOL BIOTECHNOL, V28, P147, DOI 10.1385/MB:28:2:147; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hansenne I, 2009, NEUROIMMUNOMODULAT, V16, P35, DOI 10.1159/000179665; Ho JM, 2013, ENDOCRINOLOGY, V154, P589, DOI 10.1210/en.2012-1751; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Jercinovic A., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P225, DOI 10.1109/86.340876; JOHNSON HM, 1985, J IMMUNOL, V135, pS773; Johnston GR, 2009, BRIT J ANAESTH, V102, P453, DOI 10.1093/bja/aep037; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056547; Maccio A, 2010, IN VIVO, V24, P157; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McVey Neufeld KA, 2013, TRENDS NEUROSCI; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Ndiaye K, 2008, BIOL REPROD, V78, P786, DOI 10.1095/biolreprod.107.065938; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nomura T, 2007, NAT IMMUNOL, V8, P333, DOI 10.1038/ni0407-333; Oliveira-Pelegrin GR, 2013, NEUROIMMUNOMODULAT, V20, P65, DOI 10.1159/000345044; Pittman QJ, 2011, J NEUROENDOCRINOL, V23, P1296, DOI 10.1111/j.1365-2826.2011.02176.x; Poutahidis T, 2013, PLOS ONE, V10; Poutahidis T, 2007, CARCINOGENESIS, V28, P2614, DOI 10.1093/carcin/bgm180; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Ran VP, 2007, CANCER RES, V67, P847, DOI 10.1158/0008-5472.CAN-06-3468; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Richards H, 2010, IMMUNOLOGY, V131, P583, DOI 10.1111/j.1365-2567.2010.03333.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x; Shanahan F, 2012, NAT REV GASTRO HEPAT, V9, P609, DOI 10.1038/nrgastro.2012.145; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Swift ME, 1999, LAB INVEST, V79, P1479; Tkalcevic VI, 2009, TOXICOL PATHOL, V37, P183, DOI 10.1177/0192623308329280; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Williams Z, 2012, NEW ENGL J MED, V367, P1159, DOI 10.1056/NEJMcibr1207279; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9	85	157	160	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78898	10.1371/journal.pone.0078898	http://dx.doi.org/10.1371/journal.pone.0078898			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205344	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500139
J	Preuschoft, H; Klein, N				Preuschoft, Holger; Klein, Nicole			Torsion and Bending in the Neck and Tail of Sauropod Dinosaurs and the Function of Cervical Ribs: Insights from Functional Morphology and Biomechanics	PLOS ONE			English	Article							POSTURE	The long necks of sauropods have been subject to many studies regarding their posture and flexibility. Length of the neck varies among groups. Here, we investigate neck posture and morphology in several clades from a mechanical viewpoint. Emphasis is put on comparing sauropod necks and tails with structures in living archosaurs and mammals. Differences in the use made of necks and tails lead to clear-cut differences in the mechanical loads occurring in the same models. Ways of sustaining loads are identified by theoretical considerations. If the observed skeletal structures are suited to resist the estimated loading in a particular posture, this concordance is taken as an argument that this posture or movement was of importance during the life of the individual. Apart from the often-discussed bending in side view, we analyze the often overlooked torsion. Because torsional stresses in a homogenous element concentrate near the periphery, a cylindrical cross section gives greatest strength, and the direction of forces is oblique. In a vertebrate neck, during e. g. shaking the head and twisting the neck, oblique muscles, like the mm. scaleni, if activated unilaterally initiate movement, counterbalance the torsional moments and keep the joints between neck vertebrae in equilibrium. If activated bilaterally, these muscles keep the neck balanced in an energy-saving upright posture. The tendons of the mm. scaleni may have ossified as cervical ribs The long cervical ribs in brachiosaurids and mamenchisaurids seem to have limited flexibility, whereas the shorter cervical ribs in Diplodocidae allowed free movement. The tails of sauropods do not show pronounced adaptation to torsion, and seem to have been carried more or less in a horizontal, extended posture. In this respect, sauropod tails resemble the necks of herbivorous cursorial mammals. These analyses provide an improved understanding of neck use that will be extended to other sauropods in subsequent studies.	[Preuschoft, Holger] Ruhr Univ Bochum, Inst Anat, Bochum, Germany; [Klein, Nicole] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany	Ruhr University Bochum	Klein, N (corresponding author), Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany.	nicole.klein@smns-bw.de			DFG [FOR 533/N2]	DFG(German Research Foundation (DFG))	NK (second and corresponding author) was funded by the DFG (DFG Projekt FOR 533/N2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O, 1909, ABH ZOOL BOT GESELLS, V5, P1; Cerda IA, 2009, AMEGHINIANA, V46, P193; Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; Bird Roland T., 1944, NAT HIST [NEW YORK], V53, P60; Blickhan R, 2007, BIOMECHANIK AXIALEN, P179; Bock W. J., 1974, AVIAN BIOL, V4, P119; BOCK WJ, 1965, EVOLUTION, V19, P269, DOI 10.2307/2406439; Christian A, 2002, MITTEILUNGEN MUSEUMS, V5, P269; Christian Andreas, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P73; Christian Andreas, 2007, Fossil Record, V10, P38; Christian Andreas, 2011, P251; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Dubbel H, 1981, TASCHENBUCH MASCHINE; Dzemski G, 2006, THESIS U FLENSBURG F; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Fechner R, 2009, THESIS U MUNCHEN MUN; Fechner R, 2013, J ANAT, V222, P305, DOI 10.1111/joa.12015; Frey E, 1997, ENCY DINOSAURS, P406; Furbringer M, 1876, MORPHOL JB, V1, P636; Gasc J.-P., 1981, Biology of Reptilia, V11, P355; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Guibe J, 1970, TRAITE ZOOL, VXIV, P701; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hohn Bianca, 2011, P182; Klein N., 2011, BIOL SAUROPOD DINOSA; Klein N, 2012, BIOL LETTERS, V8, P1032, DOI 10.1098/rsbl.2012.0778; KNESE KH, 1958, Z ZELLFORSCH MIK ANA, V49, P142, DOI 10.1007/BF00324425; Kummer B., 1959, BAUPRINZIPIEN SAUGER; Lehmann T, 1974, ELEMENTE MECH, V1-3; Mallison Heinrich, 2011, P237; Mallison H, 2005, J VERTEBR PALEONTOL, V25, p88A; Martin John, 1998, Oryctos, V1, P113; Nickel R, 1973, LEHRBUCH ANATOMIE HA, V5; Nishi S, 1938, HDB VERGLEICHENDEN A, V5, P351; Organ CL, 2005, J VERTEBR PALEONTOL, V25, P602, DOI 10.1671/0272-4634(2005)025[0602:THOOTI]2.0.CO;2; Pauwels F., 1965, GESAMMELTE ABHANDLUN; PREUSCHO.H, 1974, Z ANAT ENTWICKLUNGS, V143, P315, DOI 10.1007/BF00519872; PREUSCHOFT H, 1969, Z ANAT ENTWICKLUNGS, V129, P285, DOI 10.1007/BF00521122; Preuschoft H, 2005, ZBLT GEO PAL 2, VII, P339; Preuschoft H, 1976, NATURFORSCH GES EVOL, P98; Preuschoft H, 1993, EVOLUTION ANPASSUNG, P43; Preuschoft H, 2007, MERTENSIELLA, V16, P58; Preuschoft H., 1970, THE CHIMPANZEE, V3, P221; Preuschoft H., 1973, THE CHIMPANZEE, V6, P34; Preuschoft Holger, 2011, P197; Preuschoft Holger, 1994, Verhandlungen der Deutschen Zoologischen Gesellschaft, V87, P147; Romer A, 1956, OSTEOLOGY REPTILES; Ruxton GD, 2011, BIOL LETTERS, V7, P779, DOI 10.1098/rsbl.2011.0116; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2009, SCIENCE, V323, P1671; Shorrocks B, 2009, GIRAFFA, V3, P22; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Sverdlova NS, 2010, J BIOMECH, V43, P387, DOI 10.1016/j.jbiomech.2009.09.049; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Thulborn T., 1989, DINOSAUR TRACKS TRAC, P39; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; Wedel Mathew J., 2002, Paleobios, V22, P1; Wedel MJ, 2006, INTEGR ZOOL, V1, P80, DOI 10.1111/j.1749-4877.2006.00019.x; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; WITTE H, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P407; Wolff J, 1892, GESETZ TRANSFORMATIO	67	17	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78574	10.1371/journal.pone.0078574	http://dx.doi.org/10.1371/journal.pone.0078574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205268	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500127
J	Jiang, CM; Lim, VK; Wang, H; Hamm, JP				Jiang, Cunmei; Lim, Vanessa K.; Wang, Hang; Hamm, Jeff P.			Difficulties with Pitch Discrimination Influences Pitch Memory Performance: Evidence from Congenital Amusia	PLOS ONE			English	Article							SHORT-TERM-MEMORY; FREQUENCY DISCRIMINATION; PHONOLOGICAL SIMILARITY; SPEECH INTONATION; WORKING-MEMORY; PERCEPTION; TONES; INTERFERENCE; RECOGNITION; SENSITIVITY	Music processing is influenced by pitch perception and memory. Additionally these features interact, with pitch memory performance decreasing as the perceived distance between two pitches decreases. This study examined whether or not the difficulty of pitch discrimination influences pitch retention by testing individuals with congenital amusia. Pitch discrimination difficulty was equated by determining an individual's threshold with a two down one up staircase procedure and using this to create conditions where two pitches (the standard and the comparison tones) differed by 1x, 2x, and 3x the threshold setting. For comparison with the literature a condition that employed a constant pitch difference of four semitones was also included. The results showed that pitch memory performance improved as the discrimination between the standard and the comparison tones was made easier for both a music and control groups, and more importantly, that a musics did not show any pitch retention deficits when the discrimination difficulty was equated. In contrast, consistent with previous literature, a musics performed worse than controls when the physical pitch distance was held constant at four semitones. This impaired performance has been interpreted as evidence for pitch memory impairment in the past. However, employing a constant pitch distance always makes the difference closer to the discrimination threshold for the a music group than for the control group. Therefore, reduced performance in this condition may simply reflect differences in the perceptual difficulty of the discrimination. The findings indicate the importance of equating the discrimination difficulty when investigating memory.	[Jiang, Cunmei; Wang, Hang] Shanghai Normal Univ, Mus Coll, Shanghai, Peoples R China; [Lim, Vanessa K.; Hamm, Jeff P.] Univ Auckland, Cognit Neurosci Res Grp, Auckland 1, New Zealand	Shanghai Normal University; University of Auckland	Jiang, CM (corresponding author), Shanghai Normal Univ, Mus Coll, Shanghai, Peoples R China.	cunmeijiang@126.com; j.hamm@auckland.ac.nz	Jiang, Jan/ABF-1730-2020	Jiang, Cunmei/0000-0002-0264-5924	Shanghai Normal University	Shanghai Normal University	This work was supported by funding provided by Shanghai Normal University to CJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; BADDELEY A, 1984, Q J EXP PSYCHOL-A, V36, P233, DOI 10.1080/14640748408402157; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P362, DOI 10.1080/14640746608400055; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; COOK N, 1987, MUSIC PERCEPT, V5, P197; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; DEUTSCH D, 1975, MEM COGNITION, V3, P263, DOI 10.3758/BF03212909; DEUTSCH D, 1972, SCIENCE, V175, P1020, DOI 10.1126/science.175.4025.1020; DEUTSCH D, 1973, J EXP PSYCHOL, V100, P228, DOI 10.1037/h0035440; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Gosselin N, 2009, ANN NY ACAD SCI, V1169, P270, DOI 10.1111/j.1749-6632.2009.04762.x; Halliday LF, 2006, J RES READ, V29, P213, DOI 10.1111/j.1467-9817.2006.00286.x; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Hautus MJ, 2002, PERCEPT PSYCHOPHYS, V64, P89, DOI 10.3758/BF03194559; Huron D., 1993, PSYCHOMUSICOLOGY J R, V12, P154, DOI DOI 10.1037/H0094110; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Jiang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041411; Jiang CM, 2012, MEM COGNITION, V40, P1109, DOI 10.3758/s13421-012-0208-2; Jiang CM, 2011, MUSIC PERCEPT, V28, P519, DOI 10.1525/MP.2011.28.5.519; Jiang CM, 2010, NEUROPSYCHOLOGIA, V48, P2630, DOI 10.1016/j.neuropsychologia.2010.05.009; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liu F, 2012, BRAIN COGNITION, V79, P209, DOI 10.1016/j.bandc.2012.03.008; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030374; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; Macmillan NA, 2005, DETECTION THEORY USE; Marin MM, 2012, NEUROPSYCHOLOGIA, V50, P367, DOI 10.1016/j.neuropsychologia.2011.12.006; McDonald C, 2008, MUSIC PERCEPT, V25, P345, DOI 10.1525/MP.2008.25.4.345; Mengler ED, 2005, DYSLEXIA, V11, P155, DOI 10.1002/dys.302; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2009, BRAIN, V132, P1277, DOI 10.1093/brain/awp055; Schacter DL, 2000, OXFORD HDB MEMORY, P627; Schulze K, 2011, EUR J NEUROSCI, V33, P189, DOI 10.1111/j.1460-9568.2010.07470.x; Schulze K, 2012, MUSIC PERCEPT, V29, P255, DOI 10.1525/MP.2012.29.3.255; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Semal C, 1996, J ACOUST SOC AM, V100, P1132, DOI 10.1121/1.416298; SURPRENANT AM, 1993, Q J EXP PSYCHOL-A, V46, P193, DOI 10.1080/14640749308401044; Surprenant AM, 1999, MEMORY, V7, P405, DOI 10.1080/741944920; Thompson WF, 2012, P NATL ACAD SCI USA, V109, P19027, DOI 10.1073/pnas.1210344109; Tillmann B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00120; Tillmann B, 2009, BRAIN COGNITION, V71, P259, DOI 10.1016/j.bandc.2009.08.003; Williamson VJ, 2012, NEUROPSYCHOLOGIA, V50, P172, DOI 10.1016/j.neuropsychologia.2011.11.015; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Williamson VJ, 2010, ADV COGN PSYCHOL, V6, P15, DOI 10.2478/v10053-008-0073-5; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339	51	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79216	10.1371/journal.pone.0079216	http://dx.doi.org/10.1371/journal.pone.0079216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205375	Green Submitted, gold, Green Published			2022-12-27	WOS:000326155400114
J	Tortelli, F; Pisano, M; Briquez, PS; Martino, MM; Hubbell, JA				Tortelli, Federico; Pisano, Marco; Briquez, Priscilla S.; Martino, Mikael M.; Hubbell, Jeffrey A.			Fibronectin Binding Modulates CXCL11 Activity and Facilitates Wound Healing	PLOS ONE			English	Article							GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; HEPARIN; CXCR3; KERATINOCYTES; FIBRIN(OGEN); EXPRESSION; FIBRINOGEN; DOMAIN; IP-10	Engineered biomatrices offer the potential to recapitulate the regenerative microenvironment, with important implications in tissue repair. In this context, investigation of the molecular interactions occurring between growth factors, cytokines and extracellular matrix (ECM) has gained increasing interest. Here, we sought to investigate the possible interactions between the ECM proteins fibronectin (FN) and fibrinogen (Fg) with the CXCR3 ligands CXCL9, CXCL10 and CXCL11, which are expressed during wound healing. New binding interactions were observed and characterized. Heparin-binding domains within Fg (residues 15-66 of the beta chain, Fg beta 15-66) and FN (FNI1-5, but not FNIII12-14) were involved in binding to CXCL10 and CXCL11 but not CXCL9. To investigate a possible influence of FN and Fg interactions with CXCL11 in mediating its role during re-epithelialization, we investigated human keratinocyte migration in vitro and wound healing in vivo in diabetic db/db mice. A synergistic effect on CXCL11-induced keratinocyte migration was observed when cells were treated with CXCL11 in combination with FN in a transmigration assay. Moreover, wound healing was enhanced in full thickness excisional wounds treated with fibrin matrices functionalized with FN and containing CXCL11. These findings highlight the importance of the interactions occurring between cytokines and ECM and point to design concepts to develop functional matrices for regenerative medicine.	[Tortelli, Federico; Pisano, Marco; Briquez, Priscilla S.; Martino, Mikael M.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Tortelli, Federico; Pisano, Marco; Briquez, Priscilla S.; Martino, Mikael M.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	Hubbell, Jeffrey A/A-9266-2008; Martino, Mikaël M/N-9345-2013	Hubbell, Jeffrey A/0000-0003-0276-5456; Martino, Mikaël M/0000-0002-5012-4605; Briquez, Priscilla/0000-0002-4680-9636	European Commission project Angioscaff; Swiss National Science Foundation	European Commission project Angioscaff; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded in part by the European Commission project Angioscaff and by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artlett CM, 2013, J PATHOL, V229, P157, DOI 10.1002/path.4116; Campanella GSV, 2003, J BIOL CHEM, V278, P17066, DOI 10.1074/jbc.M212077200; Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49; Davidson JM, 2010, AM J PATHOL, V176, P1588, DOI 10.2353/ajpath.2010.100064; De Laporte L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062076; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Fluhr H, 2011, FERTIL STERIL, V95, P1272, DOI 10.1016/j.fertnstert.2010.04.061; Haapasalmi K, 1996, J INVEST DERMATOL, V106, P42, DOI 10.1111/1523-1747.ep12327199; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Najjam S, 1997, CYTOKINE, V9, P1013, DOI 10.1006/cyto.1997.0246; Orosz F, 2002, J IMMUNOL METHODS, V270, P155, DOI 10.1016/S0022-1759(02)00295-8; Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; Sahni A, 2006, BLOOD, V107, P126, DOI 10.1182/blood-2005-06-2460; Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554; Satish L, 2005, MOL CELL BIOL, V25, P1922, DOI 10.1128/MCB.25.5.1922-1941.2005; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Suehiro K, 2000, J BIOCHEM, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Yates CC, 2010, AM J PATHOL, V176, P1743, DOI 10.2353/ajpath.2010.090564; Yates CC, 2009, WOUND REPAIR REGEN, V17, P34, DOI 10.1111/j.1524-475X.2008.00439.x	36	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79610	10.1371/journal.pone.0079610	http://dx.doi.org/10.1371/journal.pone.0079610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205388	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400117
J	Fischer, S; Kittler, S; Klein, G; Glunder, G				Fischer, Samuel; Kittler, Sophie; Klein, Guenter; Gluender, Gerhard			Impact of a Single Phage and a Phage Cocktail Application in Broilers on Reduction of Campylobacter jejuni and Development of Resistance	PLOS ONE			English	Article							CONTROL STRATEGIES; THERMOPHILIC CAMPYLOBACTER; EXPOSURE ASSESSMENT; BACTERIOPHAGES; POULTRY; CONTAMINATION; PREVALENCE; NUMBERS; IDENTIFICATION; SENSITIVITY	Campylobacteriosis is currently the most frequent foodborne zoonosis in many countries. One main source is poultry. The aim of this study was to enhance the knowledge about the potential of bacteriophages in reducing colonization of broilers with Campylobacter, as there are only a few in vivo studies published. Commercial broilers were inoculated with 10(4) CFU/bird of a Campylobacter jejuni field strain. Groups of 88 birds each were subsequently treated with a single phage or a four-phage cocktail (10(7) PFU/bird in CaCO3 buffered SM-Buffer). Control birds received the solvent only. Afterwards, subgroups of eleven birds each were examined for their loads with phages and Campylobacter on day 1, 3, 7, 14, 21, 28, 35 and 42 after phage application. The susceptibility of the Campylobacter population to phage infection was determined using ten isolates per bird. In total 4180 re-isolates were examined. The study demonstrated that the deployed phages persisted over the whole investigation period. The Campylobacter load was permanently reduced by the phage-cocktail as well as by the single phage. The reduction was significant between one and four weeks after treatment and reached a maximum of log(10) 2.8 CFU/g cecal contents. Phage resistance rates of initially up to 43% in the single phage treated group and 24% in the cocktail treated group later stabilized at low levels. The occurrence of phage resistance influenced but did not override the Campylobacter reducing effect. Regarding the reduction potential, the cocktail treatment had only a small advantage over the singe phage treatment directly after phage administration. However, the cocktail moderated and delayed the emergence of phage resistance.	[Fischer, Samuel; Gluender, Gerhard] Univ Vet Med, Clin Poultry, Hannover, Lower Saxony, Germany; [Kittler, Sophie; Klein, Guenter] Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Lower Saxony, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Fischer, S (corresponding author), Univ Vet Med, Clin Poultry, Hannover, Lower Saxony, Germany.	samuel.fischer@tiho-hannover.de	Klein, Günter/G-5321-2013	Klein, Günter/0000-0003-1931-2701				Andreoletti O, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2105, 10.2903/j.efsa.2011.2490]; Atterbury RJ, 2005, APPL ENVIRON MICROB, V71, P4885, DOI 10.1128/AEM.71.8.4885-4887.2005; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P4511, DOI 10.1128/AEM.69.8.4511-4518.2003; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Coffey B, 2010, ANNU REV FOOD SCI T, V1, P449, DOI 10.1146/annurev.food.102308.124046; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Connerton PL, 2004, APPL ENVIRON MICROB, V70, P3877, DOI 10.1128/AEM.70.7.3877-3883.2004; ECDC, 2011, EUROSURVEILLANCE, V16, P17; El-Shibiny A, 2005, APPL ENVIRON MICROB, V71, P1259, DOI 10.1128/AEM.71.3.1259-1266.2005; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; Ellerbroek LI, 2010, ZOONOSES PUBLIC HLTH, V57, pE81, DOI 10.1111/j.1863-2378.2009.01267.x; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053899; Ghareeb K, 2013, WORLD POULTRY SCI J, V69, P57, DOI 10.1017/S0043933913000068; Glunder G, 1998, P 1 INT S TURK DIS 1, P307; Goode D, 2003, APPL ENVIRON MICROB, V69, P5032, DOI 10.1128/AEM.69.8.5032-5036.2003; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Havelaar AH, 2007, RISK ANAL, V27, P831, DOI 10.1111/j.1539-6924.2007.00926.x; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Heuer OE, 2001, LETT APPL MICROBIOL, V33, P269, DOI 10.1046/j.1472-765X.2001.00994.x; Hirsch K, 2010, THESIS U VET MED HAN; Hwang S, 2009, MICROBIOL IMMUNOL, V53, P559, DOI 10.1111/j.1348-0421.2009.00163.x; Lammerding AM, 2000, INT J FOOD MICROBIOL, V58, P147, DOI 10.1016/S0168-1605(00)00269-5; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; Louwen R, 2012, EUROPEAN J CLIN MICR; Luria SE, 1943, GENETICS, V28, P491; Ma YS, 2008, APPL ENVIRON MICROB, V74, P4799, DOI 10.1128/AEM.00246-08; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; Moran L, 2009, J FOOD PROTECT, V72, P1830, DOI 10.4315/0362-028X-72.9.1830; Nather G, 2009, POULTRY SCI, V88, P1299, DOI 10.3382/ps.2008-00389; Ogden ID, 2009, FOODBORNE PATHOG DIS, V6, P1161, DOI 10.1089/fpd.2009.0327; Osiriphun S, 2011, POULTRY SCI, V90, P1562, DOI 10.3382/ps.2009-00577; Pasquali F, 2011, WORLD POULTRY SCI J, V67, P5, DOI 10.1017/S0043933911000018; Reich F, 2008, INT J FOOD MICROBIOL, V127, P116, DOI 10.1016/j.ijfoodmicro.2008.06.018; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Rudi K, 2004, APPL ENVIRON MICROB, V70, P790, DOI 10.1128/AEM.70.2.790-797.2004; Scott AE, 2007, ENVIRON MICROBIOL, V9, P2341, DOI 10.1111/J.1462-2920.2007.01351.x; Tsuei AC, 2007, INT J FOOD MICROBIOL, V116, P121, DOI 10.1016/j.ijfoodmicro.2006.12.028; Uffing B, 2011, EINFLUSS MISCHFUTTER; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002	43	71	74	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78543	10.1371/journal.pone.0078543	http://dx.doi.org/10.1371/journal.pone.0078543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205254	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600107
J	Lopez, P; Alonso-Perez, E; Rodriguez-Carrio, J; Suarez, A				Lopez, Patricia; Alonso-Perez, Elisa; Rodriguez-Carrio, Javier; Suarez, Ana			Influence of Atg5 Mutation in SLE Depends on Functional IL-10 Genotype	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; APOPTOTIC CELLS; SERUM-LEVELS; AUTOPHAGY; POPULATION; CLEARANCE; DISEASE; POLYMORPHISMS	Increasing evidence supports the involvement of autophagy in the etiopathology of autoimmune diseases. Despite the identification of autophagy-related protein (Atg)-5 as one of the susceptibility loci in systemic Lupus erythematosus (SLE), the consequences of the carriage of these mutations for patients remain unclear. The present work analyzed the association of Atg5 rs573775 single nucleotide polymorphism (SNP) with SLE susceptibility, IFN alpha, TNF alpha and IL-10 serum levels, and clinical features, in 115 patients and 170 healthy individuals. Patients who where carriers of the rs573775 T* minor allele presented lower IFNa levels than those with the wild genotype, whereas the opposite result was detected for IL-10. Thus, since IL-10 production was regulated by rs1800896 polymorphisms, we evaluated the effect of this Atg5 mutation in genetically high and low IL-10 producers. Interestingly, we found that the rs573775 T* allele was a risk factor for SLE in carriers of the high IL-10 producer genotype, but not among genetically low producers. Moreover, IL-10 genotype influences SLE features in patients presenting the Atg5 mutated allele. Specifically, carriage of the rs573775 T* allele led to IL-10 upregulation, reduced IFNa and TNFa production and a low frequency of cytopenia in patients with the high IL-10 producer genotype, whereas patients with the same Atg5 allele that were low IL-10 producers presented reduced amounts of all these cytokines, had a lower prevalence of anti-dsDNA antibodies and the latest onset age. In conclusion, the Atg5 rs573775 T* allele seems to influence SLE susceptibility, cytokine production and disease features depending on other factors such as functional IL-10 genotype.	[Lopez, Patricia; Rodriguez-Carrio, Javier; Suarez, Ana] Univ Oviedo, Fac Med, Immunol Area, Dept Funct Biol, Oviedo, Spain; [Alonso-Perez, Elisa] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Lab Invest, Santiago De Compostela, Spain	University of Oviedo; Complexo Hospitalario Universitario de Santiago de Compostela	Lopez, P (corresponding author), Univ Oviedo, Fac Med, Immunol Area, Dept Funct Biol, Oviedo, Spain.	lopezpatricia@uniovi.es	López, Patricia/B-8603-2018; Suarez, Ana/F-4492-2015	López, Patricia/0000-0002-1843-0653; Suarez, Ana/0000-0002-4452-7539; Rodriguez-Carrio, Javier/0000-0002-0011-5102	European Union FEDER funds; Fondo de Investigacion Sanitaria (FIS) [PI08/0570, PI12/0053]; FPU grant from the Ministerio de Educacion	European Union FEDER funds(European Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); FPU grant from the Ministerio de Educacion(German Research Foundation (DFG))	This work was supported by European Union FEDER funds and the Fondo de Investigacion Sanitaria (FIS, PI08/0570 and PI12/0053). J.R.-C. is a recipient of a FPU grant from the Ministerio de Educacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3818; Bijl M, 2006, ANN RHEUM DIS, V65, P57, DOI 10.1136/ard.2005.035733; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gomez J, 2006, MEDICINE, V85, P157, DOI 10.1097/01.md.0000224711.54886.b1; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Gros F, 2012, AUTOPHAGY, V8, P1113, DOI 10.4161/auto.20275; Gualtierotti R, 2010, AUTOIMMUN REV, V10, P3, DOI 10.1016/j.autrev.2010.09.007; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lleo A, 2007, J AUTOIMMUN, V29, P61, DOI 10.1016/j.jaut.2007.06.003; Lopez P, 2003, LUPUS, V12, P860, DOI 10.1191/0961203303lu469xx; Lopez P, 2008, J RHEUMATOL, V35, P1559; Lopez P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1897; Lopez P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/838390; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Ronnblom L, 2011, SEMIN IMMUNOL, V23, P113, DOI 10.1016/j.smim.2011.01.009; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Takeshita F, 2008, AUTOPHAGY, V4, P67, DOI 10.4161/auto.5055; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Towns R, 2005, AUTOPHAGY, V1, P163, DOI 10.4161/auto.1.3.2068; WEISSMANN G, 1964, LANCET, V2, P1373; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	43	34	35	1	335	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78756	10.1371/journal.pone.0078756	http://dx.doi.org/10.1371/journal.pone.0078756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205307	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300162
J	Hu, YJ; Scherngell, T; Man, SN; Wang, YT				Hu, Yuanjia; Scherngell, Thomas; Man, Si Nga; Wang, Yitao			Is the United States Still Dominant in the Global Pharmaceutical Innovation Network?	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; GLOBALIZATION; INDUSTRY	The dramatic growth of research and development activities in the pharmaceutical sector in emerging economies raises the question of whether the United States still keeps its dominant role in the global pharmaceutical innovation landscape. This paper focuses on investigating the role of the United States in global pharmaceutical innovation, and differs from previous studies by shifting attention to a network analytic perspective to track the global distribution of pharmaceutical inventions. Our sample is composed of key patents covering all new drugs approved by the Food and Drug Administration between 1996 and 2010. The results show that the United States still dominates in the global pharmaceutical innovation network, especially when it comes to essential core inventions. However, the United States shows a slightly decreasing prominence in the networks of either total new drugs or New Molecular Entity (NME) drugs in the time period 2006-2010 as compared to previous time periods, revealed by subtle traces of network centralities.	[Hu, Yuanjia; Man, Si Nga; Wang, Yitao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macao, Peoples R China; [Scherngell, Thomas] AIT Austrian Inst Technol, Foresight & Policy Dev Dept, Vienna, Austria	University of Macau; Austrian Institute of Technology (AIT)	Hu, YJ (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macao, Peoples R China.	yuanjiahu@umac.mo; ytwang@umac.mo	Hu, Yuanjia/AAW-7721-2021; Wang, Yitao/O-5184-2016	yuanjia, Hu/0000-0001-5244-8577; Scherngell, Thomas/0000-0003-4592-4103	University of Macau [MYRG119 (Y1-L3)-ICMS12-HYJ, MYRG065 (Y2-L1)-ICMS11-HYJ, MYRG208 (Y2-L4)-ICMS11-WYT]	University of Macau	Thanks for financial support of the University of Macau for this research by the projects MYRG119 (Y1-L3)-ICMS12-HYJ, MYRG065 (Y2-L1)-ICMS11-HYJ and MYRG208 (Y2-L4)-ICMS11-WYT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, HYDROCARB PROCESS, V86, P27; [Anonymous], 2008, R&D MAG, V50, P34; [Anonymous], 2011, R&D MAG, V53, P35; Atkinson RD, 2012, LEADERSHIP DECLINE A; Breschi S, 2009, J ECON GEOGR, V9, P439, DOI 10.1093/jeg/lbp008; Ding Jingxi, 2011, Journal of Technology Management & Innovation, V6, P1, DOI 10.4067/S0718-27242011000200001; English R, 2010, TRANSFORMING CLIN RE; Friedman Y, 2010, NAT REV DRUG DISCOV, V9, P835, DOI 10.1038/nrd3298; Griliches Z, 1991, 3301 NBER; Hather GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012203; Heller-Schuh B, 2011, ANAL NETWORKS EUROPE; Higham D.J., 2004, 02 U STRATHCL; Hornberger K, 2011, VIEWPOINT POLICY J, P1; Hu YJ, 2007, DRUG INF J, V41, P425; Hu YJ, 2008, DRUG INF J, V42, P561, DOI 10.1177/009286150804200605; Hughes B, 2010, NAT REV DRUG DISCOV, V9, P417, DOI 10.1038/nrd3204; IMS Institute for Healthcare Informatics, 2011, GLOB US MED OUTL 201; Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293; Kandogan Y, 2012, J ECON BUS, V64, P306, DOI 10.1016/j.jeconbus.2012.03.004; Knoke D., 2008, SOCIAL NETWORK ANAL; Lawler A, 1998, SCIENCE, V280, P819, DOI 10.1126/science.280.5365.819; Ledford H, 2013, NATURE, V493, P13, DOI 10.1038/493013a; Liang HG, 2011, DRUG DISCOV TODAY, V16, P1, DOI 10.1016/j.drudis.2010.05.004; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Matthews JNA, 2010, PHYS TODAY, V63, P23, DOI 10.1063/1.3490492; OECD, 2007, INN GROWTH RAT INN S, P1, DOI [10.1787/9789264073975-en, DOI 10.1787/9789264073975-EN]; Powell W, 2004, OXFORD HDB INNOVATIO, P56; Ramirez P, 2006, TECHNOL ANAL STRATEG, V18, P143, DOI 10.1080/09537320600624006; Singh R, 2006, DRUG DISCOV TODAY, V11, P675, DOI 10.1016/j.drudis.2006.06.009; Talaga P, 2009, DRUG DISCOV TODAY, V14, P1003, DOI 10.1016/j.drudis.2009.09.001; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Toole AA, 2012, RES POLICY, V41, P1, DOI 10.1016/j.respol.2011.06.004; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Zu L, 2011, REV INT ECON, V19, P325, DOI 10.1111/j.1467-9396.2011.00950.x	34	20	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77247	10.1371/journal.pone.0077247	http://dx.doi.org/10.1371/journal.pone.0077247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223710	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400006
J	Inoue, Y; Tomiya, T; Nishikawa, T; Ohtomo, N; Tanoue, Y; Ikeda, H; Koike, K				Inoue, Yukiko; Tomiya, Tomoaki; Nishikawa, Takako; Ohtomo, Natsuko; Tanoue, Yasushi; Ikeda, Hitoshi; Koike, Kazuhiko			Induction of p53-Dependent p21 Limits Proliferative Activity of Rat Hepatocytes in the Presence of Hepatocyte Growth Factor	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-SYNTHESIS; LIVER; P53; PROTEIN; ARREST; EXPRESSION; INHIBITOR; INVOLVEMENT; G(1)	Background: Hepatocyte growth factor (HGF), a potent mitogen for hepatocytes, enhances hepatocyte function without stimulating proliferation, depending on the physiological conditions. p53, a transcription factor, suppresses the cell proliferation by expressing p21(WAF1/CIP1) in various tissues. Aim: To investigate the mechanism through which the hepatocytes maintain mitotically quiescent even in the presence of HGF. Methods: We studied the relationship between p53 and p21 expression and the effect of p53-p21 axis on hepatocyte proliferation in primary cultured rat hepatocytes stimulated by HGF. Hepatic p21 levels are determined serially after partial hepatectomy or sham operation in rats. Results: DNA synthesis was markedly increased by HGF addition in rat hepatocytes cultured at low density but not at high density. Cellular p53 levels increased in the hepatocytes cultured at both the densities. p21 levels were increased and correlated with cellular p53 levels in hepatocytes cultured at high density but not at low density. When the activity of p53 was suppressed by a chemical inhibitor for p53, cellular p21 levels were reduced, and DNA synthesis was increased. Similarly, p21 antisense oligonucleotide increased the DNA synthesis. In rats after partial hepatectomy, transient elevation of hepatic p21 levels was observed. In contrast, in sham-operated rats, hepatic p21 levels were increased on sustained time scales. Conclusion: p53-related induction of p21 may suppress hepatocyte proliferation in the presence of HGF in the setting that mitogenic activity of HGF is not elicitable.	[Inoue, Yukiko; Tomiya, Tomoaki; Nishikawa, Takako; Ohtomo, Natsuko; Tanoue, Yasushi; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Ikeda, Hitoshi] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan	University of Tokyo; University of Tokyo	Tomiya, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	tomiya-1im@h.u-tokyo.ac.jp						Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Albrecht JH, 1999, AM J PHYSIOL-GASTR L, V277, pG1207, DOI 10.1152/ajpgi.1999.277.6.G1207; Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; Bellamy COC, 1997, FASEB J, V11, P591, DOI 10.1096/fasebj.11.7.9212083; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN WH, 1995, ENDOCRINOLOGY, V136, P5240, DOI 10.1210/en.136.11.5240; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chou WW, 2008, TOXICOLOGY, V243, P1, DOI 10.1016/j.tox.2007.09.003; Conner EA, 1997, BIOCHEM BIOPH RES CO, V236, P396, DOI 10.1006/bbrc.1997.6938; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Faletto D L, 1993, EXS, V65, P107; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fremin C, 2009, HEPATOLOGY, V49, P930, DOI 10.1002/hep.22730; FUJIWARA K, 1993, HEPATOLOGY, V18, P1443, DOI 10.1016/0270-9139(93)90237-H; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Han JH, 2005, J BIOL CHEM, V280, P31548, DOI 10.1074/jbc.M503431200; HARPER JW, 1993, CELL, V75, P805; Inoue Y, 2002, HEPATOLOGY, V36, P336, DOI 10.1053/jhep.2002.34942; Israsena N, 2002, J NEUROSCI RES, V69, P803, DOI 10.1002/jnr.10362; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; MICHIELI P, 1994, CANCER RES, V54, P3391; MILNE DM, 1994, J BIOL CHEM, V269, P9253; Mizuno S, 2007, REGEN MED, V2, P161, DOI 10.2217/17460751.2.2.161; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shima N, 1998, J CELL PHYSIOL, V177, P130, DOI 10.1002/(SICI)1097-4652(199810)177:1<130::AID-JCP14>3.3.CO;2-O; SHIN TH, 1995, MOL CELL BIOL, V15, P4694; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; TAKEHARA T, 1992, J BIOCHEM-TOKYO, V112, P330, DOI 10.1093/oxfordjournals.jbchem.a123900; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; TOMIYA T, 1992, HEPATOLOGY, V15, P1, DOI 10.1002/hep.1840150102; Tomiya T, 2000, AM J PATHOL, V157, P1693, DOI 10.1016/S0002-9440(10)64806-7; TOMIYA T, 1992, GASTROENTEROLOGY, V103, P1621, DOI 10.1016/0016-5085(92)91186-8; Tomiya T, 1996, NEPHRON, V73, P735; Tomiya T, 1998, AM J PATHOL, V153, P955, DOI 10.1016/S0002-9440(10)65637-4; Tomiya T, 2004, BIOCHEM BIOPH RES CO, V322, P772, DOI 10.1016/j.bbrc.2004.07.191; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wierod L, 2008, ONCOGENE, V27, P2763, DOI 10.1038/sj.onc.1210937; Yamaoka M, 1998, LIVER, V18, P52; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78346	10.1371/journal.pone.0078346	http://dx.doi.org/10.1371/journal.pone.0078346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223793	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400053
J	Wang, HX; Fan, WJ; Li, H; Yang, J; Huang, JR; Zhang, P				Wang, Hongxia; Fan, Weijuan; Li, Hong; Yang, Jun; Huang, Jirong; Zhang, Peng			Functional Characterization of Dihydroflavonol-4-Reductase in Anthocyanin Biosynthesis of Purple Sweet Potato Underlies the Direct Evidence of Anthocyanins Function against Abiotic Stresses	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PROANTHOCYANIDIN BIOSYNTHESIS; FLAVONOID BIOSYNTHESIS; ACYLATED ANTHOCYANINS; CHALCONE SYNTHASE; MOLECULAR-CLONING; 4-REDUCTASE GENE; MALUS-DOMESTICA; STORAGE ROOT; CELL-LINE	Dihydroflavonol-4-reductase (DFR) is a key enzyme in the catalysis of the stereospecific reduction of dihydroflavonols to leucoanthocyanidins in anthocyanin biosynthesis. In the purple sweet potato (Ipomoea batatas Lam.) cv. Ayamurasaki, expression of the IbDFR gene was strongly associated with anthocyanin accumulation in leaves, stems and roots. Overexpression of the IbDFR in Arabidopsis tt3 mutants fully complemented the pigmentation phenotype of the seed coat, cotyledon and hypocotyl. Downregulation of IbDFR expression in transgenic sweet potato (DFRi) using an RNAi approach dramatically reduced anthocyanin accumulation in young leaves, stems and storage roots. In contrast, the increase of flavonols quercetin-3-O-hexose-hexoside and quercetin-3-O-glucoside in the leaves and roots of DFRi plants is significant. Therefore, the metabolic pathway channeled greater flavonol influx in the DFRi plants when their anthocyanin and proanthocyanidin accumulation were decreased. These plants also displayed reduced antioxidant capacity compared to the wild type. After 24 h of cold treatment and 2 h recovery, the wild-type plants were almost fully restored to the initial phenotype compared to the slower recovery of DFRi plants, in which the levels of electrolyte leakage and hydrogen peroxide accumulation were dramatically increased. These results provide direct evidence of anthocyanins function in the protection against oxidative stress in the sweet potato. The molecular characterization of the IbDFR gene in the sweet potato not only confirms its important roles in flavonoid metabolism but also supports the protective function of anthocyanins of enhanced scavenging of reactive oxygen radicals in plants under stressful conditions.	[Wang, Hongxia; Fan, Weijuan; Li, Hong; Huang, Jirong; Zhang, Peng] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wang, Hongxia; Fan, Weijuan; Li, Hong; Huang, Jirong; Zhang, Peng] Chinese Acad Sci, Natl Ctr Plant Gene Res Shanghai, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Jun; Zhang, Peng] Chinese Acad Sci, Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, P (corresponding author), Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	zhangpeng@sibs.ac.cn	Peng Zhang, Dr./A-6423-2008	Peng Zhang, Dr./0000-0002-4868-1306; wang, hong xia/0000-0003-1433-3693	National Basic Research Program [2013CB127000]; National High Technology Research and Development Program of China [2012AA101204]; Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration [G102410, F132427]	National Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration	This work was supported by grants from the National Basic Research Program (Grant No. 2013CB127000), the National High Technology Research and Development Program of China (2012AA101204), and Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration (G102410, F132427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Andersen M, 2010, ENCY LIFE SCI, P1; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Chang H, 2010, NUTR CANCER, V62, P1128, DOI 10.1080/01635581.2010.494821; Davies KM, 2007, MUTAT RES-FUND MOL M, V622, P122, DOI 10.1016/j.mrfmmm.2007.02.003; Dong XY, 2001, PLANT PHYSIOL, V127, P46, DOI 10.1104/pp.127.1.46; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Ghasemzadeh A, 2012, INT J MOL SCI, V13, P14828, DOI 10.3390/ijms131114828; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goda Y, 1997, PHYTOCHEMISTRY, V44, P183, DOI 10.1016/S0031-9422(96)00533-X; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Gould K., 2009, ANTHOCYANINS BIOSYNT; Han KH, 2007, BRIT J NUTR, V98, P914, DOI 10.1017/S0007114507761792; Hisatomi Y, 1997, THEOR APPL GENET, V95, P509, DOI 10.1007/s001220050591; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030364; Ju JH, 2011, J MED FOOD, V14, P1097, DOI 10.1089/jmf.2010.1450; Kano N, 2005, BIOSCI BIOTECH BIOCH, V69, P979, DOI 10.1271/bbb.69.979; Konczak-Islam I, 2000, PLANT CELL REP, V19, P472, DOI 10.1007/s002990050758; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Lalusin AG, 2006, MOL GENET GENOMICS, V275, P44, DOI 10.1007/s00438-005-0080-x; Li HH, 2012, MOL BIOL REP, V39, P2991, DOI 10.1007/s11033-011-1061-2; Lo Piero AR, 2006, PHYTOCHEMISTRY, V67, P684, DOI 10.1016/j.phytochem.2006.01.025; Luceri C, 2008, FOOD CHEM TOXICOL, V46, P1213, DOI 10.1016/j.fct.2007.10.007; Luo CY, 2013, FOOD CHEM, V141, P2697, DOI 10.1016/j.foodchem.2013.05.009; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Martens S, 2010, PHYTOCHEMISTRY, V71, P1040, DOI 10.1016/j.phytochem.2010.04.016; MELDGAARD M, 1992, THEOR APPL GENET, V83, P695, DOI 10.1007/BF00226687; Mendoza-Diaz S, 2012, PLANT FOOD HUM NUTR, V67, P442, DOI 10.1007/s11130-012-0326-9; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Montilla EC, 2010, J AGR FOOD CHEM, V58, P9899, DOI 10.1021/jf101898j; Mori K, 2005, SCI HORTIC-AMSTERDAM, V105, P319, DOI 10.1016/j.scienta.2005.01.032; Muller PY, 2002, BIOTECHNIQUES, V33, P514; Mylona P.V., 2010, REACTIVE OXYGEN SPEC, P1; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Pelletier MK, 1999, PLANT MOL BIOL, V40, P45, DOI 10.1023/A:1026414301100; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Philpott M, 2004, J AGR FOOD CHEM, V52, P1511, DOI 10.1021/jf034593j; Pourcel L, 2013, PLANT J, V74, P383, DOI 10.1111/tpj.12129; Pourcel L, 2012, REC ADV POLYPHEN RES, V3, P143; PRICE ML, 1978, J AGR FOOD CHEM, V26, P1214, DOI 10.1021/jf60219a031; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Rosati C, 1997, PLANT MOL BIOL, V35, P303, DOI 10.1023/A:1005881032409; Sairam RK, 2002, PLANT SCI, V162, P897, DOI 10.1016/S0168-9452(02)00037-7; Schieber A, 2001, J CHROMATOGR A, V910, P265, DOI 10.1016/S0021-9673(00)01217-6; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Stracke R, 2009, PLANTA, V229, P427, DOI 10.1007/s00425-008-0841-y; Szankowski I, 2009, ACTA HORTIC, V814, P511; Tanaka M, 2004, DNA SEQUENCE, V15, P277, DOI 10.1080/10425170400004120; Terahara N, 2000, PHYTOCHEMISTRY, V54, P919, DOI 10.1016/S0031-9422(00)00099-6; Terahara N, 2004, J BIOMED BIOTECHNOL, P279, DOI 10.1155/S1110724304406056; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian QG, 2005, J AGR FOOD CHEM, V53, P6503, DOI 10.1021/jf050671m; White BL, 2011, J AGR FOOD CHEM, V59, P4692, DOI 10.1021/jf200149a; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie DY, 2005, PHYTOCHEMISTRY, V66, P2127, DOI 10.1016/j.phytochem.2005.01.008; Yang J, 2011, PLANT SCI, V181, P701, DOI 10.1016/j.plantsci.2011.01.005; Yoshida K, 2010, J PLANT RES, V123, P801, DOI 10.1007/s10265-010-0325-6; Yu B, 2007, PLANT CELL TISS ORG, V90, P265, DOI 10.1007/s11240-007-9265-9; Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005; Zhu F, 2010, J AGR FOOD CHEM, V58, P7588, DOI 10.1021/jf101867t	68	105	119	6	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78484	10.1371/journal.pone.0078484	http://dx.doi.org/10.1371/journal.pone.0078484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223813	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400067
J	Wu, SX; Liu, B; Zhang, QY; Liu, J; Zhou, W; Wang, C; Li, MY; Bao, ST; Zhu, RH				Wu, Shixing; Liu, Bin; Zhang, Qingyu; Liu, Jie; Zhou, Wei; Wang, Chang; Li, Mingyi; Bao, Shiting; Zhu, Runzhi			Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells	PLOS ONE			English	Article							CYCLE ARREST; DNA-DAMAGE; MUTANT P53; BAX/BCL-2 RATIO; UP-REGULATION; APOPTOSIS; INHIBITION; ACTIVATION; PATHWAYS; DEATH	Dihydromyricetin (DHM) is a major active ingredient of flavonoids compounds. It exhibited anticancer activity and induced apoptosis in human hepatocellular carcinoma HepG2 cells according to our previous data. In this study, we investigated whether p53 is involved in DHM-triggered viability inhibition and apoptosis induction in cancer cells. MTT [3-(4,5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay was employed to evaluate the viability of HepG2 cells after DHM treatment. Meanwhile, p53 small interfering RNA (siRNA) was adopted to silence p53 expression. Protein level of p53 and Bax/Bcl-2 were evaluated by western blot analysis. Cell counting assay showed that DHM inhibited HepG2 cell growth effectively in a time- and dose-dependent manner. P53 expression was significantly increased after DHM treatment, whereas Bcl-2 was reduced potently. Furthermore, after co-treatment with Pifithrin-alpha (PFT-alpha, p53 inhibitor), Bcl-2 expression was reversed. The expression of Bax was no significant change, which was also observed after p53 silence. These findings defined and supported a novel function that DHM could induce human hepatocellular carcinoma HepG2 cells apoptosis by up-regulating Bax/Bcl-2 expression via p53 signal pathway.	[Wu, Shixing; Liu, Bin; Zhang, Qingyu; Liu, Jie; Zhou, Wei; Li, Mingyi; Bao, Shiting; Zhu, Runzhi] Guangdong Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Lab Regenerat Med, Zhanjiang, Peoples R China; [Wang, Chang] Fujian Med Univ, Affiliated Hosp, Ningde Hosp, Emergency Dept, Ningde, Peoples R China	Guangdong Medical University; Fujian Medical University	Li, MY (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Lab Regenerat Med, Zhanjiang, Peoples R China.	hepatolab@163.com; handuney@163.com; hepatolab@gmail.com			National Natural Science Funds, China; Guangdong Province Natural Science Funds, China	National Natural Science Funds, China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Funds, China	This work was supported in part by the following grants: The National Natural Science Funds (http://www.nsfc.gov.cn/) and Guangdong Province Natural Science Funds (http://gdsf.gdstc.gov.cn/), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, J CLIN PHARMACOL, V53, P228, DOI 10.1177/0091270011436344; Ahamed M, 2011, NANOMED-NANOTECHNOL, V7, P904, DOI 10.1016/j.nano.2011.04.011; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Burmakin M, 2013, CLIN CANC RES; Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016; Chee JLY, 2013, CELL CYCLE, V12, P278, DOI 10.4161/cc.23054; Del Poeta G, 2010, BRIT J HAEMATOL, V149, P383, DOI 10.1111/j.1365-2141.2010.08098.x; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Goeman Frauke, 2013, Methods Mol Biol, V962, P211, DOI 10.1007/978-1-62703-236-0_18; Gu HY, 2009, J CANCER RES CLIN, V135, P1777, DOI 10.1007/s00432-009-0624-2; Huang FF, 2012, MAR DRUGS, V10, P2153, DOI 10.3390/md10102153; Huang XF, 2008, BLOOD, V111, P2854, DOI 10.1182/blood-2007-07-099325; Hussein MR, 2009, EXP MOL PATHOL, V87, P63, DOI 10.1016/j.yexmp.2009.03.005; Jeon SH, 2008, ARCH PHARM RES, V31, P978, DOI 10.1007/s12272-001-1255-9; Kou XJ, 2012, PHYTOTHER RES, V26, P988, DOI 10.1002/ptr.3671; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kundakovic T, 2008, ARCH BIOL SCI, V60, P641, DOI 10.2298/ABS0804641K; Lee JH, 2013, CANCER RES, V73, P785, DOI 10.1158/0008-5472.CAN-12-1994; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038802; Qi SM, 2012, INT IMMUNOPHARMACOL, V12, P278, DOI 10.1016/j.intimp.2011.12.001; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Tasyriq M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/765316; Tian Z, 2008, INT J CANCER, V122, P31, DOI 10.1002/ijc.23048; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Voskamp P, 2013, CANCER PREV RES, V6, P129, DOI 10.1158/1940-6207.CAPR-12-0361; Woo HJ, 2012, ENZYME MICROB TECH, V51, P311, DOI 10.1016/j.enzmictec.2012.07.014; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Ye JT, 2008, PLANTA MED, V74, P252, DOI 10.1055/s-2008-1034317; Yeudall W Andrew, 2013, Methods Mol Biol, V962, P135, DOI 10.1007/978-1-62703-236-0_11; Zhang BL, 2012, ANTI-CANCER DRUG, V23, P590, DOI 10.1097/CAD.0b013e32835019f9; Zhou WM, 2010, MOLECULES, V15, P2114, DOI 10.3390/molecules15042114; Zhu HB, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-22	34	21	35	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e76886	10.1371/journal.pone.0076886	http://dx.doi.org/10.1371/journal.pone.0076886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223706	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400007
J	Blinowska, KJ; Kaminski, M				Blinowska, Katarzyna J.; Kaminski, Maciej			Functional Brain Networks: Random, "Small World'' or Deterministic?	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; EEG ACTIVITY; PROPAGATION; DYNAMICS; COHERENCE; FMRI; CONNECTIVITY; INFORMATION; MOVEMENT; SLEEP	Lately the problem of connectivity in brain networks is being approached frequently by graph theoretical analysis. In several publications based on bivariate estimators of relations between EEG channels authors reported random or "small world'' structure of networks. The results of these works often have no relation to other evidence based on imaging, inverse solutions methods, physiological and anatomical data. Herein we try to find reasons for this discrepancy. We point out that EEG signals are very much interdependent, thus bivariate measures applied to them may produce many spurious connections. In fact, they may outnumber the true connections. Giving all connections equal weights, as it is usual in the framework of graph theoretical analysis, further enhances these spurious links. In effect, close to random and disorganized patterns of connections emerge. On the other hand, multivariate connectivity estimators, which are free of the artificial links, show specific, well determined patterns, which are in a very good agreement with other evidence. The modular structure of brain networks may be identified by multivariate estimators based on Granger causality and formalism of assortative mixing. In this way, the strength of coupling may be evaluated quantitatively. During working memory task, by means of multivariate Directed Transfer Function, it was demonstrated that the modules characterized by strong internal bonds exchange the information by weaker connections.	[Blinowska, Katarzyna J.; Kaminski, Maciej] Warsaw Univ, Dept Biomed Phys, Fac Phys, Warsaw, Poland	University of Warsaw	Blinowska, KJ (corresponding author), Warsaw Univ, Dept Biomed Phys, Fac Phys, Warsaw, Poland.	kjbli@fuw.edu.pl		Blinowska, Katarzyna/0000-0001-6429-4421; Kaminski, Maciej/0000-0001-5346-4050	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The work was supported by the Statutory Grant of Polish Ministry of Science and Higher Education to Faculty of Physics of Univeristy of Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; [Anonymous], [No title captured]; [Anonymous], 2011, PRACTICAL BIOMEDICAL; [Anonymous], [No title captured]; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bialonski S, 2010, CHAOS, V20, DOI 10.1063/1.3360561; Blinowska K, 2010, BRAIN TOPOGR, V23, P205, DOI 10.1007/s10548-010-0137-y; Blinowska KJ, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0614; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Brzezicka A, 2011, ACTA NEUROBIOL EXP, V71, P479; Brzezicka A, 2011, BRAIN TOPOGR, V24, P1, DOI 10.1007/s10548-010-0158-6; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fangmeier T, 2006, J COGNITIVE NEUROSCI, V18, P320, DOI 10.1162/jocn.2006.18.3.320; Ferri R, 2005, CLIN NEUROPHYSIOL, V116, P2783, DOI 10.1016/j.clinph.2005.08.013; FRANASZCZUK PJ, 1994, ELECTROEN CLIN NEURO, V91, P413, DOI 10.1016/0013-4694(94)90163-5; Gerloff C, 1996, HUM BRAIN MAPP, V4, P199, DOI 10.1002/(SICI)1097-0193(1996)4:3<199::AID-HBM4>3.0.CO;2-Z; Ginter J, 2005, METHOD INFORM MED, V44, P106, DOI 10.1055/s-0038-1633932; Ginter J, 2001, J NEUROSCI METH, V110, P113, DOI 10.1016/S0165-0270(01)00424-1; Goel V, 2009, NEUROPSYCHOLOGIA, V47, P2790, DOI 10.1016/j.neuropsychologia.2009.06.002; Hlinka J, 2012, CHAOS, V22, DOI 10.1063/1.4732541; Jalili M, 2011, J INTEGR NEUROSCI, V10, P213, DOI 10.1142/S0219635211002725; Joudaki Amir, 2012, PLoS One, V7, pe35673, DOI 10.1371/journal.pone.0035673; Kaminski M, 1997, ELECTROEN CLIN NEURO, V102, P216, DOI 10.1016/S0013-4694(96)95721-5; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Kawasaki M, 2007, NEUROSCI LETT, V422, P141, DOI 10.1016/j.neulet.2007.04.079; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Korzeniewska A, 2008, HUM BRAIN MAPP, V29, P1170, DOI 10.1002/hbm.20458; Kuhnert MT, 2012, CHAOS, V22, DOI 10.1063/1.4729185; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Kus R, 2006, ACTA NEUROBIOL EXP, V66, P195; Langer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053199; Leistedt SJJ, 2009, HUM BRAIN MAPP, V30, P2207, DOI 10.1002/hbm.20662; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nunez P.L., 1981, ELECT FIELDS BRAIN; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pfurtscheller G, 1999, HANDB EL CL, V6, P89; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	50	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78763	10.1371/journal.pone.0078763	http://dx.doi.org/10.1371/journal.pone.0078763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205313	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500133
J	Li, S; Wang, XJ; Li, YF; Kost, CK; Martin, DS				Li, Shuai; Wang, Xuejun; Li, Yifan; Kost, Curtis K., Jr.; Martin, Douglas S.			Bortezomib, a Proteasome Inhibitor, Attenuates Angiotensin II-Induced Hypertension and Aortic Remodeling in Rats	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CELLS IN-VIVO; MATRIX METALLOPROTEINASES; ANG-II; THERAPEUTIC IMPLICATIONS; ENDOTHELIAL DYSFUNCTION; CELLULAR HYPERTROPHY; UP-REGULATION; EXPRESSION; MICROCIRCULATION	Background: Hypertension is a highly prevalent disorder and a major risk factor for cardiovascular diseases. Hypertensive vascular remodeling is the pathological mal-adaption of blood vessels to the hypertensive condition that contributes to further development of high blood pressure and end-organ damage. Hypertensive remodeling involves, at least in part, changes in protein turnover. The ubiquitin proteasome system (UPS) is a major protein quality and quantity control system. This study tested the hypothesis that the proteasome inhibitor, bortezomib, would attenuate AngII-induced hypertension and its sequelae such as aortic remodeling in rats. Methodology/Principal Findings: Male Sprague Dawley rats were subjected to AngII infusion for two weeks in the absence or presence of bortezomib. Mean arterial pressure was measured in conscious rats. Aortic tissue was collected for estimation of wall area, collagen deposition and expression of tissue inhibitors of matrix metalloproteases (TIMP), Ki67 (a marker of proliferation), reactive oxygen species (ROS) and VCAM-1 (a marker of inflammation). AngII infusion increased arterial pressure significantly (160+/-4 mmHg vs. vehicle treatment 133+/-2 mmHg). This hypertensive response was attenuated by bortezomib (138+/-5 mmHg). AngII hypertension was associated with significant increases in aortic wall to lumen ratio (similar to 29%), collagen deposition (similar to 14%) and expression of TIMP1 and TIMP2. AngII also increased MMP2 activity, proteasomal chymotrypsin-like activity, Ki67 staining, ROS generation and VCAM-1 immunoreactivity. Co-treatment of AngII-infused rats with bortezomib attenuated these AngII-induced responses. Conclusions: Collectively, these data support the idea that proteasome activity contributes to AngII-induced hypertension and hypertensive aortic vascular remodeling at least in part by modulating TIMP1/2 and MMP2 function. Preliminary observations are consistent with a role for ROS, inflammatory and proliferative mechanisms in this effect. Further understanding of the mechanisms by which the proteasome is involved in hypertension and vascular structural remodeling may reveal novel targets for pharmacological treatment of hypertension, hypertensive remodeling or both.	[Li, Shuai; Wang, Xuejun; Li, Yifan; Kost, Curtis K., Jr.; Martin, Douglas S.] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA	University of South Dakota	Martin, DS (corresponding author), Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA.	dsmartin@usd.edu	Wang, Xuejun/AAT-9490-2021; Wang, Xuejun/K-8874-2013	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343	National Institutes of Health [2R01HL063053, R01HL072166, R01HL085629]; Biomedical Research Infrastructure Network (BRIN) pilot grant [244705]; Basic Biomedical Sciences program of Sanford School of Medicine; graduate school of the University of South Dakota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072166, R01HL085629, R01HL063053] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Infrastructure Network (BRIN) pilot grant; Basic Biomedical Sciences program of Sanford School of Medicine; graduate school of the University of South Dakota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (grant no. 2R01HL063053 to DS Martin; grant nos. R01HL072166 and R01HL085629 to XJ Wang), a Biomedical Research Infrastructure Network (BRIN) pilot grant (no. 244705) (NIGMS), the Basic Biomedical Sciences program of Sanford School of Medicine, and the graduate school of the University of South Dakota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulakis E, 2012, CURR TOP MED CHEM, V12, P1149, DOI 10.2174/1568026611208011149; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; BrouwersCeiler DL, 1997, CARDIOVASC RES, V33, P478, DOI 10.1016/S0008-6363(96)00213-1; Castoldi G, 2007, CLIN EXP PHARMACOL P, V34, P205, DOI 10.1111/j.1440-1681.2007.04573.x; Castoldi G, 2003, AM J PHYSIOL-HEART C, V284, pH635, DOI 10.1152/ajpheart.00986.2001; Castro MM, 2011, PHARMACOL RES, V64, P567, DOI 10.1016/j.phrs.2011.04.002; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Deguchi JO, 2009, LAB INVEST, V89, P315, DOI 10.1038/labinvest.2008.167; Demasi M, 2012, CARDIOVASC RES, V95, P183, DOI 10.1093/cvr/cvs128; Depre C, 2010, CARDIOVASC RES, V85, P251, DOI 10.1093/cvr/cvp362; Derosa G, 2006, ENDOTHELIUM-J ENDOTH, V13, P227, DOI 10.1080/10623320600780942; Dreger H, 2009, CARDIOVASC RES, V83, P354, DOI 10.1093/cvr/cvp107; Feihl F, 2008, CARDIOVASC RES, V78, P274, DOI 10.1093/cvr/cvn022; Feihl F, 2006, HYPERTENSION, V48, P1012, DOI 10.1161/01.HYP.0000249510.20326.72; Feihl F, 2009, CURR HYPERTENS REP, V11, P182, DOI 10.1007/s11906-009-0033-6; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; Harrison DG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00128; HENRICH H, 1978, PFLUG ARCH EUR J PHY, V375, P153, DOI 10.1007/BF00584238; Kim SC, 2003, J CARDIOVASC PHARM, V42, P554, DOI 10.1097/00005344-200310000-00014; Kim SY, 2012, AM J RESP CELL MOL, V47, P698, DOI 10.1165/rcmb.2011-0331OC; Kim W, 2009, METHODS MOL BIOL, V579, P261, DOI 10.1007/978-1-60761-322-0_13; Kloss A, 2010, CARDIOVASC RES, V85, P367, DOI 10.1093/cvr/cvp217; KORSGAARD N, 1988, HYPERTENSION, V12, P162, DOI 10.1161/01.HYP.12.2.162; Kuroki MT, 2012, AM J PHYSIOL-HEART C, V302, pH763, DOI 10.1152/ajpheart.00930.2011; Leak RK, 2008, J NEUROCHEM, V106, P860, DOI 10.1111/j.1471-4159.2008.05459.x; Li YF, 2011, BBA-GENE REGUL MECH, V1809, P141, DOI 10.1016/j.bbagrm.2010.09.001; Lorenz M, 2009, LIFE SCI, V84, P929, DOI 10.1016/j.lfs.2009.04.016; Ludwig A, 2009, J MOL MED, V87, P793, DOI 10.1007/s00109-009-0469-9; Mancia G, 2007, HYPERTENSION, V50, P299, DOI 10.1161/HYPERTENSIONAHA.107.090290; Marfella R, 2006, DIABETES, V55, P622, DOI 10.2337/diabetes.55.03.06.db05-0832; Meiners S, 2004, HYPERTENSION, V44, P471, DOI 10.1161/01.HYP.0000142772.71367.65; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Meiners S, 2008, MED RES REV, V28, P309, DOI 10.1002/med.20111; Meiners S, 2008, HYPERTENSION, V51, P302, DOI 10.1161/HYPERTENSIONAHA.107.097816; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Mulvany MJ, 2008, MED BIOL ENG COMPUT, V46, P461, DOI 10.1007/s11517-008-0305-3; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; OWENS GK, 1983, CIRC RES, V53, P491, DOI 10.1161/01.RES.53.4.491; Papandreou CN, 2004, J CLIN ONCOL, V22, P2108, DOI 10.1200/JCO.2004.02.106; Pashevin DA, 2011, PHARMACOL REP, V63, P1009, DOI 10.1016/S1734-1140(11)70617-X; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Rizzoni D, 2000, HYPERTENSION, V35, P931, DOI 10.1161/01.HYP.35.4.931; Rizzoni D, 2009, BLOOD PRESSURE, V18, P242, DOI 10.1080/08037050903254923; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; SIMON G, 1995, AM J HYPERTENS, V8, P67, DOI 10.1016/0895-7061(94)00192-E; Stangl V, 2004, FASEB J, V18, P272, DOI 10.1096/fj.03-0054com; Takaoka M, 1998, LIFE SCI, V63, pPL65, DOI 10.1016/S0024-3205(98)00276-8; Takaoka M, 2001, CLIN EXP PHARMACOL P, V28, P466, DOI 10.1046/j.1440-1681.2001.03461.x; Walter A, 2008, J VASC RES, V45, P386, DOI 10.1159/000121408; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Watts SW, 2007, AM J PHYSIOL-HEART C, V292, pH2438, DOI 10.1152/ajpheart.00900.2006; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736	57	20	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78564	10.1371/journal.pone.0078564	http://dx.doi.org/10.1371/journal.pone.0078564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205262	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500124
J	Cvitic, S; Longtine, MS; Hackl, H; Wagner, K; Nelson, MD; Desoye, G; Hiden, U				Cvitic, Silvija; Longtine, Mark S.; Hackl, Hubert; Wagner, Karin; Nelson, Michael D.; Desoye, Gernot; Hiden, Ursula			The Human Placental Sexome Differs between Trophoblast Epithelium and Villous Vessel Endothelium	PLOS ONE			English	Article							FETAL SEX; GENE-EXPRESSION; MATERNAL ASTHMA; CELLS; SYNCYTIOTROPHOBLASTS; DIFFERENTIATION; ASSOCIATION; SENSITIVITY; CHROMOSOME; MICROARRAY	Molecular mechanisms underlying sexual dimorphism in mammals, fetal sex influences on intrauterine development, and the sex-biased susceptibility for selected diseases in adulthood are novel areas of current research. As importantly, two decades of multifaceted research has established that susceptibility to many adult disorders originates in utero, commonly secondary to the effects of placental dysfunction. We hypothesized that fetal sex influences gene expression and produces functional differences in human placentas. We thus extended previous studies on sexual dimorphism in mammals, which used RNA isolated from whole tissues, to investigate the effects of sex on four cell-phenotypes within a single key tissue, human placental villi. The cells studied included cytotrophoblasts, syncytiotrophoblast, arterial and venous endothelial cells. The cells were isolated from placentas of male or female fetuses and subjected to microarray analysis. We found that fetal sex differentially affected gene expression in a cell-phenotype dependent manner among all four cell-phenotypes. The markedly enriched pathways in males were identified to be signaling pathways for graft-versus-host disease as well as the immune and inflammatory systems that parallel the reported poorer outcome of male fetuses. Our study is the first to compare global gene expression by microarray analysis in purified, characterized, somatic cells from a single human tissue, i.e. placental villi. Importantly, our findings demonstrate that there are cell-phenotype specific, and tissue-specific, sex-biased responses in the human placenta, suggesting fetal sex should be considered as an independent variable in gene expression analysis of human placental villi.	[Cvitic, Silvija; Desoye, Gernot; Hiden, Ursula] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Longtine, Mark S.; Nelson, Michael D.] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA; [Hackl, Hubert] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Wagner, Karin] Med Univ Graz, Med Res Ctr, Graz, Austria	Medical University of Graz; Washington University (WUSTL); Medical University of Innsbruck; Medical University of Graz	Hiden, U (corresponding author), Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria.	ursula.hiden@medunigraz.at	Hackl, Hubert/B-3168-2018	Hackl, Hubert/0000-0003-4055-3841; Longtine, Mark/0000-0002-3315-1732; Desoye, Gernot/0000-0002-5715-3230; Hiden, Ursula/0000-0001-8009-020X	Ph.D. Program Molecular Medicine of the Medical University of Graz	Ph.D. Program Molecular Medicine of the Medical University of Graz	This work was funded by the Ph.D. Program Molecular Medicine of the Medical University of Graz (to S. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2012, ENDOCRINOLOGY, V153, P2551, DOI 10.1210/en.2011-2134; Bekedam DJ, 2002, AM J OBSTET GYNECOL, V187, P1605, DOI 10.1067/mob.2002.127379; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bracero LA, 1996, GYNECOL OBSTET INVES, V41, P10, DOI 10.1159/000292026; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Cui W, 2005, BIRTH DEFECTS RES A, V73, P876, DOI 10.1002/bdra.20196; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Engel PJ, 2008, AUST NZ J OBSTET GYN, V48, P375, DOI 10.1111/j.1479-828X.2008.00863.x; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Ghidini A, 2005, ACTA OBSTET GYN SCAN, V84, P547, DOI 10.1111/j.0001-6349.2005.00694.x; Graves JAM, 2010, PLACENTA, V31, pS27, DOI 10.1016/j.placenta.2009.12.029; Hache S, 2011, J CELL MOL MED, V15, P654, DOI 10.1111/j.1582-4934.2010.01039.x; Kim SJ, 2009, J AM SOC NEPHROL, V20, P2025, DOI 10.1681/ASN.2008101110; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306; Lang I, 2008, DIFFERENTIATION, V76, P1031, DOI 10.1111/j.1432-0436.2008.00302.x; Miao F, 2013, PHYSIOL GENOMICS, V45, P287, DOI 10.1152/physiolgenomics.00001.2013; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; Nielsen HS, 2009, HUM MOL GENET, V18, P1684, DOI 10.1093/hmg/ddp077; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Scott NM, 2009, J IMMUNOL, V182, P1411, DOI 10.4049/jimmunol.182.3.1411; Sitras V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033294; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Stark MJ, 2008, PEDIATR RES, V63, P415, DOI 10.1203/01.pdr.0000304937.38669.63; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van Abeelen AFM, 2011, PLACENTA, V32, P694, DOI 10.1016/j.placenta.2011.06.012; Wang JJ, 2010, AM J PHYSIOL-HEART C, V298, pH1146, DOI 10.1152/ajpheart.00252.2009; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zeitlin J, 2004, AM J OBSTET GYNECOL, V190, P1322, DOI 10.1016/j.ajog.2003.10.703	41	77	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79233	10.1371/journal.pone.0079233	http://dx.doi.org/10.1371/journal.pone.0079233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205377	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700104
J	Darvekar, S; Rekdal, C; Johansen, T; Sjottem, E				Darvekar, Sagar; Rekdal, Cecilie; Johansen, Terje; Sjottem, Eva			A Phylogenetic Study of SPBP and RAI1: Evolutionary Conservation of Chromatin Binding Modules	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; TANDEM PHD FINGER; HISTONE H3 TAIL; COMBINATORIAL READOUT; ADD DOMAIN; RECOGNITION; PROTEIN; TRANSCRIPTION; MUTATIONS; MECHANISM	Our genome is assembled into and array of highly dynamic nucleosome structures allowing spatial and temporal access to DNA. The nucleosomes are subject to a wide array of post-translational modifications, altering the DNA-histone interaction and serving as docking sites for proteins exhibiting effector or "reader" modules. The nuclear proteins SPBP and RAI1 are composed of several putative "reader" modules which may have ability to recognise a set of histone modification marks. Here we have performed a phylogenetic study of their putative reader modules, the C-terminal ePHD/ADD like domain, a novel nucleosome binding region and an AT-hook motif. Interactions studies in vitro and in yeast cells suggested that despite the extraordinary long loop region in their ePHD/ADD-like chromatin binding domains, the C-terminal region of both proteins seem to adopt a cross-braced topology of zinc finger interactions similar to other structurally determined ePHD/ADD structures. Both their ePHD/ADD-like domain and their novel nucleosome binding domain are highly conserved in vertebrate evolution, and construction of a phylogenetic tree displayed two well supported clusters representing SPBP and RAI1, respectively. Their genome and domain organisation suggest that SPBP and RAI1 have occurred from a gene duplication event. The phylogenetic tree suggests that this duplication has happened early in vertebrate evolution, since only one gene was identified in insects and lancelet. Finally, experimental data confirm that the conserved novel nucleosome binding region of RAI1 has the ability to bind the nucleosome core and histones. However, an adjacent conserved AT-hook motif as identified in SPBP is not present in RAI1, and deletion of the novel nucleosome binding region of RAI1 did not significantly affect its nuclear localisation.	[Darvekar, Sagar; Rekdal, Cecilie; Johansen, Terje; Sjottem, Eva] Univ Tromso, Dept Med Biol, Mol Canc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso	Sjottem, E (corresponding author), Univ Tromso, Dept Med Biol, Mol Canc Res Grp, Tromso, Norway.	eva.sjottem@uit.no	Johansen, Terje/AAY-1753-2021; Johansen, Terje/N-2971-2015	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Sjottem, Eva/0000-0003-2668-1708	Norwegian Research Council; Familien Blix Fond; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Familien Blix Fond; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Norwegian Research Council, Familien Blix Fond and the Norwegian Cancer Society to Professor Terje Johansen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Callebaut I, 2012, BIOCHIMIE, V94, P2006, DOI 10.1016/j.biochi.2012.05.025; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Darvekar S, 2012, BIOCHEM J, V442, P65, DOI 10.1042/BJ20111230; Elvenes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024659; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Gburcik V, 2005, MOL CELL BIOL, V25, P3421, DOI 10.1128/MCB.25.9.3421-3430.2005; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Hayes S, 2000, HUM MOL GENET, V9, P1753, DOI 10.1093/hmg/9.12.1753; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Kumar GS, 2012, J MOL BIOL, V422, P519, DOI 10.1016/j.jmb.2012.06.013; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lallous N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027599; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Migliori V, 2012, EPIGENETICS-US, V7, P815, DOI 10.4161/epi.21140; Morra R, 2012, FEBS LETT, V586, P2513, DOI 10.1016/j.febslet.2012.06.017; Oliver SS, 2012, BIOCHEMISTRY-US, V51, P6534, DOI 10.1021/bi3006972; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; SANZ L, 1995, MOL CELL BIOL, V15, P3164; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Vilboux T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022861; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	40	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78907	10.1371/journal.pone.0078907	http://dx.doi.org/10.1371/journal.pone.0078907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205348	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300167
J	Liu, FC; Tsai, YF; Yu, HP				Liu, Fu-Chao; Tsai, Yung-Fong; Yu, Huang-Ping			Maraviroc Attenuates Trauma-Hemorrhage-Induced Hepatic Injury through PPAR Gamma-Dependent Pathway in Rats	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CCR5 ANTAGONIST MARAVIROC; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; NUCLEAR RECEPTORS; SHOCK; INFLAMMATION; AGONIST; MICE; ANDROSTENEDIOL	Maraviroc is a CC-chemokine receptor 5 (CCR5) antagonist with potent antiviral and cancer preventive effects. Recent evidence suggests that the co-existence of CCR5 in various cell types is involved in inflammation. However, the effects that CCR5 antagonists produce in trauma-hemorrhage remain unknown. The peroxisome proliferator-activated receptor gamma (PPAR(gamma)) pathway exerts anti-inflammatory effects in injury. In this study, we hypothesized that maraviroc administration in male rats, after trauma-hemorrhage, decreases cytokine production and protects against hepatic injury through a PPAR(gamma)-dependent pathway. Male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure maintained at approximately 35-40 mmHg for 90 minutes), followed by fluid resuscitation. During resuscitation, a single dose of maraviroc (3 mg/kg, intravenously) with and without a PPAR(gamma) antagonist GW9662 (1 mg/kg, intravenously), GW9662 or vehicle was administered. Plasma alanine aminotransferase (ALT) with aspartate aminotransferase (AST) concentrations and various hepatic parameters were measured (n=8 rats/group) at 24 hours after resuscitation. The results showed that trauma-hemorrhage increased hepatic myeloperoxidase activity, intercellular adhesion molecule-1 and interleukin-6 levels, and plasma ALT and AST concentrations. These parameters were significantly improved in the maraviroc-treated rats subjected to trauma-hemorrhage. Maraviroc treatment also increased hepatic PPAR(gamma) expression compared with vehicle-treated trauma-hemorrhaged rats. Co-administration of GW9662 with maraviroc abolished the maraviroc-induced beneficial effects on the above parameters and hepatic injury. These results suggest that the protective effect of maraviroc administration on alleviation of hepatic injury after trauma-hemorrhage, which is, at least in part, through PPAR(gamma)-dependent pathway.	[Liu, Fu-Chao; Tsai, Yung-Fong; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Liu, Fu-Chao; Tsai, Yung-Fong; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Tsai, Yung-Fong] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Liu, FC (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan.	ana5189@adm.cgmh.org.tw; yuhp2001@adm.cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021	Liu, F-C/0000-0003-1712-4053	National Science Council [NSC101-2314-B-182A-010, NSC101-2314-B-182-082]; Chang Gung Memorial Hospital [CMRPG3B1052, CMRPG3B1621]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was partially supported by grants from the National Science Council (NSC101-2314-B-182A-010) and Chang Gung Memorial Hospital (CMRPG3B1052) to Huang-Ping Yu. Support was also provided by the National Science Council(NSC101-2314-B-182-082) and Chang Gung Memorial Hospital (CMRPG3B1621) to Fu-Chao Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; Akahori T, 2007, J HEPATOL, V47, P784, DOI 10.1016/j.jhep.2007.07.030; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Capetti Amedeo F, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P201, DOI 10.1177/1545109710372671; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Collin M, 2004, EUR J PHARMACOL, V486, P233, DOI 10.1016/j.ejphar.2003.12.032; Collino M, 2005, KIDNEY INT, V68, P529, DOI 10.1111/j.1523-1755.2005.00430.x; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Ito H, 2003, LAB INVEST, V83, P1715, DOI 10.1097/01.LAB.0000106724.29121.DA; Jung Y, 2008, IMMUNOL LETT, V117, P63, DOI 10.1016/j.imlet.2007.12.002; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kuboki S, 2008, HEPATOLOGY, V47, P215, DOI 10.1002/hep.21963; Lee YK, 2013, NEUROPHARMACOLOGY, V67, P57, DOI 10.1016/j.neuropharm.2012.10.030; Li J, 2011, J IMMUNOL, V186, P3753, DOI 10.4049/jimmunol.1002143; Lisi L, 2012, J NEUROCHEM, V120, P106, DOI 10.1111/j.1471-4159.2011.07549.x; Liu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053203; Liu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025907; Napimoga MH, 2008, J IMMUNOL, V180, P609, DOI 10.4049/jimmunol.180.1.609; Ochoa-Callejero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053992; Perry CM, 2010, DRUGS, V70, P1189, DOI 10.2165/11203940-000000000-00000; Ray Neelanjana, 2009, Drug Des Devel Ther, V2, P151; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Reel B, 2013, J SURG RES, V182, P176, DOI 10.1016/j.jss.2012.08.020; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Sharma R, 2009, PULM PHARMACOL THER, V22, P183, DOI 10.1016/j.pupt.2008.11.011; Shimizu T, 2005, SURGERY, V138, P204, DOI 10.1016/j.surg.2005.03.017; Shimizu T, 2006, ANN SURG, V244, P131, DOI 10.1097/01.sla.0000217709.00863.82; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Suzuki T, 2011, J CELL PHYSIOL, V226, P205, DOI 10.1002/jcp.22327; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yu HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065916; Yu HP, 2011, FREE RADICAL BIO MED, V50, P1737, DOI 10.1016/j.freeradbiomed.2011.03.026; Yu HP, 2010, SURGERY, V148, P103, DOI 10.1016/j.surg.2009.12.008; Zingarelli B, 2009, CRIT CARE MED, V37, P1978, DOI 10.1097/CCM.0b013e31819feb4d	34	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78861	10.1371/journal.pone.0078861	http://dx.doi.org/10.1371/journal.pone.0078861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205332	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300164
J	Vinader, V; Ahmet, DS; Ahmed, MS; Patterson, LH; Afarinkia, K				Vinader, Victoria; Ahmet, Djevdet S.; Ahmed, Mohaned S.; Patterson, Laurence H.; Afarinkia, Kamyar			Discovery and Computer Aided Potency Optimization of a Novel Class of Small Molecule CXCR4 Antagonists	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER METASTASIS; THERAPEUTIC TARGET; HOMOLOGY MODELS; TUMOR-GROWTH; INHIBITION; CTCE-9908; AXIS; MECHANISM; BICYCLAM	Amongst the chemokine signalling axes involved in cancer, chemokine CXCL12 acting on chemokine receptor CXCR4 is particularly significant since it orchestrates migration of cancer cells in a tissue-specific metastatic process. High CXCR4 tumour expression is associated with poor prognosis of lung, brain, CNS, blood and breast cancers. We have identified a new class of small molecule CXCR4 antagonists based on the use of computational modelling studies in concert with experimental determination of in vitro activity against CXCL12-induced intracellular calcium mobilisation, proliferation and chemotaxis. Molecular modelling proved to be a useful tool in rationalising our observed potencies, as well as informing the direction of the synthetic efforts aimed at producing more potent compounds.	[Vinader, Victoria; Ahmet, Djevdet S.; Ahmed, Mohaned S.; Patterson, Laurence H.; Afarinkia, Kamyar] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Afarinkia, K (corresponding author), Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England.	k.afarinkia@bradford.ac.uk	Afarinkia, Kamyar/B-7965-2010	Afarinkia, Kamyar/0000-0003-2819-4364; Vinader, Victoria/0000-0002-7706-8586	Yorkshire Cancer Research	Yorkshire Cancer Research	The authors thank Yorkshire Cancer Research for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Ben-Baruch A, 2008, CLIN EXP METASTAS, V25, P345, DOI 10.1007/s10585-007-9097-3; Bestebroer J, 2010, FEMS MICROBIOL REV, V34, P395, DOI 10.1111/j.1574-6976.2009.00202.x; Bhattacharya S, 2013, PROTEINS, V81, P729, DOI 10.1002/prot.24195; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Burger JA, 2011, EXPERT REV ANTICANC, V11, P621, DOI [10.1586/era.11.11, 10.1586/ERA.11.11]; Burger JA, 2009, EXPERT OPIN INV DRUG, V18, P481, DOI [10.1517/13543780902804249 , 10.1517/13543780902804249]; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Choi HY, 2010, ANN PHARMACOTHER, V44, P117, DOI 10.1345/aph.1M380; Clezardin P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2835; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; Ehtesham M, 2013, J NEURO-ONCOL, V113, P153, DOI 10.1007/s11060-013-1108-4; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Gangadhar Tara, 2010, Cancer Biol Ther, V9, P409, DOI 10.4161/cbt.9.6.11233; Gosselin RD, 2008, CURR MED CHEM, V15, P2866, DOI 10.2174/092986708786242822; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hassan S, 2011, INT J CANCER, V129, P225, DOI 10.1002/ijc.25665; Hinton CV, 2010, CLIN EXP METASTAS, V27, P97, DOI 10.1007/s10585-008-9210-2; Hirbe AC, 2010, CURR PHARM DESIGN, V16, P1284, DOI 10.2174/138161210791034012; Huang EH, 2009, J SURG RES, V155, P231, DOI 10.1016/j.jss.2008.06.044; Jantunen E, 2011, EXPERT OPIN BIOL TH, V11, P1241, DOI 10.1517/14712598.2011.601737; Jenkinson S, 2010, ANTIMICROB AGENTS CH, V54, P817, DOI 10.1128/AAC.01293-09; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kim SY, 2008, CLIN EXP METASTAS, V25, P201, DOI 10.1007/s10585-007-9133-3; Kozhevnikov VN, 2008, TETRAHEDRON, V64, P8963, DOI 10.1016/j.tet.2008.06.040; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Liang ZX, 2005, CANCER RES, V65, P967; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Moyle G, 2009, CLIN INFECT DIS, V48, P798, DOI 10.1086/597097; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Neves MAC, 2010, J COMPUT AID MOL DES, V24, P1023, DOI 10.1007/s10822-010-9393-x; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Porvasnik S, 2009, PROSTATE, V69, P1460, DOI 10.1002/pros.21008; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Ramsey DM, 2013, BIOORG MED CHEM LETT, V23, P20, DOI 10.1016/j.bmcl.2012.10.138; Richert MM, 2009, ONCOL REP, V21, P761, DOI 10.3892/or_00000282; Rodima T, 2002, J ORG CHEM, V67, P1873, DOI 10.1021/jo016185p; Ros-Blanco L, 2012, J MED CHEM, V55, P7560, DOI 10.1021/jm300862u; Rosenkilde MM, 2007, J BIOL CHEM, V282, P27354, DOI 10.1074/jbc.M704739200; Rubin JB, 2009, SEMIN CANCER BIOL, V19, P116, DOI 10.1016/j.semcancer.2008.10.001; Ruffini PA, 2007, CANCER-AM CANCER SOC, V109, P2392, DOI 10.1002/cncr.22706; Shachar I, 2013, J LEUKOCYTE BIOL, V93, P51, DOI 10.1189/jlb.0612293; Shim H, 2009, SEMIN CANCER BIOL, V19, P123, DOI 10.1016/j.semcancer.2008.11.004; Singh B, 2010, CLIN EXP METASTAS, V27, P233, DOI 10.1007/s10585-010-9321-4; Terasaki M, 2011, BRAIN TUMOR PATHOL, V28, P89, DOI 10.1007/s10014-010-0013-1; Vinader V, 2012, FUTURE MED CHEM, V4, P845, DOI [10.4155/FMC.12.49, 10.4155/fmc.12.49]; Vinader V, 2011, J PHARMACOL TOX MET, V64, P213, DOI 10.1016/j.vascn.2011.01.004; Vitry C, 2001, TETRAHEDRON, V57, P9101, DOI 10.1016/S0040-4020(01)00887-0; White FA, 2009, MOL INTERV, V9, P188, DOI 10.1124/mi.9.4.7; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Wong RSY, 2008, MOL PHARMACOL, V74, P1485, DOI 10.1124/mol.108.049775; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	65	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78744	10.1371/journal.pone.0078744	http://dx.doi.org/10.1371/journal.pone.0078744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205302	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300161
J	Artelle, KA; Anderson, SC; Cooper, AB; Paquet, PC; Reynolds, JD; Darimont, CT				Artelle, Kyle A.; Anderson, Sean C.; Cooper, Andrew B.; Paquet, Paul C.; Reynolds, John D.; Darimont, Chris T.			Confronting Uncertainty in Wildlife Management: Performance of Grizzly Bear Management	PLOS ONE			English	Article							CONSERVATION; POPULATION; FISHERIES; MORTALITY	Scientific management of wildlife requires confronting the complexities of natural and social systems. Uncertainty poses a central problem. Whereas the importance of considering uncertainty has been widely discussed, studies of the effects of unaddressed uncertainty on real management systems have been rare. We examined the effects of outcome uncertainty and components of biological uncertainty on hunt management performance, illustrated with grizzly bears (Ursus arctos horribilis) in British Columbia, Canada. We found that both forms of uncertainty can have serious impacts on management performance. Outcome uncertainty alone - discrepancy between expected and realized mortality levels - led to excess mortality in 19% of cases (population-years) examined. Accounting for uncertainty around estimated biological parameters (i.e., biological uncertainty) revealed that excess mortality might have occurred in up to 70% of cases. We offer a general method for identifying targets for exploited species that incorporates uncertainty and maintains the probability of exceeding mortality limits below specified thresholds. Setting targets in our focal system using this method at thresholds of 25% and 5% probability of overmortality would require average target mortality reductions of 47% and 81%, respectively. Application of our transparent and generalizable framework to this or other systems could improve management performance in the presence of uncertainty.	[Artelle, Kyle A.; Anderson, Sean C.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Artelle, Kyle A.; Paquet, Paul C.; Darimont, Chris T.] Raincoast Conservat Fdn, Sidney, BC, Canada; [Cooper, Andrew B.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Paquet, Paul C.; Darimont, Chris T.] Univ Victoria, Dept Geog, Victoria, BC, Canada	Simon Fraser University; Simon Fraser University; University of Victoria	Artelle, KA (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	kartelle@sfu.ca	Anderson, Sean C./AFN-3267-2022; Reynolds, John D/L-6345-2015	Anderson, Sean C./0000-0001-9563-1937; Reynolds, John D/0000-0002-0459-0074; Artelle, Kyle/0000-0002-8399-5693	David Suzuki Foundation; Raincoast Conservation Foundation; Tula Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC CGSA [Alexander Graham Bell Supplement]); C. D. Nelson Memorial Foundation; Anne Vallee Ecological Fund; Tula Foundation through the Hakai Network for Coastal Peoples and Ecosystems; NSERC PGSA; Fulbright Canada award; Wilburforce Foundation; NSERC [341481, 435683]; Tom Buell endowment; Pacific Salmon Foundation; BC Leading Edge Fund	David Suzuki Foundation; Raincoast Conservation Foundation; Tula Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC CGSA [Alexander Graham Bell Supplement]); C. D. Nelson Memorial Foundation; Anne Vallee Ecological Fund; Tula Foundation through the Hakai Network for Coastal Peoples and Ecosystems; NSERC PGSA; Fulbright Canada award; Wilburforce Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tom Buell endowment; Pacific Salmon Foundation; BC Leading Edge Fund	The authors thank the David Suzuki Foundation, the Raincoast Conservation Foundation, and the Tula Foundation for financial support. KAA was supported by Natural Sciences and Engineering Research Council of Canada (NSERC CGSA [Alexander Graham Bell Supplement]), C. D. Nelson Memorial Foundation, Anne Vallee Ecological Fund, and a scholarship funded by the Tula Foundation through the Hakai Network for Coastal Peoples and Ecosystems; SCA was supported by an NSERC PGSA and a Fulbright Canada award; PCP by the Wilburforce Foundation; JDR by an NSERC Discovery Grant (341481), the Tom Buell endowment, the Pacific Salmon Foundation, and the BC Leading Edge Fund; and CTD by an NSERC Discovery Grant (435683) as well as the Tula and Wilburforce Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins J. L., 2012, INVASIVE LIONFISH GU, P24; Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Austin M. A., 2004, GRIZZLY BEAR URSUS A; Bolker B.M, 2011, ECOLOGICAL MODELS DA; British Columbia Ministry of Environment Fish Wildlife and Habitat Branch, 2010, GRIZZL BEAR HUNT FRE; Caddy J. F., 1996, North American Journal of Fisheries Management, V16, P479, DOI 10.1577/1548-8675(1996)016&lt;0479:TOLFMO&gt;2.3.CO;2; Collins C, 2011, ANIM CONSERV, V14, P474, DOI 10.1111/j.1469-1795.2011.00458.x; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Darimont CT, 2012, FALTERING LIGHT; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Hamilton AN, 2004, ESTIMATING GRIZZLY B; HAMILTON AN, 2002, GRIZZLY BEAR HARVEST; Harris RB, 1986, MODELING SUSTA UNPUB; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; Hilborn Ray, 1997, V28; Holt CA, 2006, CAN J FISH AQUAT SCI, V63, P2722, DOI 10.1139/F06-155; Knapp A, 2007, REV EUROPEAN UNIONS; Lackey RT, 1998, LANDSCAPE URBAN PLAN, V40, P21, DOI 10.1016/S0169-2046(97)00095-9; Levi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001303; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Lunn K, 2007, GRIZZLY BEAR HARVEST; Mattson DJ, 1996, CONSERV BIOL, V10, P1013, DOI 10.1046/j.1523-1739.1996.10041013.x; McLoughlin PD, 2004, CONSERV BIOL, V18, P1665, DOI 10.1111/j.1523-1739.2004.00500.x; McLoughlin PD, 2003, MANAGING RISKS DECLI; Miller S, 1990, INT C BEAR, V8; Milner-Gulland EJ, 2001, ANIM CONSERV, V4, P157, DOI 10.1017/S1367943001001184; Ministry of Forests Lands and Natural Resource Operations, 2012, BRIT COL GRIZZL BEAR; Paquet PC, 2010, ANIM WELFARE, V19, P177; Peek J, 2003, MANAGEMENT GRI UNPUB; PEEK JM, 1987, WILDLIFE SOC B, V15, P160; Peterman RM, 2004, ICES J MAR SCI, V61, P1331, DOI 10.1016/j.icesjms.2004.08.017; Phillis CC, 2013, CONSERV LETT, V6, P98, DOI 10.1111/j.1755-263X.2012.00294.x; Prager MH, 2003, N AM J FISH MANAGE, V23, P349, DOI 10.1577/1548-8675(2003)023<0349:TALFMO>2.0.CO;2; RECKHOW KH, 1994, ENVIRON MANAGE, V18, P161, DOI 10.1007/BF02393758; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Reynolds JD, 2003, MACROECOLOGY, P195; Ross PI, 1996, WILDLIFE SOC B, V24, P490; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Wielgus RB, 2001, BIOL CONSERV, V98, P293, DOI 10.1016/S0006-3207(00)00168-3	41	35	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78041	10.1371/journal.pone.0078041	http://dx.doi.org/10.1371/journal.pone.0078041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223134	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200026
J	Behr, ER; Ritchie, MD; Tanaka, T; Kaab, S; Crawford, DC; Nicoletti, P; Floratos, A; Sinner, MF; Kannankeril, PJ; Wilde, AAM; Bezzina, CR; Schulze-Bahr, E; Zumhagen, S; Guicheney, P; Bishopric, NH; Marshall, V; Shakir, S; Dalageorgou, C; Bevan, S; Jamshidi, Y; Bastiaenen, R; Myerburg, RJ; Schott, JJ; Camm, AJ; Steinbeck, G; Norris, K; Altman, RB; Tatonetti, NP; Jeffery, S; Kubo, M; Nakamura, Y; Shen, YF; George, AL; Roden, DM				Behr, Elijah R.; Ritchie, Marylyn D.; Tanaka, Toshihiro; Kaeaeb, Stefan; Crawford, Dana C.; Nicoletti, Paola; Floratos, Aris; Sinner, Moritz F.; Kannankeril, Prince J.; Wilde, Arthur A. M.; Bezzina, Connie R.; Schulze-Bahr, Eric; Zumhagen, Sven; Guicheney, Pascale; Bishopric, Nanette H.; Marshall, Vanessa; Shakir, Saad; Dalageorgou, Chrysoula; Bevan, Steve; Jamshidi, Yalda; Bastiaenen, Rachel; Myerburg, Robert J.; Schott, Jean-Jacques; Camm, A. John; Steinbeck, Gerhard; Norris, Kris; Altman, Russ B.; Tatonetti, Nicholas P.; Jeffery, Steve; Kubo, Michiaki; Nakamura, Yusuke; Shen, Yufeng; George, Alfred L., Jr.; Roden, Dan M.			Genome Wide Analysis of Drug-Induced Torsades de Pointes: Lack of Common Variants with Large Effect Sizes	PLOS ONE			English	Article							QT INTERVAL DURATION; INDUCED LIVER-INJURY; SUDDEN-INFANT-DEATH; ATRIAL-FIBRILLATION; DISEASE GENES; ASSOCIATION; POPULATION; LINKAGE; SCN5A; RISK	Marked prolongation of the QT interval on the electrocardiogram associated with the polymorphic ventricular tachycardia Torsades de Pointes is a serious adverse event during treatment with antiarrhythmic drugs and other culprit medications, and is a common cause for drug relabeling and withdrawal. Although clinical risk factors have been identified, the syndrome remains unpredictable in an individual patient. Here we used genome-wide association analysis to search for common predisposing genetic variants. Cases of drug-induced Torsades de Pointes (diTdP), treatment tolerant controls, and general population controls were ascertained across multiple sites using common definitions, and genotyped on the Illumina 610k or 1M-Duo BeadChips. Principal Components Analysis was used to select 216 Northwestern European diTdP cases and 771 ancestry-matched controls, including treatment-tolerant and general population subjects. With these sample sizes, there is 80% power to detect a variant at genome-wide significance with minor allele frequency of 10% and conferring an odds ratio of >= 2.7. Tests of association were carried out for each single nucleotide polymorphism (SNP) by logistic regression adjusting for gender and population structure. No SNP reached genome wide-significance; the variant with the lowest P value was rs2276314, a non-synonymous coding variant in C18orf21 (p = 3 x 10(-7), odds ratio = 2, 95% confidence intervals: 1.5-2.6). The haplotype formed by rs2276314 and a second SNP, rs767531, was significantly more frequent in controls than cases (p = 3 x 10(-9)). Expanding the number of controls and a gene-based analysis did not yield significant associations. This study argues that common genomic variants do not contribute importantly to risk for drug-induced Torsades de Pointes across multiple drugs.	[Behr, Elijah R.; Dalageorgou, Chrysoula; Bevan, Steve; Jamshidi, Yalda; Bastiaenen, Rachel; Camm, A. John; Jeffery, Steve] St Georges Univ London, Cardiovasc Sci Ctr, London, England; [Behr, Elijah R.; Dalageorgou, Chrysoula; Bevan, Steve; Jamshidi, Yalda; Bastiaenen, Rachel; Camm, A. John; Jeffery, Steve] St Georges Univ London, Genet Res Ctr, London, England; [Ritchie, Marylyn D.; Crawford, Dana C.; Kannankeril, Prince J.; Norris, Kris; George, Alfred L., Jr.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Crawford, Dana C.; Kannankeril, Prince J.; Norris, Kris; George, Alfred L., Jr.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Crawford, Dana C.; Kannankeril, Prince J.; Norris, Kris; George, Alfred L., Jr.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Crawford, Dana C.; Kannankeril, Prince J.; Norris, Kris; George, Alfred L., Jr.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ritchie, Marylyn D.] Penn State Univ, Eberly Coll Sci, Huck Inst Life Sci, University Pk, PA 16802 USA; [Tanaka, Toshihiro; Kubo, Michiaki; Nakamura, Yusuke] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan; [Kaeaeb, Stefan; Sinner, Moritz F.] Univ Munich, Dept Med 1, Univ Hosp Munich, Munich, Germany; [Nicoletti, Paola; Floratos, Aris; Tatonetti, Nicholas P.; Shen, Yufeng] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Wilde, Arthur A. M.; Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Clin & Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Schulze-Bahr, Eric; Zumhagen, Sven] Univ Hosp Munster, Inst Genet Heart Dis, Dept Cardiovasc Med, Munster, Germany; [Guicheney, Pascale] Univ Paris 06, INSERM, UMRS 956, Paris, France; [Bishopric, Nanette H.; Myerburg, Robert J.] Univ Miami, Miller Sch Med, Dept Med Cardiol, Miami, FL 33136 USA; [Marshall, Vanessa; Shakir, Saad] Drug Safety Res Unit, Southampton, Hants, England; [Schott, Jean-Jacques] Univ Nantes, CNRS, INSERM, UMR1087,UMR 6291, Nantes, France; [Schott, Jean-Jacques] CHU Nantes, F-44035 Nantes 01, France; [Steinbeck, Gerhard] Hosp Starnberg, Ctr Cardiol, Starnberg, Germany; [Altman, Russ B.] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA; [Nakamura, Yusuke] Univ Chicago, Chicago, IL 60637 USA; [Tanaka, Toshihiro; Kubo, Michiaki] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Kaeaeb, Stefan] Deutsch Zentrum Herz Kreislauf Forsch eV, Munich, Germany; [Schulze-Bahr, Eric; Zumhagen, Sven] Univ Munster, IZKF, D-48149 Munster, Germany; [Myerburg, Robert J.] Univ Miami, Miller Sch Med, Dept Physiol, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA	St Georges University London; St Georges University London; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Tokyo Medical & Dental University (TMDU); University of Munich; Columbia University; University of Amsterdam; Academic Medical Center Amsterdam; University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Miami; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Stanford University; University of Chicago; RIKEN; German Centre for Cardiovascular Research; University of Munster; University of Miami; University of Miami; University of Miami	Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	dan.roden@Vanderbilt.Edu	Sinner, Moritz/AAW-5043-2020; Crawford, Dana/O-5578-2019; Jamshidi, Yalda/AAL-1377-2020; Guicheney, Pascale/D-1034-2017; Kaab, Stefan/H-3915-2012; Tanaka, Toshihiro/J-9310-2014; Kubo, Michiaki/N-7947-2015; Schott, jean-Jacques/F-8842-2013; Roden, Dan/ABD-5412-2021	Crawford, Dana/0000-0002-6437-6248; Jamshidi, Yalda/0000-0003-0151-6482; Guicheney, Pascale/0000-0002-7663-2050; Tanaka, Toshihiro/0000-0001-6201-9784; Schott, jean-Jacques/0000-0002-9578-9475; Bastiaenen, Rachel/0000-0002-5018-8035; Bezzina, Connie/0000-0002-0633-3514; Behr, Elijah/0000-0002-8731-2853; Bevan, Steve/0000-0003-0490-6830; Tatonetti, Nicholas/0000-0002-2700-2597	Pharmacogenomics of Arrhythmia Therapy site of the Pharmacogenetics Research Network; Fondation Leducq (Trans-Atlantic Network of Excellence "Alliance Against Sudden Cardiac Death'') [05 CVD 01]; BioBank Japan Project; Japanese Ministry of Education, Culture, Sports, Science and Technology; British Heart Foundation [SP/02/001]; Abbott; Amgen; Astra-Zeneca; Cerner; Daiichi-Sankyo; GlaxoSmithKline; Merck; Novartis; Pfizer; Takeda; Welcome Trust;  [U01HL65962]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962, U19HL065962] Funding Source: NIH RePORTER; British Heart Foundation [PG/12/38/29615] Funding Source: researchfish	Pharmacogenomics of Arrhythmia Therapy site of the Pharmacogenetics Research Network; Fondation Leducq (Trans-Atlantic Network of Excellence "Alliance Against Sudden Cardiac Death''); BioBank Japan Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); British Heart Foundation(British Heart Foundation); Abbott(Abbott Laboratories); Amgen(Amgen); Astra-Zeneca(AstraZeneca); Cerner; Daiichi-Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Welcome Trust(Wellcome Trust); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation)	This study was supported by U01HL65962, the Pharmacogenomics of Arrhythmia Therapy site of the Pharmacogenetics Research Network, and by a grant from the Fondation Leducq (Trans-Atlantic Network of Excellence "Alliance Against Sudden Cardiac Death'', 05 CVD 01). Genotyping the Leducq samples described in the text was performed by the RIKEN Center for Genomic Medicine, Yokohama, Japan, which is supported in part by the BioBank Japan Project funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The DARE study was funded by the British Heart Foundation under special project grant SP/02/001. The DARE samples were genotyped at Gene Expression Ltd. Further support was provided by a collaboration with the International Serious Adverse Events Consortium, whose membership currently includes Abbott, Amgen, Astra-Zeneca, Cerner, Daiichi-Sankyo, GlaxoSmithKline, Merck, Novartis, Pfizer, Takeda, and the Welcome Trust. Portions of the Leducq dataset have been deposited at dbGaP at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id = phs000331.v1.p1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akylbekova EL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P427, DOI 10.1161/CIRCEP.109.858894; ARAKAWA M, 1992, AM J CARDIOL, V70, P550, DOI 10.1016/0002-9149(92)91211-L; Carter N, 2000, J HUM HYPERTENS, V14, P389, DOI 10.1038/sj.jhh.1001026; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Darbar D, 2007, J CARDIOVASC ELECTR, V18, P636, DOI 10.1111/j.1540-8167.2007.00817.x; Fenichel RR, 2004, J CARDIOVASC ELECTR, V15, P475, DOI 10.1046/j.1540-8167.2004.03534.x; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; Haverkamp W, 2000, EUR HEART J, V21, P1216, DOI 10.1053/euhj.2000.2249; Hoppe UC, 2001, P NATL ACAD SCI USA, V98, P5335, DOI 10.1073/pnas.091239098; Itoh H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P511, DOI 10.1161/CIRCEP.109.862649; Jamshidi Y, 2012, J AM COLL C IN PRESS; Kaab S, 2012, CIRC-CARDIOVASC GENE, V5, P91, DOI 10.1161/CIRCGENETICS.111.960930; Kannankeril PJ, 2005, HEART RHYTHM, V2, P134, DOI 10.1016/j.hrthm.2004.10.039; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lu ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003623; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pirmohamed M, 2011, CLIN PHARMACOL THER, V89, P784, DOI 10.1038/clpt.2011.30; Plant LD, 2006, J CLIN INVEST, V116, P430, DOI 10.1172/JCI25618; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roden DM, 2007, EUROPACE, V9, P1, DOI 10.1093/europace/eum165; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SALERNO DM, 1993, PACE, V16, P1862, DOI 10.1111/j.1540-8159.1993.tb01821.x; Sanguinetti MC, 2003, CIRC RES, V93, P491, DOI 10.1161/01.RES.0000091829.63501.A8; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Tatonetti NP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S9; The Psychiatrist, 2004, PSYCHIATRIST, V28, P431; Van Norstrand DW, 2008, HEART RHYTHM, V5, P712, DOI 10.1016/j.hrthm.2008.02.012; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C	43	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78511	10.1371/journal.pone.0078511	http://dx.doi.org/10.1371/journal.pone.0078511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223155	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000326656200047
J	Brisson, CD; Lukewich, MK; Andrew, RD				Brisson, C. Devin; Lukewich, Mark K.; Andrew, R. David			A Distinct Boundary between the Higher Brain's Susceptibility to Ischemia and the Lower Brain's Resistance	PLOS ONE			English	Article							SPREADING DEPRESSION; ANOXIC DEPOLARIZATION; NEURONAL DAMAGE; RAT; STEM; HETEROGENEITY; DEPRIVATION; FOREBRAIN; GLUTAMATE; FAILURE	Higher brain regions are more susceptible to global ischemia than the brainstem, but is there a gradual increase in vulnerability in the caudal-rostral direction or is there a discrete boundary? We examined the interface between 'higher' thalamus and the hypothalamus the using live brain slices where variation in blood flow is not a factor. Whole-cell current clamp recording of 18 thalamic neurons in response to 10 min O-2/glucose deprivation (OGD) revealed a rapid anoxic depolarization (AD) from which thalamic neurons do not recover. Newly acquired neurons could not be patched following AD, confirming significant regional thalamic injury. Coinciding with AD, light transmittance (LT) imaging during whole-cell recording showed an elevated LT front that initiated in midline thalamus and that propagated into adjacent hypothalamus. However, hypothalamic neurons patched in paraventricular nucleus (PVN, n= 8 magnocellular and 12 parvocellular neurons) and suprachiasmatic nucleus (SCN, n= 18) only slowly depolarized as AD passed through these regions. And with return to control aCSF, hypothalamic neurons repolarized and recovered their input resistance and action potential amplitude. Moreover, newly acquired hypothalamic neurons could be readily patched following exposure to OGD, with resting parameters similar to neurons not previously exposed to OGD. Thalamic susceptibility and hypothalamic resilience were also observed following ouabain exposure which blocks the Na+/K+ pump, evoking depolarization similar to OGD in all neuronal types tested. Finally, brief exposure to elevated [K+](o) caused spreading depression (SD, a milder, AD-like event) only in thalamic neurons so SD generation is regionally correlated with strong AD. Therefore the thalamus-hypothalamus interface represents a discrete boundary where neuronal vulnerability to ischemia is high in thalamus (like more rostral neocortex, striatum, hippocampus). In contrast hypothalamic neurons are comparatively resistant, generating weaker and recoverable anoxic depolarization similar to brainstem neurons, possibly the result of a Na/K pump that better functions during ischemia.	[Brisson, C. Devin; Lukewich, Mark K.; Andrew, R. David] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Andrew, RD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	andrewd@queensu.ca		Lukewich, Mark/0000-0001-7738-4688	Heart and Stroke Foundation of Ontario [T-4478]; Faculty of Health Sciences, Queen's University	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Faculty of Health Sciences, Queen's University	This work was supported by the Heart and Stroke Foundation of Ontario (grant T-4478) and the Faculty of Health Sciences, Queen's University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Andrew R. D., 2012, Society for Neuroscience Abstract Viewer and Itinerary Planner, V42; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; BURES J, 1981, J NEUROBIOL, V12, P211, DOI 10.1002/neu.480120303; Centonze D, 2001, PROG NEUROBIOL, V63, P687, DOI 10.1016/S0301-0082(00)00037-X; Davies ML, 2007, J NEUROSCI METH, V166, P203, DOI 10.1016/j.jneumeth.2007.07.012; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Erdemli G, 1998, J NEUROSCI, V18, P5212, DOI 10.1523/JNEUROSCI.18-14-05212.1998; Falini A, 1998, AM J NEURORADIOL, V19, P648; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; FIFKOVA E, 1964, EXPERIENTIA, V20, P635, DOI 10.1007/BF02144834; Funke F, 2009, J NEUROPHYSIOL, V101, P2395, DOI 10.1152/jn.91260.2008; Gottron MA, 2009, CONTEMP NEUROSCI, P129, DOI 10.1007/978-1-60761-280-3_8; Hamann M, 2005, BRAIN, V128, P2408, DOI 10.1093/brain/awh619; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Herculano-Houzel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017514; Higuchi T, 1997, MAGNET RESON MED, V37, P851, DOI 10.1002/mrm.1910370608; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Kaminogo M, 1998, NEUROL RES, V20, P343, DOI 10.1080/01616412.1998.11740529; KAWAI K, 1992, J CEREBR BLOOD F MET, V12, P238, DOI 10.1038/jcbfm.1992.34; KIM YI, 1993, J PHYSIOL-LONDON, V464, P229, DOI 10.1113/jphysiol.1993.sp019632; Kolaj M, 2000, NEUROSCIENCE, V98, P129, DOI 10.1016/S0306-4522(00)00094-4; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Longstreth WT, 2008, NEUROLOGY GEN MED, P163; Luigetti M, 2012, ACTA NEUROL BELG, V112, P105, DOI 10.1007/s13760-012-0007-3; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Polischuk TM, 1998, NEUROBIOL DIS, V4, P423, DOI 10.1006/nbdi.1998.0172; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Richter F, 2012, J CEREBR BLOOD F MET, V32, P1535, DOI 10.1038/jcbfm.2012.40; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Senatorov VV, 1997, J PHYSIOL-LONDON, V502, P387, DOI 10.1111/j.1469-7793.1997.387bk.x; SIEBER FE, 1995, STROKE, V26, P2091, DOI 10.1161/01.STR.26.11.2091; Tanaka E, 1999, J NEUROPHYSIOL, V81, P1872, DOI 10.1152/jn.1999.81.4.1872; Tanaka E, 1997, J NEUROPHYSIOL, V78, P891, DOI 10.1152/jn.1997.78.2.891; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; WYTRZES LM, 1989, ARCH NEUROL-CHICAGO, V46, P93, DOI 10.1001/archneur.1989.00520370095028; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466; Yuill EA, 2007, EUR J NEUROSCI, V25, P425, DOI 10.1111/j.1460-9568.2006.05293.x	45	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79589	10.1371/journal.pone.0079589	http://dx.doi.org/10.1371/journal.pone.0079589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223181	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200073
J	Liu, L; Karmakar, S; Dhar, R; Mahajan, M; Choudhury, A; Weissman, S; Pace, BS				Liu, Li; Karmakar, Subhradip; Dhar, Ruby; Mahajan, Milind; Choudhury, Alina; Weissman, Sherman; Pace, Betty S.			Regulation of G gamma-Globin Gene by ATF2 and Its Associated Proteins through the cAMP-Response Element	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; CHROMATIN REMODELING COMPLEX; FETAL-HEMOGLOBIN EXPRESSION; LOCUS-CONTROL REGION; BETA; TRANSCRIPTION; INDUCTION; BCL11A; ACTIVATION; PROMOTER	The upstream G gamma-globin cAMP-response element (G-CRE) plays an important role in regulating G gamma-globin expression through binding of ATF2 and its DNA-binding partners defined in this study. ATF2 knockdown resulted in a significant reduction of gamma-globin expression accompanied by decreased ATF2 binding to the G-CRE. By contrast, stable ATF2 expression in K562 cells increased gamma-globin transcription which was reduced by ATF2 knockdown. Moreover, a similar effect of ATF2 on gamma-globin expression was observed in primary erythroid progenitors. To understand the role of ATF2 in gamma-globin expression, chromatographically purified G-CRE/ATF2-interacting proteins were subjected to mass spectrometry analysis; major binding partners included CREB1, cJun, Brg1, and histone deacetylases among others. Immunoprecipitation assays demonstrated interaction of these proteins with ATF2 and in vivo GCRE binding in CD34(+) cells undergoing erythroid differentiation which was correlated with gamma-globin expression during development. These results suggest synergism between developmental stage-specific recruitments of the ATF2 protein complex and expression of gamma-globin during erythropoiesis. Microarray studies in K562 cells support ATF2 plays diverse roles in hematopoiesis and chromatin remodeling.	[Liu, Li] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA; [Karmakar, Subhradip; Dhar, Ruby; Choudhury, Alina] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Mahajan, Milind] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Weissman, Sherman] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Pace, Betty S.] Georgia Regents Univ, Dept Pediat, Augusta, GA USA	University of Texas System; University of Texas Dallas; University of Chicago; Icahn School of Medicine at Mount Sinai; Yale University; University System of Georgia; Augusta University	Pace, BS (corresponding author), Georgia Regents Univ, Dept Pediat, Augusta, GA USA.	bpace@georgiahealth.edu	Karmakar, Subhradip/AAF-7678-2021; Karmakar, Subhradip/AAP-6043-2020	Karmakar, Subhradip/0000-0002-4757-8729; Pace, Betty/0000-0002-1275-4112	National Heart, Lung, and Blood Institute [HL69234]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069234] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant HL69234 from the National Heart, Lung, and Blood Institute to Dr. Betty Pace. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano H, 1999, MOL CELL BIOL, V19, P3571; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Brown RC, 2002, MOL CELL BIOL, V22, P161, DOI 10.1128/MCB.22.1.161-170.2002; Bungert J, 1999, MOL CELL BIOL, V19, P3062; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; Kalra IS, 2011, BRIT J HAEMATOL, V154, P248, DOI 10.1111/j.1365-2141.2011.08710.x; Karmakar S, 2010, EMBO J, V29, P3260, DOI 10.1038/emboj.2010.204; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Kodeboyina S, 2009, BLOOD CELLS MOL DIS; Kodeboyina S, 2010, BLOOD CELL MOL DIS, V44, P7, DOI 10.1016/j.bcmd.2009.10.002; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee CH, 1999, P NATL ACAD SCI USA, V96, P12311, DOI 10.1073/pnas.96.22.12311; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Li BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-153; Liu L, 2006, J BIOL CHEM, V281, P1506, DOI 10.1074/jbc.M510402200; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Mahajan MC, 2009, EXP HEMATOL, V37, P1143, DOI 10.1016/j.exphem.2009.07.001; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Muralidhar SA, 2011, J BIOL CHEM, V286, P2343, DOI 10.1074/jbc.M110.115725; Pace BS, 2006, DEV DYNAM, V235, P1727, DOI 10.1002/dvdy.20802; Pace BS, 2003, EXP HEMATOL, V31, P1089, DOI 10.1016/S0301-472X(03)00235-2; Perrine SP, 2009, EUR J HAEMATOL, V82, P466, DOI 10.1111/j.1600-0609.2009.01234.x; PISSARD S, 1994, BLOOD, V84, P331; Ramakrishnan V, 2011, BLOOD CELL MOL DIS, V47, P12, DOI 10.1016/j.bcmd.2011.03.003; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STAMATOYANNOPOU.G, 1994, MOL BASIS BLOOD DIS; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Witt O, 2003, BLOOD, V101, P2001, DOI 10.1182/blood-2002-08-2617; Yao X, 2009, EXP HEMATOL, V37, P889, DOI 10.1016/j.exphem.2009.05.004; Yu T, 2002, BLOOD, V99, P1082, DOI 10.1182/blood.V99.3.1082; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78253	10.1371/journal.pone.0078253	http://dx.doi.org/10.1371/journal.pone.0078253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223142	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200034
J	Polacek, M; Griggio, M; Bartikova, M; Hoi, H				Polacek, Miroslav; Griggio, Matteo; Bartikova, Michaela; Hoi, Herbert			Nest Sanitation as the Evolutionary Background for Egg Ejection Behaviour and the Role of Motivation for Object Removal	PLOS ONE			English	Article							CONSPECIFIC BROOD PARASITISM; EXTRA-PAIR PATERNITY; GREAT-REED WARBLERS; CUCULUS-CANORUS; EUROPEAN PASSERINES; LIFE-HISTORY; CLUTCH SIZE; CUCKOO; REJECTION; RECOGNITION	Higher interclutch colour variation can evolve under the pressure of brood parasitism to increase the detection of parasitic eggs. Nest sanitation could be a prerequisite for the evolution of anti-parasite defence in terms of egg ejection. In this respect, we used nest sanitation behaviour as a tool to identify: i) motivation and its underlying function and, ii) which features provoke ejection behaviour. Therefore, we experimentally tested whether size, colour or shape may influence ejection behaviour using artificial flat objects. We found a high interclutch variation in egg colouration and egg size in our tree sparrow (Passer montanus) population. Using colour and size we were in fact able to predict clutch affiliation for each egg. Our experiments further revealed the existence of direct anti-parasite behaviours and birds are able to recognise conspecific eggs, since only experimentally-deposited eggs have been removed. Moreover, experiments with different objects revealed that the motivation of tree sparrows to remove experimental objects from their nests was highest during egg laying for objects of varying size, most likely because of parasitism risk at this breeding stage. In contrary, motivation to remove white objects and objects with edges was higher during incubation stage as behavioural patterns connected to hatching started to emerge. The fact that rejection rate of our flat objects was higher than real egg ejection, suggests that egg ejection in tree sparrows and probably more general in small passerines, to be limited by elevated costs to eject eggs with their beaks. The presence of anti-parasite behaviour supports our suggestion that brood parasitism causes variation in egg features, as we have found that tree sparrows can recognise and reject conspecific eggs in their clutch. In conclusion, in tree sparrows it seems that nest sanitation plays a key role in the evolution of the removal of parasitic eggs.	[Polacek, Miroslav; Bartikova, Michaela] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Polacek, Miroslav; Griggio, Matteo; Bartikova, Michaela; Hoi, Herbert] Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria	Slovak Academy of Sciences; University of Veterinary Medicine Vienna	Hoi, H (corresponding author), Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria.	Herbert.hoi@vetmeduni.ac.at	Polacek, Miroslav/AGI-5698-2022	Polacek, Miroslav/0000-0003-0786-7849; Griggio, Matteo/0000-0002-3298-2905	University of Veterinary Medicine, Vienna; Slovak Academy of Sciences	University of Veterinary Medicine, Vienna; Slovak Academy of Sciences(Slovak Academy of Sciences)	The funding for this work was provided by University of Veterinary Medicine, Vienna and the Slovak Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov A, 2008, BEHAV ECOL, V19, P100, DOI 10.1093/beheco/arm102; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Bartol I, 2003, ACTA ZOOL ACAD SCI H, V49, P111; BROOKE MD, 1988, NATURE, V335, P630; Cordero PJ, 1999, J AVIAN BIOL, V30, P97, DOI 10.2307/3677248; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; de Hierro MDGL, 2008, BEHAVIOUR, V145, P949, DOI 10.1163/156853908784089270; DERRICKSON KC, 1991, CONDOR, V93, P757, DOI 10.2307/1368210; Engstrand SM, 2002, FUNCT ECOL, V16, P782, DOI 10.1046/j.1365-2435.2002.00681.x; Fenske B, 1995, AUK, V112, P415; Floerchinger Stefan, 2002, Vogelwarte, V41, P279; Griffith SC, 1999, BIOL J LINN SOC, V68, P303, DOI 10.1111/j.1095-8312.1999.tb01171.x; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Guigueno MF, 2012, J ORNITHOL, V153, P35, DOI 10.1007/s10336-011-0731-0; Guigueno MF, 2009, ETHOLOGY, V115, P247, DOI 10.1111/j.1439-0310.2008.01597.x; Hauber ME, 2003, AUK, V120, P860, DOI 10.1642/0004-8038(2003)120[0860:EIACPB]2.0.CO;2; Hoi H, 2004, AUK, V121, P557, DOI 10.1642/0004-8038(2004)121[0557:CEILGS]2.0.CO;2; Hoi H, 2010, BEHAVIOUR, V147, P1533, DOI 10.1163/000579510X511060; Honza M, 2007, BIOL J LINN SOC, V92, P269, DOI 10.1111/j.1095-8312.2007.00848.x; Horak P, 1997, OIKOS, V78, P592, DOI 10.2307/3545622; HOYT DF, 1979, AUK, V96, P73; KENDRA PE, 1988, WILSON BULL, V100, P80; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kruger O, 2007, PHILOS T R SOC B, V362, P1873, DOI 10.1098/rstb.2006.1849; Lienert G.A., 1978, VERTEILUNGSFREIE MET; Lopez-de-Hierro MDG, 2010, BEHAV ECOL SOCIOBIOL, V64, P317, DOI 10.1007/s00265-009-0811-9; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; Marchetti K, 2000, ANIM BEHAV, V59, P877, DOI 10.1006/anbe.1999.1388; MARCHETTI K, 1992, P ROY SOC B-BIOL SCI, V248, P41, DOI 10.1098/rspb.1992.0040; MOKSNES A, 1991, BEHAVIOUR, V116, P64, DOI 10.1163/156853990X00365; Moller A.P., 1991, P1041; MOLLER AP, 1987, ANIM BEHAV, V35, P247, DOI 10.1016/S0003-3472(87)80230-0; Moskat C, 2003, J AVIAN BIOL, V34, P16, DOI 10.1034/j.1600-048X.2003.02919.x; Moskat C, 2008, BEHAV ECOL SOCIOBIOL, V62, P1885, DOI 10.1007/s00265-008-0618-0; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Payne Robert B., 1997, P338; Polacikova L, 2010, J AVIAN BIOL, V41, P111, DOI 10.1111/j.1600-048X.2010.04983.x; Poysa H, 2007, AM NAT, V169, P94, DOI 10.1086/509943; Prochazka P, 2003, J ORNITHOL, V144, P354, DOI 10.1046/j.1439-0361.2003.03009.x; Reid JM, 2000, FUNCT ECOL, V14, P560, DOI 10.1046/j.1365-2435.2000.00446.x; REID WV, 1990, EVOLUTION, V44, P1780, DOI 10.1111/j.1558-5646.1990.tb05248.x; Rothstein S, 1998, PARASITIC BIRDS THEI, P444; ROTHSTEIN SI, 1976, AUK, V93, P675; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; ROTHSTEIN SI, 1982, BEHAV ECOL SOCIOBIOL, V11, P229, DOI 10.1007/BF00299299; ROTHSTEIN SI, 1975, CONDOR, V77, P250, DOI 10.2307/1366221; Ruxton GD, 2002, P ROY SOC B-BIOL SCI, V269, P1989, DOI 10.1098/rspb.2002.2125; SEALY SG, 1995, ANIM BEHAV, V49, P877, DOI 10.1006/anbe.1995.0120; Servedio MR, 2006, J EVOLUTION BIOL, V19, P1585, DOI 10.1111/j.1420-9101.2006.01124.x; Soler JJ, 1996, BEHAV ECOL, V7, P89, DOI 10.1093/beheco/7.1.89; Soler M, 2002, ETHOLOGY, V108, P1093, DOI 10.1046/j.1439-0310.2002.00841.x; Soler M, 2012, ETHOLOGY, V118, P662, DOI 10.1111/j.1439-0310.2012.02058.x; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stokke BG, 2002, BEHAVIOUR, V139, P629, DOI 10.1163/15685390260136744; Stokke BG, 2002, EVOLUTION, V56, P199; Stokke BG, 1999, P ROY SOC B-BIOL SCI, V266, P1483, DOI 10.1098/rspb.1999.0804; Summers-Smith JD, 1995, TREE SPARROW, P205; Therneau T, 2012, PACKAGE SURVIVAL SUR; TINBERGEN N., 1962, BEHAVIOUR, V19, P74, DOI 10.1163/156853961X00213; Underwood TJ, 2006, ETHOLOGY, V112, P164, DOI 10.1111/j.1439-0310.2006.01143.x; Veiga JP, 2000, J AVIAN BIOL, V31, P237, DOI 10.1034/j.1600-048X.2000.310215.x; Welbergen J, 2001, BEHAV ECOL, V12, P8, DOI 10.1093/oxfordjournals.beheco.a000382; Yom-Tov Y, 2001, IBIS, V143, P133, DOI 10.1111/j.1474-919X.2001.tb04177.x; YOMTOV Y, 1980, BIOL REV, V55, P93, DOI 10.1111/j.1469-185X.1980.tb00689.x; Zolei A, 2012, BEHAVIOUR, V149, P391, DOI 10.1163/156853912X638445	70	22	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78771	10.1371/journal.pone.0078771	http://dx.doi.org/10.1371/journal.pone.0078771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223165	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200057
J	Xu, S; Santini, GC; De Veirman, K; Vande Broek, I; Leleu, X; De Becker, A; Van Camp, B; Vanderkerken, K; Van Riet, I				Xu, Song; Santini, Gaia Cecilia; De Veirman, Kim; Vande Broek, Isabelle; Leleu, Xavier; De Becker, Ann; Van Camp, Ben; Vanderkerken, Karin; Van Riet, Ivan			Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients	PLOS ONE			English	Article							EXPRESSION; MICRORNAS; LINEAGE; MIRNA; PROLIFERATION; PROGRAM; PATHWAY; PROFILE; PCR; RNA	Previous studies have demonstrated that mesenchymal stem cells from multiple myeloma (MM) patients (MM-hMSCs) display a distinctive gene expression profile, an enhanced production of cytokines and an impaired osteogenic differentiation ability compared to normal donors (ND-hMSCs). However, the underlying molecular mechanisms are unclear. In the present study, we observed that MM-hMSCs exhibited an abnormal upregulation of miR-135b, showing meanwhile an impaired osteogenic differentiation and a decrease of SMAD5 expression, which is the target of miR-135b involved in osteogenesis. By gain and loss of function studies we confirmed that miR-135b negatively regulated hMSCs osteogenesis. We also found that MM cell-produced factors stimulated ND-hMSCs to upregulate the expression of miR-135b. Importantly, treatment with a miR-135b inhibitor promoted osteogenic differentiation in MM-hMSCs. Finally, we observed that MM cell-derived soluble factors could induce an upregulation of miR-135b expression in ND-hMSCs in an indirect coculture system and the miR-135b expression turned to normal level after the removal of MM cells. Collectively, we provide evidence that miR-135b is involved in the impaired osteogenic differentiation of MSCs derived from MM patients and might therefore be a promising target for controlling bone disease.	[Xu, Song] Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Dept Lung Canc Surg, Tianjin, Peoples R China; [Xu, Song; Santini, Gaia Cecilia; De Veirman, Kim; De Becker, Ann; Van Riet, Ivan] Univ Ziekenhuis Brussel UZ Brussel, Div Clin Hematol, Stem Cell Lab, Brussels, Belgium; [Xu, Song; De Veirman, Kim; Vande Broek, Isabelle; Van Camp, Ben; Vanderkerken, Karin; Van Riet, Ivan] Vrije Univ Brussel, Myeloma Ctr Brussels, Dept Hematol & Immunol, Brussels, Belgium; [Leleu, Xavier] CHU Lille, Serv Hematol, F-59037 Lille, France	Tianjin Medical University; University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universite de Lille - ISITE; CHU Lille	Van Riet, I (corresponding author), Univ Ziekenhuis Brussel UZ Brussel, Div Clin Hematol, Stem Cell Lab, Brussels, Belgium.	ivan.vanriet@uzbrussel.be	De Veirman, Kim/ADT-0689-2022	De Veirman, Kim/0000-0002-1313-6121; Vanderkerken, Karin/0000-0002-2137-7179; De Becker, Ann/0000-0003-0947-8708	FWO-Vlaanderen, "Vlaamse Liga tegen Kanker" (Stichting Emmanuel Van der Shueren); Vrije Universiteit Brussel (HOA); Scientific Foundation Willy Gepts (WFWG) UZ Brussel; CSC-VUB scholarship	FWO-Vlaanderen, "Vlaamse Liga tegen Kanker" (Stichting Emmanuel Van der Shueren); Vrije Universiteit Brussel (HOA); Scientific Foundation Willy Gepts (WFWG) UZ Brussel; CSC-VUB scholarship	This work was supported by grants from the FWO-Vlaanderen, "Vlaamse Liga tegen Kanker" (Stichting Emmanuel Van der Shueren), the Vrije Universiteit Brussel (HOA) and the Scientific Foundation Willy Gepts (WFWG) UZ Brussel. SX is supported by CSC-VUB scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnulf B, 2007, LEUKEMIA, V21, P158, DOI 10.1038/sj.leu.2404466; Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65; Garderet L, 2007, LEUKEMIA LYMPHOMA, V48, P2032, DOI 10.1080/10428190701593644; Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu W, 2012, MOL MED REP, DOI [10.3892/mmr.2012: 1207, DOI 10.3892/MMR.2012:1207]; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Jo DH, 2011, J PEDIAT HEMATOL ONC, V33, P529, DOI 10.1097/MPH.0b013e318228280a; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lulla Rishi R., 2011, Sarcoma, V2011, P732690, DOI 10.1155/2011/732690; Lv SQ, 2012, BRAIN PATHOL, V22, P230, DOI 10.1111/j.1750-3639.2011.00523.x; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Menu E, 2004, BRIT J CANCER, V90, P1076, DOI 10.1038/sj.bjc.6601613; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Munding JB, 2012, INT J CANCER, V131, pE86, DOI 10.1002/ijc.26466; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Wu TT, 2012, BONE, V51, P498, DOI 10.1016/j.bone.2012.05.013; Xu S, 2012, LEUKEMIA, V26, P2546, DOI 10.1038/leu.2012.126; Xu S, 2012, STEM CELLS, V30, P266, DOI 10.1002/stem.787; Zeng Y, 2012, FEBS LETT, V586, P2375, DOI 10.1016/j.febslet.2012.05.049; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	31	59	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79752	10.1371/journal.pone.0079752	http://dx.doi.org/10.1371/journal.pone.0079752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223191	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200084
J	Bhat, HS; Vaz, GJ				Bhat, Harish S.; Vaz, Garnet J.			Frequency Response and Gap Tuning for Nonlinear Electrical Oscillator Networks	PLOS ONE			English	Article							TRANSMISSION-LINES; GENERATION; SOLITONS; LATTICE; SYNCHRONIZATION; PRINCIPLES; DYNAMICS	We study nonlinear electrical oscillator networks, the smallest example of which consists of a voltage-dependent capacitor, an inductor, and a resistor driven by a pure tone source. By allowing the network topology to be that of any connected graph, such circuits generalize spatially discrete nonlinear transmission lines/lattices that have proven useful in high-frequency analog devices. For such networks, we develop two algorithms to compute the steady-state response when a subset of nodes are driven at the same fixed frequency. The algorithms we devise are orders of magnitude more accurate and efficient than stepping towards the steady-state using a standard numerical integrator. We seek to enhance a given network's nonlinear behavior by altering the eigenvalues of the graph Laplacian, i.e., the resonances of the linearized system. We develop a Newton-type method that solves for the network inductances such that the graph Laplacian achieves a desired set of eigenvalues; this method enables one to move the eigenvalues while keeping the network topology fixed. Running numerical experiments using three different random graph models, we show that shrinking the gap between the graph Laplacian's first two eigenvalues dramatically improves a network's ability to (i) transfer energy to higher harmonics, and (ii) generate large-amplitude signals. Our results shed light on the relationship between a network's structure, encoded by the graph Laplacian, and its function, defined in this case by the presence of strongly nonlinear effects in the frequency response.	[Bhat, Harish S.; Vaz, Garnet J.] Univ Calif Merced, Appl Math Unit, Merced, CA 95344 USA	University of California System; University of California Merced	Bhat, HS (corresponding author), Univ Calif Merced, Appl Math Unit, Merced, CA 95344 USA.	hbhat@ucmerced.edu		Bhat, Dr. Shijaatt Hussain/0000-0002-8735-6792; Bhat, Harish/0000-0001-7631-1831				Afshari E, 2006, J APPL PHYS, V99, DOI 10.1063/1.2174126; Afshari E, 2005, IEEE J SOLID-ST CIRC, V40, P744, DOI 10.1109/JSSC.2005.843639; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bhat HS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066602; Bhat HS, 2009, PHYSICA D, V238, P1216, DOI 10.1016/j.physd.2009.04.009; Bhat HS, 2011, IEEE T ANTENN PROPAG, V59, P3772, DOI 10.1109/TAP.2011.2163787; Bhat HS, 2011, IEEE T COMPUT AID D, V30, P1483, DOI 10.1109/TCAD.2011.2159605; Bhat HS, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/20/205101; Bhat HS, 2013, FINITE VOLUME UNPUB; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brede M, 2008, EUR PHYS J B, V62, P87, DOI 10.1140/epjb/e2008-00126-9; Brede M, 2008, PHYS LETT A, V372, P5305, DOI 10.1016/j.physleta.2008.06.017; CASE M, 1991, APPL PHYS LETT, V58, P173, DOI 10.1063/1.104963; CASE M, 1992, APPL PHYS LETT, V60, P3019, DOI 10.1063/1.106795; Dadashi M, 2010, CHAOS, V20, DOI 10.1063/1.3515170; DiDonna BA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066619; Donetti L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.188701; ERDOS P, 1960, B INT STATIST INST, V38, P343; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Han RN, 2013, ISSCC DIG TECH PAP I, V56, P138, DOI 10.1109/ISSCC.2013.6487671; Han RN, 2013, IEEE T MICROW THEORY, V61, P1150, DOI 10.1109/TMTT.2013.2243465; Jalili M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016105; Kelly D, 2011, CHAOS, V21, DOI 10.1063/1.3590855; Kori H, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066115; LANDAUER R, 1960, IBM J RES DEV, V4, P391, DOI 10.1147/rd.44.0391; LANDAUER R, 1960, J APPL PHYS, V31, P479, DOI 10.1063/1.1735612; Lee W, 2012, IEEE T MICROW THEORY, V60, P370, DOI 10.1109/TMTT.2011.2178255; Lee W, 2012, IEEE T MICROW THEORY, V60, P329, DOI 10.1109/TMTT.2011.2178318; Lilis GN, 2010, IEEE T MICROW THEORY, V58, P1713, DOI 10.1109/TMTT.2010.2049678; Momeni O, 2011, IEEE J SOLID-ST CIRC, V46, P2966, DOI 10.1109/JSSC.2011.2162469; Monthus C, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/8/085001; OSTROVSKY LA, 1980, ZH EKSP TEOR FIZ+, V78, P831; Park K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026211; STEPANYANTS YA, 1981, WAVE MOTION, V3, P335, DOI 10.1016/0165-2125(81)90025-1; Stepanyants Yu. A., 1983, Radiophysics and Quantum Electronics, V26, P601, DOI 10.1007/BF01034871; Tighe BP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168303; Togashi Y, 2007, P NATL ACAD SCI USA, V104, P8697, DOI 10.1073/pnas.0702950104; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wyart M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.215501; Yanagita T, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056206	42	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78009	10.1371/journal.pone.0078009	http://dx.doi.org/10.1371/journal.pone.0078009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223751	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400028
J	Hidaka, S				Hidaka, Shohei			A Computational Model Associating Learning Process, Word Attributes, and Age of Acquisition	PLOS ONE			English	Article							LEXICAL DEVELOPMENT; OBJECT PROPERTIES; CHILD LANGUAGE; INPUT; VERBS; SHAPE; CONSTRAINTS; EXTENSION; SYSTEM; NOUNS	We propose a new model-based approach linking word learning to the age of acquisition (AoA) of words; a new computational tool for understanding the relationships among word learning processes, psychological attributes, and word AoAs as measures of vocabulary growth. The computational model developed describes the distinct statistical relationships between three theoretical factors underpinning word learning and AoA distributions. Simply put, this model formulates how different learning processes, characterized by change in learning rate over time and/or by the number of exposures required to acquire a word, likely result in different AoA distributions depending on word type. We tested the model in three respects. The first analysis showed that the proposed model accounts for empirical AoA distributions better than a standard alternative. The second analysis demonstrated that the estimated learning parameters well predicted the psychological attributes, such as frequency and imageability, of words. The third analysis illustrated that the developmental trend predicted by our estimated learning parameters was consistent with relevant findings in the developmental literature on word learning in children. We further discuss the theoretical implications of our model-based approach.				shhidaka@jaist.ac.jp			KAKENHI [23300099]; Grants-in-Aid for Scientific Research [23300099] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI Grant-in-Aid for Scientific Research B No. 23300099 (https://kaken.nii.ac.jp/d/p/23300099.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisfeld M., 1998, FIRST LANG, V18, P165, DOI DOI 10.1177/014272379801805303; AU TKF, 1994, J MEM LANG, V33, P567, DOI 10.1006/jmla.1994.1027; Bates E, 1995, HDB CHILD LANGUAGE, P96; Bauer DJ, 2002, APPL PSYCHOLINGUIST, V23, P313, DOI 10.1017/S0142716402003016; Booth AE, 2002, COGNITION, V84, pB11, DOI 10.1016/S0010-0277(02)00015-X; Choi S, 1995, J CHILD LANG, V22, P497, DOI 10.1017/S0305000900009934; Cortese MJ, 2004, BEHAV RES METH INS C, V36, P384, DOI 10.3758/BF03195585; Dale PS, 1996, BEHAV RES METH INS C, V28, P125, DOI 10.3758/BF03203646; Fenson L, 2000, CHILD DEV, V71, P323, DOI 10.1111/1467-8624.00147; Fenson L., 1993, MACARTHUR COMMUNICAT; Ganger J, 2004, DEV PSYCHOL, V40, P621, DOI 10.1037/0012-1649.40.4.621; Gathercole V. C. M., 1997, FIRST LANG, V17, P31, DOI DOI 10.1177/014272379701705102; Gelman SA, 1991, PERSPECTIVES LANGUAG; Gentner D., 2001, LANG ACQUIS, P215, DOI [10.1017/CBO9780511620669.010, DOI 10.1017/CBO9780511620669.010]; Gentner D., 1982, WHY NOUNS ARE LEARNE; Gentner D., 2006, ACTION MEETS WORD CH, P544, DOI [DOI 10.1093/ACPROF:OSO/9780195170009.003.0022, 10.1093/ACPROF:OSO/9780195170009.003.0022]; Gershkoff-Stowe L, 2004, CHILD DEV, V75, P1098, DOI 10.1111/j.1467-8624.2004.00728.x; Golinkoff RM, 1996, CHILD DEV, V67, P3101, DOI 10.2307/1131769; Goodman JC, 2008, J CHILD LANG, V35, P515, DOI 10.1017/S0305000907008641; GOPNIK A, 1987, CHILD DEV, V58, P1523, DOI 10.2307/1130692; Hidaka S, 2010, LANG LEARN DEV, V6, P206, DOI 10.1080/15475441.2010.484380; Hidaka S, 2011, COGN SYST RES, V12, P1, DOI 10.1016/j.cogsys.2010.07.004; Hills TT, 2010, J MEM LANG, V63, P259, DOI 10.1016/j.jml.2010.06.002; Imai M, 1997, COGNITION, V62, P169, DOI 10.1016/S0010-0277(96)00784-6; Imai M., 2006, ACTION MEETS WORD CH, P450; Jones SS, 2002, DEVELOPMENTAL SCI, V5, P219, DOI 10.1111/1467-7687.00224; JONES SS, 1991, CHILD DEV, V62, P499, DOI 10.2307/1131126; Keil FC., 1994, MAPPING MIND DOMAIN; Kobayashi H, 1998, COGNITION, V68, pB41, DOI 10.1016/S0010-0277(98)00044-4; LANDAU B, 1992, J MEM LANG, V31, P807, DOI 10.1016/0749-596X(92)90040-5; Landau B, 1998, J MEM LANG, V38, P1, DOI 10.1006/jmla.1997.2533; MACWHINNEY B, 1990, J CHILD LANG, V17, P457, DOI 10.1017/S0305000900013866; Markman E. M., 1989, CATEGORIZATION NAMIN; MARKMAN EM, 1984, COGNITIVE PSYCHOL, V16, P1, DOI 10.1016/0010-0285(84)90002-1; McMurray B, 2007, SCIENCE, V317, P631, DOI 10.1126/science.1144073; MERVIS CB, 1994, CHILD DEV, V65, P1646, DOI 10.2307/1131285; Mitchell C, 2009, COGNITIVE SCI, V33, P1503, DOI 10.1111/j.1551-6709.2009.01071.x; PLUNKETT K, 1993, COGNITION, V48, P21, DOI 10.1016/0010-0277(93)90057-3; REZNICK JS, 1992, DEV PSYCHOL, V28, P406, DOI 10.1037/0012-1649.28.3.406; Sandhofer CM, 2000, J CHILD LANG, V27, P561, DOI 10.1017/S0305000900004256; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SOJA NN, 1991, COGNITION, V38, P179, DOI 10.1016/0010-0277(91)90051-5; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Tardif T, 1996, DEV PSYCHOL, V32, P492, DOI 10.1037/0012-1649.32.3.492; van Geert P, 1998, PSYCHOL REV, V105, P634, DOI 10.1037/0033-295X.105.4.634-677; Waxman SR, 1998, CHILD DEV, V69, P1313, DOI 10.2307/1132268; Xu F, 2007, PSYCHOL REV, V114, P245, DOI 10.1037/0033-295X.114.2.245; Yamashita Y, 1997, NARUTO EIGO KYOIKU; Yoshida H, 2003, DEVELOPMENTAL SCI, V6, P1, DOI 10.1111/1467-7687.00247_1; Yoshida H, 2001, COGNITION, V82, pB63, DOI 10.1016/S0010-0277(01)00153-6	51	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e76242	10.1371/journal.pone.0076242	http://dx.doi.org/10.1371/journal.pone.0076242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245XZ	24223699	gold, Green Submitted, Green Published			2022-12-27	WOS:000326499300002
J	Philips, P; Hays, D; Martin, RCG				Philips, Prejesh; Hays, David; Martin, Robert C. G.			Irreversible Electroporation Ablation (IRE) of Unresectable Soft Tissue Tumors: Learning Curve Evaluation in the First 150 Patients Treated	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; LIVER-TUMORS	Background: Irreversible electroporation (IRE) is a novel technology that uses peri-target discrete probes to deliver high-voltage localized electric current to induce cell death without thermal-induced coagulative necrosis. "Learnability" and consistently effective results by novice practitioners is essential for determining acceptance of novel techniques. This multi-center prospectively-collected database study evaluates the learning curve of IRE. Methods: Analysis of 150 consecutive patients over 7 institutions from 9/2010-7/2012 was performed with patients treated divided into 3 groups A (1st 50 patients treated), B (2nd 50) and C (3rd 50 patients treated) chronologically and analyzed for outcomes. Results: A total of 167 IRE procedures were performed, with a majority being liver(39.5%) and pancreatic(35.5%) lesions. The three groups were similar with respect to co-morbidities and demographics. Group C had larger lesions (3.9vs3cm, p=0.001), more numerous lesions (3.2vs2.2, p=0.07), more vascular invasion(p=0.001), underwent more associated procedures(p=0.001) and had longer operative times(p<0.001). Despite this, they had similar complication and high-grade complication rates(p=0.24). Attributable morbidity rate was 13.3%(total 29.3%) and high-grade complications were seen in 4.19%(total 12.6%). Pancreatic lesions(p=0.001) and laparotomy(p=0.001) were associated with complications. Conclusion: The review represents that single largest review of IRE soft tissue ablation demonstrating initial patient selection and safety. Over time, complex treatments of larger lesions and lesions with greater vascular involvement were performed without a significant increase in adverse effects or impact on local relapse free survival. This evolution demonstrates the safety profile of IRE and speed of graduation to more complex lesions, which was greater than 5 cases by institution. IRE is a safe and effective alternative to conventional ablation with a demonstrable learning curve of at least 5 cases to become proficient.	[Philips, Prejesh; Martin, Robert C. G.] Univ Louisville, Dept Surg, Div Surg Oncol, Louisville, KY 40292 USA; [Hays, David] Baptist Hosp, Dept Intervent Radiol, Little Rock, AR USA	University of Louisville	Martin, RCG (corresponding author), Univ Louisville, Dept Surg, Div Surg Oncol, Louisville, KY 40292 USA.	Robert.Martin@louisville.edu			Angiodynamics	Angiodynamics	The authors did receive partial funding for this study from Angiodynamics through an unrestricted educational grant. No additional external funding received for this study. Angiodynamics had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanch JL, 2011, HEAD NECK-J SCI SPEC, V33, P1252, DOI 10.1002/hed.21605; Bower M, 2011, J SURG ONCOL, V104, P22, DOI 10.1002/jso.21899; Cannon R, 2013, J SURG ONCOL, V107, P544, DOI 10.1002/jso.23280; CHANG DC, 1990, BIOPHYS J, V58, P1, DOI 10.1016/S0006-3495(90)82348-1; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Goldberg S N, 2001, Eur J Ultrasound, V13, P129, DOI 10.1016/S0929-8266(01)00126-4; Grambsch PM, 1995, BIOMETRICS, V51, P1469, DOI 10.2307/2533277; Hildebrand P, 2006, EJSO, V32, P430, DOI 10.1016/j.ejso.2006.01.006; Khatri VP, 2007, SURG ONCOL, V16, P71, DOI 10.1016/j.suronc.2007.05.001; Maccabee DL, 2003, SURG ENDOSC, V17, P1566, DOI 10.1007/s00464-002-8746-5; Martin 2nd RC, 2012, ANN SURG ONCOL; Martin RCG, 2012, J AM COLL SURGEONS, V215, P361, DOI 10.1016/j.jamcollsurg.2012.05.021; Okada A, 2009, ULTRASOUND OBST GYN, V34, P579, DOI 10.1002/uog.7454; Poon RT, 2004, ANN SURG, V239, P441, DOI 10.1097/01.sla.0000118565.21298.0a; Schlachta CM, 2001, DIS COLON RECTUM, V44, P217, DOI 10.1007/BF02234296; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Yan TD, 2006, ANN SURG ONCOL, V13, P1588, DOI 10.1245/s10434-006-9010-3; Yee R, 2003, CAN J CARDIOL, V19, P1273	19	92	96	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e76260	10.1371/journal.pone.0076260	http://dx.doi.org/10.1371/journal.pone.0076260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223700	gold, Green Submitted, Green Published			2022-12-27	WOS:000326499300003
J	Campbell, LG; Mehtani, S; Dozier, ME; Rinehart, J				Campbell, Lesley G.; Mehtani, Siya; Dozier, Mary E.; Rinehart, Janice			Gender-Heterogeneous Working Groups Produce Higher Quality Science	PLOS ONE			English	Article							DIVERSITY RESEARCH; GROUP COHESION; PERFORMANCE; IMPACT; COLLABORATION; AUTHORSHIP; CONFLICT; INDEX	Here we present the first empirical evidence to support the hypothesis that a gender-heterogeneous problem-solving team generally produced journal articles perceived to be higher quality by peers than a team comprised of highly-performing individuals of the same gender. Although women were historically underrepresented as principal investigators of working groups, their frequency as PIs at the National Center for Ecological Analysis and Synthesis is now comparable to the national frequencies in biology and they are now equally qualified, in terms of their impact on the accumulation of ecological knowledge (as measured by the h-index). While women continue to be underrepresented as working group participants, peer-reviewed publications with gender-heterogeneous authorship teams received 34% more citations than publications produced by gender-uniform authorship teams. This suggests that peers citing these publications perceive publications that also happen to have gender-heterogeneous authorship teams as higher quality than publications with gender uniform authorship teams. Promoting diversity not only promotes representation and fairness but may lead to higher quality science.	[Campbell, Lesley G.; Mehtani, Siya; Dozier, Mary E.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Campbell, Lesley G.] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Rinehart, Janice] Rice Univ, Natl Sci Fdn Adv Program, Houston, TX USA	Rice University; Toronto Metropolitan University; National Science Foundation (NSF); Rice University	Campbell, LG (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	Lesley.G.Campbell@Ryerson.ca	Campbell, Lesley G/G-5866-2012	Campbell, Lesley G/0000-0002-6263-5170; Dozier, Mary/0000-0002-6360-6945	Rice University National Science Foundation (NSF)-ADVANCE (NSF Grant) [0542562]	Rice University National Science Foundation (NSF)-ADVANCE (NSF Grant)(National Science Foundation (NSF))	The project was supported by Rice University National Science Foundation (NSF)-ADVANCE (NSF Grant #: 0542562) mini-grant funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DW, 2011, J AM SOC INF SCI TEC, V62, P628, DOI 10.1002/asi.21486; Balaban AT, 2012, SCIENTOMETRICS, V92, P241, DOI 10.1007/s11192-012-0637-5; Barres BA, 2006, NATURE, V442, P133, DOI 10.1038/442133a; Baugh SG, 1997, GROUP ORGAN MANAGE, V22, P366, DOI 10.1177/1059601197223004; Betz N., 1997, MINORITIES GIRLS SCH, P105; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Borsuk RM., 2009, OPEN ECOLOGY J, V2, P25, DOI [DOI 10.2174/1874213000902010025, 10.2174/1874213000902010025]; Bowers CA, 2000, SMALL GR RES, V31, P305, DOI 10.1177/104649640003100303; Chatman JA, 2004, ACAD MANAGE J, V47, P193, DOI 10.2307/20159572; Cole J. R., 1984, ADV MOTIVATION ACHIE, V2, P217; Copenheaver CA, 2010, TREE-RING RES, V66, P127, DOI 10.3959/2009-10.1; Ecklund EH, 2012, GENDER SOC, V26, P693, DOI 10.1177/0891243212451904; Ecklund EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022590; Ely RJ, 2001, ADMIN SCI QUART, V46, P229, DOI 10.2307/2667087; Fenwick Graham D., 2001, GENDER WORK ORGAN, V8, P205, DOI [10.1111/1468-0432.00129, DOI 10.1111/1468-0432.00129]; Foundation NS, 1999, WOM MIN PERS DIS SCI; [Foundation NS National Science Foundation DoSRS], 2007, WOM MIN PERS DIS SCI; Fox MF, 2001, GENDER SOC, V15, P654, DOI 10.1177/089124301015005002; Hackett EJ., 2008, SCI COLLABORATION IN, P277; HATCH O, 1980, POLICY REV, V12, P23; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; Hong L, 2001, J ECON THEORY, V97, P123, DOI 10.1006/jeth.2000.2709; Jehn KA, 1999, ADMIN SCI QUART, V44, P741, DOI 10.2307/2667054; Joshi A, 2010, WORKING PAPER; Joshi A, 2009, ACAD MANAGE J, V52, P599, DOI 10.5465/AMJ.2009.41331491; Kelly CD, 2006, TRENDS ECOL EVOL, V21, P167, DOI 10.1016/j.tree.2006.01.005; Kochan T, 2003, HUM RESOUR MANAGE-US, V42, P3, DOI 10.1002/hrm.10061; Lawrence PA, 2006, PLOS BIOL, V4, P13, DOI 10.1371/journal.pbio.0040019; Lee C, 2004, APPL PSYCHOL-INT REV, V53, P136, DOI 10.1111/j.1464-0597.2004.00164.x; Lehmann S, 2006, NATURE, V444, P1003, DOI 10.1038/4441003a; Leimu R, 2005, BIOSCIENCE, V55, P438, DOI 10.1641/0006-3568(2005)055[0438:DSCITI]2.0.CO;2; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; LONG JS, 1992, SOC FORCES, V71, P159, DOI 10.2307/2579971; Mannix Elizabeth, 2005, Psychol Sci Public Interest, V6, P31, DOI 10.1111/j.1529-1006.2005.00022.x; Myaskovsky L, 2005, SEX ROLES, V52, P645, DOI 10.1007/s11199-005-3732-8; Nisbett R. E., 1980, HUMAN INFERENCE STRA; Page SE, 2008, DIFFERENCE POWER DIV; Pelled LH, 1996, ORGAN SCI, V7, P615, DOI 10.1287/orsc.7.6.615; Rigg LS, 2012, PROF GEOGR, V64, P491, DOI 10.1080/00330124.2011.611434; Robbins S.P.P., 2010, ORG BEHAV, V15th ed.; Science NAo, 2009, GEND DIFF CRIT TRANS; Stewart GL, 2006, J MANAGE, V32, P29, DOI 10.1177/0149206305277792; Summers Lawrence H., 2005, COMMUNICATION; Thomas DA, 1996, HARVARD BUS REV, V74, P79; Valian V, 1998, WHY SO SLOW ADVANCEM; van Praag CM, 2004, 1 AUTHOR DETERMINANT; Waltman L, 2012, J AM SOC INFORM SCI, V63, P1532; Webber SS, 2001, J MANAGE, V27, P141, DOI 10.1016/S0149-2063(00)00093-3; Weltzin JF, 2006, FRONT ECOL ENVIRON, V4, P435, DOI 10.1890/1540-9295(2006)4[435:AIEAAA]2.0.CO;2; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	53	191	192	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79147	10.1371/journal.pone.0079147	http://dx.doi.org/10.1371/journal.pone.0079147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205372	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500145
J	Zhang, WS; Edwards, A; Flemington, EK; Zhang, K				Zhang, Wensheng; Edwards, Andrea; Flemington, Erik K.; Zhang, Kun			Inferring Polymorphism-Induced Regulatory Gene Networks Active in Human Lymphocyte Cell Lines by Weighted Linear Mixed Model Analysis of Multiple RNA-Seq Datasets	PLOS ONE			English	Article							BCL-2 FAMILY; EXPRESSION; VARIANTS; INHIBITOR; LONGEVITY	Single-nucleotide polymorphisms (SNPs) contribute to the between-individual expression variation of many genes. A regulatory (trait-associated) SNP is usually located near or within a (host) gene, possibly influencing the gene's transcription or/and post-transcriptional modification. But its targets may also include genes that are physically farther away from it. A heuristic explanation of such multiple-target interferences is that the host gene transfers the SNP genotypic effects to the distant gene(s) by a transcriptional or signaling cascade. These connections between the host genes (regulators) and the distant genes (targets) make the genetic analysis of gene expression traits a promising approach for identifying unknown regulatory relationships. In this study, through a mixed model analysis of multi-source digital expression profiling for 140 human lymphocyte cell lines (LCLs) and the genotypes distributed by the international HapMap project, we identified 45 thousands of potential SNP-induced regulatory relationships among genes (the significance level for the underlying associations between expression traits and SNP genotypes was set at FDR <0.01). We grouped the identified relationships into four classes (paradigms) according to the two different mechanisms by which the regulatory SNPs affect their cis- and trans-regulated genes, modifying mRNA level or altering transcript splicing patterns. We further organized the relationships in each class into a set of network modules with the cis-regulated genes as hubs. We found that the target genes in a network module were often characterized by significant functional similarity, and the distributions of the target genes in three out of the four networks roughly resemble a power-law, a typical pattern of gene networks obtained from mutation experiments. By two case studies, we also demonstrated that significant biological insights can be inferred from the identified network modules.	[Zhang, Wensheng; Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Flemington, Erik K.] Tulane Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70118 USA; [Flemington, Erik K.] Tulane Canc Ctr, New Orleans, LA USA	Xavier University of Louisiana; Tulane University; Tulane University	Zhang, K (corresponding author), Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA.	kzhang@xula.edu			National Institutes of Health [NIMHD RCMI 8G12MD007595]; US Department of Army [W911NF-12-1-0066]; Louisiana Cancer Research Consortium (LCRC); State of Louisiana; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Army; Louisiana Cancer Research Consortium (LCRC); State of Louisiana; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by a National Institutes of Health grant (NIMHD RCMI 8G12MD007595), an US Department of Army grant (W911NF-12-1-0066), and Louisiana Cancer Research Consortium (LCRC) and the State of Louisiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; Bates D., 2012, COMPUTATIONAL METHOD; Brown EM, 2007, HAPMAP HAPLOTYPE MAP, P35; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Casella G, 2002, STAT INFERENCE, Vxxviii; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Clauset A., 2009, POWER LAW DISTRIBUTI; Cline MS, 2005, BIOINFORMATICS, V21, pI107, DOI 10.1093/bioinformatics/bti1010; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Hajnoczky G, 2007, SCIENCE, V315, P607, DOI 10.1126/science.1138825; HENDERSON CR, 1959, BIOMETRICS, V15, P192, DOI 10.2307/2527669; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hogan MC, 2003, HUM MOL GENET, V12, P685, DOI 10.1093/hmg/ddg068; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Johnson M, 2011, INT J BIOCHEM CELL B, V43, P65, DOI 10.1016/j.biocel.2010.09.014; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Littell RC., 2006, SAS MIXED MODELS, Vxii; MAK TK, 1992, J ROY STAT SOC B MET, V54, P649; MCLEAN RA, 1991, AM STAT, V45, P54, DOI 10.2307/2685241; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Outteryck O, 2012, NEUROLOGY, V79, P386, DOI 10.1212/WNL.0b013e318260451b; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rao C. R., 1999, LINEAR MODELS LEAST; Real PJ, 2004, CANCER RES, V64, P7947, DOI 10.1158/0008-5472.CAN-04-0945; Rung J, 2002, BIOINFORMATICS, V18, pS202, DOI 10.1093/bioinformatics/18.suppl_2.S202; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029; Veyrieras JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030629; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang XS, 2010, EXP AGING RES, V36, P79, DOI 10.1080/03610730903418729; Yuasa T, 2002, GENOMICS, V79, P376, DOI 10.1006/geno.2002.6719; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031429	53	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78868	10.1371/journal.pone.0078868	http://dx.doi.org/10.1371/journal.pone.0078868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205334	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500137
J	Buchel, F; Mittag, F; Wrzodek, C; Zell, A; Gasser, T; Sharma, M				Buechel, Finja; Mittag, Florian; Wrzodek, Clemens; Zell, Andreas; Gasser, Thomas; Sharma, Manu			Integrative Pathway-Based Approach for Genome-Wide Association Studies: Identification of New Pathways for Rheumatoid Arthritis and Type 1 Diabetes	PLOS ONE			English	Article							B-CELL RESPONSES; GENE ONTOLOGY; TOOL; PREVALENCE; DISEASES; IGA	Genome-wide association studies (GWAS) led to the identification of numerous novel loci for a number of complex diseases. Pathway-based approaches using genotypic data provide tangible leads which cannot be identified by single marker approaches as implemented in GWAS. The available pathway analysis approaches mainly differ in the employed databases and in the applied statistics for determining the significance of the associated disease markers. So far, pathway-based approaches using GWAS data failed to consider the overlapping of genes among different pathways or the influence of protein-interactions. We performed a multistage integrative pathway (MIP) analysis on three common diseases - Crohn's disease (CD), rheumatoid arthritis (RA) and type 1 diabetes (T1D) - incorporating genotypic, pathway, protein-and domain-interaction data to identify novel associations between these diseases and pathways. Additionally, we assessed the sensitivity of our method by studying the influence of the most significant SNPs on the pathway analysis by removing those and comparing the corresponding pathway analysis results. Apart from confirming many previously published associations between pathways and RA, CD and T1D, our MIP approach was able to identify three new associations between disease phenotypes and pathways. This includes a relation between the influenza-A pathway and RA, as well as a relation between T1D and the phagosome and toxoplasmosis pathways. These results provide new leads to understand the molecular underpinnings of these diseases. The developed software herein used is available at http://www.cogsys.cs.uni-tuebingen. de/software/GWASPathwayIdentifier/index.htm.	[Buechel, Finja; Mittag, Florian; Wrzodek, Clemens; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany; [Gasser, Thomas; Sharma, Manu] Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Tubingen, Germany; [Gasser, Thomas; Sharma, Manu] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Sharma, Manu] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen	Sharma, M (corresponding author), Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Tubingen, Germany.	manu.sharma@uni-tuebingen.de	Gasser, Thomas/GNH-5293-2022; Sharma, Manu/AAX-2594-2020	Gasser, Thomas/0000-0002-1069-1146; Wrzodek, Clemens/0000-0003-4995-780X; Wrzodek, Finja/0000-0001-5031-1016; Mittag, Florian/0000-0002-6472-0221	Federal Ministry of Education and Research (BMBF, Germany) in the National Genome Research Network (NGFN+) [01GS08134]; Michael J Fox Foundation	Federal Ministry of Education and Research (BMBF, Germany) in the National Genome Research Network (NGFN+)(Federal Ministry of Education & Research (BMBF)); Michael J Fox Foundation	The research leading to these results has received funding from the Federal Ministry of Education and Research (BMBF, Germany) in the National Genome Research Network (NGFN+) under grant number 01GS08134. This study is also supported by the Michael J Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Braun R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002101; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Farber CR, 2013, G3-GENES GENOM GENET, V3, P119, DOI 10.1534/g3.112.004788; Fehringer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031816; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; JORGENSEN C, 1993, CLIN EXP RHEUMATOL, V11, P541; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kobie JJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3542; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LIBLAU RS, 1992, APMIS, V100, P709, DOI 10.1111/j.1699-0463.1992.tb03988.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Makhlouf L, 2003, J AM SOC NEPHROL, V14, P2168, DOI 10.1097/01.ASN.0000079041.15707.A9; McDonnell M, 2011, INFLAMM BOWEL DIS, V17, P298, DOI 10.1002/ibd.21424; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Ngwa Julius S, 2011, BMC Proc, V5 Suppl 9, pS18, DOI 10.1186/1753-6561-5-S9-S18; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Shahbaba B, 2012, STAT MED, V31, P988, DOI 10.1002/sim.4477; Shapira Y, 2012, J AUTOIMMUN, V39, P112, DOI 10.1016/j.jaut.2012.01.001; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229; Zamar D, 2009, BIOINFORMATICS, V25, P2444, DOI 10.1093/bioinformatics/btp431; Zhang KL, 2011, NUCLEIC ACIDS RES, V39, pW437, DOI 10.1093/nar/gkr391	39	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78577	10.1371/journal.pone.0078577	http://dx.doi.org/10.1371/journal.pone.0078577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205270	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400088
J	Huang, VJ; Stein, KC; True, HL				Huang, Vincent J.; Stein, Kevin C.; True, Heather L.			Spontaneous Variants of the [RNQ plus ] Prion in Yeast Demonstrate the Extensive Conformational Diversity Possible with Prion Proteins	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CHAIN RELEASE FACTOR; SACCHAROMYCES-CEREVISIAE; PSI+ PRION; GUANIDINE-HYDROCHLORIDE; TRANSLATION TERMINATION; ENVIRONMENTAL-STRESS; STRAIN DIFFERENCES; GENETIC-VARIATION; IN-VIVO	Prion strains (or variants) are structurally distinct amyloid conformations arising from a single polypeptide sequence. The existence of prion strains has been well documented in mammalian prion diseases. In many cases, prion strains manifest as variation in disease progression and pathology, and in some cases, these prion strains also show distinct biochemical properties. Yet, the underlying basis of prion propagation and the extent of conformational possibilities available to amyloidogenic proteins remain largely undefined. Prion proteins in yeast that are also capable of maintaining multiple self-propagating structures have provided much insight into prion biology. Here, we explore the vast structural diversity of the yeast prion [RNQ+] in Saccharomyces cerevisiae. We screened for the formation of [RNQ+] in vivo, allowing us to calculate the rate of spontaneous formation as similar to 2.96x10(-6), and successfully isolate several different [RNQ+] variants. Through a comprehensive set of biochemical and biological analyses, we show that these prion variants are indeed novel. No individual property or set of properties, including aggregate stability and size, was sufficient to explain the physical basis and range of prion variants and their resulting cellular phenotypes. Furthermore, all of the [RNQ+] variants that we isolated were able to facilitate the de novo formation of the yeast prion [PSI+], an epigenetic determinant of translation termination. This supports the hypothesis that [RNQ+] acts as a functional amyloid in regulating the formation of [PSI+] to produce phenotypic diversity within a yeast population and promote adaptation. Collectively, this work shows the broad spectrum of available amyloid conformations, and thereby expands the foundation for studying the complex factors that interact to regulate the propagation of distinct aggregate structures.	[Huang, Vincent J.; Stein, Kevin C.; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	True, HL (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	heather.true@wustl.edu		Stein, Kevin/0000-0002-0622-8319	National Institutes of Health [F31AG040899, GM072778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM072778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants F31AG040899 (KCS) and GM072778 (HLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; Bardill JP, 2009, J MOL BIOL, V388, P583, DOI 10.1016/j.jmb.2009.03.036; Bateman DA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003257; Benkemoun L, 2006, FUNGAL GENET BIOL, V43, P789, DOI 10.1016/j.fgb.2006.06.006; Bradley ME, 2004, MOL MICROBIOL, V51, P1649, DOI 10.1111/j.1365-2958.2003.03955.x; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Foo CK, 2011, J MOL BIOL, V408, P1, DOI 10.1016/j.jmb.2011.02.025; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hines JK, 2011, PRION, V5, P164, DOI 10.4161/pri.5.3.16895; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kalastavadi T, 2010, J BIOL CHEM, V285, P20748, DOI 10.1074/jbc.M110.115303; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Lancaster DL, 2013, J BIOL CHEM, V288, P1266, DOI 10.1074/jbc.M112.377564; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 2000, ARCH VIROL, P227; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2012, PRION, V6, P108, DOI 10.4161/pri.18666; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sharma J, 2013, J MOL BIOL, V425, P3046, DOI 10.1016/j.jmb.2013.06.006; Sharma J, 2012, MOL MICROBIOL, V86, P866, DOI 10.1111/mmi.12024; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stein KC, 2011, PRION, V5, P291, DOI [10.4161/pri.5.4.18213, 10.4161/pri.18213]; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; TUITE MF, 1981, GENETICS, V98, P691; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	78	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79582	10.1371/journal.pone.0079582	http://dx.doi.org/10.1371/journal.pone.0079582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205387	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400116
J	Mendenhall, E; Richter, LM; Stein, A; Norris, SA				Mendenhall, Emily; Richter, Linda M.; Stein, Alan; Norris, Shane A.			Psychological and Physical Co-Morbidity among Urban South African Women	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; MIDDLE-INCOME COUNTRIES; ADULT-POPULATION; DEPRESSION; HEALTH; POVERTY; PREVALENCE; ILLNESS; ANXIETY; DISEASE	Objectives: There is substantial evidence for the links between poverty and both physical and mental health; but limited research on the relationship of physical and mental health problems exists in low-and middle-income countries. The objective of this paper is to evaluate the prevalence and co-morbidity of psychological distress among women with common physical diseases in a socio-economically disadvantaged urban area of South Africa. Methods: Women enrolled in the Birth to twenty (Bt20) cohort study were evaluated for this paper. Bt20 was founded in 1990 and has followed more than 3,000 children and their caregivers since birth; this study evaluates the health of the caregivers (average age 44) of these children. Psychological distress was evaluated by administering the General Health Questionnaire (GHQ-28) and we evaluated the presence of physical disease by self-report. Results: Forty percent of the sample presented with psychological distress using the GHQ scoring method. More than half of the women who reported a history of a physical disease, including diabetes, heart attack, asthma, arthritis, osteoporosis, epilepsy, and tuberculosis, reported psychological disorder. Presence of one physical disease was not associated with increased rates of psychological distress. However, women who reported two diseases had increased rates of psychological symptoms, and this upward trend continued with each additional physical disease reported (measured to five). Conclusions: These data indicate high prevalence rates of co-morbid psychological distress among women with physical disease. This argues for the need of greater mental health support for women living with physical diseases.	[Mendenhall, Emily; Richter, Linda M.; Stein, Alan; Norris, Shane A.] Univ Witwatersrand, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Mendenhall, Emily] Georgetown Univ, Walsh Sch Foreign Serv, Sci Technol & Int Affairs Program, Washington, DC USA; [Richter, Linda M.] Human Sci Res Council, Durban, South Africa; [Stein, Alan] Univ Oxford, Oxford, England	University of Witwatersrand; Georgetown University; Human Sciences Research Council-South Africa; University of Oxford	Mendenhall, E (corresponding author), Univ Witwatersrand, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	em1061@georgetown.edu	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; Stein, Alan/0000-0001-8207-2822; Mendenhall, Emily/0000-0002-5826-1321	Medical Research Council of South Africa; Wellcome Trust; MRC/DFID African Research Leader Scheme; MRC [G1001333] Funding Source: UKRI; Medical Research Council [G1001333] Funding Source: researchfish	Medical Research Council of South Africa(South African Medical Research Council); Wellcome Trust(Wellcome Trust); MRC/DFID African Research Leader Scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council of South Africa, Wellcome Trust, and MRC/DFID African Research Leader Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Cameron N, 1998, AM J HUM BIOL, V10, P495, DOI 10.1002/(SICI)1520-6300(1998)10:4<495::AID-AJHB9>3.0.CO;2-F; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Kagee A, 2008, J HEALTH PSYCHOL, V13, P547, DOI 10.1177/1359105308088527; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Meader N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613151; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70; Patel V, 1999, SOC SCI MED, V49, P1461, DOI 10.1016/S0277-9536(99)00208-7; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Rumble S, 1996, PSYCHOL MED, V26, P997, DOI 10.1017/S0033291700035327; Shidhaye R, 2013, INT REV PSYCHIATR, V25, P65, DOI 10.3109/09540261.2012.748651; Tomlinson M, 2009, SAMJ S AFR MED J, V99, P368	21	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78803	10.1371/journal.pone.0078803	http://dx.doi.org/10.1371/journal.pone.0078803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205319	Green Published, gold			2022-12-27	WOS:000326155400106
J	Kroeger, PT; Shoue, DA; Mezzacappa, FM; Gerlach, GF; Wingert, RA; Schulz, RA				Kroeger, Paul T., Jr.; Shoue, Douglas A.; Mezzacappa, Frank M.; Gerlach, Gary F.; Wingert, Rebecca A.; Schulz, Robert A.			Knockdown of SCFSkp2 Function Causes Double-Parked Accumulation in the Nucleus and DNA Re-Replication in Drosophila Plasmatocytes	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEX; CDT1 DEGRADATION; CYCLIN-E; S-PHASE; IN-VIVO; GEMININ; PROTEIN; ORIGIN; HEMATOPOIESIS; HEMOCYTES	In Drosophila, circulating hemocytes are derived from the cephalic mesoderm during the embryonic wave of hematopoiesis. These cells are contributed to the larva and persist through metamorphosis into the adult. To analyze this population of hemocytes, we considered data from a previously published RNAi screen in the hematopoietic niche, which suggested several members of the SCF complex play a role in lymph gland development. eaterGal4; UAS-GFP flies were crossed to UAS-RNAi lines to knockdown the function of all known SCF complex members in a plasmatocyte-specific fashion, in order to identify which members are novel regulators of plasmatocytes. This specific SCF complex contains five core members: Lin-19-like, SkpA, Skp2, Roc1a and complex activator Nedd8. The complex was identified by its very distinctive large cell phenotype. Furthermore, these large cells stained for anti-P1, a plasmatocyte-specific antibody. It was also noted that the DNA in these cells appeared to be over-replicated. Gamma-tubulin and DAPI staining suggest the cells are undergoing re-replication as they had multiple centrioles and excessive DNA content. Further experimentation determined enlarged cells were BrdU-positive indicating they have progressed through S-phase. To determine how these cells become enlarged and undergo re-replication, cell cycle proteins were analyzed by immunofluorescence. This analysis identified three proteins that had altered subcellular localization in these enlarged cells: Cyclin E, Geminin and Double-parked. Previous research has shown that Double-parked must be degraded to exit S-phase, otherwise the DNA will undergo re-replication. When Double-parked was titrated from the nucleus by an excess of its inhibitor, geminin, the enlarged cells and aberrant protein localization phenotypes were partially rescued. The data in this report suggests that the SCFSkp2 complex is necessary to ubiquitinate Double-parked during plasmatocyte cell division, ensuring proper cell cycle progression and the generation of a normal population of this essential blood cell type.	[Kroeger, Paul T., Jr.; Shoue, Douglas A.; Mezzacappa, Frank M.; Gerlach, Gary F.; Wingert, Rebecca A.; Schulz, Robert A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Schulz, RA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	rschulz@nd.edu	Wingert, Rebecca A/ABE-2786-2020	Wingert, Rebecca A/0000-0003-3133-7549; Mezzacappa, Frank/0000-0003-3933-4844; Kroeger, Paul/0000-0002-9067-170X	National Institutes of Health, NIH [HL071540]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071540] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health, NIH HL071540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Das T, 2002, DEV GENES EVOL, V212, P134, DOI 10.1007/s00427-002-0222-7; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; De Marco V, 2009, P NATL ACAD SCI USA, V106, P19807, DOI 10.1073/pnas.0905281106; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kroeger PT, 2012, GENESIS, V50, P41, DOI 10.1002/dvg.20787; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Liu J, 2012, MOL BIOL CELL, V23, P200, DOI 10.1091/mbc.E11-05-0409; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; May NR, 2005, J CELL SCI, V118, P4207, DOI 10.1242/jcs.02534; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; RIZKI TM, 1980, EXPERIENTIA, V36, P1223, DOI 10.1007/BF01976142; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Rodriguez S, 2011, BLOOD, V117, P6509, DOI 10.1182/blood-2010-11-321521; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stofanko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014051; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Tokusumi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041604; Ullah Z, 2009, CELL CYCLE, V8, P1501, DOI 10.4161/cc.8.10.8325; Vilmos P, 2004, DEV COMP IMMUNOL, V28, P555, DOI 10.1016/j.dci.2003.10.001; Wang J, 2011, BLOOD, V118, P5429, DOI 10.1182/blood-2010-10-312785; Whittaker AJ, 2000, GENE DEV, V14, P1765; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	56	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79019	10.1371/journal.pone.0079019	http://dx.doi.org/10.1371/journal.pone.0079019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205363	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300088
J	Munkhuu, B; Essig, S; Renchinnyam, E; Schmid, R; Wilhelm, C; Bohlius, J; Chuluunbaatar, B; Shonkhuuz, E; Baumann, T				Munkhuu, Bayalag; Essig, Stefan; Renchinnyam, Erdenesuvd; Schmid, Raoul; Wilhelm, Corina; Bohlius, Julia; Chuluunbaatar, Battulga; Shonkhuuz, Enkhtur; Baumann, Thomas			Incidence and Treatment of Developmental Hip Dysplasia in Mongolia: A Prospective Cohort Study	PLOS ONE			English	Article							CONGENITAL DISLOCATION; RISK-FACTORS; ULTRASOUND	Background: In Mongolia, adequate early diagnosis and treatment of developmental hip dysplasia (DDH) have been unavailable and its incidence was unknown. We determined the incidence of ultrasonographic DDH in newborns and established adequate procedures for diagnosis and treatment of DDH at the largest maternity hospital in Ulaanbaatar, Mongolia. Methodology/Principal Findings: During one year (Sept 2010 - Aug 2011) we assessed the hips newborns using ultrasound and Graf's classification of DDH. 8,356 newborns were screened; median age at screening was 1 day. We identified 14,873 Type 1 (89.0%), 1715 Type 2a (10.3%), 36 Type 2c (0.2%), 70 Type D (0.4%), 14 Type 3 (0.08%), and 4 Type 4 hips (0.02%). Children with Type 1 hips (normal) were discharged. Children with Type 2a hips (physiologically immature) received follow-up ultrasounds at monthly intervals. Children with Type 2c to 4 (DDH; deformed or misaligned hip joint) hips were treated with a Tubingen hip flexion splint and also followed up. The hip abnormalities resolved to mature hips in all children who were followed up. There was no evidence for severe treatment related complications. Conclusion/Significance: This study suggests that the incidence of DDH in Mongolian neonates is comparable to that in neonates in Europe. Early ultrasound-based assessment and splinting treatment of DDH led to mature hips in all children followed up. Procedures are feasible and will be continued.	[Munkhuu, Bayalag; Renchinnyam, Erdenesuvd; Chuluunbaatar, Battulga; Shonkhuuz, Enkhtur] Natl Ctr Maternal & Child Hlth, Ulaanbaatar, Mongolia; [Essig, Stefan; Bohlius, Julia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Schmid, Raoul] Baarer Kinderarztpraxis Baar, Baar, Switzerland; [Baumann, Thomas] Zentrum Korper & Sinnesbehinderte Kinder, Solothurn, Switzerland	University of Bern	Baumann, T (corresponding author), Zentrum Korper & Sinnesbehinderte Kinder, Solothurn, Switzerland.	tombaum@me.com		Bohlius, Julia/0000-0003-1955-1585; Essig, Stefan/0000-0003-3228-7010	Swiss Association of Pediatric Ultrasound (SVUPP); group medical practice in Solothurn	Swiss Association of Pediatric Ultrasound (SVUPP); group medical practice in Solothurn	Funding came from the supporters of Swiss Association of Pediatric Ultrasound (SVUPP) for sponsoring the ultrasound device http://www.svupp.ch/, and the group medical practice in Solothurn for sponsoring the fixating unit http://www.gruprax.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Intelligence Agency, 2010, WORLD FACTB 2010; Chan A, 1997, ARCH DIS CHILD-FETAL, V76, pF94, DOI 10.1136/fn.76.2.F94; Clarke NMP, 2012, ARCH DIS CHILD, V97, P423, DOI 10.1136/archdischild-2011-301085; Dezateux C, 2007, LANCET, V369, P1541, DOI 10.1016/S0140-6736(07)60710-7; el-Shazly M, 1994, J Med Screen, V1, P165; Furnes O, 2001, J BONE JOINT SURG BR, V83B, P579, DOI 10.1302/0301-620X.83B4.11223; Graf R, 2006, HIP SONOGRAPHY DIAGN; Heitner H, 1977, Beitr Orthop Traumatol, V24, P543; HOLEN KJ, 1994, J PEDIATR ORTHOPED, V14, P667, DOI 10.1097/01241398-199409000-00022; Kosar P, 2011, J ULTRAS MED, V30, P677, DOI 10.7863/jum.2011.30.5.677; Lehmann HP, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e57; Mahan ST, 2009, J BONE JOINT SURG AM, V91A, P1705, DOI 10.2106/JBJS.H.00122; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; National Statistical Office of Mongolia, 2010, 2010 POP HOUS CENS M; Padilla CD, 2012, J COMMUN GENET, V3, P35, DOI 10.1007/s12687-011-0076-7; Peled E, 2008, CLIN ORTHOP RELAT R, V466, P771, DOI 10.1007/s11999-008-0132-8; Rosendahl K, 1996, ACTA PAEDIATR, V85, P64, DOI 10.1111/j.1651-2227.1996.tb13892.x; Sewell MD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4454; Shipman SA, 2006, PEDIATRICS, V117, pE557, DOI 10.1542/peds.2005-1597; Sodnompil T, 2007, HLTH IND, P13; Tschauner C, 2011, J CHILD ORTHOP, V5, P415, DOI 10.1007/s11832-011-0366-y	21	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79427	10.1371/journal.pone.0079427	http://dx.doi.org/10.1371/journal.pone.0079427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205385	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300095
J	Samanic, I; Simunic, J; Riha, K; Puizina, J				Samanic, Ivica; Simunic, Juraj; Riha, Karel; Puizina, Jasna			Evidence for Distinct Functions of MRE11 in Arabidopsis Meiosis	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-REPAIR; MEIOTIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL INSTABILITY; NUCLEASE ACTIVITY; COMPLEX; RAD50; GENE; YEAST	The evolutionary conserved Mre11/Rad50/Nbs1 complex functions as one of the guardians of genome integrity in eukaryotes; it is required for the double-strand break repair, meiosis, DNA checkpoint, and telomere maintenance. To better understand the role of the MRE11 gene in Arabidopsis, we performed comparative analysis of several mre11 alleles with respect to genome stability and meiosis. The mre11-4 and mre11-2 alleles presumably produce truncated MRE11 proteins composed of the first 499 and 529 amino acids, respectively. Although the putative MRE11 truncated proteins differ only by 30 amino acids, the mutants exhibited strikingly different phenotypes in regards to growth morphology, genome stability and meiosis. While the mre11-2 mutants are fully fertile and undergo normal meiosis, the mre11-4 plants are sterile due to aberrant repair of meiotic DNA breaks. Structural homology analysis suggests that the T-DNA insertion in the mre11-4 allele probably disrupted the putative RAD50 interaction and/or homodimerization domain, which is assumed to be preserved in mre11-2 allele. Intriguingly, introgression of the atm-2 mutant plant into the mre11-2 background renders the double mutant infertile, a phenotype not observed in either parent line. This data indicate that MRE11 partially compensates for ATM deficiency in meiosis of Arabidopsis.	[Samanic, Ivica; Puizina, Jasna] Univ Split, Fac Sci, Dept Biol, Split, Croatia; [Simunic, Juraj] Univ Split, Fac Sci, Dept Phys, Split, Croatia; [Riha, Karel] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Riha, Karel] Cent European Inst Technol CEITEC, Brno, Czech Republic	University of Split; University of Split; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Puizina, J (corresponding author), Univ Split, Fac Sci, Dept Biol, Split, Croatia.	puizina@pmfst.hr	Riha, Karel/AAM-4429-2021; Puizina, Jasna/E-2517-2017; Riha, Karel/P-9614-2018; Šamanić, Ivica/D-5728-2017; Riha, Karel/A-7717-2008	Riha, Karel/0000-0002-6124-0118; Puizina, Jasna/0000-0001-7097-7261; Riha, Karel/0000-0002-6124-0118; Šamanić, Ivica/0000-0001-8807-8184; 	Croatian Ministry of Science, Education and Sport [177-11911196]; Austrian Science Fund (FWF) [P 23495] Funding Source: researchfish	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work received financial support from project of the Croatian Ministry of Science, Education and Sport to Jasna Puizina (No. 177-11911196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJIMURA M, 1993, GENETICS, V133, P51; Amiard S, 2010, PLANT CELL, V22, P3020, DOI 10.1105/tpc.110.078527; Armstrong SJ, 2003, J EXP BOT, V54, P1, DOI 10.1093/jxb/54.380.1; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Bleuyard JY, 2004, CHROMOSOMA, V113, P197, DOI 10.1007/s00412-004-0309-1; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Borde V, 2009, INT J BIOCHEM CELL B, V41, P1249, DOI 10.1016/j.biocel.2008.12.013; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Buis J, 2012, NAT STRUCT MOL BIOL, V19, P246, DOI 10.1038/nsmb.2212; Bundock P, 2002, PLANT CELL, V14, P2451, DOI 10.1105/tpc.005959; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Doyle J. J., 1987, PHYTOCHEM B, P11; Gallego ME, 2001, PLANT J, V25, P31, DOI 10.1046/j.1365-313x.2001.00928.x; Gallego ME, 2001, P NATL ACAD SCI USA, V98, P1711, DOI 10.1073/pnas.98.4.1711; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gherbi H, 2001, EMBO REP, V2, P287, DOI 10.1093/embo-reports/kve069; Grelon M, 2001, EMBO J, V20, P589, DOI 10.1093/emboj/20.3.589; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hartung F., 1999, Plant Physiology, V121, P312; Heacock M, 2004, EMBO J, V23, P2304, DOI 10.1038/sj.emboj.7600236; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Puizina J, 2004, PLANT CELL, V16, P1968, DOI 10.1105/tpc.104.022749; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Rupnik A, 2010, CHROMOSOMA, V119, P115, DOI 10.1007/s00412-009-0242-4; Slijepcevic P, 2006, DNA REPAIR, V5, P1299, DOI 10.1016/j.dnarep.2006.05.038; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theunissen JWF, 2003, MOL CELL, V12, P1511, DOI 10.1016/S1097-2765(03)00455-6; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; van Noort J, 2003, P NATL ACAD SCI USA, V100, P7581, DOI 10.1073/pnas.1330706100; Waterworth WM, 2007, PLANT J, V52, P41, DOI 10.1111/j.1365-313X.2007.03220.x; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2005, MOL CELL, V19, P724, DOI 10.1016/j.molcel.2005.07.006; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	52	12	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78760	10.1371/journal.pone.0078760	http://dx.doi.org/10.1371/journal.pone.0078760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205310	Green Submitted, gold, Green Published			2022-12-27	WOS:000326032600110
J	Van Avondt, K; Fritsch-Stork, R; Derksen, RHWM; Meyaard, L				Van Avondt, Kristof; Fritsch-Stork, Ruth; Derksen, Ronald H. W. M.; Meyaard, Linde			Ligation of Signal Inhibitory Receptor on Leukocytes-1 Suppresses the Release of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus	PLOS ONE			English	Article							HUMAN PHAGOCYTES; CLASSIFICATION; BLOOD	Neutrophil extracellular traps (NETs) have been implicated in the pathogenesis of systemic Lupus erythematosus (SLE), since netting neutrophils release potentially immunogenic autoantigens including histones, LL37, human neutrophil peptide (HNP), and self-DNA. In turn, these NETs activate plasmacytoid dendritic cells resulting in aggravation of inflammation and disease. How suppression of NET formation can be targeted for treatment has not been reported yet. Signal Inhibitory Receptor on Leukocytes-1 (SIRL-1) is a surface molecule exclusively expressed on phagocytes. We recently identified SIRL-1 as a negative regulator of human neutrophil function. Here, we determine whether ligation of SIRL-1 prevents the pathogenic release of NETs in SLE. Peripheral blood neutrophils from SLE patients with mild to moderate disease activity and healthy donors were freshly isolated. NET release was assessed spontaneously or after exposure to anti-neutrophil antibodies or plasma obtained from SLE patients. The formation of NETs was determined by microscopic evaluation using DNA dyes and immunostaining of NET components, as well as by live cell imaging. We show that SLE neutrophils spontaneously release NETs. NET formation is enhanced by stimulation with antibodies against LL37. Inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity and MEK-ERK signaling prevents NET release in response to these antibodies. Signaling via the inhibitory receptor SIRL-1 was induced by ligation with anti-SIRL-1 specific antibodies. Both spontaneous and anti-neutrophil antibody-induced NET formation is suppressed by engagement of SIRL-1. Furthermore, NET release by healthy neutrophils exposed to SLE plasma is inhibited by SIRL-1 ligation. Thus, SIRL-1 engagement can dampen spontaneous and anti-neutrophil antibody-induced NET formation in SLE, likely by suppressing NAPDH oxidase and MEK-ERK activity. Together, these findings reveal a regulatory role for SIRL-1 in NET formation, potentially providing a novel therapeutic target to break the pathogenic loop in SLE.	[Van Avondt, Kristof; Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Fritsch-Stork, Ruth; Derksen, Ronald H. W. M.] Univ Med Ctr Utrecht, Lab Translat Immunol, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Meyaard, L (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands.	l.meyaard@umcutrecht.nl		Meyaard, Linde/0000-0003-0707-4793; Fritsch-Stork, ruth/0000-0003-0217-3629	Netherlands Organization for Scientific Research, division of Earth and Life Sciences [819.02.002]; ReumaFonds [12-2-406] Funding Source: researchfish	Netherlands Organization for Scientific Research, division of Earth and Life Sciences; ReumaFonds	This work was supported by grant 819.02.002 from the Netherlands Organization for Scientific Research, division of Earth and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Marian V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3917; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Petri M, 1999, LUPUS, V8, P685, DOI 10.1191/096120399680411281; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Steevels TAM, 2013, EUR J IMMUNOL, V43, P1297, DOI 10.1002/eji.201242916; Steevels TAM, 2010, J IMMUNOL, V184, P4741, DOI 10.4049/jimmunol.0902039; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450	17	54	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78459	10.1371/journal.pone.0078459	http://dx.doi.org/10.1371/journal.pone.0078459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205237	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300156
J	Hashimoto, T; Igarashi, J; Hasan, AU; Ohmori, K; Kohno, M; Nagai, Y; Yamashita, T; Kosaka, H				Hashimoto, Takeshi; Igarashi, Junsuke; Hasan, Arif U.; Ohmori, Koji; Kohno, Masakazu; Nagai, Yukiko; Yamashita, Tetsuo; Kosaka, Hiroaki			Mifepristone Promotes Adiponectin Production and Improves Insulin Sensitivity in a Mouse Model of Diet-Induced-Obesity	PLOS ONE			English	Article							3T3-L1 ADIPOCYTES; LIPID-METABOLISM; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; RESISTANCE; EXPRESSION; INDUCTION; RU486; MICE; PIOGLITAZONE	The steroid receptor antagonist mifepristone is used as an anti-cancer agent, eliciting both cytostatic and cytotoxic effects on malignant cells. However, the metabolic effects of long-term treatment with mifepristone have remained unclear. The effects of mifepristone on insulin sensitivity and adiponectin secretion were evaluated both in in vivo and in vitro. First, we explored the effects of mifepristone, on metabolic functions in obese mice receiving a high-fat diet. When these mice were fed mifepristone, they exhibited a marked improvement in insulin sensitivity, attenuated hepatic injury, and decreased adipocyte size, compared with mice that received only the high-fat diet. Intriguingly, mifepristone-treated mice showed significantly elevated plasma adiponectin levels. Second, we tested the effects of mifepristone on differentiated 3T3-L1 adipocytes in vitro. When differentiated adipocytes were treated with mifepristone for 48 h, adiponectin was upregulated at both mRNA and protein levels. Collectively, these results reveal novel actions of mifepristone on metabolic functions, in vivo and in vitro, in which the drug exerts antidiabetic effects associated with an upregulation in adiponectin-secretion.	[Hashimoto, Takeshi; Igarashi, Junsuke; Yamashita, Tetsuo; Kosaka, Hiroaki] Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, Kagawa, Japan; [Hasan, Arif U.; Ohmori, Koji; Kohno, Masakazu] Kagawa Univ, Dept Cardiorenal & Cerebrovasc Med, Kagawa, Japan; [Nagai, Yukiko] Kagawa Univ, Life Sci Res Ctr, Kagawa, Japan	Kagawa University; Kagawa University; Kagawa University	Hashimoto, T (corresponding author), Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, Kagawa, Japan.	hasimoty@med.kagawa-u.ac.jp	Hasan, Arif Ul/J-1062-2019	Hasan, Arif Ul/0000-0002-6491-347X; Tetsuo, Yamashita/0000-0002-4076-991X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kagawa University Faculty of Medicine Specially Promoted Research Fund; Fund for Kagawa University Young Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kagawa University Faculty of Medicine Specially Promoted Research Fund; Fund for Kagawa University Young Scientists	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. H., Kagawa, Japan). This work was also supported by grants from the Kagawa University Faculty of Medicine Specially Promoted Research Fund 2011 (to T. H., Kagawa, Japan), the Fund for Kagawa University Young Scientists 2012 (to T. H., Kagawa, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Cadepond F, 1997, ANNU REV MED, V48, P129; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FELDMAN D, 1976, J CLIN INVEST, V57, P1, DOI 10.1172/JCI108249; Gross C, 2010, OBESITY, V18, P2295, DOI 10.1038/oby.2010.51; Gross C, 2009, ADV THER, V26, P959, DOI 10.1007/s12325-009-0070-1; Hasan AU, 2011, BIOCHEM BIOPH RES CO, V411, P375, DOI 10.1016/j.bbrc.2011.06.152; Hashimoto T, 2009, J LIPID RES, V50, P602, DOI 10.1194/jlr.M800206-JLR200; Hitomi H, 2007, HYPERTENSION, V50, P750, DOI 10.1161/HYPERTENSIONAHA.107.093955; Hosoe T, 2005, J HEALTH SCI, V51, P75, DOI 10.1248/jhs.51.75; Kadowaki T, 2003, EXP BIOL MED, V228, P1111, DOI 10.1177/153537020322801003; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; KUSUNOKI M, 1995, DIABETES, V44, P718, DOI 10.2337/diabetes.44.6.718; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; LAHTEENMAKI P, 1980, FERTIL STERIL, V34, P246; Lee YM, 2006, NUTRITION, V22, P956, DOI 10.1016/j.nut.2005.12.014; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Lin SC, 2012, CELL RES, V22, P746, DOI 10.1038/cr.2011.162; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Moriuchi A, 2007, BIOCHEM BIOPH RES CO, V356, P1024, DOI 10.1016/j.bbrc.2007.03.084; Musgrove EA, 1997, MOL ENDOCRINOL, V11, P54, DOI 10.1210/me.11.1.54; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Sacco M, 2002, J Endocrinol Invest, V25, P81; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; SCHREIBER JR, 1983, CONTRACEPTION, V28, P77, DOI 10.1016/S0010-7824(83)80008-0; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Sharma AM, 2006, AM J MED, V119, p17S, DOI 10.1016/j.amjmed.2006.01.010; Taylor AI, 2009, HORM METAB RES, V41, P899, DOI 10.1055/s-0029-1234071; Wang Y, 2004, PROTEOMICS, V4, P3933, DOI 10.1002/pmic.200400826; Wang Y, 2011, DIABETOLOGIA, V54, P440, DOI 10.1007/s00125-010-1956-9; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yang Baichun, 2008, BMC Pharmacology, V8, P7, DOI 10.1186/1471-2210-8-7	46	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79724	10.1371/journal.pone.0079724	http://dx.doi.org/10.1371/journal.pone.0079724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223187	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200080
J	Lin, YC; Lu, MC; Lin, CJ; Chiang, MK; Jan, MS; Tang, HL; Liu, HC; Lin, WL; Huang, CY; Chen, CM; Lai, YC				Lin, Yi-Chun; Lu, Min-Chi; Lin, Chingju; Chiang, Ming-Ko; Jan, Ming-Shiou; Tang, Hui-Ling; Liu, Hsu-Chung; Lin, Wea-Lung; Huang, Chih-Yang; Chen, Chuan-Mu; Lai, Yi-Chyi			Activation of IFN-gamma/STAT/IRF-1 in Hepatic Responses to Klebsiella pneumoniae Infection	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; GAMMA-INDUCED APOPTOSIS; IFN-GAMMA; LIVER-ABSCESS; INTERFERON-GAMMA; INJURY; GENES; K1; SUPPRESSION; VIRULENCE	Background: Klebsiella pneumoniae-caused liver abscess (KLA) has become a health problem in Taiwan and is continually reported in other countries. Diabetes mellitus, the most common metabolic disorder, underlies half of the KLA patients in Taiwan. The clinical impact of KLA has been well-documented. Nevertheless, the molecular basis regarding how K. pneumoniae causes liver infection, particularly in diabetic individuals, remains unclear. Methodology/Principle Findings: Auto-bioluminescence-expressing K. pneumoniae was inoculated into diabetic mice and age-match naive control. With the use of in vivo imaging system, translocation of the bioluminescence-expressing K. pneumoniae from intestine to extraintestinal organs, mainly the liver, was noted in 80% of the diabetic mice, whereas the same bacteria causes extraintestinal infections in only 31% of naive mice. Besides increased morbidity, the severity of hepatic tissue injury was also enhanced in the K. pneumoniae-infected diabetic mice. Upon K. pneumoniae infection, IFN-gamma production was significantly evoked in the liver. To mediate IFN-gamma signal, STAT (signal transducers and activators of transcription) 1 and 3 were activated in hepatocytes, and so was the expression of IRF (interferon regulatory factor)-1. Moreover, accumulation of neutrophils which was triggered by prolonged production of IL-1 beta and MIP-2, and significant increases in the level of active caspase 3 and phospho-eIF2 alpha, were exclusively revealed in the K. pneumoniae-infected diabetic mice. Conclusion: The activation of IFN-gamma/STAT/IRF-1 signaling demonstrated by this work emphasizes the role of IFN-gamma for mediating the hepatic response to K. pneumoniae infection.	[Lin, Yi-Chun; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Lu, Min-Chi; Lai, Yi-Chyi] Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Lu, Min-Chi; Lai, Yi-Chyi] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan; [Lu, Min-Chi; Jan, Ming-Shiou; Lai, Yi-Chyi] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Lin, Chingju] China Med Univ, Sch Med, Dept Physiol, Taichung, Taiwan; [Chiang, Ming-Ko] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Tang, Hui-Ling] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Tang, Hui-Ling] China Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taichung, Taiwan; [Liu, Hsu-Chung; Lin, Wea-Lung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Liu, Hsu-Chung] Chung Shan Med Univ Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Lin, Wea-Lung] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan; National Chung Cheng University; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Lu, MC (corresponding author), Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan.	luminchi@csmu.edu.tw; chchen1@dragon.nchu.edu.tw; yclai@csmu.edu.tw	Yuang, Chih-Yang/O-5111-2015; Chen, Chuan-Mu/K-7049-2013	Chen, Chuan-Mu/0000-0003-2461-9150; LAI, YICHYI/0000-0003-2396-1827	National Science Council of Taiwan [NSC 101-2320-B-040-013-, NSC 101-2314-B -040-009-]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan, NSC 101-2320-B-040-013- to Yi-Chyi Lai, and NSC 101-2314-B -040-009- to Min-Chi Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebien M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002812; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Damci T, 2003, EUR J CLIN INVEST, V33, P397, DOI 10.1046/j.1365-2362.2003.01161.x; DECHAMPS C, 1989, J CLIN MICROBIOL, V27, P2887, DOI 10.1128/JCM.27.12.2887-2890.1989; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; EASTGATE JA, 1995, J BACTERIOL, V177, P932, DOI 10.1128/jb.177.4.932-937.1995; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fung CP, 2012, EMERG INFECT DIS, V18, P1322, DOI 10.3201/eid1808.111053; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; HEWETT JA, 1992, LAB INVEST, V66, P347; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jaruga B, 2004, AM J PHYSIOL-GASTR L, V287, pG1044, DOI 10.1152/ajpgi.00184.2004; Kanki K, 2009, APOPTOSIS, V14, P309, DOI 10.1007/s10495-009-0318-x; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; Karama Edison Mutsinzi, 2008, International Ophthalmology, V28, P111, DOI 10.1007/s10792-007-9111-4; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Korrapati MC, 2012, J PHARMACOL EXP THER, V343, P34, DOI 10.1124/jpet.112.196964; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Lin YC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-50; Liu CY, 2003, J CELL SCI, V116, P1861, DOI 10.1242/jcs.00408; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; Moore TA, 2002, INFECT IMMUN, V70, P6310, DOI 10.1128/IAI.70.11.6310-6318.2002; Nadasy KA, 2007, CLIN INFECT DIS, V45, pE25, DOI 10.1086/519424; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; POZZILLI P, 1994, DIABETIC MED, V11, P935, DOI 10.1111/j.1464-5491.1994.tb00250.x; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; Rothfuchs AG, 2006, J IMMUNOL, V176, P6982, DOI 10.4049/jimmunol.176.11.6982; Rowe JH, 2012, J IMMUNOL, V189, P876, DOI 10.4049/jimmunol.1103227; Secondulfo M, 2004, DIGEST LIVER DIS, V36, P35, DOI 10.1016/j.dld.2003.09.016; Shen KZ, 2008, AM J PHYSIOL-GASTR L, V294, pG1070, DOI 10.1152/ajpgi.00554.2007; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Streetz K, 2001, J IMMUNOL, V167, P514, DOI 10.4049/jimmunol.167.1.514; Sunahara KKS, 2012, J LEUKOCYTE BIOL, V91, P871, DOI 10.1189/jlb.0911488; Tagawa Y, 1997, J IMMUNOL, V159, P1418; TOYONAGA T, 1994, P NATL ACAD SCI USA, V91, P614, DOI 10.1073/pnas.91.2.614; Tu YC, 2009, INFECT IMMUN, V77, P2657, DOI 10.1128/IAI.01523-08; Vadrot N, 2006, J INTERF CYTOK RES, V26, P901, DOI 10.1089/jir.2006.26.901; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Watts T, 2005, P NATL ACAD SCI USA, V102, P2916, DOI 10.1073/pnas.0500178102; WETZSTEIN M, 1990, FEMS MICROBIOL LETT, V72, P55, DOI 10.1111/j.1574-6968.1990.tb03861.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; Yang CS, 2007, OPHTHALMOLOGY, V114, P876, DOI 10.1016/j.ophtha.2006.12.035; Yeh CC, 2007, J BIOMED SCI, V14, P183, DOI 10.1007/s11373-006-9139-x	52	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79961	10.1371/journal.pone.0079961	http://dx.doi.org/10.1371/journal.pone.0079961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223208	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200101
J	Meehan, TD; Gratton, C; Diehl, E; Hunt, ND; Mooney, DF; Ventura, SJ; Barham, BL; Jackson, RD				Meehan, Timothy D.; Gratton, Claudio; Diehl, Erica; Hunt, Natalie D.; Mooney, Daniel F.; Ventura, Stephen J.; Barham, Bradford L.; Jackson, Randall D.			Ecosystem-Service Tradeoffs Associated with Switching from Annual to Perennial Energy Crops in Riparian Zones of the US Midwest	PLOS ONE			English	Article							LAND-USE; AGRICULTURE; BIODIVERSITY; LANDSCAPE; BIOENERGY; ETHANOL; CARBON	Integration of energy crops into agricultural landscapes could promote sustainability if they are placed in ways that foster multiple ecosystem services and mitigate ecosystem disservices from existing crops. We conducted a modeling study to investigate how replacing annual energy crops with perennial energy crops along Wisconsin waterways could affect a variety of provisioning and regulating ecosystem services. We found that a switch from continuous corn production to perennial-grass production decreased annual income provisioning by 75%, although it increased annual energy provisioning by 33%, decreased annual phosphorous loading to surface water by 29%, increased below-ground carbon sequestration by 30%, decreased annual nitrous oxide emissions by 84%, increased an index of pollinator abundance by an average of 11%, and increased an index of biocontrol potential by an average of 6%. We expressed the tradeoffs between income provisioning and other ecosystem services as benefit-cost ratios. Benefit-cost ratios averaged 12.06 GJ of additional net energy, 0.84 kg of avoided phosphorus pollution, 18.97 Mg of sequestered carbon, and 1.99 kg of avoided nitrous oxide emissions for every $ 1,000 reduction in income. These ratios varied spatially, from 2- to 70-fold depending on the ecosystem service. Benefit-cost ratios for different ecosystem services were generally correlated within watersheds, suggesting the presence of hotspots - watersheds where increases in multiple ecosystem services would come at lower-than-average opportunity costs. When assessing the monetary value of ecosystem services relative to existing conservation programs and environmental markets, the overall value of enhanced services associated with adoption of perennial energy crops was far lower than the opportunity cost. However, when we monitized services using estimates for the social costs of pollution, the value of enhanced services far exceeded the opportunity cost. This disparity between recoverable costs and social value represents a fundamental challenge to expansion of perennial energy crops and sustainable agricultural landscapes.	[Meehan, Timothy D.; Gratton, Claudio] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Hunt, Natalie D.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Mooney, Daniel F.; Barham, Bradford L.] Univ Wisconsin, Dept Agr & Appl Econ, Madison, WI 53706 USA; [Ventura, Stephen J.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Jackson, Randall D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Meehan, Timothy D.; Gratton, Claudio; Barham, Bradford L.; Jackson, Randall D.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Diehl, Erica] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Meehan, TD (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	tmeehan@wisc.edu	Mooney, Daniel/AAC-5566-2022; Mooney, Daniel F/E-6264-2011; Jackson, Randall/AAE-5573-2022	Gratton, Claudio/0000-0001-6262-9670; Hunt, Natalie/0000-0002-0782-0488	Sun Grant Initiative (DOE EERE) [3TC162]; Hatch Act Formula Fund [WISO1503]; DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE OBP Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]; Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture [2011-67009-3002, 2012-67009-19715]	Sun Grant Initiative (DOE EERE)(United States Department of Energy (DOE)); Hatch Act Formula Fund; DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE OBP Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture	This project was funded in part by the Sun Grant Initiative (DOE EERE Subaward 3TC162), the Hatch Act Formula Fund (WISO1503), the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494), the DOE OBP Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830), and the Agriculture and Food Research Initiative (Competitive Grants 2011-67009-3002 and 2012-67009-19715) of the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB BIOGEOCHEM CYCL; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Boody G, 2005, BIOSCIENCE, V55, P27, DOI 10.1641/0006-3568(2005)055[0027:MAITUS]2.0.CO;2; Boryan C, 2011, GEOCARTO INT, V26, P341, DOI 10.1080/10106049.2011.562309; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; CHAVAS JP, 1993, J AGR RESOUR ECON, V18, P1; Costello C, 2009, ENVIRON SCI TECHNOL, V43, P7985, DOI 10.1021/es9011433; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; GANTZER CJ, 1990, J SOIL WATER CONSERV, V45, P641; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Horowitz J., 2010, EC INFORM B, V70; IWGSCC, 2013, ECHN UPD SOC COST CA; Jackson-Smith D, 2000, RES RUR SOC, V8, P115, DOI 10.1016/S1057-1922(00)80008-6; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Johnson KA, 2012, ECOL ECON, V79, P71, DOI 10.1016/j.ecolecon.2012.04.020; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Lathrop RC, 1998, CAN J FISH AQUAT SCI, V55, P1169, DOI 10.1139/cjfas-55-5-1169; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Ma Z, 2001, BIOMASS BIOENERG, V20, P413, DOI 10.1016/S0961-9534(01)00008-3; Meehan TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041728; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; NAS, 2009, LIQ TRANSP FUELS COA; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; NRCS Soil survey staff natural resources conservation service United States department of agriculture, 2010, SOIL SURVEY PAGE COU; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Prince SD, 2001, ECOL APPL, V11, P1194, DOI 10.1890/1051-0761(2001)011[1194:NPPOUS]2.0.CO;2; PRISM Climate Group, 2012, US PREC NORM 1981 20; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reckhow KH, 1980, ODELING PHOSPHORUS L; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Seely R, 2012, DANE COUNTY ANNOUNCE; Sissine F, 2007, ENERGY INDEPENDENCE; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Soranno PA, 1996, ECOL APPL, V6, P865, DOI 10.2307/2269490; Swinton SM, 2007, ECOL ECON, V64, P245, DOI 10.1016/j.ecolecon.2007.09.020; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Turner RE, 2003, BIOSCIENCE, V53, P563, DOI 10.1641/0006-3568(2003)053[0563:LLAWQI]2.0.CO;2; U.S. DOE, 2011, US BILLION TON UPDAT; Un FAO, 2012, GLOB MAP MONTHL REF; USDA ERS, 2011, FEED GRAINS DAT YB T; USDA ERS, 2012, SDA AGR PROJ 2021; USDA ERS, 2012, COMM COSTS RET WISC; USDA NASS, 2007, QUICKSTATS QUER TOOL; USDA NASS, 2007, ENS AGR; USDA NASS, 2007, CROPL DAT LAYER; UW CDP, 2012, AGR FIN ADV DAT; WDNR, 2012, HYDR GEOD; WDNR, 2012, PHOSPH RED WISC WAT; West TO, 2008, SOIL SCI SOC AM J, V72, P285, DOI 10.2136/sssaj2007.0113; Wisconsin DNR, 2013, OLL LOAD RAT EST TOO; Wolf Amy T., 2008, Great Lakes Entomologist, V41, P129; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	68	70	80	5	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80093	10.1371/journal.pone.0080093	http://dx.doi.org/10.1371/journal.pone.0080093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223215	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200108
J	Ohyama, Y; Imai, M; Kurabayashi, M				Ohyama, Yoshiaki; Imai, Masahiko; Kurabayashi, Masahiko			Estimated Glomerular Filtration Rate and Proteinuria Are Separately and Independently Associated with the Prevalence of Atrial Fibrillation in General Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK; EQUATION; HEART	Background: Both, proteinuria and a decline in glomerular filtration rate (GFR) are associated with greater cardiovascular mortality. However, few studies have explored that proteinuria and lower GFR are related with prevalent atrial fibrillation (AF). Methods: This cross-sectional study was based on annual health check-up program of community-based population in Gunma, Japan from April 2011 to March 2012. A total of 20,019 adult participants were included. AF was ascertained by a standard 12-lead electrocardiogram. Cross-sectional association and correlates with prevalent AF were examined using multivariable logistic regression analysis. Results: The overall prevalence of AF was 0.6% (2.2 % in participants with eGFR < 60 mL. min(-1). 1.73m(-2), 0.4% and 0.2% in those with eGFR 60 to 89 and >= 90 mL.min(-1).1.73m(-2), p for trend < 0.001). The multivariable odds ratio (OR) for AF was 2.86 (95 % CI 1.16-7.08, p<0.001) for eGFR<60 mL. min(-1). 1.73m-2 versus eGFR. 90 mL. min-1. 1.73m-2. This association remained significant with further adjustment for proteinuria. In addition, proteinuria was also strongly associated with increased prevalence of AF (OR 2.96, 95 % CI 1.55-5.68, p<0.001), an association that remained significant after adjustment for eGFR. Conclusions: Proteinuria and lower eGFR are separately and significantly associated with prevalence of AF independent of well-established risk factors for AF in general population.	[Ohyama, Yoshiaki; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 371, Japan; [Ohyama, Yoshiaki] Gunma Univ Hosp, Clin Investigat & Res Unit, Maebashi, Gunma, Japan; [Imai, Masahiko] Gunma Chuo Gen Hosp, Dept Cardiol, Maebashi, Gunma, Japan	Gunma University; Gunma University	Ohyama, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 371, Japan.	yoshiaki-ohyama@gunma-u.ac.jp			Grants-in-Aid for Scientific Research [23590661] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Baber U, 2011, CIRC-ARRHYTHMIA ELEC, V4, P26, DOI 10.1161/CIRCEP.110.957100; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668; Fabbian F, 2000, CLIN NEPHROL, V54, P234; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Iguchi Y, 2008, AM J CARDIOL, V102, P1056, DOI 10.1016/j.amjcard.2008.06.018; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; McManus DD, 2009, AM J CARDIOL, V104, P1551, DOI 10.1016/j.amjcard.2009.07.026; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Takahashi Y, 2011, CIRCULATION, V124, P2380, DOI 10.1161/CIRCULATIONAHA.111.047266; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471	19	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79717	10.1371/journal.pone.0079717	http://dx.doi.org/10.1371/journal.pone.0079717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223186	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200079
J	Papolu, PK; Gantasala, NP; Kamaraju, D; Banakar, P; Sreevathsa, R; Rao, U				Papolu, Pradeep Kumar; Gantasala, Nagavara Prasad; Kamaraju, Divya; Banakar, Prakash; Sreevathsa, Rohini; Rao, Uma			Utility of Host Delivered RNAi of Two FMRF Amide Like Peptides, flp-14 and flp-18, for the Management of Root Knot Nematode, Meloidogyne incognita	PLOS ONE			English	Article							FMRFAMIDE-RELATED PEPTIDES; PHARYNGEAL GLAND-CELL; DOUBLE-STRANDED-RNA; HETERODERA-GLYCINES; CAENORHABDITIS-ELEGANS; ASCARIS-SUUM; GENE-EXPRESSION; NERVOUS-SYSTEM; NEUROPEPTIDES; INTERFERENCE	Root knot nematode, Meloidogyne incognita, is an obligate sedentary endoparasite that infects a large number of crop species and causes substantial yield losses. Non-chemical based control strategies for these nematodes are gaining importance. In the present study, we have demonstrated the significance of two FMRFamide like peptide genes (flp-14 and flp-18) for infection and development of resistance to M. incognita through host-derived RNAi. The study demonstrated both in vitro and in planta validation of RNAi-induced silencing of the two genes cloned from J2 stage of M. incognita. In vitro silencing of both the genes interfered with nematode migration towards the host roots and subsequent invasion into the roots. Transgenic tobacco lines were developed with RNAi constructs of flp-14 and flp-18 and evaluated against M. incognita. The transformed plants did not show any visible phenotypic variations suggesting the absence of any off-target effects. Bioefficacy studies with deliberate challenging of M. incognita resulted in 50-80% reduction in infection and multiplication confirming the silencing effect. We have provided evidence for in vitro and in planta silencing of the genes by expression analysis using qRT-PCR. Thus the identified genes and the strategy can be used as a potential tool for the control of M. incognita. This is the first ever report that has revealed the utility of host delivered RNAi of flps to control M. incognita. The strategy can also be extended to other crops and nematodes.	[Papolu, Pradeep Kumar; Gantasala, Nagavara Prasad; Kamaraju, Divya; Banakar, Prakash; Rao, Uma] Indian Agr Res Inst, Div Nematol, New Delhi 110012, India; [Sreevathsa, Rohini] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB)	Rao, U (corresponding author), Indian Agr Res Inst, Div Nematol, New Delhi 110012, India.	umarao@iari.res.in	banakar, prakash/Q-1204-2019	Sreevathsa, Rohini/0000-0003-4171-6956	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funded by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Adam MAM, 2008, PHYSIOL MOL PLANT P, V72, P21, DOI 10.1016/j.pmpp.2008.05.002; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Alkharouf NW, 2007, EXP PARASITOL, V115, P247, DOI 10.1016/j.exppara.2006.09.009; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; AVERY L, 1993, J EXP BIOL, V175, P283; Bakhetia M, 2008, INT J PARASITOL, V38, P1589, DOI 10.1016/j.ijpara.2008.05.003; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Bakhetia M, 2005, TRENDS PLANT SCI, V10, P362, DOI 10.1016/j.tplants.2005.06.007; Brownlee DJA, 1996, PARASITOL TODAY, V12, P343, DOI 10.1016/0169-4758(96)10052-1; BYBD DW, 1983, J NEMATOL, V15, P142; Chen PC, 2003, NEMATOLOGY, V5, P687, DOI 10.1163/156854103322746869; Cohen M, 2009, CELL METAB, V9, P375, DOI 10.1016/j.cmet.2009.02.003; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; Dalzell JJ, 2009, INT J PARASITOL, V39, P1503, DOI 10.1016/j.ijpara.2009.05.006; Day TA, 1999, PEPTIDES, V20, P999, DOI 10.1016/S0196-9781(99)00093-5; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Fairbairn DJ, 2007, PLANTA, V226, P1525, DOI 10.1007/s00425-007-0588-x; Fellowes RA, 1998, PARASITOLOGY, V116, P277, DOI 10.1017/S0031182097002229; Fellowes RA, 2000, PARASITOLOGY, V121, P325, DOI 10.1017/S0031182099006290; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Geary TG, 1999, ANN NY ACAD SCI, V897, P212, DOI 10.1111/j.1749-6632.1999.tb07893.x; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Johnston MJG, 2010, J HELMINTHOL, V84, P253, DOI 10.1017/S0022149X09990630; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kimber MJ, 2007, FASEB J, V21, P1233, DOI 10.1096/fj.06-7343com; Kimber MJ, 2001, MOL BIOCHEM PARASIT, V116, P199, DOI 10.1016/S0166-6851(01)00323-1; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Lilley CJ, 2005, INT J PARASITOL, V35, P1577, DOI 10.1016/j.ijpara.2005.07.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maule Aaron G., 2002, Current Topics in Medicinal Chemistry, V2, P733, DOI 10.2174/1568026023393697; McVeigh P, 2006, TRENDS PARASITOL, V22, P385, DOI 10.1016/j.pt.2006.06.010; Moffett CL, 2003, INT J PARASITOL, V33, P859, DOI 10.1016/S0020-7519(03)00109-7; Mousley A, 2005, INT J PARASITOL, V35, P1557, DOI 10.1016/j.ijpara.2005.08.002; Niu JH, 2012, EUR J PLANT PATHOL, V134, P131, DOI 10.1007/s10658-012-9971-y; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Rosso MN, 2005, MOL PLANT MICROBE IN, V18, P615, DOI 10.1094/MPMI-18-0615; SASSER JN, 1980, PLANT DIS, V64, P36, DOI 10.1094/PD-64-36; Shingles J, 2007, EXP PARASITOL, V115, P114, DOI 10.1016/j.exppara.2006.07.008; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Steeves RM, 2006, FUNCT PLANT BIOL, V33, P991, DOI 10.1071/FP06130; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; Vanholme B, 2006, PARASITOL RES, V98, P414, DOI 10.1007/s00436-005-0029-3; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wang CL, 2009, NEMATOLOGY, V11, P453, DOI 10.1163/156854109X447024; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xue BY, 2013, PHYTOPATHOLOGY, V103, P175, DOI 10.1094/PHYTO-07-12-0173-R; Yadav BC, 2006, MOL BIOCHEM PARASIT, V148, P219, DOI 10.1016/j.molbiopara.2006.03.013	55	67	68	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80603	10.1371/journal.pone.0080603	http://dx.doi.org/10.1371/journal.pone.0080603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223228	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200121
J	Schueler, J; Wider, D; Klingner, K; Siegers, GM; May, AM; Wasch, R; Fiebig, HH; Engelhardt, M				Schueler, Julia; Wider, Dagmar; Klingner, Kerstin; Siegers, Gabrielle M.; May, Annette M.; Waesch, Ralph; Fiebig, Heinz-Herbert; Engelhardt, Monika			Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2R gamma(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; MODEL; TUMOR; ENGRAFTMENT; LEUKEMIA; THERAPY; GROWTH	Background: We systematically analyzed multiple myeloma (MM) cell lines and patient bone marrow cells for their engraftment capacity in immunodeficient mice and validated the response of the resulting xenografts to antimyeloma agents. Design and Methods: Using flow cytometry and near infrared fluorescence in-vivo-imaging, growth kinetics of MM cell lines L363 and RPMI8226 and patient bone marrow cells were investigated with use of a murine subcutaneous bone implant, intratibial and intravenous approach in NOD/SCID, NOD/SCID treated with CD122 antibody and NOD/SCID IL-2R gamma(null) mice (NSG). Results: Myeloma growth was significantly increased in the absence of natural killer cell activity (NSG or alpha CD122-treated NOD/SCID). Comparison of NSG and alpha CD122-treated NOD/SCID revealed enhanced growth kinetics in the former, especially with respect to metastatic tumor sites which were exclusively observed therein. In NSG, MM cells were more tumorigenic when injected intratibially than intravenously. In NOD/SCID in contrast, the use of juvenile long bone implants was superior to intratibial or intravenous cancer cell injection. Using the intratibial NSG model, mice developed typical disease symptoms exclusively when implanted with human MM cell lines or patient-derived bone marrow cells, but not with healthy bone marrow cells nor in mock-injected animals. Bortezomib and dexamethasone delayed myeloma progression in L363- as well as patient-derived MM cell bearing NSG. Antitumor activity could be quantified via flow cytometry and in vivo imaging analyses. Conclusions: Our results suggest that the intratibial NSG MM model mimics the clinical situation of the disseminated disease and serves as a valuable tool in the development of novel anticancer strategies.	[Schueler, Julia; Wider, Dagmar; Waesch, Ralph; Engelhardt, Monika] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany; [Schueler, Julia; Klingner, Kerstin; Fiebig, Heinz-Herbert] Oncotest, Dept Invivo Tumorbiol, Freiburg, Germany; [Siegers, Gabrielle M.] Univ Western Ontario, Schulich Sch Med, Dept Anat & Cell Biol, London, ON, Canada; [May, Annette M.] Univ Freiburg, Med Ctr, Dept Pathol, Freiburg, Germany	University of Freiburg; Oncotest GmbH; Western University (University of Western Ontario); University of Freiburg	Engelhardt, M (corresponding author), Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany.	monika.engelhardt@uniklinik-freiburg.de	Waesch, Ralph/F-6282-2019; Siegers, Gabrielle M/M-2042-2017	Siegers, Gabrielle M/0000-0003-2154-0279	Biothera Stiftung [1/2009]	Biothera Stiftung	This study was funded by the "Biothera Stiftung (http://www.cancer.de/main.htm); 1/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012487; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Castano AP, 2006, BRIT J CANCER, V94, P391, DOI 10.1038/sj.bjc.6602953; Chaidos A, 2013, BLOOD, V121, P318, DOI 10.1182/blood-2012-06-436220; Engelhardt M, 2010, LEUKEMIA LYMPHOMA, V51, P2006, DOI 10.3109/10428194.2010.516378; Froyland M, 2011, EUR J HAEMATOL, V86, P385, DOI 10.1111/j.1600-0609.2011.01590.x; Fryer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057641; Gado K, 2001, HAEMATOLOGICA, V86, P227; Garg TK, 2012, HAEMATOL-HEMATOL J, V97, P1348, DOI 10.3324/haematol.2011.056747; Ghosh N, 2009, CANCER LETT, V277, P1, DOI 10.1016/j.canlet.2008.08.005; Groen RWJ, 2012, BLOOD, V120, pE9, DOI 10.1182/blood-2012-03-414920; Kleber M, 2012, LEUKEMIA LYMPHOMA, V53, P1057, DOI 10.3109/10428194.2011.644548; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Medioni J, 2012, CONTEMP CLIN TRIALS, V33, P178, DOI 10.1016/j.cct.2011.09.010; Meyer LH, 2011, CANCER RES, V71, P7141, DOI 10.1158/0008-5472.CAN-11-1732; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Pesnel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030690; Riedel SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052398; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Schuler J, 2013, EXPERT OPIN BIOL TH, V13, pS111, DOI 10.1517/14712598.2013.799131; Swift BE, 2012, HAEMATOL-HEMATOL J, V97, P1020, DOI 10.3324/haematol.2011.054254; Udi J, 2013, BRIT J HAEMATOL, V161, P104, DOI 10.1111/bjh.12226; van Rhee F, 2009, MOL CANCER THER, V8, P2616, DOI 10.1158/1535-7163.MCT-09-0483; Xie BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031875; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zlei M, 2007, EXP HEMATOL, V35, P1550, DOI 10.1016/j.exphem.2007.06.016	29	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79939	10.1371/journal.pone.0079939	http://dx.doi.org/10.1371/journal.pone.0079939			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223204	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200097
J	Allareddy, V; Allareddy, V; Nalliah, RP; Rampa, S; Lee, MK				Allareddy, Veerajalandhar; Allareddy, Veerasathpurush; Nalliah, Romesh P.; Rampa, Sankeerth; Lee, Min Kyeong			Infection Related Never Events in Pediatric Patients Undergoing Spinal Fusion Procedures in United States: Prevalence and Predictors	PLOS ONE			English	Article							SURGICAL-SITE INFECTION; RISK-FACTORS; DEPRESSION; SCOLIOSIS; OUTCOMES; SURGERY; STRESS	Objective: To examine the prevalence and predictors of infection related never events (NE) associated with spinal fusion procedures (SFP) in children (age < = 18 years) in the United States. Methods: We performed a retrospective analysis of the Nationwide Inpatient Sample for the years 2004 to 2008. All pediatric hospitalizations that underwent SFP were selected for analysis. The main outcomes measures include occurrence of certain NE's. The association between the occurrence of a NE and factors (patient & hospital related) were examined using multivariable logistic regression analysis. Results: Of 56,465 hospitalizations, 61.7% occurred among females. The average age was 13.7 y and two-thirds were whites. The major insurance payer was private insurance (67.4%). About 82% of all hospitalizations occurred on an elective basis. Teaching hospitals accounted for a majority of hospitalizations (87.9%). Two-thirds were posterior fusion techniques, 52.3% had underlying musculoskeletal deformities, and the most frequently present co-morbid conditions (CMC) included paralysis (10.9%), chronic pulmonary disease (9.7%), and fluid/electrolyte disorders (7.6%). Overall rate of occurrence of a NE was 4.8%. Post-operative pneumonia was the most frequently occurring NE (2.9%). Female gender (OR = 0.78) and elective admissions (OR = 0.66) were associated with lower risk of NE occurrence. Medicaid coverage (OR = 1.46), primary diagnosis of other acquired deformities (OR = 1.82), spinal cord injury (OR = 6.94), other nervous system disorders (OR = 2.84) were associated with higher risk of NE occurrence. Among CMC, those with chronic blood loss anemia (OR = 2.57), coagulopathy (OR = 1.97), depression (OR = 2), drug abuse (OR = 3.71), fluid/electrolyte disorders (OR = 2.62), neurological disorders (OR = 1.72), paralysis (OR = 1.75), renal failure (OR = 5.45), and weight loss (OR = 4.61) were risk factors for higher odds of a NE occurrence. Hospital teaching status, region, hospital size, and patient race did not influence the occurrence of NE. Conclusion: The never events examined in the current study occurred in 4.8% of children hospitalized with SFP. Certain predictors of NE are identified in this study.	[Allareddy, Veerajalandhar] Case Western Reserve Univ, Dept Pediat Crit Care, Cleveland, OH 44106 USA; [Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Dept Orthodont, Iowa City, IA 52242 USA; [Nalliah, Romesh P.; Lee, Min Kyeong] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Rampa, Sankeerth] Texas A&M Univ, College Stn, TX USA	Case Western Reserve University; University of Iowa; Harvard University; Harvard School of Dental Medicine; Texas A&M University System; Texas A&M University College Station	Allareddy, V (corresponding author), Case Western Reserve Univ, Dept Pediat Crit Care, Cleveland, OH 44106 USA.	Veerajalandhar.Allareddy@UHhospitals.org	Nalliah, Romesh/AAV-2016-2020	Nalliah, Romesh/0000-0002-6287-0656				Agency for Healthcare Research and Quality, HEALTHC COST UT PROJ; Aleissa S, 2011, CAN J SURG, V54, P263, DOI 10.1503/cjs.008210; Apisarnthanarak A, 2003, INFECT CONT HOSP EP, V24, P31, DOI 10.1086/502112; Bhamidipati CM, 2011, SURGERY, V150, P626, DOI 10.1016/j.surg.2011.07.056; Business Wire, 2008, REUTERS; Canturk Z, 2003, OBES RES, V11, P769, DOI 10.1038/oby.2003.107; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Centers for Medicare & Medicaid Services, 2008, CMS IMPR PAT SAF MED; CHOBAN PS, 1995, AM SURGEON, V61, P1001; Engel AM, 2009, ANN THORAC SURG, V88, P1793, DOI 10.1016/j.athoracsur.2009.07.077; Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f; Fry DE, 2007, ANN SURG, V246, P875, DOI 10.1097/SLA.0b013e3180cc2e7a; Fry DE, 2010, ARCH SURG-CHICAGO, V145, P148, DOI 10.1001/archsurg.2009.277; Jain A, 2012, SPINE, V37, P1683, DOI 10.1097/BRS.0b013e318254168f; Labbe AC, 2003, INFECT CONT HOSP EP, V24, P591, DOI 10.1086/502259; Linam WM, 2009, INFECT CONT HOSP EP, V30, P109, DOI 10.1086/593952; Marawar S, 2010, SPINE, V35, P1454, DOI 10.1097/BRS.0b013e3181bef3cb; Olff M, 1999, PSYCHIAT RES, V85, P7, DOI 10.1016/S0165-1781(98)00139-5; Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb; Reiche EMV, 2006, INT REV PSYCHIATR, V17, P515, DOI 10.1080/02646830500382102; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Smith S., 2008, BOSTON GLOBE; Tsirikos AI, 2008, SPINE, V33, P1133, DOI 10.1097/BRS.0b013e31816f63cf; Veeravagu A, 2009, SPINE, V34, P1869, DOI 10.1097/BRS.0b013e3181adc989; Zeidman SM, 1997, J SPINAL DISORD, V10, P523	27	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77540	10.1371/journal.pone.0077540	http://dx.doi.org/10.1371/journal.pone.0077540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223715	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400008
J	Koo, KC; Shim, DH; Yang, CM; Lee, SB; Kim, SM; Shin, TY; Kim, KH; Yoon, HG; Rha, KH; Lee, JM; Hong, SJ				Koo, Kyo Chul; Shim, Doo Hee; Yang, Chang Mo; Lee, Saet-Byul; Kim, Shi Mun; Shin, Tae Young; Kim, Kwang Hyun; Yoon, Ho Geun; Rha, Koon Ho; Lee, Jae Myun; Hong, Sung Joon			Reduction of the CD16(-)CD56(bright) NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PERIPHERAL-BLOOD; INTERFERON-GAMMA; DENDRITIC CELLS; TUMOR-CELLS; IN-VIVO; CARCINOMA; INFECTION; PROLIFERATION; CYTOTOXICITY	Background: Natural cytotoxicity, mediated by natural killer (NK) cells plays an important role in the inhibition and elimination of malignant tumor cells. To investigate the immunoregulatory role of NK cells and their potential as diagnostic markers, NK cell activity (NKA) was analyzed in prostate cancer (PCa) patients with particular focus on NK cell subset distribution. Methods: Prospective data of NKA and NK cell subset distribution patterns were measured from 51 patients initially diagnosed with PCa and 54 healthy controls. NKA was represented by IFN-gamma levels after stimulation of the peripheral blood with Promoca (R). To determine the distribution of NK cell subsets, PBMCs were stained with fluorochrome-conjugated monoclonal antibodies. Then, CD16(+)CD56(dim) and CD16(-)CD56(bright) cells gated on CD56(+)CD3(-) cells were analyzed using a flow-cytometer. Results: NKA and the proportion of CD56(bright) cells were significantly lower in PCa patients compared to controls (430.9 pg/ml vs. 975.2 pg/ml and 2.3% vs. 3.8%, respectively; p<0.001). Both tended to gradually decrease according to cancer stage progression (p for trend = 0.001). A significantly higher CD56(dim) (-)to-CD56(bright) cell ratio was observed in PCa patients (41.8 vs. 30.3; p<0.001) along with a gradual increase according to cancer stage progression (p for trend = 0.001), implying a significant reduction of CD56(bright) cells in relation to the alteration of CD56(dim) cells. The sensitivity and the specificity of NKA regarding PCa detection were 72% and 74%, respectively (best cut-off value at 530.9 pg/ml, AUC = 0.786). Conclusions: Reduction of CD56(bright) cells may precede NK cell dysfunction, leading to impaired cytotoxicity against PCa cells. These observations may explain one of the mechanisms behind NK cell dysfunction observed in PCa microenvironment and lend support to the development of future cancer immunotherapeutic strategies.	[Koo, Kyo Chul; Shin, Tae Young; Kim, Kwang Hyun; Rha, Koon Ho; Hong, Sung Joon] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; [Koo, Kyo Chul; Shin, Tae Young; Kim, Kwang Hyun; Rha, Koon Ho; Hong, Sung Joon] Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea; [Shim, Doo Hee; Yang, Chang Mo; Lee, Saet-Byul; Lee, Jae Myun] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Yang, Chang Mo; Lee, Saet-Byul; Yoon, Ho Geun; Lee, Jae Myun] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Kim, Shi Mun] ATgen, Songnam, South Korea; [Yoon, Ho Geun] Yonsei Univ, Coll Med, Severance Med Res Inst, Dept Biochem & Mol Biol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JM (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea.	jaemyun@yuhs.ac; sjhong346@yuhs.ac	rchnds, rchnds/D-7595-2016	Lee, Jae Myun/0000-0002-5273-3113; Koo, Kyo Chul/0000-0001-7303-6256; Rha, Koon Ho/0000-0001-8588-7584; Hong, Sung Joon/0000-0001-9869-065X; Shim, Doo Hee/0000-0002-6696-7199; Yoon, Ho-Geun Yoon/0000-0003-2718-3372	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012-0000807]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012-0000807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basch E, 2012, J CLIN ONCOL, V30, P3020, DOI 10.1200/JCO.2012.43.3441; Bauernhofer T, 2003, EUR J IMMUNOL, V33, P119, DOI 10.1002/immu.200390014; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Dowell AC, 2012, CANCER IMMUNOL IMMUN, V61, P615, DOI 10.1007/s00262-011-1122-3; Ebelt K, 2008, PROSTATE, V68, P1, DOI 10.1002/pros.20661; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Harlin H, 2007, J IMMUNOL, V179, P4513, DOI 10.4049/jimmunol.179.7.4513; Izawa S, CANC IMMUNOL IMMUNOT, V60, P1801; KASTELAN M, 1992, PROSTATE, V21, P111; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Klein EA, 2008, CURR OPIN UROL, V18, P315, DOI 10.1097/MOU.0b013e3282f9b3b7; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Lin CT, 2010, CANCER LETT, V291, P39, DOI 10.1016/j.canlet.2009.09.019; Oikawa T, 2003, BJU INT, V92, P1009, DOI 10.1111/j.1464-410X.2003.04509.x; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Schroder FH, 2012, BJU INT, V110, P3, DOI 10.1111/j.1464-410X.2012.011428.x; Scordamaglia F, 2008, J ALLERGY CLIN IMMUN, V121, P479, DOI 10.1016/j.jaci.2007.09.047; Sheikhi A, 2011, IMMUNOPHARM IMMUNOT, V33, P700, DOI 10.3109/08923973.2011.561437; Sotosek S, 2011, WIEN KLIN WOCHENSCHR, V123, P718, DOI 10.1007/s00508-011-0096-7; Takahashi E, 2007, SCAND J IMMUNOL, V65, P126, DOI 10.1111/j.1365-3083.2006.01883.x; Takeuchi H, 2001, AM J GASTROENTEROL, V96, P574; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wagenlehner FME, 2007, BJU INT, V100, P733, DOI 10.1111/j.1464-410X.2007.07091.x; Watanabe M, 2010, DIS ESOPHAGUS, V23, P675, DOI 10.1111/j.1442-2050.2010.01073.x; Yamaguchi Y, 1994, In Vivo, V8, P279; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482	31	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78049	10.1371/journal.pone.0078049	http://dx.doi.org/10.1371/journal.pone.0078049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223759	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400031
J	Sarmiento, L; Frisk, G; Anagandula, M; Cabrera-Rode, E; Roivainen, M; Cilio, CM				Sarmiento, Luis; Frisk, Gun; Anagandula, Mahesh; Cabrera-Rode, Eduardo; Roivainen, Merja; Cilio, Corrado M.			Expression of Innate Immunity Genes and Damage of Primary Human Pancreatic Islets by Epidemic Strains of Echovirus: Implication for Post-Virus Islet Autoimmunity	PLOS ONE			English	Article							BETA-CELLS; ENTEROVIRUS INFECTION; PATHOGENESIS; MECHANISMS; ANTIBODIES; CYTOKINE; CHILDREN; RNA	Three large-scale Echovirus (E) epidemics (E4, E16, E30), each differently associated to the acute development of diabetes related autoantibodies, have been documented in Cuba. The prevalence of islet cell autoantibodies was moderate during the E4 epidemic but high in the E16 and E30 epidemic. The aim of this study was to evaluate the effect of epidemic strains of echovirus on beta-cell lysis, beta-cell function and innate immunity gene expression in primary human pancreatic islets. Human islets from non-diabetic donors (n = 7) were infected with the virus strains E4, E16 and E30, all isolated from patients with aseptic meningitis who seroconverted to islet cell antibody positivity. Viral replication, degree of cytolysis, insulin release in response to high glucose as well as mRNA expression of innate immunity genes (IFN-b, RANTES, RIG-I, MDA5, TLR3 and OAS) were measured. The strains of E16 and E30 did replicate well in all islets examined, resulting in marked cytotoxic effects. E4 did not cause any effects on cell lysis, however it was able to replicate in 2 out of 7 islet donors. Beta-cell function was hampered in all infected islets (P<0.05); however the effect of E16 and E30 on insulin secretion appeared to be higher than the strain of E4. TLR3 and IFN-beta mRNA expression increased significantly following infection with E16 and E30 (P<0.033 and P<0.039 respectively). In contrast, the expression of none of the innate immunity genes studied was altered in E4-infected islets. These findings suggest that the extent of the epidemic-associated islet autoimmunity may depend on the ability of the viral strains to damage islet cells and induce pro-inflammatory innate immune responses within the infected islets.	[Sarmiento, Luis; Cilio, Corrado M.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit, Malmo, Sweden; [Sarmiento, Luis] Pedro Kouri Trop Med Inst, Dept Virol, Havana, Cuba; [Frisk, Gun; Anagandula, Mahesh] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Cabrera-Rode, Eduardo] Natl Inst Endocrinol, Dept Immunol & Genet Diabet, Havana, Cuba; [Roivainen, Merja] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Div Hlth Protect, Intestinal Viruses Unit, Helsinki, Finland	Lund University; Skane University Hospital; Uppsala University; Finland National Institute for Health & Welfare	Cilio, CM (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit, Malmo, Sweden.	corrado.cilio@med.lu.se		Sarmiento, Luis/0000-0002-3694-1211	Swedish Medical Research Council; Swedish Diabetes Association	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Diabetes Association	This work was supported by Swedish Medical Research Council and Swedish Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hello H, 2009, J MED VIROL, V81, P296, DOI 10.1002/jmv.21391; Al-Hello H, 2008, J GEN VIROL, V89, P1949, DOI 10.1099/vir.0.83474-0; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Cabrera-Rode E, 2005, J MED VIROL, V76, P373, DOI 10.1002/jmv.20368; Cabrera-Rode E, 2003, DIABETOLOGIA, V46, P1348, DOI 10.1007/s00125-003-1179-4; Cabrera-Rode E, 2013, DIABETES VIRUSES, P195; Chehadeh W, 2000, J VIROL, V74, P10153, DOI 10.1128/JVI.74.21.10153-10164.2000; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Elshebani A, 2007, VIRUS RES, V124, P193, DOI 10.1016/j.virusres.2006.11.004; Frisk G, 2000, Int J Exp Diabetes Res, V1, P165, DOI 10.1155/EDR.2000.165; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Klemola P, 2008, ANN NY ACAD SCI, V1150, P210, DOI 10.1196/annals.1447.012; Lennette EH, 1969, DIAGNOSTIC PROCEDURE, P1; Nair S, 2010, J MED VIROL, V82, P1950, DOI 10.1002/jmv.21900; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Otonkoski T, 2000, DIABETOLOGIA, V43, P1235, DOI 10.1007/s001250051518; Paananen A, 2007, J MED VIROL, V79, P945, DOI 10.1002/jmv.20922; Paananen A, 2003, J MED VIROL, V69, P529, DOI 10.1002/jmv.10341; Perez LS, 2004, FOCUS ON MENINGITIS RESEARCH, P1; Richer MJ, 2009, J INNATE IMMUN, V1, P421, DOI 10.1159/000226247; Richer MJ, 2009, AUTOIMMUN REV, V8, P611, DOI 10.1016/j.autrev.2009.02.006; Roivainen M, 2002, DIABETOLOGIA, V45, P693, DOI 10.1007/s00125-002-0805-x; Roivainen M, 2000, J CLIN ENDOCR METAB, V85, P432, DOI 10.1210/jc.85.1.432; Sarmiento L, 2001, EMERG INFECT DIS, V7, P887; Sarmiento L, 2007, AUTOIMMUNITY, V40, P540, DOI 10.1080/08916930701523429; Sarmiento L, 2013, MEDICC REV, V15, P29, DOI 10.37757/MR2013V15.N1.7; Schulte BM, 2010, DIABETES, V59, P1182, DOI 10.2337/db09-1071; Skog O, 2011, J MED VIROL, V83, P658, DOI 10.1002/jmv.21924; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Szopa Teresa M., 1992, Biochemical Society Transactions, V20, p315S; SZOPA TM, 1990, DIABETOLOGIA, V33, P325, DOI 10.1007/BF00404634; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; URIARTE A, 1987, DIABETOLOGIA, V30, pA590; Uriarte A, 1991, REV CUB ENDOCRINOL, V2, P34; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; von Herrath M, 2009, DIABETES, V58, P2, DOI 10.2337/db08-9027; Williams CH, 2006, J CLIN MICROBIOL, V44, P441, DOI 10.1128/JCM.44.2.441-448.2006; Ylipaasto P, 2005, DIABETOLOGIA, V48, P1510, DOI 10.1007/s00125-005-1839-7; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z; Ylipaasto P, 2012, DIABETOLOGIA, V55, P3273, DOI 10.1007/s00125-012-2713-z	47	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77850	10.1371/journal.pone.0077850	http://dx.doi.org/10.1371/journal.pone.0077850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223733	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300010
J	Tanwar, AS; Goyal, VD; Choudhary, D; Panjikar, S; Anand, R				Tanwar, Ajay Singh; Goyal, Venuka Durani; Choudhary, Deepanshu; Panjikar, Santosh; Anand, Ruchi			Importance of Hydrophobic Cavities in Allosteric Regulation of Formylglycinamide Synthetase: Insight from Xenon Trapping and Statistical Coupling Analysis	PLOS ONE			English	Article							RIBONUCLEOTIDE AMIDOTRANSFERASE; CRYSTAL-STRUCTURE; TRIOSEPHOSPHATE ISOMERASE; PHOSPHATE SYNTHETASE; SEQUENCE STATISTICS; THERMOTOGA-MARITIMA; BACILLUS-SUBTILIS; PROTEIN; EVOLUTION; GLUTAMINE	Formylglycinamide ribonucleotide amidotransferase (FGAR-AT) is a 140 kDa bi-functional enzyme involved in a coupled reaction, where the glutaminase active site produces ammonia that is subsequently utilized to convert FGAR to its corresponding amidine in an ATP assisted fashion. The structure of FGAR-AT has been previously determined in an inactive state and the mechanism of activation remains largely unknown. In the current study, hydrophobic cavities were used as markers to identify regions involved in domain movements that facilitate catalytic coupling and subsequent activation of the enzyme. Three internal hydrophobic cavities were located by xenon trapping experiments on FGAR-AT crystals and further, these cavities were perturbed via site-directed mutagenesis. Biophysical characterization of the mutants demonstrated that two of these three voids are crucial for stability and function of the protein, although being,20 A from the active centers. Interestingly, correlation analysis corroborated the experimental findings, and revealed that amino acids lining the functionally important cavities form correlated sets (co-evolving residues) that connect these regions to the amidotransferase active center. It was further proposed that the first cavity is transient and allows for breathing motion to occur and thereby serves as an allosteric hotspot. In contrast, the third cavity which lacks correlated residues was found to be highly plastic and accommodated steric congestion by local adjustment of the structure without affecting either stability or activity.	[Tanwar, Ajay Singh; Goyal, Venuka Durani; Choudhary, Deepanshu; Anand, Ruchi] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic, Australia; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University	Anand, R (corresponding author), Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India.	ruchi@chem.iitb.ac.in	Panjikar, Santosh/D-2709-2012; Choudhary, Deepanshu/ABB-8869-2020; Goyal, Venuka/AAR-7525-2020	Panjikar, Santosh/0000-0001-7429-3879; Choudhary, Deepanshu/0000-0002-2912-1610; Goyal, Venuka/0000-0001-7838-572X	Council of Scientific and Industrial Research (CSIR) [01/2329/09/EMR-II]; DAAD; CSIR	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research (CSIR) grant 01/2329/09/EMR-II. DAAD research stay fellowship for providing financial support during data collection, CSIR for fellowship of AST, and IIT Bombay for providing infrastructure and also fellowship for VDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2004, BIOCHEMISTRY-US, V43, P10328, DOI 10.1021/bi0491301; Anand R, 2004, BIOCHEMISTRY-US, V43, P10343, DOI 10.1021/bi0491292; Arentson BW, 2012, FRONT BIOSCI-LANDMRK, V17, P375, DOI 10.2741/3932; Baker P, 2012, BIOCHEMISTRY-US, V51, P1942, DOI 10.1021/bi201832a; Batey S, 2008, HFSP J, V2, P365, DOI 10.2976/1.2991513; Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; Douangamath A, 2002, STRUCTURE, V10, P185, DOI 10.1016/S0969-2126(02)00702-5; Durani V, 2013, METHOD ENZYMOL, V523, P237, DOI 10.1016/B978-0-12-394292-0.00011-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; Gassner NC, 1996, P NATL ACAD SCI USA, V93, P12155, DOI 10.1073/pnas.93.22.12155; GUILLOU F, 1992, BIOCHEMISTRY-US, V31, P1656, DOI 10.1021/bi00121a012; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hoskins AA, 2004, BIOCHEMISTRY-US, V43, P10314, DOI 10.1021/bi049127h; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Johansson MU, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-173; Kallenbach N, 2001, P NATL ACAD SCI USA, V98, P2958, DOI 10.1073/pnas.071051798; Kappock TJ, 2000, CURR OPIN CHEM BIOL, V4, P567, DOI 10.1016/S1367-5931(00)00133-2; Li QA, 2011, J BIOL CHEM, V286, P18213, DOI 10.1074/jbc.M110.183418; List F, 2012, CHEM BIOL, V19, P1589, DOI 10.1016/j.chembiol.2012.10.012; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Morar M, 2008, BIOCHEMISTRY-US, V47, P7816, DOI 10.1021/bi800329p; Morar M, 2006, BIOCHEMISTRY-US, V45, P14880, DOI 10.1021/bi061591u; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myers RS, 2005, BIOCHEMISTRY-US, V44, P11974, DOI 10.1021/bi050706b; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Panjikar S, 2002, J APPL CRYSTALLOGR, V35, P261, DOI 10.1107/S0021889802002509; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; Reynolds KA, 2013, METHOD ENZYMOL, V523, P213, DOI 10.1016/B978-0-12-394292-0.00010-2; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Schoffelen S, 2012, SOFT MATTER, V8, P1736, DOI 10.1039/c1sm06452e; Silverman JA, 2001, P NATL ACAD SCI USA, V98, P3092, DOI 10.1073/pnas.041613598; Sullivan BJ, 2012, J MOL BIOL, V420, P384, DOI 10.1016/j.jmb.2012.04.025; Sullivan BJ, 2011, J MOL BIOL, V413, P195, DOI 10.1016/j.jmb.2011.08.001; Tanwar AS, 2012, ACTA CRYSTALLOGR D, V68, P627, DOI 10.1107/S0907444912006543; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P16158, DOI 10.1021/bi991741j; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	45	19	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77781	10.1371/journal.pone.0077781	http://dx.doi.org/10.1371/journal.pone.0077781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223728	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300008
J	Zheng, H; Zhang, LN; Zhao, YR; Yang, D; Song, FJ; Wen, Y; Hao, Q; Hu, ZB; Zhang, W; Chen, KX				Zheng, Hong; Zhang, Lina; Zhao, Yanrui; Yang, Da; Song, Fengju; Wen, Yang; Hao, Quan; Hu, Zhibin; Zhang, Wei; Chen, Kexin			Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer	PLOS ONE			English	Article							MICRORNA SIGNATURES; SERUM; LET-7; EXPRESSION; TARGETS; MARKER; CHEMOTHERAPY; REPRESSION; CARCINOMA; PROFILES	Background: Most (70%) epithelial ovarian cancers (EOCs) are diagnosed late. Non-invasive biomarkers that facilitate disease detection and predict outcome are needed. The microRNAs (miRNAs) represent a new class of biomarkers. This study was to identify and validate plasma miRNAs as biomarkers in EOC. Methodology/Principal Findings: We evaluated plasma samples of 360 EOC patients and 200 healthy controls from two institutions. All samples were grouped into screening, training and validation sets. We scanned the circulating plasma miRNAs by TaqMan low-density array in the screening set and identified/validated miRNA markers by real-time polymerase chain reaction assay in the training set. Receiver operating characteristic and logistic regression analyses established the diagnostic miRNA panel, which were confirmed in the validation sets. We found higher plasma miR-205 and lower let-7f expression in cases than in controls. MiR-205 and let-7f together provided high diagnostic accuracy for EOC, especially in patients with stage I disease. The combination of these two miRNAs and carbohydrate antigen-125 (CA-125) further improved the accuracy of detection. MiR-483-5p expression was elevated in stages III and IV compared with in stages I and II, which was consistent with its expression pattern in tumor tissues. Furthermore, lower levels of let-7f were predictive of poor prognosis in EOC patients. Conclusions/Significance: Our findings indicate that plasma miR-205 and let-7f are biomarkers for ovarian cancer detection that complement CA-125; let-7f may be predictive of ovarian cancer prognosis.	[Zheng, Hong; Zhao, Yanrui; Song, Fengju; Chen, Kexin] Tianjin Med Univ Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Zheng, Hong; Zhang, Lina; Zhao, Yanrui; Song, Fengju; Hao, Quan; Chen, Kexin] Tianjin Med Univ, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhang, Lina] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Oncol, Tianjin, Peoples R China; [Yang, Da; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wen, Yang; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Hao, Quan] Tianjin Med Univ Canc Inst & Hosp, Dept Gynaecol Oncol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of Texas System; UTMD Anderson Cancer Center; Nanjing Medical University; Tianjin Medical University	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	wzhang@mdanderson.org; chenkexin1963@yahoo.com		Yang, Da/0000-0002-8336-9457; Chen, Kexin/0000-0003-4248-7681	National Natural Science Foundation of China [81072363]; program for Changjiang Scholars and Innovative Research Team at the University in China [IRT1076]; National Key Scientific and Technological Project [2011ZX09307-001-04]; Tianjin Science and Technology Committee Foundation [09ZCZDSF04700]; Tianjin Center; US National Foundation for Cancer Research; Diane Denson Tobola Fellowship in Ovarian Cancer Research fellowship; Harold C. and Mary L. Daily Endowment Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang Scholars and Innovative Research Team at the University in China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Scientific and Technological Project; Tianjin Science and Technology Committee Foundation; Tianjin Center; US National Foundation for Cancer Research; Diane Denson Tobola Fellowship in Ovarian Cancer Research fellowship; Harold C. and Mary L. Daily Endowment Fund	This work was supported partially by the National Natural Science Foundation of China (Grants 81072363), the program for Changjiang Scholars and Innovative Research Team at the University in China (Grant IRT1076), the National Key Scientific and Technological Project (Grant 2011ZX09307-001-04), and the Tianjin Science and Technology Committee Foundation (Grant 09ZCZDSF04700). The tissue bank is jointly supported by the Tianjin Center and the US National Foundation for Cancer Research. D.Y. is an Odyssey Fellow at MD Anderson Cancer Center, and supported by The Diane Denson Tobola Fellowship in Ovarian Cancer Research fellowship and The Harold C. and Mary L. Daily Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FY, 1996, J CLIN ONCOL, V14, P2968, DOI 10.1200/JCO.1996.14.11.2968; Bakouboula B, 2008, AM J RESP CRIT CARE, V177, P536, DOI 10.1164/rccm.200706-840OC; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Eisenhauer EA, 1997, ANN ONCOL, V8, P963, DOI 10.1023/A:1008240421028; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kong XY, 2010, WORLD J GASTROENTERO, V16, P4599, DOI 10.3748/wjg.v16.i36.4599; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moss EL, 2005, J CLIN PATHOL, V58, P308, DOI 10.1136/jcp.2004.018077; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Rustin GJS, 1996, J CLIN ONCOL, V14, P1545, DOI 10.1200/JCO.1996.14.5.1545; Rustin GJS, 2001, J CLIN ONCOL, V19, P4054, DOI 10.1200/JCO.2001.19.20.4054; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Silva J, 2011, EUR RESPIR J, V37, P617, DOI 10.1183/09031936.00029610; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; White NM, 2010, BIOL CHEM, V391, P411, DOI 10.1515/BC.2010.041; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105	54	137	148	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77853	10.1371/journal.pone.0077853	http://dx.doi.org/10.1371/journal.pone.0077853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223734	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300011
J	Matsumoto, J; Urakawa, S; Takamura, Y; Malcher-Lopes, R; Hori, E; Tomaz, C; Ono, T; Nishijo, H				Matsumoto, Jumpei; Urakawa, Susumu; Takamura, Yusaku; Malcher-Lopes, Renato; Hori, Etsuro; Tomaz, Carlos; Ono, Taketoshi; Nishijo, Hisao			A 3D-Video-Based Computerized Analysis of Social and Sexual Interactions in Rats	PLOS ONE			English	Article							MOTION CAPTURE; BEHAVIOR; MODULATION; TRACKING	A large number of studies have analyzed social and sexual interactions between rodents in relation to neural activity. Computerized video analysis has been successfully used to detect numerous behaviors quickly and objectively; however, to date only 2D video recording has been used, which cannot determine the 3D locations of animals and encounters difficulties in tracking animals when they are overlapping, e. g., when mounting. To overcome these limitations, we developed a novel 3D video analysis system for examining social and sexual interactions in rats. A 3D image was reconstructed by integrating images captured by multiple depth cameras at different viewpoints. The 3D positions of body parts of the rats were then estimated by fitting skeleton models of the rats to the 3D images using a physics-based fitting algorithm, and various behaviors were recognized based on the spatio-temporal patterns of the 3D movements of the body parts. Comparisons between the data collected by the 3D system and those by visual inspection indicated that this system could precisely estimate the 3D positions of body parts for 2 rats during social and sexual interactions with few manual interventions, and could compute the traces of the 2 animals even during mounting. We then analyzed the effects of AM-251 (a cannabinoid CB1 receptor antagonist) on male rat sexual behavior, and found that AM-251 decreased movements and trunk height before sexual behavior, but increased the duration of head-head contact during sexual behavior. These results demonstrate that the use of this 3D system in behavioral studies could open the door to new approaches for investigating the neuroscience of social and sexual behavior.	[Matsumoto, Jumpei; Urakawa, Susumu; Takamura, Yusaku; Hori, Etsuro; Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Ono, Taketoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Judo Neurophysiotherapy, Toyama 930, Japan; [Malcher-Lopes, Renato; Tomaz, Carlos] Univ Brasilia, Ctr Primate, Brasilia, DF, Brazil; [Malcher-Lopes, Renato; Tomaz, Carlos] Univ Brasilia, Lab Neurosci & Behav, Dept Physiol Sci, Inst Biol, Brasilia, DF, Brazil	University of Toyama; University of Toyama; Universidade de Brasilia; Universidade de Brasilia	Nishijo, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	nishijo@med.u-toyama.ac.jp	Malcher-Lopes, Renato/I-5170-2015; Tomaz, Carlos A B/F-8626-2012	Matsumoto, Jumpei/0000-0003-4729-2816	Japan Society for the Promotion of Science Asian Core Program; Ministry of Education, Science, Sports and Culture [22240051, 25290005, 25830006]	Japan Society for the Promotion of Science Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (A) (22240051), (B) (25290005) and a Grant-in-Aid for Young Scientists (B) (25830006). No additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmo A., 2007, FUNCTIONAL DYSFUNCTI; de Chaumont F., 2009, P IEEE INT S BIOM IM; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Gorzalka BB, 2008, PSYCHOPHARMACOLOGY, V198, P479, DOI 10.1007/s00213-007-0901-1; Gorzalka BB, 2010, HORM BEHAV, V58, P91, DOI 10.1016/j.yhbeh.2009.08.009; Hull EM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P5; Ji XF, 2010, IEEE T SYST MAN CY C, V40, P13, DOI 10.1109/TSMCC.2009.2027608; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Lai PL, 2011, 2012 INT C IM PROC C; Liu YB, 2011, PROC CVPR IEEE, P1249, DOI 10.1109/CVPR.2011.5995424; Martinez-Gonzalez D, 2004, NEUROSCI LETT, V364, P1, DOI 10.1016/j.neulet.2004.03.080; Matsumoto J, 2012, J NEUROSCI, V32, P1672, DOI 10.1523/JNEUROSCI.5140-11.2012; Micilotta AS, 2006, LECT NOTES COMPUT SC, V3953, P139, DOI 10.1007/11744078_11; Moeslund TB, 2001, COMPUT VIS IMAGE UND, V81, P231, DOI 10.1006/cviu.2000.0897; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Ou-Yang TH, 2011, J NEUROSCI METH, V201, P116, DOI 10.1016/j.jneumeth.2011.07.019; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Stoll C, 2011, IEEE I CONF COMP VIS, P951, DOI 10.1109/ICCV.2011.6126338; Trezza V, 2008, PSYCHOPHARMACOLOGY, V197, P217, DOI 10.1007/s00213-007-1025-3	21	45	45	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78460	10.1371/journal.pone.0078460	http://dx.doi.org/10.1371/journal.pone.0078460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205238	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500122
J	Berecki-Gisolf, J; Sheldon, A; Wieling, W; van Dijk, N; Costantino, G; Furlan, R; Shen, WK; Sheldon, R				Berecki-Gisolf, Janneke; Sheldon, Aaron; Wieling, Wouter; van Dijk, Nynke; Costantino, Giorgio; Furlan, Raffaello; Shen, Win-Kuang; Sheldon, Robert			Identifying Cardiac Syncope Based on Clinical History: A Literature-Based Model Tested in Four Independent Datasets	PLOS ONE			English	Article							TERM SERIOUS OUTCOMES; RISK-STRATIFICATION; EMERGENCY-DEPARTMENT; VASOVAGAL SYNCOPE; HEART-DISEASE; VENTRICULAR-TACHYCARDIA; MEDICAL-STUDENTS; TRANSIENT LOSS; GUIDELINES; MECHANISM	Background: We aimed to develop and test a literature-based model for symptoms that associate with cardiac causes of syncope. Methods and Results: Seven studies (the derivation sample) reporting >= 2 predictors of cardiac syncope were identified (4 Italian, 1 Swiss, 1 Canadian, and 1 from the United States). From these, 10 criteria were identified as diagnostic predictors. The conditional probability of each predictor was calculated by summation of the reported frequencies. A model of conditional probabilities and a priori probabilities of cardiac syncope was constructed. The model was tested in four datasets of patients with syncope (the test sample) from Calgary (n=670; 21% had cardiac syncope), Amsterdam (n=503; 9%), Milan (n=689; 5%) and Rochester (3877; 11%). In the derivation sample ten variables were significantly associated with cardiac syncope: age, gender, structural heart disease, low number of spells, brief or absent prodrome, supine syncope, effort syncope, and absence of nausea, diaphoresis and blurred vision. Fitting the test datasets to the full model gave C- statistics of 0.87 (Calgary), 0.84 (Amsterdam), 0.72 (Milan) and 0.71 (Rochester). Model sensitivity and specificity were 92% and 68% for Calgary, 86% and 67% for Amsterdam, 76% and 59% for Milan, and 73% and 52% for Rochester. A model with 5 variables (age, gender, structural heart disease, low number of spells, and lack of prodromal symptoms) was as accurate as the total set. Conclusion: A simple literature-based Bayesian model of historical criteria can distinguish patients with cardiac syncope from other patients with syncope with moderate accuracy.	[Berecki-Gisolf, Janneke; Sheldon, Robert] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Sheldon, Aaron] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Wieling, Wouter] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [van Dijk, Nynke] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Costantino, Giorgio; Furlan, Raffaello] Univ Milan, Syncope Unit, L Sacco Hosp, Milan, Italy; [Shen, Win-Kuang] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Milan; Luigi Sacco Hospital; Mayo Clinic	Berecki-Gisolf, J (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.	janneke.berecki-gisolf@monash.edu	costantino, giorgio/AAC-6441-2022; Furlan, Raffaello/AAH-3167-2021	costantino, giorgio/0000-0002-6391-3849; Furlan, Raffaello/0000-0001-5209-6786; van Dijk, Nynke/0000-0001-7959-5649				Alboni P, 2001, J AM COLL CARDIOL, V37, P1921, DOI 10.1016/S0735-1097(01)01241-4; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Brignole M, 2005, EUROPACE, V7, P14, DOI 10.1016/j.eupc.2004.11.001; Brignole M, 2001, CIRCULATION, V104, P2045, DOI 10.1161/hc4201.097837; CALKINS H, 1995, AM J MED, V98, P365, DOI 10.1016/S0002-9343(99)80315-5; Chen LY, 2003, MAYO CLIN PROC, V78, P414, DOI 10.4065/78.4.414; Colman N, 2004, CLIN AUTON RES, V14, P9, DOI 10.1007/s10286-004-1003-3; Costantino G, 2008, J AM COLL CARDIOL, V51, P276, DOI 10.1016/j.jacc.2007.08.059; Del Rosso A, 2008, HEART, V94, P1620, DOI 10.1136/hrt.2008.143123; Del Rosso A, 2005, AM J CARDIOL, V96, P1431, DOI 10.1016/j.amjcard.2005.07.047; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 2001, J AM MED ASS, V285, P2486; Galizia G, 2009, J AM GERIATR SOC, V57, P18, DOI 10.1111/j.1532-5415.2008.02070.x; Ganzeboom KS, 2003, AM J CARDIOL, V91, P1006, DOI 10.1016/S0002-9149(03)00127-9; Grossman SA, 2007, J EMERG MED, V33, P233, DOI 10.1016/j.jemermed.2007.04.001; Iglesias JF, 2009, PACE, V32, pS202, DOI 10.1111/j.1540-8159.2008.02291.x; Krahn AD, 2012, J CARDIOVASC ELECTR, V23, P60, DOI 10.1111/j.1540-8167.2011.02185.x; Martin TP, 1997, ANN EMERG MED, V29, P459, DOI 10.1016/S0196-0644(97)70217-8; Menozzi C, 2002, CIRCULATION, V105, P2741, DOI 10.1161/01.CIR.0000018125.31973.87; Moya A, 2001, CIRCULATION, V104, P1261, DOI 10.1161/hc3601.095708; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Quinn JV, 2004, ANN EMERG MED, V43, P224, DOI 10.1016/S0196-0644(03)00823-0; Reed MJ, 2007, EMERG MED J, V24, P270, DOI 10.1136/emj.2006.042739; Reed MJ, 2010, J AM COLL CARDIOL, V55, P713, DOI 10.1016/j.jacc.2009.09.049; Saccilotto RT, 2011, CAN MED ASSOC J, V183, pE1116, DOI 10.1503/cmaj.101326; Serletis A, 2006, EUR HEART J, V27, P1965, DOI 10.1093/eurheartj/ehl147; Sheldon R, 2006, EUR HEART J, V27, P344, DOI 10.1093/eurheartj/ehi584; Sheldon R, 2002, J AM COLL CARDIOL, V40, P142, DOI 10.1016/S0735-1097(02)01940-X; Sheldon R, 2010, J CARDIOVASC ELECTR, V21, P1358, DOI 10.1111/j.1540-8167.2010.01835.x; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Sud S, 2009, HEART RHYTHM, V6, P238, DOI 10.1016/j.hrthm.2008.10.035; Sun BC, 2012, ACAD EMERG MED, V19, P694, DOI 10.1111/j.1553-2712.2012.01375.x; Thijs RD, 2008, NEUROLOGY, V71, P1713, DOI 10.1212/01.wnl.0000335165.68893.b0; van Dijk N, 2008, J CARDIOVASC ELECTR, V19, P48, DOI 10.1111/j.1540-8167.2007.00984.x	33	26	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75255	10.1371/journal.pone.0075255	http://dx.doi.org/10.1371/journal.pone.0075255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24223233	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200032
J	Hughes, JA; Phillips, G; Reed, P				Hughes, J. Antony; Phillips, Gordon; Reed, Phil			Brief Exposure to a Self-Paced Computer-Based Reading Programme and How It Impacts Reading Ability and Behaviour Problems	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; LITERACY; INTERVENTION; CHILDHOOD; STRENGTHS; READERS; SKILLS	Basic literacy skills underlie much future adult functioning, and are targeted in children through a variety of means. Children with reading problems were exposed either to a self-paced computer programme that focused on improving phonetic ability, or underwent a classroom-based reading intervention. Exposure was limited to 3 40-min sessions a week, for six weeks. The children were assessed in terms of their reading, spelling, and mathematics abilities, as well as for their externalising and internalising behaviour problems, before the programme commenced, and immediately after the programme terminated. Relative to the control group, the computer-programme improved reading by about seven months in boys (but not in girls), but had no impact on either spelling or mathematics. Children on the programme also demonstrated fewer externalising and internalising behaviour problems than the control group. The results suggest that brief exposure to a self-paced phonetic computer-teaching programme had some benefits for the sample.	[Hughes, J. Antony; Reed, Phil] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Phillips, Gordon] Glen Care Ctr, London, England	Swansea University	Reed, P (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	p.reed@swansea.ac.uk	Reed, Phil/H-7999-2019	Reed, Phil/0000-0002-8157-0747	Glen Care Centre	Glen Care Centre	The Glen Care Centre is a commercial business, and this commercial funder provided the funding for the employment of J. Antony Hughes to collect these data. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BOSTOCK S, 2012, BMJ OPEN, V344, pe1602, DOI DOI 10.1136/BMJ.E1602; Brooks G, 2006, EDUC STUD-UK, V32, P133, DOI 10.1080/03055690500416116; Cowling H, 1998, TOE TOE MULTISENSORY; Daly EJ, 2005, J APPL BEHAV ANAL, V38, P485, DOI 10.1901/jaba.2005.113-04; Department for Education and Skills, 2006, NAT PRIM STRAT; Department for Education and Skills. Skills for Life Survey, 2003, SKILLS LIF SURV NAT; Dugdale G., 2008, LITERACY CHANGES LIV; Eisenberger R, 1996, AM PSYCHOL, V51, P1153, DOI 10.1037/0003-066X.51.11.1153; Elliot C. D., 1996, BRIT ABILITY SCALES; Flora SR, 1999, PSYCHOL REC, V49, P3, DOI 10.1007/BF03395303; Given BK, 2008, BRAIN LANG, V106, P83, DOI 10.1016/j.bandl.2007.12.001; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Harford DP, 1994, J LEARNING DISABILIT, V27, P647; Hatcher P, 2001, SOUND LINKAGE; Hatcher PJ, 2004, J CHILD PSYCHOL PSYC, V45, P338, DOI 10.1111/j.1469-7610.2004.00225.x; Holmes W, 2012, PROCEDIA SOCIAL BEHA; Huffstetter M, 2010, J EDUC STUDENTS PLAC, V15, P279, DOI 10.1080/10824669.2010.532415; Johnston RS, 2003, INSIGHT, V17; Kohn A., 1993, PUNISHED REWARDS; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Lingard A. W., 1996, SUPPORT LEARNING, V11, P25; Macdonald P, 2010, SUPPORT LEARN, V25, P15, DOI 10.1111/j.1467-9604.2009.01434.x; Malmberg M, 2003, NORD J PSYCHIAT, V57, P357, DOI 10.1080/08039480310002697; MANN VA, 1993, J LEARN DISABIL, V26, P259, DOI 10.1177/002221949302600406; Morgan P. L., 2000, J LEARNING DISABILIT, V41, P417; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; National Center for Education Statistics, FAST FACTS DIST LEAR; O'Connor RE, 2000, READ WRIT, V13, P159, DOI 10.1023/A:1008134818771; Pool, 2006, ALPHA OMEGA; Rose J, 2006, ROSE REPORT; Saine NL, 2010, LEARN INDIVID DIFFER, V20, P402, DOI 10.1016/j.lindif.2010.06.004; Sattler JM, 1998, ASSESSMENT CHILDREN; Sharpies J, 2011, EFFECTIVE CLASSROOM; Skinner BF, 1954, HARVARD EDUC REV, V24, P86; Snowling MJ, 2012, INT J LANG COMM DIS, V47, P27, DOI 10.1111/j.1460-6984.2011.00081.x; STANOVICH KE, 1986, READ RES QUART, V21, P360, DOI 10.1598/RRQ.21.4.1; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; van Lier PAC, 2012, CHILD DEV, V83, P1775, DOI 10.1111/j.1467-8624.2012.01802.x; WAGNER RK, 1993, J EDUC PSYCHOL, V85, P83, DOI 10.1037/0022-0663.85.1.83; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wigfield A, 1997, J EDUC PSYCHOL, V89, P420, DOI 10.1037/0022-0663.89.3.420	41	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77867	10.1371/journal.pone.0077867	http://dx.doi.org/10.1371/journal.pone.0077867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223125	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200017
J	Li, SN; Yu, W; Lai, CTM; Wong, SJ; Cheung, YF				Li, Shu-na; Yu, Wei; Lai, Clare Tik-man; Wong, Sophia J.; Cheung, Yiu-fai			Left Ventricular Mechanics in Repaired Tetralogy of Fallot with and without Pulmonary Valve Replacement: Analysis by Three-Dimensional Speckle Tracking Echocardiography	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; WALL-MOTION ANALYSIS; SURGICAL REPAIR; MYOCARDIAL MECHANICS; TWIST MECHANICS; STRAIN; ADULTS; HEART; REGURGITATION; DYSSYNCHRONY	Background: Altered septal curvature and left ventricular (LV) geometry secondary to right ventricular (RV) dilation render two-dimensional assessment of LV mechanics difficult in repaired tetralogy of Fallot (TOF) patients. The novel three-dimensional (3D) speckle tracking echocardiography enables comprehensive evaluation of true 3D LV mechanics. Methods and Results: Seventy-six patients aged 23.6 +/- 8.3 years, 55 with isolated repair (group I) and 21 with subsequent pulmonary valve replacement (group II), and 34 healthy controls were studied. Three-dimensional volume datasets were acquired for assessment of LV global and regional 3D strain, systolic dyssynchrony index (SDI), twist, twist gradient (twist/LV length), and ejection fraction. A global performance index was calculated as (global 3D strain.twist gradient)/SDI. The septal curvature and LV eccentricity were determined from the mid-ventricular short-axis. Compared with controls, group I and II patients had significantly reduced LV global 3D strain, LV twist, twist gradient, septal curvature, and global performance index, and greater LV systolic and diastolic eccentricity and SDI (all p<0.05). All but the four apical LV segments in patients had reduced regional 3D strain compared with controls (all p<0.05). Septal curvature correlated with LV global 3D strain (r = 0.41, p<0.001), average septal strain (r = 0.38, p<0.001), twist (r = 0.32, p<0.001), twist gradient (r = 0.33, p<0.001), and global performance index (r = 0.43, p<0.001). Conclusions: Adverse 3D LV mechanics as characterized by impaired global and regional 3D systolic strain, mechanical dyssynchrony, and reduced twist is related to reduced septal curvature in repaired TOF patients with and without pulmonary valve replacement.	[Li, Shu-na; Yu, Wei; Lai, Clare Tik-man; Wong, Sophia J.; Cheung, Yiu-fai] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Div Paediat Cardiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Cheung, YF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Div Paediat Cardiol, Hong Kong, Hong Kong, Peoples R China.	xfcheung@hku.hk	Cheung, Yiu Fai/C-4240-2009	Cheung, Yiu Fai/0000-0002-7279-4992	Research Grants Council General Research Fund of the Hong Kong Special Administrative Region, China [HKU 763710M]	Research Grants Council General Research Fund of the Hong Kong Special Administrative Region, China	The study was funded by Research Grants Council General Research Fund of the Hong Kong Special Administrative Region, China (Project no. HKU 763710M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Rahman MY, 2005, J AM COLL CARDIOL, V45, P915, DOI 10.1016/j.jacc.2004.11.049; Ashraf M, 2010, JACC-CARDIOVASC IMAG, V3, P227, DOI 10.1016/j.jcmg.2009.09.027; Babu-Narayan SV, 2006, CIRCULATION, V113, P405, DOI 10.1161/CIRCULATIONAHA.105.548727; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chalard A, 2012, AM J CARDIOL, V110, P1828, DOI 10.1016/j.amjcard.2012.08.017; Cheung EWY, 2009, AM J CARDIOL, V104, P1264, DOI 10.1016/j.amjcard.2009.06.043; Cheung EWY, 2010, AM J CARDIOL, V106, P552, DOI 10.1016/j.amjcard.2010.03.065; Cheung YF, 2012, NAT REV CARDIOL, V9, P644, DOI 10.1038/nrcardio.2012.128; Cheung YF, 2011, CIRC J, V75, P1735, DOI 10.1253/circj.CJ-10-1253; Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4; DELORGERIL M, 1984, BRIT HEART J, V52, P536; Diller GP, 2012, CIRCULATION, V125, P2440, DOI 10.1161/CIRCULATIONAHA.111.086983; Fernandes FP, 2012, J AM SOC ECHOCARDIOG, V25, P494, DOI 10.1016/j.echo.2012.01.014; Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825; GATZOULIS MA, 1995, CIRCULATION, V92, P231, DOI 10.1161/01.CIR.92.2.231; Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045; Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Hayabuchi Y, 2011, J AM SOC ECHOCARDIOG, V24, P1205, DOI 10.1016/j.echo.2011.06.016; Henson RE, 2000, AM J PHYSIOL-HEART C, V278, pH1117, DOI 10.1152/ajpheart.2000.278.4.H1117; Hristov N, 2006, EUR J CARDIO-THORAC, V29, pS115, DOI 10.1016/j.ejcts.2006.02.041; Kim HK, 2006, AM J CARDIOL, V98, P236, DOI 10.1016/j.amjcard.2006.01.082; Li SN, 2011, J AM SOC ECHOCARDIOG, V24, P819, DOI 10.1016/j.echo.2011.03.020; Li W, 2004, AM HEART J, V147, P165, DOI 10.1016/S0002-8703(03)00527-1; Liang XC, 2008, AM J CARDIOL, V102, P1731, DOI 10.1016/j.amjcard.2008.07.062; Lurz P, 2011, J AM COLL CARDIOL, V57, P724, DOI 10.1016/j.jacc.2010.07.056; Moiduddin N, 2012, CONGENIT HEART DIS, V7, P361, DOI 10.1111/j.1747-0803.2012.00680.x; Moses DA, 2004, MAGN RESON MED, V52, P154, DOI 10.1002/mrm.20105; Muzzarelli S, 2011, RADIOLOGY, V259, P375, DOI 10.1148/radiol.10100895; Nakasato M, 1997, INT J CARDIOL, V58, P127, DOI 10.1016/S0167-5273(96)02868-9; Niezen RA, 1999, HEART, V82, P697, DOI 10.1136/hrt.82.6.697; de Isla LP, 2009, J AM SOC ECHOCARDIOG, V22, P325, DOI 10.1016/j.echo.2009.01.001; Raedle-Hurst TM, 2009, AM HEART J, V157, P791, DOI 10.1016/j.ahj.2008.12.015; Roeleveld RJ, 2005, RADIOLOGY, V234, P710, DOI 10.1148/radiol.2343040151; Santamore WP, 1998, PROG CARDIOVASC DIS, V40, P289, DOI 10.1016/S0033-0620(98)80049-2; Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P366, DOI 10.1016/j.jcmg.2008.02.006; Seo Y, 2009, CIRC-CARDIOVASC IMAG, V2, P451, DOI 10.1161/CIRCIMAGING.109.858480; Takayasu H, 2011, ECHOCARDIOGR-J CARD, V28, P720, DOI 10.1111/j.1540-8175.2011.01417.x; Tanaka H, 2010, AM J CARDIOL, V105, P235, DOI 10.1016/j.amjcard.2009.09.010; Thebault C, 2011, EUR J ECHOCARDIOGR, V12, P26, DOI 10.1093/ejechocard/jeq095; Tobler D, 2012, INT J CARDIOL, V160, P165, DOI 10.1016/j.ijcard.2011.04.007; Tzemos N, 2009, AM J CARDIOL, V103, P420, DOI 10.1016/j.amjcard.2008.09.101; van der Hulst AE, 2010, AM J CARDIOL, V106, P723, DOI 10.1016/j.amjcard.2010.04.032; Weidemann F, 2002, AM J CARDIOL, V90, P133, DOI 10.1016/S0002-9149(02)02435-9	44	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78826	10.1371/journal.pone.0078826	http://dx.doi.org/10.1371/journal.pone.0078826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223166	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200058
J	Glover, JD; Taylor, L; Sherman, A; Zeiger-Poli, C; Sang, HM; McGrew, MJ				Glover, James D.; Taylor, Lorna; Sherman, Adrian; Zeiger-Poli, Caroline; Sang, Helen M.; McGrew, Michael J.			A Novel Piggybac Transposon Inducible Expression System Identifies a Role for Akt Signalling in Primordial Germ Cell Migration	PLOS ONE			English	Article							CONDITIONAL RNA INTERFERENCE; PLURIPOTENT STEM-CELLS; STUDYING GENE-FUNCTION; MAMMALIAN-CELLS; FLUORESCENT PROTEINS; TRANSGENIC CHICKENS; MICE; MOUSE; EMBRYO; TOOL	In this work, we describe a single piggyBac transposon system containing both a tet-activator and a doxycycline-inducible expression cassette. We demonstrate that a gene product can be conditionally expressed from the integrated transposon and a second gene can be simultaneously targeted by a short hairpin RNA contained within the transposon, both in vivo and in mammalian and avian cell lines. We applied this system to stably modify chicken primordial germ cell (PGC) lines in vitro and induce a reporter gene at specific developmental stages after injection of the transposon-modified germ cells into chicken embryos. We used this vector to express a constitutively-active AKT molecule during PGC migration to the forming gonad. We found that PGC migration was retarded and cells could not colonise the forming gonad. Correct levels of AKT activation are thus essential for germ cell migration during early embryonic development.	[McGrew, Michael J.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	McGrew, MJ (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh EH8 9YL, Midlothian, Scotland.	mike.mcgrew@roslin.ed.ac.uk		Glover, James/0000-0003-4678-5643	Biotechnology and Biological Sciences Research Council; BBSRC [BB/H023593/1]; BBSRC [BBS/E/D/20320000, BBS/E/R/00001607, BBS/E/D/20221658] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001607, BB/H023593/1, BBS/E/D/20320000, BBS/E/D/20221658] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by Institute Strategic Grant funding from the Biotechnology and Biological Sciences Research Council and BBSRC grant no. BB/H023593/1 to H. M. S. and M.J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Dumstrei K, 2004, J CELL SCI, V117, P4787, DOI 10.1242/jcs.01362; Farini D, 2007, DEV BIOL, V306, P572, DOI 10.1016/j.ydbio.2007.03.031; Glover JD, 2012, J POULT SCI, V49, P155, DOI 10.2141/jpsa.011161; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Gu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025984; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hunter CV, 2005, TRENDS MOL MED, V11, P293, DOI 10.1016/j.molmed.2005.04.001; Jang CW, 2007, CSH PROTOC; Kappel S, 2007, NAT PROTOC, V2, P3257, DOI 10.1038/nprot.2007.458; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Ko JK, 2011, FASEB J, V25, P2638, DOI 10.1096/fj.11-181560; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li ZJ, 2013, P NATL ACAD SCI USA, V110, P5004, DOI 10.1073/pnas.1218620110; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Lu YY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp686; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; McJunkin K, 2011, P NATL ACAD SCI USA, V108, P7113, DOI 10.1073/pnas.1104097108; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Raz E, 2004, CURR OPIN CELL BIOL, V16, P169, DOI 10.1016/j.ceb.2004.01.004; Saridey SK, 2009, MOL THER, V17, P2115, DOI 10.1038/mt.2009.234; Serralbo O, 2013, GENESIS, V51, P372, DOI 10.1002/dvg.22388; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherman A, 1998, NAT BIOTECHNOL, V16, P1050, DOI 10.1038/3497; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sisson TH, 2006, AM J RESP CELL MOL, V34, P552, DOI 10.1165/rcmb.2005-0378OC; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Takahashi Y, 2008, METHOD CELL BIOL, V87, P271, DOI 10.1016/S0091-679X(08)00214-8; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wick G, 2006, ADV IMMUNOL, V92, P71, DOI 10.1016/S0065-2776(06)92002-1; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028	54	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77222	10.1371/journal.pone.0077222	http://dx.doi.org/10.1371/journal.pone.0077222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223709	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400009
J	Merritt, KE; Bachtell, RK				Merritt, Kathryn E.; Bachtell, Ryan K.			Initial D-2 Dopamine Receptor Sensitivity Predicts Cocaine Sensitivity and Reward in Rats	PLOS ONE			English	Article							INDUCED LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS NEURONS; CHRONIC MILD STRESS; INDIVIDUAL-DIFFERENCES; BINDING CHARACTERISTICS; SEEKING BEHAVIOR; DRUG-ABUSE; VULNERABILITY; SENSITIZATION; AGONISTS	The activation of dopamine receptors within the mesolimbic dopamine system is known to be involved in the initiation and maintenance of cocaine use. Expression of the D-2 dopamine receptor subtype has been implicated as both a predisposing factor and consequence of chronic cocaine use. It is unclear whether there is a predictive relationship between D-2 dopamine receptor function and cocaine sensitivity that would enable cocaine abuse. Therefore, we exploited individual differences in behavioral responses to D2 dopamine receptor stimulation to test its relationship with cocaine-mediated behaviors. Outbred, male Sprague-Dawley rats were initially characterized by their locomotor responsiveness to the D-2 dopamine receptor agonist, quinpirole, in a within-session ascending dose-response regimen (0, 0.1, 0.3 & 1.0 mg/kg, sc). Rats were classified as high or low quinpirole responders (HD2 and LD2, respectively) by a median split of their quinpirole-induced locomotor activity. Rats were subsequently tested for differences in the psychostimulant effects of cocaine by measuring changes in cocaine-induced locomotor activity (5 and 15 mg/kg, ip). Rats were also tested for differences in the development of conditioned place preference to a low dose of cocaine (7.5mg/kg, ip) that does not reliably produce a cocaine conditioned place preference. Finally, rats were tested for acquisition of cocaine self-administration and maintenance responding on fixed ratio 1 and 5 schedules of reinforcement, respectively. Results demonstrate that HD2 rats have enhanced sensitivity to the locomotor stimulating properties of cocaine, display greater cocaine conditioned place preference, and self-administer more cocaine compared to LD2 animals. These findings suggest that individual differences in D-2 dopamine receptor sensitivity may be predictive of cocaine sensitivity and reward.	[Merritt, Kathryn E.; Bachtell, Ryan K.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Bachtell, Ryan K.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Bachtell, Ryan K.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Bachtell, RK (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	Ryan.Bachtell@Colorado.edu	Bachtell, Ryan/H-7436-2013	Bachtell, Ryan/0000-0001-5268-5927; Merritt, Kathryn/0000-0002-5016-1510	CU Innovative Seed Grant;  [R03 DA 029420]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA029240] Funding Source: NIH RePORTER	CU Innovative Seed Grant; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by R03 DA 029420; CU Innovative Seed Grant. The funders had no role in study design, data collection and analysis, decision	Allen RM, 2007, PHARMACOL BIOCHEM BE, V86, P37, DOI 10.1016/j.pbb.2006.12.005; Anderson SM, 2005, PHARMACOL THERAPEUT, V106, P389, DOI 10.1016/j.pharmthera.2004.12.004; Bachtell RK, 2005, PSYCHOPHARMACOLOGY, V183, P41, DOI 10.1007/s00213-005-0133-1; Bachtell RK, 2008, EUR J NEUROSCI, V27, P2229, DOI 10.1111/j.1460-9568.2008.06199.x; Bailey A, 2008, EUR J NEUROSCI, V28, P759, DOI 10.1111/j.1460-9568.2008.06369.x; Briand LA, 2008, EUR NEUROPSYCHOPHARM, V18, P551, DOI 10.1016/j.euroneuro.2008.01.002; Cabib S, 1998, NEUROSCIENCE, V84, P193, DOI 10.1016/S0306-4522(97)00468-5; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Carr KD, 2001, PSYCHOPHARMACOLOGY, V154, P420, DOI 10.1007/s002130000674; Collins GT, 2011, PSYCHOPHARMACOLOGY, V215, P609, DOI 10.1007/s00213-010-2154-7; De Vries TJ, 1999, PSYCHOPHARMACOLOGY, V143, P254, DOI 10.1007/s002130050944; Del Arco A, 2004, PSYCHOPHARMACOLOGY, V171, P148, DOI 10.1007/s00213-003-1578-8; DEMINIERE JM, 1989, NEUROSCI BIOBEHAV R, V13, P141, DOI 10.1016/S0149-7634(89)80023-5; Dias C, 2004, PSYCHOPHARMACOLOGY, V175, P414, DOI 10.1007/s00213-004-1839-1; Dziedzicka-Wasylewska M, 1997, BEHAV PHARMACOL, V8, P607, DOI 10.1097/00008877-199711000-00017; Edwards S, 2007, NEUROPSYCHOPHARMACOL, V32, P354, DOI 10.1038/sj.npp.1301062; EILAM D, 1989, EUR J PHARMACOL, V161, P151, DOI 10.1016/0014-2999(89)90837-6; Fattore L, 2009, NEUROPSYCHOPHARMACOL, V34, P1091, DOI 10.1038/npp.2008.43; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Giorgi O, 2007, NEUROSCI BIOBEHAV R, V31, P148, DOI 10.1016/j.neubiorev.2006.07.008; Grant KA, 1998, SYNAPSE, V29, P80, DOI 10.1002/(SICI)1098-2396(199805)29:1<80::AID-SYN7>3.0.CO;2-7; Gulley JM, 2003, NEUROPSYCHOPHARMACOL, V28, P2089, DOI 10.1038/sj.npp.1300279; HENRY C, 1995, BRAIN RES, V685, P179, DOI 10.1016/0006-8993(95)00430-X; HOOKS MS, 1994, J NEUROSCI, V14, P6144; HOOKS MS, 1991, PHARMACOL BIOCHEM BE, V38, P467, DOI 10.1016/0091-3057(91)90308-O; HOOKS MS, 1994, PSYCHOPHARMACOLOGY, V116, P217; HU XT, 1988, BRAIN RES, V444, P389, DOI 10.1016/0006-8993(88)90953-5; Khroyan TV, 2000, J PHARMACOL EXP THER, V294, P680; KOSTRZEWA RM, 1991, LIFE SCI, V48, pPL129; KURASHIMA M, 1995, PHARMACOL BIOCHEM BE, V52, P503, DOI 10.1016/0091-3057(95)00103-4; Mandt B, 2008, PSYCHOPHARMACOLOGY, V201, P195, DOI 10.1007/s00213-008-1265-x; Marinelli M, 2000, J NEUROSCI, V20, P8876; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; O'Neill CE, 2012, NEUROPSYCHOPHARMACOL, V37, P1245, DOI 10.1038/npp.2011.312; PAPP M, 1994, PSYCHOPHARMACOLOGY, V115, P441, DOI 10.1007/BF02245566; PAPP M, 1993, PSYCHOPHARMACOLOGY, V110, P152, DOI 10.1007/BF02246965; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; PUGLISIALLEGRA S, 1991, LIFE SCI, V48, P1263, DOI 10.1016/0024-3205(91)90521-C; RILKE O, 1995, PHARMACOL BIOCHEM BE, V52, P23, DOI 10.1016/0091-3057(95)00093-C; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Sabeti J, 2003, J PHARMACOL EXP THER, V305, P180, DOI 10.1124/jpet.102.047258; Schmidt HD, 2006, NEUROSCIENCE, V142, P451, DOI 10.1016/j.neuroscience.2006.06.004; Schramm-Sapyta NL, 2011, PSYCHOPHARMACOLOGY, V215, P493, DOI 10.1007/s00213-011-2216-5; Seeman P, 2005, P NATL ACAD SCI USA, V102, P3513, DOI 10.1073/pnas.0409766102; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Thanos PK, 2008, SYNAPSE, V62, P481, DOI 10.1002/syn.20523; UJIKE H, 1990, PSYCHOPHARMACOLOGY, V102, P459, DOI 10.1007/BF02247125; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; WHITE FJ, 1986, J NEUROSCI, V6, P274	55	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78258	10.1371/journal.pone.0078258	http://dx.doi.org/10.1371/journal.pone.0078258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223783	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400045
J	Dobigny, G; Tatard, C; Gauthier, P; Ba, K; Duplantier, JM; Granjon, L; Kergoat, GJ				Dobigny, Gauthier; Tatard, Caroline; Gauthier, Philippe; Ba, Khalilou; Duplantier, Jean-Marc; Granjon, Laurent; Kergoat, Gael J.			Mitochondrial and Nuclear Genes-Based Phylogeography of Arvicanthis niloticus (Murinae) and Sub-Saharan Open Habitats Pleistocene History	PLOS ONE			English	Article							CLIMATE-CHANGE; RODENTIA MURIDAE; WEST-AFRICA; POPULATION-GENETICS; COMPLEX RODENTIA; EAST-AFRICA; EVOLUTION; REFUGIA; CONSERVATION; BIODIVERSITY	A phylogeographic study was conducted on the Nile grass rat, Arvicanthis niloticus, a rodent species that is tightly associated with open grasslands from the Sudano-Sahelian regions. Using one mitochondrial (cytochrome b) and one nuclear (intron 7 of Beta Fibrinogen) gene, robust patterns were retrieved that clearly show that (i) the species originated in East Africa concomitantly with expanding grasslands some 2 Ma, and (ii) four parapatric and genetically well-defined lineages differentiated essentially from East to West following Pleistocene bioclimatic cycles. This strongly points towards allopatric genetic divergence within savannah refuges during humid episodes, then dispersal during arid ones; secondary contact zones would have then stabilized around geographic barriers, namely, Niger River and Lake Chad basins. Our results pertinently add to those obtained for several other African rodent as well as non-rodent species that inhabit forests, humid zones, savannahs and deserts, all studies that now allow one to depict a more comprehensive picture of the Pleistocene history of the continent south of the Sahara. In particular, although their precise location remains to be determined, at least three Pleistocene refuges are identified within the West and Central African savannah biome.	[Dobigny, Gauthier; Gauthier, Philippe; Duplantier, Jean-Marc; Granjon, Laurent] IRD, CBGP, INRA, CIRAD,Montpellier SupAgro, Montferrier Sur Lez, France; [Dobigny, Gauthier] Ctr Reg Agrhymet, Niamey, Niger; [Tatard, Caroline; Kergoat, Gael J.] INRA, CBGP, IRD, CIRAD,Montpellier SupAgro, Montferrier Sur Lez, France; [Ba, Khalilou; Granjon, Laurent] IRD, CBGP, INRA, CIRAD,Montpellier SupAgro, Dakar, Senegal	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Kergoat, GJ (corresponding author), INRA, CBGP, IRD, CIRAD,Montpellier SupAgro, Campus Baillarguet, Montferrier Sur Lez, France.	kergoat@supagro.inra.fr	Granjon, Laurent/K-2111-2016; Kergoat, Gael J./AAW-6505-2020	Granjon, Laurent/0000-0003-1182-3793; Kergoat, Gael J./0000-0002-8284-6215; GAUTHIER, Philippe/0000-0001-8363-6845				Ahmed EHAR, 2008, BIOL J LINN SOC, V93, P641, DOI 10.1111/j.1095-8312.2007.00895.x; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, MOL ECOL, V7, P371, DOI 10.1046/j.1365-294x.1998.00391.x; Avise JC, 2008, SYST BIOL, V57, P503, DOI 10.1080/10635150802164587; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barlow A, 2013, MOL ECOL, V22, P1134, DOI 10.1111/mec.12157; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Baskevich M. I., 2000, BONN ZOOL MONOGR, V46, P209; Beatty GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-29; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Ben Faleh A, 2012, BIOL J LINN SOC, V107, P27, DOI 10.1111/j.1095-8312.2012.01920.x; Bobe R, 2004, PAL PAL PAL, V207, P309; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Brouat C, 2009, J BIOGEOGR, V36, P2237, DOI 10.1111/j.1365-2699.2009.02184.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Bryja J, 2010, MOL ECOL, V19, P4783, DOI 10.1111/j.1365-294X.2010.04847.x; Castiglia R, 2006, J ZOOL SYST EVOL RES, V44, P223, DOI 10.1111/j.1439-0469.2006.00356.x; Castiglia R, 2003, GENETICA, V118, P33, DOI 10.1023/A:1022903112274; Colangelo P, 2012, BIOL J LINN SOC, V108, P901; COLYN M, 1991, J BIOGEOGR, V18, P403, DOI 10.2307/2845482; Cowling SA, 2008, GLOBAL CHANGE BIOL, V14, P827, DOI 10.1111/j.1365-2486.2007.01524.x; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dobigny G, 2005, HEREDITY, V95, P358, DOI 10.1038/sj.hdy.6800730; Dobigny G, 2002, MAMMALIA, V66, P495, DOI 10.1515/mamm.2002.66.4.495; Dobigny G, 2001, COLLOQ SEMI, P445; Dobigny G, 2010, HEREDITY, V104, P378, DOI 10.1038/hdy.2009.119; Dobigny G, 2011, MAMM BIOL, V76, P417, DOI 10.1016/j.mambio.2010.10.002; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ducroz J. F., 2001, Journal of Mammalian Evolution, V8, P173, DOI 10.1023/A:1012277012303; Ducroz JF, 1997, J ZOOL, V241, P709, DOI 10.1111/j.1469-7998.1997.tb05743.x; Ducroz JF, 1998, MOL PHYLOGENET EVOL, V10, P104, DOI 10.1006/mpev.1997.0477; DUCROZ JF, 1998, THESIS MUSEUM NATL H; Duplantier JM, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P527, DOI 10.1007/978-4-431-36025-4_24; Dupont L, 2011, QUATERNARY SCI REV, V30, P3589, DOI 10.1016/j.quascirev.2011.09.019; Emerson BC, 2005, CURR BIOL, V15, pR367, DOI 10.1016/j.cub.2005.05.016; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Fontaine C, 2004, HEREDITY, V93, P639, DOI 10.1038/sj.hdy.6800591; Fu YX, 1997, GENETICS, V147, P915; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; GITHURE JI, 1986, ANN TROP MED PARASIT, V80, P501, DOI 10.1080/00034983.1986.11812056; Gomez C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-167; GRANJON L, 1992, ISRAEL J ZOOL, V38, P263; Granjon L, 2003, MAMMAL REV, V33, P77, DOI 10.1046/j.1365-2907.2003.00007.x; Granjon L., 2009, RONGEURS AFRIQUE SAH; Granjon L., 2013, MAMMALS AFRICA, VIII, P387; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, HEREDITY, V92, P1, DOI 10.1038/sj.hdy.6800365; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hima K, 2011, J ZOOL, V284, P276, DOI 10.1111/j.1469-7998.2011.00803.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Jacobs Louis L., 1994, National Science Museum Monographs, V8, P149; Julvez J, 1997, Med Trop (Mars), V57, P153; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lecompte E, 2002, J ZOOL SYST EVOL RES, V40, P8, DOI 10.1046/j.1439-0469.2002.00172.x; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; LEHOUEROU HN, 1992, J ARID ENVIRON, V22, P3; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Lorenzen ED, 2007, MOL ECOL, V16, P3241, DOI 10.1111/j.1365-294X.2007.03382.x; Lorenzen ED, 2006, MOL ECOL, V15, P3787, DOI 10.1111/j.1365-294X.2006.03059.x; Lorenzen ED, 2010, J BIOGEOGR, V37, P571, DOI 10.1111/j.1365-2699.2009.02207.x; Maddison WP, 2011, MESQUITE MODULAR SYS; Maley J., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P68; Maley J., 1980, SAHARA NILE PP, P63; Mardsen CD, 2012, MOL ECOL, V21, P1379; Matthee CA, 2002, MOL ECOL, V11, P465, DOI 10.1046/j.0962-1083.2001.01458.x; Mboumba JF, 2011, J ZOOL SYST EVOL RES, V49, P77, DOI 10.1111/j.1439-0469.2010.00579.x; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Mercier A, 2013, MEM I OSWALDO CRUZ, V108, P399, DOI 10.1590/S0074-0276108042013002; Miller JM, 2011, CONSERV GENET, V12, P423, DOI 10.1007/s10592-010-0149-x; Moodley Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000454; Morales-Hojas R, 2008, MOL ECOL, V17, P2910, DOI 10.1111/j.1365-294X.2008.03796.x; Mouline K, 2008, MOL ECOL, V17, P1036, DOI 10.1111/j.1365-294X.2007.03610.x; Musser GG, 2005, MAMMALS WORLD TAXONO, V2, P1285; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Nersting LG, 2001, MOL ECOL, V10, P711, DOI 10.1046/j.1365-294x.2001.01205.x; Nicolas V, 2008, MOL ECOL, V17, P5118, DOI 10.1111/j.1365-294X.2008.03974.x; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Nicolas V, 2008, J BIOGEOGR, V35, P2074, DOI 10.1111/j.1365-2699.2008.01950.x; Nicolas V, 2012, AFR ZOOL, V47, P100, DOI 10.3377/004.047.0119; Nicolas V, 2009, BIOL J LINN SOC, V98, P29, DOI 10.1111/j.1095-8312.2009.01273.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pease KM, 2009, MOL ECOL, V18, P1848, DOI 10.1111/j.1365-294X.2009.04112.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Poelchau MF, 2013, J BIOGEOGR, V40, P618, DOI 10.1111/j.1365-2699.2011.02599.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rohland N, 2005, MOL BIOL EVOL, V22, P2435, DOI 10.1093/molbev/msi244; SEBEK Z, 1989, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V33, P337; Seddon JM, 2001, MOL ECOL, V10, P2187, DOI 10.1046/j.0962-1083.2001.01357.x; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; Sezonlin M, 2006, MOL ECOL, V15, P407, DOI 10.1111/j.1365-294X.2005.02761.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; TAJIMA F, 1989, GENETICS, V123, P585; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; Trape JF, 1996, AM J TROP MED HYG, V54, P289, DOI 10.4269/ajtmh.1996.54.289; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Volobouev VT, 2002, CYTOGENET GENOME RES, V96, P261, DOI 10.1159/000063049; Volobouev VT, 2002, CYTOGENET GENOME RES, V96, P250, DOI 10.1159/000063041; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Winkler AJ, 2002, J HUM EVOL, V42, P237, DOI 10.1006/jhev.2001.0501; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	121	32	34	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77815	10.1371/journal.pone.0077815	http://dx.doi.org/10.1371/journal.pone.0077815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223730	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300009
J	Robert, JA; Pitt, C; Bonnett, TR; Yuen, MMS; Keeling, CI; Bohlmann, J; Huber, DPW				Robert, Jeanne A.; Pitt, Caitlin; Bonnett, Tiffany R.; Yuen, Macaire M. S.; Keeling, Christopher I.; Bohlmann, Joerg; Huber, Dezene P. W.			Disentangling Detoxification: Gene Expression Analysis of Feeding Mountain Pine Beetle Illuminates Molecular-Level Host Chemical Defense Detoxification Mechanisms	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE HOPKINS; GLUTATHIONE-S-TRANSFERASE; BARK BEETLE; PYREARINUS-TERMITILLUMINANS; HETEROLOGOUS EXPRESSION; INSECTICIDE RESISTANCE; FUNCTIONAL EXPRESSION; GROSMANNIA-CLAVIGERA; COLEOPTERA; IDENTIFICATION	The mountain pine beetle, Dendroctonus ponderosae, is a native species of bark beetle (Coleoptera: Curculionidae) that caused unprecedented damage to the pine forests of British Columbia and other parts of western North America and is currently expanding its range into the boreal forests of central and eastern Canada and the USA. We conducted a large-scale gene expression analysis (RNA-seq) of mountain pine beetle male and female adults either starved or fed in male-female pairs for 24 hours on lodgepole pine host tree tissues. Our aim was to uncover transcripts involved in coniferophagous mountain pine beetle detoxification systems during early host colonization. Transcripts of members from several gene families significantly increased in insects fed on host tissue including: cytochromes P450, glucosyl transferases and glutathione S-transferases, esterases, and one ABC transporter. Other significantly increasing transcripts with potential roles in detoxification of host defenses included alcohol dehydrogenases and a group of unexpected transcripts whose products may play an, as yet, undiscovered role in host colonization by mountain pine beetle.	[Robert, Jeanne A.; Pitt, Caitlin; Bonnett, Tiffany R.; Huber, Dezene P. W.] Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada; [Yuen, Macaire M. S.; Keeling, Christopher I.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	University of Northern British Columbia; University of British Columbia	Robert, JA (corresponding author), Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada.	jrobert@unbc.ca	Keeling, Christopher I./I-3371-2012; Huber, Dezene P.W./AAG-9638-2019	Keeling, Christopher I./0000-0001-7885-8558; Huber, Dezene P.W./0000-0002-6495-1759	Natural Science and Engineering Research Council of Canada (NSERC); Genome Canada; Genome British Columbia; Genome Alberta; Canada Research Chairs (CRC) Program; Canada Foundation for Innovation (CFI); British Columbia Knowledge Development Fund (BCKDF)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Genome British Columbia; Genome Alberta; Canada Research Chairs (CRC) Program(Canada Research Chairs); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); British Columbia Knowledge Development Fund (BCKDF)	This work was supported by the following: Natural Science and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship (http://www.nserc-crsng.gc.ca/index_eng.asp); Genome Canada (http://www.genomecanada.ca); Genome British Columbia (http://www.genomebc.ca); Genome Alberta (http://genomealberta.ca); Canada Research Chairs (CRC) Program (http://www.chairs-chaires.gc.ca); Canada Foundation for Innovation (CFI) (http://www.innovation.ca; and British Columbia Knowledge Development Fund (BCKDF) (http://www.aved.gov.bc.ca/researchandinnovation/Funding/BCKDF/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375, DOI 10.1073/pnas.89.21.10375; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aw T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-215; Barkawi LS, 2003, INSECT BIOCHEM MOLEC, V33, P773, DOI 10.1016/S0965-1748(03)00069-9; Barros MP, 1998, FREE RADICAL BIO MED, V24, P767, DOI 10.1016/S0891-5849(97)00335-3; Barros MP, 2001, INSECT BIOCHEM MOLEC, V31, P393, DOI 10.1016/S0965-1748(00)00132-6; Barros MP, 2000, PHOTOCHEM PHOTOBIOL, V71, P648, DOI 10.1562/0031-8655(2000)071&lt;0648:LAUMAA&gt;2.0.CO;2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blomquist GJ, 2010, INSECT BIOCHEM MOLEC, V40, P699, DOI 10.1016/j.ibmb.2010.07.013; Bonnett TR, 2012, INSECT BIOCHEM MOLEC, V42, P890, DOI 10.1016/j.ibmb.2012.08.003; BRATTSTEN LB, 1977, SCIENCE, V196, P1349, DOI 10.1126/science.196.4296.1349; British Columbia Ministry of Lands Forests and Natural Resource Operations, 2012, HIST BATTL MOUNT PIN; BUESA C, 1994, J BIOL CHEM, V269, P11707; Cano-Ramirez C, 2013, GENE, V520, P47, DOI 10.1016/j.gene.2012.11.059; Clark EL, 2012, ENVIRON ENTOMOL, V41, P392, DOI 10.1603/EN11295; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Day JC, 2004, LUMINESCENCE, V19, P8, DOI 10.1002/bio.749; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Feng QL, 2001, J INSECT PHYSIOL, V47, P1, DOI 10.1016/S0022-1910(00)00093-7; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Figueroa-Teran R, 2012, INSECT BIOCHEM MOLEC, V42, P81, DOI 10.1016/j.ibmb.2011.10.009; Francke W, 1996, BIOORGAN MED CHEM, V4, P363, DOI 10.1016/0968-0896(96)00013-2; Fraser JD, 2011, THESIS U N BRIT COLU; Gilg AB, 2005, P NATL ACAD SCI USA, V102, P9760, DOI 10.1073/pnas.0503277102; Gomi K, 2001, J BIOL CHEM, V276, P36508, DOI 10.1074/jbc.M105528200; Huang HS, 1998, INSECT BIOCHEM MOLEC, V28, P651, DOI 10.1016/S0965-1748(98)00049-6; Huber DPW, 2007, INSECT MOL BIOL, V16, P335, DOI 10.1111/j.1365-2583.2007.00731.x; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Keeling CI, 2006, INSECT MOL BIOL, V15, P207, DOI 10.1111/j.1365-2583.2006.00629.x; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lee S, 2006, CAN J FOREST RES, V36, P2864, DOI 10.1139/X06-194; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; LIBBEY LM, 1985, Z ANGEW ENTOMOL, V100, P381; Lopez MF, 2013, INSECT BIOCHEM MOLEC, V43, P417, DOI 10.1016/j.ibmb.2013.02.004; LYON R. L., 1958, CANADIAN ENT, V90, P582; Miller B, 2005, PLANT PHYSIOL, V137, P369, DOI 10.1104/pp.104.050187; Nealis V, 2009, BC10417 CAN FOR SERV; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pureswaran DS, 2004, CHEMOECOLOGY, V14, P59, DOI 10.1007/s00049-003-0261-1; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; REID R. W., 1958, CANADIAN ENT, V90, P464; Roth CW, 2003, MOL CELLS, V15, P150; Sandstrom P, 2006, INSECT BIOCHEM MOLEC, V36, P835, DOI 10.1016/j.ibmb.2006.08.004; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schneider R. R., 2010, International Journal of Forestry Research, V2010, P417595, DOI 10.1155/2010/417595; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SHRIMPTON DM, 1973, CAN J BOT, V51, P527, DOI 10.1139/b73-064; Song MM, 2013, INSECT BIOCHEM MOLEC, V43, P336, DOI 10.1016/j.ibmb.2013.01.003; Syvanen M, 1996, J MOL EVOL, V43, P236, DOI 10.1007/PL00006082; Tittiger C, 2005, RECENT ADV PHYTOCHEM, V39, P57; VANDERWEL D, 1992, J CHEM ECOL, V18, P1389, DOI 10.1007/BF00994364; Volney WJA, 2000, AGR ECOSYST ENVIRON, V82, P283, DOI 10.1016/S0167-8809(00)00232-2; VONRUDLOFF E, 1987, CAN J FOREST RES, V17, P1013; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119	67	46	47	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77777	10.1371/journal.pone.0077777	http://dx.doi.org/10.1371/journal.pone.0077777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223726	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300006
J	Degen, M; Barron, P; Natarajan, E; Widlund, HR; Rheinwald, JG				Degen, Martin; Barron, Patricia; Natarajan, Easwar; Widlund, Hans R.; Rheinwald, James G.			RSK Activation of Translation Factor eIF4B Drives Abnormal Increases of Laminin gamma 2 and MYC Protein during Neoplastic Progression to Squamous Cell Carcinoma	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; S6 KINASE; INITIATION-FACTORS; HELICASE ACTIVITY; MAMMALIAN TARGET; NECK-CANCER; IN-VITRO; HEAD; INHIBITOR; GROWTH	Overexpression of the basement membrane protein Laminin gamma 2 (Lam gamma 2) is a feature of many epidermal and oral dysplasias and all invasive squamous cell carcinomas (SCCs). This abnormality has potential value as an immunohistochemical biomarker of premalignancy but its mechanism has remained unknown. We recently reported that Lam gamma 2 overexpression in culture is the result of deregulated translation controls and depends on the MAPK-RSK signaling cascade. Here we identify eIF4B as the RSK downstream effector responsible for elevated Lam gamma 2 as well as MYC protein in neoplastic epithelial cells. Premalignant dysplastic keratinocytes, SCC cells, and keratinocytes expressing the E6 oncoprotein of human papillomavirus (HPV) type 16 displayed MAPK-RSK and mTOR-S6K1 activation and overexpressed Lam gamma 2 and MYC in culture. Immunohistochemical staining of oral dysplasias and SCCs for distinct, RSK- and S6K1-specific S6 phosphorylation events revealed that their respective upstream pathways become hyperactive at the same time during neoplastic progression. However, pharmacologic kinase inhibitor studies in culture revealed that Lam gamma 2 and MYC overexpression depends on MAPK-RSK activity, independent of PI3K-mTOR-S6K1. eIF4B knockdown reduced Lam gamma 2 and MYC protein expression, consistent with the known requirement for eIF4B to translate mRNAs with long, complex 5' untranslated regions (5'-UTRs). Accordingly, expression of a luciferase reporter construct preceded by the Lam gamma 2 5'-UTR proved to be RSK-dependent and mTOR-independent. These results demonstrate that RSK activation of eIF4B is causally linked to elevated Lam gamma 2 and MYC protein levels during neoplastic progression to invasive SCC. These findings have potential clinical significance for identifying premalignant lesions and for developing targeted drugs to treat SCC.	[Degen, Martin; Barron, Patricia; Widlund, Hans R.; Rheinwald, James G.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Degen, Martin; Barron, Patricia; Widlund, Hans R.; Rheinwald, James G.] Harvard Skin Dis Res Ctr, Boston, MA USA; [Natarajan, Easwar] Univ Connecticut, Ctr Hlth, Sect Oral & Maxillofacial Pathol, Farmington, CT USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Connecticut	Rheinwald, JG (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	jimrheinwald@gmail.com		Degen, Martin/0000-0002-4356-3714; Widlund, Hans/0000-0002-7506-2447	Brigham and Women's Hospital BRI grant; Swiss National Science Foundation; Novartis Foundation; Swiss Foundation for Grants in Biology and Medicine (Schweizerische Stiftung fur Biologisch-Medizinische Stipendien)	Brigham and Women's Hospital BRI grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Swiss Foundation for Grants in Biology and Medicine (Schweizerische Stiftung fur Biologisch-Medizinische Stipendien)	This work was supported by a Brigham and Women's Hospital BRI grant to J.G.R. and by postdoctoral fellowships from the Swiss National Science Foundation, Novartis Foundation, and the Swiss Foundation for Grants in Biology and Medicine (Schweizerische Stiftung fur Biologisch-Medizinische Stipendien) to M. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bremmer JF, 2011, ORAL ONCOL, V47, P956, DOI 10.1016/j.oraloncology.2011.07.025; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Chen LF, 2010, CLIN CANCER RES, V16, P2489, DOI 10.1158/1078-0432.CCR-09-2318; Chen SJ, 2009, BRIT J DERMATOL, V160, P442, DOI 10.1111/j.1365-2133.2008.08903.x; Dabelsteen S, 2009, STEM CELLS, V27, P1388, DOI 10.1002/stem.64; Degen M, 2012, AM J PATHOL, V180, P2462, DOI 10.1016/j.ajpath.2012.02.028; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FERRARI S, 1991, J BIOL CHEM, V266, P22770; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; Holmstrup P, 2006, ORAL ONCOL, V42, P461, DOI 10.1016/j.oraloncology.2005.08.011; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin C, 2013, ONCOGENE, V32, P2179, DOI 10.1038/onc.2012.236; Klein JD, 2010, CANCER BIOL THER, V9, P1; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Koshikawa N, 1999, CANCER RES, V59, P5596; LAWSON TG, 1989, BIOCHEMISTRY-US, V28, P4729, DOI 10.1021/bi00437a033; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lingen MW, 2012, ORAL ONCOL; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; MIETZ JA, 1992, EMBO J, V11, P5013, DOI 10.1002/j.1460-2075.1992.tb05608.x; Mizushima H, 1998, HORM RES, V50, P7, DOI 10.1159/000053118; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; Natarajan E, 2003, AM J PATHOL, V163, P477, DOI 10.1016/S0002-9440(10)63677-2; Natarajan E, 2006, AM J PATHOL, V168, P1821, DOI 10.2353/ajpath.2006.051027; Nordemar S, 2003, ANTICANCER RES, V23, P4985; Ono Y, 1999, CANCER, V85, P2315, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2315::AID-CNCR3>3.0.CO;2-Y; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pinto AP, 2013, MOD PATHOL IN PRESS; PYKE C, 1994, AM J PATHOL, V145, P782; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2010, CELL CYCLE, V9, P4106, DOI 10.4161/cc.9.20.13630; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; Venkatesan A, 2003, VIRUS RES, V94, P85, DOI 10.1016/S0168-1702(03)00136-9; Wakeling AE, 2002, CANCER RES, V62, P5749	54	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78979	10.1371/journal.pone.0078979	http://dx.doi.org/10.1371/journal.pone.0078979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205356	Green Submitted, Green Published, gold			2022-12-27	WOS:000326241200060
J	Bouvier, LA; Camara, MD; Canepa, GE; Miranda, MR; Pereira, CA				Bouvier, Leon A.; de los Milagros Camara, Maria; Canepa, Gaspar E.; Miranda, Mariana R.; Pereira, Claudio A.			Plasmid Vectors and Molecular Building Blocks for the Development of Genetic Manipulation Tools for Trypanosoma cruzi	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPRESSION VECTOR; PURIFICATION; CONSTRUCTION; MECHANISM; PROTEINS; SEQUENCE; BIOLOGY; SYSTEM; HOST	The post genomic era revealed the need for developing better performing, easier to use and more sophisticated genetic manipulation tools for the study of Trypanosoma cruzi, the etiological agent of Chagas disease. In this work a series of plasmids that allow genetic manipulation of this protozoan parasite were developed. First of all we focused on useful tools to establish selection strategies for different strains and which can be employed as expression vectors. On the other hand molecular building blocks in the form of diverse selectable markers, modifiable fluorescent protein and epitope-tag coding sequences were produced. Both types of modules were harboured in backbone molecules conceived to offer multiple construction and sub-cloning strategies. These can be used to confer new properties to already available genetic manipulation tools or as starting points for whole novel designs. The performance of each plasmid and building block was determined independently. For illustration purposes, some simple direct practical applications were conducted.	[Bouvier, Leon A.] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bouvier, LA (corresponding author), Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina.	lbouvier@gmail.com	Pereira, Claudio A/F-5382-2012	Pereira, Claudio A/0000-0001-7874-1894; Miranda, Mariana/0000-0002-0692-5675; Canepa, Gaspar/0000-0002-4195-8835	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2010-0685, 2011-0263]; Agencia Nacional de Promocion Cientifica y Tecnologica [FONCYT PICT 2008-1209, 2010-0289]; Fundacion Bunge y Born; E.P. Abraham Cephalosporin Fund; Wood-Whelan Research Fellowship	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Bunge y Born; E.P. Abraham Cephalosporin Fund; Wood-Whelan Research Fellowship	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2010-0685 and 2011-0263), Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT 2008-1209 and 2010-0289), and Fundacion Bunge y Born (grant 2012). CAP and MRM are members of the career of scientific investigator and MMC and LAB are research fellows from CONICET. LAB's research visit was financed by the E.P. Abraham Cephalosporin Fund and a Wood-Whelan Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Batista M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-259; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bouvier LA, 2006, BBA-GEN SUBJECTS, V1760, P913, DOI 10.1016/j.bbagen.2006.02.013; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Cevallos AM, 2003, EXP PARASITOL, V103, P27, DOI 10.1016/S0014-4894(03)00066-3; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hamilton MD, 2007, NUCLEIC ACIDS RES, V35, P143, DOI 10.1093/nar/gkl1015; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; LIGHT A, 1980, ANAL BIOCHEM, V106, P199, DOI 10.1016/0003-2697(80)90138-4; Lorenzi HA, 2003, GENE, V310, P91, DOI 10.1016/S0378-1119(03)00502-X; Cevallos AM, 2011, EXP PARASITOL, V127, P249, DOI 10.1016/j.exppara.2010.08.003; MartinezCalvillo S, 1997, GENE, V199, P71, DOI 10.1016/S0378-1119(97)00348-X; NOZAKI T, 1994, MOL BIOCHEM PARASIT, V67, P91, DOI 10.1016/0166-6851(94)90099-X; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STAMMERS DK, 1991, FEBS LETT, V283, P298, DOI 10.1016/0014-5793(91)80613-8; Sturm NR, 2010, ACTA TROP, V115, P35, DOI 10.1016/j.actatropica.2009.08.018; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; WEHLAND J, 1984, EMBO J, V3, P1295, DOI 10.1002/j.1460-2075.1984.tb01965.x; Wilkinson SR, 2008, P NATL ACAD SCI USA, V105, P5022, DOI 10.1073/pnas.0711014105; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Xu D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-90	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e80217	10.1371/journal.pone.0080217	http://dx.doi.org/10.1371/journal.pone.0080217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205392	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300097
J	Diaz-de-Durana, Y; Lau, J; Knee, D; Filippi, C; Londei, M; McNamara, P; Nasoff, M; DiDonato, M; Glynne, R; Herman, AE				Diaz-de-Durana, Yaiza; Lau, Janet; Knee, Deborah; Filippi, Christophe; Londei, Marco; McNamara, Peter; Nasoff, Marc; DiDonato, Michael; Glynne, Richard; Herman, Ann E.			IL-2 Immunotherapy Reveals Potential for Innate Beta Cell Regeneration in the Non-Obese Diabetic Mouse Model of Autoimmune Diabetes	PLOS ONE			English	Article							ANTI-CD3 MONOCLONAL-ANTIBODY; NOD MICE; PANCREATIC-ISLETS; T-CELLS; TYPE-1; INTERLEUKIN-2; PROLIFERATION; THERAPY; ONSET; ALPHA	Type-1 diabetes (T1D) is an autoimmune disease targeting insulin-producing beta cells, resulting in dependence on exogenous insulin. To date, significant efforts have been invested to develop immune-modulatory therapies for T1D treatment. Previously, IL-2 immunotherapy was demonstrated to prevent and reverse T1D at onset in the non-obese diabetic (NOD) mouse model, revealing potential as a therapy in early disease stage in humans. In the NOD model, IL-2 deficiency contributes to a loss of regulatory T cell function. This deficiency can be augmented with IL-2 or antibody bound to IL-2 (Ab/IL-2) therapy, resulting in regulatory T cell expansion and potentiation. However, an understanding of the mechanism by which reconstituted regulatory T cell function allows for reversal of diabetes after onset is not clearly understood. Here, we describe that Ab/IL-2 immunotherapy treatment, given at the time of diabetes onset in NOD mice, not only correlated with reversal of diabetes and expansion of Treg cells, but also demonstrated the ability to significantly increase beta cell proliferation. Proliferation appeared specific to Ab/IL-2 immunotherapy, as anti-CD3 therapy did not have a similar effect. Furthermore, to assess the effect of Ab/IL-2 immunotherapy well after the development of diabetes, we tested the effect of delaying treatment for 4 weeks after diabetes onset, when beta cells were virtually absent. At this late stage after diabetes onset, Ab/IL-2 treatment was not sufficient to reverse hyperglycemia. However, it did promote survival in the absence of exogenous insulin. Proliferation of beta cells could not account for this improvement as few beta cells remained. Rather, abnormal insulin and glucagon dual-expressing cells were the only insulin-expressing cells observed in islets from mice with established disease. Thus, these data suggest that in diabetic NOD mice, beta cells have an innate capacity for regeneration both early and late in disease, which is revealed through IL-2 immunotherapy.	[Diaz-de-Durana, Yaiza; Lau, Janet; Filippi, Christophe; Glynne, Richard; Herman, Ann E.] Novartis Res Fdn, Genom Inst, Dept Genet, San Diego, CA USA; [Knee, Deborah; Nasoff, Marc] Novartis Res Fdn, Genom Inst, Biotherapeut Dept, San Diego, CA USA; [Londei, Marco] Novartis Inst Biomed Res, San Diego, CA USA; [McNamara, Peter] Novartis Res Fdn, Genom Inst, Dept Pharmacol, San Diego, CA USA; [DiDonato, Michael] Novartis Res Fdn, Genom Inst, Dept Biol Struct, San Diego, CA USA	Novartis; Novartis; Novartis; Novartis; Novartis	Glynne, R (corresponding author), Novartis Res Fdn, Genom Inst, Dept Genet, San Diego, CA USA.	rglynne@gnf.org	Cerviño, Alejandro/L-5853-2014	Cerviño, Alejandro/0000-0001-8014-3279; DiDonato, Michael/0000-0002-9074-7284	Novartis Research Foundation; Novartis Institute of Biomedical Research (NIBR); Genomics Institute of the Novartis Research Foundation (GNF); Juvenile Diabetes Research Foundation (JDRF)	Novartis Research Foundation; Novartis Institute of Biomedical Research (NIBR); Genomics Institute of the Novartis Research Foundation (GNF); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation)	Funding for this work was provided by the Novartis Research Foundation and the Novartis Institute of Biomedical Research (NIBR). J. Lau was supported as a postdoctoral fellow by an agreement between the Genomics Institute of the Novartis Research Foundation (GNF) and the Juvenile Diabetes Research Foundation (JDRF). The funders had no role in the study design, data collection and analysis, or preparation of the manuscript. Legal approval for publication before submission was obtained from GNF and NIBR	Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Atkinson MJ, 2009, MED RADIOL RADIAT ON, P1, DOI 10.1007/978-3-540-74386-6_1; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; CHATENOUD L, 1992, CR ACAD SCI III-VIE, V315, P225; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gianani R, 2011, SEMIN IMMUNOPATHOL, V33, P23, DOI 10.1007/s00281-010-0235-7; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; HEROLD KC, 1992, DIABETES, V41, P385, DOI 10.2337/diabetes.41.3.385; Herold KC, 2011, SCI TRANSL MED, V3; Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Klatzmann MD, 2011, DOSE EFFECT RELATION; Long SA, 2012, DIABETES, V61, P2340, DOI 10.2337/db12-0049; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Long SA, 2013, CLIN IMMUNOL; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Pechhold K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004827; Piemonti L, 2011, DIABETOLOGIA, V54, P433, DOI 10.1007/s00125-010-1959-6; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; SERREZE DV, 1988, J IMMUNOL, V140, P3801; Shen W, 2013, J AM CHEM SOC, V135, P1669, DOI 10.1021/ja309304m; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; STRANDELL E, 1990, J CLIN INVEST, V85, P1944, DOI 10.1172/JCI114657; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tooley JE, 2012, TRENDS MOL MED, V18, P173, DOI 10.1016/j.molmed.2012.01.001; Tyrberg B, 2001, DIABETES, V50, P301, DOI 10.2337/diabetes.50.2.301; Valle A, 2009, DIABETES, V58, P875, DOI 10.2337/db08-1432; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wang M, 2012, SCI TRANSL MED, V4; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wicker LS, 2005, J AUTOIMMUN, V25, P29, DOI 10.1016/j.jaut.2005.09.009	56	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78483	10.1371/journal.pone.0078483	http://dx.doi.org/10.1371/journal.pone.0078483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205242	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300062
J	Mishra, R; Kaur, G				Mishra, Rachana; Kaur, Gurcharan			Aqueous Ethanolic Extract of Tinospora cordifolia as a Potential Candidate for Differentiation Based Therapy of Glioblastomas	PLOS ONE			English	Article							ADHESION MOLECULE NCAM; CELL-ADHESION; CYCLIN D1; POLYSIALIC ACID; IN-VITRO; DICHLOROMETHANE EXTRACT; NEUROBLASTOMA-CELLS; ANTITUMOR-ACTIVITY; OXIDATIVE STRESS; GENE-EXPRESSION	Glioblastomas are the most aggressive primary brain tumors and their heterogeneity and complexity often renders them non responsive to various conventional treatments. Search for herbal products having potential anti-cancer activity is an active area of research in the Indian traditional system of medicine i.e., Ayurveda. Tinospora cordifolia, also named as 'heavenly elixir' is used in various ayurvedic decoctions as panacea to treat several body ailments. The current study investigated the anti-brain cancer potential of 50% ethanolic extract of Tinospora cordifolia (TCE) using C6 glioma cells. TCE significantly reduced cell proliferation in dose-dependent manner and induced differentiation in C6 glioma cells, resulting in astrocyte-like morphology as indicated by phase contrast images, GFAP expression and process outgrowth data of TCE treated cells which exhibited higher number and longer processes than untreated cells. Reduced proliferation of cells was accompanied by enhanced expression of senescence marker, mortalin and its translocation from perinuclear to pancytoplasmic spaces. Further, TCE showed anti-migratory and anti-invasive potential as depicted by wound scratch assay and reduced expression of plasticity markers NCAM and PSA-NCAM along with MMP-2 and 9. On analysis of the cell cycle and apoptotic markers, TCE treatment was seen to arrest the C6 cells in G0/G1 and G2/M phase, suppressing expression of G1/S phase specific protein cyclin D1 and anti-apoptotic protein Bcl-xL, thus supporting its anti-proliferative and apoptosis inducing potential. Present study provides the first evidence for the presence of anti-proliferative, differentiation-inducing and anti-migratory/anti-metastatic potential of TCE in glioma cells and possible signaling pathways involved in its mode of action. Our primary data suggests that TCE and its active components may prove to be promising phytotherapeutic interventions in gliobalstoma multiformae.	[Mishra, Rachana; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India	Guru Nanak Dev University	Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com	Mishra, Rachana/Q-1706-2019; Kaur, Gurcharan/V-6033-2019		UGC-UPE (University Grant Commission-Universities with Potential for Excellence, Government of India); DBT, GOI	UGC-UPE (University Grant Commission-Universities with Potential for Excellence, Government of India); DBT, GOI(Department of Biotechnology (DBT) India)	The study was partially supported by UGC-UPE (University Grant Commission-Universities with Potential for Excellence, Government of India) Grant to the University. Ms Rachana Mishra is thankful to the DBT, GOI for the research fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhvaryu MR, 2008, AFR J TRADIT COMPLEM, V5, P409; Agrawal SS, 2012, FOOD CHEM TOXICOL, V50, P3126, DOI 10.1016/j.fct.2012.05.057; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; [Anonymous], 1998, BUSINESS MEDIA, DOI DOI 10.1007/978-94-009-5570-7; Aranha I, 2012, J ETHNOPHARMACOL, V139, P366, DOI 10.1016/j.jep.2011.11.013; Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO;2-O; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BATES S, 1994, ONCOGENE, V9, P1633; Bishayi Biswadev, 2002, J Toxicol Sci, V27, P139, DOI 10.2131/jts.27.139; BLACK MM, 1991, J NEUROSCI, V11, P1163; Bussolati B, 2006, EXP CELL RES, V312, P913, DOI 10.1016/j.yexcr.2005.12.004; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Chaudhary R, 2008, J ENVIRON PATHOL TOX, V27, P233, DOI 10.1615/JEnvironPatholToxicolOncol.v27.i3.70; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; Daniel L, 2003, HUM PATHOL, V34, P528, DOI 10.1016/S0046-8177(03)00178-3; Das A, 2008, BRAIN RES, V1227, P207, DOI 10.1016/j.brainres.2008.06.045; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Desai VR, 2007, INT IMMUNOPHARMACOL, V7, P1375, DOI 10.1016/j.intimp.2007.06.004; Dhanasekaran M, 2009, INVEST NEW DRUG, V27, P347, DOI 10.1007/s10637-008-9181-9; DOLE MG, 1995, CANCER RES, V55, P2576; Donnellan R, 1998, J CLIN PATHOL-MOL PA, V51, P1; Fauzi FM, 2013, J CHEM INF MODEL, V53, P661, DOI 10.1021/ci3005513; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Goel H. C., 2002, Indian Journal of Experimental Biology, V40, P727; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Guruprasad K P, 2010, J Ayurveda Integr Med, V1, P40, DOI 10.4103/0975-9476.59826; Hamsa TP, 2012, EXP TOXICOL PATHOL, V64, P307, DOI 10.1016/j.etp.2010.09.003; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HEIKKILA JJ, 1993, DEV GENET, V14, P87, DOI 10.1002/dvg.1020140202; Jagetia GC, 2006, EVID-BASED COMPL ALT, V3, P267, DOI 10.1093/ecam/nel011; Jagetia GC, 2006, BIOL PHARM BULL, V29, P460, DOI 10.1248/bpb.29.460; Jain BNG, 2010, J ADV PHARM TECHNOL, V1, P30; Kataria H, 2012, PLOS ONE, V5; Kokate C. K., 2001, PHARMACOGNOSY, V16th; Koppada R, 2009, BASIC CLIN PHARMACOL, V105, P217, DOI 10.1111/j.1742-7843.2009.00383.x; Leyon PV, 2004, INT IMMUNOPHARMACOL, V4, P1569, DOI 10.1016/j.intimp.2004.06.015; Liu Wei, 2011, Reports in Parasitology, V1, P1; Loones MT, 2000, CELL STRESS CHAPERON, V5, P291, DOI 10.1379/1466-1268(2000)005<0291:TDOHSP>2.0.CO;2; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nadig PD, 2012, INDIAN J PHARMACOL, V44, P580, DOI 10.4103/0253-7613.100380; Nair R B, 1992, Anc Sci Life, V12, P280; Pandey VK, 2012, INT IMMUNOPHARMACOL, V14, P641, DOI 10.1016/j.intimp.2012.09.020; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Patel MB, 2011, PHYTOMEDICINE, V18, P1045, DOI 10.1016/j.phymed.2011.05.006; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; PIERCE GB, 1961, CANCER, V14, P1017, DOI 10.1002/1097-0142(196109/10)14:5<1017::AID-CNCR2820140516>3.0.CO;2-P; Prince Ponnaian Stanely Mainzen, 2004, Acta Pol Pharm, V61, P283; Raghu R, 2009, IMMUNOL LETT, V123, P60, DOI 10.1016/j.imlet.2009.02.005; Rao PR, 2005, BIOL PHARM BULL, V28, P2319, DOI 10.1248/bpb.28.2319; Rao SK, 2010, INTEGR CANCER THER, V9, P378, DOI 10.1177/1534735410387598; Rawal Avinash K, 2004, BMC Complement Altern Med, V4, P11, DOI 10.1186/1472-6882-4-11; Reddy SS, 2009, FOOD CHEM TOXICOL, V47, P2224, DOI 10.1016/j.fct.2009.06.008; Rege NN, 1999, PHYTOTHER RES, V13, P275, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;275::AID-PTR510&gt;3.0.CO;2-S; Ronn LCB, 1998, EXP GERONTOL, V33, P853, DOI 10.1016/S0531-5565(98)00040-0; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; RUTKA JT, 1994, CANCER RES, V54, P3267; Saha S, 2012, ANC SCI LIFE, V31, P151, DOI 10.4103/0257-7941.107344; Sallinen SL, 1999, J PATHOL, V188, P289; Sangeetha MK, 2011, J NAT MED-TOKYO, V65, P544, DOI 10.1007/s11418-011-0538-6; Schmidt F, 2000, CELL PHYSIOL BIOCHEM, V10, P159, DOI 10.1159/000016346; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Sengupta M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-102; Sengupta S, 2009, J ENZYM INHIB MED CH, V24, P684, DOI 10.1080/14756360802333075; Sharma P, 2011, EVID-BASED COMPL ALT, V2011, DOI [10.1155/2011/643847, DOI 10.1155/2011/643847.PUBMED:21350610]; Sharma U, 2012, J ETHNOPHARMACOL, V141, P918, DOI 10.1016/j.jep.2012.03.027; Sharma V, 2010, Toxicol Int, V17, P12, DOI 10.4103/0971-6580.68343; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Shim JW, 2004, J NEUROSCI, V24, P843, DOI 10.1523/JNEUROSCI.3977-03.2004; Singh AP, 2012, INT J ONCOL, V40, P99, DOI 10.3892/ijo.2011.1225; Singh N, 2005, IMMUNOPHARM IMMUNOT, V27, P1, DOI 10.1081/IPH-200051287; Subramanian M, 2002, REDOX REP, V7, P137, DOI 10.1179/135100002125000370; Sukumari-Ramesh S, 2011, INT J DEV NEUROSCI, V29, P701, DOI 10.1016/j.ijdevneu.2011.06.002; Thippeswamy G, 2008, EUR J PHARMACOL, V588, P141, DOI 10.1016/j.ejphar.2008.04.027; Thippeswamy G, 2007, ENVIRON TOXICOL PHAR, V23, P212, DOI 10.1016/j.etap.2006.10.004; Toda M, 1999, NEUROCHEM RES, V24, P339, DOI 10.1023/A:1022538810581; Velazquez EA, 2009, BASIC CLIN PHARMACOL, V105, P301, DOI 10.1111/j.1742-7843.2009.00447.x; WADHWA R, 1995, EXP CELL RES, V216, P101, DOI 10.1006/excr.1995.1013; WADHWA R, 1993, EXP CELL RES, V207, P442, DOI 10.1006/excr.1993.1213; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082	80	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78764	10.1371/journal.pone.0078764	http://dx.doi.org/10.1371/journal.pone.0078764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205314	Green Published, gold			2022-12-27	WOS:000326152300082
J	Linville, JL; Rodriguez, M; Land, M; Syed, MH; Engle, NL; Tschaplinski, TJ; Mielenz, JR; Cox, CD				Linville, Jessica L.; Rodriguez, Miguel, Jr.; Land, Miriam; Syed, Mustafa H.; Engle, Nancy L.; Tschaplinski, Timothy J.; Mielenz, Jonathan R.; Cox, Chris D.			Industrial Robustness: Understanding the Mechanism of Tolerance for the Populus Hydrolysate-Tolerant Mutant Strain of Clostridium thermocellum	PLOS ONE			English	Article							DEGRADATION-PRODUCTS; TRANSCRIPTIONAL ANALYSIS; ETHANOL TOLERANCE; CORN STOVER; FERMENTATION; PRETREATMENT; BIOMASS; SPORULATION; BACTERIA; GROWTH	Background: An industrially robust microorganism that can efficiently degrade and convert lignocellulosic biomass into ethanol and next-generation fuels is required to economically produce future sustainable liquid transportation fuels. The anaerobic, thermophilic, cellulolytic bacterium Clostridium thermocellum is a candidate microorganism for such conversions but it, like many bacteria, is sensitive to potential toxic inhibitors developed in the liquid hydrolysate produced during biomass processing. Microbial processes leading to tolerance of these inhibitory compounds found in the pretreated biomass hydrolysate are likely complex and involve multiple genes. Methodology/Principal Findings: In this study, we developed a 17.5% v/v Populus hydrolysate tolerant mutant strain of C. thermocellum by directed evolution. The genome of the wild type strain, six intermediate population samples and seven single colony isolates were sequenced to elucidate the mechanism of tolerance. Analysis of the 224 putative mutations revealed 73 high confidence mutations. A longitudinal analysis of the intermediate population samples, a pan-genomic analysis of the isolates, and a hotspot analysis revealed 24 core genes common to all seven isolates and 8 hotspots. Genetic mutations were matched with the observed phenotype through comparison of RNA expression levels during fermentation by the wild type strain and mutant isolate 6 in various concentrations of Populus hydrolysate (0%, 10%, and 17.5% v/v). Conclusion/Significance: The findings suggest that there are multiple mutations responsible for the Populus hydrolysate tolerant phenotype resulting in several simultaneous mechanisms of action, including increases in cellular repair, and altered energy metabolism. To date, this study provides the most comprehensive elucidation of the mechanism of tolerance to a pretreated biomass hydrolysate by C. thermocellum. These findings make important contributions to the development of industrially robust strains of consolidated bioprocessing microorganisms.	[Linville, Jessica L.; Cox, Chris D.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA; [Linville, Jessica L.; Rodriguez, Miguel, Jr.; Land, Miriam; Syed, Mustafa H.; Engle, Nancy L.; Tschaplinski, Timothy J.; Mielenz, Jonathan R.; Cox, Chris D.] Oak Ridge Natl Lab, Bioenergy Sci Ctr, Oak Ridge, TN USA; [Rodriguez, Miguel, Jr.; Syed, Mustafa H.; Engle, Nancy L.; Tschaplinski, Timothy J.; Mielenz, Jonathan R.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Cox, Chris D.] Univ Tennessee, Inst Secure & Sustainable Environm, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Cox, CD (corresponding author), Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA.	ccox9@utk.edu	Tschaplinski, Timothy/D-6382-2018; Land, Miriam L/A-6200-2011; Engle, Nancy L/D-6494-2018; Cox, Chris D/A-9451-2013	Tschaplinski, Timothy/0000-0002-9540-6622; Land, Miriam L/0000-0001-7102-0031; Engle, Nancy L/0000-0003-0290-7987; Cox, Chris D/0000-0001-9818-5477	BioEnergy Science Center, a Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the Department of Energy Office of Science; Institute for a Secure and Sustainable Environment at the University of Tennessee; DOE [DE-AC05-00OR22725]	BioEnergy Science Center, a Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the Department of Energy Office of Science; Institute for a Secure and Sustainable Environment at the University of Tennessee; DOE(United States Department of Energy (DOE))	This research was supported by the BioEnergy Science Center, a Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. Additional support was provided by the Institute for a Secure and Sustainable Environment at the University of Tennessee. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the DOE under Contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; [Anonymous], 2006, SC 0095 BREAK BIOL B; Bahari L, 2011, J IND MICROBIOL BIOT, V38, P825, DOI 10.1007/s10295-010-0848-9; Barber MS, 2000, PHYTOCHEMISTRY, V54, P53, DOI 10.1016/S0031-9422(00)00038-8; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Brown SD, 2011, P NATL ACAD SCI USA, V108, P13752, DOI 10.1073/pnas.1102444108; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Conrad TM, 2011, MOL SYST BIOL, V7, P11; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; CUDECK R, 1989, PSYCHOL BULL, V105, P317, DOI 10.1037/0033-2909.105.2.317; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Du BW, 2010, BIOTECHNOL BIOENG, V107, P430, DOI 10.1002/bit.22829; Ezeji T, 2007, BIOTECHNOL BIOENG, V97, P1460, DOI 10.1002/bit.21373; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Geng AL, 2010, INT J CHEM REACT ENG, V8; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; GRIMSLEY JK, 1994, J BIOL CHEM, V269, P16977; HOCH JA, 1993, ANNU REV MICROBIOL, V47, P441, DOI 10.1146/annurev.micro.47.1.441; Hosokawa K, 2002, ENVIRON MICROBIOL, V4, P703, DOI 10.1046/j.1462-2920.2002.00348.x; Ichinose H, 2012, PROCESS BIOCHEM, V47, P358, DOI 10.1016/j.procbio.2011.06.002; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Joh LD, 2010, EFFECTS PHENOLIC MON, P1; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kahel-Raifer H, 2010, FEMS MICROBIOL LETT, V308, P84, DOI 10.1111/j.1574-6968.2010.01997.x; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Lee ASG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031934; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Malik S, 2012, PLOS ONE, V7, P10; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Miller EN, 2009, APPL ENVIRON MICROB, V75, P4315, DOI 10.1128/AEM.00567-09; Miller EN, 2009, APPL ENVIRON MICROB, V75, P6132, DOI 10.1128/AEM.01187-09; Moeller R, 2012, ARCH MICROBIOL, V194, P759, DOI 10.1007/s00203-012-0811-4; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozkan M, 2001, J IND MICROBIOL BIOT, V27, P275, DOI 10.1038/sj.jim.7000082; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 1999, BIOTECHNOL BIOENG, V62, P447, DOI 10.1002/(SICI)1097-0290(19990220)62:4<447::AID-BIT7>3.3.CO;2-S; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pienkos PT, 2009, CELLULOSE, V16, P743, DOI 10.1007/s10570-009-9309-x; Raman B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-134; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Rani KS, 1999, WORLD J MICROB BIOT, V15, P173, DOI 10.1023/A:1008863410460; Riederer A, 2011, APPL ENVIRON MICROB, V77, P1243, DOI 10.1128/AEM.02008-10; Roberts SB, 2010, BMC SYST BIOL, V4; Schell DJ, 2003, APPL BIOCHEM BIOTECH, V105, P69, DOI 10.1385/ABAB:105:1-3:69; Shao XJ, 2011, APPL MICROBIOL BIOT, V92, P641, DOI 10.1007/s00253-011-3492-z; Shi Z, 2008, APPL ENVIRON MICROB, V74, P7709, DOI 10.1128/AEM.01948-08; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Syed MH, 2012, BIOINFORMATICS, V28, P750, DOI 10.1093/bioinformatics/bts016; Tomas CA, 2003, J BACTERIOL, V185, P4539, DOI 10.1128/JB.185.15.4539-4547.2003; Varga E, 2004, BIOTECHNOL BIOENG, V88, P567, DOI 10.1002/bit.20222; Williams TI, 2007, APPL MICROBIOL BIOT, V74, P422, DOI 10.1007/s00253-006-0689-7; Yu TT, 2012, MICROBIOL RES, V167, P364, DOI 10.1016/j.micres.2012.02.006; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zhang Y, 2011, NEW BIOTECHNOLOGY; Zhang YH, 2003, ANAL CHEM, V75, P219, DOI 10.1021/ac020271n; Zhang YHP, 2005, J BACTERIOL, V187, P99, DOI 10.1128/JB.187.1.99-106.2005	65	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78829	10.1371/journal.pone.0078829	http://dx.doi.org/10.1371/journal.pone.0078829			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205326	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600112
J	Hrisos, S; Thomson, R				Hrisos, Susan; Thomson, Richard			Seeing It from Both Sides: Do Approaches to Involving Patients in Improving Their Safety Risk Damaging the Trust between Patients and Healthcare Professionals? An Interview Study	PLOS ONE			English	Article							DECISION-MAKING; ERROR PREVENTION; MEDICAL ERRORS; PARTICIPATION; INVOLVEMENT; PHYSICIANS; ATTITUDES; VIEWS; INFORMATION; PERCEPTIONS	Objective: Encouraging patients to be more vigilant about their care challenges the traditional dynamics of patient-healthcare professional interactions. This study aimed to explore, from the perspectives of both patients and frontline healthcare staff, the potential consequences of patient-mediated intervention as a way of pushing safety improvement through the involvement of patients. Design: Qualitative study, using purposive sampling and semi-structured interviews with patients, their relatives and healthcare professionals. Emergent themes were identified using grounded theory, with data coded using NVIVO 8. Participants: 16 patients, 4 relatives, (mean age (sd) 60 years (15); 12 female, 8 male) and 39 healthcare professionals, (9 pharmacists, 11 doctors, 12 nurses, 7 health care assistants). Setting: Participants were sampled from general medical and surgical wards, taking acute and elective admissions, in two hospitals in north east England. Results: Positive consequences were identified but some actions encouraged by current patient-mediated approaches elicited feelings of suspicion and mistrust. For example, patients felt speaking up might appear rude or disrespectful, were concerned about upsetting staff and worried that their care might be compromised. Staff, whilst apparently welcoming patient questions, appeared uncertain about patients' motives for questioning and believed that patients who asked many questions and/or who wrote things down were preparing to complain. Behavioural implications were identified that could serve to exacerbate patient safety problems (e. g. staff avoiding contact with inquisitive patients or relatives; patients avoiding contact with unreceptive staff). Conclusions: Approaches that aim to push improvement in patient safety through the involvement of patients could engender mistrust and create negative tensions in the patient-provider relationship. A more collaborative approach, that encourages patients and healthcare staff to work together, is needed. Future initiatives should aim to shift the current focus away from "checking up" on individual healthcare professionals to one that engages both parties in the common goal of enhancing safety.	[Hrisos, Susan; Thomson, Richard] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Hrisos, S (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	susan.hrisos@ncl.ac.uk			National Institute of Health Research under its Programme Grants for Applied Research scheme [RP-PG-0108-10049]; National Institute for Health Research [RP-PG-0108-10049] Funding Source: researchfish	National Institute of Health Research under its Programme Grants for Applied Research scheme; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute of Health Research under its Programme Grants for Applied Research scheme (RP-PG-0108-10049) [http://www.nihr.ac.uk/Pages/default.aspx]. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. No individuals employed or contracted by the funders (other than the named authors) played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NVIVO QUAL DAT AN SO; [Anonymous], 2013, IN GOV RESP REP MIDS; [Anonymous], 2010, IND INQ CAR PROV MID; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Burt RS, 2005, BROKERAGE CLOSURE IN; Chaitin E, 2003, CRIT CARE MED, V31, pS367, DOI 10.1097/01.CCM.0000066452.48589.F4; Coulter A, 2006, HEALTH EXPECT, V9, P205, DOI 10.1111/j.1369-7625.2006.00405.x; Davis R, 2012, TRANSFUSION MED, V22, P167, DOI 10.1111/j.1365-3148.2012.01148.x; Davis R, 2008, PATIENT INVOLVEMENT; Davis R, 2011, INT J NURS STUD; Davis RE, 2008, QUAL SAF HEALTH CARE, V17, P90, DOI 10.1136/qshc.2007.023754; Davis RE, 2011, BMJ QUAL SAF, V20, P108, DOI 10.1136/bmjqs.2010.041871; Davis RE, 2007, HEALTH EXPECT, V10, P259, DOI 10.1111/j.1369-7625.2007.00450.x; Davis RE, 2012, J EVAL CLIN PRACT, V18, P848, DOI 10.1111/j.1365-2753.2011.01688.x; Davis RE, 2012, J PATIENT SAF; Delbanco T, 2007, NEW ENGL J MED, V357, P1682, DOI 10.1056/NEJMp078104; Doherty C, 2012, SOC SCI MED, V75, P257, DOI 10.1016/j.socscimed.2012.02.056; Donabedian A, 1992, Qual Health Care, V1, P247, DOI 10.1136/qshc.1.4.247; Donaldson LJ, 2008, QUAL SAF HEALTH CARE, V17, P82, DOI 10.1136/qshc.2007.025262; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Entwistle V, 2011, J HLTH SERV RES POLI; Entwistle VA, 2007, QUAL SAF HEALTH CARE, V16, P82, DOI 10.1136/qshc.2006.020362; Entwistle VA, 2005, JT COMM J QUAL PATIE, V31, P483, DOI 10.1016/S1553-7250(05)31063-4; Entwistle Vikki A, 2010, Qual Saf Health Care, V19, pe33, DOI 10.1136/qshc.2009.039743; Entwistle Vikki Ann, 2006, J Health Organ Manag, V20, P397, DOI 10.1108/14777260610701786; Fiscella K, 2004, MED CARE, V42, P1049, DOI 10.1097/00005650-200411000-00003; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Hibbard JH, 2005, MED CARE RES REV, V62, P601, DOI 10.1177/1077558705279313; Hor SY, 2013, HEALTH-LONDON, V17, P567, DOI 10.1177/1363459312472082; Hovey RB, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.030908; Hovey RB, 2011, QUAL HEALTH RES, V21, P662, DOI 10.1177/1049732311399779; Johnstone MJ, 2009, HEALTH POLICY, V90, P1, DOI 10.1016/j.healthpol.2008.08.007; Kraetschmer N, 2004, HEALTH EXPECT, V7, P317, DOI 10.1111/j.1369-7625.2004.00296.x; Leape L, 2009, QUAL SAF HEALTH CARE, V18, P424, DOI 10.1136/qshc.2009.036954; Lee YY, 2009, SOC SCI MED, V68, P1060, DOI 10.1016/j.socscimed.2008.12.033; Longtin Y, 2010, MAYO CLIN PROC, V85, P53, DOI 10.4065/mcp.2009.0248; Luszczynska A, 2007, PATIENT EDUC COUNS, V68, P79, DOI 10.1016/j.pec.2007.05.008; Lyons M, 2007, QUAL SAF HEALTH CARE, V16, P140, DOI 10.1136/qshc.2006.018861; Guijarro PM, 2010, QUAL SAF HEALTH CARE, V19, P144, DOI 10.1136/qshc.2007.025585; McGuckin M, 2006, AM J MED QUAL, V21, P342, DOI 10.1177/1062860606291328; National Patient Safety Agency, 2010, PLEAS ASK; Nau DP, 2005, J AM PHARM ASSOC, V45, P452, DOI 10.1331/1544345054475441; Ovretveit J, 2009, SOC SCI MED, V69, P1780, DOI 10.1016/j.socscimed.2009.09.053; Patients First and Foremost, 2013, IN GOV RESP REP MID; Pronovost PJ, 2009, CIRCULATION, V119, P330, DOI 10.1161/CIRCULATIONAHA.107.729848; Rainey H, 2013, HLTH EXPECTATIONS; Rathert C, 2011, HLTH EXPECT; Rathert C, 2011, HEALTH CARE MANAGE R, V36, P359, DOI 10.1097/HMR.0b013e318219cda1; Rathert C, 2011, HEALTH CARE MANAGE R, V36, P134, DOI 10.1097/HMR.0b013e318208cd31; Richards L., 2005, HANDLING QUALITATIVE; Runciman B., 2007, SAFETY ETHICS HEALTH; Salkeld G, 2004, HEALTH EXPECT, V7, P104, DOI 10.1111/j.1369-7625.2004.00257.x; Schwappach DLB, 2011, ANN ONCOL, V22, P424, DOI 10.1093/annonc/mdq346; Schwappach DLB, 2010, EUR J CANCER CARE, V19, P285, DOI 10.1111/j.1365-2354.2009.01127.x; Schwappach DLB, 2011, INT J QUAL HEALTH C, V23, P713, DOI 10.1093/intqhc/mzr062; Schwappach DLB, 2010, J CLIN ONCOL, V28, P2896, DOI 10.1200/JCO.2009.27.6626; Schwappach DLB, 2010, MED CARE RES REV, V67, P119, DOI 10.1177/1077558709342254; Schwappach DLB, 2010, ONCOLOGY NURSES PERC, P84; Schwappach DLB, 2012, J EVAL CLIN PRACTICE; Seetharamu Nagashree, 2007, Palliat Support Care, V5, P405; Silverman D., 2006, INTERPRETING QUALITA, V3a; Thiede M, 2005, SOC SCI MED, V61, P1452, DOI 10.1016/j.socscimed.2004.11.076; Thom DH, 1997, J FAM PRACTICE, V44, P169; Thompson AGH, 2007, SOC SCI MED, V64, P1297, DOI 10.1016/j.socscimed.2006.11.002; Vincent CA, 2002, QUAL SAF HEALTH CARE, V11, P76, DOI 10.1136/qhc.11.1.76; Waterman AD, 2006, J GEN INTERN MED, V21, P367, DOI 10.1111/j.1525-1497.2005.00385.x; Weingart SN, 2009, JT COMM J QUAL PATIE, V35, P63, DOI 10.1016/S1553-7250(09)35009-6	67	40	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80759	10.1371/journal.pone.0080759	http://dx.doi.org/10.1371/journal.pone.0080759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223230	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200123
J	Padhi, S; Khan, N; Jameel, S; Priyakumar, UD				Padhi, Siladitya; Khan, Nabab; Jameel, Shahid; Priyakumar, U. Deva			Molecular Dynamics Simulations Reveal the HIV-1 Vpu Transmembrane Protein to Form Stable Pentamers	PLOS ONE			English	Article							ION-CHANNEL ACTIVITY; 3-DIMENSIONAL STRUCTURE; U VPU; VIRUS; DOMAIN; CHARMM; AMILORIDE; HELIX; OLIGOMERIZATION; IDENTIFICATION	The human immunodeficiency virus type I (HIV-1) Vpu protein is 81 residues long and has two cytoplasmic and one transmembrane (TM) helical domains. The TM domain oligomerizes to form a monovalent cation selective ion channel and facilitates viral release from host cells. Exactly how many TM domains oligomerize to form the pore is still not understood, with experimental studies indicating the existence of a variety of oligomerization states. In this study, molecular dynamics (MD) simulations were performed to investigate the propensity of the Vpu TM domain to exist in tetrameric, pentameric, and hexameric forms. Starting with an idealized a-helical representation of the TM domain, a thorough search for the possible orientations of the monomer units within each oligomeric form was carried out using replica-exchange MD simulations in an implicit membrane environment. Extensive simulations in a fully hydrated lipid bilayer environment on representative structures obtained from the above approach showed the pentamer to be the most stable oligomeric state, with interhelical van der Waals interactions being critical for stability of the pentamer. Atomic details of the factors responsible for stable pentamer structures are presented. The structural features of the pentamer models are consistent with existing experimental information on the ion channel activity, existence of a kink around the Ile17, and the location of tetherin binding residues. Ser23 is proposed to play an important role in ion channel activity of Vpu and possibly in virus propagation.	[Padhi, Siladitya; Priyakumar, U. Deva] Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India; [Khan, Nabab; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, New Delhi, India	International Institute of Information Technology Hyderabad; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Priyakumar, UD (corresponding author), Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India.	deva@iiit.ac.in	khan, Nabab/Z-3970-2019; Priyakumar, Deva/F-6793-2010	khan, Nabab/0000-0002-8563-5341; Padhi, Siladitya/0000-0002-4272-6040	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR12729/BID/07/297/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India (http://dbtindia.nic.in/; grant no. BT/PR12729/BID/07/297/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bu LT, 2007, BIOPHYS J, V92, P854, DOI 10.1529/biophysj.106.095216; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; CORDES FS, 2001, BIOCHIM BIOPHYS ACTA, V1512, P29; Deol SS, 2004, BIOPHYS J, V87, P3737, DOI 10.1529/biophysj.104.048397; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Ewart GD, 2002, EUR BIOPHYS J BIOPHY, V31, P26, DOI 10.1007/s002490100177; Ewart GD, 2004, ANTIMICROB AGENTS CH, V48, P2325, DOI 10.1128/AAC.48.6.2325-2330.2004; Federau T, 1996, INT J PEPT PROT RES, V47, P297; Fischer WB, 2000, BIOPOLYMERS, V53, P529, DOI 10.1002/(SICI)1097-0282(200006)53:7<529::AID-BIP1>3.0.CO;2-6; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Grice AL, 1997, FEBS LETT, V405, P299, DOI 10.1016/S0014-5793(97)00198-1; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim CG, 2006, ANAL BIOANAL CHEM, V386, P2213, DOI 10.1007/s00216-006-0832-4; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kruger J, 2010, EUR BIOPHYS J BIOPHY, V39, P1069, DOI 10.1007/s00249-009-0487-0; Kruger J, 2009, J CHEM THEORY COMPUT, V5, P2503, DOI 10.1021/ct900185n; Kukol A, 1999, BIOPHYS J, V77, P1594, DOI 10.1016/S0006-3495(99)77007-4; Lemaitre V, 2004, FEBS LETT, V563, P75, DOI 10.1016/S0014-5793(04)00251-0; Liu F, 2004, BIOPHYS J, V87, P2470, DOI 10.1529/biophysj.104.046342; Lopez CF, 2002, BIOPHYS J, V83, P1259, DOI 10.1016/S0006-3495(02)73898-8; Lu JX, 2010, PROTEIN SCI, V19, P1877, DOI 10.1002/pro.474; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; Mehnert T, 2008, PROTEINS, V70, P1488, DOI 10.1002/prot.21642; Moore PB, 1998, FEBS LETT, V431, P143, DOI 10.1016/S0014-5793(98)00714-5; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Patargias G, 2009, J BIOMOL STRUCT DYN, V27, P1; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saiz L, 2004, J PHYS CHEM B, V108, P2608, DOI 10.1021/jp0369793; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Ulmschneider JP, 2007, J CHEM THEORY COMPUT, V3, P2335, DOI 10.1021/ct700103k; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; WRAY V, 1995, INT J PEPT PROT RES, V45, P35; Wray V, 1999, BIOCHEMISTRY-US, V38, P5272, DOI 10.1021/bi982755c; ZHANG YP, 1993, BIOCHEMISTRY-US, V32, P3942, DOI 10.1021/bi00066a014	64	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79779	10.1371/journal.pone.0079779	http://dx.doi.org/10.1371/journal.pone.0079779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223193	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200086
J	Whitehouse, J; Micheletta, J; Powell, LE; Bordier, C; Waller, BM				Whitehouse, Jamie; Micheletta, Jerome; Powell, Lauren E.; Bordier, Celia; Waller, Bridget M.			The Impact of Cognitive Testing on the Welfare of Group Housed Primates	PLOS ONE			English	Article							SOCIAL-INTERACTION PATTERNS; DISPLACEMENT ACTIVITIES; RHESUS-MONKEYS; MACAQUES; RECIPROCITY; CHALLENGE; CONFLICT; EMOTIONS; SULAWESI; BEHAVIOR	Providing cognitive challenges to zoo-housed animals may provide enriching effects and subsequently enhance their welfare. Primates may benefit most from such challenges as they often face complex problems in their natural environment and can be observed to seek problem solving opportunities in captivity. However, the extent to which welfare benefits can be achieved through programmes developed primarily for cognitive research is unknown. We tested the impact of voluntary participation cognitive testing on the welfare of a socially housed group of crested macaques (Macaca nigra) at the Macaque Study Centre (Marwell Zoo). First, we compared the rate of self-directed and social behaviours on testing and non-testing days, and between conditions within testing days. Minimal differences in behaviour were found when comparing testing and non-testing days, suggesting that there was no negative impact on welfare as a result of cognitive testing. Lipsmacking behaviours were found to increase and aggressive interaction was found to decrease in the group as a result of testing. Second, social network analysis was used to assess the effect of testing on associations and interactions between individuals. The social networks showed that testing subjects increased their association with others during testing days. One interpretation of this finding could be that providing socially housed primates with an opportunity for individuals to separate from the group for short periods could help mimic natural patterns of sub-group formation and reunion in captivity. The findings suggest, therefore, that the welfare of captive primates can be improved through the use of cognitive testing in zoo environments.	[Whitehouse, Jamie; Micheletta, Jerome; Powell, Lauren E.; Bordier, Celia; Waller, Bridget M.] Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Dept Psychol, Portsmouth PO1 2UP, Hants, England; [Micheletta, Jerome; Waller, Bridget M.] Marwell Wildlife, Winchester, Hants, England	University of Portsmouth	Whitehouse, J (corresponding author), Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Dept Psychol, Portsmouth PO1 2UP, Hants, England.	jamie.whitehouse@port.ac.uk	Micheletta, Jérôme/E-4699-2014	Micheletta, Jérôme/0000-0002-4480-6781; Waller, Bridget/0000-0001-6303-7458; Whitehouse, Jamie/0000-0003-2607-5492				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; [Anonymous], ENCY MEASUREMENTS ST; Aureli F, 2010, BIOL LETTERS, V6, P27, DOI 10.1098/rsbl.2009.0513; Baker KC, 1997, BEHAVIOUR, V134, P1031, DOI 10.1163/156853997X00386; BLOOMSTRAND M, 1986, ZOO BIOL, V5, P293, DOI 10.1002/zoo.1430050307; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Borgatti S., 2002, UCINET WINDOWS SOFTW; Bowler MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034505; Brent LJN, 2013, BEHAV ECOL SOCIOBIOL, V67, P349, DOI 10.1007/s00265-012-1455-8; Clark FE, 2013, AM J PRIMATOL, V75, P807, DOI 10.1002/ajp.22141; Clark FE, 2011, APPL ANIM BEHAV SCI, V135, P1, DOI 10.1016/j.applanim.2011.10.010; De Marco A, 2011, AM J PHYS ANTHROPOL, V146, P457, DOI 10.1002/ajpa.21606; Duboscq J, 2013, AM J PRIMATOL, V75, P361, DOI 10.1002/ajp.22114; Fagot J, 2013, AM J PRIMATOLOGY; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Fernandez EJ, 2008, ZOO BIOL, V27, P470, DOI 10.1002/zoo.20215; Flack J.C., 2004, MACAQUE SOC, P157; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; FUKUDA F, 1989, INT J PRIMATOL, V10, P419, DOI 10.1007/BF02736369; Gazes RP, 2013, ANIM COGN, V16, P445, DOI 10.1007/s10071-012-0585-8; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Herrelko ES, 2012, AM J PRIMATOL, V74, P828, DOI 10.1002/ajp.22036; JANSON CH, 1988, BEHAVIOUR, V105, P165, DOI 10.1163/156853988X00502; JUDGE PG, 1993, ANIM BEHAV, V46, P221, DOI 10.1006/anbe.1993.1184; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Meehan CL, 2007, APPL ANIM BEHAV SCI, V102, P246, DOI 10.1016/j.applanim.2006.05.031; Melfi VA, 2002, ANIM WELFARE, V11, P213; MENARD N, 1990, FOLIA PRIMATOL, V55, P166, DOI 10.1159/000156512; Micheletta J, 2012, P ROY SOC B-BIOL SCI, V279, P4042, DOI 10.1098/rspb.2012.1470; NOVAK MA, 1991, LAB ANIM SCI, V41, P308; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Paulus A, 2009, THESIS U PLYMOUTH PL; Perdue BM, 2012, ZOO BIOL, V31, P27, DOI 10.1002/zoo.20378; Rosenthal R, 1991, METAANALYTIC PROCEDU; Schel AM, 2013, AM J PRIMATOL, V75, P254, DOI 10.1002/ajp.22101; Schino G, 1996, ANXIETY, V2, P186; SCUCCHI S, 1991, PRIMATES, V32, P115, DOI 10.1007/BF02381606; Smith M., 2010, NODEXL FREE OPEN NET; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Thierry B., 2000, Primate Research, V16, P203; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; Waller BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044680; Wasserman EA, 2009, COMP COGNITION EXPT, P1	48	32	32	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78308	10.1371/journal.pone.0078308	http://dx.doi.org/10.1371/journal.pone.0078308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223146	Green Published, gold			2022-12-27	WOS:000326656200038
J	Wolnicka-Glubisz, A; Pecio, A; Podkowa, D; Plonka, PM; Grabacka, M				Wolnicka-Glubisz, Agnieszka; Pecio, Anna; Podkowa, Dagmara; Plonka, Przemyslaw Mieszko; Grabacka, Maja			HGF/SF Increases Number of Skin Melanocytes but Does Not Alter Quality or Quantity of Follicular Melanogenesis	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; INFLAMMATORY RESPONSE; COMPREHENSIVE GUIDE; UV-RADIATION; TELOGEN SKIN; HAIR CYCLE; MICE; DEFICIENT; MELANIN; GROWTH	Melanins are an important factor determining the vulnerability of mammalian skin to UV radiation and thus to UV-induced skin cancers. Transgenic mice overexpressing hepatocyte growth factor/scatter factor (HGF/SF) have extra-follicular dermal melanocytes, notably in the papillary upper dermis, and are susceptible to UV-induced melanoma. Pigmented HGF/SF neonatal mice are more susceptible than albino HGF/SF animals to UVA-induced melanoma, indicating an involvement of melanin in melanoma formation. This raises the question of the effect of transgenic HGF/SF on melanization. We developed a methodology to accurately quantitate both the production of melanin and the efficiency of melanogenesis in normal, and HGF/SF transgenic mice in vivo. Skin and hair shafts of 5 day old and adult (3 week old) C57BL/6-HGF/SF and corresponding C57BL/6 wild type mice were investigated by electron paramagnetic resonance spectroscopy (EPR) to quantitate melanin, by transmission electron microscopy (TEM) for the presence of melanosomes, and by standard histology and by Western blotting and zymography to determine the expression and activity of melanogenesis-related proteins. Eumelanin but no phaeomelanin was detected in transgenic C57BL/6-HGF and C57BL/6 wild type mice. Transgenic HGF/SF overexpression did not change the type of melanin produced in the skin or hair, did not affect the terminal content of melanin production in standard samples of hair and did not influence hair cycle/morphogenesis-related changes in skin thickness. No melanocytes were found in the epidermis and no melanosomes were found in epidermal keratinocytes. HGF/SF transgenic mice thus lack the epidermal melanin UV-protection found in constitutively dark human skin. We conclude that melanocytes in the HGF/SF transgenic mouse, particularly in the papillary dermis, are vulnerable to UVA which interacts with eumelanin but not phaeomelanin to induce melanoma.	[Wolnicka-Glubisz, Agnieszka; Plonka, Przemyslaw Mieszko] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland; [Pecio, Anna; Podkowa, Dagmara] Jagiellonian Univ, Inst Zool, Dept Comparat Anat, PL-30060 Krakow, Poland; [Grabacka, Maja] Univ Agr, Dept Food Biotechnol, Krakow, Poland	Jagiellonian University; Jagiellonian University; Agricultural University Krakow	Wolnicka-Glubisz, A (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland.	a.wolnicka-glubisz@uj.edu.pl	Grabacka, Maja/ABE-5286-2021	Grabacka, Maja/0000-0003-4407-8814; Wolnicka-Glubisz, Agnieszka/0000-0003-3070-6349; Pecio, Anna/0000-0001-9052-5844; Plonka, Przemyslaw/0000-0002-0261-3439	Foundation for Polish Science-POMOST program; European Union with in European Regional Development Fund; Faculty BBBt, UJ, BW	Foundation for Polish Science-POMOST program; European Union with in European Regional Development Fund; Faculty BBBt, UJ, BW	M.G. is supported by the Foundation for Polish Science-POMOST program co-financed by the European Union with in European Regional Development Fund. A.W-G. was supported by Faculty BBBt, UJ, BW-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Hill HZ, 1997, PHOTOCHEM PHOTOBIOL, V65, P983, DOI 10.1111/j.1751-1097.1997.tb07958.x; JIMBOW K, 1975, J INVEST DERMATOL, V64, P50, DOI 10.1111/1523-1747.ep12540914; JIMENEZCERVANTES C, 1993, PIGM CELL RES, V6, P394, DOI 10.1111/j.1600-0749.1993.tb00621.x; JINDO T, 1994, J INVEST DERMATOL, V103, P306, DOI 10.1111/1523-1747.ep12394731; KORYTOWSKI W, 1987, PHOTOCHEM PHOTOBIOL, V45, P185, DOI 10.1111/j.1751-1097.1987.tb05362.x; Lindner G, 2000, FASEB J, V14, P319, DOI 10.1096/fasebj.14.2.319; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Mizuno S, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/909350; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Noonan FP, 2012, NAT COMMUN, V6, P3; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; PLONKA P, 1995, ARCH DERMATOL RES, V287, P687, DOI 10.1007/BF00371744; Plonka PM, 2008, J DERMATOL SCI, V49, P227, DOI 10.1016/j.jdermsci.2007.09.010; Plonka PM, 2009, EXP DERMATOL, V18, P472, DOI 10.1111/j.1600-0625.2009.00883.x; Sarna Tadeusz, 2005, V23, P125, DOI 10.1007/0-387-26741-7_7; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; SEALY RC, 1982, SCIENCE, V217, P545, DOI 10.1126/science.6283638; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1994, J INVEST DERMATOL, V102, P862, DOI 10.1111/1523-1747.ep12382606; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Thong HY, 2003, BRIT J DERMATOL, V149, P498, DOI 10.1046/j.1365-2133.2003.05473.x; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Wolnicka A, 1998, FOLIA BIOL-KRAKOW, V46, P7; Wolnicka-Glubisz A, 2007, J LEUKOCYTE BIOL, V81, P1352, DOI 10.1189/jlb.1206729; Wolnicka-Glubisz A, 2013, EXP DERMATOL, V22, P226, DOI 10.1111/exd.12100; Wolnicka-Glubisz A, 2012, EXP DERMATOL, V21, P537, DOI 10.1111/j.1600-0625.2012.01511.x; Yamazaki F, 2004, J INVEST DERMATOL, V123, P220, DOI 10.1111/j.0022-202X.2004.22710.x	38	13	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e74883	10.1371/journal.pone.0074883	http://dx.doi.org/10.1371/journal.pone.0074883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223113	Green Published, gold			2022-12-27	WOS:000326656200005
J	Hallal, PC; Reichert, FF; Clark, VL; Cordeira, KL; Menezes, AMB; Eaton, S; Ekelund, U; Wells, JC				Hallal, Pedro C.; Reichert, Felipe F.; Clark, Valerie L.; Cordeira, Kelly L.; Menezes, Ana M. B.; Eaton, Simon; Ekelund, Ulf; Wells, Jonathan C.			Energy Expenditure Compared to Physical Activity Measured by Accelerometry and Self-Report in Adolescents: A Validation Study	PLOS ONE			English	Article							DOUBLY-LABELED-WATER; CHILDREN; AGE	Background: Physical inactivity is responsible for 5.3 million deaths annually worldwide. To measure physical activity energy expenditure, the doubly labeled water (DLW) method is the gold standard. However, questionnaires and accelerometry are more widely used. We compared physical activity measured by accelerometer and questionnaire against total (TEE) and physical activity energy expenditure (PAEE) estimated by DLW. Methods: TEE, PAEE (TEE minus resting energy expenditure) and body composition were measured using the DLW technique in 25 adolescents (16 girls) aged 13 years living in Pelotas, Brazil. Physical activity was assessed using the Actigraph accelerometer and by self-report. Physical activity data from accelerometry and self-report were tested against energy expenditure data derived from the DLW method. Further, tests were done to assess the ability of moderate-tovigorous intensity physical activity (MVPA) to predict variability in TEE and to what extent adjustment for fat and fat-free mass predicted the variability in TEE. Results: TEE varied from 1,265 to 4,143 kcal/day. It was positively correlated with physical activity (counts) estimated by accelerometry (rho = 0.57; p = 0.003) and with minutes per week of physical activity by questionnaire (rho = 0.41; p = 0.04). An increase of 10 minutes per day in moderate-to-vigorous intensity physical activity (MVPA) relates to an increase in TEE of 141 kcal/day. PAEE was positively correlated with accelerometry (rho = 0.64; p = 0.007), but not with minutes per week of physical activity estimated by questionnaire (rho = 0.30; p = 0.15). Physical activity by accelerometry explained 31% of the vssariability in TEE. By incorporating fat and fat-free mass in the model, we were able to explain 58% of the variability in TEE. Conclusion: Objectively measured physical activity significantly contributes to the explained variance in both TEE and PAEE in Brazilian youth. Independently, body composition also explains variance in TEE, and should ideally be taken into account when using accelerometry to predict energy expenditure values.	[Hallal, Pedro C.; Reichert, Felipe F.; Clark, Valerie L.; Cordeira, Kelly L.; Menezes, Ana M. B.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Hallal, Pedro C.; Wells, Jonathan C.] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England; [Eaton, Simon] UCL, Inst Child Hlth, Dept Surg, London, England; [Ekelund, Ulf] UCL, Inst Child Hlth, MRC Epidemiol Unit, London, England; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway	Universidade Federal de Pelotas; University of London; University College London; University of London; University College London; University of London; University College London; Norwegian School of Sport Sciences	Hallal, PC (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	prchallal@gmail.com	Ekelund, Ulf/AAE-8471-2019; Hallal, Pedro C/A-3249-2011; Wells, Jonathan/A-4604-2009; Menezes, Ana MB/G-7266-2012	Ekelund, Ulf/0000-0003-2115-9267; Hallal, Pedro C/0000-0003-1470-6461; Wells, Jonathan/0000-0003-0411-8025; Menezes, Ana MB/0000-0002-2996-9427; Eaton, Simon/0000-0003-0892-9204	Royal Society through the Newton International Fellowship scheme; Wellcome Trust through an Investigator Award [095582Z11Z]; Medical Research Council [MC_U106179473, MC_UU_12015/3] Funding Source: researchfish; MRC [MC_U106179473, MC_UU_12015/3] Funding Source: UKRI	Royal Society through the Newton International Fellowship scheme; Wellcome Trust through an Investigator Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Royal Society through the Newton International Fellowship scheme. The first author is currently funded by the Wellcome Trust through an Investigator Award (Grant #095582Z11Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MG, 2008, APPL PHYSIOL NUTR ME, V33, P1155, DOI [10.1139/H08-103, 10.1139/h08-103]; Arvidsson I, 2006, INT J IND ERGONOM, V36, P613, DOI 10.1016/j.ergon.2006.03.002; Bastos JP, 2008, J PHYS ACT HEALTH, V5, P777, DOI 10.1123/jpah.5.6.777; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; COLE TJ, 1992, AM J PHYSIOL, V263, pE965, DOI 10.1152/ajpendo.1992.263.5.E965; Corder K, 2009, AM J CLIN NUTR, V89, P862, DOI 10.3945/ajcn.2008.26739; COWARD WA, 1988, P NUTR SOC, V47, P209, DOI 10.1079/PNS19880037; Ekelund U, 2004, AM J CLIN NUTR, V79, P851; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Ekelund U, 2011, BRIT J SPORT MED, V45, P859, DOI 10.1136/bjsports-2011-090190; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Hoos MB, 2003, EUR J APPL PHYSIOL, V89, P624, DOI 10.1007/s00421-003-0891-6; Johnson RK, 1998, INT J OBESITY, V22, P1046, DOI 10.1038/sj.ijo.0800723; Krishnaveni GV, 2009, INDIAN PEDIATR, V46, P1055; Montgomery C, 2004, AM J CLIN NUTR, V80, P591; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; Wells JCK, 1998, NUTRITION, V14, P817, DOI 10.1016/S0899-9007(98)00092-6; Wells JCK, 2010, AM J CLIN NUTR, V91, P610, DOI 10.3945/ajcn.2009.28428	27	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77036	10.1371/journal.pone.0077036	http://dx.doi.org/10.1371/journal.pone.0077036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223707	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000326503400008
J	Kriebel, K; Biedermann, A; Kreikemeyer, B; Lang, H				Kriebel, Katja; Biedermann, Anne; Kreikemeyer, Bernd; Lang, Hermann			Anaerobic Co-Culture of Mesenchymal Stem Cells and Anaerobic Pathogens - A New In Vitro Model System	PLOS ONE			English	Article							ORAL EPITHELIAL-CELLS; PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PERIODONTAL PATHOGENS; ENDOTHELIAL-CELLS; CYTOKINE RESPONSE; IMMUNE-RESPONSE; INVASION; HYPOXIA	Background: Human mesenchymal stem cells (hMSCs) are multipotent by nature and are originally isolated from bone marrow. In light of a future application of hMSCs in the oral cavity, a body compartment with varying oxygen partial pressures and an omnipresence of different bacterial species i. e. periodontitis pathogens, we performed this study to gain information about the behavior of hMSC in an anaerobic system and the response in interaction with oral bacterial pathogens. Methodology/Principal Findings: We established a model system with oral pathogenic bacterial species and eukaryotic cells cultured in anaerobic conditions. The facultative anaerobe bacteria Fusobacterium nucleatum, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans were studied. Their effects on hMSCs and primary as well as permanent gingival epithelial cells (Ca9-22, HGPEC) were comparatively analyzed. We show that hMSCs cope with anoxic conditions, since 40% vital cells remain after 72 h of anaerobic culture. The Ca9-22 and HGPEC cells are significantly more sensitive to lack of oxygen. All bacterial species reveal a comparatively low adherence to and internalization into hMSCs (0.2% and 0.01% of the initial inoculum, respectively). In comparison, the Ca9-22 and HGPEC cells present better targets for bacterial adherence and internalization. The production of the pro-inflammatory chemokine IL-8 is higher in both gingival epithelial cell lines compared to hMSCs and Fusobacterium nucleatum induce a time-dependent cytokine secretion in both cell lines. Porphyromonas gingivalis is less effective in stimulating secretion of IL-8 in the co-cultivation experiments. Conclusions/significance: HMSCs are suitable for use in anoxic regions of the oral cavity. The interaction with local pathogenic bacteria does not result in massive pro-inflammatory cytokine responses. The test system established in this study allowed further investigation of parameters prior to set up of oral hMSC in vivo studies.	[Kriebel, Katja] Univ Rostock, Katja Kriebel Dept Operat Dent & Periodontol, D-18055 Rostock, Germany; [Biedermann, Anne] Univ Rostock, Anne Biedermann Dept Operat Dent & Periodontol, D-18055 Rostock, Germany; [Kreikemeyer, Bernd] Univ Rostock, Bernd Kreikemeyer Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany; [Lang, Hermann] Univ Rostock, Hermann Lang Dept Operat Dent & Periodontol, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock	Lang, H (corresponding author), Univ Rostock, Hermann Lang Dept Operat Dent & Periodontol, D-18055 Rostock, Germany.	hermann.lang@uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098				Andrian E, 2004, INFECT IMMUN, V72, P4689, DOI 10.1128/IAI.72.8.4689-4698.2004; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-5; Chiesa S, 2011, P NATL ACAD SCI USA, V108, P17384, DOI 10.1073/pnas.1103650108; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Crisostomo PR, 2006, SHOCK, V26, P571, DOI 10.1097/01.shk.0000233195.63859.ef; Dabija-Wolter G, 2009, J PERIODONTOL, V80, P1174, DOI 10.1902/jop.2009.090051; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Diaz PI, 2000, FEMS MICROBIOL LETT, V187, P31, DOI 10.1016/S0378-1097(00)00174-9; Dorn BR, 2000, FEMS MICROBIOL LETT, V187, P139, DOI 10.1016/S0378-1097(00)00191-9; DUNCAN MJ, 1993, INFECT IMMUN, V61, P2260, DOI 10.1128/IAI.61.5.2260-2265.1993; Eberhard J, 2009, ORAL MICROBIOL IMMUN, V24, P325, DOI 10.1111/j.1399-302X.2009.00518.x; Ellen RP, 1999, MICROBES INFECT, V1, P621, DOI 10.1016/S1286-4579(99)80062-8; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Gursoy UK, 2008, ORAL MICROBIOL IMMUN, V23, P432, DOI 10.1111/j.1399-302X.2008.00453.x; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hirose K, 1996, ORAL MICROBIOL IMMUN, V11, P402, DOI 10.1111/j.1399-302X.1996.tb00202.x; Horikoshi M, 1974, Nihon Koku Geka Gakkai Zasshi, V20, P100; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Huang GTJ, 2001, INFECT IMMUN, V69, P1364, DOI 10.1128/IAI.69.3.1364-1372.2001; Jain Manu, 2005, Proc Am Thorac Soc, V2, P202, DOI 10.1513/pats.200501-006AC; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Madianos PN, 1996, INFECT IMMUN, V64, P660, DOI 10.1128/IAI.64.2.660-664.1996; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Meyer DH, 1996, INFECT IMMUN, V64, P2988, DOI 10.1128/IAI.64.8.2988-2997.1996; Meyer DH, 1997, CRIT REV ORAL BIOL M, V8, P389, DOI 10.1177/10454411970080040301; Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x; Nasef A, 2007, GENE EXPRESSION, V13, P217; Njoroge T, 1997, INFECT IMMUN, V65, P1980, DOI 10.1128/IAI.65.5.1980-1984.1997; Pan YP, 2009, MICROB PATHOGENESIS, V46, P73, DOI 10.1016/j.micpath.2008.10.012; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rudney JD, 2001, INFECT IMMUN, V69, P2700, DOI 10.1128/IAI.69.4.2700-2707.2001; Saito A, 2009, MICROB PATHOGENESIS, V47, P329, DOI 10.1016/j.micpath.2009.09.012; Saito A, 2008, FEMS IMMUNOL MED MIC, V54, P349, DOI 10.1111/j.1574-695X.2008.00481.x; Scheres N, 2010, J PERIODONTAL RES, V45, P262, DOI 10.1111/j.1600-0765.2009.01229.x; Shi Y, 2012, TRENDS IMMUNOLOGY; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318	47	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78226	10.1371/journal.pone.0078226	http://dx.doi.org/10.1371/journal.pone.0078226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223777	Green Published, gold			2022-12-27	WOS:000326503400040
J	Munnink, BBO; Farsani, SMJ; Deijs, M; Jonkers, J; Verhoeven, JTP; Ieven, M; Goossens, H; de Jong, MD; Berkhout, B; Loens, K; Kellam, P; Bakker, M; Canuti, M; Cotten, M; van der Hoek, L				Munnink, Bas B. Oude; Farsani, Seyed Mohammad Jazaeri; Deijs, Martin; Jonkers, Jiri; Verhoeven, Joost T. P.; Ieven, Margareta; Goossens, Herman; de Jong, Menno D.; Berkhout, Ben; Loens, Katherine; Kellam, Paul; Bakker, Margreet; Canuti, Marta; Cotten, Matthew; van der Hoek, Lia			Autologous Antibody Capture to Enrich Immunogenic Viruses for Viral Discovery	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CORONAVIRUS; IDENTIFICATION; MUSCLE; NL63	Discovery of new viruses has been boosted by novel deep sequencing technologies. Currently, many viruses can be identified by sequencing without knowledge of the pathogenicity of the virus. However, attributing the presence of a virus in patient material to a disease in the patient can be a challenge. One approach to meet this challenge is identification of viral sequences based on enrichment by autologous patient antibody capture. This method facilitates identification of viruses that have provoked an immune response within the patient and may increase the sensitivity of the current virus discovery techniques. To demonstrate the utility of this method, virus discovery deep sequencing (VIDISCA-454) was performed on clinical samples from 19 patients: 13 with a known respiratory viral infection and 6 with a known gastrointestinal viral infection. Patient sera was collected from one to several months after the acute infection phase. Input and antibody capture material was sequenced and enrichment was assessed. In 18 of the 19 patients, viral reads from immunogenic viruses were enriched by antibody capture (ranging between 1.5x to 343x in respiratory material, and 1.4x to 53x in stool). Enriched reads were also determined in an identity independent manner by using a novel algorithm Xcompare. In 16 of the 19 patients, 21% to 100% of the enriched reads were derived from infecting viruses. In conclusion, the technique provides a novel approach to specifically identify immunogenic viral sequences among the bulk of sequences which are usually encountered during virus discovery metagenomics.	[Munnink, Bas B. Oude; Farsani, Seyed Mohammad Jazaeri; Deijs, Martin; Jonkers, Jiri; Verhoeven, Joost T. P.; de Jong, Menno D.; Berkhout, Ben; Bakker, Margreet; Canuti, Marta; van der Hoek, Lia] Univ Amsterdam, Acad Med Ctr, CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Farsani, Seyed Mohammad Jazaeri] Univ Tehran Med Sci, Tehran, Iran; [Ieven, Margareta; Goossens, Herman; Loens, Katherine] Univ Antwerp Hosp, Dept Med Microbiol, Vaccine & Infect Dis Inst, Antwerp, Belgium; [Kellam, Paul; Cotten, Matthew] Wellcome Trust Sanger Inst, Hinxton, England	University of Amsterdam; Academic Medical Center Amsterdam; Tehran University of Medical Sciences; University of Antwerp; Wellcome Trust Sanger Institute	van der Hoek, L (corresponding author), Univ Amsterdam, Acad Med Ctr, CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.m.vanderhoek@amc.uva.nl	van der Hoek, Lia/Y-6412-2019; Munnink, Bas B Oude/H-8435-2018; Canuti, Marta/I-3145-2019	Canuti, Marta/0000-0002-9959-128X; Cotten, Matthew/0000-0002-3361-3351; Kellam, Paul/0000-0003-3166-4734	European Community's Seventh Framework Programme (FP7) under the project EMPERIE, EC grant [223498]; VIDI grant from the Netherlands Organization for Scientific Research (NWO) [016.066.318]; European Community's Sixth Framework Programme under the project GRACE, EC grant [LSHM-CT-2005-518226]	European Community's Seventh Framework Programme (FP7) under the project EMPERIE, EC grant; VIDI grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community's Sixth Framework Programme under the project GRACE, EC grant	This study was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project EMPERIE, EC grant agreement number 223498, and VIDI grant 016.066.318 from the Netherlands Organization for Scientific Research (NWO). European Community's Sixth Framework Programme under the project GRACE, EC grant agreement number LSHM-CT-2005-518226. The computing resources used in this work were provided by SurfSara (http://www.surfsara.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; de Vries M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016118; Dijkman R, 2008, J CLIN MICROBIOL, V46, P2368, DOI 10.1128/JCM.00533-08; Dijkman R, 2012, J CLIN VIROL, V53, P135, DOI 10.1016/j.jcv.2011.11.011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; Gouandjika-Vasilache I, 2005, TROP MED INT HEALTH, V10, P743, DOI 10.1111/j.1365-3156.2005.01454.x; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jazaeri Farsani SM, 2013, VOXS, V8, P193; LETAN V, 2013, MBIO, V4, DOI DOI 10.1128/MBI0.00231-13; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; PEREIRA HG, 1988, LANCET, V2, P103; Pyrc K, 2007, EXPERT REV ANTI-INFE, V5, P245, DOI 10.1586/14787210.5.2.245; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sauvage V, 2011, J VIROL, V85, P7948, DOI 10.1128/JVI.00639-11; Schomacker H, 2012, CURR OPIN VIROL, V2, P294, DOI 10.1016/j.coviro.2012.02.001; SIMHON A, 1985, AM J TROP MED HYG, V34, P931, DOI 10.4269/ajtmh.1985.34.931; SMITH CB, 1966, NEW ENGL J MED, V275, P1145, DOI 10.1056/NEJM196611242752101; Van der Hoek L, 2007, AIDS RES HUM RETROV, V23, P466, DOI 10.1089/aid.2006.0184; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	26	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78454	10.1371/journal.pone.0078454	http://dx.doi.org/10.1371/journal.pone.0078454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223808	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326503400062
J	Sun, X; Kay, AD; Kang, HZ; Small, GE; Liu, GF; Zhou, X; Yin, S; Liu, CJ				Sun, Xiao; Kay, Adam D.; Kang, Hongzhang; Small, Gaston E.; Liu, Guofang; Zhou, Xuan; Yin, Shan; Liu, Chunjiang			Correlated Biogeographic Variation of Magnesium across Trophic Levels in a Terrestrial Food Chain	PLOS ONE			English	Article							LEAF-LITTER; STOICHIOMETRY; SOIL; TEMPERATURE; PHOSPHORUS; PATTERNS; CALCIUM; NUTRIENTS; GRADIENT; CLIMATE	Using samples from eastern China (c. 25 - 41 degrees N and 99 - 123 degrees E) and from a common garden experiment, we investigate how Mg concentration varies with climate across multiple trophic levels. In soils, plant tissue (Oriental oak leaves and acorns), and a specialist acorn predator (the weevil Curculio davidi), Mg concentration increased significantly with different slopes from south to north, and generally decreased with both mean annual temperature (MAT) and precipitation (MAP). In addition, soil, leaf, acorn and weevil Mg showed different strengths of association and sensitivity with climatic factors, suggesting that distinct mechanisms may drive patterns of Mg variation at different trophic levels. Our findings provide a first step toward determining whether anticipated changes in temperature and precipitation due to climate change will have important consequences for the bioavailability and distribution of Mg in food chain.	[Sun, Xiao; Kang, Hongzhang; Zhou, Xuan; Yin, Shan; Liu, Chunjiang] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Kay, Adam D.; Small, Gaston E.] Univ St Thomas, Dept Biol, St Paul, MN USA; [Liu, Guofang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yin, Shan; Liu, Chunjiang] Shanghai Jiao Tong Univ, Res Ctr Low Carbon Agr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; University of St Thomas Minnesota; Chinese Academy of Sciences; Institute of Botany, CAS; Shanghai Jiao Tong University	Liu, CJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	chjliu@sjtu.edu.cn	zhou, xuan/GZA-8157-2022	Kang, Hongzhang/0000-0003-4026-3588; Small, Gaston/0000-0002-9018-7555	National Natural Science Foundation of China [NSFC 31070532, 30800138, 30671674]; Science and Technology Commission of Shanghai Municipality [10JC1407000]; U.S. National Science Foundation [NSF-DEB 0842038]; Direct For Biological Sciences [0842038] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was financially supported by the National Natural Science Foundation of China (NSFC 31070532, 30800138 and 30671674), and the Science and Technology Commission of Shanghai Municipality (10JC1407000). A. D. Kay was supported by the U.S. National Science Foundation (NSF-DEB 0842038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Agren GI, 2012, NEW PHYTOL, V194, P944, DOI 10.1111/j.1469-8137.2012.04114.x; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Bohonak A. J., 2004, RMA SOFTWARE REDUCED; De Frenne P, 2011, PLANT BIOLOGY, V13, P493, DOI 10.1111/j.1438-8677.2010.00404.x; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; ERICSSON T, 1988, PHYSIOL PLANTARUM, V72, P227, DOI 10.1111/j.1399-3054.1988.tb05827.x; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; Hermans C, 2004, PLANTA, V220, P344, DOI 10.1007/s00425-004-1340-4; Huang NH, 2009, J FIRE SCI, V27, P235, DOI 10.1177/0734904108099334; JOHANSSON MB, 1995, FORESTRY, V68, P49, DOI 10.1093/forestry/68.1.49; Kay AD, 2005, OIKOS, V109, P6, DOI 10.1111/j.0030-1299.2005.14048.x; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2004, BIODIVERS CONSERV, V13, P659; Mayland H.F., 1988, RUMINANT ANIMAL DIGE, P511; MAYLAND HF, 1989, J ANIM SCI, V67, P3437; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; NOWELL NW, 1963, J APPL PHYSIOL, V18, P967, DOI 10.1152/jappl.1963.18.5.967; Pratihar Suman, 2009, South American Journal of Herpetology, V4, P51, DOI 10.2994/057.004.0106; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; REINBOTT TM, 1994, AGRON J, V86, P523, DOI 10.2134/agronj1994.00021962008600030013x; Riedesel ML, 1956, SERUM MAGNESIUM CHAN; Sardans J, 2008, BIOGEOCHEMISTRY, V87, P49, DOI 10.1007/s10533-007-9167-2; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sun X, 2013, J INSECT PHYSL; Wang L, 1985, J BEIJING FOR COLL, V3, P57	34	11	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78444	10.1371/journal.pone.0078444	http://dx.doi.org/10.1371/journal.pone.0078444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223807	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400061
J	Hus, I; Bojarska-Junak, A; Chocholska, S; Tomczak, W; Wos, J; Dmoszynska, A; Rolinski, J				Hus, Iwona; Bojarska-Junak, Agnieszka; Chocholska, Sylwia; Tomczak, Waldemar; Wos, Justyna; Dmoszynska, Anna; Rolinski, Jacek			Th17/IL-17A Might Play a Protective Role in Chronic Lymphocytic Leukemia Immunity	PLOS ONE			English	Article							REGULATORY T-CELLS; NECROSIS-FACTOR-ALPHA; HELPER 17 CELLS; TH17 CELLS; PERIPHERAL-BLOOD; B-CELLS; INTERLEUKIN-10 LEVELS; CLINICAL-SIGNIFICANCE; DISEASE PROGRESSION; T(H)17 CELLS	Th17 cells, a recently discovered subset of T helper cells that secrete IL-17A, can affect the inflammation process autoimmune and cancer diseases development. The purpose of this study was to evaluate the role of Th17 cells and IL17A in biology of CLL. The study group included 294 untreated CLL patients in different clinical stages. Here, we show that higher Th17 and IL-17A values were associated with less advanced clinical stage of CLL. Th17 cells' percentages in PB were lower in patients who died due to CLL during follow-up due to CLL (as compared to surviving patients) and in patients responding to first-line therapy with fludarabine-based regimens (as compared to non-responders). IL-17A inversely correlated with the time from CLL diagnosis to the start of therapy and was lower in patients who required treatment during follow-up. Th-17 and IL-17A values were lower in patients with adverse prognostic factors (17p and 11q deletion, CD38 and ZAP-70 expression). CLL patients with detectable IL-17A mRNA in T cells were in Rai Stage 0 and negative for both ZAP-70 and CD38 expression. Th17 percentages positively correlated with iNKT and adversely with Treg cells. The results of this study suggest that Th17 may play a beneficial role in CLL immunity.	[Hus, Iwona; Chocholska, Sylwia; Tomczak, Waldemar; Dmoszynska, Anna] Med Univ Lublin, Dept Haematooncol & Bone Marrow Transplantat, Lublin, Poland; [Bojarska-Junak, Agnieszka; Wos, Justyna; Rolinski, Jacek] Med Univ Lublin, Dept Clin Immunol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin	Bojarska-Junak, A (corresponding author), Med Univ Lublin, Dept Clin Immunol, Lublin, Poland.	agnieszkajunak@poczta.onet.pl	Hus, Iwona/AAB-2809-2020; Bojarska-Junak, Agnieszka/AAK-3714-2021	Hus, Iwona/0000-0002-6096-4093; Bojarska-Junak, Agnieszka/0000-0003-2340-9442; Tomczak, Waldemar/0000-0002-3205-5781; Chocholska, Sylwia/0000-0002-5001-9258; Rolinski, Jacek/0000-0003-4841-6120; wos, justyna/0000-0002-9597-5331; Rolinski, Jacek Mariusz/0000-0001-5596-2651	State Funds for Scientific Research of National Science Centre (NCN) [GR831];  [N N402 351438];  [N N404 682440];  [N N402 439139];  [N N402 683140]	State Funds for Scientific Research of National Science Centre (NCN); ; ; ; 	This work was supported by research grants: N N402 351438, N N404 682440, N N402 439139, N N402 683140 and Development Grant GR831 from State Funds for Scientific Research of National Science Centre (NCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer M, 2005, BLOOD, V106, P2018, DOI 10.1182/blood-2005-02-0642; Beyer M, 2009, CURR PHARM DESIGN, V15, P1879, DOI 10.2174/138161209788453211; Bojarska-Junak A, 2002, HAEMATOLOGICA, V87, P490; Bojarska-Junak A, 2008, LEUKEMIA RES, V32, P225, DOI 10.1016/j.leukres.2007.06.007; Chong SY, 2001, GENES IMMUN, V2, P239, DOI 10.1038/sj.gene.6363773; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; D'Arena G, 2011, LEUKEMIA RES, V35, P363, DOI 10.1016/j.leukres.2010.08.010; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; de Jong E, 2010, CLIN EXP IMMUNOL, V159, P148, DOI 10.1111/j.1365-2249.2009.04041.x; Fayad L, 2001, BLOOD, V97, P256, DOI 10.1182/blood.V97.1.256; Ferrajoli A, 2002, BLOOD, V100, P1215, DOI 10.1182/blood.V100.4.1215.h81602001215_1215_1219; Furman RR, 2010, HEMATOL-AM SOC HEMAT, P77, DOI 10.1182/asheducation-2010.1.77; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hus I, 2006, ANN ONCOL, V17, P683, DOI 10.1093/annonc/mdj120; Jadidi-Niaragh F, 2013, TUMOR BIOL, V34, P929, DOI 10.1007/s13277-012-0628-4; Jain P, 2012, HAEMATOL-HEMATOL J, V97, P599, DOI 10.3324/haematol.2011.047316; Ji YQ, 2010, CANCER IMMUNOL IMMUN, V59, P979, DOI 10.1007/s00262-010-0849-6; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kordasti SY, 2009, BRIT J HAEMATOL, V145, P64, DOI 10.1111/j.1365-2141.2009.07593.x; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Lech-Maranda E, 2012, ARCH IMMUNOL THER EX, V60, P477, DOI 10.1007/s00005-012-0197-7; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Maruyama T, 2010, CANCER SCI, V101, P1947, DOI 10.1111/j.1349-7006.2010.01624.x; Mellstedt H, 2006, CANCER IMMUNOL IMMUN, V55, P210, DOI 10.1007/s00262-005-0675-4; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Palmer S, 2008, BRIT J HAEMATOL, V141, P607, DOI 10.1111/j.1365-2141.2008.07070.x; Podhorecka M, 2002, LEUKEMIA RES, V26, P657, DOI 10.1016/S0145-2126(01)00194-1; Podhorecka Monika, 2004, Postepy Hig Med Dosw (Online), V58, P236; Prabhala RH, 2010, BLOOD, V115, P5385, DOI 10.1182/blood-2009-10-246660; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Scrivener S, 2003, LEUKEMIA LYMPHOMA, V44, P383, DOI 10.1080/1042819021000029993; Seino K, 2006, CANCER SCI, V97, P807, DOI 10.1111/j.1349-7006.2006.00257.x; Tinhofer I, 2006, BLOOD, V108, P2950, DOI 10.1182/blood-2006-03-010553; Wang J, 2011, J INT MED RES, V39, P691, DOI 10.1177/147323001103900301; Weinkove R, 2013, HAEMATOLOGICA, V98, P376, DOI 10.3324/haematol.2012.072835; Wilke CM, 2011, CARCINOGENESIS, V32, P643, DOI 10.1093/carcin/bgr019; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Ye ZJ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-77; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhou P, 2010, J INT MED RES, V38, P611, DOI 10.1177/147323001003800223; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	44	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78091	10.1371/journal.pone.0078091	http://dx.doi.org/10.1371/journal.pone.0078091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223764	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300021
J	Zhong, M; Kawaguchi, R; Ter-Stepanian, M; Kassai, M; Sun, H				Zhong, Ming; Kawaguchi, Riki; Ter-Stepanian, Mariam; Kassai, Miki; Sun, Hui			Vitamin A Transport and the Transmembrane Pore in the Cell-Surface Receptor for Plasma Retinol Binding Protein	PLOS ONE			English	Article							LARGE-SCALE MUTAGENESIS; POTASSIUM CHANNELS; MEMBRANE-RECEPTOR; MOLECULAR-BASIS; VISUAL CYCLE; MICE LACKING; MUTATIONS; ACID; DEFICIENCY; STRA6	Vitamin A and its derivatives (retinoids) play diverse and crucial functions from embryogenesis to adulthood and are used as therapeutic agents in human medicine for eye and skin diseases, infections and cancer. Plasma retinol binding protein (RBP) is the principal and specific vitamin A carrier in the blood and binds vitamin A at 1:1 ratio. STRA6 is the high-affinity membrane receptor for RBP and mediates cellular vitamin A uptake. STRA6 null mice have severely depleted vitamin A reserves for vision and consequently have vision loss, even under vitamin A sufficient conditions. STRA6 null humans have a wide range of severe pathological phenotypes in many organs including the eye, brain, heart and lung. Known membrane transport mechanisms involve transmembrane pores that regulate the transport of the substrate (e.g., the gating of ion channels). STRA6 represents a new type of membrane receptor. How this receptor interacts with its transport substrate vitamin A and the functions of its nine transmembrane domains are still completely unknown. These questions are critical to understanding the molecular basis of STRA6's activities and its regulation. We employ acute chemical modification to introduce chemical side chains to STRA6 in a site-specific manner. We found that modifications with specific chemicals at specific positions in or near the transmembrane domains of this receptor can almost completely suppress its vitamin A transport activity. These experiments provide the first evidence for the existence of a transmembrane pore, analogous to the pore of ion channels, for this new type of cell-surface receptor.	[Sun, Hui] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Physiol, Los Angeles, CA 90095 USA.	hsun@mednet.ucla.edu	Kawaguchi, Riki/AAV-6090-2020		National Institutes of Health [R01EY018144]; NATIONAL EYE INSTITUTE [R01EY018144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health grant R01EY018144. H.S. is an Early Career Scientist of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; BEZANILLA F, 1974, SCIENCE, V183, P753, DOI 10.1126/science.183.4126.753; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BOK D, 1976, EXP EYE RES, V22, P395, DOI 10.1016/0014-4835(76)90177-9; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chivot M, 2005, AM J CLIN DERMATOL, V6, P13, DOI 10.2165/00128071-200506010-00002; Crouch RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P613, DOI 10.1111/j.1751-1097.1996.tb03114.x; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drager Ursula C, 2006, Sci STKE, V2006, ppe10, DOI 10.1126/stke.3242006pe10; Evans R M, 1994, Harvey Lect, V90, P105; Folli C, 2005, BIOCHEM BIOPH RES CO, V336, P1017, DOI 10.1016/j.bbrc.2005.08.227; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; HELLER J, 1973, J BIOL CHEM, V248, P6308; HELLER J, 1975, J BIOL CHEM, V250, P3613; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2013, JOVE-J VIS EXP, DOI 10.3791/50169; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kefalov VJ, 2012, J BIOL CHEM, V287, P1635, DOI 10.1074/jbc.R111.303008; Labro AJ, 2012, J GEN PHYSIOL, V140, P481, DOI 10.1085/jgp.201210817; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LOVE JM, 1994, CURR OPIN CELL BIOL, V6, P825, DOI 10.1016/0955-0674(94)90051-5; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nau H., 1994, Vitamin A in health and disease., P615; Nau H, 2001, J AM ACAD DERMATOL, V45, pS183, DOI 10.1067/mjd.2001.113720; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Orfanos CE, 1997, DRUGS, V53, P358, DOI 10.2165/00003495-199753030-00003; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; RASK L, 1976, J BIOL CHEM, V251, P6360; RASK L, 1980, SCAND J CLIN LAB INV, V40, P45; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Sun H, 2011, INT REV CEL MOL BIO, V288, P1, DOI 10.1016/B978-0-12-386041-5.00001-7; Szeto W, 2001, CANCER RES, V61, P4197; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WEST KP, 1993, LANCET, V342, P1420, DOI 10.1016/0140-6736(93)92776-P; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zanotti G, 2004, VITAM HORM, V69, P271, DOI 10.1016/S0083-6729(04)69010-8; Zhong M, 2012, NUTRIENTS, V4, P2069, DOI 10.3390/nu4122069; Zouboulis CC, 2001, SKIN PHARMACOL APPL, V14, P303, DOI 10.1159/000056361	68	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e73838	10.1371/journal.pone.0073838	http://dx.doi.org/10.1371/journal.pone.0073838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223695	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300001
J	Furuya-Kanamori, L; Kelly, MD; McKenzie, SJ				Furuya-Kanamori, Luis; Kelly, Mark D.; McKenzie, Samantha J.			Co-Morbidity, Ageing and Predicted Mortality in Antiretroviral Treated Australian Men: A Quantitative Analysis	PLOS ONE			English	Article							HIV-INFECTION; GENERAL-POPULATION; THERAPY; DISEASE; COHORT; RISK; AIDS; AGE; INDIVIDUALS; UPDATE	Background: Life expectancy has increased in HIV-positive individuals receiving combination antiretroviral therapy (cART); however, they still experience increased mortality due to ageing-associated comorbidities compared with HIV-negative individuals. Methods: A retrospective study of 314 Queensland HIV-infected males on cART was conducted. The negative impact of ageing was assessed by estimating the probability of 5-year mortality; comparisons were made between an HIV-specific predictive tool (VACS index) and the Australian Bureau of Statistics (ABS) life-tables to examine potential differences attributed to HIV. The negative impact of ageing was also assessed by the prevalence of comorbidities. Associations between comorbidity and estimates of predicted mortality by regression analysis were assessed. Results: The mean predicted 5-year mortality rate was 6% using the VACS index compared with 2.1% using the ABS life-table (p<0.001). The proportion of patients at predicted high risk of mortality (>9%) using the VACS index or ABS life-table were 17% and 1.8% respectively. Comorbidities were also more prevalent in this cohort compared with rates of comorbidities in age-matched Australian men from the general population. Metabolic disease (38.2%) was the most prevalent comorbidity followed by renal (33.1%) and cardiovascular disease (23.9%). Multivariate analysis demonstrated that patients with a history of cardiovascular disease had a higher predicted risk of mortality (OR=1.69; 95% CI: 1.17-2.45) whereas ex-smokers had a lower predicted risk of mortality (OR=0.61; 95% CI: 0.41-0.92). Conclusions: Using the VACS Index there is an increased predicted risk of mortality in cART-treated HIV infected Australian men compared with age-matched men using the ABS data. This increased predicted mortality risk is associated with cardiovascular disease and the number of comorbidities per subject; which suggests that the VACS Index may discriminate between high and low predicted mortality risks in this population. However, until the VACS Index is validated in Australia this data may suggest the VACS Index overestimates predicted mortality risk in this country.	[Furuya-Kanamori, Luis; McKenzie, Samantha J.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4072, Australia; [Kelly, Mark D.] Brisbane Sexual Hlth & HIV Serv, Brisbane, Qld, Australia	University of Queensland	Furuya-Kanamori, L (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4072, Australia.	luis.furuyakanamori@uqconnect.edu.au	McKenzie, Samantha/A-2516-2010	McKenzie, Samantha/0000-0003-1328-4527; Furuya-Kanamori, Luis/0000-0002-4337-9757				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldaz P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-300; Althoff KN, 2013, EV OCC SIM AG COMP H; American Psychiatric Association, 2000, QUICK REF DIAGN CRIT; Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Australasian Society for HIV Medicine, 2010, GUID AUSTR; Australian Bureau of Statistics, 2012, 3302 0 55 001 LIF TA; Australian Bureau of Statistics, 2012, NAT HLTH SURV SUMM R, P2011; Australian Bureau of Statistics, 2009, AUSTR SOC TRENDS; Australian Institute of Health and Welfare, 2010, AUSTR HLTH 2010; Bloch M, 2012, JAIDS-J ACQ IMM DEF, V59, P478, DOI 10.1097/QAI.0b013e31824a5473; Boyle RG, 2000, PREV MED, V31, P177, DOI 10.1006/pmed.2000.0699; Brennan M, 2010, HIV AIDS-MED SOC PSY, P1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Deeks Steven G, 2009, Top HIV Med, V17, P118; Dobson A. J., 2010, INTRO GEN LINEAR MOD, V2nd; Fisher M, 2012, CURR OPIN INFECT DIS, V25, P1, DOI 10.1097/QCO.0b013e32834f14fa; Frederic P, 2009, SOCIALIZED MED SOCIA; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Gracey D, 2013, INTERN MED J, V43, P410, DOI 10.1111/j.1445-5994.2012.02933.x; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hester EK, 2012, NUTR CLIN PRACT, V27, P51, DOI 10.1177/0884533611431985; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jacob T, 2013, ALCOHOL CLIN EXP RES, V28, P12071; Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x; Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66; Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kelly MD, 2013, AIDS, V27, P479, DOI 10.1097/QAD.0b013e32835883bf; Leeansyah E, 2013, J INFECT DIS, V207, P1157, DOI 10.1093/infdis/jit006; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Petoumenos Kathy, 2006, Sex Health, V3, P103, DOI 10.1071/SH05045; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Simard EP, 2012, ARCH INTERN MED, V172, P1591, DOI 10.1001/archinternmed.2012.4508; Smith Reuben L., 2013, Frontiers in Genetics, V3, P328, DOI 10.3389/fgene.2012.00328; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Tate JP, 2012, INT COH M 2012; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; the Queensland Government, 2012, 2011 HIV AIDS REP EP; Wyatt CM, 2010, JAIDS-J ACQ IMM DEF, V55, P73, DOI 10.1097/QAI.0b013e3181cc1070	46	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78403	10.1371/journal.pone.0078403	http://dx.doi.org/10.1371/journal.pone.0078403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205222	gold, Green Submitted, Green Published			2022-12-27	WOS:000326155400080
J	Iancu, EM; Gannon, PO; Laurent, J; Gupta, B; Romero, P; Michielin, O; Romano, E; Speiser, DE; Rufer, N				Iancu, Emanuela M.; Gannon, Philippe O.; Laurent, Julien; Gupta, Bhawna; Romero, Pedro; Michielin, Olivier; Romano, Emanuela; Speiser, Daniel E.; Rufer, Nathalie			Persistence of EBV Antigen-Specific CD8 T Cell Clonotypes during Homeostatic Immune Reconstitution in Cancer Patients	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HERPES-SIMPLEX-VIRUS; IN-VIVO PERSISTENCE; METASTATIC MELANOMA; HUMAN CYTOMEGALOVIRUS; LYMPHOCYTE RESPONSES; GENE-EXPRESSION; PHASE-I; MEMORY; INFECTION	Persistent viruses are kept in check by specific lymphocytes. The clonal T cell receptor (TCR) repertoire against Epstein-Barr virus (EBV), once established following primary infection, exhibits a robust stability over time. However, the determinants contributing to this long-term persistence are still poorly characterized. Taking advantage of an in vivo clinical setting where lymphocyte homeostasis was transiently perturbed, we studied EBV antigen-specific CD8 T cells before and after non-myeloablative lympho-depleting chemotherapy of melanoma patients. Despite more advanced T cell differentiation, patients T cells showed clonal composition comparable to healthy individuals, sharing a preference for TRBV20 and TRBV29 gene segment usage and several co-dominant public TCR clonotypes. Moreover, our data revealed the presence of relatively few dominant EBV antigen-specific T cell clonotypes, which mostly persisted following transient lympho-depletion (TLD) and lymphocyte recovery, likely related to absence of EBV reactivation and de novo T cell priming in these patients. Interestingly, persisting clonotypes frequently co-expressed memory/homing-associated genes (CD27, IL7R, EOMES, CD62L/SELL and CCR5) supporting the notion that they are particularly important for long-lasting CD8 T cell responses. Nevertheless, the clonal composition of EBV-specific CD8 T cells was preserved over time with the presence of the same dominant clonotypes after non-myeloablative chemotherapy. The observed clonotype persistence demonstrates high robustness of CD8 T cell homeostasis and reconstitution.	[Iancu, Emanuela M.; Gannon, Philippe O.; Laurent, Julien; Gupta, Bhawna; Romero, Pedro; Michielin, Olivier; Romano, Emanuela; Speiser, Daniel E.; Rufer, Nathalie] Lausanne Univ Hosp Ctr CHUV, Dept Oncol, Lausanne, Switzerland; [Iancu, Emanuela M.; Gannon, Philippe O.; Laurent, Julien; Gupta, Bhawna; Romero, Pedro; Michielin, Olivier; Romano, Emanuela; Speiser, Daniel E.; Rufer, Nathalie] Univ Lausanne, Lausanne, Switzerland; [Romero, Pedro; Michielin, Olivier; Speiser, Daniel E.; Rufer, Nathalie] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne	Rufer, N (corresponding author), Lausanne Univ Hosp Ctr CHUV, Dept Oncol, Lausanne, Switzerland.	Nathalie.Rufer@unil.ch	Romero, Pedro/S-6015-2017; Michielin, Olivier/ABE-7924-2020; Speiser, Daniel E./F-2173-2013	Romero, Pedro/0000-0002-9688-2882; Romano, Emanuela/0000-0002-1574-5545	Swiss National Center of Competence in Research (NCCR) Molecular Oncology; Swiss National Science Foundation [32003B0-118123, 310030-129670]; Canadian Institutes of Health Research (CIHR-IRSC)	Swiss National Center of Competence in Research (NCCR) Molecular Oncology(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research (CIHR-IRSC)(Canadian Institutes of Health Research (CIHR))	This study was sponsored and supported by the Swiss National Center of Competence in Research (NCCR) Molecular Oncology and the Swiss National Science Foundation grants 32003B0-118123 and 310030-129670. P. O. Gannon is also the recipient of a fellowship from the Canadian Institutes of Health Research (CIHR-IRSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annels NE, 2000, J IMMUNOL, V165, P4831, DOI 10.4049/jimmunol.165.9.4831; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Appay V, 2007, J IMMUNOTHER, V30, P240, DOI 10.1097/01.cji.0000211332.68643.98; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Barcy S, 2005, J INFECT DIS, V191, P2012, DOI 10.1086/430389; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Blackman MA, 2011, CURR OPIN IMMUNOL, V23, P537, DOI 10.1016/j.coi.2011.05.005; Chapuis AG, 2012, P NATL ACAD SCI USA, V109, P4592, DOI 10.1073/pnas.1113748109; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Derre L, 2007, J IMMUNOL, V179, P2368, DOI 10.4049/jimmunol.179.4.2368; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, J IMMUNOTHER, V25, P243, DOI 10.1097/00002371-200205000-00007; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Fonseca SG, 2011, CURR OPIN HIV AIDS, V6, P188, DOI 10.1097/COH.0b013e32834589a1; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gupta B, 2012, J IMMUNOTHER, V35, P488, DOI 10.1097/CJI.0b013e31826183a7; Havenith SHC, 2012, CLIN EXP IMMUNOL, V169, P292, DOI 10.1111/j.1365-2249.2012.04622.x; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Iancu EM, 2009, J IMMUNOL, V183, P319, DOI 10.4049/jimmunol.0803647; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Klarenbeek PL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002889; Laurent J, 2010, J IMMUNOTHER, V33, P723, DOI 10.1097/CJI.0b013e3181ea7e6e; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Levitsky V, 1998, J IMMUNOL, V161, P594; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Mueller TF, 2003, FRONT BIOSCI-LANDMRK, V8, pD1254, DOI 10.2741/1182; Naumova EN, 2009, J IMMUNOL, V183, P2851, DOI 10.4049/jimmunol.0900162; Nystad TW, 2007, J CLIN VIROL, V38, P292, DOI 10.1016/j.jcv.2007.01.006; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Posavad CM, 2000, J IMMUNOL, V165, P1146, DOI 10.4049/jimmunol.165.2.1146; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rocha B, 2006, IMMUNOL REV, V211, P182, DOI 10.1111/j.0105-2896.2006.00378.x; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Roux E, 1996, BLOOD, V87, P3984, DOI 10.1182/blood.V87.9.3984.bloodjournal8793984; Rufer N, 2005, METH MOLEC MED, V109, P265; Rufer N, 2005, CURR OPIN IMMUNOL, V17, P441, DOI 10.1016/j.coi.2005.06.003; Speiser DE, 2006, J IMMUNOL, V177, P1338, DOI 10.4049/jimmunol.177.2.1338; Speiser DE, 2011, P NATL ACAD SCI USA, V108, P15318, DOI 10.1073/pnas.1105419108; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Torti N, 2012, VIRUSES-BASEL, V4, P1116, DOI 10.3390/v4071116; van Bockel DJ, 2011, J IMMUNOL, V186, P359, DOI 10.4049/jimmunol.1001807; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Venturi V, 2008, J IMMUNOL, V181, P7853, DOI 10.4049/jimmunol.181.11.7853; Vojnov L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023515; Wang A, 2012, SCI TRANSL MED, V4; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Wieckowski S, 2009, J IMMUNOL, V183, P5397, DOI 10.4049/jimmunol.0901460; Wiesel M, 2009, APMIS, V117, P356, DOI 10.1111/j.1600-0463.2009.02459.x; Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004; Wills MR, 2002, J IMMUNOL, V168, P5455, DOI 10.4049/jimmunol.168.11.5455; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	60	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78686	10.1371/journal.pone.0078686	http://dx.doi.org/10.1371/journal.pone.0078686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205294	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400098
J	Zhang, HH; Huang, TL; Liu, TT				Zhang, Haihan; Huang, Tinglin; Liu, Tingting			Sediment Enzyme Activities and Microbial Community Diversity in an Oligotrophic Drinking Water Reservoir, Eastern China	PLOS ONE			English	Article							FRESH-WATER; LAKE-SEDIMENTS; VARIABILITY; PHOSPHORUS; ADSORPTION; PROFILES; RIVER	Drinking water reservoir plays a vital role in the security of urban water supply, yet little is known about microbial community diversity harbored in the sediment of this oligotrophic freshwater environmental ecosystem. In the present study, integrating community level physiological profiles (CLPPs), nested polymerase chain reaction (PCR)denaturing gradient gel electrophoresis (DGGE) and clone sequence technologies, we examined the sediment urease and protease activities, bacterial community functional diversity, genetic diversity of bacterial and fungal communities in sediments from six sampling sites of Zhou cun drinking water reservoir, eastern China. The results showed that sediment urease activity was markedly distinct along the sites, ranged from 2.48 to 11.81 mg NH3-N/(g.24h). The highest average well color development (AWCD) was found in site C, indicating the highest metabolic activity of heterotrophic bacterial community. Principal component analysis (PCA) revealed tremendous differences in the functional (metabolic) diversity patterns of the sediment bacterial communities from different sites. Meanwhile, DGGE fingerprints also indicated spatial changes of genetic diversity of sediment bacterial and fungal communities. The sequence BLAST analysis of all the sediment samples found that Comamonas sp. was the dominant bacterial species harbored in site A. Alternaria alternate, Allomyces macrogynus and Rhizophydium sp. were most commonly detected fungal species in sediments of the Zhou cun drinking water reservoir. The results from this work provide new insights about the heterogeneity of sediment microbial community metabolic activity and genetic diversity in the oligotrophic drinking water reservoir.	[Zhang, Haihan; Huang, Tinglin; Liu, Tingting] Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Architecture & Technology	Huang, TL (corresponding author), Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian, Shaanxi, Peoples R China.	huangtinglin@xauat.edu.cn			National Natural Science Foundation of China [51208413, 51008242]; National Science and Technology Pillar Program [2012BAC04B02]; Program of International ST Cooperation [2010DFA94550]; Doctoral Fund of Youth Scholar of Ministry of Education of China [20126120120002]; Shaanxi Provincial Natural Science Foundation [2012JQ7006]; Education Department of Shaanxi Province Special Research Project [12JK0646];  [2013T60873];  [2012M 521750]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Pillar Program; Program of International ST Cooperation; Doctoral Fund of Youth Scholar of Ministry of Education of China; Shaanxi Provincial Natural Science Foundation; Education Department of Shaanxi Province Special Research Project; ; 	This work was supported by the National Natural Science Foundation of China (51208413, 51008242), the National Science and Technology Pillar Program (2012BAC04B02), the Program of International S&T Cooperation (2010DFA94550), the Doctoral Fund of Youth Scholar of Ministry of Education of China (20126120120002), Shaanxi Provincial Natural Science Foundation (2012JQ7006), the Education Department of Shaanxi Province Special Research Project (12JK0646), and Postdoctoral Foundation (2013T60873, 2012M 521750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrea KB, 2003, HYDROBIOLOGIA, V506-509, P721, DOI [10.1023/B:HYDR.0000008586.30395.f2, DOI 10.1023/B:HYDR.0000008586.30395.F2]; Bai YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037796; Biggs CA, 2011, ENVIRON TECHNOL, V32, P133, DOI 10.1080/09593330.2010.490852; BOAVIDA MJ, 1995, HYDROBIOLOGIA, V297, P11, DOI 10.1007/BF00033497; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Bushaw-Newton KL, 2012, ENVIRON SCI POLLUT R, V19, P1271, DOI 10.1007/s11356-011-0656-4; Choi KH, 1999, J MICROBIOL METH, V36, P203, DOI 10.1016/S0167-7012(99)00034-2; Curticapean MC, 2007, J BIOCHEM BIOPH METH, V69, P261, DOI 10.1016/j.jbbm.2006.03.003; [杜萍 Du Ping], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P1436; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Guan S, 1983, SOIL ENZYME ITS RES; Hill BH, 2006, FRESHWATER BIOL, V51, P1670, DOI 10.1111/j.1365-2427.2006.01606.x; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Huang LD, 2011, J SOIL SEDIMENT, V11, P185, DOI 10.1007/s11368-010-0305-4; [黄廷林 Huang Tinglin], 2012, [西安建筑科技大学学报, Journal of Xi'an University of Architecture & Technology], V44, P876; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Izaguirre G, 2007, WATER RES, V41, P492, DOI 10.1016/j.watres.2006.10.012; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Li WH, 2012, ECOTOX ENVIRON SAFE, V75, P198, DOI 10.1016/j.ecoenv.2011.08.021; Lymperopoulou DS, 2012, MICROBES ENVIRON, V27, P1, DOI 10.1264/jsme2.ME11253; Paerl HW, 1996, MICROB ECOL, V31, P225; Rees GN, 2006, J N AM BENTHOL SOC, V25, P370, DOI 10.1899/0887-3593(2006)25[370:VISMCI]2.0.CO;2; Roske K, 2012, SYST APPL MICROBIOL, V35, P35, DOI 10.1016/j.syapm.2011.09.002; Siba H, 2010, LIMNOLOGICA, V40, P54, DOI [10.1016/j.limno.2009.01.002, DOI 10.1016/J.LIMN0.2009.01.002]; Tiquia SM, 2010, ENVIRON POLLUT, V158, P1435, DOI 10.1016/j.envpol.2009.12.035; Wang Y, 2009, J HAZARD MATER, V162, P92, DOI 10.1016/j.jhazmat.2008.05.013; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wu YC, 2012, GEOMICROBIOL J, V29, P852, DOI 10.1080/01490451.2011.635760; Zeglin LH, 2011, MICROB ECOL, V61, P543, DOI 10.1007/s00248-010-9782-7; Zhang HH, 2010, EUR J SOIL BIOL, V46, P55, DOI 10.1016/j.ejsobi.2009.10.005; Zhao DY, 2011, INT J ENVIRON SCI TE, V8, P571, DOI 10.1007/BF03326243; Zhou WH, 2010, ENVIRON CHEM, V29, P629	32	14	18	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78571	10.1371/journal.pone.0078571	http://dx.doi.org/10.1371/journal.pone.0078571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205265	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400087
J	Liu, YH; Jiang, J; Wang, XJ; Zhai, F; Cheng, XX				Liu, Yanhua; Jiang, Jing; Wang, Xinjing; Zhai, Fei; Cheng, Xiaoxing			miR-582-5p Is Upregulated in Patients with Active Tuberculosis and Inhibits Apoptosis of Monocytes by Targeting FOXO1	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CANCER-CELLS; INNATE IMMUNITY; MICRORNAS; NECROSIS; PHOSPHORYLATION; INDUCTION; RESPONSES	Macrophage apoptosis is a host innate defense mechanism against tuberculosis (TB). In this study, we found that percentage of apoptotic cells in peripheral blood monocytes from patients with active TB was lower than that from healthy controls (p<0.001). To understand whether microRNAs can modulate apoptosis of monocytes, we investigated differentially expressed microRNAs in patients with active TB. miR-582-5p was mainly expressed in monocytes and was upregulated in patients with active TB. The apoptotic percentage of THP-1 cells transfected with miR-582-5p mimics was significantly lower than those transfected with negative control of microRNA mimics (p<0.001), suggesting that miR-582-5p could inhibit apoptosis of monocytes. To our knowledge, the role of miR-582-5p in regulating apoptosis of monocytes has not been reported so far. Systematic bioinformatics analysis indicated that FOXO1 might be a target gene for miR-582-5p and its 3'UTR contains potential binding sites for miR-582-5p. To determine whether miR-582-5p could influence FOXO1 expression, miR-582-5p mimics or negative control of microRNA mimics were transfected into THP-1 cells. RT-PCR and western blot analysis showed that the miR-582-5p could suppress both FOXO1 mRNA and protein expression. Co-transfection of miR-582-5p and FOXO1 3'UTR-luciferase reporter vector into cells demonstrated that significant decrease in luciferase activity was only found in reporter vector that contained a wild type sequence of FOXO1 3'UTR, suggesting that miR-582-5p could directly target FOXO1. In conclusion, miR-582-5p inhibited apoptosis of monocytes by down-regulating FOXO1 expression and might play an important role in regulating anti-M. tuberculosis directed immune responses.	[Liu, Yanhua; Jiang, Jing; Wang, Xinjing; Zhai, Fei; Cheng, Xiaoxing] 309 Hosp, Inst TB, Lab TB Prevent & Treatment PLA, Div Res, Beijing, Peoples R China		Cheng, XX (corresponding author), 309 Hosp, Inst TB, Lab TB Prevent & Treatment PLA, Div Res, Beijing, Peoples R China.	xcheng2@139.com	liu, yan/HCI-5542-2022		National Natural Science Foundation of China [81101219]; National Health and Family Planning Commission, China [2013ZX10003006-003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission, China	The study was supported by a grant from the National Natural Science Foundation of China (81101219) (http://www.nsfc.gov.cn) and by a grant for infectious diseases from the National Health and Family Planning Commission, China (2013ZX10003006-003-001 (http://www.moh.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba M, 2012, ANTI-CANCER AGENT ME, V12, P733, DOI 10.2174/187152012802650273; Aslam MI, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-128; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Berry E, 2009, GYNECOL ONCOL, V112, P331, DOI 10.1016/j.ygyno.2008.10.017; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Gil DP, 2004, J INFECT DIS, V189, P2120, DOI 10.1086/386369; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; Lu HR, 2011, NEOPLASIA, V13, P854, DOI 10.1593/neo.11594; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Sanchez MD, 2006, MICROBES INFECT, V8, P2492, DOI 10.1016/j.micinf.2006.06.005; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; Wang WR, 2013, APOPTOSIS, V18, P689, DOI 10.1007/s10495-013-0833-7; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Zhang HT, 2010, PROSTATE, V70, P1265, DOI 10.1002/pros.21162	29	14	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78381	10.1371/journal.pone.0078381	http://dx.doi.org/10.1371/journal.pone.0078381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205217	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300058
J	Tan, CW; Hirokawa, Y; Gardiner, BS; Smith, DW; Burgess, AW				Tan, Chin Wee; Hirokawa, Yumiko; Gardiner, Bruce S.; Smith, David W.; Burgess, Antony W.			Colon Cryptogenesis: Asymmetric Budding	PLOS ONE			English	Article							MOUSE SMALL-INTESTINE; EPITHELIAL-CELL TYPES; CRYPT FISSION; STEM-CELLS; COLORECTAL-CANCER; PANETH CELLS; BETA-CATENIN; LARGE-BOWEL; RENEWAL; MIGRATION	The process of crypt formation and the roles of Wnt and cell-cell adhesion signaling in cryptogenesis are not well described; but are important to the understanding of both normal and cancer colon crypt biology. A quantitative 3D-microscopy and image analysis technique is used to study the frequency, morphology and molecular topography associated with crypt formation. Measurements along the colon reveal the details of crypt formation and some key underlying biochemical signals regulating normal colon biology. Our measurements revealed an asymmetrical crypt budding process, contrary to the previously reported symmetrical fission of crypts. 3D immunofluorescence analyses reveals heterogeneity in the subcellular distribution of E-cadherin and beta-catenin in distinct crypt populations. This heterogeneity was also found in asymmetrical budding crypts. Singular crypt formation (i.e. no multiple new crypts forming from one parent crypt) were observed in crypts isolated from the normal colon mucosa, suggestive of a singular constraint mechanism to prevent aberrant crypt production. The technique presented improves our understanding of cryptogenesis and suggests that excess colon crypt formation occurs when Wnt signaling is perturbed (e. g. by truncation of adenomatous polyposis coli, APC protein) in most colon cancers.	[Tan, Chin Wee; Hirokawa, Yumiko; Burgess, Antony W.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Tan, Chin Wee; Burgess, Antony W.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Tan, Chin Wee; Hirokawa, Yumiko; Burgess, Antony W.] Ludwig Inst Canc Res, Melbourne Parkville Branch, Parkville, Vic, Australia; [Gardiner, Bruce S.; Smith, David W.] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia; [Burgess, Antony W.] Univ Melbourne, Dept Surg, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Ludwig Institute for Cancer Research; University of Western Australia; University of Melbourne	Tan, CW (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	cwtan@wehi.edu.au	Smith, David W/H-5856-2014; Tan, Chin Wee/B-1584-2015; Gardiner, Bruce/C-8593-2012	Smith, David W/0000-0003-4864-0288; Tan, Chin Wee/0000-0001-9695-7218; Gardiner, Bruce/0000-0001-8770-5908	National Health and Medical Research Council (NHMRC) [GNT1029628, 487922]; Operational Infrastructure Support Program by the Victorian Government, Australia	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program by the Victorian Government, Australia	This work is supported by National Health and Medical Research Council (NHMRC) Project Grant GNT1029628, Program Grant 487922 and by funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally the manuscript is solely the responsibility of the institutions and individual authors and does not reflect the views of NHMRC.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahlquist DA, 2000, HUM PATHOL, V31, P51, DOI 10.1016/S0046-8177(00)80198-7; Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bashir O, 2004, CARCINOGENESIS, V25, P1507, DOI 10.1093/carcin/bgh137; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Behrens J, 1999, CANCER METAST REV, V18, P15, DOI 10.1023/A:1006200102166; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Bjerknes M, 1997, AM J PATHOL, V150, P833; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; CHANG WWL, 1982, VIRCHOWS ARCH B, V41, P17, DOI 10.1007/BF02890268; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1969, AM J ANAT, V126, P507, DOI 10.1002/aja.1001260409; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CHENG H, 1974, AM J ANAT, V141, P521, DOI 10.1002/aja.1001410406; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; CLARKE RM, 1972, J ANAT, V112, P27; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dehmer JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027070; Efstathiou JA, 1998, AM J PATHOL, V153, P341, DOI 10.1016/S0002-9440(10)65576-9; Fauser JK, 2012, J PEDIATR GASTR NUTR, V55, P26, DOI 10.1097/MPG.0b013e318246b42d; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Fletcher AG, 2012, J THEOR BIOL, V300, P118, DOI 10.1016/j.jtbi.2012.01.021; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HALL PA, 1994, J CELL SCI, V107, P3569; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; KAUR P, 1986, CELL TISSUE KINET, V19, P601, DOI 10.1111/j.1365-2184.1986.tb00761.x; KEDINGER M, 1986, DEV BIOL, V113, P474, DOI 10.1016/0012-1606(86)90183-1; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Le Blond CP, 1976, STEM CELLS RENEWING, P7; Luciano L, 2002, CELL TISSUE RES, V309, P393, DOI 10.1007/s00441-002-0593-0; Malpighi M, 1697, M MAGPIGHII PHILOS M; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; MASKENS AP, 1981, CELL TISSUE KINET, V14, P467, DOI 10.1111/j.1365-2184.1981.tb00553.x; Mathworks, 2007, MATLAB VERS 7 4 0 28; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; PARK HS, 1995, AM J PATHOL, V147, P1416; Polakis P, 2000, GENE DEV, V14, P1837; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; Sherwood L, 2011, FUNDAMENTALS HUMAN P; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; STCLAIR WH, 1985, CELL TISSUE KINET, V18, P255; Takano-Maruyama M, 2006, AM J PHYSIOL-GASTR L, V291, pG163, DOI 10.1152/ajpgi.00019.2006; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; TOTAFURNO J, 1987, BIOPHYS J, V52, P279, DOI 10.1016/S0006-3495(87)83215-0; Valizadeh A, 1997, AM J PATHOL, V150, P1977; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Wasan HS, 1998, J PATHOL, V185, P246; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P595, DOI 10.1111/j.1365-2184.1982.tb01066.x; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	68	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78519	10.1371/journal.pone.0078519	http://dx.doi.org/10.1371/journal.pone.0078519			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205248	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600105
J	Hassan, S; Karpova, Y; Flores, A; D'Agostino, R; Kulik, G				Hassan, Sazzad; Karpova, Yelena; Flores, Anabel; D'Agostino, Ralph, Jr.; Kulik, George			Surgical Stress Delays Prostate Involution in Mice	PLOS ONE			English	Article							TUMOR-GROWTH; CANCER; BICALUTAMIDE; CELLS; METASTASIS; PROMOTION; SURGERY; THERAPY	Androgens control growth of prostate epithelial cells and androgen deprivation induces apoptosis, leading to prostate involution. We investigated the effects of surgical stress on prostate involution induced by androgen ablation and determined the underlying mechanisms. Androgen ablation in mice was induced by surgical castration and administration of the anti-androgenic drugs bicalutamide and MDV3100. Surgical stress was induced by sham castration under isoflurane anesthesia. Surgical stress delayed apoptosis and prostate involution induced by anti-androgenic drugs. These effects of stress were prevented by administering the selective beta2-adrenoreceptor antagonist ICI118,551 and were also blocked in BAD 3SA/WT mice expressing phosphorylation-deficient mutant BAD3SA. These results indicate that apoptosis and prostate involution in response to androgen ablation therapy could be delayed by surgical stress via the beta2-adrenoreceptor/BAD signaling pathway. Thus, surgery could interfere with androgen ablation therapy, whereas administration of beta2-adrenoreceptor antagonists may enhance its efficacy.	[Hassan, Sazzad; Karpova, Yelena; Flores, Anabel; Kulik, George] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27106 USA; [D'Agostino, Ralph, Jr.; Kulik, George] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA; [Kulik, George] Alfaisal Univ, Coll Sci, Riyadh, Saudi Arabia	Wake Forest University; Wake Forest University; Alfaisal University	Kulik, G (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27106 USA.	gkulik@wakehealth.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	Department of Defense [PC073548]; National Cancer Institute [R01CA118329]; NCI Cancer Center Support Grant (CCSG) [P30CA012197]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA118329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064249] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Project described was supported by PC073548 award from the Department of Defense and Award Number R01CA118329 from the National Cancer Institute to George Kulik. Biostatistical support was made possible by NCI Cancer Center Support Grant (CCSG) P30CA012197. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales GT, 1996, UROLOGY, V47, P38, DOI 10.1016/S0090-4295(96)80007-0; Ben-Eliyahu S, 2003, BRAIN BEHAV IMMUN, V17, pS27; CARTER HB, 1990, PROG CLIN BIOL RES, V350, P129; Da Costa ML, 1998, SURGERY, V124, P516, DOI 10.1067/msy.1998.89410; EGGERMONT AMM, 1988, CANCER DETECT PREV, V12, P421; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Guerrero J, 2013, PROSTATE; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; Hofer SOP, 1999, EUR J SURG ONCOL, V25, P231, DOI 10.1053/ejso.1998.0634; ISAACS JT, 1992, J ANDROL, V13, P457; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; KYPRIANOU N, 1991, CANCER SURV, V11, P265; Lee JW, 2009, CLIN CANCER RES, V15, P2695, DOI 10.1158/1078-0432.CCR-08-2966; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Nickerson T, 1999, UROLOGY, V54, P1120, DOI 10.1016/S0090-4295(99)00421-5; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Scattoni V, 2006, BJU INT, V98, P54, DOI 10.1111/j.1464-410X.2006.06204.x; See WA, 2002, J UROLOGY, V168, P429, DOI 10.1016/S0022-5347(05)64652-6; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; WEESE JL, 1986, SURGERY, V100, P273	20	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78175	10.1371/journal.pone.0078175	http://dx.doi.org/10.1371/journal.pone.0078175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223137	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200029
J	Klemenc-Ketis, Z; Peterlin, B				Klemenc-Ketis, Zalika; Peterlin, Borut			Family History as a Predictor for Disease Risk in Healthy Individuals: A Cross-Sectional Study in Slovenia	PLOS ONE			English	Article							PUBLIC-HEALTH; PRIMARY-CARE; CARDIOVASCULAR RISK; SCREENING TOOL; PREVALENCE; CANCER; CHILDREN	Background: Family history can be used as a genetic risk predictor for common non-communicable diseases. The aim of this study was to determine the prevalence of healthy individuals at risk of developing these diseases, based on their self-reported family history. Methods and Findings: This was a cross-sectional observational study. Data were collected in the three largest occupational practices in primary health care centres in Slovenia, a Central European country. The study population consisted of consecutive individuals who came to occupational practices for their regular preventive check-up from November 2010 to June 2012. We included 1,696 individuals. Data were collected by a self-developed questionnaire. The main outcome was the number of participants at a moderate or high risk for the development of cardiovascular diseases, diabetes, and cancer. The final sample consisted of 1,340 respondents. Moderate or high risk for the development of cardiovascular diseases was present in 280 (20.9%) participants, for the development of diabetes in 154 (11.5%) participants and for cancer in 163 (12.1%) participants. Conclusions: In this study, we found a significant proportion of healthy individuals with an increased genetic risk for common non-communicable diseases; consequently further genetic and clinical evaluation and preventive measures should be offered.	[Klemenc-Ketis, Zalika; Peterlin, Borut] Univ Ljubljana, Sch Med, Dept Family Med, Ljubljana, Slovenia; [Klemenc-Ketis, Zalika] Univ Maribor, Sch Med, Dept Family Med, SLO-2000 Maribor, Slovenia; [Peterlin, Borut] Univ Med Ctr, Clin Inst Med Genet, Ljubljana, Slovenia	University of Ljubljana; University of Maribor; University Medical Centre Ljubljana	Klemenc-Ketis, Z (corresponding author), Univ Ljubljana, Sch Med, Dept Family Med, Ljubljana, Slovenia.	zalika.klemenc.ketis@gmail.com	Klemenc-Ketis, Zalika/V-6251-2019; Peterlin, Borut/C-6086-2011	Klemenc-Ketis, Zalika/0000-0002-0270-1754; Peterlin, Borut/0000-0001-7824-4978	National Research Agency [P3 0339]	National Research Agency(French National Research Agency (ANR))	This study was partially supported by unrestricted programme grant from National Research Agency P3 0339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDOLSEKJERAS L, 2003, ZDR VESTN, V72, P11; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; BRORSSON A, 1993, FAM PRACT, V10, P197, DOI 10.1093/fampra/10.2.197; BULC M, 2001, EUR J GEN PRACT, V7, P154, DOI DOI 10.3109/13814780109094335; Bulc Mateja, 2006, Eur J Gen Pract, V12, P128, DOI 10.1080/13814780600780759; Do CB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002973; Frezzo TM, 2003, GENET MED, V5, P84, DOI 10.1097/01.GIM.0000055197.23822.5E; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; Hariri S, 2006, GENET MED, V8, P752, DOI 10.1097/01.gim.0000250205.73963.f3; Harrison TA, 2003, AM J PREV MED, V24, P152, DOI 10.1016/S0749-3797(02)00588-3; Iski G, 2012, ZDRAV VARST, V51, P141; Kaphingst KA, 2012, PATIENT EDUC COUNS, V88, P291, DOI 10.1016/j.pec.2011.11.013; Kersnik J, 2000, INT J QUAL HEALTH C, V12, P143, DOI 10.1093/intqhc/12.2.143; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KRAJNC M, 2007, ONKOLOGIJA, V1, P4; Langlands AR, 2010, MED J AUSTRALIA, V192, P682, DOI 10.5694/j.1326-5377.2010.tb03701.x; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; O'Neill SM, 2009, AM J PREV MED, V36, P506, DOI 10.1016/j.amepre.2009.03.002; Oleszczyk M, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-15; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Qureshi N, 2005, FAM PRACT, V22, P663, DOI 10.1093/fampra/cmi073; Ramsey SD, 2006, GENET MED, V8, P571, DOI 10.1097/01.gim.0000237867.34011.12; Reid Gabrielle, 2006, Aust Fam Physician, V35, P879; Rich EC, 2004, J GEN INTERN MED, V19, P273, DOI 10.1111/j.1525-1497.2004.30401.x; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rubinstein WS, 2011, GENET MED, V13, P956, DOI 10.1097/GIM.0b013e3182241d88; Sailam V, 2008, CLIN CARDIOL, V31, P542, DOI 10.1002/ClC.20355; Scheuner MT, 2006, GENET MED, V8, P525, DOI 10.1097/01.gim.0000232480.00293.00; Scheuner MT, 1997, AM J MED GENET, V71, P315, DOI 10.1002/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N; Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740; Softic N, 2011, ZDRAV VARST, V50, P185, DOI 10.2478/v10152-010-0043-4; Ster MP, 2008, SCAND J PRIM HEALTH, V26, P29, DOI 10.1080/02813430701760789; Tepes B, 2010, ZDR VESTN, V79, P403; Valdez R, 2007, PEDIATRICS, V120, pS78, DOI 10.1542/peds.2007-1010G; Wattendorf DJ, 2005, AM FAM PHYSICIAN, V72, P441; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yoon PW, 2009, PREV CHRONIC DIS, V6; Yoon PW, 2002, GENET MED, V4, P304, DOI 10.1097/00125817-200207000-00009	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80333	10.1371/journal.pone.0080333	http://dx.doi.org/10.1371/journal.pone.0080333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223224	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200117
J	Major, E; Rigo, K; Hague, T; Berces, A; Juhos, S				Major, Endre; Rigo, Krisztina; Hague, Tim; Berces, Attila; Juhos, Szilveszter			HLA Typing from 1000 Genomes Whole Genome and Whole Exome Illumina Data	PLOS ONE			English	Article							CLASS-I; HIGH-THROUGHPUT; GENETICS; PROJECT	Specific HLA genotypes are known to be linked to either resistance or susceptibility to certain diseases or sensitivity to certain drugs. In addition, high accuracy HLA typing is crucial for organ and bone marrow transplantation. The most widespread high resolution HLA typing method used to date is Sanger sequencing based typing (SBT), and next generation sequencing (NGS) based HLA typing is just starting to be adopted as a higher throughput, lower cost alternative. By HLA typing the HapMap subset of the public 1000 Genomes paired Illumina data, we demonstrate that HLA-A, B and C typing is possible from exome sequencing samples with higher than 90% accuracy. The older 1000 Genomes whole genome sequencing read sets are less reliable and generally unsuitable for the purpose of HLA typing. We also propose using coverage % (the extent of exons covered) as a quality check (QC) measure to increase reliability.	[Major, Endre; Rigo, Krisztina; Hague, Tim; Berces, Attila; Juhos, Szilveszter] Omixon Biocomp, Budapest, Hungary		Juhos, S (corresponding author), Omixon Biocomp, Budapest, Hungary.	szilveszter.juhos@omixon.com		Juhos, Szilveszter/0000-0001-6280-4643	Swiss Contribution scheme	Swiss Contribution scheme	Supported by the Swiss Contribution scheme http://www.contribution-enlargement.admin.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; De Santis D, 2013, INT J IMMUNOGENET, V40, P72, DOI 10.1111/iji.12024; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Kilpinen H, 2013, TRENDS GENET, V29, P23, DOI 10.1016/j.tig.2012.10.001; Lank SM, 2010, HUM IMMUNOL, V71, P1011, DOI 10.1016/j.humimm.2010.07.012; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Mack SJ, 2013, TISSUE ANTIGENS, V81, P194, DOI 10.1111/tan.12093; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; R Core Team, 2012, R LANG ENV STAT COMP; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Warren RL, 2012, GENOME MED, V4, DOI 10.1186/gm396	21	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78410	10.1371/journal.pone.0078410	http://dx.doi.org/10.1371/journal.pone.0078410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223151	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200043
J	Huang, JW; Wang, K; Xu, JJ; Huang, J; Zhang, T				Huang, Jianwei; Wang, Ke; Xu, Jianjun; Huang, Jian; Zhang, Tao			Prognostic Significance of Circulating Tumor Cells in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CLINICAL-SIGNIFICANCE; PERIPHERAL-BLOOD; BREAST-CANCER; MESSENGER-RNA; MARKER GENES; VENOUS-BLOOD; END-POINTS; SURVIVAL; EXPRESSION	Background: The prognostic significance of circulating tumor cells (CTCs) detected in patients with non-small-cell lung cancer (NSCLC) is still inconsistent. We aimed to assess the prognostic relevance of CTCs using a meta-analysis. Methods: We searched PubMed, Web of Science and EMBASE for relevant studies that assessed the prognostic relevance of CTCs in NSCLC. Statistical analyses were conducted to calculate the summary incidence, odds ratio, relative risks (RRs) and 95% confidence intervals (CIs) using fixed or random-effects models according to the heterogeneity of included studies. Results: A total of 20 studies, comprising 1576 patients, met the inclusion criteria. In identified studies, CTCs were not correlated with histology (adenocarcinoma vs squamous cell carcinoma) (odds ratio [OR] = 0.88; 95% confidence interval [CI]: 0.59-1.33; Z = -0.61; P = 0.545). However, pooled analyses showed that CTCs were associated with lymph node metastasis (OR = 2.06; 95% CI: 1.18-3.62; Z = 2.20; P = 0.027) and tumor stage (OR = 1.95; 95% CI: 1.08-3.54; Z = 2.53; P = 0.011). Moreover, CTCs were significantly associated with shorter overall survival (relative risk [RR] = 2.19; 95% CI: 1.53-3.12; Z = 4.32; P<0.0001) and progression-free/disease-free survival (RR = 2.14; 95% CI: 1.36-3.38; Z = 3.28; P<0.0001). Conclusion: The presence of CTCs indicates a poor prognosis in patients with NSCLC. Further well-designed prospective studies are required to explore the clinical applications of CTCs in lung cancer.	[Huang, Jianwei; Wang, Ke; Huang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Jianjun] Zhejiang Univ Finance & Econ, Sch Finance, Hangzhou, Zhejiang, Peoples R China; [Zhang, Tao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Prevent & Hlth Care, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University of Finance & Economics; Zhejiang University	Huang, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	drhuangjian@163.com; jack_zhangtao@163.com		Huang, Jian/0000-0003-3340-5007				Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Chen TF, 2007, LUNG CANCER, V56, P105, DOI 10.1016/j.lungcan.2006.11.006; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Das M, 2012, LUNG CANCER, V77, P421, DOI 10.1016/j.lungcan.2012.04.005; Fetsch PA, 2000, DIAGN CYTOPATHOL, V22, P323, DOI 10.1002/(SICI)1097-0339(200005)22:5<323::AID-DC13>3.0.CO;2-L; Franco R, 2012, EUR J CARDIO-THORAC, V41, P368, DOI 10.1016/j.ejcts.2011.05.009; Funaki S, 2011, EUR J CARDIO-THORAC, V40, P322, DOI 10.1016/j.ejcts.2010.11.029; Hirose T, 2012, ONCOL RES, V20, P131, DOI 10.3727/096504012X13473664562583; Hirsch FR, 2008, J THORAC ONCOL, V3, P1468, DOI 10.1097/JTO.0b013e318189f551; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Huang Jin-su, 2004, Zhonghua Zhongliu Zazhi, V26, P294; Isobe K, 2012, ANTICANCER RES, V32, P3339; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Liu L, 2008, BIOCHEM BIOPH RES CO, V372, P756, DOI 10.1016/j.bbrc.2008.05.101; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nieva J, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016004; Okumura Y, 2009, ANN THORAC SURG, V87, P1669, DOI 10.1016/j.athoracsur.2009.03.073; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Rahbari NN, 2010, GASTROENTEROLOGY, V138, P1714, DOI 10.1053/j.gastro.2010.01.008; Rolle Axel, 2005, World J Surg Oncol, V3, P18, DOI 10.1186/1477-7819-3-18; Sher YP, 2005, CLIN CANCER RES, V11, P173; Sheu CC, 2006, INT J CANCER, V119, P1419, DOI 10.1002/ijc.21999; Sienel W, 2003, EUR J CARDIO-THORAC, V23, P451, DOI 10.1016/S1010-7940(02)00865-5; SMITH BD, 1991, CAN J FISH AQUAT SCI, V48, P338; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Wu C, 2009, J THORAC ONCOL, V4, P30, DOI 10.1097/JTO.0b013e3181914125; Yamashita J, 2002, J THORAC CARDIOV SUR, V124, P299, DOI 10.1067/mtc.2002.124370; Yie SM, 2009, LUNG CANCER, V63, P284, DOI 10.1016/j.lungcan.2008.05.024; Yoon SO, 2011, LUNG CANCER, V71, P209, DOI 10.1016/j.lungcan.2010.04.017; Zhang LL, 2012, CLIN CANCER RES, V18, P5701, DOI 10.1158/1078-0432.CCR-12-1587	33	45	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78070	10.1371/journal.pone.0078070	http://dx.doi.org/10.1371/journal.pone.0078070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223761	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400032
J	Mojardin, L; Botet, J; Quintales, L; Moreno, S; Salas, M				Mojardin, Laura; Botet, Javier; Quintales, Luis; Moreno, Sergio; Salas, Margarita			New Insights into the RNA-Based Mechanism of Action of the Anticancer Drug 5 '-Fluorouracil in Eukaryotic Cells	PLOS ONE			English	Article							GENOME-WIDE SCREEN; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; THYMIDYLATE SYNTHASE; PREMESSENGER RNA; SACCHAROMYCES-CEREVISIAE; COLORECTAL-CANCER; MODIFYING ENZYMES; SMALL-SUBUNIT; IN-VIVO	5-Fluorouracil (5FU) is a chemotherapeutic drug widely used in treating a range of advanced, solid tumours and, in particular, colorectal cancer. Here, we used high-density tiling DNA microarray technology to obtain the specific transcriptome-wide response induced by 5FU in the eukaryotic model Schizosaccharomyces pombe. This approach combined with real-time quantitative PCR analysis allowed us to detect splicing defects of a significant number of intron-containing mRNA, in addition to identify some rRNA and tRNA processing defects after 5FU treatment. Interestingly, our studies also revealed that 5FU specifically induced the expression of certain genes implicated in the processing of mRNA, tRNA and rRNA precursors, and in the post-transcriptional modification of uracil residues in RNA. The transcription of several tRNA genes was also significantly induced after drug exposure. These transcriptional changes might represent a cellular response mechanism to counteract 5FU damage since deletion strains for some of these up-regulated genes were hypersensitive to 5FU. Moreover, most of these RNA processing genes have human orthologs that participate in conserved pathways, suggesting that they could be novel targets to improve the efficacy of 5FU-based treatments.	[Mojardin, Laura; Salas, Margarita] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, CSIC, Madrid, Spain; [Botet, Javier; Quintales, Luis; Moreno, Sergio] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Mojardin, L (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, CSIC, Madrid, Spain.	lmojardin@cbm.uam.es; msalas@cbm.uam.es	Quintales, Luis/K-8150-2014; Salas, Margarita/J-9873-2014; Moreno, Sergio/K-3671-2014	Salas, Margarita/0000-0001-5939-3441; Moreno, Sergio/0000-0002-8039-1413; Quintales, Luis/0000-0003-3553-2237	Spanish Ministry of Economy and Competitiveness [BFU2011-23645, BFU2011-28274, BFU2011-28804]; Spanish Ministry of Science and Innovation [CSD2007-00015]; Fundacion Mutua Madrilena; Fundacion Ramon Areces	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Ramon Areces	This work was supported by the Spanish Ministry of Economy and Competitiveness (BFU2011-23645 to MS and BFU2011-28274 to SM), the CONSOLIDER-INGENIO from the Spanish Ministry of Science and Innovation CSD2007-00015 (MS and SM), the Fundacion Mutua Madrilena (MS) and an Institutional Grant from Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa". Funding for LQ research come from the Spanish Ministry of Economy and Competitiveness (BFU2011-28804); LM was holder of a CONSOLIDER-INGENIO contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2012, MOL CANCER THER, V11, P119, DOI 10.1158/1535-7163.MCT-11-0510; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Das BK, 1999, MOL CELL BIOL, V19, P6796; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; DOONG SL, 1988, J BIOL CHEM, V263, P4467; Edler D, 1997, EUR J CANCER, V33, P2278, DOI 10.1016/S0959-8049(97)00306-7; ENGELBRECHT C, 1984, BIOCHEM PHARMACOL, V33, P745, DOI 10.1016/0006-2952(84)90457-X; GHOSHAL K, 1994, CANCER RES, V54, P632; GLAZER RI, 1982, MOL PHARMACOL, V21, P468; Good L, 1997, EUR J BIOCHEM, V247, P314, DOI 10.1111/j.1432-1033.1997.00314.x; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Grivicich I, 2007, INT J COLORECTAL DIS, V22, P1201, DOI 10.1007/s00384-007-0307-x; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; Han S, 2013, BIOCHEM BIOPH RES CO, V436, P613, DOI 10.1016/j.bbrc.2013.05.138; Hellmuth K, 2000, NUCLEIC ACIDS RES, V28, P4604, DOI 10.1093/nar/28.23.4604; HERRICK D, 1984, MOL PHARMACOL, V26, P135; Hoang T, 2005, MOL CELL BIOL, V25, P5523, DOI 10.1128/MCB.25.13.5523-5534.2005; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kadota K, 2011, INT J ONCOL, V38, P355, DOI 10.3892/ijo.2010.880; KUFE DW, 1981, J BIOL CHEM, V256, P9802; LENZ HJ, 1994, J BIOL CHEM, V269, P31962; Li MH, 2004, ORAL ONCOL, V40, P63, DOI 10.1016/S1368-8375(03)00136-2; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moy TI, 2002, MICROBIOL-SGM, V148, P1081, DOI 10.1099/00221287-148-4-1081; Oltra E, 2004, J CELL SCI, V117, P967, DOI 10.1242/jcs.00946; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; Quintales L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-136; Ren LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016719; RUBY SW, 1993, GENE DEV, V7, P1909, DOI 10.1101/gad.7.10.1909; Salonga D, 2000, CLIN CANCER RES, V6, P1322; SAMUELSSON T, 1991, NUCLEIC ACIDS RES, V19, P6139, DOI 10.1093/nar/19.22.6139; SANTI DV, 1987, BIOCHEMISTRY-US, V26, P8599, DOI 10.1021/bi00400a016; SANTI DV, 1974, BIOCHEMISTRY-US, V13, P471, DOI 10.1021/bi00700a012; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sharma A, 2009, CANCER BIOL THER, V8, P2106, DOI 10.4161/cbt.8.22.9687; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; SIERAKOWSKA H, 1989, J BIOL CHEM, V264, P19185; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sturgeon Christopher M., 2006, Biotechnology Journal, V1, P289, DOI 10.1002/biot.200500039; Suzuki T, 2010, FEBS LETT, V584, P272, DOI 10.1016/j.febslet.2009.11.085; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Webb CJ, 2004, MOL CELL BIOL, V24, P4229, DOI 10.1128/MCB.24.10.4229-4240.2004; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; WU XP, 1993, MOL PHARMACOL, V44, P22; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Zembutsu H, 2002, CANCER RES, V62, P518; Zhao XL, 2007, NUCLEIC ACIDS RES, V35, P550, DOI 10.1093/nar/gkl1084; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	62	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78172	10.1371/journal.pone.0078172	http://dx.doi.org/10.1371/journal.pone.0078172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223771	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300026
J	Beitlich, T; Lorenz, T; Reinstein, J				Beitlich, Thorsten; Lorenz, Thorsten; Reinstein, Jochen			Folding Properties of Cytosine Monophosphate Kinase from E-coli Indicate Stabilization through an Additional Insert in the NMP Binding Domain	PLOS ONE			English	Article							ADENYLATE-KINASE; CMP KINASE; STRUCTURAL-CHARACTERIZATION; REFOLDING TRANSITION; CRYSTAL-STRUCTURE; UMP/CMP KINASE; PROTEINS; PATHWAY; SPECIFICITY; MECHANISM	The globular 25 kDa protein cytosine monophosphate kinase (CMPK, EC ID: 2.7.4.14) from E. coli belongs to the family of nucleoside monophosphate (NMP) kinases (NMPK). Many proteins of this family share medium to high sequence and high structure similarity including the frequently found alpha/beta topology. A unique feature of CMPK in the family of NMPKs is the positioning of a single cis-proline residue in the CORE-domain (cis-Pro124) in conjunction with a large insert in the NMP binding domain. This insert is not found in other well studied NMPKs such as AMPK or UMP/CMPK. We have analyzed the folding pathway of CMPK using time resolved tryptophan and FRET fluorescence as well as CD. Our results indicate that unfolding at high urea concentrations is governed by a single process, whereas refolding in low urea concentrations follows at least a three step process which we interpret as follows: Pro124 in the CORE-domain is in cis in the native state (N-c) and equilibrates with its trans-isomer in the unfolded state (U-c-U-t). Under refolding conditions, at least the U-t species and possibly also the U-c species undergo a fast initial collapse to form intermediates with significant amount of secondary structure, from which the trans-Pro124 fraction folds to the native state with a 100-fold lower rate constant than the cis-Pro124 species. CMPK thus differs from homologous NMP kinases like UMP/CMP kinase or AMP kinase, where folding intermediates show much lower content of secondary structure. Importantly also unfolding is up to 100-fold faster compared to CMPK. We therefore propose that the stabilizing effect of the long NMP-domain insert in conjunction with a subtle twist in the positioning of a single cis-Pro residue allows for substantial stabilization compared to other NMP kinases with alpha/beta topology.	[Beitlich, Thorsten; Lorenz, Thorsten; Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg 1, Germany	Max Planck Society	Reinstein, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg 1, Germany.	jochen.reinstein@mpimf-heidelberg.mpg.de			Max Planck Society	Max Planck Society(Max Planck Society)	Funded by the Max Planck Society, no specific grant number (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTHOFF S, 1988, J MOL BIOL, V199, P665, DOI 10.1016/0022-2836(88)90310-5; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bowman GR, 2011, CURR OPIN STRUC BIOL, V21, P4, DOI 10.1016/j.sbi.2010.10.006; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Briozzo P, 1998, STRUCTURE, V6, P1517, DOI 10.1016/S0969-2126(98)00150-6; Bucurenci N, 1996, J BIOL CHEM, V271, P2856, DOI 10.1074/jbc.271.5.2856; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; De Clercq E, 2003, CLIN MICROBIOL REV, V16, P569, DOI 10.1128/CMR.16.4.569-596.2003; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fairclough R H, 1978, Methods Enzymol, V48, P347; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gunasekaran K, 2001, CURR OPIN STRUC BIOL, V11, P83, DOI 10.1016/S0959-440X(00)00173-1; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Huang F, 2007, P NATL ACAD SCI USA, V104, P123, DOI 10.1073/pnas.0609717104; Lavie A, 1998, BIOCHEMISTRY-US, V37, P3677, DOI 10.1021/bi9720787; Lorenz T, 2008, J MOL BIOL, V381, P443, DOI 10.1016/j.jmb.2008.06.001; Lowe AR, 2007, J MOL BIOL, V365, P1245, DOI 10.1016/j.jmb.2006.10.060; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nickson AA, 2013, CURR OPIN STRUC BIOL, V23, P66, DOI 10.1016/j.sbi.2012.11.009; Nickson AA, 2010, METHODS, V52, P38, DOI 10.1016/j.ymeth.2010.06.003; Orevi T, 2009, J MOL BIOL, V385, P1230, DOI 10.1016/j.jmb.2008.10.077; PAI EF, 1977, J MOL BIOL, V114, P37, DOI 10.1016/0022-2836(77)90281-9; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Ratner V, 2005, J MOL BIOL, V352, P683, DOI 10.1016/j.jmb.2005.06.074; Ratner V, 2002, J MOL BIOL, V320, P1135, DOI 10.1016/S0022-2836(02)00520-X; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Rundqvist L, 2009, BIOCHEMISTRY-US, V48, P1911, DOI 10.1021/bi8018042; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scheffzek K, 1996, BIOCHEMISTRY-US, V35, P9716, DOI 10.1021/bi960642s; Schmid F X, 1986, Methods Enzymol, V131, P70; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Schmid FX, 1992, PROTEIN FOLDING, P916; SCHULZ GE, 1974, NATURE, V250, P142, DOI 10.1038/250142a0; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; Topalis D, 2007, FEBS J, V274, P3704, DOI 10.1111/j.1742-4658.2007.05902.x; Ulschmid JK, 2004, MOL BIOCHEM PARASIT, V136, P211, DOI 10.1016/j.molbiopara.2004.04.001; van Mierlo CPM, 2000, J BIOTECHNOL, V79, P281, DOI 10.1016/S0168-1656(00)00244-3; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; WARREN JR, 1966, J PHYS CHEM-US, V70, P297, DOI 10.1021/j100873a507; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030; Zarrine-Afsar A, 2005, CURR OPIN STRUC BIOL, V15, P42, DOI 10.1016/j.sbi.2005.01.011; Zhang HJ, 1998, BIOCHEM J, V333, P401, DOI 10.1042/bj3330401	51	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78384	10.1371/journal.pone.0078384	http://dx.doi.org/10.1371/journal.pone.0078384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205218	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500114
J	Sidorenkov, G; Voorham, J; de Zeeuw, D; Haaijer-Ruskamp, FM; Denig, P				Sidorenkov, Grigory; Voorham, Jaco; de Zeeuw, Dick; Haaijer-Ruskamp, Flora M.; Denig, Petra			Do Treatment Quality Indicators Predict Cardiovascular Outcomes in Patients with Diabetes?	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; RISK-FACTOR CONTROL; TREATMENT INTENSIFICATION; PERFORMANCE-MEASURES; RANDOMIZED-TRIALS; GLYCEMIC CONTROL; CARE; METAANALYSIS; MELLITUS; THERAPY	Background: Landmark clinical trials have led to optimal treatment recommendations for patients with diabetes. Whether optimal treatment is actually delivered in practice is even more important than the efficacy of the drugs tested in trials. To this end, treatment quality indicators have been developed and tested against intermediate outcomes. No studies have tested whether these treatment quality indicators also predict hard patient outcomes. Methods: A cohort study was conducted using data collected from >10.000 diabetes patients in the Groningen Initiative to Analyze Type 2 Treatment (GIANTT) database and Dutch Hospital Data register. Included quality indicators measured glucose-, lipid-, blood pressure-and albuminuria-lowering treatment status and treatment intensification. Hard patient outcome was the composite of cardiovascular events and all-cause death. Associations were tested using Cox regression adjusting for confounding, reporting hazard ratios (HR) with 95% confidence intervals. Results: Lipid and albuminuria treatment status, but not blood pressure lowering treatment status, were associated with the composite outcome (HR = 0.77, 0.67-0.88; HR = 0.75, 0.59-0.94). Glucose lowering treatment status was associated with the composite outcome only in patients with an elevated HbA1c level (HR = 0.72, 0.56-0.93). Treatment intensification with glucose-lowering but not with lipid-, blood pressure-and albuminuria-lowering drugs was associated with the outcome (HR = 0.73, 0.60-0.89). Conclusion: Treatment quality indicators measuring lipid-and albuminuria-lowering treatment status are valid quality measures, since they predict a lower risk of cardiovascular events and mortality in patients with diabetes. The quality indicators for glucose-lowering treatment should only be used for restricted populations with elevated HbA1c levels. Intriguingly, the tested indicators for blood pressure-lowering treatment did not predict patient outcomes. These results question whether all treatment indicators are valid measures to judge quality of health care and its economics.	[Sidorenkov, Grigory; Voorham, Jaco; de Zeeuw, Dick; Haaijer-Ruskamp, Flora M.; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Sidorenkov, Grigory; Voorham, Jaco; Haaijer-Ruskamp, Flora M.; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, Res Inst SHARE, Groningen, Netherlands	University of Groningen; University of Groningen	Denig, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands.	p.denig@umcg.nl	de Zeeuw, Dick/E-9080-2014; Denig, Petra/L-9865-2014	de Zeeuw, Dick/0000-0003-3434-7777; Denig, Petra/0000-0002-7929-4739; Voorham, Jaco/0000-0001-9002-1865; Sidorenkov, Grigory/0000-0002-1926-8862	Research Institute SHARE of the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen, the Netherlands	Research Institute SHARE of the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen, the Netherlands	The study was funded by the Research Institute SHARE of the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron D, 2008, QUAL SAF HEALTH CARE, V17, P315, DOI 10.1136/qshc.2007.026161; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Botsis T, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-11; Bouma M, 2006, Ned Tijdschr Geneeskd, V150, P2251; Bulger JB, 2012, AM J MANAG CARE, V18, P407; Central Bureau of Statistics in the Netherlands, MICR SERV COND YOUR; de Vries FM, 2012, DRUGS, V72, P2365, DOI 10.2165/11638240-000000000-00000; Dutch Health Care Insurance Board, 2013, DUTCH PHARM COMP; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Ho PM, 2008, ARCH INTERN MED, V168, P271, DOI 10.1001/archinternmed.2007.72; Lamberts W, 1987, INT CLASSIFICATION P; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lv JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001293; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; Martirosyan L, 2008, QUAL SAF HEALTH CARE, V17, P318, DOI 10.1136/qshc.2007.024224; National Quality Forum, 2010, NAT VOL CONS STAND A; NHS Employers, 2013, EINF28001 NHS CONF E; Nichols GA, 2013, J GEN INTERN MED, V28, P691, DOI 10.1007/s11606-012-2320-1; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Pittman DG, 2012, AM J CARDIOL, V110, P1459, DOI 10.1016/j.amjcard.2012.07.008; Rose AJ, 2009, CIRC-CARDIOVASC QUAL, V2, P385, DOI 10.1161/CIRCOUTCOMES.108.838649; Rose AJ, 2009, HYPERTENSION, V54, P524, DOI 10.1161/HYPERTENSIONAHA.109.133389; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sidorenkov G, 2013, BMJ QUAL SAF, V22, P339, DOI 10.1136/bmjqs-2012-001203; Sidorenkov G, 2013, MED CARE, V51, P172, DOI 10.1097/MLR.0b013e318277eaf5; Sidorenkov G, 2011, MED CARE RES REV, V68, P263, DOI 10.1177/1077558710394200; The GIANTT project, 2013, GRON IN AN TYP 2 DIA; Timbie JW, 2010, HEALTH SERV RES, V45, P437, DOI 10.1111/j.1475-6773.2009.01075.x; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; van Althuis TR, 2011, OVERVIEW DEFINITION; van Bruggen R, 2009, FAM PRACT, V26, P428, DOI 10.1093/fampra/cmp053; Voorham J, 2008, DIABETES CARE, V31, P501, DOI 10.2337/dc07-1043; Voorham J, 2008, MED CARE, V46, P133, DOI 10.1097/MLR.0b013e31815b9da0; Voorham J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038707; Voorham J, 2011, CLIN THER, V33, P121, DOI 10.1016/j.clinthera.2011.01.024; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042551	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78821	10.1371/journal.pone.0078821	http://dx.doi.org/10.1371/journal.pone.0078821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205325	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500135
J	Sun, DW; Ostermaier, MK; Heydenreich, FM; Mayer, D; Jaussi, R; Standfuss, J; Veprintsev, DB				Sun, Dawei; Ostermaier, Martin K.; Heydenreich, Franziska M.; Mayer, Daniel; Jaussi, Rolf; Standfuss, Joerg; Veprintsev, Dmitry B.			AAscan, PCRdesign and MutantChecker: A Suite of Programs for Primer Design and Sequence Analysis for High-Throughput Scanning Mutagenesis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; HOMOLOGOUS RECOMBINATION; CLONING; RECEPTOR; PCR; PROTEOMICS; SELECTION; BINDING; SINGLE	Scanning mutagenesis is a powerful protein engineering technique used to study protein structure-function relationship, map binding sites and design more stable proteins or proteins with altered properties. One of the time-consuming tasks encountered in application of this technique is the design of primers for site-directed mutagenesis. Here we present an open-source multi-platform software AAscan developed to design primers for this task according to a set of empirical rules such as melting temperature, overall length, length of overlap regions, and presence of GC clamps at the 3' end, for any desired substitution. We also describe additional software tools which are used to analyse a large number of sequencing results for the presence of desired mutations, as well as related software to design primers for ligation independent cloning. We have used AAscan software to design primers to make over 700 mutants, with a success rate of over 80%. We hope that the open-source nature of our software and ready availability of freeware tools used for its development will facilitate its adaptation and further development. The software is distributed under GPLv3 licence and is available at http://www.psi.ch/lbr/aascan.	[Veprintsev, Dmitry B.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; ETH, Dept Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Veprintsev, DB (corresponding author), Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland.	dmitry.veprintsev@psi.ch	Veprintsev, Dmitry B/H-2228-2012; Standfuss, Joerg/G-5126-2011; Mayer, Daniel/ABB-5655-2020; Heydenreich, Franziska M/N-6314-2015	Veprintsev, Dmitry B/0000-0002-3583-5409; Heydenreich, Franziska M/0000-0002-8049-4383; Ostermaier, Martin Konrad/0000-0003-4297-9133; Sun, Dawei/0000-0002-2010-6051	Swiss National Foundation [135754, 141898, 132815]; NCCR Structural Biology	Swiss National Foundation(Swiss National Science Foundation (SNSF)); NCCR Structural Biology(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation grants 135754, 141898, 132815 and NCCR Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1994, PCR METH APPL, V4, P172; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Canaves JM, 2004, BIOTECHNIQUES, V36, P1040, DOI 10.2144/04366BC01; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Festa F, 2013, PROTEOMICS, V13, P1381, DOI 10.1002/pmic.201200456; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Liang XQ, 2012, ANAL BIOCHEM, V427, P99, DOI 10.1016/j.ab.2012.05.002; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Neuweiler H, 2009, J MOL BIOL, V390, P1060, DOI 10.1016/j.jmb.2009.05.011; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Warne T, 2011, NATURE; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0	21	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78878	10.1371/journal.pone.0078878	http://dx.doi.org/10.1371/journal.pone.0078878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205336	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500138
J	Henson, J; Yates, T; Edwardson, CL; Khunti, K; Talbot, D; Gray, LJ; Leigh, TM; Carter, P; Davies, MJ				Henson, Joseph; Yates, Thomas; Edwardson, Charlotte L.; Khunti, Kamlesh; Talbot, Duncan; Gray, Laura J.; Leigh, Thomas M.; Carter, Patrice; Davies, Melanie J.			Sedentary Time and Markers of Chronic Low-Grade Inflammation in a High Risk Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACTIVITY ENERGY-EXPENDITURE; RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE REGULATION; DIABETES-MELLITUS; IMMUNE-SYSTEM	Background: Sedentary behaviour has been identified as a distinct risk factor for several health outcomes. Nevertheless, little research has been conducted into the underlying mechanisms driving these observations. This study aimed to investigate the association of objectively measured sedentary time and breaks in sedentary time with markers of chronic low-grade inflammation and adiposity in a population at a high risk of type 2 diabetes mellitus. Methods: This study reports data from an ongoing diabetes prevention programme conducted in Leicestershire, UK. High risk individuals were recruited from 10 primary care practices. Sedentary time (<25counts per 15s) was measured using Actigraph GT3X accelerometers (15s epochs). A break was considered as any interruption in sedentary time (>= 25counts per 15s). Biochemical outcomes included interleukin-6 (IL-6), C-reactive protein (CRP), leptin, adiponectin and leptin: adiponectin ratio (LAR). A sensitivity analysis investigated whether results were affected by removing participants with a CRP level >10 mg/L, as this can be indicative of acute inflammation. Results: 558 participants (age = 63.6 +/- 7.7years; male = 64.7%) had complete adipokine and accelerometer data. Following adjustment for various confounders, sedentary time was detrimentally associated with CRP (beta = 0.176 +/- 0.057, p = 0.002), IL-6 (beta = 0.24260.056, p = <0.001), leptin (beta = 0.146 +/- 0.043, p = <0.001) and LAR (beta = 0.208 +/- 0.052, p = <0.001). Associations were attenuated after further adjustment for moderate-to-vigorous physical activity (MVPA) with only IL-6 (beta = 0.231 +/- 0.073, p = 0.002) remaining significant; this result was unaffected after further adjustment for body mass index and glycosylated haemoglobin (HbA(1c)). Similarly, breaks in sedentary time were significantly inversely associated with IL-6 (beta = -0.094 +/- 0.047, p = 0.045) and leptin (beta = 20.075 +/- 0.037, p = 0.039); however, these associations were attenuated after adjustment for accelerometer derived variables. Excluding individuals with a CRP level >10 mg/L consistently attenuated the significant associations across all markers of inflammation. Conclusion: These novel findings from a high risk population recruited through primary care suggest that sedentary behaviour may influence markers associated with inflammation, independent of MVPA, glycaemia and adiposity.	[Henson, Joseph; Yates, Thomas; Edwardson, Charlotte L.; Khunti, Kamlesh; Carter, Patrice; Davies, Melanie J.] Natl Inst Hlth Res NIHR Leicester Loughborough Di, Leicester, Leics, England; [Henson, Joseph; Yates, Thomas; Edwardson, Charlotte L.; Khunti, Kamlesh; Carter, Patrice; Davies, Melanie J.] Univ Leicester, Diabet Res Ctr, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Talbot, Duncan] Unilever Discover, Sharnbrook, Beds, England; [Gray, Laura J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Leigh, Thomas M.] Leicester Gen Hosp, Leicester Diabet Ctr, Univ Hosp Leicester, Leicester LE5 4PW, Leics, England	University of Leicester; Unilever; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Henson, J (corresponding author), Natl Inst Hlth Res NIHR Leicester Loughborough Di, Leicester, Leics, England.	jjh18@le.ac.uk	/ABC-9527-2021; Stefanadis, Christodoulos/ABH-2232-2020	Carter, Patrice/0000-0003-3445-6754; Stefanadis, Christodoulos/0000-0001-5974-6454; Henson, Joseph/0000-0002-3898-7053; Edwardson, Charlotte/0000-0001-6485-9330; Khunti, Kamlesh/0000-0003-2343-7099; Davies, Melanie/0000-0002-9987-9371; Gray, Laura/0000-0002-9284-9321	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR); University of Leicester Clinical Trials Unit; NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit; Unilever Discover, UK	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR); University of Leicester Clinical Trials Unit; NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit; Unilever Discover, UK	The research was supported by The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR) (http://www.clahrc-lnr.nihr.ac.uk/index.php/walking-away-from-diabetes), the University of Leicester Clinical Trials Unit and the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester (http://www.ll.dlpa.bru.nihr.ac.uk/). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. C-reactive protein and adipokine analysis was carried out and funded by Unilever Discover, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003; Allison MA, 2012, AM J PREV MED, V42, P8, DOI 10.1016/j.amepre.2011.09.023; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ertek S, 2012, ARCH MED SCI, V8, P794, DOI 10.5114/aoms.2012.31614; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Fischer CP, 2004, J PHYSIOL-LONDON, V558, P633, DOI 10.1113/jphysiol.2004.066779; Franks PW, 2003, J CLIN ENDOCR METAB, V88, P3258, DOI 10.1210/jc.2002-021426; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Gray LJ, 2012, DIABETOLOGIA, V55, P959, DOI 10.1007/s00125-011-2432-x; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Ishii S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036062; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Nader GA, 2009, CURR OPIN RHEUMATOL, V21, P599, DOI 10.1097/BOR.0b013e3283319d53; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Panagiotakos DB, 2005, PREV MED, V40, P432, DOI 10.1016/j.ypmed.2004.07.010; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2012, MED SCI SPORT EXER, V44, P392, DOI 10.1249/MSS.0b013e31822f94ac; Pedersen M, 2004, EXERC IMMUNOL REV, V10, P42; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Tataranni PA, 2005, DIABETES, V54, P917, DOI 10.2337/diabetes.54.4.917; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; World Health Organization, 2006, WHO 2006 DEF DIAGN D; Yates T, 2010, DIABETIC MED, V27, P1256, DOI 10.1111/j.1464-5491.2010.03091.x; Yates T, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-46; Yates T, 2012, AM J PREV MED, V42, P1, DOI 10.1016/j.amepre.2011.09.022	44	106	109	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78350	10.1371/journal.pone.0078350	http://dx.doi.org/10.1371/journal.pone.0078350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205208	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700088
J	Martinov, T; Glenn-Finer, R; Burley, S; Tonc, E; Balsells, E; Ashbaugh, A; Swanson, L; Daughters, RS; Chatterjea, D				Martinov, Tijana; Glenn-Finer, Rose; Burley, Sarah; Tonc, Elena; Balsells, Evelyn; Ashbaugh, Alyssa; Swanson, Linnea; Daughters, Randy S.; Chatterjea, Devavani			Contact Hypersensitivity to Oxazolone Provokes Vulvar Mechanical Hyperalgesia in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MAST-CELLS; FACTOR-ALPHA; RAT MODEL; AMITRIPTYLINE; SKIN; EOSINOPHILS; ELICITATION; SENSITIVITY; CHEMOKINES	The interplay among pain, allergy and dysregulated inflammation promises to yield significant conceptual advances in immunology and chronic pain. Hapten-mediated contact hypersensitivity reactions are used to model skin allergies in rodents but have not been utilized to study associated changes in pain perception in the affected skin. Here we characterized changes in mechanical hyperalgesia in oxazolone-sensitized female mice challenged with single and repeated labiar skin exposure to oxazolone. Female mice were sensitized with topical oxazolone on their flanks and challenged 1-3 times on the labia. We then measured mechanical sensitivity of the vulvar region with an electronic pressure meter and evaluated expression of inflammatory genes, leukocyte influx and levels of innervation in the labiar tissue. Oxazolone-sensitized mice developed vulvar mechanical hyperalgesia after a single labiar oxazolone challenge. Hyperalgesia lasted up to 24 hours along with local influx of neutrophils, upregulation of inflammatory cytokine gene expression, and increased density of cutaneous labiar nerve fibers. Three daily oxazolone challenges produced vulvar mechanical hyperalgesic responses and increases in nerve density that were detectable up to 5 days post-challenge even after overt inflammation resolved. This persistent vulvar hyperalgesia is resonant with vulvodynia, an understudied chronic pain condition that is remarkably prevalent in 18-60 year-old women. An elevated risk for vulvodynia has been associated with a history of environmental allergies. Our pre-clinical model can be readily adapted to regimens of chronic exposures and long-term assessment of vulvar pain with and without concurrent inflammation to improve our understanding of mechanisms underlying subsets of vulvodynia and to develop new therapeutics for this condition.	[Martinov, Tijana; Glenn-Finer, Rose; Tonc, Elena; Balsells, Evelyn; Ashbaugh, Alyssa; Swanson, Linnea; Chatterjea, Devavani] Macalester Coll, Dept Biol, St Paul, MN 55105 USA; [Burley, Sarah; Daughters, Randy S.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	Macalester College; University of Minnesota System; University of Minnesota Twin Cities	Chatterjea, D (corresponding author), Macalester Coll, Dept Biol, St Paul, MN 55105 USA.	chatterjead@macalester.edu	Martinov, Tijana/AFU-5047-2022	Martinov, Tijana/0000-0002-6027-3380; Burley, Sarah/0000-0003-0614-3267	National Vulvodynia Association; NIH [AREA - R15 NS067536-01A]; NHLBI Progenitor Cell Biology Consortium;  [NHLBI - R21 SR00002157/1U01-HL099997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS067536] Funding Source: NIH RePORTER	National Vulvodynia Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Progenitor Cell Biology Consortium; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	DC is supported by the National Vulvodynia Association (http://www.nva.org/) and NIH AREA - R15 NS067536-01A. RSD is supported by the NHLBI Progenitor Cell Biology Consortium and NHLBI - R21 SR00002157/1U01-HL099997. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi S, 1998, ANESTH ANALG, V87, P1360, DOI 10.1097/00000539-199812000-00027; ACTON J, 1992, EXP NEUROL, V117, P94, DOI 10.1016/0014-4886(92)90116-8; Altawil R, 2012, ARCH DERMATOL RES, V304, P273, DOI 10.1007/s00403-011-1202-4; Arnold LD, 2006, OBSTET GYNECOL, V107, P617, DOI 10.1097/01.AOG.0000199951.26822.27; Bomstein J, 2008, INT J GYNECOL PATHOL, V27, P136, DOI 10.1097/pgp.0b013e318140021b; Bornstein J, 2004, GYNECOL OBSTET INVES, V58, P171, DOI 10.1159/000079663; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Gouveia ACC, 2013, J CLIN IMMUNOL, V33, P235, DOI 10.1007/s10875-012-9746-4; Chatterjea D, 2013, F1000 RES, P2; Chatterjea D, 2012, BIOCHEM BIOPH RES CO, V425, P237, DOI 10.1016/j.bbrc.2012.07.074; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; DIXON M, 1980, BRIT J PHARMACOL, V70, P11, DOI 10.1111/j.1476-5381.1980.tb10898.x; Done JD, 2012, J UROLOGY, V187, P1473, DOI 10.1016/j.juro.2011.11.116; Emtestam L, 2012, ARCH DERMATOL RES, V304, P781, DOI 10.1007/s00403-012-1246-0; Farmer MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002613; Forsythe P, 2012, CHEM IMMUNOL ALLERGY, V98, P196, DOI 10.1159/000336523; Foster DC, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.038; Foster DC, 1997, OBSTET GYNECOL, V89, P291, DOI 10.1016/S0029-7844(96)00447-4; Funding AT, 2009, J INVEST DERMATOL, V129, P891, DOI 10.1038/jid.2008.322; Furuno T, 2005, J IMMUNOL, V174, P6934, DOI 10.4049/jimmunol.174.11.6934; Gerber S, 2002, AM J OBSTET GYNECOL, V186, P696, DOI 10.1067/mob.2002.121869; Goetsch MF, 2010, AM J OBSTET GYNECOL, V202, pe1; Groysman V, 2010, DERMATOL CLIN, V28, P681, DOI 10.1016/j.det.2010.07.002; Harlow BL, 2009, ANN EPIDEMIOL, V19, P771, DOI 10.1016/j.annepidem.2009.06.006; Henry DE, 2011, PM&R, V3, P1116, DOI 10.1016/j.pmrj.2011.05.018; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Itakura A, 2006, INT ARCH ALLERGY IMM, V140, P8, DOI 10.1159/000092705; Kakurai M, 2006, AM J PATHOL, V169, P1713, DOI 10.2353/ajpath.2006.060602; Kubera M, 2000, PSYCHONEUROENDOCRINO, V25, P785, DOI 10.1016/S0306-4530(00)00026-3; Lavich TR, 2006, PAIN, V125, P180, DOI 10.1016/j.pain.2006.08.006; Lavich TR, 2003, EUR J PHARMACOL, V462, P185, DOI 10.1016/S0014-2999(02)02947-3; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUGER TA, 1990, J INVEST DERMATOL, V95, pS100, DOI 10.1111/1523-1747.ep12874944; Man MQ, 2008, J INVEST DERMATOL, V128, P79, DOI 10.1038/sj.jid.5701011; Martinov T, 2013, J VIS EXP IN PRESS; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Melik-Parsadaniantz S, 2008, J NEUROIMMUNOL, V198, P62, DOI 10.1016/j.jneuroim.2008.04.022; Norman MU, 2008, AM J PATHOL, V172, P1638, DOI 10.2353/ajpath.2008.070559; Ohno I, 1997, AM J RESP CELL MOL, V16, P212, DOI 10.1165/ajrcmb.16.3.9070604; Oka T, 2012, LAB INVEST, V92, P1472, DOI 10.1038/labinvest.2012.116; Pukall CF, 2002, PAIN, V96, P163, DOI 10.1016/S0304-3959(01)00442-0; Schneider C, 2009, J INVEST DERMATOL, V129, P899, DOI 10.1038/jid.2008.307; Shimada Y, 2003, J IMMUNOL, V170, P4325, DOI 10.4049/jimmunol.170.8.4325; Su X, 2009, ANESTH ANALG, V108, P1671, DOI 10.1213/ane.0b013e31819b0271; Suzuki A, 2005, BIOL PHARM BULL, V28, P1963, DOI 10.1248/bpb.28.1963; Suzuki A, 2004, BIOL PHARM BULL, V27, P1891, DOI 10.1248/bpb.27.1891; Takita E, 2013, BRIT J DERMATOL, V168, P39, DOI 10.1111/j.1365-2133.2012.11176.x; Theoharides TC, 2005, BRAIN RES REV, V49, P65, DOI 10.1016/j.brainresrev.2004.11.006; Tsunematsu M, 2007, LIFE SCI, V80, P1388, DOI 10.1016/j.lfs.2006.12.038; van Houwelingen AH, 2002, J IMMUNOL, V168, P5297, DOI 10.4049/jimmunol.168.10.5297; Ventolini G, 2013, MED HYPOTHESES, V81, P228, DOI 10.1016/j.mehy.2013.04.043; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Webb EF, 1998, J INVEST DERMATOL, V111, P86, DOI 10.1046/j.1523-1747.1998.00239.x; Yokozeki H, 2000, J EXP MED, V191, P995, DOI 10.1084/jem.191.6.995	57	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78673	10.1371/journal.pone.0078673	http://dx.doi.org/10.1371/journal.pone.0078673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205293	Green Published, gold			2022-12-27	WOS:000326155400097
J	Ilanges, A; Jahanshahi, M; Balobin, DM; Pfleger, CM				Ilanges, Anoj; Jahanshahi, Maryam; Balobin, Denis M.; Pfleger, Cathie M.			Alcohol Interacts with Genetic Alteration of the Hippo Tumor Suppressor Pathway to Modulate Tissue Growth in Drosophila	PLOS ONE			English	Article							CELL-CYCLE EXIT; IMAGINAL DISC GROWTH; ORGAN SIZE CONTROL; BREAST-CANCER; SIGNALING PATHWAY; YAP PATHWAY; PROLIFERATION ARREST; PROMOTES APOPTOSIS; PROTEIN-KINASES; CONSUMPTION	Alcohol-mediated cancers represent more than 3.5% of cancer-related deaths, yet how alcohol promotes cancer is a major open question. Using Drosophila, we identified novel interactions between dietary ethanol and loss of tumor suppressor components of the Hippo Pathway. The Hippo Pathway suppresses tumors in flies and mammals by inactivating transcriptional co-activator Yorkie, and the spectrum of cancers associated with impaired Hippo signaling overlaps strikingly with those associated with alcohol. Therefore, our findings may implicate loss of Hippo Pathway tumor suppression in alcohol-mediated cancers. Ethanol enhanced overgrowth from loss of the expanded, hippo, or warts tumor suppressors but, surprisingly, not from over-expressing the yorkie oncogene. We propose that in parallel to Yorkie-dependent overgrowth, impairing Hippo signaling in the presence of alcohol may promote overgrowth via additional alcohol-relevant targets. We also identified interactions between alcohol and Hippo Pathway over-activation. We propose that exceeding certain thresholds of alcohol exposure activates Hippo signaling to maintain proper growth control and prevent alcohol-mediated mis-patterning and tissue overgrowth.	[Ilanges, Anoj; Jahanshahi, Maryam; Balobin, Denis M.; Pfleger, Cathie M.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY USA; [Ilanges, Anoj] Yale Univ, New Haven, CT USA; [Jahanshahi, Maryam; Pfleger, Cathie M.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA; [Balobin, Denis M.] Columbia Univ, New York, NY USA	Icahn School of Medicine at Mount Sinai; Yale University; Icahn School of Medicine at Mount Sinai; Columbia University	Pfleger, CM (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY USA.	cathie.pfleger@mssm.edu		Jahanshahi, Maryam/0000-0003-3469-6280	Children's Tumor Foundation; National Institutes of Health/National Cancer Institute [CA140451]; NATIONAL CANCER INSTITUTE [R01CA140451] Funding Source: NIH RePORTER	Children's Tumor Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Children's Tumor Foundation Young Investigator grant (MJ), a Leukemia & Lymphoma Society Scholar Award (CMP), and the National Institutes of Health/National Cancer Institute CA140451 (CMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Benedetti A, 2009, CANCER DETECT PREV, V32, P352, DOI 10.1016/j.canep.2009.03.001; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Boffetta P, 2006, INT J CANCER, V119, P884, DOI 10.1002/ijc.21903; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bowlin SJ, 1997, INT J EPIDEMIOL, V26, P915, DOI 10.1093/ije/26.5.915; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; *CANC WORLD RES FU, 2007, FOOD NUTR PHYS ACT P, P244; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; COLDITZ GA, 1993, CANCER-AM CANCER SOC, V71, P1480, DOI 10.1002/cncr.2820710413; Devineni AV, 2011, FLY, V5, P191, DOI 10.4161/fly.5.3.16987; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Heberlein U, 2000, ALCOHOL RES HEALTH, V24, P185; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; LONGNECKER MP, 1994, CANCER CAUSE CONTROL, V5, P73, DOI 10.1007/BF01830729; Marcinkevicius E, 2013, DEVELOPMENT, V140, P433, DOI 10.1242/dev.083949; McClure KD, 2011, DIS MODEL MECH, V4, P335, DOI 10.1242/dmm.006411; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Murray LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043295; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Pelucchi C, 2011, NUTR CANCER, V63, P983, DOI 10.1080/01635581.2011.596642; Poschl G, 2004, P NUTR SOC, V63, P65, DOI 10.1079/PNS2003323; RANGANATHAN S, 1987, TERATOLOGY, V36, P45, DOI 10.1002/tera.1420360107; Rohan TE, 2000, CANCER CAUSE CONTROL, V11, P239, DOI 10.1023/A:1008933824645; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Shohat-Ophir G, 2012, SCIENCE, V335, P1351, DOI 10.1126/science.1215932; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Voigt Michael D, 2005, Clin Liver Dis, V9, P151, DOI 10.1016/j.cld.2004.10.003; Wehr MC, 2013, NAT CELL BIOL, V15, P61, DOI 10.1038/ncb2658; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zheng TS, 2011, CANCER LETT, V302, P91, DOI 10.1016/j.canlet.2010.12.008; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	69	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78880	10.1371/journal.pone.0078880	http://dx.doi.org/10.1371/journal.pone.0078880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205337	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600113
J	Li, R; Ma, PF; Wen, J; Yi, TS				Li, Rong; Ma, Peng-Fei; Wen, Jun; Yi, Ting-Shuang			Complete Sequencing of Five Araliaceae Chloroplast Genomes and the Phylogenetic Implications	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MAXIMUM-LIKELIHOOD; PLASTID GENOMES; SCALE DATA; EVOLUTION; GENES; DNA; MITOCHONDRIAL; NUCLEAR; RESOLVE	Background: The ginseng family (Araliaceae) includes a number of economically important plant species. Previously phylogenetic studies circumscribed three major clades within the core ginseng plant family, yet the internal relationships of each major group have been poorly resolved perhaps due to rapid radiation of these lineages. Recent studies have shown that phyogenomics based on chloroplast genomes provides a viable way to resolve complex relationships. Methodology/Principal Findings: We report the complete nucleotide sequences of five Araliaceae chloroplast genomes using next-generation sequencing technology. The five chloroplast genomes are 156,333-156,459 bp in length including a pair of inverted repeats (25,551-26,108 bp) separated by the large single-copy (86,028-86,566 bp) and small single-copy (18,021-19,117 bp) regions. Each chloroplast genome contains the same 114 unique genes consisting of 30 transfer RNA genes, four ribosomal RNA genes, and 80 protein coding genes. Gene size, content, and order, AT content, and IR/SC boundary structure are similar among all Araliaceae chloroplast genomes. A total of 140 repeats were identified in the five chloroplast genomes with palindromic repeat as the most common type. Phylogenomic analyses using parsimony, likelihood, and Bayesian inference based on the complete chloroplast genomes strongly supported the monophyly of the Asian Palmate group and the Aralia-Panax group. Furthermore, the relationships among the sampled taxa within the Asian Palmate group were well resolved. Twenty-six DNA markers with the percentage of variable sites higher than 5% were identified, which may be useful for phylogenetic studies of Araliaceae. Conclusion: The chloroplast genomes of Araliaceae are highly conserved in all aspects of genome features. The large-scale phylogenomic data based on the complete chloroplast DNA sequences is shown to be effective for the phylogenetic reconstruction of Araliaceae.	[Li, Rong; Ma, Peng-Fei; Yi, Ting-Shuang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Li, Rong; Ma, Peng-Fei; Yi, Ting-Shuang] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	wenj@si.edu; tingshuangyi@mail.kib.ac.cn			Knowledge Innovation Engineering Program of the Chinese Academy of Sciences [KSCX2-EW-J-24]; Talent Project of Yunnan Province [2011CI042]; Open Fund of Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, Chinese Academy of Sciences [KLBB201204]	Knowledge Innovation Engineering Program of the Chinese Academy of Sciences; Talent Project of Yunnan Province; Open Fund of Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, Chinese Academy of Sciences	This project is supported by the Knowledge Innovation Engineering Program of the Chinese Academy of Sciences (grant no. KSCX2-EW-J-24), the Talent Project of Yunnan Province (grant no. 2011CI042), and the Open Fund of Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, Chinese Academy of Sciences (grant no. KLBB201204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Egan AN, 2008, MOL PHYLOGENET EVOL, V46, P532, DOI 10.1016/j.ympev.2007.10.006; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao L, 2010, J SYST EVOL, V48, P77, DOI 10.1111/j.1759-6831.2010.00071.x; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim JH, 2013, GENET RESOUR CROP EV, V60, P413, DOI 10.1007/s10722-012-9844-4; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Korpelainen H, 2004, NATURWISSENSCHAFTEN, V91, P505, DOI 10.1007/s00114-004-0571-3; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JH, 2010, J SYST EVOL, V48, P426, DOI 10.1111/j.1759-6831.2010.00098.x; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MILLIGAN BG, 1989, MOL BIOL EVOL, V6, P355; Mitchell A, 2004, TAXON, V53, P29, DOI 10.2307/4135486; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Philipson WR, 1970, BOT J LINN SOC, V63, P87; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Plunkett GM, 2004, PLANT SYST EVOL, V245, P1, DOI 10.1007/s00606-003-0101-3; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Ruhlman T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-222; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHIMADA H, 1989, CURR GENET, V16, P293, DOI 10.1007/BF00422116; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wen J, 2001, SYST BOT, V26, P144; Wen Jun, 2008, Acta Botanica Yunnanica, V30, P391; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; XIANG QB, 2007, FLORA CHINA, V13, P434; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Yi TS, 2004, TAXON, V53, P987, DOI 10.2307/4135565; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	64	58	63	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78568	10.1371/journal.pone.0078568	http://dx.doi.org/10.1371/journal.pone.0078568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205264	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300159
J	Mohan, N; Chakrabarti, M; Banik, NL; Ray, SK				Mohan, Nishant; Chakrabarti, Mrinmay; Banik, Naren L.; Ray, Swapan K.			Combination of LC3 shRNA Plasmid Transfection and Genistein Treatment Inhibited Autophagy and Increased Apoptosis in Malignant Neuroblastoma in Cell Culture and Animal Models	PLOS ONE			English	Article							CANCER-CELLS; SURVIVAL FACTORS; SH-SY5Y CELLS; BECLIN 1; N-MYC; DIFFERENTIATION; EXPRESSION; MECHANISM; SK-N-BE2; THERAPY	Malignant neuroblastoma is an extracranial solid tumor that usually occurs in children. Autophagy, which is a survival mechanism in many solid tumors including malignant neuroblastoma, deters the efficacy of conventional chemotherapeutic agents. To mimic starvation, we used 200 nM rapamycin that induced autophagy in human malignant neuroblastoma SK-N-BE2 and IMR-32 cells in cell culture and animal models. Combination of microtubule associated protein light chain 3 short hairpin RNA (LC3 shRNA) plasmid transfection and genistein (GST) treatment was tested for inhibiting rapamycin-induced autophagy and promoting apoptosis. The best synergistic efficacy caused the highest decrease in cell viability due to combination of 50 nM LC3 shRNA plasmid transfection and 25 mu M GST treatment in rapamycin-treated SK-N-BE2 cells while combination of 100 nM LC3 shRNA plasmid transfection and 25 mu M GST treatment in rapamycin-treated IMR-32 cells. Quantitation of acidic vesicular organelles confirmed that combination of LC3 shRNA plasmid transfection and GST treatment prevented rapamycin-induced autophagy due to down regulation of autophagy promoting marker molecules (LC3 II, Beclin 1, TLR-4, and Myd88) and upregulation of autophagy inhibiting marker molecules (p62 and mTOR) in both cell lines. Apoptosis assays showed that combination therapy most effectively activated mitochondrial pathway of apoptosis in human malignant neuroblastoma in cell culture and animal models. Collectively, our current combination of LC3 shRNA plasmid transfection and GST treatment could serve as a promising therapeutic strategy for inhibiting autophagy and increasing apoptosis in human malignant neuroblastoma in cell culture and animal models.	[Mohan, Nishant; Chakrabarti, Mrinmay; Ray, Swapan K.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Banik, Naren L.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Ray, SK (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	swapan.ray@uscmed.sc.edu	CHAKRABARTI, MRINMAY/M-5652-2019					Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chakrabarti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055652; Chen LH, 2011, BIOCHEM PHARMACOL, V81, P594, DOI 10.1016/j.bcp.2010.12.011; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Chuang JH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-65; Das A, 2009, INT J ONCOL, V34, P757, DOI 10.3892/ijo_00000201; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fimia GM, 2010, CELL MOL LIFE SCI, V67, P1581, DOI 10.1007/s00018-010-0284-z; Gimenez-Xavier P, 2008, INT J MOL MED, V22, P781, DOI 10.3892/ijmm_00000085; Hassan F, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-281; Hou HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035665; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; JAYARAMAN T, 1993, J BIOL CHEM, V268, P25385; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604; Ma HT, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1109; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mohan N, 2011, CANCER BIOL THER, V12, P846, DOI 10.4161/cbt.12.9.17715; Mohan N, 2011, NEUROSCI LETT, V502, P24, DOI 10.1016/j.neulet.2011.07.016; Mohan N, 2011, NEUROCHEM RES, V36, P1383, DOI 10.1007/s11064-011-0463-9; Mohan N, 2009, BRAIN RES, V1283, P155, DOI 10.1016/j.brainres.2009.05.097; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Wang JR, 2008, AUTOPHAGY, V4, P947, DOI 10.4161/auto.6787; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	41	25	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78958	10.1371/journal.pone.0078958	http://dx.doi.org/10.1371/journal.pone.0078958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205354	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300168
J	de Candia, P; Torri, A; Gorletta, T; Fedeli, M; Bulgheroni, E; Cheroni, C; Marabita, F; Crosti, M; Moro, M; Pariani, E; Romano, L; Esposito, S; Mosca, F; Rossetti, G; Rossi, RL; Geginat, J; Casorati, G; Dellabona, P; Pagani, M; Abrignani, S				de Candia, Paola; Torri, Anna; Gorletta, Tatiana; Fedeli, Maya; Bulgheroni, Elisabetta; Cheroni, Cristina; Marabita, Francesco; Crosti, Mariacristina; Moro, Monica; Pariani, Elena; Romano, Luisa; Esposito, Susanna; Mosca, Fabio; Rossetti, Grazisa; Rossi, Riccardo L.; Geginat, Jens; Casorati, Giulia; Dellabona, Paolo; Pagani, Massimiliano; Abrignani, Sergio			Intracellular Modulation, Extracellular Disposal and Serum Increase of MiR-150 Mark Lymphocyte Activation	PLOS ONE			English	Article							T-CELLS; CIRCULATING MICRORNAS; VESICLES; EXOSOMES; CANCER; EXPRESSION; RNAS	Activated lymphocytes release nano-sized vesicles (exosomes) containing microRNAs that can be monitored in the bloodstream. We asked whether elicitation of immune responses is followed by release of lymphocyte-specific microRNAs. We found that, upon activation in vitro, human and mouse lymphocytes down-modulate intracellular miR-150 and accumulate it in exosomes. In vivo, miR-150 levels increased significantly in serum of humans immunized with flu vaccines and in mice immunized with ovalbumin, and this increase correlated with elevation of antibody titers. Immunization of immune-deficient mice, lacking MHCII, resulted neither in antibody production nor in elevation of circulating miR-150. This study provides proof of concept that serum microRNAs can be detected, with minimally invasive procedure, as biomarkers of vaccination and more in general of adaptive immune responses. Furthermore, the prompt reduction of intracellular level of miR-150, a key regulator of mRNAs critical for lymphocyte differentiation and functions, linked to its release in the external milieu suggests that the selective extracellular disposal of microRNAs can be a rapid way to regulate gene expression during lymphocyte activation.	[de Candia, Paola; Torri, Anna; Gorletta, Tatiana; Bulgheroni, Elisabetta; Cheroni, Cristina; Marabita, Francesco; Crosti, Mariacristina; Moro, Monica; Rossetti, Grazisa; Rossi, Riccardo L.; Geginat, Jens; Pagani, Massimiliano; Abrignani, Sergio] INGM, Milan, Italy; [Fedeli, Maya; Casorati, Giulia; Dellabona, Paolo] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Pariani, Elena; Romano, Luisa] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Esposito, Susanna] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Clin 1, Milan, Italy; [Mosca, Fabio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Milan, Italy; [Mosca, Fabio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Clin Sci & Community Hlth, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	de Candia, P (corresponding author), INGM, Milan, Italy.	decandia@ingm.org; pagani@ingm.org; abrignani@ingm.org	Esposito, Susanna/K-3475-2016; de Candia, Paola/HGC-8826-2022; Fedeli, Maya/AAN-1930-2020; Geginat, Jens/AAA-5818-2019; Dellabona, Paolo/G-5416-2012; Rossi, Riccardo/M-8999-2019; rossetti, grazisa/C-3722-2015; de Candia, Paola/Z-1498-2019; Cheroni, Cristina/AAO-2316-2020; Pariani, Elena/M-3491-2016; Marabita, Francesco/AAD-6220-2019; MOSCA, FABIO/C-5826-2017; Casorati, Giulia/J-7141-2018	Esposito, Susanna/0000-0003-4103-2837; de Candia, Paola/0000-0003-4767-446X; Fedeli, Maya/0000-0002-9946-3683; Geginat, Jens/0000-0003-4813-0384; Dellabona, Paolo/0000-0002-1414-633X; Rossi, Riccardo/0000-0002-4964-3264; rossetti, grazisa/0000-0001-6361-311X; de Candia, Paola/0000-0003-4767-446X; Pariani, Elena/0000-0001-5681-3455; Marabita, Francesco/0000-0001-6180-0106; MOSCA, FABIO/0000-0001-6477-0299; Cheroni, Cristina/0000-0002-0832-2333; Casorati, Giulia/0000-0002-5102-4112; Pagani, Massimiliano/0000-0002-7017-9304; Abrignani, Sergio/0000-0002-0794-3285	CARIPLO [2009-3603]; ERC [269022]; Fondazione Invernizzi; AIRC [IG11523]	CARIPLO(Fondazione Cariplo); ERC(European Research Council (ERC)European Commission); Fondazione Invernizzi; AIRC(Fondazione AIRC per la ricerca sul cancro)	This research was supported by a CARIPLO grant (N<SUP>o</SUP> 2009-3603) http://www.fondazionecariplo.it; by an ERC advanced grant to SA (N<SUP>o</SUP> 269022) http://erc.europa.eu; and by Fondazione Invernizzi. This study was also supported (in part) by research funding to GC from AIRC (IG11523) http://www.airc.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Esposito S, 2011, PEDIATRICS, V127, pE1161, DOI 10.1542/peds.2010-1920; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pagani M, 2013, IMMUNOL REV, V253, P82, DOI 10.1111/imr.12055; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Salomoni P, 1997, P NATL ACAD SCI USA, V94, P3296, DOI 10.1073/pnas.94.7.3296; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, P563, DOI 10.1097/INF.0b013e31819d6394; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	32	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75348	10.1371/journal.pone.0075348	http://dx.doi.org/10.1371/journal.pone.0075348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24205408	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000016
J	DeLuca, TH; Zackrisson, O; Bergman, I; Diez, B; Bergman, B				DeLuca, Thomas H.; Zackrisson, Olle; Bergman, Ingela; Diez, Beatriz; Bergman, Birgitta			Diazotrophy in Alluvial Meadows of Subarctic River Systems	PLOS ONE			English	Article							NITROGEN-FIXATION; FLOW REGULATION; BOREAL FORESTS; N-2 FIXATION; ECOSYSTEMS; FLUXES; FRAGMENTATION; COMMUNITIES; FLOODPLAIN; STREAMS	There is currently limited understanding of the contribution of biological N-2 fixation (diazotrophy) to the N budget of large river systems. This natural source of N in boreal river systems may partially explain the sustained productivity of river floodplains in Northern Europe where winter fodder was harvested for centuries without fertilizer amendments. In much of the world, anthropogenic pollution and river regulation have nearly eliminated opportunities to study natural processes that shaped early nutrient dynamics of large river systems; however, pristine conditions in northern Fennoscandia allow for the retrospective evaluation of key biochemical processes of historical significance. We investigated biological N-2 fixation (diazotrophy) as a potential source of nitrogen fertility at 71 independent floodplain sites along 10 rivers and conducted seasonal and intensive analyses at a subset of these sites. Biological N-2 fixation occurred in all floodplains, averaged 24.5 kg N ha(-1) yr(-1) and was down regulated from over 60 kg N ha(-1) yr(-1) to 0 kg N ha(-1) yr(-1) by river N pollution. A diversity of N-2-fixing cyanobacteria was found to colonize surface detritus in the floodplains. The data provide evidence for N-2 fixation to be a fundamental source of new N that may have sustained fertility at alluvial sites along subarctic rivers. Such data may have implications for the interpretation of ancient agricultural development and the design of contemporary low-input agroecosystems.	[DeLuca, Thomas H.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [DeLuca, Thomas H.; Zackrisson, Olle; Bergman, Ingela] Inst Subarctic Landscape Res, Arjeplog, Sweden; [Diez, Beatriz] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Mol Genet & Microbiol, Santiago 6513677, Chile; [Bergman, Birgitta] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	University of Washington; University of Washington Seattle; Pontificia Universidad Catolica de Chile; Stockholm University	DeLuca, TH (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	deluca@uw.edu	DeLuca, Thomas Henry/B-4547-2012; DeLuca, Thomas/GYU-3468-2022; Díez, Beatriz/AAG-2244-2021	DeLuca, Thomas Henry/0000-0003-1561-9597; Díez, Beatriz/0000-0002-9371-8083	European Regional Development Fund; Bank of Sweden Tercentenary Foundation	European Regional Development Fund(European Commission); Bank of Sweden Tercentenary Foundation	The authors thank the European Regional Development Fund and the Bank of Sweden Tercentenary Foundation for their financial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, WETLAND ECOLOGY PRIN; Brown A.G., 1997, ALLUVIAL GEOARCHAEOL; CAMPBELL A, 1982, FRAN VILDMARK BYGD E; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Dahlstrom A., 2006, Environment and History, V12, P191, DOI 10.3197/096734006776680218; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; DeLuca TH, 2008, SCIENCE, V320, P1181, DOI 10.1126/science.1154836; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Diebel MW, 2009, ECOL APPL, V19, P1127, DOI 10.1890/08-0327.1; Diez B, 2007, APPL ENVIRON MICROB, V73, P3656, DOI 10.1128/AEM.02067-06; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Ellenberg H., 1988, VEGETATION ECOLOGY C; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Helton AM, 2011, FRONT ECOL ENVIRON, V9, P229, DOI 10.1890/080211; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; Humborg C, 2004, LIMNOL OCEANOGR, V49, P1871, DOI 10.4319/lo.2004.49.5.1871; Lisuzzo NJ, 2008, ECOSCIENCE, V15, P366, DOI 10.2980/15-3-2998; Malmqvist B, 2009, RIVERS OF EUROPE, 1ST EDITION, P297, DOI 10.1016/B978-0-12-369449-2.00008-4; Marcarelli AM, 2008, J N AM BENTHOL SOC, V27, P186, DOI 10.1899/07-027.1; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Olson JB, 1998, MICROBIAL ECOL, V36, P231, DOI 10.1007/s002489900110; Parfitt SA, 2010, NATURE, V466, P229, DOI 10.1038/nature09117; Reisinger AJ, 2013, FRESHWATER BIOL, V58, P938, DOI 10.1111/fwb.12098; Rudberg S, 1959, GEOGR ANN, V4, P261; SCHOLLHORN R, 1967, P NATL ACAD SCI USA, V58, P213, DOI 10.1073/pnas.58.1.213; Sobota DJ, 2013, FRONT ECOL ENVIRON, V11, P82, DOI 10.1890/110216; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; Tockner K, 1999, FRESHWATER BIOL, V41, P521, DOI 10.1046/j.1365-2427.1999.00399.x; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Walter H, 1989, ECOLOGICAL SYSTEMS G, DOI DOI 10.1007/978-3-642-70160-3; Wassen G, 1966, KUNGLIGA SVENSKA VET, V2, P1; Wassen MJ, 2006, APPL VEG SCI, V9, P213, DOI 10.1658/1402-2001(2006)9[213:CONAPF]2.0.CO;2; Yasuda Y, 2000, BIRTH RIVERINE CIVIL; Zackrisson O., 1976, EARLY NORRLAND, V9, P7; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	43	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77342	10.1371/journal.pone.0077342	http://dx.doi.org/10.1371/journal.pone.0077342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223119	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200011
J	Fackrell, K; Edmondson-Jones, M; Hall, DA				Fackrell, Kathryn; Edmondson-Jones, Mark; Hall, Deborah A.			A Controlled Approach to the Emotional Dilution of the Stroop Effect	PLOS ONE			English	Article							LEXICAL DECISION; NEGATIVE WORDS; INTERFERENCE; STIMULI; FACILITATION; ANXIETY; SLOW; TASK	We re-examined a modified emotional Stroop task that included an additional colour-word alongside the emotional word, providing the response conflict of the traditional Stroop task. Negative emotionally salient (i.e. unpleasant') words are claimed to capture attention, producing a smaller Stroop effect for negative words compared to neutral words; this phenomenon is called the emotional dilution of the Stroop effect. To address previous limitations, this study compared negative words with lexically matched neutral words in a powered sample of 45 participants. Results demonstrated an emotional Stroop effect (slower colour-naming responses for negative words) and a traditional Stroop effect but not an emotional dilution of the Stroop effect. This finding is at odds with claims that other processing resources are diminished through the failure to disengage attention from emotional information. No matter how attention towards emotional information builds up over time, our findings indicate that attentional resources are not fully captured by negative words.	[Fackrell, Kathryn; Hall, Deborah A.] Nottingham Trent Univ, Div Psychol, Nottingham, England; [Fackrell, Kathryn; Edmondson-Jones, Mark; Hall, Deborah A.] Univ Nottingham, NIHR Nottingham Hearing Biomed Res Unit, Nottingham NG7 2RD, England	Nottingham Trent University; University of Nottingham	Fackrell, K (corresponding author), Nottingham Trent Univ, Div Psychol, Nottingham, England.	msxklf@nottingham.ac.uk		Fackrell, Kathryn/0000-0001-6529-8643; Hall, Deborah/0000-0002-3804-1452	National Institute for Health Research Biomedical Research Unit programme; Nottingham Hearing Biomedical Research Unit	National Institute for Health Research Biomedical Research Unit programme; Nottingham Hearing Biomedical Research Unit	MEJ and DAH are funded by the National Institute for Health Research Biomedical Research Unit programme. KF received funding from the Nottingham Hearing Biomedical Research Unit to prepare the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Algom D, 2009, COGNITION EMOTION, V23, P1552, DOI 10.1080/02699930802490243; Andersson G, 2005, CYBERPSYCHOL BEHAV, V8, P32, DOI 10.1089/cpb.2005.8.32; Ashley V, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-14; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Becker ES, 2001, J ANXIETY DISORD, V15, P147, DOI 10.1016/S0887-6185(01)00055-X; Borkenau P, 2006, COGNITION EMOTION, V20, P866, DOI 10.1080/02699930500348131; Bradley MM, 2010, TECHNICAL REPORT; Brown TL, 2011, J EXP PSYCHOL HUMAN, V37, P85, DOI 10.1037/a0019252; Buhlmann U, 2002, J ANXIETY DISORD, V16, P289, DOI 10.1016/S0887-6185(02)00100-7; Burt JS, 2002, J EXP PSYCHOL HUMAN, V28, P1019, DOI 10.1037//0096-1523.28.5.1019; Chajut E, 2010, EMOTION, V10, P944, DOI 10.1037/a0020172; Chajut E, 2010, J EXP PSYCHOL LEARN, V36, P1567, DOI 10.1037/a0020710; Cho YS, 2006, J EXP PSYCHOL HUMAN, V32, P826, DOI 10.1037/0096-1523.32.4.826; Dresler T, 2009, PSYCHOL RES-PSYCH FO, V73, P364, DOI 10.1007/s00426-008-0154-6; Estes Z, 2008, EMOTION, V8, P441, DOI 10.1037/1528-3542.8.4.441; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Frings C, 2010, Q J EXP PSYCHOL, V63, P42, DOI 10.1080/17470210903156594; Gootjes L, 2011, INT J PSYCHOPHYSIOL, V79, P356, DOI 10.1016/j.ijpsycho.2010.12.003; Huang YM, 2008, J EXP PSYCHOL HUMAN, V34, P328, DOI 10.1037/0096-1523.34.2.328; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Landis T, 2006, CORTEX, V42, P823, DOI 10.1016/S0010-9452(08)70424-6; Larsen RJ, 2008, EMOTION, V8, P445, DOI 10.1037/1528-3542.8.4.445; Larsen RJ, 2006, EMOTION, V6, P62, DOI 10.1037/1528-3542.6.1.62; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; McKenna FP, 2004, J EXP PSYCHOL LEARN, V30, P382, DOI 10.1037/0278-7393.30.2.382; Medler D. A., 2005, MCWORD ON LINE ORTHO; Paelecke M, 2012, EUR J PERSONALITY, V26, P111, DOI 10.1002/per.1848; PEEREMAN R, 1995, J EXP PSYCHOL LEARN, V21, P409, DOI 10.1037/0278-7393.21.2.409; Phaf RH, 2007, J BEHAV THER EXP PSY, V38, P184, DOI 10.1016/j.jbtep.2006.10.008; Putman P, 2012, INT J PSYCHOPHYSIOL, V84, P194, DOI 10.1016/j.ijpsycho.2012.02.006; van Hooff JC, 2008, INT J PSYCHOPHYSIOL, V67, P23, DOI 10.1016/j.ijpsycho.2007.09.002; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wurm LH, 2004, PSYCHOL AGING, V19, P523, DOI 10.1037/0882-7974.19.3.523	36	4	4	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80141	10.1371/journal.pone.0080141	http://dx.doi.org/10.1371/journal.pone.0080141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223219	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200112
J	Matsushima-Nishiwaki, R; Kumada, T; Nagasawa, T; Suzuki, M; Yasuda, E; Okuda, S; Maeda, A; Kaneoka, Y; Toyoda, H; Kozawa, O				Matsushima-Nishiwaki, Rie; Kumada, Takashi; Nagasawa, Tomoaki; Suzuki, Mariko; Yasuda, Eisuke; Okuda, Seiji; Maeda, Atsuyuki; Kaneoka, Yuji; Toyoda, Hidenori; Kozawa, Osamu			Direct Association of Heat Shock Protein 20 (HSPB6) with Phosphoinositide 3-kinase (PI3K) in Human Hepatocellular Carcinoma: Regulation of the PI3K Activity	PLOS ONE			English	Article							GROWTH-FACTOR; NEGATIVE REGULATION; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; SMOOTH-MUSCLE; HUMAN CANCER; P85-ALPHA; TARGET; HSP20; ACTIVATION	HSP20 (HSPB6), one of small heat shock proteins (HSPs), is constitutively expressed in various tissues and has several functions. We previously reported that the expression levels of HSP20 in human hepatocellular carcinoma (HCC) cells inversely correlated with the progression of HCC, and that HSP20 suppresses the growth of HCC cells via the AKT and mitogen-activated protein kinase signaling pathways. However, the exact mechanism underlying the effect of HSP20 on the regulation of these signaling pathways remains to be elucidated. To clarify the details of this effect in HCC, we explored the direct targets of HSP20 in HCC using human HCC-derived HuH7 cells with HSP20 overexpression. HSP20 proteins in the HuH7 cells were coimmunoprecipitated with the p85 regulatory subunit and p110 catalytic subunit of phosphoinositide 3-kinase (PI3K), an upstream kinase of AKT. Although HSP20 overexpression in HCC cells failed to affect the expression levels of PI3K, the activity of PI3K in the unstimulated cells and even in the transforming growth factor-alpha stimulated cells were downregulated by HSP20 overexpression. The association of HSP20 with PI3K was also observed in human HCC tissues in vivo. These findings strongly suggest that HSP20 directly associates with PI3K and suppresses its activity in HCC, resulting in the inhibition of the AKT pathway, and subsequently decreasing the growth of HCC.	[Matsushima-Nishiwaki, Rie; Nagasawa, Tomoaki; Suzuki, Mariko; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Kumada, Takashi; Toyoda, Hidenori] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan; [Yasuda, Eisuke] Suzuka Univ Med Sci, Dept Radiol Technol, Suzuka, Mie, Japan; [Okuda, Seiji] Ogaki Municipal Hosp, Dept Med Technol, Ogaki, Gifu, Japan; [Maeda, Atsuyuki; Kaneoka, Yuji] Ogaki Municipal Hosp, Dept Surg, Ogaki, Gifu, Japan	Gifu University; Ogaki Municipal Hospital; Ogaki Municipal Hospital; Ogaki Municipal Hospital	Kozawa, O (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan.	okozawa@gifu-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [22590726]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (22590726) from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Brophy CM, 1999, J VASC SURG, V29, P326, DOI 10.1016/S0741-5214(99)70385-X; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen YW, 2012, J CELL PHYSIOL, V227, P2818, DOI 10.1002/jcp.23038; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Daveau M, 2003, MOL CARCINOGEN, V36, P130, DOI 10.1002/mc.10103; Fan GC, 2008, CIRC RES, V103, P1270, DOI 10.1161/CIRCRESAHA.108.182832; Fan GC, 2011, J MOL CELL CARDIOL, V51, P574, DOI 10.1016/j.yjmcc.2010.09.013; Flynn CR, 2005, J APPL PHYSIOL, V98, P1836, DOI 10.1152/japplphysiol.01043.2004; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Kozawa O, 2002, LIFE SCI, V72, P113, DOI 10.1016/S0024-3205(02)02144-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsuno H, 1998, FEBS LETT, V429, P327, DOI 10.1016/S0014-5793(98)00626-7; Matsushima-Nishiwaki R, 2011, J CELL BIOCHEM, V112, P3430, DOI 10.1002/jcb.23270; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Noda T, 2007, ONCOL REP, V17, P1309; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Seit-Nebi AS, 2010, CELL STRESS CHAPERON, V15, P233, DOI 10.1007/s12192-009-0141-x; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Tanaka K, 2001, JPN J CANCER RES, V92, P959, DOI 10.1111/j.1349-7006.2001.tb01187.x; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; Viahos CJ, 1994, J BIOL CHEM, V269, P5241; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogt PK, 2011, MOL CELL, V41, P499, DOI 10.1016/j.molcel.2011.02.017; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Wang Y, 2001, DIABETES, V50, P1821, DOI 10.2337/diabetes.50.8.1821; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	39	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78440	10.1371/journal.pone.0078440	http://dx.doi.org/10.1371/journal.pone.0078440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223153	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200045
J	Preuss, UW; Winham, SJ; Biernacka, JM; Geske, JR; Bakalkin, G; Koller, G; Zill, P; Soyka, M; Karpyak, VM				Preuss, Ulrich W.; Winham, Stacey J.; Biernacka, Joanna M.; Geske, Jennifer R.; Bakalkin, Georgy; Koller, Gabriele; Zill, Peter; Soyka, Michael; Karpyak, Victor M.			PDYN rs2281285 Variant Association with Drinking to Avoid Emotional or Somatic Discomfort	PLOS ONE			English	Article							KAPPA-OPIOID RECEPTOR; ALCOHOL DEPENDENCE; GENE; SITUATIONS; INVENTORY; SYSTEM; MODEL	Introduction: One of the proposed psychobiological pathways of craving attributes the desire for drinking in the context of tension, discomfort or unpleasant emotions, to "negative'' (or "relief'') craving. The aim of this study was to replicate a previously reported association of the PDYN rs2281285 variant with negative craving using a different phenotyping approach. Methods: The TaqMan (R) Genotyping Assay was used to genotype the rs2281285 variant in 417 German alcohol-dependent subjects. The presence of negative/relief craving was assessed by asking if participants ever ingested alcohol to avoid unwanted emotional or somatic discomfort. Results: The minor allele of rs2281285 was associated with an increased risk of drinking to avoid/escape unwanted emotional or somatic events (OR = 2.29, 95% CI = 1.08-4.85, p = 0.0298). Discussion: Despite the use of a different phenotyping approach to the measurement of negative craving, our results confirm the association between negative craving and PDYN rs2281285. Genetic markers of negative craving may help to identify subgroups of alcohol-dependent individuals vulnerable to relapse in the context of negative emotions or somatic discomfort, leading to the development of specifically tailored treatment strategies.	[Preuss, Ulrich W.; Koller, Gabriele; Zill, Peter; Soyka, Michael] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Preuss, Ulrich W.] Univ Halle Wittenberg, Dept Psychiat, D-06108 Halle, Germany; [Winham, Stacey J.; Biernacka, Joanna M.; Geske, Jennifer R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Biernacka, Joanna M.; Karpyak, Victor M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Div Biol Res Drug Dependence, Uppsala, Sweden; [Soyka, Michael] Private Hosp Meiringen, Meiringen, Switzerland	University of Munich; Martin Luther University Halle Wittenberg; Mayo Clinic; Mayo Clinic; Uppsala University	Karpyak, VM (corresponding author), Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA.	karpyak.victor@mayo.edu	Karpyak, Victor M./AGJ-2595-2022	Karpyak, Victor M./0000-0002-9552-6130; Winham, Stacey/0000-0002-8492-9102; Bakalkin, Georgy/0000-0002-8074-9833	St. Marys Hospital; Samuel C. Johnson Genomics of Addiction Program; NIH/NIAAA [P20 AA17830Z]; Swedish Council for Working Life and Social Research; Swedish Science Research Council; Swedish Research Council FORMAS; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017830] Funding Source: NIH RePORTER	St. Marys Hospital; Samuel C. Johnson Genomics of Addiction Program; NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Science Research Council; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the St. Marys Hospital Sponsorship Award (VMK), Samuel C. Johnson Genomics of Addiction Program (VMK, JMB), NIH/NIAAA P20 AA17830Z (VMK, JMB), and the Swedish Council for Working Life and Social Research, Swedish Science Research Council and Swedish Research Council FORMAS (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis H.M., 1985, INVENTORY DRUG TAKIN; Annis H.M., 1997, INVENTORY DRUG TAKIN; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Edenberg HJ, 2008, HUM MOL GENET, V17, P1783, DOI 10.1093/hmg/ddn068; Falk D, 2010, ALCOHOL CLIN EXP RES, V34, P2022, DOI 10.1111/j.1530-0277.2010.01290.x; Galeote L, 2008, J NEUROCHEM, V105, P1358, DOI 10.1111/j.1471-4159.2008.05247.x; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Heinz A, 2003, ALCOHOL ALCOHOLISM, V38, P35, DOI 10.1093/alcalc/agg005; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Ji Y, 2013, PHARMACOGENOMICS J, V13, P456, DOI 10.1038/tpj.2012.32; Karpyak VM, 2013, INT J NEUROPSYCHOPH, V16, P975, DOI 10.1017/S1461145712001137; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Mann K, 2013, BIOL PSYCHIAT, V73, P706, DOI 10.1016/j.biopsych.2012.10.020; Nikoshkov A, 2005, FASEB J, V19, P1543, DOI 10.1096/fj.05-3743fje; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Todtenkopf MS, 2004, PSYCHOPHARMACOLOGY, V172, P463, DOI 10.1007/s00213-003-1680-y; Turner NE, 1997, BEHAV RES THER, V35, P465, DOI 10.1016/S0005-7967(96)00119-2; Verheul R, 1999, ALCOHOL ALCOHOLISM, V34, P197, DOI 10.1093/alcalc/34.2.197; VictorioEstrada A, 1997, ADDICT BEHAV, V22, P557, DOI 10.1016/S0306-4603(96)00061-5; VictorioEstrada A, 1996, DRUG ALCOHOL DEPEN, V41, P75, DOI 10.1016/0376-8716(96)01241-0; Wadenberg MLG, 2003, CNS DRUG REV, V9, P187; Walsh SL, 2001, PSYCHOPHARMACOLOGY, V157, P151, DOI 10.1007/s002130100788; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Williams TJ, 2007, ADDICT BIOL, V12, P496, DOI 10.1111/j.1369-1600.2007.00069.x; Wisniewski Stephen R, 2006, J Psychiatr Pract, V12, P71, DOI 10.1097/00131746-200603000-00002; Wittchen HU, 1997, SKID STRUCTURED CLIN; Xuei X, 2006, MOL PSYCHIATR, V11, P1016, DOI 10.1038/sj.mp.4001882; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525; Zywiak WH, 2006, J SUBST ABUSE TREAT, V30, P349, DOI 10.1016/j.jsat.2006.03.004; Zywiak WH, 2003, J SUBST ABUSE TREAT, V25, P287, DOI 10.1016/S0740-5472(03)00118-1	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78688	10.1371/journal.pone.0078688	http://dx.doi.org/10.1371/journal.pone.0078688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223163	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200055
J	Sakurai, A; Takayama, K; Nomura, N; Munakata, T; Yamamoto, N; Tamura, T; Yamada, J; Hashimoto, M; Kuwahara, K; Sakoda, Y; Suda, Y; Kobayashi, Y; Sakaguchi, N; Kida, H; Kohara, M; Shibasaki, F				Sakurai, Akira; Takayama, Katsuyoshi; Nomura, Namiko; Munakata, Tsubasa; Yamamoto, Naoki; Tamura, Tsuruki; Yamada, Jitsuho; Hashimoto, Masako; Kuwahara, Kazuhiko; Sakoda, Yoshihiro; Suda, Yoshihiko; Kobayashi, Yukuharu; Sakaguchi, Nobuo; Kida, Hiroshi; Kohara, Michinori; Shibasaki, Futoshi			Broad-Spectrum Detection of H5 Subtype Influenza A Viruses with a New Fluorescent Immunochromatography System	PLOS ONE			English	Article							SOUTHERN CHINA; WATER BIRDS; NOMENCLATURE; GENERATION; EVOLUTION; INFECTION; DIAGNOSIS; CHICKENS; STRAINS; ANTIGEN	Immunochromatography (IC) is an antigen-detection assay that plays an important role in the rapid diagnosis of influenza virus because the protocol is short time and easy to use. Despite the usability of IC, the sensitivity is approximately 10(3) pfu per reaction. In addition, antigen-antibody interaction-based method cannot be used for the detection of influenza viruses with major antigenic change. In this study, we established the use of fluorescent immunochromatography (FLIC) to detect a broad spectrum of H5 subtype influenza A viruses. This method has improved sensitivity 10-100 fold higher than traditional IC because of the use of fluorescent conjugated beads. Our Type-E FLIC kit detected all of the H5 subtype influenza viruses that were examined, as well as recombinant hemagglutinin (HA) proteins (rHAs) belonging to the Eurasian H5 subtype viruses and the Type-N diagnosed North American H5 subtype influenza A viruses. Thus, this kit has the improved potential to detect H5 subtype influenza viruses of different clades with both Type-E and Type-N FLIC kits. Compared with PCR-based diagnosis, FLIC has a strong advantage in usability, because the sample preparation required for FLIC is only mix-and-drop without any additional steps such as RNA extraction. Our results can provide new strategies against the spread and transmission of HPAI H5N1 viruses in birds and mammals including humans.	[Sakurai, Akira; Nomura, Namiko; Hashimoto, Masako; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, Tokyo 113, Japan; [Takayama, Katsuyoshi; Kobayashi, Yukuharu] ADTEC Co LTD, Usa City, Oita, Japan; [Munakata, Tsubasa; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Yamamoto, Naoki; Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab,Kita Ku, Sapporo, Hokkaido, Japan; [Tamura, Tsuruki; Yamada, Jitsuho; Suda, Yoshihiko] Konica Minolta Inc, Hino, Tokyo, Japan; [Kuwahara, Kazuhiko; Sakaguchi, Nobuo] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol, Chuo Ku, Kumamoto, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Hokkaido University; Konica Minolta Inc.; Kumamoto University	Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, Tokyo 113, Japan.	shibasaki-ft@igakuken.or.jp			Ministry of Economy, Trade, and Industry, Japan [2010FY]; Japan Society for the Promotion of Science KAKENHI [23659069, 23659314]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (MEXT); Target-driven R&D (Japan Science and Technology Agency); Grants-in-Aid for Scientific Research [24659224] Funding Source: KAKEN	Ministry of Economy, Trade, and Industry, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Target-driven R&D (Japan Science and Technology Agency); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Ministry of Economy, Trade, and Industry, Japan as a part of "Program to support collaboration between hospitals and businesses for development and improvement of medical equipment and devices to solve unmet medical needs'' (supplementary budget, 2010FY), Japan Society for the Promotion of Science KAKENHI (Grant Numbers 23659069 and 23659314), a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a contract research fund from the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (MEXT) to N.S. and partly by a grant for the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Japan Science and Technology Agency) to K. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assiri A, 2013, LANCET INFECT DIS; Bowman AS, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.33; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Chan KH, 2007, J CLIN VIROL, V38, P169, DOI 10.1016/j.jcv.2006.11.010; Cheung CL, 2007, J VIROL, V81, P10402, DOI 10.1128/JVI.01157-07; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; DiOrio Mary, 2012, Morbidity and Mortality Weekly Report, V61, P764; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Khan K, 2013, PLOS CURR, V5; Kuwahara K, 2001, P NATL ACAD SCI USA, V98, P10279, DOI 10.1073/pnas.181335698; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; OIE, 2012, DIAGNOSTIC TESTS VAC, V1, P721; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Sakai-Tagawa Y, 2010, J CLIN MICROBIOL, V48, P2872, DOI 10.1128/JCM.00439-10; Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Sakurai A, 2012, VIRUSES-BASEL, V4, P1235, DOI 10.3390/v4081235; Sakurai A, 2011, J VIROL METHODS, V178, P75, DOI 10.1016/j.jviromet.2011.08.015; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Soda K, 2008, ARCH VIROL, V153, P2041, DOI 10.1007/s00705-008-0226-3; Soda K, 2008, JPN J VET RES, V55, P93; Soda K, 2011, J VET MED SCI, V73, P767, DOI 10.1292/jvms.10-0532; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tsuda Y, 2007, MICROBIOL IMMUNOL, V51, P903, DOI 10.1111/j.1348-0421.2007.tb03973.x; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, 2013, CUM NUMB CONF HUM CA; WHO, 2020, PAND INFL RISK MAN W; World Health Organization, 2011, ANT GEN CHAR ZOON IN; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Zhao G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046183; Zhao SH, 2012, J VIROL, V86, P13836, DOI 10.1128/JVI.02595-12	38	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e76753	10.1371/journal.pone.0076753	http://dx.doi.org/10.1371/journal.pone.0076753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223117	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200009
J	Su, Y; D'Angelo, GM; Vlassenko, AG; Zhou, GF; Snyder, AZ; Marcus, DS; Blazey, TM; Christensen, JJ; Vora, S; Morris, JC; Mintun, MA; Benzinger, TLS				Su, Yi; D'Angelo, Gina M.; Vlassenko, Andrei G.; Zhou, Gongfu; Snyder, Abraham Z.; Marcus, Daniel S.; Blazey, Tyler M.; Christensen, Jon J.; Vora, Shivangi; Morris, John C.; Mintun, Mark A.; Benzinger, Tammie L. S.			Quantitative Analysis of PiB-PET with FreeSurfer ROIs	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; HUMAN CEREBRAL-CORTEX; DEMENTIA RATING CDR; ALZHEIMERS-DISEASE; AMYLOID DEPOSITION; GRAPHICAL ANALYSIS; HUMAN BRAIN; MRI; REGISTRATION	In vivo quantification of beta-amyloid deposition using positron emission tomography is emerging as an important procedure for the early diagnosis of the Alzheimer's disease and is likely to play an important role in upcoming clinical trials of disease modifying agents. However, many groups use manually defined regions, which are non-standard across imaging centers. Analyses often are limited to a handful of regions because of the labor-intensive nature of manual region drawing. In this study, we developed an automatic image quantification protocol based on FreeSurfer, an automated whole brain segmentation tool, for quantitative analysis of amyloid images. Standard manual tracing and FreeSurfer-based analyses were performed in 77 participants including 67 cognitively normal individuals and 10 individuals with early Alzheimer's disease. The manual and FreeSurfer approaches yielded nearly identical estimates of amyloid burden (intraclass correlation = 0.98) as assessed by the mean cortical binding potential. An MRI test-retest study demonstrated excellent reliability of FreeSurfer based regional amyloid burden measurements. The FreeSurfer-based analysis also revealed that the majority of cerebral cortical regions accumulate amyloid in parallel, with slope of accumulation being the primary difference between regions.	[Su, Yi; Vlassenko, Andrei G.; Snyder, Abraham Z.; Marcus, Daniel S.; Blazey, Tyler M.; Christensen, Jon J.; Vora, Shivangi; Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [D'Angelo, Gina M.; Zhou, Gongfu] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [D'Angelo, Gina M.; Snyder, Abraham Z.; Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Vlassenko, Andrei G.; Marcus, Daniel S.; Morris, John C.; Benzinger, Tammie L. S.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Mintun, Mark A.] Avid Radiophamaceut, Philadelphia, PA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Su, Y (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	suy@mir.wustl.edu	Benzinger, Tammie/L-6104-2013	Benzinger, Tammie/0000-0002-8114-0552; Su, Yi/0000-0002-1946-8063	National Institutes of Health (NIH) [P01AG026276, NIH P01AG03991, NIH U19AG032438, NIH P50AG005681, NIH P50NS006833, NIH P30NS048056, NIH P20MH07796]; American Roentgen Ray Society Scholar Award; Kopolow family; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048056, P50NS006833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, P01AG003991, U01AG032438, U19AG032438, P01AG026276, UF1AG032438] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Roentgen Ray Society Scholar Award; Kopolow family; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding support came from National Institutes of Health (NIH) P01AG026276, and NIH P01AG03991, NIH U19AG032438, NIH P50AG005681, NIH P50NS006833, NIH P30NS048056, NIH P20MH07796, American Roentgen Ray Society Scholar Award, and generous support of the Kopolow family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Edison P, 2009, NEUROIMAGE, V48, P329, DOI 10.1016/j.neuroimage.2009.06.079; Eisenstein SA, 2012, CHARACTERIZATION EXT; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Galvin JE, 2010, BRAIN, V133, P3290, DOI 10.1093/brain/awq204; Grimmer T, 2010, BIOL PSYCHIAT, V68, P879, DOI 10.1016/j.biopsych.2010.05.013; HAJNAL JV, 1995, J COMPUT ASSIST TOMO, V19, P289, DOI 10.1097/00004728-199503000-00022; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HOLTZMAN DM, 2011, SCI TRANSLATIONAL ME, V3; Illarioshkin S. N., 2013, ANN CLIN EXPT NEUROL, V7, P39; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; Lehmann M, 2010, J ALZHEIMERS DIS, V20, P587, DOI 10.3233/JAD-2010-1401; Li Y, 2008, EUR J NUCL MED MOL I, V35, P2169, DOI 10.1007/s00259-008-0833-y; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Lowe VJ, 2009, J NUCL MED, V50, P878, DOI 10.2967/jnumed.108.058529; Marcus DS, 2007, NEUROINFORMATICS, V5, P11, DOI 10.1385/NI:5:1:11; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Meltzer CC, 1996, NEUROLOGY, V47, P454, DOI 10.1212/WNL.47.2.454; Meltzer CC, 1999, J NUCL MED, V40, P2053; Messina D, 2011, PARKINSONISM RELAT D, V17, P172, DOI 10.1016/j.parkreldis.2010.12.010; Mikhno A, 2008, J NUCL MED, V49, P1262, DOI 10.2967/jnumed.107.049932; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Mueller SG, 2010, HUM BRAIN MAPP, V31, P1339, DOI 10.1002/hbm.20934; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Raniga P, 2008, ACAD RADIOL, V15, P1376, DOI 10.1016/j.acra.2008.07.006; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Rosario BL, 2011, NEUROIMAGE, V55, P933, DOI 10.1016/j.neuroimage.2010.12.070; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107	52	137	138	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e73377	10.1371/journal.pone.0073377	http://dx.doi.org/10.1371/journal.pone.0073377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223109	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200001
J	Tomlinson, LA; Abel, GA; Chaudhry, AN; Tomson, CR; Wilkinson, IB; Roland, MO; Payne, RA				Tomlinson, Laurie A.; Abel, Gary A.; Chaudhry, Afzal N.; Tomson, Charles R.; Wilkinson, Ian B.; Roland, Martin O.; Payne, Rupert A.			ACE Inhibitor and Angiotensin Receptor-II Antagonist Prescribing and Hospital Admissions with Acute Kidney Injury: A Longitudinal Ecological Study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CONVERTING ENZYME-INHIBITORS; RISK; COMBINATIONS; MORTALITY; BLOCKERS	Background: ACE Inhibitors (ACE-I) and Angiotensin-Receptor Antagonists (ARAs) are commonly prescribed but can cause acute kidney injury (AKI) during intercurrent illness. Rates of hospitalization with AKI are increasing. We aimed to determine whether hospital AKI admission rates are associated with increased ACE-I/ARA prescribing. Methods and Findings: English NHS prescribing data for ACE-I/ARA prescriptions were matched at the level of the general practice to numbers of hospital admissions with a primary diagnosis of AKI. Numbers of prescriptions were weighted for the demographic characteristics of general practices by expressing prescribing as rates where the denominator is Age, Sex, and Temporary Resident Originated Prescribing Units (ASTRO-PUs). We performed a mixed-effect Poisson regression to model the number of admissions for AKI occurring in each practice for each of 4 years from 1/4/2007. From 2007/8-2010/11, crude AKI admission rates increased from 0.38 to 0.57 per 1000 patients (51.6% increase), and national annual ACE-I/ARA prescribing rates increased by 0.032 from 0.202 to 0.234 (15.8% increase). There was strong evidence (p<0.001) that increases in practice-level prescribing of ACE-I/ARA over the study period were associated with an increase in AKI admission rates. The increase in prescribing seen in a typical practice corresponded to an increase in admissions of approximately 5.1% (rate ratio = 1.051 for a 0.03 per ASTRO-PU increase in annual prescribing rate, 95% CI 1.047-1.055). Using the regression model we predict that 1,636 (95% CI 1,540-1,780) AKI admissions would have been avoided if prescribing rates were at the 2007/8 level, equivalent to 14.8% of the total increase in AKI admissions. Conclusion: In this ecological analysis, up to 15% of the increase in AKI admissions in England over a 4-year time period is potentially attributable to increased prescribing of ACE-I and ARAs. However, these findings are limited by the lack of patient level data such as indication for prescribing and patient characteristics.	[Tomlinson, Laurie A.; Wilkinson, Ian B.] Univ Cambridge, Cambridge Clin Trials Unit, Cambridge, England; [Abel, Gary A.; Roland, Martin O.; Payne, Rupert A.] Cambridge Ctr Hlth Serv Res, Inst Publ Hlth, Cambridge, England; [Chaudhry, Afzal N.] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Dept Nephrol, Cambridge, England; [Tomson, Charles R.] North Bristol Natl Hlth Serv Trust, Richard Bright Renal Unit, Bristol, Avon, England	University of Cambridge; University of Cambridge	Tomlinson, LA (corresponding author), Univ Cambridge, Cambridge Clin Trials Unit, Cambridge, England.	lat42@cam.ac.uk	Abel, Gary/ABE-1765-2021	Abel, Gary/0000-0003-2231-5161; wilkinson, ian/0000-0001-6598-9399; Tomson, Charles/0000-0002-0224-8726; Tomlinson, Laurie/0000-0001-8848-9493; Roland, Martin/0000-0002-8533-3060	Cambridge Biomedical Research Institute; British Heart Foundation; British Heart Foundation [FS/12/8/29377] Funding Source: researchfish; National Institute for Health Research [CL-2010-14-003] Funding Source: researchfish	Cambridge Biomedical Research Institute; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	ANC is supported by the Cambridge Biomedical Research Institute and IBW by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KA, 2012, INEQUALITIES OUTCOME; Adhiyaman V, 2001, J ROY SOC MED, V94, P512, DOI 10.1177/014107680109401005; Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Brody H, 2011, AM J PUBLIC HEALTH, V101, P399, DOI 10.2105/AJPH.2010.199844; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Fournier JP, 2012, FUNDAM CLIN PHARM; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; National Health Service, 2011, PRESCR COST AN; National Health Service. The Information Centre, QUAL OUTC FRAM; National Health Service. The Information Centre, HOSP EP STAT; National Institute for Health and Clinical Excellence, 2011, CHRON KIDN DIS QUAL; Okunola O, 2012, Afr J Med Med Sci, V41, P119; Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610; Rifkin DE, 2012, J AM SOC NEPHROL, V23, P979, DOI 10.1681/ASN.2011121185; Rim MY, 2012, AM J KIDNEY DIS, V60, P576, DOI 10.1053/j.ajkd.2012.04.017; ROBERTS SJ, 1993, BRIT MED J, V307, P485, DOI 10.1136/bmj.307.6902.485; Smets HLE, 2008, PHARMACOEPIDEM DR S, V17, P1014, DOI 10.1002/pds.1641; Tomlinson LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-58; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wheeler DC, 2013, KIDNEY INT, V83, P377, DOI 10.1038/ki.2012.425; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 1990, INT CLASS DIS, V10th	29	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78465	10.1371/journal.pone.0078465	http://dx.doi.org/10.1371/journal.pone.0078465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223154	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200046
J	Voogt, CV; Kuntsche, E; Kleinjan, M; Poelen, EAP; Lemmers, LACJ; Engels, RCME				Voogt, Carmen V.; Kuntsche, Emmanuel; Kleinjan, Marloes; Poelen, Evelien A. P.; Lemmers, Lex A. C. J.; Engels, Rutger C. M. E.			Using Ecological Momentary Assessment in Testing the Effectiveness of an Alcohol Intervention: A Two-Arm Parallel Group Randomized Controlled Trial	PLOS ONE			English	Article							REDUCING HEAVY DRINKING; COLLEGE-STUDENTS; RECALL PERIOD; GOLD STANDARD; CONSUMPTION; ONLINE	Background: Alcohol consumption of college students has a fluctuating nature, which might impact the measurement of intervention effects. By using 25 follow-up time-points, this study tested whether intervention effects are robust or might vary over time. Methods: Data were used from a two-arm parallel group randomized controlled trial applying ecological momentary assessment (EMA) with 30 data time-points in total. Students between 18 and 24 years old who reported heavy drinking in the past six months and who were ready to change their alcohol consumption were randomly assigned to the experimental (n = 456: web-based brief alcohol intervention) and control condition (n = 451: no intervention). Outcome measures were weekly alcohol consumption, frequency of binge drinking, and heavy drinking status. Results: According to the intention-to-treat principle, regression analyses revealed that intervention effects on alcohol consumption varied when exploring multiple follow-up time-points. Intervention effects were found for a) weekly alcohol consumption at 1, 2, 3, 4, and 7 weeks follow-up, b) frequency of binge drinking at 1, 2, 7, and 12 weeks follow-up, and c) heavy drinking status at 1, 2, 7, and 16 weeks follow-up. Conclusions: This research showed that the commonly used one and six month follow-up time-points are relatively arbitrary and not using EMA might bring forth erroneous conclusions on the effectiveness of interventions. Therefore, future trials in alcohol prevention research and beyond are encouraged to apply EMA when assessing outcome measures and intervention effectiveness.	[Voogt, Carmen V.; Kuntsche, Emmanuel; Kleinjan, Marloes; Poelen, Evelien A. P.; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Kuntsche, Emmanuel] Addict Switzerland, Res Inst, Lausanne, Switzerland; [Lemmers, Lex A. C. J.] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands	Radboud University Nijmegen; Trimbos Institute	Voogt, CV (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	c.voogt@bsi.ru.nl	Kleinjan, Marloes/AAF-1128-2019	Kleinjan, Marloes/0000-0002-4545-5549; Engels, Rutger/0000-0003-1944-9126	ZonMw, The Netherlands Organization for Health Research and Development [50-50110-96-682]	ZonMw, The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study was funded by ZonMw, The Netherlands Organization for Health Research and Development with grant number 50-50110-96-682 (www.zonmw.nl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Bartholomew KL., 2001, INTERVENTION MAPPING; Boon B, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1695; Carey KB, 2009, ADDICTION, V104, P1807, DOI 10.1111/j.1360-0443.2009.02691.x; Christensen H, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e20; Clifford PR, 2007, J STUD ALCOHOL DRUGS, V68, P519, DOI 10.15288/jsad.2007.68.519; Dawson DA, 2003, ALCOHOL RES HEALTH, V27, P18; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; Del Boca FK, 2004, J CONSULT CLIN PSYCH, V72, P155, DOI 10.1037/0022-006X.72.2.155; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Ekholm O, 2004, EUR J CLIN NUTR, V58, P60, DOI 10.1038/sj.ejcn.1601746; Ekholm O, 2011, EUR J CLIN NUTR, V65, P520, DOI 10.1038/ejcn.2011.1; Engels RCME, 1997, ADDICT BEHAV, V22, P613, DOI 10.1016/S0306-4603(96)00067-6; Gezondheidsraad, 2006, RICHTL GEZ VOED 2006; Gmel G, 2007, J STUD ALCOHOL DRUGS, V68, P303, DOI 10.15288/jsad.2007.68.303; Grossman J, 2005, PERSPECT BIOL MED, V48, P516, DOI 10.1353/pbm.2005.0092; Hibell B., 2004, ESPAD REPORT 2003 AL; HOLM S, 1979, SCAND J STAT, V6, P65; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Kaptchuk TJ, 2001, J CLIN EPIDEMIOL, V54, P541, DOI 10.1016/S0895-4356(00)00347-4; Khadjesari Z, 2011, ADDICTION, V106, P267, DOI 10.1111/j.1360-0443.2010.03214.x; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; LEMMENS P, 1992, J STUD ALCOHOL, V53, P476, DOI 10.15288/jsa.1992.53.476; Maggs JL, 2011, ADDICT BEHAV, V36, P197, DOI 10.1016/j.addbeh.2010.10.005; Maisto SA, 2007, J STUD ALCOHOL DRUGS, V68, P529, DOI 10.15288/jsad.2007.68.529; Moskowitz DS, 2006, J PSYCHIATR NEUROSCI, V31, P13; Neighbors C, 2011, PSYCHOL ADDICT BEHAV, V25, P702, DOI 10.1037/a0024051; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rooke S, 2010, ADDICTION, V105, P1381, DOI 10.1111/j.1360-0443.2010.02975.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tripodi SJ, 2010, ARCH PEDIAT ADOL MED, V164, P85, DOI 10.1001/archpediatrics.2009.235; Trull TJ, 2009, PSYCHOL ASSESSMENT, V21, P457, DOI 10.1037/a0017653; Voogt CV, 2013, ALCOHOL ALCOHOLISM, V48, P312, DOI 10.1093/alcalc/ags133; Voogt CV, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-231; White A, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1479; Whitehead WE, 2004, GASTROENTEROLOGY, V126, pS159, DOI 10.1053/j.gastro.2003.10.038	38	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78436	10.1371/journal.pone.0078436	http://dx.doi.org/10.1371/journal.pone.0078436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223806	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400028
J	Acevedo, N; Mohr, J; Zakzuk, J; Samonig, M; Briza, P; Erler, A; Pomes, A; Huber, CG; Ferreira, F; Caraballo, L				Acevedo, Nathalie; Mohr, Jens; Zakzuk, Josefina; Samonig, Martin; Briza, Peter; Erler, Anja; Pomes, Anna; Huber, Christian G.; Ferreira, Fatima; Caraballo, Luis			Proteomic and Immunochemical Characterization of Glutathione Transferase as a New Allergen of the Nematode Ascaris lumbricoides	PLOS ONE			English	Article							HOUSE-DUST-MITE; IGE ANTIBODY-RESPONSES; COCKROACH BLATTELLA-GERMANICA; S-TRANSFERASE; ONCHOCERCA-VOLVULUS; CROSS-REACTIVITY; DERMATOPHAGOIDES-PTERONYSSINUS; TROPICAL ENVIRONMENT; MOLECULAR-CLONING; IMMUNOGLOBULIN-E	Helminth infections and allergy have evolutionary and clinical links. Infection with the nematode Ascaris lumbricoides induces IgE against several molecules including invertebrate pan-allergens. These antibodies influence the pathogenesis and diagnosis of allergy; therefore, studying parasitic and non-parasitic allergens is essential to understand both helminth immunity and allergy. Glutathione transferases (GSTs) from cockroach and house dust mites are clinically relevant allergens and comparative studies between them and the GST from A. lumbricoides (GSTA) are necessary to evaluate their allergenicity. We sought to analyze the allergenic potential of GSTA in connection with the IgE response to non-parasitic GSTs. IgE to purified GSTs from Ascaris (nGSTA and rGSTA), house dust mites (rDer p 8, nBlo t 8 and rBlo t 8), and cockroach (rBla g 5) was measured by ELISA in subjects from Cartagena, Colombia. Also, multidimensional proteomic approaches were used to study the extract of A. lumbricoides and investigate the existence of GST isoforms. We found that among asthmatics, the strength of IgE levels to GSTA was significantly higher than to mite and cockroach GSTs, and there was a strong positive correlation between IgE levels to these molecules. Specific IgE to GSTA was found in 13.2% of controls and 19.5% of asthmatics. In addition nGSTA induced wheal and flare in skin of sensitized asthmatics indicating that it might be of clinical relevance for some patients. Frequency and IgE levels to GSTA were higher in childhood and declined with age. At least six GST isoforms in A. lumbricoides bind human IgE. Four isoforms were the most abundant and several amino acid substitutions were found, mainly on the N-terminal domain. In conclusion, a new allergenic component of Ascaris has been discovered; it could have clinical impact in allergic patients and influence the diagnosis of mite and cockroach allergy in tropical environments.	[Acevedo, Nathalie; Zakzuk, Josefina; Caraballo, Luis] Univ Cartagena, Immunol Res Inst, Cartagena, Colombia; [Acevedo, Nathalie; Zakzuk, Josefina; Caraballo, Luis] Fdn Dev Med & Biol Sci, Cartagena, Colombia; [Mohr, Jens; Samonig, Martin; Huber, Christian G.] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria; [Briza, Peter; Erler, Anja; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Div Allergy & Immunol, A-5020 Salzburg, Austria; [Pomes, Anna] Indoor Biotechnol Inc, Charlottesville, VA USA	Universidad de Cartagena; Salzburg University; Salzburg University; INDOOR Biotechnologies	Caraballo, L (corresponding author), Univ Cartagena, Immunol Res Inst, Cartagena, Colombia.	lcaraballog@unicartagena.edu.co	Huber, Christian G./E-5445-2011; Ferreira, Fatima/E-4889-2011; Briza, Peter/D-7309-2012; Ferreira, Fatima/AAB-4321-2019; Pomés, Anna/H-7010-2019	Huber, Christian G./0000-0001-8358-1880; Ferreira, Fatima/0000-0003-0989-2335; Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335; Pomés, Anna/0000-0002-8729-1829; Acevedo, Nathalie/0000-0002-5154-2964	Administrative Department of Science, Technology and Innovation (Colciencias, Colombia) [602-2009]; University of Cartagena (Colombia); University of Salzburg (Austria); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI077653]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER	Administrative Department of Science, Technology and Innovation (Colciencias, Colombia); University of Cartagena (Colombia); University of Salzburg (Austria); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Administrative Department of Science, Technology and Innovation (Colciencias, Colombia), Contract 602-2009; the University of Cartagena (Colombia); the University of Salzburg (Austria) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI077653 (to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo N, 2011, PARASITE IMMUNOL, V33, P309, DOI 10.1111/j.1365-3024.2011.01288.x; Acevedo N, 2011, INT ARCH ALLERGY IMM, V154, P195, DOI 10.1159/000321106; Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Acevedo N, 2009, CLIN EXP IMMUNOL, V157, P282, DOI 10.1111/j.1365-2249.2009.03948.x; Acevedo N, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-13; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Al-Sherbiny M, 2003, ACTA TROP, V88, P117, DOI 10.1016/S0001-706X(03)00195-5; Arruda LK, 1997, J BIOL CHEM, V272, P20907, DOI 10.1074/jbc.272.33.20907; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; AURIAULT C, 1990, J CLIN MICROBIOL, V28, P1918, DOI 10.1128/JCM.28.9.1918-1924.1990; Caraballo L, 1996, J ALLERGY CLIN IMMUN, V98, P573, DOI 10.1016/S0091-6749(96)70091-X; Caraballo L, 2011, WORLD ALLERGY ORGAN, V4, P77, DOI 10.1097/WOX.0b013e3182167e04; Cooper PJ, 2009, CURR OPIN ALLERGY CL, V9, P29, DOI 10.1097/ACI.0b013e32831f44a6; Ebo DG, 2010, CLIN EXP ALLERGY, V40, P339, DOI 10.1111/j.1365-2222.2009.03345.x; Haahtela T, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-3; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; Hong SJ, 2002, EXP PARASITOL, V101, P231, DOI 10.1016/S0014-4894(02)00112-1; Huang CH, 2006, CLIN EXP ALLERGY, V36, P369, DOI 10.1111/j.1365-2222.2006.02447.x; Jeong KY, 2009, INT ARCH ALLERGY IMM, V148, P59, DOI 10.1159/000151506; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Jimenez S, 2007, ALLERGY CLIN IMMUNOL, V19, P233, DOI 10.1027/0838-1925.19.6.233; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Liebau E, 1997, BIOCHEM J, V324, P659, DOI 10.1042/bj3240659; Liebau E, 2008, FEBS J, V275, P3438, DOI 10.1111/j.1742-4658.2008.06494.x; Mohr J, 2010, PROTEOMICS, V10, P3598, DOI 10.1002/pmic.201000341; Nakazawa T, 2013, BIOSCI BIOTECH BIOCH, V77, P145, DOI 10.1271/bbb.120626; ONeill GM, 1995, IMMUNOL LETT, V48, P103, DOI 10.1016/0165-2478(95)02452-2; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Perbandt M, 2005, J BIOL CHEM, V280, P12630, DOI 10.1074/jbc.M413551200; Salinas G, 1996, PARASITE IMMUNOL, V18, P377, DOI 10.1046/j.1365-3024.1996.d01-124.x; Santiago HC, 2012, J ALLERGY CLIN IMMUN, V130, P248, DOI 10.1016/j.jaci.2012.02.045; Santos ABR, 2008, J ALLERGY CLIN IMMUN, V121, P1040, DOI 10.1016/j.jaci.2007.12.1147; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; Shankar J, 2006, MOL IMMUNOL, V43, P1927, DOI 10.1016/j.molimm.2005.12.006; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sommer A, 2001, INFECT IMMUN, V69, P7718, DOI 10.1128/IAI.69.12.7718-7728.2001; Weghofer M, 2008, EUR J CLIN INVEST, V38, P959, DOI 10.1111/j.1365-2362.2008.02048.x; Zhan B, 2010, INFECT IMMUN, V78, P1552, DOI 10.1128/IAI.00848-09	39	42	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78353	10.1371/journal.pone.0078353	http://dx.doi.org/10.1371/journal.pone.0078353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223794	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400054
J	Morris, RA; Dou, L; Hanken, J; Kelly, M; Lowery, DB; Ludascher, B; Macklin, JA; Morris, PJ				Morris, Robert A.; Dou, Lei; Hanken, James; Kelly, Maureen; Lowery, David B.; Ludaescher, Bertram; Macklin, James A.; Morris, Paul J.			Semantic Annotation of Mutable Data	PLOS ONE			English	Article							PROVENANCE	Electronic annotation of scientific data is very similar to annotation of documents. Both types of annotation amplify the original object, add related knowledge to it, and dispute or support assertions in it. In each case, annotation is a framework for discourse about the original object, and, in each case, an annotation needs to clearly identify its scope and its own terminology. However, electronic annotation of data differs from annotation of documents: the content of the annotations, including expectations and supporting evidence, is more often shared among members of networks. Any consequent actions taken by the holders of the annotated data could be shared as well. But even those current annotation systems that admit data as their subject often make it difficult or impossible to annotate at fine-enough granularity to use the results in this way for data quality control. We address these kinds of issues by offering simple extensions to an existing annotation ontology and describe how the results support an interest-based distribution of annotations. We are using the result to design and deploy a platform that supports annotation services overlaid on networks of distributed data, with particular application to data quality control. Our initial instance supports a set of natural science collection metadata services. An important application is the support for data quality control and provision of missing data. A previous proof of concept demonstrated such use based on data annotations modeled with XML-Schema.	[Morris, Robert A.; Kelly, Maureen; Lowery, David B.; Morris, Paul J.] Harvard Univ Hebaria, Cambridge, MA 02138 USA; [Morris, Robert A.; Lowery, David B.] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA; [Dou, Lei; Ludaescher, Bertram] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Morris, Paul J.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Macklin, James A.] Agr & Agri Food Canada, Ottawa, ON, Canada	Harvard University; University of Massachusetts System; University of Massachusetts Boston; University of California System; University of California Davis; Harvard University; Agriculture & Agri Food Canada	Morris, RA (corresponding author), Harvard Univ Hebaria, 22 Divin Ave, Cambridge, MA 02138 USA.	ram@cs.umb.edu	Hanken, James/S-9286-2019	Hanken, James/0000-0003-2782-9671; Morris, Paul/0000-0002-3673-444X	U.S. National Science Foundation [064626, 0960535]; Harvard University; University of Massachusetts at Boston; Div Of Biological Infrastructure [0960535] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Harvard University; University of Massachusetts at Boston; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the U.S. National Science Foundation grants DBI #064626 and DBI #0960535 (http://www.nsf.gov), by Harvard University (http://www.harvard.edu), and by the University of Massachusetts at Boston (http://www.umb.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiteboul S., 1998, Proceedings of the Seventeenth ACM SIGACT-SIGMOD-SIGART Symposium on Principles of Database Systems. PODS 1998, P254, DOI 10.1145/275487.275516; Agosti M, 2007, INT J DIGIT LIBRARIE, V8, P1, DOI 10.1007/s00799-007-0010-0; Allemang D, 2011, SEMANTGIC WEB WORKIN; Anceaume E., 2006, PROC 26 IEEE INT C D, P22; Arino AH, 2010, BIODIVERS INFORM, V7, P81, DOI [10.17161/bi.v7i2.3991, DOI 10.17161/BI.V7I2.3991]; Beckett D, 2011, TGURTLE TERSE RDF TR; Berendsohn WG, 2013, BIOSYST EU, P219; Berners-Lee T, 2005, INTERNET SOC, V3986, P1; Berners-Lee T, 2001, SEMANTIC WEB; Bielik J, 2009, SEON DESIGNING SOFTW; Butler D, 1998, NATURE, V394, P115, DOI 10.1038/28009; Chand R, 2005, LECT NOTES COMPUT SC, V3648, P1194; Cheney J, 2007, FOUND TRENDS DATABAS, V1, P379, DOI 10.1561/1900000006; Chernich R, 2008, P TDWG; Ciccarese P, 2010, ANNOTATIONSET ANNOTA; Ciccarese P, 2013, EXTENDING MOTIVATION; Ciccarese P, 2013, OPEN ANNOTATION DATA; Ciccarese Paolo, 2011, J Biomed Semantics, V2 Suppl 2, pS4, DOI 10.1186/2041-1480-2-S2-S4; Cornell Lab of Ornithology, 2007, CURR NEWS NUMB AV KN; Dahdul WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051070; Day-Richter J., 2006, OBO FLAT FILE FORMAT; Dickey E., 2007, ANCIENT GREEK SCHOLA; Dou L, 2012, PROCEDIA COMPUT SCI, V9, P1614, DOI 10.1016/j.procs.2012.04.177; EOL, 2013, PICT VID AUD E WHIT; Franklin M, 2012, PINUS STROBUS E WHIT; Fredericks J, 2009, P OCEANOBS 09 SUST O; GBIF, 2013, GBIF DATAPORTAL; Google, 2013, PIC WEB ALB; Halevy AY, 2000, SIGMOD RECORD, V29, P40, DOI 10.1145/369275.369284; Haslhofer B., 2011, Proceedings of the 2011 Workshop on Multimedia on the Web (MMWeb 2011), P5, DOI 10.1109/MMWeb.2011.21; Hausenblas M, 2010, MEDIA FRAGMENTS URI; Hunter J, 2012, FUTURE INTERNET, V4, P788, DOI 10.3390/fi4030788; Kahan J., 2001, P 10 INT C WORLD WID, P623, DOI DOI 10.1145/371920.372166; Koch J, 2011, REPRESENTING CONTENT; Lagoze C, 2006, INT J DIGIT LIBRARIE, V6, P124, DOI 10.1007/s00799-005-0130-3; Lenzerini Maurizio, 2002, PROC ACM SIGMOD SIGA, P233; Lim C, 2010, PROSPECTIVE RETROSPE; MacKenzie-Graham AJ, 2008, NEUROIMAGE, V42, P178, DOI 10.1016/j.neuroimage.2008.04.186; Manola F., 2004, RDF PRIMER; McNamee K, 1991, PAPYROLOGICA LUPIENS, V1, P15; Miles A, 2007, CAT CLASSIF Q, V43, P69, DOI [10.1300/J104v43n03_05, 10.1300/J104v43n03_04]; Moreau L, 2010, COMMUN ACM, V51, P52; Morris RA, 2010, OVERVIEW COMPETENCY; Neuhaus F, 2013, ONTOLOGWIKI ONTOLOGY; North Carolina State University Herbarium, 2010, COLL DAT; Nunlist R, 2009, ANCIENT CRITIC AT WORK: TERMS AND CONCEPTS OF LITERARY CRITICISM IN GREEK SCHOLIA, P1, DOI 10.1017/CBO9780511575891; Page RDM, 2011, IPHYLO DNA BARCODING; Park MJ, 2009, PROC INT CONF DATA, P1255, DOI 10.1109/ICDE.2009.214; Pautasso C., 2010, WWW, P1359, DOI DOI 10.1145/1772690.1772929; Rabler RK, 2006, COLLECT FORUM, V21, P223; Ram S, 2005, 8 ANN BIOONT M VOL D; Sadalage P.J., 2012, NOSQL DISTILLED BRIE; Sanderson R, 2013, OPEN ANNOTATION DATA; Sanderson R., 2013, OPEN ANNOTATION DATA; Sanderson R., 2012, OPEN ANNOTA IN PRESS; Simmhan YL, 2005, SIGMOD REC, V34, P31, DOI 10.1145/1084805.1084812; TDWG (n.d.), BIOD INF STAND TDWG; Tirmizi Syed Hamid, 2011, J Biomed Semantics, V2 Suppl 1, pS3, DOI 10.1186/2041-1480-2-S1-S3; University of Chicago Press, 1982, CHICAGO MANUAL STYLE; W3C, 2013, SPARQL PROP PATH LEN; W3C, 2004, WEB ONT LANG OWL; W3C, 2004, RES DESCR FRAM RDF W; W3C, 2013, RDF 1 1 DATASETS; Waddington J, 2010, COLLECTION FORUM, V25, P136; Westerki A, 2011, MARL ONTOLOGY SPECIF; Wieczorek J, 2009, BIODIVERSITY INFORM; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715; Wu Q, 2008, MICROSCOPE IMAGE PROCESSING, P1; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991; Zhimin Wang, 2009, 2009 WRI World Congress on Computer Science and Information Engineering (CSIE 2009), P731, DOI 10.1109/CSIE.2009.948	70	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e76093	10.1371/journal.pone.0076093	http://dx.doi.org/10.1371/journal.pone.0076093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223697	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400004
J	Wu, ZJ; Cheng, YJ; Aung, LHH; Li, BX				Wu, Zhenjie; Cheng, Yunjiu; Aung, Lynn Htet Htet; Li, Bixun			Association between Adiponectin Concentrations and Cardiovascular Disease in Diabetic Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CORONARY-HEART-DISEASE; EVENTS; EXPRESSION; ADIPOSE; PROTEIN	Background: This systematic review and meta-analysis of prospective studies evaluates the association between adiponectin concentrations and risk of cardiovascular disease (CVD) in individuals with diabetes mellitus (DM). Methods: PubMed and Embase were searched for prospective studies on the association of adiponectin concentrations and risk of CVD up to June 2013. Random-effect model was selected to pool the relative risk (RR) and 95% CI. Results: Five prospective cohort studies and one nested case-control studies met the included criterion. The estimated summary RR and 95% CI of five prospective cohort studies for type 2 diabetes comparing top vs low tertile of adiponectin concentrations was 0.99 (95% CI: 0.67-1.45), with significant heterogeneity between studies (p = 0.037, I-2 = 60.9%). This heterogeneity was explained by one study conducted in Korean. Conclusions: This study represents the first meta-analysis between adiponectin levels and CVD in diabetic patients and indicated no association was found. This result should be verified further by large sample size, long duration of follow-up, and well-designed prospective clinical trials.	[Wu, Zhenjie; Li, Bixun] Guangxi Med Univ, Tumor Affiliated Hosp, Dept Gen Internal Med, Nanning, Guangxi, Peoples R China; [Cheng, Yunjiu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Aung, Lynn Htet Htet] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiol, Inst Cardiovasc Dis, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Sun Yat Sen University; Guangxi Medical University	Li, BX (corresponding author), Guangxi Med Univ, Tumor Affiliated Hosp, Dept Gen Internal Med, Nanning, Guangxi, Peoples R China.	li4738@126.com	Aung, Lynn-Htet-Htet/AFN-6787-2022	Aung, Lynn-Htet-Htet/0000-0002-8853-0641; Wu, Zhen-Jie/0000-0003-1888-8469				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Costacou T, 2005, DIABETOLOGIA, V48, P41, DOI 10.1007/s00125-004-1597-y; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Hao G, 2013, ATHEROSCLEROSIS; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hung WC, 2010, ENDOCR J, V57, P793, DOI 10.1507/endocrj.K10E-020; Kang EH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3218; Kanhai DA, 2013, OBES REV; Krzyzanowska K, 2009, TRANSL RES, V153, P199, DOI 10.1016/j.trsl.2009.01.009; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Lim S, 2008, ATHEROSCLEROSIS, V196, P398, DOI 10.1016/j.atherosclerosis.2006.11.017; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Schottker B, 2013, DIABETES CARE; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zhang BC, 2012, CLIN ENDOCRINOL, V77, P370, DOI 10.1111/j.1365-2265.2011.04260.x; Zhang H, 2012, AM J MED SCI	26	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78485	10.1371/journal.pone.0078485	http://dx.doi.org/10.1371/journal.pone.0078485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223814	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400068
J	Arora, S; Saini, S; Fukuhara, S; Majid, S; Shahryari, V; Yamamura, S; Chiyomaru, T; Deng, GR; Tanaka, Y; Dahiya, R				Arora, Sumit; Saini, Sharanjot; Fukuhara, Shinichiro; Majid, Shahana; Shahryari, Varahram; Yamamura, Soichiro; Chiyomaru, Takeshi; Deng, Guoren; Tanaka, Yuichiro; Dahiya, Rajvir			MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases	PLOS ONE			English	Article							ABL EXPRESSION; METASTASIS; PREDICTION; DASATINIB; MECP2; DIFFERENTIATION; PROLIFERATION; MECHANISMS; COMPONENTS; RESISTANT	The Abelson (c-Abl) proto-oncogene encodes a highly conserved nonreceptor protein tyrosine kinase that plays a role in cell proliferation, differentiation, apoptosis and cell adhesion. c-Abl represents a specific anti-cancer target in prostate cancer as aberrant activity of this kinase has been implicated in the stimulation of prostate cancer growth and progression. However, the mechanism of regulation of c-Abl is not known. Here we report that Abl kinases are regulated by a novel microRNA, miR-4723, in prostate cancer. Expression profiling of miR-4723 expression in a cohort of prostate cancer clinical specimens showed that miR-4723 expression is widely attenuated in prostate cancer. Low miR-4723 expression was significantly correlated with poor survival outcome and our analyses suggest that miR-4723 has significant potential as a disease biomarker for diagnosis and prognosis in prostate cancer. To evaluate the functional significance of decreased miR-4723 expression in prostate cancer, miR-4723 was overexpressed in prostate cancer cell lines followed by functional assays. miR-4723 overexpression led to significant decreases in cell growth, clonability, invasion and migration. Importantly, miR-4723 expression led to dramatic induction of apoptosis in prostate cancer cell lines suggesting that miR-4723 is a pro-apoptotic miRNA regulating prostate carcinogenesis. Analysis of putative miR-4723 targets showed that miR-4723 targets integrin alpha 3 and Methyl CpG binding protein in addition to Abl1 and Abl2 kinases. Further, we found that the expression of Abl kinase is inversely correlated with miR-4723 expression in prostate cancer clinical specimens. Also, Abl1 knockdown partially phenocopies miR-4723 reexpression in prostate cancer cells suggesting that Abl is a functionally relevant target of miR-4723 in prostate cancer. In conclusion, we have identified a novel microRNA that mediates regulation of Abl kinases in prostate cancer. This study suggests that miR-4723 may be an attractive target for therapeutic intervention in prostate cancer.	[Dahiya, Rajvir] Vet Affairs Med Ctr, Dept Urol, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Dahiya, R (corresponding author), Vet Affairs Med Ctr, Dept Urol, San Francisco, CA 94121 USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health (NIH) [RO1CA 138642, RO1CA160079, T32DK007790]; VA Merit Review and VA Program Project; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review and VA Program Project(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Center for Research Resources of the National Institutes of Health (NIH) through Grant Number RO1CA 138642, RO1CA160079, T32DK007790 and VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbio F, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-19; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balan V, 2012, J BIOL CHEM, V287, P5192, DOI 10.1074/jbc.C111.331686; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; De Braekeleer E, 2011, EUR J HAEMATOL, V86, P361, DOI 10.1111/j.1600-0609.2011.01586.x; Faber J, 2008, CANCER CELL, V13, P467, DOI 10.1016/j.ccr.2008.05.013; Ganguly Sourik S, 2012, Genes Cancer, V3, P414, DOI 10.1177/1947601912458586; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iijima Y, 2000, BLOOD, V95, P2126; Iqbal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030764; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lopotova T, 2011, LEUKEMIA RES, V35, P974, DOI 10.1016/j.leukres.2011.03.029; Missan DS, 2012, CRIT REV EUKAR GENE, V22, P309, DOI 10.1615/CritRevEukarGeneExpr.v22.i4.50; Nguyen CT, 2012, ASIAN J ANDROL, V14, P349, DOI 10.1038/aja.2011.140; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; ONeill AJ, 1997, J PATHOL, V183, P325, DOI 10.1002/(SICI)1096-9896(199711)183:3<325::AID-PATH941>3.0.CO;2-A; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Rabbani SA, 2010, MOL CANCER THER, V9, P1147, DOI 10.1158/1535-7163.MCT-09-0962; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Saini S, 2010, PHARM RES-DORDR, V27, P1014, DOI 10.1007/s11095-010-0086-x; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Scholl V, 2012, LEUKEMIA RES, V36, P119, DOI 10.1016/j.leukres.2011.08.023; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Singer CF, 2004, ENDOCR-RELAT CANCER, V11, P861, DOI 10.1677/erc.1.00801; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; Yaqinuddin A, 2008, BIOSCIENCE REP, V28, P319, DOI 10.1042/BSR20080032; Ye L, 2007, INT J MOL MED, V20, P103; Yu EY, 2011, UROLOGY, V77, P1166, DOI 10.1016/j.urology.2011.01.006; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691	49	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78023	10.1371/journal.pone.0078023	http://dx.doi.org/10.1371/journal.pone.0078023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223753	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300018
J	Mallmann, RT; Elgueta, C; Sleman, F; Castonguay, J; Wilmes, T; van den Maagdenberg, A; Klugbauer, N				Mallmann, Robert Theodor; Elgueta, Claudio; Sleman, Faten; Castonguay, Jan; Wilmes, Thomas; van den Maagdenberg, Arn; Klugbauer, Norbert			Ablation of Ca(V)2.1 Voltage-Gated Ca2+ Channels in Mouse Forebrain Generates Multiple Cognitive Impairments	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CALCIUM-CHANNELS; MICE LACKING; MIGRAINE; CURRENTS; RELEASE; ATAXIA; GENE; MUTATIONS; OLIGOMERS	Voltage-gated Ca(V)2.1 (P/Q-type) Ca2+ channels located at the presynaptic membrane are known to control a multitude of Ca2+-dependent cellular processes such as neurotransmitter release and synaptic plasticity. Our knowledge about their contributions to complex cognitive functions, however, is restricted by the limited adequacy of existing transgenic Ca(V)2.1 mouse models. Global Ca(V)2.1 knock-out mice lacking the alpha 1 subunit Cacna1a gene product exhibit early postnatal lethality which makes them unsuitable to analyse the relevance of Ca(V)2.1 Ca2+ channels for complex behaviour in adult mice. Consequently we established a forebrain specific Ca(V)2.1 knock-out model by crossing mice with a floxed Cacna1a gene with mice expressing Cre-recombinase under the control of the NEX promoter. This novel mouse model enabled us to investigate the contribution of Ca(V)2.1 to complex cognitive functions, particularly learning and memory. Electrophysiological analysis allowed us to test the specificity of our conditional knock-out model and revealed an impaired synaptic transmission at hippocampal glutamatergic synapses. At the behavioural level, the forebrain-specific Ca(V)2.1 knock-out resulted in deficits in spatial learning and reference memory, reduced recognition memory, increased exploratory behaviour and a strong attenuation of circadian rhythmicity. In summary, we present a novel conditional Ca(V)2.1 knock-out model that is most suitable for analysing the in vivo functions of Ca(V)2.1 in the adult murine forebrain.	[Mallmann, Robert Theodor; Sleman, Faten; Castonguay, Jan; Wilmes, Thomas; Klugbauer, Norbert] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79106 Freiburg, Germany; [Mallmann, Robert Theodor] Univ Freiburg, Fak Biol, D-79106 Freiburg, Germany; [Elgueta, Claudio] Univ Freiburg, Inst Physiol 2, D-79106 Freiburg, Germany; [van den Maagdenberg, Arn] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van den Maagdenberg, Arn] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	University of Freiburg; University of Freiburg; University of Freiburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Klugbauer, N (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Hugstetter Str 55, D-79106 Freiburg, Germany.	n.klugbauer@pharmakol.uni-freiburg.de	van den Maagdenberg, Arn M.J.M./AAE-9052-2019		DFG [SFB780]	DFG(German Research Foundation (DFG))	This work was supported by a DFG grant to NK (SFB780, project A1) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Bedrosian TA, 2011, P NATL ACAD SCI USA, V108, P11686, DOI 10.1073/pnas.1103098108; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hauw JJ, 2011, J NEUROPATH EXP NEUR, V70, P243, DOI 10.1097/NEN.0b013e318211488e; Holl AK, 2011, NEURODEGENER DIS, V8, P208, DOI 10.1159/000322230; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaja S, 2007, NEUROSCIENCE, V144, P1278, DOI 10.1016/j.neuroscience.2006.11.006; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; LeGates TA, 2011, JOVE-J VIS EXP, DOI 10.3791/2463; Liu L, 2003, J BIOENERG BIOMEMBR, V35, P671, DOI 10.1023/B:JOBB.0000008031.12485.ee; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Mezler M, 2012, BRIT J PHARMACOL, V165, P1572, DOI 10.1111/j.1476-5381.2011.01646.x; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Nahm SS, 2005, J NEUROSCI, V25, P9304, DOI 10.1523/jneurosci.2733-05.2005; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Nimmrich V, 2009, REV NEUROSCIENCE, V20, P1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2005, CURR OPIN NEUROBIOL, V15, P257, DOI 10.1016/j.conb.2005.05.010; RANDALL A, 1995, J NEUROSCI, V15, P2995; Scheuber A, 2004, J NEUROSCI, V24, P10402, DOI 10.1523/JNEUROSCI.1664-04.2004; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9; Todorov B, 2006, GENESIS, V44, P589, DOI 10.1002/dvg.20255; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; van Oosterhout F, 2008, ANN NEUROL, V64, P315, DOI 10.1002/ana.21418; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Whishaw IQ, 1983, BEHAVIORAL APPROACHE, P141; Wu LG, 1999, J NEUROSCI, V19, P726; Xu M, 2003, J BIOL CHEM, V278, P40837, DOI 10.1074/jbc.M307598200; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	46	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78598	10.1371/journal.pone.0078598	http://dx.doi.org/10.1371/journal.pone.0078598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205277	Green Submitted, Green Published, gold			2022-12-27	WOS:000326373800020
J	Haas, MA; Bell, D; Slender, A; Lana-Elola, E; Watson-Scales, S; Fisher, EMC; Tybulewicz, VLJ; Guillemot, F				Haas, Matilda A.; Bell, Donald; Slender, Amy; Lana-Elola, Eva; Watson-Scales, Sheona; Fisher, Elizabeth M. C.; Tybulewicz, Victor L. J.; Guillemot, Francois			Alterations to Dendritic Spine Morphology, but Not Dendrite Patterning, of Cortical Projection Neurons in Tc1 and Ts1Rhr Mouse Models of Down Syndrome	PLOS ONE			English	Article							CRITICAL REGION; SYNAPTIC PLASTICITY; SYNDROME PHENOTYPES; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; IN-VITRO; ABNORMALITIES; CORTEX; GOLGI; HUMAN-CHROMOSOME-21	Down Syndrome (DS) is a highly prevalent developmental disorder, affecting 1/700 births. Intellectual disability, which affects learning and memory, is present in all cases and is reflected by below average IQ. We sought to determine whether defective morphology and connectivity in neurons of the cerebral cortex may underlie the cognitive deficits that have been described in two mouse models of DS, the Tc1 and Ts1Rhr mouse lines. We utilised in utero electroporation to label a cohort of future upper layer projection neurons in the cerebral cortex of developing mouse embryos with GFP, and then examined neuronal positioning and morphology in early adulthood, which revealed no alterations in cortical layer position or morphology in either Tc1 or Ts1Rhr mouse cortex. The number of dendrites, as well as dendrite length and branching was normal in both DS models, compared with wildtype controls. The sites of projection neuron synaptic inputs, dendritic spines, were analysed in Tc1 and Ts1Rhr cortex at three weeks and three months after birth, and significant changes in spine morphology were observed in both mouse lines. Ts1Rhr mice had significantly fewer thin spines at three weeks of age. At three months of age Tc1 mice had significantly fewer mushroom spines - the morphology associated with established synaptic inputs and learning and memory. The decrease in mushroom spines was accompanied by a significant increase in the number of stubby spines. This data suggests that dendritic spine abnormalities may be a more important contributor to cognitive deficits in DS models, rather than overall neuronal architecture defects.	[Haas, Matilda A.; Guillemot, Francois] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; [Bell, Donald] Natl Inst Med Res, MRC, Confocal Image Anal Lab, London NW7 1AA, England; [Slender, Amy; Lana-Elola, Eva; Watson-Scales, Sheona; Tybulewicz, Victor L. J.] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England; [Fisher, Elizabeth M. C.] UCL, Inst Neurol, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; University College London	Haas, MA (corresponding author), Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia.	Matilda.Haas@monash.edu	Fisher, Elizabeth MC/C-2168-2008; Lana-Elola, Eva/ABE-4012-2020; Guillemot, Francois/AAV-1482-2021	Fisher, Elizabeth MC/0000-0003-2850-9936; Lana-Elola, Eva/0000-0003-3351-5820; Tybulewicz, Victor/0000-0003-2439-0798; Haas, Matilda/0000-0002-5149-0471	UK Medical Research Council [U117527252, U117570528]; Wellcome Trust; MRC [MC_U117527252, G0601056] Funding Source: UKRI; Medical Research Council [G0601056, MC_U117527252] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (program numbers U117527252 and U117570528) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; Banks GT, 2011, J NEUROSCI, V31, P5483, DOI 10.1523/JNEUROSCI.5244-10.2011; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Berto G, 2007, J CELL SCI, V120, P1859, DOI 10.1242/jcs.000703; Chang KT, 2009, P NATL ACAD SCI USA, V106, P17117, DOI 10.1073/pnas.0904397106; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Li ZY, 2007, HUM MOL GENET, V16, P1359, DOI 10.1093/hmg/ddm086; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Martinez de Lagran M, 2012, CEREBRAL CORTEX; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Morice E, 2008, LEARN MEMORY, V15, P492, DOI 10.1101/lm.969608; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Pacary E, 2012, JOVE-J VIS EXP, DOI 10.3791/4163; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; SHOLL DA, 1953, J ANAT, V87, P387; SMALL DH, 1994, J NEUROSCI, V14, P2117; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; SUETSUGU M, 1980, ACTA NEUROPATHOL, V50, P207, DOI 10.1007/BF00688755; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi T, 1999, J NEUROSCI, V19, P10357; TAKASHIMA S, 1989, BRAIN DEV-JPN, V11, P131, DOI 10.1016/S0387-7604(89)80082-8; TAKASHIMA S, 1981, BRAIN RES, V225, P1, DOI 10.1016/0006-8993(81)90314-0; TAKASHIMA S, 1994, J INTELL DISABIL RES, V38, P265; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Velazquez-Zamora DA, 2011, INT J DEV NEUROSCI, V29, P515, DOI 10.1016/j.ijdevneu.2011.04.005; Vuksic M, 2002, PEDIATR NEUROL, V27, P36, DOI 10.1016/S0887-8994(02)00380-6; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	42	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78561	10.1371/journal.pone.0078561	http://dx.doi.org/10.1371/journal.pone.0078561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205261	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500123
J	Stevens, KA				Stevens, Kent A.			The Articulation of Sauropod Necks: Methodology and Mythology	PLOS ONE			English	Review							CERVICAL VERTEBRAL COLUMN; SEMICIRCULAR CANALS; CARDIOVASCULAR-SYSTEM; POSTCRANIAL SKELETON; FEEDING ECOLOGY; POSTURE; DINOSAURS; ORIENTATION; EVOLUTION; ANATOMY	Sauropods are often imagined to have held their heads high atop necks that ascended in a sweeping curve that was formed either intrinsically because of the shape of their vertebrae, or behaviorally by lifting the head, or both. Their necks are also popularly depicted in life with poses suggesting avian flexibility. The grounds for such interpretations are examined in terms of vertebral osteology, inferences about missing soft tissues, intervertebral flexibility, and behavior. Osteologically, the pronounced opisthocoely and conformal central and zygapophyseal articular surfaces strongly constrain the reconstruction of the cervical vertebral column. The sauropod cervico- dorsal vertebral column is essentially straight, in contrast to the curvature exhibited in those extant vertebrates that naturally hold their heads above rising necks. Regarding flexibility, extant vertebrates with homologous articular geometries preserve a degree of zygapophyseal overlap at the limits of deflection, a constraint that is further restricted by soft tissues. Sauropod necks, if similarly constrained, were capable of sweeping out large feeding surfaces, yet much less capable of retracting the head to explore the enclosed volume in an avian manner. Behaviorally, modern vertebrates generally assume characteristic neck postures which are close to the intrinsic curvature of the undeflected neck. With the exception of some vertebrates that can retract their heads to balance above their shoulders at rest (e. g., felids, lagomorphs, and some ratites), the undeflected neck generally predicts the default head height at rest and during locomotion.	Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA	University of Oregon	Stevens, KA (corresponding author), Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA.	kent@cs.uoregon.edu						ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; [Anonymous], 1992, HEAD NECK SENSORY MO; Autodesk, 2013, MAYA 3D AN VIS EFF C; Badlangana NL, 2009, ZOOL J LINN SOC-LOND, V155, P736, DOI 10.1111/j.1096-3642.2008.00458.x; BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Berman DS, 2005, LIFE O PAST, P233; BERNHARDT M, 1989, SPINE, V14, P717, DOI 10.1097/00007632-198907000-00012; BLANKS RHI, 1972, AM J PHYSIOL, V223, P55, DOI 10.1152/ajplegacy.1972.223.1.55; Boas JEV, 1929, KGL DANSKE VIDENSK S, V9, P101; Bonnan MF, 2003, J VERTEBR PALEONTOL, V23, P595, DOI 10.1671/A1108; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Bout RG, 1997, J MORPHOL, V231, P287, DOI 10.1002/(SICI)1097-4687(199703)231:3<287::AID-JMOR7>3.0.CO;2-8; Bruggeman BJ, 2012, DEV DYNAM, V241, P675, DOI 10.1002/dvdy.23750; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Cameron EZ, 2007, AM NAT, V169, P130, DOI 10.1086/509940; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; CATMULL E, 1978, COMPUT AIDED DESIGN, V10, P350, DOI 10.1016/0010-4485(78)90110-0; Chandrashekaran M, 1996, J MARKETING RES, V33, P211, DOI 10.2307/3152148; CHOY DSJ, 1992, LANCET, V340, P534, DOI 10.1016/0140-6736(92)91722-K; Christian A, 1996, PALAEONTOLOGY, V39, P801; Christian A, 2002, MITTEILUNGEN MUSEUMS, V5, P269; Christian A., 2007, FOSS REC, V10, P37; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Clauss M., 2011, BIOL SAUROPODS UNDER, P1; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; Cohen B, 2004, SPR HDB AUD, P235; Conrad JL, 2006, J MORPHOL, V267, P759, DOI 10.1002/jmor.10291; Czerkas SA, 1991, DINOSAURS GLOBAL VIE, P247; Davies DV, 1961, SYNOVIAL JOINTS THEI; de Beer G. R., 1947, Proceedings of the Linnean Society of London, V159, P125; Deng Z., 2008, DATA DRIVEN 3D FACIA, P1, DOI 10.1007/978-1-84628-907-1; Duijm M., 1951, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, V54C, P202; Dzemski G, 2006, THESIS U FLENSBURG J; DZEMSKI G, 2005, ZOOL GART, V3, P189; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; ERICHSEN JT, 1989, BRAIN BEHAV EVOLUT, V33, P268, DOI 10.1159/000115935; Feynman Richard, 1985, SURELY YOURE JOKING; Frey E, 1988, STAATLICHES MUSEUM A, V105; Ganse Bergita, 2011, P105; Gauthier-Pilters H, 1981, CAMEL ITS ECOLOGY BE, P208; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Gilmore C. W., 1925, Memoirs of the Carnegie Museum, V10, P347; GIRARD L, 1923, B MEM SOC ANTHRO PAR, V14, P14; Gould SJ, 1991, BULLY BRONTOSAURUS R, P540; GRAF W, 1995, J ANAT, V186, P55; GRAF W, 1992, HEAD NECK SENSORY MO, P129; Hall BK, 1983, CARTILAGE, V1, P400; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Hay Oliver Perry, 1910, P WASHINGTON ACAD SC, V12, P1; HEIDWEILLER J, 1989, AM J ANAT, V186, P258, DOI 10.1002/aja.1001860303; Janensch, 1936, PALAEONTOGRAPHICA S7, P299; Janensch W., 1950, Paleontographica Stuttgart Suppl 7 1 3, V2, P27; Janensch W., 1950, Paleontographica Stuttgart Suppl 7 1 3, V2, P95; Janensch WDieWirbelsa..ule, 1929, PALAEONTOGRAPHICA S7, V3, P39; Kassin S, 2010, SOCIAL PSYCHOL, P613; Klein N, 2012, BIOL LETTERS, V8, P1032, DOI 10.1098/rsbl.2012.0778; Kuznetsov AN, 2010, PALEONTOL J+, V44, P209, DOI 10.1134/S0031030110020139; LEBEDKIN S, 1924, ANAT ANZEIGER, V58, P447; Leuthold B.M., 1972, East African Wildlife Journal, V10, P129; Leuthold W, 1977, AFRICAN UNGULATES, P307; Madsen Jr JH, 1995, B CARNEGIE MUSEUM NA, V31, P115; Malda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057683; Marsh O.C, 1884, AM J SCI, V27, P329, DOI DOI 10.2475/AJS.S3-27.160.329; Martin J, 1987, 4 S MES TERR EC, P154; Marugan-Lobon J, 2013, PEERJ, V1, DOI 10.7717/peerj.124; MAZZA D, 1984, ACTA OTO-LARYNGOL, V98, P472, DOI 10.3109/00016488409107588; Mazzetta GV, 2001, ACTA PALAEONTOL POL, V46, P235; McIntosh John S., 1996, Bulletin of Gunma Museum of Natural History, V1, P1; McIntosh John S., 1997, P264; MOSCOVIC.S, 1969, J PERS SOC PSYCHOL, V12, P125, DOI 10.1037/h0027568; Muybridge E, 1957, ANIMALS MOTION, P416; MYERS DG, 1976, PSYCHOL BULL, V83, P602, DOI 10.1037/0033-2909.83.4.602; Myhrvold NP, 1997, PALEOBIOLOGY, V23, P393, DOI 10.1017/S0094837300019801; Naish D, 2009, J VERTEBR PALEONTOL, V29, p56A; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Ostrom JH, 2000, MARSHS DINOSAURS COL, P416; Owen-Smith RN., 1988, MEGAHERBIVORES INFLU, P369; Paul G, 1998, J VERTEBR PALEONTOL, V69, p70A; Paul GS., 2000, SCI AM BOOK DINOSAUR, P78; PELLEW RA, 1984, J ZOOL, V202, P57, DOI 10.1111/j.1469-7998.1984.tb04288.x; Pellionisz AJ, 1992, HEAD NECK SENSORY MO, P158; POONI JS, 1986, SURG RADIOL ANAT, V8, P175, DOI 10.1007/BF02427846; Preuschoft H, 1976, AUFSATZE REDEN SENCK, V28, P98; Preuschoft Holger, 2011, P197; Rabbitt RD, 2004, SPR HDB AUD, P153; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; Reisdorf Achim G., 2012, Palaeobiodiversity Palaeoenvironments, V92, P119, DOI 10.1007/s12549-011-0068-y; Romer A, 1956, OSTEOLOGY REPTILES; Schmidt H, 2008, CLIN BIOMECH, V23, P270, DOI 10.1016/j.clinbiomech.2007.10.001; Schwarz D, 2007, ACTA PALAEONTOL POL, V52, P167; Schwarz D, 2007, ANAT REC, V290, P32, DOI 10.1002/ar.20405; Schwarz-Wings D, 2010, P ROY SOC B-BIOL SCI, V277, P11, DOI 10.1098/rspb.2009.1275; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Seymour RS, 2009, BIOL LETTERS, V5, P317, DOI 10.1098/rsbl.2009.0096; Seymour RS, 2009, SCIENCE, V323, P1671, DOI 10.1126/science.323.5922.1671; Siegwarth JD, 2011, LETHAIA, V44, P46, DOI 10.1111/j.1502-3931.2010.00221.x; Sivers W. von, 1934, Gegenbaurs Morphologisches Jahrbuch, V74, P697; Slijper E. J., 1946, Verh K nod Akad Wet Amsterdam (2), V42, P1; Snively E, 2013, PALAEONTOL ELECTRON, V16, P29; Solounias N, 1999, J ZOOL, V247, P257, DOI 10.1111/j.1469-7998.1999.tb00989.x; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Stevens Kent A., 2001, Journal of Vertebrate Paleontology, V21, p104A; Stevens Kent A., 2002, Senckenbergiana Lethaea, V82, P23; Taylor MP, 2010, GEOL SOC SPEC PUBL, V343, P361, DOI 10.1144/SP343.22; Taylor MP, 2011, ACTA PALAEONTOL POL, V56, P75, DOI 10.4202/app.2010.0073; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Tornier G, 1909, SITZUNGSBERICHTE GES, V4, P193; Tschopp E, 2013, PALAEONTOL ELECTRON, V1998, P16; Tschopp E, 2013, J SYST PALAEONTOL, V11, P853, DOI 10.1080/14772019.2012.746589; Tsuihiji T, 2004, J VERTEBR PALEONTOL, V24, P165, DOI 10.1671/A1129-12; Upchurch P., 2000, SCIENCE, V287, P547, DOI [10.1126/science.287.5453.547b, DOI 10.1126/SCIENCE.287.5453.547B]; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; Van Sittert SJ, 2010, J EXP ZOOL PART B, V314B, P469, DOI 10.1002/jez.b.21353; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Wedel M. J., 1999, Journal of Vertebrate Paleontology, V19, p83A; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Werner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072862; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Wilhite DR, 2005, LIFE O PAST, P268; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson V.J., 1979, MAMMALIAN VESTIBULAR; Wiman C, 1929, PALAEONTOLOGIA SINIC, V6, P1; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Woolnough AP, 2001, OECOLOGIA, V129, P585, DOI 10.1007/s004420100771; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1; YOUNG TP, 1991, ETHOLOGY, V87, P79; Zhou SH, 2000, EUR SPINE J, V9, P242, DOI 10.1007/s005860000140; Zweers G., 1994, P201; ZWEERS GA, 1987, ACTA MORPHOL NEER SC, V25, P131	137	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78572	10.1371/journal.pone.0078572	http://dx.doi.org/10.1371/journal.pone.0078572			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205266	Green Submitted, gold, Green Published			2022-12-27	WOS:000326334500125
J	Bryzgalov, LO; Antontseva, EV; Matveeva, MY; Shilov, AG; Kashina, EV; Mordvinov, VA; Merkulova, TI				Bryzgalov, Leonid O.; Antontseva, Elena V.; Matveeva, Marina Yu.; Shilov, Alexander G.; Kashina, Elena V.; Mordvinov, Viatcheslav A.; Merkulova, Tatyana I.			Detection of Regulatory SNPs in Human Genome Using ChIP-seq ENCODE Data	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR-BINDING; SINGLE-NUCLEOTIDE POLYMORPHISM; DNA-BINDING; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; WIDE ANALYSIS; DISEASE; SITES; IDENTIFICATION; PREDICTION	A vast amount of SNPs derived from genome-wide association studies are represented by non-coding ones, therefore exacerbating the need for effective identification of regulatory SNPs (rSNPs) among them. However, this task remains challenging since the regulatory part of the human genome is annotated much poorly as opposed to coding regions. Here we describe an approach aggregating the whole set of ENCODE ChIP-seq data in order to search for rSNPs, and provide the experimental evidence of its efficiency. Its algorithm is based on the assumption that the enrichment of a genomic region with transcription factor binding loci (ChIP-seq peaks) indicates its regulatory function, and thereby SNPs located in this region are more likely to influence transcription regulation. To ensure that the approach preferably selects functionally meaningful SNPs, we performed enrichment analysis of several human SNP datasets associated with phenotypic manifestations. It was shown that all samples are significantly enriched with SNPs falling into the regions of multiple ChIP-seq peaks as compared with the randomly selected SNPs. For experimental verification, 40 SNPs falling into overlapping regions of at least 7 TF binding loci were selected from OMIM. The effect of SNPs on the binding of the DNA fragments containing them to the nuclear proteins from four human cell lines (HepG2, HeLaS3, HCT-116, and K562) has been tested by EMSA. A radical change in the binding pattern has been observed for 29 SNPs, besides, 6 more SNPs also demonstrated less pronounced changes. Taken together, the results demonstrate the effective way to search for potential rSNPs with the aid of ChIP-seq data provided by ENCODE project.	[Bryzgalov, Leonid O.; Antontseva, Elena V.; Matveeva, Marina Yu.; Shilov, Alexander G.; Kashina, Elena V.; Mordvinov, Viatcheslav A.; Merkulova, Tatyana I.] Inst Cytol & Genet SD RAS, Novosibirsk, Russia; [Merkulova, Tatyana I.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Antontseva, EV (corresponding author), Inst Cytol & Genet SD RAS, Novosibirsk, Russia.	antontseva@bionet.nsc.ru	Mordvinov, Viatcheslav A/S-8277-2017; Antontseva, Elena/AAD-3703-2020; Merkulova, Tatyana/R-9163-2016	Mordvinov, Viatcheslav A/0000-0002-6173-0774; 	Ministry of Education and Science of the Russian Federation [16.512.11.2274]; Integration Project of the Siberian Branch of the Russian Academy of Sciences [65]; program of the Presidium of the Russian Academy of Sciences "Basis Sciences Medicine" [23]; Russian Foundation for Basic Research [13-04-01077]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Integration Project of the Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences); program of the Presidium of the Russian Academy of Sciences "Basis Sciences Medicine"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work was supported by State Contract no. 16.512.11.2274 of Ministry of Education and Science of the Russian Federation; by the Integration Project of the Siberian Branch of the Russian Academy of Sciences no. 65; by the program of the Presidium of the Russian Academy of Sciences "Basis Sciences Medicine" no. 23; by the Russian Foundation for Basic Research project no. 13-04-01077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alj Y, 2004, GASTROENTEROLOGY, V126, P308, DOI 10.1053/j.gastro.2003.10.073; Ameur A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp381; Bandele OJ, 2011, NUCLEIC ACIDS RES, V39, P178, DOI 10.1093/nar/gkq764; Bonadies N, 2010, ONCOGENE, V29, P1062, DOI 10.1038/onc.2009.371; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Colombo F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-81; Comings DE, 1996, PHARMACOGENETICS, V6, P307, DOI 10.1097/00008571-199608000-00004; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Drachkova IA, 2011, HEALTH, V3, P577; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Epstein Douglas J., 2009, Briefings in Functional Genomics & Proteomics, V8, P310, DOI 10.1093/bfgp/elp021; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; FEI YJ, 1988, BIOCHEM BIOPH RES CO, V153, P741, DOI 10.1016/S0006-291X(88)81157-4; Gilchrist DA, 2009, METHODS, V48, P398, DOI 10.1016/j.ymeth.2009.02.024; Gonzalez S, 2012, BIOINFORMATICS, V28, P763, DOI 10.1093/bioinformatics/bts024; Halfon MS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-578; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoogendoorn B, 2004, HUM MUTAT, V24, P35, DOI 10.1002/humu.20061; Hoogendoorn B, 2003, HUM MOL GENET, V12, P2249, DOI 10.1093/hmg/ddg246; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kolchanov NA, 2007, BRIEF BIOINFORM, V8, P266, DOI 10.1093/bib/bbm027; Li JG, 2012, IMMUNOGENETICS, V64, P361, DOI 10.1007/s00251-011-0597-6; Li MJ, 2012, CELL RES, V22, P1505, DOI 10.1038/cr.2012.106; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Maston GA, 2012, ANNU REV GENOM HUM G, V13, P29, DOI 10.1146/annurev-genom-090711-163723; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Miller RD, 2005, GENOMICS, V86, P117, DOI 10.1016/j.ygeno.2005.04.012; Montgomery SB, 2007, PLOS COMPUT BIOL, V3, P1000, DOI 10.1371/journal.pcbi.0030106; Mottagui-Tabar S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-18; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ni YY, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-46; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Page SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022052; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Polman JAE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-118; Ponomarenko JV, 2002, HUM MUTAT, V20, P239, DOI 10.1002/humu.10116; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Roy AL, 2011, TRENDS IMMUNOL, V32, P532, DOI 10.1016/j.it.2011.06.012; Sakabe NJ, 2010, WIRES SYST BIOL MED, V2, P422, DOI 10.1002/wsbm.70; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sharov AA, 2006, DNA RES, V13, P123, DOI 10.1093/dnares/dsl005; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Vasiliev GV, 1999, FEBS LETT, V462, P85, DOI 10.1016/S0014-5793(99)01513-6; Weth O, 2011, BIOCHEM CELL BIOL, V89, P459, DOI [10.1139/O11-033, 10.1139/o11-033]; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xing YJ, 2013, FUNCT INTEGR GENOMIC, V13, P143, DOI 10.1007/s10142-012-0305-0; Yamashita R, 2012, NUCLEIC ACIDS RES, V40, pD150, DOI 10.1093/nar/gkr1005; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zhao YQ, 2011, HUM MUTAT, V32, P1183, DOI 10.1002/humu.21559; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	62	37	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78833	10.1371/journal.pone.0078833	http://dx.doi.org/10.1371/journal.pone.0078833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205329	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700099
J	Barron, AM; Rosario, ER; Elteriefi, R; Pike, CJ				Barron, Anna M.; Rosario, Emily R.; Elteriefi, Reem; Pike, Christian J.			Sex-Specific Effects of High Fat Diet on Indices of Metabolic Syndrome in 3xTg-AD Mice: Implications for Alzheimer's Disease	PLOS ONE			English	Article							ANDROGEN-DEPRIVATION THERAPY; TESTOSTERONE REPLACEMENT THERAPY; VISCERAL ADIPOSE-TISSUE; HYPOGONADAL MEN; PROSTATE-CANCER; RISK-FACTORS; OBESITY; DEMENTIA; INSULIN; MIDLIFE	Multiple factors of metabolic syndrome have been implicated in the pathogenesis of Alzheimer's disease (AD), including abdominal obesity, insulin resistance, endocrine dysfunction and dyslipidemia. High fat diet, a common experimental model of obesity and metabolic syndrome, has been shown to accelerate cognitive decline and AD-related neuropathology in animal models. However, sex interacts with the metabolic outcomes of high fat diet and, therefore, may alter neuropathological consequences of dietary manipulations. This study examines the effects of sex and high fat diet on metabolic and AD-related neuropathological outcomes in 3xTg-AD mice. Three month-old male and female 3xTg-AD mice were fed either standard or high fat diets for 4 months. Obesity was observed in all high fat fed mice; however, ectopic fat accumulation, hyperglycemia and hyperinsulinemia were observed only in males. Interestingly, despite the different metabolic outcomes of high fat diet, the neuropathological consequences were similar: both male and female mice maintained under high fat diet exhibited significant worsening in behavioral performance and hippocampal accumulation of beta-amyloid protein. Because high fat diet resulted in obesity and increased AD-like pathology in both sexes, these data support a role of obesity-related factors in promoting AD pathogenesis.	[Barron, Anna M.; Rosario, Emily R.; Elteriefi, Reem; Pike, Christian J.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA	University of Southern California	Pike, CJ (corresponding author), Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA.	cjpike@usc.edu	Barron, Anna/AAT-7789-2020; Pike, Christian J/D-4013-2018	Barron, Anna/0000-0002-4715-9364; Pike, Christian/0000-0003-4577-7668	NIH [AG034103, AG026572]; American Australian Association; Japan Society for the Promotion of Science; NATIONAL INSTITUTE ON AGING [P01AG026572, R01AG034103] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Australian Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIH grants AG034103 (CJP) and AG026572 (RD Brinton/CJP). AMB is funded by an American Australian Association Neurological Fellowship and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CA, 2008, J CLIN ENDOCR METAB, V93, P139, DOI 10.1210/jc.2007-1291; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1049, DOI 10.1210/jc.2006-2060; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Cahill L, 2012, ENDOCRINOLOGY, V153, P2541, DOI 10.1210/en.2011-2167; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Chiang CJ, 2007, AM J GERIAT PSYCHIAT, V15, P762, DOI 10.1097/JGP.0b013e318050c98f; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cummings BJ, 2002, NEUROBIOL AGING, V23, P161, DOI 10.1016/S0197-4580(01)00316-5; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Erol A, 2008, J ALZHEIMERS DIS, V13, P241; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Guarner-Lans V, 2011, EXP GERONTOL, V46, P517, DOI 10.1016/j.exger.2011.02.007; Gustafson DR, 2009, NEUROLOGY, V73, P1559, DOI 10.1212/WNL.0b013e3181c0d4b6; Ho L, 2004, FASEB J; Hong H, 2009, NEUROPHARMACOLOGY, V56, P1054, DOI 10.1016/j.neuropharm.2009.03.001; Hussain HK, 2005, RADIOLOGY, V237, P1048, DOI 10.1148/radiol.2373041639; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kapoor D, 2007, EUR J ENDOCRINOL, V156, P595, DOI 10.1530/EJE-06-0737; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lage MJ, 2007, UROLOGY, V70, P1104, DOI 10.1016/j.urology.2007.08.012; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014; Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267; Lee YH, 2009, NEUROENDOCRINOLOGY, V90, P383, DOI 10.1159/000235555; Levene AP, 2012, HISTOPATHOLOGY, V60, P971, DOI 10.1111/j.1365-2559.2012.04193.x; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Liu Y, 2008, NEUROSCIENCE, V153, P796, DOI 10.1016/j.neuroscience.2008.03.019; Luchsinger JA, 2007, CURR ALZHEIMER RES, V4, P127, DOI 10.2174/156720507780362100; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Olivares A, 2010, GEN COMP ENDOCR, V166, P356, DOI 10.1016/j.ygcen.2009.12.007; PASQUALI R, 1991, METABOLISM, V40, P101, DOI 10.1016/0026-0495(91)90199-7; PASQUALI R, 1988, J ENDOCRINOL INVEST, V11, P205, DOI 10.1007/BF03350136; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Shahani S, 2008, J CLIN ENDOCR METAB, V93, P2042, DOI 10.1210/jc.2007-2595; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	52	73	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78554	10.1371/journal.pone.0078554	http://dx.doi.org/10.1371/journal.pone.0078554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205258	gold, Green Published, Green Submitted			2022-12-27	WOS:000326241200058
J	Mickenautsch, S; Yengopal, V				Mickenautsch, Steffen; Yengopal, Veerasamy			Direct Contra Naive-Indirect Comparison of Clinical Failure Rates between High-Viscosity GIC and Conventional Amalgam Restorations: An Empirical Study	PLOS ONE			English	Article							IONOMER CEMENT RESTORATIONS; SURFACE ART RESTORATIONS; GLASS-IONOMER; PERMANENT DENTITION; SYSTEMATIC REVIEWS; SINGLE-SURFACE; SURVIVAL; LONGEVITY; TRIALS; TEETH	Background: Naive-indirect comparisons are comparisons between competing clinical interventions' evidence from separate (uncontrolled) trials. Direct comparisons are comparisons within randomised control trials (RCTs). The objective of this empirical study is to test the null-hypothesis that trends and performance differences inferred from naive-indirect comparisons and from direct comparisons/RCTs regarding the failure rates of amalgam and direct high-viscosity glass-ionomer cement (HVGIC) restorations in permanent posterior teeth have similar direction and magnitude. Methods: A total of 896 citations were identified through systematic literature search. From these, ten and two uncontrolled clinical longitudinal studies for HVGIC and amalgam, respectively, were included for naive-indirect comparison and could be matched with three out twenty RCTs. Summary effects sizes were computed as Odds ratios (OR; 95% Confidence intervals) and compared with those from RCTs. Trend directions were inferred from 95% Confidence interval overlaps and direction of point estimates; magnitudes of performance differences were inferred from the median point estimates (OR) with 25% and 75% percentile range, for both types of comparison. Mann-Whitney U test was applied to test for statistically significant differences between point estimates of both comparison types. Results: Trends and performance differences inferred from naive-indirect comparison based on evidence from uncontrolled clinical longitudinal studies and from direct comparisons based on RCT evidence are not the same. The distributions of the point estimates differed significantly for both comparison types (Mann-Whitney U = 25, n(indirect) = 26; n(direct) = 8; p = 0.0013, two-tailed). Conclusion: The null-hypothesis was rejected. Trends and performance differences inferred from either comparison between HVGIC and amalgam restorations failure rates in permanent posterior teeth are not the same. It is recommended that clinical practice guidance regarding HVGICs should rest on direct comparisons via RCTs and not on naive-indirect comparisons based on uncontrolled longitudinal studies in order to avoid inflation of effect estimates.	[Mickenautsch, Steffen; Yengopal, Veerasamy] Univ Witwatersrand Johannesburg, Systemat Review Initiat Evidence Based Minimum In, Dept Community Dent, Fac Hlth Sci, Johannesburg, South Africa	University of Witwatersrand	Mickenautsch, S (corresponding author), Univ Witwatersrand Johannesburg, Systemat Review Initiat Evidence Based Minimum In, Dept Community Dent, Fac Hlth Sci, Johannesburg, South Africa.	neem@global.co.za	Mickenautsch, Steffen/D-1235-2013	Mickenautsch, Steffen/0000-0002-4994-2328				Abid A, 2002, East Mediterr Health J, V8, P315; Arabi Y, 2005, SAUDI MED J, V26, P1175; Bakhai A., 2006, CLIN TRIALS PRACTICA; Bernardo M, 2007, J AM DENT ASSOC, V138, P775, DOI 10.14219/jada.archive.2007.0265; Bresciani Eduardo, 2004, J. Appl. Oral Sci., V12, P344, DOI 10.1590/S1678-77572004000400017; Busanello L, 2009, REV ODONT CIENC, V24, P295; Carvalho CA, 2007, INT DENT SA, V9, P24; Cefaly DFG, 2007, J DENT CHILD, V74, P203; DGZ/DGZMK, 2005, DIR KOMP SEIT IND LE; Ercan E, 2009, J APPL ORAL SCI, V17, P307, DOI 10.1590/S1678-77572009000400008; Ericson Dan, 2003, Oral Health Prev Dent, V1, P59; Barata TJE, 2008, J APPL ORAL SCI, V16, P155, DOI 10.1590/S1678-77572008000200014; Frencken JE, 2006, J DENT RES, V85, P622, DOI 10.1177/154405910608500708; Frencken JE, 2004, J DENT RES, V83, P120, DOI 10.1177/154405910408300207; Fuks Anna B, 2002, Pediatr Dent, V24, P448; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Heintze SD, 2007, J ADHES DENT, V9, P77; Heintze Siegward D, 2011, Schweiz Monatsschr Zahnmed, V121, P1024; Huitema BE, 2011, ANAL COVARIANCE ALTE, P609; Ibiyemi O, 2011, Afr J Med Med Sci, V40, P127; Ibiyemi O, 2011, INT DENT J, V61, P2, DOI 10.1111/j.1875-595X.2011.00001.x; JAMES KE, 1973, BIOMETRICS, V29, P121, DOI 10.2307/2529681; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kiremitci A, 2003, J ORAL REHABIL, V30, P664, DOI 10.1046/j.1365-2842.2003.01007.x; Lo ECM, 2007, COMMUNITY DENT ORAL, V35, P387, DOI 10.1111/j.1600-0528.2006.00342.x; Lopez N, 2005, AM J PUBLIC HEALTH, V95, P1338, DOI 10.2105/AJPH.2004.056945; Manhart J, 2004, OPER DENT, V29, P481; Mickenautsch S, 2012, SADJ, V67, P329; Mickenautsch S, 2009, EUR J PAEDIATR DENT, V10, P41; Mickenautsch S, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-18; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Piwowarczyk A, 2001, J Prosthodont, V10, P140, DOI 10.1053/jpro.2001.27338; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Rahimtoola Salim, 2002, ASDC J Dent Child, V69, P16; REED RB, 1967, J DENT RES, V46, P1208, DOI 10.1177/00220345670460061401; Sachdeo A, 2004, Eur J Prosthodont Restor Dent, V12, P15; Soncini JA, 2007, J AM DENT ASSOC, V138, P763, DOI 10.14219/jada.archive.2007.0264; Sutherland S E, 2001, J Can Dent Assoc, V67, P375; Torabzadeh H, 2011, BRAZ J ORAL SCI, V10, P204; Turp J C, 2003, Schweiz Monatsschr Zahnmed, V113, P36; van Gemert-Schriks MCM, 2007, CLIN ORAL INVEST, V11, P337, DOI 10.1007/s00784-007-0138-8; Van Nieuwenhuysen JP, 2003, J DENT, V31, P395, DOI 10.1016/S0300-5712(03)00084-8; Wang Linda, 2004, Spec Care Dentist, V24, P28, DOI 10.1111/j.1754-4505.2004.tb01676.x; Wang X, 2012, J MINIM INTERV DENT, V5, P377; White A, 2001, COMPLEMENT THER MED, V9, P111, DOI 10.1054/ctim.2001.0441; Yip KHK, 2002, J AM DENT ASSOC, V133, P744, DOI 10.14219/jada.archive.2002.0272; Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301; Zahra Vivian N, 2011, Acta odontol. latinoam., V24, P200; Zanata RL, 2011, CLIN ORAL INVEST, V15, P265, DOI 10.1007/s00784-009-0378-x; Ziraps A, 2002, MED PRIN PRACT, V11, P44, DOI 10.1159/000057778	50	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78397	10.1371/journal.pone.0078397	http://dx.doi.org/10.1371/journal.pone.0078397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205220	gold, Green Published, Green Submitted			2022-12-27	WOS:000326241200056
J	Moskowitz, JT; Wrubel, J; Hult, JR; Maurer, S; Acree, M				Moskowitz, Judith Tedlie; Wrubel, Judith; Hult, Jen R.; Maurer, Stephanie; Acree, Michael			Illness Appraisals and Depression in the First Year after HIV Diagnosis	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DISPOSITIONAL OPTIMISM; HIV/AIDS IDENTITY; PERSONAL MODELS; SOCIAL SUPPORT; SELF; PEOPLE; CANCER; QUESTIONNAIRE; PERCEPTIONS	Illness appraisals provide important context to help understand the way individuals cope with chronic illness. In the present study, a qualitative approach to the analysis of HIV diagnosis experience narratives in a sample of 100 people newly diagnosed with HIV revealed five groups that differed in their initial illness appraisals: HIV as Chronic Illness, Concern about Dying, Stigmatization, Threat to Identity, and Other Threats Overshadow HIV. When compared on quantitatively measured depressive mood, the groups differed on level and trajectory over the course of the first year post-diagnosis. Although the experience of living with HIV has changed significantly with the advent of effective Antiretroviral Therapies (ART), there were a number of similarities between the appraisals of this group of participants who were diagnosed post ART and groups who were diagnosed before ART became widely available. Posttest counselors and other HIV service providers should take individual differences in illness appraisals into account in order to help newly HIV-positive clients manage their healthcare and cope adaptively with their diagnosis.	[Moskowitz, Judith Tedlie; Wrubel, Judith; Hult, Jen R.; Maurer, Stephanie; Acree, Michael] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Moskowitz, JT (corresponding author), Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA.	moskj@ocim.ucsf.edu			National Institute of Mental Health [R01 MH068170, K24 MH093225]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068170, K24MH093225] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health R01 MH068170 and K24 MH093225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo AA, 2000, SOC SCI MED, V50, P1475, DOI 10.1016/S0277-9536(99)00399-8; Anderson M, 2010, AIDS CARE, V22, P1493, DOI 10.1080/09540121.2010.482125; Baumgartner LM, 2007, QUAL HEALTH RES, V17, P919, DOI 10.1177/1049732307305881; Baumgartner LM, 2013, QUAL REP, V18; Baumgartner LM, 2012, QUAL REP, V17; Baumgartner LM, 2009, QUAL HEALTH RES, V19, P1730, DOI 10.1177/1049732309352907; Bekele T, 2013, AIDS CARE, V25, P337, DOI 10.1080/09540121.2012.701716; Benner P., 1994, INTERPRETIVE PHENOME, P99, DOI DOI 10.4135/9781452204727.N6; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; BROWNE GB, 1988, NURS RES, V37, P368; Cain R, 2013, QUAL HEALTH RES, V23, P815, DOI 10.1177/1049732313482525; Carrico AW, HLTH PSYCHO IN PRESS; Chalfant AM, 2004, J TRAUMA STRESS, V17, P423, DOI 10.1023/B:JOTS.0000048955.65891.4c; Daher M, 2012, ANN ONCOL, V23, P66, DOI 10.1093/annonc/mds091; Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6; Earnshaw VA, 2013, AM PSYCHOL, V68, P225, DOI 10.1037/a0032705; Farber EW, 2010, GEN HOSP PSYCHIAT, V32, P73, DOI 10.1016/j.genhosppsych.2009.09.011; Farber EW, 2003, PSYCHOSOMATICS, V44, P485, DOI 10.1176/appi.psy.44.6.485; Fife BL, 2005, SOC SCI MED, V61, P2132, DOI 10.1016/j.socscimed.2005.04.026; FIFE BL, 1995, SOC SCI MED, V40, P1021, DOI 10.1016/0277-9536(94)00174-R; FIFE BL, 1994, SOC SCI MED, V38, P309, DOI 10.1016/0277-9536(94)90400-6; Flowers P, 2006, PSYCHOL HEALTH, V21, P109, DOI 10.1080/14768320500286286; Flowers P, 2011, PSYCHOL HEALTH, V26, P1378, DOI 10.1080/08870446.2010.551213; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Folkman S, 1988, MANUAL WAYS COPING Q; Gallagher J, 2002, BRIT J HEALTH PSYCH, V7, P365, DOI 10.1348/135910702760213733; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; HAMPSON SE, 1990, HEALTH PSYCHOL, V9, P632, DOI 10.1037/0278-6133.9.5.632; HAMPSON SE, 1994, J BEHAV MED, V17, P143, DOI 10.1007/BF01858102; Hult JR, 2012, AIDS PATIENT CARE ST, V26, P181, DOI 10.1089/apc.2011.0282; Hult JR, 2009, AIDS CARE, V21, P185, DOI 10.1080/09540120802017602; Ironson G, 2005, INT J BEHAV MED, V12, P86, DOI 10.1207/s15327558ijbm1202_6; Kamen C, 2013, J HEALTH PSYCHOL, V18, P658, DOI 10.1177/1359105312454039; Kelly C, 2012, J CLIN NURS, V21, P1554, DOI 10.1111/j.1365-2702.2011.04017.x; Lawson VL, 2010, BRIT J HEALTH PSYCH, V15, P623, DOI 10.1348/135910709X478664; Lazarus R.S., 1984, STRESS APPRAISAL COP; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Leventhal H, 1997, PERCEPTIONS HLTH ILL; Luker KA, 1996, J ADV NURS, V23, P1194, DOI 10.1046/j.1365-2648.1996.13617.x; MacQueen K.M., 1998, CAM J, V10, P31, DOI [10.1177/1525822X980100020301, DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301]; MEYER D, 1985, HEALTH PSYCHOL, V4, P115, DOI 10.1037/0278-6133.4.2.115; Mosack KE, 2005, QUAL HEALTH RES, V15, P586, DOI 10.1177/1049732304271749; Moskowitz JT, 2005, PSYCHOL HEALTH, V20, P509, DOI 10.1080/08870440412331337075; Moskowitz JT, 2012, J COMMUNITY APPL SOC, V22, P502, DOI 10.1002/casp.1133; Moskowitz JT, 2009, PSYCHOL BULL, V135, P121, DOI 10.1037/a0014210; Park CL, 2009, J GEN INTERN MED, V24, P430, DOI 10.1007/s11606-009-0993-x; Paterson Barbara, 2002, Can J Nurs Res, V34, P61; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Petrie KJ, 1997, PERCEPTIONS HLTH ILL; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao D, 2012, AIDS BEHAV, V16, P711, DOI 10.1007/s10461-011-9915-0; Riley ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035207; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; Roesch SC, 2005, J BEHAV MED, V28, P281, DOI 10.1007/s10865-005-4664-z; Sarna Linda, 2005, Oncol Nurs Forum, V32, pE9, DOI 10.1188/05.ONF.E9-E19; Schabert J, 2013, J OUTCOMES RES, P1; Schiaffino KM, 1995, J BEHAV MED, V18, P531, DOI 10.1007/BF01857894; Schwartzberg S, 1996, CRISIS MEANING GAY M; Siegel K, 2002, AIDS, V16, pS69, DOI 10.1097/00002030-200216004-00010; Skelton JA, 1991, CONTRIB PSYCHOL, p[x, 284]; Stevens P, 1997, AIDS CARE; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tomakowsky J, 2001, J PSYCHOSOM RES, V51, P577, DOI 10.1016/S0022-3999(01)00249-5; Turner-Cobb JM, 2002, J BEHAV MED, V25, P337, DOI 10.1023/A:1015814431481; Unger Hella Von, 2005, Health Care Women Int, V26, P308, DOI 10.1080/07399330590925835; Valle M, 2008, AIDS CARE, V20, P130, DOI 10.1080/09540120701459665; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Wrubel J., 2011, PSYCHOLOGY, V2, P117, DOI DOI 10.4236/PSYCH.2011.22019	68	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78904	10.1371/journal.pone.0078904	http://dx.doi.org/10.1371/journal.pone.0078904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205346	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400111
J	Sun, Z; Yu, JT; Jiang, T; Li, MM; Tan, L; Zhang, Q; Tan, L				Sun, Zhen; Yu, Jin-Tai; Jiang, Teng; Li, Meng-Meng; Tan, Lin; Zhang, Qun; Tan, Lan			Genome-Wide microRNA Profiling of Rat Hippocampus after Status Epilepticus Induced by Amygdala Stimulation Identifies Modulators of Neuronal Apoptosis	PLOS ONE			English	Article							EXPRESSION PROFILE; IN-VIVO; EPILEPSY; NEUROPROTECTION; PREDICTION; PATHWAYS; SEIZURES; DAMAGE; DEATH; MODEL	MicroRNAs (miRNAs) are small and endogenously expressed non-coding RNAs that negatively regulate the expression of protein-coding genes at the translational level. Emerging evidence suggests that miRNAs play critical roles in central nervous system under physiological and pathological conditions. However, their expression and functions in status epilepticus (SE) have not been well characterized thus far. Here, by using high-throughput sequencing, we characterized miRNA expression profile in rat hippocampus at 24 hours following SE induced by amygdala stimulation. After confirmation by qRT-PCR, six miRNAs were found to be differentially expressed in brain after SE. Subsequent Kyoto Encyclopedia of Genes and Genomes pathway analysis indicated that most of the predicted target genes for these six miRNAs were related to neuronal apoptosis. We then investigated the dynamic changes of these six miRNAs at different time-point (4 hours, 24 hours, 1 week and 3 weeks) after SE. Meanwhile, neuronal survival and apoptosis in the hippocampus after SE were evaluated by Nissl staining and terminal deoxynucleotidyl transferase-mediated dUTP end-labeling assay. We found that the expression of miR-874-3p, miR-20a-5p, miR-345-3p, miR-365-5p, and miR-764-3p were significantly increased from 24 hours to 1 week, whereas miR-99b-3p level was markedly decreased from 24 hours to 3 weeks after SE. Further analysis revealed that the levels of miR-365-5p and miR-99b-3p were significantly correlated with neuronal apoptosis after SE. Taken together, our data suggest that miRNAs are important modulators of SE-induced neuronal apoptosis. These findings also open new avenues for future studies aimed at developing strategies against neuronal apoptosis after SE.	[Sun, Zhen; Tan, Lan] Taishan Med Univ, Dept Neurol, Qingdao Municipal Hosp, Qingdao, Peoples R China; [Yu, Jin-Tai; Li, Meng-Meng; Tan, Lin; Zhang, Qun; Tan, Lan] Qingdao Univ, Sch Med, Dept Neurol, Qingdao Municipal Hosp, Qingdao 266071, Peoples R China; [Yu, Jin-Tai; Jiang, Teng; Tan, Lan] Nanjing Med Univ, Dept Neurol, Qingdao Municipal Hosp, Qingdao, Peoples R China	Qingdao Municipal Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Qingdao Municipal Hospital; Qingdao University; Nanjing Medical University; Qingdao Municipal Hospital	Yu, JT (corresponding author), Qingdao Univ, Sch Med, Dept Neurol, Qingdao Municipal Hosp, Qingdao 266071, Peoples R China.	yu-jintai@163.com; dr.tanlan@163.com	Yu, Jin-Tai/HDL-7766-2022	Yu, Jin-Tai/0000-0002-7686-0547	National Natural Science Foundation of China [81000544, 81171209]; Shandong Provincial Natural Science Foundation, China [ZR2010HQ004, ZR2011HZ001]; Medicine and Health Science Technology Development Project of Shandong Province [2011WSA02018, 2011WSA02020]; Shandong Provincial Outstanding Medical Academic Professional Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Medicine and Health Science Technology Development Project of Shandong Province; Shandong Provincial Outstanding Medical Academic Professional Program	This work was supported by grants from the National Natural Science Foundation of China (81000544, 81171209), the Shandong Provincial Natural Science Foundation, China (ZR2010HQ004, ZR2011HZ001), the Medicine and Health Science Technology Development Project of Shandong Province (2011WSA02018, 2011WSA02020), and the Shandong Provincial Outstanding Medical Academic Professional Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brandt C, 2004, EPILEPSIA, V45, P1488, DOI 10.1111/j.0013-9580.2004.16904.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; Henshall DC, 2007, BIOCHEM SOC T, V35, P421, DOI 10.1042/BST0350421; Houseweart MK, 2003, CELL DEATH DIFFER, V10, P1329, DOI 10.1038/sj.cdd.4401309; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Jimenez-Mateos EM, 2013, NEUROSCIENCE, V238, P218, DOI 10.1016/j.neuroscience.2013.02.027; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lopez-Meraz ML, 2010, EPILEPSIA, V51, P56, DOI 10.1111/j.1528-1167.2010.02611.x; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; McKiernan RC, 2012, EXP NEUROL, V237, P346, DOI 10.1016/j.expneurol.2012.06.029; Meng XF, 2013, J NEUROL SCI, V332, P4, DOI 10.1016/j.jns.2013.05.029; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Pitkanen A, 1999, EPILEPSY RES, V33, P67, DOI 10.1016/S0920-1211(98)00074-6; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Sano T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.23; Sun Z, 2013, CNS NEUROL DISORD DR; Thom Maria, 2004, Expert Rev Neurother, V4, P973, DOI 10.1586/14737175.4.6.973; Wang YS, 2004, J BIOL CHEM, V279, P41267, DOI 10.1074/jbc.C400199200; Yang YF, 2011, NEUROSCIENCE, V196, P25, DOI 10.1016/j.neuroscience.2011.08.059; Zhang Q, 2012, NEUROSCIENCE, V217, P113, DOI 10.1016/j.neuroscience.2012.05.009	31	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78375	10.1371/journal.pone.0078375	http://dx.doi.org/10.1371/journal.pone.0078375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205215	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400079
J	Amoabeng, BW; Gurr, GM; Gitau, CW; Nicol, HI; Munyakazi, L; Stevenson, PC				Amoabeng, Blankson W.; Gurr, Geoff M.; Gitau, Catherine W.; Nicol, Helen I.; Munyakazi, Louis; Stevenson, Phil C.			Tri-Trophic Insecticidal Effects of African Plants against Cabbage Pests	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA LEPIDOPTERA; CRUDE SEED EXTRACTS; DIAMONDBACK MOTH; MELIA-AZEDARACH; AZADIRACHTA-INDICA; ANNONA-SQUAMOSA; STORAGE PESTS; MANAGEMENT; L.; FIELD	Botanical insecticides are increasingly attracting research attention as they offer novel modes of action that may provide effective control of pests that have already developed resistance to conventional insecticides. They potentially offer cost-effective pest control to smallholder farmers in developing countries if highly active extracts can be prepared simply from readily available plants. Field cage and open field experiments were conducted to evaluate the insecticidal potential of nine common Ghanaian plants: goat weed, Ageratum conyzoides (Asteraceae), Siam weed, Chromolaena odorata (Asteraceae), Cinderella weed, Synedrella nodiflora (Asteraceae), chili pepper, Capsicum frutescens (Solanaceae), tobacco, Nicotiana tabacum (Solanaceae) cassia, Cassia sophera (Leguminosae), physic nut, Jatropha curcas (Euphorbiaceae), castor oil plant, Ricinus communis (Euphorbiaceae) and basil, Ocimum gratissimum (Lamiaceae). In field cage experiments, simple detergent and water extracts of all botanical treatments gave control of cabbage aphid, Brevicoryne brassicae and diamondback moth, Plutella xylostella, equivalent to the synthetic insecticide Attack (R) (emamectin benzoate) and superior to water or detergent solution. In open field experiments in the major and minor rainy seasons using a sub-set of plant extracts (A. conyzoides, C. odorata, S. nodiflora, N. tabacum and R. communis), all controlled B. brassicae and P. xylostella more effectively than water control and comparably with or better than Attack (R). Botanical and water control treatments were more benign to third trophic level predators than Attack (R). Effects cascaded to the first trophic level with all botanical treatments giving cabbage head weights, comparable to Attack (R) in the minor season. In the major season, R. communis and A conyzoides treatment gave lower head yields than Attack (R) but the remaining botanicals were equivalent or superior to this synthetic insecticide. Simply-prepared extracts from readily-available Ghanaian plants give beneficial, tri-trophic benefits and merit further research as an inexpensive plant protection strategy for smallholder farmers in West Africa.	[Amoabeng, Blankson W.; Nicol, Helen I.] Charles Sturt Univ, Sch Agr & Wine Sci, Orange, NSW, Australia; [Gurr, Geoff M.; Gitau, Catherine W.] NSW Dept Primary Ind, EH Graham Ctr Agr Innovat, Orange, NSW, Australia; [Gurr, Geoff M.; Gitau, Catherine W.] Charles Sturt Univ, Orange, NSW, Australia; [Munyakazi, Louis] Kumasi Polytech, Dept Math & Stat, Kumasi, Ghana; [Stevenson, Phil C.] Royal Bot Gardens, Richmond, Surrey, England; [Amoabeng, Blankson W.] Crops Res Inst, Council Sci & Ind Res, Kumasi, Ghana	Charles Sturt University; NSW Department of Primary Industries; Charles Sturt University; Royal Botanic Gardens, Kew	Amoabeng, BW (corresponding author), Charles Sturt Univ, Sch Agr & Wine Sci, Orange Campus, Orange, NSW, Australia.	kblanksin@yahoo.com	GURR, GEOFFREY M/F-3519-2011; Clarke, Catherine Wanjiru/K-2944-2019; stevenson, philip c/E-8741-2013; Stevenson, Philip C/E-8822-2013	Clarke, Catherine Wanjiru/0000-0002-4397-9381; stevenson, philip c/0000-0002-0736-3619; Stevenson, Philip C/0000-0002-0736-3619; Gurr, Geoff/0000-0001-5008-7966	Charles Sturt University; AusAID	Charles Sturt University; AusAID(Australian Aid (AusAID))	Financial support was given by Charles Sturt University and AusAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFUN JVK, 1991, CROP PROT, V10, P363, DOI 10.1016/S0261-2194(06)80025-6; Ahmed B. I., 2009, Journal of Biopesticides, V2, P37; [Anonymous], 1925, J ECON ENTOMOL; Ayalew G, 2006, J APPL ENTOMOL, V130, P343, DOI 10.1111/j.1439-0418.2006.01078.x; Baker GJ, 1999, AUST J ENTOMOL, V38, P132, DOI 10.1046/j.1440-6055.1999.00087.x; Buss EA, 2002, UF IFAS PUBLICATION; Charleston DS, 2006, BIOL CONTROL, V39, P105, DOI 10.1016/j.biocontrol.2006.05.012; Charleston DS, 2005, B ENTOMOL RES, V95, P457, DOI 10.1079/BER2005377; Coulibaly O., 2007, J VEG SCI, V12, P27; de Oliveira AC, 2011, SCI AGR, V68, P154, DOI 10.1590/S0103-90162011000200004; Devanand Peta, 2008, Journal of Biopesticides, V1, P170; Dubey NK, 2011, NATURAL PRODUCTS IN PLANT PEST MANAGEMENT, P1, DOI 10.1079/9781845936716.0001; Fening K. O., 2011, Organic is Life - Knowledge for Tomorrow. Volume 1 - Organic Crop Production. Proceedings of the Third Scientific Conference of the International Society of Organic Agriculture Research (ISOFAR), held at the 17th IFOAM Organic World Congress in cooperation with the International Federation of Organic Agriculture Movements (IFOAM) and the Korean Organizing Committee (KOC), 28. September - 1. October 2011 in Namyangju, Korea Republic, P567; Flint M, 1991, INTEGRATED PEST MANA; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gendo JO, 2008, J STORED PROD RES, V44, P328, DOI 10.1016/j.jspr.2008.02.009; Gerken A., 2001, PESTICIDE POLICY PRO, V10, P90; Grzywacz D, 2010, CROP PROT, V29, P68, DOI 10.1016/j.cropro.2009.08.009; HUGHES RD, 1963, J ANIM ECOL, V32, P393, DOI 10.2307/2600; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Jansson R., 1997, P 3 INT WORKSH MAN D; Kawuki RS, 2005, CROP PROT, V24, P473, DOI 10.1016/j.cropro.2004.09.017; Kestenholz C, 2007, J STORED PROD RES, V43, P79, DOI 10.1016/j.jspr.2005.11.003; Kianmatee Supawan, 2007, Journal of Asia-Pacific Entomology, V10, P69, DOI 10.1016/S1226-8615(08)60333-7; Kibrom Gebremariam, 2012, Archives of Phytopathology and Plant Protection, V45, P1273, DOI 10.1080/03235408.2012.673260; Leatemia JA, 2004, INT J PEST MANAGE, V50, P129, DOI 10.1080/096708704100001691821; Liu SS, 2000, B ENTOMOL RES, V90, P221; Macharia I, 2005, CROP PROT, V24, P981, DOI 10.1016/j.cropro.2005.02.005; Mitchell ER, 1997, FLA ENTOMOL, V80, P477, DOI 10.2307/3495613; Mochiah M. B., 2011, Journal of Applied Biosciences, V38, P2564; Mochiah M.B., 2011, J ENTOMOL NEMATOL, V3, P85; Ntow WJ, 2006, PEST MANAG SCI, V62, P356, DOI 10.1002/ps.1178; Obeng-Ofori D., 2002, AGR FOOD SCI J GHANA, V1, P83; Obopile M, 2008, CROP PROT, V27, P1220, DOI 10.1016/j.cropro.2008.03.003; Opender Koul, 2003, Predators and parasitoids, P1; Rando J. S. S., 2011, Semina: Ciencias Agrarias (Londrina), V32, P503; Rathi JM, 2005, J CENT EUR AGRIC, V6, P223; Reuben S. O. W. M., 2006, Asian Journal of Plant Sciences, V5, P85; Sarfraz M, 2005, BIOCONTROL SCI TECHN, V15, P763, DOI 10.1080/09583150500136956; SAS, 2005, SAS US GUID SAS US G; Seffrin RD, 2010, CROP PROT, V29, P20, DOI 10.1016/j.cropro.2009.09.003; Waiganjo MM., 2011, E AFR AGR FORESTRY J, V77, P545; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Weinberger Katinka, 2009, Journal of Asia-Pacific Entomology, V12, P253, DOI 10.1016/j.aspen.2009.08.003; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107	45	65	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78651	10.1371/journal.pone.0078651	http://dx.doi.org/10.1371/journal.pone.0078651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205287	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300077
J	Yadav, D; Ramanathan, S; Goswami, P; Ramakrishnan, L; Saggurti, N; Sen, S; George, B; Paranjape, R				Yadav, Diwakar; Ramanathan, Shreena; Goswami, Prabuddhagopal; Ramakrishnan, Lakshmi; Saggurti, Niranjan; Sen, Shrabanti; George, Bitra; Paranjape, Ramesh			Role of Community Group Exposure in Reducing Sexually Transmitted Infection-Related Risk among Female Sex Workers in India	PLOS ONE			English	Article							HIV PREVENTION PROGRAMS; PROPENSITY SCORE; MATCHING METHODS; KARNATAKA STATE; PEER EDUCATION; ANDHRA-PRADESH; CONDOM USE; HIV/AIDS; INTERVENTION; HEALTH	Background: Empowering female sex workers (FSWs) to address structural barriers and forming community groups (CGs) through community mobilization are seen as essential components of HIV prevention programs in India. Taking the membership of a CG as an exposure intervention, we hypothesized whether participation in a CG lead to reduced sexually transmitted infections (STIs) and increased treatment-seeking behavior among FSWs in three selected states of India - Andhra Pradesh, Maharashtra and Tamil Nadu. Methods and Findings: The propensity score matching (PSM) approach examined the effect of CG membership, as against no membership, on STI-related risk, described as selected outcome measures - presence of any STI, self-reported STI symptoms, and treatment-seeking behavior among FSWs. A cross sectional bio-behavioral survey was administered in 2009-2010 and covered 7,806 FSWs through two-stage probability-based conventional and time location cluster sampling in 23 administrative districts of Andhra Pradesh, Maharashtra and Tamil Nadu. Only 2,939 FSWs were reported to be members of a CG and among them 4.5% had any STIs. A majority of FSWs were aged above 24 years (86.4%), had ever been married (73%), operated from a public place for solicitation (81.5%), and had ever received HIV test results (75.6%). The average effect of CG exposure was reduction in STI prevalence by 4%, while self-reported STI symptom treatment-seeking behavior increased by 13.7%. Conclusion: FSWs who were exposed to a CG were at a substantially lower risk of STIs than those who were unexposed. The FSWs exposed to a CG had a higher chance of seeking STI treatment from public and private health facilities. Collectivization related challenges must be overcome to provide access to tailored STI prevention and care services.	[Yadav, Diwakar; Ramanathan, Shreena; Goswami, Prabuddhagopal; Ramakrishnan, Lakshmi; Sen, Shrabanti; George, Bitra] FHI 360, New Delhi, India; [Saggurti, Niranjan] Populat Council, New Delhi, India; [Paranjape, Ramesh] Natl AIDS Res Inst, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Yadav, D (corresponding author), FHI 360, Green Pk Extens, New Delhi, India.	yadavdiwakar7@gmail.com		Paranjape, Ramesh/0000-0003-2948-9148; Saggurti, Niranjan/0000-0002-5267-8425	Bill & Melinda Gates Foundation through Avahan, its India AIDS initiative	Bill & Melinda Gates Foundation through Avahan, its India AIDS initiative(Bill & Melinda Gates FoundationGates Foundation India)	Support for this study was provided by the Bill & Melinda Gates Foundation through Avahan, its India AIDS initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation or Avahan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, INT BEH BIOL ASS IBB; Argento E, 2011, AIDS CARE, V23, P69, DOI 10.1080/09540121.2010.498868; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beeker C, 1998, SOC SCI MED, V46, P831, DOI 10.1016/S0277-9536(97)00208-6; Benzaken Adele Schwartz, 2007, Rev. Saúde Pública, V41, P118, DOI 10.1590/S0034-89102007000900018; Bhattacharjee P, 2013, AIDS CARE, V25, pS46, DOI 10.1080/09540121.2012.736607; Biradavolu MR, 2009, SOC SCI MED, V68, P1541, DOI 10.1016/j.socscimed.2009.01.040; Biradavolu MR, 2012, J EPIDEMIOL COMMUNIT, V66, pii95, DOI [10.1136/jech-2011-200508., DOI 10.1136/JECH-2011-200508.PUBMED:22705653]; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; BMGF, 2008, AV IND AIDS IN BUS H; Busza J, 2004, AIDS CARE, V16, P507, DOI 10.1080/09540120410001683457; Campbell C, 2001, AM J PUBLIC HEALTH, V91, P1978, DOI 10.2105/AJPH.91.12.1978; Campbell C, 2007, AM J COMMUN PSYCHOL, V39, P347, DOI 10.1007/s10464-007-9116-1; Chakravarthy JBR, 2012, J EPIDEMIOL COMMUN H, V66, pII78, DOI 10.1136/jech-2011-200487; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Chattopadhyay A, 2004, AIDS PATIENT CARE ST, V18, P159, DOI 10.1089/108729104322994847; Cornish F, 2007, SOC SCI MED, V64, P496, DOI 10.1016/j.socscimed.2006.09.009; Cornish F, 2009, AM J COMMUN PSYCHOL, V44, P123, DOI 10.1007/s10464-009-9254-8; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Erausquin JT, 2012, J EPIDEMIOL COMMUN H, V66, pII49, DOI 10.1136/jech-2011-200511; Evans C, 2008, IMPLEMENTING COMMUNI; Ford K, 2002, SEX TRANSM DIS, V29, P50, DOI 10.1097/00007435-200201000-00009; Foundation BMG, 2008, AVAHAN INDIA AIDS IN; Gaikwad SS, 2012, J EPIDEMIOL COMMUN H, V66, pII69, DOI 10.1136/jech-2011-200514; Galavotti C, 2012, J EPIDEMIOL COMMUNIT, V66, pii9, DOI [10.1136/jech-2011-200465, DOI 10.1136/JECH-2011-200465.PUBMED:22760219]; Ghose T, 2008, SOC SCI MED, V67, P311, DOI 10.1016/j.socscimed.2008.03.045; Guha M, 2012, J EPIDEMIOL COMMUN H, V66, pII55, DOI 10.1136/jech-2011-200562; Gunn RA, 1998, JAMA-J AM MED ASSOC, V279, P680, DOI 10.1001/jama.279.9.680; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; Herek GM, 1999, AM BEHAV SCI, V42, P1106, DOI 10.1177/00027649921954787; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Juneja S, 2013, AIDS BEHAV, V17, P1040, DOI 10.1007/s10461-012-0314-y; Kane S, 2010, INT J TUBERC LUNG D, V14, P1066; Lechner M, 2002, J R STAT SOC A STAT, V165, P59, DOI 10.1111/1467-985X.0asp2; Mahal A, 2008, AIDS, V22, pS95, DOI 10.1097/01.aids.0000327629.62350.59; Mayaud P, 2001, BRIT MED BULL, V58, P129, DOI 10.1093/bmb/58.1.129; Narayanan P, 2012, J EPIDEMIOL COMMUN H, V66, pII34, DOI 10.1136/jech-2012-201065; Oakes JM, 2006, METHODS SOCIAL EPIDE, V1st; Parimi P, 2012, J EPIDEMIOL COMMUNIT, V66, pii62, DOI [10.1136/jech-2011-200832., DOI 10.1136/JECH-2011-200832.PUBMED:22493478]; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parker R, 2002, AM J PUBLIC HEALTH, V92, P343, DOI 10.2105/AJPH.92.3.343; Pinto RM, 2008, WOMEN HEALTH, V47, P83, DOI 10.1300/J013v47n01_05; Punyam S, 2012, J EPIDEMIOL COMMUN H, V66, pII87, DOI 10.1136/jech-2011-200478; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Rau B, 2006, INT AFF, V82, P285, DOI 10.1111/j.1468-2346.2006.00531.x; Reddy DCS, 2006, PROJECTIONS HIV EPID; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Saggurti N, 2013, AIDS CARE, V25, pS55, DOI 10.1080/09540121.2012.749334; Saidel T, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000343761.77702.04; Sarkar S, 2010, SEX TRANSM INFECT, V86, pI2, DOI 10.1136/sti.2009.039289; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; StataCorp, 2021, STATA STAT SOFTWARE; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Valdiserri RO, 2002, AM J PUBLIC HEALTH, V92, P341, DOI 10.2105/AJPH.92.3.341; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483	62	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78361	10.1371/journal.pone.0078361	http://dx.doi.org/10.1371/journal.pone.0078361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205210	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300053
J	Dalesman, S; Sunada, H; Teskey, ML; Lukowiak, K				Dalesman, Sarah; Sunada, Hiroshi; Teskey, Morgan Lee; Lukowiak, Ken			Combining Stressors That Individually Impede Long-Term Memory Blocks All Memory Processes	PLOS ONE			English	Article							AERIAL RESPIRATORY BEHAVIOR; SNAIL LYMNAEA-STAGNALIS; ALTERS ADAPTIVE BEHAVIORS; ENVIRONMENTAL CALCIUM; SYNAPTIC PLASTICITY; PREDATOR EXPOSURE; PREFRONTAL CORTEX; MODEL SYSTEM; L.; HIPPOCAMPUS	The effects of stress on memory are typically assessed individually; however, in reality different stressors are often experienced simultaneously. Here we determined the effect that two environmentally relevant stressors, crowding and low calcium availability, have on memory and neural activity following operant conditioning of aerial respiration in the pond snail, Lymnaea stagnalis. We measured aerial breathing behaviour and activity of a neuron necessary for memory formation, right pedal dorsal 1 (RPeD1), in the central pattern generator (CPG) that drives aerial respiration in untrained animals, and assessed how these traits changed following training. In naive animals both crowding and combined stressors significantly depressed burst activity in RPeD1 which correlated with a depression in aerial breathing behaviour, whereas low calcium availability had no effect on RPeD1 activity. Following training, changes in burst activity in RPeD1 correlated with behavioural changes, decreasing relative to their naive state at 3 h and 24 h in control conditions when both intermediate-term memory (ITM: 3 h) and long-term memory (LTM: 24 h) are formed, at 3 h but not 24 h when exposed to individual stressors when only ITM is formed, and did not change in combined stressors (i.e. when no memory is formed). Additionally, we also found that Lymnaea formed short-term memory (STM: 10 min) in the presence of individual stressors or under control conditions, but failed to do so in the presence of combined stressors. Our data demonstrate that by combining stressors that individually block LTM only we can block all memory processes. Therefore the effects of two stressors with similar individual affects on memory phenotype may be additive when experienced in combination.	[Dalesman, Sarah; Sunada, Hiroshi; Teskey, Morgan Lee; Lukowiak, Ken] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary	Dalesman, S (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	S.Dalesman@exeter.ac.uk		Dalesman, Sarah/0000-0001-8548-3096	Alberta Innovates - Health Solutions; Hotchkiss Brain Institute; Canadian Institutes of Health Research	Alberta Innovates - Health Solutions; Hotchkiss Brain Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Alberta Innovates - Health Solutions provided financial support for S. D., the Hotchkiss Brain Institute supports H. S. and Canadian Institutes of Health Research supports K. L. and the laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun MH, 2012, NEUROBIOL LEARN MEM, V97, P173, DOI 10.1016/j.nlm.2011.11.005; Braun MH, 2011, NEUROBIOL LEARN MEM, V96, P403, DOI 10.1016/j.nlm.2011.06.016; BROWN KM, 1979, EVOLUTION, V33, P417, DOI 10.1111/j.1558-5646.1979.tb04695.x; Dalesman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032334; Dalesman S, 2011, J EXP BIOL, V214, P4179, DOI 10.1242/jeb.064857; Dalesman S, 2011, J EXP BIOL, V214, P2528, DOI 10.1242/jeb.058024; Dalesman S, 2011, NEUROBIOL LEARN MEM, V95, P393, DOI 10.1016/j.nlm.2010.11.017; Dalesman S, 2010, J EXP BIOL, V213, P1471, DOI 10.1242/jeb.040493; Dayas CV, 2001, EUR J NEUROSCI, V14, P1143, DOI 10.1046/j.0953-816x.2001.01733.x; De Caigny P, 2008, J EXP BIOL, V211, P2678, DOI 10.1242/jeb.020347; DeBoer PACM, 1997, J EXP BIOL, V200, P941; DUSSART G B J, 1976, Journal of Molluscan Studies, V42, P181; Ebanks SC, 2010, J COMP PHYSIOL B, V180, P953, DOI 10.1007/s00360-010-0469-7; Hermann PM, 2009, J EXP BIOL, V212, P3164, DOI 10.1242/jeb.030031; Karnik V, 2012, J EXP BIOL, V215, P536, DOI 10.1242/jeb.061432; Kavushansky Alexandra, 2009, Stress, V12, P412, DOI 10.1080/10253890802556081; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Knezevic B, 2011, J EXP BIOL, V214, P2118, DOI 10.1242/jeb.054635; Lukowiak K, 2003, J PHYSIOL-PARIS, V97, P69, DOI 10.1016/j.jphysparis.2003.10.008; Lukowiak K, 1991, Curr Opin Neurobiol, V1, P577, DOI 10.1016/S0959-4388(05)80031-5; Lukowiak K, 1996, J EXP BIOL, V199, P683; Lukowiak K, 2008, J EXP BIOL, V211, P1747, DOI 10.1242/jeb.014886; Lukowiak K, 2010, BEHAV BRAIN RES, V214, P18, DOI 10.1016/j.bbr.2010.05.011; MANN KH, 1958, LIMNOL OCEANOGR, V3, P418, DOI 10.4319/lo.1958.3.4.0418; McComb C, 2003, J NEUROPHYSIOL, V90, P983, DOI 10.1152/jn.00263.2003; Orr MV, 2008, J NEUROSCI, V28, P2726, DOI 10.1523/JNEUROSCI.5132-07.2008; Robertson RM, 2004, J THERM BIOL, V29, P351, DOI 10.1016/j.jtherbio.2004.08.073; Sangha S, 2004, ADV EXP MED BIOL, V551, P311; Scheibenstock A, 2002, J NEUROPHYSIOL, V88, P1584, DOI 10.1152/jn.2002.88.4.1584; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; Spencer GE, 2000, J NEUROSCI, V20, P8077; Spencer GE, 1999, J NEUROSCI, V19, P1836; Spencer SJ, 2004, EUR J NEUROSCI, V20, P1008, DOI 10.1111/j.1460-9568.2004.03569.x; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613; Zoladz PR, 2012, HIPPOCAMPUS, V22, P577, DOI 10.1002/hipo.20922	36	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79561	10.1371/journal.pone.0079561	http://dx.doi.org/10.1371/journal.pone.0079561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223180	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200072
J	Barutta, F; Tricarico, M; Corbelli, A; Annaratone, L; Pinach, S; Grimaldi, S; Bruno, G; Cimino, D; Taverna, D; Deregibus, MC; Rastaldi, MP; Perin, PC; Gruden, G				Barutta, Federica; Tricarico, Marinella; Corbelli, Alessandro; Annaratone, Laura; Pinach, Silvia; Grimaldi, Serena; Bruno, Graziella; Cimino, Daniela; Taverna, Daniela; Deregibus, Maria Chiara; Rastaldi, Maria Pia; Perin, Paolo Cavallo; Gruden, Gabriella			Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy	PLOS ONE			English	Article							KIDNEY GLOMERULI; EXPRESSION; CELLS; MICROALBUMINURIA; TGF-BETA-1; MIR-145; PLASMA	MicroRNAs (miRNAs), a class of small non-protein-encoding RNAs, regulate gene expression via suppression of target mRNAs. MiRNAs are present in body fluids in a remarkable stable form as packaged in microvesicles of endocytic origin, named exosomes. In the present study, we have assessed miRNA expression in urinary exosomes from type 1 diabetic patients with and without incipient diabetic nephropathy. Results showed that miR-130a and miR-145 were enriched, while miR-155 and miR-424 reduced in urinary exosomes from patients with microalbuminuria. Similarly, in an animal model of early experimental diabetic nephropathy, urinary exosomal miR-145 levels were increased and this was paralleled by miR-145 overexpression within the glomeruli. Exposure of cultured mesangial cells to high glucose increased miR-145 content in both mesangial cells and mesangial cells-derived exosomes, providing a potential mechanism for diabetes-induced miR-145 overexpression. In conclusion, urinary exosomal miRNA content is altered in type 1 diabetic patients with incipient diabetic nephropathy and miR-145 may represent a novel candidate biomarker/player in the complication.	[Barutta, Federica; Tricarico, Marinella; Pinach, Silvia; Grimaldi, Serena; Bruno, Graziella; Perin, Paolo Cavallo; Gruden, Gabriella] Univ Turin, Dept Med Sci, Diabet Nephropathy Lab, Turin, Italy; [Corbelli, Alessandro] Osped Maggiore Policlin, Fdn IRCCS, Renal Res Lab, Milan, Italy; [Corbelli, Alessandro] Fdn DAmico Ric Malattie Renali, Milan, Italy; [Corbelli, Alessandro] Milano Bicocca Univ, MIA Consortium Image Anal, Milan, Italy; [Annaratone, Laura] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Cimino, Daniela; Taverna, Daniela] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Deregibus, Maria Chiara] Univ Turin, Dept Med Sci, Lab Renal & Vasc Pathophysiol, Turin, Italy	University of Turin; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milano-Bicocca; University of Turin; University of Turin; University of Turin	Barutta, F (corresponding author), Univ Turin, Dept Med Sci, Diabet Nephropathy Lab, Turin, Italy.	federica.barutta@unito.it	taverna, daniela/J-8358-2016; Corbelli, Alessandro/ABG-3900-2020; Pinach, Silvia/AAC-7490-2022; Annaratone, Laura/J-9261-2016	taverna, daniela/0000-0002-6365-527X; Corbelli, Alessandro/0000-0001-8545-8050; Pinach, Silvia/0000-0002-3234-9990; Annaratone, Laura/0000-0001-5750-1445; BRUNO, Graziella/0000-0002-3011-8304	EFSD & Sanofi European Research Programme in Micro- and Macrovascular Complications of Diabetes Grant	EFSD & Sanofi European Research Programme in Micro- and Macrovascular Complications of Diabetes Grant	This work was supported by a EFSD & Sanofi European Research Programme in Micro- and Macrovascular Complications of Diabetes Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Argyropoulos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054662; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; El Andaloussi S, 2012, ADV DRUG DELIV REV; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Giunti S, 2008, DIABETOLOGIA, V51, P198, DOI 10.1007/s00125-007-0837-3; Glassock RJ, 2010, AM J NEPHROL, V31, P462, DOI 10.1159/000313553; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; HE L, 2004, NAT REV GENET, V5, P522, DOI DOI 10.1038/NRG1379.PUBMED:15211354; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lambers Heerspink HJ, 2010, AM J NEPHROL, V31, P458, DOI 10.1159/000292501; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu MC, 2013, CLIN EXP IMMUNOL, V171, P91, DOI 10.1111/j.1365-2249.2012.04676.x; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; MANGILI R, 1992, ACTA DIABETOL, V29, P156, DOI 10.1007/BF00573481; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Natarajan R, 2012, J CARDIOVASC TRANSL, V5, P413, DOI 10.1007/s12265-012-9368-5; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stevens LA, 2006, CLIN J AM SOC NEPHRO, V1, P874, DOI 10.2215/CJN.00600206; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tarabra E, 2009, DIABETES, V58, P2109, DOI 10.2337/db08-0895; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Wang G, 2007, NEPHROLOGY, V12, P494, DOI 10.1111/j.1440-1797.2007.00836.x; Yevdokimova N, 2001, J AM SOC NEPHROL, V12, P703, DOI 10.1681/ASN.V124703	39	221	235	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e73798	10.1371/journal.pone.0073798	http://dx.doi.org/10.1371/journal.pone.0073798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223694	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400002
J	Eckrich, CA; Flaherty, EA; Ben-David, M				Eckrich, Carolyn A.; Flaherty, Elizabeth A.; Ben-David, Merav			Estimating Leaf Area Index in Southeast Alaska: A Comparison of Two Techniques	PLOS ONE			English	Article							YOUNG DOUGLAS-FIR; UNDERSTORY VEGETATION; CANOPY STRUCTURE; HEMISPHERICAL PHOTOGRAPHS; MANAGEMENT STRATEGIES; ALLOMETRIC ALGORITHMS; LIGHT ENVIRONMENT; BEECH FOREST; STANDS; BIOMASS	The relationship between canopy structure and light transmission to the forest floor is of particular interest for studying the effects of succession, timber harvest, and silviculture prescriptions on understory plants and trees. Indirect measurements of leaf area index (LAI) estimated using gap fraction analysis with linear and hemispheric sensors have been commonly used to assess radiation interception by the canopy, although the two methods often yield inconsistent results. We compared simultaneously obtained measurements of LAI from a linear ceptometer and digital hemispheric photography in 21 forest stands on Prince of Wales Island, Alaska. We assessed the relationship between these estimates and allometric LAI based on tree diameter at breast height (LAI(DBH)). LAI values measured at 79 stations in thinned, un-thinned controls, old-growth and clearcut stands were highly correlated between the linear sensor (AccuPAR) and hemispheric photography, but the latter was more negatively biased compared to LAI(DBH). In contrast, AccuPAR values were more similar to LAI(DBH) in all stands with basal area less than 30 m(2) ha(-1). Values produced by integrating hemispheric photographs over the zenith angles 0-75 degrees (Ring 5) were highly correlated with those integrated over the zenith angles 0-60 degrees (Ring 4), although the discrepancies between the two measures were significant. On average, the AccuPAR estimates were 53% higher than those derived from Ring 5, with most of the differences in closed canopy stands (unthinned controls and old-growth) and less so in clearcuts. Following typical patterns of canopy closure, AccuPAR LAI values were higher in dense control stands than in old-growth, whereas the opposite was derived from Ring 5 analyses. Based on our results we advocate the preferential use of linear sensors where canopy openness is low, canopies are tall, and leaf distributions are clumped and angles are variable, as is common in the conifer forests of coastal Alaska.	[Eckrich, Carolyn A.; Ben-David, Merav] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Eckrich, Carolyn A.; Ben-David, Merav] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Flaherty, Elizabeth A.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	University of Wyoming; University of Wyoming; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Eckrich, CA (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	ceckrich@uwyo.edu	Flaherty, Elizabeth A/F-1825-2017	Flaherty, Elizabeth A/0000-0001-6872-7984	United States Department of Agriculture (USDA) Forest Service Tongass National Forest [10JV-11100500-021]	United States Department of Agriculture (USDA) Forest Service Tongass National Forest	Funding for the project was provided by the United States Department of Agriculture (USDA) Forest Service Tongass National Forest under cooperative agreement 10JV-11100500-021 (http://www.fs.usda.gov/tongass/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALABACK PB, 1982, ECOLOGY, V63, P1932, DOI 10.2307/1940131; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; Carey AB, 2000, ECOL APPL, V10, P248, DOI 10.1890/1051-0761(2000)010[0248:EONFMS]2.0.CO;2; Chan SS, 2006, CAN J FOREST RES, V36, P2696, DOI 10.1139/X06-151; CHEN JM, 1992, PLANT CELL ENVIRON, V15, P421, DOI 10.1111/j.1365-3040.1992.tb00992.x; Chen JM, 2012, J GEOPHYS RES, V102, P29429; Clark J, 2011, CAN J FOREST RES, V41, P1060, DOI [10.1139/X11-013, 10.1139/x11-013]; Cole EC, 2010, CAN J FOREST RES, V40, P619, DOI 10.1139/X10-009; Davis LR, 2007, NORTHWEST SCI, V81, P1, DOI 10.3955/0029-344X-81.1.1; Deal RL, 2007, BIOL CONSERV, V137, P520, DOI 10.1016/j.biocon.2007.03.014; Decagon Devices, 2004, ACCUPAR MOD LP 80 OP; FASSNACHT KS, 1994, AGR FOREST METEOROL, V71, P183, DOI 10.1016/0168-1923(94)90107-4; Fox J., 2019, R COMPANION APPL REG, V.; Frazer GW, 2001, AGR FOREST METEOROL, V109, P249, DOI 10.1016/S0168-1923(01)00274-X; Frazer GW, 2000, CAN J FOREST RES, V30, P239, DOI 10.1139/cjfr-30-2-239; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Gower ST, 1999, REMOTE SENS ENVIRON, V70, P29, DOI 10.1016/S0034-4257(99)00056-5; GOWER ST, 1987, CAN J FOREST RES, V17, P630, DOI 10.1139/x87-103; Gray AN, 1996, J ECOL, V84, P635, DOI 10.2307/2261327; GRIER CC, 1977, ECOLOGY, V58, P893, DOI 10.2307/1936225; Hale SE, 2003, FOREST ECOL MANAG, V179, P341, DOI 10.1016/S0378-1127(02)00540-6; Hanley TA, 2005, LANDSCAPE URBAN PLAN, V72, P95, DOI 10.1016/j.landurbplan.2004.09.015; Hannon PE, 2010, NORTHWEST SCI, V84, P73, DOI 10.3955/046.084.0108; Hayes JP, 1997, J FOREST, V95, P28; HELGERSON OT, 1988, CAN J FOREST RES, V18, P1082, DOI 10.1139/x88-164; Hyer EJ, 2004, AGR FOREST METEOROL, V122, P157, DOI 10.1016/j.agrformet.2003.09.013; Inoue A, 2004, AGR FOREST METEOROL, V126, P89, DOI 10.1016/j.agrformet.2004.06.002; Jelaska SD, 2006, ECOL MODEL, V194, P209, DOI 10.1016/j.ecolmodel.2005.10.013; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Klinka K, 1996, NORTHWEST SCI, V70, P193; LANG ARG, 1986, AGR FOREST METEOROL, V37, P229, DOI 10.1016/0168-1923(86)90033-X; Leblanc SG, 2001, AGR FOREST METEOROL, V110, P125, DOI 10.1016/S0168-1923(01)00284-2; Lindgren PMF, 2006, CAN J FOREST RES, V36, P48, DOI 10.1139/X05-228; MARTENS SN, 1993, FOREST ECOL MANAG, V61, P91, DOI 10.1016/0378-1127(93)90192-P; McClellan Michael H., 2008, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P225; Nobis M, 2005, AGR FOREST METEOROL, V128, P243, DOI 10.1016/j.agrformet.2004.10.002; Nobis M., 2005, SIDELOOK 1 1 IMAGING; Parker Geoffrey G., 1995, P73; PIERCE LL, 1988, ECOLOGY, V69, P1762, DOI 10.2307/1941154; Planchais I, 1999, ANN FOR SCI, V56, P1, DOI 10.1051/forest:19990101; R Core Team, 2016, R FDN STAT COMP; Roe AM, 2010, ECOLOGY, V91, P3177, DOI 10.1890/09-1216.1; Schleppi P, 2011, FOREST ECOL MANAG, V261, P601, DOI 10.1016/j.foreco.2010.11.013; STENBERG P, 1994, TREE PHYSIOL, V14, P981, DOI 10.1093/treephys/14.7-8-9.981; Tobin B, 2006, FORESTRY, V79, P453, DOI 10.1093/forestry/cpl030; Turner DP, 2000, FOREST ECOL MANAG, V126, P61, DOI 10.1016/S0378-1127(99)00083-3; Welles JM, 1996, J EXP BOT, V47, P1335, DOI 10.1093/jxb/47.9.1335; Wright EF, 1998, CAN J FOREST RES, V28, P871, DOI 10.1139/cjfr-28-6-871; Zar J.H., 2010, BIOSTAT ANAL	50	12	13	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77642	10.1371/journal.pone.0077642	http://dx.doi.org/10.1371/journal.pone.0077642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223718	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400012
J	Fertig, EJ; Markovic, A; Danilova, LV; Gaykalova, DA; Cope, L; Chung, CH; Ochs, MF; Califano, JA				Fertig, Elana J.; Markovic, Ana; Danilova, Ludmila V.; Gaykalova, Daria A.; Cope, Leslie; Chung, Christine H.; Ochs, Michael F.; Califano, Joseph A.			Preferential Activation of the Hedgehog Pathway by Epigenetic Modulations in HPV Negative HNSCC Identified with Meta-Pathway Analysis	PLOS ONE			English	Article							NECK-CANCER; HUMAN-PAPILLOMAVIRUS; EXPRESSION DIFFERENCES; HEAD; PATTERNS; METHYLATION; RESISTANCE; DISCOVERY; SURVIVAL; REVEALS	Head and neck squamous cell carcinoma (HNSCC) is largely divided into two groups based on their etiology, human papillomavirus (HPV)-positive and -negative. Global DNA methylation changes are known to drive oncogene and tumor suppressor expression in primary HNSCC of both types. However, significant heterogeneity in DNA methylation within the groups results in different transcriptional profiles and clinical outcomes. We applied a meta-pathway analysis to link gene expression changes to DNA methylation in distinguishing HNSCC subtypes. This approach isolated specific epigenetic changes controlling expression in HPV- HNSCC that distinguish it from HPV+ HNSCC. Analysis of genes identified Hedgehog pathway activation specific to HPV- HNSCC. We confirmed that GLI1, the primary Hedgehog target, showed higher expression in tumors compared to normal samples with HPV- tumors having the highest GLI1 expression, suggesting that increased expression of GLI1 is a potential driver in HPV- HNSCC. Our algorithm for integration of DNA methylation and gene expression can infer biologically significant molecular pathways that may be exploited as therapeutics targets. Our results suggest that therapeutics targeting the Hedgehog pathway may be of benefit in HPV- HNSCC. Similar integrative analysis of high-throughput coupled DNA methylation and expression datasets may yield novel insights into deregulated pathways in other cancers.	[Fertig, Elana J.; Danilova, Ludmila V.; Cope, Leslie; Chung, Christine H.; Ochs, Michael F.; Califano, Joseph A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21218 USA; [Markovic, Ana] Univ Calif San Francisco, Hellen Diller Family Comprehens Canc Ctr, Dept Hematopoiet Malignancies, San Francisco, CA 94143 USA; [Gaykalova, Daria A.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Univ, Sch Med, Dept Hlth Sci Informat, Baltimore, MD USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Greater Baltimore Medical Center	Fertig, EJ (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21218 USA.	ejfertig@jhmi.edu		Fertig, Elana/0000-0003-3204-342X	NCI [CA1410503]; NLM [LM001100]; NIH/NIDCR [DE020324]; CCSG; Johns Hopkins University Head and Neck Cancer SPORE [5P50DE019032]; Flight Attendant Medical Research Institute Center of Excellence at Johns Hopkins University; NATIONAL CANCER INSTITUTE [K25CA141053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011000] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CCSG; Johns Hopkins University Head and Neck Cancer SPORE; Flight Attendant Medical Research Institute Center of Excellence at Johns Hopkins University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The following funding sources supported this research: NCI (CA1410503), NLM (LM001100), NIH/NIDCR (DE020324), CCSG, the Johns Hopkins University Head and Neck Cancer SPORE (5P50DE019032). This project was also partly funded by Flight Attendant Medical Research Institute Center of Excellence at Johns Hopkins University. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ang KK, 2002, CANCER RES, V62, P7350; Bidaut G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-99; Bidaut G, 2004, BIOINFORMATICS, V20, P2869, DOI 10.1093/bioinformatics/bth307; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Chung CH, 2011, J CLIN ONCOL, V29, P1326, DOI 10.1200/JCO.2010.32.3295; Dimitrova K, 2013, ONKOLOGIE, V36, P279, DOI 10.1159/000350322; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Fertig EJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-160; Fertig EJ, 2010, BIOINFORMATICS, V26, P2792, DOI 10.1093/bioinformatics/btq503; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Keysar SB, 2013, CANCER RES, V73, P3381, DOI 10.1158/0008-5472.CAN-12-4047; Kossenkov A, 2003, BIOINFORMATICS, V19, P675, DOI 10.1093/bioinformatics/btg056; Kossenkov AV, 2009, METHOD ENZYMOL, V467, P59, DOI 10.1016/S0076-6879(09)67003-8; Langendijk JA, 2010, ANN ONCOL, V21, P1931, DOI 10.1093/annonc/mdq439; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Ochs M F, 2003, ANAL GENE EXPRESSION, P388; Ochs MF, 2004, ANN NY ACAD SCI, V1020, P212, DOI 10.1196/annals.1310.018; Ochs Michael F, 2012, IEEE Symp Comput Intell Bioinforma Comput Biol Proc, V2012, P387, DOI 10.1109/CIBCB.2012.6217256; Ochs MF, 2009, CANCER RES, V69, P9125, DOI 10.1158/0008-5472.CAN-09-1709; Pishvaian Michael J., 2007, Cancer Biomarkers, V3, P263; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sartor MA, 2011, EPIGENETICS-US, V6, P777, DOI 10.4161/epi.6.6.16216; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Slebos RJC, 2006, CLIN CANCER RES, V12, P701, DOI 10.1158/1078-0432.CCR-05-2017; Slebos RJC, 2013, INT J CANCER, V132, P568, DOI 10.1002/ijc.27699; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabor MP, 2001, CLIN CANCER RES, V7, P1523; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang XQ, 2001, J BIOL CHEM, V276, P1311, DOI 10.1074/jbc.M005191200; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wei Y, 2011, CANC OUTLIER GENE PR; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322	49	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78127	10.1371/journal.pone.0078127	http://dx.doi.org/10.1371/journal.pone.0078127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223768	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400035
J	Gusberti, M; Gessler, C; Broggini, GAL				Gusberti, Michele; Gessler, Cesare; Broggini, Giovanni A. L.			RNA-Seq Analysis Reveals Candidate Genes for Ontogenic Resistance in Malus-Venturia Pathosystem	PLOS ONE			English	Article							AGE-RELATED RESISTANCE; APPLE SCAB; DISEASE MANAGEMENT; ALPHA-TOCOPHEROL; DEFENSE RESPONSE; FUNGAL PATHOGEN; TOBACCO-LEAVES; FRUIT-QUALITY; PLANT DEFENSE; GRAPE BERRIES	Ontogenic scab resistance in apple leaves and fruits is a horizontal resistance against the plant pathogen Venturia inaequalis and is expressed as a decrease in disease symptoms and incidence with the ageing of the leaves. Several studies at the biochemical level tried to unveil the nature of this resistance; however, no conclusive results were reported. We decided therefore to investigate the genetic origin of this phenomenon by performing a full quantitative transcriptome sequencing and comparison of young (susceptible) and old (ontogenic resistant) leaves, infected or not with the pathogen. Two time points at 72 and 96 hours post-inoculation were chosen for RNA sampling and sequencing. Comparison between the different conditions (young and old leaves, inoculated or not) should allow the identification of differentially expressed genes which may represent different induced plant defence reactions leading to ontogenic resistance or may be the cause of a constitutive (uninoculated with the pathogen) shift toward resistance in old leaves. Differentially expressed genes were then characterised for their function by homology to A. thaliana and other plant genes, particularly looking for genes involved in pathways already suspected of appertaining to ontogenic resistance in apple or other hosts, or to plant defence mechanisms in general. In this work, five candidate genes putatively involved in the ontogenic resistance of apple were identified: a gene encoding an "enhanced disease susceptibility 1 protein'' was found to be down-regulated in both uninoculated and inoculated old leaves at 96 hpi, while the other four genes encoding proteins (metallothionein3-like protein, lipoxygenase, lipid transfer protein, and a peroxidase 3) were found to be constitutively up-regulated in inoculated and uninoculated old leaves. The modulation of the five candidate genes has been validated using the real-time quantitative PCR. Thus, ontogenic resistance may be the result of the corresponding up-and down-regulation of these genes.	[Gusberti, Michele; Gessler, Cesare; Broggini, Giovanni A. L.] Swiss Fed Inst Technol, Plant Pathol Grp, Inst Integrat Biol Zurich, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gessler, C (corresponding author), Swiss Fed Inst Technol, Plant Pathol Grp, Inst Integrat Biol Zurich, Zurich, Switzerland.	cesare.gessler@usys.ethz.ch	Broggini, Giovanni/N-7034-2016	Broggini, Giovanni/0000-0002-1011-4090	EnviroChange project of the Autonomous Province of Trento, Italy	EnviroChange project of the Autonomous Province of Trento, Italy	Research was partially financed by the EnviroChange project (http://www.envirochange.eu) of the Autonomous Province of Trento, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Aderhold R, 1900, LANDW JB, V29, P541; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; BARNES EH, 1961, CAN J MICROBIOL, V7, P525, DOI 10.1139/m61-062; Blein JP, 2002, TRENDS PLANT SCI, V7, P293, DOI 10.1016/S1360-1385(02)02284-7; Bringe K, 2006, PHYTOCHEMISTRY, V67, P161, DOI 10.1016/j.phytochem.2005.10.018; Bus VGM, 2005, NEW PHYTOL, V166, P1035, DOI 10.1111/j.1469-8137.2005.01395.x; Bus VGM, 2005, MOL BREEDING, V15, P103, DOI 10.1007/s11032-004-3609-5; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49, P391, DOI 10.1146/annurev-phyto-072910-095339; Choi HW, 2007, PLANT PHYSIOL, V145, P890, DOI 10.1104/pp.107.103325; Choi HW, 2012, PLANTA, V235, P1369, DOI 10.1007/s00425-011-1580-z; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Collakova E, 2003, PLANT PHYSIOL, V133, P930, DOI 10.1104/pp.103.026138; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Degenhardt J, 2005, MOL GENET GENOMICS, V273, P326, DOI 10.1007/s00438-005-1136-7; Degenhardt J, 2006, THESIS GW LEIBNIZ U; Erdin N, 2006, GENOME, V49, P1238, DOI 10.1139/G06-096; Ficke A, 2003, PHYTOPATHOLOGY, V93, P556, DOI 10.1094/PHYTO.2003.93.5.556; Ficke A, 2002, PHYTOPATHOLOGY, V92, P671, DOI 10.1094/PHYTO.2002.92.6.671; FOTHERGILL PG, 1955, J GEN MICROBIOL, V12, P387, DOI 10.1099/00221287-12-3-387; Galiana E, 1997, PLANT PHYSIOL, V115, P1557, DOI 10.1104/pp.115.4.1557; Garcia-Ruiz H, 2001, ANN APPL BIOL, V139, P307, DOI 10.1111/j.1744-7348.2001.tb00144.x; GESSLER C, 1984, PHYTOPATHOL Z, V110, P119; Gessler C, 2012, TREES-STRUCT FUNCT, P1, DOI [10.1007/s00468-011-0618-y, DOI 10.1007/S00468-011-0618-Y:1-14]; Goethe R, 1887, GARTENFLORA, V36, P293; Gusberti M, 2012, PLANT DIS, V96, P1791, DOI 10.1094/PDIS-12-11-1058-RE; Gygax M, 2004, THEOR APPL GENET, V109, P1702, DOI 10.1007/s00122-004-1803-9; Hao W, 2011, PLANT DIS PESTS, V2, P9; Holb IJ, 2003, J PHYTOPATHOL, V151, P335, DOI 10.1046/j.1439-0434.2003.00728.x; Hrazdina G, 2003, PHYTOCHEMISTRY, V64, P485, DOI 10.1016/S0031-9422(03)00150-X; Hugot K, 1999, PLANT J, V20, P163, DOI 10.1046/j.1365-313x.1999.00587.x; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Juen YC, 1991, J PHYTOPATHOL BERL, V131, P40; Kawano T, 2003, PLANT CELL REP, V21, P829, DOI 10.1007/s00299-003-0591-z; Keitt G. W., 1926, RES B, V73, P104; Kennelly MM, 2005, PHYTOPATHOLOGY, V95, P1445, DOI 10.1094/PHYTO-95-1445; Kirubakaran SI, 2008, PLANT PHYSIOL BIOCH, V46, P918, DOI 10.1016/j.plaphy.2008.05.007; Kollar A, 1996, EUR J PLANT PATHOL, V102, P773, DOI 10.1007/BF01877152; Kus JV, 2002, PLANT CELL, V14, P479, DOI 10.1105/tpc.010481; LEBEN C, 1948, AM J BOT, V35, P337, DOI 10.2307/2437747; Li B, 2002, J PHYTOPATHOL, V150, P687, DOI 10.1046/j.1439-0434.2002.00824.x; Lindhagen M, 1996, SCI HORTIC-AMSTERDAM, V67, P65, DOI 10.1016/S0304-4238(96)00944-2; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; MacHardy WE, 2001, PLANT DIS, V85, P1036, DOI 10.1094/PDIS.2001.85.10.1036; MacHardy WE, 1996, APPLE SCAB BIOL EPID, P117; MACHARDY WE, 1996, APPLE SCAB BIOL EPID, P104; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noga G, 2000, ACTA HORTIC, P111, DOI 10.17660/ActaHortic.2000.527.12; Pagliarani G, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-51; PARISI L, 1993, PHYTOPATHOLOGY, V83, P533, DOI 10.1094/Phyto-83-533; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Patocchi A, 2005, GENOME, V48, P630, DOI 10.1139/G05-036; Patocchi A, 2004, THEOR APPL GENET, V109, P1087, DOI 10.1007/s00122-004-1723-8; PERIES OS, 1962, ANN APPL BIOL, V50, P225, DOI 10.1111/j.1744-7348.1962.tb06005.x; Petre B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044408; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Poschenrieder C, 2006, TRENDS PLANT SCI, V11, P288, DOI 10.1016/j.tplants.2006.04.007; Quiroga M, 2000, PLANT PHYSIOL, V122, P1119, DOI 10.1104/pp.122.4.1119; RAA J, 1968, Netherlands Journal of Plant Pathology, V74, P37, DOI 10.1007/BF01977511; RAA J, 1968, PHYTOCHEMISTRY, V7, P721, DOI 10.1016/S0031-9422(00)84824-4; Rence I, 1998, PNAS, V95, P6554; RISE M, 1989, PLANT PHYSIOL, V89, P1028, DOI 10.1104/pp.89.4.1028; Sabri N, 1997, PHYSIOL MOL PLANT P, V50, P321, DOI 10.1006/pmpp.1997.0095; Savory EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035796; Schmitz M, 1998, ACTA HORTIC, P89, DOI 10.17660/ActaHortic.1998.466.15; Spann TM, 2010, MINERAL NUTR CONTRIB; Stadler B, 1988, THESIS SWISS FEDERAL, V8685, P72; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Treutter D, 2001, PLANT GROWTH REGUL, V34, P71, DOI 10.1023/A:1013378702940; VALSANGIACOMO C, 1988, PHYTOPATHOLOGY, V78, P1066, DOI 10.1094/Phyto-78-1066; VAUGHN SF, 1993, J CHEM ECOL, V19, P2337, DOI 10.1007/BF00979668; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wanderley-Nogueira A. C., 2012, FUNCT PLANT SCI BIOT, V6, P134; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; WYATT SE, 1991, PHYSIOL MOL PLANT P, V39, P433, DOI 10.1016/0885-5765(91)90009-7; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245	83	40	41	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78457	10.1371/journal.pone.0078457	http://dx.doi.org/10.1371/journal.pone.0078457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223809	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400063
J	Li, QH; Xu, J; Li, HQ; Wang, SX; Yan, X; Xin, ZM; Jiang, ZP; Wang, LL; Jia, ZQ				Li, Qinghe; Xu, Jun; Li, Huiqing; Wang, Saixiao; Yan, Xiu; Xin, Zhiming; Jiang, Zeping; Wang, Linlong; Jia, Zhiqing			Effects of Aspect on Clonal Reproduction and Biomass Allocation of Layering Modules of Nitraria tangutorum in Nebkha Dunes	PLOS ONE			English	Article							SAND BURIAL; WIND EROSION; RESOURCE-ALLOCATION; PHYTOGENIC MOUNDS; LAND DEGRADATION; GROWTH DYNAMICS; ORDOS PLATEAU; SHOOT GROWTH; BUD BANKS; PLANT	The formation of many nebkha dunes relies on the layering of clonal plants. The microenvironmental conditions of such phytogenic nebkha are heterogeneous depending on the aspect and slope. Exploring the effects of aspect on clonal reproduction and biomass allocation can be useful in understanding the ecological adaptation of species. We hypothesized that on the windward side layering propagation would be promoted, that biomass allocation to leaves and stems of ramets would increase, and that the effects of aspect would be greater in the layering with larger biomass. To test these hypotheses, we surveyed the depth of germination points of axillary buds, the rate of ramet sprouting, the density of adventitious root formation points, and the biomass of modules sprouting from layering located on the NE, SE, SW and NW, aspects of Nitraria tangutorum nebkhas. The windward side was located on the NW and SW aspects. The results indicated that conditions of the NW aspect were more conducive to clonal reproduction and had the highest rate of ramet sprouting and the highest density of adventitious formation points. For the modules sprouting from layering on the SW aspect, biomass allocation to leaves and stems was greatest with biomass allocation to adventitious roots being lowest. This result supported our hypothesis. Contrary to our hypothesis, the effects of aspect were greater in layering of smaller biomass. These results support the hypothesis that aspect does affect layering propagation capacity and biomass allocation in this species. Additionally, clonal reproduction and biomass allocation of modules sprouting from layering with smaller biomass was more affected by aspect. These results suggest that the clonal growth of N. tangutorum responses to the microenvironmental heterogeneity that results from aspect of the nebkha.	[Li, Qinghe; Li, Huiqing; Wang, Saixiao; Yan, Xiu; Jiang, Zeping; Wang, Linlong] Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat, State Forestry Adm, Beijing, Peoples R China; [Xu, Jun; Xin, Zhiming] Chinese Acad Forestry, Expt Ctr Desert Forestry, Dengkou, Inner Mongolia, Peoples R China; [Jia, Zhiqing] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Experimental Center of Desert Forestry, CAF; Chinese Academy of Forestry; Institute of Desertification Studies, CAF	Jiang, ZP (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat, State Forestry Adm, Beijing, Peoples R China.	jiangzp@caf.ac.cn; jiazq@caf.ac.cn		Li, Qinghe/0000-0001-8011-1322	Key Project of Research Institute of Forestry, Chinese Academy of Forestry [ZD200915]; National Promotion Program of Forestry Sci. & Tech Achievements [[2011]28]	Key Project of Research Institute of Forestry, Chinese Academy of Forestry; National Promotion Program of Forestry Sci. & Tech Achievements	This work was supported by the grants from the Key Project of Research Institute of Forestry, Chinese Academy of Forestry(ZD200915), the National Promotion Program of Forestry Sci. & Tech Achievements ([2011]28), which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizaga S, 2002, AM J BOT, V89, P632, DOI 10.3732/ajb.89.4.632; Bach CE, 2000, AUST J BOT, V48, P159, DOI 10.1071/BT98030; Bauer BO, 2012, EARTH SURF PROC LAND, V37, P1661, DOI 10.1002/esp.3306; Bredmose N, 2001, ACTA HORTIC, P177, DOI 10.17660/ActaHortic.2001.547.21; BRISKE DD, 1980, J RANGE MANAGE, V33, P323, DOI 10.2307/3897875; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; D'Ulisse A., 1996, J COAST CONSERV, V2, P3, DOI [10.1007/BF02743032, DOI 10.1007/BF02743032]; Dech JP, 2006, ANN BOT-LONDON, V98, P1095, DOI 10.1093/aob/mcl196; Deng ZM, 2013, AQUAT BOT, V104, P121, DOI 10.1016/j.aquabot.2012.08.004; Dong BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013631; Dong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021012; Dougill AJ, 2002, J ARID ENVIRON, V50, P413, DOI 10.1006/jare.2001.0909; Du JH, 2010, J GEOGR SCI, V20, P712, DOI 10.1007/s11442-010-0806-5; El-Bana MI, 2007, J VEG SCI, V18, P635, DOI 10.1111/j.1654-1103.2007.tb02577.x; El-Bana MI, 2003, RESTOR ECOL, V11, P317, DOI 10.1046/j.1526-100X.2003.00222.x; El-Bana MI, 2002, PLANT SOIL, V247, P283, DOI 10.1023/A:1021548711206; El-Sheikh MA, 2010, FLORA, V205, P832, DOI 10.1016/j.flora.2010.01.002; ELDRED RA, 1982, CAN J BOT, V60, P1371, DOI 10.1139/b82-174; Flores-Torres A, 2012, J ARID ENVIRON, V84, P63, DOI 10.1016/j.jaridenv.2012.04.006; Fratini G, 2009, EARTH SURF PROC LAND, V34, P1743, DOI 10.1002/esp.1857; Garwood EA, 1968, GRASS FORAGE SCI, V23, P117; HARA T, 1993, J ECOL, V81, P47, DOI 10.2307/2261223; Hara T, 1997, RES POPUL ECOL, V39, P83, DOI 10.1007/BF02765253; Hartmann H.T., 2010, PLANT PROPAGATION PR; Husen A, 2007, NEW FOREST, V34, P223, DOI 10.1007/s11056-007-9050-y; Klimesova J, 2003, OIKOS, V103, P225, DOI 10.1034/j.1600-0706.2003.12725.x; Klimesova J, 2008, PRESLIA, V80, P255; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; KRATZKE MG, 1992, AM POTATO J, V69, P561, DOI 10.1007/BF02852128; Liu LY, 2005, GEOMORPHOLOGY, V67, P283, DOI 10.1016/j.geomorph.2004.10.005; Liu YX, 1987, FLORA DESERTIS REIPU, V2; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Maun MA, 1996, ECOSCIENCE, V3, P93, DOI 10.1080/11956860.1996.11682320; MAUN MA, 1994, VEGETATIO, V111, P59; Moreira DR, 1998, PESQUI AGROPECU BRAS, V33, P721; MORENOCASASOLA P, 1986, VEGETATIO, V65, P67, DOI 10.1007/BF00044876; Nicholls AM, 2011, INT J PLANT SCI, V172, P1077, DOI 10.1086/662128; Nield JM, 2008, EARTH SURF PROC LAND, V33, P724, DOI 10.1002/esp.1571; Owen NW, 2004, J VEG SCI, V15, P669, DOI 10.1111/j.1654-1103.2004.tb02309.x; Paolillo DJ, 2002, AM J BOT, V89, P1361, DOI 10.3732/ajb.89.9.1361; Shi L, 2004, ANN BOT-LONDON, V94, P553, DOI 10.1093/aob/mch174; SLADE AJ, 1987, NEW PHYTOL, V106, P759, DOI 10.1111/j.1469-8137.1987.tb00177.x; Stribling JM, 2006, MAR ECOL PROG SER, V320, P121, DOI 10.3354/meps320121; TENGBERG A, 1995, J ARID ENVIRON, V30, P265, DOI 10.1016/S0140-1963(05)80002-3; Thomas AD, 2001, SOIL EROSION RESEARCH FOR THE 21ST CENTURY, PROCEEDINGS, P490; Wang JC, 2011, J ARID LAND, V3, P34, DOI 10.3724/SP.J.1227.2011.00034; Wang X, 2006, J ARID ENVIRON, V65, P129, DOI 10.1016/j.jaridenv.2005.06.030; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; YU FH, 2001, EVOL ECOL, V15, P303; Zhang JH, 1996, ANN BOT-LONDON, V78, P591, DOI 10.1006/anbo.1996.0165; Zhang YF, 2013, J EARTH SYST SCI, V122, P831, DOI 10.1007/s12040-013-0308-9	53	11	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79927	10.1371/journal.pone.0079927	http://dx.doi.org/10.1371/journal.pone.0079927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205391	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700105
J	Anea, CB; Zhang, MX; Chen, F; Ali, MI; Hart, CMM; Stepp, DW; Kovalenkov, YO; Merloiu, AM; Pati, P; Fulton, D; Rudic, RD				Anea, Ciprian B.; Zhang, Maoxiang; Chen, Feng; Ali, M. Irfan; Hart, C. Michael M.; Stepp, David W.; Kovalenkov, Yevgeniy O.; Merloiu, Ana-Maria; Pati, Paramita; Fulton, David; Rudic, R. Daniel			Circadian Clock Control of Nox4 and Reactive Oxygen Species in the Vasculature	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; OXIDATIVE STRESS; NAD(P)H OXIDASE; NADPH OXIDASES; BLOOD-PRESSURE; DYSFUNCTION; SUPEROXIDE; METABOLISM; ACTIVATION	Recent studies have shown that circadian clock disruption is associated with pathological remodeling in the arterial structure and vascular stiffness. Moreover, chronic circadian disruption is associated with dysfunction in endothelial responses and signaling. Reactive oxygen species have emerged as key regulators in vascular pathology. Previously, we have demonstrated that circadian clock dysfunction exacerbates superoxide production through eNOS uncoupling. To date, the impact of circadian clock mutation on vascular NADPH oxidase expression and function is not known. The goal in the current study was to determine if the circadian clock controls vascular Nox4 expression and hydrogen peroxide formation in arteries, particularly in endothelial and vascular smooth muscle cells. In aorta, there was an increase in hydrogen peroxide and Nox4 expression in mice with a dysfunctional circadian rhythm (Bmal1-KO mice). In addition, the Nox4 gene promoter is activated by the core circadian transcription factors. Lastly, in synchronized cultured human endothelial cells, Nox4 gene expression exhibited rhythmic oscillations. These data reveal that the circadian clock plays an important role in the control of Nox4 and disruption of the clock leads to subsequent production of reaction oxygen species.	[Anea, Ciprian B.; Zhang, Maoxiang; Merloiu, Ana-Maria; Pati, Paramita; Rudic, R. Daniel] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30904 USA; [Chen, Feng; Ali, M. Irfan; Stepp, David W.; Kovalenkov, Yevgeniy O.; Fulton, David] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA; [Stepp, David W.] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Hart, C. Michael M.] Atlanta Vet Affairs, Dept Med, Atlanta, GA USA; [Hart, C. Michael M.] Emory Univ, Med Ctr, Atlanta, GA 30322 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Emory University	Rudic, RD (corresponding author), Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30904 USA.	rrudic@gru.edu	Chen, Feng/E-1133-2011; Zhang, Maoxiang/G-1079-2015; Rudic, Dan/B-3432-2016	Zhang, Maoxiang/0000-0003-2790-0431; Rudic, Dan/0000-0001-9122-3127; Kovalenkov, Yevgeniy/0000-0003-2396-7962	National Institutes of Health [HL089576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101902, R01HL092446, R01HL089576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the National Institutes of Health (HL089576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anea CB, 2012, CIRC RES, V111, P1157, DOI 10.1161/CIRCRESAHA.111.261750; Anea CB, 2010, ARTERIOSCL THROM VAS, V30, P2535, DOI 10.1161/ATVBAHA.110.214379; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Chabrashvili T, 2003, AM J PHYSIOL-REG I, V285, pR117, DOI 10.1152/ajpregu.00476.2002; Chatham JC, 2013, J MOL CELL CARDIOL, V55, P139, DOI 10.1016/j.yjmcc.2012.06.016; Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412; Cheng B, 2011, P NATL ACAD SCI USA, V108, P17147, DOI 10.1073/pnas.1112998108; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Durgan DJ, 2010, CIRCULATION, V122; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hwang JN, 2005, AM J PHYSIOL-CELL PH, V288, pC899, DOI 10.1152/ajpcell.00474.2004; Koinuma S, 2009, FEBS LETT, V583, P413, DOI 10.1016/j.febslet.2008.12.035; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Morris CJ, 2012, PROG BRAIN RES, V199, P337, DOI 10.1016/B978-0-444-59427-3.00019-8; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Nonaka H, 2001, CIRCULATION, V104, P1746, DOI 10.1161/hc4001.098048; Oishi K, 2009, J MOL CELL CARDIOL, V46, P545, DOI 10.1016/j.yjmcc.2009.01.001; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Richards J, 2013, AM J PHYSIOL-REG I, V304, pR1053, DOI 10.1152/ajpregu.00066.2013; Rudic RD, 2009, CIRCULATION, V120, P1714, DOI 10.1161/CIRCULATIONAHA.109.853002; Rudic RD, 2005, METHOD ENZYMOL, V393, P524, DOI 10.1016/S0076-6879(05)93027-9; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Schroder EA, 2013, AM J PHYSIOL-CELL PH, V304, pC954, DOI 10.1152/ajpcell.00383.2012; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Su W, 2012, AM J PHYSIOL-HEART C, V302, pH621, DOI 10.1152/ajpheart.00825.2011; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Touyz RM, 2002, CIRC RES, V90, P1205, DOI 10.1161/01.RES.0000020404.01971.2F; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107	54	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78626	10.1371/journal.pone.0078626	http://dx.doi.org/10.1371/journal.pone.0078626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205282	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400091
J	Borlongan, CV; Burns, J; Tajiri, N; Stahl, CE; Weinbren, NL; Shojo, H; Sanberg, PR; Emerich, DF; Kaneko, Y; van Loveren, HR				Borlongan, Cesar V.; Burns, Jack; Tajiri, Naoki; Stahl, Christine E.; Weinbren, Nathan L.; Shojo, Hideki; Sanberg, Paul R.; Emerich, Dwaine F.; Kaneko, Yuji; van Loveren, Harry R.			Epidemiological Survey-Based Formulae to Approximate Incidence and Prevalence of Neurological Disorders in the United States: a Meta-Analysis	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; HUNTINGTONS-DISEASE; POPULATION; DURATION; DEMENTIA; COUNTY; AGE	Background: This study aims to create a convenient reference for both clinicians and researchers so that vis-a-vis comparisons between brain disorders can be made quickly and accurately. We report here the incidence and prevalence of the major adult-onset brain disorders in the United States using a meta-analysis approach. Material and Methods: Epidemiological figures were collected from the most recent, reliable data available in the research literature. Population statistics were based on the most recent census from the US Census Bureau. Extrapolations were made only when necessary. The most current epidemiological studies for each disorder were chosen. All effort was made to use studies based on national cohorts. Studies reviewed were conducted between 1950 and 2009. The data of the leading studies for several neurological studies was compiled in order to obtain the most accurate extrapolations. Results were compared to commonly accepted values in order to evaluate validity. Results: It was found that 6.75% of the American adult population is afflicted with brain disorders. This number was eclipsed by the 8.02% of Floridians with brain disorders, which is due to the large aged population residing in the state. Conclusions: There was a noticeable lack of epidemiological data concerning adult-onset brain disorders. Since approximately 1 out of every 7 households is affected by brain disorders, increased research into this arena is warranted.	[Borlongan, Cesar V.; Burns, Jack; Tajiri, Naoki; Stahl, Christine E.; Weinbren, Nathan L.; Shojo, Hideki; Sanberg, Paul R.; Emerich, Dwaine F.; Kaneko, Yuji; van Loveren, Harry R.] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Tajiri, Naoki/K-1230-2012; Kaneko, Yuji/J-6447-2012	Borlongan, Cesar/0000-0002-2966-9782; Tajiri, Naoki/0000-0003-2189-662X; Sanberg, Paul/0000-0001-9130-4592	University of South Florida Department of Neurosurgery and Brain Repair; James and Esther King Biomedical Research Foundation [1KG01-33966]; NIH [5U01NS055914-04, 1R01NS071956-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS055914, R01NS071956] Funding Source: NIH RePORTER	University of South Florida Department of Neurosurgery and Brain Repair; James and Esther King Biomedical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was through the University of South Florida Department of Neurosurgery and Brain Repair funds. CVB is funded by the James and Esther King Biomedical Research Foundation 1KG01-33966, NIH 5U01NS055914-04 and NIH 1R01NS071956-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEGERS JF, 1991, ARCH NEUROL-CHICAGO, V48, P589, DOI 10.1001/archneur.1991.00530180041015; Brain Central Tumor Registry of the United States, 2009, CENTR BRAIN TUM REG; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Centers for Disease Control (CDC), 2008, MMWR-MORBID MORTAL W, V56, P469; Cronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f; Day J. C., 1996, CURRENT POPULATION R; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; EISEN A, 1993, MUSCLE NERVE, V16, P27, DOI 10.1002/mus.880160107; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN SE, 1987, AM J HUM GENET, V41, P168; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hebert LE, 2004, NEUROLOGY, V62, P1645, DOI 10.1212/01.WNL.0000123018.01306.10; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; KOKMEN E, 1994, ARCH NEUROL-CHICAGO, V51, P696, DOI 10.1001/archneur.1994.00540190076018; KURLAND L T, 1958, J Chronic Dis, V8, P378, DOI 10.1016/0021-9681(58)90002-X; Kurtzke JF, 1983, CLIN NEUROLOGY, V3, P1; Lobo A, 2000, NEUROLOGY, V54, pS4; Myrianthopoulos N., 1973, ADV NEUROL, V1, P150; PEARSON JS, 1955, P STAFF M MAYO CLIN, V30, P349; Population Estimates Program, 2009, SCEST200801 US CENS; Population Estimates Program, 2009, NSTEST200901 US CENS; Population Estimates Program, 2009, NCEST200902 US CENS; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U.S. Census Bureau Population Division, 2009, STAT COUNT QUICKFACT; Williams G R, 2001, BMC Neurol, V1, P2, DOI 10.1186/1471-2377-1-2; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	29	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78490	10.1371/journal.pone.0078490	http://dx.doi.org/10.1371/journal.pone.0078490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205243	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300063
J	Heilbronn, LK; Campbell, LV; Xu, AM; Samocha-Bonet, D				Heilbronn, Leonie K.; Campbell, Lesley V.; Xu, Aimin; Samocha-Bonet, Dorit			Metabolically Protective Cytokines Adiponectin and Fibroblast Growth Factor-21 Are Increased by Acute Overfeeding in Healthy Humans	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ADIPOSE-TISSUE MACROPHAGES; INSULIN-RESISTANCE; FATTY LIVER; CIRCADIAN-RHYTHM; FGF21 LEVELS; WEIGHT-LOSS; PPAR-ALPHA; A-FABP; LIPOCALIN-2	Context: Circulating levels of metabolically protective and adverse cytokines are altered in obese humans and rodent models. However, it is not clear whether these cytokines are altered rapidly in response to over-nutrition, or as a later consequence of the obese state. Methods: Forty sedentary healthy individuals were examined prior to and at 3 and 28 days of high fat overfeeding (+1250 kCal/day, 45% fat). Insulin sensitivity (hyperinsulinaemic-euglycaemic clamp), adiposity, serum levels of adiponectin and fibroblast growth factor-21 (FGF21), fatty acid binding protein-4 (FABP4), lipocalin-2 and plasminogen activator factor-1 (PAI1) were assessed. Statistics were performed by repeated measures ANOVA. Results: Overfeeding increased weight, body fat and liver fat, fasting glucose, insulin and reduced insulin sensitivity by clamp (all P <0.05). Metabolically protective cytokines, adiponectin and FGF21 were increased at day 3 of overfeeding (P <= 0.001) and adiponectin was also elevated at day 28 (P=0.001). FABP4, lipocalin-2 and PAI-1 were not changed by overfeeding at either time point. Conclusion: Metabolically protective cytokines, adiponectin and FGF-21, were increased by over nutrition and weight gain in healthy humans, despite increases in insulin resistance. We speculate that this was in attempt to maintain glucose homeostasis in a state of nutritional excess. PAI-I, FABP4 and lipocalin 2 were not altered by overfeeding suggesting that changes in these cytokines may be a later consequence of the obese state.	[Heilbronn, Leonie K.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Heilbronn, Leonie K.] Univ Adelaide, Res Ctr Reprod Hlth, Adelaide, SA, Australia; [Campbell, Lesley V.; Samocha-Bonet, Dorit] Garvan Inst Med Res, Sydney, NSW, Australia; [Campbell, Lesley V.; Samocha-Bonet, Dorit] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Ageing, Hong Kong, Hong Kong, Peoples R China	University of Adelaide; University of Adelaide; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Hong Kong; University of Hong Kong	Heilbronn, LK (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.	leonie.heilbronn@adelaide.edu.au	Heilbronn, Leonie/H-1874-2013	Heilbronn, Leonie/0000-0003-2106-7303; Samocha-Bonet, Dorit/0000-0001-9422-7852	National Health & Medical Research Council of Australia (NHMRC) [427639]; Future Fellowship, Australian Research Council [FT120100027]; Australian Diabetes Society Fellowship; Sachdev Foundation of the Garvan Institute Foundation; Hong Kong Research Council Collaborative Research Fund [HKU4/CRF/10R]	National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Future Fellowship, Australian Research Council(Australian Research Council); Australian Diabetes Society Fellowship; Sachdev Foundation of the Garvan Institute Foundation; Hong Kong Research Council Collaborative Research Fund	This study was funded by grants from the National Health & Medical Research Council of Australia (NHMRC #427639). LKH is funded by a Future Fellowship, Australian Research Council (FT120100027), DS-B by an Australian Diabetes Society Fellowship and the Sachdev Foundation of the Garvan Institute Foundation, and AX by Hong Kong Research Council Collaborative Research Fund (HKU4/CRF/10R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68; Andersen B, 2011, CLIN ENDOCRINOL, V75, P514, DOI 10.1111/j.1365-2265.2011.04084.x; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Choi KM, 2009, CLIN ENDOCRINOL, V70, P569, DOI 10.1111/j.1365-2265.2008.03374.x; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Habegger KM, 2013, DIABETES, V62, P1453, DOI 10.2337/db12-1116; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hickman IJ, 2012, CURR MED CHEM, V19, P5427; Jun LS, 2011, AM J PHYSIOL-ENDOC M, V301, pE825, DOI 10.1152/ajpendo.00147.2011; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Koiou E, 2012, GYNECOL ENDOCRINOL, V28, P20, DOI 10.3109/09513590.2011.588745; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Li HT, 2013, J HEPATOL, V58, P557, DOI 10.1016/j.jhep.2012.10.029; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mai K, 2011, METABOLISM, V60, P306, DOI 10.1016/j.metabol.2010.02.016; Mai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE126, DOI 10.1152/ajpendo.00020.2010; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Ong KL, 2012, J CLIN ENDOCR METAB, V97, P4701, DOI 10.1210/jc.2012-2267; OPPERT JM, 1995, METABOLISM, V44, P96, DOI 10.1016/0026-0495(95)90295-3; Pasarica M, 2009, OBESITY, V17, P1976, DOI 10.1038/oby.2009.219; Peake PW, 2003, INT J OBESITY, V27, P657, DOI 10.1038/sj.ijo.0802289; Samocha-Bonet D, 2010, DIABETOLOGIA, V53, P1700, DOI 10.1007/s00125-010-1768-y; Samocha-Bonet D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036320; Schneider DJ, 2012, DIABETES CARE, V35, P1961, DOI 10.2337/dc12-0638; Tam CS, 2010, DIABETES, V59, P2164, DOI 10.2337/db10-0162; Uebanso T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022976; Vienberg SG, 2012, EUR J ENDOCRINOL, V167, P49, DOI 10.1530/EJE-12-0039; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Xiao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066607, 10.1371/journal.pone.0071435]; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yoon MY, 2012, CLIN MOL HEPATOL, V18, P279, DOI 10.3350/cmh.2012.18.3.279; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	43	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78864	10.1371/journal.pone.0078864	http://dx.doi.org/10.1371/journal.pone.0078864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205333	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300165
J	Nishino, T; Yachie-Kinoshita, A; Hirayama, A; Soga, T; Suematsu, M; Tomita, M				Nishino, Taiko; Yachie-Kinoshita, Ayako; Hirayama, Akiyoshi; Soga, Tomoyoshi; Suematsu, Makoto; Tomita, Masaru			Dynamic Simulation and Metabolome Analysis of Long-Term Erythrocyte Storage in Adenine-Guanosine Solution	PLOS ONE			English	Article							RED-BLOOD-CELLS; ADENOSINE-TRIPHOSPHATE LEVELS; IONIZATION MASS-SPECTROMETRY; OXIDATIVE STRESS; ACID; MODEL; 2,3-BISPHOSPHOGLYCERATE; 2,3-DIPHOSPHOGLYCERATE; PRESERVATION; MAINTENANCE	Although intraerythrocytic ATP and 2,3-bisphophoglycerate (2,3-BPG) are known as direct indicators of the viability of preserved red blood cells and the efficiency of post-transfusion oxygen delivery, no current blood storage method in practical use has succeeded in maintaining both these metabolites at high levels for long periods. In this study, we constructed a mathematical kinetic model of comprehensive metabolism in red blood cells stored in a recently developed blood storage solution containing adenine and guanosine, which can maintain both ATP and 2,3-BPG. The predicted dynamics of metabolic intermediates in glycolysis, the pentose phosphate pathway, and purine salvage pathway were consistent with time-series metabolome data measured with capillary electrophoresis time-of-flight mass spectrometry over 5 weeks of storage. From the analysis of the simulation model, the metabolic roles and fates of the 2 major additives were illustrated: (1) adenine could enlarge the adenylate pool, which maintains constant ATP levels throughout the storage period and leads to production of metabolic waste, including hypoxanthine; (2) adenine also induces the consumption of ribose phosphates, which results in 2,3-BPG reduction, while (3) guanosine is converted to ribose phosphates, which can boost the activity of upper glycolysis and result in the efficient production of ATP and 2,3-BPG. This is the first attempt to clarify the underlying metabolic mechanism for maintaining levels of both ATP and 2,3-BPG in stored red blood cells with in silico analysis, as well as to analyze the trade-off and the interlock phenomena between the benefits and possible side effects of the storage-solution additives.	[Nishino, Taiko; Yachie-Kinoshita, Ayako; Hirayama, Akiyoshi; Soga, Tomoyoshi; Suematsu, Makoto; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Nishino, Taiko; Tomita, Masaru] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Yachie-Kinoshita, Ayako] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Yachie-Kinoshita, Ayako; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo, Japan; [Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan	Keio University; Keio University; University of Toronto; Keio University; Keio University	Yachie-Kinoshita, A (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	ayako.yachie.kinoshita@utoronto.ca	Suematsu, Makoto/I-8135-2013; Soga, Tomoyoshi/B-8105-2014; Suematsu, Makoto/O-5762-2018	Suematsu, Makoto/0000-0002-7165-6336; Soga, Tomoyoshi/0000-0001-9502-2509; Suematsu, Makoto/0000-0002-7165-6336; Yachie, Ayako/0000-0003-2032-227X	Yamagata prefecture Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; Japan Society for the Promotion of Science (JSPS); Uehara foundation	Yamagata prefecture Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara foundation(Uehara Memorial Foundation)	This study is funded by a grant from Yamagata prefecture Japan; Next-Generation Supercomputer Project of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; and "Global-COE Program for Human Metabolomic Systems Biology," of Japan Society for the Promotion of Science (JSPS). TN is supported by Grant-in-Aid for Young Scientists of Japan Society for the Promotion of Science (JSPS). TN and AYK were supported by "Global-COE Program for Human Metabolomic Systems Biology" of Japan Society for the Promotion of Science (JSPS). AYK is supported by Uehara foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2010, J CELL PHYSIOL, V224, P620, DOI 10.1002/jcp.22195; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Burger P, 2010, TRANSFUSION, V50, P2386, DOI 10.1111/j.1537-2995.2010.02700.x; D'Amici GM, 2007, J PROTEOME RES, V6, P3242, DOI 10.1021/pr070179d; D'Amici GM, 2012, BLOOD TRANSFUS-ITALY, V10, pS46, DOI 10.2450/2012.008S; de Korte D, 2008, TRANSFUSION, V48, P1081, DOI 10.1111/j.1537-2995.2008.01689.x; DERN RJ, 1967, J LAB CLIN MED, V69, P968; Fedosov DA, 2011, P NATL ACAD SCI USA, V108, P11772, DOI 10.1073/pnas.1101210108; Fedosov DA, 2010, BIOPHYS J, V98, P2215, DOI 10.1016/j.bpj.2010.02.002; Gevi F, 2012, J PROTEOMICS, V76, P168, DOI 10.1016/j.jprot.2012.03.012; Glicher RO, 2009, ROSSIS PRINCIPLES TR, V4th, P624; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; GUPPY M, 1992, VOX SANG, V62, P70, DOI 10.1111/j.1423-0410.1992.tb01173.x; Hess JR, 2010, TRANSFUS APHER SCI, V43, P51, DOI 10.1016/j.transci.2010.05.009; Hogman CF, 2006, TRANSFUSION, V46, P137, DOI 10.1111/j.1537-2995.2006.00681.x; Hogman CF, 2006, TRANSFUSION, V46, P1543, DOI 10.1111/j.1537-2995.2006.00893.x; Kinoshita A, 2007, J BIOL CHEM, V282, P10731, DOI 10.1074/jbc.M610717200; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Lichtman MA., 2006, WILLIAMS HEMATOLOGY, V7th, P1183; Lion N, 2010, J PROTEOMICS, V73, P374, DOI 10.1016/j.jprot.2009.11.001; MERYMAN HT, 1991, VOX SANG, V60, P99, DOI 10.1111/j.1423-0410.1991.tb00881.x; Mulquiney PJ, 1999, BIOCHEM J, V342, P567, DOI 10.1042/0264-6021:3420567; Nishino T, 2009, J BIOTECHNOL, V144, P212, DOI 10.1016/j.jbiotec.2009.08.010; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Stoychev G, 2002, EUR J BIOCHEM, V269, P4048, DOI 10.1046/j.1432-1033.2002.03097.x; Suematsu M, 2002, MICROCIRCULATION, V9, P259, DOI 10.1038/sj.mn.7800141; SUGITA Y, 1965, J CLIN INVEST, V44, P629, DOI 10.1172/JCI105176; Takahashi K, 2004, BIOINFORMATICS, V20, P538, DOI 10.1093/bioinformatics/btg442; Takahashi K, 2005, FEBS LETT, V579; Wolf MB, 2011, J APPL PHYSIOL, V110, P988, DOI 10.1152/japplphysiol.00514.2010	32	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71060	10.1371/journal.pone.0071060	http://dx.doi.org/10.1371/journal.pone.0071060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	24205395	gold, Green Published, Green Submitted			2022-12-27	WOS:000323570200021
J	DeBerge, MP; Ely, KH; Cheng, GS; Enelow, RI				DeBerge, Matthew P.; Ely, Kenneth H.; Cheng, Guang-Shing; Enelow, Richard I.			ADAM17-Mediated Processing of TNF-alpha Expressed by Antiviral Effector CD8(+) T Cells Is Required for Severe T-Cell-Mediated Lung Injury	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INFLUENZA-VIRUS INFECTION; INFLAMMATORY RESPONSE; CONVERTING-ENZYME; VIRAL CLEARANCE; INNATE IMMUNE; CUTTING EDGE; IN-VIVO; MICE; IMMUNOPATHOLOGY	Influenza infection in humans evokes a potent CD8(+) T-cell response, which is important for clearance of the virus but may also exacerbate pulmonary pathology. We have previously shown in mice that CD8(+) T-cell expression of TNF-alpha is required for severe and lethal lung injury following recognition of an influenza antigen expressed by alveolar epithelial cells. Since TNF-alpha is first expressed as a transmembrane protein that is then proteolytically processed to release a soluble form, we sought to characterize the role of TNF-alpha processing in CD8(+) T-cell-mediated injury. In this study we observed that inhibition of ADAM17-mediated processing of TNF-alpha by CD8(+) T cells significantly attenuated the diffuse alveolar damage that occurs after T-cell transfer, resulting in enhanced survival. This was due in part to diminished chemokine expression, as TNF-alpha processing was required for lung epithelial cell expression of CXCL2 and the subsequent inflammatory infiltration. We confirmed the importance of CXCL2 expression in acute lung injury by transferring influenza-specific CD8(+) T cells into transgenic mice lacking CXCR2. These mice exhibited reduced airway infiltration, attenuated lung injury, and enhanced survival. Theses studies describe a critical role for TNF-alpha processing by CD8(+) T cells in the initiation and severity of acute lung injury, which may have important implications for limiting immunopathology during influenza infection and other human infectious or inflammatory diseases.	[DeBerge, Matthew P.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA; [Ely, Kenneth H.; Enelow, Richard I.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Cheng, Guang-Shing] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Enelow, Richard I.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA	Dartmouth College; Dartmouth College; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Dartmouth College	DeBerge, MP (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA.	matthew.deberge@dartmouth.edu			Public Health Service [T32 A107363, T32HL007778, RO1AI 069360, U19AI 083024]; Ira Jerome Brody '44 Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007363, U19AI083024, R01AI069360] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Ira Jerome Brody '44 Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants T32 A107363 (MPD), T32HL007778 (GSC), RO1AI 069360 and U19AI 083024 (RIE). The authors gratefully acknowledge the generous support of the Ira Jerome Brody '44 Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2006, EUR J IMMUNOL, V36, P2768, DOI 10.1002/eji.200635921; Arndt PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019938; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Enelow RI, 1998, J CLIN INVEST, V102, P1653, DOI 10.1172/JCI4174; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Liu AN, 1999, AM J RESP CELL MOL, V20, P849, DOI 10.1165/ajrcmb.20.5.3585; Liu J, 2005, AM J RESP CELL MOL, V33, P463, DOI 10.1165/rcmb.2005-0204OC; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mueller C, 1999, J BIOL CHEM, V274, P38112, DOI 10.1074/jbc.274.53.38112; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; PEPER RL, 1995, MICROB PATHOGENESIS, V19, P175, DOI 10.1006/mpat.1995.0056; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ramana CV, 2006, J INTERF CYTOK RES, V26, P318, DOI 10.1089/jir.2006.26.318; Ramana CV, 2009, MOL IMMUNOL, V47, P623, DOI 10.1016/j.molimm.2009.09.001; Slifman NR, 2003, ARTHRITIS RHEUM, V48, P319, DOI 10.1002/art.10758; Small BA, 2001, J EXP MED, V194, P1835, DOI 10.1084/jem.194.12.1835; Small CL, 2010, J IMMUNOL, V184, P2048, DOI 10.4049/jimmunol.0902772; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Trifilieff A, 2002, BRIT J PHARMACOL, V135, P1655, DOI 10.1038/sj.bjp.0704616; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Wareing MD, 2007, VIRAL IMMUNOL, V20, P369, DOI 10.1089/vim.2006.0101; WELLS MA, 1981, J IMMUNOL, V126, P1036; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872; Zhao MQ, 2000, J CLIN INVEST, V106, pR49, DOI 10.1172/JCI9786; Zhou J, 2008, J IMMUNOL, V180, P25, DOI 10.4049/jimmunol.180.1.25	39	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79340	10.1371/journal.pone.0079340	http://dx.doi.org/10.1371/journal.pone.0079340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223177	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200069
J	Hu, JZ; Nomura, Y; Bashir, A; Fernandez-Hernandez, H; Itzkowitz, S; Pei, ZH; Stone, J; Loudon, H; Peter, I				Hu, Jianzhong; Nomura, Yoko; Bashir, Ali; Fernandez-Hernandez, Heriberto; Itzkowitz, Steven; Pei, Zhiheng; Stone, Joanne; Loudon, Holly; Peter, Inga			Diversified Microbiota of Meconium Is Affected by Maternal Diabetes Status	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; TOLERANCE TEST VALUE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; AMNIOTIC-FLUID; PRETERM LABOR; PREGNANCY; INFANTS; NEWBORNS; BACTERIA	Objectives: This study was aimed to assess the diversity of the meconium microbiome and determine if the bacterial community is affected by maternal diabetes status. Methods: The first intestinal discharge (meconium) was collected from 23 newborns stratified by maternal diabetes status: 4 mothers had pre-gestational type 2 diabetes mellitus (DM) including one mother with dizygotic twins, 5 developed gestational diabetes mellitus (GDM) and 13 had no diabetes. The meconium microbiome was profiled using multi-barcode 16S rRNA sequencing followed by taxonomic assignment and diversity analysis. Results: All meconium samples were not sterile and contained diversified microbiota. Compared with adult feces, the meconium showed a lower species diversity, higher sample-to-sample variation, and enrichment of Proteobacteria and reduction of Bacteroidetes. Among the meconium samples, the taxonomy analyses suggested that the overall bacterial content significantly differed by maternal diabetes status, with the microbiome of the DM group showing higher alpha-diversity than that of no-diabetes or GDM groups. No global difference was found between babies delivered vaginally versus via Cesarean-section. Regression analysis showed that the most robust predictor for the meconium microbiota composition was the maternal diabetes status that preceded pregnancy. Specifically, Bacteroidetes (phyla) and Parabacteriodes (genus) were enriched in the meconium in the DM group compared to the no-diabetes group. Conclusions: Our study provides evidence that meconium contains diversified microbiota and is not affected by the mode of delivery. It also suggests that the meconium microbiome of infants born to mothers with DM is enriched for the same bacterial taxa as those reported in the fecal microbiome of adult DM patients.	[Hu, Jianzhong; Bashir, Ali; Fernandez-Hernandez, Heriberto; Peter, Inga] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Nomura, Yoko] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Nomura, Yoko] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Itzkowitz, Steven] Icahn Sch Med Mt Sinai, Dept Med, Div Gastroenterol, New York, NY USA; [Pei, Zhiheng] Dept Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Pei, Zhiheng] NYU, Sch Med, NYU Langone Med Ctr, Dept Pathol, New York, NY USA; [Stone, Joanne; Loudon, Holly] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai	Hu, JZ (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA.	jianzhong.hu@mssm.edu	Hu, Jianzhong/ABE-4311-2020; Hu, Jianzhong/P-6305-2014	Hu, Jianzhong/0000-0001-8546-5111; Hu, Jianzhong/0000-0001-8546-5111; Pei, Zhiheng/0000-0001-8570-6747	CCFA Career Development Award; The Chemotherapy Foundation; National Cancer Institute [UH3CA140233, R01CA159036, R03CA159414]; National Institute of Mental Health [K01MH080062-03]; NATIONAL CANCER INSTITUTE [R01CA159036, R03CA159414, UH3CA140233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK094986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080062] Funding Source: NIH RePORTER	CCFA Career Development Award; The Chemotherapy Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work was supported by a CCFA Career Development Award (JH) and grants from The Chemotherapy Foundation (SI), the National Cancer Institute UH3CA140233, R01CA159036, and R03CA159414 (ZP) and the National Institute of Mental Health K01MH080062-03 (YN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bell R, 2012, DIABETOLOGIA; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Buchanan TA, 1995, PREGNANCY PREEXISTIN, P719; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Guarino A, 2012, J MATERN-FETAL NEO M, V25, P63, DOI 10.3109/14767058.2012.663231; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; LANGER O, 1987, AM J OBSTET GYNECOL, V157, P758, DOI 10.1016/S0002-9378(87)80045-5; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; LINDSAY MK, 1989, OBSTET GYNECOL, V73, P103; Ma YF, 2009, APPL ENVIRON MICROB, V75, P6812, DOI 10.1128/AEM.00933-09; Madan JC, 2012, ARCH DIS CHILD FETAL; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Oh KJ, 2010, J PERINAT MED, V38, P261, DOI [10.1515/JPM.2010.040, 10.1515/jpm.2010.040]; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oksanen J, 2007, MULTIVARIATE ANAL EC; Ornoy Asher, 2005, Pediatr Endocrinol Rev, V3, P104; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Sellitto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033387; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tsuji H, 2012, BENEF MICROBES, V3, P113, DOI 10.3920/BM2011.0038; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Valles Y, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/j.1469-0691.2012.03876.x; Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yap GC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-193	48	142	161	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78257	10.1371/journal.pone.0078257	http://dx.doi.org/10.1371/journal.pone.0078257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223144	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200036
J	Sriyani, KA; Wasalathanthri, S; Hettiarachchi, P; Prathapan, S				Sriyani, Kumarasinghe A.; Wasalathanthri, Sudharshani; Hettiarachchi, Priyadharshika; Prathapan, Shamini			Predictors of Diabetic Foot and Leg Ulcers in a Developing Country with a Rapid Increase in the Prevalence of Diabetes Mellitus	PLOS ONE			English	Article							SEMMES-WEINSTEIN MONOFILAMENT; DIFFERENT SCREENING-TESTS; RISK-FACTORS; PERIPHERAL NEUROPATHY; CARE; ULCERATION; POLYNEUROPATHY; ASSOCIATION; COMMUNITY; PEOPLE	Objective: To identify the socio demographic, life style and foot examination related predictors of diabetic foot and leg ulcers with a view to develop a screening tool appropriate for the use in an outpatient setting. Research design and methods: This cross sectional study included type 2 diabetes mellitus (DM) patients; 88 subjects with leg and foot ulcers and 80 non ulcer controls. Socio demographic data and life style factors were documented. Foot was examined for skin changes and structural abnormalities. Distal peripheral neuropathy was assessed by pressure sense, vibration sense and joint position sense. Multivariate analysis by logistic regression was used to determine the significant predictors in screening for foot ulcers. Results: Education of grade 6 and below (OR - 1.41, 95% CI; 1.03 - 4.68), low income (OR -23.3, 95% CI; 1.5 - 34.0), impaired vibration sense (OR - 24.79, 95% CI; 9.3 - 66.2), abnormal monofilament test on first (OR - 1.69, 95% CI; 1.36 - 16.6), third (OR - 3.4, 95% CI; 1.1 - 10.6) and fifth (OR - 1.8, 95% CI; 1.61-12.6) toes are found to be predictors of increased risk whereas incidental diagnosis of DM (OR - 0.03, 95% CI; 0.003 - 0.28), wearing covered shoes (OR - 0.003, 95% CI; 0.00 - 0.28), presence of normal skin color (OR - 0.01, 95% CI; 0.001 - 0.14) and normal monofilament test on first metatarsal head (OR - 0.10, 95% CI; 0.00 - 0.67) are protective factors for ulcers. Conclusions: Ten independent risk and protective factors identified in this study are proposed as a simple screening tool to predict the risk of developing leg and foot ulcers in patients with DM.	[Sriyani, Kumarasinghe A.] Open Univ Sri Lanka, Dept Hlth Sci, Nawala, Sri Lanka; [Wasalathanthri, Sudharshani] Univ Colombo, Dept Physiol, Colombo, Sri Lanka; [Hettiarachchi, Priyadharshika] Univ Sri Jayewardenepura, Dept Physiol, Nugegoda, Sri Lanka; [Prathapan, Shamini] Univ Sri Jayewardenepura, Dept Community Med, Nugegoda, Sri Lanka	Open University Sri Lanka; University of Colombo; University Sri Jayewardenepura; University Sri Jayewardenepura	Wasalathanthri, S (corresponding author), Univ Colombo, Dept Physiol, Colombo, Sri Lanka.	sudharshaniw@gmail.com			University of Sri Jayewardenepura [ASP/06/RE/MED/2012/35]	University of Sri Jayewardenepura	The study was funded by the University of Sri Jayewardenepura - Grant number ASP/06/RE/MED/2012/35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x; Al-Geffari M, 2012, INT J HEALTH SCI-IJH, V6, P127, DOI 10.12816/0005988; Al-Maskari F, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-59; ALGEFFARI M, 2012, INT J HLTH SCI, V609, P109; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Asad Ambreen, 2009, JPMA Journal of the Pakistan Medical Association, V59, P594; Booya F, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-24; Boulton AJ, 2005, DIABETES VOICE, V50, P5; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; Chalya Phillipo L, 2011, BMC Res Notes, V4, P365, DOI 10.1186/1756-0500-4-365; Dutta A, 2005, INT J DIABETES DEV C, V25, P30, DOI [10.4103/0973-3930.26756, DOI 10.4103/0973-3930.26756]; Fernando D. J. S., 1996, Ceylon Medical Journal, V41, P96; Forouzandeh F, 2005, ACTA NEUROL SCAND, V112, P409, DOI 10.1111/j.1600-0404.2005.00494.x; Franse LV, 2000, DIABETIC MED, V17, P105, DOI 10.1046/j.1464-5491.2000.00223.x; Giacomozzi C, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-99; IKEM RT, 2009, MERA DIABETES INT, P15; Illangasekera U, 2004, J R SOC PROMO HEALTH, V124, P92, DOI 10.1177/146642400412400214; Jayasinghe Saroj A, 2007, Rural Remote Health, V7, P692; Katulanda P, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-21; Kerr M., 2012, FOOT CARE PEOPLE DIA; Kiani J, 2013, ARCH IRAN MED, V16, P17, DOI 013161/AIM.006; KUMAR S, 1991, DIABETES RES CLIN PR, V13, P63, DOI 10.1016/0168-8227(91)90034-B; Lee SY, 2003, J KOREAN MED SCI, V18, P103; Margolis DJ, 2011, DATA POINTS PUBLICAT; Mayfield JA, 1998, DIABETES CARE, V21, P2161, DOI 10.2337/diacare.21.12.2161; McGill M, 1999, DIABETES CARE, V22, P598, DOI 10.2337/diacare.22.4.598; Meijer JWG, 2005, DIABETES CARE, V28, P2201, DOI 10.2337/diacare.28.9.2201; Morkrid K, 2010, INT J DIABETES DEV C, V30, P11, DOI 10.4103/0973-3930.60004; Murray HJ, 1996, DIABETIC MED, V13, P979, DOI 10.1002/(SICI)1096-9136(199611)13:11<979::AID-DIA267>3.3.CO;2-1; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; RIAZ M, 2012, DIABETES CARE; Shin JB, 2000, J KOREAN MED SCI, V15, P78, DOI 10.3346/jkms.2000.15.1.78; Tan LS, 2010, DIABETES RES CLIN PR, V90, P1, DOI 10.1016/j.diabres.2010.06.021; Weerasuriya N, 1998, QJM-INT J MED, V91, P439, DOI 10.1093/qjmed/91.6.439; Wijewardene K., 2005, Ceylon Medical Journal, V50, P62; YOUNG MJ, 1994, DIABETES CARE, V17, P557, DOI 10.2337/diacare.17.6.557	39	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80856	10.1371/journal.pone.0080856	http://dx.doi.org/10.1371/journal.pone.0080856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223231	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200124
J	van Tiel, J; Reijman, M; Bos, PK; Hermans, J; van Buul, GM; Bron, EE; Klein, S; Verhaar, JAN; Krestin, GP; Bierma-Zeinstra, SMA; Weinans, H; Kotek, G; Oei, EHG				van Tiel, Jasper; Reijman, Max; Bos, Pieter K.; Hermans, Job; van Buul, Gerben M.; Bron, Esther E.; Klein, Stefan; Verhaar, Jan A. N.; Krestin, Gabriel P.; Bierma-Zeinstra, Sita M. A.; Weinans, Harrie; Kotek, Gyula; Oei, Edwin H. G.			Delayed Gadolinium-Enhanced MRI of Cartilage (dGEMRIC) Shows No Change in Cartilage Structural Composition after Viscosupplementation in Patients with Early-Stage Knee Osteoarthritis	PLOS ONE			English	Article							SODIUM HYALURONATE HYALGAN(R); ARTICULAR-CARTILAGE; METHYLPREDNISOLONE ACETATE; MORPHOLOGICAL ANALYSIS; 3.0 T; PROTEOGLYCAN; ACID; GLYCOSAMINOGLYCAN; DEGENERATION; BIOPSIES	Introduction: Viscosupplementation with hyaluronic acid (HA) of osteoarthritic (OA) knee joints has a well-established positive effect on clinical symptoms. This effect, however, is only temporary and the working mechanism of HA injections is not clear. It was suggested that HA might have disease modifying properties because of its beneficial effect on cartilage sulphated glycosaminoglycan (sGAG) content. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) is a highly reproducible, non-invasive surrogate measure for sGAG content and hence composition of cartilage. The aim of this study was to assess whether improvement in cartilage structural composition is detected using dGEMRIC 14 weeks after 3 weekly injections with HA in patients with early-stage knee OA. Methods: In 20 early-stage knee OA patients (KLG I-II), 3D dGEMRIC at 3T was acquired before and 14 weeks after 3 weekly injections with HA. To evaluate patient symptoms, the knee injury and osteoarthritis outcome score (KOOS) and a numeric rating scale (NRS) for pain were recorded. To evaluate cartilage composition, six cartilage regions in the knee were analyzed on dGEMRIC. Outcomes of dGEMRIC, KOOS and NRS before and after HA were compared using paired t-testing. Since we performed multiple t-tests, we applied a Bonferroni-Holm correction to determine statistical significance for these analyses. Results: All KOOS subscales ('pain', 'symptoms', 'daily activities', 'sports' and 'quality of life') and the NRS pain improved significantly 14 weeks after Viscosupplementation with HA. Outcomes of dGEMRIC did not change significantly after HA compared to baseline in any of the cartilage regions analyzed in the knee. Conclusions: Our results confirm previous findings reported in the literature, showing persisting improvement in symptomatic outcome measures in early-stage knee OA patients 14 weeks after Viscosupplementation. Outcomes of dGEMRIC, however, did not change after Viscosupplementation, indicating no change in cartilage structural composition as an explanation for the improvement of clinical symptoms.	[van Tiel, Jasper; Reijman, Max; Bos, Pieter K.; Hermans, Job; van Buul, Gerben M.; Verhaar, Jan A. N.; Bierma-Zeinstra, Sita M. A.; Weinans, Harrie] Univ Med Ctr, Erasmus MC, Dept Orthoped Surg, Rotterdam, Netherlands; [van Tiel, Jasper; van Buul, Gerben M.; Bron, Esther E.; Klein, Stefan; Krestin, Gabriel P.; Kotek, Gyula; Oei, Edwin H. G.] Univ Med Ctr, Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Bron, Esther E.; Klein, Stefan] Univ Med Ctr, Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Bierma-Zeinstra, Sita M. A.] Univ Med Ctr, Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Weinans, Harrie] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Oei, EHG (corresponding author), Univ Med Ctr, Erasmus MC, Dept Radiol, Rotterdam, Netherlands.	e.oei@erasmusmc.nl	Reijman, Max/AFO-6451-2022; Oei, Edwin HG/E-8174-2013; Bierma-Zeinstra, Sita/AAF-2122-2019; Verhaar, Jan/AAH-1372-2020	Klein, Stefan/0000-0003-4449-6784; Bos, Pieter K/0000-0001-9285-2320; Bron, Esther/0000-0002-5778-9263; Verhaar, Jan/0000-0003-3016-9600; Weinans, Harrie/0000-0002-2275-6170				Balazs E., 1982, DISORDERS KNEE, P61; Bashir A, 1997, RADIOLOGY, V205, P551, DOI 10.1148/radiology.205.2.9356644; Bashir A, 1999, MAGNET RESON MED, V41, P857, DOI 10.1002/(SICI)1522-2594(199905)41:5<857::AID-MRM1>3.0.CO;2-E; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Bron EE, 2013, EUR RADIOL, V23, P246, DOI 10.1007/s00330-012-2590-3; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, pS6, DOI 10.1097/01.blo.0000143938.30681.9d; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; Chan AOO, 2007, JAMA-J AM MED ASSOC, V298, P1412, DOI 10.1001/jama.298.12.1412; Crema MD, 2011, RADIOGRAPHICS, V31, P37, DOI 10.1148/rg.311105084; de Groot IB, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-16; Divine JG, 2007, CLIN ORTHOP RELAT R, P113, DOI 10.1097/BLO.0b013e31802f5421; Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, P974, DOI 10.1016/j.joca.2006.03.005; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Frean SP, 1999, RES VET SCI, V67, P183, DOI 10.1053/rvsc.1999.0328; Frizziero L, 1998, CLIN EXP RHEUMATOL, V16, P441; GHOSH P, 1995, J RHEUMATOL, V22, P155; Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010; GRUSHKO G, 1989, CONNECT TISSUE RES, V19, P149, DOI 10.3109/03008208909043895; Guermazi A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3488; Guidolin DD, 2001, OSTEOARTHR CARTILAGE, V9, P371, DOI 10.1053/joca.2000.0398; Hermans J, 2012, ARTHRIT CARE RES, V64, P853, DOI 10.1002/acr.21617; Hermans J, 2011, SEMIN ARTHRITIS RHEU, V41, P106, DOI 10.1016/j.semarthrit.2011.02.007; HOLM S, 1979, SCAND J STAT, V6, P65; Huang GS, 2010, OSTEOARTHR CARTILAGE, V18, P54, DOI 10.1016/j.joca.2009.08.014; Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P990, DOI 10.1016/j.joca.2011.05.004; Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Jensen MP, 1998, CLIN J PAIN, V14, P343, DOI 10.1097/00002508-199812000-00012; Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kijowski R, 2009, RADIOLOGY, V250, P839, DOI 10.1148/radiol.2503080822; Kikuchi T, 2001, OSTEOARTHR CARTILAGE, V9, P351, DOI 10.1053/joca.2000.0395; Kimelman T, 2006, INVEST RADIOL, V41, P198, DOI 10.1097/01.rli.0000195842.49255.ea; Klein S, 2008, MED PHYS, V35, P1407, DOI 10.1118/1.2842076; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; LARSEN NE, 1992, J ORTHOPAED RES, V10, P23, DOI 10.1002/jor.1100100104; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; MAROUDAS A, 1975, PHILOS T ROY SOC B, V271, P293, DOI 10.1098/rstb.1975.0054; McAlindon TE, 2011, OSTEOARTHR CARTILAGE, V19, P399, DOI 10.1016/j.joca.2011.01.001; McKenzie CA, 2006, J MAGN RESON IMAGING, V24, P928, DOI 10.1002/jmri.20689; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; PRASAD PV, 2012, J MOL IMAG DYNAM APR; RAO CR, 1947, P CAMB PHILOS SOC, V43, P280, DOI 10.1017/S0305004100023471; Roemer FW, 2011, RADIOLOGY, V260, P332, DOI 10.1148/radiol.11101359; Ronchetti IP, 2001, RHEUMATOLOGY, V40, P158, DOI 10.1093/rheumatology/40.2.158; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P17, DOI 10.1186/1477-7525-1-17; Salo EN, 2012, OSTEOARTHR CARTILAGE, V20, P117, DOI 10.1016/j.joca.2011.11.016; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Sijbers J, 1999, INT J IMAG SYST TECH, V10, P109, DOI 10.1002/(SICI)1098-1098(1999)10:2<109::AID-IMA2>3.0.CO;2-R; Sofat N, 2011, RHEUMATOLOGY, V50, P2157, DOI 10.1093/rheumatology/ker283; Stove J, 2002, J ORTHOPAED RES, V20, P551, DOI 10.1016/S0736-0266(01)00141-3; Studler U, 2010, J MAGN RESON IMAGING, V32, P394, DOI 10.1002/jmri.22249; Tiderius C, 2006, OSTEOARTHR CARTILAGE, V14, P1091, DOI 10.1016/j.joca.2006.05.007; Tiderius CJ, 2004, ACTA RADIOL, V45, P628, DOI 10.1080/02841850410008379; Tiderius CJ, 2003, MAGNET RESON MED, V49, P488, DOI 10.1002/mrm.10389; Tiderius CJ, 2001, MAGN RESON MED, V46, P1067, DOI 10.1002/mrm.1300; van Tiel J, 2013, EUR RADIOL, V23, P496, DOI 10.1007/s00330-012-2616-x; VANKAMPEN GP, 1991, T ORTHOP RES SOC, V16; VONDENHOFF JW, 1993, MATRIX, V13, P195, DOI 10.1016/S0934-8832(11)80003-X; Wang YY, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-195; Williams A, 2007, MAGN RESON MED, V58, P830, DOI 10.1002/mrm.21376; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yoshioka M, 1997, OSTEOARTHR CARTILAGE, V5, P251, DOI 10.1016/S1063-4584(97)80021-0; Zhang M, 2013, ARTHROSCOPY, V29, P349, DOI 10.1016/j.arthro.2012.04.138; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	65	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79785	10.1371/journal.pone.0079785	http://dx.doi.org/10.1371/journal.pone.0079785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223194	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200087
J	Yu, F; Du, F; Wang, YZ; Huang, SP; Miao, RD; Major, AS; Murphy, EA; Fu, MG; Fan, DP				Yu, Fang; Du, Fen; Wang, Yuzhen; Huang, Shengping; Miao, Ruidong; Major, Amy S.; Murphy, E. Angela; Fu, Mingui; Fan, Daping			Bone Marrow Deficiency of MCPIP1 Results in Severe Multi-Organ Inflammation but Diminishes Atherogenesis in Hyperlipidemic Mice	PLOS ONE			English	Article							T-CELLS; ATHEROSCLEROSIS; IMMUNITY; ACTIVATION; ANTIBODIES; RATIONALE; PROTEIN; PLAQUE; RNASE	Objective: MCPIP1 is a newly identified protein that profoundly impacts immunity and inflammation. We aim to test if MCPIP1 deficiency in hematopoietic cells results in systemic inflammation and accelerates atherogenesis in mice. Approach and Results: After lethally irradiated, LDLR-/- mice were transplanted with bone marrow cells from either wildtype or MCPIP1(-/-) mice. These chimeric mice were fed a western-type diet for 7 weeks. We found that bone marrow MCPIP1(-/-) mice displayed a phenotype similar to that of whole body MCPIP1(-/-) mice, with severe systemic and multi-organ inflammation. However, MCPIP1(-/-) bone marrow recipients developed >10-fold less atherosclerotic lesions in the proximal aorta than WT bone marrow recipients, and essentially no lesions in en face aorta. The diminishment in atherosclerosis in bone marrow MCPIP1(-/-) mice may be partially attributed to the slight decrease in their plasma lipids. Flow cytometric analysis of splenocytes showed that bone marrow MCPIP1(-/-) mice contained reduced numbers of T cells and B cells, but increased numbers of regulatory T cells, Th17 cells, CD11b+/Gr1+ cells and CD11b+/Ly6C(low) cells. This overall anti-atherogenic leukocyte profile may also contribute to the reduced atherogenesis. We also examined the cholesterol efflux capability of MCPIP1 deficient macrophages, and found that MCPIP1 deficiency increased cholesterol efflux to apoAI and HDL, due to increased protein levels of ABCA1 and ABCG1. Conclusions: Hematopoietic deficiency of MCPIP1 resulted in severe systemic and multi-organ inflammation but paradoxically diminished atherogenesis in mice. The reduced atheroegensis may be explained by the decreased plasma cholesterol levels, the anti-atherogenic leukocyte profile, as well as enhanced cholesterol efflux capability. This study suggests that, while atherosclerosis is a chronic inflammatory disease, the mechanisms underlying atherogenesis-associated inflammation in arterial wall versus the inflammation in solid organs may be substantially different.	[Yu, Fang] Fourth Mil Med Univ, Dept Nutr & Food Hyg, Xian 710032, Shaanxi, Peoples R China; [Yu, Fang; Du, Fen; Wang, Yuzhen; Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Du, Fen] Wuhan Univ, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan 430072, Peoples R China; [Huang, Shengping; Miao, Ruidong; Fu, Mingui] Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA; [Huang, Shengping; Miao, Ruidong; Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Major, Amy S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA; [Murphy, E. Angela] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA	Air Force Military Medical University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Wuhan University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Vanderbilt University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fan, DP (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	daping.fan@uscmed.sc.edu			American Heart Association [SDG4110005]; National Institutes of Health [HL106325, HL116626, R01HL088364, R01HL089310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089310, R01HL116626, R01HL088364, R21HL106325] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Heart Association (SDG4110005 to DF), and National Institutes of Health (HL106325 and HL116626 to DF; R01HL088364 and R01HL089310 to ASM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Binder CJ, 2008, CURR DRUG TARGETS, V9, P190; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Fazio S, 2002, J LIPID RES, V43, P1602, DOI 10.1194/jlr.M200108-JLR200; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Haile LA, 2012, IMMUNOL INVEST, V41, P581, DOI 10.3109/08820139.2012.680635; Kong YY, 2013, CURR MED CHEM, V20, P1437, DOI 10.2174/0929867311320110006; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049841; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Mizgalska D, 2009, FEBS J, V276, P7386, DOI 10.1111/j.1742-4658.2009.07452.x; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2009, J THROMB HAEMOST, V7, P332, DOI 10.1111/j.1538-7836.2009.03404.x; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Stanic AK, 2006, P NATL ACAD SCI USA, V103, P7018, DOI 10.1073/pnas.0602311103; Suthers B, 2012, VACCINE, V30, P3983, DOI 10.1016/j.vaccine.2012.03.084; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Taleb S, 2008, J INTERN MED, V263, P489, DOI 10.1111/j.1365-2796.2008.01944.x; Xu JW, 2012, PROTEIN CELL, V3, P903, DOI 10.1007/s13238-012-2075-9; Yu F, 2013, MOL CANCER RES, V11, P923, DOI 10.1158/1541-7786.MCR-12-0686; Zhou XH, 2000, CIRCULATION, V102, P2919	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80089	10.1371/journal.pone.0080089	http://dx.doi.org/10.1371/journal.pone.0080089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223214	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200107
J	Fang, Z; Lu, BX; Liu, MY; Zhang, MX; Yi, ZH; Wen, CP; Shi, TL				Fang, Zhao; Lu, Bingxin; Liu, Mingyao; Zhang, Meixia; Yi, Zhenghui; Wen, Chengping; Shi, Tieliu			Evaluating the Pharmacological Mechanism of Chinese Medicine Si-Wu-Tang through Multi-Level Data Integration	PLOS ONE			English	Article							DREAM; GENE; CONSTITUENTS; POLYMORPHISM; ASSOCIATION; CYTOSCAPE; ABUNDANCE; NETWORKS; RECEPTOR; DENSITY	Si-Wu-Tang (SWT) is a Traditional Chinese Medicine (TCM) formula widely used for the treatments of gynecological diseases. To explore the pharmacological mechanism of SWT, we incorporated microarray data of SWT with our herbal target database TCMID to analyze the potential activity mechanism of SWT's herbal ingredients and targets. We detected 2,405 differentially expressed genes in the microarray data, 20 of 102 proteins targeted by SWT were encoded by these DEGs and can be targeted by 2 FDA-approved drugs and 39 experimental drugs. The results of pathway enrichment analysis of the 20 predicted targets were consistent with that of 2,405 differentially expressed genes, elaborating the potential pharmacological mechanisms of SWT. Further study from a perspective of protein-protein interaction (PPI) network showed that the predicted targets of SWT function cooperatively to perform their multi-target effects. We also constructed a network to combine herbs, ingredients, targets and drugs together which bridges the gap between SWT and conventional medicine, and used it to infer the potential mechanisms of herbal ingredients. Moreover, based on the hypothesis that the same or similar effects between different TCM formulae may result from targeting the same proteins, we analyzed 27 other TCM formulae which can also treat the gynecological diseases, the subsequent result provides additional insight to understand the potential mechanisms of SWT in treating amenorrhea. Our bioinformatics approach to detect the pharmacology of SWT may shed light on drug discovery for gynecological diseases and could be utilized to investigate other TCM formulae as well.	[Fang, Zhao; Lu, Bingxin; Liu, Mingyao; Shi, Tieliu] E China Normal Univ, Ctr Bioinformat & Computat Biol, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Fang, Zhao; Lu, Bingxin; Liu, Mingyao; Shi, Tieliu] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhang, Meixia] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Yi, Zhenghui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Schizophrenia Program, Shanghai 200030, Peoples R China; [Wen, Chengping] Zhejiang Univ Chinese Med, TCM Clin Basis Inst, Hangzhou, Zhejiang, Peoples R China; [Shi, Tieliu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	East China Normal University; East China Normal University; Sichuan University; Shanghai Jiao Tong University; Zhejiang Chinese Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shi, TL (corresponding author), E China Normal Univ, Ctr Bioinformat & Computat Biol, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	tieliushi01@gmail.com		LU, BINGXIN/0000-0002-0606-5150; Liu, Mingyao/0000-0001-7339-5048; chengping, Wen/0000-0001-9254-6235	National 973 Key Basic Research Program [2013CB127000, 2010CB945401]; National Natural Science Foundation of China [31240038, 31071162, 31000590]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National 973 Key Basic Research Program (Grant No. 2013CB127000 and 2010CB945401), the National Natural Science Foundation of China (Grant No. 31240038, 31071162, and 31000590), the Science and Technology Commission of Shanghai Municipality (11DZ2260300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen ZW, 2010, CHINA OCCUPATIONAL M, V37, P279; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Dai Y, 2002, BIOL PHARM BULL, V25, P1175, DOI 10.1248/bpb.25.1175; Debnath B, 2010, DRUG NEWS PERSPECT, V23, P670, DOI 10.1358/dnp.2010.23.10.1506088; Gao Y, 2003, TIANJIN J TRADIT CHI, V20, P47; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hinke V, 2001, CALCIFIED TISSUE INT, V69, P315, DOI 10.1007/s002230020024; [华永庆 HUA Yongqing], 2008, [中国药科大学学报, Journal of China Pharmaceutical University], V39, P72; Leng F, 2012, SCI CHINA LIFE SCI, V55, P1022; Li GB, 2012, SCI CHINA LIFE SCI, V55, P1022, DOI 10.1007/s11427-012-4397-5; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; Li Y, 2008, NEUROCHEM RES, V33, P2070, DOI 10.1007/s11064-008-9686-9; Liang QD, 2006, BIOL PHARM BULL, V29, P1378, DOI 10.1248/bpb.29.1378; [刘立 Liu Li], 2012, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V28, P2; Liu L, 2012, BIOORG MED CHEM LETT, V22, P154, DOI 10.1016/j.bmcl.2011.11.041; Ma Zeng-chun, 2003, Zhongguo Zhongyao Zazhi, V28, P1050; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; Narvekar N, 2006, HUM REPROD, V21, P2312, DOI 10.1093/humrep/del182; OHTA H, 1993, PHARMACOL BIOCHEM BE, V45, P719, DOI 10.1016/0091-3057(93)90530-7; Os I, 2002, J INTERN MED, V251, P223, DOI 10.1046/j.1365-2796.2002.00950.x; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian P, 2011, NATURE, V480, pS84, DOI 10.1038/480S84a; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang L, 2011, INT J PHARMACEUT, V406, P99, DOI 10.1016/j.ijpharm.2011.01.001; Wang ZJ, 2009, J PHARMACEUT BIOMED, V50, P232, DOI 10.1016/j.jpba.2009.04.001; Watanabe Hiroshi, 1998, Journal of Toxicological Sciences, V23, P234; Wen ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018278; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xiao X., 2002, TRADITIONAL CHINESE, V13, P11; Xue RC, 2013, NUCLEIC ACIDS RES, V41, pD1089, DOI 10.1093/nar/gks1100; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Yan Shi-Kai, 2009, Chinese Journal of Natural Medicines, V7, P249, DOI 10.3724/SP.J.1009.2009.00249; Yeh LLL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000719; Yue G., 2010, WORLD SCI TECHNOLOGY, V12, P211; Zhang B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/456747; Zhang CB, 2007, PHARM CLIN RES, V15, P459; Zhang HJ, 2004, J PHARMACEUT BIOMED, V34, P705, DOI 10.1016/S0731-7085(03)00650-2; Zhang T, 2000, J BEIJING U TRADIT C, V23, P36; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063	48	44	49	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e72334	10.1371/journal.pone.0072334	http://dx.doi.org/10.1371/journal.pone.0072334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223693	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400001
J	Huang, CH; Chen, CCV; Siow, TY; Hsu, SHS; Hsu, YH; Jaw, FS; Chang, C				Huang, Chien-Hsiang; Chen, Chiao-Chi V.; Siow, Tiing-Yee; Hsu, Sheng-Hsiou S.; Hsu, Yi-Hua; Jaw, Fu-Shan; Chang, Chen			High-Resolution Structural and Functional Assessments of Cerebral Microvasculature Using 3D Gas Delta R-2*-mMRA	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; BLOOD-VOLUME; IN-VIVO; VASCULAR ARCHITECTURE; CONTRAST AGENTS; DYNAMIC CHANGES; MR-ANGIOGRAPHY; VESSEL SIZE; BRAIN; ISCHEMIA	The ability to evaluate the cerebral microvascular structure and function is crucial for investigating pathological processes in brain disorders. Previous angiographic methods based on blood oxygen level-dependent (BOLD) contrast offer appropriate visualization of the cerebral vasculature, but these methods remain to be optimized in order to extract more comprehensive information. This study aimed to integrate the advantages of BOLD MRI in both structural and functional vascular assessments. The BOLD contrast was manipulated by a carbogen challenge, and signal changes in gradient-echo images were computed to generate Delta R-2* maps. Simultaneously, a functional index representing the regional cerebral blood volume was derived by normalizing the Delta R-2* values of a given region to those of vein-filled voxels of the sinus. This method is named 3D gas Delta R-2*-mMRA (microscopic MRA). The advantages of using 3D gas Delta R-2*-mMRA to observe the microvasculature include the ability to distinguish air-tissue interfaces, a high vessel-to-tissue contrast, and not being affected by damage to the blood-brain barrier. A stroke model was used to demonstrate the ability of 3D gas Delta R-2*-mMRA to provide information about poststroke revascularization at 3 days after reperfusion. However, this technique has some limitations that cannot be overcome and hence should be considered when it is applied, such as magnifying vessel sizes and predominantly revealing venous vessels.	[Huang, Chien-Hsiang; Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Huang, Chien-Hsiang; Chen, Chiao-Chi V.; Siow, Tiing-Yee; Hsu, Sheng-Hsiou S.; Hsu, Yi-Hua; Chang, Chen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Jaw, FS (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	jaw@ntu.edu.tw; bmcchen@ibms.sinica.edu.tw	Chang, Chen/B-5079-2009		National Science Council, Taiwan [NSC102-2321-B-001-062]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan (NSC102-2321-B-001-062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyagari AL, 2006, MAGN RESON MED, V55, P1023, DOI 10.1002/mrm.20846; Beckmann N, 1999, J MAGN RESON, V140, P442, DOI 10.1006/jmre.1999.1864; Blockley NP, 2012, NEUROIMAGE, V59, P3266, DOI 10.1016/j.neuroimage.2011.11.041; Bolan PJ, 2006, NEUROIMAGE, V32, P62, DOI 10.1016/j.neuroimage.2006.03.027; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Bulte D, 2007, J MAGN RESON IMAGING, V26, P894, DOI 10.1002/jmri.21096; Cai KJ, 2012, NMR BIOMED, V25, P1125, DOI 10.1002/nbm.2780; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; Dashner RA, 2004, J MAGN RESON IMAGING, V19, P303, DOI 10.1002/jmri.20006; Du YP, 2008, MAGN RESON MED, V59, P954, DOI 10.1002/mrm.21581; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gursoy-Ozdemir Y, 2012, J NEUROCHEM, V123, P2, DOI 10.1111/j.1471-4159.2012.07938.x; HAACKE EM, 1994, NMR BIOMED, V7, P54, DOI 10.1002/nbm.1940070109; Jochimsen TH, 2010, NEUROIMAGE, V51, P765, DOI 10.1016/j.neuroimage.2010.02.037; Klohs J, 2012, J NEUROSCI, V32, P1705, DOI 10.1523/JNEUROSCI.5626-11.2012; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Lin CY, 2013, ANGIOGENESIS, V16, P785, DOI 10.1007/s10456-013-9355-8; Lin CY, 2009, NEUROIMAGE, V45, P824, DOI 10.1016/j.neuroimage.2008.12.030; Lin TN, 2002, STROKE, V33, P2985, DOI 10.1161/01.STR.0000037675.97888.9D; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Losert C, 2002, MAGN RESON MED, V48, P271, DOI 10.1002/mrm.10215; Madore B, 2001, MAGN RESON MED, V45, P1103, DOI 10.1002/mrm.1145; Mendichovszky I, 2011, BRIT J RADIOL, V84, pS145, DOI 10.1259/bjr/82292521; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; Ozsarlak O, 2004, NEURORADIOLOGY, V46, P955, DOI 10.1007/s00234-004-1297-9; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Park SH, 2008, MAGN RESON MED, V59, P855, DOI 10.1002/mrm.21573; Pathak AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022643; Perles-Barbacaru AT, 2012, J CEREBR BLOOD F MET, V32, P489, DOI 10.1038/jcbfm.2011.151; Petrella JR, 2000, AM J ROENTGENOL, V175, P207, DOI 10.2214/ajr.175.1.1750207; PHELPS ME, 1979, J NUCL MED, V20, P328; Pipe J G, 2001, Top Magn Reson Imaging, V12, P163, DOI 10.1097/00002142-200106000-00003; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Quarles CC, 2012, MAGN RESON IMAGING, V30, P944, DOI 10.1016/j.mri.2012.03.008; Rauscher A, 2005, MAGNET RESON MED, V54, P87, DOI 10.1002/mrm.20520; Reese T, 1999, NMR BIOMED, V12, P189, DOI 10.1002/(SICI)1099-1492(199906)12:4<189::AID-NBM557>3.0.CO;2-O; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Renkin EM, 1989, TXB PHYSL, P860; Robinson SP, 2003, J MAGN RESON IMAGING, V17, P445, DOI 10.1002/jmri.10274; Robinson SP, 2001, MAGN RESON IMAGING, V19, P161, DOI 10.1016/S0730-725X(01)00230-2; Ross J, 1991, CARDIOVASCULAR SYSTE; Santosh C, 2008, J CEREBR BLOOD F MET, V28, P1742, DOI 10.1038/jcbfm.2008.56; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; SCHMIDT B, 1989, THROMB HAEMOSTASIS, V62, P1074; Sedlacik J, 2008, NEUROIMAGE, V40, P11, DOI 10.1016/j.neuroimage.2007.11.046; Shen YJ, 2011, NEUROIMAGE, V55, P1063, DOI 10.1016/j.neuroimage.2010.12.084; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Vovenko E, 1999, PFLUG ARCH EUR J PHY, V437, P617, DOI 10.1007/s004240050825; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Wise RG, 2010, MAGN RESON IMAGING, V28, P1129, DOI 10.1016/j.mri.2010.06.002; Xu YB, 2001, J MAGN RESON IMAGING, V14, P628, DOI 10.1002/jmri.1228; Xu YB, 2008, MAGN RESON IMAGING, V26, P1406, DOI 10.1016/j.mri.2008.04.008; Zerbi V, 2012, BRAIN STRUCT FUNCT	55	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78186	10.1371/journal.pone.0078186	http://dx.doi.org/10.1371/journal.pone.0078186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223773	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400037
J	Lv, YM; Fang, XH; Asmaro, K; Liu, HJ; Zhang, XQ; Zhang, HM; Qin, XM; Ji, XM				Lv, Yumei; Fang, Xianghua; Asmaro, Karam; Liu, Hongjun; Zhang, Xinqing; Zhang, Hongmei; Qin, Xiaoming; Ji, Xunming			Five-year Prognosis after Mild to Moderate Ischemic Stroke by Stroke Subtype: A Multi-Clinic Registry Study	PLOS ONE			English	Article							PERTH COMMUNITY STROKE; 1ST-EVER STROKE; LACUNAR INFARCTION; SECONDARY PREVENTION; SURVIVAL; POPULATION; RECURRENCE; RISK	Background and Purpose: Mild to moderate ischemic stroke is a common presentation in the outpatient setting. Among the various subtypes of stroke, lacunar infarction (LI) is generally very common. Currently, little is known about the long-term prognosis and factors associated with the prognosis between LI and non-LI. This study aims to compare the risk of death and acute cardiovascular events between patients with LI and non-LI, and identify potential risk factors associated with these outcomes. Methods: A total of 710 first-ever ischemic stroke patients (LI: 474, non-LI: 263) from 18 clinics were recruited consecutively from 2003 to 2004. They were prospectively followed-up until the end of 2008. Hazard ratios and 95% confidence intervals were calculated using multivariable Cox proportional hazards regression. Results: After a 5-year follow up, 54 deaths and 96 acute cardiovascular events occurred. Recurrent stroke was the most common cause of death (19 cases, 35.18%) and new acute cardiovascular events (75 cases, 78.13%). There were no significant differences between patients with LI and non-LI in their risks of death, new cardiovascular events, and recurrent stroke after adjusting for age, sex, hypertension, diabetes, cardiac diseases, body mass index, dyslipidemia, smoking, alcohol consumption, ADL dependence, and depressive symptoms. Among the modifiable risk factors, diabetes, hypertension, ADL dependency, and symptoms of depression were independent predictors of poor outcomes in patients with LI. In non-LI patients, however, no modifiable risk factors were detected for poor outcomes. Conclusion: Long-term outcomes did not differ significantly between LI and non-LI patients. Detecting and managing vascular risk factors and depression as well as functional rehabilitation may improve the prognoses of LI patients.	[Lv, Yumei; Fang, Xianghua; Liu, Hongjun] Capital Med Univ, Xuanwu Hosp, Evidence Based Med Ctr, Beijing, Peoples R China; [Lv, Yumei] Harbin Med Univ Daqing, Sch Nursing, Daqing, Heilongjiang, Peoples R China; [Asmaro, Karam] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI USA; [Zhang, Xinqing; Qin, Xiaoming] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Hongmei] Capital Med Univ, Xuanwu Hosp, Dept Geriatr, Beijing, Peoples R China; [Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Dept Neurol Surg, Beijing, Peoples R China	Capital Medical University; Harbin Medical University; Wayne State University; Capital Medical University; Capital Medical University; Capital Medical University	Fang, XH (corresponding author), Capital Med Univ, Xuanwu Hosp, Evidence Based Med Ctr, Beijing, Peoples R China.	xhfang163@163.com	Ji, Xunming/AAN-3370-2021	Asmaro, Karam/0000-0002-2084-4863	National Natural Science Foundation of China [81072361]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (project 81072361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fang X, 2008, CHIN J CHRON NONCOMM, V16, P233; Fang X, 2007, CHIN J GERIATR HEART, V9, P32; Fang XH, 2012, EUR J NEUROL, V19, P1114, DOI 10.1111/j.1468-1331.2012.03709.x; Hackam DG, 2007, STROKE, V38, P1881, DOI 10.1161/STROKEAHA.106.475525; Hankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Jiang B, 2004, STROKE, V35, P1242, DOI 10.1161/01.STR.0000128417.88694.9f; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu XF, 2006, CEREBROVASC DIS, V22, P130, DOI 10.1159/000093241; MAHONEY F I, 1965, Md State Med J, V14, P61; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Poungavarin N, 1998, LANCET, V352, pSIII19; Sander D, 2011, CEREBROVASC DIS, V31, P315, DOI 10.1159/000322603; Soda T, 2004, ACTA NEUROL SCAND, V110, P343, DOI 10.1111/j.1600-0404.2004.00290.x; Wang SL, 2000, STROKE, V31, P2354, DOI 10.1161/01.STR.31.10.2354; Wang YJ, 2012, CNS NEUROSCI THER, V18, P93, DOI 10.1111/j.1755-5949.2011.00290.x; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wu B, 2010, CEREBROVASC DIS, V29, P181, DOI 10.1159/000267277; Zung W.W., 1990, J CLIN PSYCHIAT S, V51, P1; ZUNG W W K, 1990, Journal of Clinical Psychiatry, V51, P77	23	7	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e75019	10.1371/journal.pone.0075019	http://dx.doi.org/10.1371/journal.pone.0075019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223696	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400003
J	Morohaku, K; Hoshino, Y; Sasada, H; Sato, E				Morohaku, Kanako; Hoshino, Yumi; Sasada, Hiroshi; Sato, Eimei			Incorporation of Phosphatase Inhibitor in Culture Prompts Growth Initiation of Isolated Non-Growing Oocytes	PLOS ONE			English	Article							STEM-CELL FACTOR; PHOSPHOINOSITIDE 3-KINASE PATHWAY; MOUSE OVARIAN-FOLLICLES; IN-VITRO DEVELOPMENT; PRIMORDIAL FOLLICLES; KIT-LIGAND; PREANTRAL FOLLICLES; FOLLICULAR DEVELOPMENT; TUMOR-SUPPRESSOR; ACTIVATION	In vitro folliculogenesis of primordial and early preantral follicles is necessary for increment of reproductive efficiency in domestic animals, humans and endangered species. Recent study in phosphatase and tensin homolog (Pten) - knockout mice has revealed that this phosphatase acts as an inhibitory factor in follicle activation of primordial pool with the resultant inhibition of oocyte growth. To test in vitro effect of a phosphatase inhibitor on growth initiation of isolated non-growing oocytes in neonatal ovaries, we applied a specific inhibitor (bpV (HOpic)) for PTEN in culturing system. Non-growing oocytes isolated from the ovaries of newborn BDF1 (C57BL/6 x DBA/2) pups were divided to four culture groups. Five days after culture, the oocytes in 14 mu mol/l bpV only, 14 mu mol/l bpV plus 100 ng/ml Kit Ligand (KL), and 100 ng/ml KL groups showed significantly (P<0.05) growth (19.3+/-0.55, 25.8+/-0.53 and 21.6+/-0.29 mu m, respectively) compared with that of the control (no additive) (16.9+/-0.53 mu m). In addition, western blotting in those groups showed enhanced expression of phosphorylated Akt. In conclusion, we clearly demonstrate that isolated non-growing oocytes develop in phosphatase inhibitor, especially to PTEN, incorporated culturing system, and show first as we know that oocytes with zona Pellucidae can be obtained in vitro from isolated non-growing oocytes.	[Morohaku, Kanako; Hoshino, Yumi; Sasada, Hiroshi; Sato, Eimei] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan; [Morohaku, Kanako; Sasada, Hiroshi] Kitasato Univ, Sch Vet Med, Lab Anim Reprod, Towada, Aomori, Japan	Tohoku University; Kitasato University	Morohaku, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan.	km592@cornell.edu			JSPS Research Fellowships for Young Scientists [09J0513]	JSPS Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported from the JSPS Research Fellowships for Young Scientists (Grant number 09J0513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; BORUM K, 1967, EXP CELL RES, V45, P39, DOI 10.1016/0014-4827(67)90110-3; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cortvrindt R, 1996, HUM REPROD, V11, P2656; Cuncic C, 1999, BIOCHEM PHARMACOL, V58, P1859, DOI 10.1016/S0006-2952(99)00284-1; Driancourt MA, 2000, REV REPROD, V5, P143, DOI 10.1530/revreprod/5.3.143; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Fortune JE, 1998, THERIOGENOLOGY, V49, P441, DOI 10.1016/S0093-691X(97)00416-0; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; Hu Y, 2002, MOL REPROD DEV, V61, P549, DOI 10.1002/mrd.10107; Hutt KJ, 2006, BIOL REPROD, V75, P421, DOI 10.1095/biolreprod.106.051516; Joyce IM, 1999, DEV BIOL, V214, P342, DOI 10.1006/dbio.1999.9437; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; KOHSAKA T, 1992, J REPROD FERTIL, V95, P397, DOI 10.1530/jrf.0.0950397; Kohsaka T, 2007, CELL TISSUE RES, V330, P303, DOI 10.1007/s00441-007-0492-5; Lenie S, 2004, BIOL REPROD, V71, P1730, DOI 10.1095/biolreprod.104.028415; Li J, 1998, CANCER RES, V58, P5667; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; LINTERNMOORE S, 1979, BIOL REPROD, V20, P773, DOI 10.1095/biolreprod20.4.773; Liu K, 2006, FRONT BIOSCI-LANDMRK, V11, P126, DOI 10.2741/1785; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; NEAL P, 1974, J REPROD FERTIL, V37, P399, DOI 10.1530/jrf.0.0370399; Nilsson EE, 2004, MOL CELL ENDOCRINOL, V214, P19, DOI 10.1016/j.mce.2003.12.001; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Oktay K, 1998, HUM REPROD, V13, P1133, DOI 10.1093/humrep/13.5.1133; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reynaud K, 2000, MOL REPROD DEV, V56, P483, DOI 10.1002/1098-2795(200008)56:4&lt;483::AID-MRD6&gt;3.0.CO;2-O; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Smitz J, 1998, MATURITAS, V30, P171, DOI 10.1016/S0378-5122(98)00071-1; Smitz JEJ, 2002, REPRODUCTION, V123, P185, DOI 10.1530/rep.0.1230185; Stokoe D, 2005, P NATL ACAD SCI USA, V102, P2677, DOI 10.1073/pnas.0500089102; Stokoe David, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009361; TELFER E, 1990, J REPROD FERTIL, V89, P565	44	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77533	10.1371/journal.pone.0077533	http://dx.doi.org/10.1371/journal.pone.0077533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223714	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400010
J	Rosolowski, M; Lauter, J; Abramov, D; Drexler, HG; Hummel, M; Klapper, W; MacLeod, RAF; Pellissery, S; Horn, F; Siebert, R; Loeffler, M				Rosolowski, Maciej; Laeuter, Juergen; Abramov, Dmitriy; Drexler, Hans G.; Hummel, Michael; Klapper, Wolfram; MacLeod, Roderick A. F.; Pellissery, Shoji; Horn, Friedemann; Siebert, Reiner; Loeffler, Markus			Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas	PLOS ONE			English	Article							GENE-EXPRESSION; BURKITT-LYMPHOMA; SOMATIC MUTATIONS; C-MYC; SIGNATURES; DIAGNOSIS; SURVIVAL; SUBTYPES; TARGETS; GENOME	Based on the assumption that molecular mechanisms involved in cancerogenesis are characterized by groups of coordinately expressed genes, we developed and validated a novel method for analyzing transcriptional data called Correlated Gene Set Analysis (CGSA). Using 50 extracted gene sets we identified three different profiles of tumors in a cohort of 364 Diffuse large B-cell (DLBCL) and related mature aggressive B-cell lymphomas other than Burkitt lymphoma. The first profile had high level of expression of genes related to proliferation whereas the second profile exhibited a stromal and immune response phenotype. These two profiles were characterized by a large scale gene activation affecting genes which were recently shown to be epigenetically regulated, and which were enriched in oxidative phosphorylation, energy metabolism and nucleoside biosynthesis. The third and novel profile showed only low global gene activation similar to that found in normal B cells but not cell lines. Our study indicates novel levels of complexity of DLBCL with low or high large scale gene activation related to metabolism and biosynthesis and, within the group of highly activated DLBCLs, differential behavior leading to either a proliferative or a stromal and immune response phenotype.	[Rosolowski, Maciej; Laeuter, Juergen; Loeffler, Markus] Univ Leipzig, IMISE, D-04109 Leipzig, Germany; [Laeuter, Juergen] Univ Magdeburg, D-39106 Magdeburg, Germany; [Abramov, Dmitriy; Klapper, Wolfram] Univ Kiel, Dept Pathol, Hematopathol Sect, Kiel, Germany; [Abramov, Dmitriy; Klapper, Wolfram] Univ Kiel, Lymph Node Registry, Kiel, Germany; [Abramov, Dmitriy] Russian Fed Res Ctr, Dept Pathol, Moscow, Russia; [Drexler, Hans G.; MacLeod, Roderick A. F.] DSMZ German Collect Microorganisms & Cell Culture, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Hummel, Michael] Charite, Inst Pathol, D-13353 Berlin, Germany; [Pellissery, Shoji; Siebert, Reiner] Univ Kiel, Univ Hosp Schleswig Holstein Campus Kiel, Inst Human Genet, Kiel, Germany; [Horn, Friedemann] Univ Leipzig, Fac Med, Inst Clin Immunol, D-04109 Leipzig, Germany	Leipzig University; Otto von Guericke University; University of Kiel; University of Kiel; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein University Hospital; Leipzig University	Rosolowski, M (corresponding author), Univ Leipzig, IMISE, D-04109 Leipzig, Germany.	maciej.rosolowski@imise.uni-leipzig.de	Klapper, Wolfram/S-6314-2016; Siebert, Reiner/A-8049-2010	Hummel, Michael/0000-0001-6717-605X; Abramov, Dmitry/0000-0003-3664-2876	Deutsche Krebshilfe [70-3173-Tr3]; BMBF grant HaematoSYS [0315452A]; German Minster of Education and Science (BMBF)	Deutsche Krebshilfe(Deutsche Krebshilfe); BMBF grant HaematoSYS(Federal Ministry of Education & Research (BMBF)); German Minster of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	The experimental work was carried out within the framework of the research network "Molecular Mechanisms in Malignant Lymphoma" (MMML), supported by the Deutsche Krebshilfe (70-3173-Tr3). Bioinformatic analysis was supported by the BMBF grant HaematoSYS (No. 0315452A, Markus Loeffler, Reiner Siebert, Jurgen Lauter, Maciej Rosolowski) granted by the German Minster of Education and Science (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2010, R LANG ENV STAT COMP; Bentink S, 2008, LEUKEMIA, V22, P1746, DOI 10.1038/leu.2008.166; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Klapper W, 2008, BLOOD, V112, P1374, DOI 10.1182/blood-2008-01-136465; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Kostka D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040022; Kreuz M, 2007, METHOD INFORM MED, V46, P608, DOI 10.1160/ME9064; Lauter J, 2009, BIOMETRICAL J, V51, P235, DOI 10.1002/bimj.200800207; Lauter J, 2012, ARXIV12022045V1STATM; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salaverria I, 2011, BLOOD, V118, P139, DOI 10.1182/blood-2011-01-330795; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e76287	10.1371/journal.pone.0076287	http://dx.doi.org/10.1371/journal.pone.0076287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223701	Green Published, gold			2022-12-27	WOS:000326503400006
J	Jensen, RJ				Jensen, Ralph J.			Effects of a Metabotropic Glutamate 1 Receptor Antagonist on Light Responses of Retinal Ganglion Cells in a Rat Model of Retinitis Pigmentosa	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GABA(C) RECEPTORS; AMACRINE CELLS; RHO-SUBUNITS; LOCALIZATION; INHIBITION; MGLUR1; MOUSE; ROD; TRANSMISSION	Background: Retinitis pigmentosa (RP) is a progressive retinal degenerative disease that causes deterioration of rod and cone photoreceptors. A well-studied animal model of RP is the transgenic P23H rat, which carries a mutation in the rhodopsin gene. Previously, I reported that blocking retinal GABA(C) receptors in the P23H rat increases light responsiveness of retinal ganglion cells (RGCs). Because activation of metabotropic glutamate 1 (mGlu1) receptors may enhance the release of GABA onto GABA(C) receptors, I examined the possibility that blocking retinal mGlu1 receptors might in itself increase light responsiveness of RGCs in the P23H rat. Methodology/Principal Findings: Electrical recordings were made from RGCs in isolated P23H rat retinas. Spike activity of RGCs was measured in response to brief flashes of light over a range of light intensities. Intensity-response curves were evaluated prior to and during bath application of the mGlu1 receptor antagonist JNJ16259685. I found that JNJ16259685 increased light sensitivity of all ON-center RGCs and most OFF-center RGCs studied. RGCs that were least sensitive to light showed the greatest JNJ16259685-induced increase in light sensitivity. On average, light sensitivity increased in ON-center RGCs by 0.58 log unit and in OFF-center RGCs by 0.13 log unit. JNJ16259685 increased the maximum peak response of ON-center RGCs by 7% but had no significant effect on the maximum peak response of OFF-center RGCs. The effects of JNJ16259685 on ON-center RGCs were occluded by a GABA(C) receptor antagonist. Conclusions: The results of this study indicate that blocking retinal mGlu1 receptors in a rodent model of human RP potentiates transmission of any, weak signals originating from photoreceptors. This augmentation of photoreceptor-mediated signals to RGCs occurs presumably through a reduction in GABA(C)-mediated inhibition.	VA Boston Healthcare Syst, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jensen, RJ (corresponding author), VA Boston Healthcare Syst, Boston, MA USA.	Ralph.jensen@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service [1I01RX000341-01]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (1I01RX000341-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEART PM, 1972, J NEUROCHEM, V19, P1855, DOI 10.1111/j.1471-4159.1972.tb01474.x; Cai WH, 1999, J COMP NEUROL, V407, P427, DOI 10.1002/(SICI)1096-9861(19990510)407:3<427::AID-CNE10>3.0.CO;2-9; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Eggers ED, 2007, J PHYSIOL-LONDON, V582, P569, DOI 10.1113/jphysiol.2007.131763; Enz R, 1996, J NEUROSCI, V16, P4479; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Fukunaga I, 2007, BRIT J PHARMACOL, V151, P870, DOI 10.1038/sj.bjp.0707286; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; GREFERATH U, 1993, VISUAL NEUROSCI, V10, P551, DOI 10.1017/S0952523800004764; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HARTVEIT E, 1995, EUR J NEUROSCI, V7, P1472, DOI 10.1111/j.1460-9568.1995.tb01142.x; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Jensen RJ, 2012, EXP EYE RES, V105, P21, DOI 10.1016/j.exer.2012.10.005; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Koulen P, 1997, J NEUROSCI, V17, P2200; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Lavreysen H, 2004, NEUROPHARMACOLOGY, V47, P961, DOI 10.1016/j.neuropharm.2004.08.007; Martinez-Navarrete G, 2011, EXP EYE RES, V92, P227, DOI 10.1016/j.exer.2010.12.001; PENG YW, 1995, NEUROSCIENCE, V66, P483, DOI 10.1016/0306-4522(94)00569-Q; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Ray A, 2010, CELL TISSUE RES, V339, P481, DOI 10.1007/s00441-009-0916-5; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Vigh J, 2005, NEURON, V46, P469, DOI 10.1016/j.neuron.2005.03.027; Vigh J, 2003, EUR J NEUROSCI, V17, P2237, DOI 10.1046/j.1460-9568.2003.02652.x; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695; Yu JN, 2009, J NEUROPHYSIOL, V102, P3728, DOI 10.1152/jn.00650.2009	29	1	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e79126	10.1371/journal.pone.0079126	http://dx.doi.org/10.1371/journal.pone.0079126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205371	gold, Green Published, Green Submitted			2022-12-27	WOS:000326241200061
J	Murphy, RA; Schairer, C; Gierach, GL; Byrne, C; Sherman, ME; Register, TC; Ding, JZ; Kritchevsky, SB; Harris, TB				Murphy, Rachel A.; Schairer, Catherine; Gierach, Gretchen L.; Byrne, Celia; Sherman, Mark E.; Register, Thomas C.; Ding, Jingzhong; Kritchevsky, Stephen B.; Harris, Tamara B.			Beyond Breast Cancer: Mammographic Features and Mortality Risk in a Population of Healthy Women	PLOS ONE			English	Article							BODY-MASS INDEX; TYPE-2 DIABETES-MELLITUS; SKELETAL-MUSCLE; FOLLOW-UP; INSULIN-RESISTANCE; UNITED-STATES; WHITE WOMEN; DENSITY; OBESITY; TISSUE	Background: Breast fibroglandular (dense) tissue is a risk factor for breast cancer. Beyond breast cancer, little is known regarding the prognostic significance of mammographic features. Methods: We evaluated relationships between nondense (fatty) breast area and dense area with all-cause mortality in 4,245 initially healthy women from the Breast Cancer Detection Demonstration Project; 1,361 died during a mean follow-up of 28.2 years. Dense area and total breast area were assessed using planimeter measurements from screening mammograms. Percent density reflects dense area relative to breast area and nondense area was calculated as the difference between total breast area and dense area. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated by Cox proportional hazards regression. Results: In age-adjusted models, greater nondense and total breast area were associated with increased risk of death (HR 1.17, 95% CI 1.10-1.24 and HR 1.13, 95% CI 1.06-1.19, per SD difference) while greater dense area and percent density were associated with lower risk of death (HR 0.91, 95% CI 0.86-0.95 and HR 0.87, 95% CI 0.83-0.92, per SD difference). Associations were not attenuated with adjustment for race, education, mammogram type (x-ray or xerogram), smoking status, diabetes and heart disease. With additional adjustment for body mass index, associations were diminished for all features but remained statistically significant for dense area (HR 0.94, 95% CI 0.89-0.99, per SD difference) and percent density (HR 0.93, 95% CI 0.87-0.98, per SD difference). Conclusions: These data indicate that dense area and percent density may relate to survival in healthy women and suggest the potential utility of mammograms beyond prediction of breast cancer risk.	[Murphy, Rachel A.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Schairer, Catherine; Gierach, Gretchen L.; Sherman, Mark E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Byrne, Celia] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Register, Thomas C.] Sticht Ctr Aging, Sect Comparat Med Pathol, Winston Salem, NC USA; [Ding, Jingzhong; Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Aging Sect Gerontol & Geriatr, Winston Salem, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; Wake Forest University	Murphy, RA (corresponding author), NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA.	Rachel.murphy@nih.gov	Gierach, Gretchen L/E-1817-2016; Byrne, Celia/K-2964-2015	Gierach, Gretchen L/0000-0002-0165-5522; Byrne, Celia/0000-0001-8289-4252; Register, Thomas/0000-0002-4078-0166	NIH, National Institute on Aging; Banting Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [ZIACP010183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Banting Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. RAM is supported by a Banting Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benichou J, 2003, CANCER DETECT PREV, V27, P266, DOI 10.1016/S0361-090X(03)00092-8; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Chiu SYH, 2010, CANCER EPIDEM BIOMAR, V19, P1219, DOI 10.1158/1055-9965.EPI-09-1028; Claassen H, 2011, PROG HISTOCHEM CYTO, V45, P239, DOI 10.1016/j.proghi.2010.11.002; D'Orsi C, 2003, BREAST IMAGING REPOR; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gierach GL, 2012, J NATL CANCER I, V104, P1218, DOI 10.1093/jnci/djs327; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Iso H, 2012, ATHEROSCLEROSIS, V224, P154, DOI 10.1016/j.atherosclerosis.2012.05.026; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Liberman L, 2002, RADIOL CLIN N AM, V40, P409, DOI 10.1016/S0033-8389(01)00017-3; Lokate M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3044; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Maskarinec G, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3378; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Murphy RA, 2010, CLIN NUTR, V29, P482, DOI 10.1016/j.clnu.2009.11.006; Murphy RA, 2013, J GERONTOL A-BIOL, DOI [10.1093/gerona/glt070, DOI 10.1093/GER0NA/GLT070.PUBMED:23707956]; Ogden CL, 2010, PREVALENCE OVERWEIGH; Olsen AH, 2009, BRIT J CANCER, V100, P1205, DOI 10.1038/sj.bjc.6604989; Pettersson A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3041; Porter GJR, 2007, AM J ROENTGENOL, V188, P676, DOI 10.2214/AJR.05.1950; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Razzaghi H, 2012, BREAST CANCER RES TR, V135, P571, DOI 10.1007/s10549-012-2185-3; STONE BG, 1985, SEMIN LIVER DIS, V5, P8, DOI 10.1055/s-2008-1041754; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428; van Gils CH, 1998, J EPIDEMIOL COMMUN H, V52, P267, DOI 10.1136/jech.52.4.267; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Yong LC, 1996, AM J EPIDEMIOL, V143, P985, DOI 10.1093/oxfordjournals.aje.a008681; Zhang SF, 2013, BREAST CANCER RES TR, V137, P273, DOI 10.1007/s10549-012-2310-3	45	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78722	10.1371/journal.pone.0078722	http://dx.doi.org/10.1371/journal.pone.0078722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205300	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400101
J	Stagge, F; Mitronova, GY; Belov, VN; Wurm, CA; Jakobs, S				Stagge, Franziska; Mitronova, Gyuzel Y.; Belov, Vladimir N.; Wurm, Christian A.; Jakobs, Stefan			Snap-, CLIP- and Halo-Tag Labelling of Budding Yeast Cells	PLOS ONE			English	Article							LIVING CELLS; FUSION PROTEINS; LIVE CELLS; SACCHAROMYCES-CEREVISIAE; FLUORESCENT-PROBES; FLUOROPHORES; TECHNOLOGY; MICROSCOPY; MOLECULES; NANOSCOPY	Fluorescence microscopy of the localization and the spatial and temporal dynamics of specifically labelled proteins is an indispensable tool in cell biology. Besides fluorescent proteins as tags, tag-mediated labelling utilizing self-labelling proteins as the SNAP-, CLIP-, or the Halo-tag are widely used, flexible labelling systems relying on exogenously supplied fluorophores. Unfortunately, labelling of live budding yeast cells proved to be challenging with these approaches because of the limited accessibility of the cell interior to the dyes. In this study we developed a fast and reliable electroporation-based labelling protocol for living budding yeast cells expressing SNAP-, CLIP-, or Halo-tagged fusion proteins. For the Halo-tag, we demonstrate that it is crucial to use the 6'-carboxy isomers and not the 5'-carboxy isomers of important dyes to ensure cell viability. We report on a simple rule for the analysis of H-1 NMR spectra to discriminate between 6'- and 5'-carboxy isomers of fluorescein and rhodamine derivatives. We demonstrate the usability of the labelling protocol by imaging yeast cells with STED super-resolution microscopy and dual colour live cell microscopy. The large number of available fluorophores for these self-labelling proteins and the simplicity of the protocol described here expands the available toolbox for the model organism Saccharomyces cerevisiae.	[Stagge, Franziska; Mitronova, Gyuzel Y.; Belov, Vladimir N.; Wurm, Christian A.; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Stagge, Franziska; Wurm, Christian A.; Jakobs, Stefan] Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany; [Jakobs, Stefan] Univ Gottingen, Sch Med, Dept Neurol, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Wurm, CA (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany.	cwurm@gwdg.de; sjakobs@gwdg.de	Jakobs, Stefan/F-4898-2012	Jakobs, Stefan/0000-0002-8028-3121; Belov, Vladimir N/0000-0002-7741-4653; Mitronova, Gyuzel/0000-0003-4376-6981	Deutsche Forschungsgemeinschaft through the DFG-Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain; Deutsche Forschungsgemeinschaft [JA 1129/3]	Deutsche Forschungsgemeinschaft through the DFG-Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through the DFG-Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (http://www.cmpb.de) and through grant JA 1129/3 (all to SJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen M, 2004, MOL CELL BIOL, V15, P5616, DOI [10.1091/mbc.E04-06-0454, DOI 10.1091/MBC.E04-06-0454.PUBMED:15469986]; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hein B, 2010, BIOPHYS J, V98, P158, DOI 10.1016/j.bpj.2009.09.053; Hell SW., 2009, SINGLE MOL SPECTROSC, P298; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jakobs S, 2008, FIASHLW MILLER PROTE, P73; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/NCHEM.1546, 10.1038/nchem.1546]; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; Muster B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011910; Neumann Daniel, 2010, PMC Biophys, V3, P4, DOI 10.1186/1757-5036-3-4; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Pellett PA, 2011, BIOMED OPT EXPRESS, V2, P2364, DOI 10.1364/BOE.2.002364; SCHERRER R, 1974, J BACTERIOL, V118, P534, DOI 10.1128/JB.118.2.534-540.1974; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Testa I, 2010, BIOPHYS J, V99, P2686, DOI 10.1016/j.bpj.2010.08.012; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wilmes S, 2012, ANGEW CHEM INT EDIT, V51, P4868, DOI 10.1002/anie.201200853; Wurm CA, 2010, J MICROSC-OXFORD, V240, P6, DOI 10.1111/j.1365-2818.2010.03378.x	29	67	67	6	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78745	10.1371/journal.pone.0078745	http://dx.doi.org/10.1371/journal.pone.0078745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205303	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400102
J	Hao, RX; Bondesson, M; Singh, AV; Riu, A; McCollum, CW; Knudsen, TB; Gorelick, DA; Gustafsson, JA				Hao, Ruixin; Bondesson, Maria; Singh, Amar V.; Riu, Anne; McCollum, Catherine W.; Knudsen, Thomas B.; Gorelick, Daniel A.; Gustafsson, Jan-Ake			Identification of Estrogen Target Genes during Zebrafish Embryonic Development through Transcriptomic Analysis	PLOS ONE			English	Article							CANCER-CELL-LINES; DANIO-RERIO; RECEPTOR-ALPHA; BREAST-CANCER; ER-BETA; RETINOIC ACID; DIFFERENTIAL REGULATION; REGULATES EXPRESSION; POSTMENOPAUSAL WOMEN; VITELLOGENIN GENES	Estrogen signaling is important for vertebrate embryonic development. Here we have used zebrafish (Danio rerio) as a vertebrate model to analyze estrogen signaling during development. Zebrafish embryos were exposed to 1 mu M 17 beta-estradiol (E2) or vehicle from 3 hours to 4 days post fertilization (dpf), harvested at 1, 2, 3 and 4 dpf, and subjected to RNA extraction for transcriptome analysis using microarrays. Differentially expressed genes by E2-treatment were analyzed with hierarchical clustering followed by biological process and tissue enrichment analysis. Markedly distinct sets of genes were up and down-regulated by E2 at the four different time points. Among these genes, only the well-known estrogenic marker vtg1 was co-regulated at all time points. Despite this, the biological functional categories targeted by E2 were relatively similar throughout zebrafish development. According to knowledge-based tissue enrichment, estrogen responsive genes were clustered mainly in the liver, pancreas and brain. This was in line with the developmental dynamics of estrogen-target tissues that were visualized using transgenic zebrafish containing estrogen responsive elements driving the expression of GFP (Tg(5xERE: GFP)). Finally, the identified embryonic estrogen-responsive genes were compared to already published estrogen-responsive genes identified in male adult zebrafish (Gene Expression Omnibus database). The expressions of a few genes were co-regulated by E2 in both embryonic and adult zebrafish. These could potentially be used as estrogenic biomarkers for exposure to estrogens or estrogenic endocrine disruptors in zebrafish. In conclusion, our data suggests that estrogen effects on early embryonic zebrafish development are stage-and tissue-specific.	[Hao, Ruixin; Bondesson, Maria; Riu, Anne; McCollum, Catherine W.; Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Singh, Amar V.; Knudsen, Thomas B.] US EPA, Off Res & Dev, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Gorelick, Daniel A.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA; [Gustafsson, Jan-Ake] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	University of Houston System; University of Houston; United States Environmental Protection Agency; Carnegie Institution for Science; Karolinska Institutet	Bondesson, M (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA.	mbondessonbolin@uh.edu	Bondesson, Maria/H-3027-2012	Bondesson, Maria/0000-0001-6358-5788; McCollum, Catherine/0000-0002-2238-803X	Environmental Protection Agency [R834289]; Emerging Technology Fund of Texas; Robert A Welch Foundation [E-0004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD061119] Funding Source: NIH RePORTER	Environmental Protection Agency(United States Environmental Protection Agency); Emerging Technology Fund of Texas; Robert A Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the Environmental Protection Agency (grant number R834289), the Emerging Technology Fund of Texas and the Robert A Welch Foundation (E-0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 1997, ENDOCRINOLOGY, V138, P978, DOI 10.1210/en.138.3.978; Armenti AE, 2008, TOXICOL APPL PHARM, V233, P286, DOI 10.1016/j.taap.2008.09.010; Bakker J, 2010, J NEUROENDOCRINOL, V22, P728, DOI 10.1111/j.1365-2826.2010.02016.x; Bardet PL, 2002, J MOL ENDOCRINOL, V28, P153, DOI 10.1677/jme.0.0280153; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Callard GV, 2011, J STEROID BIOCHEM, V127, P176, DOI 10.1016/j.jsbmb.2011.03.022; Celeghin A, 2011, GEN COMP ENDOCR, V172, P120, DOI 10.1016/j.ygcen.2010.12.020; Chandrasekar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009678; Chen GJ, 2011, J PHYSIOL-LONDON, V589, P1061, DOI 10.1113/jphysiol.2010.203398; Chung JK, 2002, J NUCL MED, V43, P1188; Clelland E, 2009, MOL CELL ENDOCRINOL, V312, P42, DOI 10.1016/j.mce.2009.04.009; De Geeter F, 2011, HELL J NUCL MED, V14, P76; Deb S, 2004, J CLIN ENDOCR METAB, V89, P4018, DOI 10.1210/jc.2004-0127; Deng L, 2003, J CLIN ENDOCR METAB, V88, P2157, DOI 10.1210/jc.2002-021844; Dohan O, 2006, MOL ENDOCRINOL, V20, P1121, DOI 10.1210/me.2005-0376; Dormire SL, 2009, BIOL RES NURS, V10, P241, DOI 10.1177/1099800408324558; Dubey RK, 2005, CARDIOVASC RES, V66, P295, DOI 10.1016/j.cardiores.2004.12.012; Elgort MG, 1996, MOL ENDOCRINOL, V10, P477, DOI 10.1210/me.10.5.477; Fan XT, 2010, PROG BRAIN RES, V181, P233, DOI 10.1016/S0079-6123(08)81013-8; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Froehlicher M, 2009, DEV BIOL, V330, P32, DOI 10.1016/j.ydbio.2009.03.005; Germana A, 2010, CELL MOL NEUROBIOL, V30, P787, DOI 10.1007/s10571-010-9506-z; Gorelick DA, 2011, ENDOCRINOLOGY, V152, P2690, DOI 10.1210/en.2010-1257; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Guo TL, 2005, J NUTR, V135, P2449, DOI 10.1093/jn/135.10.2449; Hamad A, 2007, CURR EYE RES, V32, P819, DOI 10.1080/02713680701573712; Han QX, 1997, DIAGN MOL PATHOL, V6, P42, DOI 10.1097/00019606-199702000-00007; Hart CD, 1998, AM J RESP CELL MOL, V19, P63, DOI 10.1165/ajrcmb.19.1.2859; HASHIMOTO S, 1991, MATURITAS, V13, P23, DOI 10.1016/0378-5122(91)90282-U; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hinfray N, 2006, ENVIRON TOXICOL, V21, P332, DOI 10.1002/tox.20203; Jansson I, 2001, PHARMACOGENETICS, V11, P793, DOI 10.1097/00008571-200112000-00007; Jennings BL, 2012, HYPERTENSION, V59, P348, DOI 10.1161/HYPERTENSIONAHA.111.183301; Jones DR, 2002, J LIPID RES, V43, P383; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Karpuzoglu-Sahin E, 2001, J REPROD IMMUNOL, V52, P113, DOI 10.1016/S0165-0378(01)00117-6; Kausch U, 2008, ENVIRON TOXICOL, V23, P15, DOI 10.1002/tox.20306; Kim R, 2005, INT J ONCOL, V26, P1025; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; KUSHWAHA RS, 1990, METABOLISM, V39, P544, DOI 10.1016/0026-0495(90)90015-5; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; Lam SH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-41; Lamon-Fava S, 1999, ARTERIOSCL THROM VAS, V19, P2960, DOI 10.1161/01.ATV.19.12.2960; Lamon-Fava S, 2006, ARTERIOSCL THROM VAS, V26, P385, DOI 10.1161/01.ATV.0000199248.53590.e1; Larsen MG, 2009, ENVIRON TOXICOL CHEM, V28, P1783, DOI 10.1897/08-563.1; Lassiter CS, 2002, GENE, V299, P141, DOI 10.1016/S0378-1119(02)01050-8; Le Saux M, 2006, J NEUROSCI RES, V84, P1076, DOI 10.1002/jnr.21007; Lee O, 2012, ENVIRON HEALTH PERSP, V120, P990, DOI 10.1289/ehp.1104433; Lengi AJ, 2007, J LEUKOCYTE BIOL, V81, P1065, DOI 10.1189/jlb.0606391; Levi L, 2012, AM J PHYSIOL-ENDOC M, V302, pE626, DOI 10.1152/ajpendo.00310.2011; Levi L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-141; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Liu XC, 2009, BIOL REPROD, V80, P1253, DOI 10.1095/biolreprod.108.070250; McCollum CW, 2007, DEV BIOL, V309, P373, DOI 10.1016/j.ydbio.2007.07.004; Medina RA, 2004, J ENDOCRINOL, V182, P467, DOI 10.1677/joe.0.1820467; Muncke J, 2007, ENVIRON TOXICOL, V22, P185, DOI 10.1002/tox.20255; Murthy AR, 2012, J HUM GENET, V57, P523, DOI 10.1038/jhg.2012.62; Nakaya M, 2006, BIOSCI BIOTECH BIOCH, V70, P47, DOI 10.1271/bbb.70.47; Nelson BP, 2008, BRAIN RES, V1222, P118, DOI 10.1016/j.brainres.2008.05.049; Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014; Pantschenko AG, 2005, J BONE MINER RES, V20, P1414, DOI 10.1359/JBMR.050315; Pellegrini E, 2005, GEN COMP ENDOCR, V142, P60, DOI 10.1016/j.ygcen.2004.12.003; Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012; Sanchez-Criado JE, 2006, J ENDOCRINOL, V188, P167, DOI 10.1677/joe.1.06377; Saxena D, 2007, ENDOCRINOLOGY, V148, P726, DOI 10.1210/en.2006-0108; Schultz JR, 2005, J BIOL CHEM, V280, P347, DOI 10.1074/jbc.M407879200; Singer CA, 1998, NEUROREPORT, V9, P2565, DOI 10.1097/00001756-199808030-00025; Stoilov I, 2004, MOL VIS, V10, P629; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Thongngarm T, 2003, AM J REPROD IMMUNOL, V49, P129, DOI 10.1034/j.1600-0897.2003.00015.x; Tiso N, 2009, MOL CELL ENDOCRINOL, V312, P24, DOI 10.1016/j.mce.2009.04.018; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tong Y, 2004, GENE, V328, P25, DOI 10.1016/j.gene.2003.12.001; Trukhacheva E, 2009, J CLIN ENDOCR METAB, V94, P615, DOI 10.1210/jc.2008-1466; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; Uzumcu M, 2006, J ENDOCRINOL, V191, P549, DOI 10.1677/joe.1.06592; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wilkins HR, 2010, TUMOR BIOL, V31, P16, DOI 10.1007/s13277-009-0003-2; Xie D, 2001, J BIOL CHEM, V276, P14187, DOI 10.1074/jbc.M009755200; Xu H, 2003, AM J PHYSIOL-GASTR L, V285, pG1317, DOI 10.1152/ajpgi.00172.2003; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061	85	76	77	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79020	10.1371/journal.pone.0079020	http://dx.doi.org/10.1371/journal.pone.0079020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223173	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200065
J	Niedworok, C; Rock, K; Kretschmer, I; Freudenberger, T; Nagy, N; Szarvas, T; Dorp, F; Reis, H; Rubben, H; Fischer, JW				Niedworok, Christian; Roeck, Katharina; Kretschmer, Inga; Freudenberger, Till; Nagy, Nadine; Szarvas, Tibor; vom Dorp, Frank; Reis, Henning; Ruebben, Herbert; Fischer, Jens W.			Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer	PLOS ONE			English	Article							ADVANCED UROTHELIAL CANCER; GROWTH-FACTOR; TOLL-LIKE; IN-VITRO; DOWN-REGULATION; EXPRESSION; DECORIN; MATRIX; CELLS; SORAFENIB	Background: Urothelial bladder cancer is the ninth most common cancer. Despite surgical and chemotherapeutic treatment the prognosis is still poor once bladder cancer progresses to a muscle-invasive state. Discovery of new diagnostic markers and pathophysiologic effectors might help to contribute to novel diagnostic and therapeutic options. The extracellular matrix microenvironment shaped by the extracellular matrix critically affects tumor cell and stroma cell functions. Therefore, aim of the present study was to assess the possible implication of the small leucine-rich proteoglycan biglycan in progression of human urothelial bladder cancer. Methods and Results: For this purpose tumor biopsies of 76 bladder cancer patients with different tumor stages (pTa, pT1-T4) were investigated with respect to biglycan expression and correlated with a long-term (10 years) clinical follow-up. Interestingly, higher biglycan mRNA expression was associated with higher tumor stages and muscle invasiveness. In vitro knock-down of endogenous biglycan in human urothelial carcinoma cells (J82 cells) increased proliferation, whereas addition of recombinant biglycan and overexpression of biglycan inhibited tumor cell proliferation. In line with this growth-inhibitory effect of biglycan, transplantation of J82 cells after knock-down of biglycan resulted in significantly increased growth of subcutaneous xenograft tumors in nude mice in vivo. Furthermore, treatment with two anti-proliferative, multi-receptor tyrosine kinase inhibitors-sunitinib and sorafenib-strongly upregulated biglycan expression. Collectively, the experimental data suggest that high biglycan expression is associated with reduced tumor cell proliferation. In accordance, Kaplan-Meier analysis revealed higher 10-year survival in patients with high biglycan mRNA expression in tumor biopsies. Conclusion: In conclusion, the present data suggest that biglycan is an endogenous inhibitor of bladder cancer cell proliferation that is upregulated in response to anti-proliferative tyrosine kinase inhibitors. In addition, high biglycan expression is associated with favorable prognosis.	[Niedworok, Christian; vom Dorp, Frank; Ruebben, Herbert] Univ Duisburg Essen, Essen Med Sch, Dept Urol, Essen, Germany; [Roeck, Katharina; Kretschmer, Inga; Freudenberger, Till; Nagy, Nadine; Fischer, Jens W.] Univ Klinikum Dusseldorf, Inst Pharmakol & Klin Pharmakol, Dusseldorf, Germany; [Reis, Henning] Univ Duisburg Essen, Essen Med Sch, Dept Pathol, Essen, Germany; [Szarvas, Tibor] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Vienna, Austria	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Duisburg Essen; Medical University of Vienna	Fischer, JW (corresponding author), Univ Klinikum Dusseldorf, Inst Pharmakol & Klin Pharmakol, Dusseldorf, Germany.	Jens.Fischer@uni-duesseldorf.de	SZARVAS, t./L-4422-2017; Reis, Henning/AAX-9545-2020	SZARVAS, t./0000-0002-6321-0799; Reis, Henning/0000-0003-1373-5295	Ifores Programm of the University Clinics Essen [D107-10800]; Deutsche Forschungsgemeinschaft, DFG [FI 682/4-1]	Ifores Programm of the University Clinics Essen; Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG))	The study was funded in part by the Ifores Programm of the University Clinics Essen (D107-10800; http://www.uni-due.de/med/forschung/forschungsfoerderung/ifores.shtml) and by the Deutsche Forschungsgemeinschaft, DFG (FI 682/4-1; http://gepris.dfg.de/gepris/OCTOPUS/;jsessionid=E43949FD6A49E805D72DE1129F1DB078?context=person&displayMode=print&findButton=Finden&id=1433803&keywords_criterion=Jens+Fischer&module=gepris&nurProjekteMitAB=false&task=showDetail). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Agarwal N, 2009, DRUGS, V69, P1173, DOI 10.2165/00003495-200969090-00003; Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Aprile G, 2013, TUMOR BIOL, V34, P131, DOI 10.1007/s13277-012-0520-2; Ayari C, 2011, J UROLOGY, V185, P1915, DOI 10.1016/j.juro.2010.12.097; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Dreicer R, 2009, CANCER-AM CANCER SOC, V115, P4090, DOI 10.1002/cncr.24467; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Gu XH, 2012, CLIN EXP MED, V12, P195, DOI 10.1007/s10238-011-0155-4; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hwang JY, 2008, AM J PATHOL, V173, P1919, DOI 10.2353/ajpath.2008.070875; Inkson CA, 2009, CELLS TISSUES ORGANS, V189, P153, DOI 10.1159/000151377; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kinsella MG, 2000, J BIOL CHEM, V275, P13924, DOI 10.1074/jbc.275.18.13924; KINSELLA MG, 1988, J BIOL CHEM, V263, P19222; Kramer MW, 2010, EUR UROL, V57, P86, DOI 10.1016/j.eururo.2009.03.057; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Melchior-Becker A, 2011, J BIOL CHEM, V286, P17365, DOI 10.1074/jbc.M110.192682; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Niedworok C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075681; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Recktenwald CV, 2012, J BIOL CHEM, V287, P24320, DOI 10.1074/jbc.M111.334425; Rock K, 2012, J BIOL CHEM, V287, P20056, DOI 10.1074/jbc.M112.353151; Rose A, 2010, BRIT J PHARMACOL, V160, P1690, DOI 10.1111/j.1476-5381.2010.00838.x; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Shabbir M, 2009, INT J UROL, V16, P143, DOI 10.1111/j.1442-2042.2008.02207.x; Singh V, 2012, ARCH MED RES; Sridhar SS, 2011, INVEST NEW DRUG, V29, P1045, DOI 10.1007/s10637-010-9408-4; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Szarvas T, 2010, CANCER SCI, V101, P1300, DOI 10.1111/j.1349-7006.2010.01506.x; Tepeli E, 2012, MOL BIOL REP, V39, P335, DOI 10.1007/s11033-011-0743-0; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Tzai TS, 1998, ANTICANCER RES, V18, P1585; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P894, DOI 10.4161/onci.20931; Wang B, 2011, EXP BIOL MED, V236, P1247, DOI 10.1258/ebm.2011.011124; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhu ZW, 2012, ANTI-CANCER AGENT ME, V12, P1081, DOI 10.2174/187152012803529673	53	37	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80084	10.1371/journal.pone.0080084	http://dx.doi.org/10.1371/journal.pone.0080084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223213	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200106
J	Ritter, S; Michalski, SG; Settele, J; Wiemers, M; Fric, ZF; Sielezniew, M; Sasic, M; Rozier, Y; Durka, W				Ritter, Sylvia; Michalski, Stefan G.; Settele, Josef; Wiemers, Martin; Fric, Zdenek F.; Sielezniew, Marcin; Sasic, Martina; Rozier, Yves; Durka, Walter			Wolbachia Infections Mimic Cryptic Speciation in Two Parasitic Butterfly Species, Phengaris teleius and P. nausithous (Lepidoptera: Lycaenidae)	PLOS ONE			English	Article							SELFISH GENETIC ELEMENTS; MALE-KILLING WOLBACHIA; MITOCHONDRIAL-DNA; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; MACULINEA-ALCON; EVOLUTIONARY; PHYLOGEOGRAPHY; DIVERSITY; PHYLOGENY	Deep mitochondrial divergence within species may result from cryptic speciation, from phylogeographic isolation or from endosymbiotic bacteria like Wolbachia that manipulate host reproduction. Phengaris butterflies are social parasites that spend most of their life in close relationship with ants. Previously, cryptic speciation has been hypothesised for two Phengaris species based on divergent mtDNA sequences. Since Phengaris species are highly endangered, the existence of cryptic species would have drastic consequences for conservation and management. We tested for cryptic speciation and alternative scenarios in P. teleius and P. nausithous based on a comprehensive sample across their Palaearctic ranges using COI gene sequences, nuclear microsatellites and tests for Wolbachia. In both species a deep mitochondrial split occurring 0.65-1.97 myrs ago was observed that did not correspond with microsatellite data but was concordant with Wolbachia infection. Haplotypes previously attributed to cryptic species were part of the Wolbachia-infected clades. In both species remaining phylogeographic structure was largely consistent between mitochondrial and nuclear genomes. In P. teleius several mitochondrial and nuclear groups were observed in East Asia while a single haplogroup and nuclear cluster prevailed across continental Eurasia. Neutrality tests suggested rapid demographic expansion into that area. In contrast, P. nausithous had several mitochondrial and nuclear groups in Europe, suggesting a complex phylogeographic history in the western part of the species range. We conclude that deep intraspecific divergences found in DNA barcode studies do not necessarily need to represent cryptic speciation but instead can be due to both infection by Wolbachia and phylogeographic structure.	[Ritter, Sylvia; Michalski, Stefan G.; Settele, Josef; Wiemers, Martin; Durka, Walter] Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Settele, Josef; Durka, Walter] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Fric, Zdenek F.] Acad Sci Czech Republ, Ctr Biol, Ceske Budejovice, Czech Republic; [Sielezniew, Marcin] Univ Bialystok, Inst Biol, Dept Invertebrate Zool, Bialystok, Poland; [Sasic, Martina] Croatian Nat Hist Museum, Dept Zool, Zagreb, Croatia; [Rozier, Yves] CED Entreprises, Ctr Activ Gorge Loup, Lyon, France	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Bialystok	Wiemers, M (corresponding author), Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	martin.wiemers@ufz.de	Durka, Walter/E-4667-2010; Wiemers, Martin/B-5715-2011; Settele, Josef/A-6371-2009; Michalski, Stefan G/O-5774-2015; FALTYNEK, FRIC ZDENEK/H-1468-2014	Durka, Walter/0000-0002-6611-2246; Wiemers, Martin/0000-0001-5272-3903; Settele, Josef/0000-0002-8624-4983; Michalski, Stefan G/0000-0002-8969-7355; FALTYNEK, FRIC ZDENEK/0000-0002-3611-8022; Sasic, Martina/0000-0002-0612-5619	VolkswagenStiftung [Az 1/82 751]; Deutsches Zentrum fur Luft- und Raumfahrt-Bundesministerium fur Bildung und Forschung (Germany); Natural Environment Research Council (UK); Department of Environment, Food & Rural Affairs (UK); French National Research Agency (France); Formas (Sweden); Swedish Environmental Protection Agency (Sweden); EU [226852]	VolkswagenStiftung(Volkswagen); Deutsches Zentrum fur Luft- und Raumfahrt-Bundesministerium fur Bildung und Forschung (Germany); Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Department of Environment, Food & Rural Affairs (UK); French National Research Agency (France)(French National Research Agency (ANR)); Formas (Sweden)(Swedish Research Council Formas); Swedish Environmental Protection Agency (Sweden); EU(European Commission)	The study was financially supported by the VolkswagenStiftung (http://www.volkswagenstiftung.de/) (Sylvia Ritter, Az 1/82 751). Furthermore, research has been conducted within the project CLIMIT (Climit Change Impacts on Insects and their Mitigation; http://www.climit-project.net/) funded by Deutsches Zentrum fur Luft- und Raumfahrt-Bundesministerium fur Bildung und Forschung (www.pt-dlr.de/?) (Germany), the Natural Environment Research Council (http://www.nerc.ac.uk/) and the Department of Environment, Food & Rural Affairs (http://www.defra.gov.uk/) (UK), the French National Research Agency (http://www.agence-nationale-recherche.fr/) (France), Formas (http://www.formas.se/) (Sweden), and Swedish Environmental Protection Agency (http://www.naturvardsverket.se/) (Sweden) through the FP6 BiodivERsA Eranet (http://www.biodiversa.org/) and was also funded within the EU funded project SCALES (http://www.scales-project.net/) (FP7 grant agreement no. 226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als TD, 2004, NATURE, V432, P386, DOI 10.1038/nature03020; [Anonymous], 2011, DISTRIBUTION ATLAS B; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bordenstein SR, 2000, HEREDITY, V84, P54, DOI 10.1046/j.1365-2540.2000.00637.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; Cassel A, 2003, CONSERV GENET, V4, P83, DOI 10.1023/A:1021884832122; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Druce HH, 1875, CISTULA ENTOMOLOGICA, V1, P357; Duplouy A, 2010, J EVOLUTION BIOL, V23, P231, DOI 10.1111/j.1420-9101.2009.01891.x; Egas M, 2002, EVOLUTION, V56, P1101; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fiedler K, 1998, J INSECT CONSERV, V2, P3, DOI 10.1023/A:1009618721239; Fric Z, 2007, SYST ENTOMOL, V32, P558, DOI 10.1111/j.1365-3113.2007.00387.x; Fu YX, 1996, GENETICS, V143, P557; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gerth M, 2011, SYST BIODIVERS, V9, P319, DOI 10.1080/14772000.2011.627953; Gompert Z, 2006, MOL ECOL, V15, P1759, DOI 10.1111/j.1365-294X.2006.02905.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatcher MJ, 2000, TRENDS ECOL EVOL, V15, P271, DOI 10.1016/S0169-5347(00)01875-9; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOFFMANN AA, 1988, GENETICS, V119, P435; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Hurst GDD, 2001, HEREDITY, V87, P220, DOI 10.1046/j.1365-2540.2001.00917.x; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Huyse T, 2005, TRENDS PARASITOL, V21, P469, DOI 10.1016/j.pt.2005.08.009; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansen VAA, 2008, P ROY SOC B-BIOL SCI, V275, P2769, DOI 10.1098/rspb.2008.0914; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; Kim I, 2006, INSECT MOL BIOL, V15, P217, DOI 10.1111/j.1365-2583.2006.00630.x; Lohman DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-301; Lukhtanov V, 1994, HERBIPOLIANA, V3; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; MATSUMURA S., 1926, INSECTA MATSUMURANA, V1, P23; Matsumura S, 1910, ENTOMOL Z, V23, P221; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Munguira ML, 1999, ACTION PLAN MACULINE; Munoz Astrid G, 2011, BMC Evol Biol, V11, P358, DOI 10.1186/1471-2148-11-358; Murayama S, 1992, NATURE INSECTS, V27, P37; Narita S, 2006, MOL ECOL, V15, P1095, DOI 10.1111/j.1365-294X.2006.02857.x; Nice CC, 2009, BIOL CONSERV, V142, P3137, DOI 10.1016/j.biocon.2009.08.020; Novikova O, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-93; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Patricelli D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-14; Pech P, 2004, CLADISTICS, V20, P362, DOI 10.1111/j.1096-0031.2004.00031.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; R Core Team, 2016, R FDN STAT COMP; Rakosy Laszlo, 2010, Nota Lepidopterologica, V33, P31; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reynolds KT, 2003, GENETICS, V164, P1027; Roine A, 2000, LEPIBASE 2 0 BUTTERF; Russell JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051027; Salunke BK, 2012, APPL ENVIRON MICROB, V78, P4458, DOI 10.1128/AEM.07298-11; Sarakatsanou A, 2011, J APPL ENTOMOL, V135, P554, DOI 10.1111/j.1439-0418.2011.01610.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schneider DI, 2013, J INVERTEBR PATHOL, V112, pS104, DOI 10.1016/j.jip.2012.03.024; Sibatani Atuhiro, 1994, Tyo To Ga, V44, P157; Sielezniew M, 2012, INSECT CONSERV DIVER, V5, P223, DOI 10.1111/j.1752-4598.2011.00163.x; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Staudinger O., 1892, Deutsche Entomologische Zeitschrift Lep, Vv, P300; Staudinger O, 1887, MEMOIRES LEPIDOPTERE, P126; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tagami Y, 2004, INSECT MOL BIOL, V13, P359, DOI 10.1111/j.0962-1075.2004.00492.x; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi A., 1973, Tyo to Ga, V23, P75; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Tshikolovets VV, 2009, BUTTERFLIES ALTAI SA; Tshikolovets VV, 2009, BUTTERFLIES MONGOLIA; Tshikolovets VV, 2002, BUTTERFLIES TRANSBAI; TSUKADA M, 1982, ECOLOGY, V63, P1091, DOI 10.2307/1937247; Ugelvig LV, 2011, MOL PHYLOGENET EVOL, V61, P237, DOI 10.1016/j.ympev.2011.05.016; van Swaay C, 2012, NAT CONSERV-BULGARIA, P73, DOI 10.3897/natureconservation.1.2786; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Wahlberg N, 2007, EUR J ENTOMOL, V104, P675, DOI 10.14411/eje.2007.085; Wang M, 2010, ZOOKEYS, P21, DOI 10.3897/zookeys.48.415; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wynhoff I, 1998, J INSECT CONSERV, V2, P15, DOI 10.1023/A:1009636605309; Zeisset I, 2005, MOL ECOL NOTES, V5, P165, DOI 10.1111/j.1471-8286.2004.00872.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	108	59	62	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78107	10.1371/journal.pone.0078107	http://dx.doi.org/10.1371/journal.pone.0078107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223136	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200028
J	Thienpont, JR; Kokelj, SV; Korosi, JB; Cheng, ES; Desjardins, C; Kimpe, LE; Blais, JM; Pisaric, MFJ; Smol, JP				Thienpont, Joshua R.; Kokelj, Steven V.; Korosi, Jennifer B.; Cheng, Elisa S.; Desjardins, Cyndy; Kimpe, Linda E.; Blais, Jules M.; Pisaric, Michael F. J.; Smol, John P.			Exploratory Hydrocarbon Drilling Impacts to Arctic Lake Ecosystems	PLOS ONE			English	Article							MACKENZIE DELTA REGION; NORTHWEST-TERRITORIES; PERMAFROST; CLADOCERA; CHEMISTRY	Recent attention regarding the impacts of oil and gas development and exploitation has focused on the unintentional release of hydrocarbons into the environment, whilst the potential negative effects of other possible avenues of environmental contamination are less well documented. In the hydrocarbon-rich and ecologically sensitive Mackenzie Delta region (NT, Canada), saline wastes associated with hydrocarbon exploration have typically been disposed of in drilling sumps (i.e., large pits excavated into the permafrost) that were believed to be a permanent containment solution. However, failure of permafrost as a waste containment medium may cause impacts to lakes in this sensitive environment. Here, we examine the effects of degrading drilling sumps on water quality by combining paleolimnological approaches with the analysis of an extensive present-day water chemistry dataset. This dataset includes lakes believed to have been impacted by saline drilling fluids leaching from drilling sumps, lakes with no visible disturbances, and lakes impacted by significant, naturally occurring permafrost thaw in the form of retrogressive thaw slumps. We show that lakes impacted by compromised drilling sumps have significantly elevated lakewater conductivity levels compared to control sites. Chloride levels are particularly elevated in sump-impacted lakes relative to all other lakes included in the survey. Paleolimnological analyses showed that invertebrate assemblages appear to have responded to the leaching of drilling wastes by a discernible increase in a taxon known to be tolerant of elevated conductivity coincident with the timing of sump construction. This suggests construction and abandonment techniques at, or soon after, sump establishment may result in impacts to downstream aquatic ecosystems. With hydrocarbon development in the north predicted to expand in the coming decades, the use of sumps must be examined in light of the threat of accelerated permafrost thaw, and the potential for these industrial wastes to impact sensitive Arctic ecosystems.	[Thienpont, Joshua R.; Korosi, Jennifer B.; Cheng, Elisa S.; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Kokelj, Steven V.] Govt Northwest Terr, Northwest Terr Geosci Off, Yellowknife, NT, Canada; [Korosi, Jennifer B.; Desjardins, Cyndy; Kimpe, Linda E.; Blais, Jules M.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Pisaric, Michael F. J.] Carleton Univ, Dept Geog & Environm Studies, Ottawa, ON K1S 5B6, Canada; [Pisaric, Michael F. J.] Brock Univ, Dept Geog, St Catharines, ON L2S 3A1, Canada	Queens University - Canada; University of Ottawa; Carleton University; Brock University	Smol, JP (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	smolj@queensu.ca	Smol, John P/A-8838-2015; Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598; Korosi, Jennifer/0000-0002-9917-8137; Smol, John/0000-0002-2499-6696; Pisaric, Michael/0000-0003-3806-8986	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Northern Supplement	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Northern Supplement	This work was funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada through Discovery grants to MFJP, JMB and JPS, and an NSERC Northern Supplement to MFJP. The Polar Continental Shelf Program (PCSP) also provided logistical support to MFJP. The cumulative impact monitoring program (CIMP) provided support for collection of water chemistry results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA, 2005, ARCTIC CLIMATE IMPAC; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Battarbee R. W., 2001, TRACKING ENV CHANGE, P155, DOI DOI 10.1007/0-306-47668-1_8; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; Bos DG, 1999, HYDROBIOLOGIA, V392, P129, DOI 10.1023/A:1003542709450; Burn CR, 2009, PERMAFROST PERIGLAC, V20, P83, DOI 10.1002/ppp.655; CHENGALATH R, 1982, CAN J ZOOL, V60, P2668, DOI 10.1139/z82-343; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Deasley K, 2012, J PALEOLIMNOL, V48, P287, DOI 10.1007/s10933-012-9577-6; Dixon J, 1994, BULLETIN, V474, P1; Dyke LD, 2001, POLAR REC, V37, P215, DOI DOI 10.1017/S0032247400027248; Falk M.R., 1973, CEN731 CAN DEP ENV F; FRENCH HM, 1980, ARCTIC, V33, P794; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Grimm EC, 2011, TIHA V1 6 COMPUTER P; Jenkins R, 2008, P 9 INT C PERM JUN 2, P833; Johnstone JF, 2008, ARCTIC, V61, P199; Kanigan J, 2010, GEO2010, P1473; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kokelj SV, 2010, COLD REG SCI TECHNOL, V64, P46, DOI 10.1016/j.coldregions.2010.04.009; Kokelj SV, 2009, PERMAFROST PERIGLAC, V20, P185, DOI 10.1002/ppp.641; Kokelj SV, 2005, PERMAFROST PERIGLAC, V16, P343, DOI 10.1002/ppp.536; Kokelj SV, 2005, CAN J EARTH SCI, V42, P37, DOI 10.1139/E04-089; Korosi JB, 2012, J PALEOLIMNOL, V48, P571, DOI 10.1007/s10933-012-9632-3; Kurek J, 2013, P NATL ACAD SCI USA, V110, P1761, DOI 10.1073/pnas.1217675110; Lantz TC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032433; Mesquita PS, 2010, FRESHWATER BIOL, V55, P2347, DOI 10.1111/j.1365-2427.2010.02450.x; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; Oksanen J., 2017, COMMUNITY ECOLOGY PA; R Core Team, 2021, R LANGUAGE ENV STAT; Rampton VN, 1988, GEOLOGICAL SURVEY CA; Smol J.P., 2008, POLLUTION LAKES RIVE, V2nd ed.; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104; Sweetman JN, 2010, J LIMNOL, V69, P76, DOI 10.4081/jlimnol.2010.76; Thienpont JR, 2013, FRESHWATER BIOL, V58, P337, DOI 10.1111/fwb.12061; Utz LRP, 2001, B ENVIRON CONTAM TOX, V66, P379, DOI 10.1007/s00128-001-0016-z	37	17	17	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78875	10.1371/journal.pone.0078875	http://dx.doi.org/10.1371/journal.pone.0078875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223170	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200062
J	Wang, LT; Chen, BL; Wu, CT; Huang, KH; Chiang, CK; Liu, SH				Wang, Li-Ting; Chen, Bo-Lin; Wu, Cheng-Tien; Huang, Kuo-How; Chiang, Chih-Kang; Liu, Shing Hwa			Protective Role of AMP-Activated Protein Kinase-Evoked Autophagy on an In Vitro Model of Ischemia/Reperfusion-Induced Renal Tubular Cell Injury	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; REPERFUSION INJURY; CARDIAC AUTOPHAGY; ISCHEMIA; KIDNEY; MTOR; PHOSPHORYLATION; EXPRESSION; APOPTOSIS; PATHWAYS	Ischemia/reperfusion (I/R) injury is a common cause of injury to target organs such as brain, heart, and kidneys. Renal injury from I/R, which may occur in renal transplantation, surgery, trauma, or sepsis, is known to be an important cause of acute kidney injury. The detailed molecular mechanism of renal I/R injury is still not fully clear. Here, we investigate the role of AMP-activated protein kinase (AMPK)-evoked autophagy in the renal proximal tubular cell death in an in vitro I/R injury model. To mimic in vivo renal I/R injury, LLC-PK1 cells, a renal tubular cell line derived from pig kidney, were treated with antimycin A and 2-deoxyglucose to mimic ischemia injury followed by reperfusion with growth medium. This I/R injury model markedly induced apoptosis and autophagy in LLC-PK1 cells in a time-dependent manner. Autophagy inhibitor 3-methyladenine (3MA) significantly enhanced I/R injury-induced apoptosis. I/R could also up-regulate the phosphorylation of AMPK and down-regulate the phosphorylation of mammalian target of rapamycin (mTOR). Cells transfected with small hairpin RNA (shRNA) for AMPK significantly increased the phosphorylation of mTOR as well as decreased the induction of autophagy followed by enhancing cell apoptosis during I/R. Moreover, the mTOR inhibitor RAD001 significantly enhanced autophagy and attenuated cell apoptosis during I/R. Taken together, these findings suggest that autophagy induction protects renal tubular cell injury via an AMPK-regulated mTOR pathway in an in vitro I/R injury model. AMPK-evoked autophagy may be as a potential target for therapeutic intervention in I/R renal injury.	[Wang, Li-Ting; Chen, Bo-Lin; Wu, Cheng-Tien; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Huang, Kuo-How] Natl Taiwan Univ, Coll Med, Dept Urol, Taipei 10764, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chiang, CK (corresponding author), Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan.	ckchiang@ntu.edu.tw; shinghwaliu@ntu.edu.tw	Wu, Cheng-Tien/ABE-9509-2022; Wu, Cheng-Tien/AAF-5177-2019	CHIANG, CHIH-KANG/0000-0001-9021-4616; Huang, Kuo-How/0000-0002-0989-0578; LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC97-2314-B-002-052-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grant from the National Science Council of Taiwan (NSC97-2314-B-002-052-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 2012, BMB REP, V45, P489, DOI 10.5483/BMBRep.2012.45.9.169; Andreucci M, 2003, KIDNEY INT, V64, P1189, DOI 10.1046/j.1523-1755.2003.00204.x; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Castaneda MP, 2003, TRANSPLANTATION, V76, P50, DOI 10.1097/01.TP.0000069835.95442.9F; Chiang CK, 2011, BRIT J PHARMACOL, V163, P586, DOI 10.1111/j.1476-5381.2011.01242.x; CONGER JD, 1995, J INVEST MED, V43, P431; Cryer HG, 1997, SHOCK, V8, P26, DOI 10.1097/00024382-199707000-00005; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Inal M, 2002, CELL BIOCHEM FUNCT, V20, P291, DOI 10.1002/cbf.953; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jeyaraj SC, 2006, AM J PHYSIOL-RENAL, V291, pF1255, DOI 10.1152/ajprenal.00440.2005; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Jin QR, 2004, BIOCHEM BIOPH RES CO, V315, P555, DOI 10.1016/j.bbrc.2004.01.093; Kolyada AY, 2008, AM J NEPHROL, V28, P203, DOI 10.1159/000110089; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Lee HT, 2002, J AM SOC NEPHROL, V13, P2753, DOI 10.1097/01.ASN.0000032421.79225.6E; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lu J, 2010, P NATL ACAD SCI USA, V107, P21665, DOI 10.1073/pnas.1014376107; Matsuyama M, 2004, EXPERT OPIN BIOL TH, V4, P1931, DOI 10.1517/14712598.4.12.1931; Meier-Kriesche HU, 2001, KIDNEY INT, V59, P1539, DOI 10.1046/j.1523-1755.2001.0590041539.x; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Molitoris BA, 2004, KIDNEY INT, V66, P871, DOI 10.1111/j.1523-1755.2004.00818.x; Munafo DB, 2001, J CELL SCI, V114, P3619; Okusa MD, 2002, AM J PHYSIOL-RENAL, V282, pF10, DOI 10.1152/ajprenal.2002.282.1.F10; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Takagi H, 2007, AUTOPHAGY, V3, P405, DOI 10.4161/auto.4281; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Tilney NL, 1997, TRANSPLANTATION, V64, P945, DOI 10.1097/00007890-199710150-00001; Wolf G, 1997, J CLIN INVEST, V100, P1047, DOI 10.1172/JCI119615; Woroniecki R, 2003, AM J PHYSIOL-RENAL, V284, pF358, DOI 10.1152/ajprenal.00100.2002; Wu CT, 2010, TOXICOL SCI, V114, P295, DOI 10.1093/toxsci/kfq006; Xie J, 2006, J AM SOC NEPHROL, V17, P3336, DOI 10.1681/ASN.2006040311; Xie ZL, 2011, AUTOPHAGY, V7, P1254, DOI 10.4161/auto.7.10.16740; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Xu M, 2011, ACTA PHARMACOL SIN, V32, P1089, DOI 10.1038/aps.2011.50; Yen YP, 2012, ARCH TOXICOL, V86, P923, DOI 10.1007/s00204-012-0864-9	47	50	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79814	10.1371/journal.pone.0079814	http://dx.doi.org/10.1371/journal.pone.0079814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223196	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200089
J	Gajda, MJ; Zapien, DM; Uchikawa, E; Dock-Bregeon, AC				Gajda, Michal Jan; Zapien, Denise Martinez; Uchikawa, Emiko; Dock-Bregeon, Anne-Catherine			Modeling the Structure of RNA Molecules with Small-Angle X-Ray Scattering Data	PLOS ONE			English	Article							PREDICTION; RESOLUTION; PROTEINS; PROGRAM; MOTIFS; LOOPS	We propose a novel fragment assembly method for low-resolution modeling of RNA and show how it may be used along with small-angle X-ray solution scattering (SAXS) data to model low-resolution structures of particles having as many as 12 independent secondary structure elements. We assessed this model-building procedure by using both artificial data on a previously proposed benchmark and publicly available data. With the artificial data, SAXS-guided models show better similarity to native structures than ROSETTA decoys. The publicly available data showed that SAXS-guided models can be used to reinterpret RNA structures previously deposited in the Protein Data Bank. Our approach allows for fast and efficient building of de novo models of RNA using approximate secondary structures that can be readily obtained from existing bioinformatic approaches. We also offer a rigorous assessment of the resolving power of SAXS in the case of small RNA structures, along with a small multimetric benchmark of the proposed method.	[Gajda, Michal Jan] Max Planck Inst Biophys Chem, NMR Based Struct Biol, D-37077 Gottingen, Niedersachsen, Germany; [Gajda, Michal Jan] European Mol Biol Labs, Hamburg, Germany; [Zapien, Denise Martinez; Uchikawa, Emiko; Dock-Bregeon, Anne-Catherine] Inst Genet & Biol Mol & Cellulaire, Lab Biol & Genom Struct, Illkirch Graffenstaden, Bas Rhin, France; [Dock-Bregeon, Anne-Catherine] Inst Biol Ecole Normale Super, Paris, Ile De France, France	Max Planck Society; European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Gajda, MJ (corresponding author), Max Planck Inst Biophys Chem, NMR Based Struct Biol, D-37077 Gottingen, Niedersachsen, Germany.	miga@nmr.mpibpc.mpg.de		Dock-Bregeon, Anne-Catherine/0000-0002-6913-4061; UCHIKAWA, Emiko/0000-0003-0442-767X	SAXIER [RIDS-011934]; French Agency for Research [ANR-06-BLAN-0072]; CNRS; INSERM; University of Strasbourg; SPINE-2 European project [LSHG-CT-2006-031220]; CONACYT, Mexico; Association pour la Recherche sur le Cancer (ARC)	SAXIER; French Agency for Research(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; SPINE-2 European project; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	The work of MJG was partially funded by the SAXIER (RIDS-011934) grant from EU. ACDB and DMZ were funded by French Agency for Research (grant TrscrREGsnRNP ANR-06-BLAN-0072); CNRS, INSERM, University of Strasbourg and the SPINE-2 European project (Contract LSHG-CT-2006-031220). DMZ received a doctoral fellowship from CONACYT, Mexico, and Association pour la Recherche sur le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindewald E, 2008, NUCLEIC ACIDS RES, V36, pD392, DOI 10.1093/nar/gkm842; Bothe JR, 2011, NAT METHODS, V8, P919, DOI [10.1038/NMETH.1735, 10.1038/nmeth.1735]; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Durney MA, 2010, J MOL BIOL, V404, P555, DOI 10.1016/j.jmb.2010.08.042; Ellson J, 2004, MATH VIS, P127; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; Gillespie J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-369; Hajdin CE, 2010, RNA, V16, P1340, DOI 10.1261/rna.1837410; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Jonikas MA, 2009, RNA, V15, P189, DOI 10.1261/rna.1270809; Jossinet F, 2010, BIOINFORMATICS; Karaduman R, 2006, J MOL BIOL, V356, P1248, DOI 10.1016/j.jmb.2005.12.013; Kladwang W, 2012, J AM CHEM SOC, V134, P1404, DOI 10.1021/ja2093508; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAVERY R, 1995, COMPUT PHYS COMMUN, V91, P135, DOI 10.1016/0010-4655(95)00046-I; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; Marz M, 2009, MOL BIOL EVOL, V26, P2821, DOI 10.1093/molbev/msp198; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Michalsky E, 2003, PROTEIN ENG, V16, P979, DOI 10.1093/protein/gzg119; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Parisien M, 2012, J STRUCT BIOL, V179, P252, DOI 10.1016/j.jsb.2011.12.024; Parisien M, 2009, RNA, V15, P1875, DOI 10.1261/rna.1700409; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Puton T, 2012, A SERVER FOR CONTINU; Reinharz V, 2012, BIOINFORMATICS, V28, pI207, DOI 10.1093/bioinformatics/bts226; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; Standley DM, 1999, J MOL BIOL, V285, P1691, DOI 10.1006/jmbi.1998.2372; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun D, 1987, STRUCTURE ANAL SMALL, DOI 10.1007/978-1-4757-6624-0_1; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Yang SC, 2010, J PHYS CHEM B, V114, P10039, DOI 10.1021/jp1057308; Zhang Q, 2008, NAT METHODS, V5, P243, DOI 10.1038/NMETH.1180; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	50	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78007	10.1371/journal.pone.0078007	http://dx.doi.org/10.1371/journal.pone.0078007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223750	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400027
J	Xu, GD; Xin, X; Zheng, CY				Xu, Guodong; Xin, Xiu; Zheng, Congyi			GPS2 Is Required for the Association of NS5A with VAP-A and Hepatitis C Virus Replication	PLOS ONE			English	Article							RNA REPLICATION; G-PROTEIN; COMPLEX; DOMAIN; PHOSPHORYLATION; PATHWAY; BINDING	Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a component of the replication complex associated with various cellular proteins. It has been reported that G protein pathway suppressor 2 (GPS2) is a potential NS5A-binding factor, as identified in a yeast two-hybrid screens of human cDNA library using viral proteins as baits [1]. In this study, we demonstrated the interaction between GPS2 and NS5A in mammalian cells by coimmunoprecipitation analysis and found that both exogenously and endogenously expressed GPS2 interacted with NS5A of genotype 1b and 2a. Mutagenesis study demonstrated that Domain I of NS5A and coiled-coil domain of GPS2 are responsible for the interaction. Knockdown of GPS2 in hepatoma cell lines suppressed the replication of HCV RNA, which can be rescued by the expression of an RNAi-resistant GPS2. Furthermore, overexpression of GPS2 enhanced the association of NS5A with a proviral cellular factor, human vesicle-associated membrane protein-associated protein A (VAP-A), while knockdown of GPS2 disrupted interaction between VAP-A and NS5A. Taken together, our results suggest that GPS2 acts as a bridge between NS5A and VAP-A and is required for efficient HCV replication.	[Xu, Guodong; Xin, Xiu; Zheng, Congyi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Zheng, Congyi] Wuhan Univ, China Ctr Type Culture Collect, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zheng, CY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	cctcc202@whu.edu.cn			National Basic Research Program of China [2011CB504800]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (Grant No. 2011CB504800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Cerny A, 1999, HEPATOLOGY, V30, P595, DOI 10.1002/hep.510300312; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Christopher V, 2005, J NEUROL, V252, P855, DOI 10.1007/s00415-005-0767-2; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Kim S, 2011, J VIROL, V85, P6645, DOI 10.1128/JVI.02156-10; Kim YK, 2002, BIOCHEM BIOPH RES CO, V290, P105, DOI 10.1006/bbrc.2001.6167; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038130; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi Kohji, 2003, Antiviral Chemistry & Chemotherapy, V14, P285; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Reed KE, 1997, J VIROL, V71, P7187, DOI 10.1128/JVI.71.10.7187-7197.1997; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Tan SL., 2006, HEPATITIS C VIRUSES; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	35	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78195	10.1371/journal.pone.0078195	http://dx.doi.org/10.1371/journal.pone.0078195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223774	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400038
J	Plumptre, CD; Ogunniyi, AD; Paton, JC				Plumptre, Charles D.; Ogunniyi, Abiodun D.; Paton, James C.			Vaccination against Streptococcus pneumoniae Using Truncated Derivatives of Polyhistidine Triad Protein D	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; SECONDARY STRUCTURE ANALYSES; VIRULENCE PROTEINS; BINDING PROTEIN; IN-VIVO; IMMUNOGENICITY; EXPRESSION; ANTIGENS; MICE; IDENTIFICATION	Polyhistidine triad protein D (PhtD) has been described as a promising vaccine candidate for use against Streptococcus pneumoniae, but there has been a lack of examination of its structure and of which region(s) of the protein are targeted by protective immune responses. In this study, we purified recombinant truncated derivatives of PhtD and examined their secondary structural composition, as well as their capacity to bind antibodies from polyclonal murine serum generated against the full length protein. This allowed the identification of a particularly immunogenic fragment of PhtD, which was also purified and characterised. The truncated derivatives were tested as vaccine antigens in mouse models of pneumococcal sepsis and colonisation, using alum and E. coli heat labile toxin B subunit respectively as adjuvants. These experiments revealed that whilst the immunogenic region identified may be a promising candidate to protect against sepsis, the full length PhtD was ineffective at conferring significant protective immunity. These results are significant for the potential for PhtD to be used in novel vaccines, which are currently being tested in clinical trials.	[Plumptre, Charles D.; Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Paton, JC (corresponding author), Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	james.paton@adelaide.edu.au		Ogunniyi, Abiodun/0000-0001-9308-5629	National Health and Medical Research Council (NHMRC) of Australia [565526]; Australian Research Council [DP120101432]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council (NHMRC; http://www.nhmrc.gov.au/) of Australia (Program Grant 565526 to JCP) and the Australian Research Council (http://www.arc.gov.au/; Discovery Project Grant DP120101432 to JCP). JCP is a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Bologa M, 2012, VACCINE, V30, P7461, DOI 10.1016/j.vaccine.2012.10.076; Briles DE, 2006, 2006 EUR INF LUNG DI; Briles DE, 2009, NEW GENERATION VACCI, P908; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Kadioglu Aras, 2005, Briefings in Functional Genomics & Proteomics, V4, P241, DOI 10.1093/bfgp/4.3.241; Khan MN, 2013, INFECT IMMU IN PRESS; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malley R, 2012, P NATL ACAD SCI USA, V109, P3623, DOI 10.1073/pnas.1121383109; McCullers JA, 2001, FRONT BIOSCI-LANDMRK, V6, pD877, DOI 10.2741/McCullers; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; PATON JC, 1991, INFECT IMMUN, V59, P2297, DOI 10.1128/IAI.59.7.2297-2304.1991; Plumptre CD, 2013, INFECT IMMU IN PRESS; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Rioux S, 2010, MICROBIOLOGY, V157, P336; Seiberling M, 2012, VACCINE, V30, P7455, DOI 10.1016/j.vaccine.2012.10.080; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhang Y, 2001, INFECT IMMUN, V69, P3827, DOI 10.1128/IAI.69.6.3827-3836.2001	32	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78916	10.1371/journal.pone.0078916	http://dx.doi.org/10.1371/journal.pone.0078916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205351	Green Published, Green Submitted, gold			2022-12-27	WOS:000326373800026
J	Xie, B; Wang, DP; Duan, Y; Yu, J; Lei, HX				Xie, Bin; Wang, Dapeng; Duan, Yong; Yu, Jun; Lei, Hongxing			Functional Networking of Human Divergently Paired Genes (DPGs)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; VIRUS TYPE-1 INFECTION; CD8(+) T-CELLS; BIDIRECTIONAL PROMOTERS; EXPRESSION; CONSERVATION; PATHWAYS; DISEASE; ORGANIZATION; METASTASIS	Divergently paired genes (DPGs), also known as bidirectional (head-to-head positioned) genes, are conserved across species and lineages, and thus deemed to be exceptional in genomic organization and functional regulation. Despite previous investigations on the features of their conservation and gene organization, the functional relationship among DPGs in a given species and lineage has not been thoroughly clarified. Here we report a network-based comprehensive analysis on human DPGs and our results indicate that the two members of the DPGs tend to participate in different biological processes while enforcing related functions as modules. Comparing to randomly paired genes as a control, the DPG pairs have a tendency to be clustered in similar "cellular components" and involved in similar "molecular functions". The functional network bridged by DPGs consists of three major modules. The largest module includes many house-keeping genes involved in core cellular activities. This module also shows low variation in expression in both CNS (central nervous system) and non-CNS tissues. Based on analyses of disease transcriptome data, we further suggest that this particular module may play crucial roles in HIV infection and its disease mechanism.	[Xie, Bin; Wang, Dapeng; Yu, Jun; Lei, Hongxing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Xie, Bin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Duan, Yong; Lei, Hongxing] UC Davis Genome Ctr, Davis, CA USA; [Duan, Yong; Lei, Hongxing] Dept Biomed Engn, Davis, CA USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Yu, J (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn; leihx@big.ac.cn	Duan, Yong/D-3475-2013; Wang, Dapeng/HGD-4818-2022	Duan, Yong/0000-0003-3793-5099; 	NIH [GM67168]; NSFC [30870474]; MOST [2011CB944100]; CAS Youth Innovation Promotion Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); MOST; CAS Youth Innovation Promotion Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from NIH (Grant GM67168 to YD), NSFC (Grant 30870474 to HL), and MOST (2011CB944100 to JY), and the special grant of CAS Youth Innovation Promotion Association awarded to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Lopez MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010654; du Plessis L, 2011, BRIEF BIOINFORM, V12, P723, DOI 10.1093/bib/bbr002; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 2004, REPROD FERT DEVELOP, V16, P527, DOI 10.1071/RD03096; Herr DR, 2004, FEBS LETT, V572, P147, DOI 10.1016/j.febslet.2004.07.026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; LaBreche HG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-61; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Liu BC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S2; Marchand A, 2011, AGING CELL, V10, P220, DOI 10.1111/j.1474-9726.2010.00661.x; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Setlur SR, 2007, CANCER RES, V67, P10296, DOI 10.1158/0008-5472.CAN-07-2173; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Sun JY, 2012, J ALZHEIMERS DIS, V28, P389, DOI 10.3233/JAD-2011-111313; Takai D, 2004, MOL BIOL EVOL, V21, P463, DOI 10.1093/molbev/msh040; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Uddin S, 2011, AM J PATHOL, V178, P537, DOI 10.1016/j.ajpath.2010.10.020; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Wang DP, 2012, EVOL BIOINFORM, V8, P39, DOI 10.4137/EBO.S8540; Wang GZ, 2011, GENOME BIOL EVOL, V3, P320, DOI [10.1093/gbe/evr049, 10.1093/gbe/evr025]; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Woo YH, 2011, P NATL ACAD SCI USA, V108, P3306, DOI 10.1073/pnas.1100210108; Yang L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-55; Yang MQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S3; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	54	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78896	10.1371/journal.pone.0078896	http://dx.doi.org/10.1371/journal.pone.0078896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205343	Green Published, Green Submitted, gold			2022-12-27	WOS:000326373800024
J	Federolf, PA				Federolf, Peter Andreas			A Novel Approach to Solve the "Missing Marker Problem'' in Marker-Based Motion Analysis That Exploits the Segment Coordination Patterns in Multi-Limb Motion Data	PLOS ONE			English	Article							GAIT; STEREOPHOTOGRAMMETRY; VARIABILITY; KINEMATICS; ARTIFACT; SYSTEMS; PCA; AGE	Marker-based human motion analysis is an important tool in clinical research and in many practical applications. Missing marker information caused by occlusions or a marker falling off is a common problem impairing data quality. The current paper proposes a conceptually new gap filling algorithm and presents results from a proof-of-principle analysis. The underlying idea of the proposed algorithm was that a multitude of internal and external constraints govern human motion and lead to a highly subject-specific movement pattern in which all motion variables are intercorrelated in a specific way. Two principal component analyses were used to determine how the coordinates of a marker with gaps correlated with the coordinates of the other, gap-free markers. Missing marker data could then be reconstructed through a series of coordinate transformations. The proposed algorithm was tested by reconstructing artificially created gaps in a 20-step walking trial and in an 18-s one-leg balance trial. The measurement accuracy's dependence on the marker position, the length of the gap, and other parameters were evaluated. Even if only 2 steps of walking or 1.8 s of postural sway (10% of the whole marker data) were provided as input in the current study, the reconstructed marker trajectory differed on average no more than 11 mm from the originally measured trajectory. The reconstructed result improved further, on average, to distances below 5 mm if the marker trajectory was available more than 50% of the trial. The results of this proof-of-principle analysis supported the assumption that missing marker information can be reconstructed from the intercorrelations between marker coordinates, provided that sufficient data with complete marker information is available. Estimating missing information cannot be avoided entirely in many situations in human motion analysis. For some of these situations, the proposed reconstruction method may provide a better solution than what is currently available.	Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway	Norwegian School of Sport Sciences	Federolf, PA (corresponding author), Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway.	peter.federolf@nih.no	Federolf, Peter/H-4481-2019	Federolf, Peter/0000-0002-0266-6813				Aristidou A, 2013, VISUAL COMPUT, V29, P7, DOI 10.1007/s00371-011-0671-y; Baumann J, 2011, WORKSH VIRT REAL INT, V33; Benoit DL, 2006, GAIT POSTURE, V24, P152, DOI 10.1016/j.gaitpost.2005.04.012; Boyer KA, 2012, J BIOMECH, V45, P1619, DOI 10.1016/j.jbiomech.2012.04.010; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Dorfmuller-Ulhaas K, 2003, TECHNICAL REPORT; Erer KS, 2007, J BIOMECH, V40, P2934, DOI 10.1016/j.jbiomech.2007.02.019; Eskofier BM, 2013, COMPUT METHOD BIOMEC, V16, P435, DOI 10.1080/10255842.2011.624515; Federolf P, 2014, SCAND J MED SCI SPOR, V24, P491, DOI 10.1111/j.1600-0838.2012.01455.x; Federolf P, 2013, J BIOMECHAN IN PRESS, DOI [10.1016/j.jbiomech.2013.08.008, DOI 10.1016/J.JBI0MECH.2013.08.008]; Federolf PA, 2013, J BIOMECH, V46, P2173, DOI 10.1016/j.jbiomech.2013.06.032; Federolf P, 2012, J BIOMECH, V45, P1127, DOI 10.1016/j.jbiomech.2012.02.008; Federolf PA, 2012, FOOTWEAR SCI, V4, P115, DOI 10.1080/19424280.2012.666270; Giakas G, 1997, J BIOMECH, V30, P851, DOI 10.1016/S0021-9290(97)00043-2; Howarth SJ, 2010, COMPUT METHOD BIOMEC, V13, P847, DOI 10.1080/10255841003664701; KAMM K, 1990, PHYS THER, V70, P763, DOI 10.1093/ptj/70.12.763; Ko YG, 2003, HUM MOVEMENT SCI, V22, P47, DOI 10.1016/S0167-9457(02)00177-X; Liu GD, 2006, VISUAL COMPUT, V22, P721, DOI 10.1007/s00371-006-0080-9; Lou H, 2010, IEEE T VIS COMPUT GR, V16, P870, DOI 10.1109/TVCG.2010.23; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Nigg BM, 2012, J BIOMECH, V45, P1692, DOI 10.1016/j.jbiomech.2012.03.027; Nikolai Bernstein, 1967, COORDINATION REGULAT; Piazza T, 2009, LECT NOTES COMPUT SC, V5903, P125, DOI 10.1007/978-3-642-10470-1_11; Qiong Wu, 2011, 2011 XIII Symposium on Virtual Reality (SVR), P161, DOI 10.1109/SVR.2011.35; Stagni R, 2005, CLIN BIOMECH, V20, P320, DOI 10.1016/j.clinbiomech.2004.11.012; THELEN E, 1987, DEV REV, V7, P39, DOI 10.1016/0273-2297(87)90004-9; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Verrel J, 2009, PSYCHOL AGING, V24, P75, DOI 10.1037/a0014272; Xiao J, 2011, COMPUT ANIMAT VIRT W, V22, P221, DOI 10.1002/cav.413	32	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78689	10.1371/journal.pone.0078689	http://dx.doi.org/10.1371/journal.pone.0078689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205295	Green Submitted, gold, Green Published			2022-12-27	WOS:000326334500129
J	Mian, OS; Li, Y; Antunes, A; Glover, PM; Day, BL				Mian, Omar S.; Li, Yan; Antunes, Andre; Glover, Paul M.; Day, Brian L.			On the Vertigo Due to Static Magnetic Fields	PLOS ONE			English	Article							ANGULAR VELOCITY; PASSIVE ROTATION; SELF-MOTION; PERCEPTION; CONSTANT; MRI; ACCELERATION; THRESHOLDS; BODY; AXIS	Vertigo is sometimes experienced in and around MRI scanners. Mechanisms involving stimulation of the vestibular system by movement in magnetic fields or magnetic field spatial gradients have been proposed. However, it was recently shown that vestibular-dependent ocular nystagmus is evoked when stationary in homogenous static magnetic fields. The proposed mechanism involves Lorentz forces acting on endolymph to deflect semicircular canal (SCC) cupulae. To investigate whether vertigo arises from a similar mechanism we recorded qualitative and quantitative aspects of vertigo and 2D eye movements from supine healthy adults (n = 25) deprived of vision while pushed into the 7T static field of an MRI scanner. Exposures were variable and included up to 135s stationary at 7T. Nystagmus was mainly horizontal, persisted during long-exposures with partial decline, and reversed upon withdrawal. The dominant vertiginous perception with the head facing up was rotation in the horizontal plane (85% incidence) with a consistent direction across participants. With the head turned 90 degrees in yaw the perception did not transform into equivalent vertical plane rotation, indicating a context-dependency of the perception. During long exposures, illusory rotation lasted on average 50 s, including 42 s whilst stationary at 7T. Upon withdrawal, perception re-emerged and reversed, lasting on average 30 s. Onset fields for nystagmus and perception were significantly correlated (p<.05). Although perception did not persist as long as nystagmus, this is a known feature of continuous SSC stimulation. These observations, and others in the paper, are compatible with magnetic-field evoked-vertigo and nystagmus sharing a common mechanism. With this interpretation, response decay and reversal upon withdrawal from the field, are due to adaptation to continuous vestibular input. Although the study does not entirely exclude the possibility of mechanisms involving transient vestibular stimulation during movement in and out of the bore, we argue these are less likely.	[Mian, Omar S.; Day, Brian L.] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Li, Yan; Antunes, Andre; Glover, Paul M.] Univ Nottingham, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England	University of London; University College London; University of Nottingham	Mian, OS (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	o.mian@ucl.ac.uk	Mian, Omar S/C-1810-2008	Mian, Omar S/0000-0003-0423-4747; Antunes, Andre/0000-0002-9428-8759; Glover, Paul/0000-0002-5694-1470	Engineering and Physical Sciences Research Council (UK) [EP/G062692/1, EP/G061653/1]; Engineering and Physical Sciences Research Council [EP/G061653/1, EP/G062692/1] Funding Source: researchfish; EPSRC [EP/G062692/1, EP/G061653/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported through funding from the Engineering and Physical Sciences Research Council (UK), http://www.epsrc.ac.uk/ (Grant numbers EP/G062692/1 and EP/G061653/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes A, 2012, PHYS MED BIOL, V57, P4477, DOI 10.1088/0031-9155/57/14/4477; BROWN JH, 1968, PERCEPT PSYCHOPHYS, V3, P115, DOI 10.3758/BF03212778; BROWN JH, 1966, J EXP PSYCHOL, V72, P169, DOI 10.1037/h0023439; Cavin ID, 2007, J MAGN RESON IMAGING, V26, P1357, DOI 10.1002/jmri.21153; CLARK B, 1968, J EXP PSYCHOL, V78, P329, DOI 10.1037/h0026276; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; GUEDRY FE, 1961, J APPL PHYSIOL, V16, P215, DOI 10.1152/jappl.1961.16.2.215; Guedry FE, 1974, HDB SENSORY PHYSL, P3; Heilmaier C, 2011, BIOELECTROMAGNETICS, V32, P610, DOI 10.1002/bem.20680; JANSSON F, 1963, ACTA OPHTHALMOL, V41, P236; MacDougall HG, 2002, EXP BRAIN RES, V144, P69, DOI 10.1007/s00221-002-1038-4; Okada T, 1999, BRAIN, V122, P1293, DOI 10.1093/brain/122.7.1293; Roberts DC, 2011, CURR BIOL, V21, P1635, DOI 10.1016/j.cub.2011.08.029; SCHENCK JF, 1992, MED PHYS, V19, P1089, DOI 10.1118/1.596827; Seemungal BM, 2004, J VESTIBUL RES-EQUIL, V14, P461; Sinha N, 2008, PROG BRAIN RES, V171, P277, DOI 10.1016/S0079-6123(08)00639-0; St George RJ, 2011, J PHYSIOL-LONDON, V589, P843, DOI 10.1113/jphysiol.2010.197053; Theysohn JM, 2008, MAGN RESON MATER PHY, V21, P63, DOI 10.1007/s10334-007-0095-x; Versluis MJ, 2013, J MAGN RESON IMAGING, V38, P722, DOI 10.1002/jmri.23904	20	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78748	10.1371/journal.pone.0078748	http://dx.doi.org/10.1371/journal.pone.0078748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205304	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500131
J	Li, SL; Zheng, QF; Ma, YY; Wang, YZ; Feng, Y; Zhao, BT; Yang, Y				Li, Shaolei; Zheng, Qingfeng; Ma, Yuanyuan; Wang, Yuzhao; Feng, Yuan; Zhao, Bingtian; Yang, Yue			Implications of False Negative and False Positive Diagnosis in Lymph Node Staging of NSCLC by Means of F-18-FDGPET/CT	PLOS ONE			English	Article							CELL LUNG-CANCER; VISCERAL PLEURAL INVASION; INTEGRATED FDG-PET/CT; RISK-FACTORS; METASTASIS; CT; TOMOGRAPHY; RECURRENCE; SURVIVAL; PATTERN	Background: Integrated F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) is widely performed in hilar and mediastinal lymph node (HMLN) staging of non-small cell lung cancer (NSCLC). However, the diagnostic efficiency of PET/CT remains controversial. This retrospective study is to evaluate the accuracy of PET/CT and the characteristics of false negatives and false positives to improve specificity and sensitivity. Methods: 219 NSCLC patients with systematic lymph node dissection or sampling underwent preoperative PET/CT scan. Nodal uptake with a maximum standardized uptake value (SUVmax) >2.5 was interpreted as PET/CT positive. The results of PET/CT were compared with the histopathological findings. The receiver operating characteristic (ROC) curve was generated to determine the diagnostic efficiency of PET/CT. Univariate and multivariate analysis were conducted to detect risk factors of false negatives and false positives. Results: The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of PET/CT in detecting HMLN metastases were 74.2% (49/66), 73.2% (112/153), 54.4% (49/90), 86.8% (112/129), and 73.5% (161/219). The ROC curve had an area under curve (AUC) of 0.791 (95% CI 0.723-0.860). The incidence of false negative HMLN metastases was 13.2% (17 of 129 patients). Factors that are significantly associated with false negatives are: concurrent lung disease or diabetes (p<0.001), non-adenocarcinoma (p<0.001), and SUVmax of primary tumor >4.0 (p=0.009). Postoperatively, 45.5% (41/90) patients were confirmed as false positive cases. The univariate analysis indicated age >65 years old (p=0.009), well differentiation (p=0.002), and SUVmax of primary tumor <= 4.0 (p=0.007) as risk factors for false positive uptake. Conclusion: The SUVmax of HMLN is a predictor of malignancy. Lymph node staging using PET/CT is far from equal to pathological staging account of some risk factors. This study may provide some aids to pre-therapy evaluation and decision-making.	[Li, Shaolei; Zheng, Qingfeng; Ma, Yuanyuan; Wang, Yuzhao; Feng, Yuan; Zhao, Bingtian; Yang, Yue] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China	Peking University	Yang, Y (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China.	zlyangyue@bjmu.edu.cn			Beijing Natural Science Foundation [11G2633]; National High Technology Research and Development Program of China (863 Program) [2012AA02A502]; Beijing Municipal Science & Technology Commission [Z111107067311018]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported partially by Beijing Natural Science Foundation (Grant Nos 11G2633), the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A502), and Beijing Municipal Science & Technology Commission (No. Z111107067311018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf N, 2008, EUR J CARDIO-THORAC, V33, P104, DOI 10.1016/j.ejcts.2007.09.026; Bayman NA, 2008, CLIN LUNG CANCER, V9, P92, DOI 10.3816/CLC.2008.n.014; Bilfinger Thomas V, 2003, Respir Care Clin N Am, V9, P141, DOI 10.1016/S1078-5337(02)00086-2; Bryant AS, 2006, ANN THORAC SURG, V82, P417, DOI 10.1016/j.athoracsur.2005.12.047; Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V130, P151, DOI 10.1016/j.jtcvs.2004.11.007; Cerfolio RJ, 2006, CHEST, V130, P1791, DOI 10.1378/chest.130.6.1791; Fischer B, 2009, NEW ENGL J MED, V361, P32, DOI 10.1056/NEJMoa0900043; Hu M, 2011, CLIN NUCL MED, V36, P429, DOI 10.1097/RLU.0b013e3182173810; Kamiyoshihara M, 2001, J CARDIOVASC SURG, V42, P119; Kanzaki R, 2011, LUNG CANCER, V71, P333, DOI 10.1016/j.lungcan.2010.06.008; Kubota K, 2011, ANN NUCL MED, V25, P777, DOI 10.1007/s12149-011-0529-4; Kudo Y, 2012, LUNG CANCER, V78, P153, DOI 10.1016/j.lungcan.2012.08.004; Lee PC, 2007, ANN THORAC SURG, V84, P177, DOI 10.1016/j.athoracsur.2007.03.081; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Senthi S, 2012, LANCET ONCOL, V13, P802, DOI 10.1016/S1470-2045(12)70242-5; Sheel ARG, 2013, ANN THORAC SURG, V95, P276, DOI 10.1016/j.athoracsur.2012.09.051; Shim SS, 2005, RADIOLOGY, V236, P1011, DOI 10.1148/radiol.2363041310; Shimizu K, 2005, J THORAC CARDIOV SUR, V130, P160, DOI 10.1016/j.jtcvs.2004.11.021; Tieu Brandon H, 2008, Thorac Surg Clin, V18, P403, DOI 10.1016/j.thorsurg.2008.07.004; Zhao L, 2012, SURG ONCOL, V21, P230, DOI 10.1016/j.suronc.2011.11.001	20	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78552	10.1371/journal.pone.0078552	http://dx.doi.org/10.1371/journal.pone.0078552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205256	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400085
J	Miyasaka, T; Akahori, Y; Toyama, M; Miyamura, N; Ishii, K; Saijo, S; Iwakura, Y; Kinjo, Y; Miyazaki, Y; Oishi, K; Kawakami, K				Miyasaka, Tomomitsu; Akahori, Yukiko; Toyama, Masahiko; Miyamura, Namiko; Ishii, Keiko; Saijo, Shinobu; Iwakura, Yoichiro; Kinjo, Yuki; Miyazaki, Yoshitsugu; Oishi, Kazunori; Kawakami, Kazuyoshi			Dectin-2-Dependent NKT Cell Activation and Serotype-Specific Antibody Production in Mice Immunized with Pneumococcal Polysaccharide Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; KILLER T-CELLS; COMMUNITY-ACQUIRED PNEUMONIA; MURINE B-CELLS; INTERFERON-GAMMA; HOST-DEFENSE; CAPSULAR POLYSACCHARIDES; DENDRITIC CELLS; ADULT PATIENTS; RESPONSES	Although thymus-independent type 2 antigens generally do not undergo Ig class switching from IgM to IgG, pneumococcal polysaccharide vaccine (PPV) induces the production of serotype-specific IgG. How this happens remains unclear, however. In the present study, PPV immunization induced production of IgG as well as IgM specific for a serotype 3-pneumococcal polysaccharide in the sera of wild-type (WT) mice, but this phenomenon was significantly reduced in Dectin-2 knockout (KO) mice. Immunization with PPV caused IL-12p40 production in WT mice, but this response was significantly reduced in Dectin-2KO mice. Likewise, immunization with PPV activated natural killer T (NKT) cells in WT mice but not in Dectin-2KO mice. Furthermore, administration of alpha-galactosylceramide, recombinant (r) IL-12 or rIFN-gamma improved the reduced IgG levels in Dectin-2KO mice, and treatment with neutralizing anti-IFN-gamma mAb resulted in the reduction of IgG synthesis in PPV-immunized WT mice. Transfer of spleen cells from PPV-immunized WT mice conferred protection against pneumococcal infection on recipient mice, whereas this effect was cancelled when the transferred spleen cells were harvested from PPV-immunized Dectin-2KO mice. These results suggest that the detection of PPV antigens via Dectin-2 triggers IL-12 production, which induces IFN-gamma synthesis by NKT cells and subsequently the production of serotype-specific IgG.	[Miyasaka, Tomomitsu; Akahori, Yukiko; Toyama, Masahiko; Miyamura, Namiko; Ishii, Keiko; Kawakami, Kazuyoshi] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 980, Japan; [Saijo, Shinobu] Chiba Univ, Div Mol Immunol, Med Mycol Res Ctr, Chiba, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Div Lab Anim, Res Inst Biomed Sci, Tokyo 162, Japan; [Kinjo, Yuki; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Lab Immune Regulat, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Tohoku University; Chiba University; Tokyo University of Science; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Kawakami, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 980, Japan.	kawakami@med.tohoku.ac.jp	Iwakura, Yoichiro/E-5457-2011; Miyasaka, Tomomitsu/AAK-1676-2021	Iwakura, Yoichiro/0000-0002-9934-5775; Miyasaka, Tomomitsu/0000-0001-7218-6981; miyazaki, yoshitsugu/0000-0001-8942-0869	Ministry of Education, Culture, Sports, Science and Technology [23659841]; Ministry of Health, Labor and Welfare of Japan [22-SHINKOU-IPPAN-014, H22-SEISAKUSOUYAKU-IPPAN-012, H25-SHINKOU-WAKATE-005]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a Grant from the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Challenging Exploratory Research: 23659841 to K. K.), Grants from the Ministry of Health, Labor and Welfare of Japan (22-SHINKOU-IPPAN-014 to K. K.; H22-SEISAKUSOUYAKU-IPPAN-012 to Y.K.: H25-SHINKOU-WAKATE-005 to Y.K.) and aid funding from Takeda Science Foundation to Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Arulanandam BP, 2001, INFECT IMMUN, V69, P6718, DOI 10.1128/IAI.69.11.6718-6724.2001; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Buchanan RM, 1998, J IMMUNOL, V161, P5525; Buchanan RM, 2001, VACCINE, V19, P2020, DOI 10.1016/S0264-410X(00)00421-7; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; CHUDWIN DS, 1987, CLIN IMMUNOL IMMUNOP, V44, P114, DOI 10.1016/0090-1229(87)90057-2; Ekdahl K, 1997, CLIN INFECT DIS, V25, P654, DOI 10.1086/513763; Fernandes MJ, 1999, CANCER RES, V59, P2709; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Ishida T, 1998, CHEST, V114, P1588, DOI 10.1378/chest.114.6.1588; Janet Y, 2004, PNEUMOCOCCUS, P30; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kitamura H, 2000, CELL IMMUNOL, V199, P37, DOI 10.1006/cimm.1999.1602; Kobrynski LJ, 2005, J IMMUNOL, V174, P1787, DOI 10.4049/jimmunol.174.4.1787; Koppel EA, 2005, IMMUNOBIOLOGY, V210, P203, DOI 10.1016/j.imbio.2005.05.014; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Lynch JM, 2003, INFECT IMMUN, V71, P4780, DOI 10.1128/IAI.71.8.4780-4788.2003; Manoff SB, 2010, J INFECT DIS, V201, P525, DOI 10.1086/651131; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; McLay J, 2002, J IMMUNOL, V168, P3437, DOI 10.4049/jimmunol.168.7.3437; Miyasaka T, 2012, VACCINE, V30, P3304, DOI 10.1016/j.vaccine.2012.03.007; Moens L, 2007, INFECT IMMUN, V75, P5748, DOI 10.1128/IAI.00574-07; Musher DM, 2010, J INFECT DIS, V201, P516, DOI 10.1086/649839; Nakamatsu M, 2007, MICROBES INFECT, V9, P364, DOI 10.1016/j.micinf.2006.12.003; Nakamura K, 2008, J IMMUNOL, V180, P4067, DOI 10.4049/jimmunol.180.6.4067; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Snapper CM, 1996, J IMMUNOL, V157, P2229; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; SNAPPER CM, 1995, J IMMUNOL, V154, P1177; Snapper CM, 1996, INT IMMUNOL, V8, P877, DOI 10.1093/intimm/8.6.877; Song JH, 2008, INT J ANTIMICROB AG, V31, P107, DOI 10.1016/j.ijantimicag.2007.09.014; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; Tomura M, 1999, J IMMUNOL, V163, P93; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Yamamoto N, 2004, MICROBES INFECT, V6, P1241, DOI 10.1016/j.micinf.2004.08.007	49	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78611	10.1371/journal.pone.0078611	http://dx.doi.org/10.1371/journal.pone.0078611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205278	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400089
J	Hiebert, PR; Boivin, WA; Zhao, HY; McManus, BM; Granville, DJ				Hiebert, Paul R.; Boivin, Wendy A.; Zhao, Hongyan; McManus, Bruce M.; Granville, David J.			Perforin and Granzyme B Have Separate and Distinct Roles during Atherosclerotic Plaque Development in Apolipoprotein E Knockout Mice	PLOS ONE			English	Article							LDL RECEPTOR-DEFICIENT; RHEUMATOID-ARTHRITIS; HUMAN KERATINOCYTES; SOLUBLE GRANZYME; AORTIC-ANEURYSM; MOUSE GRANZYME; CELL APOPTOSIS; T-LYMPHOCYTES; MURINE MODELS; EXPRESSION	The granzyme B/perforincytotoxic pathway is a well established mechanism of initiating target cell apoptosis. Previous studies have suggested a role for the granzyme B/perforin cytotoxic pathway in vulnerable atherosclerotic plaque formation. In the present study, granzyme B deficiency resulted in reduced atherosclerotic plaque development in the descending aortas of apolipoprotein E knockout mice fed a high fat diet for 30 weeks while perforindeficiency resulted in greater reduction in plaque development with significantly less plaque area than granzyme Bdeficient mice. In contrast to the descending aorta, no significant change in plaque size was observed in aortic roots from either granzyme Bdeficient or perforindeficient apolipoprotein E knockout mice. However, atherosclerotic plaques in the aortic roots did exhibit significantly more collagen in granzyme B, but not perforin deficient mice. Together these results suggest significant, yet separate roles for granzyme B and perforin in the pathogenesis of atherosclerosis that go beyond the traditional apoptotic pathway with additional implications in plaque development, stability and remodelling of extracellular matrix.	[Hiebert, Paul R.; Boivin, Wendy A.; Zhao, Hongyan; McManus, Bruce M.; Granville, David J.] St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; [Hiebert, Paul R.; Boivin, Wendy A.; McManus, Bruce M.; Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia	Granville, DJ (corresponding author), St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada.	david.granville@hli.ubc.ca	Hiebert, Paul/AAY-2278-2021	Hiebert, Paul/0000-0001-8179-4217	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC) Post Graduate Scholarship; NSERC Canada Graduate Scholarship; Michael Smith Foundation for Health Research fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC) Post Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research fellowship(Michael Smith Foundation for Health Research)	This work was generously supported by a grant-in-aid from the Canadian Institutes of Health Research (CIHR) (D.J.G.). P. R. H. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Post Graduate Scholarship. W. A. B. was supported by a NSERC Canada Graduate Scholarship and a Michael Smith Foundation for Health Research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Zen AA, 2006, ATHEROSCLEROSIS, V187, P31, DOI 10.1016/j.atherosclerosis.2005.08.023; Ang LS, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.88; Anthony DA, 2010, J IMMUNOL, V185, P1794, DOI 10.4049/jimmunol.1000430; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Boivin WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033163; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Bratke K, 2004, CLIN EXP IMMUNOL, V136, P542, DOI 10.1111/j.1365-2249.2004.02468.x; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Chamberlain CM, 2007, CAN J PHYSIOL PHARM, V85, P89, DOI 10.1139/Y06-090; Chamberlain CM, 2010, AM J PATHOL, V176, P1038, DOI 10.2353/ajpath.2010.090700; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Choy JC, 2003, MODERN PATHOL, V16, P460, DOI 10.1097/01.MP.0000067424.12280.BC; Cooper DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021484; Dai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010510; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; FROELICH CJ, 1993, J IMMUNOL, V151, P7161; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hendel A, 2010, CELL DEATH DIFFER, V17, P596, DOI 10.1038/cdd.2010.5; Hendel A, 2013, MATRIX BIOL, V32, P14, DOI 10.1016/j.matbio.2012.11.013; Hendel A, 2012, CARDIOVASC PATHOL, V21, P28, DOI 10.1016/j.carpath.2010.12.002; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Hernandez-Pigeon H, 2007, J BIOL CHEM, V282, P8157, DOI 10.1074/jbc.M607436200; Hiebert PR, 2011, EXP GERONTOL, V46, P489, DOI 10.1016/j.exger.2011.02.004; Hirayasu H, 2008, BIOSCI BIOTECH BIOCH, V72, P2294, DOI 10.1271/bbb.80140; Horiuchi K, 2003, J RHEUMATOL, V30, P1799; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Kim WJ, 2007, IMMUNOL LETT, V111, P57, DOI 10.1016/j.imlet.2007.05.004; Kondo H, 2009, CIRC J, V73, P503, DOI 10.1253/circj.CJ-08-0668; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Malmestrom C, 2008, J NEUROIMMUNOL, V196, P159, DOI 10.1016/j.jneuroim.2008.03.001; Merat S, 2000, J GERONTOL A-BIOL, V55, pB85; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Namekawa T, 1998, ARTHRITIS RHEUM, V41, P2108; Omoto Y, 2010, J DERMATOL SCI, V59, P129, DOI 10.1016/j.jdermsci.2010.05.004; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Rissoan MC, 2002, BLOOD, V100, P3295, DOI 10.1182/blood-2002-02-0638; Schiller NK, 2002, ARTERIOSCL THROM VAS, V22, P1341, DOI 10.1161/01.ATV.0000024082.46387.38; SIMON MM, 1988, BIOL CHEM H-S, V369, P107; SIMON MM, 1991, IMMUNOLOGY, V73, P117; Skjelland M, 2007, ATHEROSCLEROSIS, V195, pE142, DOI 10.1016/j.atherosclerosis.2007.05.001; SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7; Sower LE, 1996, CELL IMMUNOL, V171, P159, DOI 10.1006/cimm.1996.0187; Strik MCM, 2007, MOL IMMUNOL, V44, P3462, DOI 10.1016/j.molimm.2007.03.024; Tak PP, 1999, CLIN EXP IMMUNOL, V116, P366; Takahashi Y, 2009, EPILEPSIA; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tremblay GM, 2000, J IMMUNOL, V165, P3966, DOI 10.4049/jimmunol.165.7.3966; Tschopp CM, 2006, BLOOD, V108, P2290, DOI 10.1182/blood-2006-03-010348; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4266, DOI 10.2174/138161212802481237; Vernooy JHJ, 2007, AM J RESP CRIT CARE, V175, P464, DOI 10.1164/rccm.200602-169OC; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044694; Wagner C, 2004, BLOOD, V103, P1099, DOI 10.1182/blood-2003-04-1069; Yoshikawa Y, 2010, CYTOTECHNOLOGY, V62, P325, DOI 10.1007/s10616-010-9275-z	57	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78939	10.1371/journal.pone.0078939	http://dx.doi.org/10.1371/journal.pone.0078939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205352	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300086
J	Hvidtfeldt, UA; Lange, T; Andersen, I; Diderichsen, F; Keiding, N; Prescott, E; Sorensen, TIA; Tjonneland, A; Rod, NH				Hvidtfeldt, Ulla Arthur; Lange, Theis; Andersen, Ingelise; Diderichsen, Finn; Keiding, Niels; Prescott, Eva; Sorensen, Thorkild I. A.; Tjonneland, Anne; Rod, Naja Hulvej			Educational Differences in Postmenopausal Breast Cancer - Quantifying Indirect Effects through Health Behaviors, Body Mass Index and Reproductive Patterns	PLOS ONE			English	Article							SEX-HORMONES; RISK-FACTORS; SOCIOECONOMIC POSITION; ENDOGENOUS ESTROGEN; ALCOHOL-CONSUMPTION; PROSPECTIVE COHORT; SOCIAL GRADIENT; POOLED ANALYSIS; WOMEN; REANALYSIS	Studying mechanisms underlying social inequality in postmenopausal breast cancer is important in order to develop prevention strategies. Standard methods for investigating indirect effects, by comparing crude models to adjusted, are often biased. We applied a new method enabling the decomposition of the effect of educational level on breast cancer incidence into indirect effects through reproductive patterns (parity and age at first birth), body mass index and health behavior (alcohol consumption, physical inactivity, and hormone therapy use). The study was based on a pooled cohort of 6 studies from the Copenhagen area including 33,562 women (1,733 breast cancer cases) aged 50-70 years at baseline. The crude absolute rate of breast cancer was 399 cases per 100,000 person-years. A high educational level compared to low was associated with 74 (95% CI 22-125) extra breast cancer cases per 100,000 person-years at risk. Of these, 26% (95% CI 14%-69%) could be attributed to alcohol consumption. Similar effects were observed for age at first birth (32%; 95% CI 10%-257%), parity (19%; 95% CI 10%-45%), and hormone therapy use (10%; 95% CI 6%-18%). Educational level modified the effect of physical activity on breast cancer. In conclusion, this analysis suggests that a substantial number of the excess postmenopausal breast cancer events among women with a high educational level compared to a low can be attributed to differences in alcohol consumption, use of hormone therapy, and reproductive patterns. Women of high educational level may be more vulnerable to physical inactivity compared to women of low educational level.	[Hvidtfeldt, Ulla Arthur; Andersen, Ingelise; Diderichsen, Finn; Rod, Naja Hulvej] Univ Copenhagen, Dept Publ Hlth, Social Med Sect, Copenhagen, Denmark; [Lange, Theis; Keiding, Niels] Univ Copenhagen, Dept Publ Hlth, Biostat Sect, Copenhagen, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Inst Canc Epidemiol, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, DK-2400 Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Prescott, Eva] Bispebjerg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Danish Cancer Society; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital	Hvidtfeldt, UA (corresponding author), Univ Copenhagen, Dept Publ Hlth, Social Med Sect, Copenhagen, Denmark.	ulah@sund.ku.dk	Prescott, Eva/AAJ-7441-2020; Diderichsen, Finn/P-4654-2019; Rod, Naja/B-9411-2015	Diderichsen, Finn/0000-0002-9998-4972; Rod, Naja/0000-0002-6400-5105; Prescott, Eva/0000-0002-4134-0349; Lange, Theis/0000-0001-6807-8347; Andersen, Ingelise/0000-0002-0076-265X; Tjonneland, Anne/0000-0003-4385-2097; Hvidtfeldt, Ulla Arthur/0000-0002-0335-4838	Danish Cancer Society, Commission of Social Inequality in Cancer [SU08004]	Danish Cancer Society, Commission of Social Inequality in Cancer	This work was supported by the Danish Cancer Society, Commission of Social Inequality in Cancer [grant no. SU08004]. The authors thank the collaborators behind the Social Inequality in Cancer Database: The Copenhagen City Heart Study, the Diet, Cancer and Health Study, and The Research Center for Prevention and Health in Glostrup. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard M., 1989, SCAND J SOC MED, V41, P1; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Braaten T, 2005, CANCER EPIDEM BIOMAR, V14, P2591, DOI 10.1158/1055-9965.EPI-05-0345; Bratten T, 2004, INT J CANCER, V110, P579, DOI 10.1002/ijc.20141; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; Dalton SO, 2008, EUR J CANCER, V44, P2074, DOI 10.1016/j.ejca.2008.06.018; Dano H, 2004, INT J CANCER, V111, P451, DOI 10.1002/ijc.20203; Dano H, 2003, INT J EPIDEMIOL, V32, P218, DOI 10.1093/ije/dyg049; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; EWERTZ M, 1990, INT J CANCER, V46, P597, DOI 10.1002/ijc.2910460408; Farhat GN, 2011, JNCI-J NATL CANCER I, V103, P562, DOI 10.1093/jnci/djr031; FRIEDENREICH CM, 1993, EPIDEMIOLOGY, V4, P295, DOI 10.1097/00001648-199307000-00004; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hartz A, 2012, J CLIN ENDOCR METAB, V97, P227, DOI 10.1210/jc.2011-1151; Heck KE, 1997, AM J EPIDEMIOL, V145, P366, DOI 10.1093/oxfordjournals.aje.a009114; Hvidtfeldt UA, 2012, CANCER EPIDEM BIOMAR, V21, P1203, DOI 10.1158/1055-9965.EPI-12-0310; Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Klassen AC, 2011, CANCER EPIDEMIOL, V35, P217, DOI 10.1016/j.canep.2011.02.009; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Larsen SB, 2011, CANCER EPIDEMIOL, V35, P438, DOI 10.1016/j.canep.2010.12.005; Li CI, 2010, J NATL CANCER I, V102, P1422, DOI 10.1093/jnci/djq316; Liedtke S, 2012, OBESITY, V20, P1088, DOI 10.1038/oby.2011.383; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Martinussen T., 2006, STAT BIOL HEALTH; Menvielle G, 2011, AM J EPIDEMIOL, V173, P26, DOI 10.1093/aje/kwq319; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Opdahl S, 2011, BRIT J CANCER, V105, P731, DOI 10.1038/bjc.2011.286; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pearl J., 2001, P 17 C UNC ART INT, P411, DOI DOI 10.5555/2074022.2074073; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Strand BH, 2007, EUR J CANCER, V43, P1200, DOI 10.1016/j.ejca.2007.01.021; Thomas HV, 1997, CANCER CAUSE CONTROL, V8, P922, DOI 10.1023/A:1018476631561; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; VanderWeele TJ, 2013, EPIDEMIOLOGY, V24, P224, DOI 10.1097/EDE.0b013e318281a64e; Euler-Chelpin M, 2008, EUR J CANCER PREV, V17, P273, DOI 10.1097/CEJ.0b013e3282f0c017; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526	47	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78690	10.1371/journal.pone.0078690	http://dx.doi.org/10.1371/journal.pone.0078690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205296	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300079
J	Paco, S; Kalko, SG; Jou, C; Rodriguez, MA; Corbera, J; Muntoni, F; Feng, L; Rivas, E; Torner, F; Gualandi, F; Gomez-Foix, AM; Ferrer, A; Ortez, C; Nascimento, A; Colomer, J; Jimenez-Mallebrera, C				Paco, Sonia; Kalko, Susana G.; Jou, Cristina; Rodriguez, Maria A.; Corbera, Joan; Muntoni, Francesco; Feng, Lucy; Rivas, Eloy; Torner, Ferran; Gualandi, Francesca; Gomez-Foix, Anna M.; Ferrer, Anna; Ortez, Carlos; Nascimento, Andres; Colomer, Jaume; Jimenez-Mallebrera, Cecilia			Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; MEMBRANE ATTACK COMPLEX; SKELETAL-MUSCLE; MITOCHONDRIAL DYSFUNCTION; MYOGENIC DIFFERENTIATION; BIGLYCAN EXPRESSION; ALPHA-6 CHAINS; S100B PROTEIN; ULLRICH; DISEASE	Ullrich congenital muscular dystrophy (UCMD), caused by collagen VI deficiency, is a common congenital muscular dystrophy. At present, the role of collagen VI in muscle and the mechanism of disease are not fully understood. To address this we have applied microarrays to analyse the transcriptome of UCMD muscle and compare it to healthy muscle and other muscular dystrophies. We identified 389 genes which are differentially regulated in UCMD relative to controls. In addition, there were 718 genes differentially expressed between UCMD and dystrophin deficient muscle. In contrast, only 29 genes were altered relative to other congenital muscular dystrophies. Changes in gene expression were confirmed by real-time PCR. The set of regulated genes was analysed by Gene Ontology, KEGG pathways and Ingenuity Pathway analysis to reveal the molecular functions and gene networks associated with collagen VI defects. The most significantly regulated pathways were those involved in muscle regeneration, extracellular matrix remodelling and inflammation. We characterised the immune response in UCMD biopsies as being mainly mediated via M2 macrophages and the complement pathway indicating that anti-inflammatory treatment may be beneficial to UCMD as for other dystrophies. We studied the immunolocalisation of ECM components and found that biglycan, a collagen VI interacting proteoglycan, was reduced in the basal lamina of UCMD patients. We propose that biglycan reduction is secondary to collagen VI loss and that it may be contributing towards UCMD pathophysiology. Consequently, strategies aimed at over-expressing biglycan and restore the link between the muscle cell surface and the extracellular matrix should be considered.	[Paco, Sonia; Rodriguez, Maria A.; Ortez, Carlos; Nascimento, Andres; Colomer, Jaume; Jimenez-Mallebrera, Cecilia] Hosp Maternoinfantil St Joan de Deu, Fdn St Joan de Deu, Dept Neurol, Neuromuscular Unit, Barcelona, Spain; [Kalko, Susana G.] Inst Invest Biomed August Pi I Sunyer IDIBAPS, Bioinformat Core Facil, Barcelona, Spain; [Jou, Cristina; Corbera, Joan] Hosp Maternoinfantil St Joan de Deu, Dept Pathol, Barcelona, Spain; [Muntoni, Francesco; Feng, Lucy] UCL, Inst Child Hlth, MRC Ctr Neuromuscular Dis, Dubowitz Neuromuscular Ctr, London, England; [Rivas, Eloy] Hosp Virgen del Rocio, Dept Pathol, Seville, Spain; [Torner, Ferran] Hosp Maternoinfantil St Joan de Deu, Orthopaed Surg & Traumatol Dept, Barcelona, Spain; [Gualandi, Francesca] Azienda Osped Univ SAnna, UO Genet Med, Dipartimento Riprod & Accrescimento, Ferrara, Italy; [Gomez-Foix, Anna M.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Gomez-Foix, Anna M.] Univ Barcelona, Ctr Biomed Res Diabet & Metab Disorders CIBERDEM, Barcelona, Spain; [Ferrer, Anna] Ctr Regulac Genom, Microarray Unit, Barcelona, Spain; [Nascimento, Andres; Colomer, Jaume; Jimenez-Mallebrera, Cecilia] ISCIII, CIBERER, Ctr Biomed Res Rare Dis, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of London; University College London; Virgen del Rocio University Hospital; University of Ferrara; Arcispedale Sant'Anna; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Jimenez-Mallebrera, C (corresponding author), Hosp Maternoinfantil St Joan de Deu, Fdn St Joan de Deu, Dept Neurol, Neuromuscular Unit, Barcelona, Spain.	cjimenezm@hsjdbcn.org	Gualandi, Francesca/K-7513-2016; Ferrer-Salvador, Anna/K-6001-2015; Jiménez-Mallebrera, Cecilia/F-5030-2016; IBIS, NEUROCIENCIAS/C-2262-2016	Gualandi, Francesca/0000-0001-9551-057X; Ferrer-Salvador, Anna/0000-0001-5507-0733; Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Kalko, Susana/0000-0002-6701-0233	Ministerio de Ciencia e Innovacion & Instituto de Salud Carlos III (FIS) [PI10/00177]; Medical Research Council [MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	Ministerio de Ciencia e Innovacion & Instituto de Salud Carlos III (FIS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is funded by the Ministerio de Ciencia e Innovacion & Instituto de Salud Carlos III (FIS grant PI10/00177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Angelin A, 2008, BBA-BIOENERGETICS, V1777, P893, DOI 10.1016/j.bbabio.2008.03.026; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Angelini Corrado, 2012, Acta Myol, V31, P9; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Baron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026952; Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Collins J, 2012, NEUROLOGY, V79, P2158, DOI 10.1212/WNL.0b013e3182752ebc; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Connolly AM, 2002, J NEUROIMMUNOL, V127, P80, DOI 10.1016/S0165-5728(02)00104-2; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; ENGEL AG, 1982, ANN NEUROL, V12, P289, DOI 10.1002/ana.410120314; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Higuchi I, 2003, NEUROMUSCULAR DISORD, V13, P310, DOI 10.1016/S0960-8966(02)00282-1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Ishikawa H, 2002, NEUROLOGY, V59, P920, DOI 10.1212/WNL.59.6.920; Ishmukhametova A, 2012, EUR J HUM GENET, V20, P1096, DOI 10.1038/ejhg.2012.51; Kawahara G, 2007, NEUROLOGY, V69, P1043, DOI 10.1212/01.wnl.0000271386.89878.22; Kawahara G, 2008, MUSCLE NERVE, V38, P1192, DOI 10.1002/mus.21030; Keira Y, 2007, NEUROSCI RES, V57, P513, DOI 10.1016/j.neures.2006.12.010; Kotelnikova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002365; Krahn M, 2011, CLIN GENET, V80, P398, DOI 10.1111/j.1399-0004.2010.01620.x; Lechner BE, 2006, MUSCLE NERVE, V34, P347, DOI 10.1002/mus.20596; Lethias C, 2006, FEBS LETT, V580, P6281, DOI 10.1016/j.febslet.2006.10.037; Margaron Y, 2010, BIOPHYS CHEM, V147, P87, DOI 10.1016/j.bpc.2009.12.011; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; Matsumoto K, 2004, EXP CELL RES, V297, P404, DOI 10.1016/j.yexcr.2004.03.041; MDEL B, 2012, ACTA MYOL, V31, P4; Mercado ML, 2006, FASEB J, V20, P1724, DOI 10.1096/fj.05-5124fje; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Merlini L, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/139194; Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; Nakajima I, 2002, BIOL CELL, V94, P197, DOI 10.1016/S0248-4900(02)01189-9; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Noguchi S, 2005, NEUROLOGY, V65, P732, DOI 10.1212/01.wnl.0000174625.67484.4d; Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Rafii MS, 2006, J CELL PHYSIOL, V209, P439, DOI 10.1002/jcp.20740; Rahimov F, 2012, P NATL ACAD SCI USA, V109, P16234, DOI 10.1073/pnas.1209508109; Riuzzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028700; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Sabatelli P, 2012, MATRIX BIOL, V31, P187, DOI 10.1016/j.matbio.2011.12.003; Sabatelli P, 2011, J INVEST DERMATOL, V131, P99, DOI 10.1038/jid.2010.284; Saenz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003750; Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Selcen D, 2001, NEUROLOGY, V56, P1472, DOI 10.1212/WNL.56.11.1472; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Spuler S, 1998, NEUROLOGY, V50, P41, DOI 10.1212/WNL.50.1.41; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Young MF, 2012, CURR OPIN GENET DEV, V22, P398, DOI 10.1016/j.gde.2012.07.008; Zanotti S, 2005, BRAIN, V128, P2546, DOI 10.1093/brain/awh635; Zanotti S, 2006, THESCIENTIFICWORLDJO, V6, P446, DOI 10.1100/tsw.2006.88; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008; Zou Y, 2008, J NEUROPATH EXP NEUR, V67, P144, DOI 10.1097/nen.0b013e3181634ef7	76	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77430	10.1371/journal.pone.0077430	http://dx.doi.org/10.1371/journal.pone.0077430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24223098	Green Published, gold			2022-12-27	WOS:000325819400117
J	Robbins, AM; Gray, M; Basabose, A; Uwingeli, P; Mburanumwe, I; Kagoda, E; Robbins, MM				Robbins, Andrew M.; Gray, Maryke; Basabose, Augustin; Uwingeli, Prosper; Mburanumwe, Innocent; Kagoda, Edwin; Robbins, Martha M.			Impact of Male Infanticide on the Social Structure of Mountain Gorillas	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BERINGEI-BERINGEI; FEMALE DISPERSAL; SOCIOECOLOGICAL INFLUENCES; POPULATION-DYNAMICS; COLOBUS-VELLEROSUS; SEXUAL SELECTION; HABITAT USE; PRIMATES; STRATEGIES	Infanticide can be a major influence upon the social structure of species in which females maintain long-term associations with males. Previous studies have suggested that female mountain gorillas benefit from residing in multimale groups because infanticide occurs when one-male groups disintegrate after the dominant male dies. Here we measure the impact of infanticide on the reproductive success of female mountain gorillas, and we examine whether their dispersal patterns reflect a strategy to avoid infanticide. Using more than 40 years of data from up to 70% of the entire population, we found that only 1.7% of the infants that were born in the study had died from infanticide during group disintegrations. The rarity of such infanticide mainly reflects a low mortality rate of dominant males in one-male groups, and it does not dispel previous observations that infanticide occurs during group disintegrations. After including infanticide from causes other than group disintegrations, infanticide victims represented up to 5.5% of the offspring born during the study, and they accounted for up to 21% of infant mortality. The overall rates of infanticide were 2-3 times higher in one-male groups than multimale groups, but those differences were not statistically significant. Infant mortality, the length of interbirth intervals, and the age of first reproduction were not significantly different between one-male versus multimale groups, so we found no significant fitness benefits for females to prefer multimale groups. In addition, we found limited evidence that female dispersal patterns reflect a preference for multimale groups. If the strength of selection is modest for females to avoid group disintegrations, than any preference for multimale groups may be slow to evolve. Alternatively, variability in male strength might give some one-male groups a lower infanticide risk than some multimale groups, which could explain why both types of groups remain common.	[Robbins, Andrew M.; Robbins, Martha M.] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Gray, Maryke; Basabose, Augustin] Int Gorilla Conservat Programme, Kigali, Kigali Province, Rwanda; [Uwingeli, Prosper] Rwanda Dev Board, Parc Natl Volcans, Kigali, Kigali Province, Rwanda; [Mburanumwe, Innocent] Inst Congolais Conservat Nat, Int Gorilla Conservat Programme, Parc Natl Virunga Sud, Gisenyi, Western Provinc, Rwanda; [Kagoda, Edwin] Bwindi Mgahinga Conservat Area, Uganda Wildlife Author, Kampala, Uganda	Max Planck Society	Robbins, MM (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	robbins@eva.mpg.de						Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; ALTMANN SA, 1977, ANIM BEHAV, V25, P364, DOI 10.1016/0003-3472(77)90011-2; Bellemain E, 2006, ETHOLOGY, V112, P238, DOI 10.1111/j.1439-0310.2006.01152.x; BLAFFERHRDY S, 1977, AM SCI, V65, P40; Bradley BJ, 2005, P NATL ACAD SCI USA, V102, P9418, DOI 10.1073/pnas.0502019102; Breuer T, 2012, J HUM EVOL, V62, P466, DOI 10.1016/j.jhevol.2012.01.006; Breuer T, 2010, BEHAV ECOL SOCIOBIOL, V64, P515, DOI 10.1007/s00265-009-0867-6; BUTYNSKI TM, 1990, ECOL MONOGR, V60, P1, DOI 10.2307/1943024; Clarke Parry, 2009, P42; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Ebensperger Luis A., 2007, P267; Fossey D., 1984, P217; Fossey Diane, 1983, GORILLAS IN THE MIST; Gerald CN, 1995, THESIS PRINCETON U P, P81; Gray M, 2005, BIODIVERS CONSERV, V14, P2723, DOI 10.1007/s10531-005-8406-x; Gray M, 2009, J AFRICAN ECOLOGY, V48, P588; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harcourt A.H., 2007, GORILLA SOC CONFLICT; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HARCOURT AH, 1976, NATURE, V263, P226, DOI 10.1038/263226a0; HARCOURT AH, 1978, Z TIERPSYCHOL, V48, P401; Harcourt AH, 2001, ANIM BEHAV, V62, P905, DOI 10.1006/anbe.2001.1835; Harcourt Alexander H., 1995, Evolutionary Anthropology, V4, P121, DOI 10.1002/evan.1360040404; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Janson Charles H., 2000, P469, DOI 10.1017/CBO9780511542312.021; Kalpers J, 2003, ORYX, V37, P326, DOI 10.1017/S0030605303000589; Kappeler Peter M., 2012, P3; Knornschild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025001; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Korstjens AH, 2002, BEHAVIOUR, V139, P203, DOI 10.1163/156853902760102654; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; McNeilage A, 2006, ORYX, V40, P419, DOI 10.1017/S0030605306001311; Nunn CL, 2001, BEHAV ECOL, V12, P646, DOI 10.1093/beheco/12.5.646; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; Palombit Ryne A., 2012, P432; Pluhacek J, 2006, J MAMMAL, V87, P35, DOI 10.1644/05-MAMM-A-126R2.1; Pradhan GR, 2008, BEHAVIOUR, V145, P251, DOI 10.1163/156853907783244710; Robbins AM, 2006, AM J PHYS ANTHROPOL, V131, P511, DOI 10.1002/ajpa.20474; Robbins AM, 2009, BEHAVIOUR, V146, P525, DOI 10.1163/156853909X426354; Robbins AM, 2009, BEHAV ECOL SOCIOBIOL, V63, P477, DOI 10.1007/s00265-008-0679-0; Robbins AM, 2009, ANIM BEHAV, V77, P831, DOI 10.1016/j.anbehav.2008.12.005; Robbins MM, 2007, BEHAV ECOL SOCIOBIOL, V61, P919, DOI 10.1007/s00265-006-0321-y; Robbins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019788; Robbins MM, 2004, AM J PRIMATOL, V63, P201, DOI 10.1002/ajp.20052; ROBBINS MM, 1995, BEHAVIOUR, V132, P21, DOI 10.1163/156853995X00261; Robbins MM, 2001, MOUNTAIN GORILLAAS 3; Robbins MM, 2009, BIOL CONSERVATION, V142; Setchell JM, 2005, BEHAV ECOL SOCIOBIOL, V58, P474, DOI 10.1007/s00265-005-0946-2; Sholley C, 1989, 1989 CENSUS MOUNTAIN, P7; Sicotte P, 2000, PRIMATES, V41, P93, DOI 10.1007/BF02557465; SICOTTE P, 1993, AM J PRIMATOL, V30, P21, DOI 10.1002/ajp.1350300103; Sterck EHM, 1998, AM J PRIMATOL, V44, P235, DOI 10.1002/(SICI)1098-2345(1998)44:4<235::AID-AJP1>3.0.CO;2-X; Sterck EHM, 2005, BEHAVIOUR, V142, P845, DOI 10.1163/1568539055010093; Stoinski TS, 2009, ANIM BEHAV, V77, P1155, DOI 10.1016/j.anbehav.2008.12.030; Teichroeb JA, 2008, BEHAVIOUR, V145, P727, DOI 10.1163/156853908783929160; Teichroeb JA, 2009, BEHAVIOUR, V146, P551, DOI 10.1163/156853909X426363; van Noordwijk Maria A., 2000, P322, DOI 10.1017/CBO9780511542312.016; van Schaik C.P., 2000, INFANTICIDE MALES IT; van Schaik Carel P., 2004, P131, DOI 10.1017/CBO9780511542459.010; van Schaik Carel P., 1999, Cambridge Studies in Biological Anthropology, V22, P204; van Schaik Carel P., 2000, P361, DOI 10.1017/CBO9780511542312.017; Van Schaik CP, 2000, PRIMATE MALES, P34; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; WATTS DP, 1989, ETHOLOGY, V81, P1; Watts DP, 2000, PRIMATE MALES, P169; WATTS DP, 1994, PRIMATES, V35, P35, DOI 10.1007/BF02381484; Watts DP, 1998, INT J PRIMATOL, V19, P651, DOI 10.1023/A:1020324909101; WEBER AW, 1983, BIOL CONSERV, V26, P341, DOI 10.1016/0006-3207(83)90096-4; Wielgus RB, 2001, BIOL CONSERV, V98, P293, DOI 10.1016/S0006-3207(00)00168-3; Williamson E.A., 2001, AFR PRIMATES, V5, P48; Yamagiwa J., 2001, MOUNTAIN GORILLAS 3, P89, DOI [10.1017/CBO9780511661631.005, DOI 10.1017/CBO9780511661631.005]; Yamagiwa Juichi, 2004, Gorilla Journal, V29, P6; Yamagiwa J, 2009, PRIMATES, V50, P293, DOI 10.1007/s10329-009-0163-0; Zhao Q, 2011, BEHAV ECOL SOCIOBIOL, V65, P1535, DOI 10.1007/s00265-011-1163-9	75	47	48	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78256	10.1371/journal.pone.0078256	http://dx.doi.org/10.1371/journal.pone.0078256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223143	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200035
J	Gao, X; Cao, DH; Liu, J; Wang, XP; Geng, SJ; Liu, B; Shi, DC				Gao, Xiang; Cao, Donghui; Liu, Jie; Wang, Xiaoping; Geng, Shujuan; Liu, Bao; Shi, Decheng			Tissue-Specific and Cation/Anion-Specific DNA Methylation Variations Occurred in C. virgata in Response to Salinity Stress	PLOS ONE			English	Article							ABIOTIC-STRESS; CYTOSINE METHYLATION; RICE; PLANTS; AFLP; SALT; HYPERMETHYLATION; DEMETHYLATION; ARABIDOPSIS; ADAPTATION	Salinity is a widespread environmental problem limiting productivity and growth of plants. Halophytes which can adapt and resist certain salt stress have various mechanisms to defend the higher salinity and alkalinity, and epigenetic mechanisms especially DNA methylation may play important roles in plant adaptability and plasticity. In this study, we aimed to investigate the different influences of various single salts (NaCl, Na2SO4, NaHCO3, Na2CO3) and their mixed salts on halophyte Chloris. virgata from the DNA methylation prospective, and discover the underlying relationships between specific DNA methylation variations and specific cations/anions through the methylation-sensitive amplification polymorphism analysis. The results showed that the effects on DNA methylation variations of single salts were ranked as follows: Na2CO3 > NaHCO3 > Na2SO4 > NaCl, and their mixed salts exerted tissue-specific effects on C. virgata seedlings. Eight types of DNA methylation variations were detected and defined in C. virgata according to the specific cations/anions existed in stressful solutions; in addition, mix-specific and higher pH-specific bands were the main type in leaves and roots independently. These findings suggested that mixed salts were not the simple combination of single salts. Furthermore, not only single salts but also mixed salts showed tissue-specific and cations/anions-specific DNA methylation variations.	[Gao, Xiang] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Cao, Donghui; Liu, Jie; Wang, Xiaoping; Geng, Shujuan; Liu, Bao; Shi, Decheng] NE Normal Univ, Inst Cytol & Genet, Key Lab Mol Epigenet, MOE, Changchun, Peoples R China; [Liu, Jie] Weifang Univ Sci & Technol, Shouguang, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Shi, DC (corresponding author), NE Normal Univ, Inst Cytol & Genet, Key Lab Mol Epigenet, MOE, Changchun, Peoples R China.	shidc274@gmail.com	Liu, Jie/AAH-5117-2020; Wang, Xiaoping/P-1077-2017	Wang, Xiaoping/0000-0002-5032-3671; zakaria, seyed moein/0000-0002-0086-1279; Liu, Bao/0000-0001-5481-1675	National Natural Science Foundation of China [31072078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31072078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto-Kobayashi S, 2007, MUTAT RES-GEN TOX EN, V632, P111, DOI 10.1016/j.mrgentox.2007.05.001; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Cao DH, 2012, PLANT MOL BIOL REP, V30, P1102, DOI 10.1007/s11105-012-0420-z; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Jin H, 2008, PLANT SCI, V175, P784, DOI 10.1016/j.plantsci.2008.07.016; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kalisz S, 2008, HEREDITY, V100, P171, DOI 10.1038/sj.hdy.6800939; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Law JA, 2009, SCIENCE, V323, P1568, DOI 10.1126/science.1172782; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Marden JH, 2008, HEREDITY, V100, P111, DOI 10.1038/sj.hdy.6800904; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nishiuchi S, 2010, PLANT PHYSIOL BIOCH, V48, P247, DOI 10.1016/j.plaphy.2010.01.024; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Santos AP, 2011, CYTOGENET GENOME RES, V132, P297, DOI 10.1159/000322287; Santos AP, 2011, OMICS, V15, P839, DOI 10.1089/omi.2011.0095; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Yan HH, 2010, PLANT J, V63, P353, DOI 10.1111/j.1365-313X.2010.04246.x; Yang CW, 2009, PHOTOSYNTHETICA, V47, P79, DOI 10.1007/s11099-009-0013-8; Yang CW, 2010, AGRON J, V102, P1081, DOI 10.2134/agronj2009.0471; Zhang X, 2011, PLANT MOL BIOL REP, V29, P626, DOI 10.1007/s11105-010-0269-y; Zluvova J, 2001, J EXP BOT, V52, P2265, DOI 10.1093/jexbot/52.365.2265	34	9	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78426	10.1371/journal.pone.0078426	http://dx.doi.org/10.1371/journal.pone.0078426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223802	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400025
J	Yamada, T; Azuma, K; Muta, E; Kim, J; Sugawara, S; Zhang, GL; Matsueda, S; Kasama-Kawaguchi, Y; Yamashita, Y; Yamashita, T; Nishio, K; Itoh, K; Hoshino, T; Sasada, T				Yamada, Teppei; Azuma, Koichi; Muta, Emi; Kim, Jintaek; Sugawara, Shunichi; Zhang, Guang Lan; Matsueda, Satoko; Kasama-Kawaguchi, Yuri; Yamashita, Yuichi; Yamashita, Takuto; Nishio, Kazuto; Itoh, Kyogo; Hoshino, Tomoaki; Sasada, Tetsuro			EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; LUNG-CANCER; ACQUIRED-RESISTANCE; CLINICAL-RESPONSE; PEPTIDE COMPLEX; POINT MUTATION; HIGH-AFFINITY; GEFITINIB; LYMPHOCYTES	Treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, has achieved high clinical response rates in patients with non-small cell lung cancers (NSCLCs). However, over time, most tumors develop acquired resistance to EGFR-TKIs, which is associated with the secondary EGFR T790M resistance mutation in about half the cases. Currently there are no effective treatment options for patients with this resistance mutation. Here we identified two novel HLA-A*0201 (A2)-restricted T cell epitopes containing the mutated methionine residue of the EGFR T790M mutation, T790M-5 (MQLMPFGCLL) and T790M-7 (LIMQLMPFGCL), as potential targets for EGFR-TKI-resistant patients. When peripheral blood cells were repeatedly stimulated in vitro with these two peptides and assessed by antigen-specific IFN-gamma secretion, T cell lines responsive to T790M-5 and T790M-7 were established in 5 of 6 (83%) and 3 of 6 (50%) healthy donors, respectively. Additionally, the T790M-5- and T790M-7-specific T cell lines displayed an MHC class I-restricted reactivity against NSCLC cell lines expressing both HLA-A2 and the T790M mutation. Interestingly, the NSCLC patients with antigen-specific T cell responses to these epitopes showed a significantly less frequency of EGFR-T790M mutation than those without them [1 of 7 (14%) vs 9 of 15 (60%); chi-squared test, p = 0.0449], indicating the negative correlation between the immune responses to the EGFR-T790M-derived epitopes and the presence of EGFR-T790M mutation in NSCLC patients. This finding could possibly be explained by the hypothesis that immune responses to the mutated neo-antigens derived from T790M might prevent the emergence of tumor cell variants with the T790M resistance mutation in NSCLC patients during EGFR-TKI treatment. Together, our results suggest that the identified T cell epitopes might provide a novel immunotherapeutic approach for prevention and/or treatment of EGFR-TKI resistance with the secondary EGFR T790M resistance mutation in NSCLC patients.	[Yamada, Teppei; Muta, Emi; Kim, Jintaek; Matsueda, Satoko; Kasama-Kawaguchi, Yuri; Itoh, Kyogo; Sasada, Tetsuro] Kurume Univ, Sch Med, Dept Immunol & Immunotherapy, Kurume, Fukuoka 830, Japan; [Yamada, Teppei; Yamashita, Yuichi] Fukuoka Univ, Sch Med, Dept Surg, Fukuoka 81401, Japan; [Azuma, Koichi; Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Zhang, Guang Lan] Boston Univ, Metropolitan Coll, Boston, MA 02215 USA; [Zhang, Guang Lan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Yamashita, Takuto] Kurume Univ, Grad Sch Med, Ctr Biostat, Kurume, Fukuoka 830, Japan; [Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan	Kurume University; Fukuoka University; Kurume University; Sendai Kousei Hospital; Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Kurume University; Kindai University (Kinki University)	Sasada, T (corresponding author), Kurume Univ, Sch Med, Dept Immunol & Immunotherapy, Kurume, Fukuoka 830, Japan.	tsasada@med.kurume-u.ac.jp			JSPS [23591913]; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [23591913] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the JSPS Grant-in-Aid for Scientific Research (C) 23591913 and the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoola A, 2012, CANCER INVEST, V30, P433, DOI 10.3109/07357907.2012.666691; Bernatchez C, 2011, VACCINE, V29, P3021, DOI 10.1016/j.vaccine.2011.01.115; Buettner R, 2013, J CLIN ONCOL, V31, P1858, DOI 10.1200/JCO.2012.45.9867; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; CHEN Y, 1994, J IMMUNOL, V152, P2874; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Echchakir H, 2001, CANCER RES, V61, P4078; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Heemskerk B, 2013, EMBO J, V32, P194, DOI 10.1038/emboj.2012.333; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hogan KT, 1998, CANCER RES, V58, P5144; Ichiki Y, 2004, J IMMUNOL, V172, P4844, DOI 10.4049/jimmunol.172.8.4844; Jin M, 2008, CANCER SCI, V99, P1656, DOI 10.1111/j.1349-7006.2008.00866.x; Karanikas V, 2001, CANCER RES, V61, P3718; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; La Rosa C, 2001, BLOOD, V97, P1776; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McKee MD, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-35; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mitsudomi T, 2013, NAT REV CLIN ONCOL, V10, P235, DOI 10.1038/nrclinonc.2013.22; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; Oxnard GR, 2011, CLIN CANCER RES, V17, P5530, DOI 10.1158/1078-0432.CCR-10-2571; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Sasada T, 2004, CANCER RES, V64, P2882, DOI 10.1158/0008-5472.CAN-03-3549; Sasada T, 2010, EUR J CANCER, V46, P1514, DOI 10.1016/j.ejca.2010.03.013; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; SHICHIO S, 1995, INT J CANCER, V64, P158, DOI 10.1002/ijc.2910640303; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Takenoyama M, 2006, INT J CANCER, V118, P1992, DOI 10.1002/ijc.21594; Toubaji A, 2008, CANCER IMMUNOL IMMUN, V57, P1413, DOI 10.1007/s00262-008-0477-6; Weden S, 2011, INT J CANCER, V128, P1120, DOI 10.1002/ijc.25449; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x	49	17	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78389	10.1371/journal.pone.0078389	http://dx.doi.org/10.1371/journal.pone.0078389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223798	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400023
J	Chen, X; Chen, Y; Yang, Q; Kong, HS; Yu, F; Han, DS; Zheng, SF; Cui, DW; Li, LJ				Chen, Xiao; Chen, Yu; Yang, Qing; Kong, Haishen; Yu, Fei; Han, Dongsheng; Zheng, Shufa; Cui, Dawei; Li, Lanjuan			Plesiomonas shigelloides Infection in Southeast China	PLOS ONE			English	Article							DIARRHEAL DISEASE; CDC DEFINITIONS; ETIOLOGY; FISH	Background: Plesiomonas shigelloides can cause gastroenteritis and extra-intestinal diseases in humans. However, the prevalence of P. shigelloides infections has not been investigated in China. Methods: Consecutive fecal specimens from outpatients with acute diarrhea and non-diarrheal patients at nine sentinel hospitals in southeast China were collected from March 2010 to May 2012. Bacterial pathogens were detected by culture, and P. shigelloides isolates were subjected to antimicrobial susceptibility testing. We also retrospectively reviewed the hospital microbiology laboratory and infection-control databases for all P. shigelloides isolates identified from 2001-2012 at our institution in addition to data on the patients' clinical and demographic characteristics. Results: A total of 3,536 outpatients with acute diarrhea were enrolled in the study. P. shigelloides was isolated from 104 (2.9%) patients and accounted for 7.3% of bacterial isolates. Single-pathogen infections with P. shigelloides were present in 76 (73.1%) patients. No strain of P. shigelloides was isolated from the 478 non-diarrheal patients. Based on 444,684 nonfecal specimens, eight patients developed P. shigelloides-related extra-intestinal infections over the 12-year period. All eight patients had underlying diseases, including four with biliary tract diseases and three with liver diseases. Six cases were classified as nosocomial, and five cases were polymicrobial. P. shigelloides was sensitive to most antimicrobial drugs, except ampicillin. Conclusions: In southeast China, P. shigelloides has significant clinical relevance, although the isolation rate is low.	[Chen, Xiao; Chen, Yu; Yang, Qing; Kong, Haishen; Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Fei; Han, Dongsheng; Zheng, Shufa; Cui, Dawei] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Ctr Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022	Han, Dongsheng/0000-0002-1892-8603	National Key Programs for Infectious Diseases of China [2012ZX10004-210]; National Key Clinical Specialist Construction Project	National Key Programs for Infectious Diseases of China; National Key Clinical Specialist Construction Project	This work was supported by the National Key Programs for Infectious Diseases of China (2012ZX10004-210) and National Key Clinical Specialist Construction Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI T, 1980, J HYG-CAMBRIDGE, V84, P203, DOI 10.1017/S002217240002670X; Bodhidatta L, 2010, AM J TROP MED HYG, V83, P1106, DOI 10.4269/ajtmh.2010.10-0367; Chen Y, 2013, CLIN MICROB IN PRESS; CLSI, 2011, M100S20 CLSI, P172; Escobar JC, 2012, EMERG INFECT DIS, V18, P322, DOI 10.3201/eid1802.110562; FLOCH MH, 1970, GASTROENTEROLOGY, V59, P70; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Herrera FC, 2006, INT J FOOD MICROBIOL, V108, P233, DOI 10.1016/j.ijfoodmicro.2005.12.008; HOLMBERG SD, 1986, ANN INTERN MED, V105, P690, DOI [10.7326/0003-4819-105-5-690, 10.7326/0003-4819-105-5-683]; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; HUQ MI, 1983, INDIAN J MED RES, V77, P793; Janda JM, 2005, BERGEYS MANUAL SYSTE, V2, P740; KAIN KC, 1989, J CLIN MICROBIOL, V27, P998, DOI 10.1128/JCM.27.5.998-1001.1989; Klatte JM, 2012, PEDIATR INFECT DIS J, V31, P1200, DOI 10.1097/INF.0b013e318266b61f; KUO CH, 1991, LIVER, V11, P334; Miller WA, 2006, MICROB ECOL, V52, P198, DOI 10.1007/s00248-006-9080-6; Nweze EI, 2010, J HEALTH POPUL NUTR, V28, P245; Ozdemir O, 2010, J MICROBIOL IMMUNOL, V43, P344, DOI 10.1016/S1684-1182(10)60053-9; RUTALA WA, 1982, LANCET, V1, P739; Schneider F, 2009, MED MALADIES INFECT, V39, P397, DOI 10.1016/j.medmal.2008.11.010; SOWEID AM, 1995, AM J GASTROENTEROL, V90, P2235; Stock I, 2001, J ANTIMICROB CHEMOTH, V48, P803, DOI 10.1093/jac/48.6.803; SUNG JY, 1992, J GASTROEN HEPATOL, V7, P240, DOI 10.1111/j.1440-1746.1992.tb00971.x; VANDAMME LR, 1980, APPL ENVIRON MICROB, V39, P475, DOI 10.1128/AEM.39.3.475-479.1980; Wong T. Y., 2000, Hong Kong Medical Journal, V6, P375; Woo PCY, 2005, MICROBIOLOGICA, V28, P45; Woo PCY, 2004, J CLIN MICROBIOL, V42, P933, DOI 10.1128/JCM.42.2.933-935.2004	27	20	24	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77877	10.1371/journal.pone.0077877	http://dx.doi.org/10.1371/journal.pone.0077877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223738	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400019
J	Kouzuma, A; Kasai, T; Nakagawa, G; Yamamuro, A; Abe, T; Watanabe, K				Kouzuma, Atsushi; Kasai, Takuya; Nakagawa, Gen; Yamamuro, Ayaka; Abe, Takashi; Watanabe, Kazuya			Comparative Metagenomics of Anode-Associated Microbiomes Developed in Rice Paddy-Field Microbial Fuel Cells	PLOS ONE			English	Article							ELECTRICITY PRODUCTION; SP-NOV.; BACTERIAL COMMUNITIES; GENERATION; SEQUENCE; PERFORMANCE; RHIZODEPOSITS; RHIZOSPHERE; DIVERSITY; CELLULOSE	In sediment-type microbial fuel cells (sMFCs) operating in rice paddy fields, rice-root exudates are converted to electricity by anode-associated rhizosphere microbes. Previous studies have shown that members of the family Geobacteraceae are enriched on the anodes of rhizosphere sMFCs. To deepen our understanding of rhizosphere microbes involved in electricity generation in sMFCs, here, we conducted comparative analyses of anode-associated microbiomes in three MFC systems: a rice paddy-field sMFC, and acetate-and glucose-fed MFCs in which pieces of graphite felt that had functioned as anodes in rice paddy-field sMFC were used as rhizosphere microbe-bearing anodes. After electric outputs became stable, microbiomes associated with the anodes of these MFC systems were analyzed by pyrotag sequencing of 16S rRNA gene amplicons and Illumina shotgun metagenomics. Pyrotag sequencing showed that Geobacteraceae bacteria were associated with the anodes of all three systems, but the dominant Geobacter species in each MFC were different. Specifically, species closely related to G. metallireducens comprised 90% of the anode Geobacteraceae in the acetate-fed MFC, but were only relatively minor components of the rhizosphere sMFC and glucose-fed MFC, whereas species closely related to G. psychrophilus were abundantly detected. This trend was confirmed by the phylogenetic assignments of predicted genes in shotgun metagenome sequences of the anode microbiomes. Our findings suggest that G. psychrophilus and its related species preferentially grow on the anodes of rhizosphere sMFCs and generate electricity through syntrophic interactions with organisms that excrete electron donors.	[Kouzuma, Atsushi; Kasai, Takuya; Nakagawa, Gen; Yamamuro, Ayaka; Watanabe, Kazuya] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan; [Abe, Takashi] Niigata Univ, Grad Sch Sci & Technol, Niigata 9518510, Japan	Tokyo University of Pharmacy & Life Sciences; Niigata University	Watanabe, K (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	kazuyaw@toyaku.ac.jp	Kouzuma, Atsushi/M-4559-2019	Kouzuma, Atsushi/0000-0002-5076-3810	Japan Science and Technology Agency (JST); New Energy and Industrial Technology development Organization (NEDO)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This study was partially supported by Japan Science and Technology Agency (JST) and New Energy and Industrial Technology development Organization (NEDO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Abe T, 2005, DNA RES, V12, P281, DOI 10.1093/dnares/dsi015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Bond DR, 2005, APPL ENVIRON MICROB, V71, P2186, DOI 10.1128/AEM.71.4.2186-2189.2005; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cheng S, 2006, ELECTROCHEM COMMUN, V8, P489, DOI 10.1016/j.elecom.2006.01.010; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; de Schamphelaire L, 2008, ENVIRON SCI TECHNOL, V42, P3053, DOI 10.1021/es071938w; De Schamphelaire L, 2010, APPL ENVIRON MICROB, V76, P2002, DOI 10.1128/AEM.02432-09; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freguia S, 2008, ENVIRON SCI TECHNOL, V42, P7937, DOI 10.1021/es800482e; Holmes DE, 2007, ISME J, V1, P663, DOI 10.1038/ismej.2007.85; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ishii S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-6; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; Kaku N, 2008, APPL MICROBIOL BIOT, V79, P43, DOI 10.1007/s00253-008-1410-9; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kato S, 2013, MICROBES ENVIRON, V28, P141, DOI 10.1264/jsme2.ME12161; Kato S, 2010, ENVIRON MICROBIOL, V12, P3114, DOI 10.1111/j.1462-2920.2010.02284.x; Kouzuma A, 2010, APPL ENVIRON MICROB, V76, P4151, DOI 10.1128/AEM.00117-10; Lee HS, 2008, WATER RES, V42, P1501, DOI 10.1016/j.watres.2007.10.036; Lee JY, 2003, FEMS MICROBIOL LETT, V223, P185, DOI 10.1016/S0378-1097(03)00356-2; Miyahara M, 2013, J BIOSCI BIOENG, V115, P176, DOI 10.1016/j.jbiosc.2012.09.003; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Nevin KP, 2005, INT J SYST EVOL MICR, V55, P1667, DOI 10.1099/ijs.0.63417-0; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Parameswaran P, 2009, BIOTECHNOL BIOENG, V103, P513, DOI 10.1002/bit.22267; Plugge CM, 2012, STAND GENOMIC SCI, V7, P91, DOI 10.4056/sigs.2996379; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ren ZY, 2007, ENVIRON SCI TECHNOL, V41, P4781, DOI 10.1021/es070577h; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shelobolina ES, 2008, INT J SYST EVOL MICR, V58, P1075, DOI 10.1099/ijs.0.65377-0; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Sung Y, 2006, APPL ENVIRON MICROB, V72, P2775, DOI 10.1128/AEM.72.4.2775-2782.2006; Takanezawa K, 2010, BIOSCI BIOTECH BIOCH, V74, P1271, DOI 10.1271/bbb.90852; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmers RA, 2012, APPL MICROBIOL BIOT, V94, P537, DOI 10.1007/s00253-012-3894-6; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2004, ENV MICROBIOLOGY MET, P237; Watanabe K, 2010, PATHS SUSTAINABLE EN, P563, DOI [DOI 10.5772/12929, 10.5772/12929]; Watanabe K, 2008, J BIOSCI BIOENG, V106, P528, DOI 10.1263/jbb.106.528; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yates MD, 2012, ISME J, V6, P2002, DOI 10.1038/ismej.2012.42	50	61	65	7	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77443	10.1371/journal.pone.0077443	http://dx.doi.org/10.1371/journal.pone.0077443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223712	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300005
J	Kim, Y; Kim, J; Lee, HD; Jeong, J; Lee, W; Lee, KA				Kim, Yoonjung; Kim, Juwon; Lee, Hy-De; Jeong, Joon; Lee, Woochang; Lee, Kyung-A			Spectrum of EGFR Gene Copy Number Changes and KRAS Gene Mutation Status in Korean Triple Negative Breast Cancer Patients	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; ACTIVATING MUTATIONS; ONCOGENIC MUTATIONS; TARGETED THERAPY; CETUXIMAB; TUMORS; RESISTANCE; GEFITINIB	Anti-epidermal growth factor receptor (EGFR) therapy has been tried in triple negative breast cancer (TNBC) patients without evaluation of molecular and clinical predictors in several randomized clinical studies. Only fewer than 20% of metastatic TNBCs showed response to anti-EGFR therapy. In order to increase the overall response rate, first step would be to classify TNBC into good or poor responders according to oncogenic mutation profiles. This study provides the molecular characteristics of TNBCs including EGFR gene copy number changes and mutation status of EGFR and KRAS gene in Korean TNBC patients. Mutation analysis for EGFR, KRAS, BRAF and TP53 from a total of 105 TNBC tissue samples was performed by direct sequencing, peptide nucleic acid-mediated PCR clamping method and real-time PCR. Copy number changes of EGFR gene were evaluated using multiplex ligation-dependent probe amplification. Out of all 105 TNBCs, 15.2% (16/105) showed EGFR copy number changes. Among them, increased or decreased EGFR copy number was detected in 13 (5 single copy gain, 2 amplification and 4 high-copy number amplification) and 3 cases (3 hemizygous deletion), respectively. The mutation frequencies of KRAS, EGFR and TP53 gene were 1.9% (G12V and G12D), 1.0% (exon 19 del) and 31.4%, respectively. There was no BRAF V600E mutation found. Future studies are needed to evaluate the clinical outcomes of TNBC patients who undergo anti-EGFR therapy according to the genetic status of EGFR.	[Kim, Yoonjung; Lee, Kyung-A] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Juwon] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Seoul 120749, South Korea; [Lee, Hy-De; Jeong, Joon] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Woochang] Univ Ulsan, Coll Med, Dept Lab Med, Seoul, South Korea; [Lee, Woochang] Asan Med Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; University of Ulsan	Lee, KA (corresponding author), Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	kal1119@yuhs.ac	, 정준/I-2133-2019	, 정준/0000-0003-0397-0005; Kim, Yoonjung/0000-0002-4370-4265; Lee, Kyung-A/0000-0001-5320-6705	Yonsei University College of Medicine	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from Yonsei University College of Medicine for 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2011, ONCOL REP, V26, P1213, DOI 10.3892/or.2011.1391; Brand TM, 2011, CANCER BIOL THER, V11, P777, DOI 10.4161/cbt.11.9.15050; Carey LA, 2012, J CLIN ONCOL; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Dickler MN, 2009, BREAST CANCER RES TR, V115, P115, DOI 10.1007/s10549-008-0055-9; Fukui T, 2008, GEN THORAC CARDIOVAS, V56, P97, DOI 10.1007/s11748-007-0193-8; Grob TJ, 2012, BREAST CANCER RES TR, V134, P561, DOI 10.1007/s10549-012-2092-7; Han HS, 2012, J THORAC ONCOL, V7, P355, DOI 10.1097/JTO.0b013e31823c4c1b; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Jacot W, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3079; Jeuken J, 2006, J MOL DIAGN, V8, P433, DOI 10.2353/jmoldx.2006.060012; Jeuken J, 2009, BRAIN PATHOL, V19, P661, DOI 10.1111/j.1750-3639.2009.00320.x; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Kurebayashi J, 2007, BREAST, V16, pS72, DOI 10.1016/j.breast.2007.07.017; Kwon MJ, 2011, PATHOL RES PRACT, V207, P762, DOI 10.1016/j.prp.2011.10.002; Langer Corey J, 2011, P T, V36, P263; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lv S, 2012, INT J ONCOL; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Moran T, 2012, J CLIN ONCOL; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nakajima H, 2012, BREAST CANC; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Oden-Gangloff A, 2009, BRIT J CANCER, V100, P1330, DOI 10.1038/sj.bjc.6605008; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Olivier M, 2001, SEMIN CANCER BIOL, V11, P353, DOI 10.1006/scbi.2001.0390; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Powell B, 2000, CLIN CANCER RES, V6, P443; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sanchez-Munoz A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-136; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Tang CK, 2000, CANCER RES, V60, P3081; Teng YHF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2857; Toyama T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-309; Vargas AC, 2012, BREAST CANC RES TREA; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0	48	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79014	10.1371/journal.pone.0079014	http://dx.doi.org/10.1371/journal.pone.0079014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205362	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500142
J	Murray, CL; Obiang, P; Bannerman, D; Cunningham, C				Murray, Carol L.; Obiang, Pauline; Bannerman, David; Cunningham, Colm			Endogenous IL-1 in Cognitive Function and Anxiety: A Study in IL-1RI(-/-) Mice	PLOS ONE			English	Article							SPATIAL MEMORY; INTERLEUKIN-1; RECEPTOR; HIPPOCAMPUS; BEHAVIOR; FEAR; IL-1-BETA; C57BL/6J; MAZE; LIPOPOLYSACCHARIDE	Interleukin-1 (IL-1) is a key pro-inflammatory cytokine, produced predominantly by peripheral immune cells but also by glia and some neuronal populations within the brain. Its signalling is mediated via the binding of IL-1 alpha or IL-1 beta to the interleukin-1 type one receptor (IL-1RI). IL-1 plays a key role in inflammation-induced sickness behaviour, resulting in depressed locomotor activity, decreased exploration, reduced food and water intake and acute cognitive deficits. Conversely, IL-1 has also been suggested to facilitate hippocampal-dependent learning and memory: IL-1RI(-/-) mice have been reported to show deficits on tasks of visuospatial learning and memory. We sought to investigate whether there is a generalised hippocampal deficit in IL-1RI(-/-) animals. Therefore, in the current study we compared wildtype (WT) mice to IL-1RI(-/-) mice using a variety of hippocampal-dependent learning and memory tasks, as well as tests of anxiety and locomotor activity. We found no difference in performance of the IL-1RI(-/-) mice compared to WT mice in a T-maze working memory task. In addition, the IL-1RI(-/-) mice showed normal learning in various spatial reference memory tasks including the Y-maze and Morris mater maze, although there was a subtle deficit in choice behaviour in a spatial discrimination, beacon watermaze task. IL-1RI(-/-) mice also showed normal memory for visuospatial context in the contextual fear conditioning paradigm. In the open field, IL-1RI(-/-) mice showed a significant increase in distance travelled and rearing behaviour compared to the WT mice and in the elevated plus-maze spent more time in the open arms than did the WT animals. The data suggest that, contrary to prior studies, IL-1RI(-/-) mice are not robustly impaired on hippocampal-dependent memory and learning but do display open field hyperactivity and decreased anxiety compared to WT mice. The results argue for a careful evaluation of the roles of endogenous IL-1 in hippocampal and limbic system function.	[Murray, Carol L.; Obiang, Pauline; Cunningham, Colm] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Murray, Carol L.; Obiang, Pauline; Cunningham, Colm] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Bannerman, David] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Trinity College Dublin; Trinity College Dublin; University of Oxford	Cunningham, C (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	colm.cunningham@tcd.ie	Cunningham, Colm/A-1743-2010	Cunningham, Colm/0000-0003-1423-5209; Bannerman, David/0000-0002-3024-7595	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (SRF granted to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; Balogh SA, 1999, BRAIN RES, V836, P38, DOI 10.1016/S0006-8993(99)01586-3; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Barkus C, 2012, GENES BRAIN BEHAV, V11, P342, DOI 10.1111/j.1601-183X.2012.00767.x; Beynon AL, 2010, CHRONOBIOL INT, V27, P1546, DOI 10.3109/07420528.2010.501927; BLUTHE RM, 1992, BRAIN RES, V573, P318, DOI 10.1016/0006-8993(92)90779-9; Contet C, 2001, BEHAV BRAIN RES, V125, P261, DOI 10.1016/S0166-4328(01)00295-9; Cunningham C, 2005, J VIROL, V79, P5174, DOI 10.1128/JVI.79.8.5174-5184.2005; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Cunningham C, 2008, BRAIN BEHAV IMMUN, V22, P1117, DOI 10.1016/j.bbi.2008.05.007; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Engler H, 2011, BRAIN BEHAV IMMUN, V25, P1384, DOI 10.1016/j.bbi.2011.04.005; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Goshen I, 2009, J NEUROSCI, V29, P3395, DOI 10.1523/JNEUROSCI.5352-08.2009; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Hultgren OH, 2002, J IMMUNOL, V168, P5207, DOI 10.4049/jimmunol.168.10.5207; Hut RA, 2011, BEHAV BRAIN RES, V221, P466, DOI 10.1016/j.bbr.2010.11.039; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Konsman JP, 2000, NEUROSCIENCE, V101, P957, DOI 10.1016/S0306-4522(00)00403-6; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Kuriyama K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00127; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; Loh DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012546; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Murray C, 2012, NEUROBIOL AGING, V33, P603, DOI 10.1016/j.neurobiolaging.2010.04.002; Murray CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-50; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; Pugh CR, 2001, NEUROSCI BIOBEHAV R, V25, P29, DOI 10.1016/S0149-7634(00)00048-8; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wolff M, 2002, BEHAV BRAIN RES, V136, P463, DOI 10.1016/S0166-4328(02)00192-4; Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072	45	33	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78385	10.1371/journal.pone.0078385	http://dx.doi.org/10.1371/journal.pone.0078385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205219	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500115
J	Vasserman, G; Schneidman, E; Segev, R				Vasserman, Genadiy; Schneidman, Elad; Segev, Ronen			Adaptive Colour Contrast Coding in the Salamander Retina Efficiently Matches Natural Scene Statistics	PLOS ONE			English	Article							TEMPORAL CONTRAST; LIGHT ADAPTATION; GAIN-CONTROL; MECHANISMS; REDUNDANCY; CIRCUITRY; PRIMATE; VISION; CORTEX; CODE	The visual system continually adjusts its sensitivity to the statistical properties of the environment through an adaptation process that starts in the retina. Colour perception and processing is commonly thought to occur mainly in high visual areas, and indeed most evidence for chromatic colour contrast adaptation comes from cortical studies. We show that colour contrast adaptation starts in the retina where ganglion cells adjust their responses to the spectral properties of the environment. We demonstrate that the ganglion cells match their responses to red-blue stimulus combinations according to the relative contrast of each of the input channels by rotating their functional response properties in colour space. Using measurements of the chromatic statistics of natural environments, we show that the retina balances inputs from the two ( red and blue) stimulated colour channels, as would be expected from theoretical optimal behaviour. Our results suggest that colour is encoded in the retina based on the efficient processing of spectral information that matches spectral combinations in natural scenes on the colour processing level.	[Vasserman, Genadiy; Segev, Ronen] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Vasserman, Genadiy; Segev, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Ben Gurion University; Ben Gurion University; Weizmann Institute of Science	Vasserman, G (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	genawas@gmail.com		schneidman, elad/0000-0001-8653-9848; Segev, Ronen/0000-0002-8109-1076				Babadi B, 2010, J VISION, V10, DOI 10.1167/10.10.22; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; COLLINS J. T, 1998, FIELD GUIDE REPTILES; Conway BR, 2002, CEREB CORTEX, V12, P915, DOI 10.1093/cercor/12.9.915; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; GREEN DG, 1982, VISION RES, V22, P209, DOI 10.1016/0042-6989(82)90120-1; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Himstedt W, 1972, J COMP PHYSL, V81, P229; Hurley JB, 2002, J GEN PHYSIOL, V119, P125, DOI 10.1085/jgp.119.2.125; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nascimento SMC, 2002, J OPT SOC AM A, V19, P1484, DOI 10.1364/JOSAA.19.001484; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PRZYREMBEL C, 1995, J COMP PHYSIOL A, V176, P575; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rodieck R.W., 1998, 1 STEPS SEEING; Ruderman DL, 1998, J OPT SOC AM A, V15, P2036, DOI 10.1364/JOSAA.15.002036; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Sharon R, 1997, J MORPHOL, V231, P149, DOI 10.1002/(SICI)1097-4687(199702)231:2<149::AID-JMOR4>3.0.CO;2-9; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Tailby C, 2008, J NEUROSCI, V28, P1131, DOI 10.1523/JNEUROSCI.4682-07.2008; Wandell B, 2008, CURR BIOL, V18, pR250, DOI 10.1016/j.cub.2008.01.045; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Webster MA, 1996, NETWORK-COMP NEURAL, V7, P587, DOI 10.1088/0954-898X/7/4/002; WEBSTER MA, 1991, NATURE, V349, P235, DOI 10.1038/349235a0; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; Wyszecki G, 1982, COLOR SCI CONCEPTS M, P117; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; ZAIDI Q, 1993, BIOL CYBERN, V69, P415, DOI 10.1007/BF01185413; Zhou CH, 2008, J VISION, V8, DOI 10.1167/8.4.4	49	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79163	10.1371/journal.pone.0079163	http://dx.doi.org/10.1371/journal.pone.0079163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205373	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500146
J	Then, C; Wahl, S; Kirchhofer, A; Grallert, H; Krug, S; Kastenmuller, G; Romisch-Margl, W; Claussnitzer, M; Illig, T; Heier, M; Meisinger, C; Adamski, J; Thorand, B; Huth, C; Peters, A; Prehn, C; Heukamp, I; Laumen, H; Lechner, A; Hauner, H; Seissler, J				Then, Cornelia; Wahl, Simone; Kirchhofer, Anna; Grallert, Harald; Krug, Susanne; Kastenmueller, Gabi; Roemisch-Margl, Werner; Claussnitzer, Melina; Illig, Thomas; Heier, Margit; Meisinger, Christa; Adamski, Jerzy; Thorand, Barbara; Huth, Cornelia; Peters, Annette; Prehn, Cornelia; Heukamp, Ina; Laumen, Helmut; Lechner, Andreas; Hauner, Hans; Seissler, Jochen			Plasma Metabolomics Reveal Alterations of Sphingo- and Glycerophospholipid Levels in Non-Diabetic Carriers of the Transcription Factor 7-Like 2 Polymorphism rs7903146	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; TCF7L2 GENE; INSULIN-SECRETION; ADIPOSE-TISSUE; RISK; ASSOCIATION; ACID; METABOLISM; INCREASES; VARIANTS	Aims/Hypothesis: Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene have been shown to display a powerful association with type 2 diabetes. The aim of the present study was to evaluate metabolic alterations in carriers of a common TCF7L2 risk variant. Methods: Seventeen non-diabetic subjects carrying the T risk allele at the rs7903146 TCF7L2 locus and 24 subjects carrying no risk allele were submitted to intravenous glucose tolerance test and euglycemic-hyperinsulinemic clamp. Plasma samples were analysed for concentrations of 163 metabolites through targeted mass spectrometry. Results: TCF7L2 risk allele carriers had a reduced first-phase insulin response and normal insulin sensitivity. Under fasting conditions, carriers of TCF7L2 rs7903146 exhibited a non-significant increase of plasma sphingomyelins (SMs), phosphatidylcholines (PCs) and lysophosphatidylcholines (lysoPCs) species. A significant genotype effect was detected in response to challenge tests in 6 SMs (C16:0, C16:1, C18:0, C18:1, C24:0, C24:1), 5 hydroxy-SMs (C14:1, C16:1, C22:1, C22:2, C24:1), 4 lysoPCs (C14:0, C16:0, C16:1, C17:0), 3 diacyl-PCs (C28:1, C36:6, C40:4) and 4 long-chain acyl-alkyl-PCs (C40:2, C40:5, C44:5, C44:6). Discussion: Plasma metabolomic profiling identified alterations of phospholipid metabolism in response to challenge tests in subjects with TCF7L2 rs7903146 genotype. This may reflect a genotype-mediated link to early metabolic abnormalities prior to the development of disturbed glucose tolerance.	[Then, Cornelia; Kirchhofer, Anna; Heukamp, Ina; Lechner, Andreas; Seissler, Jochen] Klinikum Univ Munchen, Med Klin & Poliklin 4, Diabet Zentrum, Munich, Germany; [Then, Cornelia; Grallert, Harald; Lechner, Andreas; Seissler, Jochen] Univ Munich, Clin Cooperat Grp Diabet, Munich, Germany; [Then, Cornelia; Grallert, Harald; Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Lechner, Andreas; Hauner, Hans; Seissler, Jochen] Helmholtz Zentrum Munchen, Munich, Germany; [Wahl, Simone; Grallert, Harald] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Hauner, Hans] Tech Univ Munich, Else Kroener Fresenius Ctr Nutr Med, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Krug, Susanne; Claussnitzer, Melina; Laumen, Helmut; Hauner, Hans] Tech Univ Munich, Clin Cooperat Grp Nutrigen & Type Diabet 2, D-80290 Munich, Germany; [Kastenmueller, Gabi; Roemisch-Margl, Werner] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Heier, Margit; Meisinger, Christa; Thorand, Barbara; Huth, Cornelia; Peters, Annette] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Thorand, Barbara; Huth, Cornelia] German Ctr Diabet Res DZD, Neuherberg, Germany; [Adamski, Jerzy; Prehn, Cornelia] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Seissler, J (corresponding author), Klinikum Univ Munchen, Med Klin & Poliklin 4, Diabet Zentrum, Campus Innenstadt, Munich, Germany.	jochen.seissler@med.uni-muenchen.de	Peters, Annette/A-6117-2011; Grallert, Harald/B-3424-2013; Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Thorand, Barbara/B-5349-2014; Huth, Cornelia/B-5350-2014; Laumen, Helmut/M-5140-2013; Kastenmüller, Gabi/ABF-5987-2020	Peters, Annette/0000-0001-6645-0985; Thorand, Barbara/0000-0002-8416-6440; Huth, Cornelia/0000-0003-2421-433X; Laumen, Helmut/0000-0002-5885-5242; Kastenmuller, Gabi/0000-0002-2368-7322; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen-National Research Center for Environmental Health; German Federal Ministry of Education and Science, Research and Technology; State of Bavaria; Virtual Diabetes Institute (Helmholtz Zentrum Munchen); Clinical Cooperation Group LMU (Ludwig-Maximilians-Universitat Munchen - Helmholtz Zentrum Muenchen); Clinical Cooperation Group TU (Else Kroner-Fresenius-Center for Nutritional Medicine, Technische Universitat Munchen - Helmholtz Zentrum Munchen); German Center for Diabetes Research (DZD e.V.)	Helmholtz Zentrum Munchen-National Research Center for Environmental Health; German Federal Ministry of Education and Science, Research and Technology; State of Bavaria; Virtual Diabetes Institute (Helmholtz Zentrum Munchen); Clinical Cooperation Group LMU (Ludwig-Maximilians-Universitat Munchen - Helmholtz Zentrum Muenchen); Clinical Cooperation Group TU (Else Kroner-Fresenius-Center for Nutritional Medicine, Technische Universitat Munchen - Helmholtz Zentrum Munchen); German Center for Diabetes Research (DZD e.V.)	The KORA research platform studies were initiated and financed by the Helmholtz Zentrum Munchen-National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Science, Research and Technology and by the State of Bavaria. The study was supported by a research grant from the Virtual Diabetes Institute (Helmholtz Zentrum Munchen), the Clinical Cooperation Group LMU (Ludwig-Maximilians-Universitat Munchen - Helmholtz Zentrum Muenchen), the Clinical Cooperation Group TU (Else Kroner-Fresenius-Center for Nutritional Medicine, Technische Universitat Munchen - Helmholtz Zentrum Munchen) and in part by the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibegovic AC, 2010, DIABETES, V59, P836, DOI 10.2337/db09-0918; [Anonymous], HORM METAB RES, V43, P355, DOI [10.1055/s-0031-1275270, DOI 10.1055/S-0031-1275270.PUBMED:21448848]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Chen XY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-25; Dohi T, 2012, CLIN CHIM ACTA, V413, P207, DOI 10.1016/j.cca.2011.09.027; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gonzalez-Sanchez JL, 2008, DIABETOLOGIA, V51, P1993, DOI 10.1007/s00125-008-1129-2; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Huo TG, 2009, J PHARMACEUT BIOMED, V49, P976, DOI 10.1016/j.jpba.2009.01.008; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Ip W, 2012, AM J PHYSIOL-ENDOC M, V303, pE1166, DOI 10.1152/ajpendo.00249.2012; Ishida-Oku M, 2010, ISLETS, V2, P274, DOI 10.4161/isl.2.5.12728; Kaminska D, 2012, DIABETES, V61, P2807, DOI 10.2337/db12-0239; Kouglas P, 2006, MED SCI MONITOR, V12, pRA5; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marzi C, 2007, HORM METAB RES, V39, P46, DOI 10.1055/s-2007-957345; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pietilainen KH, 2006, J CLIN ENDOCR METAB, V91, P2776, DOI 10.1210/jc.2005-2848; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Villareal DT, 2010, DIABETES, V59, P479, DOI 10.2337/db09-1169; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Xu FG, 2013, J CLIN ENDOCR METAB, V98, pE1060, DOI 10.1210/jc.2012-4132; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yea K, 2009, J BIOL CHEM, V284, P33833, DOI 10.1074/jbc.M109.024869; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z; Zhang Y, 2009, APOPTOSIS, V14, P878, DOI 10.1007/s10495-009-0364-4; Zhu C, 2011, TALANTA, V85, P1711, DOI 10.1016/j.talanta.2011.05.036	48	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78430	10.1371/journal.pone.0078430	http://dx.doi.org/10.1371/journal.pone.0078430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205231	Green Published, gold			2022-12-27	WOS:000326152300060
J	Stier, I; Kiss, A				Stier, Ildiko; Kiss, Antal			Cytosine-to-Uracil Deamination by SssI DNA Methyltransferase	PLOS ONE			English	Article							ESCHERICHIA-COLI; HPAII METHYLTRANSFERASE; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; METHYLATION; MUTAGENESIS; RESTRICTION; EXPRESSION; BISULFITE; SEQUENCE	The prokaryotic DNA(cytosine-5)methyltransferase M. SssI shares the specificity of eukaryotic DNA methyltransferases (CG) and is an important model and experimental tool in the study of eukaryotic DNA methylation. Previously, M. SssI was shown to be able to catalyze deamination of the target cytosine to uracil if the methyl donor S-adenosyl-methionine (SAM) was missing from the reaction. To test whether this side-activity of the enzyme can be used to distinguish between unmethylated and C5-methylated cytosines in CG dinucleotides, we re-investigated, using a sensitive genetic reversion assay, the cytosine deaminase activity of M. SssI. Confirming previous results we showed that M. SssI can deaminate cytosine to uracil in a slow reaction in the absence of SAM and that the rate of this reaction can be increased by the SAM analogue 5'-amino-5'-deoxyadenosine. We could not detect M. SssI-catalyzed deamination of C5-methylcytosine (C-m5). We found conditions where the rate of M. SssI mediated C-to-U deamination was at least 100-fold higher than the rate of C-m5-to-T conversion. Although this difference in reactivities suggests that the enzyme could be used to identify C5-methylated cytosines in the epigenetically important CG dinucleotides, the rate of M. SssI mediated cytosine deamination is too low to become an enzymatic alternative to the bisulfite reaction. Amino acid replacements in the presumed SAM binding pocket of M. SssI (F17S and G19D) resulted in greatly reduced methyltransferase activity. The G19D variant showed cytosine deaminase activity in E. coli, at physiological SAM concentrations. Interestingly, the C-to-U deaminase activity was also detectable in an E. coli ung(+) host proficient in uracil excision repair.	[Stier, Ildiko; Kiss, Antal] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center	Kiss, A (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	kiss.antal@brc.mta.hu	Kiss, Antal/A-1656-2008		Hungarian Scientific Research Fund (OTKA) [K83983]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the K83983 grant from the Hungarian Scientific Research Fund (OTKA); URL: www.otka.hu/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDARU B, 1995, J BACTERIOL, V177, P2950, DOI 10.1128/jb.177.10.2950-2952.1995; Bandaru B, 1996, J BIOL CHEM, V271, P7851, DOI 10.1074/jbc.271.13.7851; Beletskii A, 2001, J BACTERIOL, V183, P6491, DOI 10.1128/JB.183.21.6491-6493.2001; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Jeltsch A, 2007, APPL MICROBIOL BIOT, V75, P1233, DOI 10.1007/s00253-007-0966-0; Koudan EV, 2004, J BIOMOL STRUCT DYN, V22, P339, DOI 10.1080/07391102.2004.10507005; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Luria SE, 1943, GENETICS, V28, P491; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Posfai G, 1997, J BACTERIOL, V179, P4426, DOI 10.1128/jb.179.13.4426-4428.1997; RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x; Rathert P, 2007, CHEMBIOCHEM, V8, P202, DOI 10.1002/cbic.200600358; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sambrook J., 2006, CONDENSED PROTOCOLS; Sankpal UT, 2002, NUCLEIC ACIDS RES, V30, P2628, DOI 10.1093/nar/gkf380; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SHAPIRO R, 1973, J BIOL CHEM, V248, P4060; Sharath AN, 2000, BIOCHEMISTRY-US, V39, P14611, DOI 10.1021/bi001610e; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SHEN JC, 1995, NUCLEIC ACIDS RES, V23, P4275, DOI 10.1093/nar/23.21.4275; Sibley MH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1085; Stier I, 2010, NUCLEIC ACIDS RES, V38, P8231, DOI 10.1093/nar/gkq676; van der Gun BTF, 2010, BIOCONJUGATE CHEM, V21, P1239, DOI 10.1021/bc1000388; WAITEREES PA, 1991, J BACTERIOL, V173, P5207, DOI 10.1128/jb.173.16.5207-5219.1991; WANG RYH, 1980, NUCLEIC ACIDS RES, V8, P4777, DOI 10.1093/nar/8.20.4777; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; WYSZYNSKI M, 1994, P NATL ACAD SCI USA, V91, P1574, DOI 10.1073/pnas.91.4.1574; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; YANG AS, 1995, NUCLEIC ACIDS RES, V23, P1380, DOI 10.1093/nar/23.8.1380; ZHANG XL, 1994, J BIOL CHEM, V269, P7066; Zingg JM, 1998, BIOCHEM J, V332, P223, DOI 10.1042/bj3320223; Zingg JM, 1996, NUCLEIC ACIDS RES, V24, P3267, DOI 10.1093/nar/24.16.3267	45	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e79003	10.1371/journal.pone.0079003	http://dx.doi.org/10.1371/journal.pone.0079003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205358	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000326032600117
J	Tschinkel, WR; King, JR				Tschinkel, Walter R.; King, Joshua R.			The Role of Habitat in the Persistence of Fire Ant Populations	PLOS ONE			English	Article							SOLENOPSIS-INVICTA HYMENOPTERA; NATIVE ANTS; FORMICIDAE; FLORIDA; COMMUNITIES; DISTURBANCE; SUCCESSION; ABUNDANCE; POLYGYNE; PATTERNS	The association of the exotic fire ant, Solenopsis invicta with man-modified habitats has been amply demonstrated, but the fate of such populations if ecological succession proceeds has rarely been investigated. Resurvey of a fire ant population in a longleaf pine plantation after 25 years showed that the recovery of the site from habitat disturbance was associated with a large fire ant population decline. Most of the persisting colonies were associated with the disturbance caused by vehicle tracks. In a second study, mature monogyne fire ant colonies that had been planted in experimental plots in native groundcover of the north Florida longleaf pine forest had mostly vanished six years later. These observations and experiments show that S. invicta colonies rarely persist in the native habitat of these pine forests, probably because they are not replaced when they die. A single site harbored a modest population of polygyne fire ants whose persistence was probably facilitated by reproduction through colony fission.	[Tschinkel, Walter R.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [King, Joshua R.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	State University System of Florida; Florida State University; State University System of Florida; University of Central Florida	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation [DEB 1020415]	National Science Foundation(National Science Foundation (NSF))	This work was carried out with support from National Science Foundation grant DEB 1020415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPERSON CS, 1984, FLA ENTOMOL, V67, P383, DOI 10.2307/3494717; BROWN VK, 1986, J ECOL, V74, P963, DOI 10.2307/2260227; CAMILO GR, 1990, WESTV STUD, P190; Cherry R, 2001, J ENTOMOL SCI, V36, P411, DOI 10.18474/0749-8004-36.4.411; CHERRY RH, 1992, ENVIRON ENTOMOL, V21, P767, DOI 10.1093/ee/21.4.767; CLABORN DM, 1986, SOUTHWEST NAT, V31, P555, DOI 10.2307/3671722; Fraelich BA, 1991, THESIS U FLORIDA, P158; HENDRIX SD, 1988, J ANIM ECOL, V57, P1053, DOI 10.2307/5111; HOWARD FW, 1979, J GEORGIA ENTOMOL SO, V14, P259; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; King JR, 2013, ECOL ENTOMOL, V38, P68, DOI 10.1111/j.1365-2311.2012.01405.x; King JR, 2009, BIOL INVASIONS, V11, P373, DOI 10.1007/s10530-008-9254-x; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; King JR, 1998, BIODIVERS CONSERV, V7, P1627, DOI 10.1023/A:1008857214743; LeBrun EG, 2012, J ANIM ECOL, V81, P884, DOI 10.1111/j.1365-2656.2012.01954.x; LOFGREN CS, 1975, ANNU REV ENTOMOL, V20, P1, DOI 10.1146/annurev.en.20.010175.000245; Lubertazzi D, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.21; Majer JD, 1998, J APPL ECOL, V35, P161, DOI 10.1046/j.1365-2664.1998.00286.x; MARKIN GP, 1974, ENVIRON ENTOMOL, V3, P895, DOI 10.1093/ee/3.6.895; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; Morrison LW, 2002, ECOLOGY, V83, P2337, DOI 10.1890/0012-9658(2002)083[2337:LTIOAA]2.0.CO;2; Pass BC, 1960, THESIS AUBURN U AUBU, P54; Phillips Jr SA, 1986, TEMPORAL FORAGING PA, P114; Phillips Jr SA, 1987, TEXAS J AGR NATURAL, V1, P11; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; PORTER SD, 1992, J ECON ENTOMOL, V85, P1155; PORTER SD, 1993, J ECON ENTOMOL, V86, P1344, DOI 10.1093/jee/86.5.1344; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Siemann E, 1999, ECOGRAPHY, V22, P406, DOI 10.1111/j.1600-0587.1999.tb00577.x; Steffan-Dewenter I, 2001, ECOGRAPHY, V24, P83, DOI 10.1034/j.1600-0587.2001.240110.x; Stiles JH, 1998, LANDSCAPE ECOL, V13, P335, DOI 10.1023/A:1008073813734; Stimac Jerry L., 1994, P353; Stuble KL, 2011, CONSERV BIOL, V25, P618, DOI 10.1111/j.1523-1739.2010.01634.x; Stuble KL, 2009, ECOL ENTOMOL, V34, P520, DOI 10.1111/j.1365-2311.2009.01098.x; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P76, DOI 10.1093/aesa/81.1.76; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P777, DOI 10.1093/aesa/81.5.777; TSCHINKEL WR, 1987, ANN ENTOMOL SOC AM, V80, P263, DOI 10.1093/aesa/80.2.263; Tschinkel WR, 2006, FIRE ANTS; WALKER LR, 1987, OIKOS, V50, P131, DOI 10.2307/3565409; Wetterer JK, 2004, SOCIOBIOLOGY, V44, P1; Wojcik Daniel P., 2001, American Entomologist, V47, P16; WOJCIK DP, 1983, FLA ENTOMOL, V66, P101, DOI 10.2307/3494556; Zettler JA, 2004, ANN ENTOMOL SOC AM, V97, P513, DOI 10.1603/0013-8746(2004)097[0513:COFCFN]2.0.CO;2	43	16	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78580	10.1371/journal.pone.0078580	http://dx.doi.org/10.1371/journal.pone.0078580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205272	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600108
J	Blasco-Lafarga, C; Martinez-Navarro, I; Mateo-March, M				Blasco-Lafarga, Cristina; Martinez-Navarro, Ignacio; Mateo-March, Manuel			Is Baseline Cardiac Autonomic Modulation Related to Performance and Physiological Responses Following a Supramaximal Judo Test?	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PARASYMPATHETIC REACTIVATION; RATE RECOVERY; HIGH-INTENSITY; EXERCISE; LACTATE; POWER; RELIABILITY; ADAPTATIONS; ENDURANCE	Little research exists concerning Heart Rate (HR) Variability (HRV) following supramaximal efforts focused on upper-body explosive strength-endurance. Since they may be very demanding, it seems of interest to analyse the relationship among performance, lactate and HR dynamics (i.e. HR, HRV and complexity) following them; as well as to know how baseline cardiac autonomic modulation mediates these relationships. The present study aimed to analyse associations between baseline and post-exercise HR dynamics following a supramaximal Judo test, and their relationship with lactate, in a sample of 22 highly-trained male judoists (20.70 +/- 4.56 years). A large association between the increase in HR from resting to exercise condition and performance suggests that individuals exerted a greater sympathetic response to achieve a better performance (Rating of Perceived Exertion: 20; post-exercise peak lactate: 11.57 +/- 2.24 mmol/L; 95.76 +/- 4.13 % of age-predicted HRmax). Athletes with higher vagal modulation and lower sympathetic modulation at rest achieved both a significant larger Delta HR and a faster post-exercise lactate removal. A enhanced resting parasympathetic modulation might be therefore related to a further usage of autonomic resources and a better immediate metabolic recovery during supramaximal exertions. Furthermore, analyses of variance displayed a persistent increase in alpha(1) and a decrease in lnRMSSD along the 15 min of recovery, which are indicative of a diminished vagal modulation together with a sympathovagal balance leaning to sympathetic domination. Eventually, time-domain indices (lnRMSSD) showed no lactate correlations, while nonlinear indices (alpha(1) and lnSaEn) appeared to be moderate to strongly correlated with it, thus pointing to shared mechanisms between neuroautonomic and metabolic regulation.	[Blasco-Lafarga, Cristina; Martinez-Navarro, Ignacio] Univ Valencia, Phys Educ & Sports Dept, Valencia, Spain; [Mateo-March, Manuel] Univ Miguel Hernandez, Alicante, Spain	University of Valencia; Universidad Miguel Hernandez de Elche	Mateo-March, M (corresponding author), Univ Miguel Hernandez, Alicante, Spain.	m.cristina.blasco@uv.es	Mateo-March, Manuel/AAF-8979-2021; Blasco-Lafarga, Cristina/J-1916-2012; March, Manuel Mateo/A-8938-2012	Mateo-March, Manuel/0000-0003-4418-8263; Blasco-Lafarga, Cristina/0000-0001-8798-306X; March, Manuel Mateo/0000-0003-4418-8263; MARTINEZ-NAVARRO, IGNACIO/0000-0002-2942-1293				Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Ba A, 2009, CLIN RES CARDIOL, V98, P52, DOI 10.1007/s00392-008-0723-0; Bastos FN, 2012, INT J SPORTS MED, V33, P873, DOI 10.1055/s-0032-1301905; Blasco Lafarga C, 2010, CIENCIA CULTURA DEPO, P1; Blasco Lafarga C, 2009, PROPUESTA RESULTADOS; Bloomfield DM, 2001, AM J PHYSIOL-HEART C, V280, pH1145, DOI 10.1152/ajpheart.2001.280.3.H1145; Borg G, 1998, BORGS PERCEIVED EXER; Bosquet L, 2007, EUR J APPL PHYSIOL, V100, P363, DOI 10.1007/s00421-007-0438-3; Brooks GA, 2007, SPORTS MED, V37, P341, DOI 10.2165/00007256-200737040-00017; Buchheit M, 2009, EXP PHYSIOL, V94, P795, DOI 10.1113/expphysiol.2009.048041; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Buchheit M, 2010, APPL PHYSIOL NUTR ME, V35, P142, DOI 10.1139/H09-140; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Oliveira TP, 2013, CLIN PHYSIOL FUNCT I, V33, P143, DOI 10.1111/cpf.12009; Degoutte F, 2003, BRIT J SPORT MED, V37, P245, DOI 10.1136/bjsm.37.3.245; Esco MR, 2010, CLIN AUTON RES, V20, P33, DOI 10.1007/s10286-009-0033-2; Franchini E., 2004, REV BRASILEIRA CINEA, V6, P07; Franchini E, 2011, SPORTS MED, V41, P147, DOI 10.2165/11538580-000000000-00000; Fukusaki C, 2000, CLIN AUTON RES, V10, P123, DOI 10.1007/BF02278016; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Glaister M, 2005, J STRENGTH COND RES, V19, P831, DOI 10.1519/00124278-200511000-00018; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Goldberger Jeffrey J, 2006, Am J Physiol Heart Circ Physiol, V290, pH2446; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Goulopoulou S, 2009, EUR J APPL PHYSIOL, V105, P525, DOI 10.1007/s00421-008-0930-4; GREEN S, 1993, SPORTS MED, V15, P312, DOI 10.2165/00007256-199315050-00003; Hale T, 2008, J SPORT SCI, V26, P365, DOI 10.1080/02640410701701016; Halliwill JR, 1996, J PHYSIOL-LONDON, V495, P279, DOI 10.1113/jphysiol.1996.sp021592; Hynynen E, 2008, INT J SPORTS MED, V29, P552, DOI 10.1055/s-2007-989286; Javorka M, 2002, BRAZ J MED BIOL RES, V35, P991, DOI 10.1590/S0100-879X2002000800018; Kaikkonen P, 2012, EUR J APPL PHYSIOL, V112, P829, DOI 10.1007/s00421-011-2031-z; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Laursen PB, 2002, SPORTS MED, V32, P53, DOI 10.2165/00007256-200232010-00003; Leeper NJ, 2007, CIRCULATION, V115, P468, DOI 10.1161/CIRCULATIONAHA.106.666388; Mendonca GV, 2010, APPL PHYSIOL NUTR ME, V35, P439, DOI 10.1139/H10-028; Miladi I, 2011, J STRENGTH COND RES, V25, P205, DOI 10.1519/JSC.0b013e3181af5152; Millar PJ, 2011, INT J SPORTS MED, V32, P174, DOI 10.1055/s-0030-1268473; Millar PJ, 2009, APPL PHYSIOL NUTR ME, V34, P875, DOI 10.1139/H09-086; Nakamura FY, 2009, INT J SPORTS MED, V30, P808, DOI 10.1055/s-0029-1234055; Negrao CE, 2008, HEART FAIL REV, V13, P51, DOI 10.1007/s10741-007-9057-7; Niewiadomski W, 2007, CLIN PHYSIOL FUNCT I, V27, P309, DOI 10.1111/j.1475-097X.2007.00753.x; Nunan D, 2010, RESTING AUTONOMIC MO, V8; Nunan D, 2009, MED SCI SPORT EXER, V41, P243, DOI 10.1249/MSS.0b013e318184a4b1; Obminski Z., 2010, J COMBAT SPORTS MART, V1, P95; Olek RA, 2010, J SPORT MED PHYS FIT, V50, P52; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Platisa MM, 2006, PHYSIOL MEAS, V27, P145, DOI 10.1088/0967-3334/27/2/005; Pyne DB, 2000, EUR J APPL PHYSIOL, V82, P112, DOI 10.1007/s004210050659; Ravier G, 2009, SCAND J MED SCI SPOR, V19, P687, DOI 10.1111/j.1600-0838.2008.00807.x; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; ROWELL LB, 1990, J APPL PHYSIOL, V69, P407, DOI 10.1152/jappl.1990.69.2.407; Saboul D, 2013, EUR J SPORT SCI, V13, P534, DOI 10.1080/17461391.2013.767947; Sbriccoli P, 2007, J STRENGTH COND RES, V21, P738; Simos RP, 2013, INT J SPORTS MED, V34, P991, DOI 10.1055/s-0033-1337946; Strobel G, 1999, MED SCI SPORT EXER, V31, P560, DOI 10.1097/00005768-199904000-00011; Stuckey MI, 2012, SCAND J MED SCI SPOR, V22, P756, DOI 10.1111/j.1600-0838.2011.01320.x; Thomas C, 2004, J APPL PHYSIOL, V97, P2132, DOI 10.1152/japplphysiol.00387.2004; Thomas C, 2005, J APPL PHYSIOL, V98, P804, DOI 10.1152/japplphysiol.01057.2004; THOMAS SG, 1989, CAN J SPORT SCI, V14, P142; Tulppo MP, 2011, CLIN PHYSIOL FUNCT I, V31, P272, DOI 10.1111/j.1475-097X.2011.01012.x; Tulppo MP, 2005, CIRCULATION, V112, P314, DOI 10.1161/CIRCULATIONAHA.104.523712; Wallen MB, 2012, EUR J APPL PHYSIOL, V112, P1153, DOI 10.1007/s00421-011-2079-9; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; Zouhal H, 2001, J SPORT MED PHYS FIT, V41, P330	69	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78584	10.1371/journal.pone.0078584	http://dx.doi.org/10.1371/journal.pone.0078584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205273	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300160
J	Slater, PG; Ramirez, VT; Gonzalez-Billault, C; Varela-Nallar, L; Inestrosa, NC				Slater, Paula G.; Ramirez, Valerie T.; Gonzalez-Billault, Christian; Varela-Nallar, Lorena; Inestrosa, Nibaldo C.			Frizzled-5 Receptor Is Involved in Neuronal Polarity and Morphogenesis of Hippocampal Neurons	PLOS ONE			English	Article							N-TERMINAL KINASE; GROWTH CONE; AXON FORMATION; SYNAPTIC DIFFERENTIATION; RHO-GTPASES; ACTIN; WNTS; GUIDANCE; FAMILY; RAT	The Wnt signaling pathway plays important roles during different stages of neuronal development, including neuronal polarization and dendritic and axonal outgrowth. However, little is known about the identity of the Frizzled receptors mediating these processes. In the present study, we investigated the role of Frizzled-5 (Fzd5) on neuronal development in cultured Sprague-Dawley rat hippocampal neurons. We found that Fzd5 is expressed early in cultured neurons on actin-rich structures localized at minor neurites and axonal growth cones. At 4 DIV, Fzd5 polarizes towards the axon, where its expression is detected mainly at the peripheral zone of axonal growth cones, with no obvious staining at dendrites; suggesting a role of Fzd5 in neuronal polarization. Overexpression of Fzd5 during the acquisition of neuronal polarity induces mislocalization of the receptor and a loss of polarized axonal markers. Fzd5 knock-down leads to loss of axonal proteins, suggesting an impaired neuronal polarity. In contrast, overexpression of Fzd5 in neurons that are already polarized did not alter polarity, but decreased the total length of axons and increased total dendrite length and arborization. Fzd5 activated JNK in HEK293 cells and the effects triggered by Fzd5 overexpression in neurons were partially prevented by inhibition of JNK, suggesting that a non-canonical Wnt signaling mechanism might be involved. Our results suggest that, Fzd5 has a role in the establishment of neuronal polarity, and in the morphogenesis of neuronal processes, in part through the activation of the non-canonical Wnt mechanism involving JNK.	[Slater, Paula G.; Ramirez, Valerie T.; Varela-Nallar, Lorena; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile; [Gonzalez-Billault, Christian] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Alameda 340, Santiago, Chile.	ninestrosa@bio.puc.cl	Slater, Paula G/AAP-8728-2021; Varela-Nallar, Lorena/AAV-3304-2021; Gonzalez-Billault, Christian/P-2393-2019; Gonzalez-Billault, Christian/K-9622-2013	Slater, Paula G/0000-0003-2601-0613; Gonzalez-Billault, Christian/0000-0003-0335-1482; Varela-Nallar, Lorena/0000-0003-2588-6437	Basal Center of Excellence in Aging and Regeneration [CONICYT-PFB12/2007]; Fondecyt [1120156, 11110012]; CONICYT; Insertion of Postdoctoral Researchers in the Academy-CONICYT [79090027]	Basal Center of Excellence in Aging and Regeneration(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Insertion of Postdoctoral Researchers in the Academy-CONICYT	This work was supported by Basal Center of Excellence in Aging and Regeneration (CONICYT-PFB12/2007) and Fondecyt (1120156) to N.C.I., Predoctoral Fellowships from CONICYT to P. G. S and V. T. R, Fondecyt (11110012) and Insertion of Postdoctoral Researchers in the Academy-CONICYT (No 79090027) to LV-N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Alvania RS, 2006, NEURON, V50, P813, DOI 10.1016/j.neuron.2006.06.001; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009; Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Burns CJ, 2008, DEV DYNAM, V237, P1614, DOI 10.1002/dvdy.21565; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CACERES A, 1986, J NEUROSCI, V6, P714; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Codocedo JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047073; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Conde C, 2010, J NEUROSCI, V30, P6793, DOI 10.1523/JNEUROSCI.5420-09.2010; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Farrar NR, 2008, DEV BIOL, V318, P102, DOI 10.1016/j.ydbio.2008.03.012; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Georges PC, 2008, MOL NEUROBIOL, V38, P270, DOI 10.1007/s12035-008-8046-8; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HINE RJ, 1974, Z ANAT ENTWICKLUNGS, V144, P173, DOI 10.1007/BF00519773; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kobayashi T, 2010, J THEOR BIOL, V266, P712, DOI 10.1016/j.jtbi.2010.07.036; Komiya Yuko, 2008, Organogenesis, V4, P68; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Podkowa M, 2010, MOL CELL BIOL, V30, P2241, DOI 10.1128/MCB.01166-09; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Varela-Nallar L, 2012, CYTOSKELETON, V69, P528, DOI 10.1002/cm.21022; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x	70	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78892	10.1371/journal.pone.0078892	http://dx.doi.org/10.1371/journal.pone.0078892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205342	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300166
J	Chao, CT; Lin, YF; Tsai, HB; Hsu, NC; Tseng, CL; Ko, WJ				Chao, Chia-Ter; Lin, Yu-Feng; Tsai, Hung-Bin; Hsu, Nin-Chieh; Tseng, Chia-Lin; Ko, Wen-Je		HINT Study Grp	In Nonagenarians, Acute Kidney Injury Predicts In-Hospital Mortality, while Heart Failure Predicts Hospital Length of Stay	PLOS ONE			English	Article							ELDERLY-PATIENTS; FUNCTIONAL STATUS; NUTRITIONAL-STATUS; INTERNAL-MEDICINE; PHYSICAL FUNCTION; HEALTH-INSURANCE; PROGNOSTIC INDEX; OLDER-PEOPLE; RISK-FACTORS; MORBIDITY	Background/Aims: The elderly constitute an increasing proportion of admitted patients worldwide. We investigate the determinants of hospital length of stay and outcomes in patients aged 90 years and older. Methods: We retrospectively analyzed all admitted patients aged >90 years from the general medical wards in a tertiary referral medical center between August 31, 2009 and August 31, 2012. Patients' clinical characteristics, admission diagnosis, concomitant illnesses at admission, and discharge diagnosis were collected. Each patient was followed until discharge or death. Multivariate logistic regression analysis was utilized to study factors associated with longer hospital length of stay (>7 days) and in-hospital mortality. Results: A total of 283 nonagenarian in-patients were recruited, with 118 (41.7%) hospitalized longer than one week. Nonagenarians admitted with pneumonia (p = 0.04) and those with lower Barthel Index (p = 0.012) were more likely to be hospitalized longer than one week. Multivariate logistic regression analysis revealed that patients with lower Barthel Index (odds ratio [OR] 0.98; p = 0.021) and those with heart failure (OR 3.05; p = 0.046) had hospital stays >7 days, while patients with lower Barthel Index (OR 0.93; p = 0.005), main admission nephrologic diagnosis (OR 4.83; p = 0.016) or acute kidney injury (OR 30.7; p = 0.007) had higher in-hospital mortality. Conclusion: In nonagenarians, presence of heart failure at admission was associated with longer hospital length of stay, while acute kidney injury at admission predicted higher hospitalization mortality. Poorer functional status was associated with both prolonged admission and higher in-hospital mortality.	[Chao, Chia-Ter; Lin, Yu-Feng; Tsai, Hung-Bin] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Chao, Chia-Ter; Lin, Yu-Feng; Tsai, Hung-Bin; Hsu, Nin-Chieh; Tseng, Chia-Lin; Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Chao, Chia-Ter; Lin, Yu-Feng; Tsai, Hung-Bin; Hsu, Nin-Chieh; Tseng, Chia-Lin; Ko, Wen-Je; HINT Study Grp] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, HB (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan.	b88401084@gmail.com	Tsai, Hung-Bin/G-3761-2011; Chao, Chia-Ter/H-7994-2019	Chao, Chia-Ter/0000-0003-2892-7986; LIN, YU-FENG/0000-0002-4350-7755; HSU, NIN-CHIEH/0000-0002-4997-1081; Tsai, Hung-Bin/0000-0002-0689-8339				Ailshire JA, 2011, J AGING RES, V2011, DOI DOI 10.4061/2011/530534; Alarcon T, 1999, AGE AGEING, V28, P429, DOI 10.1093/ageing/28.5.429; Barba R, 2011, EUR J INTERN MED, V22, P49, DOI 10.1016/j.ejim.2010.11.001; Beckett LA, 1996, AM J EPIDEMIOL, V143, P766; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Butchart C, 2013, ARCH GERONTOL GERIAT, V56, P188, DOI 10.1016/j.archger.2012.07.005; CAMPBELL AJ, 1985, J EPIDEMIOL COMMUN H, V39, P337, DOI 10.1136/jech.39.4.337; Casas-Vara A, 2012, NUTRITION, V28, P616, DOI 10.1016/j.nut.2011.10.006; Cervera R, 2012, ANN THORAC SURG, V93, P1950, DOI 10.1016/j.athoracsur.2012.02.071; Chan TC, 2012, GERIATR GERONTOL INT, V12, P555, DOI 10.1111/j.1447-0594.2011.00804.x; Chao CT, 2013, J AM COLL SURGEONS, V217, P240, DOI 10.1016/j.jamcollsurg.2013.03.024; Chao CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050675; Chao CT, 2012, KIDNEY INT, V82, P920, DOI 10.1038/ki.2012.237; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chronopoulos A, 2010, NAT REV NEPHROL, V6, P141, DOI 10.1038/nrneph.2009.234; Cohen SD, 2012, CURR OPIN CRIT CARE, V18, P623, DOI 10.1097/MCC.0b013e328358d3f5; Conde-Martel A, 2012, EUR J INTERN MED, V23, P513, DOI 10.1016/j.ejim.2012.02.007; Ebrahim S, 1997, J EPIDEMIOL COMMUN H, V51, P469, DOI 10.1136/jech.51.5.469-a; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Finlayson E, 2012, J AM GERIATR SOC, V60, P967, DOI 10.1111/j.1532-5415.2012.03915.x; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gambier N, 2012, SOUTH MED J, V105, P63, DOI 10.1097/SMJ.0b013e318242d74d; Garcia-Perez L, 2011, QJM-INT J MED, V104, P639, DOI 10.1093/qjmed/hcr070; Guimaraes T, 2012, INT J INFECT DIS, V16, pE442, DOI 10.1016/j.ijid.2012.02.005; Howie-Esquivel J, 2012, AM J CRIT CARE, V21, pE65, DOI 10.4037/ajcc2012382; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1016/S0272-6386(04)01080-7; Khan SK, 2013, AGE AGEING, V42, P76, DOI 10.1093/ageing/afs152; Kimm H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-54; Koch AM, 2009, J HOSP INFECT, V71, P269, DOI 10.1016/j.jhin.2008.10.032; Lin SJ, 2012, J NURS RES, V20, P110, DOI 10.1097/jnr.0b013e318254eac9; Liu LF, 2012, HEALTH POLICY, V108, P246, DOI 10.1016/j.healthpol.2012.08.022; Lonnroos E, 2012, DRUG AGING, V29, P395, DOI 10.2165/11631420-000000000-00000; MAHONEY F I, 1965, Md State Med J, V14, P61; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Meller I, 1999, EUR ARCH PSY CLIN N, V249, P180, DOI 10.1007/s004060050085; Menotti A, 1996, PREV MED, V25, P319, DOI 10.1006/pmed.1996.0062; Miyashita J, 2012, J HOSP MED, V7, P464, DOI 10.1002/jhm.1936; Nybo H, 2003, J AM GERIATR SOC, V51, P1365, DOI 10.1046/j.1532-5415.2003.51453.x; Ponzetto M, 2003, J GERONTOL A-BIOL, V58, P1049; Robine JM, 2005, J EPIDEMIOL COMMUN H, V59, P31, DOI 10.1136/jech.2003.018663; Shu CC, 2011, J HOSP MED, V6, P378, DOI [10.1002/Thm.896, 10.1002/jhm.896]; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Toumi Z, 2010, INT J CLIN PRACT, V64, P1570, DOI 10.1111/j.1742-1241.2010.02468.x; von Stauss E, 2000, J AM GERIATR SOC, V48, P1462, DOI 10.1111/j.1532-5415.2000.tb02638.x; Walsh B, 2012, J AM GERIATR SOC, V60, P2104, DOI 10.1111/j.1532-5415.2012.04198.x; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Yust-Katz S, 2005, ISR MED ASSOC J, V7, P635; Zafrir B, 2010, ISR MED ASSOC J, V12, P10	50	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77929	10.1371/journal.pone.0077929	http://dx.doi.org/10.1371/journal.pone.0077929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223127	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200019
J	Harris, RMB; McQuillan, P; Hughes, L				Harris, Rebecca M. B.; McQuillan, Peter; Hughes, Lesley			Experimental Manipulation of Melanism Demonstrates the Plasticity of Preferred Temperature in an Agricultural Pest (Phaulacridium vittatum)	PLOS ONE			English	Article							CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; BODY TEMPERATURES; WINGLESS GRASSHOPPER; THERMAL TOLERANCE; ORTHOPTERA; THERMOREGULATION; RESPONSES; ACRIDIDAE; INVASION	Phenotypic plasticity is a key trait of successful pest species, and may increase the ability to cope with higher, more variable temperatures under climate change. We investigate the plasticity of preferred temperature in a widespread agricultural pest, the wingless grasshopper (Phaulacridium vittatum). Preferred temperature is a measure of thermoregulatory behaviour through habitat selection. It is influenced by melanism, which affects body temperature by determining the amount of radiation absorbed by the body. First we demonstrate that body temperature and preferred temperature in P. vittatum is influenced by melanism, by comparing the preferred temperature of the colour morphs in laboratory thermal gradients and field body temperatures in natural populations. We then test whether preferred temperature changes in response to changes in body temperature, by determining preferred temperature before and after manipulation of melanism by painting. When melanism was manipulated experimentally in live grasshoppers, preferred temperature changed to reflect the thermal qualities of the new colour. The preferred temperature of light grasshoppers increased after they were painted black, and decreased after being painted white. Similarly, dark individuals that were painted white behaved like a light individual, maintaining a lower body temperature. Preferred temperature in P. vittatum is a plastic thermoregulatory response to ambient temperature, mediated by the influence of melanism on body temperature.	[Harris, Rebecca M. B.] Univ Tasmania, Antarctic Climate Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [McQuillan, Peter] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia; [Hughes, Lesley] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; University of Tasmania; Macquarie University	Harris, RMB (corresponding author), Univ Tasmania, Antarctic Climate Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia.	R.M.B.Harris@acecrc.org.au	McQuillan, Peter B/C-2373-2014; Harris, Rebecca/N-2790-2013	Harris, Rebecca/0000-0002-6426-2179; Hughes, Lesley/0000-0003-0313-9780; McQuillan, Peter/0000-0001-6334-372X	Australian Postgraduate Award; ANZ (Australia and New Zealand Banking Group) Holsworth Wildlife Research Endowment	Australian Postgraduate Award(Australian Government); ANZ (Australia and New Zealand Banking Group) Holsworth Wildlife Research Endowment	RMH was the recipient of an Australian Postgraduate Award, and the study was partially funded by an ANZ (Australia and New Zealand Banking Group) Holsworth Wildlife Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker G., 2005, WINGLESS GRASSHOPPER; Brian M. V., 1965, INSECT SOC, V12, P347, DOI DOI 10.1007/BF02222724; Brian MV, 1963, INSECT SOC, V10, P91, DOI 10.1007/BF02336490; Butler A., 2001, MINITAB MACROS RESAM; Chown SL, 2007, P ROY SOC B-BIOL SCI, V274, P2531, DOI 10.1098/rspb.2007.0772; CLARK D. P., 1967, AUST J ZOOL, V15, P799, DOI 10.1071/ZO9670799; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; CRITCHLOW DE, 1991, COMMUN STAT THEORY, V20, P127, DOI 10.1080/03610929108830487; Deal J, 1941, J ANIM ECOL, V10, P323, DOI 10.2307/1316; Donnelly A, 2012, CLIM RES, V53, P245, DOI 10.3354/cr01102; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gvozdik L, 2012, BIOL LETTERS, V8, P262, DOI 10.1098/rsbl.2011.0960; Harris R, 2012, J BIOGEOGR, V39, P1450, DOI 10.1111/j.1365-2699.2012.02710.x; Harris RM, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.5101; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Institute SAS I, 2012, JMP VERS 10; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; KEY K H L, 1992, Invertebrate Taxonomy, V6, P197, DOI 10.1071/IT9920197; Lactin DJ, 1996, J THERM BIOL, V21, P231, DOI 10.1016/0306-4565(96)00007-1; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; MASAKI S, 1967, EVOLUTION, V21, P725, DOI 10.1111/j.1558-5646.1967.tb03430.x; MAY ML, 1979, ANNU REV ENTOMOL, V24, P313, DOI 10.1146/annurev.en.24.010179.001525; Miller GA, 2009, P ROY SOC B-BIOL SCI, V276, P3581, DOI 10.1098/rspb.2009.1030; MILNER RJ, 1994, J AUST ENTOMOL SOC, V33, P165; MiniTab I, 2010, INITAB REL 16 1 0 WI; Nyamukondiwa C, 2010, ECOL ENTOMOL, V35, P565, DOI 10.1111/j.1365-2311.2010.01215.x; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; PORTER K, 1982, OIKOS, V38, P308, DOI 10.2307/3544670; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Slabber S, 2007, J INSECT PHYSIOL, V53, P113, DOI 10.1016/j.jinsphys.2006.10.010; Smolinsky R, 2012, OECOLOGIA, V170, P47, DOI 10.1007/s00442-012-2283-2; TERBRAAK CJF, 1992, LECT NOTES ECON MATH, V376, P79; UVAROV B. P., 1931, TRANS ENT SOC [LONDON], V79, P1; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	36	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80243	10.1371/journal.pone.0080243	http://dx.doi.org/10.1371/journal.pone.0080243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223223	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200116
J	Moy, I; Lin, ZH; Rademaker, AW; Reierstad, S; Khan, SA; Bulun, SE				Moy, Irene; Lin, Zhihong; Rademaker, Alfred W.; Reierstad, Scott; Khan, Seema A.; Bulun, Serdar E.			Expression of Estrogen-Related Gene Markers in Breast Cancer Tissue Predicts Aromatase Inhibitor Responsiveness	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; POSTMENOPAUSAL WOMEN; PROGESTERONE-RECEPTORS; IMMUNOHISTOCHEMICAL-DEMONSTRATION; TAMOXIFEN THERAPY; ANASTROZOLE; BRCA1; COMBINATION	Aromatase inhibitors (AIs) are the most effective class of drugs in the endocrine treatment of breast cancer, with an approximate 50% treatment response rate. Our objective was to determine whether intratumoral expression levels of estrogen-related genes are predictive of AI responsiveness in postmenopausal women with breast cancer. Primary breast carcinomas were obtained from 112 women who received AI therapy after failing adjuvant tamoxifen therapy and developing recurrent breast cancer. Tumor ER alpha and PR protein expression were analyzed by immunohistochemistry (IHC). Messenger RNA (mRNA) levels of 5 estrogen-related genes-AKR1C3, aromatase, ER alpha, and 2 estradiol/ER alpha target genes, BRCA1 and PR-were measured by real-time PCR. Tumor protein and mRNA levels were compared with breast cancer progression rates to determine predictive accuracy. Responsiveness to AI therapy-defined as the combined complete response, partial response, and stable disease rates for at least 6 months-was 51%; rates were 56% in ER alpha-IHC-positive and 14% in ER alpha-IHC-negative tumors. Levels of ER alpha, PR, or BRCA1 mRNA were independently predictive for responsiveness to AI. In cross-validated analyses, a combined measurement of tumor ER alpha and PR mRNA levels yielded a more superior specificity (36%) and identical sensitivity (96%) to the current clinical practice (ER alpha/PR-IHC). In patients with ER alpha/PR-IHC-negative tumors, analysis of mRNA expression revealed either non-significant trends or statistically significant positive predictive values for AI responsiveness. In conclusion, expression levels of estrogen-related mRNAs are predictive for AI responsiveness in postmenopausal women with breast cancer, and mRNA expression analysis may improve patient selection.	[Moy, Irene; Lin, Zhihong; Reierstad, Scott; Bulun, Serdar E.] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Rademaker, Alfred W.] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Khan, Seema A.] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Bulun, SE (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	s-bulun@northwestern.edu			Dixon Priority Research Initiative grant from the Northwestern Medical Foundation, U.S.A.; Avon Foundation; Breast Cancer Research Fund, U.K.	Dixon Priority Research Initiative grant from the Northwestern Medical Foundation, U.S.A.; Avon Foundation; Breast Cancer Research Fund, U.K.	This work was supported by a Dixon Priority Research Initiative grant from the Northwestern Medical Foundation, U.S.A., Avon Foundation and Breast Cancer Research Fund, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Amin AA, 2006, MOL CELL ENDOCRINOL, V253, P44, DOI 10.1016/j.mce.2006.04.029; ANDERSEN J, 1988, J HISTOCHEM CYTOCHEM, V36, P1553, DOI 10.1177/36.12.2461414; Anderson H, 2007, J STEROID BIOCHEM, V106, P49, DOI 10.1016/j.jsbmb.2007.05.024; Anderson WF, 2002, BREAST CANCER RES TR, V76, P27, DOI 10.1023/A:1020299707510; BAEHNER FL, 2006, 29 ANN SAN ANT BREAS; Baum M, 2002, LANCET, V359, P2131; Baum M, 2003, Cancer, V98, P1802; Bernhard J, 1999, J CLIN ONCOL, V17, P1672, DOI 10.1200/JCO.1999.17.6.1672; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Buzdar Aman U, 2004, Clin Breast Cancer, V5 Suppl 1, pS6, DOI 10.3816/CBC.2004.s.008; BUZDAR AU, 1982, CANCER RES, V42, P3448; Chand AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-148; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Dowsett M, 2005, J CLIN ONCOL, V23, P2477, DOI 10.1200/JCO.2005.07.559; Dowsett M, 2003, SEMIN ONCOL, V30, P58, DOI 10.1016/S0093-7754(03)00300-2; Dowsett M, 2010, J CLIN ONCOL, V28, P1829, DOI 10.1200/JCO.2009.24.4798; Esteva FJ, 2005, CLIN CANCER RES, V11, P3315, DOI 10.1158/1078-0432.CCR-04-1707; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Febbo PG, 2011, J NATL COMPR CANC NE, V9, pS1, DOI 10.6004/jnccn.2011.0137; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Imir AG, 2007, J CLIN ENDOCR METAB, V92, P1979, DOI 10.1210/jc.2006-2482; Ishikawa H, 2009, J CLIN ENDOCR METAB, V94, P1752, DOI 10.1210/jc.2008-2327; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; KNIGHT WA, 1980, CLIN ENDOCRINOL META, V9, P361, DOI 10.1016/S0300-595X(80)80038-7; Lu ML, 2006, J CLIN ENDOCR METAB, V91, P4514, DOI 10.1210/jc.2006-1364; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Ma YX, 2005, ONCOGENE, V24, P1831, DOI 10.1038/sj.onc.1208190; MATHEWS A. W, 2008, WALL STREET J; Milla-Santos A, 2003, AM J CLIN ONCOL-CANC, V26, P317, DOI 10.1097/00000421-200306000-00022; Miller WR, 2010, EXPERT OPIN PHARMACO, V11, P1873, DOI 10.1517/14656566.2010.487863; Miller WR, 2009, J CLIN ONCOL, V27, P1382, DOI 10.1200/JCO.2008.16.8849; Miller WR, 2003, J STEROID BIOCHEM, V86, P413, DOI 10.1016/S0960-0760(03)00352-2; Mina L, 2007, BREAST CANCER RES TR, V103, P197, DOI 10.1007/s10549-006-9366-x; Mita K, 2007, JPN J CLIN ONCOL, V37, P575, DOI 10.1093/jjco/hym066; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Murphy CG, 2010, CANCER J, V16, P39, DOI 10.1097/PPO.0b013e3181cf0204; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Paridaens R, 2003, ANN ONCOL, V14, P1391, DOI 10.1093/annonc/mdg362; Possinger K, 2004, EXPERT OPIN PHARMACO, V5, P2549, DOI 10.1517/14656566.5.12.2549; Rhodes A, 2000, J CLIN PATHOL, V53, P292, DOI 10.1136/jcp.53.4.292; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Yamashita H, 2005, BREAST CANCER RES, V7, pR753, DOI 10.1186/bcr1285; Yamashita H, 2004, BREAST CANCER RES, V6, pR24, DOI 10.1186/bcr738; Yamashita H, 2008, ENDOCR-RELAT CANCER, V15, P755, DOI 10.1677/ERC-08-0078; Zhang ZH, 2003, BREAST CANCER RES, V5, pR250, DOI 10.1186/bcr657; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77543	10.1371/journal.pone.0077543	http://dx.doi.org/10.1371/journal.pone.0077543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223121	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200013
J	Velayutham, TS; Kolli, D; Ivanciuc, T; Garofalo, RP; Casola, A				Velayutham, Thangam Sudha; Kolli, Deepthi; Ivanciuc, Teodora; Garofalo, Roberto P.; Casola, Antonella			Critical Role of TLR4 in Human Metapneumovirus Mediated Innate Immune Responses and Disease Pathogenesis	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TOLL-LIKE RECEPTOR-4; INDUCIBLE GENE-I; AIRWAY HYPERRESPONSIVENESS; RECOGNITION; INFECTION; ACTIVATION; YOUNG; MACROPHAGES; CHILDREN	Human metapneumovirus (hMPV) is one of the main causes of acute respiratory tract infections in children, elderly and immunocompromised patients. The mammalian Toll-like receptors (TLR) were identified as critical regulators of innate immunity to a variety of microbes, including viruses. We have recently shown that hMPV-induced cytokine, chemokine and type I interferon secretion in dendritic cells occurs via TLR4, however, its role in hMPV-induced disease is unknown. In this study, wild-type(WT) and TLR4-deficient mice (TLR4(-/-)) were infected with hMPV and examined for clinical disease parameters, such as body weight loss and airway obstruction, viral clearance, lung inflammation, dendritic cell maturation, T-cell proliferation and antibody production. Our results demonstrate that absence of TLR4 in hMPV-infected mice significantly reduced the inflammatory response as well as disease severity, shown by reduced body weight loss and airway obstruction and hyperresponsiveness (AHR), compared to WT mice. Levels of cytokines and chemokines were also significantly lower in the TLR4(-/-) mice. Accordingly, recruitment of inflammatory cells in the BAL, lungs, as well as in lymph nodes, was significantly reduced in the TLR4(-/-) mice, however, viral replication and clearance, as well as T-cell proliferation and neutralizing antibody production, were not affected. Our findings indicate that TLR4 is important for the activation of the innate immune response to hMPV, however it does play a role in disease pathogenesis, as lack of TLR4 expression is associated with reduced clinical manifestations of hMPV disease, without affecting viral protection.	[Velayutham, Thangam Sudha; Kolli, Deepthi; Ivanciuc, Teodora; Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Casola, A (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	ancasola@utmb.edu	Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022		National Institutes of Health [R01 AI079246, P01 AI062885, P30 ES006676]; James W. McLaughlin Fellowship Fund from UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079246, P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James W. McLaughlin Fellowship Fund from UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01 AI079246, P01 AI062885 and P30 ES006676, and James W. McLaughlin Fellowship Fund from UTMB (TSV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtekar AR, 2008, J LEUKOCYTE BIOL, V84, P1434, DOI 10.1189/jlb.0308215; Banos-Lara MD, 2013, J VIROL, V87, P1242, DOI 10.1128/JVI.01213-12; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Carey MA, 2007, AM J RESP CRIT CARE, V175, P126, DOI 10.1164/rccm.200509-1493OC; Carty M, 2010, CLIN EXP IMMUNOL, V161, P397, DOI 10.1111/j.1365-2249.2010.04196.x; Castro SM, 2006, AM J RESP CRIT CARE, V174, P1361, DOI 10.1164/rccm.200603-319OC; Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262; Cyr SL, 2009, VACCINE, V27, P421, DOI 10.1016/j.vaccine.2008.10.073; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Englund JA, 2006, ANN INTERN MED, V144, P344, DOI 10.7326/0003-4819-144-5-200603070-00010; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Huck B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-6; Jartti T, 2002, LANCET, V360, P1393, DOI 10.1016/S0140-6736(02)11391-2; Jartti T, 2012, CURR OPIN PULM MED, V18, P271, DOI 10.1097/MCP.0b013e328351f8d4; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kolli D, 2008, J VIROL, V82, P8560, DOI 10.1128/JVI.00699-08; Kolli D, 2013, PATHOGENS, V2, P232, DOI 10.3390/pathogens2020232; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Liao S, 2008, J GEN VIROL, V89, P1978, DOI 10.1099/vir.0.2008/000778-0; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274; Wyde PR, 2005, ANTIVIR RES, V66, P57, DOI 10.1016/j.antiviral.2004.12.009; Wyde PR, 2003, ANTIVIR RES, V60, P51, DOI 10.1016/S0166-3542(03)00153-0; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	48	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78849	10.1371/journal.pone.0078849	http://dx.doi.org/10.1371/journal.pone.0078849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205331	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700100
J	Caut, S; Holden, M; Jowers, MJ; Boistel, R; Ineich, I				Caut, Stephane; Holden, Magaly; Jowers, Michael J.; Boistel, Renaud; Ineich, Ivan			Is Bocourt's Terrific Skink Really So Terrific? Trophic Myth and Reality	PLOS ONE			English	Article							STABLE-ISOTOPES; EXTINCTION; REDISCOVERY; RATS; DIET; TRAJECTORIES; DELTA-N-15; DYNAMICS; CAUTION; DECLINE	Many scientists argue that our planet is undergoing a mass extinction event that is largely due to human influences. In this context, rediscoveries of species presumed to be extinct are encouraging and of great potential interest. During a 2003 expedition to New Caledonia, Bocourt's terrific skink, Phoboscincus bocourti, was unexpectedly rediscovered on a small islet by one of us. This skink species had been described from a single specimen collected around 1872 in New Caledonia. Since that time, however, no data on the species' biology, trophic interactions, or role in the ecosystem have been collected, making it difficult to follow the established conservation plan. In this study, we used a multidisciplinary approach involving natural history, anatomy, morphology, genetics, and stable isotopes to elucidate the ecology of Bocourt's terrific skink. Over the course of three different expeditions to the islet (total of 55 days across 2005 and 2012), we captured 4 individuals and observed another 4 individuals. The species' dentition and trophic ecology suggest that it is a top predator in its ecosystem and a major consumer of small terrestrial reptiles. Its high degree of genetic relatedness to another New Caledonian skink, which has a broad distribution, suggests that P. bocourti underwent genetic isolation at a geographical remote location, where dispersal or colonization was highly improbable. Moreover, the lack of genetic variation among the four individuals we captured may imply that a unique lineage, characterized by few inter-island exchanges, exists on the islet. Bocourt's terrific skink may be the largest terrestrial squamate predator alive in New Caledonia today. As a result, it is likely vulnerable to habitat modifications and especially the invasive rodents found on this islet. Further information is necessary to assess the conservation plans and practices in place as no concrete changes have been made since the species' rediscovery almost 10 years ago.	[Caut, Stephane; Jowers, Michael J.] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Holden, Magaly] Ecole Prat Hautes Etud, Ctr Ecol Fonct, CNRS UMR 5175, Montpellier, France; [Boistel, Renaud] Univ Poitiers, CNRS INEE, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, Poitiers, France; [Ineich, Ivan] Museum Natl Hist Nat, Dept Systemat & Evolut, CNRS, UMR 7205, F-75231 Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Caut, S (corresponding author), CSIC, Estn Biol Donana, E-41080 Seville, Spain.	stephanecaut@gmail.com; ineich@mnhn.fr	Jowers, Michael/AAT-8514-2021	Jowers, Michael J/0000-0001-8935-5913	CSIC (Consejo Superior de Investigaciones Cientificas)	CSIC (Consejo Superior de Investigaciones Cientificas)	This work was supported by CSIC (Consejo Superior de Investigaciones Cientificas) contracts to S. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; AFIK D, 1995, ECOLOGY, V76, P2247, DOI 10.2307/1941699; [Anonymous], 2004, THESIS; Balouet JC, 1987, CR HEBD ACAD SCI, P853; Balouet Jean Christophe, 1991, P1383; Bauer AM, 2000, HERPETOFAUNA NEW CAL; Bishop PJ, 2012, SAPIENS IUCN COMMISS, V5; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Campbell DJ, 2002, BIOL CONSERV, V107, P19, DOI 10.1016/S0006-3207(02)00039-3; Carranza S., 2004, Systematics and Biodiversity, V2, P57, DOI 10.1017/S1477200004001355; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; Caut S, 2013, BIOL OPEN, V2, P629, DOI 10.1242/bio.20134945; Caut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039125; Caut S, 2009, BIOL INVASIONS, V11, P1689, DOI 10.1007/s10530-008-9397-9; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; Crowley BE, 2011, J BIOGEOGR, V38, P1633, DOI 10.1111/j.1365-2699.2011.02571.x; *CTRDP, 1987, EC NOUV CAL; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Dimond WJ, 2012, HERPETOL CONSERV BIO, V7, P132; Dulloo ME, 2002, INT FOREST REV, V4, P277, DOI 10.1505/ifor.4.4.277.40525; Edwards GP, 2013, AUST MAMMAL, V35, P144, DOI 10.1071/AM12031; Fisher DO, 2011, BIOL CONSERV, V144, P1712, DOI 10.1016/j.biocon.2011.03.005; Fisher DO, 2011, GLOBAL ECOL BIOGEOGR, V20, P415, DOI 10.1111/j.1466-8238.2010.00624.x; Fisher DO, 2011, P ROY SOC B-BIOL SCI, V278, P1090, DOI 10.1098/rspb.2010.1579; Fitzpatrick JW, 2005, SCIENCE, V308, P1460, DOI 10.1126/science.1114103; Flannery TF, 1994, FUTURE EATERS, P423; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gidiere S, 2005, TRENDS, V37, P13; Girard Francis, 1998, Bulletin de la Societe Herpetologique de France, V85-86, P60; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grandcolas P, 2009, MEM MUS NAT HIST NAT, V198, P149; GREER AE, 1974, AUST J ZOOL, P1; Greer AE, 2001, J HERPETOL, V35, P383, DOI 10.2307/1565956; Hemerik L, 2006, ACTA BIOTHEOR, V54, P255, DOI 10.1007/s10441-007-9001-1; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Ineich I, 2006, ORYX, V40, P136; Ineich I, 2005, PREDATION HERPETOL R, V36, P445; Ineich I, 1999, REPTILES AMPHIBIENS, P60; Ineich I, 2013, MEMOIRES MU IN PRESS; *IUCN, 2010, INT UN CONS NAT RED; Jowers MJ, 2013, HERPETOLOGICA, V69, P227, DOI 10.1655/HERPETOLOGICA-D-12-00085; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Ladle RJ, 2009, NATURE, V461, P723, DOI 10.1038/461723c; Ladle RJ, 2011, FRONT J BIOGEOGR, V3, P11; LEVEY DJ, 1994, AUK, V111, P478, DOI 10.2307/4088614; Melbourne BA, 2004, BIODIVERS CONSERV, V13, P275, DOI 10.1023/B:BIOC.0000004321.58196.d8; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; OLSON SL, 1995, P BIOL SOC WASH, V108, P373; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pisanu B, 2011, POLAR BIOL, V34, P169, DOI 10.1007/s00300-010-0867-z; Posada D, 2008, JMODELTEST; Poulakakis N, 2005, MOL PHYLOGENET EVOL, V34, P245, DOI 10.1016/j.ympev.2004.10.006; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Schander C, 2003, ORG DIVERS EVOL, V3, P195, DOI 10.1078/1439-6092-00071; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; St Clair JJH, 2011, BIOL CONSERV, V144, P68, DOI 10.1016/j.biocon.2010.10.006; Struck U, 2002, NATURWISSENSCHAFTEN, V89, P470, DOI 10.1007/s00114-002-0361-8; Stuckas H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057116; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Ward EJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00190.1; Warne RW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P608, DOI 10.1086/651585; Whitaker AH, 2005, BIODIVERSITY C UNPUB, P59; White A, 2010, LIBR J, V135, P107	76	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78638	10.1371/journal.pone.0078638	http://dx.doi.org/10.1371/journal.pone.0078638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205285	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400093
J	Masuda, T; Sato, K; Murakoshi, T; Utsumi, K; Kimura, A; Shirai, N; Kanazawa, S; Yamaguchi, MK; Wada, Y				Masuda, Tomohiro; Sato, Kazuki; Murakoshi, Takuma; Utsumi, Ken; Kimura, Atsushi; Shirai, Nobu; Kanazawa, So; Yamaguchi, Masami K.; Wada, Yuji			Perception of Elasticity in the Kinetic Illusory Object with Phase Differences in Inducer Motion	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; SUBJECTIVE CONTOURS; WATERCOLOR ILLUSION; COLOR; TRANSFORMATIONS; RECOVERY; HUMANS; DEPTH	Background: It is known that subjective contours are perceived even when a figure involves motion. However, whether this includes the perception of rigidity or deformation of an illusory surface remains unknown. In particular, since most visual stimuli used in previous studies were generated in order to induce illusory rigid objects, the potential perception of material properties such as rigidity or elasticity in these illusory surfaces has not been examined. Here, we elucidate whether the magnitude of phase difference in oscillation influences the visual impressions of an object's elasticity (Experiment 1) and identify whether such elasticity perceptions are accompanied by the shape of the subjective contours, which can be assumed to be strongly correlated with the perception of rigidity (Experiment 2). Methodology/Principal Findings: In Experiment 1, the phase differences in the oscillating motion of inducers were controlled to investigate whether they influenced the visual impression of an illusory object's elasticity. The results demonstrated that the impression of the elasticity of an illusory surface with subjective contours was systematically flipped with the degree of phase difference. In Experiment 2, we examined whether the subjective contours of a perceived object appeared linear or curved using multi-dimensional scaling analysis. The results indicated that the contours of a moving illusory object were perceived as more curved than linear in all phase-difference conditions. Conclusions/Significance: These findings suggest that the phase difference in an object's motion is a significant factor in the material perception of motion-related elasticity.	[Masuda, Tomohiro; Utsumi, Ken; Kimura, Atsushi; Wada, Yuji] Natl Agr & Food Res Org, Food Funct Div, Natl Food Res Inst, Ibaraki, Japan; [Sato, Kazuki; Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Tokyo 112, Japan; [Murakoshi, Takuma] RIKEN BSI TOYOTA Collaborat Ctr, Behav & Cognit Neurosci Unit, Saitama, Japan; [Kimura, Atsushi] Tokyo Denki Univ, Dept Informat Environm, Chiba, Japan; [Shirai, Nobu] Niigata Univ, Dept Psychol, Niigata, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Tokyo, Kanagawa, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Chuo University; RIKEN; Tokyo Denki University; Niigata University; Japan Womens University	Wada, Y (corresponding author), Natl Agr & Food Res Org, Food Funct Div, Natl Food Res Inst, Ibaraki, Japan.	yujiwd@affrc.go.jp			Japan Society for Promotion of Science [23730718, 25780452];  [25135735]; Grants-in-Aid for Scientific Research [23730697] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grant-in-aids for Young Scientists (B) from the Japan Society for Promotion of Science (23730718 awarded to Y. Wada and 25780452 awarded to T. Masuda) and the Grant-in-Aid for Scientific Research on Innovative Areas (25135735 awarded to Y. Wada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2011, CURR BIOL, V21, P492, DOI 10.1016/j.cub.2011.02.011; BRESSAN P, 1986, PERCEPTION, V15, P409, DOI 10.1068/p150409; BRESSAN P, 1991, PERCEPTION, V20, P637, DOI 10.1068/p200637; Bressan P, 1997, PERCEPTION, V26, P1353, DOI 10.1068/p261353; Cicerone CM, 1992, ADV COLOR VISION, V4, P66; CORTESE JM, 1991, PERCEPT PSYCHOPHYS, V49, P315, DOI 10.3758/BF03205987; Ehrenstein W, 1941, Z PSYCHOLOGIE, V150, P83; Ffytche DH, 1996, NEUROIMAGE, V3, P104, DOI 10.1006/nimg.1996.0012; Gori S, 2011, NEURAL NETWORKS, V24, P1082, DOI 10.1016/j.neunet.2011.06.017; Halko MA, 2008, J VIS, V8; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; JANSSON G, 1973, PERCEPTION, V2, P321, DOI 10.1068/p020321; JOHANSSON G, 1964, SCAND J PSYCHOL, V5, P181, DOI 10.1111/j.1467-9450.1964.tb01425.x; Kanizsa G., 1955, RIV PSICOL, V49, P7; KELLMAN PJ, 1984, PERCEPT PSYCHOPHYS, V35, P237, DOI 10.3758/BF03205937; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Liinasuo M, 2004, NEUROSCI LETT, V354, P18, DOI 10.1016/j.neulet.2003.09.069; Liinasuo M, 2000, NEUROSCI LETT, V281, P119, DOI 10.1016/S0304-3940(00)00818-1; Masuda T, 2011, JPN PSYCHOL RES, V53, P440, DOI 10.1111/j.1468-5884.2011.00487.x; Norman JF, 2007, PERCEPTION, V36, P980, DOI 10.1068/p5641; NORMAN JF, 1993, PERCEPT PSYCHOPHYS, V53, P279, DOI 10.3758/BF03205183; Pinna B, 2003, VISION RES, V43, P43, DOI 10.1016/S0042-6989(02)00132-3; Pinna B, 2001, VISION RES, V41, P2669, DOI 10.1016/S0042-6989(01)00105-5; Pinna B, 2005, J OPT SOC AM A, V22, P2207, DOI 10.1364/JOSAA.22.002207; Rao SS., 2010, MECH VIBRATIONS; Ruzzoli M, 2011, NEUROPSYCHOLOGIA, V49, P3648, DOI 10.1016/j.neuropsychologia.2011.09.020; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; Sato K, 2013, INFANT BEHAV DEV, V36, P557, DOI 10.1016/j.infbeh.2013.05.004; Seghier M, 2000, CEREB CORTEX, V10, P663, DOI 10.1093/cercor/10.7.663; Tse PU, 1998, PERCEPTION, V27, P977, DOI 10.1068/p270977; ULLMAN S, 1984, PERCEPTION, V13, P255, DOI 10.1068/p130255; VANTUIJL HFJM, 1975, ACTA PSYCHOL, V39, P441, DOI 10.1016/0001-6918(75)90042-6; Varin D., 1971, RIV PSICOL, V65, P101; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WARREN WH, 1987, PERCEPTION, V16, P309, DOI 10.1068/p160309; Yazdanbakhsh A, 2011, NEURAL NETWORKS, V24, P1093, DOI 10.1016/j.neunet.2011.06.016	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78621	10.1371/journal.pone.0078621	http://dx.doi.org/10.1371/journal.pone.0078621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205281	Green Submitted, gold, Green Published			2022-12-27	WOS:000326155400090
J	Kunasundari, B; Murugaiyah, V; Kaur, G; Maurer, FHJ; Sudesh, K				Kunasundari, Balakrishnan; Murugaiyah, Vikneswaran; Kaur, Gurjeet; Maurer, Frans H. J.; Sudesh, Kumar			Revisiting the Single Cell Protein Application of Cupriavidus necator H16 and Recovering Bioplastic Granules Simultaneously	PLOS ONE			English	Article							RECOMBINANT ESCHERICHIA-COLI; HYDROGENOMONAS EUTROPHA; BIODEGRADABLE PLASTICS; ALCALIGENES-EUTROPHUS; RALSTONIA-EUTROPHA; POLYHYDROXYALKANOATES; RATS; POLY(3-HYDROXYBUTYRATE); EFFICIENT; ACID	Cupriavidus necator H16 (formerly known as Hydrogenomonas eutropha) was famous as a potential single cell protein (SCP) in the 1970s. The drawback however was the undesirably efficient accumulation of non-nutritive polyhydroxybutyrate (PHB) storage compound in the cytoplasm of this bacterium. Eventually, competition from soy-based protein resulted in SCP not receiving much attention. Nevertheless, C. necator H16 remained in the limelight as a producer of PHB, which is a material that resembles commodity plastics such as polypropylene. PHB is a 100% biobased and biodegradable polyester. Although tremendous achievements have been attained in the past 3 decades in the efficient production of PHB, this bioplastic is still costly. One of the main problems has been the recovery of PHB from the cell cytoplasm. In this study, we showed for the first time that kilogram quantities of PHB can be easily recovered in the laboratory without the use of any solvents and chemicals, just by using the cells as SCP. In addition, the present study also demonstrated the safety and tolerability of animal model used, Sprague Dawley given lyophilized cells of C. necator H16. The test animals readily produced fecal pellets that were whitish in color, as would be expected of PHB granules. The pellets were determined to contain about 82-97 wt% PHB and possessed molecular mass of around 930 kg/mol. The PHB granules recovered biologically possessed similar molecular mass compared to chloroform extracted PHB [950 kg/mol]. This method now allows the production and purification of substantial quantities of PHB for various experimental trials. The method reported here is easy, does not require expensive instrumentation, scalable and does not involve extensive use of solvents and strong chemicals.	[Kunasundari, Balakrishnan; Sudesh, Kumar] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Murugaiyah, Vikneswaran] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Kaur, Gurjeet] Univ Sains Malaysia, Inst Res Mol Med, George Town, Malaysia; [Maurer, Frans H. J.] Lund Univ, Dept Chem Polymer & Mat Chem, Lund, Sweden	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; Lund University	Sudesh, K (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.	ksudesh@usm.my	Kaur, Gurjeet/AAN-7934-2020; Sudesh, Kumar/ABG-4333-2020; Kaur, Gurjeet/A-1085-2011; Sudesh, Kumar/C-2942-2011	Kaur, Gurjeet/0000-0002-6232-5703; Sudesh, Kumar/0000-0003-4756-9192; Kaur, Gurjeet/0000-0002-6232-5703; Sudesh, Kumar/0000-0003-4756-9192; Kunasundari, Balakrishnan/0000-0002-5998-8944; Murugaiyah, Vikneswaran/0000-0003-1768-7577	Long Term Research Grant Scheme (LRGS); International Research Collaboration Fund (IReC Fund) [1002/PBIOLOGI/910401]; USM's Fellowship	Long Term Research Grant Scheme (LRGS); International Research Collaboration Fund (IReC Fund); USM's Fellowship	This study was supported by Long Term Research Grant Scheme (LRGS) and International Research Collaboration Fund (IReC Fund), Grant No: 1002/PBIOLOGI/910401 entitled: A novel environmentally friendly extraction method of polyhydroxyalkanoates (PHA) from biomass through biological approach. BK acknowledges USM's Fellowship for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO E. J. A., 2005, ARQ CIEN VET ZOOL UN, V8, P139; Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954; Bengtsson S, 2008, BIORESOURCE TECHNOL, V99, P509, DOI 10.1016/j.biortech.2007.01.020; Bhubalan K, 2008, POLYM DEGRAD STABIL, V93, P17, DOI 10.1016/j.polymdegradstab.2007.11.004; Boon N, 2010, US Patent Application, Patent No. [2010/0093860, 20100093860]; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Budde CF, 2011, APPL MICROBIOL BIOT, V89, P1611, DOI 10.1007/s00253-011-3102-0; CALLOWAY DH, 1969, APPL MICROBIOL, V17, P176, DOI 10.1128/AEM.17.1.176-178.1969; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Choi J, 1999, APPL MICROBIOL BIOT, V51, P13, DOI 10.1007/s002530051357; Choi JI, 1999, BIOTECHNOL BIOENG, V62, P546, DOI 10.1002/(SICI)1097-0290(19990305)62:5<546::AID-BIT6>3.0.CO;2-0; CLIFFORD AJ, 1976, J NUTR, V106, P435, DOI 10.1093/jn/106.3.435; De Mey M, 2008, BIOLOGICALS, V36, P198, DOI 10.1016/j.biologicals.2007.10.001; Defoirdt T, 2009, BIOTECHNOL ADV, V27, P680, DOI 10.1016/j.biotechadv.2009.04.026; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; Forni D, 1999, ANN ZOOTECH, V48, P163, DOI 10.1051/animres:19990302; Forni D, 1999, J ANIM PHYSIOL AN N, V81, P31, DOI 10.1046/j.1439-0396.1999.811190.x; Forni D, 1999, J ANIM PHYSIOL AN N, V81, P41, DOI 10.1046/j.1439-0396.1999.811190.x; Fukui T, 1998, APPL MICROBIOL BIOT, V49, P333, DOI 10.1007/s002530051178; Hahn Sei Kwang, 1993, Biotechnology Techniques, V7, P209, DOI 10.1007/BF02566149; HAHN SK, 1995, APPL ENVIRON MICROB, V61, P34, DOI 10.1128/AEM.61.1.34-39.1995; Jacquel N, 2008, BIOCHEM ENG J, V39, P15, DOI 10.1016/j.bej.2007.11.029; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Kahar P, 2004, POLYM DEGRAD STABIL, V83, P79, DOI 10.1016/S0141-3910(03)00227-1; Kek YK, 2008, CAN J CHEM, V86, P533, DOI 10.1139/V08-001; KHOR GL, 1977, CAN J COMP MED, V41, P428; KIHLBERG R, 1972, ANNU REV MICROBIOL, V26, P427, DOI 10.1146/annurev.mi.26.100172.002235; Kim M, 2003, BIOTECHNOL LETT, V25, P55, DOI 10.1023/A:1021734216612; KREBS HA, 1961, BIOCHEM J, V80, P225, DOI 10.1042/bj0800225; Kruger Nicholas J., 1996, P15, DOI 10.1007/978-1-60327-259-9_4; Kuhad RC, 1997, NUTR REV, V55, P65, DOI 10.1111/j.1753-4887.1997.tb01599.x; Kunasundari B, 2011, EXPRESS POLYM LETT, V5, P620, DOI 10.3144/expresspolymlett.2011.60; Kuriyama M., 2006, US Patent, Patent No. [US 2006/0275253, 20060275253]; Lakshman K, 2006, ENZYME MICROB TECH, V39, P1471, DOI 10.1016/j.enzmictec.2006.03.037; Molck AM, 2002, TOXICOLOGY, V174, P183, DOI 10.1016/S0300-483X(02)00079-3; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Nasseri A. T., 2011, American Journal of Food Technology, V6, P103; Peoples O. P, 2001, US Patent, Patent No. [6207217, 06207217]; PETERS JC, 1985, J NUTR, V115, P382, DOI 10.1093/jn/115.3.382; SCHARRER E, 1980, PFLUG ARCH EUR J PHY, V388, P165, DOI 10.1007/BF00584123; Schlegel H., 1971, ADV BIOCHEM ENG, P143; SCHOENMAKERS ACM, 1989, INT J VITAM NUTR RES, V59, P200; Selye H, 1950, MONTREAL ACTA, P1025; SHIMAMURA E, 1994, MACROMOLECULES, V27, P878, DOI 10.1021/ma00081a041; Shinaberger CS, 2008, AM J CLIN NUTR, V88, P1511, DOI 10.3945/ajcn.2008.26665; Subcommittee on Laboratory Animal Nutrition Committee on Animal Nutrition Board on Agriculture National Research Council, 1995, NUTR REQ LAB AN; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Sudesh K., 2010, International Patent, Patent No. [WO2010134798A1, 2010134798, WO 2010134798 A1]; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Travlos GS, 1996, TOXICOLOGY, V107, P17, DOI 10.1016/0300-483X(95)03197-N; Valappil SP, 2007, J BIOTECHNOL, V132, P251, DOI 10.1016/j.jbiotec.2007.03.013; WARNES TW, 1972, GUT, V13, P926, DOI 10.1136/gut.13.11.926; WASLIEN CI, 1969, APPL MICROBIOL, V18, P152, DOI 10.1128/AEM.18.2.152-155.1969; Yamada M, 2009, BIOMACROMOLECULES, V10, P677, DOI 10.1021/bm8013846; Yu J, 2006, BIOTECHNOL PROGR, V22, P547, DOI 10.1021/bp050362g	56	42	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78528	10.1371/journal.pone.0078528	http://dx.doi.org/10.1371/journal.pone.0078528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205250	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300066
J	Zhang, Y; Zhou, ZC; Yang, Q				Zhang, Yi; Zhou, Zhichun; Yang, Qing			Nitrogen (N) Deposition Impacts Seedling Growth of Pinus massoniana via N:P Ratio Effects and the Modulation of Adaptive Responses to Low P (Phosphorus)	PLOS ONE			English	Article							CUNNINGHAMIA-LANCEOLATA; LITTER DECOMPOSITION; PHOSPHATASE-ACTIVITY; NUTRIENT LIMITATION; USE EFFICIENCY; ROOT; TRAITS; AVAILABILITY; FRACTIONS; FOREST	Background: In forest ecosystems with phosphorus (P) deficiency, the impact of atmospheric nitrogen (N) deposition on nutritional traits related to P uptake and P use potentially determines plant growth and vegetation productivity. Methodology/Principal Findings: Two N deposition simulations were combined with three soil P conditions (homogeneous P deficiency with evenly low P; heterogeneous P deficiency with low subsoil P and high topsoil P; high P) using four full-sib families of Masson pine (Pinus massoniana). Under homogeneous P deficiency, N had a low effect on growth due to higher N:P ratios, whereas N-sensitive genotypes had lower N:P ratios and greater N sensitivity. The N effect increased under higher P conditions due to increased P concentration and balanced N:P ratios. An N:P threshold of 12.0-15.0 was detected, and growth was increased by N with an N:P ratio <= 12.0 and increased by P with an N:P ratio >= 15.0. Under homogeneous P deficiency, increased P use efficiency by N deposition improved growth. Under heterogeneous P deficiency, a greater P deficiency under N deposition due to increased N:P ratios induced greater adaptive responses to low P (root acid phosphatase secretion and topsoil root proliferation) and improved P acquisition and growth. Conclusions/Significance: N deposition diversely affected seedling growth across different P conditions and genotypes via N:P ratio effects and the modulation of adaptive responses to low P. The positive impact of N on growth was genotype-specific and increased by soil P addition due to balanced N:P ratios. These results indicate the significance of breeding N-sensitive tree genotypes and improving forest soil P status to compensate for increasing N deposition.	[Zhang, Yi; Zhou, Zhichun; Yang, Qing] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fu Yang, Zhe Jiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Zhang, Y (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Fu Yang, Zhe Jiang, Peoples R China.	zhang1978yi@gmail.com			Hi-Tech Research and Development Program ("863" Program) [2011AA100203]; National Natural Science Foundation of China [31070599, 31370671]	Hi-Tech Research and Development Program ("863" Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a research project from the Hi-Tech Research and Development Program ("863" Program) (2011AA100203), the National Natural Science Foundation of China (31070599), and the National Natural Science Foundation of China (31370671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Chen HJ, 2003, FOREST ECOL MANAG, V178, P301, DOI 10.1016/S0378-1127(02)00478-4; Chen M, 2007, GEODERMA, V142, P136, DOI 10.1016/j.geoderma.2007.08.004; COLE DW, 1995, PLANT SOIL, V168, P43, DOI 10.1007/BF00029312; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Fita A, 2011, EUPHYTICA, V181, P323, DOI 10.1007/s10681-011-0432-z; Fujita Y, 2010, OIKOS, V119, P1665, DOI 10.1111/j.1600-0706.2010.18427.x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; GILL JGS, 1987, SILVAE GENET, V36, P189; Goncalves PDS, 2005, GENET MOL BIOL, V28, P758, DOI 10.1590/S1415-47572005000500018; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2003, ECOL APPL, V13, P372, DOI 10.1890/1051-0761(2003)013[0372:BNRAIO]2.0.CO;2; Hammond JP, 2009, J EXP BOT, V60, P1953, DOI 10.1093/jxb/erp083; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hawkins BJ, 2007, TREE PHYSIOL, V27, P911, DOI 10.1093/treephys/27.6.911; Hidaka A, 2011, J ECOL, V99, P849, DOI 10.1111/j.1365-2745.2011.01805.x; Hidaka A, 2009, J ECOL, V97, P984, DOI 10.1111/j.1365-2745.2009.01540.x; Hu Y, 2005, J PLANT NUTR, V33, P889; Kubartova A, 2009, MICROB ECOL, V58, P98, DOI 10.1007/s00248-008-9458-8; Lambeth C., 2001, Forest Genetics, V8, P101; Li JZ, 2009, J GENET GENOMICS, V36, P173, DOI 10.1016/S1673-8527(08)60104-6; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028601; Limpens J, 2004, ECOSYSTEMS, V7, P793, DOI 10.1007/s10021-004-0274-9; Liu Y, 2004, PLANT SCI, V167, P217, DOI 10.1016/j.plantsci.2004.02.026; Lu XK, 2010, GLOBAL CHANGE BIOL, V16, P2688, DOI 10.1111/j.1365-2486.2010.02174.x; Luizao FJ, 2007, PLANT ECOL, V192, P209, DOI 10.1007/s11258-007-9317-6; Nakaji T, 2001, TREES-STRUCT FUNCT, V15, P453, DOI 10.1007/s00468-001-0130-x; Plassard C, 2010, TREE PHYSIOL, V30, P1129, DOI 10.1093/treephys/tpq063; Radersma S, 2004, PLANT SOIL, V259, P209, DOI 10.1023/B:PLSO.0000020970.40167.40; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; Wang XR, 2010, PLANT SCI, V179, P302, DOI 10.1016/j.plantsci.2010.06.007; Wu PF, 2011, CAN J FOREST RES, V41, P228, DOI 10.1139/X10-198; Xie YX, 2008, ATMOS ENVIRON, V42, P5182, DOI 10.1016/j.atmosenv.2008.03.008; Zhang Y, 2013, PLANT SOIL, V364, P93, DOI 10.1007/s11104-012-1352-y; Zhang Y, 2012, PLANT BIOSYST, V146, P7, DOI 10.1080/11263504.2011.593199; Zhang Y, 2010, J FOREST RES-JPN, V15, P91, DOI 10.1007/s10310-009-0153-5; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; Zobel RW, 2007, PLANT SOIL, V297, P243, DOI 10.1007/s11104-007-9341-2	42	6	13	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e79229	10.1371/journal.pone.0079229	http://dx.doi.org/10.1371/journal.pone.0079229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205376	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600119
J	Chikahisa, S; Kodama, T; Soya, A; Sagawa, Y; Ishimaru, Y; Sei, H; Nishino, S				Chikahisa, Sachiko; Kodama, Tohru; Soya, Atsushi; Sagawa, Yohei; Ishimaru, Yuji; Sei, Hiroyoshi; Nishino, Seiji			Histamine from Brain Resident MAST Cells Promotes Wakefulness and Modulates Behavioral States	PLOS ONE			English	Article							W-WV MICE; NERVOUS-SYSTEM; LOCOMOTOR-ACTIVITY; BODY-TEMPERATURE; IN-VIVO; SLEEP; RATS; DEFICIENT; AROUSAL; NEURONS	Mast cell activation and degranulation can result in the release of various chemical mediators, such as histamine and cytokines, which significantly affect sleep. Mast cells also exist in the central nervous system (CNS). Since up to 50% of histamine contents in the brain are from brain mast cells, mediators from brain mast cells may significantly influence sleep and other behaviors. In this study, we examined potential involvement of brain mast cells in sleep/wake regulations, focusing especially on the histaminergic system, using mast cell deficient (W/Wv) mice. No significant difference was found in the basal amount of sleep/wake between W/Wv mice and their wild-type littermates (WT), although W/Wv mice showed increased EEG delta power and attenuated rebound response after sleep deprivation. Intracerebroventricular injection of compound 48/80, a histamine releaser from mast cells, significantly increased histamine levels in the ventricular region and enhanced wakefulness in WT mice, while it had no effect in W/Wv mice. Injection of H1 antagonists (triprolidine and mepyramine) significantly increased the amounts of slow-wave sleep in WT mice, but not in W/Wv mice. Most strikingly, the food-seeking behavior observed in WT mice during food deprivation was completely abolished in W/Wv mice. W/Wv mice also exhibited higher anxiety and depression levels compared to WT mice. Our findings suggest that histamine released from brain mast cells is wake-promoting, and emphasizes the physiological and pharmacological importance of brain mast cells in the regulation of sleep and fundamental neurobehavior.	[Chikahisa, Sachiko; Soya, Atsushi; Sagawa, Yohei; Ishimaru, Yuji; Nishino, Seiji] Stanford Univ, Sch Med, Sleep & Circadian Neurobiol Lab, Palo Alto, CA 94304 USA; [Chikahisa, Sachiko; Sei, Hiroyoshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Integrat Physiol, Tokushima 770, Japan; [Kodama, Tohru] Tokyo Metropolitan Inst Med Sci, Dept Psychophysiol, Tokyo 113, Japan	Stanford University; Tokushima University; Tokyo Metropolitan Institute of Medical Science	Nishino, S (corresponding author), Stanford Univ, Sch Med, Sleep & Circadian Neurobiol Lab, Palo Alto, CA 94304 USA.	nishino@stanford.EDU		KODAMA, TOHRU/0000-0001-6915-4428	Japan Society for the Promotion of Science [21-8162]; Grants-in-Aid for Scientific Research [25860985] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	S.C. is supported by the Excellent Young Researcher Overseas Visit Program (21-8162) of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNATI LF, 1995, MED RES REV, V15, P33, DOI 10.1002/med.2610150104; BORBELY AA, 1977, BRAIN RES, V124, P457, DOI 10.1016/0006-8993(77)90947-7; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; BUGAJSKI AJ, 1994, AGENTS ACTIONS, V41, pC75, DOI 10.1007/BF02007774; CARR KD, 1985, NEUROPEPTIDES, V5, P411, DOI 10.1016/0143-4179(85)90041-1; Challet E, 1997, BEHAV BRAIN RES, V84, P275, DOI 10.1016/S0166-4328(97)83335-9; Chikahisa S, 2008, ENDOCRINOLOGY, V149, P5262, DOI 10.1210/en.2008-0285; Chikahisa S, 2009, NEUROPHARMACOLOGY, V57, P369, DOI 10.1016/j.neuropharm.2009.07.015; Cirulli F, 1998, BRAIN BEHAV IMMUN, V12, P123, DOI 10.1006/brbi.1998.0505; DEWASMES G, 1989, PHYSIOL BEHAV, V46, P179, DOI 10.1016/0031-9384(89)90252-7; Domino EF, 1999, PSYCHOSOM MED, V61, P591, DOI 10.1097/00006842-199909000-00002; Florenzano F, 2000, J COMP NEUROL, V424, P651; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; GALLI SJ, 1987, BLOOD, V69, P1661; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; HAYAISHI O, 1995, ADV NEUROIMMUNOL, V5, P211, DOI 10.1016/0960-5428(95)00010-Y; Hendrix S, 2006, NEUROSCI LETT, V392, P174, DOI 10.1016/j.neulet.2005.09.029; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Ikeda-Sagara M, 2012, BRIT J PHARMACOL, V165, P167, DOI 10.1111/j.1476-5381.2011.01547.x; JOHNSON D, 1992, NEUROCHEM RES, V17, P939, DOI 10.1007/BF00993271; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami S, 2000, BRAIN RES, V857, P313, DOI 10.1016/S0006-8993(99)02466-X; Kim YS, 2000, BRAIN RES, V881, P190, DOI 10.1016/S0006-8993(00)02860-2; KITAMURA Y, 1979, NATURE, V281, P154, DOI 10.1038/281154a0; KUBO N, 1987, JPN J PHARMACOL, V43, P277, DOI 10.1254/jjp.43.277; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; Lin JS, 1996, J NEUROSCI, V16, P1523; Valdes JL, 2010, EUR J NEUROSCI, V31, P2073, DOI 10.1111/j.1460-9568.2010.07241.x; MAEYAMA K, 1983, J NEUROCHEM, V41, P128, DOI 10.1111/j.1471-4159.1983.tb11823.x; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mattila OS, 2011, STROKE, V42, P3600, DOI 10.1161/STROKEAHA.111.632224; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MOCHIZUKI T, 1991, N-S ARCH PHARMACOL, V343, P190, DOI 10.1007/BF00168609; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; Okuro M, 2010, SLEEP, V33, P930, DOI 10.1093/sleep/33.7.930; OOHARA A, 1994, J NEUROCHEM, V63, P677; Parmentier R, 2002, J NEUROSCI, V22, P7695; Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; SAKATA T, 1994, BRAIN RES BULL, V35, P135, DOI 10.1016/0361-9230(94)90093-0; Sangalli BC, 1997, PROG NEUROBIOL, V52, P145, DOI 10.1016/S0301-0082(97)00011-7; SHIMADA M, 1980, NATURE, V283, P662, DOI 10.1038/283662a0; Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7; Silverman AJ, 2000, J NEUROSCI, V20, P401, DOI 10.1523/JNEUROSCI.20-01-00401.2000; Soya A, 2008, NEUROSCI LETT, V430, P224, DOI 10.1016/j.neulet.2007.11.002; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041; Unno K, 2012, EUR J PHARMACOL, V683, P179, DOI 10.1016/j.ejphar.2012.03.017; Valdes JL, 2005, EUR J NEUROSCI, V21, P1931, DOI 10.1111/j.1460-9568.2005.04013.x; WERSHIL BK, 1994, ADV EXP MED BIOL, V347, P39; Wilhelm M, 2000, ENDOCRINOLOGY, V141, P1178, DOI 10.1210/en.141.3.1178; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; YAMATODANI A, 1982, BIOCHEM PHARMACOL, V31, P305; YAMATODANI A, 1985, J CHROMATOGR, V344, P115, DOI 10.1016/S0378-4347(00)82012-5; Yuzurihara M, 2000, PHARMACOL BIOCHEM BE, V67, P145, DOI 10.1016/S0091-3057(00)00320-8	59	47	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78434	10.1371/journal.pone.0078434	http://dx.doi.org/10.1371/journal.pone.0078434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205232	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300155
J	Rossi, C; Schwartzman, K; Oxlade, O; Klein, MB; Greenaway, C				Rossi, Carmine; Schwartzman, Kevin; Oxlade, Olivia; Klein, Marina B.; Greenaway, Chris			Hepatitis B Screening and Vaccination Strategies for Newly Arrived Adult Canadian Immigrants and Refugees: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							NEW-SOUTH-WALES; VIRUS INFECTION; CANCER-MORTALITY; ASIAN MIGRANTS; UNITED-STATES; RECOMMENDATIONS; CHINESE; HEALTH; EPIDEMIOLOGY; PREVENTION	Background: Immigrants have increased mortality from hepatocellular carcinoma as compared to the host populations, primarily due to undetected chronic hepatitis B virus (HBV) infection. Despite this, there are no systematic programs in most immigrant-receiving countries to screen for chronic HBV infection and immigrants are not routinely offered HBV vaccination outside of the universal childhood vaccination program. Methods and findings: A cost-effective analysis was performed to compare four HBV screening and vaccination strategies with no intervention in a hypothetical cohort of newly-arriving adult Canadian immigrants. The strategies considered were a) universal vaccination, b) screening for prior immunity and vaccination, c) chronic HBV screening and treatment, and d) combined screening for chronic HBV and prior immunity, treatment and vaccination. The analysis was performed from a societal perspective, using a Markov model. Seroprevalence estimates, annual transition probabilities, health-care costs (in Canadian dollars), and utilities were obtained from the published literature. Acute HBV infection, mortality from chronic HBV, quality-adjusted life years (QALYs), and costs were modeled over the lifetime of the cohort of immigrants. Costs and QALYs were discounted at a rate of 3% per year. Screening for chronic HBV infection, and offering treatment if indicated, was found to be the most cost-effective intervention and was estimated to cost $40,880 per additional QALY gained, relative to no intervention. This strategy was most cost-effective for immigrants < 55 years of age and would cost < $50,000 per additional QALY gained for immigrants from areas where HBV seroprevalence is >= 3%. Strategies that included HBV vaccination were either prohibitively expensive or dominated by the chronic HBV screening strategy. Conclusions: Screening for chronic HBV infection from regions where most Canadian immigrants originate, except for Latin America and the Middle East, was found to be reasonably cost-effective and has the potential to reduce HBV-associated morbidity and mortality.	[Rossi, Carmine; Schwartzman, Kevin; Klein, Marina B.; Greenaway, Chris] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Rossi, Carmine; Greenaway, Chris] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E2, Canada; [Schwartzman, Kevin] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Schwartzman, Kevin] McGill Univ, Ctr Hlth, Div Resp, Montreal, PQ, Canada; [Oxlade, Olivia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Klein, Marina B.] McGill Univ, Dept Med, Ctr Hlth, Div Infect Dis Immunodeficiency, Montreal, PQ, Canada; [Greenaway, Chris] McGill Univ, Jewish Gen Hosp, Div Infect Dis, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; McGill University; Harvard University; Harvard T.H. Chan School of Public Health; McGill University; McGill University	Rossi, C (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	carmine.rossi@mail.mcgill.ca		Klein, Marina/0000-0002-3063-8430	Fonds de la recherche en sante du Quebec through the Bourse de Maitrise [22577]; Chercheur Boursier Clinicien programs; Canadian Institutes for Health Research	Fonds de la recherche en sante du Quebec through the Bourse de Maitrise; Chercheur Boursier Clinicien programs; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	CR, MK and CG receive salary support from the Fonds de la recherche en sante du Quebec (http://www.frsq.gouv.qc.ca/en/index.shtml) through the Bourse de Maitrise (CR) [grant number 22577] and the Chercheur Boursier Clinicien programs (MK, CG). OO receives salary support from a post-doctoral fellowship from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga-Rodriguez A, 2010, EUR J GASTROEN HEPAT, V22, P961, DOI 10.1097/MEG.0b013e32833783b4; BOUCHARDY C, 1994, INT J CANCER, V58, P638, DOI 10.1002/ijc.2910580504; Briggs AH, 1999, BRIT MED J, V319, P635, DOI 10.1136/bmj.319.7210.635; *COL BRIT MIN HLTH, 2012, MED SERV COMM PAYM S, P57564; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; DesMeules Marie, 2005, J Immigr Health, V7, P221, DOI 10.1007/s10903-005-5118-y; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Eckman MH, 2011, CLIN INFECT DIS, V52, P1294, DOI 10.1093/cid/cir199; Gagnon YM, 2004, J CLIN GASTROENTEROL, V38, pS179, DOI 10.1097/00004836-200411003-00011; Gray A., 2011, APPL METHODS COST EF; Greenaway C, 2011, CMAJ, V183, pE847; GRULICH AE, 1995, BRIT J CANCER, V71, P400, DOI 10.1038/bjc.1995.82; GRULICH AE, 1992, BRIT J CANCER, V66, P905, DOI 10.1038/bjc.1992.383; Hatzakis A, 2011, J VIRAL HEPATITIS, V18, P1, DOI 10.1111/j.1365-2893.2011.01499.x; Hemminki K, 2010, EUR J CANCER, V46, P926, DOI 10.1016/j.ejca.2009.12.031; Hislop TG, 2007, CAN J PUBLIC HEALTH, V98, P125, DOI 10.1007/BF03404323; Hu KQ, 2011, DIGEST DIS SCI, V56, P3163, DOI 10.1007/s10620-011-1840-6; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; *INT AG RES CANC, 2011, CANC INC 5 CONT ANN, P57564; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; *LASS REG MAL QUEB, 2012, LIST MED, P57564; *LASS REG MAL QUEB, 2011, MAN MED SPEC, P57564; Levy AR, 2008, VALUE HEALTH, V11, P527, DOI 10.1111/j.1524-4733.2007.00297.x; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Luo Wei, 2004, J Immigr Health, V6, P41, DOI 10.1023/B:JOIH.0000014641.68476.2d; Ma Grace X, 2007, J Immigr Minor Health, V9, P213, DOI 10.1007/s10903-006-9028-4; Ma GX, 2008, AM J HEALTH BEHAV, V32, P178; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; McCredie M, 1999, BRIT J CANCER, V79, P1277, DOI 10.1038/sj.bjc.6690205; McDermott S, 2011, J IMMIGR MINOR HEALT, V13, P15, DOI 10.1007/s10903-010-9347-3; McMahon BJ, 2010, CLIN LIVER DIS, V14, P381, DOI 10.1016/j.cld.2010.05.007; Merrett P, 2007, CLIN INFECT DIS, V44, P1040, DOI 10.1086/512673; Mitchell AE, 2010, HEPATOLOGY, V51, P729, DOI 10.1002/hep.23561; Public Health Agency of Canada, 2011, BRIEF REP HEP B INF; Rein DB, 2010, J VIRAL HEPATITIS, V17, P28, DOI 10.1111/j.1365-2893.2009.01165.x; Rossi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044611; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Shepard CW, 2005, PEDIATR INFECT DIS J, V24, P755, DOI 10.1097/01.inf.0000177279.72993.d5; Sherman M, 2007, CAN J GASTROENTER SC, V21, P5; *STAT CAN, 2011, TABLE 326 0020 CAN C, P57564; *STAT CAN, 2011, CANC INC 5 CONT ANN, P57564; Statistics Canada, 2006, PLAC BIRTH IMM POP P; Statistics Canada, 2007, IMM CAN PORTR FOR BO; Tong MJ, 2011, DIGEST DIS SCI, V56, P3143, DOI 10.1007/s10620-011-1841-5; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wong WWL, 2011, LIVER INT, V31, P1179, DOI 10.1111/j.1478-3231.2011.02559.x; Wu H, 2009, CAN J GASTROENTEROL, V23, P31, DOI 10.1155/2009/608352	53	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78548	10.1371/journal.pone.0078548	http://dx.doi.org/10.1371/journal.pone.0078548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205255	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300158
J	Joshi, A; Vaidyanathan, S; Mondol, S; Edgaonkar, A; Ramakrishnan, U				Joshi, Aditya; Vaidyanathan, Srinivas; Mondol, Samrat; Edgaonkar, Advait; Ramakrishnan, Uma			Connectivity of Tiger (Panthera tigris) Populations in the Human-Influenced Forest Mosaic of Central India	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; COMPUTER-PROGRAM; NATAL DISPERSAL; GENE FLOW; LANDSCAPE; DENSITY; INFERENCE; COUGAR; MIGRATION; IDENTIFICATION	Today, most wild tigers live in small, isolated Protected Areas within human dominated landscapes in the Indian subcontinent. Future survival of tigers depends on increasing local population size, as well as maintaining connectivity between populations. While significant conservation effort has been invested in increasing tiger population size, few initiatives have focused on landscape-level connectivity and on understanding the effect different landscape elements have on maintaining connectivity. We combined individual-based genetic and landscape ecology approaches to address this issue in six protected areas with varying tiger densities and separation in the Central Indian tiger landscape. We non-invasively sampled 55 tigers from different protected areas within this landscape. Maximum-likelihood and Bayesian genetic assignment tests indicate long-range tiger dispersal (on the order of 650 km) between protected areas. Further geo-spatial analyses revealed that tiger connectivity was affected by landscape elements such as human settlements, road density and host-population tiger density, but not by distance between populations. Our results elucidate the importance of landscape and habitat viability outside and between protected areas and provide a quantitative approach to test functionality of tiger corridors. We suggest future management strategies aim to minimize urban expansion between protected areas to maximize tiger connectivity. Achieving this goal in the context of ongoing urbanization and need to sustain current economic growth exerts enormous pressure on the remaining tiger habitats and emerges as a big challenge to conserve wild tigers in the Indian subcontinent.	[Joshi, Aditya] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Wildlife Conservat Soc India Program, Postgrad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India; [Mondol, Samrat; Ramakrishnan, Uma] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Edgaonkar, Advait] Indian Inst Forest Management, Bhopal, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Forest Management	Ramakrishnan, U (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	uramakri@ncbs.res.in		Mondol, Samrat/0000-0003-3034-9396; Joshi, Aditya/0000-0002-9335-8508; Vaidyanathan, Srinivas/0000-0003-3642-0309	Department of Science and Technology, Government of India; Tata Institute of Fundamental Research; Wildlife Conservation society- India Program	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Wildlife Conservation society- India Program	This research was funded by the Department of Science and Technology, Government of India, Tata Institute of Fundamental Research and the Wildlife Conservation society- India Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bhagat R.B., 2009, ASIAN POPUL STUD, V5, P5, DOI [10.1080/17441730902790024, DOI 10.1080/17441730902790024]; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Carr D, 2007, OIKOS, V116, P629, DOI 10.1111/j.2007.0030-1299.15568.x; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; Gubbi S, 2012, CURR SCI INDIA, V102, P1047; Jhala Y. V., 2011, STATUS TIGERS COPRED; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 2011, SCIENCE, V332, P791, DOI 10.1126/science.332.6031.791-a; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KK, 2011, CONSERV LETT, V4, P137, DOI 10.1111/j.1755-263X.2010.00154.x; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2012, MOL ECOL RESOUR, V12, P276, DOI 10.1111/j.1755-0998.2011.03077.x; Luque S, 2012, LANDSCAPE ECOL, V27, P153, DOI 10.1007/s10980-011-9700-5; Maehr DS, 2002, BIOL CONSERV, V106, P187, DOI 10.1016/S0006-3207(01)00245-2; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; MINCH E, 1995, MICROSAT VERSION 1 5; Mondol S, 2012, CONSERV GENET RESOUR, V4, P63, DOI 10.1007/s12686-011-9475-7; Mondol S, 2009, BIOL CONSERV, V142, P2350, DOI 10.1016/j.biocon.2009.05.014; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; Mukherjee N, 2007, CONSERV GENET, V8, P1465, DOI 10.1007/s10592-007-9289-z; Munshi-South J, 2012, MOL ECOL, V21, P1360, DOI 10.1111/j.1365-294X.2012.05476.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Patil N, 2011, ORYX, V45, P472, DOI 10.1017/S0030605311001591; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Ranganathan J, 2008, BIOL CONSERV, V141, P67, DOI 10.1016/j.biocon.2007.09.003; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Sanderson E, 2006, SETTING PRIORITIES C; Sharma S, 2013, ECOL EVOL, V3, P48, DOI 10.1002/ece3.432; Singleton PH, 2004, URSUS, V15, P90, DOI 10.2192/1537-6176(2004)015<0090:LPFGBM>2.0.CO;2; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Stoner DC, 2008, J WILDLIFE MANAGE, V72, P933, DOI 10.2193/2007-219; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Sutton PC, 2010, REMOTE SENS DIGIT IM, V10, P329, DOI 10.1007/978-1-4020-4385-7_17; Team RDC, 2008, LANG ENV STAT COMP; Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404; Thompson DJ, 2005, J WILDLIFE MANAGE, V69, P818, DOI 10.2193/0022-541X(2005)069[0818:LDBASM]2.0.CO;2; TREWHELLA WJ, 1988, J APPL ECOL, V25, P423, DOI 10.2307/2403834; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vounatsou P, 2000, Biostatistics, V1, P177, DOI 10.1093/biostatistics/1.2.177; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; Wilson GA, 2003, GENETICS, V163, P1177; Yang M., 2009, JOINT URBAN REMOTE S, DOI [10.1109/URS.2009.5137530, DOI 10.1109/URS.2009.5137530]	71	69	71	1	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77980	10.1371/journal.pone.0077980	http://dx.doi.org/10.1371/journal.pone.0077980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223132	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200024
J	Lalor, MK; Greig, J; Allamuratova, S; Althomsons, S; Tigay, Z; Khaemraev, A; Braker, K; Telnov, O; du Cros, P				Lalor, Maeve K.; Greig, Jane; Allamuratova, Sholpan; Althomsons, Sandy; Tigay, Zinaida; Khaemraev, Atadjan; Braker, Kai; Telnov, Oleksander; du Cros, Philipp			Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis	PLOS ONE			English	Article							TREATMENT OUTCOMES; PROGRAM; TB	Background: The Medecins Sans Frontieres project of Uzbekistan has provided multidrug-resistant tuberculosis treatment in the Karakalpakstan region since 2003. Rates of default from treatment have been high, despite psychosocial support, increasing particularly since programme scale-up in 2007. We aimed to determine factors associated with default in multi- and extensively drug-resistant tuberculosis patients who started treatment between 2003 and 2008 and thus had finished approximately 2 years of treatment by the end of 2010. Methods: A retrospective cohort analysis of multi- and extensively drug-resistant tuberculosis patients enrolled in treatment between 2003 and 2008 compared baseline demographic characteristics and possible risk factors for default. Default was defined as missing >= 60 consecutive days of treatment (all drugs). Data were routinely collected during treatment and entered in a database. Potential risk factors for default were assessed in univariate analysis using chi-square test and in multivariate analysis with logistic regression. Results: 20% (142/710) of patients defaulted after a median of 6 months treatment (IQR 2.6-9.9). Factors associated with default included severity of resistance patterns (pre-extensively drug-resistant/extensively drug-resistant tuberculosis adjusted odds ratio 0.52, 95% CI: 0.31-0.86), previous default (2.38, 1.09-5.24) and age >45 years (1.77, 1.10-2.87). The default rate was 14% (42/294) for patients enrolled 2003-2006 and 24% (100/416) for 2007-2008 enrolments (p = 0.001). Conclusions: Default from treatment was high and increased with programme scale-up. It is essential to ensure scale-up of treatment is accompanied with scale-up of staff and patient support. A successful first course of tuberculosis treatment is important; patients who had previously defaulted were at increased risk of default and death. The protective effect of severe resistance profiles suggests that understanding disease severity or fear may motivate against default. Targeted health education and support for at-risk patients after 5 months of treatment when many begin to feel better may decrease default.	[Lalor, Maeve K.; Allamuratova, Sholpan; Althomsons, Sandy; Telnov, Oleksander] Med Sans Frontieres, Nukus, Karakalpakstan, Uzbekistan; [Greig, Jane; du Cros, Philipp] Med Sans Frontieres, London, England; [Tigay, Zinaida; Khaemraev, Atadjan] Minist Hlth, Karakalpakstan, Uzbekistan; [Braker, Kai] Med Sans Frontieres, Berlin, Germany	Doctors Without Borders; Doctors Without Borders	Lalor, MK (corresponding author), Med Sans Frontieres, Nukus, Karakalpakstan, Uzbekistan.	maeve_lalor@yahoo.com		du Cros, Philipp/0000-0002-3599-029X; Greig, Jane/0000-0003-2732-0023	M�decins Sans Fronti�res [OCA009-42] Funding Source: researchfish	M�decins Sans Fronti�res		Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; [Anonymous], 2008, GUID PROGR MAN DRUG; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Cox HS, 2004, EMERG INFECT DIS, V10, P865, DOI 10.3201/eid1005.030718; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Gler MT, 2012, INT J TUBERC LUNG D, V16, P955, DOI 10.5588/ijtld.11.0502; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Ministry of Health Uzbekistan, 2009, TUB DAT UZB; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organisation, 2012, TUB COUNTR WORK SUMM; World Health Organization, 2011, WHO PROGRESS REPORT; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10	20	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78364	10.1371/journal.pone.0078364	http://dx.doi.org/10.1371/journal.pone.0078364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223148	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200040
J	Martinez, A; Halliez, MCM; Aliouat, E; Chabe, M; Standaert-Vitse, A; Frealle, E; Gantois, N; Pottier, M; Pinon, A; Dei-Cas, E; Aliouat-Denis, CM				Martinez, Anna; Halliez, Marie C. M.; Aliouat, El Moukhtar; Chabe, Magali; Standaert-Vitse, Annie; Frealle, Emilie; Gantois, Nausicaa; Pottier, Muriel; Pinon, Anthony; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie			Growth and Airborne Transmission of Cell-Sorted Life Cycle Stages of Pneumocystis carinii	PLOS ONE			English	Article							F-SP HOMINIS; SP MURIS; IMMUNOCOMPETENT; INFECTION; DIAGNOSIS; MODELS; MOUSE; HOSTS; RAT	Pneumocystis organisms are airborne opportunistic pathogens that cannot be continuously grown in culture. Consequently, the follow-up of Pneumocystis stage-to-stage differentiation, the sequence of their multiplication processes as well as formal identification of the transmitted form have remained elusive. The successful high-speed cell sorting of trophic and cystic forms is paving the way for the elucidation of the complex Pneumocystis life cycle. The growth of each sorted Pneumocystis stage population was followed up independently both in nude rats and in vitro. In addition, by setting up a novel nude rat model, we attempted to delineate which cystic and/or trophic forms can be naturally aerially transmitted from host to host. The results showed that in axenic culture, cystic forms can differentiate into trophic forms, whereas trophic forms are unable to evolve into cystic forms. In contrast, nude rats inoculated with pure trophic forms are able to produce cystic forms and vice versa. Transmission experiments indicated that 12 h of contact between seeder and recipient nude rats was sufficient for cystic forms to be aerially transmitted. In conclusion, trophic-to cystic-form transition is a key step in the proliferation of Pneumocystis microfungi because the cystic forms (but not the trophic forms) can be transmitted by aerial route from host to host.	[Martinez, Anna; Halliez, Marie C. M.; Aliouat, El Moukhtar; Chabe, Magali; Standaert-Vitse, Annie; Frealle, Emilie; Gantois, Nausicaa; Pottier, Muriel; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM U1019,CNRS UMR 8204,EA 4547, Lille, France; [Martinez, Anna] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Halliez, Marie C. M.] Univ Calgary, Dept Biol Sci, Inflammat Res Network, Calgary, AB T2N 1N4, Canada; [Pinon, Anthony] Inst Pasteur, Unite Securite Microbiol, F-59019 Lille, France; [Frealle, Emilie; Dei-Cas, Eduardo] Ctr Reg Hosp Univ, Biol & Pathol Ctr, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; RIKEN; University of Calgary; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; CHU Lille	Aliouat-Denis, CM (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM U1019,CNRS UMR 8204,EA 4547, Lille, France.	cecile.aliouat@univ-lille2.fr	Standaert, Annie/R-5826-2018; Martinez, Anna/AAI-6447-2021; Fréalle, Emilie/AAF-5162-2020; Aliouat, El Moukhtar/D-2859-2018; Standaert, Annie/AAD-8209-2020; Aliouat-Denis, Cecile-Marie/P-1934-2016; Chabe, Magali/H-6045-2017	Standaert, Annie/0000-0002-7752-3964; Aliouat, El Moukhtar/0000-0003-2905-7126; Standaert, Annie/0000-0002-7752-3964; Pinon, Anthony/0000-0001-7048-3085; Aliouat-Denis, Cecile-Marie/0000-0001-8388-4662; Martinez, Anna/0000-0001-7245-9687; Frealle, Emilie/0000-0003-3129-979X; Chabe, Magali/0000-0002-6732-6772	ANR-ERA-NET 'Pneumocystis' PathoGenoMics [ANR-06-PATHO-009-01]; Lille-Nord-de-France University; Pasteur Institute of Lille; microscopy and flow cytometry platform of the BioImaging Center of Lille Nord de France (BiCeL) [IFR142]	ANR-ERA-NET 'Pneumocystis' PathoGenoMics(French National Research Agency (ANR)); Lille-Nord-de-France University; Pasteur Institute of Lille; microscopy and flow cytometry platform of the BioImaging Center of Lille Nord de France (BiCeL)	This work was supported by ANR-ERA-NET 'Pneumocystis' PathoGenoMics (ANR-06-PATHO-009-01). We also thank the Lille-Nord-de-France University, the Pasteur Institute of Lille and the microscopy and flow cytometry platform of the BioImaging Center of Lille Nord de France (BiCeL, IFR142) for their support. The funders (ANR-ERA-NET, Lille Nord de France University and Pasteur Institute of Lille) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat E, 1999, J EUKARYOT MICROBIOL, V46, p116S; Aliouat EM, 1998, EUR RESPIR J, V11, P542; ALIOUAT EM, 1993, J PROTOZOOL RES, V3, P94; Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Aliouat-Denis CM, 2009, MEM I OSWALDO CRUZ, V104, P419, DOI 10.1590/S0074-02762009000300004; Ambrose HE, 2004, MICROBIOL-SGM, V150, P293, DOI 10.1099/mic.0.26539-0; An CL, 2003, INFECT IMMUN, V71, P2065, DOI 10.1128/IAI.71.4.2065-2070.2003; Aviles P, 2000, ANTIMICROB AGENTS CH, V44, P1284, DOI 10.1128/AAC.44.5.1284-1290.2000; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/eri.10.11, 10.1586/ERI.10.42]; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Chabe M, 2004, EUR J CLIN MICROBIOL, V23, P89, DOI 10.1007/s10096-003-1092-2; Cushion MT, 2010, ANNU REV MICROBIOL, V64, P431, DOI 10.1146/annurev.micro.112408.134335; Cushion MT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001009; Cushion MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008524; Dei-Cas E, 1998, FEMS IMMUNOL MED MIC, V22, P163, DOI [10.1111/j.1574-695X.1998.tb01201.x, 10.1111/j.1574-695X.1998.tb01203.x]; DeiCas E, 1996, PARASITOL TODAY, V12, P245, DOI 10.1016/0169-4758(96)80812-X; DEICAS E, 2004, PNEUMOCYSTIS PNEUMON, P61; Dumoulin A, 2000, EUR J CLIN MICROBIOL, V19, P671, DOI 10.1007/s100960000354; Durand-Joly I, 2005, FEMS IMMUNOL MED MIC, V45, P405, DOI 10.1016/j.femsim.2005.06.006; Durand-Joly I, 2002, J CLIN MICROBIOL, V40, P1862, DOI 10.1128/JCM.40.5.1862-1865.2002; Garry S, 2003, MUTAT RES-GEN TOX EN, V538, P19, DOI 10.1016/S1383-5718(03)00082-2; Gigliotti F, 2003, INFECT IMMUN, V71, P3852, DOI 10.1128/IAI.71.7.3852-3856.2003; HUGHES WT, 1982, J INFECT DIS, V145, P842, DOI 10.1093/infdis/145.6.842; ITATANI CA, 1994, J PARASITOL, V80, P644, DOI 10.2307/3283204; Martinez A, 2009, J EUKARYOT MICROBIOL, V56, P446, DOI 10.1111/j.1550-7408.2009.00423.x; SCHMATZ DM, 1992, ANTIMICROB AGENTS CH, V36, P1964, DOI 10.1128/AAC.36.9.1964; SOULEZ B, 1991, J PARASITOL, V77, P449, DOI 10.2307/3283134; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Wakefield AE, 1996, J CLIN MICROBIOL, V34, P1754, DOI 10.1128/JCM.34.7.1754-1759.1996; WALZER PD, 1977, SCIENCE, V197, P177, DOI 10.1126/science.301657; YOSHIDA Y, 1989, J PROTOZOOL, V36, P53	32	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79958	10.1371/journal.pone.0079958	http://dx.doi.org/10.1371/journal.pone.0079958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223207	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200100
J	Zhao, M; Zang, BC; Cheng, MJ; Ma, Y; Yang, YH; Yang, NH				Zhao, Min; Zang, Baocai; Cheng, Mengjie; Ma, Yan; Yang, Yanhong; Yang, Nianhong			Differential Responses of Hepatic Endoplasmic Reticulum Stress and Inflammation in Diet-Induced Obese Rats with High-Fat Diet Rich in Lard Oil or Soybean Oil	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ER STRESS; REGULATOR GRP78/BIP; OXIDATIVE STRESS; SKELETAL-MUSCLE; CRUCIAL ROLE; CELL FATE; LIVER	Scopes: To investigate the effects of high-fat diet enriched with lard oil or soybean oil on liver endoplasmic reticulum (ER) stress and inflammation markers in diet-induced obese (DIO) rats and estimate the influence of following low-fat diet feeding. Methods and Results: Male SD rats were fed with standard low-fat diet (LF, n = 10) and two isoenergentic high-fat diets enriched with lard (HL, n = 45) or soybean oil (HS, n = 45) respectively for 10 weeks. Then DIO rats from HL and HS were fed either high-fat diet continuously (HL/HL, HS/HS) or switched to low-fat diet (HL/LF, HS/LF) for another 8 weeks. Rats in control group were maintained with low-fat diet. Body fat, serum insulin level, HOMA-IR and ectopic lipid deposition in liver were increased in HL/HL and HS/HS compared to control, but increased to a greater extent in HL/HL compared to HS/HS. Markers of ER stress including PERK and CHOP protein expression and phosphorylation of eIF2 alpha were significantly elevated in HL/HL group while phosphorylation of IRE1 alpha and GRP78 protein expression were suppressed in both HL/HL and HS/HS. Besides, inflammatory signals (OPN, TLR2, TLR4 and TNF-alpha) expressions significantly increased in HL/HL compared to others. Switching to low-fat diet reduced liver fat deposition, HOMA-IR, mRNA expression of TLR4, TNF-alpha, PERK in both HL/LF and HS/LF, but only decreased protein expression of OPN, PERK and CHOP in HL/LF group. In addition, HL/LF and HS/LF exhibited decreased phosphorylation of eIF2 alpha and increased phosphorylation of IRE1 alpha and GRP78 protein expression when compared with HL/HL and HS/HS respectively. Conclusions: Lard oil was more deleterious in insulin resistance and hepatic steatosis via promoting ER stress and inflammation responses in DIO rats, which may be attributed to the enrichment of saturated fatty acid. Low-fat diet was confirmed to be useful in recovering from impaired insulin sensitivity and liver fat deposition in this study.	[Zhao, Min; Zang, Baocai; Cheng, Mengjie; Ma, Yan; Yang, Yanhong; Yang, Nianhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Wuhan 430074, Hubei Province, Peoples R China; [Zhao, Min; Zang, Baocai; Yang, Nianhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ Key Lab Environm & Hlth, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, NH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Wuhan 430074, Hubei Province, Peoples R China.	zynh@mails.tjmu.edu.cn			National Natural Science Foundation of China [30671765]; Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China [20101561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by National Natural Science Foundation of China (No. 30671765; http://www.nsfc.gov.cn/Portal0/default152.htm) and Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China (No. 20101561; http://www.cscse.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Foreyt JP, 2002, AM J MED, V113, P60, DOI 10.1016/S0002-9343(01)00993-7; Golay A, 1997, INT J OBESITY, V21, pS2; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kim SJ, 2010, MOL NUTR FOOD RES, V54, P1014, DOI 10.1002/mnfr.200800512; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li J, 2012, J HEPATOL, V56, P900, DOI 10.1016/j.jhep.2011.10.018; Liao FH, 2010, INT J OBESITY, V34, P1608, DOI 10.1038/ijo.2010.88; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin M, 2013, KIDNEY INT; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nivala AM, 2013, METABOLISM CLIN EXPT; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pacana T, 2012, CURR OPIN CLIN NUTR, V15, P641, DOI 10.1097/MCO.0b013e328357f747; Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; Vinayagamoorthi R, 2008, J ENDOCRINOL, V197, P287, DOI 10.1677/JOE-08-0061; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wang X, 2012, EUROPEAN J NUTR; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312	70	25	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78620	10.1371/journal.pone.0078620	http://dx.doi.org/10.1371/journal.pone.0078620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223162	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200054
J	Diegelmann, J; Czamara, D; Le Bras, E; Zimmermann, E; Olszak, T; Bedynek, A; Goke, B; Franke, A; Glas, J; Brand, S				Diegelmann, Julia; Czamara, Darina; Le Bras, Emmanuelle; Zimmermann, Eva; Olszak, Torsten; Bedynek, Andrea; Goeke, Burkhard; Franke, Andre; Glas, Juergen; Brand, Stephan			Intestinal DMBT1 Expression Is Modulated by Crohn's Disease- Associated IL23R Variants and by a DMBT1 Variant Which Influences Binding of the Transcription Factors CREB1 and ATF-2	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SCAVENGER RECEPTOR GP340; ULCERATIVE-COLITIS; SUSCEPTIBILITY LOCI; FRAMESHIFT MUTATION; GERMAN POPULATION; EPITHELIAL-CELLS; GENE-EXPRESSION; GENOTYPE STATUS	Objectives: DMBT is an antibacterial pattern recognition and scavenger receptor. In this study, we analyzed the role of DMBT1 single nucleotide polymorphisms (SNPs) regarding inflammatory bowel disease (IBD) susceptibility and examined their functional impact on transcription factor binding and downstream gene expression. Methods: Seven SNPs in the DMBT1 gene region were analyzed in 2073 individuals including 818 Crohn's disease (CD) patients and 972 healthy controls in two independent case-control panels. Comprehensive epistasis analyses for the known CD susceptibility genes NOD2, IL23R and IL27 were performed. The influence of IL23R variants on DMBT1 expression was analyzed. Functional analysis included siRNA transfection, quantitative PCR, western blot, electrophoretic mobility shift and luciferase assays. Results: IL-22 induces DMBT1 protein expression in intestinal epithelial cells dependent on STAT3, ATF-2 and CREB1. IL-22 expression-modulating, CD risk-associated IL23R variants influence DMBT1 expression in CD patients and DMBT1 levels are increased in the inflamed intestinal mucosa of CD patients. Several DMBT1 SNPs were associated with CD susceptibility. SNP rs2981804 was most strongly associated with CD in the combined panel (p = 3.06 x 10(-7), OR 1.42; 95% CI 1.24-1.63). All haplotype groups tested showed highly significant associations with CD (including omnibus P-values as low as 6.16 x 10(-18)). The most strongly CD risk-associated, non-coding DMBT1 SNP rs2981804 modifies the DNA binding sites for the transcription factors CREB1 and ATF-2 and the respective genomic region comprising rs2981804 is able to act as a transcriptional regulator in vitro. Intestinal DMBT1 expression is decreased in CD patients carrying the rs2981804 CD risk allele. Conclusion: We identified novel associations of DMBT1 variants with CD susceptibility and discovered a novel functional role of rs2981804 in regulating DMBT1 expression. Our data suggest an important role of DMBT1 in CD pathogenesis.	[Diegelmann, Julia; Le Bras, Emmanuelle; Olszak, Torsten; Goeke, Burkhard; Glas, Juergen; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Diegelmann, Julia; Zimmermann, Eva; Glas, Juergen] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Czamara, Darina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Bedynek, Andrea] Univ Munich, Dept Clin Chem, Munich, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany	University of Munich; University of Munich; Max Planck Society; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Munich; University of Kiel; RWTH Aachen University	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Franke, Andre/B-2151-2010	Franke, Andre/0000-0003-1530-5811	Ludwig-Maximilians-University of Munich (Promotionsstipendium); Deutsche Forschungsgemeinschaft (DFG) [BR 1912/6-1]; Else-Kroner-Fresenius-Stiftung [Else Kroner-Exzellenzstipendium 2010_EKES.32]; Ludwig-Maximilians-University of Munich (Excellence Initiative); Ludwig-Maximilians-University of Munich (Investment funds); Ludwig-Maximilians-University of Munich (FoFoLe); DFG [Ol 324/1-1]; German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft (German Research Foundation) [EXC 1010 SyNergy]	Ludwig-Maximilians-University of Munich (Promotionsstipendium); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung; Ludwig-Maximilians-University of Munich (Excellence Initiative); Ludwig-Maximilians-University of Munich (Investment funds); Ludwig-Maximilians-University of Munich (FoFoLe); DFG(German Research Foundation (DFG)); German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	JD was supported by a grant from the Ludwig-Maximilians-University of Munich (Promotionsstipendium). SB was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BR 1912/6-1), the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32) and by grants from the Ludwig-Maximilians-University of Munich (Excellence Initiative, Investment funds 2008 and FoFoLe). TO was supported by DFG grant Ol 324/1-1. AF was supported by the German Ministry of Education and Research through the National Genome Research Network and receives infrastructure support through the DFG cluster of excellence 'Inflammation at Interfaces'. DC was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Browning BL, 2008, J MED GENET, V45, P36, DOI 10.1136/jmg.2007.050773; Cayatte C, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.2; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; De Lisle RC, 2008, AM J PHYSIOL-GASTR L, V294, pG717, DOI 10.1152/ajpgi.00525.2007; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinu I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043035; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x; End C, 2009, EUR J IMMUNOL, V39, P833, DOI 10.1002/eji.200838689; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Glas J, 2010, PLOS ONE, V5; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054338; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, AM J GASTROENTEROL, V105, P1811, DOI 10.1038/ajg.2010.95; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Loimaranta V, 2009, J BIOL CHEM, V284, P18614, DOI 10.1074/jbc.M900581200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Renner M, 2007, GASTROENTEROLOGY, V133, P1499, DOI 10.1053/j.gastro.2007.08.007; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007	51	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77773	10.1371/journal.pone.0077773	http://dx.doi.org/10.1371/journal.pone.0077773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223725	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400013
J	Branco, R; Morais, PV				Branco, Rita; Morais, Paula V.			Identification and Characterization of the Transcriptional Regulator ChrB in the Chromate Resistance Determinant of Ochrobactrum tritici 5bvl1	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; GENOMIC ANALYSIS; BACTERIAL; EXPRESSION; CHROMIUM; BIOTECHNOLOGY; BIOSENSORS; PROMOTER; PROTEIN; EFFLUX	Ochrobactrum tritici 5bvl1 is able to resist to high concentrations of chromate through the expression of an inducible chromate-resistant determinant, found in a mobile element (TnOtChr), which carries the genes, chrB, chrA, chrC and chrF. The regulation of chr operon present in TnOtChr, which is controlled by a transcriptional regulator, ChrB, was characterized in the current work. Fusions of chr promoter, or chr promoter and chrB gene, upstream of a gfp reporter gene, identified the most probable promoter sequence within the tnpR-chrB intergenic region. This region contains an AT-rich imperfect inverted repeat sequence, which overlaps a part of the -10 sequence. The results of the in vitro DNA-binding assays with purified ChrB (His-or no-tagged) showed that the protein binds directly to the chr promoter region. In order to identify the ChrB functional domain for sensing chromate stress and for DNA-binding, site-directed mutagenesis of ChrB was performed. Among several single amino acid mutants, three mutants (R180; R187 and H229) prevented chromate induction without any modification to the protein's stability. Interestingly, two ChrB mutants (R18 and R23) were constitutively active, regardless of chromate stress conditions, indicating that the residues most probably belong to the protein-DNA binding site. As such, the ChrB was classified as a transcriptional regulator that recognizes a specific DNA sequence, regulating the expression of a chromate resistance determinant.	[Branco, Rita; Morais, Paula V.] IMAR CMA Marine & Environm Res Ctr, Coimbra, Portugal; [Branco, Rita] Univ Coimbra, Interdisciplinary Res Inst, Coimbra, Portugal; [Morais, Paula V.] Univ Coimbra, FCTUC, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Morais, PV (corresponding author), IMAR CMA Marine & Environm Res Ctr, Coimbra, Portugal.	pvmorais@ci.uc.pt	Branco, Rita/AAQ-4007-2021; Morais, Paula Vasconcelos/C-9756-2014; Branco, Rita/Q-9573-2018	Branco, Rita/0000-0003-0291-8029; Morais, Paula Vasconcelos/0000-0002-1939-6389; Branco, Rita/0000-0003-0291-8029	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/MAR/109057/2008, SFRH/BPD/48330/2008]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao para a Ciencia e Tecnologia (FCT) under the PTDC/MAR/109057/2008 project. Rita Branco was supported by a grant, SFRH/BPD/48330/2008, from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Barajas E, 2008, FEMS MICROBIOL LETT, V285, P97, DOI 10.1111/j.1574-6968.2008.01220.x; Aguilar-Barajas E, 2012, WORLD J MICROB BIOT, V28, P865, DOI 10.1007/s11274-011-0883-3; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Branco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054005; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; CERVANTES C, 1990, J BACTERIOL, V172, P287, DOI 10.1128/JB.172.1.287-291.1990; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Dua M, 2002, APPL MICROBIOL BIOT, V59, P143, DOI 10.1007/s00253-002-1024-6; Giedroc DP, 2007, DALTON T, P3107, DOI 10.1039/b706769k; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; He MY, 2011, J HAZARD MATER, V185, P682, DOI 10.1016/j.jhazmat.2010.09.072; He MY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-221; Helmann JD, 2007, MICROBIOL MONOGR, V6, P38; Henne KL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-199; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobman JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-109; Juhnke S, 2002, ARCH MICROBIOL, V179, P15, DOI 10.1007/s00203-002-0492-5; Lin Z, 2013, BIOTECHNOL IN PRESS; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Morais PV, 2011, BIOMETALS, V24, P401, DOI 10.1007/s10534-011-9446-1; NIES A, 1990, J BIOL CHEM, V265, P5648; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Osman D, 2010, NAT PROD REP, V27, P668, DOI 10.1039/b906682a; Pimentel BE, 2002, FEMS MICROBIOL LETT, V212, P249, DOI 10.1111/j.1574-6968.2002.tb11274.x; Ramirez-Diaz MI, 2008, BIOMETALS, V21, P321, DOI 10.1007/s10534-007-9121-8; Sambrook J., 2001, MOL CLONING LAB MANU; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Tecon R, 2008, SENSORS-BASEL, V8, P4062, DOI 10.3390/s8074062; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; Yagi K, 2007, APPL MICROBIOL BIOT, V73, P1251, DOI 10.1007/s00253-006-0718-6; Yeom S, 2010, MICROBIOL-SGM, V156, P1487, DOI 10.1099/mic.0.034181-0; Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t	39	18	19	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77987	10.1371/journal.pone.0077987	http://dx.doi.org/10.1371/journal.pone.0077987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223748	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400025
J	Chang, WY; Huang, A; Yang, CY; Lee, CH; Chen, YC; Wu, TY; Chen, GS				Chang, Wen-Yu; Huang, Adam; Yang, Chung-Yi; Lee, Chien-Hung; Chen, Yin-Chun; Wu, Tian-Yau; Chen, Gwo-Shing			Computer-Aided Diagnosis of Skin Lesions Using Conventional Digital Photography: A Reliability and Feasibility Study	PLOS ONE			English	Article							PULMONARY NODULES; NEURAL-NETWORK; IMAGE-ANALYSIS; GENERAL-PRACTITIONERS; MALIGNANT-MELANOMA; CT COLONOGRAPHY; CANCER; ACCURACY; FEATURES; CLASSIFICATION	Background: Computer-aided diagnosis (CADx) software that provides a second opinion has been widely used to assist physicians with various tasks. In dermatology, however, CADx has been mostly limited to melanoma or melanocytic skin cancer diagnosis. The frequency of non-melanocytic skin cancers and the accessibility of regular digital macrographs have raised interest in developing CADx for broader applications. Objectives: To investigate the feasibility of using CADx to diagnose both melanocytic and non-melanocytic skin lesions based on conventional digital photographic images. Methods: This study was approved by an institutional review board, and the requirement to obtain informed consent was waived. In total, 769 conventional photographs of melanocytic and non-melanocytic skin lesions were retrospectively reviewed and used to develop a CADx system. Conventional and new color-related image features were developed to classify the lesions as benign or malignant using support vector machines (SVMs). The performance of CADx was compared with that of dermatologists. Results: The clinicians' overall sensitivity, specificity, and accuracy were 83.33%, 85.88%, and 85.31%, respectively. New color correlation and principal component analysis (PCA) features improved the classification ability of the baseline CADx (p = 0.001). The estimated area under the receiver operating characteristic (ROC) curve (Az) of the proposed CADx system was 0.949, with a sensitivity and specificity of 85.63% and 87.65%, respectively, and a maximum accuracy of 90.64%. Conclusions: We have developed an effective CADx system to classify both melanocytic and non-melanocytic skin lesions using conventional digital macrographs. The system's performance was similar to that of dermatologists at our institute. Through improved feature extraction and SVM analysis, we found that conventional digital macrographs were feasible for providing useful information for CADx applications. The new color-related features significantly improved CADx applications for skin cancer.	[Chang, Wen-Yu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chang, Wen-Yu] I Shou Univ, E Da Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Huang, Adam; Wu, Tian-Yau] Natl Cent Univ, Ctr Biomarkers & Translat Med, Res Ctr Adapt Data Anal, Jhongli, Taiwan; [Huang, Adam; Wu, Tian-Yau] Natl Cent Univ, Grad Inst Biomed Engn, Jhongli, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lee, Chien-Hung] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Chen, Yin-Chun] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; [Chen, Yin-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Chen, Gwo-Shing] Kaohsiung Med Univ, Kaohsiung Med Univ Hospital, Coll Med, Dept Dermatol, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; National Central University; National Central University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, GS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hospital, Coll Med, Dept Dermatol, Kaohsiung, Taiwan.	d700086@kmu.edu.tw	Lee, Chien-Hung/D-4437-2009; Wu, Tian-Yau/AAK-9024-2021	Lee, Chien-Hung/0000-0002-0988-264X; Wu, Tian-Yau/0000-0002-2693-3365; Huang, Adam/0000-0001-5478-2763	National Science Council of Republic of China (Taiwan) [NSC 100-2221-E-008-009, 101-2221-E-008-021, NSC 101-2911-I-008-001, NSC 99-2627-B-008-005]	National Science Council of Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council of Republic of China (Taiwan) under Grants NSC 100-2221-E-008-009, 101-2221-E-008-021, NSC 101-2911-I-008-001, and NSC 99-2627-B-008-005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kadi OS, 2010, PATTERN RECOGN, V43, P2043, DOI 10.1016/j.patcog.2010.01.005; Albanese D, 2012, MLPY MACHINE LEARNIN; Awai K, 2004, RADIOLOGY, V230, P347, DOI 10.1148/radiol.2302030049; Binder M, 2000, MELANOMA RES, V10, P556, DOI 10.1097/00008390-200012000-00007; Blum A, 2004, BRIT J DERMATOL, V151, P1029, DOI 10.1111/j.1365-2133.2004.06210.x; Blum A, 2008, SEMIN CUTAN MED SURG, V27, P11, DOI 10.1016/j.sder.2007.12.005; Bogoni L, 2005, BRIT J RADIOL, V78, pS57, DOI 10.1259/bjr/25777270; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Burhenne LJW, 2000, RADIOLOGY, V215, P554; Burroni M, 2004, CLIN CANCER RES, V10, P1881, DOI 10.1158/1078-0432.CCR-03-0039; Christensen JH, 2010, SKIN RES TECHNOL, V16, P98, DOI 10.1111/j.1600-0846.2009.00408.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi K, 2005, BRIT J RADIOL, V78, pS3, DOI 10.1259/bjr/82933343; DURG A, 1993, IEEE ENG MED BIOL, V12, P71, DOI 10.1109/51.232345; ERCAL F, 1994, IEEE T BIO-MED ENG, V41, P837, DOI 10.1109/10.312091; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Freer TW, 2001, RADIOLOGY, V220, P781, DOI 10.1148/radiol.2203001282; FUJITA H, 1992, J NUCL MED, V33, P272; Gutkowicz-Krusin D, 1997, Skin Res Technol, V3, P15, DOI 10.1111/j.1600-0846.1997.tb00154.x; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harrell FE, 2001, REGRESSION MODELING; Heal CF, 2008, BRIT J DERMATOL, V159, P661, DOI 10.1111/j.1365-2133.2008.08715.x; Hoffmann K, 2003, BRIT J DERMATOL, V149, P801, DOI 10.1046/j.1365-2133.2003.05547.x; Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186; Joel G, 2002, SKIN RES TECHNOL, V8, P240, DOI 10.1034/j.1600-0846.2002.00334.x; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kim JS, 2005, RADIOLOGY, V236, P295, DOI 10.1148/radiol.2361041288; LeAnder R, 2010, SKIN RES TECHNOL, V16, P297, DOI 10.1111/j.1600-0846.2010.00429.x; Lessmann B, 2007, J BIOMED INFORM, V40, P631, DOI 10.1016/j.jbi.2007.06.007; Li J, 2008, MED PHYS, V35, P3527, DOI 10.1118/1.2938517; MARCHESINI R, 1992, PHOTOCHEM PHOTOBIOL, V55, P515, DOI 10.1111/j.1751-1097.1992.tb04272.x; McKenna DB, 2004, BRIT J DERMATOL, V151, P636, DOI 10.1111/j.1365-2133.2004.06065.x; Moffatt CRM, 2006, INT J DERMATOL, V45, P656, DOI 10.1111/j.1365-4632.2006.02772.x; Morton CA, 1998, BRIT J DERMATOL, V138, P283; Perrinaud A, 2007, BRIT J DERMATOL, V157, P926, DOI 10.1111/j.1365-2133.2007.08168.x; Piccolo D, 2002, BRIT J DERMATOL, V147, P481, DOI 10.1046/j.1365-2133.2002.04978.x; Qian W, 2007, ANAL QUANT CYTOL, V29, P103; R Core Team, 2021, R LANGUAGE ENV STAT; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Rogers HW, 2012, DERMATOL SURG; Schmid-Saugeon P, 2003, COMPUT MED IMAG GRAP, V27, P65, DOI 10.1016/S0895-6111(02)00048-4; Sertel O, 2009, PATTERN RECOGN, V42, P1093, DOI 10.1016/j.patcog.2008.08.027; Shiraishi J, 2007, MED PHYS, V34, P25, DOI 10.1118/1.2401044; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sinclair R, 2013, BRIT J DERMATOL, V168, P1, DOI 10.1111/bjd.12167; Sng J, 2009, J AM ACAD DERMATOL, V61, P426, DOI 10.1016/j.jaad.2009.03.031; Su May Hsu, 2003, Lincoln Laboratory Journal, V14, P145; TAMURA H, 1978, IEEE T SYST MAN CYB, V8, P460, DOI 10.1109/TSMC.1978.4309999; Tan E, 2010, BRIT J DERMATOL, V162, P803, DOI 10.1111/j.1365-2133.2010.09673.x; Thomson MA, 2005, BRIT J DERMATOL, V153, P453, DOI 10.1111/j.1365-2133.2005.06730.x; UMBAUGH SE, 1991, IEEE ENG MED BIOL, V10, P57, DOI 10.1109/51.107171; Vapnik V., 2013, NATURE STAT LAERNING; Wallace VP, 2000, PHYS MED BIOL, V45, P735, DOI 10.1088/0031-9155/45/3/312; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wormanns D, 2002, EUR RADIOL, V12, P1052, DOI 10.1007/s003300101126; Youl PH, 2007, CLIN EXP DERMATOL, V32, P365, DOI 10.1111/j.1365-2230.2007.02414.x; Zagrouba E., 2004, Image Analysis & Stereology, V23, P121, DOI 10.5566/ias.v23.p121-135	60	71	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e76212	10.1371/journal.pone.0076212	http://dx.doi.org/10.1371/journal.pone.0076212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223698	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400005
J	Hilbe, C; Nowak, MA; Traulsen, A				Hilbe, Christian; Nowak, Martin A.; Traulsen, Arne			Adaptive Dynamics of Extortion and Compliance	PLOS ONE			English	Article							CONTINUOUS PRISONERS-DILEMMA; TIT-FOR-TAT; STRATEGIES; COOPERATION; EVOLUTION; EMERGENCE; GAME	Direct reciprocity is a mechanism for the evolution of cooperation. For the iterated prisoner's dilemma, a new class of strategies has recently been described, the so-called zero-determinant strategies. Using such a strategy, a player can unilaterally enforce a linear relationship between his own payoff and the co-player's payoff. In particular the player may act in such a way that it becomes optimal for the co-player to cooperate unconditionally. In this way, a player can manipulate and extort his co-player, thereby ensuring that the own payoff never falls below the co-player's payoff. However, using a compliant strategy instead, a player can also ensure that his own payoff never exceeds the co-player's payoff. Here, we use adaptive dynamics to study when evolution leads to extortion and when it leads to compliance. We find a remarkable cyclic dynamics: in sufficiently large populations, extortioners play a transient role, helping the population to move from selfish strategies to compliance. Compliant strategies, however, can be subverted by altruists, which in turn give rise to selfish strategies. Whether cooperative strategies are favored in the long run critically depends on the size of the population; we show that cooperation is most abundant in large populations, in which case average payoffs approach the social optimum. Our results are not restricted to the case of the prisoners dilemma, but can be extended to other social dilemmas, such as the snowdrift game. Iterated social dilemmas in large populations do not lead to the evolution of strategies that aim to dominate their co-player. Instead, generosity succeeds.	[Hilbe, Christian; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany; [Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Max Planck Society; Harvard University	Hilbe, C (corresponding author), Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany.	hilbe@evolbio.mpg.de	Hilbe, Christian/K-9412-2013; Traulsen, Arne/A-4955-2009	Hilbe, Christian/0000-0001-5116-955X; Traulsen, Arne/0000-0002-0669-5267				Adami C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3193; Akin E., 2013, ARXIV12110969V2; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Ball P, 2012, NATURE, DOI [10.1038/nature.2012.11254, DOI 10.1038/NATURE.2012.11254]; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Boerlijst MC, 1997, AM MATH MON, V104, P303, DOI 10.2307/2974578; BOYD R, 1987, NATURE, V327, P58, DOI 10.1038/327058a0; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; FREAN MR, 1994, P ROY SOC B-BIOL SCI, V257, P75, DOI 10.1098/rspb.1994.0096; FRIEDMAN JW, 1971, REV ECON STUD, V38, P1, DOI 10.2307/2296617; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hauert C, 1997, P ROY SOC B-BIOL SCI, V264, P513, DOI 10.1098/rspb.1997.0073; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Hilbe C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00458; Hilbe C, 2011, B MATH BIOL, V73, P2068, DOI 10.1007/s11538-010-9608-2; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Imhof LA, 2010, P ROY SOC B-BIOL SCI, V277, P463, DOI 10.1098/rspb.2009.1171; Killingback T, 2002, AM NAT, V160, P421, DOI 10.1086/342070; Killingback T, 1999, NATURE, V400, P518, DOI 10.1038/22913; Lessard S, 2011, DYN GAMES APPL, V1, P301, DOI 10.1007/s13235-011-0014-7; Metz J. A. J., 1996, STOCHASTIC SPATIAL S, P183; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; MOLANDER P, 1985, J CONFLICT RESOLUT, V29, P611, DOI 10.1177/0022002785029004004; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rapoport A, 1965, PRISONERS DILEMMA; Roberts G, 1998, NATURE, V394, P175, DOI 10.1038/28160; Roemheld L, 2013, ARXIV13082576; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Stewart AJ, 2013, P NATL ACAD IN PRESS; Stewart AJ, 2012, P NATL ACAD SCI USA, V109, P10134, DOI 10.1073/pnas.1208087109; Sugden R, 1986, EC RIGHTS COOPERATIO; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; Wahl LM, 1999, J THEOR BIOL, V200, P323, DOI 10.1006/jtbi.1999.0997; Wahl LM, 1999, J THEOR BIOL, V200, P307, DOI 10.1006/jtbi.1999.0996; Wu B, 2012, J MATH BIOL, V64, P803, DOI 10.1007/s00285-011-0430-8	46	64	65	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77886	10.1371/journal.pone.0077886	http://dx.doi.org/10.1371/journal.pone.0077886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245XZ	24223739	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300013
J	Doyle, TJ; Goodin, K; Hamilton, JJ				Doyle, Timothy J.; Goodin, Kate; Hamilton, Janet J.			Maternal and Neonatal Outcomes among Pregnant Women with 2009 Pandemic Influenza A(H1N1) Illness in Florida, 2009-2010: A Population-Based Cohort Study	PLOS ONE			English	Article							H1N1 VIRUS-INFECTION; RISK-FACTOR; A H1N1; INFANT-DEATH; OBESITY; HOSPITALIZATION	Introduction: Pregnant women have been identified as a high risk group for severe illness with 2009 pandemic influenza A(H1N1) virus infection (pH1N1). Obesity has also been identified as a risk factor for severe illness, though this has not been thoroughly assessed among pregnant women. The objectives of this study were to provide risk estimates for adverse maternal and neonatal outcomes associated with pH1N1 illness during pregnancy and to assess the role of obesity in these outcomes. Methods: We established a retrospective population-based cohort of all live births occurring in Florida during the first 15 months of the pandemic. Illness with pH1N1 during pregnancy was ascertained through record linkage with the Florida state notifiable disease surveillance database. Data from the birth record, including pre-pregnancy body mass index, were analyzed to assess risk of adverse outcomes associated with pH1N1 illness. Results: A total of 194 women were identified through surveillance with pH1N1 illness during pregnancy. Children born to women with pH1N1 illness during pregnancy were at increased risk for low birth weight [OR (95% CI): 1.78 (1.11-2.860)], premature birth [2.21 (1.47-3.330)], and infant death [4.46 (1.80-11.00)], after adjusting for other factors. Women with pH1N1 illness during pregnancy were at increased risk for severe outcomes including admission to an intensive care unit. Obesity was an observed risk factor, both for the more severe pH1N1 illness detected through surveillance, and for severe maternal outcomes. Conclusions: Case-patients in this analysis likely represent the most severely ill subset of all women infected with pH1N1 during pregnancy, limiting the generalizability of these findings to more severely ill patients rather than influenza infection in general. Nevertheless, these results suggest that more severe pH1N1 illness during pregnancy is associated with adverse neonatal outcomes and that pregnant women should continue to be targeted for appropriate prophylaxis and early treatment.	[Doyle, Timothy J.; Goodin, Kate; Hamilton, Janet J.] Florida Dept Hlth, Bur Epidemiol, Tallahassee, FL USA; [Doyle, Timothy J.] Ctr Dis Control & Prevent, Atlanta, GA USA	Florida Department of Health; Centers for Disease Control & Prevention - USA	Doyle, TJ (corresponding author), Florida Dept Hlth, Bur Epidemiol, Tallahassee, FL USA.	tdoyle@cdc.gov	Doyle, Timothy/AAM-3263-2021	Doyle, Timothy/0000-0002-4501-9157				Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS21, DOI 10.1016/j.fertnstert.2008.08.005; [Anonymous], FLOR ADM COD CHAP 64; Burch D, 2012, SEMIN PERINATOL, V36, P31, DOI 10.1053/j.semperi.2011.09.007; Coleman LA, 2013, INFLUENZA OTHER RESP, V7, P160, DOI 10.1111/j.1750-2659.2012.00377.x; Community Health Assessment, TOOL SET RES CHARTS; Cox CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029301; Creanga AA, 2011, AM J OBSTET GYNECOL, V204, pS38, DOI 10.1016/j.ajog.2011.02.037; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dede FS, 2011, BJOG-INT J OBSTET GY, V118, P1216, DOI 10.1111/j.1471-0528.2011.03002.x; Dowse GK, 2011, MED J AUSTRALIA, V194, P68, DOI 10.5694/j.1326-5377.2011.tb04170.x; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Fine A., 2010, Morbidity and Mortality Weekly Report, V59, P321; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fonseca V., 2009, Morbidity and Mortality Weekly Report, V58, P497; Hernandez L, 2009, FLORIDAS PREGNANCY A; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Heyl PS, 2013, MATERN CHILD HLTH J, V17, P1230, DOI 10.1007/s10995-012-1117-5; Huo XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017995; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Knight M, 2011, BJOG-INT J OBSTET GY, V118, P232, DOI 10.1111/j.1471-0528.2010.02736.x; Kroger Andrew T., 2006, Morbidity and Mortality Weekly Report, V55, P1; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lowcock Elizabeth C, 2012, Am J Public Health, V102, pe51, DOI 10.2105/AJPH.2012.300814; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; McNeil SA, 2011, AM J OBSTET GYNECOL, V204, pS54, DOI 10.1016/j.ajog.2011.04.031; Memoli MJ, 2012, INFLUENZA OTHER RESP, DOI [10.1111/irv.12055, DOI 10.1111/IRV.12055.PUBMED:23170853]; Mendez-Figueroa H, 2011, AM J OBSTET GYNECOL, V204, pS58, DOI 10.1016/j.ajog.2011.02.058; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Newsome Kimberly, 2011, Morbidity and Mortality Weekly Report, V60, P1193; Nieman DC, 1999, J AM DIET ASSOC, V99, P294, DOI 10.1016/S0002-8223(99)00077-2; Park S, 2011, MATERN CHILD HLTH J, V15, P851, DOI 10.1007/s10995-009-0544-4; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Schrauwers C, 2009, J MATERN-FETAL NEO M, V22, P218, DOI 10.1080/14767050902801652; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Smith GCS, 2007, AM J PUBLIC HEALTH, V97, P157, DOI 10.2105/AJPH.2005.074294; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Thompson DR, 2008, PUBLIC HEALTH REP, V123, P487, DOI 10.1177/003335490812300410; U.S. Census Bureau, 2010, 2010 CENS DAT; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842	47	58	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79040	10.1371/journal.pone.0079040	http://dx.doi.org/10.1371/journal.pone.0079040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205364	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300089
J	Hardtke-Wolenski, M; Kraus, L; Schmetz, C; Trautewig, B; Noyan, F; Vondran, FWR; Bektas, H; Klempnauer, J; Jaeckel, E; Lieke, T				Hardtke-Wolenski, Matthias; Kraus, Lilli; Schmetz, Christel; Trautewig, Britta; Noyan, Fatih; Vondran, Florian W. R.; Bektas, Hueseyin; Klempnauer, Juergen; Jaeckel, Elmar; Lieke, Thorsten			Exchange of Cytosolic Content between T Cells and Tumor Cells Activates CD4 T Cells and Impedes Cancer Growth	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; V-BETA USAGE; ESTABLISHED MELANOMA; IMMUNE-RESPONSE; LYMPHOCYTES; EXPRESSION; TOLERANCE; INFECTION; BINDING; HUMANS	Background: T cells are known to participate in the response to tumor cells and react with cytotoxicity and cytokine release. At the same time tumors established versatile mechanisms for silencing the immune responses. The interplay is far from being completely understood. In this study we show contacts between tumor cells and lymphocytes revealing novel characteristics in the interaction of T cells and cancer cells in a way not previously described. Methods/Findings: Experiments are based on the usage of a hydrophilic fluorescent dye that occurs free in the cytosol and thus transfer of fluorescent cytosol from one cell to the other can be observed using flow cytometry. Tumor cells from cell lines of different origin or primary hepatocellular carcinoma (HCC) cells were incubated with lymphocytes from human and mice. This exposure provoked a contact dependent uptake of tumor derived cytosol by lymphocytes - even in CD4(+) T cells and murine B cells - which could not be detected after incubation of lymphocytes with healthy cells. The interaction was a direct one, not requiring the presence of accessory cells, but independent of cytotoxicity and TCR engagement. Electron microscopy disclosed 100-200 nm large gaps in the cell membranes of connected cells which separated viable and revealed astonishing outcome. While the lymphocytes were induced to proliferate in a long term fashion, the tumor cells underwent a temporary break in cell division. The in vitro results were confirmed in vivo using a murine acute lymphoblastic leukemia (ALL) model. The arrest of tumor proliferation resulted in a significant prolonged survival of challenged mice. Conclusions: The reported cell-cell contacts reveal new characteristics i.e. the enabling of cytosol flow between the cells including biological active proteins that influence the cell cycle and biological behaviour of the recipient cells. This adds a completely new aspect in tumor induced immunology.	[Hardtke-Wolenski, Matthias; Noyan, Fatih; Jaeckel, Elmar] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Kraus, Lilli; Trautewig, Britta; Klempnauer, Juergen] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Hannover, Germany; [Schmetz, Christel] Bernhard Nocht Inst Trop Med, Parasitol Sect, D-20359 Hamburg, Germany; [Vondran, Florian W. R.; Bektas, Hueseyin; Lieke, Thorsten] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, Hannover, Germany	Hannover Medical School; Hannover Medical School; Bernhard Nocht Institut fur Tropenmedizin; Hannover Medical School	Lieke, T (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, Hannover, Germany.	lieke.thorsten@mh-hannover.de	Noyan, Fatih/B-9449-2018; Hardtke-Wolenski, Matthias/I-2993-2019	Hardtke-Wolenski, Matthias/0000-0002-2827-7787	Novartis Pharma GmbH; HILF grant of the Hannover Medical School	Novartis Pharma GmbH; HILF grant of the Hannover Medical School	This work was funded by Novartis Pharma GmbH and the HILF grant of the Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkwright PD, 2010, CELL RES, V20, P72, DOI 10.1038/cr.2009.112; Blohm U, 2002, J IMMUNOL, V169, P5522, DOI 10.4049/jimmunol.169.10.5522; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Finn OJ, 2008, J IMMUNOL, V181, P1589, DOI 10.4049/jimmunol.181.3.1589; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; KAEFFER B, 1990, INT J CANCER, V46, P481, DOI 10.1002/ijc.2910460326; KURT RA, 1995, J IMMUNOL, V154, P3969; Kurt RA, 2000, INT IMMUNOL, V12, P639, DOI 10.1093/intimm/12.5.639; Lee BS, 1997, HEPATOLOGY, V25, P913, DOI 10.1002/hep.510250421; Lee KH, 1998, J IMMUNOL, V161, P4183; Lieke T, 2004, INT J MED MICROBIOL, V293, P72; Lieke T, 2011, PARASITOLOGY, P1; MARANO N, 1989, J IMMUNOL, V143, P931; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; MELIEF CJM, 1989, COLD SH Q B, V54, P597; Musgrave BL, 2003, J INTERF CYTOK RES, V23, P67, DOI 10.1089/107999003321455462; Noyan F, 2012, CANCER GENE THER, V19, P352, DOI 10.1038/cgt.2012.8; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Poschke I, 2011, CANCER IMMUNOL IMMUN, V60, P1161, DOI 10.1007/s00262-011-1012-8; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stevanovic S, 2012, LEUKEMIA, V26, P312, DOI 10.1038/leu.2011.222; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stripecke R, 1998, HUM GENE THER, V9, P2049, DOI 10.1089/hum.1998.9.14-2049; Ueda H, 2011, P NATL ACAD SCI USA, V108, P17099, DOI 10.1073/pnas.1113703108; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; WEINHOLD KJ, 1979, J EXP MED, V149, P732, DOI 10.1084/jem.149.3.732; WEINHOLD KJ, 1977, NATURE, V270, P59, DOI 10.1038/270059a0; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Zhang Y, 2012, IMMUNOLOGY	39	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78558	10.1371/journal.pone.0078558	http://dx.doi.org/10.1371/journal.pone.0078558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205259	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300067
J	Hu, JY; Wang, GH; Liu, XT; Zhou, LN; Jiang, ML; Yang, L				Hu, Jinyue; Wang, Guihua; Liu, Xueting; Zhou, Lina; Jiang, Manli; Yang, Li			Polo-Like Kinase 1 (PLK1) Is Involved in Toll-like Receptor (TLR)-Mediated TNF-alpha Production in Monocytic THP-1 Cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; APOPTOSIS; SECRETION; IMMUNITY; INNATE	Polo-like kinases (PLKs) have been reported to be essential components of anti-viral pathways. However, the role of PLKs in the production of pro-inflammatory cytokines induced by TLR activation is uncertain. We report here that monocytic THP-1 cells expressed PLK1, PLK2, PLK3 and PLK4. When THP-1 cells were treated with GW843682X, an inhibitor of PLK1 and PLK3, the results showed that GW843682X down-regulated Pam3CSK4- and LPS-induced TNF-alpha at both the gene and protein levels. GW843682X did not impact Pam3CSK4-induced IL-1 beta and IL-8 or LPS-induced IL-1 beta, but it down-regulated LPS-induced IL-8 significantly. Moreover, western blot results showed that TLRs activated PLK1, and PLK1 inhibition by RNA interference down-regulated Pam3CSK4-induced TNF-alpha production, suggesting the involvement of PLK1 in TNF-alpha up-regulation. In addition, GW843682X treatment for 12 to 24 h induced cell death and down-regulated MyD88, but neither of these roles contributed to the down-regulation of TNF-alpha, as TNF-alpha gene expression was up-regulated at 1 h. Furthermore, GW843682X inhibited Pam3CSK4-induced activation of ERK and NF-kappa B, which contributed to Pam3CSK4-induced up-regulation of TNF-alpha. GW843682X also inhibited LPS-induced activation of ERK, p38 and NF-kappa B, which contributed to LPS-induced up-regulation of TNF-alpha. Taken together, these results suggested that PLK1 is involved in TLR2- and TLR4-induced inflammation, and GW843682X may be valuable for the regulation of the inflammatory response.	[Hu, Jinyue; Liu, Xueting; Jiang, Manli] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Wang, Guihua] Changsha Cent Hosp, Ctr Canc, Changsha, Hunan, Peoples R China; [Zhou, Lina] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan 430072, Hubei, Peoples R China; [Yang, Li] Changsha Cent Hosp, TB Res Ctr, Changsha, Hunan, Peoples R China	Wuhan University	Hu, JY (corresponding author), Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.	jinyueh@yahoo.com; YL7618@126.com			National Natural Science Foundation of China [81172042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81172042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Du Q, 2012, J SURG RES, V173, P354, DOI 10.1016/j.jss.2010.10.016; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Feng YB, 2009, INT J CANCER, V124, P578, DOI 10.1002/ijc.23990; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koida N, 2008, J BIOL CHEM, V283, P8555, DOI 10.1074/jbc.M710608200; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Ma L, 2012, J BIOL CHEM, V287, P40502, DOI 10.1074/jbc.M112.413245; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Martin BT, 2006, CELL CYCLE, V5, P2881, DOI 10.4161/cc.5.24.3538; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Masuda Y, 2003, ONCOGENE, V22, P1012, DOI 10.1038/sj.onc.1206200; Noman Abu Shadat M, 2009, Innate Immun, V15, P33, DOI 10.1177/1753425908099317; Parsons SA, 2006, J LEUKOCYTE BIOL, V80, P1522, DOI 10.1189/jlb.0506350; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Steiner TS, 2010, CELL IMMUNOL, V264, P135, DOI 10.1016/j.cellimm.2010.05.012; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao SS, 2012, AM J RESP CELL MOL, V46, P660, DOI 10.1165/rcmb.2011-0340OC; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xiao Z, 2011, J CELL BIOCHEM, V112, P2257, DOI 10.1002/jcb.23144; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375	28	24	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78832	10.1371/journal.pone.0078832	http://dx.doi.org/10.1371/journal.pone.0078832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205328	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300163
J	Buiting, HM; Terpstra, W; Dalhuisen, F; Gunnink-Boonstra, N; Sonke, GS; den Hartogh, G				Buiting, Hilde M.; Terpstra, Wim; Dalhuisen, Floriske; Gunnink-Boonstra, Nicolette; Sonke, Gabe S.; den Hartogh, Govert			The Facilitating Role of Chemotherapy in the Palliative Phase of Cancer: Qualitative Interviews with Advanced Cancer Patients	PLOS ONE			English	Article							SHARED DECISION-MAKING; OF-LIFE CARE; BREAST-CANCER; HEALTH-CARE; END; AGGRESSIVENESS; COMMUNICATION; PERSPECTIVES; DISCUSSIONS; PROGNOSIS	Objective: To explore the extent to which patients have a directing role in decisions about chemotherapy in the palliative phase of cancer and (want to) anticipate on the last stage of life. Design: Qualitative interview study. Methods: In depth-interviews with 15 patients with advanced colorectal or breast cancer at the medical oncology department in a Dutch teaching hospital; interviews were analysed following the principles of thematic content-analysis. Results: All patients reported to know that the chemotherapy they received was with palliative intent. Most of them did not express the wish for information about (other) treatment options and put great trust in their physicians' treatment advice. The more patients were aware of the severity of their disease, the more they seemed to 'live their life' in the present and enjoy things besides having cancer. Such living in the present seemed to be facilitated by the use of chemotherapy. Patients often considered the 'chemotherapy-free period' more stressful than periods when receiving chemotherapy despite their generally improved physical condition. Chemotherapy (regardless of side-effects) seemed to shift patients' attention away from the approaching last stage of life. Interestingly, although patients often discussed advance care planning, they were reluctant to bring on end-of-life issues that bothered them at that specific moment. Expressing real interest in people 'as a person' was considered an important element of appropriate care. Conclusions: Fearing their approaching death, patients deliberately focus on living in the present. Active (chemotherapy) treatment facilitates this focus, regardless of the perceived side-effects. However, if anxiety for what lies ahead is the underlying reason for treatment, efforts should be made in assisting patients to find other ways to cope with this fear. Simultaneously, such an approach may reduce the use of burdensome and sometimes costly treatment in the last stage of life.	[Buiting, Hilde M.; Dalhuisen, Floriske; Sonke, Gabe S.] Comprehens Canc Ctr Netherlands, Dept Registry & Res, Utrecht, Netherlands; [Buiting, Hilde M.; den Hartogh, Govert] Univ Amsterdam, Dept Philosophy, Amsterdam, Netherlands; [Terpstra, Wim; Gunnink-Boonstra, Nicolette] Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands; [Sonke, Gabe S.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands	University of Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Netherlands Cancer Institute	Buiting, HM (corresponding author), Comprehens Canc Ctr Netherlands, Dept Registry & Res, Utrecht, Netherlands.	h.buiting@iknl.nl		Sonke, Gabe/0000-0001-8088-9628	ZonMw, The Netherlands Organization for Health Research and Development [70-71300-98-048]; Comprehensive Cancer Centre The Netherlands	ZonMw, The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Comprehensive Cancer Centre The Netherlands	This study was supported by a grant from ZonMw, The Netherlands Organization for Health Research and Development. Grant number: 70-71300-98-048. The study was further supported by the Comprehensive Cancer Centre The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Balboni T, 2011, CANCER-AM CANCER SOC, V117, P5383, DOI 10.1002/cncr.26221; Barclay S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4862; Bensing J, 2013, PATIENT EDUC COUNS, V90, P287, DOI 10.1016/j.pec.2013.01.005; Buiting HM, 2011, J PAIN SYMPTOM MANAG, V42, P32, DOI 10.1016/j.jpainsymman.2010.10.260; Buiting HM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1933; Buiting HM, 2011, PALLIATIVE MED, V25, P83, DOI 10.1177/0269216310382589; Cardoso F, 2002, ANN ONCOL, V13, P197, DOI 10.1093/annonc/mdf101; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Clayton JM, 2007, J CLIN ONCOL, V25, P715, DOI 10.1200/JCO.2006.06.7827; Clayton JM, 2013, PALLIATIVE MED, V27, P236, DOI 10.1177/0269216312449683; de Kort S, 2009, THESIS; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Grant L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4859; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P740, DOI 10.1136/bmj.315.7110.740; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Kiely BE, 2011, J CLIN ONCOL, V29, P456, DOI 10.1200/JCO.2010.30.2174; Mack JW, 2012, J CLIN ONCOL, V30, P2715, DOI 10.1200/JCO.2012.42.4564; Mack JW, 2012, ANN INTERN MED, V156, P204, DOI 10.7326/0003-4819-156-3-201202070-00008; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Nappa U, 2011, ANN ONCOL, V22, P2375, DOI 10.1093/annonc/mdq778; Oostendorp LJM, 2011, LANCET ONCOL, V12, P1053, DOI 10.1016/S1470-2045(11)70045-6; Pasman HRW, 2009, J PAIN SYMPTOM MANAG, V38, P145, DOI 10.1016/j.jpainsymman.2008.07.008; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ritchie J, 2007, QUALITATIVE RES PRAC, P336; Schuette W, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-14; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; SULMASY DP, 1994, J MED ETHICS, V20, P218, DOI 10.1136/jme.20.4.218; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; van Laarhoven HWM, 2011, J PAIN SYMPTOM MANAG, V41, P1048, DOI 10.1016/j.jpainsymman.2010.08.015; van Vliet L, 2013, PATIENT EDUC COUNS, V90, P315, DOI 10.1016/j.pec.2011.03.021; Walczak A, 2013, PATIENT EDUC COUNS, V90, P307, DOI 10.1016/j.pec.2011.08.009; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Weinfurt KP, 2013, NEW ENGL J MED, V368, P479, DOI 10.1056/NEJMc1214249	40	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77959	10.1371/journal.pone.0077959	http://dx.doi.org/10.1371/journal.pone.0077959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223130	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200022
J	Loewen, MA; Irmis, RB; Sertich, JJW; Currie, PJ; Sampson, SD				Loewen, Mark A.; Irmis, Randall B.; Sertich, Joseph J. W.; Currie, Philip J.; Sampson, Scott D.			Tyrant Dinosaur Evolution Tracks the Rise and Fall of Late Cretaceous Oceans	PLOS ONE			English	Article							CRANIAL OSTEOLOGY; UTAH IMPLICATIONS; GEOGRAPHIC RANGE; THEROPOD; ORIGIN	The Late Cretaceous (similar to 95-66 million years ago) western North American landmass of Laramidia displayed heightened non-marine vertebrate diversity and intracontinental regionalism relative to other latest Cretaceous Laurasian ecosystems. Processes generating these patterns during this interval remain poorly understood despite their presumed role in the diversification of many clades. Tyrannosauridae, a clade of large-bodied theropod dinosaurs restricted to the Late Cretaceous of Laramidia and Asia, represents an ideal group for investigating Laramidian patterns of evolution. We use new tyrannosaurid discoveries from Utah-including a new taxon which represents the geologically oldest member of the clade-to investigate the evolution and biogeography of Tyrannosauridae. These data suggest a Laramidian origin for Tyrannosauridae, and implicate sea-level related controls in the isolation, diversification, and dispersal of this and many other Late Cretaceous vertebrate clades.	[Loewen, Mark A.; Irmis, Randall B.; Sampson, Scott D.] Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT USA; [Loewen, Mark A.; Irmis, Randall B.; Sampson, Scott D.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Sertich, Joseph J. W.; Sampson, Scott D.] Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO USA; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Alberta	Loewen, MA (corresponding author), Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT USA.	mloewen@nhmu.utah.edu	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161	National Science Foundation [EAR 0745454]; Bureau of Land Management; Natural History Museum of Utah	National Science Foundation(National Science Foundation (NSF)); Bureau of Land Management; Natural History Museum of Utah	Fieldwork and research were funded by the National Science Foundation (EAR 0745454), the Bureau of Land Management, and the Natural History Museum of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnosky AD, 2005, PLOS BIOL, V3, P1356, DOI 10.1371/journal.pbio.0030266; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Bell PR, 2011, ACTA PALAEONTOL POL, V56, P703, DOI 10.4202/app.2010.0061; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2011, AM MUS NOVIT, P1, DOI 10.1206/3717.2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, J VERTEBR PALEONTOL, V30, P1, DOI 10.1080/02724630903413032; Edwards AWF, 1992, LIKELIHOOD; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042135; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; Hutchison J. Howard, 2013, P295; Irmis Randall B., 2013, P424; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Jinnah ZA, 2009, CRETACEOUS RES, V30, P287, DOI 10.1016/j.cretres.2008.07.012; Kauffman E.G., 1977, Mountain Geologist, V14, P75; Kirschbaum M. A., 1995, US GEOLOGICAL SURVEY, V1561, P1; Lehman Thomas M., 1997, P223; Li D, 2009, P ROY SOC LOND B BIO, V277, P183; Liu Yongqing, 2011, Dixue Qianyuan, V18, P9; Lyson TR, 2009, J PALEONTOL, V83, P833, DOI 10.1666/09-035.1; Maddison WP, 2011, MESQUITE MODULAR SYS; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; O'Leary MA, 2008, MORPHOBANK 2 5 WEB A; Osborn HF, 1906, B AM MUS NAT HIST, V22, P281; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Padian Kevin, 1993, Bulletin of the New Mexico Museum of Natural History and Science, V3, P379; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts Eric M., 2013, P85; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 2005, J VERTEBR PALEONTOL, V25, P469, DOI 10.1671/0272-4634(2005)025[0469:TRFTUC]2.0.CO;2; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; SERENO PC, 2005, PHYLOINFORMATICS, V8, P1, DOI DOI 10.5281/ZENODO.59797; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Thomson TJ, 2013, CRETACEOUS RES, V43, P70, DOI 10.1016/j.cretres.2013.02.006; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; VONHUENE F, 1914, ANIMALIA FOSSILIUM C, V4, P1; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Walker J.D., 2012, GEOLOGIC TIME SCALE, DOI [10.1130/2012.CTS004R3C, DOI 10.1130/2012.CTS004R3C]; Webb L, 1981, DESERET NEWS    0903; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5	66	90	96	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79420	10.1371/journal.pone.0079420	http://dx.doi.org/10.1371/journal.pone.0079420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223179	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200071
J	Yonekura, K; Watanabe, M; Kageyama, Y; Hirata, K; Yamamoto, M; Maki-Yonekura, S				Yonekura, Koji; Watanabe, Masahiro; Kageyama, Yuko; Hirata, Kunio; Yamamoto, Masaki; Maki-Yonekura, Saori			Post-Transcriptional Regulator Hfq Binds Catalase HPII: Crystal Structure of the Complex	PLOS ONE			English	Article							RNA CHAPERONE HFQ; SM-LIKE PROTEINS; ESCHERICHIA-COLI; MOLECULAR-GRAPHICS; FLAGELLAR MOTOR; RPOS; TRANSCRIPTION; TRANSLATION; IDENTIFICATION; SEQUENCE	We report a crystal structure of Hfq and catalase HPII from Escherichia coli. The post-transcriptional regulator Hfq plays a key role in the survival of bacteria under stress. A small non-coding RNA (sRNA) DsrA is required for translation of the stationary phase sigma factor RpoS, which is the central regulator of the general stress response. Hfq facilitates efficient translation of rpoS mRNA, which encodes RpoS. Hfq helps in the function of other specific proteins involved in RNA processing, indicating its versatility in the cell. However, structural information regarding its interactions with partners is missing. Here we obtained crystals of Hfq and HPII complexes from cell lysates following attempts to overexpress a foreign membrane protein. HPII is one of two catalases in E. coli and its mRNA is transcribed by an RNA polymerase holoenzyme containing RpoS, which in turn is under positive control of small non-coding RNAs and of the RNA chaperone Hfq. This sigma factor is known to have a pronounced effect on the expression of HPII. The crystal structure reveals that a Hfq hexamer binds each subunit of a HPII tetramer. Each subunit of the Hfq hexamer exhibits a unique binding mode with HPII. The hexamer of Hfq interacts via its distal surface. The proximal and distal surfaces are known to specifically bind different sRNAs, and binding of HPII could affect Hfq function. Hfq-HPII complexation has no effect on catalase HPII activity.	[Yonekura, Koji; Watanabe, Masahiro; Kageyama, Yuko] RIKEN, SPring Ctr 8, Biostruct Mech Lab, Sayo, Hyogo, Japan; [Maki-Yonekura, Saori] RIKEN, SPring Ctr 8, Biospecimen Platform Grp, Sayo, Hyogo, Japan; [Hirata, Kunio; Yamamoto, Masaki] RIKEN, SPring Ctr 8, Res Infrastruct Grp, Sayo, Hyogo, Japan	RIKEN; RIKEN; RIKEN	Yonekura, K (corresponding author), RIKEN, SPring Ctr 8, Biostruct Mech Lab, Sayo, Hyogo, Japan.	yone@spring8.or.jp	YONEKURA, Koji/N-5060-2015; Yamamoto, Masaki/B-7844-2015	Yamamoto, Masaki/0000-0002-1311-1768; Yonekura, Koji/0000-0001-5520-4391; Watanabe, Masahiro/0000-0001-5211-1333	Ministry of Education, Culture, Sports, Science and Technology of JAPAN [20370064, 24657111]	Ministry of Education, Culture, Sports, Science and Technology of JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by Grant-in-aid No. 20370064 and 24657111 by the Ministry of Education, Culture, Sports, Science and Technology of JAPAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Beich-Frandsen M, 2011, ACTA CRYSTALLOGR F, V67, P536, DOI 10.1107/S174430911100786X; Bravo J, 1999, PROTEINS, V34, P155, DOI 10.1002/(SICI)1097-0134(19990201)34:2<155::AID-PROT1>3.0.CO;2-P; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franze de Fernandez M T, 1972, J Biol Chem, V247, P824; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hirata K, 2010, AIP CONF PROC, V1234, P901, DOI 10.1063/1.3463362; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lease RA, 2004, J MOL BIOL, V344, P1211, DOI 10.1016/j.jmb.2004.10.006; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Li Yi, 2007, J Biomol Tech, V18, P185; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; LOEWEN PC, 1984, J BACTERIOL, V160, P668, DOI 10.1128/JB.160.2.668-675.1984; LOEWEN PC, 1986, BIOCHEM CELL BIOL, V64, P638, DOI 10.1139/o86-088; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Melik-Adamyan W, 2001, PROTEINS, V44, P270, DOI 10.1002/prot.1092; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Mulvey MR, 1989, NUCL ACIDS RES, V17, P9979; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Scofield DG, 2008, MOL BIOL EVOL, V25, P2255, DOI 10.1093/molbev/msn175; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vassilieva IM, 2002, MOL BIOL+, V36, P785, DOI 10.1023/A:1021621623503; Vincent HA, 2012, J MOL BIOL, V420, P56, DOI 10.1016/j.jmb.2012.03.028; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang WW, 2011, GENE DEV, V25, P2106, DOI 10.1101/gad.16746011; Yonekura K, 2006, J MOL BIOL, V357, P73, DOI 10.1016/j.jmb.2005.12.041; Yonekura K, 2011, J BACTERIOL, V193, P3863, DOI 10.1128/JB.05021-11	41	5	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78216	10.1371/journal.pone.0078216	http://dx.doi.org/10.1371/journal.pone.0078216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223139	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200031
J	Zhao, YJ; Tang, L; Rennaker, R; Hutchens, C; Ibrahim, TS				Zhao, Yujuan; Tang, Lin; Rennaker, Robert; Hutchens, Chris; Ibrahim, Tamer S.			Studies in RF Power Communication, SAR, and Temperature Elevation in Wireless Implantable Neural Interfaces	PLOS ONE			English	Article							BRAIN-MACHINE INTERFACES; 0.25-MM 2-D MODEL; HIGH-FIELD MRI; RETINAL STIMULATOR; COMPUTER INTERFACE; THERMAL ELEVATION; HUMAN EYE; ABLATION; ANTENNAS; HEAD	Implantable neural interfaces are designed to provide a high spatial and temporal precision control signal implementing high degree of freedom real-time prosthetic systems. The development of a Radio Frequency (RF) wireless neural interface has the potential to expand the number of applications as well as extend the robustness and longevity compared to wired neural interfaces. However, it is well known that RF signal is absorbed by the body and can result in tissue heating. In this work, numerical studies with analytical validations are performed to provide an assessment of power, heating and specific absorption rate (SAR) associated with the wireless RF transmitting within the human head. The receiving antenna on the neural interface is designed with different geometries and modeled at a range of implanted depths within the brain in order to estimate the maximum receiving power without violating SAR and tissue temperature elevation safety regulations. Based on the size of the designed antenna, sets of frequencies between 1 GHz to 4 GHz have been investigated. As expected the simulations demonstrate that longer receiving antennas (dipole) and lower working frequencies result in greater power availability prior to violating SAR regulations. For a 15 mm dipole antenna operating at 1.24 GHz on the surface of the brain, 730 uW of power could be harvested at the Federal Communications Commission (FCC) SAR violation limit. At approximately 5 cm inside the head, this same antenna would receive 190 uW of power prior to violating SAR regulations. Finally, the 3-D bio-heat simulation results show that for all evaluated antennas and frequency combinations we reach FCC SAR limits well before 1 degrees C. It is clear that powering neural interfaces via RF is possible, but ultra-low power circuit designs combined with advanced simulation will be required to develop a functional antenna that meets all system requirements.	[Zhao, Yujuan; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA; [Tang, Lin] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA; [Rennaker, Robert] Univ Texas Dallas, Erik Jonsson Sch Engn, Richardson, TX 75083 USA; [Hutchens, Chris] Oklahoma State Univ, Sch Elect & Comp Engn, Stillwater, OK 74078 USA; [Ibrahim, Tamer S.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma - Norman; University of Texas System; University of Texas Dallas; Oklahoma State University System; Oklahoma State University - Stillwater; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA.	tibrahim@pitt.edu	Hutchens, Chriswell/F-1472-2016; Rennaker II, Robert/K-9049-2013	Rennaker II, Robert/0000-0003-1260-1973	National Institutes of Health [R01NS062065]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institutes of Health Grant R01NS062065 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreuccetti D., 1997, CALCULATION DIELECTR; Balanis C. A., 2005, ANTENNA THEORY ANAL; BALANIS CA, 1989, DVANCED ENG ELECTROM; Bashirullah R, 2007, IEEE INT SYMP CIRC S, P2084, DOI 10.1109/ISCAS.2007.378509; Bell CJ, 2008, J NEURAL ENG, V5, P214, DOI 10.1088/1741-2560/5/2/012; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Bernardi P, 2004, IEEE T MICROW THEORY, V52, P1978, DOI 10.1109/TMTT.2004.832031; Bjorninen T, 2012, IEEE ANTENN WIREL PR, V11, P1663, DOI 10.1109/LAWP.2013.2239252; Borton DA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026010; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chase SM, 2012, J NEUROPHYSIOL, V108, P624, DOI 10.1152/jn.00371.2011; CHEN JY, 1992, IEEE T BIO-MED ENG, V39, P209, DOI 10.1109/10.125005; CHENG DK, 2001, FIELD WAVE ELECTROMA; Chow EY, 2013, IEEE MICROW MAG, V14, P64, DOI 10.1109/MMM.2013.2248586; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; DeMarco SC, 2003, IEEE T ANTENN PROPAG, V51, P2274, DOI 10.1109/TAP.2003.816395; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; *FCC, 1996, FCC POL HUM EXP RAD; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Gilja V, 2012, NAT NEUROSCI, V15, P1752, DOI 10.1038/nn.3265; Gosalia K, 2004, IEEE T MICROW THEORY, V52, P1925, DOI 10.1109/TMTT.2004.832007; GRIFFITHS JRJ, 2011, RF COILS MRI; Gu ZJ, 1999, IEEE T BIO-MED ENG, V46, P1480, DOI 10.1109/10.804576; Hall PS, 2012, ARTECH HSE ANTENN PR, P1; Harrison RR, 2009, IEEE T NEUR SYS REH, V17, P322, DOI 10.1109/TNSRE.2009.2023298; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hutchens C, 2011, IEEE ENG MED BIO, P2886, DOI 10.1109/IEMBS.2011.6090796; Ibrahim TS, 2007, J MAGN RESON IMAGING, V26, P1362, DOI 10.1002/jmri.21148; Ibrahim TS, 2007, ANN BIOMED ENG, V35, P825, DOI 10.1007/s10439-007-9264-3; Ibrahim TS, 2009, NMR BIOMED, V22, P927, DOI 10.1002/nbm.1406; Ibrahim TS, 2001, PHYS MED BIOL, V46, P2545, DOI 10.1088/0031-9155/46/10/303; Ibrahim TS, 2005, IEEE T BIO-MED ENG, V52, P1278, DOI 10.1109/TBME.2005.847564; Ibrahim TS, 2001, MAGN RESON IMAGING, V19, P1339, DOI 10.1016/S0730-725X(01)00404-0; Ibrahim TS, 2001, MAGN RESON IMAGING, V19, P219, DOI 10.1016/S0730-725X(01)00300-9; Kang G, 2002, PHYS MED BIOL, V47, P4301, DOI 10.1088/0031-9155/47/23/314; Kim J, 2004, IEEE T MICROW THEORY, V52, P1934, DOI 10.1109/TMTT.2004.832018; Kim S, 2007, IEEE T NEUR SYS REH, V15, P493, DOI 10.1109/TNSRE.2007.908429; Kiourti A, 2012, IEEE ANTENN PROPAG M, V54, P210, DOI 10.1109/MAP.2012.6293992; Lazzi G, 2005, IEEE ENG MED BIOL, V24, P75, DOI 10.1109/MEMB.2005.1511503; Lazzi G, 2003, IEEE T ANTENN PROPAG, V51, P2286, DOI 10.1109/TAP.2003.816394; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Makinen R, 2002, MICROW OPT TECHN LET, V34, P193, DOI 10.1002/mop.10415; MALONEY JG, 1994, IEEE T ANTENN PROPAG, V42, P289, DOI 10.1109/8.277228; Mojarradi M, 2003, IEEE T NEUR SYS REH, V11, P38, DOI 10.1109/TNSRE.2003.810431; Mussa-Ivaldi FA, 2003, TRENDS NEUROSCI, V26, P329, DOI 10.1016/S0166-2236(03)00121-8; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Oh S, 2010, MAGN RESON MED, V63, P218, DOI 10.1002/mrm.22174; Petersen R, 2006, IEEE ANTENN PROPAG M, V48, P129, DOI 10.1109/MAP.2006.1715260; Poon ASY, 2010, IEEE T ANTENN PROPAG, V58, P1739, DOI 10.1109/TAP.2010.2044310; Rappaport C, 2004, INT J HYPERTHER, V20, P769, DOI 10.1080/02656730412331286885; Schwerdt HN, 2013, IEEE T MICROW THEORY, V61, P2170, DOI 10.1109/TMTT.2013.2252916; Shock SA, 2004, RADIOLOGY, V231, P143, DOI 10.1148/radiol.2311021342; Sitaram R., 2007, COMPUTATIONAL INTELL; Tai CT, 2000, IEEE T ANTENN PROPAG, V48, P1501, DOI 10.1109/8.899665; Wang ZW, 2007, J MAGN RESON IMAGING, V26, P437, DOI 10.1002/jmri.20977; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yakovlev A, 2012, IEEE COMMUN MAG, V50, P152, DOI 10.1109/MCOM.2012.6178849; 1999, NOMINATIONS FDAS CTR	59	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77759	10.1371/journal.pone.0077759	http://dx.doi.org/10.1371/journal.pone.0077759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223123	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000326656200015
J	Hall, HI; Halverson, J; Wilson, DP; Suligoi, B; Diez, M; Le Vu, S; Tang, T; McDonald, A; Camoni, L; Semaille, C; Archibald, C				Hall, H. Irene; Halverson, Jessica; Wilson, David P.; Suligoi, Barbara; Diez, Mercedes; Le Vu, Stephane; Tang, Tian; McDonald, Ann; Camoni, Laura; Semaille, Caroline; Archibald, Chris			Late Diagnosis and Entry to Care after Diagnosis of Human Immunodeficiency Virus Infection: A Country Comparison	PLOS ONE			English	Article							HIV-INFECTION; ANTIRETROVIRAL TREATMENT; EARLY RETENTION; VIRAL LOAD; TRANSMISSION; RECOMMENDATIONS; AUSTRALIA; SOCIETY; THERAPY	Background: Testing for HIV infection and entry to care are the first steps in the continuum of care that benefit individual health and may reduce onward transmission of HIV. We determined the percentage of people with HIV who were diagnosed late and the percentage linked into care overall and by demographic and risk characteristics by country. Methods: Data were analyzed from national HIV surveillance systems. Six countries, where available, provided data on two late diagnosis indicators (AIDS diagnosis within 3 months of HIV diagnosis, and AIDS diagnosis within 12 months before HIV diagnosis) and linkage to care (>= 1 CD4 or viral load test result within 3 months of HIV diagnosis) for people diagnosed with HIV in 2009 or 2010 (most recent year data were available). Principal Findings: The percentage of people presenting with late stage disease at HIV diagnosis varied by country, overall with a range from 28.7% (United States) to 8.8% (Canada), and by transmission categories. The percentage of people diagnosed with AIDS who had their initial HIV diagnosis within 12 months before AIDS diagnosis varied little among countries, except the percentages were somewhat lower in Spain and the United States. Overall, the majority of people diagnosed with HIV were linked to HIV care within 3 months of diagnosis (more than 70%), but varied by age and transmission category. Conclusions: Differences in patterns of late presentation at HIV diagnosis among countries may reflect differences in screening practices by providers, public health agencies, and people with HIV. The percentage of people who received assessments of immune status and viral load within 3 months of diagnosis was generally high.	[Hall, H. Irene] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Halverson, Jessica; Archibald, Chris] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Wilson, David P.; McDonald, Ann] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Suligoi, Barbara; Camoni, Laura] Ist Super Sanita, I-00161 Rome, Italy; [Diez, Mercedes] Ctr Nacl Epidemiol, Secretaria Plan Nacl Sida, Madrid, Spain; [Le Vu, Stephane; Semaille, Caroline] Inst Veille Sanit, St Maurice, France; [Tang, Tian] ICF Marcro Int, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Public Health Agency of Canada; University of New South Wales Sydney; Kirby Institute; Istituto Superiore di Sanita (ISS); Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Institute of Public Health Surveillance	Hall, HI (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	ixh1@cdc.gov	SULIGOI, BARBARA/C-6494-2016; CAMONI, LAURA/C-6483-2016; Suligoi, Barbara/O-6490-2019	CAMONI, LAURA/0000-0001-9007-6479; Suligoi, Barbara/0000-0001-9623-7659; Le Vu, Stephane/0000-0002-1303-8281				Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Antinori A, 2010, ANTIVIR THER, V15, P31, DOI 10.3851/IMP1525; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; British Columbia Centre for Disease Control, 2011, ADV HIV DIS TIM HIV; Cazein F., 2011, Bulletin Epidemiologique Hebdomadaire, P446; Centers for Disease Control and Prevention, 2012, 17 CDCP HIV SURV S A; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Department of agriculture forestry and fisheries, 2012, GUID US ANT AG HIV 1, P1; Diez M, 2012, GAC SANIT, V26, P107, DOI 10.1016/j.gaceta.2011.07.023; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; [European Centre for Disease Prevention and Control WHO Regional Office for Europe], 2011, HIV AIDS SURV EUR 20; de Olalla PG, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-22; Gray KM, 2013, AM J PUBLIC HEALTH, V103, P141, DOI 10.2105/AJPH.2012.300859; Guy RJ, 2008, SEX HEALTH, V5, P91, DOI 10.1071/SH07070; Guy RJ, 2007, MED J AUSTRALIA, V187, P437, DOI 10.5694/j.1326-5377.2007.tb01353.x; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jauffret-Roustide M, 2006, SUBST USE MISUSE, V41, P1603, DOI 10.1080/10826080600847951; Johnson M, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1522; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Lot F, 2004, Euro Surveill, V9, P7, DOI 10.2807/esm.09.10.00481-en; McDonald AM, 2003, AUST NZ J PUBL HEAL, V27, P608, DOI 10.1111/j.1467-842X.2003.tb00607.x; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Oliva J, 2010, ENFERM INFEC MICR CL, V28, P583, DOI 10.1016/j.eimc.2010.02.013; Plitt SS, 2009, AIDS PATIENT CARE ST, V23, P93, DOI 10.1089/apc.2007.0238; Public Health Agency of Canada, 2012, HIV AIDS CAN SURV RE; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rank C, 2009, 18 ANN CAN C HIV AID; Sabin CA, 2010, AIDS, V24, P723, DOI 10.1097/QAD.0b013e328333fa0f; Smith JC., 2012, INCOME POVERTY HLTH; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132	40	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77763	10.1371/journal.pone.0077763	http://dx.doi.org/10.1371/journal.pone.0077763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223724	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400012
J	Mui, LWH; Chan, AYS; Lee, A; Lee, J				Mui, Lancelot W. H.; Chan, Alvin Y. S.; Lee, Albert; Lee, John			Cross-Sectional Study on Attitudes among General Practitioners towards Pneumococcal Vaccination for Middle-Aged and Elderly Population in Hong Kong	PLOS ONE			English	Article							PHARMACEUTICAL-INDUSTRY; CLINICAL EFFECTIVENESS; MYOCARDIAL-INFARCTION; HEALTH-PROMOTION; OLDER-PEOPLE; BARRIERS; RISK; AUSTRALIA; KNOWLEDGE; COVERAGE	Objective: To study the attitudes among general practitioners towards pneumococcal vaccination for middle-aged (50-64) and elderly population (over 65) in Hong Kong and the factors affecting their decision to advise pneumococcal vaccination for those age groups. Design: Cross-sectional study of general practitioners in private practice in Hong Kong. Participants: Members of Hong Kong Medical Association delivering general practice services in private sector. Measuring Tool: Self-administered questionnaire. Main Outcome Measures: Intention to recommend pneumococcal vaccination, barriers against pneumococcal vaccination. Results: 53.4% of the respondents would actively recommend pneumococcal vaccination to elderly patients but only 18.8% would recommend for middle-aged patients. Consultation not related to pneumococcal vaccine was the main reason for not recommending pneumococcal vaccine (43.6%). Rarity of pneumonia in their daily practice was another reason with 68.4% of respondents attending five or less patients with pneumonia each year. In multivariate analysis, factors such as respondents would get vaccination when reaching age 50 (ORm 10.1), and attending 6 pneumonia cases or more per year (ORm 2.28) were found to be associated with increasing likelihood for recommending vaccination to the middle-aged. While concerns of marketing a product (ORm 0.41), consultation not related to vaccination (ORm 0.45) and limited time (ORm 0.38) were factors that reduced the likelihood. Conclusion: Public policy is needed to increase the awareness of impact of pneumococcal pneumonia and the availability of preventive measures.	[Mui, Lancelot W. H.; Lee, Albert; Lee, John] Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chan, Alvin Y. S.] Hong Kong Med Assoc, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Lee, A (corresponding author), Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	alee@cuhk.edu.hk			Hong Kong Medical Association Health Education Fund	Hong Kong Medical Association Health Education Fund	This project is supported by The Hong Kong Medical Association Health Education Fund. The Hong Kong Medical Association Task Force on Vaccination PPI is involved in the design of the questionnaire and assisted in data collection.	Achhra A, 2009, AUST FAM PHYSICIAN, V38, P605; Allender S, 2012, HEALTH PROMOT INT, V27, P261, DOI 10.1093/heapro/dar018; Andrews RM, 2005, VACCINE, V23, P2756, DOI 10.1016/j.vaccine.2004.11.039; Andrews RM, 2004, VACCINE, V23, P132, DOI 10.1016/j.vaccine.2004.06.016; Badertscher N, 2012, INT J GEN MED, V5, P967, DOI 10.2147/IJGM.S38472; Bovier PA, 2001, VACCINE, V19, P4760, DOI 10.1016/S0264-410X(01)00223-7; Breen KJ, 2004, MED J AUSTRALIA, V180, P409, DOI 10.5694/j.1326-5377.2004.tb05994.x; Brotons C, 2005, PREV MED, V40, P595, DOI 10.1016/j.ypmed.2004.07.020; Department of Health, 2012, PNEUM; Department of Health, 2011, PNEUM INF; Department of Health, 2012, HLTH FACTS HONG KONG; Forrest J M, 2000, Commun Dis Intell, V24, P89; Halsey NA, 2007, CLIN INFECT DIS, V44, pE104, DOI 10.1086/519541; Holt T, 2010, RADCLIFFE SERIES, P87; Immunisation Program, 2009, GUID IMM PRACT LOC G; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Keating KM, 2008, J ADOLESCENT HEALTH, V43, pS61, DOI 10.1016/j.jadohealth.2008.06.015; Komesaroff PA, 2002, MED J AUSTRALIA, V176, P118, DOI 10.5694/j.1326-5377.2002.tb04318.x; Lamontagne F, 2008, CAN MED ASSOC J, V179, P773, DOI 10.1503/cmaj.070221; Lee A, 2012, 50 ANN MULT C; Lee Albert, 2007, J Urban Health, V84, pi75; Lee Albert, 2010, Hong Kong Medical Journal, V16, P106; Lo YY., 2010, HK PRACT, V32, P17; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Nori A, 2009, AUST FAM PHYSICIAN, V38, P891; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Ridda I, 2008, VACCINE, V26, P5633, DOI 10.1016/j.vaccine.2008.07.070; Ridda I, 2009, VACCINE, V27, P3775, DOI 10.1016/j.vaccine.2009.03.075; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Scottish Executive, 2003, PNEUM VACC PEOPL AG; Sharp Merck, 2012, PNEUM 23; Thornton H, 2010, J EPIDEMIOL COMMUN H, V64, P101, DOI 10.1136/jech.2009.090829; van Achterberg T, 2011, HEALTH PROMOT INT, V26, P148, DOI 10.1093/heapro/daq050; Vila-Corcoles A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-222; Vila-Corcoles A, 2009, VACCINE, V27, P1504, DOI 10.1016/j.vaccine.2009.01.013; Wyeth Pharmaceuticals Inc, 2012, PREVN 13; Wynia MK, 1999, NEW ENGL J MED, V341, P1612, DOI 10.1056/NEJM199911183412112; Zimmerman RK, 2003, VACCINE, V21, P1510, DOI 10.1016/S0264-410X(02)00698-9	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78210	10.1371/journal.pone.0078210	http://dx.doi.org/10.1371/journal.pone.0078210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223775	Green Submitted, gold, Green Published			2022-12-27	WOS:000326597400019
J	Shah, SM; Carey, IM; Harris, T; DeWilde, S; Victor, CR; Cook, DG				Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Victor, Christina R.; Cook, Derek G.			Initiation of Psychotropic Medication after Partner Bereavement: A Matched Cohort Study	PLOS ONE			English	Article							OLDER-PEOPLE; HEALTH; DSM-5; DEPRESSION; VALIDATION; EXCLUSION; DATABASE	Background: Recent changes to diagnostic criteria for depression in DSM-5 remove the bereavement exclusion, allowing earlier diagnosis following bereavement. Evaluation of the potential effect of this change requires an understanding of existing psychotropic medication prescribing by non-specialists after bereavement. Aims: To describe initiation of psychotropic medication in the first year after partner bereavement. Methods: In a UK primary care database, we identified 21,122 individuals aged 60 and over with partner bereavement and no psychotropic drug use in the previous year. Prescribing (anxiolytic/hypnotic, antidepressant, antipsychotic) after bereavement was compared to age, sex and practice matched controls. Results: The risks of receiving a new psychotropic prescription within two and twelve months of bereavement were 9.5% (95% CI 9.1 to 9.9%) and 17.9% (17.3 to 18.4%) respectively; an excess risk of initiation in the first year of 12.4% compared to non-bereaved controls. Anxiolytic/hypnotic and antidepressant initiation rates were highest in the first two months. In this period, the hazard ratio for initiation of anxiolytics/hypnotics was 16.7 (95% CI 14.7 to 18.9) and for antidepressants was 5.6 (4.7 to 6.7) compared to non-bereaved controls. 13.3% of those started on anxiolytics/hypnotics within two months continued to receive this drug class at one year. The marked variation in background family practice prescribing of anxiolytics/hypnotics was the strongest determinant of their initiation in the first two months after bereavement. Conclusion: Almost one in five older people received a new psychotropic drug prescription in the year after bereavement. The early increase and trend in antidepressant use after bereavement suggests some clinicians did not adhere to the bereavement exclusion, with implications for its recent removal in DSM-5. Family practice variation in use of anxiolytics/hypnotics suggests uncertainty over their role in bereavement with the potential for inappropriate long term use.	[Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Cook, Derek G.] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Victor, Christina R.] Brunel Univ, Sch Hlth Sci & Social Care, Uxbridge UB8 3PH, Middx, England	St Georges University London; Brunel University	Shah, SM (corresponding author), St Georges Univ London, Div Populat Hlth Sci & Educ, London, England.	sushah@sgul.ac.uk	Carey, Iain/O-6973-2014; Cook, Derek G/C-3271-2008	Carey, Iain/0000-0003-1099-8460; Cook, Derek/0000-0002-9723-5759; Harris, Tess/0000-0002-8671-1553; Victor, Christina/0000-0002-4213-3974; DeWilde, Stephen/0000-0002-4238-4474	Dunhill Medical Trust [R169/0710]; The Dunhill Medical Trust [R169/0710] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); The Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported by The Dunhill Medical Trust (grant number R169/0710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourke Alison, 2004, Inform Prim Care, V12, P171; Brown Gary, 2010, Health Stat Q, P58, DOI 10.1057/hsq.2010.21; Bui Eric, 2012, Dialogues Clin Neurosci, V14, P149; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook JM, 2007, ARCH INTERN MED, V167, P2006, DOI 10.1001/archinte.167.18.2006; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Editorial, 2012, LANCET, V379, P589; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Forte Amanda L, 2004, BMC Palliat Care, V3, P3, DOI 10.1186/1472-684X-3-3; Fosbol EL, 2013, EUR HEART J, V34, P649, DOI 10.1093/eurheartj/ehs242; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Illich I., 1976, MED NEMESIS EXPROPRI; Joint Formulary Committee, 2012, BRIT NATL FORMULARY; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Mojtabai R, 2011, ARCH GEN PSYCHIAT, V68, P920, DOI 10.1001/archgenpsychiatry.2011.95; Moller J, 2011, AGING MENT HEALTH, V15, P259, DOI 10.1080/13607863.2010.513041; National Institute for Health and Clinical Excellence, 2009, DEPR AD TREATM MAN D; Shah SM, 2013, AM J PUBLIC HEALTH, V103, P1140, DOI 10.2105/AJPH.2012.301050; Shah SM, 2012, AM J EPIDEMIOL, V176, P689, DOI 10.1093/aje/kws162; Shah SM, 2010, AGE AGEING, V39, P617, DOI 10.1093/ageing/afq086; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; TOWNSEND P, 1998, HLTH DEPRIVATION INE; Wakefield JC, 2012, WORLD PSYCHIATRY, V11, P3, DOI 10.1016/j.wpsyc.2012.01.002; Warner J, 2001, BRIT J PSYCHIAT, V178, P36, DOI 10.1192/bjp.178.1.36; Zisook S, 2007, PSYCHOL MED, V37, P779, DOI 10.1017/S0033291707009865; Zisook S, 2012, DEPRESS ANXIETY, V29, P425, DOI 10.1002/da.21927	26	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77734	10.1371/journal.pone.0077734	http://dx.doi.org/10.1371/journal.pone.0077734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223722	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400011
J	Vaugeois, M; Diaz, F; Carlotti, F				Vaugeois, Maxime; Diaz, Frederic; Carlotti, Francois			A Mechanistic Individual-Based Model of the Feeding Processes for Oikopleura dioica	PLOS ONE			English	Article							FUNCTIONAL-RESPONSE; GRAZING IMPACT; APPENDICULARIAN; TUNICATA; FOOD; HOUSE; SIZE; VANHOEFFENI; WATERS; PARTICLES	A mechanistic physiological model of the appendicularian Oikopleura dioica has been built to represent its three feeding processes (filtration, ingestion and assimilation). The mathematical formulation of these processes is based on laboratory observations from the literature, and tests different hypotheses. This model accounts for house formation dynamics, the food storage capacity of the house and the gut throughput dynamics. The half-saturation coefficient for ingestion resulting from model simulations is approximately 28 mu gCl(-1) and is independent of the weight of the organism. The maximum food intake for ingestion is also a property of the model and depends on the weight of the organism. Both are in accordance with data from the literature. The model also provides a realistic representation of carbon accumulation within the house. The modelled half-saturation coefficient for assimilation is approximately 15 mu gCl(-1) and is also independent of the weight of the organism. Modelled gut throughput dynamics are based on faecal pellet formation by gut compaction. Model outputs showed that below a food concentration of 30 mu gCl(-1), the faecal pellet weight should represent a lower proportion of the body weight of the organism, meaning that the faecal pellet formation is not driven by gut filling. Simulations using fluctuating environmental food availability show that food depletion is not immediately experienced by the organism but that it occurs after a lag time because of house and gut buffering abilities. This lag time duration lasts at least 30 minutes and can reach more than 2 hours, depending on when the food depletion occurs during the house lifespan.	[Vaugeois, Maxime; Diaz, Frederic; Carlotti, Francois] Aix Marseille Univ, French Natl Ctr Sci Research, INSU, IRD,Mediterranean Inst Oceanog,UM 110, Marseille, France; [Vaugeois, Maxime; Diaz, Frederic; Carlotti, Francois] Univ Toulon & Var, CNRS, INSU, IRD,Mediterranean Inst Oceanog,UM 110, La Garde, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon	Vaugeois, M (corresponding author), Aix Marseille Univ, French Natl Ctr Sci Research, INSU, IRD,Mediterranean Inst Oceanog,UM 110, Marseille, France.	maxime.vaugeois@univ-amu.fr	Vaugeois, Maxime/ABD-6118-2020	Vaugeois, Maxime/0000-0002-3599-4506; Diaz, Frederic/0000-0002-2456-6733	Ministere de l'Education Nationale, de la Recherche et de la Technologie	Ministere de l'Education Nationale, de la Recherche et de la Technologie	MV is financed by a Ministere de l'Education Nationale, de la Recherche et de la Technologie Ph.D. grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna JL, 2000, LIMNOL OCEANOGR, V45, P608, DOI 10.4319/lo.2000.45.3.0608; ALLDREDGE AL, 1976, LIMNOL OCEANOGR, V21, P14, DOI 10.4319/lo.1976.21.1.0014; ALLDREDGE AL, 1981, LIMNOL OCEANOGR, V26, P247, DOI 10.4319/lo.1981.26.2.0247; BEDO AW, 1993, B MAR SCI, V53, P2; BELISLE CJP, 1992, J APPL PROBAB, V29, P885, DOI 10.2307/3214721; Berline L, 2011, J PLANKTON RES, V33, P855, DOI 10.1093/plankt/fbq163; Bochdansky AB, 1999, LIMNOL OCEANOGR, V44, P415, DOI 10.4319/lo.1999.44.2.0415; Broms F, 2003, J PLANKTON RES, V25, P573, DOI 10.1093/plankt/25.5.573; Burighel P, 2001, INVERTEBR BIOL, V120, P278, DOI 10.1111/j.1744-7410.2001.tb00038.x; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Capitanio FL, 2005, J APPL ICHTHYOL, V21, P414, DOI 10.1111/j.1439-0426.2005.00657.x; Cima F, 2002, MAR BIOL, V141, P479, DOI 10.1007/s00227-002-0850-5; Dagg MJ, 2004, RESPONSE MARINE ECOS, P293; Deibel, 2004, RESPONSE MARINE ECOS, P309; Deibel D., 1998, P139; DEIBEL D, 1992, MAR ECOL PROG SER, V88, P297, DOI 10.3354/meps088297; DEIBEL D, 1988, MAR BIOL, V99, P177, DOI 10.1007/BF00391979; Fenaux R., 1985, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V29, P291; FENAUX R, 1985, B MAR SCI, V37, P498; Fenaux R., 1998, P251; FENAUX R, 1986, ZOOMORPHOLOGY, V106, P224, DOI 10.1007/BF00312043; FENAUX R, 1979, ANN I OCEANOGR PARIS, V55, P195; Fernandez D, 2004, MAR ECOL PROG SER, V266, P89, DOI 10.3354/meps266089; Flood Per R., 1998, P105; Gorsky G., 1998, P161; Hansen JLS, 1996, MAR ECOL PROG SER, V141, P205, DOI 10.3354/meps141205; King KR, 1980, MAR BIOL, V27, P886; Lombard F, 2006, THESIS U PARIS 6, P6; Lombard F, 2010, DEEP-SEA RES PT I, V57, P1304, DOI 10.1016/j.dsr.2010.06.008; Lombard F, 2009, J MARINE SYST, V78, P606, DOI 10.1016/j.jmarsys.2009.01.004; Lombard F, 2009, J MARINE SYST, V78, P617, DOI 10.1016/j.jmarsys.2009.01.005; Lopez-Urrutia A, 2003, MAR ECOL PROG SER, V252, P125, DOI 10.3354/meps252125; Lopez-Urrutia A, 2003, MAR ECOL PROG SER, V252, P143, DOI 10.3354/meps252143; Lopez-Urrutia A, 1999, MAR ECOL PROG SER, V191, P195, DOI 10.3354/meps191195; PAFFENHOFER GA, 1973, MAR BIOL, V22, P183, DOI 10.1007/BF00391782; PURCELL J.E., 2004, RESPONSE MARINE ECOS, P359; Sato R, 2003, MAR ECOL PROG SER, V259, P163, DOI 10.3354/meps259163; Sato R, 2001, J PLANKTON RES, V23, P415, DOI 10.1093/plankt/23.4.415; Selander E, 2003, MAR BIOL, V142, P263, DOI 10.1007/s00227-002-0949-8; Tiselius P, 2003, MAR BIOL, V142, P253, DOI 10.1007/s00227-002-0961-z; Touratier F, 2003, MAR ECOL PROG SER, V248, P141, DOI 10.3354/meps248141; Troedsson C, 2005, MAR ECOL PROG SER, V289, P165, DOI 10.3354/meps289165; Troedsson C, 2007, LIMNOL OCEANOGR, V52, P416, DOI 10.4319/lo.2007.52.1.0416; UYE S, 1995, J EXP MAR BIOL ECOL, V189, P1, DOI 10.1016/0022-0981(95)00004-B	44	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78255	10.1371/journal.pone.0078255	http://dx.doi.org/10.1371/journal.pone.0078255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223782	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400020
J	Okubo, N; Minami, Y; Fujiwara, H; Umemura, Y; Tsuchiya, Y; Shirai, T; Oda, R; Inokawa, H; Kubo, T; Yagita, K				Okubo, Naoki; Minami, Yoichi; Fujiwara, Hiroyoshi; Umemura, Yasuhiro; Tsuchiya, Yoshiki; Shirai, Toshiharu; Oda, Ryo; Inokawa, Hitoshi; Kubo, Toshikazu; Yagita, Kazuhiro			Prolonged Bioluminescence Monitoring in Mouse Ex Vivo Bone Culture Revealed Persistent Circadian Rhythms in Articular Cartilages and Growth Plates	PLOS ONE			English	Article							GENE-EXPRESSION; PARATHYROID-HORMONE; CLOCK; TRANSCRIPTION; OSCILLATORS; RESORPTION	The bone is a metabolically active organ which undergoes repeated remodeling cycles of bone resorption and formation. In this study, we revealed a robust and extremely long-lasting circadian rhythm in ex vivo culture maintained for over six months from the femoral bone of a PERIOD2(Luciferase) mouse. Furthermore, we also identified robust circadian clocks in flat bones. High- or low-magnification real-time bioluminescence microscopic imaging revealed that the robust circadian rhythms emanated from the articular cartilage and the epiphyseal cartilage within the growth plate of juvenile animals. Stimulation by forskolin or dexamethasone treatment caused type 0 phase resetting, indicating canonical entraining properties of the bone clock. Together, our findings from long-term ex vivo culture revealed that "tissue-autonomous'' circadian rhythm in the articular cartilage and the growth plate of femoral bone functions for several months even in an organ culture condition, and provided a useful in vitro assay system investigating the role of the biological clock in bone formation or development.	[Okubo, Naoki; Minami, Yoichi; Umemura, Yasuhiro; Tsuchiya, Yoshiki; Inokawa, Hitoshi; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Physiol & Syst Biosci, Kyoto, Japan; [Okubo, Naoki; Fujiwara, Hiroyoshi; Shirai, Toshiharu; Oda, Ryo; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto, Japan; [Okubo, Naoki; Minami, Yoichi; Kubo, Toshikazu; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Musculoskeletal Chronobiol, Kyoto, Japan; [Shirai, Toshiharu] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan; [Yagita, Kazuhiro] Japan Sci & Technol Agcy, PREST, Saitama, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kanazawa University; Japan Science & Technology Agency (JST)	Yagita, K (corresponding author), Kyoto Prefectural Univ Med, Dept Physiol & Syst Biosci, Kyoto, Japan.	kyagita@koto.kpu-m.ac.jp		Okubo, Naoki/0000-0001-9405-8462	PRESTO Program of the Japan Science and Technology Agency; JSPS KAKENHI [23390051, 25861335]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23390051] Funding Source: KAKEN	PRESTO Program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by PRESTO Program of the Japan Science and Technology Agency (K.Y.), and by JSPS KAKENHI Grant Number 23390051 (K.Y.) and 25861335 (Y.M.). This work was also supported by the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2000, GENE DEV, V14, P645; Aoshima H, 1998, BONE, V22, P73, DOI 10.1016/S8756-3282(97)00225-1; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; El-Hajj Fuleihan G, 1997, J CLIN ENDOCR METAB, V82, P281, DOI 10.1210/jc.82.1.281; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Izumo M, 2006, PLOS COMPUT BIOL, V2, P1248, DOI 10.1371/journal.pcbi.0020136; Ju HSJ, 1997, CLIN CHEM, V43, P1570; JUBIZ W, 1972, J CLIN INVEST, V51, P2040, DOI 10.1172/JCI107010; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Komoto S, 2012, CHRONOBIOL INT, V29, P66, DOI 10.3109/07420528.2011.636496; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lui JC, 2011, ENDOCR DEV, V20, P187, DOI 10.1159/000321244; Maronde E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011527; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Smith BJ, 2011, OSTEOPOROSIS INT, V22, P1633, DOI 10.1007/s00198-010-1325-z; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Swaminathan R, 2001, CLIN CHIM ACTA, V313, P95, DOI 10.1016/S0009-8981(01)00656-8; Takarada T, 2012, J BIOL CHEM, V287, P36081, DOI 10.1074/jbc.M112.408963; van der Veen DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047692; Vergely N, 2002, BONE, V30, P428, DOI 10.1016/S8756-3282(01)00677-9; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1359/jbmr.061114	38	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78306	10.1371/journal.pone.0078306	http://dx.doi.org/10.1371/journal.pone.0078306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223788	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400049
J	Oliveira-Sales, EB; Maquigussa, E; Semedo, P; Pereira, LG; Ferreira, VM; Camara, NO; Bergamaschi, CT; Campos, RR; Boim, MA				Oliveira-Sales, Elizabeth B.; Maquigussa, Edgar; Semedo, Patricia; Pereira, Luciana G.; Ferreira, Vanessa M.; Camara, Niels O.; Bergamaschi, Cassia T.; Campos, Ruy R.; Boim, Mirian A.			Mesenchymal Stem Cells (MSC) Prevented the Progression of Renovascular Hypertension, Improved Renal Function and Architecture	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ACUTE KIDNEY INJURY; OXIDATIVE STRESS; WATER CHANNELS; BLOOD-PRESSURE; RATS; MECHANISMS; EXPRESSION; 2-KIDNEY; THERAPY	Renovascular hypertension induced by 2 Kidney-1 Clip (2K-1C) is a renin-angiotensin-system (RAS)-dependent model, leading to renal vascular rarefaction and renal failure. RAS inhibitors are not able to reduce arterial pressure (AP) and/or preserve the renal function, and thus, alternative therapies are needed. Three weeks after left renal artery occlusion, fluorescently tagged mesenchymal stem cells (MSC) (2x10(5) cells/animal) were injected weekly into the tail vein in 2K-1C hypertensive rats. Flow cytometry showed labeled MSC in the cortex and medulla of the clipped kidney. MSC prevented a further increase in the AP, significantly reduced proteinuria and decreased sympathetic hyperactivity in 2K-1C rats. Renal function parameters were unchanged, except for an increase in urinary volume observed in 2K-1C rats, which was not corrected by MSC. The treatment improved the morphology and decreased the fibrotic areas in the clipped kidney and also significantly reduced renal vascular rarefaction typical of 2K-1C model. Expression levels of IL-1 beta, TNF-alpha angiotensinogen, ACE, and Ang II receptor AT(1) were elevated, whereas AT(2) levels were decreased in the medulla of the clipped kidney. MSC normalized these expression levels. In conclusion, MSC therapy in the 2K-1C model (i) prevented the progressive increase of AP, (ii) improved renal morphology and microvascular rarefaction, (iii) reduced fibrosis, proteinuria and inflammatory cytokines, (iv) suppressed the intrarenal RAS, iv) decreased sympathetic hyperactivity in anesthetized animals and v) MSC were detected at the CNS suggesting that the cells crossed the blood-brain barrier. This therapy may be a promising strategy to treat renovascular hypertension and its renal consequences in the near future.	[Oliveira-Sales, Elizabeth B.; Maquigussa, Edgar; Semedo, Patricia; Pereira, Luciana G.; Ferreira, Vanessa M.; Boim, Mirian A.] Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil; [Bergamaschi, Cassia T.; Campos, Ruy R.] Univ Fed Sao Paulo, Div Cardiovasc, Dept Physiol, Sao Paulo, Brazil; [Camara, Niels O.] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Boim, MA (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil.	mirian@nefro.epm.br	Campos, Ruy R/H-8339-2017; Bergamaschi, Cassia/AAZ-9441-2020; Boim, Mirian A/L-6574-2013; Semedo-Kuriki, Patricia/D-2429-2010; Maquigussa, Edgar/G-7685-2016; Oliveira-Sales, Elizabeth B/B-5895-2014; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011; Campos, Ruy R R/I-3691-2015	Campos, Ruy R/0000-0002-9404-0817; Oliveira-Sales, Elizabeth B/0000-0003-4129-8643; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Campos, Ruy R R/0000-0002-9404-0817; Maquigussa, Edgar/0000-0003-1756-1579; Bergamaschi, Cassia/0000-0002-5741-6993; Semedo-Kuriki, Patricia/0000-0002-2136-3308	Coordenacao de Aperfeicoamento de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Coordenacao de Aperfeicoamento de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from the Coordenacao de Aperfeicoamento de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli LS, 2012, CAN J PHYSIOL PHARM, V90, P307, DOI [10.1139/Y11-130, 10.1139/y11-130]; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Braga LMGD, 2008, CLIN EXP PHARMACOL P, V35, P113, DOI 10.1111/j.1440-1681.2007.04820.x; Chade AR, 2006, FASEB J, V20, P1706, DOI 10.1096/fj.05-5680fje; Chade AR, 2010, STEM CELLS, V28, P1039, DOI 10.1002/stem.426; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; Chade AR, 2003, ARTERIOSCL THROM VAS, V23, P1295, DOI 10.1161/01.ATV.0000077477.40824.52; Chade AR, 2002, CIRCULATION, V106, P1165, DOI 10.1161/01.CIR.0000027105.02327.48; Glover LE, 2012, TRANSL STROKE RES, V3, P90, DOI 10.1007/s12975-011-0127-8; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Goldblatt H, 1934, J EXP MED, V59, P347, DOI 10.1084/jem.59.3.347; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Imgrund M, 1999, KIDNEY INT, V56, P1423, DOI 10.1046/j.1523-1755.1999.00663.x; Inumaru J, 2009, GENES CELLS, V14, P703, DOI 10.1111/j.1365-2443.2009.01303.x; Lee J, 2001, J KOREAN MED SCI, V16, P462, DOI 10.3346/jkms.2001.16.4.462; Lerman LO, 2005, J LAB CLIN MED, V146, P160, DOI 10.1016/j.lab.2005.05.005; Luan Y, 2012, AM J MED SCI, V343, P402, DOI 10.1097/MAJ.0b013e31822dc5d3; Ma SK, 2009, KIDNEY BLOOD PRESS R, V32, P411, DOI 10.1159/000264232; Maclean S., 2012, STEM CELLS INT, V2012; Mitchell Kenneth D., 1995, P1437; Navar LG, 2011, CURR OPIN PHARMACOL, V11, P180, DOI 10.1016/j.coph.2011.01.009; Navar LG, 1998, NEWS PHYSIOL SCI, V13, P170; Oliveira-Sales EB, 2008, AM J HYPERTENS, V21, P98, DOI 10.1038/ajh.2007.12; Oliveira-Sales EB, 2010, HYPERTENSION, V56, P290, DOI 10.1161/HYPERTENSIONAHA.110.150425; Oliveira-Sales EB, 2009, AM J HYPERTENS, V22, P484, DOI 10.1038/ajh.2009.17; Ploth DW, 1983, AM J PHYSIOL, V245, P131; Prieto-Carrasquero MC, 2008, HYPERTENSION, V51, P1590, DOI 10.1161/HYPERTENSIONAHA.108.110916; RABITO SF, 1981, HYPERTENSION, V3, P34, DOI 10.1161/01.HYP.3.1.34; Semedo P, 2010, LAB INVEST, V90, P685, DOI 10.1038/labinvest.2010.45; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Yerram P, 2012, MINERVA UROL NEFROL, V64, P63; Zhu XY, 2004, ARTERIOSCL THROM VAS, V24, P1854, DOI 10.1161/01.ATV.0000142443.52606.81	34	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78464	10.1371/journal.pone.0078464	http://dx.doi.org/10.1371/journal.pone.0078464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223811	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400064
J	Henry, MJ; Obleser, J				Henry, Molly J.; Obleser, Jonas			Dissociable Neural Response Signatures for Slow Amplitude and Frequency Modulation in Human Auditory Cortex	PLOS ONE			English	Article							STEADY-STATE RESPONSES; SPEECH-INTELLIGIBILITY; PHASE; TONES; DISCRIMINATION; ADAPTATION; PATTERNS; STIMULI; MEG; AM	Natural auditory stimuli are characterized by slow fluctuations in amplitude and frequency. However, the degree to which the neural responses to slow amplitude modulation (AM) and frequency modulation (FM) are capable of conveying independent time-varying information, particularly with respect to speech communication, is unclear. In the current electroencephalography (EEG) study, participants listened to amplitude- and frequency-modulated narrow-band noises with a 3-Hz modulation rate, and the resulting neural responses were compared. Spectral analyses revealed similar spectral amplitude peaks for AM and FM at the stimulation frequency (3 Hz), but amplitude at the second harmonic frequency (6 Hz) was much higher for FM than for AM. Moreover, the phase delay of neural responses with respect to the full-band stimulus envelope was shorter for FM than for AM. Finally, the critical analysis involved classification of single trials as being in response to either AM or FM based on either phase or amplitude information. Time-varying phase, but not amplitude, was sufficient to accurately classify AM and FM stimuli based on single-trial neural responses. Taken together, the current results support the dissociable nature of cortical signatures of slow AM and FM. These cortical signatures potentially provide an efficient means to dissect simultaneously communicated slow temporal and spectral information in acoustic communication signals.	[Henry, Molly J.; Obleser, Jonas] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Auditory Cognit, Leipzig, Germany	Max Planck Society	Henry, MJ (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Auditory Cognit, Leipzig, Germany.	henry@cbs.mpg.de	Obleser, Jonas/C-9891-2011	Obleser, Jonas/0000-0002-7619-0459	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The research was funded by a grant to J.O. from the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN CF, 2013, HEARING RES, P33098; Byrne AJ, 2012, J ACOUST SOC AM, V132, P3375, DOI 10.1121/1.4754531; EDWARDS BW, 1994, J ACOUST SOC AM, V95, P2202, DOI 10.1121/1.408680; EGGERMONT JJ, 1994, HEARING RES, V74, P51, DOI 10.1016/0378-5955(94)90175-9; EGGERMONT JJ, 1979, J ACOUST SOC AM, V65, P463, DOI 10.1121/1.382345; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Geisler CD, 1960, 380 MIT RES LAB EL; Ghitza O, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00340; Greenberg S, 2003, J PHONETICS, V31, P465, DOI 10.1016/j.wocn.2003.09.005; Harrison D., 1988, J APPL STAT, V15, P197, DOI [10.1080/02664768800000026, DOI 10.1080/02664768800000026]; Hart HC, 2003, CEREB CORTEX, V13, P773, DOI 10.1093/cercor/13.7.773; Henry MJ, 2012, P NATL ACAD SCI USA, V109, P20095, DOI 10.1073/pnas.1213390109; HERRMANN B, 2013, J NEUROSCI, P89487; HOUTGAST T, 1985, J ACOUST SOC AM, V77, P1069, DOI 10.1121/1.392224; John MS, 2002, EAR HEARING, V23, P106, DOI 10.1097/00003446-200204000-00004; John MS, 2001, AUDIOL NEURO-OTOL, V6, P12, DOI 10.1159/000046805; John MS, 2000, HEARING RES, V141, P57, DOI 10.1016/S0378-5955(99)00209-9; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; LINS OG, 1995, EVOKED POTENTIAL, V96, P420, DOI 10.1016/0168-5597(95)00048-W; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2006, J NEUROPHYSIOL, V96, P2712, DOI 10.1152/jn.01256.2005; Macmillan NA, 2005, DETECTION THEORY USE; MAISTE A, 1989, EAR HEARING, V10, P153, DOI 10.1097/00003446-198906000-00003; Millman RE, 2010, NEUROIMAGE, V49, P745, DOI 10.1016/j.neuroimage.2009.08.029; MOORE BCJ, 1987, HEARING RES, V28, P209, DOI 10.1016/0378-5955(87)90050-5; Moore BCJ, 1996, J ACOUST SOC AM, V100, P2320, DOI 10.1121/1.417941; MOORE BCJ, 1992, J ACOUST SOC AM, V92, P3119, DOI 10.1121/1.404208; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1722, DOI 10.1121/1.398603; Munhall KG, 2004, PSYCHOL SCI, V15, P133, DOI 10.1111/j.0963-7214.2004.01502010.x; Ng BSW, 2013, CEREB CORTEX, V23, P389, DOI 10.1093/cercor/bhs031; Obleser J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00250; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Patel AD, 2004, CEREB CORTEX, V14, P35, DOI 10.1093/cercor/bhg089; PATTERSON RD, 1992, ADV BIOSCI, V83, P429; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; PICTON TW, 1987, J ACOUST SOC AM, V82, P165, DOI 10.1121/1.395560; REES A, 1986, HEARING RES, V23, P123, DOI 10.1016/0378-5955(86)90009-2; REGAN D, 1979, J ACOUST SOC AM, V65, P1249, DOI 10.1121/1.382792; RICKARDS FW, 1984, EVOKED POTENTIAL, V2, P163; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; SABERI K, 1995, NATURE, V374, P537, DOI 10.1038/374537a0; Sapsford DJ, 1996, ANESTH ANALG, V83, P1273; Slaney M, 1993, APPLE COMPUT PERCEPT, V35; Slaney M., 1998, 10 INT RES CORP; STAPELLS DR, 1984, EAR HEARING, V5, P105, DOI 10.1097/00003446-198403000-00009; TANSLEY BW, 1983, J ACOUST SOC AM, V74, P765, DOI 10.1121/1.389864; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102; Zwicker E., 2013, PSYCHOACOUSTICS FACT; ZWICKER EBERHARD, 1962, JOUR ACOUSTICAL SOC AMER, V34, P1425, DOI 10.1121/1.1918362	53	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78758	10.1371/journal.pone.0078758	http://dx.doi.org/10.1371/journal.pone.0078758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205309	Green Published, gold			2022-12-27	WOS:000326270700096
J	Breschi, GL; Cametti, M; Mastropietro, A; Librizzi, L; Baselli, G; Resnati, G; Metrangolo, P; de Curtis, M				Breschi, Gian Luca; Cametti, Massimo; Mastropietro, Alfonso; Librizzi, Laura; Baselli, Giuseppe; Resnati, Giuseppe; Metrangolo, Pierangelo; de Curtis, Marco			Different Permeability of Potassium Salts across the Blood-Brain Barrier Follows the Hofmeister Series	PLOS ONE			English	Article							GUINEA-PIG BRAIN; IN-VITRO; EPILEPTIFORM DISCHARGES; FLUORIDE; CURRENTS; 4-AMINOPYRIDINE; EPILEPSY; NEURONS; BIOLOGY; SYSTEM	The passage of ions across biological membranes is regulated by passive and active mechanisms. Passive ion diffusion into organs depends on the ion-pairing properties of salts present in the serum. Potassium ions could affect brain activity by crossing the blood-brain barrier (BBB) and its accumulation in the extracellular cerebral space could precipitate seizures. In the present study, we analyze passive diffusion of a series of potassium salts in the in vitro isolated guinea pig brain preparation. Different potassium counter-anions confer ion-pairing and lipophilicity properties that modulate membrane diffusion of the salt. Extracellular recordings in different cortical areas demonstrated the presence of epileptiform activities that strongly relate to anion identity, following the qualitative order of the Hofmeister series. Indeed, highly lipophilic salts that easily cross the BBB enhanced extracellular potassium concentration measured by ion-selective electrodes and were the most effective pro-epileptic species. This study constitutes a novel contribution for the understanding of the potential epileptogenicity of potassium salts and, more generally, of the role of counter-anions in the passive passage of salts through biological membranes.	[Breschi, Gian Luca; Librizzi, Laura; de Curtis, Marco] Fdn Ist Neurol Carlo Besta, Unit Epileptol & Expt Neurophysiol, Milan, Italy; [Breschi, Gian Luca] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Cametti, Massimo; Resnati, Giuseppe; Metrangolo, Pierangelo] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy; [Mastropietro, Alfonso] Fdn Ist Neurol Carlo Besta, Sci Direct Unit, Milan, Italy; [Mastropietro, Alfonso; Baselli, Giuseppe] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy	IRCCS Istituto Neurologico Besta; Istituto Italiano di Tecnologia - IIT; Polytechnic University of Milan; IRCCS Istituto Neurologico Besta; Polytechnic University of Milan	de Curtis, M (corresponding author), Fdn Ist Neurol Carlo Besta, Unit Epileptol & Expt Neurophysiol, Milan, Italy.	decurtis@istituto-besta.it	Cametti, Massimo/F-6644-2013; de Curtis, Marco M/J-8704-2016; Resnati, Giuseppe/C-8650-2011; Cametti, Massimo/O-9808-2019; Metrangolo, Pierangelo/D-4106-2011; Mastropietro, Alfonso/AAY-7271-2020; Librizzi, Laura/J-7889-2016	Cametti, Massimo/0000-0002-9280-3155; de Curtis, Marco M/0000-0001-7443-6737; Resnati, Giuseppe/0000-0002-0797-9296; Cametti, Massimo/0000-0002-9280-3155; Mastropietro, Alfonso/0000-0003-3358-7111; Librizzi, Laura/0000-0002-2741-4452; METRANGOLO, PIERANGELO/0000-0002-7945-099X; de Curtis, Marco/0000-0002-5608-929X	CARIPLO Foundation [2009-2150]; Italian Ministry of Education, University, and Research; Italian Ministry of Health	CARIPLO Foundation(Fondazione Cariplo); Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	The study was supported by the CARIPLO Foundation grant (project 2009-2150, New Generation Fluorinated Materials as Smart Reporter Agents in 19F-MRI) by the Italian Ministry of Education, University, and Research (project Firb 2010 "Nanostructured Fluorinated Materials as Smart Reporter Agents in 19F MRI)" and by the Italian Ministry of Health (Ricerca Corrente 2009-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Arrhenius S., 1887, Z PHYS CHEM, V1U, P631, DOI [10.1515/zpch-1887-0164, DOI 10.1515/ZPCH-1887-0164]; Avoli M, 1996, J NEUROSCI, V16, P3912; BERTOLLINI L, 1994, NEUROREPORT, V5, P553, DOI 10.1097/00001756-199401000-00005; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; Bostrom M, 2005, LANGMUIR, V21, P2619, DOI 10.1021/la047437v; Bruckner C, 2000, BRAIN RES, V859, P15, DOI 10.1016/S0006-8993(99)02348-3; de Curtis M, 1991, Hippocampus, V1, P341, DOI 10.1002/hipo.450010402; de Curtis M, 1998, BRAIN RES PROTOC, V3, P221, DOI 10.1016/S1385-299X(98)00044-0; DECURTIS M, 1994, NEUROSCIENCE, V59, P775, DOI 10.1016/0306-4522(94)90194-5; Frohlich F, 2008, COMPUTATIONAL NEUROSCIENCE IN EPILEPSY, P419, DOI 10.1016/B978-012373649-9.50029-6; Gnatkovsky V, 2008, ANN NEUROL, V64, P674, DOI 10.1002/ana.21519; HERMANN A, 1981, J GEN PHYSIOL, V78, P63, DOI 10.1085/jgp.78.1.63; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; KAY AR, 1986, J NEUROSCI, V6, P2915; Kunz W, 2010, CURR OPIN COLLOID IN, V15, P34, DOI 10.1016/j.cocis.2009.11.008; Lee G, 2001, PHARMACOL REV, V53, P569; Librizzi L, 2001, J NEUROSCI RES, V66, P289, DOI 10.1002/jnr.1223; LLINAS R, 1981, FED PROC, V40, P2240; Marchi N, 2012, EPILEPSIA, V53, P1877, DOI 10.1111/j.1528-1167.2012.03637.x; Mazzetti S, 2004, BRAIN RES, V999, P81, DOI 10.1016/j.brainres.2003.11.032; MCIVOR ME, 1990, DRUG SAFETY, V5, P79, DOI 10.2165/00002018-199005020-00001; Miller JM, 2010, MOL PHARMACEUT, V7, P1223, DOI 10.1021/mp100050d; Miller JM, 2009, J CONTROL RELEASE, V137, P31, DOI 10.1016/j.jconrel.2009.02.018; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MUHLETHALER M, 1993, EUR J NEUROSCI, V5, P915, DOI 10.1111/j.1460-9568.1993.tb00942.x; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Pardridge William M, 2003, Methods Mol Med, V89, P385; Peruzzi N, 2012, J PHYS CHEM B, V116, P14398, DOI 10.1021/jp309157x; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Uva L, 2008, NEUROSCIENCE, V151, P303, DOI 10.1016/j.neuroscience.2007.10.037; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	40	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78553	10.1371/journal.pone.0078553	http://dx.doi.org/10.1371/journal.pone.0078553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205257	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200057
J	Soto-Arias, JP; Groves, R; Barak, JD				Soto-Arias, Jose Pablo; Groves, Russell; Barak, Jeri D.			Interaction of Phytophagous Insects with Salmonella enterica on Plants and Enhanced Persistence of the Pathogen with Macrosteles quadrilineatus Infestation or Frankliniella occidentalis Feeding	PLOS ONE			English	Article							ESCHERICHIA-COLI O157/H7; THRIPS THYSANOPTERA; COLONIZATION; LETTUCE; OUTBREAK; VECTOR; INTERNALIZATION; TRANSMISSION; ARABIDOPSIS; MECHANISMS	Recently, most foodborne illness outbreaks of salmonellosis have been caused by consumption of contaminated fresh produce. Yet, the mechanisms that allow the human pathogen Salmonella enterica to contaminate and grow in plant environments remain poorly described. We examined the effect of feeding by phytophagous insects on survival of S. enterica on lettuce. Larger S. enterica populations were found on leaves infested with Macrosteles quadrilineatus. In contrast, pathogen populations among plants exposed to Frankliniella occidentalis or Myzus persicae were similar to those without insects. However, on plants infested with F. occidentalis, areas of the infested leaf with feeding damage sustained higher S. enterica populations than areas without damage. The spatial distribution of S. enterica cells on leaves infested with F. occidentalis may be altered resulting in higher populations in feeding lesions or survival may be different across a leaf dependent on local damage. Results suggest the possibility of some specificity with select insects and the persistence of S. enterica. Additionally, we demonstrated the potential for phytophagous insects to become contaminated with S. enterica from contaminated plant material. S. enterica was detected in approximately 50% of all M. quadrilineatus, F. occidentalis, and M. persicae after 24 h exposure to contaminated leaves. Particularly, 17% of F. occidentalis, the smallest of the insects tested, harbored more than 10(2) CFU/F. occidentalis. Our results show that phytophagous insects may influence the population dynamics of S. enterica in agricultural crops. This study provides evidence of a human bacterial pathogen interacting with phytophagous insect during plant infestation.	[Soto-Arias, Jose Pablo; Barak, Jeri D.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Groves, Russell] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Barak, JD (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	barak@plantpath.wisc.edu		Dundore-Arias, Jose Pablo (JP)/0000-0002-4944-0125	USDA-Hatch grant [WIS01574]	USDA-Hatch grant	This work was partially supported by USDA-Hatch grant WIS01574 to JDB and RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe H, 2008, PLANT CELL PHYSIOL, V49, P68, DOI 10.1093/pcp/pcm168; [Anonymous], 2010, R LANG ENV STAT COMP; Aruscavage D, 2008, J FOOD PROTECT, V71, P2384, DOI 10.4315/0362-028X-71.12.2384; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001657; Barak JD, 2012, ANNU REV PHYTOPATHOL, V50, P241, DOI 10.1146/annurev-phyto-081211-172936; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Batz M. B. S., 2011, FOOD SAFETY RES CONS; Beanland L, 2005, ANN ENTOMOL SOC AM, V98, P756, DOI 10.1603/0013-8746(2005)098[0756:TDOALS]2.0.CO;2; Blazar Jeffrey M., 2011, Terrestrial Arthropod Reviews, V4, P5, DOI 10.1163/187498311X543989; CHISHOLM IF, 1984, B ENTOMOL RES, V74, P663, DOI 10.1017/S0007485300014048; Cloyd RA., 2009, PEST TECH, V3, P1; Cummings K, 2001, EMERG INFECT DIS, V7, P1046, DOI 10.3201/eid0706.010625; De Vries EJ, 2006, EUR J ENTOMOL, V103, P779, DOI 10.14411/eje.2006.106; Erickson MC, 2010, J FOOD PROTECT, V73, P1809, DOI 10.4315/0362-028X-73.10.1809; Felkey K, 2006, HORTTECHNOLOGY, V16, P253, DOI 10.21273/HORTTECH.16.2.0253; Fletcher J, 2013, PHYTOPATHOLOGY, V103, P306, DOI 10.1094/PHYTO-09-12-0236-IA; Frost KE, 2011, J ECON ENTOMOL, V104, P1800, DOI 10.1603/EC11183; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Gitaitis RD, 2003, PLANT DIS, V87, P675, DOI 10.1094/PDIS.2003.87.6.675; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Hogenhout SA, 2008, CURR OPIN PLANT BIOL, V11, P449, DOI 10.1016/j.pbi.2008.05.007; Inami GB, 1999, J FOOD PROTECT, V62, P662, DOI 10.4315/0362-028X-62.6.662; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Jacobsen CS, 2012, FOOD RES INT, V45, P557, DOI 10.1016/j.foodres.2011.07.026; Jin S, 2012, J INSECT PHYSIOL, V58, P1235, DOI 10.1016/j.jinsphys.2012.06.008; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; KOPANIC RJ, 1994, J FOOD PROTECT, V57, P125, DOI 10.4315/0362-028X-57.2.125; Kwan G, 2013, MBIO, V4, DOI 10.1128/mBio.00557-12; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Mian LS, 2002, J VECTOR ECOL, V27, P82; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mohle-Boetani JC, 2001, ANN INTERN MED, V135, P239, DOI 10.7326/0003-4819-135-4-200108210-00008; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Parker WE, 2002, CROP PROT, V21, P235, DOI 10.1016/S0261-2194(01)00090-4; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08; ULLMAN DE, 1992, PHYTOPATHOLOGY, V82, P1333, DOI 10.1094/Phyto-82-1333; van de Wetering F, 1998, ENTOMOL EXP APPL, V88, P9, DOI 10.1046/j.1570-7458.1998.00340.x; Wasala L, 2013, PHYTOPATHOLOGY, V103, P373, DOI [10.1094/PHYTO-09-12-0217-FI, 10]; Yamazaki A, 2011, APPL ENVIRON MICROB, V77, P156, DOI 10.1128/AEM.01079-10; YUDIN LS, 1988, ENVIRON ENTOMOL, V17, P522, DOI 10.1093/ee/17.3.522; Zheng J, 2013, APPL ENVIRON MICROB, V79, P2494, DOI 10.1128/AEM.03704-12	50	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79404	10.1371/journal.pone.0079404	http://dx.doi.org/10.1371/journal.pone.0079404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205384	Green Submitted, gold, Green Published			2022-12-27	WOS:000326152300094
J	Igarashi, S; Izuchi, S; Ogawa, Y; Yoshimathu, M; Takizawa, K; Nakajima, Y; Tanaka, M; Ishizuka, B; Suzuki, N				Igarashi, Suguru; Izuchi, Shinichirou; Ogawa, Yukihisa; Yoshimathu, Misako; Takizawa, Kenji; Nakajima, Yasuo; Tanaka, Mamoru; Ishizuka, Bunpei; Suzuki, Nao			N-Butyl Cyanoacrylate Is Very Effective for Massive Haemorrhage during the Perinatal Period	PLOS ONE			English	Article							UTERINE ARTERY EMBOLIZATION; POSTPARTUM HEMORRHAGE; PREGNANCY; NECROSIS	Objective: The liquid embolic agent n-butyl cyanoacrylate (NBCA) is a tissue adhesive used as an immediate and permanent embolic agent when mixed with oil-based contrast medium. In this study, the preservation of fertility with TAE using NBCA for massive haemorrhage during pregnancy or the peripartum period and the utility of this therapy were investigated. Methods: Cases from January 2005 to October 2010 in which TAE was performed for massive haemorrhage in pregnant women, particularly during the peripartum period, were investigated. Results: TAE was performed in 27 pregnant women. The embolic agent used was GS only in five cases, NBCA only in 19 cases, and additional embolization with NBCA when the effect with GS was insufficient in three cases, one each of abruptio placentae, cervical pregnancy, and uterine atony. A comparison of mean blood loss when each embolic agent was used for haemostasis showed a significant difference between cases in which GS only was used and cases in which NBCA only was used. In a comparison of mean transfusion volume, a significant difference was seen between cases in which both GS and NBCA were used and cases in which NBCA only was used. In a postoperative follow-up survey, menses resumed in eight patients, including four patients who later became pregnant and three who delivered. Conclusions: TAE with NBCA, which has an embolic effect unrelated to clotting dysfunction for massive haemorrhage during the peripartum period, is a minimally invasive and very effective treatment method for patients with severe DIC.	[Igarashi, Suguru; Tanaka, Mamoru; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Obstet, Kawasaki, Kanagawa, Japan; [Igarashi, Suguru; Tanaka, Mamoru; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Gynecol, Kawasaki, Kanagawa, Japan; [Izuchi, Shinichirou] Rose Ladies Clin, Tokyo, Japan; [Ogawa, Yukihisa; Yoshimathu, Misako; Takizawa, Kenji; Nakajima, Yasuo] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Ishizuka, Bunpei] St Marianna Univ, Sch Med, Dept Adv Reprod Med, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University	Igarashi, S (corresponding author), St Marianna Univ, Sch Med, Dept Obstet, Kawasaki, Kanagawa, Japan.	iganosuke-10@marianna-u.ac.jp						Badawy SZA, 2001, CLIN IMAG, V25, P288, DOI 10.1016/S0899-7071(01)00307-2; BROWN BJ, 1979, OBSTET GYNECOL, V54, P361; Cheng Yung-Yi, 2003, J Chin Med Assoc, V66, P727; Igarashi S, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.04.081; Ornan D, 2003, OBSTET GYNECOL, V102, P904, DOI 10.1016/S0029-7844(03)00769-5; Pelage JP, 1998, RADIOLOGY, V208, P359, DOI 10.1148/radiology.208.2.9680559; Pirard C, 2002, FERTIL STERIL, V78, P412, DOI 10.1016/S0015-0282(02)03229-6; Porcu G, 2005, BJOG-INT J OBSTET GY, V112, P122, DOI 10.1111/j.1471-0528.2005.00306.x; Salomon LJ, 2003, HUM REPROD, V18, P849, DOI 10.1093/humrep/deg168; SCHWARTZ P E, 1975, Gynecologic Oncology, V3, P276, DOI 10.1016/0090-8258(75)90035-9; StancatoPasik A, 1997, RADIOLOGY, V204, P791, DOI 10.1148/radiology.204.3.9280261; Tourne G, 2003, EUR J OBSTET GYN R B, V110, P29, DOI 10.1016/S0301-2115(03)00091-5; Tsai CC, 2006, INT J GYNECOL CANCER, V16, P439, DOI 10.1111/j.1525-1438.2006.00238.x; YAMASHITA Y, 1994, BRIT J RADIOL, V67, P530, DOI 10.1259/0007-1285-67-798-530	14	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77494	10.1371/journal.pone.0077494	http://dx.doi.org/10.1371/journal.pone.0077494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24223099	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400121
J	Conceicao, T; Diamantino, F; Coelho, C; de Lencastre, H; Aires-de-Sousa, M				Conceicao, Teresa; Diamantino, Fernanda; Coelho, Celine; de Lencastre, Herminia; Aires-de-Sousa, Marta			Contamination of Public Buses with MRSA in Lisbon, Portugal: A Possible Transmission Route of Major MRSA Clones within the Community	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; UNITED-STATES; PCR STRATEGY; CHROMOSOME; SEQUENCE; USA300; EPIDEMIOLOGY; SURVEILLANCE	In a previous study we have shown that public buses in Oporto, the second largest city in Portugal, were highly contaminated with MRSA. Here we describe the results of a similar study performed in another urban area of Portugal-Lisbon, the capital. Between May 2011 and May 2012, hand touched surfaces of 199 public buses in Lisbon were screened for MRSA contamination. Subsequently, the hands of 575 passengers who frequently use these bus lines were also screened. All hand carriers of MRSA were further screened for nasal carriage. The isolates were characterized by PFGE, staphylococcal cassette chromosome (SCC) mec typing, spa typing, MLST and were tested for the presence of mecA, Panton-Valentine leukocidin and arginine catabolic mobile element genes. MRSA contamination was shown in 72 buses (36.2%). The majority of the isolates belonged to three major clones: Clone A was identified as EMRSA-15 defined by pattern PFGE A, spa types t2357/t747/t025/t379/t910, ST22, and SCCmec IVh (n=21; 29%). Clone B was the New York/Japan clone characterized by PFGE B-t002/t10682-ST5-II (n=15; 21%). Clone C included isolates with characteristics of the international community-acquired USA300 or related clones, PFGE C-t008-ST8-IVa/IVc/IVg/IVnt/VI (n=19; 26%). The first two clones are currently the two major lineages circulating in Portuguese hospitals. The hands of 15 individuals were contaminated with MRSA belonging to the nosocomial clones A or B. Eleven of these individuals were not nasal carriers of MRSA and all but one had travelled by public transportation, namely by bus, prior to sampling. In conclusion, public buses in two major cities in Portugal are often contaminated with MRSA representing clones dominant in hospitals in the particular geographic area. MRSA contamination of public transport and the transfer of the bacteria to the hands of passengers may represent a route through which hospital-acquired MRSA clones may spread to the community.	[Conceicao, Teresa; Coelho, Celine; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Diamantino, Fernanda] Univ Lisboa FCUL & CEAUL, Fac Ciencias, Lisbon, Portugal; [Diamantino, Fernanda] Univ Lisboa FCUL & CEAUL, Ctr Estat & Aplicacoes, Lisbon, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Aires-de-Sousa, Marta] Escola Super Saude Cruz Vermelha Portuguesa ESSVP, Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Rockefeller University	Aires-de-Sousa, M (corresponding author), Escola Super Saude Cruz Vermelha Portuguesa ESSVP, Lisbon, Portugal.	msousa@esscvp.eu	Conceição, Teresa/M-3449-2014	Conceição, Teresa/0000-0002-9818-2767; Aires-de-Sousa, Marta/0000-0001-5036-2446; Diamantino, Maria_Fernanda/0000-0002-9217-167X; /0000-0001-6816-8932	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/SAU-SAP/118813/2010, PEst-OE/EQB/LA0004/2011, PEst-OE/MAT/UI0006/2011]; FCT, Portugal [036/BI-BI/2012];  [SFRH/BPD/72422/2010]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); 	This work was partially supported by project PTDC/SAU-SAP/118813/2010 and grants No. PEst-OE/EQB/LA0004/2011 and PEst-OE/MAT/UI0006/2011 from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. T. Conceicao was supported by grant SFRH/BPD/72422/2010. C. Coelho was supported by grant 036/BI-BI/2012 from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Carpaij N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016419; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Coelho C, 2011, MICROB DRUG RESIST, V17, P333, DOI 10.1089/mdr.2010.0080; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; de Lencastre H, 2011, INT J MED MICROBIOL, V301, P623, DOI 10.1016/j.ijmm.2011.09.010; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; European Centre for Disease Prevention and Control, 2012, ANT RES SURV EUR 201; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Koning S, 2006, BRIT J DERMATOL, V154, P239, DOI 10.1111/j.1365-2133.2005.06766.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mermel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017925; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nazareth R, 2012, REV PORT PNEUMOL, V18, P34, DOI 10.1016/j.rppneu.2011.05.007; O'Hara FP, 2012, MICROB DRUG RESIST, V18, P555, DOI 10.1089/mdr.2012.0056; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Otter JA, 2009, LETT APPL MICROBIOL, V49, P803, DOI 10.1111/j.1472-765X.2009.02728.x; Patel M, 2009, DRUGS, V69, P693, DOI 10.2165/00003495-200969060-00004; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Sa-Leao R, 2001, MICROB DRUG RESIST, V7, P237, DOI 10.1089/10766290152652783; Simoes RR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017630, 10.1371/journal.pone.0029279]; Stepanovic S, 2008, LETT APPL MICROBIOL, V47, P339, DOI 10.1111/j.1472-765X.2008.02436.x; Tavares A, 2013, EUR J CLIN IN PRESS; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11	40	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77812	10.1371/journal.pone.0077812	http://dx.doi.org/10.1371/journal.pone.0077812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223124	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200016
J	Fox, NJ; Marion, G; Davidson, RS; White, PCL; Hutchings, MR				Fox, Naomi J.; Marion, Glenn; Davidson, Ross S.; White, Piran C. L.; Hutchings, Michael R.			Modelling Parasite Transmission in a Grazing System: The Importance of Host Behaviour and Immunity	PLOS ONE			English	Article							HAEMONCHUS-CONTORTUS POPULATIONS; FREE-LIVING STAGES; OSTERTAGIA-OSTERTAGI; GASTROINTESTINAL NEMATODES; FORAGING BEHAVIOR; FOOD-INTAKE; SPATIAL HETEROGENEITY; MATHEMATICAL-MODELS; INFECTIVE LARVAE; FECAL AVOIDANCE	Parasitic helminths present one of the most pervasive challenges to grazing herbivores. Many macro-parasite transmission models focus on host physiological defence strategies, omitting more complex interactions between hosts and their environments. This work represents the first model that integrates both the behavioural and physiological elements of gastro-intestinal nematode transmission dynamics in a managed grazing system. A spatially explicit, individual-based, stochastic model is developed, that incorporates both the hosts' immunological responses to parasitism, and key grazing behaviours including faecal avoidance. The results demonstrate that grazing behaviour affects both the timing and intensity of parasite outbreaks, through generating spatial heterogeneity in parasite risk and nutritional resources, and changing the timing of exposure to the parasites' free-living stages. The influence of grazing behaviour varies with the host-parasite combination, dependent on the development times of different parasite species and variations in host immune response. Our outputs include the counterintuitive finding that under certain conditions perceived parasite avoidance behaviours (faecal avoidance) can increase parasite risk, for certain host-parasite combinations. Through incorporating the two-way interaction between infection dynamics and grazing behaviour, the potential benefits of parasite-induced anorexia are also demonstrated. Hosts with phenotypic plasticity in grazing behaviour, that make grazing decisions dependent on current parasite burden, can reduce infection with minimal loss of intake over the grazing season. This paper explores how both host behaviours and immunity influence macro-parasite transmission in a spatially and temporally heterogeneous environment. The magnitude and timing of parasite outbreaks is influenced by host immunity and behaviour, and the interactions between them; the incorporation of both regulatory processes is required to fully understand transmission dynamics. Understanding of both physiological and behavioural defence strategies will aid the development of novel approaches for control.	[Fox, Naomi J.; Davidson, Ross S.; Hutchings, Michael R.] SRUC, Dis Syst Team, Edinburgh, Midlothian, Scotland; [Fox, Naomi J.; White, Piran C. L.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Fox, Naomi J.; Marion, Glenn; Davidson, Ross S.] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland	University of York - UK; James Hutton Institute	Marion, G (corresponding author), Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland.	glenn@bioss.ac.uk	Davidson, Ross/I-8210-2014; Marion, Glenn/J-4738-2013; Hutchings, Mike/P-6836-2019; White, Piran Crawfurd Limond/AAH-6851-2021	White, Piran Crawfurd Limond/0000-0002-7496-5775; Marion, Glenn/0000-0002-0454-9338; Hutchings, Mike/0000-0003-3338-471X; Davidson, Ross/0000-0003-1468-5867	Scottish Government	Scottish Government	SRUC and Biomathematics and Statistics Scotland (BioSS) receive funding from the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DB, 1981, INT J PARASITOL, V11, P381, DOI 10.1016/0020-7519(81)90009-6; ANDERSON RM, 1987, INT J PARASITOL, V17, P519, DOI 10.1016/0020-7519(87)90128-7; [Anonymous], 2003, GROSS PATHOLOGY RUMI; ARNOLD GW, 1987, J APPL ECOL, V24, P759, DOI 10.2307/2403979; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Bao J, 1998, ANIM SCI, V66, P65, DOI 10.1017/S1357729800008845; BARGER IA, 1985, INT J PARASITOL, V15, P529, DOI 10.1016/0020-7519(85)90049-9; BARGER IA, 1988, INT J PARASITOL, V18, P269, DOI 10.1016/0020-7519(88)90067-7; Basanez MG, 2001, TRENDS PARASITOL, V17, P430, DOI 10.1016/S1471-4922(01)02013-X; BLACK JL, 1984, AUST J AGR RES, V35, P565, DOI 10.1071/AR9840565; BOAG B, 1989, INT J PARASITOL, V19, P681, DOI 10.1016/0020-7519(89)90047-7; Burgess CGS, 2012, VET PARASITOL, V189, P299, DOI 10.1016/j.vetpar.2012.04.009; CALLINAN APL, 1982, AGR SYST, V9, P199, DOI 10.1016/0308-521X(82)90020-8; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Churcher TS, 2006, J ANIM ECOL, V75, P1313, DOI 10.1111/j.1365-2656.2006.01154.x; Claerebout E, 1998, VET PARASITOL, V75, P153, DOI 10.1016/S0304-4017(97)00218-5; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; COOP RL, 1982, J AGR SCI, V98, P247, DOI 10.1017/S0021859600041782; Cooper J, 2000, APPL ANIM BEHAV SCI, V69, P15, DOI 10.1016/S0168-1591(00)00116-7; Cornell S, 2005, TRENDS PARASITOL, V21, P542, DOI 10.1016/j.pt.2005.08.019; COYNE MJ, 1991, INT J PARASITOL, V21, P847, DOI 10.1016/0020-7519(91)90153-X; DOBSON RJ, 1990, INT J PARASITOL, V20, P365, DOI 10.1016/0020-7519(90)90153-E; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; Fernandez S, 2001, VET PARASITOL, V96, P291, DOI 10.1016/S0304-4017(01)00380-6; Forbes AB, 2007, VET PARASITOL, V150, P321, DOI 10.1016/j.vetpar.2007.09.031; Forbes AB, 2000, VET PARASITOL, V90, P111, DOI 10.1016/S0304-4017(00)00218-1; FORBES TDA, 1985, GRASS FORAGE SCI, V40, P177, DOI 10.1111/j.1365-2494.1985.tb01735.x; Fox MT, 2002, VET PARASITOL, V105, P285, DOI 10.1016/S0304-4017(02)00026-2; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Gunn A, 2003, WILDLIFE SOC B, V31, P117; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; HILDERSON H, 1993, VET PARASITOL, V47, P255, DOI 10.1016/0304-4017(93)90027-K; Hutchings MR, 2000, OECOLOGIA, V124, P242, DOI 10.1007/s004420000367; Hutchings MR, 1999, J ANIM ECOL, V68, P310, DOI 10.1046/j.1365-2656.1999.00287.x; Hutchings MR, 1998, ANIM SCI, V67, P97, DOI 10.1017/S1357729800009838; Hutchings MR, 2002, OIKOS, V96, P235, DOI 10.1034/j.1600-0706.2002.960205.x; Hutchings MR, 2002, OECOLOGIA, V132, P453, DOI 10.1007/s00442-002-0971-z; Hutchings MR, 2001, ECOLOGY, V82, P1138, DOI 10.1890/0012-9658(2001)082[1138:HPSAFT]2.0.CO;2; Hutchings MR, 2001, ANIM BEHAV, V62, P955, DOI 10.1006/anbe.2001.1837; Johnson RW, 1998, DOMEST ANIM ENDOCRIN, V15, P309, DOI 10.1016/S0739-7240(98)00031-9; Kao RR, 2000, PARASITOLOGY, V121, P85, DOI 10.1017/S0031182099006095; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Langhans W, 2000, NUTRITION, V16, P996, DOI 10.1016/S0899-9007(00)00421-4; LAZO A, 1993, APPL ANIM BEHAV SCI, V36, P99, DOI 10.1016/0168-1591(93)90002-7; LEATHWICK DM, 1992, INT J PARASITOL, V22, P789, DOI 10.1016/0020-7519(92)90129-9; Louie K, 2005, PARASITOLOGY, V130, P437, DOI 10.1017/S003118200400678X; Marion G, 2008, J AGR SCI-CAMBRIDGE, V146, P507, DOI 10.1017/S0021859608008022; Marion G, 1998, IMA J MATH APPL MED, V15, P97; Marion G, 2005, J THEOR BIOL, V232, P127, DOI 10.1016/j.jtbi.2004.08.005; PANDEY VS, 1972, J PARASITOL, V58, P1037, DOI 10.2307/3278128; PANDEY VS, 1993, VET PARASITOL, V49, P219, DOI 10.1016/0304-4017(93)90121-3; Phillips C.J.C., 1993, CATTLE BEHAV WELFARE; PLOEGER HW, 1995, VET PARASITOL, V58, P61, DOI 10.1016/0304-4017(94)00711-K; Ractliffe L H, 1971, Int J Parasitol, V1, P297, DOI 10.1016/0020-7519(71)90032-4; REID GW, 1972, J AGR SCI-CAMBRIDGE, V78, P491, DOI 10.1017/S0021859600026435; ROBERTS MG, 1991, IMA J MATH APPL MED, V8, P83; ROBERTS MG, 1992, IMA J MATH APPL MED, V9, P29; SMITH G, 1988, VET PARASITOL, V27, P73, DOI 10.1016/0304-4017(88)90063-5; Smith G., 1985, Parasitology Today, V1, P76, DOI 10.1016/0169-4758(85)90047-X; SMITH G, 1986, PARASITOLOGY, V92, P471, DOI 10.1017/S0031182000064222; Smith LA, 2010, ANIM BEHAV, V80, P527, DOI 10.1016/j.anbehav.2010.06.016; Smith LA, 2009, EPIDEMIOL INFECT, V137, P630, DOI 10.1017/S0950268808001313; Stear MJ, 1997, VET J, V154, P111, DOI 10.1016/S1090-0233(97)80049-4; Swain DL, 2007, ECOL MODEL, V203, P319, DOI 10.1016/j.ecolmodel.2006.11.031; THOMAS RJ, 1982, VET PARASITOL, V11, P9, DOI 10.1016/0304-4017(82)90118-2; van der Wal R, 2000, OECOLOGIA, V124, P19, DOI 10.1007/s004420050020; Vercruysse J, 1997, VET PARASITOL, V72, P309, DOI 10.1016/S0304-4017(97)00103-9; Vlassoff A, 2001, NEW ZEAL VET J, V49, P213, DOI 10.1080/00480169.2001.36235; Waller PJ, 2006, ANIM FEED SCI TECH, V126, P277, DOI 10.1016/j.anifeedsci.2005.08.007; WallisDeVries MF, 1998, APPL ANIM BEHAV SCI, V60, P301, DOI 10.1016/S0168-1591(98)00158-0; WILLIAMS JC, 1993, VET PARASITOL, V46, P313, DOI 10.1016/0304-4017(93)90069-Y	72	27	28	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77996	10.1371/journal.pone.0077996	http://dx.doi.org/10.1371/journal.pone.0077996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223133	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200025
J	Garanto, A; van Beersum, SEC; Peters, TA; Roepman, R; Cremers, FPM; Collin, RWJ				Garanto, Alejandro; van Beersum, Sylvia E. C.; Peters, Theo A.; Roepman, Ronald; Cremers, Frans P. M.; Collin, Rob W. J.			Unexpected CEP290 mRNA Splicing in a Humanized Knock-In Mouse Model for Leber Congenital Amaurosis	PLOS ONE			English	Article							RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; GENE-THERAPY; MUTATIONS; CILIOPATHIES; PHENOTYPE; MEMBRANE; ORTHOLOG; CERKL; MICE	Leber congenital amaurosis (LCA) is the most severe form of retinal dystrophy with an onset in the first year of life. The most frequent genetic cause of LCA, accounting for up to 15% of all LCA cases in Europe and North-America, is a mutation (c. 2991+1655AG) in intron 26 of CEP290. This mutation generates a cryptic splice donor site resulting in the insertion of an aberrant exon (exon X) containing a premature stop codon to CEP290 mRNA. In order to study the pathophysiology of the intronic CEP290 mutation, we generated two humanized knock-in mouse models each carrying similar to 6.3 kb of the human CEP290 gene, either with or without the intronic mutation. Transcriptional characterization of these mouse models revealed an unexpected splice pattern of CEP290 mRNA, especially in the retina. In both models, a new cryptic exon (coined exon Y) was identified in similar to 5 to 12% of all Cep290 transcripts. This exon Y was expressed in all murine tissues analyzed but not detected in human retina or fibroblasts of LCA patients. In addition, exon x that is characteristic of LCA in humans, was expressed at only very low levels in the retina of the LCA mouse model. Western blot and immunohistochemical analyses did not reveal any differences between the two transgenic models and wild-type mice. Together, our results show clear differences in the recognition of splice sites between mice and humans, and emphasize that care is warranted when generating animal models for human genetic diseases caused by splice mutations.	[Garanto, Alejandro; van Beersum, Sylvia E. C.; Roepman, Ronald; Cremers, Frans P. M.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Garanto, Alejandro; van Beersum, Sylvia E. C.; Roepman, Ronald; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6525 ED Nijmegen, Netherlands; [van Beersum, Sylvia E. C.; Peters, Theo A.; Roepman, Ronald; Cremers, Frans P. M.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Peters, Theo A.] Radboud Univ Nijmegen, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-6525 ED Nijmegen, Netherlands; [Peters, Theo A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Collin, RWJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	rob.collin@radboudumc.nl	Garanto, Alejandro/D-5022-2014; van Beersum, Sylvia E.C./P-8653-2015; Collin, Rob/N-3575-2014; Peters, T.A./L-4571-2015; Cremers, Frans/A-5625-2014; Roepman, Ronald/B-1339-2014	Garanto, Alejandro/0000-0001-5721-1560; van Beersum, Sylvia E.C./0000-0002-4552-2908; Peters, T.A./0000-0001-8443-5500; Cremers, Frans/0000-0002-4954-5592; Roepman, Ronald/0000-0002-5178-8163	Netherlands Organisation for Scientific Research (NWO) [VENI 916.10.096]; Foundation Fighting Blindness (FFB) USA [TA-GT-0912-0582-RAD]; Stichting August F. Deutman Researchfonds Oogheelkunde; Rotterdamse Vereniging Blindenbelangen; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blindenstichting; Stichting Winckel-Sweep; Stichting Nederlands Oogheelkundig Onderzoek	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness (FFB) USA; Stichting August F. Deutman Researchfonds Oogheelkunde; Rotterdamse Vereniging Blindenbelangen; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blindenstichting; Stichting Winckel-Sweep; Stichting Nederlands Oogheelkundig Onderzoek	This work is financially supported by the Netherlands Organisation for Scientific Research (NWO) (VENI 916.10.096 to RWJC), the Foundation Fighting Blindness (FFB) USA (TA-GT-0912-0582-RAD to RWJC), the Stichting August F. Deutman Researchfonds Oogheelkunde, the Rotterdamse Vereniging Blindenbelangen, the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the Gelderse Blindenstichting, the Stichting Winckel-Sweep and the Stichting Nederlands Oogheelkundig Onderzoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Barbelanne M, 2013, HUM MOL GENET; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Collin RWJ, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.3; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Garanto A, 2012, BBA-MOL BASIS DIS, V1822, P1258, DOI 10.1016/j.bbadis.2012.04.004; Garanto A, 2011, INVEST OPHTH VIS SCI, V52, P5202, DOI 10.1167/iovs.10-7101; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerard X, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.21; Gladman JT, 2010, HUM MOL GENET, V19, P4239, DOI 10.1093/hmg/ddq343; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Kolb H, 2003, AM SCI, V91, P28, DOI 10.1511/2003.11.841; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P3646, DOI 10.1167/iovs.09-5074; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Menotti-Raymond M, 2007, J HERED, V98, P211, DOI 10.1093/jhered/esm019; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; NARFSTROM K, 1985, INVEST OPHTH VIS SCI, V26, P193; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Song BJ, 2007, GENE THER MOL BIOL, V11B, P229; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Vadolas J, 2006, J BIOL CHEM, V281, P7399, DOI 10.1074/jbc.M512931200; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Yang YP, 2003, HUM MOL GENET, V12, P2121, DOI 10.1093/hmg/ddg222	39	34	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79369	10.1371/journal.pone.0079369	http://dx.doi.org/10.1371/journal.pone.0079369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223178	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200070
J	Hou, YM; Hu, JL; Po, SS; Wang, H; Zhang, L; Zhang, F; Wang, K; Zhou, Q				Hou, Yuemei; Hu, Jialu; Po, Sunny S.; Wang, Huan; Zhang, Ling; Zhang, Feng; Wang, Kun; Zhou, Qina			Catheter-Based Renal Sympathetic Denervation Significantly Inhibits Atrial Fibrillation Induced by Electrical Stimulation of the Left Stellate Ganglion and Rapid Atrial Pacing	PLOS ONE			English	Article							DRUG-RESISTANT HYPERTENSION; SUDDEN CARDIAC DEATH; RADIOFREQUENCY ABLATION; PULMONARY VEINS; BLOOD-PRESSURE; CANINE MODEL; INNERVATION; INDUCIBILITY; TACHYCARDIA	Background: Sympathetic activity involves the pathogenesis of atrial fibrillation (AF). Renal sympathetic denervation (RSD) decreases sympathetic renal afferent nerve activity, leading to decreased central sympathetic drive. The aim of this study was to identify the effects of RSD on AF inducibility induced by hyper-sympathetic activity in a canine model. Methods: To establish a hyper-sympathetic tone canine model of AF, sixteen dogs were subjected to stimulation of left stellate ganglion (LSG) and rapid atrial pacing (RAP) for 3 hours. Then animals in the RSD group (n = 8) underwent radiofrequency ablation of the renal sympathetic nerve. The control group (n = 8) underwent the same procedure except for ablation. AF inducibility, effective refractory period (ERP), ERP dispersion, heart rate variability and plasma norepinephrine levels were measured at baseline, after stimulation and after ablation. Results: LSG stimulation combined RAP significantly induced higher AF induction rate, shorter ERP, larger ERP dispersion at all sites examined and higher plasma norepinephrine levels (P < 0.05 in all values), compared to baseline. The increased AF induction rate, shortened ERP, increased ERP dispersion and elevated plasma norepinephrine levels can be almost reversed by RSD, compared to the control group (P, 0.05). LSG stimulation combined RAP markedly shortened RR-interval and standard deviation of all RR-intervals (SDNN), Low-frequency (LF), high-frequency (HF) and LF/HF ratio (P < 0.05). These changes can be reversed by RSD, compared to the control group (P < 0.05). Conclusions: RSD significantly reduced AF inducibility and reversed the atrial electrophysiological changes induced by hyper-sympathetic activity.	[Hou, Yuemei] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Cardiovasc Dis, Shanghai 200030, Peoples R China; [Hu, Jialu] Fudan Univ, Zhongshan Hosp, Dept Cardiovasc Dis, Shanghai 200433, Peoples R China; [Po, Sunny S.] Univ Oklahoma, Hlth Sci Ctr, Heart Rhythm Inst, Oklahoma City, OK USA; [Po, Sunny S.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Wang, Huan; Zhang, Ling; Zhang, Feng; Wang, Kun; Zhou, Qina] Xinjiang Med Univ, Affiliated Hosp 1, Arrhythmia Res Lab, Urumqi, Peoples R China	Shanghai Jiao Tong University; Fudan University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Xinjiang Medical University	Zhou, Q (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Arrhythmia Res Lab, Urumqi, Peoples R China.	zhouqina_5217@sina.com			International Science and Technology Cooperation Project of the Ministry of Science and Technology of China [2011DFA32860]; Shanghai Science and Technology Commission Research Projects [10411956900]	International Science and Technology Cooperation Project of the Ministry of Science and Technology of China; Shanghai Science and Technology Commission Research Projects	This study was supported by the International Science and Technology Cooperation Project of the Ministry of Science and Technology of China (2011DFA32860) and the Shanghai Science and Technology Commission Research Projects (10411956900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2012, JACC-CARDIOVASC INTE, V5, P758, DOI 10.1016/j.jcin.2012.01.027; BARAJAS L, 1978, FED PROC, V37, P1192; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Chang CM, 2001, CIRCULATION, V103, P22; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Gould PA, 2006, PACE, V29, P821, DOI 10.1111/j.1540-8159.2006.00447.x; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Ishida Yuji, 2008, Okajimas Folia Anatomica Japonica, V84, P133, DOI 10.2535/ofaj.84.133; Jayachandran JV, 2000, CIRCULATION, V101, P1185, DOI 10.1161/01.CIR.101.10.1185; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kuhlkamp V, 2000, J AM COLL CARDIOL, V36, P139, DOI 10.1016/S0735-1097(00)00693-8; Lehnart SE, 2004, BIOCHEM BIOPH RES CO, V322, P1267, DOI 10.1016/j.bbrc.2004.08.032; Linz D, 2013, J CARDIOVASC ELECTRO, DOI 10:1111/jce.12284; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Lu ZB, 2008, CIRC-ARRHYTHMIA ELEC, V1, P184, DOI 10.1161/CIRCEP.108.784272; Ogawa M, 2009, HEART RHYTHM, V6, P1772, DOI 10.1016/j.hrthm.2009.08.011; Oral H, 2008, J CARDIOVASC ELECTR, V19, P466, DOI 10.1111/j.1540-8167.2007.01089.x; Patterson E, 2006, J AM COLL CARDIOL, V47, P1196, DOI 10.1016/j.jacc.2005.12.023; Prochnau D, 2012, EUROINTERVENTION, V7, P1077, DOI 10.4244/EIJV7I9A171; Qina Z, 2012, HEART, V98, pE30; RAGER G, 1979, STAIN TECHNOL, V54, P193, DOI 10.3109/10520297909112682; Schlaich MP, 2004, HYPERTENSION, V43, P169, DOI 10.1161/01.HYP.0000103160.35395.9E; Sharifov OF, 2004, J AM COLL CARDIOL, V43, P483, DOI 10.1016/j.jacc.2003.09.030; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Sobotka PA, 2011, CLIN RES CARDIOL, V100, P1049, DOI 10.1007/s00392-011-0335-y; Swissa M, 2005, AM J PHYSIOL-HEART C, V289, pH1851, DOI 10.1152/ajpheart.00083.2005; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Ukena C, 2012, CLIN RES CARDIOL, V101, P63, DOI 10.1007/s00392-011-0365-5; Ukena C, 2011, J AM COLL CARDIOL, V58, P1176, DOI 10.1016/j.jacc.2011.05.036; Vonend O, 2003, J HYPERTENS, V21, P1709, DOI 10.1097/00004872-200309000-00021; Witkowski A, 2011, HYPERTENSION, V58, P559, DOI 10.1161/HYPERTENSIONAHA.111.173799; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y	33	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78218	10.1371/journal.pone.0078218	http://dx.doi.org/10.1371/journal.pone.0078218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223140	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200032
J	Nicol, K; Pope, M; Sprengelmeyer, R; Young, AW; Hall, J				Nicol, Katie; Pope, Merrick; Sprengelmeyer, Reiner; Young, Andrew W.; Hall, Jeremy			Social Judgement in Borderline Personality Disorder	PLOS ONE			English	Article							CHILDHOOD TRAUMA; BRAIN ABNORMALITIES; AMYGDALA; FACE; MENTALIZATION; COGNITION; SCHIZOPHRENIA; NEUROBIOLOGY; METAANALYSIS; PSYCHOSIS	Background: Borderline personality disorder (BPD) is a common and serious mental illness, associated with a high risk of suicide and self harm. Those with a diagnosis of BPD often display difficulties with social interaction and struggle to form and maintain interpersonal relationships. Here we investigated the ability of participants with BPD to make social inferences from faces. Method: 20 participants with BPD and 21 healthy controls were shown a series of faces and asked to judge these according to one of six characteristics (age, distinctiveness, attractiveness, intelligence, approachability, trustworthiness). The number and direction of errors made (compared to population norms) were recorded for analysis. Results: Participants with a diagnosis of BPD displayed significant impairments in making judgements from faces. In particular, the BPD Group judged faces as less approachable and less trustworthy than controls. Furthermore, within the BPD Group there was a correlation between scores on the Childhood Trauma Questionnaire (CTQ) and bias towards judging faces as unapproachable. Conclusion: Individuals with a diagnosis of BPD have difficulty making appropriate social judgements about others from their faces. Judging more faces as unapproachable and untrustworthy indicates that this group may have a heightened sensitivity to perceiving potential threat, and this should be considered in clinical management and treatment.	[Nicol, Katie; Hall, Jeremy] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Pope, Merrick] Royal Edinburgh & Associated Hosp, Edinburgh, Midlothian, Scotland; [Sprengelmeyer, Reiner] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Young, Andrew W.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Hall, Jeremy] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales	University of Edinburgh; Royal Infirmary of Edinburgh; University of St Andrews; University of York - UK; Cardiff University	Nicol, K (corresponding author), Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland.	K.Nicol-3@staffmail.ed.ac.uk	Young, Andy/G-2189-2011	Young, Andy/0000-0002-1202-6297; Sprengelmeyer, Reiner Heinrich/0000-0002-3083-5995; Hall, Jeremy/0000-0002-0403-3278	Chief Scientist Office (Scotland) [SCD/10]; Scottish Senior Clinical Fellowship; Chief Scientist Office [SCD/10] Funding Source: researchfish	Chief Scientist Office (Scotland); Scottish Senior Clinical Fellowship; Chief Scientist Office	Although the study itself was not directly funded, Professor Jeremy Hall is supported by a Chief Scientist Office (Scotland) grant (No: SCD/10), and by a Scottish Senior Clinical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ball JS, 2009, CURR PSYCHIAT REP, V11, P63, DOI 10.1007/s11920-009-0010-4; Bateman A, 2010, WORLD PSYCHIATRY, V9, P11, DOI 10.1002/j.2051-5545.2010.tb00255.x; Billeke Pablo, 2013, Front Psychiatry, V4, P4, DOI 10.3389/fpsyt.2013.00004; Bland Ann R, 2004, Issues Ment Health Nurs, V25, P655, DOI 10.1080/01612840490486692; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; Choi-Kain LW, 2008, AM J PSYCHIAT, V165, P1127, DOI 10.1176/appi.ajp.2008.07081360; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Domes G, 2008, J PERS DISORD, V22, P135, DOI 10.1521/pedi.2008.22.2.135; Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fonagy P, 2011, INFANT MENT HEALTH J, V32, P47, DOI 10.1002/imhj.20283; Grant MM, 2011, J PSYCHIATR RES, V45, P886, DOI 10.1016/j.jpsychires.2010.12.004; Hall J, 2004, BRIT J PSYCHIAT, V185, P169, DOI 10.1192/bjp.185.2.169; Hall J, 2010, PSYCHOL MED, V40, P1183, DOI 10.1017/S0033291709991395; Hall J, 2010, PERSONAL MENT HEALTH, V4, P172, DOI 10.1002/pmh.128; Hammersley P, 2003, BRIT J PSYCHIAT, V182, P543, DOI 10.1192/bjp.182.6.543; Hill J, 2008, PSYCHOL MED, V38, P135, DOI 10.1017/S0033291707001626; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Levine D, 1997, J NERV MENT DIS, V185, P240, DOI 10.1097/00005053-199704000-00004; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Martens MA, 2009, NEUROPSYCHOLOGIA, V47, P2446, DOI 10.1016/j.neuropsychologia.2009.04.017; Marwick K, 2008, BRIT MED BULL, V88, P43, DOI 10.1093/bmb/ldn035; Mauchnik J, 2010, CURR PSYCHIAT REP, V12, P46, DOI 10.1007/s11920-009-0089-7; MCDONALD S, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI DOI 10.1017/S1355617713000428.PUBMED:23351330; Meyer B, 2004, J PERS DISORD, V18, P320, DOI 10.1521/pedi.18.4.320.40344; Minzenberg MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P231, DOI 10.1016/j.pscychresns.2007.03.006; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Philip RCM, 2010, PSYCHOL MED, V40, P1919, DOI 10.1017/S0033291709992364; Preissler S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00182; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Santos IM, 2008, PERCEPTION, V37, P1061, DOI 10.1068/p5278; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Wolf RC, 2011, J PSYCHIATR NEUROSCI, V36, P402, DOI 10.1503/jpn.100150; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Zanarini MC, 2010, ACTA PSYCHIAT SCAND, V122, P103, DOI 10.1111/j.1600-0447.2010.01543.x	48	30	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e73440	10.1371/journal.pone.0073440	http://dx.doi.org/10.1371/journal.pone.0073440			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223110	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000326656200002
J	Olofsson, J; Axelsson-Olsson, D; Brudin, L; Olsen, B; Ellstrom, P				Olofsson, Jenny; Axelsson-Olsson, Diana; Brudin, Lars; Olsen, Bjorn; Ellstrom, Patrik			Campylobacter jejuni Actively Invades the Amoeba Acanthamoeba polyphaga and Survives within Non Digestive Vacuoles	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; PHAGOSOME-LYSOSOME FUSION; FREE-LIVING AMEBAS; LEGIONELLA-PNEUMOPHILA; DICTYOSTELIUM-DISCOIDEUM; MYCOBACTERIUM-AVIUM; FRESH-WATER; CASTELLANII; CELLS; ASSOCIATION	The Gram-negative bacterium Campylobacter jejuni is able to enter, survive and multiply within the free living amoeba Acanthamoeba polyphaga, but the molecular mechanisms behind these events are still unclear. We have studied the uptake and intracellular trafficking of viable and heat killed bacterial cells of the C. jejuni strain 81-176 in A. polyphaga. We found that viable bacteria associated with a substantially higher proportion of Acanthamoeba trophozoites than heat killed bacteria. Furthermore, the kinetics of internalization, the total number of internalized bacteria as well as the intracellular localization of internalized C. jejuni were dramatically influenced by bacterial viability. Viable bacteria were internalized at a high rate already after 1 h of co-incubation and were observed in small vacuoles tightly surrounding the bacteria. In contrast, internalization of heat killed C. jejuni was low at early time points and did not peak until 96 h. These cells were gathered in large spacious vacuoles that were part of the degradative pathway as determined by the uptake of fluorescently labeled dextran. The amount of heat killed bacteria internalized by A. polyphaga did never reach the maximal amount of internalized viable bacteria. These results suggest that the uptake and intracellular survival of C. jejuni in A. polyphaga is bacterially induced.	[Olofsson, Jenny; Olsen, Bjorn; Ellstrom, Patrik] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Olofsson, Jenny; Olsen, Bjorn] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Axelsson-Olsson, Diana] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Brudin, Lars] Kalmar Cty Hosp, Dept Clin Physiol, Kalmar, Sweden; [Brudin, Lars] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Uppsala University; Linnaeus University; Linnaeus University; Linkoping University	Olofsson, J (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	jenny.olofsson@lnu.se		Brudin, Lars/0000-0002-6278-1362; Axelsson Olsson, Diana/0000-0003-4474-8531; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council FORMAS [FORMAS 2007-438]; Royal Swedish Academy of Agriculture and Forestry [KSLA H-578]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Royal Swedish Academy of Agriculture and Forestry	This work was supported financially by the Swedish Research Council FORMAS (FORMAS 2007-438) and the Royal Swedish Academy of Agriculture and Forestry (KSLA H-578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsam S, 2006, J MED MICROBIOL, V55, P689, DOI 10.1099/jmm.0.46497-0; Armitage P., 2002, STAT METHODS MED RES; AUBRY L, 1993, EUR J CELL BIOL, V61, P225; Axelsson-Olsson D, 2005, APPL ENVIRON MICROB, V71, P987, DOI 10.1128/AEM.71.2.987-992.2005; Axelsson-Olsson D, 2007, APPL ENVIRON MICROB, V73, P6864, DOI 10.1128/AEM.01305-07; Axelsson-Olsson D, 2010, EXP PARASITOL, V126, P59, DOI 10.1016/j.exppara.2009.12.016; Bare J, 2010, FEMS MICROBIOL ECOL, V74, P371, DOI 10.1111/j.1574-6941.2010.00955.x; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1111/j.1574-6968.1999.tb13516.x; Berk SG, 1998, APPL ENVIRON MICROB, V64, P279; Bozue JA, 1996, INFECT IMMUN, V64, P668, DOI 10.1128/IAI.64.2.668-673.1996; Bui XT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-232; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; First MR, 2012, J EUKARYOT MICROBIOL, V59, P12, DOI 10.1111/j.1550-7408.2011.00589.x; FREHEL C, 1986, INFECT IMMUN, V52, P252, DOI 10.1128/IAI.52.1.252-262.1986; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2002, APPL ENVIRON MICROB, V68, P3076, DOI 10.1128/AEM.68.6.3076-3084.2002; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; KONKEL ME, 1992, INFECT IMMUN, V60, P4945, DOI 10.1128/IAI.60.11.4945-4949.1992; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Lamothe J, 2004, CELL MICROBIOL, V6, P1127, DOI 10.1111/j.1462-5822.2004.00424.x; Landers P, 2000, EUR J CLIN MICROBIOL, V19, P121, DOI 10.1007/s100960050442; Marolda CL, 1999, MICROBIOL-SGM, V145, P1509, DOI 10.1099/13500872-145-7-1509; Neuhaus EM, 2002, MOL BIOL CELL, V13, P1390, DOI 10.1091/mbc.01-08-0392; Nygard K, 2004, EPIDEMIOL INFECT, V132, P317, DOI 10.1017/S0950268803001900; Pickup ZL, 2007, FEMS MICROBIOL ECOL, V59, P556, DOI 10.1111/j.1574-6941.2006.00224.x; Pryor PR, 2012, METHOD ENZYMOL, V505, P145, DOI 10.1016/B978-0-12-388448-0.00016-4; RODRIGUEZPARIS JM, 1993, J BIOL CHEM, V268, P9110; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Schonberg-Norio D, 2004, EMERG INFECT DIS, V10, P1474, DOI 10.3201/eid1008.030924; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Snelling WJ, 2006, MICROBES INFECT, V8, P578, DOI 10.1016/j.micinf.2005.09.001; Snelling WJ, 2005, APPL ENVIRON MICROB, V71, P5560, DOI 10.1128/AEM.71.9.5560-5571.2005; THOM S, 1992, J MED MICROBIOL, V36, P303, DOI 10.1099/00222615-36-5-303; Thomas JM, 2011, ENVIRON SCI TECHNOL, V45, P860, DOI 10.1021/es102876y; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014	39	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78873	10.1371/journal.pone.0078873	http://dx.doi.org/10.1371/journal.pone.0078873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223169	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200061
J	Sieger, T; Bonnet, C; Serranova, T; Wild, J; Novak, D; Ruzicka, F; Urgosik, D; Ruzicka, E; Gaymard, B; Jech, R				Sieger, Tomas; Bonnet, Cecilia; Serranova, Tereza; Wild, Jiri; Novak, Daniel; Ruzicka, Filip; Urgosik, Dusan; Ruzicka, Evzen; Gaymard, Bertrand; Jech, Robert			Basal Ganglia Neuronal Activity during Scanning Eye Movements in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; NIGRA PARS RETICULATA; HUMAN SUBTHALAMIC NUCLEUS; CEREBRAL-BLOOD-FLOW; EXTERNALLY TRIGGERED MOVEMENTS; SUBSTANTIA-NIGRA; GLOBUS-PALLIDUS; OCULOMOTOR FUNCTIONS; MOTOR CORTEX; SACCADES	The oculomotor role of the basal ganglia has been supported by extensive evidence, although their role in scanning eye movements is poorly understood. Nineteen Parkinsons disease patients, which underwent implantation of deep brain stimulation electrodes, were investigated with simultaneous intraoperative microelectrode recordings and single channel electrooculography in a scanning eye movement task by viewing a series of colored pictures selected from the International Affective Picture System. Four patients additionally underwent a visually guided saccade task. Microelectrode recordings were analyzed selectively from the subthalamic nucleus, substantia nigra pars reticulata and from the globus pallidus by the WaveClus program which allowed for detection and sorting of individual neurons. The relationship between neuronal firing rate and eye movements was studied by crosscorrelation analysis. Out of 183 neurons that were detected, 130 were found in the subthalamic nucleus, 30 in the substantia nigra and 23 in the globus pallidus. Twenty percent of the neurons in each of these structures showed eye movement-related activity. Neurons related to scanning eye movements were mostly unrelated to the visually guided saccades. We conclude that a relatively large number of basal ganglia neurons are involved in eye motion control. Surprisingly, neurons related to scanning eye movements differed from neurons activated during saccades suggesting functional specialization and segregation of both systems for eye movement control.	[Sieger, Tomas; Bonnet, Cecilia; Serranova, Tereza; Ruzicka, Filip; Urgosik, Dusan; Ruzicka, Evzen; Jech, Robert] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Sieger, Tomas; Bonnet, Cecilia; Serranova, Tereza; Ruzicka, Filip; Urgosik, Dusan; Ruzicka, Evzen; Jech, Robert] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Sieger, Tomas; Bonnet, Cecilia; Serranova, Tereza; Ruzicka, Filip; Urgosik, Dusan; Ruzicka, Evzen; Jech, Robert] Gen Univ Hosp, Prague, Czech Republic; [Sieger, Tomas; Wild, Jiri; Novak, Daniel] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Urgosik, Dusan] Na Homolce Hosp, Dept Stereotact & Radiat Neurosurg, Prague, Czech Republic; [Gaymard, Bertrand] UPMC, Pitie Salpetriere Hosp, CRICM, INSERM UMR S975,CNRS UMR7225,ICM, Paris, France; [Gaymard, Bertrand] Univ Paris 06, Paris, France	Charles University Prague; Charles University Prague; General University Hospital Prague; Czech Technical University Prague; Na Homolce Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Jech, R (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.	jech@cesnet.cz	Jech, Robert/HHY-7342-2022; Novak, Daniel/G-9231-2014; Serranová, Tereza/AAY-2386-2021; Sieger, Tomas/AAD-9342-2019; Růžička, Evžen/F-9299-2017; Urgošík, Dušan/AAA-9551-2021	Jech, Robert/0000-0002-9732-8947; Novak, Daniel/0000-0001-6996-9344; Serranová, Tereza/0000-0001-6525-3971; Růžička, Evžen/0000-0002-4893-9661; Ruzicka, Filip/0000-0003-2743-2703; Sieger, Tomas/0000-0003-4960-1934	Czech Science Foundation [309/09/1145]; Czech Ministry of Health [IGA MZ ACER NT12282-5/2011, IGA MZ ACER NT12288-5/2011]; Czech Ministry of Education [MA M 0021620849, MA M 6840770012]; Charles University in Prague [PRVOUK-P26/LF1/4]; MRC [MC_U130059811, MC_UU_12017/1, MC_EX_G0701943, MC_UU_12017/3, MC_U130015185] Funding Source: UKRI; Medical Research Council [MC_U130015185, MC_U130059811, MC_EX_G0701943, MC_UU_12017/1, MC_UU_12017/3] Funding Source: researchfish	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Czech Science Foundation: grant project 309/09/1145, by the Czech Ministry of Health: IGA MZ ACER NT12282-5/2011, IGA MZ ACER NT12288-5/2011, by the Czech Ministry of Education: research project MA M 0021620849, MA M 6840770012 Transdisciplinary Research in the Area of Biomedical Engineering II, by the Charles University in Prague: research project PRVOUK-P26/LF1/4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahyane N, 2008, CEREBELLUM, V7, P595, DOI 10.1007/s12311-008-0065-5; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Antoniades CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032830; Antoniades CA, 2012, NEUROREPORT, V23, P179, DOI 10.1097/WNR.0b013e32834f6daa; Araujo C, 2001, VISION RES, V41, P3613, DOI 10.1016/S0042-6989(01)00196-1; Averbuch-Heller L, 1999, NEUROLOGY, V52, P185, DOI 10.1212/WNL.52.1.185; Baron MS, 2002, J NEUROSCI, V22, P592, DOI 10.1523/JNEUROSCI.22-02-00592.2002; Bartanusz V, 2005, J CLIN NEUROSCI, V12, P92, DOI 10.1016/j.jocn.2004.03.033; Basso MA, 2005, EUR J NEUROSCI, V22, P448, DOI 10.1111/j.1460-9568.2005.04215.x; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; BAUSWEIN E, 1989, BRAIN RES, V493, P198, DOI 10.1016/0006-8993(89)91018-4; BECKSTEAD RM, 1981, J NEUROSCI, V1, P121; Blekher T, 2000, INVEST OPHTH VIS SCI, V41, P2177; BURMAN DD, 1994, J NEUROPHYSIOL, V71, P1266, DOI 10.1152/jn.1994.71.3.1266; CORIN MS, 1972, J NEUROL SCI, V15, P251, DOI 10.1016/0022-510X(72)90068-8; Cui DM, 2003, J NEUROPHYSIOL, V89, P2678, DOI 10.1152/jn.00501.2002; DEJONG JD, 1971, EXP NEUROL, V32, P58, DOI 10.1016/0014-4886(71)90165-8; DENIAU JM, 1978, NEUROSCI LETT, V9, P117, DOI 10.1016/0304-3940(78)90058-7; Fawcett AP, 2007, CLIN NEUROPHYSIOL, V118, P155, DOI 10.1016/j.clinph.2006.09.016; Fawcett AP, 2010, NEUROMODULATION, V13, P17, DOI 10.1111/j.1525-1403.2009.00246.x; Fawcett AP, 2005, EXP BRAIN RES, V162, P357, DOI 10.1007/s00221-004-2184-7; FILION M, 1994, REV NEUROL-FRANCE, V150, P627; Gross RE, 2006, MOVEMENT DISORD, V21, pS259, DOI 10.1002/mds.20960; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; Hodgson TL, 2002, NEUROPSYCHOLOGIA, V40, P411, DOI 10.1016/S0028-3932(01)00099-9; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jech R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049056; KITA H, 1987, J COMP NEUROL, V260, P435, DOI 10.1002/cne.902600309; Kitama T, 1999, J NEUROPHYSIOL, V82, P2235, DOI 10.1152/jn.1999.82.5.2235; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lohnes CA, 2012, EXP NEUROL, V236, P389, DOI 10.1016/j.expneurol.2012.05.001; Manly BFJ, 1997, RANDOMIZATION BOOTST; MATSUMURA M, 1992, J NEUROPHYSIOL, V67, P1615, DOI 10.1152/jn.1992.67.6.1615; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nambu A, 1996, J NEUROSCI, V16, P2671; NOTON D, 1971, SCI AM, V224, P34; O'Sullivan JD, 2003, J CLIN NEUROSCI, V10, P181, DOI 10.1016/S0967-5868(02)00125-X; Pinkhardt EH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-5; Pollak P, 2002, MOVEMENT DISORD, V17, pS155, DOI 10.1002/mds.10158; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; R Core Team, 2012, R LANG ENV STAT COMP; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Rivaud-Pechoux S, 2000, J NEUROL NEUROSUR PS, V68, P381, DOI 10.1136/jnnp.68.3.381; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Sauleau P, 2008, CLIN NEUROPHYSIOL, V119, P1857, DOI 10.1016/j.clinph.2008.04.013; Sauleau P, 2007, MOVEMENT DISORD, V22, P1810, DOI 10.1002/mds.21650; SELEMON LD, 1990, J COMP NEUROL, V297, P359, DOI 10.1002/cne.902970304; SHIBASAKI H, 1979, ARCH NEUROL-CHICAGO, V36, P360, DOI 10.1001/archneur.1979.00500420070009; Shields DC, 2007, J NEUROSURG, V107, P37, DOI 10.3171/JNS-07/07/0037; Shin SY, 2010, J NEUROPHYSIOL, V103, P1874, DOI 10.1152/jn.00101.2009; Simpson DM, 2001, MED BIOL ENG COMPUT, V39, P428, DOI 10.1007/BF02345364; Temel Y, 2008, CURR BIOL, V18, pR412, DOI 10.1016/j.cub.2008.03.008; Temel Y, 2009, EXP NEUROL, V216, P481, DOI 10.1016/j.expneurol.2009.01.007; Toh WL, 2011, COMPR PSYCHIAT, V52, P567, DOI 10.1016/j.comppsych.2010.12.005; Trukenbrod HA, 2012, J VIS, V12; TSUNODA M, 1992, SCHIZOPHR RES, V7, P159, DOI 10.1016/0920-9964(92)90046-8; VENTRE J, 1992, BRAIN, V115, P1147, DOI 10.1093/brain/115.4.1147; von Wartburg R, 2007, PERCEPTION, V36, P355, DOI 10.1068/p5552; Wark HAC, 2008, J NEUROL NEUROSUR PS, V79, P443, DOI 10.1136/jnnp.2007.117192; Wiese H, 2004, NEUROSCI LETT, V371, P220, DOI 10.1016/j.neulet.2004.08.078; Wild J, 2012, J NEUROSCI METH, V203, P369, DOI 10.1016/j.jneumeth.2011.10.013; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001; Yan YJ, 2001, J NEUROPHYSIOL, V86, P3056, DOI 10.1152/jn.2001.86.6.3056; Yoshida A, 2009, CEREB CORTEX, V19, P206, DOI 10.1093/cercor/bhn069; Yugeta A, 2010, NEUROLOGY, V74, P743, DOI 10.1212/WNL.0b013e3181d31e0b; Zihl J, 1997, NEUROPSYCHOLOGIA, V35, P893, DOI 10.1016/S0028-3932(97)00006-7	75	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78581	10.1371/journal.pone.0078581	http://dx.doi.org/10.1371/journal.pone.0078581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223158	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200050
J	Feng, Y; Wang, BY; Du, FY; Li, HB; Wang, SL; Hu, CH; Zhu, CH; Yu, XR				Feng, Yan; Wang, Baoying; Du, Fangying; Li, Hongbo; Wang, Shaolan; Hu, Chenghu; Zhu, Chunhui; Yu, Xiaorui			The Involvement of PI3K-Mediated and L-VGCC-Gated Transient Ca2+ Influx in 17 beta-Estradiol-Mediated Protection of Retinal Cells from H2O2-Induced Apoptosis with Ca2+ Overload	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; HYDROGEN-PEROXIDE; DEPENDENT NEURODEGENERATION; MOLECULAR-MECHANISMS; NEURONAL DEATH; SIGNAL PATHWAY; TRPC CHANNELS; ESTROGEN; RECEPTOR; EXPRESSION	Intracellular calcium concentration ([Ca2+](i)) plays an important role in regulating most cellular processes, including apoptosis and survival, but its alterations are different and complicated under diverse conditions. In this study, we focused on the [Ca2+](i) and its control mechanisms in process of hydrogen peroxide (H2O2)-induced apoptosis of primary cultured Sprague-Dawley (SD) rat retinal cells and 17 beta-estradiol (beta E2) anti-apoptosis. Fluo-3AM was used as a Ca2+ indicator to detect [Ca2+](i) through fluorescence-activated cell sorting (FACS), cell viability was assayed using MTT assay, and apoptosis was marked by Hoechst 33342 and annexin V/Propidium Iodide staining. Besides, PI3K activity was detected by Western blotting. Results showed: a) 100 mu M H2O2-induced retinal cell apoptosis occurred at 4 h after H2O2 stress and increased in a time-dependent manner, but [Ca2+](i) increased earlier at 2 h, sustained to 12 h, and then recovered at 24 h after H2O2 stress; b) 10 mu M beta E2 treatment for 0.5-24 hrs increased cell viability by transiently increasing [Ca2+](i), which appeared only at 0.5 h after beta E2 application; c) increased [Ca2+](i) under 100 mu M H2O2 treatment for 2 hrs or 10 mu M beta E2 treatment for 0.5 hrs was, at least partly, due to extracellular Ca2+ stores; d) importantly, the transiently increased [Ca2+](i) induced by 10 mu M beta E2 treatment for 0.5 hrs was mediated by the phosphatidylinositol-3-kinase (PI3K) and gated by the L-type voltage-gated Ca2+ channels (L-VGCC), but the increased [Ca2+](i) induced by 100 mu M H2O2 treatment for 2 hrs was not affected; and e) pretreatment with 10 mu M beta E2 for 0.5 hrs effectively protected retinal cells from apoptosis induced by 100 mu M H2O2, which was also associated with its transient [Ca2+](i) increase through L-VGCC and PI3K pathway. These findings will lead to better understanding of the mechanisms of beta E2-mediated retinal protection and to exploration of the novel therapeutic strategies for retina degeneration.	[Feng, Yan; Wang, Baoying; Du, Fangying; Li, Hongbo; Wang, Shaolan; Hu, Chenghu; Zhu, Chunhui; Yu, Xiaorui] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Peoples R China; [Yu, Xiaorui] Xi An Jiao Tong Univ, Sch Med, Key Lab Environm & Gene Related Dis, Minist Educ, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yu, XR (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Peoples R China.	xiaoruiy@mail.xjtu.edu.cn	Hu, Cheng-Hu/I-4210-2013	Hu, Cheng-Hu/0000-0003-2443-6485	National Natural Science Foundation of China [30672286, 81271013]; National Research Foundation for the Doctoral Program of Higher Education of China [20120201110051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No: 30672286 and No: 81271013) and the National Research Foundation for the Doctoral Program of Higher Education of China (No: 20120201110051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Arroba AI, 2009, EUR J NEUROSCI, V30, P975, DOI 10.1111/j.1460-9568.2009.06902.x; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Berliocchi L, 2005, PHILOS T R SOC B, V360, P2255, DOI 10.1098/rstb.2005.1765; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Brandt SK, 2011, NEUROSCIENCE, V172, P387, DOI 10.1016/j.neuroscience.2010.10.071; Brzyska M, 2003, ACTA NEUROBIOL EXP, V63, P171; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen KC, 2000, P NATL ACAD SCI USA, V97, P4357, DOI 10.1073/pnas.070056097; Chen Q, 1999, EXP NEUROL, V159, P283, DOI 10.1006/exnr.1999.7135; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Darios F, 2005, J NEUROSCI, V25, P4159, DOI 10.1523/JNEUROSCI.0060-05.2005; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Duncan RS, 2010, MOLECULES, V15, P1168, DOI 10.3390/molecules15031168; Farkas I, 2012, NEUROCHEM INT, V60, P631, DOI 10.1016/j.neuint.2012.02.024; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Guarneri P, 2003, ANN NY ACAD SCI, V1007, P117, DOI 10.1196/annals.1286.012; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Herson PS, 1999, J BIOL CHEM, V274, P833, DOI 10.1074/jbc.274.2.833; Hwang JY, 2009, CELL CALCIUM, V45, P233, DOI 10.1016/j.ceca.2008.10.006; Irnaten M, 2009, STEROIDS, V74, P642, DOI 10.1016/j.steroids.2009.02.002; Kobayashi K, 1998, INVEST OPHTH VIS SCI, V39, P2105; Lapanantasin S, 2006, SYNAPSE, V60, P406, DOI 10.1002/syn.20308; Lee HJ, 2005, LIFE SCI, V78, P294, DOI 10.1016/j.lfs.2005.04.043; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mo MS, 2013, NEUROSCIENCE, V228, P1, DOI 10.1016/j.neuroscience.2012.10.002; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Moosmann B, 2002, EXPERT OPIN INV DRUG, V11, P1407, DOI 10.1517/13543784.11.10.1407; Munaut C, 2001, BRIT J OPHTHALMOL, V85, P877, DOI 10.1136/bjo.85.7.877; Nguyen TTH, 2008, BIOL PHARM BULL, V31, P2028, DOI 10.1248/bpb.31.2028; Noguchi A, 2008, LIFE SCI, V83, P865, DOI 10.1016/j.lfs.2008.10.002; Paschen W, 2000, BRAIN RES BULL, V53, P409, DOI 10.1016/S0361-9230(00)00369-5; PRINCE RL, 1994, ENDOCR REV, V15, P301, DOI 10.1210/er.15.3.301; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Seigel G, 1999, MOL VIS, V5; Selvaraj S, 2010, CNS NEUROL DISORD-DR, V9, P94, DOI 10.2174/187152710790966650; Sokolova T, 2001, NEUROSCI LETT, V297, P129, DOI 10.1016/S0304-3940(00)01689-X; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Vicencio JM, 2006, ENDOCRINOLOGY, V147, P1386, DOI 10.1210/en.2005-1139; Wu SZ, 2009, J NEUROCHEM, V109, P1225, DOI 10.1111/j.1471-4159.2009.06037.x; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Xiang GX, 2007, J CELL PHYSIOL, V212, P126, DOI 10.1002/jcp.21008; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Yoshida I, 2006, NEUROCHEM INT, V48, P696, DOI 10.1016/j.neuint.2005.12.012; Yu XR, 2005, MECH AGEING DEV, V126, P1135, DOI 10.1016/j.mad.2005.05.005; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	55	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77218	10.1371/journal.pone.0077218	http://dx.doi.org/10.1371/journal.pone.0077218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223708	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400005
J	Han, M; Zheng, Y				Han, Miao; Zheng, Yun			Comprehensive Analysis of Single Nucleotide Polymorphisms in Human MicroRNAs	PLOS ONE			English	Article							FRAGILE SITES; GENETIC-VARIATION; LET-7; EXPRESSION; DATABASE; COMMON; VARIANTS; SNP; IDENTIFICATION; BIOGENESIS	MicroRNAs (miRNAs) are endogenous small non-coding RNAs that repress their targets at post transcriptional level. Single Nucleotide Polymorphisms (SNPs) in miRNAs can lead to severe defects to the functions of miRNAs and might result in diseases. Although several studies have tried to identify the SNPs in human miRNA genes or only in the mature miRNAs, there are only limited endeavors to explain the distribution of SNPs in these important genes. After a genome-wide scan for SNPs in human miRNAs, we totally identified 1899 SNPs in 961 out of the 1527 reported miRNA precursors of human, which is the most complete list of SNPs in human miRNAs to date. More importantly, to explain the distributions of SNPs existed in human miRNAs, we comprehensively and systematically analyzed the identified SNPs in miRNAs from several aspects. Our results suggest that conservation, genomic context, secondary structure, and functional importance of human miRNAs affect the accumulations of SNPs in these genes. Our results also show that the number of SNPs with significantly different frequencies among various populations in the HapMap and 1000 Genome Project data are consistent with the geographical distributions of these populations. These analyses provide a better insight of SNPs in human miRNAs and the spreading of the SNPs in miRNAs in different populations.	[Han, Miao] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Han, Miao] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Zheng, Yun] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China	Fudan University; Fudan University; Kunming University of Science & Technology	Zheng, Y (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.	zhengyun5488@gmail.com	Zheng, Yun/I-7011-2012; Zheng, Yun/AAS-1149-2021	Zheng, Yun/0000-0003-4292-9806; Zheng, Yun/0000-0003-4292-9806	Kunming University of Science and Technology	Kunming University of Science and Technology	The research was supported by a start-up grant of Kunming University of Science and Technology to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Armengol L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007230; Arola-Arnal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025982; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhartiya D, 2011, HUM MUTAT, V32, pE2226, DOI 10.1002/humu.21482; BROWN GG, 1982, P NATL ACAD SCI-BIOL, V79, P3246, DOI 10.1073/pnas.79.10.3246; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Debacker K, 2007, HUM MOL GENET, V16, pR150, DOI 10.1093/hmg/ddm136; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; El-Murr N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031862; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Gartel AL, 2006, BIOMOL ENG, V23, P17, DOI 10.1016/j.bioeng.2006.01.002; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kasinski AL, 2009, NUCLEIC ACIDS RES, V461, P747; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; SCHMID M, 1985, HUM GENET, V71, P342, DOI 10.1007/BF00388461; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134; Zorc M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030737; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78028	10.1371/journal.pone.0078028	http://dx.doi.org/10.1371/journal.pone.0078028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223755	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400016
J	Li, Y; Wang, JX; Chen, Z; Tang, X				Li, Ying; Wang, Jiaxing; Chen, Zhuo; Tang, Xin			Effect of Hydrophobic Acrylic versus Hydrophilic Acrylic Intraocular Lens on Posterior Capsule Opacification: Meta-Analysis	PLOS ONE			English	Article							OPTIC EDGE DESIGN; 2-YEAR FOLLOW-UP; IMPLANTATION; SILICONE; ACRYSOF; RATES; EYES; CATARACT; HYDROGEL; INHIBITION	Purpose: This meta-analysis aims to evaluate the differences in performance of posterior capsular opacification (PCO) between hydrophobic acrylic intraocular lens (IOLs) and hydrophilic acrylic IOLs. Setting: Tianjin Medical University, Tianjin Eye Hospital, Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin, China. Design: Systematic review of randomized controlled trials (RCTs) or meta-analysis. Methods: An electronic literature search was performed using the PubMed, EMBASE and Cochrane Library database before May in 2013 to identify prospective RCTs comparing hydrophobic acrylic IOLs and hydrophilic acrylic IOLs in patients after phacoemulsification with IOL implantation with a follow-up time of at least 1 year. Pertinent studies were selected by meeting predefined criteria and reviewed systematically by meta-analysis. The PCO scores and YAG capsulotomy rate, as indicator of PCO, were measured and discussed in a meta-analysis. Standardized mean differences (SMD), relative risk ratio (RR), and the pooled estimates were computed according to a random effect model or fixed effect model. Results: Nine prospective RCTs involving 861 eyes were included in the current meta-analysis. The hydrophobic acrylic IOLs were favored and the pooled SMD of PCO severity was 1.72 (95% confidence interval (CI), 0.20 to 1.23, P = 0.0002) and 1.79 (95% CI, 0.95 to 2.64, P<0.0001) with 1-year follow-up and 2-year follow-up respectively. The pooled RR of Nd:YAG laser capsulotomy rates at postoperative 2-year follow-up was 6.96 (95% CI, 3.69 to 13.11, P<0.00001) comparing hydrophilic acrylic IOLs with hydrophobic acrylic IOLs. Conclusions: Compared with hydrophilic acrylic IOLs, the hydrophobic acrylic IOLs showed superior reduction in rates of PCO and laser capsulotomy in 2-year follow-up. More RCTs with standard methods for longer follow-up are needed to validate the association.	[Li, Ying; Chen, Zhuo; Tang, Xin] Tianjin Med Univ, Tianjin Eye Hosp, Clin Coll Ophthalmol, Tianjin, Peoples R China; [Wang, Jiaxing] Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Tang, X (corresponding author), Tianjin Med Univ, Tianjin Eye Hosp, Clin Coll Ophthalmol, Tianjin, Peoples R China.	xtang2013@gmail.com	wang, jiaxing/I-1193-2019	wang, jiaxing/0000-0001-8958-6893; Li, Ying/0000-0002-9615-4914				Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6; Apple DJ, 2001, OPHTHALMOLOGY, V108, P505, DOI 10.1016/S0161-6420(00)00589-3; Aslam TM, 2003, GRAEF ARCH CLIN EXP, V241, P208, DOI 10.1007/s00417-003-0626-8; Beltrame G, 2002, EUR J OPHTHALMOL, V12, P388, DOI 10.1177/112067210201200508; Biber JM, 2009, J CATARACT REFR SURG, V35, P1234, DOI 10.1016/j.jcrs.2009.03.013; Buehl W, 2005, J CATARACT REFR SURG, V31, P954, DOI 10.1016/j.jcrs.2004.09.053; Buehl W, 2008, J CATARACT REFR SURG, V34, P1976, DOI 10.1016/j.jcrs.2008.07.029; Cheng JW, 2007, AM J OPHTHALMOL, V143, P428, DOI 10.1016/j.ajo.2006.11.045; Cleary G, 2009, J CATARACT REFR SURG, V35, P265, DOI 10.1016/j.jcrs.2008.10.048; Dorey MW, 2003, AM J OPHTHALMOL, V135, P591, DOI 10.1016/S0002-9394(02)02154-2; Findl O, 2005, OPHTHALMOLOGY, V112, P67, DOI 10.1016/j.ophtha.2004.07.032; Findl O, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003738.pub3; Fujita S, 2012, OPHTHALMIC RES, V48, P102, DOI 10.1159/000335981; Gangwani V, 2011, J CATARACT REFR SURG, V37, P1988, DOI 10.1016/j.jcrs.2011.05.035; Hancox J, 2008, J CATARACT REFR SURG, V34, P1489, DOI 10.1016/j.jcrs.2008.05.024; Hancox J, 2007, J CATARACT REFR SURG, V33, P413, DOI 10.1016/j.jcrs.2006.10.056; Hayashi K, 2004, BRIT J OPHTHALMOL, V88, P182, DOI 10.1136/bjo.2003.023580; Heatley CJ, 2005, J CATARACT REFR SURG, V31, P718, DOI 10.1016/j.jcrs.2004.08.060; Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7; Iwase T, 2011, J CATARACT REFR SURG, V37, P1060, DOI 10.1016/j.jcrs.2010.12.059; Kang S, 2009, JPN J OPHTHALMOL, V53, P204, DOI 10.1007/s10384-008-0646-3; Khandwala MA, 2007, J CATARACT REFR SURG, V33, P1409, DOI 10.1016/j.jcrs.2007.04.022; Kugelberg M, 2008, ACTA OPHTHALMOL, V86, P533, DOI 10.1111/j.1600-0420.2007.01094.x; Kugelberg M, 2006, J CATARACT REFR SURG, V32, P1627, DOI 10.1016/j.jcrs.2006.05.011; Leydolt C, 2007, OPHTHALMOLOGY, V114, P1663, DOI 10.1016/j.ophtha.2006.12.016; Li N, 2008, OPHTHALMOLOGY, V115, P830, DOI 10.1016/j.ophtha.2007.06.037; Nagamoto T, 2003, J CATARACT REFR SURG, V29, P1605, DOI 10.1016/S0886-3350(03)00050-6; Nagata T, 1998, J CATARACT REFR SURG, V24, P367, DOI 10.1016/S0886-3350(98)80325-8; Nishi O, 2007, J CATARACT REFR SURG, V33, P1065, DOI 10.1016/j.jcrs.2007.02.022; Nishi Y, 2007, J CATARACT REFR SURG, V33, P227, DOI 10.1016/j.jcrs.2006.10.020; Ramos Macias A, 1992, Acta Otorrinolaringol Esp, V43, P117; Richter-Mueksch S, 2007, J CATARACT REFR SURG, V33, P1414, DOI 10.1016/j.jcrs.2007.05.009; Sacu S, 2004, J CATARACT REFR SURG, V30, P2322, DOI 10.1016/j.jcrs.2004.03.042; Vasavada AR, 2011, J CATARACT REFR SURG, V37, P1050, DOI 10.1016/j.jcrs.2010.12.060; Werner L, 2009, J CATARACT REFR SURG, V35, P556, DOI 10.1016/j.jcrs.2008.11.042; Wren SME, 2005, AM J OPHTHALMOL, V139, P691, DOI 10.1016/j.ajo.2004.12.013; Zhu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033013	37	34	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77864	10.1371/journal.pone.0077864	http://dx.doi.org/10.1371/journal.pone.0077864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223736	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400015
J	Campos, F; Sobrino, T; Vieites-Prado, A; Perez-Mato, M; Rodriguez-Yanez, M; Blanco, M; Castillo, J				Campos, Francisco; Sobrino, Tomas; Vieites-Prado, Alba; Perez-Mato, Maria; Rodriguez-Yanez, Manuel; Blanco, Miguel; Castillo, Jose			Hyperthermia in Human Ischemic and Hemorrhagic Stroke: Similar Outcome, Different Mechanisms	PLOS ONE			English	Article							EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; BODY-TEMPERATURE; AMINO-ACIDS; THERAPIES; MORTALITY; INFARCT; INJURY	Hyperthermia is a predictor of poor outcome in ischemic (IS) and intracerebral hemorrhagic (ICH) stroke. Our aim was to study the plausible mechanisms involved in the poor outcome associated to hyperthermia in stroke. We conducted a case-control study including patients with IS (n = 100) and ICH (n = 100) within the first 12 hours from symptom onset. Specifically, IS and ICH patients were consecutively included into 2 subgroups, according to the highest body temperature within the first 24 hours: Tmax <37.5 degrees C and Tmax >= 37.5 degrees C, up to reach 50 patients per subgroup of temperature for both IS and ICH patients. Body temperature was determined at admission and every 4 hours during the first 48 hours. Main outcome variable was poor functional outcome (modified Rankin scale score >2) at 3 months. Serum levels of glutamate and active MMP-9 were measured at admission. Our results showed that Tmax >= 37.5 degrees C within the first 24 hours was independently associated with poor outcome in both IS (OR, 12.43; 95% CI, 3.73-41.48; p<0.0001) and ICH (OR, 4.29; 95% CI, 1.32-13.91; p = 0.015) after adjusting for variables with a proven biological relevance for outcome. However, when molecular markers levels were included in the logistic regression model, we observed that glutamate (OR, 1.01; 95% CI, 1.00-1.02; p = 0.001) and infarct volume (OR, 1.06; 95% CI, 1.01-1.10; p = 0.015) were the only variables independently associated to poor outcome in IS, and active MMP-9 (OR, 1.04; 95% CI, 1.00-1.08; p = 0.002) and National Institute of Health Stroke Scale (NIHSS) at admission (OR, 1.29; 95% CI, 1.13-1.49; p<0.0001) in ICH. In conclusion, these results suggest that although the outcome associated to hyperthermia is similar in human IS and ICH, the underlying mechanisms may be different.	[Campos, Francisco; Sobrino, Tomas; Vieites-Prado, Alba; Perez-Mato, Maria; Rodriguez-Yanez, Manuel; Blanco, Miguel; Castillo, Jose] Univ Santiago de Compostela, Hlth Res Inst Santiago de Compostela IDIS, Hosp Clin Univ, Dept Neurol,Neurovasc Area,Clin Neurosci Res Lab, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Castillo, J (corresponding author), Univ Santiago de Compostela, Hlth Res Inst Santiago de Compostela IDIS, Hosp Clin Univ, Dept Neurol,Neurovasc Area,Clin Neurosci Res Lab, Santiago De Compostela, Spain.	jose.castillo@usc.es	Sobrino, Tomás/D-2498-2017; Vieites-Prado, Alba/AAD-3378-2022; Rodríguez-Yáñez, Manuel/ABI-1283-2020; Vieites-Prado, Alba/GVS-3749-2022	Sobrino, Tomás/0000-0002-9760-8690; Vieites-Prado, Alba/0000-0002-8807-3321; Rodríguez-Yáñez, Manuel/0000-0002-5381-8557; Vieites-Prado, Alba/0000-0002-8807-3321; Castillo, Jose/0000-0002-6685-3001	Spanish Ministry of Economy and Competitiveness [SAF2011-30517]; Xunta de Galicia [Conselleria Economia Industria: 10PXIB918282PR, Conselleria Educacion: CN2011/010]; Instituto de Salud Carlos III [PI11/00909, CP12/03121]; Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS [RD12/0014]; COST Action "Brain Extracellular Matrix in Health and Disease'' [BM1001]; Fundacion Mutua Madrilena; European Union program FEDER; Miguel Servet Program of Instituto de Salud Carlos III	Spanish Ministry of Economy and Competitiveness(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS; COST Action "Brain Extracellular Matrix in Health and Disease''; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); European Union program FEDER; Miguel Servet Program of Instituto de Salud Carlos III	This project has been partially supported by grants from the Spanish Ministry of Economy and Competitiveness SAF2011-30517, Xunta de Galicia (Conselleria Economia Industria: 10PXIB918282PR; and Conselleria Educacion: CN2011/010), Instituto de Salud Carlos III (PI11/00909 and CP12/03121), Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS (RD12/0014), COST Action BM1001 "Brain Extracellular Matrix in Health and Disease'', Fundacion Mutua Madrilena and by the European Union program FEDER. Furthermore, T. Sobrino is recipient of a research contract from Miguel Servet Program of Instituto de Salud Carlos III. Sponsors did not participate in study design, collection, analysis and interpretation of the data, writing the report or in the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Belur PK, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1317; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; Campos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044191; Campos F, 2012, NEUROCHEM INT, V60, P495, DOI 10.1016/j.neuint.2012.02.003; Campos F, 2012, INT J BIOCHEM CELL B, V44, P262, DOI 10.1016/j.biocel.2011.11.003; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; CASTILLO J, 1994, CEREBROVASC DIS, V4, P66, DOI 10.1159/000108454; den Hertog HM, 2011, J NEUROL, V258, P302, DOI 10.1007/s00415-010-5756-4; Katsuki H, 2010, J PHARMACOL SCI, V114, P366, DOI 10.1254/jphs.10R05CR; Lee ST, 2006, J CEREBR BLOOD F MET, V26, P536, DOI 10.1038/sj.jcbfm.9600213; Leira R, 2006, J INTERN MED, V260, P343, DOI 10.1111/j.1365-2796.2006.01694.x; Li N, 2013, STROKE, V44, P658, DOI 10.1161/STROKEAHA.112.673590; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rincon F, 2013, NEUROCRIT CARE, V18, P45, DOI 10.1007/s12028-012-9779-9; Rodriguez-Yanez M, 2011, STROKE, V42, P2813, DOI 10.1161/STROKEAHA.111.614503; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Tomsick TA, 2010, NEUROLOGY, V74, P1069, DOI 10.1212/WNL.0b013e3181d76b8f	22	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78429	10.1371/journal.pone.0078429	http://dx.doi.org/10.1371/journal.pone.0078429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223804	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400060
J	Miller, D; Turner, SW; Spiteri-Cornish, D; McInnes, N; Scaife, A; Danielian, PJ; Devereux, G; Walsh, GM				Miller, David; Turner, Steve W.; Spiteri-Cornish, Daniella; McInnes, Neil; Scaife, Alison; Danielian, Peter J.; Devereux, Graham; Walsh, Garry M.			Culture of Airway Epithelial Cells from Neonates Sampled within 48-Hours of Birth	PLOS ONE			English	Article							ASTHMA PATHOGENESIS; PEDIATRIC-AIRWAY; CHILDREN; NASAL; REPAIR	Introduction: Little is known about how neonatal airway epithelial cell phenotype impacts on respiratory disease in later life. This study aimed to establish a methodology to culture and characterise neonatal nasal epithelial cells sampled from healthy, non-sedated infants within 48 hours of delivery. Methods: Nasal epithelial cells were sampled by brushing both nostrils with an interdental brush, grown to confluence and sub-cultured. Cultured cells were characterised morphologically by light and electron microscopy and by immunocytochemistry. As an exemplar pro-inflammatory chemokine, IL-8 concentrations were measured in supernatants from unstimulated monolayers and after exposure to IL-1 beta/TNF-alpha a or house dust mite extract. Results: Primary cultures were successfully established in 135 (91%) of 149 neonatal samples seeded, with 79% (n = 117) successfully cultured to passage 3. The epithelial lineage of the cells was confirmed by morphological analysis and immunostaining. Constitutive IL-8 secretion was observed and was upregulated by IL-1 beta/TNF-alpha or house dust mite extract in a dose dependent manner. Conclusion: We describe a safe, minimally invasive method of culturing nasal epithelial cells from neonates suitable for functional cell analysis offering an opportunity to study "naive'' cells that may prove useful in elucidating the role of the epithelium in the early origins of asthma and/or allergic rhinitis.	[Miller, David; Turner, Steve W.; Spiteri-Cornish, Daniella; McInnes, Neil; Devereux, Graham] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Dept Child Hlth, Aberdeen, Scotland; [Miller, David; Spiteri-Cornish, Daniella; McInnes, Neil; Scaife, Alison; Walsh, Garry M.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Danielian, Peter J.] Aberdeen Matern Hosp, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Miller, D (corresponding author), Univ Aberdeen, Royal Aberdeen Childrens Hosp, Dept Child Hlth, Aberdeen, Scotland.	d.miller@nhs.net		Spiteri Cornish, Daniella/0000-0002-5814-2461	Chief Scientist Office, Edinburgh, UK [CAF/10/06]; Chief Scientist Office [CAF/10/06] Funding Source: researchfish	Chief Scientist Office, Edinburgh, UK; Chief Scientist Office	This study was funded by the Chief Scientist Office, Edinburgh, UK (CAF/10/06). http://www.cso.scot.nhs.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush A, 2000, ALLERGY, V55, P685, DOI 10.1034/j.1398-9995.2000.00031.x; Carlsen KCL, 1997, EUR RESPIR J, V10, P1774, DOI 10.1183/09031936.97.10081774; Devereux G, 2007, PEDIATR PULM, V42, P663, DOI 10.1002/ppul.20640; Doherty GM, 2003, CLIN EXP ALLERGY, V33, P1221, DOI 10.1046/j.1365-2222.2003.01752.x; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; HOLT PG, 2006, EARLY LIFE ORIGINS A, P223; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Lane C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-53; LEE RMKW, 1984, AM REV RESPIR DIS, V129, P190; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; McNamara PS, 2008, EUR RESPIR J, V32, P763, DOI 10.1183/09031936.00162507; Mosler K, 2008, J CYST FIBROS, V7, P44, DOI 10.1016/j.jcf.2007.04.005; O'Callaghan C, 1991, ARCH DIS CHILD, V66, P4431; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Prescott SL, 2003, CURR OPIN ALLERGY CL, V3, P125, DOI 10.1097/01.all.0000064776.57552.32; Pringle EJ, 2012, PEDIATR PULM, V47, P1215, DOI 10.1002/ppul.22672; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Stevens PT, 2008, CLIN EXP ALLERGY, V38, P1901, DOI 10.1111/j.1365-2222.2008.03093.x; Turner SW, 2010, THORAX, V65, P391, DOI 10.1136/thx.2008.111385; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78321	10.1371/journal.pone.0078321	http://dx.doi.org/10.1371/journal.pone.0078321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223790	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400050
J	Mudgil, Y; Ghawana, S; Jones, AM				Mudgil, Yashwanti; Ghawana, Sanjay; Jones, Alan M.			N-MYC DOWN-REGULATED-LIKE Proteins Regulate Meristem Initiation by Modulating Auxin Transport and MAX2 Expression	PLOS ONE			English	Article							SUPPRESSOR GENE DRG-1; ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; TUMOR-METASTASIS; BETA-SUBUNIT; CYTOKININ BIOSYNTHESIS; DEPENDENT REGULATION; BUD OUTGROWTH; BREAST-CANCER; PIN PROTEINS	Background: N-MYC DOWN-REGULATED-LIKE (NDL) proteins interact with the G beta subunit (AGB1) of the heterotrimeric G protein complex and play an important role in AGB1-dependent regulation of lateral root formation by affecting root auxin transport, auxin gradients and the steady-state levels of mRNA encoding the PIN-FORMED 2 and AUXIN 1 auxin transport facilitators. Auxin transport in aerial tissue follows different paths and utilizes different transporters than in roots; therefore, in the present study, we analyzed whether NDL proteins play an important role in AGB1-dependent, auxin-mediated meristem development. Methodology/Principal Findings: Expression levels of NDL gene family members need to be tightly regulated, and altered expression (both over-expression and down-regulation) confers ectopic growth. Over-expression of NDL1 disrupts vegetative and reproductive organ development. Reduced expression of the NDL gene family members results in asymmetric leaf emergence, twinning of rosette leaves, defects in leaf formation, and abnormal silique distribution. Reduced expression of the NDL genes in the agb1-2 (null allele) mutant rescues some of the abnormal phenotypes, such as silique morphology, silique distribution, and peduncle angle, suggesting that proper levels of NDL proteins are maintained by AGB1. We found that all of these abnormal aerial phenotypes due to altered NDL expression were associated with increases in basipetal auxin transport, altered auxin maxima and altered MAX2 expression within the inflorescence stem. Conclusion/Significance: NDL proteins, together with AGB1, act as positive regulators of meristem initiation and branching. AGB1 and NDL1 positively regulate basipetal inflorescence auxin transport and modulate MAX2 expression in shoots, which in turn regulates organ and lateral meristem formation by the establishment and maintenance of auxin gradients.	[Mudgil, Yashwanti; Ghawana, Sanjay] Univ Delhi, Dept Bot, Delhi 110007, India; [Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of Delhi; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mudgil, Y (corresponding author), Univ Delhi, Dept Bot, Delhi 110007, India.	ymudgil@botany.du.ac.in	Ariel, Pablo/AGJ-4118-2022	MUDGIL, YASHWANTI/0000-0002-0423-3499	Government of India; Department of Biotechnology-BIO-CARE grant [102/IFD/SAN/3538/2011-2012]; DST FAST-TRACK grant from SERB [SR/FT/LS-30/2011]; UGC, University of Delhi; DBT CREST award; NIGMS [R01GM065989]; DOE [DE-FG02-05er15671]; NSF [MCB-0723515, MCB-1158054, MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy; Div Of Molecular and Cellular Bioscience [1158054] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER	Government of India; Department of Biotechnology-BIO-CARE grant; DST FAST-TRACK grant from SERB; UGC, University of Delhi; DBT CREST award; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial source: This work was supported by the Government of India, Department of Biotechnology-BIO-CARE grant (102/IFD/SAN/3538/2011-2012), DST FAST-TRACK (SR/FT/LS-30/2011) grant from SERB, a research grant provided by UGC, University of Delhi and DBT CREST award (2011-2012) to YM. Work in the Jones Lab is supported by grants from the NIGMS (R01GM065989), DOE (DE-FG02-05er15671), and NSF (MCB-0723515, MCB-1158054, and MCB-0718202). The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy funded technical support in this study. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Balla J, 2011, PLANT J, V65, P571, DOI 10.1111/j.1365-313X.2010.04443.x; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Benjamins R, 2005, BIOESSAYS, V27, P1246, DOI 10.1002/bies.20322; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Cheng Y, 2007, PLANT CELL; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Cheng ZJ, 2012, PLANT PHYSL; Crawford S, 2010, DEVELOPMENT, V137, P2905, DOI 10.1242/dev.051987; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Fan LM, 2008, P NATL ACAD SCI USA, V105, P8476, DOI 10.1073/pnas.0800980105; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; Fourquin C, 2007, ANN BOT-LONDON, V100, P651, DOI 10.1093/aob/mcm136; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J., 2009, EUR J CELL BIOL; GALAVAZI G, 1965, STAIN TECHNOL, V40, P1; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Goldshmidt A, 2008, PLANT CELL, V20, P1217, DOI 10.1105/tpc.107.057877; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Grunewald W, 2010, EMBO J, V29, P2700, DOI 10.1038/emboj.2010.181; Guang RJ, 2000, CANCER RES, V60, P749; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hayward A, 2009, PLANT PHYSIOL, V151, P400, DOI 10.1104/pp.109.137646; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kato C, 2004, PLANT J, V38, P320, DOI 10.1111/j.1365-313X.2004.02046.x; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Kumaran MK, 2002, PLANT CELL, V14, P2761, DOI 10.1105/tpc.004911; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lazar G, 2006, P NATL ACAD SCI USA, V103, P472, DOI 10.1073/pnas.0509463102; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Li J, 2003, MOL CELL BIOCHEM, V250, P91, DOI 10.1023/A:1024918328162; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Meister RJ, 2005, PLANT PHYSIOL, V137, P651, DOI 10.1104/pp.104.055368; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; Mudgil Y, 2009, PLANT CELL, V21, P3591, DOI 10.1105/tpc.109.065557; Murphy AS, 2012, CURR BIOL, V22, pR576, DOI 10.1016/j.cub.2012.06.008; Naramoto S, 2009, DEVELOPMENT, V136, P1529, DOI 10.1242/dev.030098; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Peskan-Berghofer T, 2005, PLANTA, V220, P737, DOI 10.1007/s00425-004-1393-4; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Prunet N, 2009, PLANT PHYSIOL, V150, P1764, DOI 10.1104/pp.109.141812; Reinhardt D, 2005, CURR OPIN PLANT BIOL, V8, P487, DOI 10.1016/j.pbi.2005.07.012; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Santos F, 2010, PLANT BIOLOGY, V12, P3, DOI 10.1111/j.1438-8677.2010.00388.x; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Schmulling T, 2002, J PLANT GROWTH REGUL, V21, P40, DOI 10.1007/s003440010046; Shimizu-Sato S, 2009, PLANT MOL BIOL, V69, P429, DOI 10.1007/s11103-008-9416-3; Shinohara N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001474; SIEBURTH LE, 1995, PLANT CELL, V7, P1249, DOI 10.1105/tpc.7.8.1249; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Smith SM, 2012, CURR BIOL, V22, pR924, DOI 10.1016/j.cub.2012.09.016; Stirnberg P, 2010, BIOCHEM SOC T, V38, P717, DOI 10.1042/BST0380717; Sun J.-P., 2012, ELECT J DIFFERENTIAL, V2012, P1; Tanaka H, 2009, CURR BIOL, V19, P391, DOI 10.1016/j.cub.2009.01.057; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ureshino H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041312; vanBelzen N, 1997, LAB INVEST, V77, P85; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4	86	13	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77863	10.1371/journal.pone.0077863	http://dx.doi.org/10.1371/journal.pone.0077863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223735	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400018
J	Xu, YY; Zhou, Y; Hong, S; Xia, ZH; Cui, DQ; Guo, JC; Xu, HX; Jiang, XY				Xu, Yuanyuan; Zhou, Yang; Hong, Sha; Xia, Zhihui; Cui, Dangqun; Guo, Jianchun; Xu, Haixia; Jiang, Xingyu			Functional Characterization of a Wheat NHX Antiporter Gene TaNHX2 That Encodes a K+/H+ Exchanger	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SALT TOLERANCE; NA+/H+ ANTIPORTERS; SACCHAROMYCES-CEREVISIAE; STRESS TOLERANCE; CATION/H+ ANTIPORTER; TRANSPORT; YEAST; HOMEOSTASIS; PLANTS	The subcellular localization of a wheat NHX antiporter, TaNHX2, was studied in Arabidopsis protoplasts, and its function was evaluated using Saccharomyces cerevisiae as a heterologous expression system. Fluorescence patterns of TaNHX2-GFP fusion protein in Arabidopsis cells indicated that TaNHX2 localized at endomembranes. TaNHX2 has significant sequence homology to NHX sodium exchangers from Arabidopsis, is abundant in roots and leaves and is induced by salt or dehydration treatments. Western blot analysis showed that TaNHX2 could be expressed in transgenic yeast cells. Expressed TaNHX2 protein suppressed the salt sensitivity of a yeast mutant strain by increasing its K+ content when exposed to salt stress. TaNHX2 also increased the tolerance of the strain to potassium stress. However, the expression of TaNHX2 did not affect the sodium concentration in transgenic cells. Western blot analysis for tonoplast proteins indicated that the TaNHX2 protein localized at the tonoplast of transgenic yeast cells. The tonoplast vesicles from transgenic yeast cells displayed enhanced K+/H+ exchange activity but very little Na+/H+ exchange compared with controls transformed with the empty vector; Na+/H+ exchange was not detected with concentrations of less than 37.5 mM Na+ in the reaction medium. Our data suggest that TaNHX2 is a endomembrane-bound protein and may primarily function as a K+/H+ antiporter, which is involved in cellular pH regulation and potassium nutrition under normal conditions. Under saline conditions, the protein mediates resistance to salt stress through the intracellular compartmentalization of potassium to regulate cellular pH and K+ homeostasis.	[Xu, Yuanyuan; Cui, Dangqun; Xu, Haixia] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Zhou, Yang; Hong, Sha; Xia, Zhihui; Jiang, Xingyu] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Zhou, Yang; Guo, Jianchun] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China	Henan Agricultural University; Hainan University; Chinese Academy of Tropical Agricultural Sciences	Xu, HX (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	haixiaxu@sohu.com; jiangxingyu2002@yahoo.com			National Natural Science Foundation of China [31160185, 31101207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 31160185 and No. 31101207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Batelli G, 2007, MOL CELL BIOL, V27, P7781, DOI 10.1128/MCB.00430-07; BLUMWALD E, 1985, PLANT PHYSIOL, V78, P163, DOI 10.1104/pp.78.1.163; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brini F, 2007, J EXP BOT, V58, P301, DOI 10.1093/jxb/erl251; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Carden DE, 2003, PLANT PHYSIOL, V131, P676, DOI 10.1104/pp.011445; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hernandez A, 2009, J BIOL CHEM, V284, P14276, DOI 10.1074/jbc.M806203200; Jiang X, 2010, PLANT SIGNALING BEHA, V5, P1; Li HT, 2009, BIOCHEM BIOPH RES CO, V382, P637, DOI 10.1016/j.bbrc.2009.03.091; Liu H, 2010, PLANT CELL ENVIRON, V33, P1989, DOI 10.1111/j.1365-3040.2010.02200.x; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; ROBERTS CJ, 1991, METHODS ENZYMOL, V194, P644; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Sychrova H, 2004, PHYSIOL RES, V53, pS91; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Xu HX, 2008, ARCH BIOCHEM BIOPHYS, V473, P8, DOI 10.1016/j.abb.2008.02.018; Xue ZY, 2004, PLANT SCI, V167, P849, DOI 10.1016/j.plantsci.2004.05.034; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yu JN, 2007, J BIOSCIENCES, V32, P1153, DOI 10.1007/s12038-007-0117-x; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhu J., 2007, ENCY LIFE SCI ELS, DOI [10.1002/9780470015902.a0001300.pub2, DOI 10.1002/9780470015902.A0001300.PUB2]	43	36	40	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78098	10.1371/journal.pone.0078098	http://dx.doi.org/10.1371/journal.pone.0078098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223765	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300022
J	Allen, CL; Clare, G; Stewart, EA; Branch, MJ; McIntosh, OD; Dadhwal, M; Dua, HS; Hopkinson, A				Allen, Claire L.; Clare, Gerry; Stewart, Elizabeth A.; Branch, Matthew J.; McIntosh, Owen D.; Dadhwal, Megha; Dua, Harminder S.; Hopkinson, Andrew			Augmented Dried versus Cryopreserved Amniotic Membrane as an Ocular Surface Dressing	PLOS ONE			English	Article							HUMAN CORNEAL; STEM-CELLS; MYOFIBROBLAST DIFFERENTIATION; PLACENTAL MEMBRANES; IN-VITRO; EX-VIVO; TRANSPLANTATION; RECONSTRUCTION; TREHALOSE; SUPPRESSION	Purpose: Dried amniotic membrane (AM) can be a useful therapeutic adjunct in ophthalmic surgery and possesses logistical advantages over cryopreserved AM. Differences in preservation techniques can significantly influence the biochemical composition and physical properties of AM, potentially affecting clinical efficacy. This study was established to investigate the biochemical and structural effects of drying AM in the absence and presence of saccharide lyoprotectants and its biocompatibility compared to cryopreserved material. Methods: AM was cryopreserved or dried with and without pre-treatment with trehalose or raffinose and the antioxidant epigallocatechin (EGCG). Structural and visual comparisons were assessed using electron microscopy. Localisation, expression and release of AM biological factors were determined using immunoassays and immunofluorescence. The biocompatibility of the AM preparations co-cultured with corneal epithelial cell (CEC) or keratocyte monolayers were assessed using cell proliferation, cytotoxicity, apoptosis and migration assays. Results: Drying devitalised AM epithelium, but less than cryopreservation and cellular damage was reduced in dried AM pre-treated with trehalose or raffinose. Dried AM alone, and with trehalose or raffinose showed greater factor retention efficiencies and bioavailability compared to cryopreserved AM and demonstrated a more sustained biochemical factor time release in vitro. Cellular health assays showed that dried AM with trehalose or raffinose are compatible and superior substrates compared to cryopreserved AM for primary CEC expansion, with increased proliferation and reduced LDH and caspase-3 levels. This concept was supported by improved wound healing in an immortalised human CEC line (hiCEC) cocultured with dried and trehalose or raffinose membranes, compared to cryopreserved and fresh AM. Conclusions: Our modified preservation process and our resultant optimised dried AM has enhanced structural properties and biochemical stability and is a superior substrate to conventional cryopreserved AM. In addition this product is stable and easily transportable allowing it to be globally wide reaching for use in clinical and military sectors.	[Allen, Claire L.; Clare, Gerry; Stewart, Elizabeth A.; Branch, Matthew J.; McIntosh, Owen D.; Dadhwal, Megha; Dua, Harminder S.; Hopkinson, Andrew] Univ Nottingham, Div Clin Neurosci, Nottingham NG7 2RD, England	University of Nottingham	Hopkinson, A (corresponding author), Univ Nottingham, Div Clin Neurosci, Nottingham NG7 2RD, England.	andrew.hopkinson@nottingham.ac.uk	Branch, Matthew/AAE-9105-2019; Verma, Megha/I-3172-2019; Stewart, Elizabeth/K-5013-2014	Branch, Matthew James/0000-0002-8734-0037; Verma, Megha/0000-0001-7767-612X; Stewart, Elizabeth A/0000-0002-6248-4464	University of Nottingham; Defence Science & Technology Laboratory [RC23AX]	University of Nottingham; Defence Science & Technology Laboratory	This work has been supported by the University of Nottingham and the Defence Science & Technology Laboratory (RC23AX), https://www.dstl.gov.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andonovska D, 2008, Prilozi, V29, P183; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arora R, 2005, EYE, V19, P273, DOI 10.1038/sj.eye.6701490; Beattie GM, 1997, DIABETES, V46, P519, DOI 10.2337/diabetes.46.3.519; Branch MJ, 2012, INVEST OPHTH VIS SCI, V53, P5109, DOI 10.1167/iovs.11-8673; Calvin SE, 2007, ANN NY ACAD SCI, V1101, P166, DOI 10.1196/annals.1389.009; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Choi TH, 2001, CORNEA, V20, P197, DOI 10.1097/00003226-200103000-00019; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064; Davis JS, 1910, SKIN TRANSPLANTATION; de Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522; Dobreva MP, 2010, INT J DEV BIOL, V54, P761, DOI 10.1387/ijdb.092935md; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; FISHMAN IJ, 1987, J UROLOGY, V138, P1291, DOI 10.1016/S0022-5347(17)43586-5; Gicquel JJ, 2009, TISSUE ENG PT A, V15, P1919, DOI 10.1089/ten.tea.2008.0432; Grueterich M, 2002, ARCH OPHTHALMOL-CHIC, V120, P783; Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415; Hopkinson A, 2006, J PROTEOME RES, V5, P2226, DOI 10.1021/pr050425q; Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Jang IK, 2006, ARTIF ORGANS, V30, P424, DOI 10.1111/j.1525-1594.2006.00237.x; Kitagawa K, 2011, JPN J OPHTHALMOL, V55, P16, DOI 10.1007/s10384-010-0903-0; Kitagawa K, 2009, AM J OPHTHALMOL, V148, P383, DOI 10.1016/j.ajo.2009.03.030; Kjaergaard N, 2001, EUR J OBSTET GYN R B, V94, P224, DOI 10.1016/S0301-2115(00)00345-6; Kobayashi N, 2002, CORNEA, V21, P62, DOI 10.1097/00003226-200201000-00014; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; LAWSON VG, 1985, ARCH OTOLARYNGOL, V111, P230; Liang HS, 2009, J NEUROTRAUM, V26, P1745, DOI [10.1089/neu.2008.0850, 10.1089/neu.2008-0850]; Libera RD, 2008, ARQ BRAS OFTALMOL, V71, P669, DOI 10.1590/S0004-27492008000500011; Lim LS, 2010, ARCH OPHTHALMOL-CHIC, V128, P1303, DOI 10.1001/archophthalmol.2010.222; Lopez-Valladares MJ, 2010, ACTA OPHTHALMOL, V88, pe211, DOI 10.1111/j.1755-3768.2010.01908.x; Matsuo T, 2001, BRIT J OPHTHALMOL, V85, P610, DOI 10.1136/bjo.85.5.610; Nakamura T, 2006, ACTA OPHTHALMOL SCAN, V84, P401, DOI 10.1111/j.1600-0420.2006.00667.x; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Niknejad H, 2008, EUR CELLS MATER, V15, P88; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; QUINBY WC, 1982, PLAST RECONSTR SURG, V70, P711, DOI 10.1097/00006534-198212000-00009; Rejzek A., 2001, Cell and Tissue Banking, V2, P95, DOI 10.1023/A:1014316232009; Satpathy GR, 2004, CRYOBIOLOGY, V49, P123, DOI 10.1016/j.cryobiol.2004.06.001; Saw VPJ, 2007, BRIT J OPHTHALMOL, V91, P1042, DOI 10.1136/bjo.2006.098525; Schneider T, 2009, PLANT CELL PHYSIOL, V50, P2174, DOI 10.1093/pcp/pcp151; Sekiyama E, 2007, INVEST OPHTH VIS SCI, V48, P1528, DOI 10.1167/iovs.06-1104; Shanmuganathan VA, 2006, BRIT J OPHTHALMOL, V90, P55, DOI 10.1136/bjo.2005.071910; Singh Rita, 2004, Cell and Tissue Banking, V5, P129, DOI 10.1023/B:CATB.0000034077.05000.29; Solomon A, 2005, CLIN EXP ALLERGY, V35, P941, DOI 10.1111/j.1365-2222.2005.02285.x; Srinivas S, 2007, EUR J OPHTHALMOL, V17, P7, DOI 10.1177/112067210701700102; Rodriguez-Ares MT, 2009, ACTA OPHTHALMOL, V87, P396, DOI 10.1111/j.1755-3768.2008.01261.x; Thiex NW, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-117; Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.0.CO;2-X; Tuncer PB, 2011, THERIOGENOLOGY, V75, P1459, DOI 10.1016/j.theriogenology.2010.12.006; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306	54	58	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78441	10.1371/journal.pone.0078441	http://dx.doi.org/10.1371/journal.pone.0078441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205233	Green Published, gold			2022-12-27	WOS:000326334500119
J	Frappier, J; Toupin, I; Levy, JJ; Aubertin-Leheudre, M; Karelis, AD				Frappier, Julie; Toupin, Isabelle; Levy, Joseph J.; Aubertin-Leheudre, Mylene; Karelis, Antony D.			Energy Expenditure during Sexual Activity in Young Healthy Couples	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; BLOOD-PRESSURE RESPONSES; UPDATED RECOMMENDATION; PHYSICAL-ACTIVITY; SPORTS-MEDICINE; PUBLIC-HEALTH; UNITED-STATES; OLDER-ADULTS; ARMBAND; VALIDATION	Objective: To determine energy expenditure in kilocalories (kcal) during sexual activity in young healthy couples in their natural environment and compare it to a session of endurance exercise. Methods: The study population consisted of twenty one heterosexual couples (age: 22.6 +/- 2.8 years old) from the Montreal region. Free living energy expenditure during sexual activity and the endurance exercise was measured using the portable mini SenseWear armband. Perceived energy expenditure, perception of effort, fatigue and pleasure were also assessed after sexual activity. All participants completed a 30 min endurance exercise session on a treadmill at a moderate intensity. Results: Mean energy expenditure during sexual activity was 101 kCal or 4.2 kCal/min in men and 69.1 kCal or 3.1 kCal/min in women. In addition, mean intensity was 6.0 METS in men and 5.6 METS in women, which represents a moderate intensity. Moreover, the energy expenditure and intensity during the 30 min exercise session in men was 276 kCal or 9.2 kCal/min and 8.5 METS, respectively and in women 213 kCal or 7.1 kCal/min and 8.4 METS, respectively. Interestingly, the highest range value achieved by men for absolute energy expenditure can potentially be higher than that of the mean energy expenditure of the 30 min exercise session (i.e. 306.1 vs. 276 kCal, respectively) whereas this was not observed in women. Finally, perceived energy expenditure during sexual activity was similar in men (100 kCal) and in women (76.2 kCal) when compared to measured energy expenditure. Conclusion: The present study indicates that energy expenditure during sexual activity appears to be approximately 85 kCal or 3.6 kCal/min and seems to be performed at a moderate intensity (5.8 METS) in young healthy men and women. These results suggest that sexual activity may potentially be considered, at times, as a significant exercise.	[Frappier, Julie; Aubertin-Leheudre, Mylene; Karelis, Antony D.] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada; [Levy, Joseph J.] Univ Quebec, Dept Sexol, Montreal, PQ H3C 3P8, Canada; [Toupin, Isabelle] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; Universite de Montreal	Karelis, AD (corresponding author), Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada.	karelis.antony@uqam.ca	aubertin, rebeckah/O-9624-2015	aubertin, rebeckah/0000-0002-0558-7571	Foundation for the Scientific Study of Sexuality; l'Institut Sante et societe of the Universite du Quebec a Montreal	Foundation for the Scientific Study of Sexuality; l'Institut Sante et societe of the Universite du Quebec a Montreal	This study was supported by grants from The Foundation for the Scientific Study of Sexuality and l'Institut Sante et societe of the Universite du Quebec a Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; BARTLETT RG, 1956, J APPL PHYSIOL, V9, P469, DOI 10.1152/jappl.1956.9.3.469; BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745; Brazeau AS, 2011, APPL PHYSIOL NUTR ME, V36, P339, DOI [10.1139/H11-016, 10.1139/h11-016]; Casazza K, 2013, NEW ENGL J MED, V368, P446, DOI 10.1056/NEJMsa1208051; Drenowatz C, 2011, EUR J APPL PHYSIOL, V111, P883, DOI 10.1007/s00421-010-1695-0; Ebrahim S, 2002, J EPIDEMIOL COMMUN H, V56, P99, DOI 10.1136/jech.56.2.99; Gormley J, 2013, EUR J SPORT SCI, P1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HELLERSTEIN HK, 1970, ARCH INTERN MED, V125, P987, DOI 10.1001/archinte.125.6.987; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; LARSON JL, 1980, HEART LUNG, V9, P1025; Laumann EO, 2009, INT J IMPOT RES, V21, P171, DOI 10.1038/ijir.2009.7; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Mackey DC, 2011, J GERONTOL A-BIOL, V66, P1108, DOI 10.1093/gerona/glr101; MASINI V, 1980, Giornale Italiano di Cardiologia, V10, P1442; Masters WH., 1966, HUMAN SEXUAL RESPONS; McCall-Hosenfeld JS, 2008, J GEN INTERN MED, V23, P2000, DOI 10.1007/s11606-008-0820-9; Mignault D, 2005, DIABETES CARE, V28, P225, DOI 10.2337/diacare.28.1.225-a; NEMEC ED, 1976, AM HEART J, V92, P274, DOI 10.1016/S0002-8703(76)80106-8; Palmeri ST, 2007, AM J CARDIOL, V100, P1795, DOI 10.1016/j.amjcard.2007.07.040; Smith GD, 1997, BMJ-BRIT MED J, V315, P1641, DOI 10.1136/bmj.315.7123.1641; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Steinke EE, 2013, CIRCULATION; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624; Wetten AA, 2013, J PHYS ACT HEALTH	28	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79342	10.1371/journal.pone.0079342	http://dx.doi.org/10.1371/journal.pone.0079342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205382	Green Submitted, gold, Green Published			2022-12-27	WOS:000326152300093
J	Rosenberg, C; Kickhefel, A; Mensel, B; Pickartz, T; Puls, R; Roland, J; Hosten, N				Rosenberg, Christian; Kickhefel, Antje; Mensel, Birger; Pickartz, Tilman; Puls, Ralf; Roland, Joerg; Hosten, Norbert			PRFS-Based MR Thermometry Versus an Alternative T1 Magnitude Method - Comparative Performance Predicting Thermally Induced Necrosis in Hepatic Tumor Ablation	PLOS ONE			English	Article							LASER-INDUCED THERMOTHERAPY; MAGNETIC-RESONANCE THERMOMETRY; RADIOFREQUENCY ABLATION; THERAPY; ECHO; GUIDANCE	Objective: To compare the accuracy of a semi-quantitative proton resonance frequency shift (PRFS) thermal mapping interface and an alternative qualitative T1 thermometry model in predicting tissue necrosis in an established routine setting of MRI-guided laser ablation in the human liver. Materials and Methods: 34 cases of PRFS-guided (GRE) laser ablation were retrospectively matched with 34 cases from an earlier patient population of 73 individuals being monitored through T1 magnitude image evaluation (FLASH 2D). The model-specific real-time estimation of necrotizing thermal impact (above 54 C zone and T1 signal loss, respectively) was correlated in size with the resulting necrosis as shown by lack of enhancement on the first-day contrast exam (T1). Matched groups were compared using the Mann-Whitney test. Results: Online PRFS guidance was available in 33 of 34 cases. Positive size correlation between calculated impact zone and contrast defect at first day was evident in both groups (p < 0.0004). The predictive error estimating necrosis was median 21 % (range 1 % - 52 %) in the PRFS group and 61 % (range 22 - 84 %) in the T1 magnitude group. Differences in estimating lethal impact were significant (p = 0.004), whereas the real extent of therapy-induced necrosis showed no significant difference (p > 0.28) between the two groups. Conclusion: PRFS thermometry is feasible in a clinical setting of thermal hepatic tumor ablation. As an interference-free MR-tool for online therapy monitoring its accuracy to predict tissue necrosis is superior to a competing model of thermally induced alteration of the T1 magnitude signal.	[Rosenberg, Christian; Kickhefel, Antje; Mensel, Birger; Puls, Ralf; Hosten, Norbert] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Mecklenburg Vor, Germany; [Pickartz, Tilman] Univ Med Greifswald, Clin Internal Med, Div Gastroenterol Endocrinol & Nutrit Med, Greifswald, Mecklenburg Vor, Germany; [Kickhefel, Antje; Roland, Joerg] Siemens Healthcare, Erlangen, Bavaria, Germany	Greifswald Medical School; Greifswald Medical School; Siemens AG; Siemens Germany	Rosenberg, C (corresponding author), Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Mecklenburg Vor, Germany.	rosenberg@uni-greifswald.de			Utilized Siemens software prototype	Utilized Siemens software prototype	Utilized Siemens software prototype. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cernicanu A, 2008, NMR BIOMED, V21, P849, DOI 10.1002/nbm.1267; Chen J, 2008, MAGN RESON MED, V59, P1365, DOI 10.1002/mrm.21589; Chen X, 2007, J MAGN RESON IMAGING, V26, P123, DOI 10.1002/jmri.20956; Cheng HLM, 2002, J MAGN RESON IMAGING, V16, P598, DOI 10.1002/jmri.10199; Clasen S, 2008, J MAGN RESON IMAGING, V27, P421, DOI 10.1002/jmri.21264; de Senneville BD, 2007, EUR RADIOL, V17, P2401, DOI 10.1007/s00330-007-0646-6; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Eyrich GKH, 2000, LASER SURG MED, V26, P467, DOI 10.1002/1096-9101(2000)26:5<467::AID-LSM6>3.0.CO;2-8; Firbank MJ, 2000, BRIT J RADIOL, V73, P376, DOI 10.1259/bjr.73.868.10844863; Garcia-Medina O, 2011, LASER SURG MED, V43, P298, DOI 10.1002/lsm.21044; Germain D, 2001, MAGN RESON MATER PHY, V13, P47, DOI 10.1016/S1352-8661(01)00123-5; Goldberg SN, 2009, J VASC INTERV RADIOL, V20, pS377, DOI 10.1016/j.jvir.2009.04.011; Grissom WA, 2009, MAGN RESON MED, V62, P1242, DOI 10.1002/mrm.22118; Han B, 2009, ANN BIOMED ENG, V37, P1230, DOI 10.1007/s10439-009-9681-6; Holbrook AB, 2010, MAGN RESON MED, V63, P365, DOI 10.1002/mrm.22206; Kickhefel A, 2010, PHYS MEDICA, V26, P192, DOI 10.1016/j.ejmp.2009.11.006; Kickhefel A, 2011, J MAGN RESON IMAGING, V33, P704, DOI 10.1002/jmri.22499; KIM JH, 1979, CANCER RES, V39, P2258; Kuhn JP, 2008, ROFO-FORTSCHR RONTG, V180, P816, DOI 10.1055/s-2008-1027478; Lepetit-Coiffe M, 2010, EUR RADIOL, V20, P193, DOI 10.1007/s00330-009-1532-1; Li C, 2009, MAGN RESON MED, V62, P1251, DOI 10.1002/mrm.22121; McDannold N, 2008, J MAGN RESON IMAGING, V28, P1026, DOI 10.1002/jmri.21506; Meister D, 2007, ROFO-FORTSCHR RONTG, V179, P497, DOI 10.1055/s-2007-962979; Nour Sherif Gamal, 2005, Magn Reson Imaging Clin N Am, V13, P561, DOI 10.1016/j.mric.2005.04.007; PARKER DL, 1984, IEEE T BIO-MED ENG, V31, P161, DOI 10.1109/TBME.1984.325382; Peters RD, 2000, MAGN RESON MED, V44, P873, DOI 10.1002/1522-2594(200012)44:6<873::AID-MRM8>3.0.CO;2-X; Puls R, 2007, J MAGN RESON IMAGING, V25, P1174, DOI 10.1002/jmri.20936; Puls R, 2009, J VASC INTERV RADIOL, V20, P225, DOI 10.1016/j.jvir.2008.10.018; Rempp H, 2012, EUR RADIOL, V22, P1091, DOI 10.1007/s00330-011-2335-8; Rieke V, 2004, MAGNET RESON MED, V51, P1223, DOI 10.1002/mrm.20090; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Rosenberg C, 2009, AM J ROENTGENOL, V192, P785, DOI 10.2214/AJR.08.1425; Scheffler K, 2004, MAGNET RESON MED, V51, P1205, DOI 10.1002/mrm.20081; Schmiegel W, 2010, Z GASTROENTEROL, V48, P65, DOI 10.1055/s-0028-1109936; Streitparth F, 2013, EUR RADIOL, V23, P2739, DOI 10.1007/s00330-013-2872-4; Terraz S, 2010, EUR RADIOL, V20, P886, DOI 10.1007/s00330-009-1611-3; THOMSEN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P825, DOI 10.1111/j.1751-1097.1991.tb09897.x; Vogel MW, 2003, J MAGN RESON IMAGING, V18, P507, DOI 10.1002/jmri.10393	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78559	10.1371/journal.pone.0078559	http://dx.doi.org/10.1371/journal.pone.0078559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205260	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300068
J	Pawliczek, CM; Derntl, B; Kellermann, T; Gur, RC; Schneider, F; Habel, U				Pawliczek, Christina M.; Derntl, Birgit; Kellermann, Thilo; Gur, Ruben C.; Schneider, Frank; Habel, Ute			Anger under Control: Neural Correlates of Frustration as a Function of Trait Aggression	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; AMYGDALA ACTIVATION; PERSONALITY-TRAITS; BRAIN ACTIVATION; CONDUCT PROBLEMS; DECISION-MAKING; EMOTION; PSYCHOPATHY; RESPONSES; BEHAVIOR	Antisocial behavior and aggression are prominent symptoms in several psychiatric disorders including antisocial personality disorder. An established precursor to aggression is a frustrating event, which can elicit anger or exasperation, thereby prompting aggressive responses. While some studies have investigated the neural correlates of frustration and aggression, examination of their relation to trait aggression in healthy populations are rare. Based on a screening of 550 males, we formed two extreme groups, one including individuals reporting high (n=21) and one reporting low (n=18) trait aggression. Using functional magnetic resonance imaging (fMRI) at 3T, all participants were put through a frustration task comprising unsolvable anagrams of German nouns. Despite similar behavioral performance, males with high trait aggression reported higher ratings of negative affect and anger after the frustration task. Moreover, they showed relatively decreased activation in the frontal brain regions and the dorsal anterior cingulate cortex (dACC) as well as relatively less amygdala activation in response to frustration. Our findings indicate distinct frontal and limbic processing mechanisms following frustration modulated by trait aggression. In response to a frustrating event, HA individuals show some of the personality characteristics and neural processing patterns observed in abnormally aggressive populations. Highlighting the impact of aggressive traits on the behavioral and neural responses to frustration in non-psychiatric extreme groups can facilitate further characterization of neural dysfunctions underlying psychiatric disorders that involve abnormal frustration processing and aggression.	[Pawliczek, Christina M.; Derntl, Birgit; Kellermann, Thilo; Schneider, Frank; Habel, Ute] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Pawliczek, Christina M.; Derntl, Birgit; Kellermann, Thilo; Schneider, Frank; Habel, Ute] JARA Translat Brain Med, Aachen, Germany; [Gur, Ruben C.] Univ Penn, Dept Psychiat, Neuropsychiat Div, Philadelphia, PA 19104 USA; [Gur, Ruben C.] Philadelphia Vet Adm Med Ctr, Philadelphia, PA 19104 USA	RWTH Aachen University; University of Pennsylvania	Pawliczek, CM (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	cpawliczek@ukaachen.de	Gur, Ruben/K-1999-2019; Kellermann, Thilo/B-1712-2012	Gur, Ruben/0000-0002-9657-1996; Kellermann, Thilo/0000-0003-4081-5581; Derntl, Birgit/0000-0003-0133-4486; Habel, Ute/0000-0003-0703-7722; Schneider, Frank/0000-0003-1557-7956	German Research Foundation (DFG) [IRTG 1328]; IZKF Aachen (Interdisciplinary Center for Clinical Research within the Faculty of Medicine at RWTH Aachen University) [N4-4]; Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany; Initiative and Networking Fund of the Helmholtz Association (Helmholtz Alliance for Mental Health in an Ageing Society)	German Research Foundation (DFG)(German Research Foundation (DFG)); IZKF Aachen (Interdisciplinary Center for Clinical Research within the Faculty of Medicine at RWTH Aachen University); Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany; Initiative and Networking Fund of the Helmholtz Association (Helmholtz Alliance for Mental Health in an Ageing Society)	The authos thank the German Research Foundation (IRTG 1328, DFG), IZKF Aachen (Interdisciplinary Center for Clinical Research within the Faculty of Medicine at RWTH Aachen University, N4-4), the Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany and the Initiative and Networking Fund of the Helmholtz Association (Helmholtz Alliance for Mental Health in an Ageing Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2005, NEUROREPORT, V16, P669, DOI 10.1097/00001756-200505120-00003; Alpers G. W., 2008, PSYCHOPATHIC PERSONA; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; Aschenbrenner A, 2000, RWT REGENSBURGER WOR; Benning SD, 2005, ASSESSMENT, V12, P3, DOI 10.1177/1073191104271223; BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037/0033-2909.106.1.59; Berkowitz L, 2004, EMOTION, V4, P107, DOI 10.1037/1528-3542.4.2.107; BERKOWITZ L, 1990, AM PSYCHOL, V45, P494, DOI 10.1037/0003-066X.45.4.494; Berkowitz RL, 2007, REV NEUROSCIENCE, V18, P191; Bettencourt BA, 2006, PSYCHOL BULL, V132, P751, DOI 10.1037/0033-2909.132.5.751; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bond AJ, 2010, INTERNATIONAL HANDBOOK OF ANGER, P79, DOI 10.1007/978-0-387-89676-2_6; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carre J.M., 2010, SOCIAL COGNITIVE AFF, V2, P213; Carretie L, 2009, INT J PSYCHOPHYSIOL, V71, P57, DOI 10.1016/j.ijpsycho.2008.07.006; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Coccaro EF, 2011, BIOL PSYCHIAT, V69, P1153, DOI 10.1016/j.biopsych.2011.02.032; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Denson TF, 2009, J COGNITIVE NEUROSCI, V21, P734, DOI 10.1162/jocn.2009.21051; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Eisenberger NI, 2007, NEUROIMAGE, V35, P1601, DOI 10.1016/j.neuroimage.2007.01.038; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fullam RS, 2009, BRIT J PSYCHIAT, V194, P229, DOI 10.1192/bjp.bp.108.053199; Gansler DA, 2011, PSYCHIAT RES-NEUROIM, V191, P16, DOI 10.1016/j.pscychresns.2010.09.003; Gelman A, 2009, AM STAT, V63, P1, DOI 10.1198/tast.2009.0001; Gordon HL, 2004, BIOL PSYCHIAT, V56, P516, DOI 10.1016/j.biopsych.2004.06.030; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; HAMPEL R, 1975, FREIBURGER AGGRESSIO, P57564; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Herpertz SC, 2001, ARCH GEN PSYCHIAT, V58, P737, DOI 10.1001/archpsyc.58.8.737; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiehl KA, 2001, BIOL PSYCHIAT, V50, P677, DOI 10.1016/S0006-3223(01)01222-7; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; Li CSR, 2006, NEUROREPORT, V17, P243, DOI 10.1097/01.wnr.0000199471.06487.a2; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; Lobbestael J, 2008, COGNITION EMOTION, V22, P353, DOI 10.1080/02699930701438285; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; New AS, 2009, BIOL PSYCHIAT, V66, P1107, DOI 10.1016/j.biopsych.2009.07.015; Osumi T, 2012, J AFFECT DISORDERS, V142, P331, DOI 10.1016/j.jad.2012.05.012; PATRICK CJ, 1994, J ABNORM PSYCHOL, V103, P523, DOI 10.1037/0021-843X.103.3.523; PAWLICZEK C, 2012, POSITIONEN PSYCHIAT, P57564; PAWLICZEK C, 2012, EFPPP JB 2012 EMPIRI, P57564; Pawliczek CM, 2013, NEUROIMAGE, V79, P264, DOI 10.1016/j.neuroimage.2013.04.104; Perach-Barzilay N, 2013, SOC NEUROSCI-UK, V8, P178, DOI 10.1080/17470919.2012.720602; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Reitan RM, 1985, HALSTEAD REITAN NEUR; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHNEIDER F, 1994, PSYCHIAT RES, V51, P19, DOI 10.1016/0165-1781(94)90044-2; Schneider F, 1996, AM J PSYCHIAT, V153, P206; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Siegrist J, 2005, NEUROREPORT, V16, P1899, DOI 10.1097/01.wnr.0000186601.50996.f7; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Silbersweig D, 2007, AM J PSYCHIAT, V164, P1832, DOI 10.1176/appi.ajp.2007.06010126; Stemmler G, 2010, INTERNATIONAL HANDBOOK OF ANGER, P103, DOI 10.1007/978-0-387-89676-2_7; Sterzer P, 2005, BIOL PSYCHIAT, V57, P7, DOI 10.1016/j.biopsych.2004.10.008; Strenziok M, 2011, SOC COGN AFFECT NEUR, V6, P2, DOI 10.1093/scan/nsp036; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Williams JE, 2010, INTERNATIONAL HANDBOOK OF ANGER, P435, DOI 10.1007/978-0-387-89676-2_25; Williams KD, 2009, MASS COMMUN SOC, V12, P291, DOI 10.1080/15205430802461087; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012	81	34	34	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78503	10.1371/journal.pone.0078503	http://dx.doi.org/10.1371/journal.pone.0078503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24205247	Green Published, gold			2022-12-27	WOS:000326029300157
J	Jones, AA; Vila-Rodriguez, F; Panenka, WJ; Leonova, O; Strehlau, V; Lang, DJ; Thornton, AE; Wong, H; Barr, AM; Procyshyn, RM; Smith, GN; Buchanan, T; Krajden, M; Krausz, M; Montaner, JS; MacEwan, GW; Nutt, DJ; Honer, WG				Jones, Andrea A.; Vila-Rodriguez, Fidel; Panenka, William J.; Leonova, Olga; Strehlau, Verena; Lang, Donna J.; Thornton, Allen E.; Wong, Hubert; Barr, Alasdair M.; Procyshyn, Ric M.; Smith, Geoffrey N.; Buchanan, Tari; Krajden, Mel; Krausz, Michael; Montaner, Julio S.; MacEwan, G. William; Nutt, David J.; Honer, William G.			Personalized Risk Assessment of Drug-Related Harm Is Associated with Health Outcomes	PLOS ONE			English	Article							GLOBAL BURDEN; PSYCHOTIC DISORDERS; SYSTEMATIC ANALYSIS; ILLICIT DRUGS; PREDICTORS; DEPENDENCE; MORTALITY; DISEASES; RANKING; HEROIN	Background: The Independent Scientific Committee on Drugs (ISCD) assigned quantitative scores for harm to 20 drugs. We hypothesized that a personalized, ISCD-based Composite Harm Score (CHS) would be associated with poor health outcomes in polysubstance users. Methods: A prospective community sample (n=293) of adults living in marginal housing was assessed for substance use. The CHS was calculated based on the ISCD index, and the personal substance use characteristics over four weeks. Regression models estimated the association between CHS and physical, psychological, and social health outcomes. Results: Polysubstance use was pervasive (95.8%), as was multimorbid illness (median 3, possible range 0-12). The median CHS was 2845 (interquartile range 1865-3977). Adjusting for age and sex, every 1000-unit CHS increase was associated with greater mortality (odds ratio [OR] 1.47, 95% confidence interval [CI] 1.07-2.01, p = 0.02), and persistent hepatitis C infection (OR 1.29, 95% CI 1.02-1.67, p = 0.04). The likelihood of substance-induced psychosis increased 1.39-fold (95% CI 1.13-1.67, p = 0.001). The amount spent on drugs increased 1.51-fold (1.40-1.62, p < 0.001) and the odds of having committed a crime increased 1.74-fold (1.46-2.10, p < 0.001). Multimorbid illness increased 1.43-fold (95% CI 1.26-1.63, p < 0.001). Conclusions: Greater CHS predicts poorer physical, psychological, and social health, and may be a useful quantitative, personalized measure of risk for drug-related harm.	[Jones, Andrea A.; Vila-Rodriguez, Fidel; Panenka, William J.; Leonova, Olga; Strehlau, Verena; Procyshyn, Ric M.; Smith, Geoffrey N.; Buchanan, Tari; Krausz, Michael; MacEwan, G. William; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Lang, Donna J.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Wong, Hubert] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Barr, Alasdair M.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Krajden, Mel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Montaner, Julio S.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Nutt, David J.] Univ London Imperial Coll Sci Technol & Med, Ctr Neuropsychopharmacol & Mol Imaging, Div Brain Sci, London, England	University of British Columbia; University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Imperial College London	Honer, WG (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	william.honer@ubc.ca	Vila, Fidel/L-3463-2019; Lang, Donna/GVR-9040-2022; Procyshyn, Ric/AAE-5499-2019	Vila, Fidel/0000-0002-8273-8820; Barr, Alasdair/0000-0002-3407-1574; Krausz, Michael/0000-0002-3509-7274; Procyshyn, Ric/0000-0002-4348-0855; Panenka, William/0000-0001-7143-6512; Lang, Donna/0000-0001-9373-1555; nutt, david/0000-0002-1286-1401; Thornton, Allen/0000-0002-9942-0122; Wong, Hubert/0000-0001-8840-4509	Canadian Institutes of Health Research [CBG-101827]; BC Mental Health and Addictions Services; MRC [G1002226] Funding Source: UKRI; Medical Research Council [G1002226] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); BC Mental Health and Addictions Services; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Canadian Institutes of Health Research (CBG-101827) and BC Mental Health and Addictions Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews P, 1997, J ADDICT DIS, V16, P75, DOI 10.1300/J069v16n03_08; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Canada Mortgage and Housing Corporation, 2009, FFORD COR HOUS NEED, P81; Caton CLM, 2006, SCHIZOPHRENIA BULL, V32, P618, DOI 10.1093/schbul/sbl007; Caton CLM, 2005, ARCH GEN PSYCHIAT, V62, P137, DOI 10.1001/archpsyc.62.2.137; Caulkins JP, 2011, ADDICTION, V106, P1886, DOI 10.1111/j.1360-0443.2011.03461.x; Community Health and Safety Evaluation Project Team, 2005, COMM HLTH SAF EV CHA; Connell PH, 1958, AMPHETAMINE PSYCHOSI; DeBeck K, 2009, CAN MED ASSOC J, V181, P585, DOI 10.1503/cmaj.082054; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V113, P88, DOI 10.1016/j.drugalcdep.2010.07.026; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Devlin RJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6166; Drake RE, 2002, J NERV MENT DIS, V190, P100, DOI 10.1097/00005053-200202000-00006; Endicott J., 1988, BEST ESTIMATE CLIN E; Fischer B, 1997, PUBLIC HEALTH, V111, P271, DOI 10.1016/S0033-3506(97)00053-X; Fox J, 2009, J STAT SOFTW, V32, P1; GOODMAN SH, 1993, COMMUNITY MENT HLT J, V29, P119, DOI 10.1007/BF00756338; Johnson J., 2008, LESSONS LEARNED SCOR; Kapadia F, 2005, ADDICTION, V100, P990, DOI 10.1111/j.1360-0443.2005.01098.x; Larney S, 2012, DRUG ALCOHOL DEPEND; LEVINE SR, 1990, NEW ENGL J MED, V323, P699, DOI 10.1056/NEJM199009133231102; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacCoun RJ., 2001, DRUG WAR HERESIES LE; Malcolm BP, 2006, SUBST USE MISUSE, V41, P729, DOI 10.1080/10826080500391803; Marsden J, 1998, ADDICTION, V93, P1857, DOI 10.1046/j.1360-0443.1998.9312185711.x; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Mathias S, 2008, J CLIN PSYCHIAT, V69, P358, DOI 10.4088/JCP.v69n0304; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; O'Driscoll PT, 2001, AM J PUBLIC HEALTH, V91, P984, DOI 10.2105/AJPH.91.6.984; Shand FL, 2011, ADDICT BEHAV, V36, P27, DOI 10.1016/j.addbeh.2010.08.008; Sobell M. B., 1980, EVALUATING ALCOHOL D, P129, DOI DOI 10.1016/B978-0-08-022997-3.50013-2; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; Urban Health Research Initiative, 2013, DRUG SIT; van Amsterdam J, 2010, EUR ADDICT RES, V16, P202, DOI 10.1159/000317249; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Whiteford HA, 2013, LANCET, P2010; Wood Evan, 2012, Open Med, V6, pe35; Wood E, 2010, LANCET, V376, P310, DOI 10.1016/S0140-6736(10)60958-0; Zhang T, 2006, REV MED VIROL, V16, P311, DOI 10.1002/rmv.508	43	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79754	10.1371/journal.pone.0079754	http://dx.doi.org/10.1371/journal.pone.0079754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223192	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200085
J	Li, H; Chen, TW; Zhang, XM; Li, ZL; Zhang, JL; Wang, D; Li, T; Wu, JL; Guo, X; Chen, XL; Li, L; Xie, XY; Zhang, ZS				Li, Hang; Chen, Tian-wu; Zhang, Xiao-ming; Li, Zhen-lin; Zhang, Jin-ling; Wang, Dan; Li, Ting; Wu, Jian-lin; Guo, Xing; Chen, Xiao-li; Li, Li; Xie, Xian-yong; Zhang, Zi-shu			Liver Lobe Volumes and the Ratios of Liver Lobe Volumes to Spleen Volume on Magnetic Resonance Imaging for Staging Liver Fibrosis in a Minipig Model	PLOS ONE			English	Article							CARBON-TETRACHLORIDE; HEPATIC-FIBROSIS; CIRRHOSIS; BIOPSY; SIZE; MRI	Objective: To investigate liver lobe volumes and the ratios of liver lobe volumes to spleen volume measured with magnetic resonance imaging (MRI) for quantitatively monitoring and staging liver fibrosis. Methods: Animal study was approved by Institutional Animal Care and Use Committee. Sixteen minipigs were prospectively used to model liver fibrosis, and underwent abdominal gadolinium-enhanced MRI on 0, 5th, 9th, 16th and 21st weekend after modeling this disease staged by biopsy according to METAVIR classification system. On MRI, volume parameters including left lateral liver lobe volume (LLV), left medial liver lobe volume (LMV), right liver lobe volume (RV), caudate lobe volume (CV), and spleen volume (SV) were measured; and LLV/SV, LMV/SV, RV/SV and CV/SV were calculated. Statistical analyses were performed for staging this fibrosis. Results: LLV and CV increased with increasing stage of fibrosis (r = 0.711, 0.526, respectively; all P < 0.05). RV and LMV increased from stage 0 to 2 and decreased from 2 to 4; and RV/SV decreased from 0 to 1, increased from 1 to 2, and decreased from 3 to 4 (all P > 0.05). LLV/SV, LMV/SV and CV/SV decreased from stage 0 to 4 (r = -0.566, -0.748 and -0.620, respectively; all P < 0.05). LLV, CV, LLV/SV, LMV/SV, RV/SV, and CV/SV could distinguish stage 0-1 from 2-4 and 0-2 from 3-4 (all P < 0.05). Among these parameters, LLV and LMV/SV could best classify stage = 2 and = 3, respectively (area under receiver operating characteristic curve = 0.893 and 0.946, respectively). Conclusion: LLV and LMV/SV complement each other in staging liver fibrosis, and both parameters should be used to stage this disease.	[Li, Hang; Chen, Tian-wu; Zhang, Xiao-ming; Wang, Dan; Li, Ting; Chen, Xiao-li] Affiliated Hosp, North Sichuan Med Coll, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China; [Li, Hang; Chen, Tian-wu; Zhang, Xiao-ming; Wang, Dan; Li, Ting; Chen, Xiao-li] Affiliated Hosp, North Sichuan Med Coll, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Li, Hang] Sichuan Acad Med Sci, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Li, Hang] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Li, Zhen-lin] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Jin-ling] Harbin Med Univ, Affiliated Hosp 2, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Wu, Jian-lin] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian 116012, Liaoning, Peoples R China; [Guo, Xing] Affiliated Hosp, North Sichuan Med Coll, Dept Ultrasonog, Nanchong, Sichuan, Peoples R China; [Li, Li; Xie, Xian-yong] Affiliated Hosp, North Sichuan Med Coll, Dept Pathol, Nanchong, Sichuan, Peoples R China; [Zhang, Zi-shu] Univ Michigan Hlth Syst, Dept Radiol, Ann Arbor, MI USA	North Sichuan Medical University; North Sichuan Medical University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Harbin Medical University; Dalian University; North Sichuan Medical University; North Sichuan Medical University; University of Michigan System; University of Michigan	Chen, TW (corresponding author), Affiliated Hosp, North Sichuan Med Coll, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	chentw@aliyun.com; cjr.wujianlin@vip.163.com	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506				Aguirre DA, 2006, RADIOLOGY, V239, P425, DOI 10.1148/radiol.2392050505; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berg T, 2004, HEPATOLOGY, V39, P1456, DOI 10.1002/hep.20226; BOSMA A, 1988, J PATHOL, V156, P15, DOI 10.1002/path.1711560106; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Chen XL, 2013, J MAGN RESON IMAGING, V38, P540, DOI 10.1002/jmri.24007; Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512; Feng S, 2004, AM J MED, V117, P125, DOI [10.1016/j.amjmed.2004.01.026., DOI 10.1016/J.AMJMED.2004.01.026.PUBMED:15234650]; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; HENNEBRUNS D, 1989, LANGENBECK ARCH CHIR, V374, P150, DOI 10.1007/BF01261725; Hoofs JC, 1999, J NUCL MED, V40, P1745; JOHNSON CR, 1995, INT J RADIAT ONCOL, V32, P635, DOI 10.1016/0360-3016(95)00031-S; Kim AI, 2005, AM J MED, V118, P808, DOI 10.1016/j.amjmed.2005.01.073; Li H, 2012, WORLD J GASTROENTERO, V18, P7225, DOI 10.3748/wjg.v18.i48.7225; Li WX, 2010, J DIGEST DIS, V11, P215, DOI 10.1111/j.1751-2980.2010.00441.x; Liu P, 2009, WORLD J GASTROENTERO, V15, P3298, DOI 10.3748/wjg.15.3298; Mazonakis M, 2002, J MAGN RESON IMAGING, V15, P557, DOI 10.1002/jmri.10109; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Shah SHA, 1996, AM J GASTROENTEROL, V91, P2580; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; TARAO K, 1989, HEPATOLOGY, V9, P589, DOI 10.1002/hep.1840090413; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15, DOI [10.1002/hep.1840200104., DOI 10.1002/HEP.1840200104.PUBMED:8020885]; Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599; WITTE CL, 1974, GASTROENTEROLOGY, V67, P498; Zhang JJ, 2009, EUR SURG RES, V42, P35, DOI 10.1159/000167855	26	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79681	10.1371/journal.pone.0079681	http://dx.doi.org/10.1371/journal.pone.0079681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223184	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200077
J	Merle, BMJ; Maubaret, C; Korobelnik, JF; Delyfer, MN; Rougier, MB; Lambert, JC; Amouyel, P; Malet, F; Le Goff, M; Dartigues, JF; Barberger-Gateau, P; Delcourt, C				Merle, Benedicte M. J.; Maubaret, Cecilia; Korobelnik, Jean-Francois; Delyfer, Marie-Noelle; Rougier, Marie-Benedicte; Lambert, Jean-Charles; Amouyel, Philippe; Malet, Florence; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile			Association of HDL-Related Loci with Age-Related Macular Degeneration and Plasma Lutein and Zeaxanthin: the Alienor Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; HEPATIC LIPASE; RISK-FACTORS; COMMON VARIANTS; MACULOPATHY; CAROTENOIDS; LIPOPROTEIN; PREVALENCE; SMOKING	Background: Several genes implicated in high-density lipoprotein (HDL) metabolism have been reported to be associated with age-related macular degeneration (AMD). Furthermore, HDL transport the two carotenoids, lutein and zeaxanthin, which are highly suspected to play a key-role in the protection against AMD. The objective is to confirm the associations of HDL-related loci with AMD and to assess their associations with plasma lutein and zeaxanthin concentrations. Methods: Alienor study is a prospective population-based study on nutrition and age-related eye diseases performed in 963 elderly residents of Bordeaux, France. AMD was graded according to the international classification, from non-mydriatic colour retinal photographs. Plasma lutein and zeaxanthin were determined by normal-phase high-performance liquid chromatography. The following polymorphisms were studied: rs493258 and rs10468017 (LIPC), rs3764261 (CETP), rs12678919 (LPL) and rs1883025 (ABCA1). Results: After multivariate adjustment, the TT genotype of the LIPC rs493258 variant was significantly associated with a reduced risk for early and late AMD (OR=0.64, 95% CI: 0.41-0.99; p=0.049 and OR=0.26, 95% CI: 0.08-0.85; p=0.03, respectively), and with higher plasma zeaxanthin concentrations (p=0.03), while plasma lipids were not significantly different according to this SNP. Besides, the LPL variant was associated with early AMD (OR=0.67, 95% CI: 0.45-1.00; p=0.05) and both with plasma lipids and plasma lutein (p=0.047). Associations of LIPC rs10468017, CETP and ABCA1 polymorphisms with AMD did not reach statistical significance. Conclusion: These findings suggest that LIPC and LPL genes could both modify the risk for AMD and the metabolism of lutein and zeaxanthin.	[Merle, Benedicte M. J.; Maubaret, Cecilia; Korobelnik, Jean-Francois; Delyfer, Marie-Noelle; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile] INSERM, ISPED, Ctr INSERM, Epidemiol Biostat U897, Bordeaux, France; [Merle, Benedicte M. J.; Maubaret, Cecilia; Korobelnik, Jean-Francois; Delyfer, Marie-Noelle; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile] Univ Bordeaux, Bordeaux, France; [Korobelnik, Jean-Francois; Delyfer, Marie-Noelle; Rougier, Marie-Benedicte; Malet, Florence] CHU Bordeaux, Serv Ophtalmol, Bordeaux, France; [Lambert, Jean-Charles; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille Nord France, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille	Merle, BMJ (corresponding author), INSERM, ISPED, Ctr INSERM, Epidemiol Biostat U897, Bordeaux, France.	benedicte.merle@isped.u-bordeaux2.fr	DARTIGUES, Jean François/T-4513-2019; Delyfer, Marie-Noelle/T-3304-2019; Lambert, jean-charles/A-9553-2014; Delcourt, Cecile/I-2627-2013; Merle, Benedicte MJ/F-1247-2015; Merle, Benedicte MJ/AAQ-5021-2021; lambert, jean-charles/F-8787-2013; KOROBELNIK, Jean-Francois/A-5448-2016; LE GOFF, Mélanie/A-3541-2016	Lambert, jean-charles/0000-0003-0829-7817; Delcourt, Cecile/0000-0002-2099-0481; Merle, Benedicte MJ/0000-0003-1332-0954; Merle, Benedicte MJ/0000-0003-1332-0954; lambert, jean-charles/0000-0003-0829-7817; LE GOFF, Melanie/0000-0003-2848-6287; Amouyel, Philippe/0000-0001-9088-234X	Fondation Voir et Entendre (Paris, France); Conseil Regional d'Aquitaine (Bordeaux, France) [20091301029]; Fondation pour la recherche medicale, France (FRM)	Fondation Voir et Entendre (Paris, France); Conseil Regional d'Aquitaine (Bordeaux, France)(Region Nouvelle-Aquitaine); Fondation pour la recherche medicale, France (FRM)	Laboratoires Thea participated in the design of the study, but had no role in the data collection and analysis, decision to publish or preparation of the manuscript. Others funders: Fondation Voir et Entendre (Paris, France), Conseil Regional d'Aquitaine (Convention no 20091301029, Bordeaux, France) and Fondation pour la recherche medicale, France (FRM) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalain JH, 2002, CLIN CHIM ACTA, V326, P97, DOI 10.1016/S0009-8981(02)00288-7; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1993, Arch Ophthalmol, V111, P104; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Borel P, 2012, MOL NUTR FOOD RES, V56, P228, DOI 10.1002/mnfr.201100322; Borel P, 2011, ANN MED, V43, P47, DOI 10.3109/07853890.2010.531757; Borel P, 2009, BRIT J NUTR, V101, P680, DOI 10.1017/S0007114508030754; Chan D, 1998, OPTOMETRY VISION SCI, V75, P476, DOI 10.1097/00006324-199807000-00015; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Cipriani V, 2012, HUM MOL GENET, V21, P4138, DOI 10.1093/hmg/dds225; CLEVIDENCE BA, 1993, METHOD ENZYMOL, V214, P33; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Delcourt C, 2010, J NUTR HEALTH AGING, V14, P854, DOI 10.1007/s12603-010-0131-9; Delcourt C, 2012, ARCH OPHTHALMOL-CHIC, V130, P1077, DOI 10.1001/archophthalmol.2012.420; Delcourt C, 2011, INVEST OPHTH VIS SCI, V52, P5955, DOI 10.1167/iovs.10-6235; Delcourt C, 2006, INVEST OPHTH VIS SCI, V47, P2329, DOI 10.1167/iovs.05-1235; Fauser S, 2011, INVEST OPHTH VIS SCI, V52, P5525, DOI 10.1167/iovs.10-6827; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gale CR, 2003, INVEST OPHTH VIS SCI, V44, P2461, DOI 10.1167/iovs.02-0929; Hartmann D, 2004, AM J CLIN NUTR, V79, P410; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Ma L, 2012, BRIT J NUTR, V107, P350, DOI 10.1017/S0007114511004260; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Meyers KJ, 2013, INVEST OPHTH VIS SCI, V54, P2333, DOI [10.1167/iovs.12-10867, 10.1167/iovs.13-13216]; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Nowak M, 2005, CLIN EXP MED, V4, P183, DOI 10.1007/s10238-004-0054-z; Peter I, 2011, AM J OPHTHALMOL, V152, P1005, DOI 10.1016/j.ajo.2011.05.016; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; Seddon JM, 2010, MOL VIS, V16, P2412; Sobrin L, 2011, AM J OPHTHALMOL, V151, P345, DOI 10.1016/j.ajo.2010.08.015; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tian J, 2012, INVEST OPHTH VIS SCI, V53, P4262, DOI 10.1167/iovs.11-8542; Tyssandier V, 2002, INT J VITAM NUTR RES, V72, P300, DOI 10.1024/0300-9831.72.5.300; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wachter A, 2004, OPHTHALMOLOGE, V101, P50, DOI 10.1007/s00347-003-0868-1; Whitehead AJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1038, DOI 10.1001/archopht.124.7.1038; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zhang XZ, 2013, EXP EYE RES, V108, P16, DOI 10.1016/j.exer.2012.12.005; 2013, JAMA, P1	55	36	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79848	10.1371/journal.pone.0079848	http://dx.doi.org/10.1371/journal.pone.0079848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223199	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200092
J	Murugan, RN; Ahn, M; Lee, WC; Kim, HY; Song, JH; Cheong, C; Hwang, E; Seo, JH; Shin, SY; Choi, SH; Park, JE; Bang, JK				Murugan, Ravichandran N.; Ahn, Mija; Lee, Woo Cheol; Kim, Hye-Yeon; Song, Jung Hyun; Cheong, Chaejoon; Hwang, Eunha; Seo, Ji-Hyung; Shin, Song Yub; Choi, Sun Ho; Park, Jung-Eun; Bang, Jeong Kyu			Exploring the Binding Nature of Pyrrolidine Pocket-Dependent Interactions in the Polo-Box Domain of Polo-Like Kinase 1	PLOS ONE			English	Article							DISCOVERY; AFFINITY; PEPTIDE	Background: Over the years, a great deal of effort has been focused on the design and synthesis of potent, linear peptide inhibitors targeting the polo-like kinase 1 (Plk1), which is critically involved in multiple mitotic processes and has been established as an adverse prognostic marker for tumor patients. Plk1 localizes to its intracellular anchoring sites via its polo-box domain, and inhibiting the Plk1 polo-box domain has been considered as an approach to circumvent the specificity problems associated with inhibiting the conserved adenosine triphosphate-binding pocket. The polo-box domain consists of two different binding regions, such as the unique, broader pyrrolidine-binding pocket and the conserved, narrow, Tyr-rich hydrophobic channel, among the three Plk polo-box domains (Plks 1-3), respectively. Therefore, the studies that provide insights into the binding nature of the unique, broader pyrrolidine-binding pocket might lead to the development of selective Plk1-inhibitory compounds. Methodology/Principal Findings: In an attempt to retain the monospecificity by targeting the unique, broader pyrrolidine-binding pocket, here, for the first time, a systematic approach was undertaken to examine the structure-activity relationship of N-terminal-truncated PLHSpTM derivatives, to apply a site-directed ligand approach using bulky aromatic and non-aromatic systems, and to characterize the binding nature of these analogues using X-ray crystallographic studies. We have identified a new mode of binding interactions, having improved binding affinity and retaining the Plk1 polo-box domain specificity, at the pyrrolidine-binding pocket. Furthermore, our data revealed that the pyrrolidine-binding pocket was very specific to recognize a short and bulky hydrophobic ligand like adamantane, whereas the Tyr-rich hydrophobic channel was specific with lengthy and small hydrophobic groups. Conclusion/Significance: The progress made using our site-directed ligands validated this approach to specifically direct the ligand into the unique pyrrolidine-binding region, and it extends the applicability of the strategy for discovering selective protein-protein interaction inhibitors.	[Murugan, Ravichandran N.; Ahn, Mija; Lee, Woo Cheol; Kim, Hye-Yeon; Song, Jung Hyun; Cheong, Chaejoon; Hwang, Eunha; Seo, Ji-Hyung; Bang, Jeong Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang, Chung Buk, South Korea; [Shin, Song Yub] Chosun Univ, Grad Sch, Dept Biomat, Kwangju, South Korea; [Shin, Song Yub] Chosun Univ, Sch Med, Dept Cellular & Mol Med, Kwangju, South Korea; [Choi, Sun Ho] Dong A ST, Res Labs, Yongin, Gyeonggi Do, South Korea; [Choi, Sun Ho; Park, Jung-Eun] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Korea Basic Science Institute (KBSI); Chosun University; Chosun University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Park, JE (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	parkju@mail.nih.gov; bangjk@kbsi.re.kr	Cheong, Chaejoon/GWC-3135-2022		Korea Basic Science Institute's Research Program [T33418]	Korea Basic Science Institute's Research Program	This work was supported by the Korea Basic Science Institute's Research Program grant T33418 (JKB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kim YK, 2004, J AM CHEM SOC, V126, P14740, DOI 10.1021/ja048170p; Liu F, 2012, CHEMBIOCHEM, V13, P1291, DOI 10.1002/cbic.201200206; Liu F, 2012, ACS CHEM BIOL, V7, P805, DOI 10.1021/cb200469a; Liu F, 2011, NAT CHEM BIOL, V7, P595, DOI 10.1038/nchembio.614; McInnes C, 2012, MOL CANCER THER, V11, P1683, DOI 10.1158/1535-7163.MCT-12-0006-T; Murugan RN, 2011, MOL CELLS, V32, P209, DOI 10.1007/s10059-011-0126-3; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Qian WJ, 2012, BIOORG MED CHEM LETT, V22, P7306, DOI 10.1016/j.bmcl.2012.10.093; Qian WJ, 2013, BIOORGAN MED CHEM, V21, P3996, DOI 10.1016/j.bmc.2012.05.036; Sledz P, 2012, ANGEW CHEM INT EDIT, V51, P7680, DOI 10.1002/anie.201202660; Sledz P, 2011, ANGEW CHEM INT EDIT, V50, P4003, DOI 10.1002/anie.201008019; Ueki H, 2003, J ORG CHEM, V68, P7104, DOI 10.1021/jo0301494; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whitty A, 2006, NAT CHEM BIOL, V2, P112, DOI 10.1038/nchembio0306-112; Xu J, 2013, NAT STRUCT MOL BIOL, V20, P1047, DOI 10.1038/nsmb.2623; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	21	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80043	10.1371/journal.pone.0080043	http://dx.doi.org/10.1371/journal.pone.0080043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223211	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200104
J	Partanen, E; Kujala, T; Tervaniemi, M; Huotilainen, M				Partanen, Eino; Kujala, Teija; Tervaniemi, Mari; Huotilainen, Minna			Prenatal Music Exposure Induces Long-Term Neural Effects	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ELECTROPHYSIOLOGICAL EVIDENCE; AUDITORY-CORTEX; EARLY INFANCY; FETAL; PLASTICITY; BRAIN; MATURATION; NEWBORNS; PREFER	We investigated the neural correlates induced by prenatal exposure to melodies using brains' event-related potentials (ERPs). During the last trimester of pregnancy, the mothers in the learning group played the 'Twinkle twinkle little star' melody 5 times per week. After birth and again at the age of 4 months, we played the infants a modified melody in which some of the notes were changed while ERPs to unchanged and changed notes were recorded. The ERPs were also recorded from a control group, who received no prenatal stimulation. Both at birth and at the age of 4 months, infants in the learning group had stronger ERPs to the unchanged notes than the control group. Furthermore, the ERP amplitudes to the changed and unchanged notes at birth were correlated with the amount of prenatal exposure. Our results show that extensive prenatal exposure to a melody induces neural representations that last for several months.	[Partanen, Eino; Kujala, Teija; Tervaniemi, Mari; Huotilainen, Minna] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Partanen, Eino; Tervaniemi, Mari; Huotilainen, Minna] Univ Jyvaskyla, Finnish Ctr Excellence Interdisciplinary Music Re, Deparment Mus, Jyvaskyla, Finland; [Kujala, Teija] Univ Helsinki, Cicero Learning, Helsinki, Finland; [Huotilainen, Minna] Finnish Inst Occupat Hlth, Helsinki, Finland	University of Helsinki; University of Jyvaskyla; University of Helsinki; Finnish Institute of Occupational Health	Partanen, E (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.	eino.partanen@helsinki.fi	Kujala, Teija/G-6704-2016	Huotilainen, Minna/0000-0002-7251-6984; Kujala, Teija/0000-0002-8814-605X; Tervaniemi, Mari/0000-0002-9651-2929; Partanen, Eino/0000-0002-3569-1062	Academy of Finland [128840, 1135304, 1135161]; ERANET-NEURON project Probing the Auditory Novelty System (PANS); University of Helsinki; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); ERANET-NEURON project Probing the Auditory Novelty System (PANS); University of Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This study was financially supported by the Academy of Finland (grants 128840, 1135304, and 1135161; http://www.aka.fi/eng), ERANET-NEURON (http://www.neuron-eranet.eu/) project Probing the Auditory Novelty System (PANS), the University of Helsinki (http://www.helsinki.fi/university/index.html) graduate school grant and the Finnish Cultural Foundation (http://www.skr.fi/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1990, ELECTROEN CLIN NEURO, V77, P151, DOI 10.1016/0168-5597(90)90031-8; ANDO Y, 1970, J ACOUST SOC AM, V47, P1128, DOI 10.1121/1.1912014; Aoun P, 2005, NEUROL RES, V27, P791, DOI 10.1179/016164105X63647; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Cheour M, 2002, NATURE, V415, P599, DOI 10.1038/415599b; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; FIFER WP, 1994, ACTA PAEDIATR, V83, P86, DOI 10.1111/j.1651-2227.1994.tb13270.x; Friederici AD, 2002, NEUROREPORT, V13, P1251, DOI 10.1097/00001756-200207190-00006; Friedrich M, 2004, PSYCHOPHYSIOLOGY, V41, P772, DOI 10.1111/j.1469-8986.2004.00202.x; Granier-Deferre C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017304; GRIFFITHS SK, 1994, J ACOUST SOC AM, V96, P2055, DOI 10.1121/1.410147; He C, 2007, J COGNITIVE NEUROSCI, V19, P878, DOI 10.1162/jocn.2007.19.5.878; HEPPER PG, 1988, LANCET, V1, P1347, DOI 10.1016/S0140-6736(88)92170-8; HEPPER PG, 1994, ARCH DIS CHILD-FETAL, V71, pF81, DOI 10.1136/fn.71.2.F81; Johnson JK, 2011, COGN BEHAV NEUROL, V24, P74, DOI 10.1097/WNN.0b013e31821de326; Kujala T, 2010, PROG NEUROBIOL, V91, P55, DOI 10.1016/j.pneurobio.2010.01.006; Kushnerenko E, 2002, NEUROREPORT, V13, P1843, DOI 10.1097/00001756-200210280-00002; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lappe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021493; Lecanuet JP, 1996, EUR J OBSTET GYN R B, V68, P1, DOI 10.1016/0301-2115(96)02509-2; Leppanen PHT, 2010, CORTEX, V46, P1362, DOI 10.1016/j.cortex.2010.06.003; Mirmiran M, 2003, SLEEP MED REV, V7, P321, DOI 10.1053/smrv.2002.0243; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Moon C M, 2000, J Perinatol, V20, pS37; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Novitski N, 2007, CLIN NEUROPHYSIOL, V118, P412, DOI 10.1016/j.clinph.2006.10.008; PARMELEE AH, 1964, J PEDIATR-US, V65, P576, DOI 10.1016/S0022-3476(64)80291-2; Partanen E, 2013, P NATL ACAD SCI USA, V110, P15145, DOI 10.1073/pnas.1302159110; Peters A. J. M., 1993, Journal of Low Frequency Noise & Vibration, V12, P16; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; Ruusuvirta T, 2003, NEUROREPORT, V14, P2117, DOI 10.1097/00001756-200311140-00021; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Seppanen M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00043; Shtyrov Y, 2010, J NEUROSCI, V30, P16864, DOI 10.1523/JNEUROSCI.1376-10.2010; Spence MJ, 1996, INFANT BEHAV DEV, V19, P199, DOI 10.1016/S0163-6383(96)90019-3; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; Tervaniemi M, 2003, MUSIC SCI, V7, P241, DOI 10.1177/102986490300700203; Tew S, 2009, ANN NY ACAD SCI, V1169, P287, DOI 10.1111/j.1749-6632.2009.04845.x; Trainor LJ, 2012, ANN NY ACAD SCI, V1252, P129, DOI 10.1111/j.1749-6632.2012.06462.x; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283; Woldorff MG, 1998, PSYCHOPHYSIOLOGY, V35, P283, DOI 10.1017/S0048577298961601; Xu JH, 2009, BEHAV BRAIN RES, V196, P49, DOI 10.1016/j.bbr.2008.07.018	43	75	78	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78946	10.1371/journal.pone.0078946	http://dx.doi.org/10.1371/journal.pone.0078946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205353	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500141
J	Chen, HY; Osuna, D; Colville, L; Lorenzo, O; Graeber, K; Kuster, H; Leubner-Metzger, G; Kranner, I				Chen, Hongying; Osuna, Daniel; Colville, Louise; Lorenzo, Oscar; Graeber, Kai; Kuester, Helge; Leubner-Metzger, Gerhard; Kranner, Ilse			Transcriptome-Wide Mapping of Pea Seed Ageing Reveals a Pivotal Role for Genes Related to Oxidative Stress and Programmed Cell Death	PLOS ONE			English	Article							PROTEIN S-GLUTATHIONYLATION; BAX INHIBITOR-1; DIFFERENTIAL EXPRESSION; LIPID-PEROXIDATION; INDUCED APOPTOSIS; MESSENGER-RNA; FUNCTIONAL-ANALYSIS; CYSTEINE PROTEASES; MAILLARD REACTIONS; JASMONIC ACID	Understanding of seed ageing, which leads to viability loss during storage, is vital for ex situ plant conservation and agriculture alike. Yet the potential for regulation at the transcriptional level has not been fully investigated. Here, we studied the relationship between seed viability, gene expression and glutathione redox status during artificial ageing of pea (Pisum sativum) seeds. Transcriptome-wide analysis using microarrays was complemented with qRT-PCR analysis of selected genes and a multilevel analysis of the antioxidant glutathione. Partial degradation of DNA and RNA occurred from the onset of artificial ageing at 60% RH and 50 degrees C, and transcriptome profiling showed that the expression of genes associated with programmed cell death, oxidative stress and protein ubiquitination were altered prior to any sign of viability loss. After 25 days of ageing viability started to decline in conjunction with progressively oxidising cellular conditions, as indicated by a shift of the glutathione redox state towards more positive values (>-190 mV). The unravelling of the molecular basis of seed ageing revealed that transcriptome reprogramming is a key component of the ageing process, which influences the progression of programmed cell death and decline in antioxidant capacity that ultimately lead to seed viability loss.	[Chen, Hongying] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Chen, Hongying; Colville, Louise; Kranner, Ilse] Kew, Royal Bot Gardens, Seed Conservat Dept, Ardingly, W Sussex, England; [Osuna, Daniel; Lorenzo, Oscar] Univ Salamanca, Fac Biol, Ctr Hispano Luso Invest Agr CIALE, Dept Fisiol Vegetal, E-37008 Salamanca, Spain; [Graeber, Kai; Leubner-Metzger, Gerhard] Univ Freiburg, Fac Biol, Inst Biol 2, D-79106 Freiburg, Germany; [Graeber, Kai; Kuester, Helge] Leibniz Univ Hannover, Inst Plant Genet, Unit Plant Genom 4, D-30167 Hannover, Germany	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Royal Botanic Gardens, Kew; University of Salamanca; University of Freiburg; Leibniz University Hannover	Colville, L (corresponding author), Kew, Royal Bot Gardens, Seed Conservat Dept, Ardingly, W Sussex, England.	l.colville@kew.org	Lorenzo, Oscar/K-8170-2014; Osuna, Daniel/I-1535-2015; Leubner, Gerhard/A-1999-2013; Küster, Helge/A-4487-2013; Kranner, Ilse/B-1039-2011; Colville, Louise/I-7841-2012	Lorenzo, Oscar/0000-0001-9523-0789; Osuna, Daniel/0000-0002-7515-3007; Leubner, Gerhard/0000-0002-6045-8713; Küster, Helge/0000-0002-9197-9802; Kranner, Ilse/0000-0003-4959-9109; Colville, Louise/0000-0003-4626-4522	Spanish Ministerio de Educacion y Ciencia; Junta de Castilla y Leon [BIO2011-26940, CSD2007-00057, SA048A10-2]; German Research Foundation [DFGLe720/ 7]; Chinese Academy of Sciences [KSCX2-EW-J-24, Y3221411W1]; Millennium Commission; Wellcome Trust; Orange Plc.; Defra	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); German Research Foundation(German Research Foundation (DFG)); Chinese Academy of Sciences(Chinese Academy of Sciences); Millennium Commission; Wellcome Trust(Wellcome TrustEuropean Commission); Orange Plc.; Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by the Spanish Ministerio de Educacion y Ciencia and Junta de Castilla y Leon [BIO2011-26940, CSD2007-00057(TRANSPLANTA) and SA048A10-2 to O.L.], the German Research Foundation [DFGLe720/ 7 to G. L. M.], and the Chinese Academy of Sciences [KSCX2-EW-J-24 and Y3221411W1 to H. C.]. The Millennium Seed Bank Project is supported by the Millennium Commission, The Wellcome Trust, Orange Plc. and Defra. The Royal Botanic Gardens, Kew receive grant-in-aid from Defra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Adamakis IDS, 2011, PLANTA, V234, P21, DOI 10.1007/s00425-011-1372-5; Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Amirsadeghi S, 2007, PHYSIOL PLANTARUM, V129, P253, DOI 10.1111/j.1399-3054.2006.00775.x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birtic S, 2011, FREE RADICAL RES, V45, P1093, DOI 10.3109/10715762.2011.595409; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Bove J, 2005, PLANT MOL BIOL, V57, P593, DOI 10.1007/s11103-005-0953-8; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Cazalis R, 2006, J EXP BOT, V57, P2165, DOI 10.1093/jxb/erj174; Cereser C, 2001, TOXICOLOGY, V163, P153, DOI 10.1016/S0300-483X(01)00401-2; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chen X, 2009, PLANT PHYSIOL BIOCH, V47, P407, DOI 10.1016/j.plaphy.2008.12.021; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Colville L, 2012, J EXP BOT, V63, P6519, DOI 10.1093/jxb/ers307; Copois V, 2007, J BIOTECHNOL, V127, P549, DOI 10.1016/j.jbiotec.2006.07.032; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; De Pinto MC, 2012, PLANT CELL ENVIRON, V35, P234, DOI 10.1111/j.1365-3040.2011.02387.x; del Prete MJ, 2002, FASEB J, V16, P2003, DOI 10.1096/fj.02-0392fje; Dell'Aquila A, 1994, SEED SCI RES, V4, P293, DOI 10.1017/S0960258500002324; DELOUCHE J C, 1973, Seed Science and Technology, V1, P427; Desai MK, 2006, PLANT PHYSIOL BIOCH, V44, P483, DOI 10.1016/j.plaphy.2006.08.008; Di Stefano A, 2006, BBA-MOL CELL RES, V1763, P214, DOI 10.1016/j.bbamcr.2005.12.012; Diaz M, 2003, FEBS LETT, V543, P136, DOI 10.1016/S0014-5793(03)00426-5; Drake R, 1996, PLANT MOL BIOL, V30, P755, DOI 10.1007/BF00019009; Duan YF, 2010, NEW PHYTOL, V186, P681, DOI 10.1111/j.1469-8137.2010.03207.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; El-Maarouf-Bouteau H, 2011, J EXP BOT, V62, P5003, DOI 10.1093/jxb/err198; FOYER CH, 1995, PLANT PHYSIOL, V109, P1047, DOI 10.1104/pp.109.3.1047; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Han JJ, 2012, PLANT J, V72, P129, DOI 10.1111/j.1365-313X.2012.05070.x; He X, 2010, PLANT CELL PHYSIOL, V51, P1707, DOI 10.1093/pcp/pcq130; He YH, 2001, PLANT MOL BIOL, V47, P595, DOI 10.1023/A:1012211011538; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Hu D, 2012, PLANT CELL ENVIRON, V35, P2045, DOI 10.1111/j.1365-3040.2012.02535.x; Huang Z, 2008, BIOCHEM PHARMACOL, V75, P2234, DOI 10.1016/j.bcp.2008.02.026; Huckelhoven R, 2001, PLANT MOL BIOL, V47, P739, DOI 10.1023/A:1013635427949; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Ishitani R, 1996, J NEUROCHEM, V66, P928; Johnson RR, 2000, SEED SCI RES, V10, P233, DOI 10.1017/S096025850000026X; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kibinza S, 2011, PLANT SCI, V181, P309, DOI 10.1016/j.plantsci.2011.06.003; Kim M, 2003, J BIOL CHEM, V278, P19406, DOI 10.1074/jbc.M210539200; Kim M, 2006, PLANT CELL, V18, P2341, DOI 10.1105/tpc.106.041509; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Kranner I, 1996, PHYTOCHEM ANALYSIS, V7, P24, DOI 10.1002/(SICI)1099-1565(199601)7:1<24::AID-PCA277>3.0.CO;2-2; Kranner I., 2012, MYCORRHIZA MANUAL, V1st ed., P227; Kranner I, 2006, FREE RADICAL BIO MED, V40, P2155, DOI 10.1016/j.freeradbiomed.2006.02.013; Kranner I, 2011, PLANT GROWTH REGUL, V63, P63, DOI 10.1007/s10725-010-9512-7; Kranner I, 2010, P NATL ACAD SCI USA, V107, P3912, DOI 10.1073/pnas.0914197107; Kuthanova A, 2008, J EXP BOT, V59, P2233, DOI 10.1093/jxb/ern090; Lacomme C, 1999, FEBS LETT, V459, P149, DOI 10.1016/S0014-5793(99)01233-8; Lam E, 2000, PLANT MOL BIOL, V44, P417, DOI 10.1023/A:1026509012695; Leubner-Metzger G, 2005, PLANT J, V41, P133, DOI 10.1111/j.1365-313X.2004.02284.x; Leymarie J, 2007, J EXP BOT, V58, P425, DOI 10.1093/jxb/erl211; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Martins LM, 1997, TRENDS CELL BIOL, V7, P111; Minami A, 1995, PLANT CELL PHYSIOL, V36, P1599; Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x; Morigasaki S, 2008, MOL CELL, V30, P108, DOI 10.1016/j.molcel.2008.01.017; Murphy NB, 1997, CELL DEATH DIFFER, V4, P365, DOI 10.1038/sj.cdd.4400253; Murthy UMN, 2003, J EXP BOT, V54, P1057, DOI 10.1093/jxb/erg092; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nasirudeen AMA, 2001, PARASITOLOGY, V123, P235, DOI 10.1017/S0031182001008332; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Osborne DJ, 2002, CRIT REV PLANT SCI, V21, P127, DOI 10.1080/0735-260291044214; PASTORI GM, 1992, PLANT CELL PHYSIOL, V33, P957; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Perez-Novo CA, 2005, BIOTECHNIQUES, V39, P52; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pias EK, 2002, CELL DEATH DIFFER, V9, P1007, DOI 10.1038/sj.cdd.4401064; Polci R, 2004, CANCER RES, V64, P8800, DOI 10.1158/0008-5472.CAN-04-2243; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schiebold S, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-19; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; SITAL JS, 2008, INDIAN J AGR BIOCH, V21, P16; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Stein RJ, 2009, PLANT SCI, V177, P563, DOI 10.1016/j.plantsci.2009.08.001; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Subbaiah CC, 2006, J BIOL CHEM, V281, P15625, DOI 10.1074/jbc.M600355200; Swidzinski JA, 2002, PLANT J, V30, P431, DOI 10.1046/j.1365-313X.2002.01301.x; Swidzinski JA, 2004, PHYTOCHEMISTRY, V65, P1829, DOI 10.1016/j.phytochem.2004.04.020; Tateda C, 2009, PLANT CELL REP, V28, P41, DOI 10.1007/s00299-008-0630-x; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Wagstaff C, 2003, NEW PHYTOL, V160, P49, DOI 10.1046/j.1469-8137.2003.00853.x; Wagstaff C, 2009, PLANT J, V57, P690, DOI 10.1111/j.1365-313X.2008.03722.x; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watanabe N, 2004, MOL PLANT PATHOL, V5, P65, DOI 10.1111/j.1364-3703.2004.00206.x; Weigelt K, 2008, PLANT J, V55, P909, DOI 10.1111/j.1365-313X.2008.03560.x; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhao Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P56, DOI 10.1016/j.abb.2009.03.001	121	57	63	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78471	10.1371/journal.pone.0078471	http://dx.doi.org/10.1371/journal.pone.0078471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205239	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700090
J	Dias, FC; Medina, TD; Mendes, CT; Dantas, RO; Pissetti, CW; Rodrigues, V; Dellalibera-Joviliano, R; Marin-Neto, JA; Gutierrez, FRS; Moreau, P; Silva, JS; Donadi, EA				Dias, Fabricio C.; Medina, Tiago da S.; Mendes-Junior, Celso T.; Dantas, Roberto O.; Pissetti, Cristina W.; Rodrigues Junior, Virmondes; Dellalibera-Joviliano, Renata; Marin-Neto, Jose A.; Gutierrez, Fredy R. S.; Moreau, Philippe; Silva, Joao S.; Donadi, Eduardo A.			Polymorphic Sites at the Immunoregulatory CTLA-4 Gene Are Associated with Chronic Chagas Disease and Its Clinical Manifestations	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRYPANOSOMA-CRUZI INFECTION; B7 FAMILY; T-CELLS; SUSCEPTIBILITY; AUTOIMMUNE; PD-1; CYTOTOXIC-T-LYMPHOCYTE-ANTIGEN-4; CARDIOMYOPATHY; INDETERMINATE	Background: Chagas disease affects approximately 10 million people mainly in Latin America. The immune regulation by the host seems to be an essential factor for disease evolution, and immune system inhibitory molecules such as CTLA-4 and PD-1 favor the maintenance of peripheral tolerance. Considering that polymorphisms at the immunoregulatory CTLA-4 and PDCD1 genes may alter their inhibitory function, we investigated the association of alleles, genotypes and haplotypes of polymorphic sites observed at the CTLA-4 and PDCD1 genes with different clinical manifestations of chronic Chagas disease (indeterminate, cardiac, digestive and mixed). Methods: The polymorphisms at the CTLA-4 (-1722T/C, -318C/T and +49A/G) and PDCD1 (PD-1.3G/A) genes were typed using TaqMan methodology in 277 chronic Chagas disease patients classified into four groups, according to clinical characteristics, and 326 non-infected controls. Results: Our results showed that CTLA-4-1722CC genotype (22%), -1722C allele (27%) and CTLA-4 TCG (8.6%), TCA (26%) and CCA (15%) haplotypes were strongly associated with the indeterminate form, while the CTLA-4-318CT genotype (82%) and CTLA-4-318T allele (47%) were found mainly in patients with the mixed form of the disease. The CTLA-4 TCG haplotype (10.2%) was associated with the digestive form. On the other hand, the PD-1.3G/A polymorphism was not associated with chronic Chagas disease and its clinical manifestations. Conclusions: Here, we showed that alleles, genotypes and haplotypes reported to increase the expression of the regulatory molecule CTLA-4 were associated with the indeterminate form of the disease. Taken together, our data support the idea that polymorphic sites at immunoregulatory genes may influence the development of Chagas disease variants.	[Dias, Fabricio C.; Medina, Tiago da S.; Silva, Joao S.; Donadi, Eduardo A.] Univ Sao Paulo, Dept Bioquim & Imunol, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Mendes-Junior, Celso T.] Univ Sao Paulo, Dept Quim, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Dantas, Roberto O.; Marin-Neto, Jose A.; Donadi, Eduardo A.] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Pissetti, Cristina W.; Rodrigues Junior, Virmondes] Univ Triangulo Mineiro, Lab Imunol, Uberaba, MG, Brazil; [Dellalibera-Joviliano, Renata] Univ Sao Paulo, Dept Cirurgia & Anat, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Gutierrez, Fredy R. S.] Univ Antonio Narino, Sch Med, Bogota, Colombia; [Dias, Fabricio C.; Moreau, Philippe] St Louis Hosp, Inst Emerging Dis & Innovat Therapies, Res Div Hematol & Immunol, CEA, Paris, France	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Universidade de Sao Paulo; Universidad Antonio Narino; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite	Donadi, EA (corresponding author), Univ Sao Paulo, Dept Bioquim & Imunol, Fac Med Ribeirao Preto, Sao Paulo, Brazil.	eadonadi@fmrp.usp.br	Silva, Joao/A-4484-2008; Mendes-Junior, Celso Teixeira/B-1994-2010; Medina, Tiago S/B-3084-2018; Marin-Neto, Jose Antonio/F-6099-2012; DELLALIBERA-JOVILIANO, RENATA/E-3242-2019; donadi, eduardo A/H-7080-2013; Gutierrez, Fredy RS/C-3911-2009	Silva, Joao/0000-0002-3410-3927; Mendes-Junior, Celso Teixeira/0000-0002-7337-1203; Medina, Tiago S/0000-0001-8674-8842; DELLALIBERA-JOVILIANO, RENATA/0000-0002-5102-6724; donadi, eduardo A/0000-0002-9457-9601; Moreau, Philippe/0000-0002-2868-7401; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Rodrigues Jr, Virmondes/0000-0001-8706-4223; Gutierrez, Fredy RS/0000-0001-9873-8342	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PRODOC288/05-5, CAPES/COFECUB 653/09, PNPD 02883/09-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PRODOC288/05-5, CAPES/COFECUB 653/09 and PNPD 02883/09-0]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; Brener Z, 1997, INT ARCH ALLERGY IMM, V114, P103, DOI 10.1159/000237653; Brunner MC, 1999, J IMMUNOL, V162, P5813; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; de Oliveira RB, 1998, AM J GASTROENTEROL, V93, P884, DOI 10.1111/j.1572-0241.1998.270_r.x; Dong HD, 1999, NAT MED, V5, P1365; Duan SQ, 2011, MOL BIOL REP, V38, P5125, DOI 10.1007/s11033-010-0660-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez-Mestre M, 2009, HUM IMMUNOL, V70, P532, DOI 10.1016/j.humimm.2009.03.016; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; GeneCards, 2012, PROGR CELL DEATH; Gomes J. A. S., 2003, Infection and Immunity, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Gutierrez FRS, 2011, INFECT IMMUN, V79, P1873, DOI 10.1128/IAI.01047-10; Hudson LL, 2002, HUM GENET, V111, P452, DOI 10.1007/s00439-002-0807-2; Khalilzadeh O, 2009, ARCH DERMATOL RES, V301, P719, DOI 10.1007/s00403-008-0919-1; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kuo HC, 2011, J CLIN IMMUNOL, V31, P240, DOI 10.1007/s10875-010-9484-4; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Maciel BC, 2010, EVIDENCE BASED CARDI, P823; Marin Neto J A, 1999, Arq Bras Cardiol, V72, P247; Martin TM, 2009, MOL VIS, V15, P208; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; Pincerati MR, 2010, INT J IMMUNOGENET, V37, P253, DOI 10.1111/j.1744-313X.2010.00917.x; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Rahimifar S, 2010, GYNECOL ONCOL, V119, P136, DOI 10.1016/j.ygyno.2010.06.006; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rezende JM, 1994, SCI PUBLICATION, V547, P149; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Slot MC, 2008, CLIN IMMUNOL, V128, P39, DOI 10.1016/j.clim.2008.03.506; Souza PEA, 2007, INFECT IMMUN, V75, P1886, DOI 10.1128/IAI.01931-06; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun T, 2008, CANCER RES, V68, P7025, DOI 10.1158/0008-5472.CAN-08-0806; Sun T, 2009, CANCER RES, V69, P6011, DOI 10.1158/0008-5472.CAN-09-0176; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vitelli-Avelar DM, 2006, CLIN EXP IMMUNOL, V145, P81, DOI 10.1111/j.1365-2249.2006.03123.x; Wang XB, 2002, GENES IMMUN, V3, P233, DOI 10.1038/sj.gene.6363869; World Health Organization (WHO), 2020, CHAG DIS AM TRYP	48	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78367	10.1371/journal.pone.0078367	http://dx.doi.org/10.1371/journal.pone.0078367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205212	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300055
J	Planck, M; Edlund, K; Botling, J; Micke, P; Isaksson, S; Staaf, J				Planck, Maria; Edlund, Karolina; Botling, Johan; Micke, Patrick; Isaksson, Sofi; Staaf, Johan			Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; COPY-NUMBER ALTERATION; CANCER; PATHWAY; HETEROZYGOSITY; CLASSIFICATION; IDENTIFICATION; ACTIVATION; RESISTANCE; IMBALANCES	Introduction: In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutations. Improved knowledge about genomic and transcriptional alterations in and between mutation-defined subgroups may identify genes involved in disease development or progression. Methods: Genomic profiles from 457 adenocarcinomas, including 113 EGFR-mutated, 134 KRAS-mutated and 210 EGFR and KRAS-wild type tumors (EGFRwt/KRASwt), and gene expression profiles from 914 adenocarcinomas, including 309 EGFR-mutated, 192 KRAS-mutated, and 413 EGFRwt/KRASwt tumors, were assembled from different repositories. Genomic and transcriptional differences between the three mutational groups were analyzed by both supervised and unsupervised methods. Results: EGFR-mutated adenocarcinomas displayed a larger number of copy number alterations and recurrent amplifications, a higher fraction of total loss-of-heterozygosity, higher genomic complexity, and a more distinct expression pattern than EGFR-wild type adenocarcinomas. Several of these differences were also consistent when the three mutational groups were stratified by stage, gender and smoking status. Specific copy number alterations were associated with mutation status, predominantly including regions of gain with the highest frequency in EGFR-mutated tumors. Differential regions included both large and small regions of gain on 1p, 5q34-q35.3, 7p, 7q11.21, 12p12.1, 16p, and 21q, and losses on 6q16.3-q21, 8p, and 9p, with 20-40% frequency differences between the mutational groups. Supervised gene expression analyses identified 96 consistently differentially expressed genes between the mutational groups, and together with unsupervised analyses these analyses highlighted the difficulty in broadly resolving the three mutational groups into distinct transcriptional entities. Conclusions: We provide a comprehensive overview of the genomic and transcriptional landscape in lung adenocarcinoma stratified by EGFR and KRAS mutations. Our analyses suggest that the overall genomic and transcriptional landscape of lung adenocarcinoma is affected, but only to a minor extent, by EGFR and KRAS mutation status.	[Planck, Maria; Isaksson, Sofi; Staaf, Johan] Lund Univ, Dept Oncol, Lund, Sweden; [Planck, Maria; Isaksson, Sofi; Staaf, Johan] Skane Univ Hosp, Lund, Sweden; [Edlund, Karolina; Botling, Johan; Micke, Patrick] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Staaf, Johan] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Uppsala University; Lund University	Staaf, J (corresponding author), Lund Univ, Dept Oncol, Lund, Sweden.	johan.staaf@med.lu.se	Botling, Johan/ABA-2586-2020	Botling, Johan/0000-0003-2226-3517	Swedish Cancer Society; Knut & Alice Wallenberg Foundation; Foundation for Strategic Research through the Lund Centre for Translational Cancer Research (CREATE Health); Mrs Berta Kamprad Foundation; Gunnar Nilsson Cancer Foundation; Swedish Research Council; Lund University Hospital Research Funds; Gustav V:s Jubilee Foundation; IngaBritt and Arne Lundberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Foundation for Strategic Research through the Lund Centre for Translational Cancer Research (CREATE Health); Mrs Berta Kamprad Foundation; Gunnar Nilsson Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Hospital Research Funds; Gustav V:s Jubilee Foundation; IngaBritt and Arne Lundberg Foundation	Financial support for this study was provided by the Swedish Cancer Society, the Knut & Alice Wallenberg Foundation, the Foundation for Strategic Research through the Lund Centre for Translational Cancer Research (CREATE Health), the Mrs Berta Kamprad Foundation, the Gunnar Nilsson Cancer Foundation, the Swedish Research Council, the Lund University Hospital Research Funds, the Gustav V:s Jubilee Foundation, and the IngaBritt and Arne Lundberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Blons H, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-25; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Botling J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Fong Y, 2010, RESPIROLOGY, V15, P700, DOI 10.1111/j.1440-1843.2010.01746.x; Fouret R, 2012, CLIN CANCER RES, V18, P5606, DOI 10.1158/1078-0432.CCR-12-0505; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Huang YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022961; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kitamura M, 2007, CANCER LETT, V252, P184, DOI 10.1016/j.canlet.2006.11.015; Kono SA, 2009, DRUG RESIST UPDATE, V12, P95, DOI 10.1016/j.drup.2009.05.001; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Micke P, 2011, J THORAC ONCOL, V6, P1833, DOI 10.1097/JTO.0b013e3182295917; Nakanishi H, 2009, CANCER RES, V69, P1615, DOI 10.1158/0008-5472.CAN-08-3218; Newnham GM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-93; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Planck M, 2013, CLIN CANC RES; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Reinmuth N, 2008, LUNG CANCER, V62, P193, DOI 10.1016/j.lungcan.2008.03.011; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Shibata T, 2007, CANCER SCI, V98, P985, DOI 10.1111/j.1349-7006.2007.00483.x; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Staaf J, 2013, INT J CANCER, V132, P2020, DOI 10.1002/ijc.27879; Staaf J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3075; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Terai H, 2013, MOL CANCER RES, V11, P759, DOI 10.1158/1541-7786.MCR-12-0652; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Travis W, 2004, WHO CLASSIFICATION T; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yuan SS, 2011, J CLIN ONCOL, V29, P3435, DOI 10.1200/JCO.2011.35.3979; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	56	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78614	10.1371/journal.pone.0078614	http://dx.doi.org/10.1371/journal.pone.0078614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205279	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300073
J	Devanathan, S; Nemanich, ST; Kovacs, A; Fettig, N; Gropler, RJ; Shoghi, KI				Devanathan, Sriram; Nemanich, Samuel T.; Kovacs, Attila; Fettig, Nicole; Gropler, Robert J.; Shoghi, Kooresh I.			Genomic and Metabolic Disposition of Non-Obese Type 2 Diabetic Rats to Increased Myocardial Fatty Acid Metabolism	PLOS ONE			English	Article							GOTO-KAKIZAKI RAT; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CORONARY; EXPRESSION; INFARCTION; MORTALITY; OXIDATION; TURNOVER; MELLITUS	Lipotoxicity of the heart has been implicated as a leading cause of morbidity in Type 2 Diabetes Mellitus (T2DM). While numerous reports have demonstrated increased myocardial fatty acid (FA) utilization in obese T2DM animal models, this diabetic phenotype has yet to be demonstrated in non-obese animal models of T2DM. Therefore, the present study investigates functional, metabolic, and genomic differences in myocardial FA metabolism in non-obese type 2 diabetic rats. The study utilized Goto-Kakizaki (GK) rats at the age of 24 weeks. Each rat was imaged with small animal positron emission tomography (PET) to estimate myocardial blood flow (MBF) and myocardial FA metabolism. Echocardiograms (ECHOs) were performed to assess cardiac function. Levels of triglycerides (TG) and non-esterified fatty acids (NEFA) were measured in both plasma and cardiac tissues. Finally, expression profiles for 168 genes that have been implicated in diabetes and FA metabolism were measured using quantitative PCR (qPCR) arrays. GK rats exhibited increased NEFA and TG in both plasma and cardiac tissue. Quantitative PET imaging suggests that GK rats have increased FA metabolism. ECHO data indicates that GK rats have a significant increase in left ventricle mass index (LVMI) and decrease in peak early diastolic mitral annular velocity (E') compared to Wistar rats, suggesting structural remodeling and impaired diastolic function. Of the 84 genes in each the diabetes and FA metabolism arrays, 17 genes in the diabetes array and 41 genes in the FA metabolism array were significantly up-regulated in GK rats. Our data suggest that GK rats' exhibit increased genomic disposition to FA and TG metabolism independent of obesity.	[Devanathan, Sriram; Nemanich, Samuel T.; Fettig, Nicole; Gropler, Robert J.; Shoghi, Kooresh I.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Kovacs, Attila] Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res, St Louis, MO 63110 USA; [Gropler, Robert J.; Shoghi, Kooresh I.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO USA; [Shoghi, Kooresh I.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Shoghi, KI (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	shoghik@wustl.edu	Shoghi, Kooresh/H-7398-2014; devanathan, sriram/H-6519-2014; Nemanich, Samuel/AAK-8775-2020	Shoghi, Kooresh/0000-0003-3204-457X; Nemanich, Samuel/0000-0001-6093-7266	NIH/NIDDK [5R01DK085298]; NIH/NHLBI [R01EB012284]; Diabetes Research Center (DRC) [P60DK020579]; Nutrition Obesity Research Center (NORC) [P30DK056341]; Center for Cardiovascular Research (CCR); NIH [S10RR026949]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P60DK020579, P30DK056341, R01DK085298] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Diabetes Research Center (DRC); Nutrition Obesity Research Center (NORC); Center for Cardiovascular Research (CCR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH/NIDDK grant 5R01DK085298 and NIH/NHLBI grant R01EB012284. The work utilized core-services provided by the Diabetes Research Center (DRC) grant P60DK020579, the Nutrition Obesity Research Center (NORC) grant P30DK056341, and the Center for Cardiovascular Research (CCR) supported by NIH Shared Instrumentation Grant S10RR026949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth AM, 1998, DIABETES CARE, V21, P539, DOI 10.2337/diacare.21.4.539; Borradaile NA, 2005, CURR HYPERTENS REP, V7, P412, DOI 10.1007/s11906-005-0035-y; Chandler MP, 2007, AM J PHYSIOL-HEART C, V293, pH1609, DOI 10.1152/ajpheart.01338.2006; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Desrois M, 2004, CARDIOVASC RES, V61, P288, DOI 10.1016/j.cardiores.2003.11.021; El-Omar MM, 2004, BASIC RES CARDIOL, V99, P133, DOI 10.1007/s00395-004-0440-4; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Flier JS, 2001, NATURE, V409, P292, DOI 10.1038/35053251; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Herrero P, 2006, J NUCL MED, V47, P477; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Matikainen N, 2006, DIABETOLOGIA, V49, P2049, DOI 10.1007/s00125-006-0340-2; ORourke CM, 1997, METABOLISM, V46, P192, DOI 10.1016/S0026-0495(97)90301-2; Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003; Rudolph W, 1973, Recent Adv Stud Cardiac Struct Metab, V2, P739; SADDIK M, 1991, J BIOL CHEM, V266, P8162; SADDIK M, 1994, CAN J PHYSIOL PHARM, V72, P1110, DOI 10.1139/y94-157; Sharp TL, 2005, NUCL MED BIOL, V32, P875, DOI 10.1016/j.nucmedbio.2005.05.010; Shoghi KI, 2008, J NUCL MED, V49, P1320, DOI 10.2967/jnumed.108.051672; Shoghi KI, 2007, NUCL MED BIOL, V34, P989, DOI 10.1016/j.nucmedbio.2007.07.010; Shoghi KI, 2009, CIRC-CARDIOVASC IMAG, V2, P373, DOI 10.1161/CIRCIMAGING.108.843227; Sidossis LS, 1996, J CLIN INVEST, V98, P2244, DOI 10.1172/JCI119034; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Wang BW, 2007, AM J PHYSIOL-HEART C, V293, pH2305, DOI 10.1152/ajpheart.00361.2007; Weikert C, 2008, J CLIN ENDOCR METAB, V93, P2647, DOI 10.1210/jc.2007-2735; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2001, ENDOCRIN METAB CLIN, V30, P857, DOI 10.1016/S0889-8529(05)70219-X	33	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78477	10.1371/journal.pone.0078477	http://dx.doi.org/10.1371/journal.pone.0078477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205240	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600103
J	Sedej, S; Klemen, MS; Schluter, OM; Rupnik, MS				Sedej, Simon; Klemen, Masa Skelin; Schlueter, Oliver M.; Rupnik, Marjan Slak			Rab3a Is Critical for Trapping Alpha-MSH Granules in the High Ca2+-Affinity Pool by Preventing Constitutive Exocytosis	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; PITUITARY TISSUE-SLICES; CA2+-DEPENDENT EXOCYTOSIS; NEUROTRANSMITTER RELEASE; NEUROENDOCRINE CELLS; MEMBRANE CAPACITANCE; GENE-EXPRESSION; GTPASE RAB3A; PC12 CELLS; MELANOTROPHS	Rab3a is a small GTPase of the Rab3 subfamily that acts during late stages of Ca2+-regulated exocytosis. Previous functional analysis in pituitary melanotrophs described Rab3a as a positive regulator of Ca2+-dependent exocytosis. However, the precise role of the Rab3a isoform on the kinetics and intracellular [Ca2+] sensitivity of regulated exocytosis, which may affect the availability of two major peptide hormones, alpha-melanocyte stimulating hormone (alpha-MSH) and beta-endorphin in plasma, remain elusive. We employed Rab3a knock-out mice (Rab3a KO) to explore the secretory phenotype in melanotrophs from fresh pituitary tissue slices. High resolution capacitance measurements showed that Rab3a KO melanotrophs possessed impaired Ca2+-triggered secretory activity as compared to wild-type cells. The hampered secretion was associated with the absence of cAMP-guanine exchange factor II/ Epac2-dependent secretory component. This component has been attributed to high Ca2+-sensitive release-ready vesicles as determined by slow photo-release of caged Ca2+. Radioimmunoassay revealed that alpha-MSH, but not beta-endorphin, was elevated in the plasma of Rab3a KO mice, indicating increased constitutive exocytosis of alpha-MSH. Increased constitutive secretion of alpha-MSH from incubated tissue slices was associated with reduced alpha-MSH cellular content in Rab3a-deficient pituitary cells. Viral re-expression of the Rab3a protein in vitro rescued the secretory phenotype of melanotrophs from Rab3a KO mice. In conclusion, we suggest that Rab3a deficiency promotes constitutive secretion and underlies selective impairment of Ca2+-dependent release of alpha-MSH.	[Sedej, Simon] Med Univ Graz, Div Cardiol, Graz, Austria; [Sedej, Simon; Schlueter, Oliver M.; Rupnik, Marjan Slak] European Neurosci Inst, Gottingen, Germany; [Klemen, Masa Skelin; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Schlueter, Oliver M.] Gottingen Grad Sch Neurosci & Mol, Gottingen, Germany; [Rupnik, Marjan Slak] Univ Maribor, Ctr Open Innovat & Res, SLO-2000 Maribor, Slovenia; [Rupnik, Marjan Slak] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	Medical University of Graz; University of Maribor; University of Maribor	Sedej, S (corresponding author), Med Univ Graz, Div Cardiol, Graz, Austria.	simon.sedej@medunigraz.at; marjan.rupnik@um.si	Slak Rupnik, Marjan/E-6246-2015; Sedej, Simon/L-3066-2015; Rupnik, Marjan Slak/R-4738-2019	Slak Rupnik, Marjan/0000-0002-3744-4882; Sedej, Simon/0000-0002-4419-6821; Rupnik, Marjan Slak/0000-0002-3744-4882	The Centre for Molecular Physiology of the Brain; Max-Planck Society	The Centre for Molecular Physiology of the Brain; Max-Planck Society(Max Planck Society)	The Centre for Molecular Physiology of the Brain supported the work of Simon Sedej, while the European Neuroscience Institute-Gottingen (Neuroendocrinology group) as a whole has been supported by the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; DARCHEN F, 1995, J CELL SCI, V108, P1639; Doussau F, 1998, J NEUROSCI, V18, P3147; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Fass DM, 1999, J NEUROSCI, V19, P3345; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Gomora JC, 1996, J PHYSIOL-LONDON, V492, P763, DOI 10.1113/jphysiol.1996.sp021344; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; Lin CC, 2007, J CELL PHYSIOL, V211, P316, DOI 10.1002/jcp.20938; Lipovsek S, 2013, GEN COMP ENDOCR, V185, P67, DOI 10.1016/j.ygcen.2013.01.007; MAINS RE, 1979, J BIOL CHEM, V254, P7885; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Pavlos Nathan J, 2011, Small GTPases, V2, P77; Rupnik M, 2007, AM J PHYSIOL-CELL PH, V292, pC98, DOI 10.1152/ajpcell.00005.2006; RUPNIK M, 1992, FEBS LETT, V303, P221, DOI 10.1016/0014-5793(92)80524-K; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Sedej S, 2005, J PHYSIOL-LONDON, V567, P799, DOI 10.1113/jphysiol.2005.090381; Sedej S, 2004, J PHYSIOL-LONDON, V555, P769, DOI 10.1113/jphysiol.2003.058271; Skelin M, 2011, CELL CALCIUM, V49, P89, DOI 10.1016/j.ceca.2010.12.005; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Thiagarajan R, 2004, J PHYSIOL-LONDON, V555, P439, DOI 10.1113/jphysiol.2003.056333; Turner JE, 2005, J PHYSIOL-LONDON, V566, P443, DOI 10.1113/jphysiol.2005.088997; Weber E, 1996, J BIOL CHEM, V271, P6963, DOI 10.1074/jbc.271.12.6963; ZOREC R, 1991, J GEN PHYSIOL, V97, P473, DOI 10.1085/jgp.97.3.473	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78883	10.1371/journal.pone.0078883	http://dx.doi.org/10.1371/journal.pone.0078883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205339	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600114
J	Lemke, HW; Tarka, M; Klaassen, RHG; Akesson, M; Bensch, S; Hasselquist, D; Hansson, B				Lemke, Hilger W.; Tarka, Maja; Klaassen, Raymond H. G.; Akesson, Mikael; Bensch, Staffan; Hasselquist, Dennis; Hansson, Bengt			Annual Cycle and Migration Strategies of a Trans-Saharan Migratory Songbird: A Geolocator Study in the Great Reed Warbler	PLOS ONE			English	Article							LIGHT-LEVEL GEOLOCATORS; DISTANCE MIGRANT BIRD; ACROCEPHALUS-ARUNDINACEUS; SPRING MIGRATION; WINTERING AREAS; CLIMATE-CHANGE; ARRIVAL DATE; LONG-TERM; TRACKING; ROUTES	Recent technological advancements now allow us to obtain geographical position data for a wide range of animal movements. Here we used light-level geolocators to study the annual migration cycle in great reed warblers (Acrocephalus arundinaceus), a passerine bird breeding in Eurasia and wintering in sub-Saharan Africa. We were specifically interested in seasonal strategies in routes and schedules of migration. We found that the great reed warblers (all males, no females were included) migrated from the Swedish breeding site in early August. After spending up to three weeks at scattered stopover sites in central to south-eastern Europe, they resumed migration and crossed the Mediterranean Sea and Sahara Desert without lengthy stopovers. They then spread out over a large overwintering area and each bird utilised two (or even three) main wintering sites that were spatially separated by a distinct mid-winter movement. Spring migration initiation date differed widely between individuals (1-27 April). Several males took a more westerly route over the Sahara in spring than in autumn, and in general there were fewer long-distance travels and more frequent shorter stopovers, including one in northern Africa, in spring. The shorter stopovers made spring migration on average faster than autumn migration. There was a strong correlation between the spring departure dates from wintering sites and the arrival dates at the breeding ground. All males had a high migration speed in spring despite large variation in departure dates, indicating a time-minimization strategy to achieve an early arrival at the breeding site; the latter being decisive for high reproductive success in great reed warblers. Our results have important implications for the understanding of long-distance migrants' ability to predict conditions at distant breeding sites and adapt to rapid environmental change.	[Lemke, Hilger W.; Tarka, Maja; Bensch, Staffan; Hasselquist, Dennis; Hansson, Bengt] Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, Lund, Sweden; [Klaassen, Raymond H. G.] Univ Groningen, Montagus Harrier Fdn, Groningen, Netherlands; [Klaassen, Raymond H. G.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Akesson, Mikael] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Lund University; University of Groningen; University of Groningen; Swedish University of Agricultural Sciences	Hansson, B (corresponding author), Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, Lund, Sweden.	bengt.hansson@biol.lu.se	Åkesson, Mikael/K-5370-2014; Hasselquist, Dennis/M-5223-2014; Hansson, Bengt/L-8874-2013; Klaassen, Raymond/K-3027-2013; Tarka, Maja/L-8065-2013	Hasselquist, Dennis/0000-0002-0056-6616; Hansson, Bengt/0000-0001-6694-8169; Tarka, Maja/0000-0001-9651-1101	Swedish Research Council; Oscar and Lili Lamm Foundation; Lunds Djurskyddsfond; Crafoord Foundation; Linnaeus Research Excellence Center CAnMove; Lund University; Kvismare Bird Observatory	Swedish Research Council(Swedish Research CouncilEuropean Commission); Oscar and Lili Lamm Foundation; Lunds Djurskyddsfond; Crafoord Foundation; Linnaeus Research Excellence Center CAnMove; Lund University; Kvismare Bird Observatory	This study was supported by grants from the Swedish Research Council (BH, DH, SB), the Oscar and Lili Lamm Foundation (to BH), Lunds Djurskyddsfond (to BH, MT, DH), the Crafoord Foundation (to BH), the Linnaeus Research Excellence Center CAnMove funded by the Swedish Research Council and Lund University, and the Kvismare Bird Observatory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2007, J AVIAN BIOL, V38, P58, DOI 10.1111/j.2006.0908-8857.03669.x; Akesson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041195; Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; BAS, 2010, GEOLOCATOR MANUAL V8; Bensch S, 1998, EVOLUTION, V52, P877, DOI 10.1111/j.1558-5646.1998.tb03712.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Coppack T, 2009, INTEGR COMP BIOL, V49, P493, DOI 10.1093/icb/icp029; Cramp S., 1992, HDB BIRDS EUROPE MID; De Roo A., 1969, Gerfaut, V59, P260; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Hansson B, 2002, OECOLOGIA, V130, P536, DOI 10.1007/s00442-001-0831-2; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; HEDENSTROM A, 1993, IBIS, V135, P177, DOI 10.1111/j.1474-919X.1993.tb02829.x; Jahn AE, 2013, AUK, V130, P223, DOI 10.1525/auk.2013.12077; Jahn AE, 2013, AUK, V130, P247, DOI 10.1525/auk.2013.13010; Kemp MU, 2010, J AVIAN BIOL, V41, P672, DOI 10.1111/j.1600-048X.2010.05053.x; Kennerley P, 2010, REED BUSH WARBLERS; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kvist A, 2000, PHYSIOL BIOCHEM ZOOL, V73, P30, DOI 10.1086/316719; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Moller AP, 2001, P ROY SOC B-BIOL SCI, V268, P203; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Moreau RE, 1961, IBIS A, V103a, P372; Nilsson C, 2013, AM NAT; PEARSON DJ, 1975, IBIS, V117, P506, DOI 10.1111/j.1474-919X.1975.tb04244.x; PETTERSSON J, 1985, Ringing and Migration, V6, P66; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Robson D, 2011, J ANIM ECOL, V80, P320, DOI 10.1111/j.1365-2656.2010.01772.x; Schmaljohann H, 2012, BEHAV ECOL SOCIOBIOL, V66, P915, DOI 10.1007/s00265-012-1340-5; Seavy NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034886; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tarka M, 2010, P ROY SOC B-BIOL SCI, V277, P2361, DOI 10.1098/rspb.2010.0033; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Yohannes E, 2008, OECOLOGIA, V158, P299, DOI 10.1007/s00442-008-1138-3	55	68	71	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e79209	10.1371/journal.pone.0079209	http://dx.doi.org/10.1371/journal.pone.0079209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205374	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300171
J	Ding, DL; Qi, WD; Yu, DZ; Jiang, HY; Han, C; Kim, MJ; Katsuno, K; Hsieh, YH; Miyakawa, T; Salvi, R; Tanokura, M; Someya, S				Ding, Dalian; Qi, Weidong; Yu, Dongzhen; Jiang, Haiyan; Han, Chul; Kim, Mi-Jung; Katsuno, Kana; Hsieh, Yun Hua; Miyakawa, Takuya; Salvi, Richard; Tanokura, Masaru; Someya, Shinichi			Addition of Exogenous NAD(+) Prevents Mefloquine-Induced Neuroaxonal and Hair Cell Degeneration through Reduction of Caspase-3-Mediated Apoptosis in Cochlear Organotypic Cultures	PLOS ONE			English	Article							AXONAL DEGENERATION; TRANSCRIPTION FACTORS; HEARING-LOSS; NICOTINAMIDE; CISPLATIN; SIRT1; DEACETYLASE; STRESS; RAT; P53	Background: Mefloquine is widely used for the treatment of malaria. However, this drug is known to induce neurological side effects including depression, anxiety, balance disorder, and sensorineural hearing loss. Yet, there is currently no treatment for these side effects. Principal Findings: In this study, we show that the coenzyme NAD(+), known to play a critical role in maintaining the appropriate cellular redox environment, protects cochlear axons and sensory hair cells from mefloquine-induced degeneration in cultured rat cochleae. Mefloquine alone destroyed hair cells and nerve fiber axons in rat cochlear organotypics cultures in a dose-dependent manner, while treatment with NAD(+) protected axons and hair cells from mefloquine-induced degeneration. Furthermore, cochlear organs treated with mefloquine showed increased oxidative stress marker levels, including superoxide and protein carbonyl, and increased apoptosis marker levels, including TUNEL-positive nuclei and caspases-3. Treatment with NAD(+) reduced the levels of these oxidative stress and apoptosis markers. Conclusions/Significance: Taken together, our findings suggest that that mefloquine disrupts the cellular redox environment and induces oxidative stress in cochlear hair cells and nerve fibers leading to caspases-3-mediated apoptosis of these structures. Exogenous NAD(+) suppresses mefloquine-induced oxidative stress and prevents the degeneration of cochlear axons and sensory hair cells caused by mefloquine treatment.	[Ding, Dalian; Jiang, Haiyan; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA; [Ding, Dalian; Yu, Dongzhen] Shanghai Jiao Tong Univ, Shanghai Oriental Otolaryngol Inst, Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ding, Dalian] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Ding, Dalian; Katsuno, Kana; Hsieh, Yun Hua; Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Qi, Weidong] Fudan Univ, Huashan Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200433, Peoples R China; [Han, Chul; Kim, Mi-Jung; Someya, Shinichi] Univ Florida, Dept Aging, Gainesville, FL USA; [Han, Chul; Kim, Mi-Jung; Someya, Shinichi] Univ Florida, Dept Geriatr Res, Div Biol Aging, Gainesville, FL USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Shanghai Jiao Tong University; Central South University; University of Tokyo; Fudan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tanokura, M (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp; someya@ufl.edu		Yu, Dongzhen/0000-0001-9424-4855; Tanokura, Masaru/0000-0001-5072-2480	NIH [R01 DC06630-01, R01 DC06630, RO1 DC012552, RO3 DC011840-01]; AFAR Research Grant; Claude D. Pepper Older Americans Independence Center Junior Scholar Award; Japan Society for the Promotion of Science (JSPS) [23228003]; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006630, R03DC011840, R01DC012552] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFAR Research Grant; Claude D. Pepper Older Americans Independence Center Junior Scholar Award; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIH grant R01 DC06630-01 (R. S), NIH grant R01 DC06630 (R. S.), NIH grant RO1 DC012552 (S. S.), NIH grant RO3 DC011840-01 (S. S.), AFAR Research Grant (S. S.), Claude D. Pepper Older Americans Independence Center Junior Scholar Award (S. S.), and Grant-in-Aid for Scientific Research (S) (23228003) from the Japan Society for the Promotion of Science (JSPS) (M. T., T. M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Barennes H, 2006, BMJ-BRIT MED J, V332, P1055, DOI 10.1136/bmj.332.7549.1055; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Crawley Jane, 2004, Semin Pediatr Infect Dis, V15, P169, DOI 10.1053/j.spid.2004.05.009; Dalian Ding, 2012, J Otol, V7, P92; Diaz-Hernandez JI, 2007, CELL DEATH DIFFER, V14, P1211, DOI 10.1038/sj.cdd.4402117; Ding D, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P510; Ding D, 2011, CISPLATIN OTOTOXICIT, V2, P39; Ding D., 2011, J OTOL, V6, P1, DOI [10.1016/S1672-2930(11)50001-7, DOI 10.1016/S1672-2930(11)50001-7, 10.1016/51672-2930(11)50001-7]; Ding D, 2013, ABSTR ASS RES OT; Ding D, 2001, JF WILLOTT HDB MOUSE, P189; Ding DL, 2007, HEARING RES, V226, P129, DOI 10.1016/j.heares.2006.07.015; Ding DL, 2012, ANAT REC, V295, P1851, DOI 10.1002/ar.22577; Ding DL, 2011, HEARING RES, V282, P196, DOI 10.1016/j.heares.2011.08.002; Ding DL, 2011, NEUROTOXICOLOGY, V32, P233, DOI 10.1016/j.neuro.2010.12.003; Ding DL, 2005, VOLTA REV, V105, P407; Ding DL, 2002, HEARING RES, V164, P115, DOI 10.1016/S0378-5955(01)00417-8; Dow Geoffrey S, 2003, Malar J, V2, P14, DOI 10.1186/1475-2875-2-14; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fu Y, 2012, NEUROTOX RES, V22, P158, DOI 10.1007/s12640-012-9320-0; Fusetti M, 1999, Clin Ter, V150, P379; Hipkiss Alan R, 2010, Front Aging Neurosci, V2, P10, DOI 10.3389/fnagi.2010.00010; Hood JE, 2010, NEUROTOXICOLOGY, V31, P518, DOI 10.1016/j.neuro.2010.05.005; Kaneko S, 2006, J NEUROSCI, V26, P9794, DOI 10.1523/JNEUROSCI.2116-06.2006; Kawai Y, 2006, J PHARMACOL SCI, V100, P65, DOI 10.1254/jphs.FP0050661; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Kollaritsch H, 2000, WIEN KLIN WOCHENSCHR, V112, P441; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; Milatovic D, 2011, NEUROTOXICOLOGY, V32, P578, DOI 10.1016/j.neuro.2011.01.001; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Navaratnam S, 2000, J PHOTOCH PHOTOBIO B, V56, P25, DOI 10.1016/S1011-1344(00)00056-7; Oliver FJ, 1999, AM J HUM GENET, V64, P1282, DOI 10.1086/302389; Piskunova Tatiana S, 2008, Curr Gerontol Geriatr Res, P754190, DOI 10.1155/2008/754190; Qi W., 2009, J OTOL, V4, P29, DOI [10.1016/S1672-2930(09)50018-9, DOI 10.1016/S1672-2930(09)50018-9]; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sadanaga-Akiyoshi F, 2003, NEUROCHEM RES, V28, P1227, DOI 10.1023/A:1024236614015; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Simpson JA, 1999, CLIN PHARMACOL THER, V66, P472, DOI 10.1016/S0009-9236(99)70010-X; Smith JS, 2002, TRENDS CELL BIOL, V12, P404, DOI 10.1016/S0962-8924(02)02342-5; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Toovey S, 2009, TRAVEL MED INFECT DI, V7, P2, DOI 10.1016/j.tmaid.2008.12.004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wang H, 2001, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V15, P261; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; WEINKE T, 1991, AM J TROP MED HYG, V45, P86, DOI 10.4269/ajtmh.1991.45.86; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu DZ, 2011, NEUROTOX RES, V20, P51, DOI 10.1007/s12640-010-9221-z; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JG, 1996, PHARMACOL TOXICOL, V79, P191	57	35	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79817	10.1371/journal.pone.0079817	http://dx.doi.org/10.1371/journal.pone.0079817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223197	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200090
J	Hassiotou, F; Hepworth, AR; Williams, TM; Twigger, AJ; Perrella, S; Lai, CT; Filgueira, L; Geddes, DT; Hartmann, PE				Hassiotou, Foteini; Hepworth, Anna R.; Williams, Tracey M.; Twigger, Alecia-Jane; Perrella, Sharon; Lai, Ching Tat; Filgueira, Luis; Geddes, Donna T.; Hartmann, Peter E.			Breastmilk Cell and Fat Contents Respond Similarly to Removal of Breastmilk by the Infant	PLOS ONE			English	Article							ACID-COMPOSITION; FREQUENCY; VOLUME	Large inter- and intra-individual variations exist in breastmilk composition, yet factors associated with these variations in the short-term are not well understood. In this study, the effects of breastfeeding on breastmilk cellular and biochemical content were examined. Serial breastmilk samples (similar to 5 mL) were collected from both breasts of breastfeeding women before and immediately after the first morning breastfeed, and then at 30-minute intervals for up to 3 hours post-feed on 24 mornings per participant. The infant fed from one breast only at each feed. Effects of pump versus hand expression for samples were evaluated. A consistent response pattern of breastmilk cell and fat contents to breastmilk removal was observed. Maximum fat and cell levels were obtained 30 minutes post-feed (P<0.01), with up to 8-fold increase in fat and 12-fold increase in cell content compared to the pre-feed values, and then they gradually decreased. Breastmilk cell viability and protein concentration did not change with feeding (P>0.05), although large intra-individual variability was noted for protein. Expression mode for samples did not influence breastmilk composition (P>0.05). It is concluded that breastmilk fat content, and thus breast fullness, is closely associated with breastmilk cell content. This will now form the basis for standardization of sampling protocols in lactation studies and investigation of the mechanisms of milk synthesis and cell movement into breastmilk. Moreover, these findings generate new avenues for clinical interventions exploring growth and survival benefits conferred to preterm infants by providing the highest in fat and cells milk obtained at 30 min post-expression.	[Hassiotou, Foteini; Hepworth, Anna R.; Williams, Tracey M.; Twigger, Alecia-Jane; Perrella, Sharon; Lai, Ching Tat; Geddes, Donna T.; Hartmann, Peter E.] Univ Western Australia, Fac Sci, Sch Chem & Biochem, Perth, WA 6009, Australia; [Hassiotou, Foteini; Twigger, Alecia-Jane; Filgueira, Luis] Univ Western Australia, Fac Sci, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Filgueira, Luis] Univ Fribourg, Dept Med, Anat Unit, CH-1700 Fribourg, Switzerland	University of Western Australia; University of Western Australia; University of Fribourg	Hassiotou, F (corresponding author), Univ Western Australia, Fac Sci, Sch Chem & Biochem, Perth, WA 6009, Australia.	foteini.hassiotou@uwa.edu.au	Hepworth, Anna/X-6724-2019; Geddes, Donna/H-9254-2014; Lai, ching tat/M-2452-2018	Filgueira, Luis/0000-0002-2266-6650; Geddes, Donna/0000-0002-0431-7078; Perrella, Sharon/0000-0002-7727-7767; Lai, ching tat/0000-0002-9025-4922; Hartmann, Peter/0000-0002-7709-0740; Twigger, Alecia-Jane/0000-0003-4361-817X; Hepworth, Anna/0000-0003-0204-6347	Medela AG, Baar, Switzerland	Medela AG, Baar, Switzerland	Funding for this study was provided by an unrestricted research grant from Medela AG, Baar, Switzerland http://www.medela.com/IW/en/breastfeeding.html?force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR PG, 1987, J PEDIATR GASTR NUTR, V6, P758, DOI 10.1097/00005176-198709000-00017; ATWOOD CS, 1992, J DAIRY RES, V59, P287, DOI 10.1017/S0022029900030569; Buescher E. S., 1986, Human milk in infant nutrition and health, P160; BUTTE NF, 1984, AM J CLIN NUTR, V39, P296, DOI 10.1093/ajcn/39.2.296; Cregan MD, 2002, PARACELLULAR PATHWAY; Czank C, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-3; da Cunha J, 2005, EARLY HUM DEV, V81, P303, DOI 10.1016/j.earlhumdev.2004.08.004; DALY SEJ, 1993, EXP PHYSIOL, V78, P741, DOI 10.1113/expphysiol.1993.sp003722; Daly SEJ, 1996, EXP PHYSIOL, V81, P861, DOI 10.1113/expphysiol.1996.sp003982; de Mello TRB, 2000, CHARACTERIZATION MAM; DEWEY KG, 1984, J PEDIATR GASTR NUTR, V3, P713, DOI 10.1097/00005176-198411000-00014; FLEET IR, 1964, J PHYSIOL-LONDON, V175, pP15; HALL B, 1979, AM J CLIN NUTR, V32, P304, DOI 10.1093/ajcn/32.2.304; Hassiotou F, 2012, STEM CELLS; Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242; HO FCS, 1979, ACTA PAEDIATR SCAND, V68, P389, DOI 10.1111/j.1651-2227.1979.tb05025.x; HYTTEN FE, 1954, BMJ-BRIT MED J, V1, P175, DOI 10.1136/bmj.1.4855.175; Keenan TW, 1995, MILK FAT GLOBULE MEM; Kent JC, 2006, PEDIATRICS, V117, pE387, DOI 10.1542/peds.2005-1417; Khan S, 2013, J HUM LACT, V29, P81, DOI 10.1177/0890334412448841; Khan S, 2012, J PEDIATR GASTR NUTR, V55, P136, DOI 10.1097/MPG.0b013e31824cf386; Martin FL, 2000, CARCINOGENESIS, V21, P799, DOI 10.1093/carcin/21.4.799; Mitoulas LR, 2002, BRIT J NUTR, V88, P29, DOI [10.1079/BJN2002579, 10.1079/BJNBJN2002579]; Neville MC, 1983, MECH MILK SECRETION, P49; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; Piper KM, 2005, USE MAMMARY EPITHELI; R Development Core Team, 2009, R LANG ENV STAT COMP; RUEGG M, 1981, BIOCHIM BIOPHYS ACTA, V666, P7, DOI 10.1016/0005-2760(81)90085-0; Sarkar D., 2009, LATTICE LATTICE GRAP; WHITTLESTONE WG, 1953, J DAIRY RES, V20, P146, DOI 10.1017/S0022029900006798; Woodward D. R., 1976, Dairy Science Abstracts, V38, P137	31	40	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78232	10.1371/journal.pone.0078232	http://dx.doi.org/10.1371/journal.pone.0078232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223141	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200033
J	Mizushima, D; Tanuma, J; Kanaya, F; Nishijima, T; Gatanaga, H; Lam, NT; Dung, NTH; Van Kinh, N; Kikuchi, Y; Oka, S				Mizushima, Daisuke; Tanuma, Junko; Kanaya, Fumihide; Nishijima, Takeshi; Gatanaga, Hiroyuki; Nguyen Tien Lam; Nguyen Thi Hoai Dung; Nguyen Van Kinh; Kikuchi, Yoshimi; Oka, Shinichi			WHO Antiretroviral Therapy Guidelines 2010 and Impact of Tenofovir on Chronic Kidney Disease in Vietnamese HIV-Infected Patients	PLOS ONE			English	Article							DISOPROXIL FUMARATE; RENAL DYSFUNCTION; RISK-FACTORS; PREVALENCE; MORTALITY; SAFETY; COHORT; ERA	Objective: The 2010 WHO antiretroviral therapy (ART) guidelines have resulted in increased tenofovir use. Little is known about tenofovir-induced chronic kidney disease (CKD) in HIV-infected Vietnamese with mean body weight of 55 kg. We evaluated the prevalence and risk factors of CKD in this country. Design: Cross-sectional study was performed. Methods: Clinical data on HIV-infected Vietnamese cohort were collected twice a year. To evaluate the prevalence of CKD, serum creatinine was measured in 771 patients in October 2011 and April 2012. CKD was defined as creatinine clearance less than 60 ml/min at both time points. Multivariate logistic regression was used to determine the factors associated with CKD Results: Tenofovir use increased in Vietnam from 11.9% in April 2011 to 40.3% in April 2012. CKD was diagnosed in 7.3%, of which 7% was considered moderate and 0.3% was severe. Multivariate analysis of October-2011 data identified age per year-increase (OR: 1.229, 95% CI, 1.170-1.291), body weight per 1 kg-decrement (1.286, 1.193-1.386), and tenofovir use (2.715, 1.028-7.168) as risk factors for CKD. Conclusions: Older age, low body weight and tenofovir use were independent risk factors for CKD in Vietnam. Further longitudinal study is required to evaluate the impact of TDF on renal function in Vietnam and other countries with small-body weight patients.	[Mizushima, Daisuke; Tanuma, Junko; Kanaya, Fumihide; Nishijima, Takeshi; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Mizushima, Daisuke; Nishijima, Takeshi; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Nguyen Tien Lam; Nguyen Thi Hoai Dung; Nguyen Van Kinh] Natl Hosp Trop Dis, Hanoi, Vietnam	National Center for Global Health & Medicine - Japan; Kumamoto University; National Hospital of Tropical Diseases	Mizushima, D (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	dmizushi@acc.ncgm.go.jp; oka@acc.ncgm.go.jp	Tanuma, Junko/AAE-5395-2020	Oka, Shinichi/0000-0002-9283-2167	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Japan Initiative for Global Research Network on Infectious Diseases (J-GRID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios A, 2004, AIDS, V18, P960, DOI 10.1097/00002030-200404090-00019; Chaisiri K, 2010, CURR HIV RES, V8, P504, DOI 10.2174/157016210793499259; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V34, P320, DOI 10.1097/00126334-200311010-00011; Ito J, 2008, NEPHRON CLIN PRACT, V109, pC25, DOI 10.1159/000134379; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Menezes AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026042; Michaels SH, 1998, NEW ENGL J MED, V339, P405, DOI 10.1056/NEJM199808063390612; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Soares A, 2010, AM J KIDNEY DIS, V55, P1162, DOI 10.1053/j.ajkd.2010.03.008; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; Stohr W, 2008, ANTIVIR THER, V13, P761; Van Rompay KKA, 2008, ANTIMICROB AGENTS CH, V52, P3144, DOI 10.1128/AAC.00350-08; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4	26	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79885	10.1371/journal.pone.0079885	http://dx.doi.org/10.1371/journal.pone.0079885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223203	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200096
J	Zou, YF; Jiang, ZY; Yu, X; Sun, M; Zhang, YY; Zuo, Q; Zhou, J; Yang, NN; Han, P; Ge, ZP; De, W; Sun, LZ				Zou, Yanfen; Jiang, Ziyan; Yu, Xiang; Sun, Ming; Zhang, Yuanyuan; Zuo, Qing; Zhou, Jing; Yang, Nana; Han, Ping; Ge, Zhiping; De, Wei; Sun, Lizhou			Upregulation of Long Noncoding RNA SPRY4-IT1 Modulates Proliferation, Migration, Apoptosis, and Network Formation in Trophoblast Cells HTR-8SV/neo	PLOS ONE			English	Article							ANTIANGIOGENIC FACTORS; NORMAL-PREGNANCY; PREECLAMPSIA; GENE; EXPRESSION; PATHOGENESIS; LIFE	SPRY4-IT1 has been reported to have extremely high expression in normal placenta tissues. It is a Long noncoding RNA (lncRNA), which is associated with cell growth, migration, invasion, and apoptosis in melanoma. A 2.8-fold increase of SPRY4-IT1 expression was validated by Real-time reverse transcription-polymerase chain reaction (qRT-PCR) in severe preeclamptic placenta as compared with that of the normal ones (n=25) in this study. Furthermore, the role of SPRY4-IT1 in proliferation, migration, apoptosis, and network formation ability of trophoblast cells HTR-8/SVneo was assessed. Suppression of SPRY4-IT1 using siRNA treatment and its overexpression using plasmid targeting SPRY4-IT1 were performed in order to explore the biological function of SPRY4-IT1 in the development and progression of trophoblast cells HTR-8/SVneo, in vitro. The results showed that SPRY4-IT1 knockdown enhanced the cell migration and proliferation, and reduced the response of cells to apoptosis. However, exogenous SPRY4-IT1 overexpression significantly decreased the cell migration and proliferation, while increased cell apoptosis. Our study showed for the first time that aberrant expression of lncRNA SPRY4-IT1 might contribute to the abnormal condition of trophoblast cells HTR-8/SVneo. Therefore, we proposed SPRY4-IT1 as a novel lncRNA molecule, which might be associated with the pathogenesis of preeclampsia and might provide a new target for its early diagnosis and treatment.	[Zou, Yanfen; Jiang, Ziyan; Zhang, Yuanyuan; Zuo, Qing; Yang, Nana; Han, Ping; Ge, Zhiping; Sun, Lizhou] Nanjing Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Yu, Xiang; Sun, Ming; Zhou, Jing; De, Wei] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, LZ (corresponding author), Nanjing Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	lizhou_sun121@hotmail.com			National Natural Science Foundation of China [81070511, 81270710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by The National Natural Science Foundation of China, grant number 81070511 (http://www.nsfc.gov.cn/Portal0/default152.htm) The National Natural Science Foundation of China, grant number 81270710 (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha JL, 2002, AM J OBSTET GYNECOL, V187, P735, DOI 10.1067/mob.2002.126283; Basak S, 2013, PROSTAG LEUKOTR ESS, V88, P155, DOI 10.1016/j.plefa.2012.10.001; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burton GJ, 2011, PREGNANCY HYPERTENS, V1, P72, DOI 10.1016/j.preghy.2010.12.002; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Cui ZL, 2013, UROL ONCOL-SEMIN ORI, V31, P1117, DOI 10.1016/j.urolonc.2011.11.030; Dewing AST, 2012, RNA BIOL, V9, P1361, DOI 10.4161/rna.22290; Dokras A, 2001, BIOL REPROD, V65, P1278, DOI 10.1095/biolreprod65.4.1278; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Heazell AEP, 2008, REPROD SCI, V15, P1034, DOI 10.1177/1933719108322438; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Khalil AM, 2011, SEMIN CELL DEV BIOL, V22, P359, DOI 10.1016/j.semcdb.2011.02.016; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kitroser E, 2012, PLACENTA, V33, P717, DOI 10.1016/j.placenta.2012.06.004; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Liu S, 2012, PLACENTA, V33, P712, DOI 10.1016/j.placenta.2012.06.010; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2009, BIOESSAYS, V31, P51, DOI 10.1002/bies.080099; Noris M, 2004, HYPERTENSION, V43, P614, DOI 10.1161/01.HYP.0000116220.39793.c9; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052275; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saftlas AF, 2005, OBSTET GYNECOL, V106, P162, DOI 10.1097/01.AOG.0000167389.97019.37; Stein TP, 2008, FREE RADICAL RES, V42, P841, DOI 10.1080/10715760802510069; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Waddell JM, 2011, HUM REPROD, V26, P67, DOI 10.1093/humrep/deq294; Walsh SW, 1998, SEMIN REPROD ENDOCR, V16, P93, DOI 10.1055/s-2007-1016256; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011	48	71	81	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79598	10.1371/journal.pone.0079598	http://dx.doi.org/10.1371/journal.pone.0079598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223182	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200075
J	Chorna, NE; Santos-Soto, IJ; Carballeira, NM; Morales, JL; de la Nuez, J; Catala-Valentin, A; Chornyy, AP; Vazquez-Montes, A; De Ortiz, SP				Chorna, Nataliya E.; Santos-Soto, Ivan J.; Carballeira, Nestor M.; Morales, Joan L.; de la Nuez, Janneliz; Catala-Valentin, Alma; Chornyy, Anatoliy P.; Vazquez-Montes, Adrinel; De Ortiz, Sandra Pena			Fatty Acid Synthase as a Factor Required for Exercise-Induced Cognitive Enhancement and Dentate Gyrus Cellular Proliferation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REDUCES FOOD-INTAKE; GENE-EXPRESSION; HIPPOCAMPAL NEUROGENESIS; PROTEIN PALMITOYLATION; PHYSICAL-ACTIVITY; NEURONAL DEVELOPMENT; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; MEMORY ACQUISITION	Voluntary running is a robust inducer of adult hippocampal neurogenesis. Given that fatty acid synthase (FASN), the key enzyme for de novo fatty acid biosynthesis, is critically involved in proliferation of embryonic and adult neural stem cells, we hypothesized that FASN could mediate both exercise-induced cell proliferation in the subgranular zone (SGZ) of the dentate gyrus (DG) and enhancement of spatial learning and memory. In 20 week-old male mice, voluntary running-induced hippocampal-specific upregulation of FASN was accompanied also by hippocampal-specific accumulation of palmitate and stearate saturated fatty acids. In experiments addressing the functional role of FASN in our experimental model, chronic intracerebroventricular (i.c.v.) microinfusions of C75, an irreversible FASN inhibitor, and significantly impaired exercise-mediated improvements in spatial learning and memory in the Barnes maze. Unlike the vehicle-injected mice, the C75 group adopted a non-spatial serial escape strategy and displayed delayed escape latencies during acquisition and memory tests. Furthermore, pharmacologic blockade of FASN function with C75 resulted in a significant reduction, compared to vehicle treated controls, of the number of proliferative cells in the DG of running mice as measured by immunoreactive to Ki-67 in the SGZ. Taken together, our data suggest that FASN plays an important role in exercise-mediated cognitive enhancement, which might be associated to its role in modulating exercise-induced stimulation of neurogenesis.	[Chorna, Nataliya E.] Univ Puerto Rico, Dept Biol, Metabol Res Ctr, San Juan, PR 00936 USA; [Chorna, Nataliya E.; Vazquez-Montes, Adrinel; De Ortiz, Sandra Pena] Univ Puerto Rico, Dept Biol, Funct Genom Res Core, San Juan, PR 00936 USA; [Santos-Soto, Ivan J.; Morales, Joan L.; de la Nuez, Janneliz; Catala-Valentin, Alma; Vazquez-Montes, Adrinel; De Ortiz, Sandra Pena] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Carballeira, Nestor M.] Univ Puerto Rico, Dept Chem, San Juan, PR 00936 USA; [Chornyy, Anatoliy P.] Univ Puerto Rico, Cent Adm, High Performance Comp Facil, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico	De Ortiz, SP (corresponding author), Univ Puerto Rico, Dept Biol, Funct Genom Res Core, Rio Piedras Campus, San Juan, PR 00936 USA.	sandra@hpcf.upr.edu	Chorna, Nataliya/AHC-2895-2022	Chorna, Nataliya/0000-0002-7761-6802; Carballeira, Nestor/0000-0001-7404-0505	NIH-NIGMS [NIH-NIGMS/P20RR016470, P20GM103475, 5SC1MH086072, SC1GM084708, 5R25GM061151]; NIH-NIMH; UPR-Graduate Dean's Dissertation Fellowship; UPR-RP [PBDTP2010-2011]; Undergraduate Research Fellowship; NIH [8R25NS080687]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103475, SC1GM084708, R25GM061151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [SC1MH086072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS080687] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UPR-Graduate Dean's Dissertation Fellowship; UPR-RP; Undergraduate Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants and fellowships to: SPO (P20GM103475 by NIH-NIGMS/P20RR016470, NIH-NIGMS & 5SC1MH086072, and NIH-NIMH); NCarballeira (SC1GM084708 by NIH-NIGMS); IJSS (Graduate Research Fellowships, 5R25GM061151 by NIH-NIGMS, UPR-Graduate Dean's Dissertation Fellowship, and PBDTP2010-2011 by UPR-RP); ACV (Undergraduate Research Fellowship, and 8R25NS080687 by NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Aja S, 2006, AM J PHYSIOL-REG I, V291, pR148, DOI 10.1152/ajpregu.00041.2006; Ambrogini P, 2004, NEUROSCI LETT, V359, P13, DOI 10.1016/j.neulet.2003.12.123; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camassei FD, 2003, INVEST OPHTH VIS SCI, V44, P2399, DOI 10.1167/iovs.02-0934; Carballeira NM, 2007, LIPIDS, V42, P1047, DOI 10.1007/s11745-007-3110-0; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colon-Cesario M, 2006, J NEUROSCI, V26, P5524, DOI 10.1523/JNEUROSCI.3050-05.2006; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Ehrmann Jiri Jr., 2002, Biomedical Papers (Olomouc), V146, P11; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Fabricius K, 2008, BRAIN STRUCT FUNCT, V212, P403, DOI 10.1007/s00429-007-0169-6; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Fowler CJ, 2001, BIOCHEM PHARMACOL, V62, P517, DOI 10.1016/S0006-2952(01)00712-2; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jump DB, 2009, METHODS MOL BIOL, V579, P375, DOI 10.1007/978-1-60761-322-0_19; Kannangara TS, 2011, NEUROBIOL AGING; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; Knobloch M, 2012, NATURE; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kumar MV, 2002, P NATL ACAD SCI USA, V99, P1921, DOI 10.1073/pnas.042683699; Kusakabe T, 2000, J HISTOCHEM CYTOCHEM, V48, P613, DOI 10.1177/002215540004800505; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez M, 2007, RECENT PATENTS ENDOC, V1, P53, DOI 10.2174/187221407779814615; Maccarrone M, 2002, MOL CELL NEUROSCI, V21, P126, DOI 10.1006/mcne.2002.1164; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Mazzola C, 2009, LEARN MEMORY, V16, P332, DOI 10.1101/lm.1145209; McNay EC, 2011, NEUROBIOL LEARN MEM, V96, P517, DOI 10.1016/j.nlm.2011.11.001; Menendez Javier A., 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P877; Morell P., 1996, HDB CLIN NEUROL, V22, P33; Nicolle MM, 2003, LEARN MEMORY, V10, P520, DOI 10.1101/lm.64803; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; Orita H, 2007, CLIN CANCER RES, V13, P7139, DOI 10.1158/1078-0432.CCR-07-1186; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Pham K, 2005, NEUROSCIENCE, V130, P17, DOI 10.1016/j.neuroscience.2004.09.015; Radak Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2; Rendina AR, 2005, BIOCHEM J, V388, P895, DOI 10.1042/BJ20041963; Ronnett GV, 2006, OBESITY, V14, P201; Saavedra-Rodriguez L, 2009, J NEUROSCI, V29, P5726, DOI 10.1523/JNEUROSCI.4033-08.2009; Schweitzer NB, 2006, NEUROCHEM INT, V48, P9, DOI 10.1016/j.neuint.2005.08.006; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sunyer B, 2007, NATURE PROTOCOLS, DOI [10.1038/nprot.2007.1390, DOI 10.1038/NPR0T.2007.1390]; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Thupari JN, 2004, AM J PHYSIOL-ENDOC M, V287, pE97, DOI 10.1152/ajpendo.00261.2003; Tu YJ, 2005, ENDOCRINOLOGY, V146, P486, DOI 10.1210/en.2004-0976; Uysal N, 2005, NEUROSCI LETT, V383, P241, DOI 10.1016/j.neulet.2005.04.054; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Wang ZJ, 2006, ACTA PHARMACOL SIN, V27, P145, DOI 10.1111/j.1745-7254.2006.00259.x; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Wong-Goodrich SJE, 2010, CANCER RES, V70, P9329, DOI 10.1158/0008-5472.CAN-10-1854; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yoshii A, 2011, J NEUROSCI, V31, P11894, DOI 10.1523/JNEUROSCI.2190-11.2011	82	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77845	10.1371/journal.pone.0077845	http://dx.doi.org/10.1371/journal.pone.0077845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223732	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400014
J	Courtois, B; Audebert, A; Dardou, A; Roques, S; Ghneim-Herrera, T; Droc, G; Frouin, J; Rouan, L; Goze, E; Kilian, A; Ahmadi, N; Dingkuhn, M				Courtois, Brigitte; Audebert, Alain; Dardou, Audrey; Roques, Sandrine; Ghneim-Herrera, Thaura; Droc, Gaetan; Frouin, Julien; Rouan, Lauriane; Goze, Eric; Kilian, Andrzej; Ahmadi, Nourollah; Dingkuhn, Michael			Genome-Wide Association Mapping of Root Traits in a Japonica Rice Panel	PLOS ONE			English	Article							MIXED-MODEL APPROACH; LINKAGE DISEQUILIBRIUM; MORPHOLOGICAL TRAITS; SYSTEM ARCHITECTURE; GENOTYPIC VARIATION; DROUGHT AVOIDANCE; COMPLEX TRAITS; GROWTH; PLATFORM; QTLS	Rice is a crop prone to drought stress in upland and rainfed lowland ecosystems. A deep root system is recognized as the best drought avoidance mechanism. Genome-wide association mapping offers higher resolution for locating quantitative trait loci (QTLs) than QTL mapping in biparental populations. We performed an association mapping study for root traits using a panel of 167 japonica accessions, mostly of tropical origin. The panel was genotyped at an average density of one marker per 22.5 kb using genotyping by sequencing technology. The linkage disequilibrium in the panel was high (r(2) > 0.6, on average, for 20 kb mean distances between markers). The plants were grown in transparent 50 cm x 20 cm x 2 cm Plexiglas nailboard sandwiches filled with 1.5 mm glass beads through which a nutrient solution was circulated. Root system architecture and biomass traits were measured in 30-day-old plants. The panel showed a moderate to high diversity in the various traits, particularly for deep (below 30 cm depth) root mass and the number of deep roots. Association analyses were conducted using a mixed model involving both population structure and kinship to control for false positives. Nineteen associations were significant at P<1e-05, and 78 were significant at P<1e-04. The greatest numbers of significant associations were detected for deep root mass and the number of deep roots, whereas no significant associations were found for total root biomass or deep root proportion. Because several QTLs for different traits were co-localized, 51 unique loci were detected; several co-localized with meta-QTLs for root traits, but none co-localized with rice genes known to be involved in root growth. Several likely candidate genes were found in close proximity to these loci. Additional work is necessary to assess whether these markers are relevant in other backgrounds and whether the genes identified are robust candidates.	[Courtois, Brigitte; Audebert, Alain; Dardou, Audrey; Roques, Sandrine; Droc, Gaetan; Frouin, Julien; Rouan, Lauriane; Ahmadi, Nourollah; Dingkuhn, Michael] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR AGAP, Montpellier, France; [Ghneim-Herrera, Thaura] Univ Icesi, Dept Ciencias Biol, Cali, Colombia; [Goze, Eric] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR SCA, Montpellier, France; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd DArT PL, Canberra, ACT, Australia	CIRAD; Universite de Montpellier; Universidad ICESI; CIRAD	Courtois, B (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UMR AGAP, Montpellier, France.	brigitte.courtois@cirad.fr	COURTOIS, Brigitte/A-4004-2009; Gaetan, DROC/AAH-2616-2021	COURTOIS, Brigitte/0000-0003-2118-7102; Gaetan, DROC/0000-0003-1849-1269; Ghneim Herrera, Thaura/0000-0001-5716-0900; Kilian, Andrzej/0000-0002-2730-7462; AHMADI, Nourollah/0000-0003-0072-6285; Goze, Eric/0000-0001-9121-7835	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD-France)	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD-France)	This research was funded by the Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD-France) in the framework of its Orytage project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ADD, 2011, XLAST VERS 2011 4 02; [Anonymous], [No title captured]; Audebert A., 2010, 3 INT RIC C P HAN VI, P102; BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P969, DOI 10.1007/BF00222910; Clark RT, 2013, PLANT CELL ENVIRON, V36, P454, DOI 10.1111/j.1365-3040.2012.02587.x; Cobb JN, 2013, THEOR APPL GENET, V126, P867, DOI 10.1007/s00122-013-2066-0; Courtois B., 1999, Genetic improvement of rice for water-limited environments., P35; COURTOIS B, 1996, IRRI DISCUSSION PAPE, V16, P154; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; French A, 2009, PLANT PHYSIOL, V150, P1784, DOI 10.1104/pp.109.140558; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Groleau-Renaud V, 1998, CR ACAD SCI III-VIE, V321, P63, DOI 10.1016/S0764-4469(97)89627-8; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; *INT RIC RES I, 2002, RIC ALM VERS 3; Iyer-Pascuzzi AS, 2010, PLANT PHYSIOL, V152, P1148, DOI 10.1104/pp.109.150748; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kato Y, 2006, PLANT SOIL, V287, P117, DOI 10.1007/s11104-006-9008-4; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kondo M., 1999, Genetic improvement of rice for water-limited environments., P117; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Lafitte HR, 2001, FIELD CROP RES, V71, P57, DOI 10.1016/S0378-4290(01)00150-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; MacMillan K, 2006, THEOR APPL GENET, V113, P977, DOI 10.1007/s00122-006-0356-5; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; NEMOTO K, 1995, CROP SCI, V35, P24, DOI 10.2135/cropsci1995.0011183X003500010005x; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; OTOOLE JC, 1987, ADV AGRON, V41, P91, DOI 10.1016/S0065-2113(08)60803-2; Perrier X., 2006, DARWIN SOFTWARE; Price A, 1999, PLANT GROWTH REGUL, V29, P123, DOI 10.1023/A:1006255832479; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2008, R LANG ENV STAT COMP; Rich SM, 2013, J EXP BOT, V64, P1193, DOI 10.1093/jxb/ert043; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Shen L, 2001, THEOR APPL GENET, V103, P75, DOI 10.1007/s001220100538; Singh V, 2012, EUR J AGRON, V42, P3, DOI 10.1016/j.eja.2012.04.006; STEELE K, 2009, PLANT BREEDING NEWS; Steele KA, 2006, THEOR APPL GENET, V112, P208, DOI 10.1007/s00122-005-0110-4; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; Trachsel S, 2011, PLANT SOIL, V341, P75, DOI 10.1007/s11104-010-0623-8; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang L, 2009, J EVOLUTION BIOL, V22, P751, DOI 10.1111/j.1420-9101.2009.01698.x; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	69	202	206	0	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78037	10.1371/journal.pone.0078037	http://dx.doi.org/10.1371/journal.pone.0078037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223758	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400017
J	Yang, ZZ; Xu, YQ; Xu, L; Maccauro, G; Rossi, B; Chen, YJ; Li, HJ; Zhang, J; Sun, HP; Yang, YH; Xu, D; Liu, XF				Yang, Zuozhang; Xu, Yongqing; Xu, Lei; Maccauro, Giulio; Rossi, Barbara; Chen, Yanjin; Li, Hongjun; Zhang, Jing; Sun, Hongpu; Yang, Yihao; Xu, Da; Liu, Xuefeng			Regulation of Autophagy Via PERK-eIF2 alpha Effectively Relieve the Radiation Myelitis Induced by Iodine-125	PLOS ONE			English	Article							METASTATIC SPINAL TUMORS; RENAL-CELL CARCINOMA; PERCUTANEOUS VERTEBROPLASTY; INTERSTITIAL IMPLANTATION; TARGETING AUTOPHAGY; IN-VITRO; DEATH; PROLIFERATION; BRACHYTHERAPY; INDUCTION	Radiation myelitis is the most serious complication in clinical radiotherapy for spinal metastases. We previously showed that I-125 brachytherapy induced apoptosis of spinal cord neurons accompanied by autophagy. In this study, we further investigated the mechanism by which I-125 radiation triggered autophagy in neural cells. We found that autophagy induced by I-125 radiation was involved in endoplasmic reticulum (ER) stress and mainly dependent on PERK-eIF2 alpha pathway. The expressions of LC3II, ATG12 and PI3K were significantly suppressed in PERK knockout neural cells. Meanwhile, the expressions of phosphorylated-Akt s473 and caspase 3/8 all significantly increased in neural cells transfected with a PERK siRNA and which enhanced apoptosis of neurons after I-125 radiation. The results were consistent with that by MTT and Annexin-FITC/PT staining. In annimal model of banna pigs with radiation myelitis caused by I-125 brachytherapy, we have successfully decreased PERK expression by intrathecal administration of the lentivirus vector. The apoptosis rate was significantly higher than that in control group and which deteriorated radiation myelitis of banna pigs. Thus, autophagy caused by I-125 radiation was mainly as an attempt of cell survival at an early stage, but it would be a self-destructive process and promoted the process of apoptosis and necrosis radiated by I-125 for more than 72 hours. The study would be useful and helpful to maximize efficiency of radiation therapy in clinical therapy.	[Yang, Zuozhang; Xu, Yongqing; Xu, Lei; Chen, Yanjin; Zhang, Jing; Sun, Hongpu; Yang, Yihao; Xu, Da; Liu, Xuefeng] Kunming Med Univ, Kunming Gen Hosp Chengdu Mil Command, Affiliated Hosp 3, Dept Orthopaed, Kunming, Yunnan, Peoples R China; [Yang, Zuozhang; Maccauro, Giulio; Rossi, Barbara] Univ Cattolica Sacro Cuore, Agostino Gemelli Hosp, Dept Orthopaed Oncol, Rome, Italy; [Li, Hongjun] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China	Kunming General Hospital; Kunming Medical University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College	Yang, ZZ (corresponding author), Kunming Med Univ, Kunming Gen Hosp Chengdu Mil Command, Affiliated Hosp 3, Dept Orthopaed, Kunming, Yunnan, Peoples R China.	yangzuozhang@hotmail.com		Multhoff, Gabriele/0000-0002-2616-3137; MACCAURO, Giulio/0000-0002-7359-268X	National Natural Science Foundation of China [81260322/H1606, 81372322/H1606]; Natural Science Foundation of Yunnan Province [2012FB163]; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University [2011FB201]; Kunming Major Program of Science and Technology Development [11S030003]; specialty fund of high-level talents medical personnel training of Yunnan province [D-201242]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University; Kunming Major Program of Science and Technology Development; specialty fund of high-level talents medical personnel training of Yunnan province	This research was supported in part by grants (no. 81260322/H1606 and no. 81372322/H1606) from the National Natural Science Foundation of China, a grant (no. 2012FB163) from the Natural Science Foundation of Yunnan Province, a grant (no. 2011FB201) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University, a grant (no. 11S030003) from Kunming Major Program of Science and Technology Development, and a grant (no. D-201242) from the specialty fund of high-level talents medical personnel training of Yunnan province. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird EG, 2001, BRIT J RADIOL, V74, P56, DOI 10.1259/bjr.74.877.740056; Anbalagan S, 2012, RADIOTHER ONCOL, V103, P388, DOI 10.1016/j.radonc.2012.04.001; Bartels RHMA, 2008, CA-CANCER J CLIN, V58, P245, DOI 10.3322/CA.2007.0016; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; BERGLER W, 1993, ORL J OTO-RHINO-LARY, V55, P230, DOI 10.1159/000276429; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Calgarotto AK, 2012, EUR J PHARMACOL, V678, P6, DOI 10.1016/j.ejphar.2011.12.031; Cetin Y, 2005, J AGR FOOD CHEM, V53, P6558, DOI 10.1021/jf051120z; Cheng Yan, 2011, World J Biol Chem, V2, P226, DOI 10.4331/wjbc.v2.i10.226; Donovan DJ, 2006, SPINE, V31, pE460, DOI 10.1097/01.brs.0000222022.67502.4e; Efeyan A, 2012, NATURE; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jaboin JJ, 2007, TECHNOL CANCER RES T, V6, P443, DOI 10.1177/153303460700600510; Jang JS, 2005, J NEUROSURG-SPINE, V2, P243, DOI 10.3171/spi.2005.2.3.0243; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee CS, 2012, ASIAN SPINE J, V6, P71, DOI 10.4184/asj.2012.6.1.71; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levy JMM, 2011, PHARMACOL THERAPEUT, V131, P130, DOI 10.1016/j.pharmthera.2011.03.009; Mancias JD, 2011, ONCOTARGET, V2, P1302; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; Merrick GS, 2003, J UROLOGY, V169, P1643, DOI 10.1097/01.ju.0000035544.25483.61; Neufeld TP, 2012, J CELL SCI, V125, P2359, DOI 10.1242/jcs.103333; Park JH, 2012, J CLIN NEUROSCI, V19, P1573, DOI 10.1016/j.jocn.2011.12.027; Pradeep AN, 2012, CELL TISSUE RES; Roeloffzen EMA, 2011, INT J RADIAT ONCOL, V80, P76, DOI 10.1016/j.ijrobp.2010.01.022; Sahgal A, 2010, INT J RADIAT ONCOL, V77, P548, DOI 10.1016/j.ijrobp.2009.05.023; Seybold VS, 2004, METH MOLEC MED, P203; Ueda Y, 2012, BIOMATERIALS, V33, P9061, DOI 10.1016/j.biomaterials.2012.09.003; Yang ZZ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-48; Yang ZZ, 2012, ONCOL LETT, V3, P315, DOI 10.3892/ol.2011.489; Yang ZZ, 2009, ACTA RADIOL, V50, P1142, DOI 10.3109/02841850903229133	34	10	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e76819	10.1371/journal.pone.0076819	http://dx.doi.org/10.1371/journal.pone.0076819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223705	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400004
J	Zada, G; Kintz, N; Pulido, M; Amezcua, L				Zada, Gabriel; Kintz, Natalie; Pulido, Mario; Amezcua, Lilyana			Prevalence of Neurobehavioral, Social, and Emotional Dysfunction in Patients Treated for Childhood Craniopharyngioma: A Systematic Literature Review	PLOS ONE			English	Review							QUALITY-OF-LIFE; CHILDREN; ADOLESCENTS; EXPERIENCE; SURVIVORS; OXYTOCIN; FEATURES; SURGERY; REMOVAL; OBESITY	Background: Craniopharyngiomas (CP) are locally invasive and frequently recurring neoplasms often resulting in neurological and endocrinological dysfunction in children. In addition, social-behavioral impairment is commonly reported following treatment for childhood CP, yet remains to be fully understood. The authors aimed to further characterize the prevalence of neurobehavioral, social, and emotional dysfunction in survivors of childhood craniopharyngiomas. Materials and Methods: A systematic literature review was conducted in PubMed to identify studies formally assessing neurobehavioral, social, and emotional outcomes in patients treated for CP prior to 18 years of age. Studies published between the years 1990-2012 that reported the primary outcome (prevalence of neurobehavioral, social, emotional/affective dysfunction, and/or impaired quality of life (QoL)) in >= 10 patients were included. Results: Of the 471 studies screened, 11 met inclusion criteria. Overall neurobehavioral dysfunction was reported in 51 of 90 patients (57%) with available data. Social impairment (i.e. withdrawal, internalizing behavior) was reported in 91 of 222 cases (41%). School dysfunction was reported in 48 of 136 patients (35%). Emotional/affective dysfunction was reported in 58 of 146 patients (40%), primarily consisting of depressive symptoms. Health related quality of life was affected in 49 of 95 patients (52%). Common descriptors of behavior in affected children included irritability, impulsivity, aggressiveness, and emotional outbursts. Conclusions: Neurobehavioral, social, and emotional impairment is highly prevalent in survivors of childhood craniopharyngioma, and often affects quality of life. Thorough neurobehavioral/emotional screening and appropriate counseling is recommended in this population. Additional research is warranted to identify risk factors and treatment strategies for these disorders.	[Zada, Gabriel] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Kintz, Natalie] Univ So Calif, Keck Sch Med, George & MaryLou Boone Ctr Parkinsons Dis Res, Los Angeles, CA 90033 USA; [Kintz, Natalie; Amezcua, Lilyana] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Pulido, Mario] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zada, G (corresponding author), Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA.	gzada@usc.edu		Pulido, Mario/0000-0002-3845-2614	Southern California Clinical and Translational Science Institute at the University of Southern California [TL1RR031992, KL2RR031992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000131] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR031992] Funding Source: NIH RePORTER	Southern California Clinical and Translational Science Institute at the University of Southern California; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	No funding was provided for the current study. The authors NK and MP are TL1 trainees awarded under the TL1 (Pre-doctoral) Training Award (TL1RR031992), and authors LA and GZ are KL2 trainees (KL2RR031992) through Southern California Clinical and Translational Science Institute at the University of Southern California. The authors used protected research time to write this paper.	Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Anderson CA, 1997, PEDIATR NEUROSURG, V26, P255; Armstrong C L, 2001, Appl Neuropsychol, V8, P129, DOI 10.1207/S15324826AN0803_1; Armstrong CL, 2002, NEUROLOGY, V59, P40, DOI 10.1212/WNL.59.1.40; Bawden HN, 2009, J CLIN EXP NEUROPSYC, V31, P140, DOI 10.1080/13803390802064599; Campbell A, 2010, PERS SOC PSYCHOL REV, V14, P281, DOI 10.1177/1088868310363594; Carpentieri SC, 2003, NEUROSURGERY, V52, P1348, DOI 10.1227/01.NEU.0000064804.00766.62; CLOPPER RR, 1977, PSYCHONEUROENDOCRINO, V2, P365, DOI 10.1016/0306-4530(77)90006-3; Cohen Michal, 2011, Front Endocrinol (Lausanne), V2, P81, DOI 10.3389/fendo.2011.00081; Dolson EP, 2009, PEDIATR BLOOD CANCER, V52, P860, DOI 10.1002/pbc.21947; GALATZER A, 1981, CHILD CARE HLTH DEV, V7, P307, DOI 10.1111/j.1365-2214.1981.tb00848.x; Gautier A, 2012, J CLIN ENDOCR METAB, V97, P1258, DOI 10.1210/jc.2011-2817; Graustella AJ, 2012, HORM BEHAV, V61, P410, DOI [10.1016/j.yhbeh.2012.01.002, 10.1016/j.yhbeh.2012.04.008]; Hammond JL, 2011, DEV MED CHILD NEUROL, V53, P369, DOI 10.1111/j.1469-8749.2010.03887.x; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Jackson AC, 2003, SOC WORK HEALTH CARE, V38, P81, DOI 10.1300/J010v38n01_05; Kendall-Taylor P, 2005, EUR J ENDOCRINOL, V152, P557, DOI 10.1530/eje.1.01877; Laffond C, 2012, BRAIN INJURY, V26, P270, DOI 10.3109/02699052.2011.648709; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Merchant TE, 2002, INT J RADIAT ONCOL, V53, P533, DOI 10.1016/S0360-3016(02)02799-2; Meyers CA, 2000, INT J RADIAT ONCOL, V46, P51, DOI 10.1016/S0360-3016(99)00376-4; Muller HL, 2011, EUR J ENDOCRINOL, V165, P17, DOI 10.1530/EJE-11-0158; Muller HL, 2010, NAT REV ENDOCRINOL, V6, P609, DOI 10.1038/nrendo.2010.168; Muller HL, 2001, KLIN PADIATR, V213, P244, DOI 10.1055/s-2001-16855; Netherton E, 2011, HUM PSYCHOPHARM CLIN, V26, P271, DOI 10.1002/hup.1212; Ondruch A, 2011, CHILD NERV SYST, V27, P391, DOI 10.1007/s00381-010-1301-0; Pedreira CC, 2006, J PEDIATR ENDOCR MET, V19, P15; Pierre-Kahn A, 2005, CHILD NERV SYST, V21, P817, DOI 10.1007/s00381-005-1205-6; Poretti A, 2004, DEV MED CHILD NEUROL, V46, P220, DOI 10.1017/S0012162204000374; Puget Stephanie, 2012, Front Endocrinol (Lausanne), V3, P64, DOI 10.3389/fendo.2012.00064; Riva D, 1998, CHILD NERV SYST, V14, P179, DOI 10.1007/s003810050207; Sands SA, 2005, J NEUROSURG, V103, P302, DOI 10.3171/ped.2005.103.4.0302; Shiminski-Maher T, 1990, J Neurosci Nurs, V22, P220; Smith AS, 2010, HORM BEHAV, V57, P255, DOI 10.1016/j.yhbeh.2009.12.004; Srinivasan S, 2004, J CLIN ENDOCR METAB, V89, P81, DOI 10.1210/jc.2003-030442; Waber DP, 2006, PEDIATR NEUROL, V34, P13, DOI 10.1016/j.pediatrneurol.2005.06.002; Zada G, 2010, WORLD NEUROSURG, V74, P256, DOI 10.1016/j.wneu.2010.06.027; Zada G, 2010, HORM RES PAEDIAT, V74, P62, DOI 10.1159/000309349; Zada G, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS09318	39	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e76562	10.1371/journal.pone.0076562	http://dx.doi.org/10.1371/journal.pone.0076562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223703	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400002
J	Akinlade, KS; Atere, AD; Olaniyi, JA; Rahamon, SK; Adewale, CO				Akinlade, Kehinde Sola; Atere, Adedeji David; Olaniyi, John Ayodele; Rahamon, Sheu Kadiri; Adewale, Christiana Odunayo			Serum Copeptin and Cortisol Do Not Accurately Predict Sickle Cell Anaemia Vaso-Occlusive Crisis as C-Reactive Protein	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; STABLE PEPTIDE; VASOPRESSIN PRECURSOR; CRITICALLY-ILL; SEPTIC SHOCK; DISEASE; INFLAMMATION; MORTALITY; BIOMARKER; SEVERITY	Objective: This study assessed the diagnostic performance and prognostic properties of C-reactive protein (CRP), copeptin and cortisol in individuals with sickle cell anaemia (SCA). Design: Prospective case-control study Methods: Sixty consecutive SCA subjects (18-40 years) comprising 30 subjects in the steady state and 30 subjects in vaso-occlusive crisis (VOC) were recruited into this study. Thirty (30) apparently healthy individuals with HbAA genotype served as controls. ELISA was used for the determination of serum levels of copeptin, CRP and cortisol. Data obtained were statistically analyzed using the Student's t-test and Mann Whitney U as appropriate and P<0.05 was considered significant. Results: SCA subjects in VOC had significantly lower copeptin level and significantly higher CRP level compared with controls. However, serum levels of copeptin, cortisol and CRP were significantly higher in SCA subjects in VOC compared with SCA subjects in steady state. Furthermore, CRP had the widest Area under the ROC curve (AUROC) than copeptin and cortisol. No significant difference was observed in the levels of copeptin, CRP and cortisol when SCA subjects in VOC who were hospitalized for less <= 5 days were compared with subjects who had longer stays. Conclusion: It could be concluded that C-reactive protein has a superior diagnostic performance for vaso-occlusive crisis in individuals with sickle cell anaemia and that C-reactive protein, cortisol and copeptin are not good prognostic markers in SCA subjects in vaso-occlusive crisis.	[Akinlade, Kehinde Sola; Atere, Adedeji David; Rahamon, Sheu Kadiri; Adewale, Christiana Odunayo] Univ Ibadan, Univ Coll Hosp, Dept Chem Pathol, Ibadan, Nigeria; [Olaniyi, John Ayodele] Univ Ibadan, Univ Coll Hosp, Dept Haematol, Ibadan, Nigeria	University of Ibadan; University College Hospital, Ibadan; University of Ibadan; University College Hospital, Ibadan	Akinlade, KS (corresponding author), Univ Ibadan, Univ Coll Hosp, Dept Chem Pathol, Ibadan, Nigeria.	ksakinlade@yahoo.co.uk	Rahamon, Sheu K/C-9676-2018; Atere, Adedeji/GRE-8275-2022; Olaniyi, John/AAO-8849-2021; Olaniyi, John/H-2856-2019	Rahamon, Sheu K/0000-0003-0305-5026; Olaniyi, John/0000-0002-0048-0337; Atere, A. David/0000-0002-8802-3762; Akinlade, Kehinde Sola/0000-0002-9413-3562				Abbiyesuku F M, 1999, Afr J Med Med Sci, V28, P65; Akohoue SA, 2007, PEDIATR RES, V61, P233, DOI 10.1203/pdr.0b013e31802d7754; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Arnon B, 2005, HAEMA, V8, P462; CHRISTOU NV, 1989, ANN SURG, V210, P69, DOI 10.1097/00000658-198907000-00011; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; DIXON JS, 1984, SCAND J RHEUMATOL, V13, P39, DOI 10.3109/03009748409102666; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; ELHAZMI MAF, 1992, J TROP PEDIATRICS, V38, P307, DOI 10.1093/tropej/38.6.307; HEDO CC, 1993, J INTERN MED, V233, P467, DOI 10.1111/j.1365-2796.1993.tb01000.x; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kao PC, 2006, ANN CLIN LAB SCI, V36, P163; Katan M, 2011, NEUROLOGY, V76, P563, DOI 10.1212/WNL.0b013e31820b75e6; Katan M, 2010, EUR J MED SERVICES, V140, P13101; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Krishnan S, 2010, BRIT J HAEMATOL, V148, P797, DOI 10.1111/j.1365-2141.2009.08013.x; KUSHNER I, 1991, ARTHRITIS RHEUM, V34, P1065, DOI 10.1002/art.1780340819; Latendresse G, 2008, BIOL RES NURS, V10, P54, DOI 10.1177/1099800408320970; Limper M, 2010, J INFECTION, V61, P92, DOI 10.1016/j.jinf.2010.03.029; Makis AC, 2006, ARCH INTERN MED, V166, P366, DOI 10.1001/archinte.166.3.366; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Mohammed FA, 2010, BLOOD CELL MOL DIS, V45, P293, DOI 10.1016/j.bcmd.2010.08.003; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; NADEL C, 1977, NEW YORK STATE J MED, V77, P1075; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Omoti CE, 2005, ANN AFR MED, V4, P62; OSIFO BOA, 1988, ACTA HAEMATOL-BASEL, V79, P44, DOI 10.1159/000205689; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Porter L S, 2000, J Health Psychol, V5, P53, DOI 10.1177/135910530000500109; ROSENBLOOM BE, 1980, AM J HEMATOL, V9, P373; SAAD STO, 1992, TROP GEOGR MED, V44, P86; Sam S, 2004, CLIN ENDOCRINOL, V60, P29, DOI 10.1111/j.1365-2265.2004.01923.x; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Soyannwo OA, 2000, W AFR J MED, V4, P242; Stolz D, 2007, CHEST, V131, P1058, DOI 10.1378/chest.06-2336; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; STUART J, 1994, J CLIN PATHOL, V47, P166, DOI 10.1136/jcp.47.2.166; Urwyler SA, 2010, STROKE, V41, P1564, DOI 10.1161/STROKEAHA.110.584649; van Wolfswinkel ME, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-6; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	45	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77913	10.1371/journal.pone.0077913	http://dx.doi.org/10.1371/journal.pone.0077913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223742	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400021
J	Fong, JT; Jacobs, RJ; Moravec, DN; Uppada, SB; Botting, GM; Nlend, M; Puri, N				Fong, Jason T.; Jacobs, Ryan J.; Moravec, David N.; Uppada, Srijayaprakash B.; Botting, Gregory M.; Nlend, Marie; Puri, Neelu			Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; ACQUIRED-RESISTANCE; BETA-CATENIN; CROSS-TALK; CLINICAL-RESPONSE; DUAL INHIBITION; T790M MUTATIONS; GEFITINIB; WNT	The use of tyrosine kinase inhibitors (TKIs) against EGFR/c-Met in non-small cell lung cancer (NSCLC) has been shown to be effective in increasing patient progression free survival (PFS), but their efficacy is limited due to the development of resistance and tumor recurrence. Therefore, understanding the molecular mechanisms underlying development of drug resistance in NSCLC is necessary for developing novel and effective therapeutic approaches to improve patient outcome. This study aims to understand the mechanism of EGFR/c-Met tyrosine kinase inhibitor (TKI) resistance in NSCLC. H2170 and H358 cell lines were made resistant to SU11274, a c-Met inhibitor, and erlotinib, an EGFR inhibitor, through step-wise increases in TKI exposure. The IC50 concentrations of resistant lines exhibited a 4-5 and 11-22-fold increase for SU11274 and erlotinib, respectively, when compared to parental lines. Furthermore, mTOR and Wnt signaling was studied in both cell lines to determine their roles in mediating TKI resistance. We observed a 2-4-fold upregulation of mTOR signaling proteins and a 2- to 8-fold upregulation of Wnt signaling proteins in H2170 erlotinib and SU11274 resistant cells. H2170 and H358 cells were further treated with the mTOR inhibitor everolimus and the Wnt inhibitor XAV939. H358 resistant cells were inhibited by 95% by a triple combination of everolimus, erlotinib and SU11274 in comparison to 34% by a double combination of these drugs. Parental H2170 cells displayed no sensitivity to XAV939, while resistant cells were significantly inhibited (39%) by XAV939 as a single agent, as well as in combination with SU11274 and erlotinib. Similar results were obtained with H358 resistant cells. This study suggests a novel molecular mechanism of drug resistance in lung cancer.	[Fong, Jason T.; Jacobs, Ryan J.; Moravec, David N.; Uppada, Srijayaprakash B.; Botting, Gregory M.; Puri, Neelu] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Nlend, Marie] Thermo Fisher Sci, Rockford, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Thermo Fisher Scientific	Puri, N (corresponding author), Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA.	neelupur@uic.edu	Uppada, Srijayaprakash/AAD-7728-2021		National Cancer Institute of the National Institutes of Health [R21CA158965-01A1]; NATIONAL CANCER INSTITUTE [R21CA158965] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by National Cancer Institute of the National Institutes of Health under award number R21CA158965-01A1 http://www.nih.gov to Neelu Puri. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bianco R, 2007, CURR PHARM DESIGN, V13, P3358, DOI 10.2174/138161207782360537; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Casas-Selves M, 2012, CANC RES; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Choo AY, 2006, CELL, V126, P834, DOI 10.1016/j.cell.2006.08.025; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Coley HM, 2004, METH MOLEC MED, V88, P267; Dienstmann R, 2011, MOL ONCOL; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fu YJ, 2011, INT J CANCER, V129, P1541, DOI 10.1002/ijc.26102; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; Goldman JW, 2012, CANCER; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jeon SH, 2007, J BIOL CHEM, V282, P14482, DOI 10.1074/jbc.M611129200; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; La Monica S, 2009, BIOCHEM PHARMACOL, V78, P460, DOI 10.1016/j.bcp.2009.04.033; Laux I, 2009, J CLIN ONCOL, V27, pCP46; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Li ZG, 2008, ONCOGENE, V27, P596, DOI 10.1038/sj.onc.1210694; Ma PC, 2005, CLIN CANCER RES, V11, P2312, DOI 10.1158/1078-0432.CCR-04-1708; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; MacDonald BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023537; Maulik G, 2002, CLIN CANCER RES, V8, P620; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Nakachi I, 2010, MOL CANCER RES, V8, P1142, DOI 10.1158/1541-7786.MCR-09-0388; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Puri Neelu, 2008, J Carcinog, V7, P9; Ramalingam S, 2008, J THORAC ONCOL, V3, P258, DOI 10.1097/JTO.0b013e3181653d1b; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Sattler M, 2003, CANCER RES, V63, P5462; Schmid K, 2010, BRIT J CANCER, V103, P622, DOI 10.1038/sj.bjc.6605761; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Shahi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030814; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Spigel DR, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7505; Spix JK, 2007, EXP CELL RES, V313, P3319, DOI 10.1016/j.yexcr.2007.06.006; Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Tahir SA, 2013, CANCER RES, V73, P1900, DOI 10.1158/0008-5472.CAN-12-3040; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wedel S, 2011, CANCER LETT, V301, P17, DOI 10.1016/j.canlet.2010.11.003; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Xu Y, 2010, CANCER BIOL THER, V9, P572, DOI 10.4161/cbt.9.8.11881; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622; Zhu H, 2011, MOL BIOL REP	64	36	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78398	10.1371/journal.pone.0078398	http://dx.doi.org/10.1371/journal.pone.0078398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223799	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400058
J	Sohel, MMH; Hoelker, M; Noferesti, SS; Salilew-Wondim, D; Tholen, E; Looft, C; Rings, F; Uddin, MJ; Spencer, TE; Schellander, K; Tesfaye, D				Sohel, Md. Mahmodul Hasan; Hoelker, Michael; Noferesti, Sina Seifi; Salilew-Wondim, Dessie; Tholen, Ernst; Looft, Christian; Rings, Franca; Uddin, Muhammad Jasim; Spencer, Thomas E.; Schellander, Karl; Tesfaye, Dawit			Exosomal and Non-Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications for Bovine Oocyte Developmental Competence	PLOS ONE			English	Article							EXPRESSION; PATHWAY; IDENTIFICATION; MATURATION; GROWTH; CELLS; DEGRADATION; PROTEINS; MARKERS; QUALITY	Cell-cell communication within the follicle involves many signaling molecules, and this process may be mediated by secretion and uptake of exosomes that contain several bioactive molecules including extra-cellular miRNAs. Follicular fluid and cells from individual follicles of cattle were grouped based on Brilliant Cresyl Blue (BCB) staining of the corresponding oocytes. Both Exoquick precipitation and differential ultracentrifugation were used to separate the exosome and non-exosomal fraction of follicular fluid. Following miRNA isolation from both fractions, the human miRCURY LNA(TM) Universal RT miRNA PCR array system was used to profile miRNA expression. This analysis found that miRNAs were present in both exosomal and non-exosomal fraction of bovine follicular fluid. We found 25 miRNAs differentially expressed (16 up and 9 down) in exosomes and 30 miRNAs differentially expressed (21 up and 9 down) in non-exosomal fraction of follicular fluid in comparison of BCB-versus BCB+ oocyte groups. Expression of selected miRNAs was detected in theca, granulosa and cumulus oocyte complex. To further explore the potential roles of these follicular fluid derived extra-cellular miRNAs, the potential target genes were predicted, and functional annotation and pathway analysis revealed most of these pathways are known regulators of follicular development and oocyte growth. In order to validate exosome mediated cell-cell communication within follicular microenvironment, we demonstrated uptake of exosomes and resulting increase of endogenous miRNA level and subsequent alteration of mRNA levels in follicular cells in vitro. This study demonstrates for the first time, the presence of exosome or non-exosome mediated transfer of miRNA in the bovine follicular fluid, and oocyte growth dependent variation in extra-cellular miRNA signatures in the follicular environment.	[Sohel, Md. Mahmodul Hasan; Hoelker, Michael; Noferesti, Sina Seifi; Salilew-Wondim, Dessie; Tholen, Ernst; Looft, Christian; Rings, Franca; Uddin, Muhammad Jasim; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Dept Anim Breeding & Husb, Bonn, Germany; [Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	University of Bonn; Washington State University	Tesfaye, D (corresponding author), Univ Bonn, Dept Anim Breeding & Husb, Bonn, Germany.	tesfaye@itw.uni-bonn.de	Sohel, Mahmodul Hasan/X-8820-2019; Uddin, Muhammad Jasim/N-3866-2013; Sohel, Mahmodul Hasan/I-5063-2019; Spencer, Thomas/AAD-6434-2020; Uddin, Muhammad Jasim/P-8497-2019	Sohel, Mahmodul Hasan/0000-0003-2224-085X; Uddin, Muhammad Jasim/0000-0002-6732-5534; Spencer, Thomas/0000-0003-2815-766X; Wondim, Dr. Dessie Salilew/0000-0002-8756-0865				Araujo VR, 2011, CELL TISSUE RES, V346, P273, DOI 10.1007/s00441-011-1251-1; Armstrong D G, 1997, Rev Reprod, V2, P139, DOI 10.1530/revreprod/2.3.139; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; Cortez Maria Angelica, 2012, Recent Results Cancer Res, V195, P151, DOI 10.1007/978-3-642-28160-0_13; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Ding F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009402; Dissen GA, 2009, SEMIN REPROD MED, V27, P24, DOI 10.1055/s-0028-1108007; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Forde N, 2012, PHYSIOL GENOMICS, V44, P799, DOI 10.1152/physiolgenomics.00067.2012; Gad A, 2011, HUM REPROD, V26, P1693, DOI 10.1093/humrep/der110; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Ghanem N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-90; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; GOSDEN RG, 1988, J REPROD FERTIL, V82, P813, DOI 10.1530/jrf.0.0820813; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; Hossain MM, 2012, CELL TISSUE RES, V349, P679, DOI 10.1007/s00441-012-1469-6; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Huo LJ, 2004, MECH DEVELOP, V121, P1275, DOI 10.1016/j.mod.2004.05.007; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; MCNATTY KP, 1978, J ENDOCRINOL, V76, P527, DOI 10.1677/joe.0.0760527; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mongan M, 2011, DEVELOPMENT, V138, P4001, DOI 10.1242/dev.065003; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Patsoula E, 2001, REPRODUCTION, V121, P455, DOI 10.1530/rep.0.1210455; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Pujol M, 2004, THERIOGENOLOGY, V61, P735, DOI 10.1016/S0093-691X(03)00250-4; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Silva DS, 2011, ZYGOTE, V27, P1; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; SPANELBOROWSKI K, 1994, MOL CELL ENDOCRINOL, V104, P11, DOI 10.1016/0303-7207(94)90046-9; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Sutherland JM, 2012, J CELL PHYSIOL, V227, P1188, DOI 10.1002/jcp.22837; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; TORRI AF, 1988, MOL CELL BIOL, V8, P4625, DOI 10.1128/MCB.8.11.4625; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yamaura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030250; Yokoo M, 2002, BIOL REPROD, V67, P1165, DOI 10.1095/biolreprod67.4.1165; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zheng P, 2006, MOL REPROD DEV, V73, P667, DOI 10.1002/mrd.20428; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	65	204	214	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78505	10.1371/journal.pone.0078505	http://dx.doi.org/10.1371/journal.pone.0078505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223816	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400069
J	Liu, YW; Song, N; Ren, KX; Meng, SL; Xie, Y; Long, QD; Chen, XC; Zhao, X				Liu, Yingwei; Song, Na; Ren, Kexing; Meng, Shenglan; Xie, Yao; Long, Qida; Chen, Xiancheng; Zhao, Xia			Expression Loss and Revivification of RhoB Gene in Ovary Carcinoma Carcinogenesis and Development	PLOS ONE			English	Article							RAS TRANSFORMATION; CELL-ADHESION; CANCER; PROTEINS; GTPASES; GROWTH; FARNESYLTRANSFERASE; ADENOCARCINOMA; TRICHOSTATIN; DEGRADATION	RhoB, a member of small GTPases belonging to the Ras protein superfamily, might have a suppressive activity in cancer progression. Here, expression of RhoB gene was evaluated in human benign, borderline and malignant ovary tumors by immunostaining, with normal ovary tissue as control. Malignant tumors were assessed according to Federation Internationale de Gynecologie Obstetrique (FIGO) guidelines and classified in stage I-IV. Revivification of RhoB gene was investigated by analyzing the effect of histone deacetylase (HDAC) inhibitor trichostatin (TSA) and methyltransferase inhibitor 5-azacytidine (5-Aza) on ovarian cancer cells via RT-PCR and western blot. Apoptosis of ovary cancer cells was detected using flowcytometry and fluorescence microscopy. Subsequently, RhoB expression is detected in normal ovary epithelium, borderline tumors, and decreases significantly or lost in the majority of ovarian cancer specimen (P<0.05). RhoB expression decreases significantly from stage II (71.4%) to stage III (43.5%) to stage IV (18.2%, P<0.05). TSA can both significantly revive the RhoB gene and mediate apoptosis of ovarian cancer cells, but 5-Aza couldn't. Interference into Revivification of RhoB gene results in reduction of ovary carcinoma cell apoptosis. It is proposed that loss of RhoB expression occurs frequently in ovary carcinogenesis and progression and its expression could be regulated by histone deacetylation but not by promoter hypermethylation, which may serve as a prospective gene treatment target for the patients with ovarian malignancy not responding to standard therapies.	[Liu, Yingwei; Xie, Yao; Long, Qida; Zhao, Xia] Sichuan Univ, West China Hosp 2, Dept Gynecol & Obstet, Chengdu 610064, Sichuan, Peoples R China; [Song, Na; Ren, Kexing; Meng, Shenglan; Chen, Xiancheng] Sichuan Univ, West China Hosp, Natl Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Song, Na; Ren, Kexing; Meng, Shenglan; Chen, Xiancheng] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Chen, XC (corresponding author), Sichuan Univ, West China Hosp, Natl Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	chenwcrs@126.com; xia-zhao@126.com			National 973 Program of China [2010CB529905, 2011CB910702, 2011CB910703]; National Natural Science Foundation of China [NSFC81071861]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National 973 Program of China(grant nos. 2010CB529905, 2011CB910702, 2011CB910703), National Natural Science Foundation of China (NSFC81071861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane J, 2002, CLIN CANCER RES, V8, P2225; Allal C, 2002, CELL CYCLE, V1, P430, DOI 10.4161/cc.1.6.272; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Couderc B, 2008, CANCER GENE THER, V15, P456, DOI 10.1038/cgt.2008.12; Delarue FL, 2007, ONCOGENE, V26, P633, DOI 10.1038/sj.onc.1209819; Della Ragione F, 2001, FEBS LETT, V499, P199, DOI 10.1016/S0014-5793(01)02539-X; DeWard AD, 2009, PLOS ONE, V4, P7102, DOI [10.1371/journal.pone.0007102, DOI 10.1371/J0URNAL.P0NE.0007102.PUBMED:19768111]; Eickhoff B, 2000, BIOL CHEM, V381, P107, DOI 10.1515/BC.2000.015; Ferrara FF, 2001, CANCER RES, V61, P2; Forget MA, 2002, CLIN EXP METASTAS, V19, P9, DOI 10.1023/A:1013884426692; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Harter P, 2007, INT J GYNECOL CANCER, V17, P1238, DOI 10.1111/j.1525-1438.2007.00931.x; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; MANT JWF, 1994, CANCER SURV, V20, P287; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Momtahen S, 2007, ASCO M, p[25, 5550]; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Wang SW, 2003, ONCOGENE, V22, P6204, DOI 10.1038/sj.onc.1206653; Weidle UH, 2000, ANTICANCER RES, V20, P1471; Wheeler AP, 2007, EXP CELL RES, V313, P3505, DOI 10.1016/j.yexcr.2007.07.014; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	43	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78417	10.1371/journal.pone.0078417	http://dx.doi.org/10.1371/journal.pone.0078417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223801	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300028
J	Kwan, MWM; Wong, MCS; Wang, HHX; Liu, KQL; Lee, CLS; Yan, BPY; Yu, CM; Griffiths, SM				Kwan, Mandy Wing-Man; Wong, Martin Chi-Sang; Wang, Harry Hao-Xiang; Liu, Kirin Qi-Lin; Lee, Catherine Lok-Sze; Yan, Bryan Ping-Yen; Yu, Cheuk-Man; Griffiths, Sian Meryl			Compliance with the Dietary Approaches to Stop Hypertension (DASH) Diet: A Systematic Review	PLOS ONE			English	Review							BLOOD-PRESSURE; OLDER-ADULTS; WEIGHT-LOSS; ADHERENCE; EXERCISE; WOMEN; RISK	Background: The Dietary Approaches to Stop Hypertension (DASH) diet has been recognized as effective to lower blood pressure in feeding trials, but compliance with the diet must be persistent to maximize health benefits in clinical practice. This paper reports a systematic review of the latest evidence on the method to assess DASH compliance and the corresponding patients' compliance in interventional settings. Methods: The databases including MEDLINE, EBM Reviews, EMBASE, and CINAHL Plus were searched for original research studies published in the period of January 1992-December 2012 that evaluated compliance with DASH diet. Studies written in English language, with DASH intervention, with complete documentation of the degree of DASH compliance and the assessment method used were included in this review. The search terms included: dietary approaches to stop hypertension, DASH, compliance, adherence, consistency, and concordance. Results: Nine studies were included. Different types of interventions were identified, ranging from feeding trial to dietary counseling. These studies differed in the assessment methods used to evaluate DASH compliance, which included objective approaches like measurement of urinary excretion, and subjective approaches like dietary intake assessment for DASH target comparison and construction of DASH scoring systems. Compliance levels were lower in educational interventions than that of the original DASH feeding trial. Conclusions: To conclude, although no consensus existed regarding the best approach to assess DASH compliance, its suboptimal compliance warrants attention. This study implied a need to investigate effective approaches to sustain the DASH dietary pattern beyond counselling alone.	[Kwan, Mandy Wing-Man; Wong, Martin Chi-Sang; Wang, Harry Hao-Xiang; Liu, Kirin Qi-Lin; Lee, Catherine Lok-Sze; Griffiths, Sian Meryl] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, Harry Hao-Xiang] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Yan, Bryan Ping-Yen; Yu, Cheuk-Man] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Glasgow; Chinese University of Hong Kong	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wang, Harry H.X./E-9027-2015; Yu, Cheuk-man/P-3747-2015; Wong, Martin/L-4568-2014; Yan, Bryan P/P-5928-2015	Wang, Harry H.X./0000-0002-0361-6527; Wong, Martin/0000-0001-7706-9370; 	Health and Health Services Research Fund, Food and Health Bureau, Hong Kong [09100701]	Health and Health Services Research Fund, Food and Health Bureau, Hong Kong	Funding support provided by Health and Health Services Research Fund, Food and Health Bureau, Hong Kong [Project No. 09100701]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, NUTR ASSESSMENT; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Bacon SL, 2004, SPORTS MED, V34, P307, DOI 10.2165/00007256-200434050-00003; Bentley B, 2006, J CARDIOVASC NURS, V21, P63, DOI 10.1097/00005082-200601000-00012; Blumenthal JA, 2010, ARCH INTERN MED, V170, P126, DOI 10.1001/archinternmed.2009.470; Booth AO, 2003, ASIA PAC J CLIN NU S, V12, pS10; Centre for Health Protection Department of Health, 2007, NONC DIS RISK FACT H; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Couch SC, 2008, J PEDIATR-US, V152, P494, DOI 10.1016/j.jpeds.2007.09.022; Daskalopoulou SS, 2012, CAN J CARDIOL, V28, P270, DOI 10.1016/j.cjca.2012.02.018; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Epstein DE, 2012, J ACAD NUTR DIETETIC; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Levitan EB, 2009, AM J CARDIOL, V104, P1416, DOI 10.1016/j.amjcard.2009.06.061; Liese AD, 2009, DIABETES CARE, V32, P1434, DOI 10.2337/dc09-0228; Lin PH, 2007, J AM DIET ASSOC, V107, P1541, DOI 10.1016/j.jada.2007.06.019; National Institutes of Health-National Heart Lung and Blood Institute, 2006, YOUR GUID LOW YOUR B; Nowson CA, 2004, J NUTR, V134, P2322, DOI 10.1093/jn/134.9.2322; Nowson CA, 2009, BRIT J NUTR, V102, P1161, DOI 10.1017/S0007114509371731; Nowson CA, 2009, NUTR RES, V29, P8, DOI 10.1016/j.nutres.2008.12.002; Obarzanek E, 2007, AM J HEALTH BEHAV, V31, P545, DOI 10.5993/AJHB.31.5.10; Racine E, 2011, J NUTR HEALTH AGING, V15, P868, DOI 10.1007/s12603-011-0102-9; Troyer JL, 2010, AM J CLIN NUTR, V91, P1204, DOI 10.3945/ajcn.2009.28780; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20; Windhauser MM, 1999, J AM DIET ASSOC, V99, pS76, DOI 10.1016/S0002-8223(99)00420-4; World Health Organization, 2012, WORLD HLTH STAT 2012	26	64	65	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78412	10.1371/journal.pone.0078412	http://dx.doi.org/10.1371/journal.pone.0078412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205227	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000326334500118
J	Sander, PM				Sander, P. Martin			An Evolutionary Cascade Model for Sauropod Dinosaur Gigantism - Overview, Update and Tests	PLOS ONE			English	Article							WATER-VAPOR CONDUCTANCE; BODY-MASS; THEROPOD DINOSAUR; BONE-GROWTH; COPES RULE; 1ST RECORD; EGGS; SIZE; NECK; DIGESTIBILITY	Sauropod dinosaurs are a group of herbivorous dinosaurs which exceeded all other terrestrial vertebrates in mean and maximal body size. Sauropod dinosaurs were also the most successful and long-lived herbivorous tetrapod clade, but no abiological factors such as global environmental parameters conducive to their gigantism can be identified. These facts justify major efforts by evolutionary biologists and paleontologists to understand sauropods as living animals and to explain their evolutionary success and uniquely gigantic body size. Contributions to this research program have come from many fields and can be synthesized into a biological evolutionary cascade model of sauropod dinosaur gigantism (sauropod gigantism ECM). This review focuses on the sauropod gigantism ECM, providing an updated version based on the contributions to the PLoS ONE sauropod gigantism collection and on other very recent published evidence. The model consist of five separate evolutionary cascades ("Reproduction'', "Feeding'', "Head and neck'', "Avian-style lung'', and "Metabolism''). Each cascade starts with observed or inferred basal traits that either may be plesiomorphic or derived at the level of Sauropoda. Each trait confers hypothetical selective advantages which permit the evolution of the next trait. Feedback loops in the ECM consist of selective advantages originating from traits higher in the cascades but affecting lower traits. All cascades end in the trait "Very high body mass''. Each cascade is linked to at least one other cascade. Important plesiomorphic traits of sauropod dinosaurs that entered the model were ovipary as well as no mastication of food. Important evolutionary innovations (derived traits) were an avian-style respiratory system and an elevated basal metabolic rate. Comparison with other tetrapod lineages identifies factors limiting body size.	Univ Bonn, Steinmann Inst Geol Mineral & Paleontol, Bonn, Germany	University of Bonn	Sander, PM (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Paleontol, Bonn, Germany.	martin.sander@uni-bonn.de			DFG (Deutsche Forschungsgemeinschaft/FOR 533: Biology of the Sauropod Dinosaurs: The Evolution of Gigantism)	DFG (Deutsche Forschungsgemeinschaft/FOR 533: Biology of the Sauropod Dinosaurs: The Evolution of Gigantism)(German Research Foundation (DFG))	This study was funded by the DFG (Deutsche Forschungsgemeinschaft/FOR 533: Biology of the Sauropod Dinosaurs: The Evolution of Gigantism). The funder's URL is www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; AR A, 1979, CONDOR, V81, P331, DOI 10.2307/1366955; Benson RBJ, 2013, PALAEOGEOGR PALAEOCL, V372, P88, DOI 10.1016/j.palaeo.2012.10.028; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Benton M.J., 1990, P11; Birchard GF, 2009, J ZOOL, V279, P95, DOI 10.1111/j.1469-7998.2009.00596.x; Bonner J.T., 2006, WHY SIZE MATTERS; Brown CM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0582; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034094; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Carballido JL, 2013, J SYSTEMATIC PALAEON, P1, DOI DOI 10.1080/14772019.2013.764935; Carballido JL, 2011, ZOOL J LINN SOC-LOND, V163, P605, DOI 10.1111/j.1096-3642.2011.00723.x; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2011, P ROY SOC B-BIOL SCI, V278, P2682, DOI 10.1098/rspb.2010.2497; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Cerda IA, 2012, PALAEONTOL Z, V86, P441, DOI 10.1007/s12542-012-0140-6; Cerda IA, 2012, NATURWISSENSCHAFTEN, V99, P83, DOI 10.1007/s00114-011-0869-x; Charig A.J., 1972, P121; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Christian Andreas, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P271; Christian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071172; Christian Andreas, 2011, P251; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; Clauss M, 2013, PLOS ONE, V8; Clauss Marcus, 2011, P3; Clauss M, 2009, COMP BIOCHEM PHYS A, V154, P376, DOI 10.1016/j.cbpa.2009.07.016; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; Codron D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077110; Codron D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0922; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069235; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; D'Emic MD, 2011, J VERTEBR PALEONTOL, V31, P1072, DOI 10.1080/02724634.2011.595856; Deeming DC, 2008, AVIAN BIOL RES, V1, P187, DOI 10.3184/175815508X402482; Deeming DC, 2006, PALAEONTOLOGY, V49, P171, DOI 10.1111/j.1475-4983.2005.00536.x; DePalma RA, 2013, P NATL ACAD SCI; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Falkingham PL, 2010, BIOL LETT; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; Farlow JO, 2010, SWISS J GEOSCI, V103, P173, DOI 10.1007/s00015-010-0021-5; Farmer CG, 2010, SCIENCE, V327, P338, DOI 10.1126/science.1180219; Filippi LS, 2011, ACTA PALAEONTOL POL, V56, P505, DOI 10.4202/app.2010.0019; Foster JR., 2007, JURASSIC W THE DINOS, P389; Fowler DW, 2011, HIST BIOL, V23, P27, DOI 10.1080/08912963.2010.504852; Fowler DW, 2011, ACTA PALAEONTOL POL, V56, P685, DOI 10.4202/app.2010.0105; Franz R, 2009, P ROY SOC B-BIOL SCI, V276, P1731, DOI 10.1098/rspb.2008.1735; Fricke HC, 2011, NATURE, V480, P513, DOI 10.1038/nature10570; Fritz J, 2011, PALEOBIOLOGY, V37, P577, DOI 10.1666/10031.1; Futuyma DJ, 2010, EVOLUTION, V64, P1865, DOI 10.1111/j.1558-5646.2010.00960.x; Gatesy Stephen M., 2002, P432; Gaudin Timothy J., 2006, P1; Gee Carole T., 2011, P34; Gee CT, PALAEOBIODI IN PRESS; Georgi JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058517; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gottmann-Quesada A, 2009, PALAEONTOGR ABT A, V287, P123; Gould GC, 2004, B AM MUS NAT HIST, P219; Grellet-Tinner G, 2004, CAN J EARTH SCI, V41, P949, DOI 10.1139/E04-049; Grellet-Tinner G, 2012, PALAIOS, V27, P35, DOI 10.2110/palo.2011.p11-061r; Griebeler EM, 2013, PLOS ONE, P8; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067012; Griebeler Eva Maria, 2011, P263; Hedrick BP, 2013, ACTA PALAEONTOLOGICA; Henderson D, 2013, PLOS ONE, V8; Hildebrand M., 2001, ANAL VERTEBRATE STRU, V5th, P635; HOKKANEN JEI, 1986, J THEOR BIOL, V118, P491, DOI 10.1016/S0022-5193(86)80167-9; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Hudson L, 2013, J ANIMAL ECOLOGY; Hummel J, 2008, EVOLUTIONARY ECOLOGY; Hummel Juergen, 2011, P11; Hutchinson JR, 2006, CR PALEVOL, V5, P519, DOI 10.1016/j.crpv.2005.09.002; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; Janensch W., 1935, PALAEONTOGRAPHICA S7, V7, P147; Kellner AWA, 2011, AN ACAD BRAS CIENC, V83, P211, DOI 10.1590/S0001-37652011000100011; Kemp TS, 2007, P ROY SOC B-BIOL SCI, V274, P1667, DOI 10.1098/rspb.2007.0288; Klein N., 2011, BIOL SAUROPOD DINOSA; Klein N, 2012, BIOL LETTERS, V8, P1032, DOI 10.1098/rsbl.2012.0778; Klein N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036907; Knoll F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054991; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Carballido JL, 2012, HIST BIOL, V24, P631, DOI 10.1080/08912963.2012.672416; MacFadden BJ., 1994, FOSSIL HORSES SYSTEM; Mannion P, 2013, ZOOLOGICAL J LINNEAN; Mannion PD, 2012, GLOBAL ECOL BIOGEOGR, V21, P898, DOI 10.1111/j.1466-8238.2011.00735.x; Mannion PD, 2012, J SYST PALAEONTOL, V10, P521, DOI 10.1080/14772019.2011.595432; Mannion PD, 2012, J VERTEBR PALEONTOL, V32, P614, DOI 10.1080/02724634.2012.660898; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Mannion PD, 2010, PALEOBIOLOGY, V36, P253, DOI 10.1666/08085.1; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Mateus O, 2011, AN ACAD BRAS CIENC, V83, P221, DOI 10.1590/S0001-37652011000100012; Mcgarrity CT, 2013, ZOOL J LINN SOC-LOND, V167, P531, DOI 10.1111/zoj.12009; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Midgley JJ, 2002, EVOL ECOL RES, V4, P1093; Mohabey DM, 2005, LIFE O PAST, P466; Morhardt A, 2009, J VERTEBR PALEONTOL, V29, p152A; Muller DWH, 2013, COMP BIOCHEM PHYS A, V164, P129, DOI 10.1016/j.cbpa.2012.09.018; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Owen-Smith RN., 1988, MEGAHERBIVORES INFLU, P369; Paladino Frank V., 1997, P491; Parrish J.M., 1986, Hunteria, V1, P1; Perry SF, 2011, BIOL SAUROPOD DINOSA, P83; Polly PD, 1998, SCIENCE, V282, P47, DOI [10.1126/science.282.5386.47f, DOI 10.1126/SCIENCE.282.5386.47F]; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Preuschoft H, 2013, PLOS ONE, V8; Preuschoft Holger, 2011, P197; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Redelstorff R, 2013, ACTA PALAEONTOLOGICA; Reisz RR, 2013, NATURE, V496, P210, DOI 10.1038/nature11978; Rogers KAC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P1; Rowe MF, 2013, J EXP BIOL, V216, P1774, DOI 10.1242/jeb.076521; Royo-Torres R, 2006, SCIENCE, V314, P1925, DOI 10.1126/science.1132885; Russell Dale E., 1995, Historical Biology, V10, P3; Ruxton GD, 2011, BIOL LETTERS, V7, P779, DOI 10.1098/rsbl.2011.0116; Sachs JL, 2012, MBIO, V3, DOI 10.1128/mBio.00099-12; Sander P. M., 2011, BIOL SAUROPOD DINOSA; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM., 2010, PLANTS MESOZOIC TIME, P331; Schachner ER, 2013, ARCHOSAURIA PEER J, V2013, P1; Schanz T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077606; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Schwenk Kurt, 1995, Zoology (Jena), V98, P251; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Senter P, 2007, J ZOOL, V271, P45, DOI 10.1111/j.1469-7998.2006.00197.x; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2007, ACTA PALAEONTOL POL, V52, P275; Seymour R. S., 2011, P ROYAL SOC B, V279, P451; Seymour RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069361; Seymour RS, 2009, BIOL LETTERS, V5, P317, DOI 10.1098/rsbl.2009.0096; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Sookias RB, 2012, BIOL LETT, P1; Stein K, 2013, BIOL REV CAMBRIDGE P; Stein K, 2013, PLOS ONE, V8; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Steuer P, 2013, COMP BIOCHEM PHYS A, V164, P319, DOI 10.1016/j.cbpa.2012.10.026; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Sverdlova NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045315; Taylor MP, 2011, J ZOOL, V285, P150, DOI 10.1111/j.1469-7998.2011.00824.x; Taylor MP, 2013, PLOS ONE, V8; Taylor MP, 2013, PEERJ, V2013, P1; Thompson Mary E., 2007, Bulletin of the New Mexico Museum of Natural History and Science, V42, P309; Tidwell V, 2005, THUNDER LIZARDS SAUR, P495; Trammer J, 2011, ACTA GEOL POL, V61, P125; Tschopp E, 2013, J ANAT, V222, P321, DOI 10.1111/joa.12012; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Vila B, 2012, PALAEOGEOGRAPHY PALA; Vila B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057408; Vila B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010362; Waskow K, J VERTEBRAT IN PRESS; Wedel Mathew J., 2002, Paleobios, V22, P1; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Wedel MJ, 2012, ACTA PALAEONTOLOGICA, V57, P85; Wedel MJ, 2013, PLOS ONE, V8; Werner J, 2013, PLOS ONE; Werner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028442; Westneat DF, 2000, VERTEBRATE MATING SY, P253; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Wilkinson DM, 2012, BIOL REV, V87, P616, DOI 10.1111/j.1469-185X.2011.00212.x; Wilson J.A., 2012, COMPLETE DINOSAUR, P444; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000322; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763; Wings O, 2011, NEUES JAHRB GEOL P-A, V262, P129, DOI 10.1127/0077-7749/2011/0183; Witzel Ulrich, 2011, P171; Yates AM, 2012, ACTA PALAEONTOL POL, V57, P85, DOI 10.4202/app.2010.0075; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; [No title captured]	188	43	44	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78573	10.1371/journal.pone.0078573	http://dx.doi.org/10.1371/journal.pone.0078573			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205267	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500126
J	Michel, L; Makowski, D				Michel, Lucie; Makowski, David			Comparison of Statistical Models for Analyzing Wheat Yield Time Series	PLOS ONE			English	Article							TRENDS; STABILITY; SELECTION; RICE	The world's population is predicted to exceed nine billion by 2050 and there is increasing concern about the capability of agriculture to feed such a large population. Foresight studies on food security are frequently based on crop yield trends estimated from yield time series provided by national and regional statistical agencies. Various types of statistical models have been proposed for the analysis of yield time series, but the predictive performances of these models have not yet been evaluated in detail. In this study, we present eight statistical models for analyzing yield time series and compare their ability to predict wheat yield at the national and regional scales, using data provided by the Food and Agriculture Organization of the United Nations and by the French Ministry of Agriculture. The Holt-Winters and dynamic linear models performed equally well, giving the most accurate predictions of wheat yield. However, dynamic linear models have two advantages over Holt-Winters models: they can be used to reconstruct past yield trends retrospectively and to analyze uncertainty. The results obtained with dynamic linear models indicated a stagnation of wheat yields in many countries, but the estimated rate of increase of wheat yield remained above 0.06 t ha(-1) year(-1) in several countries in Europe, Asia, Africa and America, and the estimated values were highly uncertain for several major wheat producing countries. The rate of yield increase differed considerably between French regions, suggesting that efforts to identify the main causes of yield stagnation should focus on a subnational scale.	[Michel, Lucie; Makowski, David] INRA, UMR Agron 211, Thiverval Grignon, France; [Michel, Lucie; Makowski, David] AgroParisTech, UMR Agron 211, Thiverval Grignon, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Makowski, D (corresponding author), INRA, UMR Agron 211, Thiverval Grignon, France.	makowski@grignon.inra.fr	Makowski, David/V-4233-2019	Makowski, David/0000-0001-6385-3703				[Anonymous], FOR LAND US FOOD INS; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Brockwell P. J., 2002, INTRO TIME SERIES FO, P434; Calderini DF, 1998, FIELD CROP RES, V57, P335, DOI 10.1016/S0378-4290(98)00080-X; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Finger R, 2010, FOOD POLICY, V35, P175, DOI 10.1016/j.foodpol.2009.11.004; Hafner S, 2003, AGR ECOSYST ENVIRON, V97, P275, DOI 10.1016/S0167-8809(03)00019-7; Kalra N, 2008, CURR SCI INDIA, V94, P82; Kumar V, FORECASTING WHEAT YE; Kumar-Boken V., 2000, AGRON J, V92, P1047; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Licker R, 2013, AGR FOREST METEOROL, V176, P25, DOI 10.1016/j.agrformet.2013.02.010; Lin M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024016; Oury FX, 2012, EUR J AGRON, V40, P28, DOI 10.1016/j.eja.2012.02.007; Peltonen-Sainio P, 2009, FIELD CROP RES, V110, P85, DOI 10.1016/j.fcr.2008.07.007; Petris G, 2009, USE R, P1, DOI 10.1007/b135794_1; Petris G, 2010, J STAT SOFTW, V36, P1; Prado R, 2010, TIME SERIES MODELING, P368; Prost L, 2008, ECOL MODEL, V219, P66, DOI 10.1016/j.ecolmodel.2008.07.026; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rondanini DP, 2012, EUR J AGRON, V37, P56, DOI 10.1016/j.eja.2011.10.005; United Nations, 2011, WORLD POP PROSP 2010; Ye LM, 2013, AGRON SUSTAIN DEV, V33, P363, DOI 10.1007/s13593-012-0102-0	23	25	26	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78615	10.1371/journal.pone.0078615	http://dx.doi.org/10.1371/journal.pone.0078615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205280	Green Published, gold			2022-12-27	WOS:000326270700094
J	Jagirdar, K; Yin, K; Harrison, M; Lim, W; Muscat, GEO; Sturm, RA; Smith, AG				Jagirdar, Kasturee; Yin, Kelvin; Harrison, Matthew; Lim, Wen; Muscat, George E. O.; Sturm, Richard A.; Smith, Aaron G.			The NR4A2 Nuclear Receptor Is Recruited to Novel Nuclear Foci in Response to UV Irradiation and Participates in Nucleotide Excision Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; INDUCED DNA-DAMAGE; UBIQUITIN LIGASE; POLY(ADP-RIBOSE) POLYMERASE-1; H2AX PHOSPHORYLATION; IONIZING-RADIATION; ORPHAN RECEPTORS; MELANOMA-CELLS; DDB2; GAMMA-H2AX	Ultraviolet radiation (UVR) is one of the most common mutagens encountered by humans and induces the formation of cyclobutane pyrimidine dimers (CPDs) and pyrimidine-(6-4)-pyrimidone photoproduct (6-4PP) lesions in the genomic DNA. To prevent the accumulation of deleterious mutations these lesions must be efficiently repaired, primarily by nucleotide excision repair. We have previously demonstrated that the NR4A family of nuclear receptors are crucial mediators of the DNA repair function of the MC1R signalling pathway in melanocytes. Here we explore the role of the NR4A2 protein in the DNA repair process further. Using EYFP tagged-NR4A2 we have demonstrated a UVR induced recruitment to distinct nuclear foci where they co-localise with known DNA repair proteins. We reveal that the N-terminal domain of the receptor is required for this translocation and identify a role for p38 and PARP signalling in this process. Moreover disruption of the functional integrity of the Ligand Binding Domain of the receptor by deleting the terminal helix 12 effectively blocks co-localisation of the receptor with DNA repair factors. Restored co-localisation of the mutant receptor with DNA repair proteins in the presence of a Histone Deacetylase Inhibitor suggests that impaired chromatin accessibility underpins the mis-localisation observed. Finally NR4A2 over-expression facilitated a more efficient clearance of UVR induced CPD and 6-4PP lesions. Taken together these data uncover a novel role for the NR4A nuclear receptors as direct facilitators of nucleotide excision repair.	[Jagirdar, Kasturee; Harrison, Matthew; Lim, Wen; Muscat, George E. O.; Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Yin, Kelvin; Smith, Aaron G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Smith, AG (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	aaron.smith@uq.edu.au	Jagirdar, Kasturee/J-1810-2014; Smith, Aaron/A-8329-2010; Sturm, Richard A/C-9943-2009; Muscat, George/A-6401-2017	Jagirdar, Kasturee/0000-0001-8761-132X; Sturm, Richard A/0000-0003-1301-0294; Muscat, George/0000-0002-5829-5695; Yin, Kelvin/0000-0003-2993-6374; Smith, Aaron/0000-0003-2937-1713	National Health and Medical Research Grant [631510]	National Health and Medical Research Grant	This work was funded by a National Health and Medical Research Grant (ID: 631510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; De Leseleuc L, 2006, EXP CELL RES, V312, P1507, DOI 10.1016/j.yexcr.2006.01.014; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; HUANG JC, 1994, J BIOL CHEM, V269, P19034; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Limoli CL, 2002, P NATL ACAD SCI USA, V99, P233, DOI 10.1073/pnas.231611798; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Luijsterburg MS, 2012, J CELL BIOL, V197, P267, DOI 10.1083/jcb.201106074; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Malewicz M, 2011, GENE DEV, V25, P2031, DOI 10.1101/gad.16872411; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nag R, 2009, MUTAT RES-REV MUTAT, V682, P13, DOI 10.1016/j.mrrev.2009.01.002; Oh KS, 2007, DNA REPAIR, V6, P1359, DOI 10.1016/j.dnarep.2007.03.025; Ohkura N, 2008, J CELL BIOCHEM, V105, P785, DOI 10.1002/jcb.21876; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; PARSONS PG, 1986, BIOCHEM PHARMACOL, V35, P655, DOI 10.1016/0006-2952(86)90363-1; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Pols TWH, 2007, CURR OPIN LIPIDOL, V18, P515, DOI 10.1097/MOL.0b013e3282ef77d1; Ramirez-Herrick AM, 2011, BLOOD, V117, P2681, DOI 10.1182/blood-2010-02-267906; Rebecca VW, 2012, MELANOMA RES, V22, P114, DOI 10.1097/CMR.0b013e328351fa4d; Robu M, 2013, P NATL ACAD SCI USA, V110, P1658, DOI 10.1073/pnas.1209507110; Sekine Y, 2011, J CELL SCI, V124, P3006, DOI 10.1242/jcs.085902; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; Smith AG, 2011, PIGM CELL MELANOMA R, V24, P551, DOI 10.1111/j.1755-148X.2011.00843.x; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhao Q, 2008, J BIOL CHEM, V283, P32553, DOI 10.1074/jbc.M803963200	44	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78075	10.1371/journal.pone.0078075	http://dx.doi.org/10.1371/journal.pone.0078075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223135	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200027
J	Li, S; Shih, CK; Wang, C; Pang, H; Ren, D				Li, Shu; Shih, Chungkun; Wang, Chen; Pang, Hong; Ren, Dong			Forever Love: The Hitherto Earliest Record of Copulating Insects from the Middle Jurassic of China	PLOS ONE			English	Article							HOMOPTERA; EVOLUTION	Background: Mating behaviors have been widely studied for extant insects. However, cases of mating individuals are particularly rare in the fossil record of insects, and most of them involved preservation in amber while only in rare cases found in compression fossils. This considerably limits our knowledge of mating position and genitalia orientation during the Mesozoic, and hinders our understanding of the evolution of mating behaviors in this major component of modern ecosystems. Principal Finding: Here we report a pair of copulating froghoppers, Anthoscytina perpetua sp. nov., referable to the Procercopidae, from the Middle Jurassic of northeastern China. They exhibit belly-to-belly mating position as preserved, with male's aedeagus inserting into the female's bursa copulatrix. Abdominal segments 8 to 9 of male are disarticulated suggesting these segments were twisted and flexed during mating. Due to potential taphonomic effect, we cannot rule out that they might have taken side-by-side position, as in extant froghoppers. Genitalia of male and female, based on paratypes, show symmetric structures. Conclusions/Significance: Our findings, consistent with those of extant froghoppers, indicate froghoppers' genitalic symmetry and mating position have remained static for over 165 million years.	[Li, Shu; Shih, Chungkun; Wang, Chen; Ren, Dong] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China; [Li, Shu] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Pang, Hong] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Pang, Hong] Sun Yat Sen Univ, Inst Entomol, Guangzhou 510275, Guangdong, Peoples R China	Capital Normal University; Beijing Academy of Agriculture & Forestry; Sun Yat Sen University; Sun Yat Sen University	Ren, D (corresponding author), Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn	Pang, Hong/AAL-7785-2020; Pang, Hong/J-8710-2014	Pang, Hong/0000-0002-0585-3577; 	National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [31172143, 31230065, 31272352, 41272006]; Beijing Municipal Commission of Education [KZ201310028033]; China Geological Survey [1212011120115]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); China Geological Survey(China Geological Survey)	This research is supported by the National Basic Research Program of China (973 Program) (grant 2012CB821906), the National Natural Science Foundation of China (grants 31172143, 31230065, 31272352 and 41272006), Project of Great Wall Scholar and KEY project of Beijing Municipal Commission of Education (grants KZ201310028033), and China Geological Survey (grant 1212011120115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RD, 1964, EVOLUTION MATING BEH, P78; Ansorge J, 1996, INSECTS UPPER LIAS P; ANUFRIEV G. A., 1988, OPREDELITELNASEKOMYK, V2, P12; Becker-Migdisova E. E, 1949, T PALEONTOLOGICHESKO, V22, P1; Biedermann R, 2002, J ETHOL, V20, P13, DOI 10.1007/s10164-002-0048-9; Boucot A. J., 2011, FOSSIL BEHAV COMPEND, P147; Boucot AJ, 1990, EVOLUTIONARY PALEOBI, P385; [陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; Cryan JR, 2010, SYST ENTOMOL, V35, P393, DOI 10.1111/j.1365-3113.2009.00520.x; DWORAKOWSKA I, 1988, Entomologische Abhandlungen (Dresden), V52, P63; Evans JW, 1966, LEAFHOPPERS FROGHOPP; Hamilton K.G. Andrew, 2001, Biodiversity, V2, P15; Hong YC, 1983, MIDDLE JURASSIC FOSS, P61; Huber BA, 2007, BIOL REV, V82, P647, DOI 10.1111/j.1469-185X.2007.00029.x; Huber BA, 2010, GENETICA, V138, P19, DOI 10.1007/s10709-008-9339-6; HUNT RE, 1993, ANN ENTOMOL SOC AM, V86, P356, DOI 10.1093/aesa/86.3.356; Ji Qiang, 2005, Geological Review (Beijing), V51, P609; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Ma N, 2010, MICRON, V41, P931, DOI 10.1016/j.micron.2010.07.008; Nel A, 2012, J MORPHOL, V273, P480, DOI 10.1002/jmor.11036; Ren D, 1995, FAUNAE STRATIGRAPHY, V8, P222; Ren D, 2010, SILENT STORIES INSEC, P13; Ren Dong, 1998, Acta Zootaxonomica Sinica, V23, P281; Shcherbakov D. E., 1988, PALEONTOL J, V4, P52; Wang B, 2012, PALAEONTOLOGY, V55, P1223, DOI 10.1111/j.1475-4983.2012.01185.x; Wang RR, 2009, SYST ENTOMOL, V34, P434, DOI 10.1111/j.1365-3113.2009.00475.x; WEBER H., 1931, Biol. Tiere Deutschlands, P71; Yang W, 2004, S PETR GEOD CHIN HAI, P326	28	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78188	10.1371/journal.pone.0078188	http://dx.doi.org/10.1371/journal.pone.0078188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223138	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200030
J	Ling, Y; Nefs, HT; Brinkman, WP; Qu, C; Heynderickx, I				Ling, Yun; Nefs, Harold T.; Brinkman, Willem-Paul; Qu, Chao; Heynderickx, Ingrid			The Effect of Perspective on Presence and Space Perception	PLOS ONE			English	Article							OBSERVER VANTAGE POINT; DEPTH; PICTURES	In this paper we report two experiments in which the effect of perspective projection on presence and space perception was investigated. In Experiment 1, participants were asked to score a presence questionnaire when looking at a virtual classroom. We manipulated the vantage point, the viewing mode (binocular versus monocular viewing), the display device/screen size (projector versus TV) and the center of projection. At the end of each session of Experiment 1, participants were asked to set their preferred center of projection such that the image seemed most natural to them. In Experiment 2, participants were asked to draw a floor plan of the virtual classroom. The results show that field of view, viewing mode, the center of projection and display all significantly affect presence and the perceived layout of the virtual environment. We found a significant linear relationship between presence and perceived layout of the virtual classroom, and between the preferred center of projection and perceived layout. The results indicate that the way in which virtual worlds are presented is critical for the level of experienced presence. The results also suggest that people ignore veridicality and they experience a higher level of presence while viewing elongated virtual environments compared to viewing the original intended shape.	[Ling, Yun; Nefs, Harold T.; Brinkman, Willem-Paul; Qu, Chao; Heynderickx, Ingrid] Delft Univ Technol, Interact Intelligence Grp, Delft, Netherlands; [Heynderickx, Ingrid] Philips Res Labs, Eindhoven, Netherlands	Delft University of Technology; Philips; Philips Research	Ling, Y (corresponding author), Delft Univ Technol, Interact Intelligence Grp, Delft, Netherlands.	yunlingcn@gmail.com	Brinkman, Willem-Paul/H-8159-2013	Brinkman, Willem-Paul/0000-0001-8485-7092; Nefs, Harold/0000-0002-4943-7938	Chinese Scholarship Council [F2009609048]; The Netherlands Organization for Scientific Research (NWO) [655.010.207]; The EIT ICT LABS	Chinese Scholarship Council(China Scholarship Council); The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); The EIT ICT LABS	This work is supported in part by the Chinese Scholarship Council (F2009609048), http://en.csc.edu.cn/. The Netherlands Organization for Scientific Research (NWO), grant number 655.010.207, http://www.nwo.nl/en. The EIT ICT LABS, project title: SSP 12197 RIHA Mediating Presence 2013, http://www.eitictlabs.eu/home/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ames A, 1925, J OPT SOC AM REV SCI, V10, P137, DOI 10.1364/JOSA.10.000137; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Cherni H, 2011, J CYBER THER REHAB, V4, P73; Criminisi A, 1999, IMAGE VISION COMPUT, V17, P625, DOI 10.1016/S0262-8856(98)00183-8; Czerwinski M., 2002, P SIGCHI C HUMAN FAC, P195, DOI DOI 10.1145/503376.503412; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Goldstein EB, 2001, BLACKWELL HDB PERCEP, P344; Hendrix C., 1995, Proceedings. Virtual Reality Annual International Symposium '95 (Cat. No.95CH35761), P74, DOI 10.1109/VRAIS.1995.512482; Hoffman HG, 1998, INT J HUM-COMPUT INT, V10, P251, DOI 10.1207/s15327590ijhc1003_3; Howard I. P., 2002, SEEING DEPTH, V2; Juricevic I, 2006, J EXP PSYCHOL GEN, V135, P448, DOI 10.1037/0096-3445.135.3.448; Kellner F, 2012, IEEE T VIS COMPUT GR, V18, P589, DOI 10.1109/TVCG.2012.45; Koenderink JJ, 2004, PERCEPTION, V33, P513, DOI 10.1068/p3454; KOENDERINK JJ, 1994, PERCEPTION, V23, P583, DOI 10.1068/p230583; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lin JJW, 2002, P IEEE VIRT REAL ANN, P164, DOI 10.1109/VR.2002.996519; Ling Y, 2013, COMPUT HUM BEHAV, V29, P1519, DOI 10.1016/j.chb.2012.12.010; Ling Y, 2012, PRESENCE-TELEOP VIRT, V21, P254, DOI 10.1162/PRES_a_00111; Ni T, 2006, PROC GRAPH INTERF, P139; Pont SC, 2012, SEEING PERCEIVING, V25, P339, DOI 10.1163/187847611X595891; Regenbrecht H, 2002, MEASURING PRESENCE A; Romano DM, 2001, CYBERPSYCHOL BEHAV, V4, P265, DOI 10.1089/109493101300117947; Schlosberg H, 1941, AM J PSYCHOL, V54, P601, DOI 10.2307/1417214; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Sedgwick HA, 1993, PICTORIAL COMMUNICAT, P460; Shafer DM, 2011, PRESENCE-TELEOP VIRT, V20, P591, DOI 10.1162/PRES_a_00084; Shepard RN., 1990, MIND SIGHTS; Steinicke F, 2011, ACM T GRAPHIC, V30, DOI 10.1145/2019627.2019631; Sylaiou S, 2010, INT J HUM-COMPUT ST, V68, P243, DOI 10.1016/j.ijhcs.2009.11.002; Todorovic D, 2005, PERCEPTION, V34, P521, DOI 10.1068/p5225; Todorovic D, 2009, ATTEN PERCEPT PSYCHO, V71, P183, DOI 10.3758/APP.71.1.183; Tyndiuk F., 2005, P ACM S VIRT REAL SO, P117, DOI [10.1145/1101616.1101641, DOI 10.1145/1101616.1101641]; Usoh M, 1999, COMP GRAPH, P359, DOI 10.1145/311535.311589; Vishwanath D, 2005, NAT NEUROSCI, V8, P1401, DOI 10.1038/nn1553; Vishwanath D, 2013, PSYCHOL SCI, V24, P1673, DOI 10.1177/0956797613477867; Wiederhold B.K., 2005, VIRTUAL REALITY THER; Wilhelm FH, 2005, APPL PSYCHOPHYS BIOF, V30, P271, DOI 10.1007/s10484-005-6383-1; Witmer BG, 2005, PRESENCE-TELEOP VIRT, V14, P298, DOI 10.1162/105474605323384654; WOBBROCK JO, 2011, CHI 11, P143; Youngblut C, 2002, IMAGE 2002 C 8 12 JU	40	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78513	10.1371/journal.pone.0078513	http://dx.doi.org/10.1371/journal.pone.0078513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223156	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200048
J	Nakano, M; Nakashima, A; Nagano, T; Ishikawa, S; Kikkawa, U; Kamada, S				Nakano, Masayuki; Nakashima, Akio; Nagano, Taiki; Ishikawa, Shintaro; Kikkawa, Ushio; Kamada, Shinji			Branched-Chain Amino Acids Enhance Premature Senescence through Mammalian Target of Rapamycin Complex I-Mediated Upregulation of p21 Protein	PLOS ONE			English	Article							P53-DEPENDENT CELLULAR SENESCENCE; P70 S6 KINASE; HUMAN FIBROBLASTS; DNA-DAMAGE; TELOMERASE ACTIVITY; LIVER-CIRRHOSIS; HUMAN CANCER; G(1) ARREST; CELLS; VIVO	Branched-chain amino acids (BCAAs) have been applied as an oral supplementation to patients with liver cirrhosis. BCAAs not only improve nutritional status of patients but also decrease the incidence of liver cancer. Mammalian target of rapamycin (mTOR) links cellular metabolism with growth and proliferation in response to nutrients, energy, and growth factors. BCAAs, especially leucine, have been shown to regulate protein synthesis through mTOR activities. On the other hand, cellular senescence is suggested to function as tumor suppressor mechanisms, and induced by a variety of stimuli including DNA damage-inducing drugs. However, it is not clear how BCAA supplementation prevents the incidence of liver cancer in patients with cirrhosis. Here we showed that human cancer cells, HepG2 and U2OS, cultured in medium containing BCAAs with Fischer's ratio about 3, which was shown to have highest activities to synthesize and secrete of albumin, had higher activities to induce premature senescence and elevate mTORC1 activities. Furthermore, BCAAs themselves enhanced the execution of premature senescence induced by DNA damage-inducing drugs, which was effectively prevented by rapamycin. These results strongly suggested the contribution of the mTORC1 pathway to the regulation of premature senescence. Interestingly, the protein levels of p21, a p53 target and well-known gene essential for the execution of cellular senescence, were upregulated in the presence of BCAAs. These results suggested that BCAAs possibly contribute to tumor suppression by enhancing cellular senescence mediated through the mTOR signalling pathway.	[Nakano, Masayuki; Nakashima, Akio; Nagano, Taiki; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan; [Nakano, Masayuki; Nagano, Taiki; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan; [Ishikawa, Shintaro] Otsuka Pharmaceut Co Ltd, Minato Ku, Tokyo, Japan	Kobe University; Kobe University; Otsuka Pharmaceutical	Kamada, S (corresponding author), Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan.	skamada@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Grant-in-Aid for Scientific Research (B) of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2000, J NUTR, V130, P2413; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; FISCHER JE, 1974, AM J SURG, V127, P40, DOI 10.1016/0002-9610(74)90009-9; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Hagiwara A, 2012, J CELL PHYSIOL, V227, P2097, DOI 10.1002/jcp.22941; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hasegawa J, 1996, CANCER RES, V56, P1713; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002; Marchesini G, 2005, J NUTR, V135, p1596S, DOI 10.1093/jn/135.6.1596S; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; MCCULLOUGH AJ, 1981, GASTROENTEROLOGY, V81, P645; Medcalf ASC, 1996, CANCER RES, V56, P4582; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; OKUNO M, 1995, BIOCHEM BIOPH RES CO, V214, P1045, DOI 10.1006/bbrc.1995.2391; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Roninson IB, 2003, CANCER RES, V63, P2705; Shigemitsu K, 1999, FEBS LETT, V447, P303, DOI 10.1016/S0014-5793(99)00304-X; te Poele RH, 2002, CANCER RES, V62, P1876; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; YOSHIDA T, 1989, Gastroenterologia Japonica, V24, P692; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80411	10.1371/journal.pone.0080411	http://dx.doi.org/10.1371/journal.pone.0080411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223226	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200119
J	Zhang, XJ; Li, H; Mao, YQ; Li, ZX; Wang, R; Guo, TT; Jin, L; Song, RJ; Xu, W; Zhou, N; Zhang, YZ; Hu, RB; Wang, X; Huang, HK; Lei, Z; Niu, G; Irwin, DM; Tan, HR				Zhang, Xiaojing; Li, Hui; Mao, Yiqing; Li, Zhixin; Wang, Rong; Guo, Tingting; Jin, Ling; Song, Rongjing; Xu, Wei; Zhou, Na; Zhang, Yizhuang; Hu, Ruobi; Wang, Xi; Huang, Huakang; Lei, Zhen; Niu, Gang; Irwin, David M.; Tan, Huanran			An Over Expression APP Model for Anti-Alzheimer Disease Drug Screening Created by Zinc Finger Nuclease Technology	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; HOMOLOGOUS RECOMBINATION; GAMMA-SECRETASE; KNOCKOUT RATS; PROTEIN; CELLS; CYCLOOXYGENASE; INDUCTION; NSAIDS; ROAD	Zinc Finger Nucleases (ZFNs), famous for their ability to precisely and efficiently modify specific genomic loci, have been employed in numerous transgenic model organism and cell constructions. Here we employ the ZFNs technology, with homologous recombination (HR), to construct sequence-specific Amyloid Precursor Protein (APP) knock-in cells. With the use of ZFNs, we established APP knock in cell lines with gene-modification efficiencies of about 7%. We electroporated DNA fragment containing the promoter and the protein coding regions of the zinc finger nucleases into cells, instead of the plasmids, to avoid problems associated with off target homologous recombination, and adopted a pair of mutated FokI cleavage domains to reduce the toxic effects of the ZFNs on cell growth. Since over-expression of APP, or a subdomain of it, might lead to an immediately lethal effect, we used the Cre-LoxP System to regulate APP expression. Our genetically transformed cell lines, w5c1 and s12c8, showed detectable APP and Amyloid beta (A beta) production. The Swedish double mutation in the APP coding sequence enhanced APP and A beta abundance. What is more, the activity of the three key secretases in A beta formation could be modulated, indicating that these transgenic cells have potential for drug screening to modify amyloid metabolism in cells. Our transformed cells could readily be propagated in culture and should provide an excellent experimental medium for elucidating aspects of the molecular pathogenesis of Alzheimer's disease, especially those concerning the amyloidogenic pathways involving mutations in the APP coding sequence. The cellular models may also serve as a tool for deriving potentially useful therapeutic agents.	[Zhang, Xiaojing; Li, Hui; Mao, Yiqing; Li, Zhixin; Wang, Rong; Guo, Tingting; Jin, Ling; Song, Rongjing; Xu, Wei; Zhou, Na; Zhang, Yizhuang; Hu, Ruobi; Wang, Xi; Huang, Huakang; Irwin, David M.; Tan, Huanran] Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Niu, Gang] Beijing N&N Genetech Co, Beijing, Peoples R China; [Lei, Zhen] Ningxia Med Univ, Dept Pharmacol, Yinchuan, Peoples R China	Peking University; University of Toronto; Ningxia Medical University	Irwin, DM (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China.	david.irwin@utoronto.ca; tanlab@bjmu.edu.cn		Irwin, David/0000-0001-6131-4933; Jin, Ling/0000-0002-0687-9234	National Natural Science Foundation of China (NSFC) [30772603]; National Key Technologies RD Program [2006BAF07B01, 2009BAK61B01, 2009BAK61B04?2012BAK25B01]; National Science Foundation of China - Canadian Institutes of Health Research (NSFC-CIHR) China-Canada Joint Health Research Initiative [81061120525, CCI-109605]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); National Science Foundation of China - Canadian Institutes of Health Research (NSFC-CIHR) China-Canada Joint Health Research Initiative(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the National Natural Science Foundation of China (NSFC) Grant Number 30772603, National Key Technologies R&D Program (Grant Numbers 2006BAF07B01, 2009BAK61B01, 2009BAK61B04?2012BAK25B01), and a grant from the National Science Foundation of China - Canadian Institutes of Health Research (NSFC-CIHR) China-Canada Joint Health Research Initiative (Grant Numbers 81061120525 and CCI-109605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarir-Bouhram J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028876; Asai M, 2010, J NEUROSCI RES, V88, P3588, DOI 10.1002/jnr.22503; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Forsyth E, 1998, PHYS THER, V78, P1325, DOI 10.1093/ptj/78.12.1325; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hampel H, 2012, ALZHEIMERS DEMENT, V8, P312, DOI 10.1016/j.jalz.2012.05.2116; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harrill JA, 2011, TOXICOL IN VITRO, V25, P368, DOI 10.1016/j.tiv.2010.10.011; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Kane JM, 2010, J CLIN PSYCHIAT, V71, P1115, DOI 10.4088/JCP.10r06264yel; Karnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047389; Koob AO, 2012, ANAL BIOCHEM, V425, P120, DOI 10.1016/j.ab.2012.02.034; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Li QQ, 2010, EXP GERONTOL, V45, P842, DOI 10.1016/j.exger.2010.06.008; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ruminy P, 2001, J MOL BIOL, V310, P523, DOI 10.1006/jmbi.2001.4788; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Shaughnessy L, 2004, J MOL NEUROSCI, V24, P23, DOI 10.1385/JMN:24:1:023; Skovronsky DM, 2001, J BIOL CHEM, V276, P17036, DOI 10.1074/jbc.M006285200; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Tsuchiya H, 2005, J GENE MED, V7, P486, DOI 10.1002/jgm.673; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vasileva A, 2006, NUCLEIC ACIDS RES, V34, P3345, DOI 10.1093/nar/gkl455; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zimmermann M, 2004, J NEUROCHEM, V90, P1489, DOI 10.1111/j.1471-4159.2004.02680.x	49	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e75493	10.1371/journal.pone.0075493	http://dx.doi.org/10.1371/journal.pone.0075493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223114	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200006
J	Lynch, J; Meehan, MH; Crean, J; Copeland, J; Stallings, RL; Bray, IM				Lynch, Jennifer; Meehan, Maria H.; Crean, John; Copeland, John; Stallings, Raymond L.; Bray, Isabella M.			Metastasis Suppressor microRNA-335 Targets the Formin Family of Actin Nucleators	PLOS ONE			English	Article							CELL MOTILITY; LIM-KINASE; COFILIN; NEUROBLASTOMA; CANCER; CARCINOMA; PROTEINS; INVASION; FMNL2; DEPHOSPHORYLATION	MiRNAs can have pleiotropic effects by targeting multiple genes belonging to diverse signalling networks. Alternatively, miRNAs can enhance the potency of their cellular effects by targeting multiple genes within the same genetic pathway. Previously, we and others have demonstrated that miR-335 is a potent suppressor of tumour cell migration, invasion and metastasis, in part by targeting several genes involved in these cellular processes, including ROCK1, MAPK1, LRG1, SP1 and SOX4. Here, we demonstrate that direct targeting of multiple members of the formin family of actin nucleators contributes to the inhibitory effects of miR-335 in neuroblastoma cells. We demonstrate that miR-335 regulates the expression of at least five formin family members and validate three family members, FMNL3, FMN2 and DAAM2, as direct targets of miR-335. The contribution of the formin family genes to cancer progression and metastasis has recently begun to emerge and here we demonstrate for the first time the ability of FMN2 and DAAM2 to regulate tumour cell migration and invasion, using siRNA-mediated inhibition of each of these formin genes. Finally, we demonstrate that the formin genes, in particular FMNL3, are responsible for the protrusion of actin-rich filopodia structures that contribute to the enhanced migratory and invasive potential associated with reduced expression of miR-335. Thus, direct targeting of the formin family contributes to the metastasis suppressing abilities of miR-335 by providing a direct regulatory link to the actin assembly machinery of the cell. We conclude that miR-335 is a master regulator of tumour cell migration and invasion by directly targeting a plethora of genes that effectively control cell migratory processes.	[Lynch, Jennifer; Meehan, Maria H.; Stallings, Raymond L.; Bray, Isabella M.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Lynch, Jennifer; Meehan, Maria H.; Stallings, Raymond L.; Bray, Isabella M.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Crean, John] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Copeland, John] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Dublin; University of Ottawa	Bray, IM (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	ibray@rcsi.ie	Stallings, Raymond/A-7213-2008	/0000-0002-4337-6177				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Favaro PMB, 2003, BIOCHEM BIOPH RES CO, V311, P365, DOI 10.1016/j.bbrc.2003.10.012; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; KANAMORI T, 1995, J BIOL CHEM, V270, P8061, DOI 10.1074/jbc.270.14.8061; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Liang L, 2013, GASTROENTEROLOGY; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Meyer G, 2005, CELL MOL LIFE SCI, V62, P461, DOI 10.1007/s00018-004-4456-6; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Okada K, 1996, EXP CELL RES, V227, P116, DOI 10.1006/excr.1996.0256; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zhu XL, 2008, INT J COLORECTAL DIS, V23, P1041, DOI 10.1007/s00384-008-0520-2; Zhu XL, 2011, J PATHOL, V224, P377, DOI 10.1002/path.2871	41	28	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78428	10.1371/journal.pone.0078428	http://dx.doi.org/10.1371/journal.pone.0078428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223803	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400026
J	Moussaid, M; Kammer, JE; Analytis, PP; Neth, H				Moussaid, Mehdi; Kaemmer, Juliane E.; Analytis, Pantelis P.; Neth, Hansjoerg			Social Influence and the Collective Dynamics of Opinion Formation	PLOS ONE			English	Article							BOUNDED CONFIDENCE; WISDOM; CROWD; CONSENSUS; PHYSICS; SPREAD; MODELS	Social influence is the process by which individuals adapt their opinion, revise their beliefs, or change their behavior as a result of social interactions with other people. In our strongly interconnected society, social influence plays a prominent role in many self-organized phenomena such as herding in cultural markets, the spread of ideas and innovations, and the amplification of fears during epidemics. Yet, the mechanisms of opinion formation remain poorly understood, and existing physics-based models lack systematic empirical validation. Here, we report two controlled experiments showing how participants answering factual questions revise their initial judgments after being exposed to the opinion and confidence level of others. Based on the observation of 59 experimental subjects exposed to peer-opinion for 15 different items, we draw an influence map that describes the strength of peer influence during interactions. A simple process model derived from our observations demonstrates how opinions in a group of interacting people can converge or split over repeated interactions. In particular, we identify two major attractors of opinion: (i) the expert effect, induced by the presence of a highly confident individual in the group, and (ii) the majority effect, caused by the presence of a critical mass of laypeople sharing similar opinions. Additional simulations reveal the existence of a tipping point at which one attractor will dominate over the other, driving collective opinion in a given direction. These findings have implications for understanding the mechanisms of public opinion formation and managing conflicting situations in which self-confident and better informed minorities challenge the views of a large uninformed majority.	[Moussaid, Mehdi; Kaemmer, Juliane E.; Analytis, Pantelis P.; Neth, Hansjoerg] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society	Moussaid, M (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	mehdi.moussaid@gmail.com		Neth, Hansjorg/0000-0001-5427-3141; Kammer, Juliane E./0000-0001-6042-8453	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research has been supported by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Baron J., 2000, THINKING DECIDING; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Galam S, 1997, PHYSICA A, V238, P66, DOI 10.1016/S0378-4371(96)00456-6; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; GALAM S, 1991, EUR J SOC PSYCHOL, V21, P49, DOI 10.1002/ejsp.2420210105; Galam S, 2007, PHYSICA A, V381, P366, DOI 10.1016/j.physa.2007.03.034; GIGERENZER G, 1991, PSYCHOL REV, V98, P506, DOI 10.1037/0033-295X.98.4.506; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Hertwig R, 2012, SCIENCE, V336, P303, DOI 10.1126/science.1221403; ISENBERG DJ, 1986, J PERS SOC PSYCHOL, V50, P1141, DOI 10.1037/0022-3514.50.6.1141; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; King AJ, 2012, BIOL LETTERS, V8, P197, DOI 10.1098/rsbl.2011.0795; Koriat A, 2012, SCIENCE, V336, P360, DOI 10.1126/science.1216549; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mas M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000959; Martins ACR, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042807; MARTINS ML, 1991, PHYS REV LETT, V66, P2045, DOI 10.1103/PhysRevLett.66.2045; Mason WA, 2007, PERS SOC PSYCHOL REV, V11, P279, DOI 10.1177/1088868307301032; Moussaid M, 2009, TOP COGN SCI, V1, P469, DOI 10.1111/j.1756-8765.2009.01028.x; MYERS DG, 1970, SCIENCE, V169, P778, DOI 10.1126/science.169.3947.778; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schelling T., 1978, MICROMOTIVES MACROBE; Schweitzer F, 2000, EUR PHYS J B, V15, P723, DOI 10.1007/s100510051177; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Sobkowicz P, 2009, JASSS-J ARTIF SOC S, V12; Soll JB, 2009, J EXP PSYCHOL LEARN, V35, P780, DOI 10.1037/a0015145; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Valori L, 2012, P NATL ACAD SCI USA, V109, P1068, DOI 10.1073/pnas.1109514109; Wu F., 2004, COMPUTATIONAL EC; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Xie J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011130	45	122	122	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78433	10.1371/journal.pone.0078433	http://dx.doi.org/10.1371/journal.pone.0078433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223805	gold, Green Published			2022-12-27	WOS:000326597400027
J	Stolk, L; Bouwland-Both, MI; van Mill, NH; Verbiest, MMPJ; Eilers, PHC; Zhu, HP; Suarez, L; Uitterlinden, AG; Steegers-Theunissen, RPM				Stolk, Lisette; Bouwland-Both, Marieke I.; van Mill, Nina H.; Verbiest, Michael M. P. J.; Eilers, Paul H. C.; Zhu, Huiping; Suarez, Lucina; Uitterlinden, Andre G.; Steegers-Theunissen, Regine P. M.			Epigenetic Profiles in Children with a Neural Tube Defect; A Case-Control Study in Two Populations	PLOS ONE			English	Article							MATERNAL VITAMIN-B-12 STATUS; SPINA-BIFIDA; DNA METHYLATION; REDUCTASE GENE; FOLIC-ACID; METHYLENETETRAHYDROFOLATE REDUCTASE; HOMOCYSTEINE METABOLISM; PLASMA HOMOCYSTEINE; MASS-SPECTROMETRY; COMMON MUTATION	Folate deficiency is implicated in the causation of neural tube defects (NTDs). The preventive effect of periconceptional folic acid supplement use is partially explained by the treatment of a deranged folate-dependent one carbon metabolism, which provides methyl groups for DNA-methylation as an epigenetic mechanism. Here, we hypothesize that variations in DNA-methylation of genes implicated in the development of NTDs and embryonic growth are part of the underlying mechanism. In 48 children with a neural tube defect and 62 controls from a Dutch case-control study and 34 children with a neural tube defect and 78 controls from a Texan case-control study, we measured the DNA-methylation levels of imprinted candidate genes (IGF2-DMR, H19, KCNQ1OT1) and non-imprinted genes (the LEKR/CCNL gene region associated with birth weight, and MTHFR and VANGL1 associated with NTD). We used the MassARRAY EpiTYPER assay from Sequenom for the assessment of DNA-methylation. Linear mixed model analysis was used to estimate associations between DNA-methylation levels of the genes and a neural tube defect. In the Dutch study group, but not in the Texan study group we found a significant association between the risk of having an NTD and DNA methylation levels of MTHFR (absolute decrease in methylation of -0.33% in cases, P-value = 0.001), and LEKR/CCNL (absolute increase in methylation: 1.36% in cases, P-value = 0.048), and a borderline significant association for VANGL (absolute increase in methylation: 0.17% in cases, P-value = 0.063). Only the association between MTHFR and NTD-risk remained significant after multiple testing correction. The associations in the Dutch study were not replicated in the Texan study. We conclude that the associations between NTDs and the methylation of the MTHFR gene, and maybe VANGL and LEKKR/CNNL, are in line with previous studies showing polymorphisms in the same genes in association with NTDs and embryonic development, respectively.	[Stolk, Lisette; Verbiest, Michael M. P. J.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Bouwland-Both, Marieke I.; van Mill, Nina H.; Steegers-Theunissen, Regine P. M.] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; [van Mill, Nina H.] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Eilers, Paul H. C.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Zhu, Huiping] UT Austin, Dept Nutr Sci, Dell Pediat Res Inst, Austin, TX USA; [Suarez, Lucina] Dept State Hlth Serv, Div Dis Control & Prevent Serv, Austin, TX USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P. M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6525 ED Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Austin; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Steegers-Theunissen, RPM (corresponding author), Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands.	r.steegers@erasmusmc.nl		Mills, Hilla/0000-0003-2032-9279	Bo Hjelt foundation [2009]	Bo Hjelt foundation	M.I. Bouwland-Both is financially supported by the Bo Hjelt foundation (grant 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba Y, 2011, EUR J CLIN NUTR, V65, P480, DOI 10.1038/ejcn.2010.294; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Chang HB, 2011, J NUTR BIOCHEM, V22, P1172, DOI 10.1016/j.jnutbio.2010.10.003; Chen XL, 2010, BIRTH DEFECTS RES A, V88, P575, DOI 10.1002/bdra.20670; Crider KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028144; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Fryer Anthony A, 2009, Epigenetics, V4, P394; Groenen PM, 2003, AM J OBSTET GYNECOL, V189, P1713, DOI 10.1016/S0002-9378(03)00807-X; Groenen PMW, 2004, J NUTR, V134, P1516, DOI 10.1093/jn/134.6.1516; Groenen PMW, 2004, AM J OBSTET GYNECOL, V191, P11, DOI 10.1016/j.ajog.2003.12.032; Groenen PMW, 2004, EUR J OBSTET GYN R B, V112, P16, DOI 10.1016/S0301-2115(03)00279-3; Groenen PMW, 2003, EARLY HUM DEV, V71, P1, DOI 10.1016/S0378-3782(02)00040-3; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kibar Z, 2009, HUM MUTAT, V30, pE706, DOI 10.1002/humu.21026; Liu Z, 2012, EUR J HUM GENET, V20, P516, DOI 10.1038/ejhg.2011.242; MATSUDA M, 1990, TERATOLOGY, V41, P147, DOI 10.1002/tera.1420410204; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Molloy AM, 2009, PEDIATRICS, V123, P917, DOI 10.1542/peds.2008-1173; Nafee TM, 2008, BJOG-INT J OBSTET GY, V115, P158, DOI 10.1111/j.1471-0528.2007.01528.x; Ratan SK, 2008, PEDIATR SURG INT, V24, P803, DOI 10.1007/s00383-008-2167-z; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Steegers-Theunissen RP, 2013, HUM REPROD UPDATE; Steegers-Theunissen RP, 2013, HUMAN REPRO IN PRESS; STEEGERSTHEUNISSEN RPM, 1991, NEW ENGL J MED, V324, P199; Suarez L, 2000, AM J EPIDEMIOL, V152, P1017, DOI 10.1093/aje/152.11.1017; Suarez L, 2003, ANN EPIDEMIOL, V13, P81, DOI 10.1016/S1047-2797(02)00267-3; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Tran S, 2012, J MOL NEUROSCI, V47, P42, DOI 10.1007/s12031-011-9676-2; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Zhang HY, 2008, EXP NEUROL, V212, P515, DOI 10.1016/j.expneurol.2008.04.044; Zhu HP, 2003, MOL GENET METAB, V78, P216, DOI 10.1016/S1096-7192(03)00008-8	44	13	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78462	10.1371/journal.pone.0078462	http://dx.doi.org/10.1371/journal.pone.0078462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223810	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400029
J	Bao, XQ; Li, N; Wang, T; Kong, XC; Tai, WJ; Sun, H; Zhang, D				Bao, Xiu-Qi; Li, Ning; Wang, Tao; Kong, Xiang-Chen; Tai, Wen-Jiao; Sun, Hua; Zhang, Dan			FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer's Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation	PLOS ONE			English	Article							A-BETA; COMPOUND FLZ; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; ACCUMULATION; OLIGOMERS; MICE; PHOSPHORYLATION; SECRETASE; PATHOLOGY	Alzheimer's disease (AD) is the most common cause of dementia worldwide and mainly characterized by the aggregated beta-amyloid (A beta) and hyperphosphorylated tau. FLZ is a novel synthetic derivative of natural squamosamide and has been proved to improve memory deficits in dementia animal models. In this study, we aimed to investigate the mechanisms of FLZ's neuroprotective effect in APP/PS1 double transgenic mice and SH-SY5Y (APPwt/swe) cells. The results showed that treatment with FLZ significantly improved the memory deficits of APP/PS1 transgenic mice and decreased apoptosis of SH SY5Y (APPwt/swe) cells. FLZ markedly attenuated A beta accumulation and tau phosphorylation both in vivo and in vitro. Mechanistic study showed that FLZ interfered APP processing, i.e., FLZ decreased beta-amyloid precursor protein (APP) phosphorylation, APP-carboxy-terminal fragment (APP-CTF) production and b-amyloid precursor protein cleaving enzyme 1 (BACE1) expression. These results indicated that FLZ reduced Ab production through inhibiting amyloidogenic pathway. The mechanistic study about FLZ's inhibitory effect on tau phosphorylation revealed t the involvement of Akt/glycogen synthase kinase 3 beta (GSK3 beta) pathway. FLZ treatment increased Akt activity and inhibited GSK3 beta activity both in vivo and in vitro. The inhibitory effect of FLZ on GSK3 beta activity and tau phosphorylation was suppressed by inhibiting Akt activity, indicating that Akt/GSK3 beta pathway might be the possible mechanism involved in the inhibitory effect of FLZ on tau hyperphosphorylation. These results suggested FLZ might be a potential anti-AD drug as it not only reduced A beta production via inhibition amyloidogenic APP processing pathway, but also attenuated tau hyperphosphoylation mediated by Akt/GSK3 beta.	[Bao, Xiu-Qi; Li, Ning; Tai, Wen-Jiao; Sun, Hua; Zhang, Dan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Bao, Xiu-Qi; Li, Ning; Tai, Wen-Jiao; Sun, Hua; Zhang, Dan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Tao] Chinese Peoples Armed Police Force, Beijing Municipal Corps Hosp, Beijing, Peoples R China; [Kong, Xiang-Chen] Shenzhen Univ, Sch Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shenzhen University	Zhang, D (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	danzhang@imm.ac.cn			National 973 Fundamental Project of China [2011CB504105]; Beijing NOVA Program [Z111102054511129]; PUMC Youth Fund [2012J19]; Fundamental Research Funds for the Central Universities [2012S08]; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study [BZ0150]	National 973 Fundamental Project of China(National Basic Research Program of China); Beijing NOVA Program(Beijing Municipal Science & Technology Commission); PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study	This work was supported by grants from National 973 Fundamental Project of China (2011CB504105), Beijing NOVA Program (Z111102054511129), PUMC Youth Fund (2012J19) and Supported by the Fundamental Research Funds for the Central Universities (2012S08). This work was supported by Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study (NO.BZ0150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; [鲍秀琦 Bao Xiuqi], 2010, [中国新药杂志, Chinese Journal New Drugs], V19, P867; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fang F, 2008, ACTA PHARMACOL SIN, V29, P152, DOI 10.1111/j.1745-7254.2008.00714.x; Fang F, 2007, BASIC CLIN PHARMACOL, V101, P447, DOI 10.1111/j.1742-7843.2007.00138.x; Fang F, 2006, ACTA PHARMACOL SIN, V27, P651, DOI 10.1111/j.1745-7254.2006.00347.x; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Hou JF, 2012, J PHARMACEUT BIOMED, V66, P232, DOI 10.1016/j.jpba.2012.03.001; Hou Y, 2009, J ALZHEIMERS DIS, V18, P153, DOI 10.3233/JAD-2009-1133; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kerchner GA, 2010, EXPERT OPIN BIOL TH, V10, P1121, DOI 10.1517/14712598.2010.493872; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kulic L, 2006, NEUROBIOL DIS, V22, P50, DOI 10.1016/j.nbd.2005.10.002; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lemere CA, 2009, PROG BRAIN RES, V175, P83, DOI 10.1016/S0079-6123(09)17506-4; Luan KL, 2013, AGEING RES REV, V12, P174, DOI 10.1016/j.arr.2012.06.002; Matsuoka Y, 2007, J MOL NEUROSCI, V31, P165, DOI 10.1385/JMN/31:02:165; Oddo S, 2008, J NEUROSCI, V28, P12163, DOI 10.1523/JNEUROSCI.2464-08.2008; Paris D, 2011, MOL MED, V17, P149, DOI 10.2119/molmed.2010.00180; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Yu YX, 2009, HIPPOCAMPUS, V19, P1247, DOI 10.1002/hipo.20587; Zhang ZX, 2011, J NEUROSCI RES, V89, P437, DOI 10.1002/jnr.22563	31	32	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78033	10.1371/journal.pone.0078033	http://dx.doi.org/10.1371/journal.pone.0078033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223757	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400030
J	Hu, JW; Yang, ZL; Wang, J; Tang, YY; Liu, H; Zhang, B; Chen, H				Hu, JiangWei; Yang, ZaiLiang; Wang, Jun; Tang, YongYong; Liu, Hao; Zhang, Bin; Chen, Hu			Infusion of Trx-1-Overexpressing hucMSC Prolongs the Survival of Acutely Irradiated NOD/SCID Mice by Decreasing Excessive Inflammatory Injury	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXPRESSING INTERFERON-BETA; STROMAL CELLS; BONE-MARROW; MAMMALIAN THIOREDOXIN; DNA-DAMAGE; IN-VIVO; PROTECTION; OXIDATION; APOPTOSIS	A protective reagent for ARI should have the ability to repair injured tissue caused by radiation and prevent continuous damage from secondary risk factors. Trx-1 was explored as a candidate therapy for ARI, as it scavenges reactive oxygen species, regulates cell growth and differentiation, participates in immune reactions, and inhibits apoptosis by acting inside and/or outside cells. Trx-1 can also decrease excessive inflammation in ARI by regulating the creation of inflamed media, by inhibiting the activation of complement, and by reducing the chemotaxis, adhesion, and migration of inflammatory cells. As effectively and stably expressing exogenous genes in the long term and regulating immune inflammation and tissue repair, MSC are a good choice for Trx-1 gene therapy. In this study, Trx-1-overexpressing hucMSC-Trx-1 were obtained by adenoviral vector-mediated infection. We first measured the redox capacity of hucMSC-Trx-1 with an antioxidant capacity (T-AOC) assay, a hydrogen peroxide (H2O2) content determination assay in vivo, a H2O2-induced oxidation hemolysis assay, and a lipid peroxidation assay in vitro. Then, we measured survival time, the protection of the hematopoietic system, and the regulation of inflammation in important organs in three treatment groups of NOD/SCID mice (treated with hucMSC-Trx1, with hucMSC, and with saline) that were exposed to 4.5 Gy Co-60-gamma-ray radiation. The hucMSC-Trx-1 group achieved superior antioxidation results, protecting bone marrow hematopoietic stem cells (Lin(-)CD117(+): hucMSC-Trx-1 vs. hucMSC, P<0.05; hucMSC-Trx-1 vs. NS, P<0.01), promoting the formation of red blood cells and hemoglobin (hucMSC-Trx-1 vs. hucMSC or NS, P<0.05), reducing inflammation and damage in important organs (Bone marrow and lung: hucMSC-Trx-1 vs. NS, P<0.01; hucMSC-Trx-1 vs. hucMSC, P<0.05. Liver and intestine: hucMSC-Trx-1 vs. NS, P<0.05; hucMSC-Trx-1 vs. hucMSC, P<0.05), and prolonging survival (hucMSC-Trx-1 vs. hucMSC or NS, P<0.01). Therefore, hucMSC-Trx-1 combines the merits of gene and cell therapy as a multifunctional radioprotector for ARI.	[Hu, JiangWei; Yang, ZaiLiang; Wang, Jun; Tang, YongYong; Liu, Hao; Zhang, Bin; Chen, Hu] Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China; [Hu, JiangWei; Yang, ZaiLiang; Wang, Jun; Tang, YongYong; Liu, Hao; Zhang, Bin; Chen, Hu] Acad Mil Med Sci, Affiliated Hosp, Gene Therapy Ctr, Beijing, Peoples R China; [Yang, ZaiLiang] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 4, Chongqing, Peoples R China; [Yang, ZaiLiang] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Army Medical University; Army Medical University	Zhang, B (corresponding author), Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China.	zb307ctc@163.com; chenhu217@aliyun.com			"863 Projects'' of Ministry of Science and Technology of PR China [2011AA020114]; Military Clinical High-Tech Key Program [2010gxjs100]; Clinical Feature Application Research of Beijing [Z111107058811107]	"863 Projects'' of Ministry of Science and Technology of PR China; Military Clinical High-Tech Key Program; Clinical Feature Application Research of Beijing	This work was supported by the "863 Projects'' of Ministry of Science and Technology of PR China (No. 2011AA020114), Military Clinical High-Tech Key Program (No. 2010gxjs100) and the Clinical Feature Application Research of Beijing (Z111107058811107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh T, 2002, J BIOL CHEM, V277, P9655, DOI 10.1074/jbc.M110701200; Arora R, 2005, PHYTOTHER RES, V19, P1, DOI 10.1002/ptr.1605; Besse A, 2000, CYTOKINE, V12, P522, DOI 10.1006/cyto.1999.0580; Cavarretta IT, 2010, MOL THER, V18, P223, DOI 10.1038/mt.2009.237; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fliedner TM, 2001, MED MANAGEMENT RAD A, P18; Fliedner TM., 2005, BRIT J RADIOL, V27, P1, DOI [10.1259/bjr/77700378, DOI 10.1259/BJR/77700378]; GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Hirama T, 2003, BRIT J RADIOL, V76, P246, DOI 10.1259/bjr/82373369; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Hosseinimehr SJ, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017; Inomata Y, 2008, INVEST OPHTH VIS SCI, V49, P5118, DOI 10.1167/iovs.07-1659; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; Kidd S, 2010, CYTOTHERAPY, V12, P615, DOI 10.3109/14653241003631815; Kondo N, 2004, J IMMUNOL, V172, P442, DOI 10.4049/jimmunol.172.1.442; Kucerova L, 2008, J GENE MED, V10, P1071, DOI 10.1002/jgm.1239; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Kuter DJ, 2010, SEMIN HEMATOL, V47, P243, DOI 10.1053/j.seminhematol.2010.02.005; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Lomax ME, 2002, RADIAT PROT DOSIM, V99, P63, DOI 10.1093/oxfordjournals.rpd.a006840; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Meineke V., 2005, BR J RADIOL S, P196, DOI DOI 10.1259/BJR/25654769; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Nakamura H, 2005, ANTIOXID REDOX SIGN, V7, P823, DOI 10.1089/ars.2005.7.823; NAKAMURA H, 1994, IMMUNOL LETT, V42, P75, DOI 10.1016/0165-2478(94)90038-8; Nakamura H, 2008, NOVART FDN SYMP, V291, P221; Nakamura T, 2007, FREE RADICAL RES, V41, P1089, DOI 10.1080/10715760701487682; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Obermeier F, 2003, CLIN EXP IMMUNOL, V134, P217, DOI 10.1046/j.1365-2249.2003.02288.x; OKADA S, 1992, BLOOD, V80, P3044; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; POWIS G, 1994, ONCOL RES, V6, P539; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Rube CE, 2004, STRAHLENTHER ONKOL, V180, P541, DOI 10.1007/s00066-004-1279-1; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sak A, 2000, INT J RADIAT BIOL, V76, P749, DOI 10.1080/09553000050028896; Sato H, 2005, CANCER GENE THER, V12, P757, DOI 10.1038/sj.cgt.7700827; Sharma M, 2011, STEM CELLS DEV, V20, P933, DOI 10.1089/scd.2010.0263; Srinivasan M, 2007, BBA-GEN SUBJECTS, V1770, P659, DOI 10.1016/j.bbagen.2006.11.008; Takamiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025265; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Tmyer DL, 2008, STEM CELLS, V26, P591; Turai I, 2004, BRIT MED J, V328, P568, DOI 10.1136/bmj.328.7439.568; Underwood S, 1995, EUR RESPIR J, V8, P2104, DOI 10.1183/109031936.95.08122104; Valeyrie-Allanore L, 2008, RADIOTHER ONCOL, V87, P300, DOI 10.1016/j.radonc.2008.01.021; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Xin H, 2007, STEM CELLS, V25, P1618, DOI 10.1634/stemcells.2006-0461	55	17	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78227	10.1371/journal.pone.0078227	http://dx.doi.org/10.1371/journal.pone.0078227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223778	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400041
J	van Roekel, E; Verhagen, M; Scholte, RHJ; Kleinjan, M; Goossens, L; Engels, RCME				van Roekel, Eeske; Verhagen, Maaike; Scholte, Ron H. J.; Kleinjan, Marloes; Goossens, Luc; Engels, Rutger C. M. E.			The Oxytocin Receptor Gene (OXTR) in Relation to State Levels of Loneliness in Adolescence: Evidence for Micro-Level Gene-Environment Interactions	PLOS ONE			English	Article							DIFFERENTIAL SUSCEPTIBILITY; 5-HTT GENES; HUMANS; ASSOCIATION; EXPRESSION; EXPERIENCE; CHILDHOOD; CONTEXT; STRESS; HEALTH	Previous research has shown that the rs53576 variant of the oxytocin receptor gene (OXTR) is associated with trait levels of loneliness, but results are inconsistent. The aim of the present study is to examine micro-level effects of the OXTR rs53576 variant on state levels of loneliness in early adolescents. In addition, gene-environment interactions are examined between this OXTR variant and positive and negative perceptions of company. Data were collected in 278 adolescents (58% girls), by means of the Experience Sampling Method (ESM). Sampling periods consisted of six days with nine assessments per day. A relation was found between the OXTR rs53576 variant and state loneliness, in girls only. Girls carrying an A allele had higher levels of state loneliness than girls carrying the GG genotype. In addition, adolescents with an A allele were more affected by negative perceptions of company than GG carriers, on weekend days only. No significant gene-environment interactions were found with positive company. Adolescents carrying an A allele were more susceptible to negative environments during weekend days than GG carriers. Our findings emphasize the importance of operationalizing the phenotype and the environment accurately.	[van Roekel, Eeske; Verhagen, Maaike; Scholte, Ron H. J.; Kleinjan, Marloes; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Goossens, Luc] KU Leuven Univ Leuven, Sch Psychol & Child & Adolescent Dev, Louvain, Belgium	Radboud University Nijmegen; KU Leuven	Goossens, L (corresponding author), KU Leuven Univ Leuven, Sch Psychol & Child & Adolescent Dev, Louvain, Belgium.	G.vanRoekel@pwo.ru.nl	van Roekel, Eeske/E-7889-2012; Kleinjan, Marloes/AAF-1128-2019	van Roekel, Eeske/0000-0002-0829-8089; Kleinjan, Marloes/0000-0002-4545-5549; Engels, Rutger/0000-0003-1944-9126; Goossens, Luc/0000-0003-3851-0412	Behavioural Science Institute, Radboud University Nijmegen	Behavioural Science Institute, Radboud University Nijmegen	This research was supported by a grant from the Behavioural Science Institute, Radboud University Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bartels M, 2008, AM J MED GENET B, V147B, P385, DOI 10.1002/ajmg.b.30608; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Boomsma DI, 2005, BEHAV GENET, V35, P745, DOI 10.1007/s10519-005-6040-8; Bradley B, 2011, DEV PSYCHOPATHOL, V23, P439, DOI 10.1017/S0954579411000162; Cacioppo JT, 2006, J RES PERS, V40, P1054, DOI 10.1016/j.jrp.2005.11.007; Chen FS, 2011, P NATL ACAD SCI US; Cornelis MC, 2012, MOL PSYCHIATR, V17, P1157, DOI 10.1038/mp.2011.178; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; Costello DM, 2008, J CONSULT CLIN PSYCH, V76, P173, DOI 10.1037/0022-006X.76.2.173; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Feng M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1059, DOI 10.1152/ajpendo.90609.2008; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Kleinjan M, 2009, DRUG ALCOHOL DEPEN, V99, P204, DOI 10.1016/j.drugalcdep.2008.08.002; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; LARSON R, 1998, TEMPORAL RHYTHMS ADO, P37; LARSON RW, 1983, J MARRIAGE FAM, V45, P739, DOI 10.2307/351787; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; MacDonald K, 2010, HARVARD REV PSYCHIAT, V18, P1, DOI 10.3109/10673220903523615; McGuire S, 2000, PSYCHOL SCI, V11, P487, DOI 10.1111/1467-9280.00293; Muthen B., 2010, MPLUS USERS GUIDE; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Poulin MJ, 2013, HORM BEHAV, V63, P510, DOI 10.1016/j.yhbeh.2013.01.004; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Schneiders J, 2007, J RES ADOLESCENCE, V17, P697, DOI 10.1111/j.1532-7795.2007.00543.x; Shanahan MJ, 2005, J GERONTOL B-PSYCHOL, V60, P65, DOI 10.1093/geronb/60.Special_Issue_1.65; Sturge-Apple ML, 2012, J FAM PSYCHOL, V26, P431, DOI 10.1037/a0028302; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; van Roekel E, PSYCHIATR GENET IN P; van Roekel E, 2014, J RES ADOLESCENCE, V24, P350, DOI 10.1111/jora.12061; Waaktaar T, 2012, AM J MED GENET B, V159B, P580, DOI 10.1002/ajmg.b.32064	35	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77689	10.1371/journal.pone.0077689	http://dx.doi.org/10.1371/journal.pone.0077689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223720	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400013
J	Seppala, O; Karvonen, A; Kuosa, M; Haataja, M; Jokela, J				Seppala, Otto; Karvonen, Anssi; Kuosa, Marja; Haataja, Maarit; Jokela, Jukka			Are Sick Individuals Weak Competitors? Competitive Ability of Snails Parasitized by a Gigantism-Inducing Trematode	PLOS ONE			English	Article							LARVAL TREMATODES; INTRASPECIFIC COMPETITION; GROWTH; INFECTION; GASTROPODA; FECUNDITY; PATTERNS; ECOLOGY; VIRUS	Parasitized individuals are often expected to be poor competitors because they are weakened by infections. Many trematode species, however, although extensively exploiting their mollusc hosts, also induce gigantism (increased host size) by diverting host resources towards growth instead of reproduction. In such systems, alternatively to reduced competitive ability due to negative effects of parasitism on host performance, larger size could allow more efficient resource acquisition and thus increase the relative competitive ability of host individuals. We addressed this hypothesis by testing the effect of a trematode parasite Diplostomum pseudospathaceum on the competitive ability of its snail host Lymnaea stagnalis. We experimentally examined the growth of snails kept in pairs in relation to their infection status and intensity of resource competition (i.e. food availability). We found that parasitized snails grew faster and their reproduction was reduced compared to unparasitized individuals indicating parasite-induced gigantism. However, growth of the snails was faster when competing with parasitized individuals compared to unparasitized snails indicating reduced competitive ability due to parasitism. The latter effect, however, was relatively weak suggesting that the effects of the parasite on snail physiology may partly override each other in determining competitive ability.	[Seppala, Otto; Jokela, Jukka] ETH, Inst Integrat Biol, Zurich, Switzerland; [Seppala, Otto; Jokela, Jukka] Eawag, Dept Aquat Ecol, Dubendorf, Switzerland; [Karvonen, Anssi] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kuosa, Marja] Univ Oulu, Dept Biol, Oulu, Finland; [Haataja, Maarit] Univ Helsinki, Res Funding Serv, Helsinki, Finland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Jyvaskyla; University of Oulu; University of Helsinki	Seppala, O (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	otto.seppaelae@eawag.ch		Karvonen, Anssi/0000-0002-2731-3344; Jokela, Jukka/0000-0002-1731-727X; Seppala, Otto/0000-0001-7902-3069	Emil Aaltonen Foundation; Swiss National Science Foundation [31003A 140876, 31003A 129961]; Centre of Excellence in Evolutionary Research (Academy of Finland); Centre of Excellence in Evolutionary Research (University of Jyvaskyla)	Emil Aaltonen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre of Excellence in Evolutionary Research (Academy of Finland)(Academy of Finland); Centre of Excellence in Evolutionary Research (University of Jyvaskyla)	This study was supported by the Emil Aaltonen Foundation (to OS), the Swiss National Science Foundation (grant 31003A 140876 to OS, grant 31003A 129961 to JJ), and the Centre of Excellence in Evolutionary Research (Academy of Finland and University of Jyvaskyla) (to AK and JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedhomme S, 2005, PLOS BIOL, V3, P1403, DOI 10.1371/journal.pbio.0030262; Bieger A, 2009, OECOLOGIA, V160, P247, DOI 10.1007/s00442-009-1297-x; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cameron TC, 2007, ECOLOGY, V88, P1225, DOI 10.1890/06-0661; CATHERALL PL, 1966, ANN APPL BIOL, V57, P155, DOI 10.1111/j.1744-7348.1966.tb06876.x; Faltynkova A, 2007, PARASITE, V14, P39, DOI 10.1051/parasite/2007141039; Faltynkova A, 2006, PARASITOL RES, V99, P572, DOI 10.1007/s00436-006-0197-9; Friess N, 1996, NEW PHYTOL, V132, P103, DOI 10.1111/j.1469-8137.1996.tb04514.x; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Hechinger RF, 2009, EVOL ECOL, V23, P651, DOI 10.1007/s10682-008-9262-4; HOCHBERG ME, 1991, OIKOS, V61, P297, DOI 10.2307/3545237; Jokela J, 1999, OECOLOGIA, V119, P320, DOI 10.1007/s004420050792; Karvonen A, 2006, PARASITOLOGY, V132, P357, DOI 10.1017/S0031182005009091; Karvonen A, 2004, PARASITOLOGY, V129, P87, DOI 10.1017/S0031182004005281; Karvonen A, 2008, AQUACULTURE, V279, P6, DOI 10.1016/j.aquaculture.2008.04.013; KAUFMANN KW, 1981, OECOLOGIA, V49, P293, DOI 10.1007/BF00347588; Koprivnikar J, 2008, OECOLOGIA, V155, P641, DOI 10.1007/s00442-007-0937-2; Kusch J, 2002, PROTIST, V153, P47, DOI 10.1078/1434-4610-00082; LAFFERTY KD, 1993, MAR ECOL PROG SER, V96, P229, DOI 10.3354/meps096229; LIVELY CM, 1995, ECOLOGY, V76, P1859, DOI 10.2307/1940718; Louhi KR, 2010, INFECT GENET EVOL, V10, P1271, DOI 10.1016/j.meegid.2010.08.013; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; MOURITSEN KN, 1994, J EXP MAR BIOL ECOL, V181, P53, DOI 10.1016/0022-0981(94)90103-1; Pagan I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000531; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poulin R., 2007, EVOL ECOL, V2; Rellstab C, 2011, INFECT GENET EVOL, V11, P1276, DOI 10.1016/j.meegid.2011.04.018; ROTHSCHILD MIRIAM, 1936, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V20, P537; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Seppala O, 2008, OIKOS, V117, P749, DOI 10.1111/j.0030-1299.2008.16396.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sisterson MS, 2003, OECOLOGIA, V135, P362, DOI 10.1007/s00442-003-1205-8; Sorensen RE, 1998, OECOLOGIA, V115, P188, DOI 10.1007/s004420050507; Vayrynen T, 2000, ANN ZOOL FENN, V37, P189; WASHBURN JO, 1991, SCIENCE, V253, P185, DOI 10.1126/science.1906637	35	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e79366	10.1371/journal.pone.0079366	http://dx.doi.org/10.1371/journal.pone.0079366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205383	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800027
J	Campbell, MJ; Wolf, D; Mukhtar, RA; Tandon, V; Yau, C; Au, A; Baehner, F; van't Veer, L; Berry, D; Esserman, LJ				Campbell, Michael J.; Wolf, Denise; Mukhtar, Rita A.; Tandon, Vickram; Yau, Christina; Au, Alfred; Baehner, Frederick; van't Veer, Laura; Berry, Donald; Esserman, Laura J.			The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INFILTRATING LYMPHOCYTES; MICROENVIRONMENTS; POLARIZATION; RECURRENCE; CARCINOMA; SURVIVAL; CD68	Tumor associated macrophages (TAMs) are recruited from the circulation to the tumor site, and can undergo a spectrum of phenotypic changes, with two contrasting activation states described in the literature: the M1 and M2 phenotypes. We previously identified a population of TAMs that express proliferating cell nuclear antigen (PCNA) and are associated with high grade, hormone receptor negative breast cancers and poor outcomes. In the present exploratory study we again found that high PCNA(+) TAM counts in pre-treatment tumor biopsies (102 invasive breast cancer cases from the I-SPY 1 Trial, a prospective neoadjuvant trial with serial core biopsies and gene array data) were associated with high grade, hormone receptor negativity, and decreased recurrence free survival. We explored the association of these PCNA(+) TAMs with the expression of M1 and M2 related genes and, contrary to expectation, observed that high PCNA(+) TAM levels were associated with more M1- than M2-related genes. An immune gene signature, derived from cytotoxic T cell and MHC Class II genes (Tc/ClassII), was developed and we found that high PCNA(+) TAM counts, in the context of a low Tc/ClassII signature score, were associated with significantly worse recurrence free survival in all cases and in hormone receptor negative only cases. We observed similar results using a gene signature-proxy for PCNA(+) TAMs in a larger independent set of 425 neoadjuvant-treated breast cancer cases. The results of this exploratory study indicate that high numbers of PCNA(+) TAMs, in the absence of an anti-tumor immune microenvironment (as indicated by a low Tc/ClassII signature score), are associated with poor outcomes in breast cancer patients treated with neoadjuvant chemotherapy. This, along with the observation that PCNA(+) TAMs were associated predominantly with M1-related genes, may provide new insights into the role of the immune microenvironment in breast cancer.	[Campbell, Michael J.; Mukhtar, Rita A.; Tandon, Vickram; Esserman, Laura J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Wolf, Denise; Yau, Christina; van't Veer, Laura] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Au, Alfred; Baehner, Frederick] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Berry, Donald] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [van't Veer, Laura] Agendia, Amsterdam, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; Agendia	Campbell, MJ (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.	michael.campbell@ucsfmedctr.org			National Cancer Institute Specialized Program of Research Excellence in Breast Cancer [CA58207]; Breast Cancer Research Foundation; National Cancer Institute [CA31946]; Alliance Statistics and Data Center [CA33601]; NATIONAL CANCER INSTITUTE [U10CA031946, U10CA033601, P50CA058207] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence in Breast Cancer; Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alliance Statistics and Data Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the National Cancer Institute Specialized Program of Research Excellence in Breast Cancer (CA58207) and the Breast Cancer Research Foundation. The research for CALGB 150007/150012 ACRIN 6657 (Alliance) was supported, in part, by grants from the National Cancer Institute (CA31946) to the Alliance for Clinical Trials in Oncology (Monica M. Bertagnolli, M. D., Chair) and to the Alliance Statistics and Data Center (Daniel J. Sargent, Ph.D., CA33601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXEVANIS CN, 1994, CANCER, V74, P1275, DOI 10.1002/1097-0142(19940815)74:4<1275::AID-CNCR2820740416>3.0.CO;2-Q; Berry D, 2012, J NATL CANCER I, V104, P1124, DOI 10.1093/jnci/djs301; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Campbell MJ, 2010, 33 ANN SAN ANT BREAS; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Esserman LJ, 2011, BREAST CANC RES TREA; FALINI B, 1993, AM J PATHOL, V142, P1359; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; Guo XJ, 2008, MODERN PATHOL, V21, P1101, DOI 10.1038/modpathol.2008.72; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Leek RD, 1996, CANCER RES, V56, P4625; Leong PP, 2006, IMMUNOL LETT, V102, P229, DOI 10.1016/j.imlet.2005.09.006; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Mukhtar RA, 2011, BREAST CANCER RES TR, V130, P635, DOI 10.1007/s10549-011-1646-4; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Volodko N, 1998, BREAST, V7, P99, DOI 10.1016/S0960-9776(98)90065-0	27	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79114	10.1371/journal.pone.0079114	http://dx.doi.org/10.1371/journal.pone.0079114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205370	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700103
J	Grigera, F; Bellacosa, A; Kenter, AL				Grigera, Fernando; Bellacosa, Alfonso; Kenter, Amy L.			Complex Relationship between Mismatch Repair Proteins and MBD4 during Immunoglobulin Class Switch Recombination	PLOS ONE			English	Article							BASE EXCISION-REPAIR; NUCLEAR-LOCALIZATION; B-CELLS; DNA; MLH1; RNA; GLYCOSYLASE; ACTIVATION; ALPHA; ACTIN	Mismatch repair (MMR) safeguards against genomic instability and is required for efficient Ig class switch recombination (CSR). Methyl CpG binding domain protein 4 (MBD4) binds to MutL homologue 1 (MLH1) and controls the post-transcriptional level of several MMR proteins, including MutS homologue 2 (MSH2). We show that in WT B cells activated for CSR, MBD4 is induced and interacts with MMR proteins, thereby implying a role for MBD4 in CSR. However, CSR is in the normal range in Mbd4 deficient mice deleted for exons 2-5 despite concomitant reduction of MSH2. We show by comparison in Msh2(+/-) B cells that a two-fold reduction of MSH2 and MBD4 proteins is correlated with impaired CSR. It is therefore surprising that CSR occurs at normal frequencies in the Mbd4 deficient B cells where MSH2 is reduced. We find that a variant Mbd4 transcript spanning exons 1,6-8 is expressed in Mbd4 deficient B cells. This transcript can be ectopically expressed and produces a truncated MBD4 peptide. Thus, the 3' end of the Mbd4 locus is not silent in Mbd4 deficient B cells and may contribute to CSR. Our findings highlight a complex relationship between MBD4 and MMR proteins in B cells and a potential reconsideration of their role in CSR.	[Grigera, Fernando; Kenter, Amy L.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Bellacosa, Alfonso] Fox Chase Canc Ctr, Canc Epigenet Program, Philadelphia, PA 19111 USA; [Bellacosa, Alfonso] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Fox Chase Cancer Center; Fox Chase Cancer Center	Kenter, AL (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	star1@uic.edu			National Institutes of Health [AI052400]; NATIONAL CANCER INSTITUTE [R01CA078412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106328, R01AI052400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI052400) to A. L. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bardwell PD, 2003, J IMMUNOL, V170, P1620, DOI 10.4049/jimmunol.170.4.1620; Bellacosa A, 1999, P NATL ACAD SCI USA, V96, P3969, DOI 10.1073/pnas.96.7.3969; Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Cerutti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025854; Cortellino S, 2003, P NATL ACAD SCI USA, V100, P15071, DOI 10.1073/pnas.2334585100; Hashimoto H, 2012, NUCL ACIDS RES; Hendrich B, 1999, MAMM GENOME, V10, P906, DOI 10.1007/s003359901112; Kenter AL, 2012, SEMIN IMMUNOL, V24, P281, DOI 10.1016/j.smim.2012.06.001; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Lin SC, 1996, MOL CELL BIOL, V16, P4591; Maas S, 2009, NUCLEIC ACIDS RES, V37, P5822, DOI 10.1093/nar/gkp599; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Mohd AB, 2006, DNA REPAIR, V5, P347, DOI 10.1016/j.dnarep.2005.11.001; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Owen RM, 2007, ONCOL REP, V17, P111; Pena-Diaz J, 2012, TRENDS BIOCHEM SCI, V37, P206, DOI 10.1016/j.tibs.2012.03.001; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Stavnezer J, 2006, TRENDS GENET, V22, P23, DOI 10.1016/j.tig.2005.11.002; Turner DP, 2006, CANCER RES, V66, P7686, DOI 10.1158/0008-5472.CAN-05-4488; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020	34	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78370	10.1371/journal.pone.0078370	http://dx.doi.org/10.1371/journal.pone.0078370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205214	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700089
J	Antonelli, A; Sfara, C; Battistelli, S; Canonico, B; Arcangeletti, M; Manuali, E; Salamida, S; Papa, S; Magnani, M				Antonelli, Antonella; Sfara, Carla; Battistelli, Serafina; Canonico, Barbara; Arcangeletti, Marcella; Manuali, Elisabetta; Salamida, Sonia; Papa, Stefano; Magnani, Mauro			New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI	PLOS ONE			English	Article							RED-BLOOD-CELLS; SUPERPARAMAGNETIC NANOPARTICLES; MAGNETIC NANOPARTICLES; BIOMEDICAL APPLICATIONS; MACROPHAGE APOPTOSIS; LOADED ERYTHROCYTES; OXIDE; CLODRONATE; ENCAPSULATION; REPOPULATION	Superparamagnetic iron oxide (SPIO) and ultra small superparamagnetic iron oxide (USPIO) nanoparticles have been developed as magnetic resonance imaging (MRI) contrast agents. Iron oxide nanoparticles, that become superparamagnetic if the core particle diameter is (similar to) 30nm or less, present R1 and R2 relaxivities which are much higher than those of conventional paramagnetic gadolinium chelates. Generally, these magnetic particles are coated with biocompatible polymers that prevent the agglomeration of the colloidal suspension and improve their blood distribution profile. In spite of their potential as MRI blood contrast agents, the biomedical application of iron oxide nanoparticles is still limited because of their intravascular half-life of only few hours; such nanoparticles are rapidly cleared from the bloodstream by macrophages of the reticulo-endothelial system (RES). To increase the life span of these MRI contrast agents in the bloodstream we proposed the encapsulation of SPIO nanoparticles in red blood cells (RBCs) through the transient opening of cell membrane pores. We have recently reported results obtained by applying our loading procedure to several SPIO nanoparticles with different chemical physical characteristics such as size and coating agent. In the current investigation we showed that the life span of iron-based contrast agents in the mice bloodstream was prolonged to 12 days after the intravenous injection of murine SPIO-loaded RBCs. Furthermore, we developed an animal model that implicates the pretreatment of animals with clodronate to induce a transient suppression of tissue macrophages, followed by the injection of human SPIO-loaded RBCs which make it possible to encapsulate nanoparticle concentrations (5.3-16.7mM Fe) higher than murine SPIO-loaded RBCs (1.4-3.55mM Fe). The data showed that, when human RBCs are used as more capable SPIO nanoparticle containers combined with a depletion of tissue macrophages, Fe concentration in animal blood is 2-3 times higher than iron concentration obtained by the use of murine SPIO-loaded RBCs.	[Antonelli, Antonella; Sfara, Carla; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Biochem & Mol Biol Sect, Urbino, Italy; [Battistelli, Serafina] Univ Urbino Carlo Bo, Dept Biomol Sci, Clin Biochem Sect, Urbino, Italy; [Canonico, Barbara] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, Italy; [Arcangeletti, Marcella; Papa, Stefano] Univ Urbino Carlo Bo, Dept Biomol Sci, Pharmacol & Pharmacognosy Sect, Urbino, Italy; [Manuali, Elisabetta; Salamida, Sonia] Expt Zooprofilact Inst Umbria & Marche, Lab Elect Microscopy & Histopathol, Perugia, Italy	University of Urbino; University of Urbino; University of Urbino; University of Urbino; IZS Umbria e Marche	Antonelli, A (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Biochem & Mol Biol Sect, Urbino, Italy.	antonella.antonelli@uniurb.it	ANTONELLI, ANTONELLA/C-6238-2011; Magnani, Mauro/A-1919-2008; Manuali, Elisabetta/K-8491-2016	Manuali, Elisabetta/0000-0003-3680-0926; Canonico, Barbara/0000-0003-3383-715X; Magnani, Mauro/0000-0001-6456-6626	FIRB funds from the Italian Minister for University and Research [RBFR1299K0]	FIRB funds from the Italian Minister for University and Research	The authors have received support from FIRB funds with contract RBFR1299K0 from the Italian Minister for University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allkemper T, 2002, RADIOLOGY, V223, P432, DOI 10.1148/radiol.2232010241; Antonelli A, 2012, SPRINGER PROC PHYS, V140, P175; Antonelli A, 2008, J NANOSCI NANOTECHNO, V8, P2270, DOI 10.1166/jnn.2008.190; Antonelli A, 2011, NANOMEDICINE-UK, V6, P211, DOI 10.2217/NNM.10.163; Araujo L, 1999, J DRUG TARGET, V6, P373, DOI 10.3109/10611869908996844; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203; Boni A, 2013, CONTRAST ME IN PRESS; Brahler M, 2006, NANO LETT, V6, P2505, DOI 10.1021/nl0618501; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cambos M, 2011, J LEUKOCYTE BIOL, V89, P159, DOI 10.1189/jlb.0510249; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; CASTRO O, 1973, P NATL ACAD SCI USA, V70, P2356, DOI 10.1073/pnas.70.8.2356; Corot C, 2003, INVEST RADIOL, V38, P311, DOI 10.1097/01.rli.0000066814.82006.be; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6; DELOACH JR, 1987, METHOD ENZYMOL, V149, P235; Frith JC, 2001, ARTHRITIS RHEUM, V44, P2201, DOI 10.1002/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E; Gadian DG, 1984, NUCL MAGNETIC RESONA; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Jun YW, 2008, ANGEW CHEM INT EDIT, V47, P5122, DOI 10.1002/anie.200701674; KREUTER J, 1994, EUR J DRUG METAB PH, V19, P253, DOI 10.1007/BF03188928; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Magnani M, 2012, THER DELIV, V3, P405, DOI 10.4155/TDE.12.6; Markov DE, 2010, PHYS MED BIOL, V55, P6461, DOI 10.1088/0031-9155/55/21/008; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Moghimi SM, 2001, PHARMACOL REV, V53, P283; MONKKONEN J, 1989, DRUG METAB DISPOS, V17, P690; Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064; Rahmer J, 2013, PHYS MED BIOL, V58, P3965, DOI 10.1088/0031-9155/58/12/3965; Rossi L, 2005, J DRUG TARGET, V13, P99, DOI 10.1080/10611860500064123; Rumenapp C, 2012, PHARM RES-DORDR, V29, P1165, DOI 10.1007/s11095-012-0711-y; Selander KS, 1996, MOL PHARMACOL, V50, P1127; SPRANDEL U, 1987, METHOD ENZYMOL, V149, P301; VANROOIJEN N, 1989, J LEUKOCYTE BIOL, V45, P97, DOI 10.1002/jlb.45.2.97; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002; VYAS SP, 1994, J MICROENCAPSUL, V11, P19, DOI 10.3109/02652049409040435; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; WESTERMANN J, 1989, J LEUKOCYTE BIOL, V46, P263, DOI 10.1002/jlb.46.3.263; Zhang C, 2010, MINI-REV MED CHEM, V10, P194, DOI 10.2174/138955710791185073; Zhao XR, 2009, STROKE, V40, pS92, DOI 10.1161/STROKEAHA.108.533158; Zhu HM, 2011, CRIT CARE MED, V39, P2478, DOI 10.1097/CCM.0b013e318225754f	47	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78542	10.1371/journal.pone.0078542	http://dx.doi.org/10.1371/journal.pone.0078542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24223101	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400084
J	Pillay, D; Izotte, J; Fikru, R; Buscher, P; Mucache, H; Neves, L; Boulange, A; Seck, MT; Bouyer, J; Napier, GB; Chevtzoff, C; Coustou, V; Baltz, T				Pillay, Davita; Izotte, Julien; Fikru, Regassa; Buescher, Philipe; Mucache, Hermogenes; Neves, Luis; Boulange, Alain; Seck, Momar Talla; Bouyer, Jeremy; Napier, Grant B.; Chevtzoff, Cyrille; Coustou, Virginie; Baltz, Theo			Trypanosoma vivax GM6 Antigen: A Candidate Antigen for Diagnosis of African Animal Trypanosomosis in Cattle	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; BOVINE TRYPANOSOMOSIS; DUTTONELLA VIVAX; EAST-AFRICA; CONGOLENSE; ANTIBODY; TSETSE; BRUCEI; INFECTIONS; EXPRESSION	Background: Diagnosis of African animal trypanosomosis is vital to controlling this severe disease which hampers development across 10 million km(2) of Africa endemic to tsetse flies. Diagnosis at the point of treatment is currently dependent on parasite detection which is unreliable, and on clinical signs, which are common to several other prevalent bovine diseases. Methodology/Principle Findings: the repeat sequence of the GM6 antigen of Trypanosoma vivax (TvGM6), a flagellar-associated protein, was analysed from several isolates of T. vivax and found to be almost identical despite the fact that T. vivax is known to have high genetic variation. The TvGM6 repeat was recombinantly expressed in E. coli and purified. An indirect ELISA for bovine sera based on this antigen was developed. The TvGM6 indirect ELISA had a sensitivity of 91.4% (95% CI: 91.3 to 91.6) in the period following 10 days post experimental infection with T. vivax, which decreased ten-fold to 9.1% (95% CI: 7.3 to 10.9) one month post treatment. With field sera from cattle infected with T. vivax from two locations in East and West Africa, 91.5% (95% CI: 83.2 to 99.5) sensitivity and 91.3% (95% CI: 78.9 to 93.1) specificity was obtained for the TvGM6 ELISA using the whole trypanosome lysate ELISA as a reference. For heterologous T. congolense field infections, the TvGM6 ELISA had a sensitivity of 85.1% (95% CI: 76.8 to 94.4). Conclusion/Significance: this study is the first to analyse the GM6 antigen of T. vivax and the first to test the GM6 antigen on a large collection of sera from experimentally and naturally infected cattle. This study demonstrates that the TvGM6 is an excellent candidate antigen for the development of a point-of-treatment test for diagnosis of T. vivax, and to a lesser extent T. congolense, African animal trypanosomosis in cattle.	[Pillay, Davita; Izotte, Julien; Coustou, Virginie; Baltz, Theo] Univ Bordeaux Segalen, CNRS, UMR 5234, Bordeaux, France; [Fikru, Regassa] Univ Addis Ababa, Coll Vet Med, Debre Zeit, Ethiopia; [Fikru, Regassa; Buescher, Philipe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Fikru, Regassa] Katholieke Univ Leuven, Fac Biosci Engn, Dept Biosyst, Louvain, Belgium; [Mucache, Hermogenes; Neves, Luis; Boulange, Alain] Univ Eduardo Mondlane, Ctr Biotechnol, Maputo, Mozambique; [Seck, Momar Talla; Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Serv Bioecol & Pathol Parasitaires, Dakar, Senegal; [Boulange, Alain; Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR CMAEE, Montpellier, France; [Bouyer, Jeremy] INRA, UMR CMAEE 1309, F-34060 Montpellier, France; [Napier, Grant B.] Global Alliance Vet Med GALVmed, Edinburgh, Midlothian, Scotland; [Chevtzoff, Cyrille] Ceva Sante Anim, Libourne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Addis Ababa University; Institute of Tropical Medicine (ITM); KU Leuven; Eduardo Mondlane University; CIRAD; INRAE; Ceva Sante Animale	Pillay, D (corresponding author), Univ Bordeaux Segalen, CNRS, UMR 5234, Bordeaux, France.	davita.pillay@u-bordeaux2.fr	Bouyer, Jérémy/AAK-7370-2020; Büscher, Philippe/B-9956-2012	Bouyer, Jérémy/0000-0002-1913-416X; Büscher, Philippe/0000-0002-1926-7472; Neves, Luis/0000-0002-5435-5996; Pillay, Davita/0000-0002-7828-6841	GALVmed; UK Government's Department for International Development (DFID) as part of GALVmed's Animal African Trypanosomosis Programme (DFID Programme: Controlling African Animal Trypanosomosis (AAT) [202040-101]; CEVA sante animale (Libourne, France); CNRS; Ministere de l'Education Nationale de la Recherche et de la Technologie; Conseil Regional d'Aquitaine; Laboratoire d'Excellence (LabEx) ParaFrap (French Parasitology Alliance for Health Care) [ANR-11-LABX-0024]; Belgian Directorate General of Development Cooperation	GALVmed; UK Government's Department for International Development (DFID) as part of GALVmed's Animal African Trypanosomosis Programme (DFID Programme: Controlling African Animal Trypanosomosis (AAT); CEVA sante animale (Libourne, France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale de la Recherche et de la Technologie; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Laboratoire d'Excellence (LabEx) ParaFrap (French Parasitology Alliance for Health Care); Belgian Directorate General of Development Cooperation	This research was supported by the GALVmed with funding from the UK Government's Department for International Development (DFID) as part of GALVmed's Animal African Trypanosomosis Programme (DFID Programme: Controlling African Animal Trypanosomosis (AAT) (Aries code 202040-101), and by CEVA sante animale (Libourne, France). This work was also supported by the CNRS, the Ministere de l'Education Nationale de la Recherche et de la Technologie, the Conseil Regional d'Aquitaine and the Laboratoire d'Excellence (LabEx) ParaFrap (French Parasitology Alliance for Health Care) ANR-11-LABX-0024. Regassa Fikru received a PhD grant from the Belgian Directorate General of Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ER, 2010, PARASITOLOGY, V137, P641, DOI 10.1017/S0031182009991508; Osorio ALAR, 2008, MEM I OSWALDO CRUZ, V103, P1, DOI 10.1590/S0074-02762008000100001; AUTHIE E, 1993, PARASITE IMMUNOL, V15, P101, DOI 10.1111/j.1365-3024.1993.tb00589.x; Auty H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001828; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Bhatia A, 1999, MOL BIOCHEM PARASIT, V102, P249, DOI 10.1016/S0166-6851(99)00098-5; Bossard G, 2010, VET PARASITOL, V173, P39, DOI 10.1016/j.vetpar.2010.06.016; Boulange A, 2002, EXP PARASITOL, V100, P6, DOI 10.1006/expr.2001.4667; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; COPPEL RL, 1984, NATURE, V310, P789, DOI 10.1038/310789a0; Cortez AP, 2006, PARASITOLOGY, V133, P159, DOI 10.1017/S0031182006000254; Coustou V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000618; D'Archivio S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001461; Desquesnes M, 2004, LIVESTOCK TRYPANOSOM; Eisler MC, 1998, VET PARASITOL, V79, P187, DOI 10.1016/S0304-4017(98)00173-3; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; FASOGBON AI, 1990, INT J PARASITOL, V20, P389, DOI 10.1016/0020-7519(90)90156-H; Fikru R, 2012, VET PARASITOL, V190, P355, DOI 10.1016/j.vetpar.2012.07.010; Gibson W, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-71; Goto Y, 2010, INFECT IMMUN, V78, P2138, DOI 10.1128/IAI.01102-09; GRUBER A, 1993, EXP PARASITOL, V76, P1, DOI 10.1006/expr.1993.1001; Habila N, 2012, RES VET SCI, V93, P13, DOI 10.1016/j.rvsc.2011.08.011; Hamilton PB, 2012, TRENDS PARASITOL, V28, P173, DOI 10.1016/j.pt.2012.02.003; IJAGBONE IF, 1989, VET PARASITOL, V32, P293, DOI 10.1016/0304-4017(89)90040-X; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; LEEFLANG P, 1976, INT J PARASITOL, V6, P413, DOI 10.1016/0020-7519(76)90027-8; LUCKINS AG, 1978, TROP ANIM HEALTH PRO, V10, P149, DOI 10.1007/BF02235328; LUCKINS AG, 1977, TROP ANIM HEALTH PRO, V9, P53, DOI 10.1007/BF02297393; Magona JW, 2008, ACTA TROP, V107, P186, DOI 10.1016/j.actatropica.2008.05.019; Mamoudou A, 2006, REV ELEV MED VET PAY, V59, P11; McDermott JJ, 2002, AFRICAN TRYPANOSOMES, P25; Morrison LJ, 2010, INFECT IMMUN, V78, P1096, DOI 10.1128/IAI.00943-09; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; Murray M, 1983, LIVESTOCK PRODUCTIVI; Nantulya V.M., 1990, Revue Scientifique et Technique Office International des Epizooties, V9, P357; Thuy N, 2012, PARASITOL RES, V110, P733, DOI 10.1007/s00436-011-2632-9; Pagabeleguem S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049762; Rebeski DE, 1999, PARASITOL RES, V85, P550, DOI 10.1007/s004360050594; Rodrigues AC, 2008, PARASITOLOGY, V135, P1317, DOI 10.1017/S0031182008004848; Seck MT, 2010, PARASITE, V17, P257, DOI 10.1051/parasite/2010173257; Smuts CM, 2009, THESIS MURDOCH U PER; Sullivan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002087; Taylor K., 2004, The trypanosomiases, P331, DOI 10.1079/9780851994758.0331; Van den Bossche P, 2000, ACTA TROP, V77, P263, DOI 10.1016/S0001-706X(00)00138-8; Woo P. T. K., 1970, Acta trop., V27, P384; Wright P F, 1993, Rev Sci Tech, V12, P435	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78565	10.1371/journal.pone.0078565	http://dx.doi.org/10.1371/journal.pone.0078565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205263	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400086
J	Asp, ML; Martindale, JJ; Metzger, JM				Asp, Michelle L.; Martindale, Joshua J.; Metzger, Joseph M.			Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium Handling	PLOS ONE			English	Article							HIGH-DOSE TAMOXIFEN; SARCOPLASMIC-RETICULUM; ESTROGEN-RECEPTOR; VENTRICULAR MYOCYTES; K+ CURRENTS; CELL-LINES; STEM-CELLS; RAT-HEART; PHASE-I; INHIBITION	Tamoxifen (Tam), a selective estrogen receptor modulator, is in wide clinical use for the treatment and prevention of breast cancer. High Tam doses have been used for treatment of gliomas and cancers with multiple drug resistance, but long QT Syndrome is a side effect. Tam is also used experimentally in mice for inducible gene knockout in numerous tissues, including heart; however, the potential direct effects of Tam on cardiac myocyte mechanical function are not known. The goal of this study was to determine the direct, acute effects of Tam, its active metabolite 4-hydroxytamoxifen (4OHT), and related drug raloxifene (Ral) on isolated rat cardiac myocyte mechanical function and calcium handling. Tam decreased contraction amplitude, slowed relaxation, and decreased Ca2+ transient amplitude. Effects were primarily observed at 5 and 10 mu M Tam, which is relevant for high dose Tam treatment in cancer patients as well as Tam-mediated gene excision in mice. Myocytes treated with 4OHT responded similarly to Tam-treated cells with regard to both contractility and calcium handling, suggesting an estrogen-receptor independent mechanism is responsible for the effects. In contrast, Ral increased contraction and Ca2+ transient amplitudes. At 10 mu M, all drugs had a time-dependent effect to abolish cellular contraction. In conclusion, Tam, 4OHT, and Ral adversely and differentially alter cardiac myocyte contractility and Ca2+ handling. These findings have important implications for understanding the Tam-induced cardiomyopathy in gene excision studies and may be important for understanding effects on cardiac performance in patients undergoing high-dose Tam therapy.	[Asp, Michelle L.; Martindale, Joshua J.; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Metzger, JM (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	metzgerj@umn.edu			NIH; NIH NRSA [1F32HL115876]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059301, F32HL115876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by NIH (JMM) and NIH NRSA 1F32HL115876 (MLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beca S, 2008, PFLUG ARCH EUR J PHY, V457, P121, DOI 10.1007/s00424-008-0510-9; BERMAN E, 1991, BLOOD, V77, P818; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Duan JH, 2004, ENDOCRINE, V24, P33, DOI 10.1385/ENDO:24:1:033; Filice E, 2009, J PHYSIOL PHARMACOL, V60, P3; Filice E, 2011, CELL PHYSIOL BIOCHEM, V28, P41, DOI 10.1159/000331712; Furlanut M, 2007, THER DRUG MONIT, V29, P349, DOI 10.1097/FTD.0b013e318067ded7; Gomez-Casati ME, 2010, JARO-J ASSOC RES OTO, V11, P19, DOI 10.1007/s10162-009-0191-x; He JY, 2003, AM J PHYSIOL-HEART C, V285, pH661, DOI 10.1152/ajpheart.00686.2002; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hougen K, 2010, AM J PHYSIOL-HEART C, V299, pH1671, DOI 10.1152/ajpheart.01155.2009; Kargacin ME, 2000, PFLUG ARCH EUR J PHY, V440, P573, DOI 10.1007/s004240000318; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Kravtsov GM, 2007, AM J PHYSIOL-CELL PH, V292, pC1625, DOI 10.1152/ajpcell.00368.2006; Kulpa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041076; LEWARTOWSKI B, 1990, J MOL CELL CARDIOL, V22, P1221, DOI 10.1016/0022-2828(90)90059-B; Liew R, 2004, BRIT J PHARMACOL, V142, P89, DOI 10.1038/sj.bjp.0705736; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Michalski A, 2010, J NEURO-ONCOL, V100, P81, DOI 10.1007/s11060-010-0141-9; OBRIAN CA, 1985, CANCER RES, V45, P2462; Patel S, 2012, INT J RADIAT ONCOL, V82, P739, DOI 10.1016/j.ijrobp.2010.12.053; Pollack IF, 1997, CLIN CANCER RES, V3, P1109; Ponce-Balbuena D, 2010, J PHARMACOL SCI, V113, P66, DOI 10.1254/jphs.10024FP; Ponce-Balbuena D, 2009, J PHARMACOL EXP THER, V331, P563, DOI 10.1124/jpet.109.156075; PRATT WB, 1990, MOL CELL ENDOCRINOL, V74, pC69, DOI 10.1016/0303-7207(90)90198-H; Sideras K, 2010, J CLIN ONCOL, V28, P2768, DOI 10.1200/JCO.2009.23.8931; Slovacek L, 2008, J CLIN PHARM THER, V33, P453, DOI 10.1111/j.1365-2710.2008.00928.x; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Song JB, 1996, J PHARMACOL EXP THER, V277, P1444; STUART NSA, 1992, BRIT J CANCER, V66, P833, DOI 10.1038/bjc.1992.369; Tang PA, 2006, J NEURO-ONCOL, V78, P311, DOI 10.1007/s11060-005-9104-y; TRUMP DL, 1992, JNCI-J NATL CANCER I, V84, P1811, DOI 10.1093/jnci/84.23.1811; Ullrich ND, 2008, AM J PHYSIOL-HEART C, V294, pH2421, DOI 10.1152/ajpheart.01225.2007; Umar A, 2012, NAT REV CANCER, V12, P835, DOI 10.1038/nrc3397; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang W, 2013, NAT MED, V19, P305, DOI 10.1038/nm.3079; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	43	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78768	10.1371/journal.pone.0078768	http://dx.doi.org/10.1371/journal.pone.0078768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205315	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300083
J	Barcena-Uribarri, I; Thein, M; Maier, E; Bonde, M; Bergstrom, S; Benz, R				Barcena-Uribarri, Ivan; Thein, Marcus; Maier, Elke; Bonde, Mari; Bergstrom, Sven; Benz, Roland			Use of Nonelectrolytes Reveals the Channel Size and Oligomeric Constitution of the Borrelia burgdorferi P66 Porin	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CURRENT NOISE-ANALYSIS; SITE-DIRECTED MUTAGENESIS; LAMB MALTOPORIN CHANNEL; LIPID BILAYER-MEMBRANES; ESCHERICHIA-COLI; LYME-DISEASE; ION CHANNELS; BINDING-KINETICS; SUGAR-TRANSPORT	In the Lyme disease spirochete Borrelia burgdorferi, the outer membrane protein P66 is capable of pore formation with an atypical high single-channel conductance of 11 nS in 1 M KCl, which suggested that it could have a larger diameter than 'normal' Gram-negative bacterial porins. We studied the diameter of the P66 channel by analyzing its single-channel conductance in black lipid bilayers in the presence of different nonelectrolytes with known hydrodynamic radii. We calculated the filling of the channel with these nonelectrolytes and the results suggested that nonelectrolytes (NEs) with hydrodynamic radii of 0.34 nm or smaller pass through the pore, whereas neutral molecules with greater radii only partially filled the channel or were not able to enter it at all. The diameter of the entrance of the P66 channel was determined to be <= 1.9 nm and the channel has a central constriction of about 0.8 nm. The size of the channel appeared to be symmetrical as judged from one-sidedness of addition of NEs. Furthermore, the P66-induced membrane conductance could be blocked by 80-90% by the addition of the nonelectrolytes PEG 400, PEG 600 and maltohexaose to the aqueous phase in the low millimolar range. The analysis of the power density spectra of ion current through P66 after blockage with these NEs revealed no chemical reaction responsible for channel block. Interestingly, the blockage of the single-channel conductance of P66 by these NEs occurred in about eight subconductance states, indicating that the P66 channel could be an oligomer of about eight individual channels. The organization of P66 as a possible octamer was confirmed by Blue Native PAGE and immunoblot analysis, which both demonstrated that P66 forms a complex with a mass of approximately 460 kDa. Two dimension SDS PAGE revealed that P66 is the only polypeptide in the complex.	[Barcena-Uribarri, Ivan; Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Barcena-Uribarri, Ivan; Thein, Marcus; Maier, Elke; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Bonde, Mari; Bergstrom, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden	Jacobs University; German Research Foundation (DFG); University of Wurzburg; Umea University	Benz, R (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany.	r.benz@jacobs-university.de		Benz, Roland/0000-0002-9510-9265	Deutsche Forschungsgemeinschaft [Be 865/15-1]; Jacobs University; Swedish Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jacobs University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided by Deutsche Forschungsgemeinschaft, http://www.dfg.de; Be 865/15-1, Jacobs University http://www.jacobs-university.de; Swedish Research Council, http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411; Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Barcena-Uribarri I, 2010, BBA-BIOMEMBRANES, V1798, P1197, DOI 10.1016/j.bbamem.2010.02.011; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1985, CRC CR REV BIOCH MOL, V19, P145, DOI 10.3109/10409238509082542; Berestovsky GN, 2001, J EXP BOT, V52, P1173, DOI 10.1093/jexbot/52.359.1173; Bezrukov SM, 2000, PHYS REV LETT, V85, P202, DOI 10.1103/PhysRevLett.85.202; BUNIKIS J, 1995, FEMS MICROBIOL LETT, V131, P139, DOI 10.1111/j.1574-6968.1995.tb07768.x; Bunikis J, 1996, INFECT IMMUN, V64, P5111, DOI 10.1128/IAI.64.12.5111-5116.1996; Coburn J, 2003, P NATL ACAD SCI USA, V100, P7301, DOI 10.1073/pnas.1131117100; Coburn J, 1999, MOL MICROBIOL, V34, P926, DOI 10.1046/j.1365-2958.1999.01654.x; Defoe G, 2001, INFECT IMMUN, V69, P3455, DOI 10.1128/IAI.69.5.3455-3459.2001; Denker K, 2005, J MOL BIOL, V352, P534, DOI 10.1016/j.jmb.2005.07.025; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; HOLZ R, 1970, J GEN PHYSIOL, V56, P125, DOI 10.1085/jgp.56.1.125; HOOGE FN, 1971, PHILIPS RES REP, V26, P77; Jordy M, 1996, J MOL BIOL, V259, P666, DOI 10.1006/jmbi.1996.0348; Kaulin YA, 1998, BIOPHYS J, V74, P2918, DOI 10.1016/S0006-3495(98)77999-8; KRASILNIKOV OV, 1995, BRAZ J MED BIOL RES, V28, P693; Krasilnikov OV, 1998, J MEMBRANE BIOL, V161, P83; KRASILNIKOV OV, 1992, FEMS MICROBIOL IMMUN, V105, P93; Krasilnikov OV, 2002, NATO SCI S PRT 3 HI, V87, P97; KROPINSKI AM, 1987, J BACTERIOL, V169, P172, DOI 10.1128/jb.169.1.172-179.1987; MAGNARELLI LA, 1989, J INFECT DIS, V159, P43, DOI 10.1093/infdis/159.1.43; MARK JE, 1965, J AM CHEM SOC, V87, P1415, DOI 10.1021/ja01085a001; MARKIN VS, 1974, INDUCED ION TRANSPOR; MCKIM S, 1994, BBA-BIOMEMBRANES, V1193, P186, DOI 10.1016/0005-2736(94)90348-4; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Nablo BJ, 2008, BIOPHYS J, V95, P1157, DOI 10.1529/biophysj.107.121715; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Orlik F, 2002, BIOPHYS J, V83, P309, DOI 10.1016/S0006-3495(02)75171-0; Pinne M, 2007, FEMS MICROBIOL LETT, V266, P241, DOI 10.1111/j.1574-6968.2006.00529.x; Rempp P., 1957, J CHIM PHYS PCB, V54, P432; Rostovtseva TK, 2002, BIOPHYS J, V82, P160, DOI 10.1016/S0006-3495(02)75383-6; SABIROV RZ, 1993, GEN PHYSIOL BIOPHYS, V12, P95; SADZIENE A, 1992, J EXP MED, V176, P799, DOI 10.1084/jem.176.3.799; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Sizonenko VL, 1995, BIOFIZIKA+, V40, P1251; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; Ternovsky VI, 2004, FEBS LETT, V576, P433, DOI 10.1016/j.febslet.2004.09.051; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VODYANOY I, 1992, BIOPHYS J, V62, P10, DOI 10.1016/S0006-3495(92)81762-9; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wohnsland F, 1997, J MEMBRANE BIOL, V158, P77, DOI 10.1007/s002329900245; Yang XL, 2011, J PROTEOME RES, V10, P4556, DOI 10.1021/pr200395b	51	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78272	10.1371/journal.pone.0078272	http://dx.doi.org/10.1371/journal.pone.0078272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223145	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200037
J	Gaudio, E; Paduano, F; Spizzo, R; Ngankeu, A; Zanesi, N; Gaspari, M; Ortuso, F; Lovat, F; Rock, J; Hill, GA; Kaou, M; Cuda, G; Aqeilan, RI; Alcaro, S; Croce, CM; Trapasso, F				Gaudio, Eugenio; Paduano, Francesco; Spizzo, Riccardo; Ngankeu, Apollinaire; Zanesi, Nicola; Gaspari, Marco; Ortuso, Francesco; Lovat, Francesca; Rock, Jonathan; Hill, Grace A.; Kaou, Mohamed; Cuda, Giovanni; Aqeilan, Rami I.; Alcaro, Stefano; Croce, Carlo M.; Trapasso, Francesco			Fhit Delocalizes Annexin A4 from Plasma Membrane to Cytosol and Sensitizes Lung Cancer Cells to Paclitaxel	PLOS ONE			English	Article							DEFICIENT MICE; TUMOR-DEVELOPMENT; INDUCED APOPTOSIS; GENE; EXPRESSION; RESISTANCE; LINES; ANNEXINOPATHIES; TUMORIGENICITY; MALIGNANCIES	Fhit protein is lost or reduced in a large fraction of human tumors, and its restoration triggers apoptosis and suppresses tumor formation or progression in preclinical models. Here, we describe the identification of candidate Fhit-interacting proteins with cytosolic and plasma membrane localization. Among these, Annexin 4 (ANXA4) was validated by co-immunoprecipitation and confocal microscopy as a partner of this novel Fhit protein complex. Here we report that overexpression of Fhit prevents Annexin A4 translocation from cytosol to plasma membrane in A549 lung cancer cells treated with paclitaxel. Moreover, paclitaxel administration in combination with AdFHIT acts synergistically to increase the apoptotic rate of tumor cells both in vitro and in vivo experiments.	[Gaudio, Eugenio; Ngankeu, Apollinaire; Zanesi, Nicola; Lovat, Francesca; Hill, Grace A.; Kaou, Mohamed; Aqeilan, Rami I.; Croce, Carlo M.] Ohio State Univ, Dept Mol Immunol Virol & Med Genet, Columbus, OH 43210 USA; [Gaudio, Eugenio] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland; [Gaudio, Eugenio; Paduano, Francesco; Gaspari, Marco; Cuda, Giovanni; Trapasso, Francesco] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy; [Spizzo, Riccardo] CRO, Div Expt Oncol 2, Aviano, Italy; [Ortuso, Francesco; Alcaro, Stefano] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Catanzaro, Italy; [Rock, Jonathan] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Aqeilan, Rami I.] Hebrew Univ Jerusalem, Inst Med Res, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel	University System of Ohio; Ohio State University; Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Magna Graecia University of Catanzaro; IRCCS Aviano (CRO); Magna Graecia University of Catanzaro; University System of Ohio; Ohio State University; Hebrew University of Jerusalem	Croce, CM (corresponding author), Ohio State Univ, Dept Mol Immunol Virol & Med Genet, Columbus, OH 43210 USA.	carlo.croce@osumc.edu; trapasso@unicz.it	Cuda, Giovanni/F-5359-2012; Cuda, Giovanni/AAC-2821-2019; Aqeilan, Rami/R-4443-2016; Gaspari, Marco/C-2756-2009; Gaspari, Marco/ABE-1539-2020; Aqeilan, Rami/AAT-7785-2020; Gaspari, Marco/HGB-2399-2022; Paduano, Francesco/A-2548-2015; Young, Richard A/F-6495-2012; Spizzo, Riccardo/V-1057-2019	Cuda, Giovanni/0000-0001-6313-1866; Cuda, Giovanni/0000-0001-6313-1866; Aqeilan, Rami/0000-0002-6034-023X; Gaspari, Marco/0000-0002-5411-8800; Gaspari, Marco/0000-0002-5411-8800; Paduano, Francesco/0000-0003-0916-8101; Young, Richard A/0000-0001-8855-8647; Spizzo, Riccardo/0000-0001-7772-0960; ALCARO, Stefano/0000-0002-0437-358X; ORTUSO, Francesco/0000-0001-6235-8161	AIRC (Associazione Italiana Ricerca Cancro); National Institutes of Health (NIH) [CA152758]; NATIONAL CANCER INSTITUTE [U01CA152758, U01CA166905] Funding Source: NIH RePORTER	AIRC (Associazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by AIRC (Associazione Italiana Ricerca Cancro) and National Institutes of Health (NIH) grant CA152758 (C. M. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani F, 2006, NEOPLASIA, V8, P9; Baffa R, 1998, CANCER RES, V58, P4708; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Bianchi F, 2007, CELL CYCLE, V6, P643, DOI 10.4161/cc.6.6.4033; Bianchi F, 2006, P NATL ACAD SCI USA, V103, P18981, DOI 10.1073/pnas.0605821103; Cortinovis DL, 2008, CURR CANCER DRUG TAR, V8, P342, DOI 10.2174/156800908785133204; D'Agostini F, 2006, CANCER RES, V66, P3936, DOI 10.1158/0008-5472.CAN-05-3666; Ding S, 2001, BRIT J CANCER, V85, P1175, DOI 10.1054/bjoc.2001.2044; Draganescu A, 2000, J BIOL CHEM, V275, P4555, DOI 10.1074/jbc.275.7.4555; Dumon KR, 2001, P NATL ACAD SCI USA, V98, P3346, DOI 10.1073/pnas.061020098; Dumon KR, 2001, CANCER RES, V61, P4827; Fong LYY, 2000, P NATL ACAD SCI USA, V97, P4742, DOI 10.1073/pnas.080063497; Gaudio E, 2013, BLOOD, V121, P351, DOI 10.1182/blood-2012-09-457374; Gaudio E, 2012, BLOOD, V119, P180, DOI 10.1182/blood-2011-08-374561; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Han EKH, 2000, BRIT J CANCER, V83, P83; Hayes M. J., 2007, V45, P1; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Hendricks DT, 1997, CANCER RES, V57, P2112; Huebner K, 2011, ADV ENZYME REGUL, V51, P208, DOI 10.1016/j.advenzreg.2010.09.003; Ishii H, 2003, MOL CANCER RES, V1, P940; Ishii H, 2001, CANCER RES, V61, P1578; Ji L, 1999, CANCER RES, V59, P3333; Kim CH, 2006, INT J CANCER, V118, P1692, DOI 10.1002/ijc.21573; Matsuyama A, 2003, P NATL ACAD SCI USA, V100, P14988, DOI 10.1073/pnas.2336256100; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Pekarsky Y, 2004, P NATL ACAD SCI USA, V101, P3775, DOI 10.1073/pnas.0400481101; Pichiorri F, 2006, CLIN CANCER RES, V12, P3494, DOI 10.1158/1078-0432.CCR-05-2581; Rand JH, 2000, BBA-MOL CELL RES, V1498, P169, DOI 10.1016/S0167-4889(00)00093-8; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rimessi A, 2009, P NATL ACAD SCI USA, V106, P12753, DOI 10.1073/pnas.0906484106; Semba S, 2006, ONCOGENE, V25, P2860, DOI 10.1038/sj.onc.1209323; Sevignani C, 2003, CANCER RES, V63, P1183; Song J, 2007, CLIN CANCER RES, V13, P6842, DOI 10.1158/1078-0432.CCR-07-0569; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Trapasso F, 2003, P NATL ACAD SCI USA, V100, P1592, DOI 10.1073/pnas.0437915100; Trapasso F, 2008, J BIOL CHEM, V283, P13736, DOI 10.1074/jbc.M709062200; Virgilio L, 1996, P NATL ACAD SCI USA, V93, P9770, DOI 10.1073/pnas.93.18.9770; Wang Y, 2004, BIOCHEM BIOPH RES CO, V314, P565, DOI 10.1016/j.bbrc.2003.12.117; Zanesi N, 2005, CANCER RES, V65, P6576, DOI 10.1158/0008-5472.CAN-05-1128; Zanesi N, 2001, P NATL ACAD SCI USA, V98, P10250, DOI 10.1073/pnas.191345898	42	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78610	10.1371/journal.pone.0078610	http://dx.doi.org/10.1371/journal.pone.0078610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223161	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200053
J	Iakoubov, L; Mossakowska, M; Szwed, M; Duan, ZB; Sesti, F; Puzianowska-Kuznicka, M				Iakoubov, Leonid; Mossakowska, Malgorzata; Szwed, Malgorzata; Duan, Zhibing; Sesti, Federico; Puzianowska-Kuznicka, Monika			A Common Copy Number Variation (CNV) Polymorphism in the CNTNAP4 Gene: Association with Aging in Females	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LONGEVITY; MORTALITY; DISEASE; HAPLOTYPES; SURVIVAL; FOXO1A; RISK	Background: Aging is a biological process strongly determined by genetics. However, only a few single nucleotide polymorphisms (SNPs) have been reported to be consistently associated with aging. While investigating whether copy number variations (CNVs) could fill this gap, we focused on CNVs that have not been studied in previous SNP-based searches via tagging SNPs. Methods: TaqMan qPCR assays were developed to quantify 20 common CNVs in 222 senior American Caucasians in order to reveal possible association with longevity. The replication study was comprised of 1283 community-dwelling senior European Caucasians. Replicated CNVs were further investigated for association with healthy aging and aging-related diseases, while association with longevity was additionally tested in Caenorhabditis elegans. Results: In the discovery study of >= 80 vs. <80 years old seniors, a homozygous intronic CNV deletion in the CNTNAP4 gene was inversely associated with survival to the age of 80 (OR=0.51, 95% CI 0.29-0.87, p=0.015 before correction for multiple testing). After stratification by sex, association remained significant in females (OR=0.41, 95% CI 0.21-0.77, p=0.007), but not in males (OR=0.97, 95% CI 0.33-2.79, p=1). The finding was validated in a replication study (OR=0.66, 95% CI 0.48-0.90, p=0.011 for females). CNTNAP4 association with longevity was supported by a marked 25% lifespan change in C. elegans after knocking down the ortholog gene. An inverse association of the CNV del/del variant with female healthy aging was observed (OR=0.39, 95% CI 0.19-0.76, p=0.006). A corresponding positive association with aging-related diseases was revealed for cognitive impairment (OR=2.17, 95% CI 1.11-4.22, p=0.024) and, in independent studies, for Alzheimer's (OR=4.07, 95% CI 1.17-14.14, p=0.036) and Parkinson's (OR=1.59, 95% CI 1.03-2.42, p=0.041) diseases. Conclusion: This is the first demonstration for association of the CNTNAP4 gene and one of its intronic CNV polymorphisms with aging. Association with particular aging-related diseases awaits replication and independent validation.	[Iakoubov, Leonid] GeneCona LLC, Vallejo, CA USA; [Mossakowska, Malgorzata] Int Inst Mol & Cell Biol, PolSenior Project, Warsaw, Poland; [Szwed, Malgorzata; Puzianowska-Kuznicka, Monika] Mossakowski Med Res Ctr, Dept Human Epigenet, Warsaw, Poland; [Duan, Zhibing; Sesti, Federico] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA; [Puzianowska-Kuznicka, Monika] Med Ctr Postgrad Educ, Dept Geriatr & Gerontol, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centre of Postgraduate Medical Education - Poland	Iakoubov, L (corresponding author), GeneCona LLC, Vallejo, CA USA.	iakoubov@comcast.net; mpuzianowska@wum.edu.pl	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020	Duan, Zhibing/0000-0002-6241-7296; Iakoubov, Leonid/0000-0001-9666-2110; Puzianowska-Kuznicka, Monika/0000-0001-5295-3848	Polish Ministry of Science and Higher Education [PBZ-MEiN-9/2/2006 - K143/P01/2007/1]; NSF [1026958]; NATIONAL INSTITUTE ON AGING [U24AG021886] Funding Source: NIH RePORTER	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	M.P-K., M. M., and M. S. were supported by the Polish Ministry of Science and Higher Education grant PBZ-MEiN-9/2/2006 - K143/P01/2007/1 ("PolSenior"). F. S. and Z.D. were supported by NSF award number 1026958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bledowski P, 2011, EXP GERONTOL, V46, P1003, DOI 10.1016/j.exger.2011.09.006; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dastani Z, 2010, EUR J HUM GENET, V18, P342, DOI 10.1038/ejhg.2009.157; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; EICHNER JE, 1993, AM J CARDIOL, V71, P160, DOI 10.1016/0002-9149(93)90732-R; Gamazon ER, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001292; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hart AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042646; He KW, 2009, NEUROSCI BULL, V25, P335, DOI 10.1007/s12264-009-6123-2; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Ji WD, 2013, PSYCHIAT RES, V207, P225, DOI 10.1016/j.psychres.2012.09.024; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kryspin-Exner I, 2011, GERONTOLOGY, V57, P539, DOI 10.1159/000323154; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; Kuningas M, 2011, HUM MOL GENET, V20, P4290, DOI 10.1093/hmg/ddr340; Laslett Peter, 1995, AGING DEMOGRAPHY SOC, P4; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Lord C, 2011, CELL, V147, P24, DOI 10.1016/j.cell.2011.09.017; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Perls T, 2002, J MOL NEUROSCI, V19, P233, DOI 10.1007/s12031-002-0039-x; Pilling LC, 2012, J GERONTOL A-BIOL, V67, P511, DOI 10.1093/gerona/gls091; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ronchi CL, 2012, NEOPLASIA, V14, P206, DOI 10.1593/neo.111758; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Shi H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.014; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Ulmer M, 2012, INVEST OPHTH VIS SCI, V53, P4468, DOI 10.1167/iovs.12-9784; van Abel D, 2012, J ALZHEIMERS DIS, V31, P793, DOI 10.3233/JAD-2012-120472; Zeng Y, 2010, J GERONTOL A-BIOL, V65, P1285, DOI 10.1093/gerona/glq156	44	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79790	10.1371/journal.pone.0079790	http://dx.doi.org/10.1371/journal.pone.0079790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223195	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200088
J	Mi, D; Huang, YT; Kleinjan, DA; Mason, JO; Price, DJ				Mi, Da; Huang, Yu-Ting; Kleinjan, Dirk A.; Mason, John O.; Price, David J.			Identification of Genomic Regions Regulating Pax6 Expression in Embryonic Forebrain Using YAC Reporter Transgenic Mouse Lines	PLOS ONE			English	Article							CORTICAL PROGENITOR PROLIFERATION; PALLIAL-SUBPALLIAL BOUNDARY; RADIAL GLIA; DEVELOPING NEOCORTEX; NEURONAL DIVERSITY; NASAL DEVELOPMENT; CEREBRAL-CORTEX; LIMBIC SYSTEM; MUTANT MICE; CELL-CYCLE	The transcription factor Pax6 is a crucial regulator of eye and central nervous system development. Both the spatiotemporal patterns and the precise levels of Pax6 expression are subject to tight control, mediated by an extensive set of cis-regulatory elements. Previous studies have shown that a YAC reporter transgene containing 420Kb of genomic DNA spanning the human PAX6 locus drives expression of a tau-tagged GFP reporter in mice in a pattern that closely resembles that of endogenous Pax6. Here we have closely compared the pattern of tau-GFP reporter expression at the cellular level in the forebrains and eyes of transgenic mice carrying either complete or truncated versions of the YAC reporter transgene with endogenous Pax6 expression and found several areas where expression of tau-GFP and Pax6 diverge. Some discrepancies are due to differences between the intracellular localization or perdurance of tau-GFP and Pax6 proteins, while others are likely to be a consequence of transcriptional differences. We show that cis-regulatory elements that lie outside the 420kb fragment of PAX6 are required for correct expression around the pallial-subpallial boundary, in the amygdala and the prethalamus. Further, we found that the YAC reporter transgene effectively labels cells that contribute to the lateral cortical stream, including cells that arise from the pallium and subpallium, and therefore represents a useful tool for studying lateral cortical stream migration.	[Mi, Da; Huang, Yu-Ting; Mason, John O.; Price, David J.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Kleinjan, Dirk A.] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Mi, D (corresponding author), Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	D.Mi@sms.ed.ac.uk; David.Price@ed.ac.uk	Mason, John O/A-1926-2010	Mason, John O/0000-0002-0489-2400; Mi, Da/0000-0002-7829-1923; Price, David/0000-0002-5318-307X	Wellcome Trust [08420]; Medical Research Council (MRC) [G0800429]; Medical Research Council [MR/J003662/1, G0800429] Funding Source: researchfish; MRC [G0800429, MR/J003662/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from: 1. Wellcome Trust (08420), http://www.wellcome.ac.uk/index.htm. 2. Medical Research Council (MRC) (G0800429), http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2008, DEV NEUROSCI-BASEL, V30, P144, DOI 10.1159/000109859; Baumer N, 2002, DEVELOPMENT, V129, P4535; Caric D, 1997, DEVELOPMENT, V124, P5087; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; Carney RSE, 2009, CEREB CORTEX, V19, P745, DOI 10.1093/cercor/bhn123; Cocas LA, 2011, J NEUROSCI, V31, P5313, DOI 10.1523/JNEUROSCI.3867-10.2011; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Dimanlig PV, 2001, DEVELOPMENT, V128, P4415; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FUKUSHIMA Y, 1993, HUM GENET, V91, P205; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Georgala PA, 2011, CEREB CORTEX, V21, P81, DOI 10.1093/cercor/bhq061; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Hevner RF, 2006, MOL NEUROBIOL, V33, P33, DOI 10.1385/MN:33:1:033; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirata T, 2009, NAT NEUROSCI, V12, P141, DOI 10.1038/nn.2241; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kim J, 2006, DEV BIOL, V292, P486, DOI 10.1016/j.ydbio.2005.12.041; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; Kleinjan DA, 2002, MAMM GENOME, V13, P102, DOI 10.1007/s00335-001-3058-y; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McBride DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028616; Mi D, 2013, NEURON, V78, P269, DOI 10.1016/j.neuron.2013.02.012; Miles C, 1998, P NATL ACAD SCI USA, V95, P13068, DOI 10.1073/pnas.95.22.13068; Morgan R, 2004, TRENDS GENET, V20, P283, DOI 10.1016/j.tig.2004.04.009; Plaza S, 1999, DEV GENES EVOL, V209, P165, DOI 10.1007/s004270050240; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Theil T, 2005, DEV BIOL, V286, P559, DOI 10.1016/j.ydbio.2005.08.033; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Tyas DA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-21; Waclaw RR, 2010, J NEUROSCI, V30, P6944, DOI 10.1523/JNEUROSCI.5772-09.2010; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1997, DEVELOPMENT, V124, P1573; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Xu PX, 1999, DEVELOPMENT, V126, P383	60	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80208	10.1371/journal.pone.0080208	http://dx.doi.org/10.1371/journal.pone.0080208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223221	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200114
J	Skardhamar, T; Skirbekk, V				Skardhamar, Torbjorn; Skirbekk, Vegard			Relative Mortality among Criminals in Norway and the Relation to Drug and Alcohol Related Offenses	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; PRISON; DEATH; RELEASE; DELINQUENCY; DISORDERS; OFFENDERS; COUNTRIES; INMATES; COHORT	Background: Registered offenders are known to have a higher mortality rate, but given the high proportion of offenders with drug-addiction, particularly among offenders with a custodial sentence, higher mortality is expected. While the level of overall mortality compared to the non-criminal population is of interest in itself, we also estimate the risk of death by criminal records related to substance abuse and other types of criminal acts, and separate between those who receive a prison sentence or not. Methods: Age-adjusted relative risks of death for 2000-2008 were studied in a population based dataset. Our dataset comprise the total Norwegian population of 2.9 million individuals aged 15-69 years old in 1999, of whom 10% had a criminal record in the 1992-1999 period. Results: Individuals with a criminal record have twice the relative risk (RR) of death of the control group (non-offenders). Males with a record of use/possession of drugs and a prison record have an 11.9 RR (females, 15.6); males with a drug record but no prison record have a 6.9 RR (females 10.5). Males imprisoned for driving under the influence of substances have a 4.4 RR (females 5.6); males with a record of driving under the influence but no prison sentence have a 3.2 RR (females 6.5). Other male offenders with a prison record have a 2.8 RR (females 3.7); other male offenders with no prison record have a 1.7 RR (females 2.3). Conclusion: Significantly higher mortality was found for people with a criminal record, also for those without any record of drug use. Mortality is much higher for those convicted of substance-related crimes: more so for drug-than for alcohol-related crimes and for women.	[Skardhamar, Torbjorn] Stat Norway, Oslo, Norway; [Skirbekk, Vegard] Int Inst Appl Syst Anal, Age & Cohort Change Program ACC, A-2361 Laxenburg, Austria	Statistics Norway; International Institute for Applied Systems Analysis (IIASA)	Skirbekk, V (corresponding author), Int Inst Appl Syst Anal, Age & Cohort Change Program ACC, A-2361 Laxenburg, Austria.	skirbekk@iiasa.ac.at			European Research Council [241003-COHORT]; Norwegian Research Council [202453/S20]	European Research Council(European Research Council (ERC)European Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by a Starting Grant of the European Research Council [241003-COHORT], and from the Norwegian Research Council, [202453/S20]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SA, 2000, ADDICT BEHAV, V25, P167, DOI 10.1016/S0306-4603(99)00053-2; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; Bjorkenstam E, 2011, INT J EPIDEMIOL, V40, P1585, DOI 10.1093/ije/dyr127; Christensen PB, 2006, INT J PRISON HEALTH, V2, P13, DOI 10.1080/17449200600743644; Christophersen AS, 1999, FORENSIC SCI INT, V106, P173, DOI 10.1016/S0379-0738(99)00194-2; Darke S., 2007, MORTALITY ILLICIT DR; Dye MH, 2010, J CRIM JUST, V38, P796, DOI 10.1016/j.jcrimjus.2010.05.007; ETSC, 2008, DRINK DRIV FACT SHEE; Farrell M, 2008, ADDICTION, V103, P251, DOI 10.1111/j.1360-0443.2007.02081.x; Galanter M, 1983, RECENT DEV ALCOHOLIS, V8; Giertsen H, 2012, NORD STUD ALCOHOL DR, V29, P589, DOI 10.2478/v10199-012-0049-0; Gjerde H, 2008, ACCIDENT ANAL PREV, V40, P1765, DOI 10.1016/j.aap.2008.06.015; Graham A, 2003, AUST NZ J CRIMINOL, V36, P94, DOI 10.1375/000486503764805365; Greenfield SF, 2009, PSYCHIAT SERV, V60, P880, DOI 10.1176/appi.ps.60.7.880; Haggard-Grann U, 2006, ADDICTION, V101, P100, DOI 10.1111/j.1360-0443.2005.01293.x; Hausken AM, 2005, DRUG ALCOHOL DEPEN, V79, P423, DOI 10.1016/j.drugalcdep.2005.03.014; Helsedirektoratet, 2013, HELS OMS FENGS; James D. J., 2006, HIGHLIGHTS MENTAL HL; Joukamaa M, 1998, FORENSIC SCI INT, V96, P11, DOI 10.1016/S0379-0738(98)00098-X; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kjelsberg E, 2010, EUR J EPIDEMIOL, V25, P237, DOI 10.1007/s10654-010-9436-6; Lappi-Seppala T, 2011, CRIME JUSTICE, V40, P1, DOI 10.1086/660822; Laub JH, 2000, AM J PSYCHIAT, V157, P96, DOI 10.1176/ajp.157.1.96; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Little M, 2006, J RES CRIME DELINQ, V43, P357, DOI 10.1177/0022427806291260; Lyngstad TH, 2011, CRIME JUSTICE, V40, P613; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Nieuwbeerta P, 2008, J RES CRIME DELINQ, V45, P256, DOI 10.1177/0022427808317573; Nochajski TH, 2006, CLIN PSYCHOL REV, V26, P179, DOI 10.1016/j.cpr.2005.11.006; Norwegian Parhamentary, 2008, STRAFF SOM VIRK MIND; Nyhlen A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-122; Paula H, 2010, AM J GASTROENTEROL, V105, P1782, DOI 10.1038/ajg.2010.46; Room R, 2005, DRUG ALCOHOL REV, V24, P143, DOI 10.1080/09595230500102434; Room R, 2001, J SUBST USE, V4, P218, DOI DOI 10.1080/146598901753325048; Rosen DL, 2008, AM J PUBLIC HEALTH, V98, P2278, DOI 10.2105/AJPH.2007.121855; Sailas ES, 2006, EUR J PUBLIC HEALTH, V16, P193, DOI 10.1093/eurpub/cki169; Singleton N, 2003, DRUG RELATED MORTALI; Skarohamar T., 2003, J SCANDINAVIAN STUDI, V4, P39, DOI [DOI 10.1080/14043850310012314, 10.1080/14043850310012314]; Stattin H., 1995, CRIM BEHAV MENT HEAL, V5, P279, DOI [10.1002/cbm.1995.5.4.279, DOI 10.1002/CBM.1995.5.4.279]; Steinman KJ, 2005, J ADOLESCENT HEALTH, V36, DOI [10.1016/j.jadohealth.2003.12.012, DOI 10.1016/J.JAD0HEALTH.2003.12.012]; Stenbacka M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-38; Sun F., 2002, PROPORTIONS CRIMES A; Unlu A., 2012, INT J HUMAN SCI, V9, P161; Verger P, 2003, J FORENSIC SCI, V48, P614; Waal H, 2013, LAR SOM VIL BLI FREM; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	49	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78893	10.1371/journal.pone.0078893	http://dx.doi.org/10.1371/journal.pone.0078893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223171	Green Published, gold, Green Accepted			2022-12-27	WOS:000326656200063
J	Del Barrio, MG; Bourane, S; Grossmann, K; Schule, R; Britsch, S; O'Leary, DDM; Goulding, M				Del Barrio, Marta Garcia; Bourane, Steeve; Grossmann, Katja; Schuele, Roland; Britsch, Stefan; O'Leary, Dennis D. M.; Goulding, Martyn			A Transcription Factor Code Defines Nine Sensory Interneuron Subtypes in the Mechanosensory Area of the Spinal Cord	PLOS ONE			English	Article							DORSAL-HORN NEURONS; VESICULAR GLUTAMATE TRANSPORTERS; LAMINAE III-V; HOMEOBOX GENES; C-MAF; EXPRESSION; LBX1; DIFFERENTIATION; TRANSMITTER; POPULATIONS	Interneurons in the dorsal spinal cord process and relay innocuous and nociceptive somatosensory information from cutaneous receptors that sense touch, temperature and pain. These neurons display a well-defined organization with respect to their afferent innervation. Nociceptive afferents innervate lamina I and II, while cutaneous mechanosensory afferents primarily innervate sensory interneurons that are located in lamina III-IV. In this study, we outline a combinatorial transcription factor code that defines nine different inhibitory and excitatory interneuron populations in laminae III-IV of the postnatal cord. This transcription factor code reveals a high degree of molecular diversity in the neurons that make up laminae III-IV, and it lays the foundation for systematically analyzing and manipulating these different neuronal populations to assess their function. In addition, we find that many of the transcription factors that are expressed in the dorsal spinal cord at early postnatal times continue to be expressed in the adult, raising questions about their function in mature neurons and opening the door to their genetic manipulation in adult animals.	[Del Barrio, Marta Garcia; Bourane, Steeve; Grossmann, Katja; O'Leary, Dennis D. M.; Goulding, Martyn] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Schuele, Roland] Univ Freiburg Klinikum, Frauenklin, Urol Klin, Freiburg, Germany; [Schuele, Roland] Univ Freiburg Klinikum, Zent Klin Forsch, Freiburg, Germany; [Britsch, Stefan] Max Delbruck Ctr Mol Med, Dept Med Genet, Berlin, Germany; [Britsch, Stefan] Univ Ulm, Inst Mol & Cellular Anat, D-89069 Ulm, Germany	Salk Institute; University of Freiburg; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ulm University	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	goulding@salk.edu	Bourane, Steeve/AAI-6143-2020	Bourane, Steeve/0000-0002-9805-2196	NIH [NS031978, NS080586, NS31558, R01 MH086147]; Hoffman Foundation; Spanish Instituto de Salud Carlos III [Salk-08-02]; Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt) [Schu688/12-1, Schu 688/9-1, SFB 850]; Dr. Oetker-Stiftung by DFG [SFB 497-A9]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080586, R01NS031978, R01NS031558, R37NS031558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hoffman Foundation; Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt)(German Research Foundation (DFG)); Dr. Oetker-Stiftung by DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS031978 and NS080586 to MG, by the Hoffman Foundation and the Spanish Instituto de Salud Carlos III (Salk-08-02), by the Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt Schu688/12-1, Schu 688/9-1, SFB 850) and by the Dr. Oetker-Stiftung to RS by a grant from the DFG (SFB 497-A9) to SB and by NIH NS31558 and R01 MH086147 grants to DDMO'L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khater KM, 2008, J COMP NEUROL, V511, P1, DOI 10.1002/cne.21811; Altman J, 2001, DEV HUMAN SPINAL COR; Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; ANTAL M, 1991, J COMP NEUROL, V314, P114, DOI 10.1002/cne.903140111; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Brown AG, 1981, ORG SPINAL CORD; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Ding YQ, 2004, DEVELOPMENT, V131, P3693, DOI 10.1242/dev.01250; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Grossmann KS, 2010, PROG BRAIN RES, V187, P19, DOI [10.1016/S0079-6123(10)87002-5, 10.1016/B978-0-444-53613-6.00002-2]; Han SI, 2011, J BIOL CHEM, V286, P10449, DOI 10.1074/jbc.M110.209510; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hochman S, 1997, BRAIN RES, V767, P214, DOI 10.1016/S0006-8993(97)00578-7; Hu J, 2012, J NEUROSCI, V32, P5362, DOI 10.1523/JNEUROSCI.6239-11.2012; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; JIANG MC, 1995, J NEUROPHYSIOL, V74, P1819, DOI 10.1152/jn.1995.74.5.1819; John A, 2005, DEV DYNAM, V234, P767, DOI 10.1002/dvdy.20568; Kanai K, 2010, GENES CELLS, V15, P971, DOI 10.1111/j.1365-2443.2010.01431.x; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Lecoin L, 2010, DEV NEUROBIOL, V70, P485, DOI 10.1002/dneu.20790; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Li Y, 2012, FRONT BIOSCI-LANDMRK, V17, P2391, DOI 10.2741/4060; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Pillai A, 2007, DEVELOPMENT, V134, P357, DOI 10.1242/dev.02717; Qian Y, 2002, GENE DEV, V16, P1220, DOI 10.1101/gad.982802; Ramon y Cajal S., 1909, HISTOLOGY NERVOUS SY; Rhinn M, 2004, DEV DYNAM, V229, P334, DOI 10.1002/dvdy.10435; Sakai M, 1997, ONCOGENE, V14, P745, DOI 10.1038/sj.onc.1200869; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; SCHNEIDER SP, 1992, J NEUROPHYSIOL, V68, P1746, DOI 10.1152/jn.1992.68.5.1746; Schneider SP, 2005, BRAIN RES, V1034, P71, DOI 10.1016/j.brainres.2004.11.046; Schneider SP, 2003, J NEUROPHYSIOL, V90, P245, DOI 10.1152/jn.01012.2002; Schouenborg J, 2008, BRAIN RES REV, V57, P111, DOI 10.1016/j.brainresrev.2007.08.007; Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Waters ST, 2003, GENE EXPR PATTERNS, V3, P313, DOI 10.1016/S1567-133X(03)00041-3; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Willis W.D., 2004, SENSORY MECH SPINAL, V207, P1067, DOI [10.1126/science.207.4435.1067.b, DOI 10.1126/SCIENCE.207.4435.1067.B]; Xiang CX, 2010, MOL CELL NEUROSCI, V44, P394, DOI 10.1016/j.mcn.2010.05.005; Xu Y, 2008, J NEUROSCI, V28, P4037, DOI 10.1523/JNEUROSCI.4126-07.2008; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	66	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77928	10.1371/journal.pone.0077928	http://dx.doi.org/10.1371/journal.pone.0077928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223744	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000326503400023
J	Ghulam, MM; Courtois, F; Lerbs-Mache, S; Merendino, L				Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia			Complex Processing Patterns of mRNAs of the Large ATP Synthase Operon in Arabidopsis Chloroplasts	PLOS ONE			English	Article							BINDING; TERMINI; NUCLEUS; GENES	Chloroplasts are photosynthetic cell organelles which have evolved from endosymbiosis of the cyanobacterial ancestor. In chloroplasts, genes are still organized into transcriptional units as in bacteria but the corresponding poly-cistronic mRNAs undergo complex processing events, including inter- genic cleavage and 5' and 3' end-definition. The current model for processing proposes that the 3' end of the upstream cistron transcripts and the 5' end of the downstream cistron transcripts are defined by the same RNA-binding protein and overlap at the level of the protein-binding site. We have investigated the processing mechanisms that operate within the large ATP synthase (atp) operon, in Arabidopsis thaliana chloroplasts. This operon is transcribed by the plastid-encoded RNA polymerase starting from two promoters, which are upstream and within the operon, respectively, and harbors four potential sites for RNA-binding proteins. In order to study the functional significance of the promoters and the protein-binding sites for the maturation processes, we have performed a detailed mapping of the atp transcript ends. Our data indicate that in contrast to maize, atpI and atpH transcripts with overlapping ends are very rare in Arabidopsis. In addition, atpA mRNAs, which overlap with atpF mRNAs, are even truncated at the 3' end, thus representing degradation products. We observe, instead, that the 5' ends of nascent poly-cistronic atp transcripts are defined at the first protein-binding site which follows either one of the two transcription initiation sites, while the 3' ends are defined at the subsequent protein-binding sites or at hairpin structures that are encountered by the progressing RNA polymerase. We conclude that the overlapping mechanisms of mRNA protection have only a limited role in obtaining stable processed atp mRNAs in Arabidopsis. Our findings suggest that during evolution of different plant species as maize and Arabidopsis, chloroplasts have evolved multiple strategies to produce mature transcripts suitable for translation.	[Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia] CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, Grenoble, France; [Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia] Univ Grenoble Alpes, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia] CEA, DSV, iRTSV, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia] INRA, Lab Physiol Cellulaire & Vegetale, USC1359, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Merendino, L (corresponding author), CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, Grenoble, France.	livia.merendino@cea.fr		Courtois, Florence/0000-0003-0357-9401	Centre National de la Recherche Scientifique; French Ministry of Education	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Education	The Centre National de la Recherche Scientifique and the French Ministry of Education have funded the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkan A, 2011, PLANT PHYSIOL, V155, P1520, DOI 10.1104/pp.110.171231; Demarsy E, 2012, J EXP BOT, V63, P925, DOI 10.1093/jxb/err322; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Ghulam MM, 2012, PLANT MOL BIOL, V79, P259, DOI 10.1007/s11103-012-9910-5; Hocine S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000752; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Perrin R, 2004, J BIOL CHEM, V279, P25440, DOI 10.1074/jbc.M401182200; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Ruwe H, 2012, NUCLEIC ACIDS RES, V40, P3106, DOI 10.1093/nar/gkr1138; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; Zghidi W, 2007, NUCLEIC ACIDS RES, V35, P455, DOI 10.1093/nar/gkl1067; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	13	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78265	10.1371/journal.pone.0078265	http://dx.doi.org/10.1371/journal.pone.0078265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223785	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400047
J	Llorente-Berzal, A; Puighermanal, E; Burokas, A; Ozaita, A; Maldonado, R; Marco, EM; Viveros, MP				Llorente-Berzal, Alvaro; Puighermanal, Emma; Burokas, Aurelijus; Ozaita, Andres; Maldonado, Rafael; Marco, Eva M.; Viveros, Maria-Paz			Sex-Dependent Psychoneuroendocrine Effects of THC and MDMA in an Animal Model of Adolescent Drug Consumption	PLOS ONE			English	Article							LONG-LASTING CONSEQUENCES; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; MATERNAL-DEPRIVATION; CHRONIC DELTA(9)-TETRAHYDROCANNABINOL; DIFFERENTIALLY AFFECTS; UNPREDICTABLE STRESS; INDUCED HYPERTHERMIA; PREPULSE INHIBITION; SYNAPTIC PLASTICITY; RECOGNITION MEMORY	Ecstasy is a drug that is usually consumed by young people at the weekends and frequently, in combination with cannabis. In the present study we have investigated the long-term effects of administering increasing doses of delta-9-tetrahydrocannabinol [THC; 2.5, 5, 10 mg/kg; i.p.] from postnatal day (pnd) 28 to 45, alone and/or in conjunction with 3,4-methylenedioxymethamphetamine [MDMA; two daily doses of 10 mg/kg every 5 days; s.c.] from pnd 30 to 45, in both male and female Wistar rats. When tested one day after the end of the pharmacological treatment (pnd 46), MDMA administration induced a reduction in directed exploration in the holeboard test and an increase in open-arm exploration in an elevated plus maze. In the long-term, cognitive functions in the novel object test were seen to be disrupted by THC administration to female but not male rats. In the prepulse inhibition test, MDMA-treated animals showed a decrease in prepulse inhibition at the most intense prepulse studied (80 dB), whereas in combination with THC it induced a similar decrease at 75 dB. THC decreased hippocampal Arc expression in both sexes, while in the frontal cortex this reduction was only evident in females. MDMA induced a reduction in ERK1/2 immunoreactivity in the frontal cortex of male but not female animals, and THC decreased prepro-orexin mRNA levels in the hypothalamus of males, although this effect was prevented when the animals also received MDMA. The results presented indicate that adolescent exposure to THC and/or MDMA induces long-term, sex-dependent psychophysiological alterations and they reveal functional interactions between the two drugs.	[Llorente-Berzal, Alvaro; Marco, Eva M.; Viveros, Maria-Paz] Univ Complutense Madrid, Fac Biol, Dept Fisiol Fisiol Anim 2, Madrid, Spain; [Llorente-Berzal, Alvaro; Marco, Eva M.; Viveros, Maria-Paz] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Puighermanal, Emma; Burokas, Aurelijus; Ozaita, Andres; Maldonado, Rafael] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Neurofarmacol, Barcelona, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; Pompeu Fabra University	Maldonado, R (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Neurofarmacol, Barcelona, Spain.	rafael.maldonado@upf.edu; pazviver@bio.ucm.es	Llorente-Berzal, Alvaro/C-8232-2018; Burokas, Aurelijus/ABC-9268-2021; Marco, Eva M./Q-3870-2019; Marco, Eva M./ABH-3257-2020; Llorente-Berzal, Alvaro/GLQ-8115-2022; Maldonado, Rafael/F-5657-2014; Viveros, Maria-Paz/S-6855-2016; Puighermanal, Emma/J-4426-2019; Ozaita, Andres/H-3411-2015	Llorente-Berzal, Alvaro/0000-0002-9787-2619; Burokas, Aurelijus/0000-0002-0364-3496; Marco, Eva M./0000-0002-2457-475X; Llorente-Berzal, Alvaro/0000-0002-9787-2619; Maldonado, Rafael/0000-0002-4359-8773; Viveros, Maria-Paz/0000-0002-4119-4636; Puighermanal, Emma/0000-0003-4271-9104; Ozaita, Andres/0000-0002-2239-7403	Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en salud (ISCIII y FEDER): Red de trastornos adictivos [RD06/0001/1013, RD2012/0028/0021, RD06/001/001]; GRUPOS UCM-BSCH [GRUPO UCM 951579]; Plan Nacional sobre Drogas en la convocatoria de Orden [SAS/1250/2009]; Ministerio de Ciencia e Innovacion	Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en salud (ISCIII y FEDER): Red de trastornos adictivos; GRUPOS UCM-BSCH; Plan Nacional sobre Drogas en la convocatoria de Orden; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en salud (ISCIII y FEDER): Red de trastornos adictivos RD06/0001/1013, RD2012/0028/0021 and RD06/001/001; GRUPOS UCM-BSCH (GRUPO UCM 951579); Plan Nacional sobre Drogas en la convocatoria de Orden SAS/1250/2009. ALB has a FPU predoctoral grant from the Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat-Mendes C, 2003, NEUROPHARMACOLOGY, V45, P106, DOI 10.1016/S0028-3908(03)00135-7; Acuna-Goycolea C, 2010, J NEUROSCI, V30, P10061, DOI 10.1523/JNEUROSCI.5838-09.2010; Allott K, 2007, NEUROSCI BIOBEHAV R, V31, P327, DOI 10.1016/j.neubiorev.2006.09.009; Anderson BM, 2010, J PSYCHOACTIVE DRUGS, V42, P413; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Beveridge TJR, 2004, PSYCHOPHARMACOLOGY, V173, P346, DOI 10.1007/s00213-003-1753-y; Biscaia M, 2003, PSYCHOPHARMACOLOGY, V170, P301, DOI 10.1007/s00213-003-1550-7; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Bubenikova V, 2005, BEHAV PHARMACOL, V16, P127, DOI 10.1097/00008877-200503000-00009; Cai XJ, 1999, DIABETES, V48, P2132, DOI 10.2337/diabetes.48.11.2132; Carroll ME, 2004, TRENDS PHARMACOL SCI, V25, P273, DOI 10.1016/j.tips.2004.03.011; Cha YM, 2007, BEHAV PHARMACOL, V18, P563, DOI 10.1097/FBP.0b013e3282ee7b7e; Craft RM, 2013, LIFE SCI, V92, P476, DOI 10.1016/j.lfs.2012.06.009; Cunningham JI, 2009, BEHAV NEUROSCI, V123, P1076, DOI 10.1037/a0016716; Davis JF, 2009, NEUROSCIENCE, V162, P23, DOI 10.1016/j.neuroscience.2009.04.039; DEFONSECA FR, 1993, NEUROREPORT, V4, P135, DOI 10.1097/00001756-199302000-00005; Di Benedetto M, 2011, N-S ARCH PHARMACOL, V383, P169, DOI 10.1007/s00210-010-0587-5; Dumont GJ, 2009, CLIN PHARMACOL THER, V86, P160, DOI 10.1038/clpt.2009.62; Einat H, 2003, J NEUROSCI, V23, P7311; EMCDDA, 2011, ANN REP 2011 STAT DR; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Gerra G, 2003, PSYCHIAT RES, V120, P115, DOI 10.1016/S0165-1781(03)00175-6; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gouzoulis-Mayfrank Euphrosyne, 2009, Dialogues Clin Neurosci, V11, P305; Graham DL, 2010, NEUROTOXICOL TERATOL, V32, P152, DOI 10.1016/j.ntt.2009.08.012; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hill MN, 2012, NEUROSCIENCE, V204, P5, DOI 10.1016/j.neuroscience.2011.12.030; Kobeissy FH, 2008, ADDICT BIOL, V13, P15, DOI 10.1111/j.1369-1600.2007.00083.x; Kolyaduke OV, 2012, PHARM BIOCH BEHAV, V103, P742; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lieb R, 2002, DRUG ALCOHOL DEPEN, V68, P195, DOI 10.1016/S0376-8716(02)00190-4; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Llorente R, 2007, PSYCHONEUROENDOCRINO, V32, P636, DOI 10.1016/j.psyneuen.2007.04.002; Llorente-Berzal A, 2011, ADDICT BIOL, V16, P624, DOI 10.1111/j.1369-1600.2011.00318.x; Lopez-Gallardo M, 2012, NEUROSCIENCE, V204, P90, DOI 10.1016/j.neuroscience.2011.09.063; Ludwig V, 2008, BEHAV BRAIN RES, V189, P52, DOI 10.1016/j.bbr.2007.12.008; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Malberg JE, 1998, J NEUROSCI, V18, P5086; Malone DT, 2010, BRIT J PHARMACOL, V160, P511, DOI 10.1111/j.1476-5381.2010.00721.x; Mateos B, 2011, J PSYCHOPHARMACOL, V25, P1676, DOI 10.1177/0269881110370503; Meyer JS, 2008, ANN NY ACAD SCI, V1139, P151, DOI 10.1196/annals.1432.029; Montgomery C, 2005, PSYCHOPHARMACOLOGY, V180, P141, DOI 10.1007/s00213-004-2131-0; Montoya AG, 2002, HARVARD REV PSYCHIAT, V10, P212, DOI 10.1093/hrp/10.4.212; Morgan MJ, 2000, PSYCHOPHARMACOLOGY, V152, P230, DOI 10.1007/s002130000545; Morley KC, 2004, NEUROPHARMACOLOGY, V46, P954, DOI 10.1016/j.neuropharm.2004.01.002; NASH JF, 1988, J PHARMACOL EXP THER, V245, P873; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Palenicek T, 2005, PHYSIOL BEHAV, V86, P546, DOI 10.1016/j.physbeh.2005.08.043; Parrott AC, 2007, J NEURAL TRANSM, V114, P959, DOI 10.1007/s00702-007-0715-7; Parrott AC, 2004, NEUROPSYCHOBIOLOGY, V50, P329, DOI 10.1159/000080961; Parrott AC, 1998, J PSYCHOPHARMACOL, V12, P79, DOI 10.1177/026988119801200110; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Piper BJ, 2007, NEUROTOXICOL TERATOL, V29, P288, DOI 10.1016/j.ntt.2006.10.002; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Quednow BB, 2007, PSYCHOPHARMACOLOGY, V189, P517, DOI 10.1007/s00213-005-0256-4; Quednow BB, 2006, J PSYCHOPHARMACOL, V20, P373, DOI 10.1177/0269881106061200; Rao Y, 2013, J PHYSIOL-LONDON, V591, P1951, DOI 10.1113/jphysiol.2012.246983; Robledo P, 2007, PSYCHOPHARMACOLOGY, V195, P255, DOI 10.1007/s00213-007-0879-8; Robledo P, 2010, CURR DRUG TARGETS, V11, P429, DOI 10.2174/138945010790980330; Rodsiri R, 2011, PSYCHOPHARMACOLOGY, V213, P365, DOI 10.1007/s00213-010-1921-9; Rubino T, 2008, MOL CELL ENDOCRINOL, V286, pS108, DOI 10.1016/j.mce.2008.02.003; Rubino T, 2004, MOL CELL NEUROSCI, V25, P355, DOI 10.1016/j.mcn.2003.11.003; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; Rubino T, 2009, HIPPOCAMPUS, V19, P763, DOI 10.1002/hipo.20554; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; Schneider M, 2008, ADDICT BIOL, V13, P345, DOI 10.1111/j.1369-1600.2008.00117.x; Schulz Sybille, 2011, Curr Drug Abuse Rev, V4, P81; Senn Ch, 2007, Ther Umsch, V64, P109, DOI 10.1024/0040-5930.64.2.109; Shen EY, 2011, NEUROPHARMACOLOGY, V61, P1183, DOI 10.1016/j.neuropharm.2011.07.002; Sher KJ, 2000, J CONSULT CLIN PSYCH, V68, P818, DOI 10.1037/0022-006X.68.5.818; Shortall SE, 2012, EUR NEUROPS IN PRESS; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Skelton MR, 2008, BEHAV PHARMACOL, V19, P91, DOI 10.1097/FBP.0b013e3282f62c76; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Taffe MA, 2012, NEUROSCIENCE, V201, P125, DOI 10.1016/j.neuroscience.2011.11.040; Viveros MP, 2012, J PSYCHOPHARMACOL, V26, P164, DOI 10.1177/0269881111408956; Viveros M P, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS217, DOI 10.1016/j.psyneuen.2009.05.015; Viveros MP, 2006, NEUROSCI BIOBEHAV R, V30, P1161, DOI 10.1016/j.neubiorev.2006.08.002; Viveros MP, 2011, NEUROSCI BIOBEHAV R, V35, P1740, DOI 10.1016/j.neubiorev.2010.09.005; Vollenweider FX, 1999, PSYCHOPHARMACOLOGY, V143, P365, DOI 10.1007/s002130050960; Walker QD, 2007, PSYCHOPHARMACOLOGY, V189, P435, DOI 10.1007/s00213-006-0531-z; Wegener N, 2009, BRAIN RES, V1253, P81, DOI 10.1016/j.brainres.2008.11.081; Wish ED, 2006, J AM COLL HEALTH, V55, P99, DOI 10.3200/JACH.55.2.99-104; Wittmann G, 2007, J COMP NEUROL, V503, P270, DOI 10.1002/cne.21383; Young JM, 2005, NEUROPSYCHOPHARMACOL, V30, P1475, DOI 10.1038/sj.npp.1300692	87	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78386	10.1371/journal.pone.0078386	http://dx.doi.org/10.1371/journal.pone.0078386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223797	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400057
J	Nicoli, F; Finessi, V; Sicurella, M; Rizzotto, L; Gallerani, E; Destro, F; Cafaro, A; Marconi, P; Caputo, A; Ensoli, B; Gavioli, R				Nicoli, Francesco; Finessi, Valentina; Sicurella, Mariaconcetta; Rizzotto, Lara; Gallerani, Eleonora; Destro, Federica; Cafaro, Aurelio; Marconi, Peggy; Caputo, Antonella; Ensoli, Barbara; Gavioli, Riccardo			The HIV-1 Tat Protein Induces the Activation of CD8(+) T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EPSTEIN-BARR-VIRUS; NF-KAPPA-B; DENDRITIC CELLS; TRANSACTIVATOR GENE; IMMUNE-RESPONSES; MEMORY; EXPRESSION; RECOMBINANT; APOPTOSIS	T cells are functionally compromised during HIV infection despite their increased activation and proliferation. Although T cell hyperactivation is one of the best predictive markers for disease progression, its causes are poorly understood. Anti-tat natural immunity as well as anti-tat antibodies induced by Tat immunization protect from progression to AIDS and reverse signs of immune activation in HIV-infected patients suggesting a role of Tat in T cell dysfunctionality. The Tat protein of HIV-1 is known to induce, in vitro, the activation of CD4(+) T lymphocytes, but its role on CD8(+) T cells and how these effects modulate, in vivo, the immune response to pathogens are not known. To characterize the role of Tat in T cell hyperactivation and dysfunction, we examined the effect of Tat on CD8(+) T cell responses and antiviral immunity in different ex vivo and in vivo models of antigenic stimulation, including HSV infection. We demonstrate for the first time that the presence of Tat during priming of CD8(+) T cells favors the activation of antigen-specific CTLs. Effector CD8(+) T cells generated in the presence of Tat undergo an enhanced and prolonged expansion that turns to a partial dysfunctionality at the peak of the response, and worsens HSV acute infection. Moreover, Tat favors the development of effector memory CD8(+) T cells and a transient loss of B cells, two hallmarks of the chronic immune activation observed in HIV-infected patients. Our data provide evidence that Tat affects CD8(+) T cell responses to co-pathogens and suggest that Tat may contribute to the CD8(+) T cell hyperactivation observed in HIV-infected individuals.	[Nicoli, Francesco; Finessi, Valentina; Sicurella, Mariaconcetta; Gallerani, Eleonora; Destro, Federica; Marconi, Peggy; Gavioli, Riccardo] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Sicurella, Mariaconcetta; Destro, Federica; Caputo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy; [Rizzotto, Lara] Azienda Osped Univ St Anna, Dept Biomed Sci, Ferrara, Italy; [Cafaro, Aurelio; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy	University of Ferrara; University of Padua; University of Ferrara; Arcispedale Sant'Anna; Istituto Superiore di Sanita (ISS)	Gavioli, R (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy.	r.gavioli@unife.it	Destro, Federica/K-5904-2016; Cafaro, Aurelio/K-5314-2016; Ensoli, Barbara/J-9169-2016; Sicurella, Mariaconcetta/AAA-7030-2019; Caputo, Antonella/ABE-7851-2020; , Francesco/I-8040-2019; Gavioli, Riccardo/K-7594-2016; Marconi, Peggy/K-7733-2016	Destro, Federica/0000-0002-3014-0165; Ensoli, Barbara/0000-0002-0545-8737; Sicurella, Mariaconcetta/0000-0003-3996-3667; Caputo, Antonella/0000-0002-1241-0299; , Francesco/0000-0001-6327-5958; Gavioli, Riccardo/0000-0002-7805-4290; Cafaro, Aurelio/0000-0001-9675-6344; Rizzotto, Lara/0000-0002-2658-9103; Marconi, Peggy C. R./0000-0003-3488-0491	University of Ferrara; University of Padova; Italian National AIDS Program; Gilead Fellowship Program	University of Ferrara; University of Padova; Italian National AIDS Program; Gilead Fellowship Program(Gilead Sciences)	This work was supported by grants from the University of Ferrara and the University of Padova and the Italian National AIDS Program, and by the Gilead Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; [Anonymous], 2014, WORLD AIDS DAY 2014; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; Bachler BC, 2013, J VIROL, V87, P4403, DOI 10.1128/JVI.02888-12; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Bellino S, 2009, REV RECENT CLIN TRIA, V4, P195, DOI 10.2174/157488709789957529; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bullock TNJ, 2000, J IMMUNOL, V164, P2354, DOI 10.4049/jimmunol.164.5.2354; BUONAGURO L, 1994, J VIROL, V68, P2677, DOI 10.1128/JVI.68.4.2677-2682.1994; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Caputo A, 2009, INT REV IMMUNOL, V28, P285, DOI 10.1080/08830180903013026; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Cellini S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-81; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chen G, 2001, BLOOD, V98, P156, DOI 10.1182/blood.V98.1.156; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Colombrino E, 2004, EXP CELL RES, V295, P539, DOI 10.1016/j.yexcr.2004.01.018; Dabrowska A, 2008, J IMMUNOL, V181, P8460, DOI 10.4049/jimmunol.181.12.8460; Decman V, 2005, VIRAL IMMUNOL, V18, P466, DOI 10.1089/vim.2005.18.466; Demarchi F, 1999, J VIROL, V73, P7080, DOI 10.1128/JVI.73.8.7080-7086.1999; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Fanales-Belasio E, 2009, J IMMUNOL, V182, P2888, DOI 10.4049/jimmunol.0711406; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Fortin JF, 2004, J BIOL CHEM, V279, P39520, DOI 10.1074/jbc.M407477200; Fraefel C, 2011, METHODS MOL BIOL, V737, P303, DOI 10.1007/978-1-61779-095-9_13; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Goepfert PA, 2000, J VIROL, V74, P10249, DOI 10.1128/JVI.74.21.10249-10255.2000; Haas A, 2011, J VIROL, V85, P12102, DOI 10.1128/JVI.05607-11; Hayes PJ, 1999, CLIN EXP IMMUNOL, V117, P331; Huang LL, 1997, BIOCHEM BIOPH RES CO, V237, P461, DOI 10.1006/bbrc.1997.7162; Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; Kostense S, 2001, EUR J IMMUNOL, V31, P677, DOI 10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M; Krebs P, 2005, J IMMUNOL, V174, P4559, DOI 10.4049/jimmunol.174.8.4559; Krisky DM, 1998, GENE THER, V5, P1517, DOI 10.1038/sj.gt.3300755; Krisky DM, 1997, GENE THER, V4, P1120, DOI 10.1038/sj.gt.3300497; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Ladell K, 2008, J IMMUNOL, V180, P7907, DOI 10.4049/jimmunol.180.12.7907; Lefevre EA, 1999, J IMMUNOL, V163, P1119; Leifert JA, 2003, GENE THER, V10, P2067, DOI 10.1038/sj.gt.3302115; Li CJ, 1997, P NATL ACAD SCI USA, V94, P8116, DOI 10.1073/pnas.94.15.8116; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Minami R, 2006, CELL IMMUNOL, V243, P41, DOI 10.1016/j.cellimm.2006.11.003; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Mohr E, 2010, P NATL ACAD SCI USA, V107, P17292, DOI 10.1073/pnas.1004879107; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Peruzzi F, 2006, FRONT BIOSCI-LANDMRK, V11, P708, DOI 10.2741/1829; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Richardson MW, 2003, BIOMED PHARMACOTHER, V57, P4, DOI 10.1016/S0753-3322(02)00327-X; Secchiero P, 2000, P NATL ACAD SCI USA, V97, P14620, DOI 10.1073/pnas.011512398; Sgadari C, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/452729; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Slyker JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020375; Song JX, 2008, J IMMUNOL, V180, P7240, DOI 10.4049/jimmunol.180.11.7240; Sun Y, 2003, J IMMUNOL METHODS, V272, P23, DOI 10.1016/S0022-1759(02)00328-9; TOGNON M, 1985, INT OPHTHALMOL, V8, P13, DOI 10.1007/BF00136456; van Baarle D, 2001, BLOOD, V98, P146, DOI 10.1182/blood.V98.1.146; Varbanov M, 2006, AIDS REV, V8, P221; Voltan R, 2009, VACCINE, V27, P4498, DOI 10.1016/j.vaccine.2009.05.031; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994; Wherry EJ, 2002, J IMMUNOL, V168, P4455, DOI 10.4049/jimmunol.168.9.4455; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yang TC, 2003, J VIROL, V77, P13407, DOI 10.1128/JVI.77.24.13407-13411.2003; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851; ZAULI G, 1995, BLOOD, V86, P3823, DOI 10.1182/blood.V86.10.3823.bloodjournal86103823; Zauli G, 1996, J IMMUNOL, V157, P2216	87	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77746	10.1371/journal.pone.0077746	http://dx.doi.org/10.1371/journal.pone.0077746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223723	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400015
J	Li, YX; Zhao, YL; Huang, X; Lin, XF; Guo, YL; Wang, DY; Li, CJ; Wang, DY				Li, Yinxia; Zhao, Yunli; Huang, Xu; Lin, Xingfeng; Guo, Yuling; Wang, Daoyong; Li, Chaojun; Wang, Dayong			Serotonin Control of Thermotaxis Memory Behavior in Nematode Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; MODEL SYSTEM; TERM-MEMORY; TRANSPORTER; PLASTICITY; GENE; CHEMOTAXIS; NEURONS; PATHWAY; FOOD	Caenorhabditis elegans is as an ideal model system for the study of mechanisms underlying learning and memory. In the present study, we employed C. elegans assay system of thermotaxis memory to investigate the possible role of serotonin neurotransmitter in memory control. Our data showed that both mutations of tph-1, bas-1, and cat-4 genes, required for serotonin synthesis, and mutations of mod-5 gene, encoding a serotonin reuptake transporter, resulted in deficits in thermotaxis memory behavior. Exogenous treatment with serotonin effectively recovered the deficits in thermotaxis memory of tph-1 and bas-1 mutants to the level of wild-type N2. Neuron-specific activity assay of TPH-1 suggests that serotonin might regulate the thermotaxis memory behavior by release from the ADF sensory neurons. Ablation of ADF sensory neurons by expressing a cell-death activator gene egl-1 decreased the thermotaxis memory, whereas activation of ADF neurons by expression of a constitutively active protein kinase C homologue (pkc-1(gf)) increased the thermotaxis memory and rescued the deficits in thermotaxis memory in tph-1 mutants. Moreover, serotonin released from the ADF sensory neurons might act through the G-protein-coupled serotonin receptors of SER-4 and SER-7 to regulate the thermotaxis memory behavior. Genetic analysis implies that serotonin might further target the insulin signaling pathway to regulate the thermotaxis memory behavior. Thus, our results suggest the possible crucial role of serotonin and ADF sensory neurons in thermotaxis memory control in C. elegans.	[Li, Yinxia; Zhao, Yunli; Huang, Xu; Lin, Xingfeng; Guo, Yuling; Wang, Daoyong; Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Li, Chaojun] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Southeast University - China; Nanjing University	Wang, DY (corresponding author), Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.	dayongw@seu.edu.cn		Li, Chaojun/0000-0001-9474-7321	National Natural Science Foundation of China [30870810, 30300062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30870810, 30300062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Braskie MN, 2011, HUM BRAIN MAPP, V32, P947, DOI 10.1002/hbm.21081; BRENNER S, 1974, GENETICS, V77, P71; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chase DL, 2007, BIOGENIC AMINE NEURO, DOI [10.1895/worm-book.1.132.1, DOI 10.1895/W0RM-B00K.1.132.1]; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Giles AC, 2009, NEUROBIOL LEARN MEM, V92, P139, DOI 10.1016/j.nlm.2008.08.004; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Hare EE, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-24; Hartley CA, 2012, P NATL ACAD SCI USA, V109, P5493, DOI 10.1073/pnas.1202044109; Hu Ya-Ou, 2007, Neurosci Bull, V23, P9, DOI 10.1007/s12264-007-0002-5; Li Z, 2012, NAT COMMUN, DOI [10.1038/ncomms1780, DOI 10.1038/NC0MMS1780]; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; Loer CM, 1999, J NEUROGENET, V13, P157, DOI 10.3109/01677069909083472; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meneses A, 2012, REV NEUROSCIENCE, V23, P543, DOI 10.1515/revneuro-2012-0060; Meneses A, 2011, NEUROPHARMACOLOGY, V61, P355, DOI 10.1016/j.neuropharm.2011.01.018; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 1997, BIOESSAYS, V19, P1055, DOI 10.1002/bies.950191204; Mori I, 2007, CURR OPIN NEUROBIOL, V17, P712, DOI 10.1016/j.conb.2007.11.010; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Sasakura H, 2013, CURR OPIN NEUROBIOL, V23, P92, DOI 10.1016/j.conb.2012.09.005; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Wang WH, 2011, ANAT REC, V294, P1025, DOI 10.1002/ar.21389; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Ye Hua-Yue, 2008, Neurosci Bull, V24, P49, DOI 10.1007/s12264-008-0808-9; Ye Hua-Yue, 2008, Neurosci Bull, V24, P1, DOI 10.1007/s12264-008-0920-x; Ye HY, 2008, NEUROBIOL LEARN MEM, V90, P10, DOI 10.1016/j.nlm.2007.12.001; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	38	7	12	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77779	10.1371/journal.pone.0077779	http://dx.doi.org/10.1371/journal.pone.0077779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223727	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300007
J	Guillon, L; Altenburger, S; Graumann, PL; Schalk, IJ				Guillon, Laurent; Altenburger, Stephan; Graumann, Peter L.; Schalk, Isabelle J.			Deciphering Protein Dynamics of the Siderophore Pyoverdine Pathway in Pseudomonas aeruginosa	PLOS ONE			English	Article							VIRULENCE FACTOR PRODUCTION; ESCHERICHIA-COLI; FPVA RECEPTOR; SPATIAL-DISTRIBUTION; IRON ACQUISITION; BINDING-PROTEINS; EFFLUX PUMP; TONB; MEMBRANE; EXBD	Pseudomonas aeruginosa produces the siderophore, pyoverdine (PVD), to obtain iron. Siderophore pathways involve complex mechanisms, and the machineries responsible for biosynthesis, secretion and uptake of the ferri-siderophore span both membranes of Gram-negative bacteria. Most proteins involved in the PVD pathway have been identified and characterized but the way the system functions as a whole remains unknown. By generating strains expressing fluorescent fusion proteins, we show that most of the proteins are homogeneously distributed throughout the bacterial cell. We also studied the dynamics of these proteins using fluorescence recovery after photobleaching (FRAP). This led to the first diffusion coefficients ever determined in P. aeruginosa. Cytoplasmic and periplamic diffusion appeared to be slower than in Escherichia coli but membrane proteins seemed to behave similarly in the two species. The diffusion of cytoplasmic and periplasmic tagged proteins involved in the PVD pathway was dependent on the interaction network to which they belong. Importantly, the TonB protein, motor of the PVD-Fe uptake process, was mostly immobile but its mobility increased substantially in the presence of PVD-Fe.	[Guillon, Laurent; Schalk, Isabelle J.] Univ Strasbourg, CNRS, UMR 7242, Strasbourg, France; [Altenburger, Stephan; Graumann, Peter L.] Univ Marburg, SYMMIKRO, LOEWE Ctr Synthet Microbiol, Marburg, Germany; [Altenburger, Stephan; Graumann, Peter L.] Univ Marburg, Dept Chem, Marburg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Philipps University Marburg; Philipps University Marburg	Schalk, IJ (corresponding author), Univ Strasbourg, CNRS, UMR 7242, Strasbourg, France.	isabelle.schalk@unistra.fr		Graumann, Peter/0000-0002-8033-5171	Centre National de la Recherche Scientifique; icFRC; Deutsche Forshungsgemeinschaft (DFG) [MemProtDynamic ANR-08-BLAN-0315-01, IronPath ANR-12-BSV8-0007-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); icFRC; Deutsche Forshungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Centre National de la Recherche Scientifique, grants from the icFRC (http://www.icfrc.fr/) and from the ANR (Agence Nationale de Recherche, MemProtDynamic ANR-08-BLAN-0315-01 and IronPath ANR-12-BSV8-0007-01) and from the Deutsche Forshungsgemeinschaft (DFG). L. Guillon received a fellowship from the icFRC (http://www.icfrc.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams H, 2006, J BACTERIOL, V188, P5752, DOI 10.1128/JB.00435-06; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Bratton BP, 2011, J BACTERIOL, V193, P5138, DOI 10.1128/JB.00198-11; Brillet K, 2007, STRUCTURE, V15, P1383, DOI 10.1016/j.str.2007.08.013; Brillet K, 2012, ACS CHEM BIOL, V7, P2036, DOI 10.1021/cb300330v; Carter DM, 2006, J BIOL CHEM, V281, P35413, DOI 10.1074/jbc.M607611200; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Gibbs KA, 2004, MOL MICROBIOL, V53, P1771, DOI 10.1111/j.1365-2958.2004.04242.x; Greenwald J, 2007, J BIOL CHEM, V282, P2987, DOI 10.1074/jbc.M609238200; Gresock MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00206; Guillon L, 2012, ENVIRON MICROBIOL, V14, P1982, DOI 10.1111/j.1462-2920.2012.02741.x; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; Hannauer M, 2010, FEBS LETT, V584, P4751, DOI 10.1016/j.febslet.2010.10.051; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Higgs PI, 1998, J BACTERIOL, V180, P6031, DOI 10.1128/JB.180.22.6031-6038.1998; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Imperi F, 2009, P NATL ACAD SCI USA, V106, P20440, DOI 10.1073/pnas.0908760106; James HE, 2005, J BACTERIOL, V187, P4514, DOI 10.1128/JB.187.13.4514-4520.2005; James KJ, 2009, BIOCHEMISTRY-US, V48, P9212, DOI 10.1021/bi900722p; Jana B, 2011, J BACTERIOL, V193, P5649, DOI 10.1128/JB.05674-11; Kaserer WA, 2008, J BACTERIOL, V190, P4001, DOI 10.1128/JB.00135-08; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Nader M, 2007, BIOCHEMISTRY-US, V46, P11707, DOI 10.1021/bi700997w; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Oddershede L, 2002, BIOPHYS J, V83, P3152, DOI 10.1016/S0006-3495(02)75318-6; Ollis AA, 2009, MOL MICROBIOL, V73, P466, DOI 10.1111/j.1365-2958.2009.06785.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; R Core Team, 2012, R LANG ENV STAT COMP; Redly GA, 2005, J BACTERIOL, V187, P5648, DOI 10.1128/JB.187.16.5648-5657.2005; Schalk IJ, 1999, BIOCHEMISTRY-US, V38, P9357, DOI 10.1021/bi990421x; Schalk IJ, 2002, BIOCHEMISTRY-US, V41, P1663, DOI 10.1021/bi0157767; Schalk IJ, 2013, ENV MICROBI IN PRESS; Schalk IJ, 2008, J INORG BIOCHEM, V102, P1159, DOI 10.1016/j.jinorgbio.2007.11.017; Schalk IJ, 2012, CURR TOP MEMBR, V69, P37, DOI 10.1016/B978-0-12-394390-3.00002-1; Schalk IJ, 2009, BIOMETALS, V22, P671, DOI 10.1007/s10534-008-9203-2; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Schulmeister S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-222; Shen JS, 2002, J BACTERIOL, V184, P3268, DOI 10.1128/JB.184.12.3268-3275.2002; Shirley M, 2009, J BACTERIOL, V191, P5634, DOI 10.1128/JB.00742-09; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sochacki KA, 2011, BIOPHYS J, V100, P22, DOI 10.1016/j.bpj.2010.11.044; Spector J, 2010, BIOPHYS J, V99, P3880, DOI 10.1016/j.bpj.2010.10.029; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takase H, 2000, INFECT IMMUN, V68, P4498, DOI 10.1128/IAI.68.8.4498-4504.2000; Tiburzi F, 2008, MOL MICROBIOL, V67, P213, DOI 10.1111/j.1365-2958.2007.06051.x; TUKEY JW, 1951, BIOMETRICS, V7, P33, DOI 10.2307/3001602; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Voulhoux R, 2006, J BACTERIOL, V188, P3317, DOI 10.1128/JB.188.9.3317-3323.2006; Wirth C, 2007, J MOL BIOL, V368, P398, DOI 10.1016/j.jmb.2007.02.023; Yeterian E, 2010, ENV MICROBIOL REP, V2, P412, DOI 10.1111/j.1758-2229.2009.00115.x; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0	64	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79111	10.1371/journal.pone.0079111	http://dx.doi.org/10.1371/journal.pone.0079111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205369	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500144
J	Gasymov, OK; Abduragimov, AR; Glasgow, BJ				Gasymov, Oktay K.; Abduragimov, Adil R.; Glasgow, Ben J.			Effect of Short- and Long-Range Interactions on Trp Rotamer Populations Determined by Site-Directed Tryptophan Fluorescence of Tear Lipocalin	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; INDUCED-FIT; CYCLIC HEXAPEPTIDES; LIGAND-BINDING; EXCITED-STATE; PEPTIDE-BOND; REVEALS; CONFORMATION; ACID	In the lipocalin family, the conserved interaction between the main alpha-helix and the beta-strand H is an ideal model to study protein side chain dynamics. Site-directed tryptophan fluorescence (SDTF) has successfully elucidated tryptophan rotamers at positions along the main alpha helical segment of tear lipocalin (TL). The rotamers assigned by fluorescent lifetimes of Trp residues corroborate the restriction expected based on secondary structure. Steric conflict constrains Trp residues to two (t, g(-)) of three possible chi(1) (t, g(-), g(+)) canonical rotamers. In this study, investigation focused on the interplay between rotamers for a single amino acid position, Trp 130 on the alpha-helix and amino acids Val 113 and Leu 115 on the H strand, i.e. long range interactions. Trp130 was substituted for Phe by point mutation (F130W). Mutations at positions 113 and 115 with combinations of Gly, Ala, Phe residues alter the rotamer distribution of Trp130. Mutations, which do not distort local structure, retain two rotamers (two lifetimes) populated in varying proportions. Replacement of either long range partner with a small amino acid, V113A or L115A, eliminates the dominance of the t rotamer. However, a mutation that distorts local structure around Trp130 adds a third fluorescence lifetime component. The results indicate that the energetics of long-range interactions with Trp 130 further tune rotamer populations. Diminished interactions, evident in W130G113A115, result in about a 22% increase of alpha-helix content. The data support a hierarchic model of protein folding. Initially the secondary structure is formed by short-range interactions. TL has non-native alpha-helix intermediates at this stage. Then, the long-range interactions produce the native fold, in which TL shows alpha-helix to beta-sheet transitions. The SDTF method is a valuable tool to assess long-range interaction energies through rotamer distribution as well as the characterization of low-populated rotameric states of functionally important excited protein states.	[Gasymov, Oktay K.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gasymov, OK (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	ogassymov@mednet.ucla.edu; bglasgow@mednet.ucla.edu			NIH, National Eye Institute; NATIONAL EYE INSTITUTE [R01EY011224, P30EY000331] Funding Source: NIH RePORTER	NIH, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH, National Eye Institute. The funders had no role in study design, data collection, analysis, decision to publish, preparation of the manuscript.	Adams PD, 2002, J AM CHEM SOC, V124, P9278, DOI 10.1021/ja0167710; Anderson JS., 1982, J PROTEIN CHEM, V1, P281, DOI [10.1007/BF01039553, DOI 10.1007/BF01039553]; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Baldwin RL, 2008, ANNU REV BIOPHYS, V37, P1, DOI 10.1146/annurev.biophys.37.032807.125948; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Breustedt DA, 2005, J BIOL CHEM, V280, P484, DOI 10.1074/jbc.M410466200; Breustedt DA, 2009, ACTA CRYSTALLOGR D, V65, P1118, DOI 10.1107/S0907444909031011; Callis PR, 2007, J PHYS CHEM B, V111, P10335, DOI 10.1021/jp0744883; Callis PR, 2004, J PHYS CHEM B, V108, P4248, DOI 10.1021/jp0310551; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chen Y, 1996, J AM CHEM SOC, V118, P9271, DOI 10.1021/ja961307u; Clayton AHA, 1999, BIOPHYS J, V76, P3235, DOI 10.1016/S0006-3495(99)77475-8; Correnti C, 2011, STRUCTURE, V19, P1796, DOI 10.1016/j.str.2011.09.019; Dean AW, 2012, INVEST OPHTH VIS SCI, V53, P1773, DOI 10.1167/iovs.11-9419; Flower DR, 1996, BIOCHEM J, V318, P1; Gasymov OK, 2004, BIOCHEMISTRY-US, V43, P12894, DOI 10.1021/bi049076o; Gasymov OK, 2002, BIOCHEMISTRY-US, V41, P8837, DOI 10.1021/bi0121003; Gasymov OK, 2001, BIOCHEMISTRY-US, V40, P14754, DOI 10.1021/bi0110342; Gasymov OK, 1999, BBA-PROTEIN STRUCT M, V1433, P307, DOI 10.1016/S0167-4838(99)00133-8; Gasymov Oktay K, 2007, Biochim Biophys Acta, V1774, P1307, DOI 10.1016/j.bbapap.2007.07.014; Gasymov OK, 2012, J PHYS CHEM B, V116, P13381, DOI 10.1021/jp309318r; Gasymov OK, 2012, BIOCHEMISTRY-US, V51, P2991, DOI 10.1021/bi3002902; Gasymov OK, 2011, BBA-PROTEINS PROTEOM, V1814, P671, DOI 10.1016/j.bbapap.2011.03.017; Gasymov OK, 2010, BIOCHEMISTRY-US, V49, P582, DOI 10.1021/bi901435q; Glasgow BJ, 2010, INVEST OPHTH VIS SCI, V51, P1981, DOI 10.1167/iovs.09-4622; GLASGOW BJ, 1995, GRAEF ARCH CLIN EXP, V233, P513, DOI 10.1007/BF00183433; GLASGOW BJ, 1995, CURR EYE RES, V14, P363, DOI 10.3109/02713689508999934; Glasgow BJ, 1999, BIOCHEMISTRY-US, V38, P13707, DOI 10.1021/bi9913449; GLASGOW BJ, 1993, CURR EYE RES, V12, P1019, DOI 10.3109/02713689309029229; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Kuwata K, 2001, NAT STRUCT BIOL, V8, P151, DOI 10.1038/84145; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Liu B, 2002, J AM CHEM SOC, V124, P13329, DOI 10.1021/ja016542d; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; MacArthur MW, 1999, ACTA CRYSTALLOGR D, V55, P994, DOI 10.1107/S0907444999002231; McMahon LP, 1997, J PHYS CHEM B, V101, P3269, DOI 10.1021/jp963273i; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Pan CP, 2011, J PHYS CHEM B, V115, P3245, DOI 10.1021/jp111925w; Pan CP, 2006, J PHYS CHEM B, V110, P7009, DOI 10.1021/jp056164p; Pan CP, 2004, BIOPHYS J, V86, P3828, DOI 10.1529/biophysj.103.038901; REDL B, 1992, J BIOL CHEM, V267, P20282; SAITO I, 1984, J AM CHEM SOC, V106, P4286, DOI 10.1021/ja00327a048; Sakurai K, BIOCHEMISTRY, V50, P6498; Shapovalov MV, 2007, PROTEINS, V66, P279, DOI 10.1002/prot.21150; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; SHIZUKA H, 1988, J AM CHEM SOC, V110, P1726, DOI 10.1021/ja00214a011; Spyrakis F, 2011, CURR TOP MED CHEM, V11, P131, DOI 10.2174/156802611794863553; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tuttle LM, 2013, BIOCHEMISTRY-US, V52, P3464, DOI 10.1021/bi400322e; Vander Donckt E, 1969, B SOC CHIM BELG, V78, P60; Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223	59	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78754	10.1371/journal.pone.0078754	http://dx.doi.org/10.1371/journal.pone.0078754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205305	Green Submitted, Green Published, gold			2022-12-27	WOS:000326241200059
J	Bjersing, JL; Lundborg, C; Bokarewa, MI; Mannerkorpi, K				Bjersing, Jan L.; Lundborg, Christopher; Bokarewa, Maria I.; Mannerkorpi, Kaisa			Profile of Cerebrospinal microRNAs in Fibromyalgia	PLOS ONE			English	Article							LONG-TERM; EXPRESSION; PAIN; GROWTH; PROTECTS; IMPACT; INFLAMMATION; RELIABILITY; INVOLVEMENT; EXERCISE	Introduction: Fibromyalgia (FM) is characterized by chronic pain and reduced pain threshold. The pathophysiology involves disturbed neuroendocrine function, including impaired function of the growth hormone/insulin-like growth factor-1 axis. Recently, microRNAs have been shown to be important regulatory factors in a number of diseases. The aim of this study was to try to identify cerebrospinal microRNAs with expression specific for FM and to determine their correlation to pain and fatigue. Methods: The genome-wide profile of microRNAs in cerebrospinal fluid was assessed in ten women with FM and eight healthy controls using real-time quantitative PCR. Pain thresholds were examined by algometry. Levels of pain (FIQ pain) were rated on a 0-100 mm scale (fibromyalgia impact questionnaire, FIQ). Levels of fatigue (FIQ fatigue) were rated on a 0-100 mm scale using FIQ and by multidimensional fatigue inventory (MFI-20) general fatigue (MFIGF). Results: Expression levels of nine microRNAs were significantly lower in patients with FM patients compared to healthy controls. The microRNAs identified were miR-21-5p, miR-145-5p, miR-29a-3p, miR-99b-5p, miR-125b-5p, miR-23a-3p, 23b-3p, miR-195-5p, miR-223-3p. The identified microRNAs with significantly lower expression in FM were assessed with regard to pain and fatigue. miR-145-5p correlated positively with FIQ pain (r=0.709, p=0.022, n=10) and with FIQ fatigue (r=0.687, p=0.028, n=10). Conclusion: To our knowledge, this is the first study to show a disease-specific pattern of cerebrospinal microRNAs in FM. We have identified nine microRNAs in cerebrospinal fluid that differed between FM patients and healthy controls. One of the identified microRNAs, miR-145 was associated with the cardinal symptoms of FM, pain and fatigue.	[Bjersing, Jan L.; Bokarewa, Maria I.; Mannerkorpi, Kaisa] Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden; [Lundborg, Christopher] Univ Gothenburg, Inst Clin Sci, Dept Anaesthesiol & Intens Care Med, Sahlgrenska Acad, Gothenburg, Sweden; [Mannerkorpi, Kaisa] Univ Gothenburg, Sahlgrenska Acad, Univ Gothenburg Ctr Person Centred Care GPCC, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Bjersing, JL (corresponding author), Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden.	jan.bjersing@rheuma.gu.se	Bjersing, Jan/F-2901-2011; Bokarewa, Maria I/A-8114-2019	Bokarewa, Maria I/0000-0001-9424-5145; Mannerkorpi, Kaisa/0000-0003-4997-9523; Bjersing, Jan/0000-0002-3538-1240	Swedish Research Council; Medical Society of Goteborg; Swedish Rheumatism Association; King Gustaf V:s 80-year Foundation,; Wilhelm and Martina Lundgrens Foundation; Foundation to the Memory of Sigurd and Elsa Golje, Rune and Ulla Amlovs Trust; University of Goteborg; Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF); Health and Medical Care Executive Board of Vastra Gotaland Region	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Society of Goteborg; Swedish Rheumatism Association; King Gustaf V:s 80-year Foundation,; Wilhelm and Martina Lundgrens Foundation; Foundation to the Memory of Sigurd and Elsa Golje, Rune and Ulla Amlovs Trust; University of Goteborg; Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF); Health and Medical Care Executive Board of Vastra Gotaland Region	This work has been funded by grants from the Swedish Research Council, the Medical Society of Goteborg, the Swedish Rheumatism Association, the King Gustaf V:s 80-year Foundation, the Wilhelm and Martina Lundgrens Foundation, the Foundation to the Memory of Sigurd and Elsa Golje, Rune and Ulla Amlovs Trust, the University of Goteborg, the Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF), the Health and Medical Care Executive Board of Vastra Gotaland Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron LA, 2000, ARCH INTERN MED, V160, P221, DOI 10.1001/archinte.160.2.221; Ai J, 2013, J NEUROSCI, V33, P3989, DOI 10.1523/JNEUROSCI.1997-12.2013; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bennett RM, 1997, J RHEUMATOL, V24, P1384; Bennett Robert M, 2002, Curr Rheumatol Rep, V4, P306, DOI 10.1007/s11926-002-0039-4; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bjersing JL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3902; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; Ericsson A, 2007, DISABIL REHABIL, V29, P1665, DOI 10.1080/09638280601055782; Fei X, 2012, FEBS LETT, V586, P392, DOI 10.1016/j.febslet.2012.01.006; Harraz MM, 2012, P NATL ACAD SCI USA, V109, P18962, DOI 10.1073/pnas.1121288109; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; KOSEK E, 1993, SCAND J REHABIL MED, V25, P117; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Lee YH, 2012, RHEUMATOL INT, V32, P417, DOI 10.1007/s00296-010-1678-9; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mannerkorpi K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3159; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Markkula R, 2009, EUR J PAIN, V13, P744, DOI 10.1016/j.ejpain.2008.09.007; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Mease PJ, 2011, J RHEUMATOL, V38, P1487, DOI 10.3899/jrheum.110277; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Meza-Sosa KF, 2012, J NEUROSCI RES, V90, P1, DOI 10.1002/jnr.22701; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P94, DOI 10.1002/ibd.21742; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Poh KW, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.02.002; Qiu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-124; Rodriguez Raquel E., 2012, Frontiers in Genetics, V3, P223, DOI 10.3389/fgene.2012.00223; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Schouten M, 2013, NEUROSCIENCE, V241, P188, DOI 10.1016/j.neuroscience.2013.02.065; Shi Y, 2012, RADIAT RES, V177, P124, DOI 10.1667/RR2764.1; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Smith SB, 2012, ARTHRITIS RHEUM-US, V64, P584, DOI 10.1002/art.33338; Soci UPR, 2011, PHYSIOL GENOMICS, V43, P665, DOI 10.1152/physiolgenomics.00145.2010; Staud R, 2012, CURR RHEUMATOL REP, V14, P539, DOI 10.1007/s11926-012-0277-z; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang WT, 2013, J CLIN ENDOCR METAB, V98, P281, DOI 10.1210/jc.2012-2415; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zhang L, 2012, GLIA, V60, P1888, DOI 10.1002/glia.22404; Zhu HC, 2012, BRAIN RES BULL, V88, P596, DOI 10.1016/j.brainresbull.2012.05.018; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	50	66	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78762	10.1371/journal.pone.0078762	http://dx.doi.org/10.1371/journal.pone.0078762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205312	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400104
J	Francisco-Ramos, V; Arias-Gonzalez, JE				Francisco-Ramos, Vanessa; Ernesto Arias-Gonzalez, Jesus			Additive Partitioning of Coral Reef Fish Diversity across Hierarchical Spatial Scales throughout the Caribbean	PLOS ONE			English	Article							SPECIES-DIVERSITY; BETA-DIVERSITY; ALPHA-DIVERSITY; GLOBAL PATTERNS; MARINE RESERVE; BIODIVERSITY; RESILIENCE; RICHNESS; COASTAL; BIOGEOGRAPHY	There is an increasing need to examine regional patterns of diversity in coral-reef systems since their biodiversity is declining globally. In this sense, additive partitioning might be useful since it quantifies the contribution of alpha and beta to total diversity across different scales. We applied this approach using an unbalanced design across four hierarchical scales (80 sites, 22 subregions, six ecoregions, and the Caribbean basin). Reef-fish species were compiled from the Reef Environmental Education Foundation (REEF) database and distributions were confirmed with published data. Permutation tests were used to compare observed values to those expected by chance. The primary objective was to identify patterns of reef-fish diversity across multiple spatial scales under different scenarios, examining factors such as fisheries and demographic connectivity. Total diversity at the Caribbean scale was attributed to beta-diversity (nearly 62% of the species), with the highest beta-diversity at the site scale. (alpha) over bar -diversity was higher than expected by chance in all scenarios and at all studied scales. This suggests that fish assemblages are more homogenous than expected, particularly at the ecoregion scale. Within each ecoregion, diversity was mainly attributed to alpha, except for the Southern ecoregion where there was a greater difference in species among sites. beta-components were lower than expected in all ecoregions, indicating that fishes within each ecoregion are a subsample of the same species pool. The scenario involving the effects of fisheries showed a shift in dominance for beta-diversity from regions to subregions, with no major changes to the diversity patterns. In contrast, demographic connectivity partially explained the diversity pattern. beta-components were low within connectivity regions and higher than expected by chance when comparing between them. Our results highlight the importance of ecoregions as a spatial scale to conserve local and regional coral reef-fish diversity.	[Francisco-Ramos, Vanessa; Ernesto Arias-Gonzalez, Jesus] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Recursos Mar, Unidad Merida, Merida, Yucatan, Mexico	Instituto Politecnico Nacional - Mexico	Arias-Gonzalez, JE (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Recursos Mar, Unidad Merida, Merida, Yucatan, Mexico.	earias@mda.cinvestav.mx		Francisco, Vanessa/0000-0002-7736-7746; Arias-Gonzalez, Jesus Ernesto/0000-0003-4601-710X	CONACYT [229484]; Biodiversidad y Conectividad de los Arrecifes Coralinos del Atlantico Mexicano Ante el Cambio Global, Red Tematica de investigacion de Ecosistemas [CLAVE: 000000000194539]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biodiversidad y Conectividad de los Arrecifes Coralinos del Atlantico Mexicano Ante el Cambio Global, Red Tematica de investigacion de Ecosistemas	The work was supported by the following: CONACYT (doctoral scholarship 229484). Biodiversidad y Conectividad de los Arrecifes Coralinos del Atlantico Mexicano Ante el Cambio Global. CLAVE: 000000000194539, Red Tematica de investigacion de Ecosistemas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gonzalez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065665; Agardy T, 2000, ICES J MAR SCI, V57, P761, DOI 10.1006/jmsc.2000.0721; Albany GR, 2004, OIKOS, V106, P275, DOI [10.1111/j.0030-1299.2004.13193.x., DOI 10.1111/J.0030-1299.2004.13193.X]; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Bohlke J.E., 1993, FISHES BAHAMAS ADJAC; Carpenter K.E., 2002, FAO SPECIES IDENTIFI, V5; Carpenter K.E., 2002, FAO SPECIES IDENTIFI, V5; CARPENTER KE, 2002, FAO SPECIES IDENTIFI, V5, P601; Cervigon F., 1993, PECES MARINOS VENEZU, V2; Cervigon F., 1994, PECES MARINOS VENEZU, V3; Cervigon F., 1991, PECES MARINOS VENEZU, V1; Cervigon F., 1992, GUIA CAMPO ESPECIES; Chandy S, 2006, J APPL ECOL, V43, P792, DOI 10.1111/j.1365-2664.2006.01178.x; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Chong-Seng KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042167; Clarke A, 2010, DIVERS DISTRIB, V16, P725, DOI 10.1111/j.1472-4642.2010.00692.x; Clarke K, 2006, PRIMER V6 USER MANUA, P190; Clifton KE, 1998, REV BIOL TROP, V46, P109; Clough Y, 2007, J APPL ECOL, V44, P804, DOI 10.1111/j.1365-2664.2007.01294.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Debrot D, 2007, P 60 GULF CAR FISH I, P335; FAO Statistics and Information Service of the Fisheries and Aquaculture Department, 2012, CAPT PROD 1950 2010; Fleishman E, 2003, LANDSCAPE ECOL, V18, P675, DOI 10.1023/B:LAND.0000004183.82140.48; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Froese R., 2012, FISHBASE; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Geertjes GJ, 2004, MAR ECOL PROG SER, V279, P225, DOI 10.3354/meps279225; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Gering JC, 2002, ECOL LETT, V5, P433, DOI 10.1046/j.1461-0248.2002.00335.x; Getty SR, 2001, GEOLOGY, V29, P639, DOI 10.1130/0091-7613(2001)029<0639:APCEIT>2.0.CO;2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Holland SM, 2010, PALAEONTOLOGY, V53, P1237, DOI 10.1111/j.1475-4983.2010.01017.x; Holt BG, 2010, GLOBAL ECOL BIOGEOGR, V19, P432, DOI 10.1111/j.1466-8238.2010.00539.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jimenez-Valverde Alberto, 2003, Revista Iberica de Aracnologia, V8, P151; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Josefson AB, 2009, MAR ECOL PROG SER, V396, P283, DOI 10.3354/meps08375; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lara EN, 1998, J FISH BIOL, V53, P209, DOI 10.1111/j.1095-8649.1998.tb01028.x; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Moreno CE, 2009, ENTOMOLOGIA MEXICANA, V9, P209; Morrison RA, 2011, CHANGING DIVERSITY IN CHANGING ENVIRONMENT, P299; Muller-Karger F, 2004, DEEP-SEA RES PT II, V51, P927, DOI 10.1016/j.dsr2.2003.10.010; Nystrom M, 2006, AMBIO, V35, P30, DOI 10.1639/0044-7447(2006)035[0030:RARDOF]2.0.CO;2; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pech-Canche JM, 2011, ECOSCIENCE, V18, P42, DOI 10.2980/18-1-3392; Reyes-Nivia María Catalina, 2004, Bol. Invest. Mar. Cost., V33, P101; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Rodriguez-Zaragoza FA, 2011, BIODIVERS CONSERV, V20, P1655, DOI 10.1007/s10531-011-0053-9; Russel P., 1940, J MALAR I INDIA, V3, P154; Sadovy Y, 1999, 146 NOAANMFS; Sale PF, 2008, CAR CONN IMPL MAR PR, P12; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Schmitt EF, 2002, CORAL REEFS, V21, P216, DOI 10.1007/s00338-002-0216-y; Semmens BX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008895; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Smith C. L., 1997, NATL AUDUBON SOC FIE, P720; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; StatSoft Inc, 2005, TATISTICA DAT AN SOF; Summerville KS, 2005, BIODIVERS CONSERV, V14, P3393, DOI 10.1007/s10531-004-0546-x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Vanden Berghe E, 2007, OCEAN BIOGEOGRAPHIC; Vanderklift MA, 2013, OECOLOGIA, V171, P309, DOI 10.1007/s00442-012-2408-7; Veech JA, 2009, PARTITION 3 0 SOFTWA; Wagner HH, 2000, LANDSCAPE ECOL, V15, P219, DOI 10.1023/A:1008114117913; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Zvuloni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009941	88	20	20	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78761	10.1371/journal.pone.0078761	http://dx.doi.org/10.1371/journal.pone.0078761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205311	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400103
J	Nguyen, HM; Ruppender, N; Zhang, XT; Brown, LG; Gross, TS; Morrissey, C; Gulati, R; Vessella, RL; Schimmoller, F; Aftab, DT; Corey, E				Nguyen, Holly M.; Ruppender, Nazanin; Zhang, Xiaotun; Brown, Lisha G.; Gross, Ted S.; Morrissey, Colm; Gulati, Roman; Vessella, Robert L.; Schimmoller, Frauke; Aftab, Dana T.; Corey, Eva			Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling	PLOS ONE			English	Article							MEDULLARY-THYROID CARCINOMA; C-MET EXPRESSION; KINASE INHIBITOR; TUMOR-CELLS; PHASE-II; RECEPTOR; VEGF; METASTASES; ANGIOGENESIS; PROGRESSION	Cabozantinib is an inhibitor of multiple receptor tyrosine kinases, including MET and VEGFR2. In a phase II clinical trial in advanced prostate cancer (PCa), cabozantinib treatment improved bone scans in 68% of evaluable patients. Our studies aimed to determine the expression of cabozantinib targets during PCa progression and to evaluate its efficacy in hormone-sensitive and castration-resistant PCa in preclinical models while delineating its effects on tumor and bone. Using immunohistochemistry and tissue microarrays containing normal prostate, primary PCa, and soft tissue and bone metastases, our data show that levels of MET, P-MET, and VEGFR2 are increasing during PCa progression. Our data also show that the expression of cabozantinib targets are particularly pronounced in bone metastases. To evaluate cabozantinib efficacy on PCa growth in the bone environment and in soft tissues we used androgen-sensitive LuCaP 23.1 and castration-resistant C4-2B PCa tumors. In vivo, cabozantinib inhibited the growth of PCa in bone as well as growth of subcutaneous tumors. Furthermore, cabozantinib treatment attenuated the bone response to the tumor and resulted in increased normal bone volume. In summary, the expression pattern of cabozantinib targets in primary and castration-resistant metastatic PCa, and its efficacy in two different models of PCa suggest that this agent has a strong potential for the effective treatment of PCa at different stages of the disease.	[Nguyen, Holly M.; Ruppender, Nazanin; Zhang, Xiaotun; Brown, Lisha G.; Morrissey, Colm; Vessella, Robert L.; Corey, Eva] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Gross, Ted S.] Univ Washington, Dept Orthoped, Seattle, WA 98195 USA; [Gulati, Roman] Fred Hutchinson Canc Res Ctr, Biostat & Biomath Program, Seattle, WA 98104 USA; [Schimmoller, Frauke; Aftab, Dana T.] Exelixis Inc, San Francisco, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Exelixis, Inc.	Corey, E (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98195 USA.	ecorey@uw.edu	Gulati, Roman/AAE-4298-2019	Gulati, Roman/0000-0002-7592-6567	Exelixis Inc.	Exelixis Inc.	The studies in this manuscript were in part funded by Exelixis Inc. Two of the co-authors (DTA and FS) are employees of Exelixis. They were involved in study design, data analyses and in manuscript preparation.	Bok RA, 2001, CANCER RES, V61, P2533; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Ceolin L, 2012, EUR J ENDOCRINOL, V166, P847, DOI 10.1530/EJE-11-1060; Ceolin L, 2012, INT J MOL SCI, V13, P221, DOI 10.3390/ijms13010221; Coleman IM, 2006, NEOPLASIA, V8, P862, DOI 10.1593/neo.06328; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Corey Eva, 2007, P3, DOI 10.1007/978-1-59745-224-3_1; Dai Y, 2010, MOL CANCER THER, V9, P1554, DOI 10.1158/1535-7163.MCT-10-0359; Dawson DM, 1998, J NATL CANCER I, V90, P519, DOI 10.1093/jnci/90.7.519; Duque JLF, 1999, UROLOGY, V54, P523, DOI 10.1016/S0090-4295(99)00167-3; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Emami KH, 2009, PROSTATE, V69, P1481, DOI 10.1002/pros.20998; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Humphrey PA, 2006, CLIN GENITOURIN CANC, V4, P269, DOI 10.3816/CGC.2006.n.006; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; Kitajima Y, 2008, CANCER SCI, V99, P1341, DOI 10.1111/j.1349-7006.2008.00828.x; Knudsen BS, 2009, APPL IMMUNOHISTO M M, V17, P57, DOI 10.1097/PAI.0b013e3181816ae2; Knudsen BS, 2004, ADV CANCER RES, V91, P31, DOI 10.1016/S0065-230X(04)91002-0; Koreckij TD, 2009, NEOPLASIA, V11, P1216, DOI 10.1593/neo.09960; Kurzrock R, 2011, J CLIN ONCOL, V29, P2660, DOI 10.1200/JCO.2010.32.4145; Maeda A, 2006, BIOCHEM BIOPH RES CO, V347, P1158, DOI 10.1016/j.bbrc.2006.07.040; Morrissey C, 2010, NEOPLASIA, V12, P192, DOI 10.1593/neo.91836; Nakashiro K, 2003, ONCOL REP, V10, P1149; Nurmio M, 2011, TOXICOL APPL PHARM, V254, P267, DOI 10.1016/j.taap.2011.04.019; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pfeiffer MJ, 2011, MOL MED, V17, P657, DOI 10.2119/molmed.2010.00143; Pfitzenmaier J, 2003, J BONE MINER RES, V18, P1882, DOI 10.1359/jbmr.2003.18.10.1882; Ryan CJ, 2013, CLIN CANCER RES, V19, P215, DOI 10.1158/1078-0432.CCR-12-2605; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Shojaei F, 2012, CANCER LETT, V320, P48, DOI 10.1016/j.canlet.2012.01.026; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Small AC, 2012, EXPERT OPIN BIOL TH, V12, P1241, DOI 10.1517/14712598.2012.704015; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Strohmeyer D, 2004, ANTICANCER RES, V24, P1797; Tomic TT, 2012, PROSTATE, V72, P705, DOI 10.1002/pros.21472; Tu WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-556; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wiesner C, 2008, NEOPLASIA, V10, P996, DOI 10.1593/neo.08618; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Yap TA, 2011, J CLIN ONCOL, V29, P1271, DOI 10.1200/JCO.2010.31.0367; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9	44	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78881	10.1371/journal.pone.0078881	http://dx.doi.org/10.1371/journal.pone.0078881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205338	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400110
J	Robertson, JL; Tsubouchi, A; Tracey, WD				Robertson, Jessica L.; Tsubouchi, Asako; Tracey, W. Daniel			Larval Defense against Attack from Parasitoid Wasps Requires Nociceptive Neurons	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; SENSORY NEURONS; OVIPOSITOR CLIP; DENDRITE; DIFFERENTIATION; HYMENOPTERA; MECHANISMS; STRATEGIES; RESPONSES; DYNAMICS	Parasitoid wasps are a fierce predator of Drosophila larvae. Female Leptopilina boulardi (LB) wasps use a sharp ovipositor to inject eggs into the bodies of Drosophila melanogaster larvae. The wasp then eats the Drosophila larva alive from the inside, and an adult wasp ecloses from the Drosophila pupal case instead of a fly. However, the Drosophila larvae are not defenseless as they may resist the attack of the wasps through somatosensory-triggered behavioral responses. Here we describe the full range of behaviors performed by the larval prey in immediate response to attacks by the wasps. Our results suggest that Drosophila larvae primarily sense the wasps using their mechanosensory systems. The range of behavioral responses included both "gentle touch" like responses as well as nociceptive responses. We found that the precise larval response depended on both the somatotopic location of the attack, and whether or not the larval cuticle was successfully penetrated during the course of the attack. Interestingly, nociceptive responses are more likely to be triggered by attacks in which the cuticle had been successfully penetrated by the wasp. Finally, we found that the class IV neurons, which are necessary for mechanical nociception, were also necessary for a nociceptive response to wasp attacks. Thus, the class IV neurons allow for a nociceptive behavioral response to a naturally occurring predator of Drosophila.	[Robertson, Jessica L.; Tracey, W. Daniel] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Tsubouchi, Asako; Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Tracey, W. Daniel] Duke Univ, Dept Neurobiol, Durham, NC USA	Duke University; Duke University; Duke University	Tracey, WD (corresponding author), Duke Univ, Dept Cell Biol, Durham, NC 27710 USA.	dan.tracey@duke.edu		Tracey, W. Daniel/0000-0003-4666-8199; Tsubouchi, Asako/0000-0002-6284-8221	National Science Foundation; James B. Duke Fellowship; National Institutes of Health [5T32-GM007184-39]; Duke University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); James B. Duke Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Science Foundation (Graduate Research Fellowship (JLR)), the James B. Duke Fellowship (JLR), and the National Institutes of Health (5T32-GM007184-39). Support to WDT was through discretionary funding by Duke University Medical Center. nsf.govnih.gov http://gradschool.duke.edu/financial_support/phd%20support/incoming.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Babcock DT, 2009, CURR BIOL, V19, P799, DOI 10.1016/j.cub.2009.03.062; Belshaw R, 2003, ZOOL J LINN SOC-LOND, V139, P213, DOI 10.1046/j.1096-3642.2003.00078.x; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Buffington ML, 2007, J NAT HIST, V41, P2267, DOI 10.1080/00222930701579732; Carton Y., 1986, P347; Dupas S, 1996, PARASITOLOGY, V113, P207, DOI 10.1017/S0031182000081981; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Goecks J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064125; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Grueber WB, 2002, DEVELOPMENT, V129, P2867; HACCOU P, 1991, J ANIM ECOL, V60, P93, DOI 10.2307/5447; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Im SH, 2011, DEV DYNAMICS; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaiser L, 2009, ADV PARASIT, V70, P67, DOI 10.1016/S0065-308X(09)70003-X; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim ME, 2012, NEURON, V73, P79, DOI 10.1016/j.neuron.2011.10.033; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Lee MJ, 2009, ADV PARASIT, V70, P123, DOI 10.1016/S0065-308X(09)70005-3; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Oswald M, 2011, FLY, V5, P304, DOI 10.4161/fly.5.4.17810; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Perez-Maluf R, 2008, PHYSIOL ENTOMOL, V33, P226, DOI 10.1111/j.1365-3032.2008.00636.x; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; RUANGVORAVAT CP, 1992, DEV DYNAM, V193, P70, DOI 10.1002/aja.1001930110; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; SILVERS MJ, 1986, J PARASITOL, V72, P405, DOI 10.2307/3281680; SOKOLOWSKI MB, 1987, CAN J ZOOL, V65, P461, DOI 10.1139/z87-071; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tsubouchi A, 2012, CURR BIOL, V22, P2124, DOI 10.1016/j.cub.2012.09.019; van Lenteren JC, 1998, INT J INSECT MORPHOL, V27, P263, DOI 10.1016/S0020-7322(98)00019-1; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P589, DOI 10.1007/s00265-006-0198-9; Whitfield JB, 2003, J INSECT PHYSIOL, V49, P397, DOI 10.1016/S0022-1910(03)00057-X; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Williams DW, 1999, J NEUROBIOL, V39, P275, DOI 10.1002/(SICI)1097-4695(199905)39:2<275::AID-NEU11>3.0.CO;2-0; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	47	45	45	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78704	10.1371/journal.pone.0078704	http://dx.doi.org/10.1371/journal.pone.0078704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205297	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400099
J	Sheidy, DT; Zielke, RA				Sheidy, Daniel T.; Zielke, Ryszard A.			Analysis and Expansion of the Role of the Escherichia coli Protein ProQ	PLOS ONE			English	Article							OSMOREGULATORY TRANSPORTER PROP; PROLINE PORTER-II; ANTISENSE RNA; TRANSCRIPTION; EXPRESSION; PREDICTION; REPRESSOR; FIS; IDENTIFICATION; PURIFICATION	The decrease in proline transport by the proline porter ProP in a Delta proQ strain has been well documented; however, the reason for this phenotype remains undefined. Previous studies have speculated that ProQ facilitates translation of proP mRNA. Here, we demonstrate that ProQ is enriched in the polysome fractions of sucrose gradient separations of E. coli lysates and the 30S fractions of lysates separated under conditions causing ribosomal subunit dissociation. Thus, ProQ is a bona fide ribosome associated protein. Analysis of proQ constructs lacking predicted structural domains implicates the N-terminal domain in ribosome association. Association with the ribosome appears to be mediated by an interaction with the mRNA being translated, as limited treatment of lysates with Micrococcal Nuclease maintains ribosome integrity but disrupts ProQ localization with polysomes. ProQ also fails to robustly bind to mRNA-free 70S ribosomes in vitro. Interestingly, deletion of proP does not disrupt the localization of ProQ with translating ribosomes, and deletion of proP in combination with the proU operon has no effect on ProQ localization. We also demonstrate that ProQ is necessary for robust biofilm formation, and this phenotype is independent of ProP. Binding studies were carried out using tryptophan fluorescence and in vitro transcribed proP mRNAs. proP is transcribed from two differentially regulated promoters, and ProQ interacts with proP mRNA transcribed from both promoters, as well as a control mRNA with similar affinities. In total, these data suggest that ProQ is positioned to function as a novel translational regulator, and its cellular role extends beyond its effects on proline uptake by ProP.	[Sheidy, Daniel T.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zielke, Ryszard A.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	University of Michigan System; University of Michigan; Oregon State University	Sheidy, DT (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	dtsheidy@umich.edu			Department of Health and Human Services, National Institutes of Health [GM077628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077628] Funding Source: NIH RePORTER	Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Department of Health and Human Services, National Institutes of Health Grant No. GM077628 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Brandi A, 1996, MOL MICROBIOL, V19, P231, DOI 10.1046/j.1365-2958.1996.362897.x; Chaulk SG, 2011, BIOCHEMISTRY-US, V50, P3095, DOI 10.1021/bi101683a; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fuentes JL, 2007, MOL GENET GENOMICS, V278, P105, DOI 10.1007/s00438-007-0233-1; Ghetu AF, 2000, NAT STRUCT BIOL, V7, P565; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jiang M, 2007, J BACTERIOL, V189, P3434, DOI 10.1128/JB.00090-07; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koraimann G, 1996, MOL MICROBIOL, V21, P811, DOI 10.1046/j.1365-2958.1996.361401.x; Kunte HJ, 1999, J BACTERIOL, V181, P1537, DOI 10.1128/JB.181.5.1537-1543.1999; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Landis L, 1999, GENE DEV, V13, P3081, DOI 10.1101/gad.13.23.3081; LEDERBERG S, 1961, EXP CELL RES, V25, P198, DOI 10.1016/0014-4827(61)90325-1; MacMillan SV, 1999, BBA-BIOMEMBRANES, V1420, P30, DOI 10.1016/S0005-2736(99)00085-1; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; MELLIES J, 1995, J BACTERIOL, V177, P144, DOI 10.1128/jb.177.1.144-151.1995; MILNER JL, 1988, J BIOL CHEM, V263, P14900; MILNER JL, 1989, J BACTERIOL, V171, P947, DOI 10.1128/jb.171.2.947-951.1989; Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; SCHRENK WJ, 1974, MOL GEN GENET, V131, P9, DOI 10.1007/BF00269382; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Smith MN, 2007, BIOCHEMISTRY-US, V46, P3084, DOI 10.1021/bi6023786; Smith MN, 2004, BIOCHEMISTRY-US, V43, P12979, DOI 10.1021/bi048561g; Smith-Frieday MN, 2009, THESIS U GUELPH GUEL; VANBIESEN T, 1994, MOL MICROBIOL, V14, P427, DOI 10.1111/j.1365-2958.1994.tb02177.x; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wood Janet M, 2006, Sci STKE, V2006, ppe43; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Xu JM, 1997, J MOL BIOL, V270, P346, DOI 10.1006/jmbi.1997.1133; Xu JM, 1997, J BACTERIOL, V179, P2410, DOI 10.1128/jb.179.7.2410-2417.1997; XU JM, 1995, J BACTERIOL, V177, P5222, DOI 10.1128/jb.177.18.5222-5231.1995; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	40	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79656	10.1371/journal.pone.0079656	http://dx.doi.org/10.1371/journal.pone.0079656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205389	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400118
J	Hwang, J; Kim, JE; Kaufman, MJ; Renshaw, PF; Yoon, S; Yurgelun-Todd, DA; Choi, Y; Jun, C; Lyoo, IK				Hwang, Jaeuk; Kim, Jieun E.; Kaufman, Marc J.; Renshaw, Perry F.; Yoon, Sujung; Yurgelun-Todd, Deborah A.; Choi, Yera; Jun, Chansoo; Lyoo, In Kyoon			Enlarged Cavum Septum Pellucidum as a Neurodevelopmental Marker in Adolescent-Onset Opiate Dependence	PLOS ONE			English	Article							SCHIZOTYPAL PERSONALITY-DISORDER; 1ST-EPISODE SCHIZOPHRENIA; AMYGDALA VOLUME; SUBSTANCE USE; BRAIN; MRI; ABNORMALITIES; PREVALENCE; POSTMORTEM; ADDICTION	Objective: Adolescent-onset exposure to highly addictive substances such as opiates may induce far-reaching deleterious effects on later mental and physical health. However, little is known about the neurodevelopmental basis for adolescent-onset opiate dependence. Here we examined whether having an abnormally large cavum septum pellucidum (CSP), a putative marker of limbic structural maldevelopment, is associated with opiate dependence particularly beginning in adolescence. Method: The overall length of the CSP and the prevalence of abnormal enlargement of the CSP were assessed and compared in 65 opiate-dependent subjects (41 adolescent-onset opiate users and 24 adult-onset opiate users) and 67 healthy subjects. Results: Opiate-dependent subjects showed a greater prevalence of abnormal CSP enlargement relative to healthy subjects (odds ratio [OR]=3.64, p=0.034). The overall CSP length of adolescent-onset opiate-dependent subjects was greater, as compared not only with healthy subjects (F-1,F-104=11.03, p=0.001) but also with those who began opiate use during adulthood (F-1,F-61=4.43, p=0.039). Conclusions: The current findings provide the first evidence that abnormal CSP enlargement, which reflects limbic system dysgenesis of neurodevelopmental origin, may be linked to later development of opiate dependence. In addition, a greater CSP length, which indicates more severe limbic abnormalities, appears to confer higher risk for earlier onset of opiate use.	[Hwang, Jaeuk] Soonchunhyang Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Jieun E.] Ewha Womans Univ, Dept Brain & Cognit Sci, Grad Sch, Seoul, South Korea; [Kaufman, Marc J.] McLean Hosp, McLean Imaging Ctr, Belmont, MA 02178 USA; [Renshaw, Perry F.; Yoon, Sujung; Yurgelun-Todd, Deborah A.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Renshaw, Perry F.; Yoon, Sujung; Yurgelun-Todd, Deborah A.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Yoon, Sujung] Catholic Univ Korea, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Yera] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Brain Sci, Seoul 151742, South Korea; [Jun, Chansoo; Lyoo, In Kyoon] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Jun, Chansoo; Lyoo, In Kyoon] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea	Soonchunhyang University; Ewha Womans University; Harvard University; McLean Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Catholic University of Korea; Seoul National University (SNU); Ewha Womans University; Ewha Womans University	Lyoo, IK (corresponding author), Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea.	inkylyoo@ewha.ac.kr	Renshaw, Perry/O-1384-2018	Kaufman, Marc/0000-0002-4383-1264; Hwang, Jaeuk/0000-0003-0528-3305	National Institute of Health [DA024070]; Korean Health Technology R&D Project, the Korean Ministry of Health Welfare [A101219]; Global Top 5 program, the Ewha W. University; Basic Science Research Program, the National Research Foundation of Korea [2011-0014500]; Medi-Star Program, the Korean Ministry of Health and Welfare [A11200]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247, R01DA024070] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Health Technology R&D Project, the Korean Ministry of Health Welfare; Global Top 5 program, the Ewha W. University; Basic Science Research Program, the National Research Foundation of Korea; Medi-Star Program, the Korean Ministry of Health and Welfare; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The present study was supported by the grants from the National Institute of Health (DA024070, Drs. Renshaw and Lyoo), from the Korean Health Technology R&D Project, the Korean Ministry of Health & Welfare (A101219, Dr. Lyoo), from the Global Top 5 program, the Ewha W. University (Dr. Lyoo), from the Basic Science Research Program, the National Research Foundation of Korea (2011-0014500, Dr. Hwang), and from the Medi-Star Program, the Korean Ministry of Health and Welfare (A11200, Dr. Kim). The sponsors of the study had no role in the study design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Aviv RI, 2010, CAN ASSOC RADIOL J, V61, P29, DOI 10.1016/j.carj.2009.09.002; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Dickey CC, 2007, SCHIZOPHR RES, V89, P49, DOI 10.1016/j.schres.2006.08.004; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P286; Fiellin DA, 2008, JAMA-J AM MED ASSOC, V300, P2057, DOI 10.1001/jama.2008.567; Filipovic B, 2005, PSYCHIAT CLIN NEUROS, V59, P106, DOI 10.1111/j.1440-1819.2005.01341.x; Filipovic B, 2004, EUR ARCH PSY CLIN N, V254, P228, DOI 10.1007/s00406-004-0483-4; First M. D., 1996, USERS GUIDE STRUCTUR; Fowler Joanna S, 2007, Sci Pract Perspect, V3, P4; Gallinat J, 2008, NEURODEGENER DIS, V5, P277, DOI 10.1159/000135612; Gavello-Baudy S, 2008, PSYCHOPHARMACOLOGY, V201, P219, DOI 10.1007/s00213-008-1263-z; GONG WH, 1995, BRAIN RES, V683, P221, DOI 10.1016/0006-8993(95)00376-2; Grella CE, 2011, DRUG ALCOHOL DEPEN, V118, P251, DOI 10.1016/j.drugalcdep.2011.04.004; Hill SY, 2001, BIOL PSYCHIAT, V49, P894, DOI 10.1016/S0006-3223(01)01088-5; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; Kasai K, 2004, SCHIZOPHR RES, V71, P65, DOI 10.1016/j.schres.2003.12.010; Kim MJ, 2007, BIPOLAR DISORD, V9, P274, DOI 10.1111/j.1399-5618.2007.00442.x; Kirk RE, 1995, EXPT DESIGN; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kwon JS, 1998, AM J PSYCHIAT, V155, P509, DOI 10.1176/ajp.155.4.509; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Lyoo IK, 2006, PSYCHOPHARMACOLOGY, V184, P139, DOI 10.1007/s00213-005-0198-x; Makris N, 2004, NEURON, V44, P729, DOI 10.1016/j.neuron.2004.10.027; May FS, 2004, BIOL PSYCHIAT, V55, P656, DOI 10.1016/j.biopsych.2003.09.018; Nopoulos PC, 1998, AM J PSYCHIAT, V155, P1074, DOI 10.1176/ajp.155.8.1074; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Pittella JEH, 2005, SURG NEUROL, V63, P30, DOI 10.1016/j.surneu.2004.09.012; Raine A, 2010, BRIT J PSYCHIAT, V197, P186, DOI 10.1192/bjp.bp.110.078485; Rajarethinam R, 2008, SCHIZOPHR RES, V103, P22, DOI 10.1016/j.schres.2007.11.031; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; SARWAR M, 1989, AM J NEURORADIOL, V10, P989; SHAW CM, 1969, BRAIN, V92, P213, DOI 10.1093/brain/92.1.213; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; Takahashi T, 2007, PROG NEURO-PSYCHOPH, V31, P1235, DOI 10.1016/j.pnpbp.2007.04.019; Trzesniak C, 2011, SCHIZOPHR RES, V125, P1, DOI 10.1016/j.schres.2010.09.016; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78590	10.1371/journal.pone.0078590	http://dx.doi.org/10.1371/journal.pone.0078590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205275	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300071
J	Panganiban, RAM; Day, RM				Panganiban, Ronald Allan M.; Day, Regina M.			Inhibition of IGF-1R Prevents Ionizing Radiation-Induced Primary Endothelial Cell Senescence	PLOS ONE			English	Article							GROWTH-FACTOR-I; LIFE-SPAN; SENSITIZES CELLS; OXIDATIVE STRESS; INSULIN; RECEPTOR; MTOR; EXPRESSION; RAPAMYCIN; P53	Accelerated senescence is a primary response to cellular stresses including DNA damaging agents (e. g., ionizing radiation) and is widely believed to be caused by continuous proliferative signaling in the presence of cell cycle arrest. Studies of signal transduction pathways leading to accelerated senescence have revealed that inhibition of mammalian target of rapamycin (mTOR) by rapamycin rescues cells from senescence. However, the molecular mechanisms upstream of mTOR following ionizing radiation (IR) are not well defined. We investigated signal transduction leading to IR-induced accelerated senescence in human pulmonary artery endothelial cells (HPAEC). Exposure of HPAEC to X-rays (10 Gy, 2.4 Gy/min) upregulated senescence markers including p53, p21/waf1, and senescence-associated beta galactosidase (SA-beta-gal). Ly294002 (a phosphatidylinositol-3-kinase [PI3K] inhibitor) or rapamycin (an mTOR inhibitor) blocked the induction of cellular senescence markers suggesting roles for PI3K and mTOR. Pathway-directed microarrays revealed increased transcription of insulin-like growth factor I (IGF-1), a modulator of cell growth and proliferation upstream of mTOR. qRT-PCR confirmed that both IGF-1 and IGF-2 mRNA were increased in response to X-rays, and ELISA showed increased secretion of IGF-1 protein into the medium of irradiated HPAEC. Consistent with upregulation of these ligands, we found that X-ray exposure led to hyperphosphorylation of IGF-1R, the receptor for IGF-1 and -2. Treatment with AG1024, an IGF-1R inhibitor, suppressed IR-induced upregulation of p53, p21/waf1, and SA-beta-gal. Together these findings suggest that IGF-1R is a key regulator of IR-induced accelerated senescence in a pathway that requires intact mTOR activity upstream of both p53 and p21/waf1.	[Panganiban, Ronald Allan M.; Day, Regina M.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Day, RM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	regina.day@usuhs.edu	Panganiban, Ronald Allan/AAH-3859-2020	Panganiban, Ronald Allan/0000-0003-0894-1318	USUHS Intramural Grant; USUHS	USUHS Intramural Grant; USUHS	This study was supported by a USUHS Intramural Grant, and a USUHS predoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOUD SL, 1991, J CLIN INVEST, V88, P470, DOI 10.1172/JCI115327; Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394; Bandyopadhyay Debdutta, 2005, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1809s27; Baserga R, 1999, EXP CELL RES; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Blagosklonny MV, 2011, AGING-US, V3, P685, DOI 10.18632/aging.100352; Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281; Bouallegue A, 2009, FREE RADICAL BIO MED, V47, P858, DOI 10.1016/j.freeradbiomed.2009.06.022; Boucher MJ, 2004, AM J PHYSIOL-GASTR L, V286, pG736, DOI 10.1152/ajpgi.00453.2003; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chenal J, 2008, EUR J NEUROSCI, V27, P53, DOI 10.1111/j.1460-9568.2007.05981.x; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Cosaceanu D, 2007, ONCOGENE, V26, P2423, DOI 10.1038/sj.onc.1210037; Costantini C, 2010, J MOL NEUROSCI, V40, P342, DOI 10.1007/s12031-009-9305-5; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dricu A, 1997, GLYCOBIOLOGY, V7, P625, DOI 10.1093/glycob/7.5.625; Dricu A, 1997, CANCER RES, V57, P543; Drullion C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.111; FERRARI S, 1991, J BIOL CHEM, V266, P22770; Floratou K, 2012, J RADIAT RES, V53, P672, DOI 10.1093/jrr/rrs019; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hampel B, 2004, EXP GERONTOL, V39, P1713, DOI 10.1016/j.exger.2004.05.010; Handayaningsih AE, 2012, BIOCHEM BIOPH RES CO, V425, P478, DOI 10.1016/j.bbrc.2012.07.140; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Khalid M, 2000, ANIM REPROD SCI, V58, P261, DOI 10.1016/S0378-4320(99)00075-5; Kojima K, 2008, LEUKEMIA, V22, P1728, DOI 10.1038/leu.2008.158; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leach JK, 2001, CANCER RES, V61, P3894; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Leontieva OV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026126; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; LEROITH D, 1995, ANN INTERN MED, V122, P54, DOI 10.7326/0003-4819-122-1-199501010-00009; Leroith Derek, 1995, Progress in Growth Factor Research, V6, P433, DOI 10.1016/0955-2235(96)00009-9; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lopaczynski W, 2000, BIOCHEM BIOPH RES CO, V279, P955, DOI 10.1006/bbrc.2000.4046; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Panganiban RAM, 2013, INT J RADIAT BIOL, V89, P656, DOI 10.3109/09553002.2012.711502; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Qiu W, 2010, ONCOGENE, V29, P1622, DOI 10.1038/onc.2009.451; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Salatino M, 2004, ONCOGENE, V23, P5161, DOI 10.1038/sj.onc.1207659; Tezuka M, 2001, CLIN CANCER RES, V7, P3206; Tran D, 2008, THESIS BOSTON U; Tran D, 2008, IGF 1 INDUCES PREMAT; Turner BC, 1997, CANCER RES, V57, P3079; Valenciano A, 2012, TRANSL ONCOL, V5, P1, DOI 10.1593/tlo.11265; Weitsman GE, 2009, BREAST CANCER RES TR, V118, P269, DOI 10.1007/s10549-008-0221-0; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828	62	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78589	10.1371/journal.pone.0078589	http://dx.doi.org/10.1371/journal.pone.0078589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205274	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300070
J	Sebastian, V; Estil, JB; Chen, D; Schrott, LM; Serrano, PA				Sebastian, Veronica; Estil, Jim Brian; Chen, Daniel; Schrott, Lisa M.; Serrano, Peter A.			Acute Physiological Stress Promotes Clustering of Synaptic Markers and Alters Spine Morphology in the Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; SPATIAL WORKING-MEMORY; DENDRITIC SPINES; PKM-ZETA; AMPA RECEPTORS; DENTATE GYRUS; PLASTICITY; CORTICOSTERONE; DYNAMICS	GluA2-containing AMPA receptors and their association with protein kinase M zeta (PKM zeta) and post-synaptic density-95 (PSD-95) are important for learning, memory and synaptic plasticity processes. Here we investigated these synaptic markers in the context of an acute 1h platform stress, which can disrupt spatial memory retrieval for a short-term memory on the object placement task and long-term memory retrieval on a well-learned radial arm maze task. Acute stress increased serum corticosterone and elevated the expression of synaptic PKM zeta while decreasing synaptic GluA2. Using co-immunoprecipitation, we found that this stressor promotes the clustering of GluA2, PKM zeta and PSD-95, which is consistent with effects reported from overexpression of PKM zeta in cell culture. Because PKM zeta overexpression has also been shown to induce spine maturation in culture, we examined how stress impacts synaptic markers within changing spines across various hippocampal subfields. To achieve this, we employed a new technique combining Golgi staining and immmunohistochemistry to perform 3D reconstruction of tertiary dendrites, which can be analyzed for differences in spine types and the colocalization of synaptic markers within these spines. In CA1, stress increased the densities of long-thin and mushroom spines and the colocalization of GluA2/PSD-95 within these spines. Conversely, in CA3, stress decreased the densities of filopodia and stubby spines, with a concomitant reduction in the colocalization of GluA2/PSD-95 within these spines. In the outer molecular layer (OML) of the dentate gyrus (DG), stress increased both stubby and long-thin spines, together with greater GluA2/PSD-95 colocalization. These data reflect the rapid effects of stress on inducing morphological changes within specific hippocampal subfields, highlighting a potential mechanism by which stress can modulate memory consolidation and retrieval.	[Sebastian, Veronica; Estil, Jim Brian; Chen, Daniel; Serrano, Peter A.] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Schrott, Lisa M.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Serrano, Peter A.] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; City University of New York (CUNY) System	Serrano, PA (corresponding author), CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA.	serrano@genectr.hunter.cuny.edu		Chen, Daniel/0000-0003-3857-1741	National Institute on Minority Health and Health Disparities from the National Institutes of Health [MD007599]; Department of Defense [W81XWH-08-1-0243]; Professional Staff Congress-City University of New York [PSC-CUNY 43]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS080686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA012136] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities from the National Institutes of Health; Department of Defense(United States Department of Defense); Professional Staff Congress-City University of New York; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding was provided by the National Institute on Minority Health and Health Disparities (MD007599) from the National Institutes of Health to Hunter College, and by the Department of Defense (W81XWH-08-1-0243) and the Professional Staff Congress-City University of New York (PSC-CUNY 43) to P. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cazakoff BN, 2010, PROG NEURO-PSYCHOPH, V34, P733, DOI 10.1016/j.pnpbp.2010.04.002; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Deller T, 1996, J NEUROSCI, V16, P3322; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Diamond DM, 1996, BEHAV NEUROSCI, V110, P661, DOI 10.1037/0735-7044.110.4.661; Dorey R, 2012, NEUROPSYCHOPHARMACOL, V37, P2870, DOI 10.1038/npp.2012.170; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Finnie PSB, 2012, NEUROSCI BIOBEHAV R, V36, P1667, DOI 10.1016/j.neubiorev.2012.03.008; Garner CC, 2006, CELL TISSUE RES, V326, P249, DOI 10.1007/s00441-006-0278-1; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Hara Y, 2012, J NEUROSCI, V32, P7336, DOI 10.1523/JNEUROSCI.0605-12.2012; Hardt O, 2010, HIPPOCAMPUS, V20, P691, DOI 10.1002/hipo.20708; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Joels M, 2011, TRENDS COGN SCI, V15, P280, DOI 10.1016/j.tics.2011.04.004; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kesner RP, 2008, BEHAV NEUROSCI, V122, P1217, DOI 10.1037/a0013592; Kesner RP, 2001, HIPPOCAMPUS, V11, P240, DOI 10.1002/hipo.1040; Kesner RP, 2013, FRONT CELL NEUROSCI, V122, P1217; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kole MHP, 2004, NEUROSCIENCE, V125, P337, DOI 10.1016/j.neuroscience.2004.02.014; Lee I, 2003, BEHAV NEUROSCI, V117, P1044, DOI 10.1037/0735-7044.117.5.1044; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Madronal N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010400; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Nakagawa S, 2011, NEUROSCI BIOBEHAV R, V35, P462, DOI 10.1016/j.neubiorev.2010.06.003; NOGUES X, 1994, HIPPOCAMPUS, V4, P71, DOI 10.1002/hipo.450040109; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pinto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033114; Ron S, 2012, CEREB CORTEX, V22, P2519, DOI 10.1093/cercor/bhr323; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Schrott LM, 2008, BRAIN RES, V1198, P132, DOI 10.1016/j.brainres.2008.01.020; Segal M, 2010, EUR J NEUROSCI, V31, P2178, DOI 10.1111/j.1460-9568.2010.07270.x; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shao CY, 2012, HIPPOCAMPUS, V22, P1501, DOI 10.1002/hipo.20996; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Spiga S, 2011, BRAIN STRUCT FUNCT, V216, P171, DOI 10.1007/s00429-011-0312-2; VANEEKELEN JAM, 1992, PROG HISTOCHEM CYTOC, V26, P250, DOI 10.1016/S0079-6336(11)80102-6; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	75	50	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79077	10.1371/journal.pone.0079077	http://dx.doi.org/10.1371/journal.pone.0079077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205365	Green Published, gold			2022-12-27	WOS:000326152300090
J	Yeung, CY; Tso, AWK; Xu, AM; Wang, Y; Woo, YC; Lam, TH; Lo, SV; Fong, CHY; Wat, NMS; Woo, J; Cheung, BMY; Lam, KSL				Yeung, Chun-Yip; Tso, Annette Wai-Kwan; Xu, Aimin; Wang, Yu; Woo, Yu-Cho; Lam, Tai-Hing; Lo, Su-Vui; Fong, Carol Ho-Yee; Wat, Nelson Ming-Sang; Woo, Jean; Cheung, Bernard Man-Yung; Lam, Karen Siu-Ling			Pro-Inflammatory Adipokines as Predictors of Incident Cancers in a Chinese Cohort of Low Obesity Prevalence in Hong Kong	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; PROSTATE-CANCER; GROWTH-FACTOR; RISK-FACTORS; ADIPONECTIN; IL-6; INTERLEUKIN-6; HYPERTENSION; ASSOCIATION	Background: Cytokines released from adipose tissues induce chronic low-grade inflammation, which may enhance cancer development. We investigated whether indices of obesity and circulating adipokine levels could predict incident cancer risk. Materials and Methods: This longitudinal community-based study included subjects from the Hong Kong Cardiovascular Risk Factors Prevalence Study (CRISPS) study commenced in 1995-1996 (CRISP-1) with baseline assessments including indices of obesity. Subjects were reassessed in 2000-2004 (CRISPS-2) with measurement of serum levels of adipokines including interleukin-6 (IL-6), soluble tumor necrosis factor receptor 2 (sTNFR2; as a surrogate marker of tumor necrosis factor-a activity), leptin, lipocalin 2, adiponectin and adipocyte-fatty acid binding protein (A-FABP). Incident cancer cases were identified up to 31 December 2011. Results: 205 of 2893 subjects recruited at CRISPS-1 had developed incident cancers. More of the subjects who developed cancers were obese (22.1 vs 16.1%) or had central obesity (36.6 vs 24.5%) according to Asian cut-offs. Waist circumference (adjusted HR 1.02 [1.00-1.03] per cm; p=0.013), but not body mass index (adjusted HR 1.04 [1.00-1.08] per kg/m(2); p=0.063), was a significant independent predictor for incident cancers after adjustment for age, sex and smoking status. 99 of 1899 subjects reassessed at CRISPS-2 had developed cancers. Subjects who developed cancers had significantly higher level of hsCRP, IL-6, sTNFR2 and lipocalin 2. After adjustment for conventional risk factors, only IL-6 (HR 1.51, 95% CI 1.18-1.95) and sTNFR2 (HR 3.27, 95% CI 1.65-6.47) predicted cancer development. Conclusions: Our data supported the increased risk of malignancy by chronic low grade inflammation related to central obesity.	[Yeung, Chun-Yip; Tso, Annette Wai-Kwan; Xu, Aimin; Wang, Yu; Woo, Yu-Cho; Fong, Carol Ho-Yee; Wat, Nelson Ming-Sang; Cheung, Bernard Man-Yung; Lam, Karen Siu-Ling] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Tso, Annette Wai-Kwan; Xu, Aimin; Wang, Yu; Cheung, Bernard Man-Yung; Lam, Karen Siu-Ling] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China; [Lam, Tai-Hing] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Lo, Su-Vui] Hosp Author, Dept Strategy & Planning, Kowloon, Hong Kong, Peoples R China; [Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong	Cheung, BMY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	mycheung@hku.hk; ksllam@hku.hk	Woo, Jean/K-2625-2014; /E-9829-2010; Lam, Tai Hing/C-4317-2009	Woo, Jean/0000-0001-7593-3081; /0000-0001-9106-7363; Lam, Tai Hing/0000-0002-2033-9971; wang, yu/0000-0001-8697-2940	Hong Kong Research Grants Council [HKU780210M]; Health and Health Services Research Fund of Food and Health Bureau of Hong Kong (HHSRF) [06070951]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Health and Health Services Research Fund of Food and Health Bureau of Hong Kong (HHSRF)	This study was finanically supported by funding from the Hong Kong Research Grants Council (http://www.ugc.edu.hk/eng/rgc/index.htm, reference number HKU780210M) and Health and Health Services Research Fund of Food and Health Bureau of Hong Kong (http://www.fhb.gov.hk/grants/english/welcome/welcome.html, HHSRF reference number 06070951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ansary-Moghaddam A, 2006, CANCER EPIDEM BIOMAR, V15, P2435, DOI 10.1158/1055-9965.EPI-06-0368; Baillargeon J, 2006, CANCER EPIDEM BIOMAR, V15, P1331, DOI 10.1158/1055-9965.EPI-06-0082; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chan AT, 2011, GASTROENTEROLOGY, V140, P799, DOI 10.1053/j.gastro.2010.11.041; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Fernandez-Real JM, 2003, INT J OBESITY, V27, P1552, DOI 10.1038/sj.ijo.0802472; Folkerd EJ, 2010, J CLIN ONCOL, V28, P4038, DOI 10.1200/JCO.2009.27.4290; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Ho GYF, 2012, CANCER RES, V72, P3029, DOI 10.1158/0008-5472.CAN-11-2771; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hsing AW, 2000, CANCER EPIDEM BIOMAR, V9, P1335; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Leung L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046677, DOI 10.1371/J0URNAL.P0NE.0046677.PUBMED:23056397]; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McMillan DC, 2006, BRIT MED J, V333, P1109, DOI 10.1136/bmj.39042.565035.BE1; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Petridou ET, 2007, ONCOLOGY-BASEL, V73, P261, DOI 10.1159/000127424; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tworoger SS, 2007, OBESITY, V15, P2217, DOI 10.1038/oby.2007.263; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; World Health Organization Office of Health Communications and Public Relations, 2006, OB OV, P3	42	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78594	10.1371/journal.pone.0078594	http://dx.doi.org/10.1371/journal.pone.0078594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205276	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300072
J	Ou, M; Sandri-Goldin, RM				Ou, Mark; Sandri-Goldin, Rozanne M.			Inhibition of cdk9 during Herpes Simplex Virus 1 Infection Impedes Viral Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; EARLY PROTEIN ICP22; P-TEFB; REPLICATION COMPARTMENTS; ARGININE METHYLATION; ELONGATION-FACTOR; NUCLEAR EXPORT; LARGE SUBUNIT; PHOSPHORYLATION	During herpes simplex virus 1 (HSV-1) infection there is a loss of the serine-2 phosphorylated form of RNA polymerase II (RNAP II) found in elongation complexes. This occurs in part because RNAP II undergoes ubiquitination and proteasomal degradation during times of highly active viral transcription, which may result from stalled elongating complexes. In addition, a viral protein, ICP22, was reported to trigger a loss of serine-2 RNAP II. These findings have led to some speculation that the serine-2 phosphorylated form of RNAP II may not be required for HSV-1 transcription, although this form is required for cellular transcription elongation and RNA processing. Cellular kinase cdk9 phosphorylates serine-2 in the C-terminal domain (CTD) of RNAP II. To determine if serine-2 phosphorylated RNAP II is required for HSV-1 transcription, we inhibited cdk9 during HSV-1 infection and measured viral gene expression. Inhibition was achieved by adding cdk9 inhibitors 5,6-dichlorobenzimidazone-1-beta-D-ribofuranoside (DRB) or flavopiridol (FVP) or by expression of a dominant-negative cdk9 or HEXIM1, which in conjunction with 7SK snRNA inhibits cdk9 in complex with cyclin 1. Here we report that inhibition of cdk9 resulted in decreased viral yields and levels of late proteins, poor formation of viral transcription-replication compartments, reduced levels of poly(A)+ mRNA and decreased RNA synthesis as measured by uptake of 5-bromouridine into nascent RNA. Importantly, a global reduction in viral mRNAs was seen as determined by microarray analysis. We conclude that serine-2 phosphorylation of the CTD of RNAP II is required for HSV-1 transcription.	[Ou, Mark; Sandri-Goldin, Rozanne M.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine	Sandri-Goldin, RM (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	rmsandri@uci.edu			United Stated National Institutes of Health [R37 AI21515]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021515] Funding Source: NIH RePORTER	United Stated National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United Stated National Institutes of Health grant R37 AI21515. The funders had no role in study design, data collection and analysis, decision to publish. or preparation of the manuscript.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Bastian TW, 2009, J VIROL, V83, P128, DOI 10.1128/JVI.01954-08; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Bigalke JM, 2011, J MOL BIOL, V414, P639, DOI 10.1016/j.jmb.2011.10.022; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Chen IHB, 2002, J VIROL, V76, P12877, DOI 10.1128/JVI.76.24.12877-12889.2002; Cho WK, 2010, J VIROL, V84, P12801, DOI 10.1128/JVI.00943-10; CHRISTOFORI G, 1989, MOL CELL BIOL, V9, P193, DOI 10.1128/MCB.9.1.193; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; Doyle O, 2002, J STRUCT BIOL, V140, P154, DOI 10.1016/S1047-8477(02)00547-6; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Durand LO, 2005, J VIROL, V79, P6757, DOI 10.1128/JVI.79.11.6757-6762.2005; Feichtinger S, 2011, J GEN VIROL, V92, P1519, DOI 10.1099/vir.0.030494-0; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Fraser KA, 2005, J VIROL, V79, P11323, DOI 10.1128/JVI.79.17.11323-11334.2005; Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07; Garriga J, 2010, J CELL PHYSIOL, V222, P200, DOI 10.1002/jcp.21938; Grondin B, 2000, J VIROL, V74, P11504, DOI 10.1128/JVI.74.24.11504-11510.2000; Gu B, 2013, NUCLEIC ACIDS RES, V41, P1591, DOI 10.1093/nar/gks1327; Guo L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045749; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Kapasi AJ, 2009, J VIROL, V83, P5904, DOI 10.1128/JVI.02651-08; KNIPE DM, 1987, J VIROL, V61, P276, DOI 10.1128/JVI.61.2.276-284.1987; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001491; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Long MC, 1999, J VIROL, V73, P5593, DOI 10.1128/JVI.73.7.5593-5604.1999; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x; Palermo RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002334; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; RICE SA, 1994, J VIROL, V68, P988, DOI 10.1128/JVI.68.2.988-1001.1994; RICE SA, 1995, J VIROL, V69, P5550, DOI 10.1128/JVI.69.9.5550-5559.1995; Salerno D, 2007, GENE, V405, P65, DOI 10.1016/j.gene.2007.09.010; Sandri-Goldin RM, 1998, GENE DEV, V12, P868, DOI 10.1101/gad.12.6.868; SMITH IL, 1992, VIROLOGY, V186, P74, DOI 10.1016/0042-6822(92)90062-T; Souki SK, 2009, J VIROL, V83, P8970, DOI 10.1128/JVI.00801-09; Souki SK, 2009, J VIROL, V83, P5309, DOI 10.1128/JVI.00238-09; Stingley SW, 2000, J VIROL, V74, P9916, DOI 10.1128/JVI.74.21.9916-9927.2000; Sun AX, 2004, J VIROL, V78, P10470, DOI 10.1128/JVI.78.19.10470-10478.2004; Tamrakar S, 2005, J VIROL, V79, P15477, DOI 10.1128/JVI.79.24.15477-15493.2005; Taylor TJ, 2003, VIROLOGY, V309, P232, DOI 10.1016/S0042-6822(03)00107-7; Toth Z, 2012, J VIROL, V86, P9696, DOI 10.1128/JVI.01012-12; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	62	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e79007	10.1371/journal.pone.0079007	http://dx.doi.org/10.1371/journal.pone.0079007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205359	Green Published, gold			2022-12-27	WOS:000326029300169
J	Alemu, K; Worku, A; Berhane, Y				Alemu, Kassahun; Worku, Alemayehu; Berhane, Yemane			Malaria Infection Has Spatial, Temporal, and Spatiotemporal Heterogeneity in Unstable Malaria Transmission Areas in Northwest Ethiopia	PLOS ONE			English	Article							VILLAGE LEVEL; EPIDEMIC; PATTERNS; FALCIPARUM; CLUSTERS	Background: Malaria elimination requires successful nationwide control efforts. Detecting the spatiotemporal distribution and mapping high-risk areas are useful to effectively target pockets of malaria endemic regions for interventions. Objective: The aim of the study was to identify patterns of malaria distribution by space and time in unstable malaria transmission areas in northwest Ethiopia. Methods: Data were retrieved from the monthly reports stored in the district malaria offices for the period between 2003 and 2012. Eighteen districts in the highland and fringe malaria areas were included and geo-coded for the purpose of this study. The spatial data were created in ArcGIS10 for each district. The Poisson model was used by applying Kulldorff methods using the SaTScan (TM) software to analyze the purely temporal, spatial and space-time clusters of malaria at a district levels. Results: The study revealed that malaria case distribution has spatial, temporal, and spatiotemporal heterogeneity in unstable transmission areas. Most likely spatial malaria clusters were detected at Dera, Fogera, Farta, Libokemkem and Misrak Este districts (LLR = 197764.1, p<0.001). Significant spatiotemporal malaria clusters were detected at Dera, Fogera, Farta, Libokemkem and Misrak Este districts (LLR=197764.1, p<0.001) between 2003/1/1 and 2012/12/31. A temporal scan statistics identified two high risk periods from 2009/1/1 to 2010/12/31 (LLR=72490.5, p<0.001) and from 2003/1/1 to 2005/12/31 (LLR=26988.7, p<0.001). Conclusion: In unstable malaria transmission areas, detecting and considering the spatiotemporal heterogeneity would be useful to strengthen malaria control efforts and ultimately achieve elimination.	[Alemu, Kassahun] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Addis Ababa, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia	University of Gondar; Addis Ababa University; Addis Continental Institute of Public Health	Alemu, K (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia.	alemukass@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	University of Gondar	University of Gondar	University of Gondar is the source of the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Chowell G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-142; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; ESRI, 2011, ARCGIS DESKT REL 10; FDREMoH, 2009, ED DEM REP ETH MIN H; FMOH, 2012, PRES MAL IN MAL OP P; FONTAINE RE, 1961, AM J TROP MED HYG, V10, P795, DOI 10.4269/ajtmh.1961.10.795; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Haque U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-185; Hui FM, 2009, AM J TROP MED HYG, V81, P503; Jackson MC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-55; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kleinschmidt I, 2002, AM J EPIDEMIOL, V155, P257, DOI 10.1093/aje/155.3.257; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2009, SER GUIDE VERSION 9; Kulldorff M., 1999, J NATL I PUBLIC HLTH, V48, P94; Mboera LEG, 2010, GEOSPATIAL HEALTH, V4, P167, DOI 10.4081/gh.2010.198; Negash K, 2005, East Afr Med J, V82, P186; Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662; Robertson C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-16; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Wen L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-88; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5	25	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79966	10.1371/journal.pone.0079966	http://dx.doi.org/10.1371/journal.pone.0079966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223209	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200102
J	Yao, LL; Kan, EM; Kaur, C; Dheen, ST; Hao, AJ; Lu, J; Ling, EA				Yao, Linli; Kan, Enci Mary; Kaur, Charanjit; Dheen, S. Thameem; Hao, Aijun; Lu, Jia; Ling, Eng-Ang			Notch-1 Signaling Regulates Microglia Activation via NF-kappa B Pathway after Hypoxic Exposure In Vivo and In Vitro	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; MURINE BV-2 CELLS; INNATE IMMUNITY; INFLAMMATORY RESPONSE; AMEBOID MICROGLIA; NITRIC-OXIDE; RAT-BRAIN; RECEPTOR; DIFFERENTIATION; EXPRESSION	Neuroinflammation mediated by the activated microglia is suggested to play a pivotal role in the pathogenesis of hypoxic brain injury; however, the underlying mechanism of microglia activation remains unclear. Here, we show that the canonical Notch signaling orchestrates microglia activation after hypoxic exposure which is closely associated with multiple pathological situations of the brain. Notch-1 and Delta-1 expression in primary microglia and BV-2 microglial cells was significantly elevated after hypoxia. Hypoxia-induced activation of Notch signaling was further confirmed by the concomitant increase in the expression and translocation of intracellular Notch receptor domain (NICD), together with RBPJk and target gene Hes-1 expression. Chemical inhibition of Notch signaling with N-[N-(3,5-difluorophenacetyl)-1-alany1-Sphenyglycine t-butyl ester (DAPT), a gamma-secretase inhibitor, effectively reduced hypoxia-induced upregulated expression of most inflammatory mediators. Notch inhibition also reduced NF-kappa B/p65 expression and translocation. Remarkably, Notch inhibition suppressed expression of TLR4/MyD88/TRAF6 pathways. In vivo, Notch signaling expression and activation in microglia were observed in the cerebrum of postnatal rats after hypoxic injury. Most interestingly, hypoxia-induced upregulation of NF-kappa B immunoexpression in microglia was prevented when the rats were given DAPT pretreatment underscoring the interrelationship between Notch signaling and NF-kappa B pathways. Taken together, we conclude that Notch signaling is involved in regulating microglia activation after hypoxia partly through the cross talk between TLR4/MyD88/TRAF6/NF-kappa B pathways. Therefore, Notch signaling may serve as a prospective target for inhibition of microglia activation known to be implicated in brain damage in the developing brain.	[Yao, Linli; Hao, Aijun] Shandong Univ, Sch Med, Dept Histol & Embryol, Key Lab Minist Educ Expt Teratol,Shandong Prov Ke, Jinan 250100, Shandong, Peoples R China; [Kan, Enci Mary; Lu, Jia] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore; [Yao, Linli; Kaur, Charanjit; Dheen, S. Thameem; Ling, Eng-Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore	Shandong University; National University of Singapore	Ling, EA (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore.	antlea@nus.edu.sg	Dheen, S. Thameem/AAU-8627-2020	Dheen, S. Thameem/0000-0001-9600-6789	National University of Singapore [R-181-000-140-592]	National University of Singapore(National University of Singapore)	This study was supported by grant No. R-181-000-140-592 from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Basovich SN, 2010, BIOSCI TRENDS, V4, P288; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cao Q, 2011, NEUROSCIENCE, V192, P140, DOI 10.1016/j.neuroscience.2011.06.060; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Cao Q, 2008, GLIA, V56, P1224, DOI 10.1002/glia.20692; Chen YP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030437, 10.1371/journal.pone.0046512, 10.1371/journal.pone.0036329]; Correia SC, 2013, CURR PHARM IN PRESS; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Cummins AG, 2013, DIGEST DIS SCI, V58, P678, DOI 10.1007/s10620-012-2422-y; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Grandbarbe L, 2007, GLIA, V55, P1519, DOI 10.1002/glia.20553; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Heyen JRR, 2000, MOL BRAIN RES, V77, P138, DOI 10.1016/S0169-328X(00)00042-5; Johnston MV, 1997, BRAIN DEV-JPN, V19, P235, DOI 10.1016/S0387-7604(96)00561-X; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kim MY, 2008, J CELL SCI, V121, P1466, DOI 10.1242/jcs.019018; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kopan R, 2002, J CELL SCI, V115, P1095; Koscso B, 2012, J IMMUNOL, V188, P445, DOI 10.4049/jimmunol.1101224; Kramer H, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.29.pe1; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lanner F, 2013, STEM CELLS DEV, V22, P1360, DOI 10.1089/scd.2012.0259; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Li P, 2009, NEUROSCIENCE, V164, P948, DOI 10.1016/j.neuroscience.2009.08.044; Lutolf S, 2002, DEVELOPMENT, V129, P373; Marignol L, 2013, NAT REV UROL, V10, P405, DOI 10.1038/nrurol.2013.110; Matsuno Y, 2012, INT J BIOCHEM CELL B, V44, P776, DOI 10.1016/j.biocel.2012.01.021; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Morga E, 2009, GLIA, V57, P1741, DOI 10.1002/glia.20887; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; Outtz HH, 2011, BLOOD, V118, P3436, DOI 10.1182/blood-2010-12-327015; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Parer JT, 1998, COMP BIOCHEM PHYS A, V119, P711, DOI 10.1016/S1095-6433(98)01009-5; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Richards GS, 2009, COLD SH Q B, V74, P81, DOI 10.1101/sqb.2009.74.028; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tsao PN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-56; Valapala M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2624; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wearing HJ, 2000, B MATH BIOL, V62, P293, DOI 10.1006/bulm.1999.0152; Wei ZL, 2011, STROKE, V42, P2589, DOI 10.1161/STROKEAHA.111.614834; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Yonekura S, 2013, ANTICANCER RES, V33, P3099; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhou ZD, 2010, IUBMB LIFE, V62, P618, DOI 10.1002/iub.362	62	88	97	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78439	10.1371/journal.pone.0078439	http://dx.doi.org/10.1371/journal.pone.0078439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223152	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200044
J	Melo, HPM; Franks, A; Moreira, AA; Diermeier, D; Andrade, JS; Amaral, LAN				Melo, Hygor Piaget M.; Franks, Alexander; Moreira, Andre A.; Diermeier, Daniel; Andrade, Jose S., Jr.; Amaral, Luis A. Nunes			A Solution to the Challenge of Optimization on "Golf-Course"-Like Fitness Landscapes	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; EVOLUTION; NETWORKS	Genetic algorithms (GAs) have been used to find efficient solutions to numerous fundamental and applied problems. While GAs are a robust and flexible approach to solve complex problems, there are some situations under which they perform poorly. Here, we introduce a genetic algorithm approach that is able to solve complex tasks plagued by so-called ''golf-course''-like fitness landscapes. Our approach, which we denote variable environment genetic algorithms (VEGAs), is able to find highly efficient solutions by inducing environmental changes that require more complex solutions and thus creating an evolutionary drive. Using the density classification task, a paradigmatic computer science problem, as a case study, we show that more complex rules that preserve information about the solution to simpler tasks can adapt to more challenging environments. Interestingly, we find that conservative strategies, which have a bias toward the current state, evolve naturally as a highly efficient solution to the density classification task under noisy conditions.	[Melo, Hygor Piaget M.; Moreira, Andre A.; Andrade, Jose S., Jr.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil; [Franks, Alexander; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Franks, Alexander] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Diermeier, Daniel] Northwestern Univ, Kellogg Sch Management, MEDS, Evanston, IL USA; [Diermeier, Daniel; Amaral, Luis A. Nunes] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL USA; [Diermeier, Daniel] Canadian Inst Adv Res, Toronto, ON, Canada; [Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA	Universidade Federal do Ceara; Northwestern University; Harvard University; Northwestern University; Northwestern University; Canadian Institute for Advanced Research (CIFAR); Howard Hughes Medical Institute; Northwestern University	Melo, HPM (corresponding author), Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil.	hygor@fisica.ufc.br	Amaral, LAN/A-4980-2008; Moreira, Andre Auto A/C-5290-2013; Amaral, Luis N./C-5485-2009; Andrade, José S/C-5451-2013	Amaral, LAN/0000-0002-3762-789X; Moreira, Andre Auto A/0000-0003-1046-5218; Andrade, José S/0000-0002-5571-7610; Franks, Alexander/0000-0002-9329-206X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP); Financiadora de Estudos e Projetos; National Institute of Science and Technology for Complex Systems in Brazil; National Institutes of Health [1-P50-GM081892]; FUNCAP/CNPq Pronex grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); National Institute of Science and Technology for Complex Systems in Brazil; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FUNCAP/CNPq Pronex grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Brazilian Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) and Financiadora de Estudos e Projetos, the FUNCAP/CNPq Pronex grant, and the National Institute of Science and Technology for Complex Systems in Brazil for financial support and the National Institutes of Health grant number 1-P50-GM081892 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alharbi A, 2010, INT J COMPUT INTELL, V9, P33, DOI 10.1142/S1469026810002756; Asch S. E., 1951, GROUPS LEADERSHIP ME, P177; CRUTCHFIELD JP, 1995, P NATL ACAD SCI USA, V92, P10742, DOI 10.1073/pnas.92.23.10742; Ferreira C, 2002, GENETIC PROGRAMMING, P123; Gashler M, 2011, IEEE T SYST MAN CY B, V41, P1458, DOI 10.1109/TSMCB.2011.2151187; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; Greulich P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.088101; Haupt R.L., 2004, PRACTICAL GENETIC AL, VSecond, DOI DOI 10.1002/0471671746; Hermsen R, 2012, P NATL ACAD SCI USA, V109, P10775, DOI 10.1073/pnas.1117716109; Hermsen R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248104; Holland, 1975, ADAPTATION NATURAL A; Holland J. H., 1973, SIAM Journal on Computing, V2, P88, DOI 10.1137/0202009; Hoyle F., 1984, INTELLIGENT UNIVERSE; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Maynard Smith J, 1986, PROBLEMS BIOL, V144; Mitchell M., 1996, INTRO GENETIC ALGORI; Moreira AA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218702; Moreira AA, 2004, P NATL ACAD SCI USA, V101, P12085, DOI 10.1073/pnas.0400672101; Ramon y Cajal S, 1999, ADVICE YOUNG INVESTI; Seaver SMD, 2009, EUR PHYS J B, V67, P369, DOI 10.1140/epjb/e2008-00406-4; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; Werfel J, 2000, IEEE T EVOLUT COMPUT, V4, P388, DOI 10.1109/4235.887238; Wolpert DH, 2005, IEEE T EVOLUT COMPUT, V9, P721, DOI 10.1109/TEVC.2005.856205; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Wu ZJ, 1996, SIAM J OPTIMIZ, V6, P748, DOI 10.1137/S1052623493254698; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78401	10.1371/journal.pone.0078401	http://dx.doi.org/10.1371/journal.pone.0078401			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223800	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400024
J	Dang, D; Wang, DX; Zhang, C; Zhou, WL; Zhou, Q; Wu, H				Dang, Dan; Wang, Dongxuan; Zhang, Chuan; Zhou, Wenli; Zhou, Qi; Wu, Hui			Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial	PLOS ONE			English	Article							BILIRUBIN-ALBUMIN BINDING; CLOSURE; ACETAMINOPHEN; MANAGEMENT; DRUG	Trial Design: Oral ibuprofen has demonstrated good effects on symptomatic patent ductus arteriosus (PDA) but with many contraindications and potential side-effects. In the past two years, oral paracetamol administration to several preterm infants with PDA has been reported. Here, a randomized, non-blinded, parallel-controlled and non-inferiority trial was designed to evaluate the efficacy and safety profiles of oral paracetamol to those of standard ibuprofen for PDA closure in premature infants. Methods: One hundred and sixty infants (gestational age <= 34 weeks) with echocardiographically confirmed PDA were randomly assigned to receive either oral paracetamol (n = 80) or ibuprofen (n = 80). After the initial treatment course in both groups, the need for a second course was determined by echocardiographic evaluation. The main outcome was rate of ductal closure, and secondary outcomes were adverse effects and complications. Result: The ductus was closed in 65 (81.2%) infants of the paracetamol group compared with 63 (78.8%) of the ibuprofen group. The 95% confidence interval of the difference between these groups was [-0.080,0.128], demonstrating that the effectiveness of paracetamol treatment was not inferior to that of ibuprofen. In fact, the incidence of hyperbilirubinemia or gastrointestinal bleeding in the paracetamol group was significantly lower than that of the ibuprofen group. No significant differences in other clinical side effects or complications were noted. Conclusion: This comparison of drug efficacy and safety profiles in premature infants with PDA revealed that oral paracetamol was comparable to ibuprofen in terms of the rate of ductal closure and even showed a decreased risk of hyperbilirubinemia or gastrointestinal bleeding. Therefore, paracetamol may be accepted as a first-line drug treatment for PDA in preterm infants.	[Dang, Dan; Zhou, Wenli; Zhou, Qi; Wu, Hui] Jilin Univ, Dept Neonatol, Hosp 1, Changchun 130023, Peoples R China; [Wang, Dongxuan] Jilin Univ, Dept Ultrason Diag, Hosp 1, Changchun 130023, Peoples R China; [Zhang, Chuan] Jilin Univ, Dept Pediat Surg, Hosp 1, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Wu, H (corresponding author), Jilin Univ, Dept Neonatol, Hosp 1, Changchun 130023, Peoples R China.	wuhui97@126.com		Wu, Hui/0000-0002-7649-4575; Zhang, Chuan/0000-0002-2448-8392	Jilin Department of Health [2012Z033]	Jilin Department of Health	The trial "Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial" was funded from Jilin Department of Health (2012Z033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrouche-Amrani L, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-10; Ahlfors CE, 2004, J PEDIATR-US, V144, P386, DOI 10.1016/j.jpeds.2003.11.027; Aranda JV, 2005, NEOREVIEWS, P516; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Capozzi G, 2011, J MATERN-FETAL NEO M, V24, P15, DOI 10.3109/14767058.2011.607564; CooperPeel C, 1996, PHARMACOL TOXICOL, V79, P297, DOI 10.1111/j.1600-0773.1996.tb00012.x; Diot C, 2010, EARLY HUM DEV, V86, P315, DOI [10.1016/j.earlhumdev.2010.04.006, 10.1016/j.earlhumdev.2010.04,006]; Erdeve O, 2012, ARCH DIS CHILD-FETAL, V97, pF279, DOI 10.1136/archdischild-2011-300532; FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003; Gokmen T, 2011, J PEDIATR-US, V158, P549, DOI 10.1016/j.jpeds.2010.10.008; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; GREEN K, 1989, PROSTAG OTH LIPID M, V37, P311, DOI 10.1016/0090-6980(89)90001-4; Hammerman C, 2011, PEDIATRICS, V128, pE1618, DOI 10.1542/peds.2011-0359; Hamrick SEG, 2010, PEDIATRICS, V125, P1020, DOI 10.1542/peds.2009-3506; HEYMANN MA, 1976, NEW ENGL J MED, V295, P530, DOI 10.1056/NEJM197609022951004; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kabra NS, 2007, J PEDIATR-US, V150, P229, DOI 10.1016/j.jpeds.2006.11.039; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Kushnir Alla, 2011, BMC Clin Pharmacol, V11, P8, DOI 10.1186/1472-6904-11-8; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Lucas R, 2005, FASEB J, V19, P635, DOI 10.1096/fj.04-2437fje; Maisels MJ, 2003, ARCH DIS CHILD-FETAL, V88, pF459, DOI 10.1136/fn.88.6.F459; Malviya M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003951.pub2; Ohlsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003481.pub4; Oncel MY, 2013, NEONATOLOGY, V103, P166, DOI 10.1159/000345337; Oncel MY, 2013, ARCH DIS CHILD-FETAL, V98, pF94, DOI 10.1136/archdischild-2012-302044; Rao R, 2011, J PERINATOL, V31, P465, DOI 10.1038/jp.2010.199; Rheinlaender C, 2009, ACTA PAEDIATR, V98, P36, DOI 10.1111/j.1651-2227.2008.01007.x; Shah NA, 2011, J PEDIATR-US, V158, P919, DOI 10.1016/j.jpeds.2010.11.018; Soligard HT, 2010, PEDIATR RES, V67, P614, DOI 10.1203/PDR.0b013e3181da7578; Yurttutan S, 2013, J MATERN-FETAL NEO M, V26, P825, DOI 10.3109/14767058.2012.755162; Zecca E, 2009, PEDIATRICS, V124, P480, DOI 10.1542/peds.2008-2433	32	120	128	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77888	10.1371/journal.pone.0077888	http://dx.doi.org/10.1371/journal.pone.0077888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223740	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400020
J	Shi, L; Shu, XO; Li, HL; Cai, H; Liu, QL; Zheng, W; Xiang, YB; Villegas, R				Shi, Liang; Shu, Xiao-Ou; Li, Honglan; Cai, Hui; Liu, Qiaolan; Zheng, Wei; Xiang, Yong-Bing; Villegas, Raquel			Physical Activity, Smoking, and Alcohol Consumption in Association with Incidence of Type 2 Diabetes among Middle-Aged and Elderly Chinese Men	PLOS ONE			English	Article							RISK-FACTORS; HEALTH; REPRODUCIBILITY; PREVALENCE; VALIDITY; POPULATION; BEHAVIORS; EXERCISE; MELLITUS	Background: Type 2 diabetes mellitus (T2DM) is a prevalent chronic disease worldwide. The prevalence of T2DM is increasing rapidly in China. Understanding the contribution of modifiable lifestyle factors on T2DM risk is imperative to prevent the development of T2DM in China. Methods: We examined associations between lifestyle factors including physical activity, smoking and alcohol consumption with incidence of T2DM among middle-aged and elderly men in urban Shanghai. Information on socio-demographics, lifestyle habits, dietary habits, and disease history was collected via in-person interviews. Anthropometric measurements were taken. A total of 51 464 Chinese men aged 40-74 years free of T2DM, coronary heart disease (CHD), and stroke at baseline were included in the current study. Incident T2DM was identified through follow-up surveys conducted every 2-3 years. Cox proportional hazard analyses were conducted to evaluate associations between lifestyle risk factors and incidence of T2DM. Results: We documented 1304 new cases of T2DM during 276 929 person-years of follow-up (average: 5.4 years). Physical activity was inversely associated with T2DM risk. Daily living, commuting, and total physical activity METs had inverse negative dose-response relationships with T2DM (P-trend = 0.0033, 0.0022, and <0.0001, respectively). Regular participation in exercise or sports reduced T2DM risk (HR = 0.86, 95% CI: 0.76-0.98). Moderate alcohol intake (1-3 drinks/day) was inversely related to T2DM risk (HR = 0.80, 95% CI: 0.67-0.94). Cigarette smoking, on the other hand, was associated with increased T2DM risk; HRs were 1.25 (95% CI: 1.00-1.56) for smoking more than 20 cigarettes per day and 1.28 (95% CI: 1.04-1.57) for smoking more than 40 pack-years. Conclusions: Physical activity and moderate alcohol intake are inversely associated with T2DM risk, whereas smoking was positively associated with T2DM risk among middle-age and elderly Chinese men. Preventive measures should be developed to focus on these modifiable lifestyle habits to reduce the upward trend of T2DM.	[Shi, Liang; Shu, Xiao-Ou; Cai, Hui; Liu, Qiaolan; Zheng, Wei] Vanderbilt Univ, Dept Med, Div Epidemiol, Med Ctr, Nashville, TN 37235 USA; [Shi, Liang; Shu, Xiao-Ou; Cai, Hui; Liu, Qiaolan; Zheng, Wei; Villegas, Raquel] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Nashville, TN 37235 USA; [Shi, Liang] Shanghai Municipal Ctr Dis Control & Prevent, Dept Diabet Control & Prevent, Shanghai, Peoples R China; [Li, Honglan; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Liu, Qiaolan] Sichuan Univ, Huaxi Sch Publ Hlth, Chengdu 610064, Peoples R China; [Villegas, Raquel] Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; Sichuan University; Vanderbilt University	Villegas, R (corresponding author), Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN 37212 USA.	raquel.villegas@vanderbilt.edu	Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; 	US PHS from the National Cancer Institute [R01 CA082729]; Fogarty International Institute [D43 TX008313]; NATIONAL CANCER INSTITUTE [UM1CA173640, R01CA082729] Funding Source: NIH RePORTER	US PHS from the National Cancer Institute; Fogarty International Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by US PHS grant number R01 CA082729 (to Xiao-Ou Shu) from the National Cancer Institute. The work of Liang Shi was supported by a grant from the Fogarty International Institute (D43 TX008313 to Xiao-Ou Shu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Ansari RM, 2009, J ENVIRON PUBLIC HEA, V2009, DOI 10.1155/2009/195285; Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Cullmann M, 2012, DIABETIC MED, V29, P441, DOI 10.1111/j.1464-5491.2011.03450.x; Esposito K, 2008, CURR ATHEROSCLER REP, V10, P523, DOI 10.1007/s11883-008-0081-4; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Hu Gang, 2005, Metabolic Syndrome and Related Disorders, V3, P35, DOI 10.1089/met.2005.3.35; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; James SA, 1998, DIABETES CARE, V21, P555, DOI 10.2337/diacare.21.4.555; Jurj AL, 2007, AM J EPIDEMIOL, V165, P1124, DOI 10.1093/aje/kwk119; Kao WHL, 2001, AM J EPIDEMIOL, V154, P748, DOI 10.1093/aje/154.8.748; Koletsi-Kounari H, 2011, COMMUNITY DENT HLTH, V28, P47, DOI 10.1922/CDH_2474Kounari06; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; Nagaya T, 2008, ANN EPIDEMIOL, V18, P113, DOI 10.1016/j.annepidem.2007.07.107; Narayan KMV, 2012, HEALTH AFFAIR, V31, P84, DOI 10.1377/hlthaff.2011.1040; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Palipudi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033466; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Pietraszek A, 2010, NUTR METAB CARDIOVAS, V20, P366, DOI 10.1016/j.numecd.2010.05.001; PULLEN E, 1992, J EPIDEMIOL COMMUN H, V46, P455, DOI 10.1136/jech.46.4.455; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; SHU XO, 1995, EPIDEMIOLOGY, V6, P115, DOI 10.1097/00001648-199503000-00005; Villegas R, 2007, BRIT J NUTR, V97, P993, DOI 10.1017/S0007114507669189; Villegas R, 2006, INT J EPIDEMIOL, V35, P1553, DOI 10.1093/ije/dyl209; Villegas R, 2009, METAB SYNDR RELAT D, V7, P37, DOI 10.1089/met.2008.0042; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wannamethee SG, 2000, ARCH INTERN MED, V160, P2108, DOI 10.1001/archinte.160.14.2108; Wei Ming, 2000, Comprehensive Therapy, V26, P176, DOI 10.1007/s12019-000-0006-9; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Xu F, 2007, ASIA PAC J CLIN NUTR, V16, P240; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P420, DOI 10.1016/S0895-3988(11)60001-9; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	42	74	82	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77919	10.1371/journal.pone.0077919	http://dx.doi.org/10.1371/journal.pone.0077919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223743	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400022
J	McCreesh, N; Copas, A; Seeley, J; Johnston, LG; Sonnenberg, P; Hayes, RJ; Frost, SDW; White, RG				McCreesh, Nicky; Copas, Andrew; Seeley, Janet; Johnston, Lisa G.; Sonnenberg, Pam; Hayes, Richard J.; Frost, Simon D. W.; White, Richard G.			Respondent Driven Sampling: Determinants of Recruitment and a Method to Improve Point Estimation	PLOS ONE			English	Article							HIV PREVALENCE	Introduction: Respondent-driven sampling (RDS) is a variant of a link-tracing design intended for generating unbiased estimates of the composition of hidden populations that typically involves giving participants several coupons to recruit their peers into the study. RDS may generate biased estimates if coupons are distributed non-randomly or if potential recruits present for interview non-randomly. We explore if biases detected in an RDS study were due to either of these mechanisms, and propose and apply weights to reduce bias due to non-random presentation for interview. Methods: Using data from the total population, and the population to whom recruiters offered their coupons, we explored how age and socioeconomic status were associated with being offered a coupon, and, if offered a coupon, with presenting for interview. Population proportions were estimated by weighting by the assumed inverse probabilities of being offered a coupon (as in existing RDS methods), and also of presentation for interview if offered a coupon by age and socioeconomic status group. Results: Younger men were under-recruited primarily because they were less likely to be offered coupons. The under-recruitment of higher socioeconomic status men was due in part to them being less likely to present for interview. Consistent with these findings, weighting for non-random presentation for interview by age and socioeconomic status group greatly improved the estimate of the proportion of men in the lowest socioeconomic group, reducing the root-mean-squared error of RDS estimates of socioeconomic status by 38%, but had little effect on estimates for age. The weighting also improved estimates for tribe and religion (reducing root-mean-squared-errors by 19-29%), but had little effect for sexual activity or HIV status. Conclusions: Data collected from recruiters on the characteristics of men to whom they offered coupons may be used to reduce bias in RDS studies. Further evaluation of this new method is required.	[Hayes, Richard J.; White, Richard G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England; [McCreesh, Nicky] Univ Durham, Sch Med Pharm & Hlth, Durham, England; [Copas, Andrew; Sonnenberg, Pam] UCL, Dept Infect & Populat Hlth, London, England; [Seeley, Janet] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Seeley, Janet] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England; [Johnston, Lisa G.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, Ctr Global Hlth Equ, New Orleans, LA USA; [Frost, Simon D. W.] Univ Cambridge, Dept Vet Med, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine; Durham University; University of London; University College London; University of East Anglia; Tulane University; University of Cambridge	McCreesh, N (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Durham, England.	nicky.mccreesh@durham.ac.uk	Frost, Simon/F-3648-2010; White, Richard G/D-5407-2009	Frost, Simon/0000-0002-5207-9879; White, Richard G/0000-0003-4410-6635; Seeley, Janet/0000-0002-0583-5272; McCreesh, Nicky/0000-0003-1409-8531; Copas, Andrew/0000-0001-8968-5963; Sonnenberg, Pam/0000-0002-1067-1583; Hayes, Richard/0000-0002-1729-9892	Medical Research Council (UK) [G0802414]; Gates Foundation [19790.01]; EU [242061, 266327]; National Institutes of Nursing Research [NR10961]; National Institute on Drug Abuse [DA24998]; Royal Society Wolfson Research Merit Award; Medical Research Council [G0802414, MR/K012126/1] Funding Source: researchfish; MRC [G0802414] Funding Source: UKRI; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR010961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024998] Funding Source: NIH RePORTER	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gates Foundation(Bill & Melinda Gates Foundation); EU(European Commission); National Institutes of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RW is funded by a Medical Research Council (UK) Methodology Research Fellowship (G0802414), the Gates Foundation (19790.01), and the EU FP7 (242061). SF is funded by the National Institutes of Nursing Research (grant NR10961), the National Institute on Drug Abuse (grant DA24998), and by a Royal Society Wolfson Research Merit Award. NM is funded by an EU FP7 collaborative grant (266327). The general population cohort in Uganda is funded by the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Gile KJ, 2011, J AM STAT ASSOC, V106, P135, DOI 10.1198/jasa.2011.ap09475; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; HOLT D, 1979, J ROY STAT SOC A STA, V142, P33, DOI 10.2307/2344652; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; McCreesh N, 2012, INT J SOCIAL RES MET; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; McCreesh N, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-56; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Volz E, 2008, J OFF STAT, V24, P79	13	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78402	10.1371/journal.pone.0078402	http://dx.doi.org/10.1371/journal.pone.0078402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24205221	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000326373800019
J	Maranga, IO; Hampson, L; Oliver, AW; Gamal, A; Gichangi, P; Opiyo, A; Holland, CM; Hampson, IN				Maranga, Innocent O.; Hampson, Lynne; Oliver, Anthony W.; Gamal, Anas; Gichangi, Peter; Opiyo, Anselmy; Holland, Catharine M.; Hampson, Ian N.			Analysis of Factors Contributing to the Low Survival of Cervical Cancer Patients Undergoing Radiotherapy in Kenya	PLOS ONE			English	Article							RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; HUMAN-PAPILLOMAVIRUS; PAP-SMEAR; CARCINOMA; CHEMORADIOTHERAPY; WOMEN; MANAGEMENT; IMPACT; OXYGENATION	Background: In contrast to the developed nations, invasive cervical cancer (ICC) is the most common womens malignancy in Kenya and many other locations in sub-Saharan Africa. However, studies on survival from this disease in this area of the world are severely restricted by lack of patient follow-up. We now report a prospective cohort study of ICC in Kenyan women analysing factors affecting tumour response and overall survival in patients undergoing radiotherapy. Methods and Findings: Between 2008 and 2010, 355 patients with histologically confirmed ICC were recruited at the Departments of Gynaecology and Radiotherapy at Kenyatta National Hospital (KNH). Structured questionnaires were completed recording socio-demographics, tumour response and overall survival following treatment with combinations of external beam radiation (EBRT), brachytherapy and adjuvant chemotherapy. Of the 355 patients, 42% (146) were lost to follow-up while 18% (64) died during the two year period. 80.5% of patients presented with advanced stage IIB disease or above, with only 6.7% of patients receiving optimal combined EBRT, brachytherapy and adjuvant chemotherapy. Kaplan Meier survival curves projected two year survival at <20%. Conclusion: Cervical cancer is preventable yet poverty, poor education, lack of cancer awareness coupled with an absence of regular screening programs, late patient presentation, sub-optimal diagnosis and treatments are major factors contributing to the alarmingly low survival rate of cervical cancer patients in Kenya. It is concluded that simple cost-effective changes in clinical practice could be introduced which would have a marked impact on patient survival in this setting.	[Maranga, Innocent O.; Hampson, Lynne; Oliver, Anthony W.; Holland, Catharine M.; Hampson, Ian N.] Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England; [Maranga, Innocent O.; Gichangi, Peter] Univ Nairobi, Nairobi, Kenya; [Opiyo, Anselmy] Kenyatta Natl Hosp, Canc Treatment Ctr, Nairobi, Kenya; [Gamal, Anas] Mansoura Univ Hosp, Cairo, Egypt	University of Manchester; University of Nairobi; Kenyatta National Hospital; Egyptian Knowledge Bank (EKB); Mansoura University	Hampson, IN (corresponding author), Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England.	Ian.n.hampson@manchester.ac.uk		Gamal Eldin Mansour, Mohamed/0000-0001-8443-476X; Hampson, Lynne/0000-0002-0656-0127	Janice Cholerton Cancer and Postgraduate Studentship Fund; Humane Research Trust; International Atomic Energy Agency (IAEA); Wellbeing of Women; Caring Cancer Trust; Cancer Prevention Research Trust; United in Cancer; Quest Cancer Research	Janice Cholerton Cancer and Postgraduate Studentship Fund; Humane Research Trust; International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Wellbeing of Women(Wellbeing of Women (WoW)); Caring Cancer Trust; Cancer Prevention Research Trust; United in Cancer; Quest Cancer Research	The authors would like to thank The Janice Cholerton Cancer and Postgraduate Studentship Fund, The Humane Research Trust (http://www.humaneresearch.org.uk/), The International Atomic Energy Agency (IAEA; http://www.iaea.org/) and Wellbeing of Women (http://www.wellbeingofwomen.org.uk/) for their financial support. All work carried out in the Gynaecological Oncology laboratories at Manchester was also supported by The Caring Cancer Trust (http://www.caringcancertrust.com/), the Cancer Prevention Research Trust (http://www.cancer-prevention-research.co.uk/), United in Cancer, and Quest Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniebue PN, 2010, J CANCER EDUC, V25, P106, DOI 10.1007/s13187-009-0023-z; [Anonymous], 1996, B WORLD HEALTH ORGAN, V74, P345; Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Berclaz G, 2002, INT J ONCOL, V20, P1313; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; Brookfield KF, 2009, CANCER-AM CANCER SOC, V115, P166, DOI 10.1002/cncr.24007; Brown J, 2004, NATURE REV CANC, V4; Candelaria M, 2005, MED ONCOL, V22, P1357; Claeys P, 2002, TROP MED INT HEALTH, V7, P935, DOI 10.1046/j.1365-3156.2002.00953.x; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Curado MP EB, 2007, CANC INCIDENCE 5 CON; Dim CC, 2009, J OBSTET GYNAECOL, V29, P754, DOI 10.3109/01443610903225323; Dim Cyril C, 2009, Medscape J Med, V11, P19; Eifel Patricia J., 1997, P1433; Eifel PJ, 2006, NAT CLIN PRACT ONCOL, V3, P248, DOI 10.1038/ncponc0486; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Engin G, 2011, DIAGN INTERV RADIOL, V17, P44, DOI 10.4261/1305-3825.DIR.3114-09.1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gatune JW, 2005, INT J GYNECOL CANCER, V15, P1049, DOI 10.1111/j.1525-1438.2005.00261.x; Gichangi P, 2006, GYNECOL ONCOL, V100, P405, DOI 10.1016/j.ygyno.2005.10.006; Gichangi P, 2002, INT J GYNECOL OBSTET, V76, P55, DOI 10.1016/S0020-7292(01)00560-4; Gichangi P, 2003, INT J GYNECOL CANCER, V13, P827, DOI 10.1111/j.1525-1438.2003.13612.x; Harford JB, 2009, TUMORI, V95, P568; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Kesic V, 2006, EJSO-EUR J SURG ONC, V32, P832, DOI 10.1016/j.ejso.2006.03.037; Kidanto H L, 2002, East Afr Med J, V79, P467; King M, 2006, CLIN ONCOL-UK, V18, P38, DOI 10.1016/j.clon.2005.09.001; Kitchener HC, 2010, INT J GYNECOL CANCER, V20, P1092, DOI 10.1111/IGC.0b013e3181e730aa; Kodaira T, 2003, INT J RADIAT ONCOL, V56, P769, DOI 10.1016/S0360-3016(03)00007-5; Korn AP, 1997, OBSTET GYN CLIN N AM, P855; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; Maduro JH, 2003, CANCER TREAT REV, V29, P471, DOI 10.1016/S0305-7372(03)00117-8; Maiman M, 1997, OBSTET GYNECOL, V89, P76, DOI 10.1016/S0029-7844(96)00378-X; McArdle O, 2007, RADIOTHER ONCOL, V83, P94, DOI 10.1016/j.radonc.2007.02.006; MMH, 2007, CERV CANC CANC FEM R; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ndlovu N, 2003, Cent Afr J Med, V49, P107; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Obi SN, 2008, J OBSTET GYNAECOL, V28, P526, DOI 10.1080/01443610802273507; Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080; Pearcey R, 2007, J CLIN ONCOL, V25, P2383, DOI 10.1200/JCO.2006.09.1926; PETEREIT DG, 1995, INT J RADIAT ONCOL, V32, P1301, DOI 10.1016/0360-3016(94)00635-X; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; RELLIHAN MA, 1990, GYNECOL ONCOL, V36, P435, DOI 10.1016/0090-8258(90)90159-I; Samant R, 2010, INT J GYNECOL CANCER, V20, P1087, DOI 10.1111/IGC.0b013e3181e0ef81; Schwartz L, 1991, GYNECOL ONCOL, P225; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Shanta V, 1091, ASIAN PAC J CANC PRE, V11, P1091; Spence AR, 2007, PREV MED, V45, P93, DOI 10.1016/j.ypmed.2007.06.007; SUBAK LL, 1995, OBSTET GYNECOL, V86, P43, DOI 10.1016/0029-7844(95)00109-5; Survey KDH, 2009, HIV PREVALENCE KENYA; Teh J, 2010, INT J GYNECOL CANCER, V20, P428, DOI 10.1111/IGC.0b013e3181d4a0d1; Vale CL, 2010, CLIN ONCOL-UK, V22, P590, DOI 10.1016/j.clon.2010.06.002; Watkins MM, 2002, INT J GYNECOL CANCER, V12, P475, DOI 10.1046/j.1525-1438.2002.01170.x; Wong LP, 2008, INT J BEHAV MED, V15, P289, DOI 10.1080/10705500802365490; World Health Organization (WHO), 2004, GLOB BURD DIS 2004 U	57	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78411	10.1371/journal.pone.0078411	http://dx.doi.org/10.1371/journal.pone.0078411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205226	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500117
J	Seguin-Orlando, A; Schubert, M; Clary, J; Stagegaard, J; Alberdi, MT; Prado, JL; Prieto, A; Willerslev, E; Orlando, L				Seguin-Orlando, Andaine; Schubert, Mikkel; Clary, Joel; Stagegaard, Julia; Alberdi, Maria T.; Luis Prado, Jose; Prieto, Alfredo; Willerslev, Eske; Orlando, Ludovic			Ligation Bias in Illumina Next-Generation DNA Libraries: Implications for Sequencing Ancient Genomes	PLOS ONE			English	Article							EXTINCT; DAMAGE; CAVE; PATTERNS; INSIGHTS; HISTORY; HOMININ; REVEAL	Ancient DNA extracts consist of a mixture of endogenous molecules and contaminant DNA templates, often originating from environmental microbes. These two populations of templates exhibit different chemical characteristics, with the former showing depurination and cytosine deamination by-products, resulting from post-mortem DNA damage. Such chemical modifications can interfere with the molecular tools used for building second-generation DNA libraries, and limit our ability to fully characterize the true complexity of ancient DNA extracts. In this study, we first use fresh DNA extracts to demonstrate that library preparation based on adapter ligation at AT-overhangs are biased against DNA templates starting with thymine residues, contrarily to blunt-end adapter ligation. We observe the same bias on fresh DNA extracts sheared on Bioruptor, Covaris and nebulizers. This contradicts previous reports suggesting that this bias could originate from the methods used for shearing DNA. This also suggests that AT-overhang adapter ligation efficiency is affected in a sequence-dependent manner and results in an uneven representation of different genomic contexts. We then show how this bias could affect the base composition of ancient DNA libraries prepared following AT-overhang ligation, mainly by limiting the ability to ligate DNA templates starting with thymines and therefore deaminated cytosines. This results in particular nucleotide misincorporation damage patterns, deviating from the signature generally expected for authenticating ancient sequence data. Consequently, we show that models adequate for estimating post-mortem DNA damage levels must be robust to the molecular tools used for building ancient DNA libraries.	[Seguin-Orlando, Andaine; Schubert, Mikkel; Willerslev, Eske; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Clary, Joel] Musee Confluences, Ctr Conservat & Etud Collect, Lyon, France; [Stagegaard, Julia] Ebeltoft Safari, Ree Pk, Ebeltoft, Denmark; [Alberdi, Maria T.] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain; [Luis Prado, Jose] Univ Nacl Ctr Prov Buenos Aires, Consejo Nacl Invest Cient & Tecn, Olavarria, Argentina; [Prieto, Alfredo] Univ Magallanes, Inst Patagonia, Punta Arenas, Chile; [Prieto, Alfredo] Univ Autonoma Barcelona, Programa Doctorado, E-08193 Barcelona, Spain	University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Comision Nacional de Energia Atomica (CNEA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Magallanes; Autonomous University of Barcelona	Seguin-Orlando, A (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	ASOrlando@snm.ku.dk	Willerslev, Eske/AAA-5686-2019; Prado, Jose Luis/N-2001-2019; prieto, alfredo/D-5033-2013; Schubert, Mikkel/I-6911-2013; Willerslev, Eske/A-9619-2011; Orlando, Ludovic/A-8932-2013; Alberdi, Maria Teresa/ABG-8623-2020	Prado, Jose Luis/0000-0003-0579-8747; Schubert, Mikkel/0000-0003-2401-9921; Willerslev, Eske/0000-0002-7081-6748; Orlando, Ludovic/0000-0003-3936-1850; Alberdi, Maria Teresa/0000-0002-7071-360X; prieto, alfredo/0000-0001-7622-2353	Lundbeck Foundation [R52-A5062]; Danish Council for Independent Research (FNU); Danish National Research Foundation; Marie-Curie Career Integration Grant [FP7 CIG-293845]	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); Marie-Curie Career Integration Grant	MS was supported by the Lundbeck Foundation (R52-A5062). This work was supported by the Danish Council for Independent Research (FNU); the Danish National Research Foundation and a Marie-Curie Career Integration Grant (FP7 CIG-293845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bon C, 2012, P ROY SOC B-BIOL SCI, V279, P2825, DOI 10.1098/rspb.2012.0358; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2012, METHODS MOL BIOL, V840, P143, DOI 10.1007/978-1-61779-516-9_18; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Garcia-Garcera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024161; Ginolhac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-177; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer M., 2010, COLD SPRING HARB PRO; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Mitchell D, 2005, MUTAT RES-FUND MOL M, V571, P265, DOI 10.1016/j.mrfmmm.2004.06.060; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Orlando L, 2003, J MOL EVOL, V57, pS29, DOI 10.1007/s00239-003-0005-4; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Overballe-Petersen S, 2012, TRENDS BIOTECHNOL, V30, P364, DOI 10.1016/j.tibtech.2012.03.007; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Vilstrup JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055950; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	50	50	52	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78575	10.1371/journal.pone.0078575	http://dx.doi.org/10.1371/journal.pone.0078575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205269	Green Published, gold			2022-12-27	WOS:000326270700093
J	Abateneh, A; Tesfaye, M; Bekele, S; Gelaw, Y				Abateneh, Aemero; Tesfaye, Markos; Bekele, Sisay; Gelaw, Yeshigeta			Vision Loss and Psychological Distress among Ethiopians Adults: A Comparative Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL DISTRESS; PSYCHIATRIC MORBIDITY; VISUAL IMPAIRMENT; ADDIS-ABABA; PREVALENCE; POPULATION; ILLNESS; IMPACT; EYE	Background: Vision loss causes major changes in lifestyle and habits that may result in psychological distress and further reduction in the quality of life. Little is known about the magnitude of psychological distress in patients with vision loss and its variation with the normal. The aim of this study is, therefore, to investigate the psychological effects of vision loss and its determinants among Ethiopians. Methods: A comparative cross-sectional study was conducted on adults attending the Eye clinic of Jimma University Hospital. One hundred fifteen consecutive adults with visual loss at least in one eye and 115 age-and sex-matched controls with normal vision were studied. The psychological distress was measured using standardized Self-Reporting Questionnaire (SRQ-20). Chi-square test and logistic regression were carried out and associations were considered significant at P<0.05. Results: The overall prevalence of psychological distress was 33.4%. While psychological distress was found in 49.8% of patients who had loss of vision at least in one eye, only 18.3% of the controls had it. In the adjusted analysis, patients with vision loss had 4.6 times higher risk of suffering from psychological distress compared to patients with normal vision (AOR 4.56; 95% CI 2.16-9.62). Moreover, patients with vision loss in both eyes (AOR 4.00; 95% CI 1.453-11.015) and with worse visual acuity in the better eye (AOR 3.66; 95% CI 1.27-10.54) were significantly more likely to have psychological distress than those patients with vision loss in one eye only and good visual acuity in the better eye respectively. The cause of visual loss, pattern of visual loss, duration of visual loss and sociodemographic variables did not influence the likelihood of having psychological distress. Conclusion: Prevalence of psychological distress was significantly higher in patients with visual loss compared to patients with normal vision. There is a need for integration of psychosocial care into the current medical and surgical treatment of patients with vision loss.	[Abateneh, Aemero; Bekele, Sisay; Gelaw, Yeshigeta] Jimma Univ, Dept Ophthalmol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Tesfaye, Markos] Jimma Univ, Dept Psychiat, Coll Publ Hlth & Med Sci, Jimma, Ethiopia	Jimma University; Jimma University	Gelaw, Y (corresponding author), Jimma Univ, Dept Ophthalmol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia.	dryeshi@yahoo.com	Tesfaye, Markos/H-9297-2019	Tesfaye, Markos/0000-0002-3351-701X	Jimma University; Light for the World	Jimma University; Light for the World	This research was financially supported by Jimma University and Light for the World. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademola-Popoola DS, 2010, MIDDLE EAST AFR J OP, V17, P335, DOI 10.4103/0974-9233.71603; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P48, DOI 10.1111/j.1600-0447.1999.tb10694.x; Beusenberg M., 1994, WHOMNHPSF948; Chia EM, 2004, INVEST OPHTH VIS SCI, V45, P71, DOI 10.1167/iovs.03-0661; Chincholikar SV, 2006, INDIAN J COM MED, V31, P7; DORMAAR M, 1974, SOC PSYCHIATR, V9, P155, DOI 10.1007/BF00583931; FARMER CJ, 1979, PSYCHOL MED, V9, P509, DOI 10.1017/S0033291700032062; Foxall M J, 1992, West J Nurs Res, V14, P86, DOI 10.1177/019394599201400107; GIEL R, 1968, PSYCHIAT NEUROL NEUR, V71, P169; Hess RF, 2011, ADLERS PHYSL EYE, P613; Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x; JACOBSSON L, 1985, ACTA PSYCHIAT SCAND, V71, P417, DOI 10.1111/j.1600-0447.1985.tb02542.x; Johnson G FA, 2003, EPIDEMIOLOGY EYE DIS, P3; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P5, DOI 10.1111/j.1600-0447.1999.tb10687.x; KORTMANN F, 1990, CULT MED PSYCHIAT, V14, P381, DOI 10.1007/BF00117562; LaGrow S.J., 1998, COMPREHENSIVE CLIN P, V9, P57; Laurin C, 2007, CHEST, V132, P148, DOI 10.1378/chest.07-0134; Leekassa R, 2004, LEPROSY REV, V75, P367; Nakimuli ME, 2009, AFR HEALTH SCI, V9, P2; Nirmalan PK, 2005, INVEST OPHTH VIS SCI, V46, P2308, DOI 10.1167/iovs.04-0830; Nyman SR, 2010, BRIT J OPHTHALMOL, V94, P1427, DOI 10.1136/bjo.2009.164814; Olver J., 2005, OPHTHALMOLOGY GLANCE; Pascolini D, 2012, GLOBAL DATA VISUAL I; Rebecca A, 1998, ARCH OPHTHALMOL-CHIC, V116, P514, DOI [10.1001/archopht.116.4.514, DOI 10.1001/ARCH0PHT.116.4.514.PUBMED:9565052]; Safir A, 1972, MODERN OPHTHALMOLOGY, V4, P1199; Scherer M, 2007, BRIT J GEN PRACT, V57, P801; TAFARI S, 1991, SOC SCI MED, V32, P197, DOI 10.1016/0277-9536(91)90060-P; Tournier M, 2008, ACTA OPHTHALMOL, V86, P196, DOI 10.1111/j.1600-0420.2007.01024.x; Tunde-Ayinmode MF, 2011, ANN AFR MED, V10, P155, DOI 10.4103/1596-3519.82073; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y	30	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78335	10.1371/journal.pone.0078335	http://dx.doi.org/10.1371/journal.pone.0078335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205202	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400078
J	Courtney, HS; Li, Y				Courtney, Harry S.; Li, Yi			Non-Immune Binding of Human IgG to M-Related Proteins Confers Resistance to Phagocytosis of Group A Streptococci in Blood	PLOS ONE			English	Article							PYOGENES; PLASMINOGEN; REGION; FAMILY; GENE; IDENTIFICATION; EXPRESSION; SELECTION; ACID	The non-immune binding of immunoglobulins by bacteria is thought to contribute to the pathogenesis of infections. M-related proteins (Mrp) are group A streptococcal (GAS) receptors for immunoglobulins, but it is not known if this binding has any impact on virulence. To further investigate the binding of immunoglobulins to Mrp, we engineered mutants of an M type 4 strain of GAS by inactivating the genes for mrp, emm, enn, sof, and sfbX and tested these mutants in IgG-binding assays. Inactivation of mrp dramatically decreased the binding of human IgG, whereas inactivation of emm, enn, sof, and sfbx had only minor effects, indicating that Mrp is a major IgG-binding protein. Binding of human immunoglobulins to a purified, recombinant form of Mrp indicated that it selectively binds to the Fc domain of human IgG, but not IgA or IgM and that it preferentially bound subclasses IgG(1)>IgG(4)>IgG(2)>IgG(3). Recombinant proteins encompassing different regions of Mrp were engineered and used to map its IgG-binding domain to its A-repeat region and a recombinant protein with 3 A-repeats was a better inhibitor of IgG binding than one with a single A-repeat. A GAS mutant expressing Mrp with an in-frame deletion of DNA encoding the A-repeats had a dramatically reduced ability to bind human IgG and to grow in human blood. Mrp exhibited host specificity in binding IgG; human IgG was the best inhibitor of the binding of IgG followed by pig, horse, monkey, and rabbit IgG. IgG from goat, mouse, rat, cow, donkey, chicken, and guinea pig were poor inhibitors of binding. These findings indicate that Mrp preferentially binds human IgG and that this binding contributes to the ability of GAS to resist phagocytosis and may be a factor in the restriction of GAS infections to the human host.	[Courtney, Harry S.] Univ Tennessee, Ctr Hlth Sci, Vet Affairs Med Ctr, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center	Courtney, HS (corresponding author), Univ Tennessee, Ctr Hlth Sci, Vet Affairs Med Ctr, Memphis, TN 38163 USA.	hcourtney@uthsc.edu			US Department of Veterans Affairs; US Public Health Service [AI-095852]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI095852] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research funds from the US Department of Veterans Affairs (HSC) and from US Public Health Service grant AI-095852 (HSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer E A, 1979, Methods Enzymol, V62, P308; Berggard K, 2001, MOL MICROBIOL, V42, P539, DOI 10.1046/j.1365-2958.2001.02664.x; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; BESSEN DE, 1994, INFECT IMMUN, V62, P1968, DOI 10.1128/IAI.62.5.1968-1974.1994; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Courtney HS, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956071; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Courtney HS, 1997, INFECT IMMUN, V65, P2472, DOI 10.1128/IAI.65.6.2472-2474.1997; HEATH DG, 1987, INFECT IMMUN, V55, P1233, DOI 10.1128/IAI.55.5.1233-1238.1987; HEATH DG, 1990, MOL MICROBIOL, V4, P2071, DOI 10.1111/j.1365-2958.1990.tb00567.x; JOHNSSON E, 1994, J IMMUNOL, V153, P3557; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Krebs B, 1996, MED MICROBIOL IMMUN, V185, P39, DOI 10.1007/s004300050013; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Li Y, 2011, MICROBES INFECT, V13, P413, DOI 10.1016/j.micinf.2010.12.008; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Nordenfelt P, 2012, J EXP MED, V209, P2367, DOI 10.1084/jem.20120325; OTOOLE P, 1992, P NATL ACAD SCI USA, V89, P8661, DOI 10.1073/pnas.89.18.8661; Pack TD, 1996, GENE, V171, P65, DOI 10.1016/0378-1119(96)00102-3; Pack TD, 1995, MOL IMMUNOL, V32, P1235, DOI 10.1016/0161-5890(95)00074-7; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Podbielski A, 1996, MOL MICROBIOL, V19, P429, DOI 10.1046/j.1365-2958.1996.377910.x; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; STENBERG L, 1992, MOL MICROBIOL, V6, P1185, DOI 10.1111/j.1365-2958.1992.tb01557.x; Su YF, 2011, MOL IMMUNOL, V49, P134, DOI 10.1016/j.molimm.2011.08.002; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; Woof JM, 2002, BIOCHEM SOC T, V30, P491, DOI 10.1042/bst0300491	32	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78719	10.1371/journal.pone.0078719	http://dx.doi.org/10.1371/journal.pone.0078719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205299	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400100
J	Marti, E; Jofre, J; Balcazar, JL				Marti, Elisabet; Jofre, Juan; Luis Balcazar, Jose			Prevalence of Antibiotic Resistance Genes and Bacterial Community Composition in a River Influenced by a Wastewater Treatment Plant	PLOS ONE			English	Article							TIME PCR ASSAYS; EMERGING CONTAMINANTS; NATURAL ENVIRONMENTS; MASS-SPECTROMETRY; AQUATIC SYSTEMS; PLASMID; SEDIMENT; QUANTIFICATION; DETERMINANTS; MANAGEMENT	Antibiotic resistance represents a global health problem, requiring better understanding of the ecology of antibiotic resistance genes (ARGs), their selection and their spread in the environment. Antibiotics are constantly released to the environment through wastewater treatment plant (WWTP) effluents. We investigated, therefore, the effect of these discharges on the prevalence of ARGs and bacterial community composition in biofilm and sediment samples of a receiving river. We used culture-independent approaches such as quantitative PCR to determine the prevalence of eleven ARGs and 16S rRNA gene-based pyrosequencing to examine the composition of bacterial communities. Concentration of antibiotics in WWTP influent and effluent were also determined. ARGs such as qnrS, bla(TEM), bla(CTX-M), bla(SHV), erm(B), sul(I), sul(II), tet(O) and tet(W) were detected in all biofilm and sediment samples analyzed. Moreover, we observed a significant increase in the relative abundance of ARGs in biofilm samples collected downstream of the WWTP discharge. We also found significant differences with respect to community structure and composition between upstream and downstream samples. Therefore, our results indicate that WWTP discharges may contribute to the spread of ARGs into the environment and may also impact on the bacterial communities of the receiving river.	[Marti, Elisabet; Luis Balcazar, Jose] Univ Girona, Catalan Inst Water Res ICRA, Girona, Spain; [Jofre, Juan] Univ Barcelona, Dept Microbiol, Barcelona, Spain	Institut Catala de Recerca de l'Aigua (ICRA); Universitat de Girona; University of Barcelona	Balcazar, JL (corresponding author), Univ Girona, Catalan Inst Water Res ICRA, Sci & Technol Pk, Girona, Spain.	jlbalcazar@icra.cat	Balcazar, Jose Luis/A-8390-2008; Marti, Elisabet/AAJ-9027-2020	Balcazar, Jose Luis/0000-0002-6866-9347; Marti, Elisabet/0000-0002-5301-3548	Fundacion Eugenio Rodriguez Pascual, Spain; Ramon y Cajal research fellowship from the Spanish Ministry of Economy and Competitiveness [RYC-2011-08154]	Fundacion Eugenio Rodriguez Pascual, Spain; Ramon y Cajal research fellowship from the Spanish Ministry of Economy and Competitiveness	This study was supported by the Fundacion Eugenio Rodriguez Pascual, Spain. J. L. B. acknowledges the Ramon y Cajal research fellowship (RYC-2011-08154) from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Carneiro AR, 2012, J BACTERIOL, V194, P6689, DOI 10.1128/JB.01791-12; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Di Cesare A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062838; Engemann CA, 2008, ENVIRON SCI TECHNOL, V42, P5131, DOI 10.1021/es800238e; Gros M, 2012, J CHROMATOGR A, V1248, P104, DOI 10.1016/j.chroma.2012.05.084; Gros M, 2009, ANAL CHEM, V81, P898, DOI 10.1021/ac801358e; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Iwane T, 2001, WATER SCI TECHNOL, V43, P91; Janzon A, 2012, ANTIMICROBIAL RESIST, P483; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Lapara T., 2012, ANTIMICROBIAL RESIST, P241; LaPara TM, 2011, ENVIRON SCI TECHNOL, V45, P9543, DOI 10.1021/es202775r; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li J, 2012, ENVIRON HEALTH PERSP, V120, P1144, DOI 10.1289/ehp.1104776; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Mak JK, 2009, J ANTIMICROB CHEMOTH, V63, P47, DOI 10.1093/jac/dkn454; Marti E, 2012, CLIN MICROBIOL INFEC, V18, pE366, DOI 10.1111/j.1469-0691.2012.03935.x; Marti E, 2013, APPL ENVIRON MICROB, V79, P1743, DOI 10.1128/AEM.03409-12; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; MCCOY E, 1954, ANNU REV MICROBIOL, V8, P257, DOI 10.1146/annurev.mi.08.100154.001353; Mokracka J, 2012, WATER RES, V46, P3353, DOI 10.1016/j.watres.2012.03.037; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Petrovic M, 2003, TRAC-TREND ANAL CHEM, V22, P685, DOI 10.1016/S0165-9936(03)01105-1; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sigee D.C., 2005, FRESHWATER MICROBIOL, P524, DOI [10.1002/0470011254, DOI 10.1002/0470011254]; Tamminen M, 2012, MOL BIOL EVOL, V29, P1225, DOI 10.1093/molbev/msr292; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Wakelin SA, 2008, APPL ENVIRON MICROB, V74, P2659, DOI 10.1128/AEM.02348-07; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang K, 2007, WATER RES, V41, P2816, DOI 10.1016/j.watres.2007.03.010; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z	43	247	261	10	209	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78906	10.1371/journal.pone.0078906	http://dx.doi.org/10.1371/journal.pone.0078906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205347	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400112
J	Shao, YC; Wang, LB; Ye, EM; Jin, X; Ni, W; Yang, Y; Wen, B; Hu, DW; Yang, Z				Shao, Yongcong; Wang, Lubin; Ye, Enmao; Jin, Xiao; Ni, Wei; Yang, Yue; Wen, Bo; Hu, Dewen; Yang, Zheng			Decreased Thalamocortical Functional Connectivity after 36 Hours of Total Sleep Deprivation: Evidence from Resting State fMRI	PLOS ONE			English	Article							DEFAULT NETWORK; WORKING-MEMORY; GLOBAL SIGNAL; BRAIN; WAKING; FREQUENCIES; IMPACT; MODE	Objectives: The thalamus and cerebral cortex are connected via topographically organized, reciprocal connections, which hold a key function in segregating internally and externally directed awareness information. Previous task-related studies have revealed altered activities of the thalamus after total sleep deprivation (TSD). However, it is still unclear how TSD impacts on the communication between the thalamus and cerebral cortex. In this study, we examined changes of thalamocortical functional connectivity after 36 hours of total sleep deprivation by using resting state function MRI (fMRI). Materials and Methods: Fourteen healthy volunteers were recruited and performed fMRI scans before and after 36 hours of TSD. Seed-based functional connectivity analysis was employed and differences of thalamocortical functional connectivity were tested between the rested wakefulness (RW) and TSD conditions. Results: We found that the right thalamus showed decreased functional connectivity with the right parahippocampal gyrus, right middle temporal gyrus and right superior frontal gyrus in the resting brain after TSD when compared with that after normal sleep. As to the left thalamus, decreased connectivity was found with the right medial frontal gyrus, bilateral middle temporal gyri and left superior frontal gyrus. Conclusion: These findings suggest disruptive changes of the thalamocortical functional connectivity after TSD, which may lead to the decline of the arousal level and information integration, and subsequently, influence the human cognitive functions.	[Shao, Yongcong; Wang, Lubin; Ye, Enmao; Jin, Xiao; Ni, Wei; Yang, Yue; Yang, Zheng] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Shao, Yongcong; Ye, Enmao; Jin, Xiao; Ni, Wei; Yang, Yue; Yang, Zheng] Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Wang, Lubin; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Wen, Bo] Peoples Liberat Army, Gen Hosp, Dept Radiol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; National University of Defense Technology - China; Chinese People's Liberation Army General Hospital	Hu, DW (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn; yangzhengchina@aliyun.com	Hu, Dewen/AAN-8511-2020; Hu, Dewen/D-1978-2015		National Military Science Foundation of China [BWS11J045, 06z066]	National Military Science Foundation of China	This work was supported by the National Military Science Foundation of China, Grant No. BWS11J045 and No. 06z066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cajochen C, 1995, SLEEP, V18, P890, DOI 10.1093/sleep/18.10.890; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Chen GY, 2011, BRAIN CONNECT, V1, P195, DOI 10.1089/brain.2011.0025; Chuah LYM, 2008, ANN ACAD MED SINGAP, V37, P689; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Galvert G.A., 2001, CEREB CORTEX, V11, P1110; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Killgore WDS, 2008, SLEEP MED, V9, P517, DOI 10.1016/j.sleep.2007.07.003; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Samann PG, 2010, MAGN RESON MATER PHY, V23, P375, DOI 10.1007/s10334-010-0213-z; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Strijkstra AM, 2003, NEUROSCI LETT, V340, P17, DOI 10.1016/S0304-3940(03)00033-8; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Wang WC, 2010, NEURON, V68, P835, DOI 10.1016/j.neuron.2010.11.009; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	36	69	72	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78830	10.1371/journal.pone.0078830	http://dx.doi.org/10.1371/journal.pone.0078830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205327	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400109
J	Kornblau, SM; Qutub, A; Yao, H; York, H; Qiu, YH; Graber, D; Ravandi, F; Cortes, J; Andreeff, M; Zhang, NX; Coombes, KR				Kornblau, Steven M.; Qutub, Amina; Yao, Hui; York, Heather; Qiu, Yi Hua; Graber, David; Ravandi, Farhad; Cortes, Jorge; Andreeff, Michael; Zhang, Nianxiang; Coombes, Kevin R.			Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38-Stem-Like Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ABILITY IN-VITRO; STEM-CELLS; EXPRESSION DATA; GENE; PROGENITORS; MICROARRAY; SIGNATURES; INDUCTION; HIERARCHY	Acute myeloid leukemia (AML) is believed to arise from leukemic stem-like cells (LSC) making understanding the biological differences between LSC and normal stem cells (HSC) or common myeloid progenitors (CMP) crucial to understanding AML biology. To determine if protein expression patterns were different in LSC compared to other AML and CD34+ populations, we measured the expression of 121 proteins by Reverse Phase Protein Arrays (RPPA) in 5 purified fractions from AML marrow and blood samples: Bulk (CD3/CD19 depleted), CD34-, CD34+(CMP), CD34+CD38+ and CD34+CD38-(LSC). LSC protein expression differed markedly from Bulk (n=31 cases, 93/121 proteins) and CD34+ cells (n= 30 cases, 88/121 proteins) with 54 proteins being significantly different (31 higher, 23 lower) in LSC than in either Bulk or CD34+ cells. Sixty-seven proteins differed significantly between CD34+ and Bulk blasts (n= 69 cases). Protein expression patterns in LSC and CD34+ differed markedly from normal CD34+ cells. LSC were distinct from CD34+ and Bulk cells by principal component and by protein signaling network analysis which confirmed individual protein analysis. Potential targetable submodules in LSC included the proteins PU.1(SP1), P27, Mcl1, HIF1 alpha, cMET, P53, Yap, and phospho-Stats 1, 5 and 6. Protein expression and activation in LSC differs markedly from other blast populations suggesting that studies of AML biology should be performed in LSC.	[Kornblau, Steven M.; Qiu, Yi Hua; Graber, David; Ravandi, Farhad; Cortes, Jorge; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Qutub, Amina; York, Heather] Rice Univ, Dept Bioengn, Houston, TX USA; [Yao, Hui; Zhang, Nianxiang; Coombes, Kevin R.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Texas System; UTMD Anderson Cancer Center	Kornblau, SM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	skornblau@mdanderson.org	Yao, Huiqin/AAX-3787-2020	Yao, Huiqin/0000-0003-4742-8971; Cortes, Jorge/0000-0002-8636-1071; Qutub, Amina/0000-0003-1737-9208	Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a translational research grant from the Leukemia and Lymphoma Society to SMK. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Blair A, 1998, BLOOD, V92, P4325, DOI 10.1182/blood.V92.11.4325; Blair A, 2000, EXP HEMATOL, V28, P660, DOI 10.1016/S0301-472X(00)00155-7; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Burger JA, 2003, BRIT J HAEMATOL, V122, P579, DOI 10.1046/j.1365-2141.2003.04466.x; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan WI, 2008, SEMIN ONCOL, V35, P326, DOI 10.1053/j.seminoncol.2008.04.003; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gal H, 2006, LEUKEMIA, V20, P2147, DOI 10.1038/sj.leu.2404401; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Kornblau SM, 2006, BLOOD, V108, P2358, DOI 10.1182/blood-2006-02-003475; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kornblau SM, 2008, BLOOD, V112, P281; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; LORD BI, 1990, INT J CELL CLONING, V8, P317, DOI 10.1002/stem.5530080501; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Moshaver B, 2008, STEM CELLS; Neeley ES, 2012, CANCER INFORM, V11, P77, DOI 10.4137/CIN.S9055; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pabst T, 2007, ONCOGENE, V26, P6829, DOI 10.1038/sj.onc.1210765; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Ran D, 2009, EXP HEMATOL, V37, P1423, DOI 10.1016/j.exphem.2009.10.001; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Sutherland HJ, 1996, BLOOD, V87, P4754, DOI 10.1182/blood.V87.11.4754.bloodjournal87114754; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; York H, 2012, PROTEOMICS, V12, P2084, DOI 10.1002/pmic.201100491; Yoshimoto G, 2009, BLOOD, V114, P5034, DOI 10.1182/blood-2008-12-196055	53	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78453	10.1371/journal.pone.0078453	http://dx.doi.org/10.1371/journal.pone.0078453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24223100	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300061
J	Nemecek, J; Nag, N; Carlson, CM; Schneider, JR; Heisey, DM; Johnson, CJ; Asher, DM; Gregori, L				Nemecek, Julie; Nag, Nabanita; Carlson, Christina M.; Schneider, Jay R.; Heisey, Dennis M.; Johnson, Christopher J.; Asher, David M.; Gregori, Luisa			Red-Backed Vole Brain Promotes Highly Efficient In Vitro Amplification of Abnormal Prion Protein from Macaque and Human Brains Infected with Variant Creutzfeldt-Jakob Disease Agent	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; BLOOD-TRANSFUSION; PRPSC; ASSAY; VCJD; PROPAGATION; CONVERSION; PATIENT; BSE; CJD	Rapid antemortem tests to detect individuals with transmissible spongiform encephalopathies (TSE) would contribute to public health. We investigated a technique known as protein misfolding cyclic amplification (PMCA) to amplify abnormal prion protein (PrPTSE) from highly diluted variant Creutzfeldt-Jakob disease (vCJD)-infected human and macaque brain homogenates, seeking to improve the rapid detection of PrPTSE in tissues and blood. Macaque vCJD PrPTSE did not amplify using normal macaque brain homogenate as substrate (intraspecies PMCA). Next, we tested interspecies PMCA with normal brain homogenate of the southern red-backed vole (RBV), a close relative of the bank vole, seeded with macaque vCJD PrPTSE. The RBV has a natural polymorphism at residue 170 of the PrP-encoding gene (N/N, S/S, and S/N). We investigated the effect of this polymorphism on amplification of human and macaque vCJD PrPTSE. Meadow vole brain (170N/N PrP genotype) was also included in the panel of substrates tested. Both humans and macaques have the same 170S/S PrP genotype. Macaque PrPTSE was best amplified with RBV 170S/S brain, although 170N/N and 170S/N were also competent substrates, while meadow vole brain was a poor substrate. In contrast, human PrPTSE demonstrated a striking narrow selectivity for PMCA substrate and was successfully amplified only with RBV 170S/S brain. These observations suggest that macaque PrPTSE was more permissive than human PrPTSE in selecting the competent RBV substrate. RBV 170S/S brain was used to assess the sensitivity of PMCA with PrPTSE from brains of humans and macaques with vCJD. PrPTSE signals were reproducibly detected by Western blot in dilutions through 10(-12) of vCJD-infected 10% brain homogenates. This is the first report showing PrPTSE from vCJD-infected human and macaque brains efficiently amplified with RBV brain as the substrate. Based on our estimates, PMCA showed a sensitivity that might be sufficient to detect PrPTSE in vCJD-infected human and macaque blood.	[Nemecek, Julie; Nag, Nabanita; Asher, David M.; Gregori, Luisa] US FDA, Lab Bacterial & TSE Agents, Div Emerging Transfus Transmitted Dis, Off Blood Res & Review,Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Carlson, Christina M.; Schneider, Jay R.; Heisey, Dennis M.; Johnson, Christopher J.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Carlson, Christina M.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA	US Food & Drug Administration (FDA); United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Gregori, L (corresponding author), US FDA, Lab Bacterial & TSE Agents, Div Emerging Transfus Transmitted Dis, Off Blood Res & Review,Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	luisa.gregori@fda.hhs.gov	Johnson, Christopher/B-1436-2009; Carlson, Christina/P-6507-2015; Carlson, Christina/D-8327-2013	Johnson, Christopher/0000-0003-4539-2581; Carlson, Christina/0000-0002-4950-8273; Carlson, Christina/0000-0002-4950-8273	FDA Commissioner's fellowship program; FDA Chief Scientist Challenge Award; USGS Wildlife: Terrestrial and Endangered Resources Program	FDA Commissioner's fellowship program; FDA Chief Scientist Challenge Award; USGS Wildlife: Terrestrial and Endangered Resources Program	This work was supported by the FDA Commissioner's fellowship program and by an FDA Chief Scientist Challenge Award. Support also came from the USGS Wildlife: Terrestrial and Endangered Resources Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Dangerous Pathogens, 2012, SE RISK ASS SUBGR PO; Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Cooper JK, 2012, VOX SANG, V102, P100, DOI 10.1111/j.1423-0410.2011.01525.x; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Gregori L, 2008, J VIROL METHODS, V149, P251, DOI 10.1016/j.jviromet.2008.01.028; Gregori L, 2011, TRANSFUSION, V51, P2596, DOI 10.1111/j.1537-2995.2011.03199.x; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Johnson CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035383; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Jones M, 2009, EMERG INFECT DIS, V15, P2013, DOI 10.3201/eid1512.090194; Jones M, 2008, NEUROREPORT, V19, P1783, DOI 10.1097/WNR.0b013e328318edfa; Kurt TD, 2011, J VIROL, V85, P8528, DOI 10.1128/JVI.00809-11; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Minor P, 2004, J GEN VIROL, V85, P1777, DOI 10.1099/vir.0.79959-0; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; UK Health Protection Agency, 2012, SUMM RES 2 NAT SURV; UK Health Protection Agency, 2006, EUROSURVEILLANCE, V11; UK Health Protection Agency, 2007, EUROSURVEILLANCE, V12	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78710	10.1371/journal.pone.0078710	http://dx.doi.org/10.1371/journal.pone.0078710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205298	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300080
J	Mizzau, TW; Garner, SR; Marklevitz, SAC; Thompson, GJ; Morbey, YE				Mizzau, Tosh W.; Garner, Shawn R.; Marklevitz, Stephen A. C.; Thompson, Graham J.; Morbey, Yolanda E.			A Genetic Test of Sexual Size Dimorphism in Pre-Emergent Chinook Salmon	PLOS ONE			English	Article							EARLY-LIFE HISTORY; MASU SALMON; ONCORHYNCHUS-MASOU; PACIFIC SALMON; DNA MARKERS; GROWTH; COHO; TEMPERATURE; EVOLUTION; MATURITY	Sex differences in early development may play an important role in the expression of sexual size dimorphism at the adult stage. To test whether sexual size dimorphism is present in pre-emergent chinook salmon (Oncorhynchus tshawytscha), alevins were reared at two temperatures (10 degrees C and 15 degrees C) and sexed using the OtY1 marker on the Y-chromosome. Linear mixed models were used to test for sex differences in alevin size within families while controlling for the random effects of sire and dam nested within sire. Males and females did not differ in weight at 10 degrees C but males were heavier than females at 15 degrees C. Sex accounted for 2% of the within-family variance in weight. In addition, at 15 degrees C, the relationship between weight and sex was greater in families with larger eggs. Whereas male-biased sexual size dimorphism was present at the juvenile stage, female-biased sexual size dimorphism was present at sexual maturity. Males were also younger than females at sexual maturity. A head start on growth by males may underlie their earlier maturation at a smaller size, thus leading to female-biased SSD at the adult stage.	[Mizzau, Tosh W.; Garner, Shawn R.; Marklevitz, Stephen A. C.; Thompson, Graham J.; Morbey, Yolanda E.] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Morbey, YE (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	ymorbey@uwo.ca	Thompson, Graham J/B-6508-2008; Morbey, Yolanda/F-9035-2013; Garner, Shawn/D-9170-2013		Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation - Leaders Opportunity Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation - Leaders Opportunity Fund(Canada Foundation for Innovation)	Funding was provided by Natural Sciences and Engineering Research Council of Canada Discovery Grants to GJT and YEM, and by a Canada Foundation for Innovation - Leaders Opportunity Fund to YEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; Beckman BR, 2008, T AM FISH SOC, V137, P1285, DOI 10.1577/T07-170.1; Burt JM, 2011, REV FISH BIOL FISHER, V21, P377, DOI 10.1007/s11160-010-9179-1; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Devlin RH, 2005, CAN J FISH AQUAT SCI, V62, P1386, DOI 10.1139/F05-048; Devlin RH, 2001, GENETICA, V111, P43, DOI 10.1023/A:1013759802604; DEVLIN RH, 1994, AQUACULTURE, V128, P211, DOI 10.1016/0044-8486(94)90310-7; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FEIST G, 1990, GEN COMP ENDOCR, V80, P299, DOI 10.1016/0016-6480(90)90174-K; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Healey M.C., 1991, PACIFIC SALMON LIFE, P312; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Heath DD, 1996, J EXP MAR BIOL ECOL, V208, P239; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; Jensen JOT, 2009, CAN TECH REP FISH AQ, V2389, P49; Lynch M., 1998, GENETICS ANAL QUANTI; METCALFE NB, 1995, ANIM BEHAV, V49, P431, DOI 10.1006/anbe.1995.0056; Nagata M, 1997, J FISH BIOL, V51, P601, DOI 10.1006/jfbi.1997.0463; Quinn TP, 2002, T AM FISH SOC, V131, P591, DOI 10.1577/1548-8659(2002)131&lt;0591:ASAECC&gt;2.0.CO;2; R Core Development Team, 2009, R LANG ENV STAT COMP; Rhen Turk, 2007, P167; Schielzeth H, 2013, METHODS ECOL EVOL, V4, P14, DOI 10.1111/j.2041-210x.2012.00251.x; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tamate T, 2006, EVOLUTION, V60, P196, DOI 10.1111/j.0014-3820.2006.tb01094.x; Tamate T, 2004, ECOL FRESHW FISH, V13, P96, DOI 10.1111/j.1600-0633.2004.00043.x; Vollestad LA, 2004, T AM FISH SOC, V133, P495, DOI 10.1577/T03-033.1; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weeder JA, 2005, N AM J FISH MANAGE, V25, P861, DOI 10.1577/M03-227.1; Williamson KS, 2005, T AM FISH SOC, V134, P1253, DOI 10.1577/T04-208.1; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Yamamoto T, 2004, ECOL FRESHW FISH, V13, P203, DOI 10.1111/j.1600-0633.2004.00051.x; Young KA, 2005, P ROY SOC B-BIOL SCI, V272, P167, DOI 10.1098/rspb.2004.2931	33	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78421	10.1371/journal.pone.0078421	http://dx.doi.org/10.1371/journal.pone.0078421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205229	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600101
J	Piedrafita, D; Preston, S; Kemp, J; de Veer, M; Sherrard, J; Kraska, T; Elhay, M; Meeusen, E				Piedrafita, David; Preston, Sarah; Kemp, Joanna; de Veer, Michael; Sherrard, Jayne; Kraska, Troy; Elhay, Martin; Meeusen, Els			The Effect of Different Adjuvants on Immune Parameters and Protection following Vaccination of Sheep with a Larval-Specific Antigen of the Gastrointestinal Nematode, Haemonchus contortus	PLOS ONE			English	Article							MECHANISMS; IMMUNIZATION; CHALLENGE; INFECTION; PARASITES; ALUMINUM; KINETICS; VACCINES; ANTIBODY; CELLS	It has recently been recognised that vaccine adjuvants play a critical role in directing the nature of a vaccine induced effector response. In the present study, several adjuvants were evaluated for their ability to protect sheep after field vaccination with the larval-specific Haemonchus contortus antigen, HcsL3. Using a suboptimal antigen dose, aluminium adjuvant was shown to reduce the cumulative faecal egg counts (cFEC) and worm burden by 23% and 25% respectively, in agreement with a previous study. The addition of Quil A to the aluminium-adjuvanted vaccine brought cFEC back to control levels. Vaccination with the adjuvant DEAE-dextran almost doubled the protection compared to the aluminium-adjuvanted vaccine resulting in 40% and 41% reduction in cFEC and worm counts compared to controls. Examination of skin responses following i.d. injection of exsheathed L3, revealed that cFEC was negatively correlated with wheal size and tissue eosinophils for the DEAE-dextran and aluminium-adjuvanted groups respectively. These studies have for the first time shown the potential of DEAE-dextran adjuvant for helminth vaccines, and discovered significant cellular correlates of vaccine-induced protection.	[Piedrafita, David; Preston, Sarah; Kemp, Joanna; de Veer, Michael; Sherrard, Jayne; Kraska, Troy; Meeusen, Els] Monash Univ, Sch Biomed Sci, Clayton, Vic, Australia; [Piedrafita, David; Preston, Sarah; Meeusen, Els] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia; [Elhay, Martin] Pfizer Anim Hlth, Vet Med Res & Dev, Parkville, Vic, Australia	Monash University; Monash University; Pfizer	Piedrafita, D (corresponding author), Monash Univ, Sch Biomed Sci, Clayton, Vic, Australia.	david.piedrafita@monash.edu		Preston, Sarah/0000-0002-4227-1664; piedrafita, david/0000-0001-8692-990X; Meeusen, Els/0000-0003-1239-6287	Australian Research Council [LP0668945]; ARC-Centre of Excellence in Structural and Functional Microbial Genomics	Australian Research Council(Australian Research Council); ARC-Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council)	Australian Research Council Linkage grant LP0668945 and the ARC-Centre of Excellence in Structural and Functional Microbial Genomics. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2002, VACCINE, V20, pS56, DOI 10.1016/S0264-410X(02)00174-3; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Balic A, 2006, PARASITE IMMUNOL, V28, P107, DOI 10.1111/j.1365-3024.2006.00816.x; BEH KJ, 1987, VET IMMUNOL IMMUNOP, V14, P187, DOI 10.1016/0165-2427(87)90053-5; Bethony JM, 2006, PARASITOLOGY, V133, pS63, DOI 10.1017/S0031182006001818; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; de Veer M, 2010, VACCINE, V28, P6597, DOI 10.1016/j.vaccine.2010.07.056; de Veer M, 2011, DISCOV MED, V12, P195; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Hein WR, 2010, PARASITE IMMUNOL, V32, P541, DOI 10.1111/j.1365-3024.2010.01213.x; Jacobs HJ, 1999, VACCINE, V17, P362, DOI 10.1016/S0264-410X(98)00206-0; Jankovic D, 2004, J IMMUNOL, V173, P2419, DOI 10.4049/jimmunol.173.4.2419; Korsholm KS, 2010, IMMUNOLOGY, V129, P75, DOI 10.1111/j.1365-2567.2009.03164.x; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Meeusen ENT, 2005, VET IMMUNOL IMMUNOP, V108, P121, DOI 10.1016/j.vetimm.2005.07.002; Meeusen ENT, 2000, PARASITOL TODAY, V16, P95, DOI 10.1016/S0169-4758(99)01607-5; Piedrafita DP, 2012, VACCINE, V30, P7199, DOI 10.1016/j.vaccine.2012.10.019; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Rainbird MA, 1998, PARASITE IMMUNOL, V20, P93, DOI 10.1046/j.1365-3024.1998.00132.x; Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091; Thakur A, 2012, VACCINE, V30, P4907, DOI 10.1016/j.vaccine.2012.05.049; TURNBULL IF, 1992, INT J PARASITOL, V22, P537, DOI 10.1016/0020-7519(92)90157-G; Vizcarra JA, 2012, J ANIM SCI, V90, P1479, DOI 10.2527/jas.2011-4554; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	25	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78357	10.1371/journal.pone.0078357	http://dx.doi.org/10.1371/journal.pone.0078357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205209	Green Published, gold			2022-12-27	WOS:000326032600099
J	Ratcliffe, N; Takahashi, A; O'Sullivan, C; Adlard, S; Trathan, PN; Harris, MP; Wanless, S				Ratcliffe, Norman; Takahashi, Akinori; O'Sullivan, Claire; Adlard, Stacey; Trathan, Philip N.; Harris, Michael P.; Wanless, Sarah			The Roles of Sex, Mass and Individual Specialisation in Partitioning Foraging-Depth Niches of a Pursuit-Diving Predator	PLOS ONE			English	Article							BLUE-EYED SHAG; REARING CROZET SHAGS; ANTARCTIC FUR SEALS; PHALACROCORAX-ALBIVENTER; INTERSEXUAL DIFFERENCES; JAPANESE CORMORANTS; SPATIAL SEGREGATION; STABLE-ISOTOPES; KING CORMORANTS; SITE FIDELITY	Intra-specific foraging niche partitioning can arise due to gender differences or individual specialisation in behaviour or prey selection. These may in turn be related to sexual size dimorphism or individual variation in body size through allometry. These variables are often inter-related and challenging to separate statistically. We present a case study in which the effects of sex, body mass and individual specialisation on the dive depths of the South Georgia shag on Bird Island, South Georgia are investigated simultaneously using a linear mixed model. The nested random effects of trip within individual explained a highly significant amount of the variance. The effects of sex and body mass were both significant independently but could not be separated statistically owing to them being strongly interrelated. Variance components analysis revealed that 45.5% of the variation occurred among individuals, 22.6% among trips and 31.8% among Dives, while R-2 approximations showed gender explained 31.4% and body mass 55.9% of the variation among individuals. Male dive depths were more variable than those of females at the levels of individual, trip and dive. The effect of body mass on individual dive depths was only marginally significant within sexes. The percentage of individual variation in dive depths explained by mass was trivial in males (0.8%) but substantial in females (24.1%), suggesting that differences in dive depths among males was largely due to them adopting different behavioural strategies whereas in females allometry played an additional role. Niche partitioning in the study population therefore appears to be achieved through the interactive effects of individual specialisation and gender upon vertical foraging patch selection, and has the potential to interact in complex ways with other axes of the niche hypervolume such as foraging locations, timing of foraging and diet.	[Ratcliffe, Norman; O'Sullivan, Claire; Adlard, Stacey; Trathan, Philip N.] British Antarctic Survey, Cambridge CB3 0ET, England; [Takahashi, Akinori] Natl Inst Polar Res, Tokyo, Japan; [Harris, Michael P.; Wanless, Sarah] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; UK Centre for Ecology & Hydrology (UKCEH)	Ratcliffe, N (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	notc@bas.ac.uk			Natural Environment Research Council (NERC); British Ecological Society and Akinori Takahashi; Natural Environment Research Council [bas0100025, CEH010021] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Ecological Society and Akinori Takahashi; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NERC) as part of the British Antarctic Ecosystems programme. SW received a travel grant from the British Ecological Society and Akinori Takahashi one from the Japan Society the Promotion of Science. BAS and CEH are institutions within the NERC funding organisation, but no member of NERC other than the authors had any role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Beck CA, 2003, ANIM BEHAV, V66, P777, DOI 10.1006/anbe.2003.2284; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Casaux R, 2006, ANTARCT SCI, V18, P3, DOI 10.1017/S0954102006000010; Casaux R, 2001, J FIELD ORNITHOL, V72, P22, DOI 10.1648/0273-8570-72.1.22; Coleman JTH, 2005, WATERBIRDS, V28, P498, DOI 10.1675/1524-4695(2005)28[498:FLASFO]2.0.CO;2; Cook TR, 2008, ANIM BEHAV, V76, P565, DOI 10.1016/j.anbehav.2008.02.010; Cook TR, 2007, ANTARCT SCI, V19, P55, DOI 10.1017/S0954102007000089; Cook TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056297; Cook TR, 2008, MAR BIOL, V154, P383, DOI 10.1007/s00227-008-0939-6; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; CROXALL JP, 1991, J ZOOL, V225, P177, DOI 10.1111/j.1469-7998.1991.tb03810.x; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Elliott KH, 2009, WATERBIRDS, V32, P491; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Laich AG, 2012, J ORNITHOL, V153, P139, DOI 10.1007/s10336-011-0714-1; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Gremillet D, 1999, MAR ECOL PROG SER, V183, P263, DOI 10.3354/meps183263; Harris S, 2013, MAR BIOL, V160, P1249, DOI 10.1007/s00227-013-2177-9; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ishikawa K, 2002, J ETHOL, V20, P49, DOI 10.1007/s10164-002-0053-z; Kato A, 1999, CR ACAD SCI III-VIE, V322, P557, DOI 10.1016/S0764-4469(00)88525-X; Kato A, 1996, CONDOR, V98, P844, DOI 10.2307/1369867; Kato A, 2000, AUK, V117, P718, DOI 10.1642/0004-8038(2000)117[0718:VIFAPB]2.0.CO;2; Kock K-H, 1992, ANTARCTIC FISH FISHE; Kotzerka J, 2011, CONDOR, V113, P80, DOI 10.1525/cond.2011.090158; LABEELUND JH, 1993, J ANIM ECOL, V62, P160, DOI 10.2307/5490; Laidre KL, 2002, CAN J ZOOL, V80, P624, DOI 10.1139/Z02-041; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Ludynia K, 2013, ANIM BEHAV, V85, P255, DOI 10.1016/j.anbehav.2012.11.001; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacArthur R.H., 1969, POPULATION BIOL EVOL, P159; MALACALAZA VE, 1988, COLON WATERBIRD, V11, P32, DOI 10.2307/1521167; McIntyre T, 2010, MAR ECOL PROG SER, V412, P293, DOI 10.3354/meps08680; Mori Y, 2002, J EVOLUTION BIOL, V15, P269, DOI 10.1046/j.1420-9101.2002.00382.x; Mori Y, 2010, AQUAT BIOL, V8, P247, DOI 10.3354/ab00219; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; ORTA J, 1992, HDB BIRDS WORLD, P00326; Page B, 2006, MAR ECOL PROG SER, V323, P263, DOI 10.3354/meps323263; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paredes R, 2008, CAN J ZOOL, V86, P610, DOI 10.1139/Z08-036; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Pinheiro J, 2001, R PACKAGE VERSION, P31; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quintana F, 2007, MAR ECOL PROG SER, V334, P299, DOI 10.3354/meps334299; Quintana F, 2011, OIKOS, V120, P350, DOI 10.1111/j.1600-0706.2010.18387.x; Rey AR, 2012, EMU, V112, P90, DOI 10.1071/MU11065; Rezsu E, 2006, ECOL FRESHW FISH, V15, P339, DOI 10.1111/j.1600-0633.2006.00172.x; Ropert-Coudert Y, 2003, WATERBIRDS, V26, P403, DOI 10.1675/1524-4695(2003)026[0403:IDSITL]2.0.CO;2; Ruckstuhl K, 2005, SEXUAL SEGREGATION V; Staniland IJ, 2008, ANIM BEHAV, V75, P1581, DOI 10.1016/j.anbehav.2007.10.012; Staniland IJ, 2004, MAR ECOL PROG SER, V275, P263, DOI 10.3354/meps275263; Svagelj WS, 2007, WATERBIRDS, V30, P97, DOI 10.1675/1524-4695(2007)030[0097:SSDASD]2.0.CO;2; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Tremblay Y, 2005, CAN J ZOOL, V83, P971, DOI 10.1139/Z05-085; Wanless S, 1999, MAR ECOL PROG SER, V188, P219, DOI 10.3354/meps188219; WANLESS S, 1992, POLAR BIOL, V12, P713; WANLESS S, 1995, CONDOR, V97, P550, DOI 10.2307/1369040; Watanuki Y, 2005, J EXP BIOL, V208, P2207, DOI 10.1242/jeb.01639; Watanuki Y, 2004, MAR BIOL, V145, P427, DOI 10.1007/s00227-004-1345-3; Watanuki Y, 1996, CAN J ZOOL, V74, P1098, DOI 10.1139/z96-122; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Wilson RP, 2008, ECOL MONOGR, V78, P633, DOI 10.1890/07-0677.1; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zavalaga CB, 2007, MAR ECOL PROG SER, V336, P291, DOI 10.3354/meps336291; Zuur Alain F., 2009, P1	74	24	24	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e79107	10.1371/journal.pone.0079107	http://dx.doi.org/10.1371/journal.pone.0079107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205368	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000326032600118
J	Beyth, N; Shvero, DK; Zaltsman, N; Houri-Haddad, Y; Abramovitz, I; Davidi, MP; Weiss, EI				Beyth, Nurit; Shvero, Dana Kesler; Zaltsman, Nathan; Houri-Haddad, Yael; Abramovitz, Itzhak; Davidi, Michael Perez; Weiss, Ervin I.			Rapid Kill-Novel Endodontic Sealer and Enterococcus faecalis	PLOS ONE			English	Article							PYRIDINIUM-TYPE POLYMERS; ROOT-CANAL SEALERS; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; IN-VITRO; POLYETHYLENEIMINE NANOPARTICLES; FUNCTIONAL POLYMERS; GUTTA-PERCHA; BACTERIA; SURFACES	With growing concern over bacterial resistance, the identification of new antimicrobial means is paramount. In the oral cavity microorganisms are essential to the development of periradicular diseases and are the major causative factors associated with endodontic treatment failure. As quaternary ammonium compounds have the ability to kill a wide array of bacteria through electrostatic interactions with multiple anionic targets on the bacterial surface, it is likely that they can overcome bacterial resistance. Melding these ideas, we investigated the potency of a novel endodontic sealer in limiting Enterococcus faecalis growth. We used a polyethyleneimine scaffold to synthesize nano-sized particles, optimized for incorporation into an epoxy-based endodontic sealer. The novel endodontic sealer was tested for its antimicrobial efficacy and evaluated for biocompatibility and physical eligibility. Our results show that the novel sealer foundation affixes the nanoparticles, achieving surface bactericidal properties, but at the same time impeding nanoparticle penetration into eukaryotic cells and thereby mitigating a possible toxic effect. Moreover, adequate physical properties are maintained. The nanosized quaternary amine particles interact within minutes with bacteria, triggering cell death across wide pH values. Throughout this study we demonstrate a new antibacterial perspective for endodontic sealers; a novel antibacterial, effective and safe antimicrobial means.	[Beyth, Nurit; Shvero, Dana Kesler; Zaltsman, Nathan; Houri-Haddad, Yael; Davidi, Michael Perez; Weiss, Ervin I.] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Fac Dent, Dept Prosthodont, Jerusalem, Israel; [Abramovitz, Itzhak] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Fac Dent, Dept Endodont, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Beyth, N (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Fac Dent, Dept Prosthodont, Jerusalem, Israel.	nuritb@ekmd.huji.ac.il		perez davidi, michael/0000-0002-8596-5025				Aal-Saraj AB, 2012, AUST ENDOD J, V38, P60, DOI 10.1111/j.1747-4477.2010.00241.x; Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003; Beyth N, 2008, BIOMATERIALS, V29, P4157, DOI 10.1016/j.biomaterials.2008.07.003; Beyth N, 2007, J DENT, V35, P201, DOI 10.1016/j.jdent.2006.07.009; Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107; Beyth N, 2010, QUINTESSENCE INT, V41, P827; Bouillaguet S, 2006, J ENDODONT, V32, P989, DOI 10.1016/j.joen.2006.05.006; EGUCHI DS, 1985, J ENDODONT, V11, P166, DOI 10.1016/S0099-2399(85)80141-2; Foschi F, 2005, ORAL MICROBIOL IMMUN, V20, P289, DOI 10.1111/j.1399-302X.2005.00227.x; Gao BJ, 2007, J BIOMAT SCI-POLYM E, V18, P531, DOI 10.1163/156856207780852523; Gatewood R Scott, 2007, Dent Clin North Am, V51, P695, DOI 10.1016/j.cden.2007.04.005; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hancock HH, 2001, ORAL SURG ORAL MED O, V91, P579, DOI 10.1067/moe.2001.113587; IKEDA T, 1990, BIOCHIM BIOPHYS ACTA, V1026, P105, DOI 10.1016/0005-2736(90)90339-P; ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859, DOI 10.1128/AEM.24.6.859-863.1972; KAWABATA N, 1988, APPL ENVIRON MICROB, V54, P2532, DOI 10.1128/AEM.54.10.2532-2535.1988; Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004; Li GJ, 2000, J APPL POLYM SCI, V78, P676, DOI 10.1002/1097-4628(20001017)78:3<676::AID-APP240>3.0.CO;2-E; Li GJ, 2000, J APPL POLYM SCI, V78, P668, DOI 10.1002/1097-4628(20001017)78:3<668::AID-APP230>3.0.CO;2-A; Lin J, 2003, BIOTECHNOL BIOENG, V83, P168, DOI 10.1002/bit.10651; Lin J, 2002, BIOTECHNOL PROGR, V18, P1082, DOI 10.1021/bp025597w; Moradi Saeed, 2009, J Oral Sci, V51, P207; Morgental RD, 2011, INT ENDOD J, V44, P1128, DOI 10.1111/j.1365-2591.2011.01931.x; Neetakantan P, 2008, J CLIN PEDIATR DENT, V33, P117, DOI 10.17796/jcpd.33.2.d526512310970142; Nonaka T, 2000, J APPL POLYM SCI, V77, P1077, DOI 10.1002/1097-4628(20000801)77:5<1077::AID-APP15>3.3.CO;2-H; ORSTAVIK D, 1990, ENDOD DENT TRAUMATOL, V6, P6; Pasqualini D, 2010, J ENDODONT, V36, P1358, DOI 10.1016/j.joen.2010.03.035; Peters OA, 2001, INT ENDOD J, V34, P221, DOI 10.1046/j.1365-2591.2001.00373.x; Pizzo G, 2006, J DENT, V34, P35, DOI 10.1016/j.jdent.2005.03.001; Ricucci D, 2010, J ENDODONT, V36, P1, DOI 10.1016/j.joen.2009.09.038; Rocas IN, 2004, J ENDODONT, V30, P315, DOI 10.1097/00004770-200405000-00004; Saha S, 2010, J Indian Soc Pedod Prev Dent, V28, P251, DOI 10.4103/0970-4388.76151; Senges C, 2011, J ENDODONT, V37, P1247, DOI 10.1016/j.joen.2011.05.034; Shen Y, 2009, J ENDODONT, V35, P981, DOI 10.1016/j.joen.2009.04.030; Shipper G, 2005, J ENDODONT, V31, P91, DOI 10.1097/01.don.0000140569.33867.bf; Siqueira JF, 2000, J ENDODONT, V26, P274, DOI 10.1097/00004770-200005000-00005; Siqueira JF, 2008, J ENDODONT, V34, P1291, DOI 10.1016/j.joen.2008.07.028; Slutzky-Goldberg I, 2008, J ENDODONT, V34, P735, DOI 10.1016/j.joen.2008.03.012; Tanomaru Juliane M G, 2008, Acta Odontol Latinoam, V21, P147; Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; TOBIAS RS, 1988, INT ENDOD J, V21, P155, DOI 10.1111/j.1365-2591.1988.tb00969.x; Waltimo T, 2005, J ENDODONT, V31, P863, DOI 10.1097/01.don.0000164856.27920.85; Zhang H, 2009, J ENDODONT, V35, P1051, DOI 10.1016/j.joen.2009.04.022	44	16	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78586	10.1371/journal.pone.0078586	http://dx.doi.org/10.1371/journal.pone.0078586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223159	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200051
J	Bihari, V; Kesavachandran, CN; Mathur, N; Pangtey, BS; Kamal, R; Pathak, MK; Srivastava, AK				Bihari, Vipin; Kesavachandran, Chandrasekharan Nair; Mathur, Neeraj; Pangtey, Balram Singh; Kamal, Ritul; Pathak, Manoj Kumar; Srivastava, Anup Kumar			Mathematically Derived Body Volume and Risk of Musculoskeletal Pain among Housewives in North India	PLOS ONE			English	Article							LOW-BACK-PAIN; MASS INDEX; TRONDELAG HEALTH; LEISURE-TIME; OBESITY; WOMEN; ASSOCIATION; NETHERLANDS; PREVALENCE; DISABILITY	Background: Global Burden of Disease Study 2010 demonstrates the impact of musculoskeletal diseases as the second greatest cause of disability globally in all regions of the world. The study was conducted to determine the role of mathematically derived body volume (BV), body volume index (BVI), body mass index (BMI), body surface area (BSA) and body fat % (BF %) on musculoskeletal pain (MSP) among housewives in National Capital Region (NCR). Methods: A cross sectional study was undertaken among 495 housewives from Gurgaon and New Okhla Industrial Development Area (NOIDA) in National Capital Region (NCR), New Delhi, India. The study includes questionnaire survey, clinical examination and body composition monitoring among housewives. Results: A significantly higher BMI, BVI, BV and BSA were observed in subjects with MSP as compared to those who had no MSP. This was also true for subjects with pain in knee for BMI category for overweight. Subjects with pain in limbs had significantly high BMI and BVI as compared to subjects with no MSP. A significant positive correlation of age with BMI, BVI, BV and BSA was observed among subjects having no MSP denoting a direct relationship of age and these body factors. Conclusions: The prevalence of MSP among housewives is associated with increasing age, BMI and BVI. This can possibly be used for formulating a strategy for prevention of MSP.	[Bihari, Vipin; Kesavachandran, Chandrasekharan Nair; Mathur, Neeraj; Pangtey, Balram Singh; Kamal, Ritul; Pathak, Manoj Kumar; Srivastava, Anup Kumar] CSIR, Indian Inst Toxicol Res, Div Epidemiol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Srivastava, AK (corresponding author), CSIR, Indian Inst Toxicol Res, Div Epidemiol, Lucknow, Uttar Pradesh, India.	srianup1@yahoo.co.in		Kamal, Ritul/0000-0001-9741-1698; Srivastava, Anup Kumar/0000-0002-0211-7814	CSIR - Network Program [NWP - 17]	CSIR - Network Program	Financial support for the study was provided from CSIR - Network Program (NWP - 17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adera Tilahun, 1994, Annals of Epidemiology, V4, P416; Al-Awadhi AM, 2005, ANN SAUDI MED, V25, P459, DOI 10.5144/0256-4947.2005.459; Bigal ME, 2006, NEUROLOGY, V66, P545, DOI 10.1212/01.wnl.0000197218.05284.82; Bihari V, 2011, Indian J Occup Environ Med, V15, P59, DOI 10.4103/0019-5278.90375; Cardoso J.P., 2009, REV BRAS EPIDEMIOL, V12, P604, DOI [10.1590/S1415-790X2009000400010, DOI 10.1590/S1415-790X2009000400010]; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Escalante A, 2005, ARCH INTERN MED, V165, P1624, DOI 10.1001/archinte.165.14.1624; Haq SA, 2008, INT J RHEUM DIS, V11, P216, DOI 10.1111/j.1756-185X.2008.00364.x; Hildebrandt VH, 2000, INT ARCH OCC ENV HEA, V73, P507, DOI 10.1007/s004200000167; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Koley S, 2009, LIFE SCI, V1, P129; Korkmaz NC, 2003, PAIN CLINIC, V15, P219; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; LAU EMC, 1995, J EPIDEMIOL COMMUN H, V49, P492, DOI 10.1136/jech.49.5.492; Leavitt SB, 2012, SOARING BURDEN MUSCU; Linton SJ, 2001, SPINE, V26, P778, DOI 10.1097/00007632-200104010-00019; Lohman TG, 1996, EXERCISE SPORT SCI R, V14, P325; Loshak VD, 2002, J CLIN ENDOCR METAB, V87, P1509, DOI [10.1210/jc.87.4.1509, DOI 10.1210/JC.87.4.1509.PUBMED:11932273]; Marino PL, 2009, LITTLE ICU BOOK FACT, P106; Miranda H, 2002, OSTEOARTHR CARTILAGE, V10, P623, DOI 10.1053/joca.2002.0796; Moore R, 1999, EPIDEMIOL PAIN, P53; Mork PJ, 2010, ARTHRIT CARE RES, V62, P611, DOI 10.1002/acr.20118; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; SENDROY J, 1966, J APPL PHYSIOL, V21, P167, DOI 10.1152/jappl.1966.21.1.167; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Sorensen MB, 2001, OBES RES, V9, P622, DOI 10.1038/oby.2001.81; Suryapani R., 1996, TRIBUNE, V6, P16; van den Heuvel SG, 2005, PREV MED, V41, P260, DOI 10.1016/j.ypmed.2004.11.006; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Weevers HJA, 2005, FAM PRACT, V22, P197, DOI 10.1093/fampra/cmh727; *WHO SCI GROUP, 2003, WHO TECHN REP SER, V919; Woolf AD, 2001, BMJ-BRIT MED J, V322, P1079, DOI 10.1136/bmj.322.7294.1079; Yip YB, 2001, INT J OBESITY, V25, P887, DOI 10.1038/sj.ijo.0801557; Yunus MB, 2002, SCAND J RHEUMATOL, V31, P27, DOI 10.1080/030097402317255336	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80133	10.1371/journal.pone.0080133	http://dx.doi.org/10.1371/journal.pone.0080133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223218	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200111
J	Lavelle, A; Lennon, G; Docherty, N; Balfe, A; Mulcahy, HE; Doherty, G; O'Donoghue, D; Hyland, JM; Shanahan, F; Sheahan, K; Coffey, JC; Winter, DC; O'Connell, PR				Lavelle, Aonghus; Lennon, Grainne; Docherty, Neil; Balfe, Aine; Mulcahy, Hugh E.; Doherty, Glen; O'Donoghue, Diarmuid; Hyland, John M.; Shanahan, Fergus; Sheahan, Kieran; Coffey, J. Calvin; Winter, Desmond C.; O'Connell, P. Ronan			Depth-Dependent Differences in Community Structure of the Human Colonic Microbiota in Health	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOTA; DIVERSITY; DISEASE; ENTEROTYPES; STABILITY; THERAPY; COLITIS; TRACT	Objective: The aims of this study were to develop techniques for spatial microbial assessment in humans and to establish colonic luminal and mucosal spatial ecology, encompassing longitudinal and cross-sectional axes. Design: A microbiological protected specimen brush was used in conjunction with a biopsy forceps to sample the colon in nine healthy volunteers undergoing colonoscopy. Terminal Restriction Fragment Length Polymorphism analysis was used to determine the major variables in the spatial organization of the colonic microbiota. Results: Protected Specimen Brush sampling retrieved region-specific, uncontaminated samples that were enriched for bacterial DNA and depleted in human DNA when compared to biopsy samples. Terminal Restriction Fragment Length Polymorphism analysis revealed a segmentation of bacterial communities between the luminal brush and biopsy-associated ecological niches with little variability across the longitudinal axis of the colon and reduced diversity in brush samples. Conclusion: These results support the concept of a microbiota with little longitudinal variability but with some degree of segregation between luminal and mucosal communities.	[Lavelle, Aonghus; Lennon, Grainne; Balfe, Aine; Winter, Desmond C.; O'Connell, P. Ronan] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Lavelle, Aonghus; Lennon, Grainne; Mulcahy, Hugh E.; Doherty, Glen; O'Donoghue, Diarmuid; Hyland, John M.; Sheahan, Kieran; Winter, Desmond C.; O'Connell, P. Ronan] St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin 4, Ireland; [Docherty, Neil] Trin Coll Dublin, Dept Physiol, Dublin, Ireland; [Coffey, J. Calvin] Univ Limerick, Grad Entry Med Sch, Ctr Intervent Inflammat Infect & Immun 4i, Limerick, Ireland; [Shanahan, Fergus] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Dublin; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin; University of Limerick; University College Cork	O'Connell, PR (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	Ronan.OConnell@ucd.ie	O'Connell, Patrick Ronan/H-6583-2019; Shanahan, Fergus/ABF-2390-2020	O'Connell, Patrick Ronan/0000-0002-1846-5629; Shanahan, Fergus/0000-0003-0467-0936; Docherty, Neil/0000-0002-0961-2607; Doherty, Glen/0000-0003-4384-5049; mulcahy, hugh/0000-0002-7087-6177	Science Foundation Ireland [09/IN.1/B2606]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Funding was provided by a Science Foundation Ireland grant (09/IN.1/B2606). www.sfi.ie. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler D, 2012, COMPREHENSIVE R ARCH; Araujo-Perez F, 2012, GUT MICROBES, V3, P530, DOI 10.4161/gmic.22157; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Dave M, 2011, GUT, V60, P1043, DOI 10.1136/gut.2010.224337; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Hong PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025042; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jeffery IB, 2012, NAT REV MICROBIOL, V10, P591, DOI 10.1038/nrmicro2859; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; O'Brien CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062815; Oksanen J, 2012, COMPREHENSIVE R ARCH; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Core Team, 2012, R LANG ENV STAT COMP; Rees GN, 2004, ANTON LEEUW INT J G, V86, P339, DOI 10.1007/s10482-004-0498-x; Rowan F, 2010, ANN SURG, V252, P869, DOI 10.1097/SLA.0b013e3181fdc54c; Rowan F, 2010, DIS COLON RECTUM, V53, P1530, DOI 10.1007/DCR.0b013e3181f1e620; Shanahan F, 2011, CURR OPIN GASTROEN, V27, P61, DOI 10.1097/MOG.0b013e328340076f; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Fodor Lab, 2012, PEAKSTUDIO; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	45	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78835	10.1371/journal.pone.0078835	http://dx.doi.org/10.1371/journal.pone.0078835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223167	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200059
J	Su, HT; Kodiha, M; Lee, S; Stochaj, U				Su, Haitong; Kodiha, Mohamed; Lee, Sunghoon; Stochaj, Ursula			Identification of Novel Markers That Demarcate the Nucleolus during Severe Stress and Chemotherapeutic Treatment	PLOS ONE			English	Article							RIBOSOME BIOGENESIS; MESSENGER-RNA; SIGNALING EVENTS; PROTEINS; HUR; HETEROCHROMATIN; COMPONENTS; IMAGE	The nucleolus, the ribosomal factory of the cell, has emerged as a key player that regulates many aspects of cell biology. Several thousand proteins associate at least transiently with nucleoli, thereby generating a highly dynamic compartment with a protein profile which is sensitive to changes in cell physiology and pharmacological agents. Powerful tools that reliably demarcate the nucleoli are a prerequisite to measure their composition and activities. Previously, we developed quantitative methods to measure fluorescently labeled molecules in nucleoli. While these tools identify nucleoli under control and mild stress conditions, the accurate detection of nucleolar boundaries under harsh experimental conditions is complicated by the lack of appropriate markers for the nucleolar compartment. Using fluorescence microscopy we have now identified new marker proteins to detect nucleoli upon (a) severe stress and (b) drug treatments that trigger a pronounced reorganization of nucleoli. Our results demonstrate that nucleolin is an ideal marker to delimit nucleoli when cells are exposed to heat or oxidative stress. Furthermore, we show for the first time that cellular apoptosis susceptibility protein (CAS) and human antigen R protein (HuR) are excluded from nucleoli and can be employed to delimit these compartments under severe conditions that redistribute major nucleolar proteins. As proof-of-principle, we used these markers to demarcate nucleoli in cells treated with pharmacological compounds that disrupt the nucleolar organization. Furthermore, to gain new insights into the biology of the nucleolus, we applied our protocols and quantified stress-and drug-induced changes in nucleolar organization and function. Finally, we show that CAS, HuR and nucleolin not only identify nucleoli in optical sections, but are also suitable to demarcate the nucleolar border following 3D reconstruction. Taken together, our studies present novel marker proteins that delimit nucleoli with high confidence under a variety of experimental settings.	[Su, Haitong; Kodiha, Mohamed; Lee, Sunghoon; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Stochaj, U (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	ursula.stochaj@mcgill.ca	stochaj, ursula/AAC-1865-2021		Natural Sciences and Engineering Research Council (NSERC); Fonds de Recherche Nature et Technologies Quebec (FQRNT); Heart and Stroke Foundation of Canada (HSFC)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Nature et Technologies Quebec (FQRNT); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This research was supported by grants and fellowships from Natural Sciences and Engineering Research Council (NSERC), Fonds de Recherche Nature et Technologies Quebec (FQRNT), and Heart and Stroke Foundation of Canada (HSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Avitabile D, 2011, P NATL ACAD SCI USA, V108, P6145, DOI 10.1073/pnas.1017935108; Banski P, 2010, TRENDS BIOCHEM SCI, V35, P361, DOI 10.1016/j.tibs.2010.02.010; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bierne H, 2013, EMBO REP, V14, P663, DOI 10.1038/embor.2013.105; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Cisterna B, 2010, INT REV CEL MOL BIO, V284, P67, DOI 10.1016/S1937-6448(10)84002-X; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Ginisty H, 1999, J CELL SCI, V112, P761; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Guetg C, 2012, EPIGENETICS-US, V7, P811, DOI 10.4161/epi.21072; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hiscox JA, 2010, PROTEOMICS, V10, P4077, DOI 10.1002/pmic.201000251; Kar B, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-33; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Khandelwal N, 2011, CELL DEATH DIFFER, V18, P1889, DOI 10.1038/cdd.2011.79; Kodiha M, 2008, CELL MOL LIFE SCI, V65, P1756, DOI 10.1007/s00018-008-7588-2; Kodiha M, 2013, CHAPERONES MULTITASK, P149; Kodiha M, 2012, J SIGNAL TRANSDUCTIO, V2012; Kodiha M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-25; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Kodiha M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008420; Lindenboim L, 2010, CELL DEATH DIFFER, V17, P346, DOI 10.1038/cdd.2009.145; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Louvet E, 2006, MOL BIOL CELL, V17, P2537, DOI 10.1091/mbc.E05-10-0923; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Maggi LB, 2005, CANCER INVEST, V23, P599, DOI 10.1080/07357900500283085; Mahboubi H, 2013, MICROSC MICROANAL, P1; Mahboubi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068356; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Politz JCR, 2005, MOL BIOL CELL, V16, P3401, DOI 10.1091/mbc.E05-02-0106; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Turner AJ, 2012, RNA BIOL, V9, DOI [10.4161/rna.18811, 10.4161/rna.9.2.18811]; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414	50	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80237	10.1371/journal.pone.0080237	http://dx.doi.org/10.1371/journal.pone.0080237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223222	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200115
J	Voss, MW; Wong, CN; Baniqued, PL; Burdette, JH; Erickson, KI; Prakash, RS; McAuley, E; Laurienti, PJ; Kramer, AF				Voss, Michelle W.; Wong, Chelsea N.; Baniqued, Pauline L.; Burdette, Jonathan H.; Erickson, Kirk I.; Prakash, Ruchika Shaurya; McAuley, Edward; Laurienti, Paul J.; Kramer, Arthur F.			Aging Brain from a Network Science Perspective: Something to Be Positive About?	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; CARDIORESPIRATORY FITNESS; AGE; FMRI; SYSTEMS; MOTION; ROBUST; LIFE	To better understand age differences in brain function and behavior, the current study applied network science to model functional interactions between brain regions. We observed a shift in network topology whereby for older adults subcortical and cerebellar structures overlapping with the Salience network had more connectivity to the rest of the brain, coupled with fragmentation of large-scale cortical networks such as the Default and Fronto-Parietal networks. Additionally, greater integration of the dorsal medial thalamus and red nucleus in the Salience network was associated with greater satisfaction with life for older adults, which is consistent with theoretical predictions of age-related increases in emotion regulation that are thought to help maintain well-being and life satisfaction in late adulthood. In regard to cognitive abilities, greater ventral medial prefrontal cortex coherence with its topological neighbors in the Default Network was associated with faster processing speed. Results suggest that large-scale organizing properties of the brain differ with normal aging, and this perspective may offer novel insight into understanding age-related differences in cognitive function and well-being.	[Voss, Michelle W.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Wong, Chelsea N.; Baniqued, Pauline L.; Kramer, Arthur F.] Univ Illinois, Beckman Inst, Urbana, IL USA; [Wong, Chelsea N.; Baniqued, Pauline L.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Urbana, IL USA; [McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Erickson, Kirk I.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Prakash, Ruchika Shaurya] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Burdette, Jonathan H.; Laurienti, Paul J.] Wake Forest Univ, Wake Forest Sch Med, Winston Salem, NC 27109 USA	University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; Wake Forest University	Voss, MW (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	michelle-voss@uiowa.edu	Prakash, Ruchika S/K-2030-2013; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	National Institute on Aging at the National Institutes of Health [R37 AG025667, RO1 AG25032]; NATIONAL INSTITUTE ON AGING [R01AG025032] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging at the National Institutes of Health (grant numbers R37 AG025667, RO1 AG25032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; Carp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029411; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gana K, 2012, J GERONTOL B-PSYCHOL; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044067; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Madden DJ, 2010, NEUROIMAGE, V52, P643, DOI 10.1016/j.neuroimage.2010.04.249; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Minzenberg MJ, 2011, PSYCHOPHARMACOLOGY, V215, P23, DOI 10.1007/s00213-010-2111-5; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Nioche C, 2009, AM J NEURORADIOL, V30, P396, DOI 10.3174/ajnr.A1375; Nolte J, 2009, HUMAN BRAIN INTRO IT, P390; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prakash RS, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00229; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Steketee JD, 2003, BRAIN RES REV, V41, P203, DOI 10.1016/S0165-0173(02)00233-3; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Urry HL, 2010, CURR DIR PSYCHOL SCI, V19, P352, DOI 10.1177/0963721410388395; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Voss MW, 2008, BRAIN RES, V1244, P121, DOI 10.1016/j.brainres.2008.09.051; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	58	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78345	10.1371/journal.pone.0078345	http://dx.doi.org/10.1371/journal.pone.0078345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223147	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200039
J	Lear, BC; Darrah, EJ; Aldrich, BT; Gebre, S; Scott, RL; Nash, HA; Allada, R				Lear, Bridget C.; Darrah, Eric J.; Aldrich, Benjamin T.; Gebre, Senetibeb; Scott, Robert L.; Nash, Howard A.; Allada, Ravi			UNC79 and UNC80, Putative Auxiliary Subunits of the NARROW ABDOMEN Ion Channel, Are Indispensable for Robust Circadian Locomotor Rhythms in Drosophila	PLOS ONE			English	Article							CATION CHANNEL; NEURONAL EXCITABILITY; GENE; EXPRESSION	In the fruit fly Drosophila melanogaster, a network of circadian pacemaker neurons drives daily rhythms in rest and activity. The ion channel NARROW ABDOMEN (NA), orthologous to the mammalian sodium leak channel NALCN, functions downstream of the molecular circadian clock in pacemaker neurons to promote behavioral rhythmicity. To better understand the function and regulation of the NA channel, we have characterized two putative auxiliary channel subunits in Drosophila, unc79 (aka dunc79) and unc80 (aka CG18437). We have generated novel unc79 and unc80 mutations that represent strong or complete loss-of-function alleles. These mutants display severe defects in circadian locomotor rhythmicity that are indistinguishable from na mutant phenotypes. Tissue-specific RNA interference and rescue analyses indicate that UNC79 and UNC80 likely function within pacemaker neurons, with similar anatomical requirements to NA. We observe an interdependent, post-transcriptional regulatory relationship among the three gene products, as loss of na, unc79, or unc80 gene function leads to decreased expression of all three proteins, with minimal effect on transcript levels. Yet despite this relationship, we find that the requirement for unc79 and unc80 in circadian rhythmicity cannot be bypassed by increasing NA protein expression, nor can these putative auxiliary subunits substitute for each other. These data indicate functional requirements for UNC79 and UNC80 beyond promoting channel subunit expression. Immunoprecipitation experiments also confirm that UNC79 and UNC80 form a complex with NA in the Drosophila brain. Taken together, these data suggest that Drosophila NA, UNC79, and UNC80 function together in circadian clock neurons to promote rhythmic behavior.	[Lear, Bridget C.; Darrah, Eric J.; Aldrich, Benjamin T.; Gebre, Senetibeb] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Scott, Robert L.; Nash, Howard A.] NIMH, Mol Biol Lab, Bethesda, MD 20892 USA; [Allada, Ravi] Northwestern Univ, Dept Neurobiol, Evanston, IL USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Northwestern University	Lear, BC (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bridget-lear@uiowa.edu			NIH [R00 GM080107, R01 NS052903]; NARSAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R00 GM080107 to B. C. L, NIH R01 NS052903 to R. A., and a NARSAD Young Investigator Award to B. C. L. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUBREUIL R, 1987, J CELL BIOL, V105, P2095, DOI 10.1083/jcb.105.5.2095; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lear BC, 2012, CIRCADIAN RHYTHMS EN, P1; LeSauter J, 2011, J NEUROPHYSIOL, V106, P576, DOI 10.1152/jn.00060.2011; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; MORGAN PG, 1988, ANESTHESIOLOGY, V69, P246, DOI 10.1097/00000542-198808000-00015; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Speca DJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001057; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Wang H, 2009, CHANNELS, V3, P161, DOI 10.4161/chan.3.3.8853; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	28	34	35	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78147	10.1371/journal.pone.0078147	http://dx.doi.org/10.1371/journal.pone.0078147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223770	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400018
J	Onwujekwe, O; Uguru, N; Etiaba, E; Chikezie, I; Uzochukwu, B; Adjagba, A				Onwujekwe, Obinna; Uguru, Nkoli; Etiaba, Enyi; Chikezie, Ifeanyi; Uzochukwu, Benjamin; Adjagba, Alex			The Economic Burden of Malaria on Households and the Health System in Enugu State Southeast Nigeria	PLOS ONE			English	Article							PAYMENT; ILLNESS	Background: Malaria is the number one public health problem in Nigeria, responsible for about 30% of deaths in under-fives and 25% of deaths in infants and 11% maternal mortality. This study estimated the economic burden of malaria in Nigeria using the cost of illness approach. Methods: A cross-sectional study was undertaken in two malaria holo-endemic communities in Nigeria, involving both community and hospital based surveys. A random sample of 500 households was interviewed using interviewer administered questionnaire. In addition, 125 exit interviews for inpatient department stays (IPD) and outpatient department visits (OPD) were conducted and these were complemented with data abstraction from 125 patient records. Results: From the household survey, over half of the households (57.6%) had an episode of malaria within one month to the date of the interview. The average household expenditure per case was 12.57US$ and 23.20US$ for OPD and IPD respectively. Indirect consumer costs of treatment were higher than direct consumer medical costs. From a health system perspective, the recurrent provider costs per case was 30.42 US$ and 48.02 US$ for OPD and IPD while non recurrent provider costs were 133.07US$ and 1857.15US$ for OPD and IPD. The mode of payment was mainly through out-of-pocket spending (OOPS). Conclusion: Private expenditure on treatment of malaria constitutes a high economic burden to households and to the health system. Removal of user fees and interventions that will decrease the use of OOPS for treatment of malaria will significantly decrease the economic burden of malaria to both households and the health system.	[Onwujekwe, Obinna; Uguru, Nkoli; Etiaba, Enyi; Chikezie, Ifeanyi; Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu, Nigeria; [Onwujekwe, Obinna; Etiaba, Enyi; Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Hlth Adm & Management, Enugu, Nigeria; [Uguru, Nkoli] Univ Nigeria, Coll Med, Dept Prevent Dent, Enugu, Nigeria; [Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria; [Adjagba, Alex] Agence Med Prevent, SIVAC Supporting Natl Independent Immunizat & Vac, Paris, France	University of Nigeria; University of Nigeria; University of Nigeria; University of Nigeria; Agence de Medecine Preventive	Etiaba, E (corresponding author), Univ Nigeria, Coll Med, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu Campus, Enugu, Nigeria.	enyietiaba@yahoo.co.uk	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285	Partnership for Transforming Health Systems (PATHS)	Partnership for Transforming Health Systems (PATHS)	Funding for this study was provided by the Partnership for Transforming Health Systems (PATHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedotun AA, 2010, J VECTOR DIS, V47, P155; AsensoOkyere WK, 1997, SOC SCI MED, V45, P659, DOI 10.1016/S0277-9536(96)00383-8; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; Chuma JM, 2006, MALARIA J, V30, P5; Cleary SM, 2006, COST EFFECTIVENESS R, V4; Elden S, 2010, MALARIA BURDEN INTER; Erhun W. O., 2005, African Journal of Biomedical Research, V8, P25; Ezeoke OP, 2012, AM J TROP MED HYG, V86, P52, DOI 10.4269/ajtmh.2012.11-0090; Federal Ministry of Health Nigeria, 2005, NAT MAL CONTR PROGR; Federal Ministry of Health Nigeria, 2006, MAL EP; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Jimoh A, 2007, COST EFFECTIVENESS R; Meessen B, 2006, LANCET, V368, P2253, DOI 10.1016/S0140-6736(06)69899-1; National Population Commission, 2006, NAT CENS 2006; Okorosobo T, 2011, EUROPEAN J BUSINESS, V3; Oluka GP, 2008, PRESENTATION ROLL OU; Oluyole K. A., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P696; Onoka C, 2012, WHY STATES ADOPTING; Onwujekwe O, 2000, HEALTH POLICY, V54, P143, DOI 10.1016/S0168-8510(00)00105-6; Onwujekwe O, 2006, AM J TROP MED HYG, V75, P421, DOI 10.4269/ajtmh.2006.75.421; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Uguru NP, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-21; Uzochukwu BSC, 2004, INT J EQUITY HLTH, V3; WHO, 2010, WORLD MALARIA REPORT 2010, P1	25	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78362	10.1371/journal.pone.0078362	http://dx.doi.org/10.1371/journal.pone.0078362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223796	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400056
J	Yang, SD; Ding, WY; Yang, DL; Gu, TX; Zhang, F; Zhang, D; Sun, YP; Ma, L; Song, YL				Yang, Sidong; Ding, Wenyuan; Yang, Dalong; Gu, Tixin; Zhang, Feng; Zhang, Di; Sun, Yapeng; Ma, Lei; Song, Yanli			Epidemiology and Risk Factors of Cervical Spine Injury during Heating Season in the Patients with Cervical Trauma: A Cross-Sectional Study	PLOS ONE			English	Article							CORD-INJURY; HEAD-INJURIES; FRACTURES; CANADA	Purpose: The purpose of this study was to describe the epidemiology of cervical spine injury in the patients with cervical trauma and analyze its associated risk factors during the special heating season in North China. Methods: This cross-sectional study investigated predictors for cervical spine injury in cervical trauma patients using retrospectively collected data of Hebei Provincial Orthopaedic Hospital from 11/2011 to 02/2012, and 11/2012 to 02/2013. Binary logistic regression analysis was used to determine risk factors for cervical fractures/dislocations or cord injury. Results: A total of 106 patients were admitted into this study. Of all, 34 patients (32.1%) were treated from 11/2011 to 02/2012 and 72 patients (67.9%) from 11/2012 to 02/2013. The mean age was 41.9 +/- 13.3 years old; 85 patients (80.2%) were male and 82 (77.4%) from rural areas. Eighty patients (75.5%) were caused by fall including 45 (42.5%) by severe fall (>2 m). Sixty-five patients (61.3%) of all suffered injuries to other body regions and 32 (30.2%) got head injury. Thirty-one patients (29.2%) sustained cervical cord injury with cervical fractures/dislocations. Twenty-six (83.9%) of cervical cord injury patients were from rural areas and 24 (77.4%) of those resulted from fall including 15 (48.4%) from severe fall (>2 m). Logistic regression displayed that age (OR, 1.47; 95% CI, 1.05-2.07), head injury (OR, 5.63; 95% CI, 2.23-14.26), were risk factors for cervical cord injury and snowing (OR, 8.25; 95% CI, 2.26-30.15) was a risk factor for cervical spine injury due to severe fall (>2 m). Conclusions: The elder male patients and patients with head trauma are high-risk population for cervical cord injury. As a seasonal factor, snowing during heating season is of note a risk factor for cervical spine injury resulting from severe fall (>2 m) in the patients with cervical trauma in North China.	[Yang, Sidong; Ding, Wenyuan; Yang, Dalong; Zhang, Di; Sun, Yapeng; Ma, Lei; Song, Yanli] Hebei Med Univ, Hosp 3, Dept Spine Surg, Shijiazhuang, Hebei, Peoples R China; [Gu, Tixin] Hebei Med Univ, Hosp 1, Dept VIP Ward, Shijiazhuang, Hebei, Peoples R China; [Zhang, Feng] Hebei Med Univ, Hosp 3, Dept Rehabil Med, Shijiazhuang, Hebei, Peoples R China; [Yang, Sidong; Ding, Wenyuan; Yang, Dalong; Zhang, Di; Sun, Yapeng; Ma, Lei] Hebei Prov Key Lab Orthoped Biomech, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Ding, WY (corresponding author), Hebei Med Univ, Hosp 3, Dept Spine Surg, Shijiazhuang, Hebei, Peoples R China.	dingwyster@126.com	zhang, feng/AAD-1724-2019; Yang, Sidong/AAP-5389-2021	zhang, feng/0000-0002-7845-7970; Yang, Sidong/0000-0003-2342-4714; Ding, Wenyuan/0000-0002-7257-4316	Department of Spine Surgery, The Third Hospital of Hebei Medical University	Department of Spine Surgery, The Third Hospital of Hebei Medical University	The authors were supported by the Department of Spine Surgery, The Third Hospital of Hebei Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLESS P, 1989, AM J EMERG MED, V7, P139, DOI 10.1016/0735-6757(89)90125-3; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Gupta A, 2009, ANZ J SURG, V79, P898, DOI 10.1111/j.1445-2197.2009.05141.x; Hasler RM, 2012, J TRAUMA ACUTE CARE, V72, P975, DOI 10.1097/TA.0b013e31823f5e8e; Ho CH, 2007, ARCH PHYS MED REHAB, V88, pS49, DOI 10.1016/j.apmr.2006.12.001; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Knop C, 1999, UNFALLCHIRURG, V102, P924, DOI 10.1007/s001130050507; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lenehan B, 2009, EUR SPINE J, V18, P938, DOI 10.1007/s00586-009-0923-y; Leucht P, 2009, INJURY, V40, P166, DOI 10.1016/j.injury.2008.06.040; Mulford JS, 2001, AUST NZ J SURG, V71, P32, DOI 10.1046/j.1440-1622.2001.02021.x; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; RIGGINS RS, 1977, J TRAUMA, V17, P126, DOI 10.1097/00005373-197702000-00007; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; Smith JA, 2005, J TRAUMA, V59, P117, DOI 10.1097/01.TA.0000171534.75347.52; SOICHER E, 1991, BRIT J SURG, V78, P1013, DOI 10.1002/bjs.1800780837; Tian HL, 2009, J TRAUMA, V67, P1305, DOI 10.1097/TA.0b013e31819db57c; World Health Organisation, 2009, WORLD HLTH REP; Zargar M, 2005, East Mediterr Health J, V11, P235	22	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78358	10.1371/journal.pone.0078358	http://dx.doi.org/10.1371/journal.pone.0078358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223795	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400055
J	Denholm, SJ; Norman, RA; Hoyle, AS; Shinn, AP; Taylor, NGH				Denholm, Scott J.; Norman, Rachel A.; Hoyle, Andrew S.; Shinn, Andrew P.; Taylor, Nick G. H.			Reproductive Trade-Offs May Moderate the Impact of Gyrodactylus salaris in Warmer Climates	PLOS ONE			English	Article							SALMON SALMO-SALAR; ATLANTIC SALMON; RAINBOW-TROUT; COMPARATIVE SUSCEPTIBILITY; POPULATION-GROWTH; RIVER; RISK; INFECTION; MALMBERG; EXPRESSION	Gyrodactylus salaris is a notifiable freshwater ectoparasite of salmonids. Its primary host is Atlantic salmon (Salmo salar), upon which infections can cause death, and have led to massive declines in salmon numbers in Norway, where the parasite is widespread. Different strains of S. salar vary in their susceptibility, with Atlantic strains (such as those found in Norway) exhibiting no resistance to the parasite, and Baltic strains demonstrating an innate resistance sufficient to regulate parasite numbers on the host causing it to either die out or persist at a low level. In this study, Leslie matrix and compartmental models were used to generate data that demonstrated the population growth of G. salaris on an individual host is dependent on the total number of offspring per parasite, its longevity and the timing of its births. The data demonstrated that the key factor determining the rate of G. salaris population growth is the time at which the parasite first gives birth, with rapid birth rate giving rise to large population size. Furthermore, it was shown that though the parasite can give birth up to four times, only two births are required for the population to persist as long as the first birth occurs before a parasite is three days old. As temperature is known to influence the timing of the parasite's first birth, greater impact may be predicted if introduced to countries with warmer climates than Norway, such as the UK and Ireland which are currently recognised to be free of G. salaris. However, the outputs from the models developed in this study suggest that temperature induced trade-offs between the total number of offspring the parasite gives birth to and the first birth timing may prevent increased population growth rates over those observed in Norway.	[Denholm, Scott J.; Norman, Rachel A.; Hoyle, Andrew S.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Norman, Rachel A.; Shinn, Andrew P.] Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Taylor, Nick G. H.] Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci Cefas, Weymouth, England	University of Stirling; University of Stirling; Centre for Environment Fisheries & Aquaculture Science	Denholm, SJ (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	sde@stir.ac.uk	Norman, Rachel A/A-2930-2009; Norman, R/AAI-8164-2021; Norman, R/AFT-9458-2022; Denholm, Scott J/L-2520-2015	Norman, Rachel A/0000-0002-7398-6064; Norman, R/0000-0002-7398-6064; Norman, R/0000-0002-7398-6064; Denholm, Scott J/0000-0002-6291-8269; Hoyle, Andrew/0000-0002-9117-7041	Department of the Environment, Fisheries and Rural Affairs (DEFRA) of the English Government [FC1197]; Department of the Environment, Fisheries and Rural Affairs (DEFRA) of the Welsh Government [FC1197]	Department of the Environment, Fisheries and Rural Affairs (DEFRA) of the English Government; Department of the Environment, Fisheries and Rural Affairs (DEFRA) of the Welsh Government	This research was supported by the Department of the Environment, Fisheries and Rural Affairs (DEFRA, http://www.defra.gov.uk/) of the English and Welsh Governments (project no. FC1197) awarded to NGHT and RAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PS, 1998, J HELMINTHOL, V72, P9, DOI 10.1017/S0022149X00000900; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Bakke TA, 1998, CAN J FISH AQUAT SCI, V55, P247, DOI 10.1139/cjfas-55-S1-247; BAKKE TA, 1993, FISH RES, V17, P69, DOI 10.1016/0165-7836(93)90008-U; BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; Buchmann K, 1999, FOLIA PARASIT, V46, P1; Cable J, 2007, BIOL J LINN SOC, V90, P647, DOI 10.1111/j.1095-8312.2006.00755.x; Cable J, 2000, PARASITOLOGY, V121, P621, DOI 10.1017/S0031182000006971; Dalgaard MB, 2004, J AQUAT ANIM HEALTH, V16, P109, DOI 10.1577/H03-004.1; Dalgaard MB, 2003, DIS AQUAT ORGAN, V53, P173, DOI 10.3354/dao053173; Des Clers Sophie, 1993, Fisheries Research (Amsterdam), V17, P237, DOI 10.1016/0165-7836(93)90023-Z; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Harris PD, 2000, PARASITOLOGY, V120, P57, DOI 10.1017/S0031182099005223; HEGGBERGET TG, 1982, J FISH BIOL, V21, P15, DOI 10.1111/j.1095-8649.1982.tb02819.x; Hogasen HR, 2003, DIS AQUAT ORGAN, V57, P247, DOI 10.3354/dao057247; JANSEN PA, 1991, PARASITOLOGY, V102, P105, DOI 10.1017/S0031182000060406; Jansen PA, 2007, DIS AQUAT ORGAN, V74, P139, DOI 10.3354/dao074139; JOHNSEN BO, 1986, J FISH BIOL, V29, P233, DOI 10.1111/j.1095-8649.1986.tb04941.x; JOHNSEN BO, 1992, J FISH BIOL, V40, P433, DOI 10.1111/j.1095-8649.1992.tb02588.x; JOHNSEN BO, 1999, NINA OPPDRAGSMELDING, V617, P1; JOHNSEN BO, 2003, ATLANTIC SALMON BIOL, P38; Kania P, 2007, DIS AQUAT ORGAN, V76, P81, DOI 10.3354/dao076081; Kochin BF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000524; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lindenstrom T, 2006, J FISH DIS, V29, P123, DOI 10.1111/j.1365-2761.2006.00696.x; Lindenstrom T, 2004, VET IMMUNOL IMMUNOP, V97, P137, DOI 10.1016/j.vetimm.2003.08.016; Lindenstrom T, 2003, FISH SHELLFISH IMMUN, V15, P107, DOI 10.1016/S1050-4648(02)00142-0; Malmberg G., 1989, P88; Malmberg G, 1998, INT J PARASITOL, V28, P1625, DOI 10.1016/S0020-7519(98)00058-7; Mo T.A., 1994, P43; MO TA, 2004, NORSK VETERINAERTIDS, V3, P164; NOU (Norges Offentlige Utredninger), 1999, LAKS KAN INGEN GJERA, P1; Paisley LG, 1999, DIS AQUAT ORGAN, V37, P145, DOI 10.3354/dao037145; Peeler E, 2006, AQUACULTURE, V258, P187, DOI 10.1016/j.aquaculture.2005.07.042; Peeler EJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-94; Peeler EJ, 2004, PREV VET MED, V64, P175, DOI 10.1016/j.prevetmed.2004.05.005; Peeler EJ, 2004, DIS AQUAT ORGAN, V62, P103, DOI 10.3354/dao062103; Ramirez R, 2012, INT J PARASITOL, V42, P809, DOI 10.1016/j.ijpara.2012.05.012; SCOTT ME, 1984, PARASITOLOGY, V89, P159, DOI 10.1017/S0031182000001207; Tanum K, 1983, THESIS U OSLO; Van der Linden P., 2009, ENSEMBLES CLIMATE CH; van Oosterhout C, 2008, INT J PARASITOL, V38, P541, DOI 10.1016/j.ijpara.2007.09.016; 1999, NORGES OFFENTLIGE UT, V9, P1	43	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78909	10.1371/journal.pone.0078909	http://dx.doi.org/10.1371/journal.pone.0078909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205349	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500140
J	Shi, LL; Zhang, S; Wu, HG; Zhang, LL; Dai, XF; Hu, JL; Xue, J; Liu, T; Liang, YC; Wu, G				Shi, Liangliang; Zhang, Sheng; Wu, Hongge; Zhang, Lilin; Dai, Xiaofang; Hu, Jianli; Xue, Jun; Liu, Tao; Liang, Yichen; Wu, Gang			MiR-200c Increases the Radiosensitivity of Non-Small-Cell Lung Cancer Cell Line A549 by Targeting VEGF-VEGFR2 Pathway	PLOS ONE			English	Article							EXPRESSION; RADIATION; VEGF; ANGIOGENESIS; GLIOBLASTOMA; RADIOTHERAPY; SENSITIVITY; INVASION; EGFR	MicroRNAs (miRNAs) have been demonstrated to participate in many important cellular processes including radiosensitization. VEGF family, an important regulator of angiogenesis, also plays a crucial role in the regulation of cancer cell radiosensitivity. VEGFR2 mediates the major growth and permeability actions of VEGF in a paracrine/autocrine manner. MiR-200c, at the nexus of epithelial-mesenchymal transition (EMT), is predicted to target VEGFR2. The purpose of this study is to test the hypothesis that regulation of VEGFR2 pathway by miR-200c could modulate the radiosensitivity of cancer cells. Bioinformatic analysis, luciferase reporter assays and biochemical assays were carried out to validate VEGFR2 as a direct target of miR-200c. The radiosensitizing effects of miR-200c on A549 cells were determined by clonogenic assays. The downstream regulating mechanism of miR-200c was explored with western blotting assays, FCM, tube formation assays and migration assays. We identified VEGFR2 as a novel target of miR-200c. The ectopic miR-200c increased the radiosensitivity of A549 while miR-200c down-regulation decreased it. Besides, we proved that miR-200c radiosensitized A549 cells by targeting VEGF-VEGFR2 pathway specifically, thus leading to inhibition of its downstream pro-survival signaling transduction and angiogenesis, and serves as a potential target for radiosensitizition research.	[Shi, Liangliang; Zhang, Sheng; Wu, Hongge; Zhang, Lilin; Dai, Xiaofang; Hu, Jianli; Xue, Jun; Liu, Tao; Liang, Yichen; Wu, Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Wu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430074, Peoples R China.	wg1893@hotmail.com		Shi, Liangliang/0000-0001-6457-2890	Hubei Provincial Natural Science Foundation [2009CDA061]	Hubei Provincial Natural Science Foundation	This work was supported by Hubei Provincial Natural Science Foundation project (No: 2009CDA061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, CANCER RES, V63, P3755; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Cittelly DM, 2012, MOL CANCER THER, V11, P2556, DOI 10.1158/1535-7163.MCT-12-0463; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Li J, 2005, INT J RADIAT ONCOL, V62, P1477, DOI 10.1016/j.ijrobp.2005.04.028; Li ZY, 2011, TUMOR BIOL, V32, P677, DOI 10.1007/s13277-011-0168-3; Peng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034646; Rowell NP, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002140.PUB2; Sechler M, 2013, PHARMACOGN PERS MED, V6, P25, DOI 10.2147/PGPM.S26058; Shibuya K, 2007, INT J RADIAT ONCOL, V69, P1534, DOI 10.1016/j.ijrobp.2007.07.2350; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Solberg TD, 2008, INT J RADIAT ONCOL, V72, P918, DOI 10.1016/j.ijrobp.2008.06.1925; Wachsberger PR, 2007, INT J RADIAT ONCOL, V67, P1526, DOI 10.1016/j.ijrobp.2006.11.011; Wang N, 2012, BREAST CANCER RES TR, V134, P943, DOI 10.1007/s10549-012-1977-9; Wang Q, 2009, EUR J CANCER PREV, V18, P510, DOI 10.1097/CEJ.0b013e32832f9c00; Wang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-29; Wu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029043; Zhu F, 2011, MED ONCOL, V28, P565, DOI 10.1007/s12032-010-9468-5	19	74	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78344	10.1371/journal.pone.0078344	http://dx.doi.org/10.1371/journal.pone.0078344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205206	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500113
J	Siniscalchi, M; Stipo, C; Quaranta, A				Siniscalchi, Marcello; Stipo, Carlo; Quaranta, Angelo			"Like Owner, Like Dog": Correlation between the Owner's Attachment Profile and the Owner-Dog Bond	PLOS ONE			English	Article							CANIS-FAMILIARIS; GUIDE DOGS; BEHAVIOR; TEMPERAMENT; SITUATION	During recent years, several studies have revealed that human-dog relationships are based on a well-established and complex bond. There is now evidence suggesting that the dog-human affectional bond can be characterized as an "attachment". The present study investigated possible association between the owners' attachment profile assessed throughout a new semi-projective test (the 9 Attachment Profile) and the owner-dog attachment bond evaluated using a modified version of those used in studying human infants: Ainsworth's "strange situation". The findings represented the first evidence for the presence of a correlation between the owners' attachment profile and the owner-dog attachment bond throughout procedure and behavioural analyses involving controlled observations.	[Siniscalchi, Marcello; Stipo, Carlo; Quaranta, Angelo] Univ Bari Aldo Moro, Dept Vet Med, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Siniscalchi, M (corresponding author), Univ Bari Aldo Moro, Dept Vet Med, Bari, Italy.	marcello.siniscalchi@uniba.it		Quaranta, Angelo/0000-0001-7835-2485				AINSWORT.MD, 1970, CHILD DEV, V41, P49, DOI 10.2307/1127388; AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; Bard K., 1991, AM J PRIMATOL, V24, P88; Bowlby J., 1973, ATTACHMENT LOSS, V2; BOWLBY J, 1973, ATTACHMENT LOSS LOSS, V3; Bowlby J., 1982, ATTACHMENT LOSS ATTA, V1; Boxall J, 2004, ATLA-ALTERN LAB ANIM, V32, P81, DOI 10.1177/026119290403202s16; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Bretherton I., 1999, HDB ATTACHMENT THEOR, P89, DOI DOI 10.2307/1166187; Candilera G., 2007, 9 ATTACHMENT PROFILE; Cassidy J, 1999, HDB ATTACHMENT THEOR, P3; Fallani G, 2007, PHYSIOL BEHAV, V90, P648, DOI 10.1016/j.physbeh.2006.12.001; Fallani G, 2006, APPL ANIM BEHAV SCI, V100, P241, DOI 10.1016/j.applanim.2005.12.005; Fuchs T, 2005, APPL ANIM BEHAV SCI, V94, P287, DOI 10.1016/j.applanim.2005.02.016; Iliceto P, 2011, J RELIG HEALTH, V50, P321, DOI 10.1007/s10943-009-9301-7; Kubinyi E, 2003, J COMP PSYCHOL, V117, P156, DOI 10.1037/0735-7036.117.2.156; Murphy JA, 1995, ANTHROZOOS, V8, P224, DOI 10.2752/089279395787156536; Pietromonaco P.R., 2000, REV GEN PSYCHOL, V4, P155, DOI [10.1037/1089-2680.4.2.155, DOI 10.1037/1089-2680.4.2.155]; Prato Previde E, 2005, ETHOLOGY, V111, P1; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Serpell James, 1995, P79; Siniscalchi M, 2011, ANIM BEHAV, V82, P399, DOI 10.1016/j.anbehav.2011.05.020; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Slabbert JM, 1997, APPL ANIM BEHAV SCI, V53, P309, DOI 10.1016/S0168-1591(96)01163-X; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012	28	31	31	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78455	10.1371/journal.pone.0078455	http://dx.doi.org/10.1371/journal.pone.0078455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205235	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500121
J	Liu, XQ; Olsen, J; Agerbo, E; Yuan, W; Cnattingius, S; Gissler, M; Li, J				Liu, Xiaoqin; Olsen, Jorn; Agerbo, Esben; Yuan, Wei; Cnattingius, Sven; Gissler, Mika; Li, Jiong			Psychological Stress and Hospitalization for Childhood Asthma-a Nationwide Cohort Study in Two Nordic Countries	PLOS ONE			English	Article							MATERNAL DEPRESSIVE SYMPTOMS; TOBACCO-SMOKE; CHILDREN; POPULATION; EXPOSURE; VIOLENCE; ADULT; ONSET; LIFE; PRESCRIPTION	Objective: Exposures to psychological stress in early life may contribute to the development or exacerbation of asthma. We undertook a cohort study based on data from several population-based registers in Denmark and Sweden to examine whether bereavement in childhood led to increased asthma hospitalization. Methods: All singleton children born in Denmark during 1977-2008 and in Sweden during 1973-2006 were included in the study (N=5,202,576). The children were followed from birth to the date of first asthma hospitalization, emigration, death, their 18th birthday, or the end of study (31 December 2007 in Sweden and 31 December 2008 in Denmark), whichever came first. All the children were assigned to the non-bereaved group until they lost a close relative (mother, father or a sibling), from when they were included in the bereaved group. We evaluated the hazard ratio (HR) of first hospitalization for asthma in bereaved children using Cox proportional hazards regression models, compared to those who were in the non-bereaved group. We also did a sub-analysis on the association between bereavement and first asthma medication. Results: A total of 147,829 children were hospitalized for asthma. The overall adjusted HR of asthma hospitalization in bereaved children was 1.10 (95% confidence interval (CI): 1.04-1.16), compared to non-bereaved children. The risk of asthma hospitalization was increased in those who lost a close relative at age of 14-17 years (HR=1.54, 95% CI: 1.23-1.92), but not in younger age groups. The association between bereavement and asthma hospitalization did not change over time since bereavement. In the sub-analysis in singleton live births during 1996-2008 recorded in the DMBR, bereavement was associated with a lower use of asthma medication (HR=0.87, 95% CI: 0.80-0.95). Conclusions: Our data suggests that psychological stress following bereavement in late adolescence is associated with an increased risk of asthma hospitalization or lowers the threshold for asthma hospitalization.	[Liu, Xiaoqin; Olsen, Jorn; Li, Jiong] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Liu, Xiaoqin; Yuan, Wei] WHO Collaborating Ctr Res Human Reprod, Shanghai Inst Planned Parenthood Res, Dept Epidemiol & Social Sci Reprod Hlth, Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China; [Olsen, Jorn] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Agerbo, Esben] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Agerbo, Esben] Aarhus Univ, CIRRAU Ctr Integrated Register Based Res, Aarhus, Denmark; [Cnattingius, Sven] Karolinska Univ Hosp, Karolinska Inst, Clin Epidemiol Unit, Dept Med Solna, Stockholm, Sweden; [Gissler, Mika] THL Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Gissler, Mika] NHV Nord Sch Publ Hlth, Gothenburg, Sweden	Aarhus University; University of California System; University of California Los Angeles; Aarhus University; Aarhus University; Karolinska Institutet; Karolinska University Hospital; Finland National Institute for Health & Welfare	Liu, XQ (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	lxq@soci.au.dk	li, jiong/L-6534-2014; Agerbo, Esben/A-2645-2012; Liu, Xiaoqin/AAB-7509-2019	li, jiong/0000-0002-1716-8067; Agerbo, Esben/0000-0002-2849-524X; Liu, Xiaoqin/0000-0003-4519-1536; li, jiong/0000-0003-1125-026X; Gissler, Mika/0000-0001-8254-7525	European Research Council (ERC) 'Prog Euro' [260242]; Danish Medical Research Council [09-072986]; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	European Research Council (ERC) 'Prog Euro'(European Research Council (ERC)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the European Research Council (ERC, starting grant no. 260242, 'Prog Euro') and the Danish Medical Research Council (project no. 09-072986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Bahreinian S, 2013, AM J RESP CRIT CARE, V187, P144, DOI 10.1164/rccm.201201-0025OC; Balk D., 2001, HDB BEREAVEMENT RES, P199, DOI DOI 10.1037/10436-008; Bartlett SJ, 2004, PEDIATRICS, V113, P229, DOI 10.1542/peds.113.2.229; Biank NM, 2011, OMEGA-J DEATH DYING, V63, P271, DOI 10.2190/OM.63.3.e; Black D, 1998, BMJ-BRIT MED J, V316, P931, DOI 10.1136/bmj.316.7135.931; Bloomberg GR, 2005, IMMUNOL ALLERGY CLIN, V25, P83, DOI 10.1016/j.iac.2004.09.001; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; Brooks AM, 2001, ARCH PEDIAT ADOL MED, V155, P401, DOI 10.1001/archpedi.155.3.401; Burke W, 2003, AM J PREV MED, V24, P160, DOI 10.1016/S0749-3797(02)00589-5; Christ GH, 2002, JAMA-J AM MED ASSOC, V288, P1269, DOI 10.1001/jama.288.10.1269; de Nijs SB, 2013, EUR RESPIR REV, V22, P44, DOI 10.1183/09059180.00007112; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027202; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036328; Hesselmar Bill, 2012, J Allergy (Cairo), V2012, P163089, DOI 10.1155/2012/163089; Juel K, 1999, DAN MED BULL, V46, P354; Kanter RK, 2006, J PEDIATR-US, V148, P637, DOI 10.1016/j.jpeds.2005.11.035; Kaugars AS, 2004, J PEDIATR PSYCHOL, V29, P475, DOI 10.1093/jpepsy/jsh051; Khashan AS, 2012, PSYCHOSOM MED, V74, P635, DOI 10.1097/PSY.0b013e31825ac5e7; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kocevar VS, 2004, CHEST, V125, P1680, DOI 10.1378/chest.125.5.1680; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Lange NE, 2011, J ALLERGY CLIN IMMUN, V127, P734, DOI 10.1016/j.jaci.2010.11.010; Lazarus R. S., 1984, STRESS APPRAISAL COP; Li J, 2011, INT J EPIDEMIOL, V40, P1161, DOI 10.1093/ije/dyq127; Lietzen R, 2011, EUR RESPIR J, V37, P1360, DOI 10.1183/09031936.00164609; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McLearn KT, 2006, ARCH PEDIAT ADOL MED, V160, P279, DOI 10.1001/archpedi.160.3.279; Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041; Moonie SA, 2006, J SCHOOL HEALTH, V76, P18, DOI 10.1111/j.1746-1561.2006.00062.x; National Board of Health and Welfare, 2003, SWED MED BIRTH REG A; National Board of Health and Welfare, 2013, CAUS DEATH 2010; National Board of Health and Welfare, 2009, KVAL INN PAT UTSKR F; Pedersen CB, 2006, DAN MED BULL, V53, P441; Quinn K, 2010, J URBAN HEALTH, V87, P688, DOI 10.1007/s11524-010-9465-1; Raherison C, 2007, RESP MED, V101, P107, DOI 10.1016/j.rmed.2006.04.010; Reed CE, 2006, J ALLERGY CLIN IMMUN, V118, P543, DOI 10.1016/j.jaci.2006.06.020; Rosenkranz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040921; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sandberg S, 2000, LANCET, V356, P982, DOI 10.1016/S0140-6736(00)02715-X; Shalowitz MU, 2001, AMBUL PEDIATR, V1, P185, DOI 10.1367/1539-4409(2001)001<0185:TROLSA>2.0.CO;2; Statistics Sweden, 2010, BACKGR FACTS POP WEL, V3; Statistics Sweden, 2006, BACKGR FACTS EV SWED; Sternthal MJ, 2010, EUR RESPIR J, V36, P1400, DOI 10.1183/09031936.00003010; Sternthal MJ, 2011, J ALLERGY CLIN IMMUN, V128, P337, DOI 10.1016/j.jaci.2011.05.008; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P569, DOI 10.1093/ije/dym007; Suglia SF, 2010, J EPIDEMIOL COMMUN H, V64, P636, DOI 10.1136/jech.2008.082842; Suglia SF, 2009, ARCH PEDIAT ADOL MED, V163, P244, DOI 10.1001/archpediatrics.2008.555; Timmermans B, 2010, DANISH INTEGRATED DA; Tsai CH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-11; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; Willfuhr KP, 2009, AM J HUM BIOL, V21, P488, DOI 10.1002/ajhb.20909; Wisnivesky JP, 2010, J ASTHMA, V47, P100, DOI 10.3109/02770900903426989; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; Wright Rosalind J, 2008, Allergy Asthma Clin Immunol, V4, P29, DOI 10.1186/1710-1492-4-1-29; Zuidgeest MG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-16	62	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78816	10.1371/journal.pone.0078816	http://dx.doi.org/10.1371/journal.pone.0078816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205324	gold, Green Submitted, Green Published			2022-12-27	WOS:000326155400108
J	Kemter, E; Pruckl, P; Rathkolb, B; Micklich, K; Adler, T; Becker, L; Beckers, J; Busch, DH; Gotz, AA; Hans, W; Horsch, M; Ivandic, B; Klingenspor, M; Klopstock, T; Rozman, J; Schrewe, A; Schulz, H; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Wolf, E; Aigner, B				Kemter, Elisabeth; Prueckl, Petra; Rathkolb, Birgit; Micklich, Kateryna; Adler, Thure; Becker, Lore; Beckers, Johannes; Busch, Dirk H.; Goetz, Alexander A.; Hans, Wolfgang; Horsch, Marion; Ivandic, Boris; Klingenspor, Martin; Klopstock, Thomas; Rozman, Jan; Schrewe, Anja; Schulz, Holger; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Wolf, Eckhard; Aigner, Bernhard			Standardized, Systemic Phenotypic Analysis of Umod(C93F) and Umod(A227T) Mutant Mice	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; KIDNEY-DISEASE; STONE FORMATION; UROMODULIN; GENE; MUTAGENESIS; MUTATION	Uromodulin-associated kidney disease (UAKD) summarizes different clinical features of an autosomal dominant heritable disease syndrome in humans with a proven uromodulin (UMOD) mutation involved. It is often characterized by hyperuricemia, gout, alteration of urine concentrating ability, as well as a variable rate of disease progression inconstantly leading to renal failure and histological alterations of the kidneys. We recently established the two Umod mutant mouse lines Umod(C93F) and Umod(A227T) on the C3H inbred genetic background both showing kidney defects analogous to those found in human UAKD patients. In addition, disease symptoms were revealed that were not yet described in other published mouse models of UAKD. To examine if further organ systems and/or metabolic pathways are affected by Umod mutations as primary or secondary effects, we describe a standardized, systemic phenotypic analysis of the two mutant mouse lines Umod(A227T) and Umod(C93F) in the German Mouse Clinic. Different genotypes as well as different ages were tested. Beside the already published changes in body weight, body composition and bone metabolism, the influence of the Umod mutation on energy metabolism was confirmed. Hematological analysis revealed a moderate microcytic and erythropenic anemia in older Umod mutant mice. Data of the other analyses in 7-10 month-old mutant mice showed single small additional effects.	[Kemter, Elisabeth; Prueckl, Petra; Rathkolb, Birgit; Micklich, Kateryna; Wolf, Eckhard; Aigner, Bernhard] LMU, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Kemter, Elisabeth; Prueckl, Petra; Rathkolb, Birgit; Micklich, Kateryna; Wolf, Eckhard; Aigner, Bernhard] LMU, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Rathkolb, Birgit; Micklich, Kateryna; Adler, Thure; Becker, Lore; Beckers, Johannes; Hans, Wolfgang; Horsch, Marion; Rozman, Jan; Schrewe, Anja; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Adler, Thure; Busch, Dirk H.] TU, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Becker, Lore; Klopstock, Thomas] LMU, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] TU, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [Goetz, Alexander A.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, German Mouse Clin,Comprehens Pneumol Ctr, Neuherberg, Germany; [Ivandic, Boris; Schrewe, Anja] Heidelberg Univ, Dept Med 3, Div Cardiol, Heidelberg, Germany; [Klingenspor, Martin; Rozman, Jan] TU, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Klopstock, Thomas; de Angelis, Martin Hrabe] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Schulz, Holger] Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Aigner, B (corresponding author), LMU, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany.	b.aigner@gen.vetmed.uni-muenchen.de	Beckers, Johannes/K-7237-2012; Fuchs, Helmut/M-7347-2014; Gailus-Durner, Valerie/M-7337-2014; Becker, Lore/E-3717-2010; Rozman, Jan/A-2540-2010; Becker, Lore/AAJ-1203-2020; Klingenspor, Martin/D-6930-2011; Schulz, Holger/J-5643-2015; Klingenspor, Martin/K-5033-2019; de Angelis, Martin Hrabe/F-5531-2012	Beckers, Johannes/0000-0001-7874-3822; Fuchs, Helmut/0000-0002-5143-2677; Rozman, Jan/0000-0002-8035-8904; Becker, Lore/0000-0002-6890-4984; Klingenspor, Martin/0000-0002-4502-6664; Schulz, Holger/0000-0002-1157-200X; de Angelis, Martin Hrabe/0000-0002-7898-2353; Aigner, Bernhard/0000-0003-1644-2711; Kemter, Elisabeth/0000-0001-7785-7502; Wolf, Eckhard/0000-0002-0430-9510	German Research Foundation (DFG) [KE1673/1-1]; German Federal Ministry of Education and Research [01 EO 0901, 01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, 01GS0868, 01GS0869, 01KX1012]; Initiative and Networking Fund of the Helmholtz Association [HA-215]; Helmholtz Alliance ICEMED (Initiative and Network Fund of the Helmholtz Association)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Initiative and Networking Fund of the Helmholtz Association; Helmholtz Alliance ICEMED (Initiative and Network Fund of the Helmholtz Association)	This work has been funded by the German Research Foundation (DFG) (grant KE1673/1-1), by the German Federal Ministry of Education and Research to the German Center for Vertigo and Balance Disorders (grant 01 EO 0901), to the DZD (German Center for Diabetes Research) and to the GMC (NGFN-Plus grants no. 01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, 01GS0868, 01GS0869; Infrafrontier grant 01KX1012), and by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Ageing Society (HA-215) and the Helmholtz Alliance ICEMED (Initiative and Network Fund of the Helmholtz Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2007, AM J PHYSIOL-RENAL, V292, pF1560, DOI 10.1152/ajprenal.00213.2006; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Bleyer AJ, 2011, GENEREVIEWS; Bleyer AJ, 2011, NEPHRON CLIN PRACT, V118, pC31, DOI 10.1159/000320889; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Fuchs H, 2012, MAMM GENOME, V23, P611, DOI 10.1007/s00335-012-9415-1; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Liu Y, 2012, J BIOL CHEM, V287, P16365, DOI 10.1074/jbc.M112.348243; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Takiue Y, 2008, NUCLEOS NUCLEOT NUCL, V27, P596, DOI 10.1080/15257770802136065	21	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78337	10.1371/journal.pone.0078337	http://dx.doi.org/10.1371/journal.pone.0078337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205203	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300050
J	Veenstra, AA; Tang, J; Kern, TS				Veenstra, Alexander A.; Tang, Jie; Kern, Timothy S.			Antagonism of CD11b with Neutrophil Inhibitory Factor (NIF) Inhibits Vascular Lesions in Diabetic Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL-CELL INJURY; ADHESION MOLECULE-1; MONOCLONAL-ANTIBODY; LEUKOSTASIS; MODEL; ALPHA(M)BETA(2); RECEPTOR; THERAPY; LEAKAGE; RETINA	Leukocytes and proteins that govern leukocyte adhesion to endothelial cells play a causal role in retinal abnormalities characteristic of the early stages of diabetic retinopathy, including diabetes-induced degeneration of retinal capillaries. Leukocyte integrin alpha m beta 2 (CD11b/CD18, MAC1), a protein mediating adhesion, has been shown to mediate damage to endothelial cells by activated leukocytes in vitro. We hypothesized that Neutrophil Inhibitory Factor (NIF), a selective antagonist of integrin alpha m beta 2, would inhibit the diabetes-induced degeneration of retinal capillaries by inhibiting the excessive interaction between leukocytes and retinal endothelial cells in diabetes. Wild type animals and transgenic animals expressing NIF were made diabetic with streptozotocin and assessed for diabetes-induced retinal vascular abnormalities and leukocyte activation. To assess if the leukocyte blocking therapy compromised the immune system, animals were challenged with bacteria. Retinal superoxide production, leukostasis and leukocyte superoxide production were increased in wild type mice diabetic for 10 weeks, as was the ability of leukocytes isolated from diabetic animals to kill retinal endothelial cells in vitro. Retinal capillary degeneration was significantly increased in wild type mice diabetic 40 weeks. In contrast, mice expressing NIF did not develop any of these abnormalities, with the exception that non-diabetic and diabetic mice expressing NIF generated greater amounts of superoxide than did similar mice not expressing NIF. Importantly, NIF did not significantly impair the ability of mice to clear an opportunistic bacterial challenge, suggesting that NIF did not compromise immune surveillance. We conclude that antagonism of CD11b (integrin alpha m beta 2) by NIF is sufficient to inhibit early stages of diabetic retinopathy, while not compromising the basic immune response.	[Veenstra, Alexander A.; Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Tang, Jie; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Stokes Vet Adm Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Veenstra, AA (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	aav2@case.edu			National Institute of Health [EY000300]; Medical Research Service of the Department of Veterans Affairs; National Eye Institute [5T32EY007157]; CWRU Visual Science Research Center core facility [P30EY11373]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY000300, R56EY000300, T32EY007157] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); CWRU Visual Science Research Center core facility; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institute of Health EY000300 and the Medical Research Service of the Department of Veterans Affairs. Support was also provided by the Visual Science Research Training Grant 5T32EY007157 from the National Eye Institute (AAV) and the CWRU Visual Science Research Center core facility (P30EY11373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2001, PARASITE IMMUNOL, V23, P237, DOI 10.1046/j.1365-3024.2001.00383.x; BARNARD JW, 1995, J IMMUNOL, V155, P4876; Barouch FC, 2000, INVEST OPHTH VIS SCI, V41, P1153; Bowen JD, 1998, CLIN PHARMACOL THER, V64, P339, DOI 10.1016/S0009-9236(98)90183-7; BRESNICK GH, 1976, T AM ACAD OPHTHALMOL, V81, pO694; Chibber R, 2007, CURR DIABETES REV, V3, P3, DOI 10.2174/157339907779802139; Ding J, 2012, CURR DIABETES REP, V12, P346, DOI 10.1007/s11892-012-0283-6; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; ENGERMAN RL, 1976, T AM ACAD OPHTHALMOL, V81, pO710; Faridi MH, 2013, BBA-GEN SUBJECTS, V1830, P3696, DOI 10.1016/j.bbagen.2013.02.018; Frank RN, 2011, ARCH OPHTHALMOL-CHIC, V129, P788, DOI 10.1001/archophthalmol.2011.125; Gao XP, 2005, PHYSIOL GENOMICS, V21, P230, DOI 10.1152/physiolgenomics.00291.2004; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kaji Y, 2007, INVEST OPHTH VIS SCI, V48, P858, DOI 10.1167/iovs.06-0495; Kamen LA, 2011, J IMMUNOL, V186, P1656, DOI 10.4049/jimmunol.1002093; Kern TS, 2007, DIABETES, V56, P373, DOI 10.2337/db05-1621; KERN TS, 2007, RETINAL VASCULAR DIS; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; LAVER NM, 1993, INVEST OPHTH VIS SCI, V34, P2097; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; LUM H, 1994, J LEUKOCYTE BIOL, V55, P58, DOI 10.1002/jlb.55.1.58; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; MOYLE M, 1994, J BIOL CHEM, V269, P10008; Ohno S, 1997, J CELL PHYSIOL, V171, P212, DOI 10.1002/(SICI)1097-4652(199705)171:2<212::AID-JCP12>3.3.CO;2-0; RIEU P, 1994, J CELL BIOL, V127, P2081, DOI 10.1083/jcb.127.6.2081; SCHRODER S, 1991, AM J PATHOL, V139, P81; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Simon DI, 2011, CIRC RES, V109, P1199, DOI 10.1161/CIRCRESAHA.111.257980; Su XJ, 2003, MOL VIS, V9, P171; Takahashi K, 1998, AM J OPHTHALMOL, V126, P791, DOI 10.1016/S0002-9394(98)00242-6; Tamura H, 2005, INVEST OPHTH VIS SCI, V46, P1440, DOI 10.1167/iovs.04-0905; TIAN HGP, 2013, MOL VIS IN PRESS; Uettwiller F, 2011, MABS-AUSTIN, V3, P461, DOI 10.4161/mabs.3.5.16553; Ustinov VA, 2002, J BIOL CHEM, V277, P18769, DOI 10.1074/jbc.M110242200; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Zhang L, 2003, STROKE, V34, P1790, DOI 10.1161/01.STR.0000077016.55891.2E; Zhang L, 1996, J BIOL CHEM, V271, P18211, DOI 10.1074/jbc.271.30.18211; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789	46	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78405	10.1371/journal.pone.0078405	http://dx.doi.org/10.1371/journal.pone.0078405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205223	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600100
J	Castillo-Melendez, M; Baburamani, AA; Cabalag, C; Yawno, T; Witjaksono, A; Miller, SL; Walker, DW				Castillo-Melendez, Margie; Baburamani, Ana A.; Cabalag, Carlos; Yawno, Tamara; Witjaksono, Anissa; Miller, Suzie L.; Walker, David W.			Experimental Modelling of the Consequences of Brief Late Gestation Asphyxia on Newborn Lamb Behaviour and Brain Structure	PLOS ONE			English	Article							OVINE FETAL-BRAIN; UMBILICAL-CORD OCCLUSION; NEONATAL ENCEPHALOPATHY; CEREBRAL-PALSY; INTRAVENTRICULAR HEMORRHAGE; SHEEP; TERM; PRETERM; INJURY; HYPOXIA	Brief but severe asphyxia in late gestation or at the time of birth may lead to neonatal hypoxic ischemic encephalopathy and is associated with long-term neurodevelopmental impairment. We undertook this study to examine the consequences of transient in utero asphyxia in late gestation fetal sheep, on the newborn lamb after birth. Surgery was undertaken at 125 days gestation for implantation of fetal catheters and placement of a silastic cuff around the umbilical cord. At 132 days gestation (0.89 term), the cuff was inflated to induce umbilical cord occlusion (UCO), or sham (control). Fetal arterial blood samples were collected for assessment of fetal wellbeing and the pregnancy continued until birth. At birth, behavioral milestones for newborn lambs were recorded over 24 h, after which the lambs were euthanased for brain collection and histopathology assessments. After birth, UCO lambs displayed significant latencies to (i) use all four legs, (ii) attain a standing position, (iii) find the udder, and (iv) successfully suckle-compared to control lambs. Brains of UCO lambs showed widespread pathologies including cell death, white matter disruption, intra-parenchymal hemorrhage and inflammation, which were not observed in full term control brains. UCO resulted in some preterm births, but comparison with age-matched preterm non-UCO control lambs showed that prematurity per se was not responsible for the behavioral delays and brain structural abnormalities resulting from the in utero asphyxia. These results demonstrate that a single, brief fetal asphyxic episode in late gestation results in significant grey and white matter disruption in the developing brain, and causes significant behavioral delay in newborn lambs. These data are consistent with clinical observations that antenatal asphyxia is causal in the development of neonatal encephalopathy and provide an experimental model to advance our understanding of neuroprotective therapies.	[Castillo-Melendez, Margie; Baburamani, Ana A.; Cabalag, Carlos; Yawno, Tamara; Miller, Suzie L.; Walker, David W.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Witjaksono, Anissa; Miller, Suzie L.; Walker, David W.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	Monash University; Monash University	Walker, DW (corresponding author), Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	david.walker@monash.edu	Castillo-Melendez, Margie/AAB-8383-2020; Baburamani, Ana/AGD-2259-2022; Baburamani, Ana/J-4920-2019	Baburamani, Ana/0000-0002-7537-6534; Miller, Suzanne/0000-0002-0451-8304	National Health & Medical Research Council of Australia (NHMRC); Cerebral Palsy Alliance Australia; Network in Genes, Environment and Development (NGED), an initiative of the NHMRC; Australia Research Council (ARC); Victorian Government	National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cerebral Palsy Alliance Australia; Network in Genes, Environment and Development (NGED), an initiative of the NHMRC; Australia Research Council (ARC)(Australian Research Council); Victorian Government	This study was supported by grants to DWW and MCM from the National Health & Medical Research Council of Australia (NHMRC), Cerebral Palsy Alliance Australia, and the Network in Genes, Environment and Development (NGED), an initiative of the NHMRC and Australia Research Council (ARC). The authors also gratefully acknowledge support from the Victorian Government's Operational Infrastucture Support Program to Monash Institute of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Baburamani AA, 2013, PEDIATR RES, V73, P310, DOI 10.1038/pr.2012.191; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BECK DW, 1984, J NEUROPATH EXP NEUR, V43, P219, DOI 10.1097/00005072-198405000-00001; Castillo-Melendez M, 2005, DEV NEUROSCI-BASEL, V27, P220, DOI 10.1159/000085995; Castillo-Melendez M, 2004, PEDIATR RES, V55, P864, DOI 10.1203/01.PDR.0000115679.86566.C4; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Dammann O, 2011, PEDIATR RES, V70, P1, DOI 10.1203/01.pdr.0000403893.61640.b6; De Matteo R, 2008, CLIN EXP PHARMACOL P, V35, P1426, DOI 10.1111/j.1440-1681.2008.05014.x; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Duncan JR, 2004, J SOC GYNECOL INVEST, V11, P369, DOI 10.1016/j.jsgi.2004.03.004; Dwyer CM, 2003, THERIOGENOLOGY, V59, P1027, DOI 10.1016/S0093-691X(02)01137-8; Dwyer CM, 1996, REPROD FERT DEVELOP, V8, P1123, DOI 10.1071/RD9961123; Dwyer CM, 1999, PHYSIOL BEHAV, V67, P443, DOI 10.1016/S0031-9384(99)00089-X; Dwyer CM, 2000, BEHAVIOUR, V137, P1629, DOI 10.1163/156853900502754; GARCIA JH, 1994, AM J PATHOL, V144, P188; GIBSON KJ, 1995, J PHYSIOL-LONDON, V485, P835, DOI 10.1113/jphysiol.1995.sp020773; Goursaud AP, 1999, PHYSIOL BEHAV, V67, P49, DOI 10.1016/S0031-9384(99)00037-2; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Huang AH, 2004, AM J NEURORADIOL, V25, P469; Ikeda T, 1999, INT J DEV NEUROSCI, V17, P1, DOI 10.1016/S0736-5748(98)00055-0; Juul S, 2007, SEMIN FETAL NEONAT M, V12, P250, DOI 10.1016/j.siny.2007.01.015; Juul SE, 2008, DEV NEUROSCI-BASEL, V30, P231, DOI 10.1159/000110348; Juul SE, 2007, DEV NEUROSCI-BASEL, V29, P311, DOI 10.1159/000105472; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kishimoto T K, 1994, Adv Pharmacol, V25, P117, DOI 10.1016/S1054-3589(08)60431-7; Leviton A, 2013, AM J OBSTET GYNECOL, V208, P176, DOI 10.1016/j.ajog.2012.07.020; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; MALLARD EC, 1994, AM J OBSTET GYNECOL, V170, P206; Nishigori H, 2008, REPROD SCI, V15, P895, DOI 10.1177/1933719108324135; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Ohyu J, 1999, BRAIN DEV-JPN, V21, P248, DOI 10.1016/S0387-7604(99)00018-2; Pfister JA, 2006, SMALL RUMINANT RES, V65, P70, DOI 10.1016/j.smallrumres.2005.05.025; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Ramachandrappa A, 2009, PEDIATR CLIN N AM, V56, P565, DOI 10.1016/j.pcl.2009.03.009; Reddy K, 1998, PEDIATR RES, V43, P674, DOI 10.1203/00006450-199805000-00017; Rocha E, 2004, AM J OBSTET GYNECOL, V191, P488, DOI 10.1016/j.ajog.2004.01.039; Roelants-van Rijn AM, 2001, NEUROPEDIATRICS, V32, P80, DOI 10.1055/s-2001-13875; ROLAND EH, 1990, PEDIATRICS, V85, P737; Saadani-Makki F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.090; SILVER M, 1991, J DEV PHYSIOL, V15, P169; Volpe J J, 1998, Semin Pediatr Neurol, V5, P135, DOI 10.1016/S1071-9091(98)80030-2; Volpe JJ, 2012, ANN NEUROL, V72, P156, DOI 10.1002/ana.23647; WEHBERG K, 1992, PEDIATRICS, V89, P327; Yan EB, 2009, AM J PHYSIOL-REG I, V297, pR60, DOI 10.1152/ajpregu.00047.2009	49	34	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77377	10.1371/journal.pone.0077377	http://dx.doi.org/10.1371/journal.pone.0077377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223120	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200012
J	Huang, YZ; Li, MX; Wang, J; Zhan, ZY; Sun, YJ; Sun, JJ; Li, CJ; Lan, XY; Lei, CZ; Zhang, CL; Chen, H				Huang, Yong-Zhen; Li, Ming-Xun; Wang, Jing; Zhan, Zhao-Yang; Sun, Yu-Jia; Sun, Jia-Jie; Li, Cong-Jun; Lan, Xian-Yong; Lei, Chu-Zhao; Zhang, Chun-Lei; Chen, Hong			A 5 '-Regulatory Region and Two Coding Region Polymorphisms Modulate Promoter Activity and Gene Expression of the Growth Suppressor Gene ZBED6 in Cattle	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MUSCLE MASS; TRAITS; INSULIN; BINDING; QTL; SKELETAL; PIT-1; MAPS; MICE	Zinc finger, BED-type containing 6 (ZBED6) is an important transcription factor in placental mammals, affecting development, cell proliferation and growth. Polymorphisms in its promoter and coding regions are likely to impact ZBED6 transcription and growth traits. In this study, rapid amplification of 5' cDNA ends (5'-RACE) analysis revealed two transcription start sites (TSS) for the bovine ZBED6 starting within exon 1 of the ZC3H11A gene (TSS-1) and upstream of the translation start codon of the ZBED6 gene (TSS-2). There was one SNP in the promoter and two missense mutations in the coding region of the bovine ZBED6 by sequencing of the pooled DNA samples (Pool-Seq, n = 100). The promoter and coding region are the key regions for gene function; polymorphisms in these regions can alter gene expression. Quantitative real-time PCR (qPCR) analysis showed that ZBED6 has a broad tissue distribution in cattle and is highly expressed in skeletal muscle. Eleven promoter-detection vectors were constructed, which enabled the cloning of putative promoter sequences and analysis of ZBED6 transcriptional activity by luciferase reporter gene assays. The core region of the basal promoter of bovine ZBED6 is located within region -866 to -556. The activity of WT-826G-pGL3 in driving reporter gene transcription is significantly higher than that of the M-826A-pGL3 construct (P < 0.01). Analysis of gene expression patterns in homozygous full-sibling Chinese Qinchuan cattle showed that the mutant-type Hap-AGG exhibited a lower mRNA level than the wild-type Hap-GCA (P < 0.05) in longissimus dorsi muscle (LDM). Moreover, ZBED6 mRNA expression was low in C2C12 cells overexpressing the mutant-type ZBED6 (pcDNA3.1(+)-Hap-GG) (P < 0.01). Our results suggest that the polymorphisms in the promoter and coding regions may modulate the promoter activity and gene expression of bovine ZBED6 in the skeletal muscles of these cattle breeds.	[Huang, Yong-Zhen; Li, Ming-Xun; Wang, Jing; Zhan, Zhao-Yang; Sun, Yu-Jia; Sun, Jia-Jie; Lan, Xian-Yong; Lei, Chu-Zhao; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Li, Cong-Jun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Zhang, Chun-Lei] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; United States Department of Agriculture (USDA); Jiangsu Normal University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Li, Mingxun/Y-7161-2019; WANG, JINGYI/GSJ-1241-2022; Li, Cong-jun/J-8572-2014	Li, Cong-jun/0000-0003-1389-9820	National 863 Program of China [2013AA102505]; National Natural Science Foundation of China [31272408]; Agricultural Science and Technology Innovation Projects of Shaanxi Province [2012NKC01-13]; Program of National Beef Cattle and Yak Industrial Technology System [CARS-38]	National 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Projects of Shaanxi Province; Program of National Beef Cattle and Yak Industrial Technology System	This study was supported by the National 863 Program of China (Grant No. 2013AA102505), National Natural Science Foundation of China (Grant No. 31272408), Agricultural Science and Technology Innovation Projects of Shaanxi Province (No. 2012NKC01-13), Program of National Beef Cattle and Yak Industrial Technology System (CARS-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2009, COLD SH Q B, V74, P319, DOI 10.1101/sqb.2009.74.039; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Andersson L, 2010, TRANSCR-AUSTIN, V1, P144, DOI 10.4161/trns.1.3.13343; Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Bahar B, 2011, ANIM GENET, V42, P270, DOI 10.1111/j.1365-2052.2010.02151.x; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Bjornsdottir G, 2008, NUCLEIC ACIDS RES, V36, P2906, DOI 10.1093/nar/gkn130; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Hayward A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059940; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Huang YZ, 2013, GENE, V526, P107, DOI 10.1016/j.gene.2013.04.049; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Jia Xiang-Jie, 2011, Yichuan, V33, P1359, DOI 10.3724/SP.J.1005.2011.01359; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jonsen MD, 2009, MOL ENDOCRINOL, V23, P1371, DOI 10.1210/me.2008-0137; Kotaja N, 2004, NAT GENET, V36, P551, DOI 10.1038/ng0604-551; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Renaville R, 1997, J DAIRY SCI, V80, P3431, DOI 10.3168/jds.S0022-0302(97)76319-7; Sambrook J., 2002, MOL CLONING LAB MANU; Stancekova K, 1999, ANIM GENET, V30, P313, DOI 10.1046/j.1365-2052.1999.00484.x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064	32	10	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79744	10.1371/journal.pone.0079744	http://dx.doi.org/10.1371/journal.pone.0079744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223190	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200083
J	Teuber, L; Schukat, A; Hagen, W; Auel, H				Teuber, Lena; Schukat, Anna; Hagen, Wilhelm; Auel, Holger			Distribution and Ecophysiology of Calanoid Copepods in Relation to the Oxygen Minimum Zone in the Eastern Tropical Atlantic	PLOS ONE			English	Article							ELECTRON-TRANSPORT-SYSTEM; VERTICAL-DISTRIBUTION; METABOLIC SUPPRESSION; ZOOPLANKTON ECOLOGY; ARABIAN SEA; PACIFIC; HYPOXIA; RATES; RESPIRATION; COMMUNITIES	Oxygen minimum zones (OMZs) affect distribution patterns, community structure and metabolic processes of marine organisms. Due to the prominent role of zooplankton, especially copepods, in the marine carbon cycle and the predicted intensification and expansion of OMZs, it is essential to understand the effects of hypoxia on zooplankton distribution and ecophysiology. For this study, calanoid copepods were sampled from different depths (0-1800 m) at eight stations in the eastern tropical Atlantic (3 degrees 47'N to 18 degrees S) during three expeditions in 2010 and 2011. Their horizontal and vertical distribution was determined and related to the extent and intensity of the OMZ, which increased from north to south with minimum O-2 concentrations (12.7 mu mol kg(-1)) in the southern Angola Gyre. Calanoid copepod abundance was highest in the northeastern Angola Basin and decreased towards equatorial regions as well as with increasing depth. Maximum copepod biodiversity was observed in the deep waters of the central Angola Basin. Respiration rates and enzyme activities were measured to reveal species-specific physiological adaptations. Enzyme activities of the electron transport system (ETS) and lactate dehydrogenase (LDH) served as proxies for aerobic and anaerobic metabolic activity, respectively. Mass-specific respiration rates and ETS activities decreased with depth of occurrence, consistent with vertical changes in copepod body mass and ambient temperature. Copepods of the families Eucalanidae and Metridinidae dominated within the OMZ. Several of these species showed adaptive characteristics such as lower metabolic rates, additional anaerobic activity and diel vertical migration that enable them to successfully inhabit hypoxic zones.	[Teuber, Lena; Schukat, Anna; Hagen, Wilhelm; Auel, Holger] Univ Bremen, Bremen Marine Ecol, D-28359 Bremen, Germany	University of Bremen	Teuber, L (corresponding author), Univ Bremen, Bremen Marine Ecol, D-28359 Bremen, Germany.	teuber@uni-bremen.de		Hagen, Wilhelm/0000-0002-7462-9931	German Federal Ministry of Education and Research; University of Bremen	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); University of Bremen	This study was partly funded by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/index.php) in the framework of the GENUS "Geochemistry and Ecology of the Namibian Upwelling System" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The additional part of the funding was provided by the University of Bremen.	[Anonymous], 1994, CHANGES MARINE COMMU; Antezana T., 2002, OCEANOGRAPHY E PACIF, VII, P29; Auel H, 2007, J EXP MAR BIOL ECOL, V352, P234, DOI 10.1016/j.jembe.2007.07.020; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bode M, 2013, J EXP MAR BIOL ECOL, V444, P1, DOI 10.1016/j.jembe.2013.03.003; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bradford-Grieve Janet M., 1999, P869; Champalbert G, 2005, HYDROBIOLOGIA, V548, P251, DOI 10.1007/s10750-005-5194-y; CHILDRESS JJ, 1975, COMP BIOCHEM PHYS A, V50, P787, DOI 10.1016/0300-9629(75)90146-2; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; CHILDRESS JJ, 1979, MAR BIOL, V52, P273, DOI 10.1007/BF00398141; Childress JJ, 1998, J EXP BIOL, V201, P1223; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Escribano Rubén, 2006, Gayana (Concepc.), V70, P19; Escribano R, 2009, DEEP-SEA RES PT II, V56, P1049, DOI 10.1016/j.dsr2.2008.09.009; FLINT MV, 1991, MAR BIOL, V111, P199, DOI 10.1007/BF01319701; Gonzalez RR, 2002, J PLANKTON RES, V24, P1349, DOI 10.1093/plankt/24.12.1349; GORDON AL, 1991, DEEP-SEA RES, V38, pS323, DOI 10.1016/S0198-0149(12)80015-X; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Ikeda T, 2001, MAR BIOL, V139, P587, DOI 10.1007/s002270100608; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Lass HU, 2008, J MARINE SYST, V74, P1, DOI 10.1016/j.jmarsys.2007.09.008; Le Borgne R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000745; Loick N, 2005, AFR J MAR SCI, V27, P597, DOI 10.2989/18142320509504120; LONGHURST AR, 1967, DEEP-SEA RES, V14, P51, DOI 10.1016/0011-7471(67)90028-9; Maas AE, 2012, MAR BIOL, V159, P1955, DOI 10.1007/s00227-012-1982-x; MAHNKEN CVW, 1969, B MAR SCI, V19, P550; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mohrholz V, 2008, CONT SHELF RES, V28, P424, DOI 10.1016/j.csr.2007.10.001; Mohrholz V, 2001, S AFR J SCI, V97, P199; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; Ohman MD, 1998, DEEP-SEA RES PT II, V45, P1709, DOI 10.1016/S0967-0645(98)80014-3; OWENS TG, 1975, MAR BIOL, V30, P27, DOI 10.1007/BF00393750; PACKARD TT, 1971, J MAR RES, V29, P235; PACKARD TT, 1971, LIMNOL OCEANOGR, V16, P60, DOI 10.4319/lo.1971.16.1.0060; Parker-Stetter SL, 2009, ESTUAR COAST SHELF S, V81, P13, DOI 10.1016/j.ecss.2008.09.021; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Piontkovski SA, 2003, OCEANOL ACTA, V26, P255, DOI 10.1016/S0399-1784(03)00014-8; Saltzman J, 1997, DEEP-SEA RES PT I, V44, P931, DOI 10.1016/S0967-0637(97)00006-X; Saltzman J, 1997, DEEP-SEA RES PT I, V44, P907, DOI 10.1016/S0967-0637(97)00007-1; SCHALK PH, 1988, MAR ECOL PROG SER, V44, P25, DOI 10.3354/meps044025; Schnack-Schiel SB, 2008, J PLANKTON RES, V30, P655, DOI 10.1093/plankt/fbn029; Schnack-Schiel SB, 2010, DEEP-SEA RES PT II, V57, P2064, DOI 10.1016/j.dsr2.2010.09.010; Schukat A, 2013, J EXP MAR BIOL ECOL, V442, P1, DOI 10.1016/j.jembe.2013.01.024; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; SHANNON LV, 1987, S AFR J MARINE SCI, V5, P11, DOI 10.2989/025776187784522261; Smith S, 1998, DEEP-SEA RES PT II, V45, P2369, DOI 10.1016/S0967-0645(98)00075-7; SOMERO GN, 1980, PHYSIOL ZOOL, V53, P322, DOI 10.1086/physzool.53.3.30155794; Stramma L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004369; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Stramma L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039593; Svetlichny LS, 2000, MAR BIOL, V137, P963, DOI 10.1007/s002270000405; TEAL JM, 1967, LIMNOL OCEANOGR, V12, P548, DOI 10.4319/lo.1967.12.3.0548; Teuber L, 2013, J EXP MAR BIOL ECOL, V448, P28, DOI 10.1016/j.jembe.2013.06.012; Thuesen EV, 1998, MAR ECOL PROG SER, V168, P95, DOI 10.3354/meps168095; VINOGRADOV ME, 1962, DEEP-SEA RES, V9, P523, DOI 10.1016/0011-7471(62)90105-5; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811; Wishner KF, 2008, PROG OCEANOGR, V78, P163, DOI 10.1016/j.pocean.2008.03.001; Wishner KF, 2013, DEEP-SEA RES PT I, V79, P122, DOI 10.1016/j.dsr.2013.05.012; WONG CK, 1988, J PLANKTON RES, V10, P1285, DOI 10.1093/plankt/10.6.1285; Woodd-Walker RS, 2001, HYDROBIOLOGIA, V453, P161, DOI 10.1023/A:1013140606293	63	29	29	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77590	10.1371/journal.pone.0077590	http://dx.doi.org/10.1371/journal.pone.0077590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223716	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400009
J	Li, XY; Song, BA; Chen, X; Wang, ZC; Zeng, MJ; Yu, DD; Hu, DY; Chen, Z; Jin, LH; Yang, S; Yang, CG; Chen, BE				Li, Xiangyang; Song, Baoan; Chen, Xi; Wang, Zhenchao; Zeng, Mengjiao; Yu, Dandan; Hu, Deyu; Chen, Zhuo; Jin, Linhong; Yang, Song; Yang, Caiguang; Chen, Baoen			Crystal Structure of a Four-Layer Aggregate of Engineered TMV CP Implies the Importance of Terminal Residues for Oligomer Assembly	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; ELECTRON-MICROSCOPY; COAT PROTEIN; RESOLUTION; RNA; MECHANISM; DISK; PURIFICATION; STRAIN; MODEL	Background: Crystal structures of the tobacco mosaic virus (TMV) coat protein (CP) in its helical and disk conformations have previously been determined at the atomic level. For the helical structure, interactions of proteins and nucleic acids in the main chains were clearly observed; however, the conformation of residues at the C-terminus was flexible and disordered. For the four-layer aggregate disk structure, interactions of the main chain residues could only be observed through water-mediated hydrogen bonding with protein residues. In this study, the effects of the C-terminal peptides on the interactions of TMV CP were investigated by crystal structure determination. Methodology/Principal Findings: The crystal structure of a genetically engineered TMV CP was resolved at 3.06 angstrom. For the genetically engineered TMV CP, a six-histidine (His) tag was introduced at the N-terminus, and the C-terminal residues 155 to 158 were truncated (N-His-TMV CP19). Overall, N-His-TMV CP19 protein self-assembled into the four-layer aggregate form. The conformations of residues Gln36, Thr59, Asp115 and Arg134 were carefully analyzed in the high radius and low radius regions of N-His-TMV CP19, which were found to be significantly different from those observed previously for the helical and four-layer aggregate forms. In addition, the aggregation of the N-His-TMV CP19 layers was found to primarily be mediated through direct hydrogen-bonding. Notably, this engineered protein also can package RNA effectively and assemble into an infectious virus particle. Conclusion: The terminal sequence of amino acids influences the conformation and interactions of the four-layer aggregate. Direct protein-protein interactions are observed in the major overlap region when residues Gly155 to Thr158 at the C-terminus are truncated. This engineered TMV CP is reassembled by direct protein-protein interaction and maintains the normal function of the four-layer aggregate of TMV CP in the presence of RNA.	[Li, Xiangyang; Song, Baoan; Chen, Xi; Wang, Zhenchao; Yu, Dandan; Hu, Deyu; Chen, Zhuo; Jin, Linhong; Yang, Song] Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang 550003, Peoples R China; [Zeng, Mengjiao] S China Univ Technol, Sch Chem & Chem Engn, Guangzhou, Guangdong, Peoples R China; [Yang, Caiguang; Chen, Baoen] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Guizhou University; South China University of Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Song, BA (corresponding author), Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang 550003, Peoples R China.	basong@gzu.edu.cn; yangsdqj@126.com	Chen, Zhuo/AFX-0411-2022; Yang, Song/H-2765-2013	Yang, Song/0000-0003-1301-3030	National Basic Research Program of China [2010CB126105]; Key Technologies RD Program [2011BAE06B05-6]; National Natural Science Foundation of China [21132003]	National Basic Research Program of China(National Basic Research Program of China); Key Technologies RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant No. 2010CB126105), the Key Technologies R&D Program (Grant No. 2011BAE06B05-6), and the National Natural Science Foundation of China (Grant No. 21132003). The funders had no role in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergfors TE, 2009, PROTEIN CRYSTALLIZAT, P95; Bhyravbhatla B, 1998, BIOPHYS J, V74, P604, DOI 10.1016/S0006-3495(98)77819-1; BLOOMER AC, 1978, NATURE, V276, P362, DOI 10.1038/276362a0; Bloomer AC, 1986, TOBACCO MOSAIC VIRUS, P19; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruckman MA, 2011, ACS NANO, V5, P1606, DOI 10.1021/nn1025719; BUTLER PJG, 1984, J GEN VIROL, V65, P253, DOI 10.1099/0022-1317-65-2-253; Caspar D L, 1990, Adv Biophys, V26, P157, DOI 10.1016/0065-227X(90)90011-H; CastellanosSerra LR, 1996, ELECTROPHORESIS, V17, P1564, DOI 10.1002/elps.1150171012; Clare DK, 2010, J STRUCT BIOL, V171, P303, DOI 10.1016/j.jsb.2010.06.011; Dedeo MT, 2010, NANO LETT, V10, P181, DOI 10.1021/nl9032395; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRAENK.H, 1961, VIROLOGY, V14, P54, DOI 10.1016/0042-6822(61)90131-3; Ge P, 2011, P NATL ACAD SCI USA, V108, P9637, DOI 10.1073/pnas.1018104108; Geiger FC, 2013, NANOSCALE, V5, P3808, DOI 10.1039/c3nr33724c; GOODING GV, 1967, PHYTOPATHOLOGY, V57, P1285; HEBERT TT, 1963, PHYTOPATHOLOGY, V53, P362; Jonathan P, 1977, ADV PROTEIN CHEM, V31, P188; Kadri A, 2013, J VIROL METHODS, V189, P328, DOI 10.1016/j.jviromet.2013.02.017; Kadri A, 2011, VIRUS RES, V157, P35, DOI 10.1016/j.virusres.2011.01.014; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kainov DE, 2003, J BIOL CHEM, V278, P48084, DOI 10.1074/jbc.M306928200; Kegel WK, 2006, BIOPHYS J, V91, P1501, DOI 10.1529/biophysj.105.072603; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Li XY, 2012, VIROLOGY J IN PRESS; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Mancini EJ, 2012, ADV EXP MED BIOL, V726, P609, DOI 10.1007/978-1-4614-0980-9_27; MANDELKOW E, 1976, J MOL BIOL, V102, P265, DOI 10.1016/S0022-2836(76)80053-8; MANDELKOW E, 1981, J MOL BIOL, V152, P375, DOI 10.1016/0022-2836(81)90248-5; Mueller A, 2010, J VIROL METHODS, V166, P77, DOI 10.1016/j.jviromet.2010.02.026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; NAMBA K, 1989, J MOL BIOL, V208, P307, DOI 10.1016/0022-2836(89)90391-4; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Okada Y, 1986, Adv Biophys, V22, P95, DOI 10.1016/0065-227X(86)90004-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTANAYEK R, 1992, J MOL BIOL, V228, P516, DOI 10.1016/0022-2836(92)90839-C; RAGHAVENDRA K, 1988, BIOCHEMISTRY-US, V27, P7583, DOI 10.1021/bi00420a002; RAGHAVENDRA K, 1985, BIOCHEMISTRY-US, V24, P3298, DOI 10.1021/bi00334a034; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; SCHUSTER TM, 1980, BIOPHYS J, V32, P313, DOI 10.1016/S0006-3495(80)84959-9; SHIRE SJ, 1979, P NATL ACAD SCI USA, V76, P2745, DOI 10.1073/pnas.76.6.2745; SHIRE SJ, 1979, J MOL BIOL, V127, P487, DOI 10.1016/0022-2836(79)90233-X; SPERLING R, 1975, J MOL BIOL, V96, P425, DOI 10.1016/0022-2836(75)90169-2; STUBBS G, 1977, NATURE, V267, P216, DOI 10.1038/267216a0; Stubbs G, 2012, ADV EXP MED BIOL, V726, P631, DOI 10.1007/978-1-4614-0980-9_28; WILCOCKSON J, 1974, J GEN VIROL, V23, P107, DOI 10.1099/0022-1317-23-1-107	50	24	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77717	10.1371/journal.pone.0077717	http://dx.doi.org/10.1371/journal.pone.0077717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223721	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400014
J	Romero, L; Trenor, B; Ferrero, JM; Starmer, CF				Romero, Lucia; Trenor, Beatriz; Ferrero, Jose M.; Starmer, C. Frank			Non-Uniform Dispersion of the Source-Sink Relationship Alters Wavefront Curvature	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; CARDIAC TISSUE; SAFETY FACTOR; VULNERABLE PERIOD; SLOW CONDUCTION; EXCITABILITY; MUSCLE; FIBRILLATION; ARRHYTHMIAS; MECHANISMS	The distribution of cellular source-sink relationships plays an important role in cardiac propagation. It can lead to conduction slowing and block as well as wave fractionation. It is of great interest to unravel the mechanisms underlying evolution in wavefront geometry. Our goal is to investigate the role of the source-sink relationship on wavefront geometry using computer simulations. We analyzed the role of variability in the microscopic source-sink relationship in driving changes in wavefront geometry. The electrophysiological activity of a homogeneous isotropic tissue was simulated using the ten Tusscher and Panfilov 2006 action potential model and the source-sink relationship was characterized using an improved version of the Romero et al. safety factor formulation (SFm2). Our simulations reveal that non-uniform dispersion of the cellular source-sink relationship (dispersion along the wavefront) leads to alterations in curvature. To better understand the role of the source-sink relationship in the process of wave formation, the electrophysiological activity at the initiation of excitation waves in a 1D strand was examined and the source-sink relationship was characterized using the two recently updated safety factor formulations: the SFm2 and the Boyle-Vigmond (SFVB) definitions. The electrophysiological activity at the initiation of excitation waves was intimately related to the SFm2 profiles, while the SFVB led to several counterintuitive observations. Importantly, with the SFm2 characterization, a critical source-sink relationship for initiation of excitation waves was identified, which was independent of the size of the electrode of excitation, membrane excitability, or tissue conductivity. In conclusion, our work suggests that non-uniform dispersion of the source-sink relationship alters wavefront curvature and a critical source-sink relationship profile separates wave expansion from collapse. Our study reinforces the idea that the safety factor represents a powerful tool to study the mechanisms of cardiac propagation in silico, providing a better understanding of cardiac arrhythmias and their therapy.	[Romero, Lucia; Trenor, Beatriz; Ferrero, Jose M.] Univ Politecn Valencia, Inst Invest Interuniv Bioingn & Tecnol Orientada, E-46071 Valencia, Spain; [Starmer, C. Frank] Duke NUS Grad Med Sch, Singapore, Singapore; [Starmer, C. Frank] Duke Univ, Durham, NC USA	Universitat Politecnica de Valencia; National University of Singapore; Duke University	Romero, L (corresponding author), Univ Politecn Valencia, Inst Invest Interuniv Bioingn & Tecnol Orientada, E-46071 Valencia, Spain.	lurope@eln.upv.es	Romero, Lucia/H-6815-2015; Trenor, Beatriz/H-1716-2015; Ferrero, Jose M/I-2034-2015	Romero, Lucia/0000-0003-4605-8630; Trenor, Beatriz/0000-0001-9166-6112; Ferrero, Jose M/0000-0003-4200-9225; Starmer, C Frank/0000-0002-9877-1537	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from the Ministerio de Economia y Competitividad of Spain [TIN2012?37546?C03?01]; European Commission (European Regional Development Funds - ERDF ? FEDER); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Plan Avanza en el marco de la Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion del Ministerio de Industria Turismo y Comercio of Spain [TSI?020100?2010?469]; Programa de Apoyo a la Investigacion y Desarrollo [PAID?06?11?2002]; de la Universidad Politecnica de Valencia; Direccion General de Politica Cientifica de la Generalitat Valenciana [GV/2013/119]; Programa Prometeo de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana [PROMETEO/2012/030]	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from the Ministerio de Economia y Competitividad of Spain; European Commission (European Regional Development Funds - ERDF ? FEDER); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Plan Avanza en el marco de la Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion del Ministerio de Industria Turismo y Comercio of Spain; Programa de Apoyo a la Investigacion y Desarrollo; de la Universidad Politecnica de Valencia; Direccion General de Politica Cientifica de la Generalitat Valenciana; Programa Prometeo de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana	This work was partially supported by the "VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from the Ministerio de Economia y Competitividad of Spain (TIN2012?37546?C03?01) and the European Commission (European Regional Development Funds - ERDF ? FEDER), Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Plan Avanza en el marco de la Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion del Ministerio de Industria Turismo y Comercio of Spain (TSI?020100?2010?469), Programa de Apoyo a la Investigacion y Desarrollo (PAID?06?11?2002) de la Universidad Politecnica de Valencia, Direccion General de Politica Cientifica de la Generalitat Valenciana (GV/2013/119) and Programa Prometeo (PROMETEO/2012/030) de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLESSIE MA, 1976, CIRC RES, V39, P168, DOI 10.1161/01.RES.39.2.168; Aslanidi OV, 2009, BIOPHYS J, V97, P20, DOI 10.1016/j.bpj.2009.03.061; Azene EM, 2001, ANN BIOMED ENG, V29, P35, DOI 10.1114/1.1332083; Boyle PM, 2010, BIOPHYS J, V98, pL57, DOI 10.1016/j.bpj.2010.03.018; CABO C, 1994, CIRC RES, V75, P1014, DOI 10.1161/01.RES.75.6.1014; Clayton RH, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-11; Danse PW, 2000, J CARDIOVASC ELECTR, V11, P262, DOI 10.1111/j.1540-8167.2000.tb01795.x; DELGADO C, 1990, CIRC RES, V67, P97, DOI 10.1161/01.RES.67.1.97; Efimov IR, 1997, J CARDIOVASC ELECTR, V8, P1031, DOI 10.1111/j.1540-8167.1997.tb00627.x; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fast VG, 1997, CARDIOVASC RES, V33, P258, DOI 10.1016/S0008-6363(96)00216-7; HAN J, 1964, CIRC RES, V14, P44, DOI 10.1161/01.RES.14.1.44; Hubbard ML, 2010, AM J PHYSIOL-HEART C, V298, pH1209, DOI 10.1152/ajpheart.00689.2009; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kucera JP, 2001, CIRC RES, V89, P799, DOI 10.1161/hh2101.098442; LEON LJ, 1991, CIRC RES, V69, P378, DOI 10.1161/01.RES.69.2.378; ONG JJC, 1995, J CLIN INVEST, V96, P2284, DOI 10.1172/JCI118284; Romero L, 2005, COMPUT CARDIOL, V32, P873; Romero L, 2009, ANN BIOMED ENG, V37, P1560, DOI 10.1007/s10439-009-9721-2; RUSHTON WAH, 1937, P R SOC B, V124, P213; Sambelashvili AT, 2003, AM J PHYSIOL-HEART C, V284, pH2368, DOI 10.1152/ajpheart.00988.2002; SELFRIDGE O., 1948, ARCH INST CARDIOL [MEXICO], V18, P177; Shaw RM, 1997, CIRC RES, V81, P727; SPACH MS, 1981, CIRC RES, V48, P39, DOI 10.1161/01.RES.48.1.39; Starmer CF, 1997, PACE, V20, P445, DOI 10.1111/j.1540-8159.1997.tb06203.x; Starmer CF, 2003, CARDIOVASC RES, V57, P82, DOI 10.1016/S0008-6363(02)00613-2; Stein M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020310; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; VANCAPELLE FJL, 1980, CIRC RES, V47, P454, DOI 10.1161/01.RES.47.3.454; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Wang Y, 2000, AM J PHYSIOL-HEART C, V278, pH1019, DOI 10.1152/ajpheart.2000.278.4.H1019; Wellner M, 1997, PHYS REV E, V55, P7656, DOI 10.1103/PhysRevE.55.7656; Zhao JC, 2009, J CARDIOVASC ELECTR, V20, P675, DOI 10.1111/j.1540-8167.2008.01420.x; ZYKOV VS, 1980, BIOFIZIKA+, V25, P888	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78328	10.1371/journal.pone.0078328	http://dx.doi.org/10.1371/journal.pone.0078328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223791	Green Published, gold			2022-12-27	WOS:000326503400051
J	Fan, WH; Li, Q; Yang, XP; Zhang, L				Fan, Wenhong; Li, Qian; Yang, Xiuping; Zhang, Li			Zn Subcellular Distribution in Liver of Goldfish (Carassius Auratus) with Exposure to Zinc Oxide Nanoparticles and Mechanism of Hepatic Detoxification	PLOS ONE			English	Article							WATER RAINBOW-TROUT; HEAVY-METAL; FISH; TOXICITY; METALLOTHIONEIN; CADMIUM; COPPER; BIOACCUMULATION; ACCUMULATION; GILLS	Zinc Oxide Nanoparticles (ZnO NPs) have attracted increasing concerns because of their widespread use and toxic potential. In this study, Zn accumulations in different tissues (gills, liver, muscle, and gut) of goldfish (Carassius auratus) after exposure to ZnO NPs were studied in comparison with bulk ZnO and Zn2+. And the technique of subcellular partitioning was firstly used on the liver of goldfish to study the hepatic accumulation of ZnO NPs. The results showed that at sublethal Zn concentration (2 mg/L), bioaccumulation in goldfish was tissue-specific and dependent on the exposure materials. Compared with Zn2+, the particles of bulk ZnO and the ZnO NPs appeared to aggregate in the environmentally contacted tissues (gills and gut), rather than transport to the internal tissues (liver and muscle). The subcellular distributions of liver differed for the three exposure treatments. After ZnO NPs exposure, Zn percentage in metal-rich granule (MRG) increased significantly, and after Zn2+ exposure, it increased significantly in the organelles. Metallothionein-like proteins (MTLP) were the main target for Zn2+, while MRG played dominant role for ZnO NPs. The different results of subcellular distributions revealed that metal detoxification mechanisms of liver for ZnO NPs, bulk ZnO, and Zn2+ were different. Overall, subcellular partitioning provided an interesting start to better understanding of the toxicity of nano-and conventional materials.	[Fan, Wenhong; Li, Qian; Yang, Xiuping] Beihang Univ, Sch Chem & Environm, Dept Environm Sci & Engn, Beijing, Peoples R China; [Zhang, Li] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China	Beihang University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Fan, WH (corresponding author), Beihang Univ, Sch Chem & Environm, Dept Environm Sci & Engn, Beijing, Peoples R China.	fanwh@buaa.edu.cn	Zhang, Li/A-7762-2014; fan, wen hong/F-6415-2012	Zhang, Li/0000-0001-5705-6548; 	National Natural Science Foundation of China [51290283]; Major Science and Technology Program for Water Pollution Control and Treatment of China [2012ZX07501001]; China's National Basic Research Program [2011CB935700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment of China; China's National Basic Research Program(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (51290283), Major Science and Technology Program for Water Pollution Control and Treatment of China (No. 2012ZX07501001), and China's National Basic Research Program (No. 2011CB935700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; BOOTH JH, 1978, J EXP BIOL, V73, P119; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Collins D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042663; Dowling A., 2004, NANOSCIENCE NANOTECH, P61; Dural M, 2007, FOOD CHEM, V102, P415, DOI 10.1016/j.foodchem.2006.03.001; Farre M, 2009, ANAL BIOANAL CHEM, V393, P81, DOI 10.1007/s00216-008-2458-1; Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r; Giguere A, 2006, AQUAT TOXICOL, V77, P178, DOI 10.1016/j.aquatox.2005.12.001; Glover CN, 2004, BBA-BIOMEMBRANES, V1663, P214, DOI 10.1016/j.bbamem.2004.03.008; Goto D, 2010, MAR ENVIRON RES, V69, P163, DOI 10.1016/j.marenvres.2009.09.008; Hariharan C, 2006, APPL CATAL A-GEN, V304, P55, DOI 10.1016/j.apcata.2006.02.020; Hogstrand C, 1996, AM J PHYSIOL-REG I, V270, pR1141; Jabeen F, 2010, ENVIRON MONIT ASSESS, V170, P645, DOI 10.1007/s10661-009-1263-4; Jiang W, 2009, ENVIRON POLLUT, V157, P1619, DOI 10.1016/j.envpol.2008.12.025; Johnston BD, 2010, ENVIRON SCI TECHNOL, V44, P1144, DOI 10.1021/es901971a; KAGI JHR, 1991, METHOD ENZYMOL, V205, P613; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kotze P, 1999, WATER SA, V25, P99; Li LZ, 2011, ENVIRON INT, V37, P1098, DOI 10.1016/j.envint.2011.01.008; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Ma HB, 2013, ENVIRON POLLUT, V172, P76, DOI 10.1016/j.envpol.2012.08.011; Murugan SS, 2008, TURK J FISH AQUAT SC, V8, P55; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Papagiannis I, 2004, ENVIRON INT, V30, P357, DOI 10.1016/j.envint.2003.08.002; Peralta-Videa JR, 2011, J HAZARD MATER, V186, P1, DOI 10.1016/j.jhazmat.2010.11.020; ROCH M, 1982, CAN J FISH AQUAT SCI, V39, P1596, DOI 10.1139/f82-215; ROESIJADI G, 1992, AQUAT TOXICOL, V22, P81, DOI 10.1016/0166-445X(92)90026-J; Sappal R, 2009, AQUAT TOXICOL, V91, P281, DOI 10.1016/j.aquatox.2008.10.007; Shaw BJ, 2011, ENVIRON INT, V37, P1083, DOI 10.1016/j.envint.2011.03.009; Urena R, 2007, ENVIRON INT, V33, P532, DOI 10.1016/j.envint.2006.10.007; Uysal K, 2011, INT J FOOD PROP, V14, P280, DOI 10.1080/10942910903176378; Wallace WG, 2003, MAR ECOL PROG SER, V249, P183, DOI 10.3354/meps249183; Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146; Wang WX, 2010, ENVIRON TOXICOL CHEM, V29, P1841, DOI 10.1002/etc.229; Wang WX, 2010, COMP BIOCHEM PHYS C, V152, P1, DOI 10.1016/j.cbpc.2010.02.015; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; Wu SM, 2006, B ENVIRON CONTAM TOX, V76, P595, DOI 10.1007/s00128-006-0961-7; Yang WH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045233, 10.1371/journal.pone.0046789, 10.1371/journal.pone.0053429]; Yin H, 2010, LANGMUIR, V26, P15399, DOI 10.1021/la101033n	40	7	7	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78123	10.1371/journal.pone.0078123	http://dx.doi.org/10.1371/journal.pone.0078123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223767	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300024
J	Kling, JC; Mack, M; Korner, H				Kling, Jessica C.; Mack, Matthias; Koerner, Heinrich			The Absence of CCR7 Results in Dysregulated Monocyte Migration and Immunosuppression Facilitating Chronic Cutaneous Leishmaniasis	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSES; MAJOR INFECTION; DENDRITIC CELLS; WOUND REPAIR; LYMPH-NODES; NAIVE-LIKE; IN-VIVO; SUBSETS; EXPRESSION	The protozoan parasite Leishmania major causes cutaneous lesions to develop at the site of infection, which are resolved with a strong Th1 immune response in resistant hosts, such as C57BL/6 mice. In contrast, the lesions ulcerate in susceptible hosts which display a Th2 response, such as BALB/c mice. The migration of cells in the immune response to L. major is regulated by chemokines and their receptors. The chemokine receptor CCR7 is expressed on activated DCs and naive T cells, allowing them to migrate to the correct micro-anatomical positions within secondary lymphoid organs. While there have been many studies on the function of CCR7 during homeostasis or using model antigens, there are very few studies on the role of CCR7 during infection. In this study, we show that B6. CCR7(-/-) mice were unable to resolve the lesion and developed a chronic disease. The composition of the local infiltrate at the lesion was significantly skewed toward neutrophils while the proportion of CCR2(+) monocytes was reduced. Furthermore, a greater percentage of CCR2(+) monocytes expressed CCR7 in the footpad than in the lymph node or spleen of B6. WT mice. We also found an increased percentage of regulatory T cells in the draining lymph node of B6. CCR7(-/-) mice throughout infection. Additionally, the cytokine milieu of the lymph node showed a Th2 bias, rather than the resistant Th1 phenotype. This data shows that CCR7 is required for a protective immune response to intracellular L. major infection.	[Kling, Jessica C.; Koerner, Heinrich] Menzies Res Inst, Hobart, Australia; [Mack, Matthias] Univ Klinikum Regensburg, Regensburg, Germany	University of Tasmania; Menzies Institute for Medical Research; University of Regensburg	Korner, H (corresponding author), Menzies Res Inst, Hobart, Australia.	heinrich.korner@utas.edu.au	Korner, Heinrich/D-9970-2014	Korner, Heinrich/0000-0003-4610-2814	NHMRC [485807]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The work was funded by the NHMRC (http://www.nhmrc.gov.au/, grant: 485807 to HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Banas B, 2002, J IMMUNOL, V168, P4301, DOI 10.4049/jimmunol.168.9.4301; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bonacchi A, 2003, GASTROENTEROLOGY, V125, P1060, DOI 10.1016/S0016-5085(03)01194-6; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Conrad SM, 2007, INFECT IMMUN, V75, P653, DOI 10.1128/IAI.01314-06; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Ding YZ, 2012, TRENDS IMMUNOL, V33, P174, DOI 10.1016/j.it.2012.01.002; Eller K, 2010, J AM SOC NEPHROL, V21, P42, DOI 10.1681/ASN.2009020133; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fromm PD, 2012, J IMMUNOL, V188, P6258, DOI 10.4049/jimmunol.1100977; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Junt T, 2002, J IMMUNOL, V168, P6032, DOI 10.4049/jimmunol.168.12.6032; Junt T, 2004, J IMMUNOL, V173, P6684, DOI 10.4049/jimmunol.173.11.6684; Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC; Kling J, 2011, EXP PARASITOL, V129, P270, DOI 10.1016/j.exppara.2011.07.015; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; LOCKSLEY RM, 1987, ANN INST PASTEUR IMM, V138, P744, DOI 10.1016/S0769-2625(87)80030-2; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Menezes-Souza D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001566; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moschovakis GL, 2012, EUR J IMMUNOL, V42, P48, DOI 10.1002/eji.201141753; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Noor S, 2010, INFECT IMMUN, V78, P2257, DOI 10.1128/IAI.01314-09; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Quinones MP, 2007, PARASITE IMMUNOL, V29, P211, DOI 10.1111/j.1365-3024.2006.00935.x; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Sakthianandeswaren A, 2005, P NATL ACAD SCI USA, V102, P15551, DOI 10.1073/pnas.0505630102; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Seth S, 2011, J IMMUNOL, V186, P3364, DOI 10.4049/jimmunol.1002598; SOLBACH W, 1986, INFECT IMMUN, V54, P909, DOI 10.1128/IAI.54.3.909-912.1986; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Trujillo G, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-18; Unsoeld H, 2007, INT IMMUNOL, V19, P1281, DOI 10.1093/intimm/dxm098; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Weaver CT, 2007, CURR BIOL, V17, pR61, DOI 10.1016/j.cub.2006.12.015; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79098	10.1371/journal.pone.0079098	http://dx.doi.org/10.1371/journal.pone.0079098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205367	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326334500143
J	Lillis, A; Eggleston, DB; Bohnenstiehl, DR				Lillis, Ashlee; Eggleston, David B.; Bohnenstiehl, DelWayne R.			Oyster Larvae Settle in Response to Habitat-Associated Underwater Sounds	PLOS ONE			English	Article							PELAGIC LARVAE; REEF FISHES; ORIENTATION; CUE; INVERTEBRATES; RECRUITMENT; DISPERSAL; INDUCTION; DYNAMICS; PATTERNS	Following a planktonic dispersal period of days to months, the larvae of benthic marine organisms must locate suitable seafloor habitat in which to settle and metamorphose. For animals that are sessile or sedentary as adults, settlement onto substrates that are adequate for survival and reproduction is particularly critical, yet represents a challenge since patchily distributed settlement sites may be difficult to find along a coast or within an estuary. Recent studies have demonstrated that the underwater soundscape, the distinct sounds that emanate from habitats and contain information about their biological and physical characteristics, may serve as broad-scale environmental cue for marine larvae to find satisfactory settlement sites. Here, we contrast the acoustic characteristics of oyster reef and off-reef soft bottoms, and investigate the effect of habitat-associated estuarine sound on the settlement patterns of an economically and ecologically important reef-building bivalve, the Eastern oyster (Crassostrea virginica). Subtidal oyster reefs in coastal North Carolina, USA show distinct acoustic signatures compared to adjacent off-reef soft bottom habitats, characterized by consistently higher levels of sound in the 1.5-20 kHz range. Manipulative laboratory playback experiments found increased settlement in larval oyster cultures exposed to oyster reef sound compared to unstructured soft bottom sound or no sound treatments. In field experiments, ambient reef sound produced higher levels of oyster settlement in larval cultures than did off-reef sound treatments. The results suggest that oyster larvae have the ability to respond to sounds indicative of optimal settlement sites, and this is the first evidence that habitat-related differences in estuarine sounds influence the settlement of a mollusk. Habitat-specific sound characteristics may represent an important settlement and habitat selection cue for estuarine invertebrates and could play a role in driving settlement and recruitment patterns in marine communities.	[Lillis, Ashlee; Eggleston, David B.; Bohnenstiehl, DelWayne R.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Lillis, A (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Box 8208, Raleigh, NC 27695 USA.	aslillis@ncsu.edu		Eggleston, David/0000-0001-7840-2665; Lillis, Ashlee/0000-0001-5754-2861	National Science Foundation [OCE-1234688, DDIG-1210292]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by National Science Foundation Grants OCE-1234688 and DDIG-1210292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au W.W.L., 2008, PRINCIPLES MARINE BI; Boudreaux ML, 2006, J SHELLFISH RES, V25, P1079; Bradbury IR, 2001, CAN J FISH AQUAT SCI, V58, P811, DOI 10.1139/cjfas-58-4-811; BUDELMANN BU, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P141; Cotter AJR, 2008, ADVANCES IN FISHERIES SCIENCE: 50 YEARS ON FROM BEVERTON AND HOLT, P451, DOI 10.1002/9781444302653.ch19; Gaylord B, 2013, P NATL ACAD SCI USA, V110, P6901, DOI 10.1073/pnas.1220680110; Glade S, 1982, SOUND INTENSITY 1; Hawkins A, 2008, BIOACOUSTICS, V17, P1; Huijbers CM, 2012, ECOLOGY, V93, P46, DOI 10.1890/10-2236.1; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Kalmijn A.J., 1988, P83; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Kennedy V.S., 1996, E OYSTER CRASSOSTREA; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; Kingsford MJ, 2002, B MAR SCI, V70, P309; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lillis A, 2010, MAR ECOL PROG SER, V401, P161, DOI 10.3354/meps08427; Luczkovich Joseph J., 2002, Bioacoustics, V12, P289; MacGillivray A., 2005, SOUND PRESSURE PARTI; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Mooney TA, 2010, J EXP BIOL, V213, P3748, DOI 10.1242/jeb.048348; Morgan SG, 2001, MARINE COMMUNITY ECOLOGY, P159; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; Okumura Tsuyoshi, 2002, Bioacoustics, V12, P330; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PAWLIK JR, 1991, SCIENCE, V251, P421, DOI 10.1126/science.251.4992.421; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Ritchie T. P., 1969, P NATL SHELLFISHERIE, V59, P116; Rittschof D, 1998, BIOFOULING, V12, P31, DOI 10.1080/08927019809378344; Rogers P.H., 1988, P131; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; SHAW R, 1970, J FISH RES BOARD CAN, V27, P743, DOI 10.1139/f70-078; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Simpson SD, 2010, BEHAV ECOL, V21, P1098, DOI 10.1093/beheco/arq117; Slabbekoorn H, 2008, ANIM BEHAV, V76, pE5, DOI 10.1016/j.anbehav.2008.06.010; Sprague Mark W., 2000, Journal of the Elisha Mitchell Scientific Society, V116, P124; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Stocks J.R., 2012, Open Marine Biology Journal, V6, P57; TAMBURRI MN, 1992, BIOL BULL, V183, P327, DOI 10.2307/1542218; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; TURNER EJ, 1994, LIMNOL OCEANOGR, V39, P1579, DOI 10.4319/lo.1994.39.7.1579; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; WELLS HW, 1961, ECOL MONOGR, V31, P239, DOI 10.2307/1948554; Wilkens SL, 2012, BIOFOULING, V28, P65, DOI 10.1080/08927014.2011.651717; Zhadan P.M., 2005, RUSSIAN J MARINE BIO, V31, P28, DOI DOI 10.1007/S11179-005-0040-7; ZHADAN PM, 1984, COMP BIOCHEM PHYS A, V78, P865, DOI 10.1016/0300-9629(84)90647-9; Zimmer RK, 2009, ECOLOGY, V90, P1933, DOI 10.1890/08-0786.1	53	97	97	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79337	10.1371/journal.pone.0079337	http://dx.doi.org/10.1371/journal.pone.0079337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205381	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500149
J	Pielen, A; Feltgen, N; Isserstedt, C; Callizo, J; Junker, B; Schmucker, C				Pielen, Amelie; Feltgen, Nicolas; Isserstedt, Christin; Callizo, Josep; Junker, Bernd; Schmucker, Christine			Efficacy and Safety of Intravitreal Therapy in Macular Edema Due to Branch and Central Retinal Vein Occlusion: a Systematic Review	PLOS ONE			English	Review							VEGF-TRAP; TRIAMCINOLONE ACETONIDE; SUSTAINED BENEFITS; 12-MONTH OUTCOMES; STANDARD-CARE; BEVACIZUMAB; SECONDARY; RANIBIZUMAB; PEGAPTANIB; INJECTION	Background: Intravitreal agents have replaced observation in macular edema in central (CRVO) and grid laser photocoagulation in branch retinal vein occlusion (BRVO). We conducted a systematic review to evaluate efficacy and safety outcomes of intravitreal therapies for macular edema in CRVO and BRVO. Methods: And Findings: MEDLINE, Embase, and the Cochrane Library were systematically searched for RCTs with no limitations of language and year of publication. 11 RCTs investigating anti-VEGF agents (ranibizumab, bevacizumab, aflibercept) and steroids (triamcinolone, dexamethasone implant) with a minimum follow-up of 1 year were evaluated. Efficacy: CRVO: Greatest gain in visual acuity after 12 months was observed both under aflibercept 2 mg: +16.2 letters (8.5 injections), and under bevacizumab 1.25 mg: +16.1 letters (8 injections). Ranibizumab 0.5 mg improved vision by +13.9 letters (8.8 injections). Triamcinolone 1 mg and 4 mg stabilized visual acuity at a lower injection frequency (-1.2 letters, 2 injections). BRVO: Ranibizumab 0.5 mg resulted in a visual acuity gain of +18.3 letters (8.4 injections). The effect of dexamethasone implant was transient after 1.9 implants in both indications. Safety: Serious ocular adverse events were rare, e. g., endophthalmitis occurred in 0.0-0.9%. Major differences were found in an indirect comparison between steroids and anti-VEGF agents for cataract progression (19.8-35.0% vs. 0.9-7.0%) and in required treatment of increased intraocular pressure (7.0-41.0% vs. none). No major differences were identified in systemic adverse events. Conclusions: Anti-VEGF agents result in a promising gain of visual acuity, but require a high injection frequency. Dexamethasone implant might be an alternative, but comparison is impaired as the effect is temporary and it has not yet been tested in PRN regimen. The ocular risk profile seems to be favorable for anti-VEGF agents in comparison to steroids. Because comparative data from head-to-head trials are missing currently, clinicians and patients should carefully weigh the benefit-harm ratio.	[Pielen, Amelie; Junker, Bernd] Univ Freiburg, Univ Eye Hosp, D-79106 Freiburg, Germany; [Pielen, Amelie; Junker, Bernd] Hannover Med Sch, Univ Eye Hosp, Hannover, Germany; [Feltgen, Nicolas; Isserstedt, Christin; Callizo, Josep] Univ Gottingen, Univ Eye Hosp, D-37073 Gottingen, Germany; [Schmucker, Christine] Univ Med Ctr, German Cochrane Ctr, Inst Med Biometry & Med Informat, Dept Med Biometry & Stat, Freiburg, Germany	University of Freiburg; Hannover Medical School; University of Gottingen; University of Freiburg	Pielen, A (corresponding author), Univ Freiburg, Univ Eye Hosp, Hugstetter Str 55, D-79106 Freiburg, Germany.	amelie.pielen@uniklinik-freiburg.de		Pielen, Amelie/0000-0001-9401-2501; Schmucker, Christine/0000-0002-1188-3158	Bayer HealthCare; Novartis Pharma; GlaxoSmithKline; Pfizer; Alcon; Accovion; Genentech; Novartis	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Novartis Pharma; GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Alcon(Novartis); Accovion; Genentech(Roche HoldingGenentech); Novartis(Novartis)	The authors have the following interests. Amelie Pielen is consultant for Allergan, Bayer HealthCare and Novartis Pharma, investigator in multicenter clinical trials sponsored by Bayer HealthCare, Novartis Pharma, GlaxoSmithKline, Pfizer, Alcon, Accovion and Genentech, received research grants from Novartis Pharma and travel grants from Bayer HealthCare. Nicolas Feltgen is consultant for Bayer, Novartis and Allergan, investigator in clinical trials sponsored by Bayer, Novartis and Allergan and received research and travel grants from Novartis. Josep Callizo is consultant for Bayer, Allergan and Novartis, investigator in clinical trials sponsored by Bayer, Allergan and Novartis and received travel grant from Novartis. Bernd Junker is investigator in multicenter clinical trials sponsored by Bayer HealthCare, Novartis Pharma, GlaxoSmithKline, Pfizer, Alcon, Accovion and Genentech and functioned as lecturer for Heidelberg Engeneering, Allergan and Novartis. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1984, AM J OPHTHALMOL, V98, P271; Boyer D, 2012, OPHTHALMOLOGY, V119, P1024, DOI 10.1016/j.ophtha.2012.01.042; Braithwaite T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007325.pub2; Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Centre for Reviews and Dissemination, SYST REV ADV EFF SYS, P177; Chakravarthy U, 2006, OPHTHALMOLOGY, V113, P1508, DOI 10.1016/j.ophtha.2006.02.064; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Chan CK, 2011, OPHTHALMOLOGY, V118, P1364, DOI 10.1016/j.ophtha.2010.11.020; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; Donati S, 2012, EUR J OPHTHALMOL, V22, P607, DOI 10.5301/ejo.5000085; Epstein DL, 2012, OPHTHALMOLOGY, V119, P2587, DOI 10.1016/j.ophtha.2012.06.037; Epstein DLJ, 2012, OPHTHALMOLOGY, V119, P1184, DOI 10.1016/j.ophtha.2012.01.022; Haller JA, 2011, OPHTHALMOLOGY, V118, P2453, DOI 10.1016/j.ophtha.2011.05.014; Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032; Heier JS, 2012, OPHTHALMOLOGY, V119, P802, DOI 10.1016/j.ophtha.2011.12.005; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P278, DOI 10.1136/bjophthalmol-2012-301504; Ip MS, 2009, OPHTHALMOLOGY, V116, P1770, DOI 10.1016/j.ophtha.2009.03.022; Ip MS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1101, DOI 10.1001/archophthalmol.2009.234; Jain N, 2012, OPHTHALMOLOGY, V119, P132, DOI 10.1016/j.ophtha.2011.06.019; Jaissle GB, 2011, GRAEF ARCH CLIN EXP, V249, P183, DOI 10.1007/s00417-010-1470-2; Jonas JB, 2002, GRAEF ARCH CLIN EXP, V240, P782, DOI 10.1007/s00417-002-0529-0; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kondo M, 2009, RETINA-J RET VIT DIS, V29, P1242, DOI 10.1097/IAE.0b013e3181aa8e20; Kube T, 2006, GRAEF ARCH CLIN EXP, V244, P1385, DOI 10.1007/s00417-006-0326-2; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Mitry D, 2013, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD009510.pub2, DOI 10.1002/14651858.CD009510.PUB2.PUBMED:23440840]; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Parodi MB, 2008, BRIT J OPHTHALMOL, V92, P1046, DOI 10.1136/bjo.2007.128025; Russo V, 2009, RETINA-J RET VIT DIS, V29, P511, DOI 10.1097/IAE.0b013e318195ca65; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Schmucker C, 2010, CURR OPIN OPHTHALMOL, V21, P218, DOI 10.1097/ICU.0b013e3283386783; Scott IU, 2009, ARCH OPHTHALMOL-CHIC, V127, P1115, DOI 10.1001/archophthalmol.2009.233; Smiddy WE, 2011, OPHTHALMOLOGY, V118, P1827, DOI 10.1016/j.ophtha.2010.12.034; Stahl A, 2010, EUR J OPHTHALMOL, V20, P180, DOI 10.1177/112067211002000125; Wroblewski JJ, 2010, AM J OPHTHALMOL, V149, P147, DOI 10.1016/j.ajo.2009.08.005; Wroblewski JJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P374, DOI 10.1001/archophthalmol.2009.14	42	78	82	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78538	10.1371/journal.pone.0078538	http://dx.doi.org/10.1371/journal.pone.0078538			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205253	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400083
J	Hojjat-Farsangi, M; Khan, AS; Daneshmanesh, AH; Moshfegh, A; Sandin, A; Mansouri, L; Palma, M; Lundin, J; Osterborg, A; Mellstedt, H				Hojjat-Farsangi, Mohammad; Khan, Abdul Salam; Daneshmanesh, Amir Hossein; Moshfegh, Ali; Sandin, Asa; Mansouri, Ladan; Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan			The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells	PLOS ONE			English	Article							BREAST-CANCER; SUBCELLULAR-LOCALIZATION; PROTEIN-PHOSPHORYLATION; NUCLEAR-LOCALIZATION; SURFACE RECEPTORS; EXPRESSION; AUTOPHOSPHORYLATION; FAMILY; WNT5A; HOMODIMERIZATION	Phosphorylation of receptor tyrosine kinases (RTKs) has a key role in cellular functions contributing to the malignant phenotype of tumor cells. We and others have previously demonstrated that RTK ROR1 is overexpressed in chronic lymphocytic leukemia (CLL). Silencing siRNA downregulated ROR1 and induced apoptosis of CLL cells. In the present study we analysed ROR1 isoforms and the phosphorylation pattern in CLL cells (n=38) applying western blot and flow-cytometry using anti-ROR1 antibodies and an anti-phospho-ROR1 antibody against the TK domain. Two major ROR1 bands with the size of 105 and 130 kDa respectively were identified, presumably representing unglycosylated (immature) and glycosylated (mature) ROR1 respectively as well as a 260 kDa band which may represent dimerized ROR1. A ROR1 band of 64 kDa that may correspond to a C-terminal fragment was also noted, present only in the nucleus. The 105 kDa ROR1 isoform was more frequently expressed in non-progressive as compared to progressive CLL patients (p=0.03). The 64, 105, 130 and 260 kDa bands were constitutively phosphorylated both at tyrosine and serine residues. Phosphorylation intensity of the mature (130 kDa) isoform was significantly higher in progressive than in non-progressive disease (p<0.001). Incubation of CLL cells with a mouse anti-ROR1 KNG or an anti-ROR1 CRD mAb respectively induced dephosphorylation of ROR1 before entering apoptosis. In conclusion CLL cells expressed different isoforms of ROR1 which were constitutively phosphorylated. The mature, phosphorylated ROR1 isoform was associated with a progressive disease stage. Targeting ROR1 by mAbs induced specific dephosphorylation and leukemic cell death. ROR1 might be an interesting therapeutic target.	[Hojjat-Farsangi, Mohammad; Khan, Abdul Salam; Daneshmanesh, Amir Hossein; Moshfegh, Ali; Sandin, Asa; Mansouri, Ladan; Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, CCK, Immune & Gene therapy Lab, Dept Oncol Pathol, Stockholm, Sweden; [Hojjat-Farsangi, Mohammad; Khan, Abdul Salam; Daneshmanesh, Amir Hossein; Moshfegh, Ali; Sandin, Asa; Mansouri, Ladan; Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan] Karolinska Inst, Stockholm, Sweden; [Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Oncol, Stockholm, Sweden; [Palma, Marzia; Lundin, Jeanette; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Mellstedt, H (corresponding author), Karolinska Univ Hosp Solna, CCK, Immune & Gene therapy Lab, Dept Oncol Pathol, Stockholm, Sweden.	hakan.mellstedt@karolinska.se	Palma, Marzia/AGN-7362-2022; Hojjat-Farsangi, Mohammad/E-8171-2018	Hojjat-Farsangi, Mohammad/0000-0002-0589-5523; Khan, Salam/0000-0003-1171-8870; Palma, Marzia/0000-0003-4287-3179	VINNOVA [2009-00116, P36147-1]; CLL Global Research Foundation [10501300]; EU Seventh Framework Programme [EUCAAD 200755, 200755]; Swedish Research Council [C0235101, K2013-64X-21464-04-3]; Swedish Cancer Society [12 0842]; Cancer Society in Stockholm [121273]; King Gustaf Vth Jubilee Fund [124272]; Stockholm County Council [20120051]	VINNOVA(Vinnova); CLL Global Research Foundation; EU Seventh Framework Programme; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; King Gustaf Vth Jubilee Fund; Stockholm County Council(Stockholm County Council)	This study was supported by grants from VINNOVA (http://www.vinnova.se/sv/), Proj. No: 2009-00116, P36147-1. The CLL Global Research Foundation (http://www.cllglobal.org/), Proj No: 10501300. EUCAAD 200755 project funded under the auspices of the EU Seventh Framework Programme (http://ki.se/ki/jsp/polopoly.jsp?d=9877&a=128974&dispd=40337&l=sv). Grant Agreement No: 200755. The Swedish Research Council (http://www.vr.se/), Avtals-ID: C0235101, Proj. No: K2013-64X-21464-04-3. The Swedish Cancer Society (http://www.cancerfonden.se/), Contract No: 12 0842. The Cancer Society in Stockholm (http://www.uicc.org/membership/cancer-society-stockholm), Contract No: 121273. The King Gustaf Vth Jubilee Fund (http://www.rahfo.se/Om-Cancer/), Contract No: 124272. The Stockholm County Council (http://sll.se/), Proj No: 20120051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Bennasroune A, 2004, CRIT REV ONCOL HEMAT, V50, P23, DOI 10.1016/j.critrevonc.2003.08.004; Cheng CJ, 2007, MOL CANCER RES, V5, P675, DOI 10.1158/1541-7786.MCR-06-0306; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Daneshmanesh AH, 2012, LEUKEMIA, V26, P1348, DOI 10.1038/leu.2011.362; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Daneshmanesh AH, 2013, LEUKEMIA LYMPHOMA, V54, P843, DOI 10.3109/10428194.2012.731599; Eksioglu-Demiralp E, 2011, CYTOM PART B-CLIN CY, V80B, P1, DOI 10.1002/cyto.b.20553; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; GULLICK WJ, 1991, BRIT J CANCER, V63, P434, DOI 10.1038/bjc.1991.100; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hashempoor T, 2010, IRAN J IMMUNOL, V7, P177, DOI IJIv7i3A5; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hojjat-Farsangi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061167; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Kaucka M, 2011, ACTA PHYSIOL, V203, P351, DOI 10.1111/j.1748-1716.2011.02306.x; Kazemi T, 2008, INT J CANCER, V123, P2113, DOI 10.1002/ijc.23751; Khoury H, 2001, ONCOGENE, V20, P788, DOI 10.1038/sj.onc.1204166; Liu PCC, 2006, CANCER BIOL THER, V5, P657, DOI 10.4161/cbt.5.6.2708; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Liu Y, 2007, MOL ENDOCRINOL, V21, P3050, DOI 10.1210/me.2007-0323; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Memarian A, 2009, LEUKEMIA LYMPHOMA, V50, P2061, DOI 10.3109/10428190903331082; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; PATERSON MC, 1991, CANCER RES, V51, P556; Pillai G, 2005, HISTOPATHOLOGY, V46, P209, DOI 10.1111/j.1365-2559.2005.02081.x; Reddy UR, 1996, ONCOGENE, V13, P1555; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 1987, HUMAN BREAST CANC CO, DOI [10.1126/science.3798106, DOI 10.1126/SCIENCE.3798106.PUBMED:3798106]; Tseng HC, 2011, ANTICANCER RES, V31, P4239; Tseng HC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-48; Widhopf 2nd GF, 2011, 53 AM SOC HEM ASH DE; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]	47	38	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78339	10.1371/journal.pone.0078339	http://dx.doi.org/10.1371/journal.pone.0078339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205204	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300051
J	Nagel, S; Rohr, F; Weber, C; Kier, J; Siemers, F; Kruse, C; Danner, S; Brandenburger, M; Matthiessen, AE				Nagel, Sabine; Rohr, Franziska; Weber, Caroline; Kier, Janina; Siemers, Frank; Kruse, Charli; Danner, Sandra; Brandenburger, Matthias; Matthiessen, Anna Emilia			Multipotent Nestin-Positive Stem Cells Reside in the Stroma of Human Eccrine and Apocrine Sweat Glands and Can Be Propagated Robustly In Vitro	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; PROGENITOR CELLS; GENE-EXPRESSION; GROWTH-FACTORS; SELF-RENEWAL; HFPS CELLS; HAIR; SKIN; DIFFERENTIATION; PLURIPOTENCY	Human skin harbours multiple different stem cell populations. In contrast to the relatively well-characterized niches of epidermal and hair follicle stem cells, the localization and niches of stem cells in other human skin compartments are as yet insufficiently investigated. Previously, we had shown in a pilot study that human sweat gland stroma contains Nestin-positive stem cells. Isolated sweat gland stroma-derived stem cells (SGSCs) proliferated in vitro and expressed Nestin in 80% of the cells. In this study, we were able to determine the precise localization of Nestin-positive cells in both eccrine and apocrine sweat glands of human axillary skin. We established a reproducible isolation procedure and characterized the spontaneous, long-lasting multipotent differentiation capacity of SGSCs. Thereby, a pronounced ectodermal differentiation was observed. Moreover, the secretion of prominent cytokines demonstrated the immunological potential of SGSCs. The comparison to human adult epidermal stem cells (EpiSCs) and bone marrow stem cells (BMSCs) revealed differences in protein expression and differentiation capacity. Furthermore, we found a coexpression of the stem cell markers Nestin and I alpha 6 within SGSCs and human sweat gland stroma. In conclusion the initial results of the pilot study were confirmed, indicating that human sweat glands are a new source of unique stem cells with multilineage differentiation potential, high proliferation capacity and remarkable self renewal. With regard to the easy accessibility of skin tissue biopsies, an autologous application of SGSCs in clinical therapies appears promising.	[Nagel, Sabine; Rohr, Franziska; Weber, Caroline; Kier, Janina; Kruse, Charli; Danner, Sandra; Brandenburger, Matthias; Matthiessen, Anna Emilia] Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany; [Siemers, Frank] Med Univ Lubeck, Dept Plast & Hand Surg, D-23538 Lubeck, Germany	University of Lubeck	Brandenburger, M (corresponding author), Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany.	Matthias.Brandenburger@emb.fraunhofer.de		Schumann, Sandra/0000-0001-5316-6424; Brandenburger, Matthias/0000-0001-8686-2186	European Union, European Regional Development Fund (ERDF)	European Union, European Regional Development Fund (ERDF)	This work was sponsored by the European Union, European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2004, LAB INVEST, V84, P1581, DOI 10.1038/labinvest.3700186; Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Amoh Y, 2004, P NATL ACAD SCI USA, V101, P13291, DOI 10.1073/pnas.0405250101; Amoh Y, 2010, METHODS MOL BIOL, V585, P401, DOI 10.1007/978-1-60761-380-0_28; Amoh Y, 2009, J DERMATOL, V36, P1, DOI 10.1111/j.1346-8138.2008.00578.x; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Biedermann T, 2010, J INVEST DERMATOL, V130, P1996, DOI 10.1038/jid.2010.83; Bouvard C, 2010, ARTERIOSCL THROM VAS, V30, P1569, DOI 10.1161/ATVBAHA.110.209163; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Cowin P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003251; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; Danner S, 2012, J INVEST DERMATOL, V132, P1707, DOI 10.1038/jid.2012.31; Distler JHW, 2003, Q J NUCL MED, V47, P149; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Ernst N, 2010, EXP DERMATOL, V19, P549, DOI 10.1111/j.1600-0625.2009.01041.x; Ersch J, 1999, OBSTET GYNECOL, V94, P753, DOI 10.1016/S0029-7844(99)00379-8; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gho CG, 2004, BRIT J DERMATOL, V150, P860, DOI 10.1111/j.1365-2133.2004.05862.x; Gorjup E, 2009, EUR J CELL BIOL, V88, P409, DOI 10.1016/j.ejcb.2009.02.187; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoffman RM, 2007, EXPERT OPIN BIOL TH, V7, P289, DOI 10.1517/14712598.7.3.289; HOLBROOK KA, 1991, ANN NY ACAD SCI, V642, P167; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Ji KH, 2008, ANN HEMATOL, V87, P431, DOI 10.1007/s00277-008-0470-3; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim DS, 2004, CELL MOL LIFE SCI, V61, P2774, DOI 10.1007/s00018-004-4288-4; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Kolar Z, 2007, VIRCHOWS ARCH, V450, P607, DOI 10.1007/s00428-007-0403-x; Kruse C, 2004, APPL PHYS A-MATER, V79, P1617, DOI 10.1007/s00339-004-2816-6; Kruse C, 2006, EXP DERMATOL, V15, P794, DOI 10.1111/j.1600-0625.2006.00471.x; Larouche Danielle, 2005, Methods Mol Biol, V289, P103; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li H, 2007, CANCER RES, V67, P501, DOI 10.1158/0008-5472.CAN-05-4571; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Mokry J, 2004, STEM CELLS DEV, V13, P658, DOI 10.1089/scd.2004.13.658; Mokry Jaroslav, 2008, Acta Medica (Hradec Kralove), V51, P173; MOLL I, 1992, J INVEST DERMATOL, V98, P777, DOI 10.1111/1523-1747.ep12499950; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Petschnik AE, 2010, BRIT J DERMATOL, V162, P380, DOI 10.1111/j.1365-2133.2009.09512.x; Petschnik AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024944; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontiggia L, 2009, J INVEST DERMATOL, V129, P480, DOI 10.1038/jid.2008.254; PURKIS PE, 1990, J CELL SCI, V97, P39; Rapoport DH, 2009, ANN ANAT, V191, P446, DOI 10.1016/j.aanat.2009.07.002; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rittie L, 2013, AM J PATHOL, V182, P163, DOI 10.1016/j.ajpath.2012.09.019; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Schreder A, 2010, INT J MOL MED, V26, P171, DOI 10.3892/ijmm_00000449; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; Sinha S, 2001, P NATL ACAD SCI USA, V98, P2455, DOI 10.1073/pnas.051633598; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Tiede S, 2009, J INVEST DERMATOL, V129, P2711, DOI 10.1038/jid.2009.148; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yang C, 2009, J AM PODIAT MED ASSN, V99, P489, DOI 10.7547/0990489; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052	77	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78365	10.1371/journal.pone.0078365	http://dx.doi.org/10.1371/journal.pone.0078365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205211	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300054
J	Belevych, AE; Ho, HT; Terentyeva, R; Bonilla, IM; Terentyev, D; Carnes, CA; Gyorke, S; Billman, GE				Belevych, Andriy E.; Ho, Hsiang-Ting; Terentyeva, Radmila; Bonilla, Ingrid M.; Terentyev, Dmitry; Carnes, Cynthia A.; Gyorke, Sandor; Billman, George E.			Dietary Omega-3 Fatty Acids Promote Arrhythmogenic Remodeling of Cellular Ca2+ Handling in a Postinfarction Model of Sudden Cardiac Death	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; VENTRICULAR-FIBRILLATION; EICOSAPENTAENOIC ACID; MYOCARDIAL-ISCHEMIA; FISH CONSUMPTION; CANINE MODEL; TRIGGERED ARRHYTHMIAS; ISOLATED MYOCYTES; CALCIUM SPARKS; IN-VIVO	It has been proposed that dietary omega-3 polyunsaturated fatty acids (n-3 PUFAs) can reduce the risk of ventricular arrhythmias in post-MI patients. Abnormal Ca2+ handling has been implicated in the genesis of post-MI ventricular arrhythmias. Therefore, we tested the hypothesis that dietary n-3 PUFAs alter the vulnerability of ventricular myocytes to cellular arrhythmia by stabilizing intracellular Ca2+ cycling. To test this hypothesis, we used a canine model of post-MI ventricular fibrillation (VF) and assigned the animals to either placebo (1 g/day corn oil) or n-3 PUFAs (1-4 g/day) groups. Using Ca2+ imaging techniques, we examined the intracellular Ca2+ handling in myocytes isolated from post-MI hearts resistant (VF-) and susceptible (VF+) to VF. Frequency of occurrence of diastolic Ca2+ waves (DCWs) in VF+ myocytes from placebo group was significantly higher than in placebo-treated VF- myocytes. n-3 PUFA treatment did not decrease frequency of DCWs in VF+ myocytes. In contrast, VF- myocytes from the n-3 PUFA group had a significantly higher frequency of DCWs than myocytes from the placebo group. In addition, n-3 PUFA treatment increased beat-to-beat alterations in the amplitude of Ca2+ transients (Ca2+ alternans) in VF- myocytes. These n-3 PUFAs effects in VF- myocytes were associated with an increased Ca2+ spark frequency and reduced sarcoplasmic reticulum Ca2+ content, indicative of increased activity of ryanodine receptors. Thus, dietary n-3 PUFAs do not alleviate intracellular Ca2+ cycling remodeling in myocytes isolated from post-MI VF+ hearts. Furthermore, dietary n-3 PUFAs increase vulnerability of ventricular myocytes to cellular arrhythmia in post-MI VF- hearts by destabilizing intracellular Ca2+ handling.	[Belevych, Andriy E.; Ho, Hsiang-Ting; Terentyeva, Radmila; Terentyev, Dmitry; Carnes, Cynthia A.; Gyorke, Sandor; Billman, George E.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Belevych, Andriy E.; Ho, Hsiang-Ting; Terentyeva, Radmila; Terentyev, Dmitry; Carnes, Cynthia A.; Gyorke, Sandor; Billman, George E.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bonilla, Ingrid M.; Carnes, Cynthia A.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Terentyeva, Radmila; Terentyev, Dmitry] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Terentyeva, Radmila; Terentyev, Dmitry] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Ohio State University; Ohio State University; Ohio State University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Belevych, AE (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Andriy.Belevych@osumc.edu	Billman, George E/E-2758-2011; Terentyev, Dmitry/V-2037-2019	Terentyeva, Radmila/0000-0002-0133-3515; Terentyev, Dmitry/0000-0002-9530-7384; Belevych, Andriy/0000-0002-1272-5784	National Institute of Health [HL074045, HL063043, HL089836, HL086700]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089836, R01HL063043, R01HL086700, R01HL074045] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health Grants HL074045 and HL063043 (to Sandor Gyorke), HL089836 (to Cynthia A. Carnes), and HL086700 (to George E. Billman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdukeyum GG, 2008, J NUTR, V138, P1902, DOI 10.1093/jn/138.10.1902; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Belevych AE, 2013, CARDIOVASC RES, V98, P240, DOI 10.1093/cvr/cvt024; Belevych AE, 2012, CIRC RES, V110, P569, DOI 10.1161/CIRCRESAHA.111.260455; Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246; Berecki G, 2007, HEART RHYTHM, V4, P1452, DOI 10.1016/j.hrthm.2007.07.015; BILLMAN GE, 1994, P NATL ACAD SCI USA, V91, P4427, DOI 10.1073/pnas.91.10.4427; BILLMAN GE, 1982, CIRCULATION, V66, P874, DOI 10.1161/01.CIR.66.4.874; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Billman GE, 2012, CIRC-ARRHYTHMIA ELEC, V5, P553, DOI 10.1161/CIRCEP.111.966739; Billman GE, 2010, AM J PHYSIOL-HEART C, V298, pH1219, DOI 10.1152/ajpheart.01065.2009; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Coronel R, 2007, CARDIOVASC RES, V73, P386, DOI 10.1016/j.cardiores.2006.10.006; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; Den Ruijter HM, 2008, CIRCULATION, V117, P536, DOI 10.1161/CIRCULATIONAHA.107.733329; Den Ruijter HM, 2007, CARDIOVASC RES, V73, P316, DOI 10.1016/j.cardiores.2006.06.014; Di Stasi D, 2004, EUR J CLIN PHARMACOL, V60, P183, DOI 10.1007/s00228-004-0758-8; Ferrier GR, 2002, CARDIOVASC RES, V54, P601, DOI 10.1016/S0008-6363(02)00275-4; Harris WS, 2004, CIRCULATION, V110, P1645, DOI 10.1161/01.CIR.0000142292.10048.B2; Honen BN, 2003, J MEMBRANE BIOL, V196, P95, DOI 10.1007/s00232-003-0628-9; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; Leifert WR, 2001, J NUTR BIOCHEM, V12, P365, DOI 10.1016/S0955-2863(01)00151-6; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Negretti N, 2000, J PHYSIOL-LONDON, V523, P367, DOI 10.1111/j.1469-7793.2000.t01-1-00367.x; Niggli E, 2013, BBA-MOL CELL RES, V1833, P866, DOI 10.1016/j.bbamcr.2012.08.016; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Rauch B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00057; Richardson ES, 2011, J CARDIOVASC TRANSL, V4, P42, DOI 10.1007/s12265-010-9243-1; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Rodrigo GC, 1999, J MOL CELL CARDIOL, V31, P733, DOI 10.1006/jmcc.1998.0914; SCHWARTZ PJ, 1984, CIRCULATION, V69, P790, DOI 10.1161/01.CIR.69.4.790; Sridhar A, 2008, AM J PHYSIOL-REG I, V295, pR1463, DOI 10.1152/ajpregu.90583.2008; Swan JS, 2003, CARDIOVASC RES, V60, P337, DOI 10.1016/S0008-6363(03)00545-5; Szentandrassy N, 2007, J PHYSIOL-LONDON, V582, P349, DOI 10.1113/jphysiol.2007.132753; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Xiao YF, 1997, P NATL ACAD SCI USA, V94, P4182, DOI 10.1073/pnas.94.8.4182	40	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78414	10.1371/journal.pone.0078414	http://dx.doi.org/10.1371/journal.pone.0078414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205228	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300154
J	Akiyama, H; Iwahana, Y; Suda, M; Yoshimura, A; Kogai, H; Nagashima, A; Ohtsuka, H; Komiya, Y; Tashiro, F				Akiyama, Hirotada; Iwahana, Yoshimasa; Suda, Mikiya; Yoshimura, Atsunori; Kogai, Hiroyuki; Nagashima, Ai; Ohtsuka, Hiroko; Komiya, Yuko; Tashiro, Fumio			The FBI1/Akirin2 Target Gene, BCAM, Acts as a Suppressive Oncogene	PLOS ONE			English	Article							CELL-ADHESION-MOLECULE; B-CAM; MATRIX METALLOPROTEINASES; EXPRESSION; LAMININ; LUTHERAN; GROWTH; DIFFERENTIATION; GLYCOPROTEIN; INVASION	Basal cell adhesion molecule (BCAM), known to be a splicing variant of Lutheran glycoprotein (LU), is an immunoglobulin superfamily membrane protein that acts as a laminin alpha 5 receptor. The high affinity of BCAM/LU for laminin alpha 5 is thought to contribute to the pathogenesis of sickle red blood cells and to various developmental processes. However, the function of BCAM in carcinogenesis is poorly understood. Based on microarray expression analysis, we found that BCAM was one of the target genes of the oncogenic 14-3-3 beta-FBI1/Akirin2 complex, which acts as a transcriptional repressor and suppresses MAPK phosphatase-1 gene expression. To elucidate the detailed function of BCAM in malignant tumors, we established BCAM-expressing hepatoma K2 cells. These cells lost the malignant characteristics of parental cells, such as anchorage-independent growth, migration, invasion, and tumorigenicity. Moreover, luciferase reporter assays and chromatin immunoprecipitation analysis revealed that the 14-3-3 beta-FBI1/Akirin2 complex bound to the BCAM promoter and repressed transcription. Thus, these data indicate that BCAM is a suppressive oncoprotein, and that FBI1/Akirin2 is involved in tumorigenicity and metastasis of hepatoma through the downregulation of suppressive oncogenes.	[Akiyama, Hirotada; Iwahana, Yoshimasa; Suda, Mikiya; Yoshimura, Atsunori; Kogai, Hiroyuki; Nagashima, Ai; Ohtsuka, Hiroko; Komiya, Yuko; Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 162, Japan	Tokyo University of Science	Akiyama, H (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 162, Japan.	hakiyama@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [70089332, 23701104, 25870775]; Grants-in-Aid for Scientific Research [23501271] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research Grant Numbers 70089332, 23701104, 25870775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2003, DEV BRAIN RES, V140, P45, DOI 10.1016/S0165-3806(02)00574-6; Akiyama H, 2003, J BIOL CHEM, V278, P10752, DOI 10.1074/jbc.M209856200; Bernemann TM, 2000, J CUTAN PATHOL, V27, P108, DOI 10.1034/j.1600-0560.2000.027003108.x; CAMPBELL IG, 1994, CANCER RES, V54, P5761; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; Drewniok C, 2004, ARCH DERMATOL RES, V296, P59, DOI 10.1007/s00403-004-0481-4; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Nemer W, 1998, J BIOL CHEM, V273, P16686; GARINCHESA P, 1994, INT J ONCOL, V5, P1261; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Komiya Y, 2005, MYCOTOXINS, V55, P107; Komiya Y, 2008, J BIOL CHEM, V283, P18753, DOI 10.1074/jbc.M802530200; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Latini FRM, 2013, BLOOD CELL MOL DIS, V50, P161, DOI 10.1016/j.bcmd.2012.10.009; MORIMURA S, 1990, CHEM PHARM BULL, V38, P460, DOI 10.1248/cpb.38.460; Moulson CL, 2001, DEV DYNAM, V222, P101, DOI 10.1002/dvdy.1169; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Planaguma J, 2011, HUM PATHOL, V42, P57, DOI 10.1016/j.humpath.2010.01.025; Schon M, 2000, J INVEST DERMATOL, V115, P1047, DOI 10.1046/j.1523-1747.2000.00189.x; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Suda M, 2013, MYCOTOXINS IN PRESS, V64; Sugiyama A, 2003, CARCINOGENESIS, V24, P1549, DOI 10.1093/carcin/bgg113; Sugiyama A., 2000, Mycotoxins, V50, P83, DOI 10.2520/myco1975.50.83; Sugiyama A, 1999, MYCOTOXINS, V48, P59; TAKAI R, 1995, J BIOCHEM, V118, P1045, DOI 10.1093/jb/118.5.1045; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Yu KH, 2009, J PROTEOME RES, V8, P1565, DOI 10.1021/pr800904z	32	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78716	10.1371/journal.pone.0078716	http://dx.doi.org/10.1371/journal.pone.0078716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223164	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200056
J	Chang, KC; Chang, WC; Chang, Y; Hung, LY; Lai, CH; Yeh, YM; Chou, YW; Chen, CH				Chang, Kung-Chao; Chang, Wei-Chao; Chang, Yao; Hung, Liang-Yi; Lai, Chien-Hsien; Yeh, Yu-Min; Chou, Yu-Wei; Chen, Chung-Hsuan			Ran GTPase-Activating Protein 1 Is a Therapeutic Target in Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							SERUM LACTATE-DEHYDROGENASE; NON-HODGKINS-LYMPHOMA; PROGNOSTIC-FACTOR; CYSTATIN-C; RANGAP1; LEVEL; EXPRESSION; CYCLE; BETA-2-MICROGLOBULIN; DEREGULATION	Lymphoma-specific biomarkers contribute to therapeutic strategies and the study of tumorigenesis. Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoma. However, only 50% of patients experience long-term survival after current treatment; therefore, developing novel therapeutic strategies is warranted. Comparative proteomic analysis of two DLBCL lines with a B-lymphoblastoid cell line (LCL) showed differential expression of Ran GTPase-activating protein 1 (RanGAP1) between them, which was confirmed using immunoblotting. Immunostaining showed that the majority of DLBCLs (92%, 46/50) were RanGAP1(+), while reactive lymphoid hyperplasia (n = 12) was RanGAP1+ predominantly in germinal centers. RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%). Interestingly, serum RanGAP1 level was higher in patients with high-grade BCL (1.71 +/- 2.28 ng/mL, n = 62) than in low-grade BCL (0.75 +/- 2.12 ng/mL, n = 52) and healthy controls (0.55 +/- 1.58 ng/mL, n = 75) (high-grade BCL vs. low-grade BCL, p = 0.002; high-grade BCL vs. control, p < 0.001, Mann-Whitney U test). In vitro, RNA interference of RanGAP1 showed no effect on LCL but enhanced DLBCL cell death (41% vs. 60%; p = 0.035) and cell-cycle arrest (G0/G1: 39% vs. 49%, G2/M: 19.0% vs. 7.5%; p = 0.030) along with decreased expression of TPX2 and Aurora kinases, the central regulators of mitotic cell division. Furthermore, ON 01910. Na (Estybon), a multikinase inhibitor induced cell death, mitotic cell arrest, and hyperphosphorylation of RanGAP1 in DLBCL cell lines but no effects in normal B and T cells. Therefore, RanGAP1 is a promising marker and therapeutic target for aggressive B-cell lymphoma, especially DLBCL.	[Chang, Kung-Chao; Chou, Yu-Wei] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Pathol, Tainan, Taiwan; [Chang, Wei-Chao; Chen, Chung-Hsuan] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Yao] Natl Hlth Res Inst, Div Infect Dis, Tainan, Taiwan; [Hung, Liang-Yi; Lai, Chien-Hsien] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Yeh, Yu-Min] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Chang, KC (corresponding author), Natl Cheng Kung Univ & Hosp, Coll Med, Dept Pathol, Tainan, Taiwan.	changkc@mail.ncku.edu.tw; winschen@gate.sinica.edu.tw	Chen, Chung-Hsuan/F-7940-2012; Hung, Liang-Yi/AAG-4174-2019; Chang, Yao/B-2653-2010; Lai, Chien-Hsien/ABD-9379-2020	, Liang-Yi/0000-0002-7284-2608	National Cheng Kung University Hospital [NCKUH-98-02004]; National Science Council, Taiwan [NSC100-2320-B-006-005-MY3];  [DOH101-TD-C-111-003]	National Cheng Kung University Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); 	This work was supported by grants NCKUH-98-02004 from National Cheng Kung University Hospital, NSC100-2320-B-006-005-MY3 from the National Science Council, Taiwan, and DOH101-TD-C-111-003 (To establish centers of excellence for cancer research in Taiwan) to KC Chang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2005, IN VIVO, V19, P439; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; BRONDYK WH, 1995, MOL CELL BIOL, V15, P1137; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Chang KC, 2004, LEUKEMIA LYMPHOMA, V45, P1375, DOI 10.1080/10428194042000198849; Chang KC, 2011, CANCER SCI, V102, P275, DOI 10.1111/j.1349-7006.2010.01765.x; Chang KC, 2009, AM J CLIN PATHOL, V132, P50, DOI 10.1309/AJCPBDFR5L5UOAUZ; Chang Wei-Chao, 2010, Int J Proteomics, V2010, P726968, DOI 10.1155/2010/726968; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chapman CM, 2012, CLIN CANCER RES, V18, P1979, DOI 10.1158/1078-0432.CCR-11-2113; Cimerman N, 2000, CLIN CHIM ACTA, V300, P83, DOI 10.1016/S0009-8981(00)00298-9; Coiffier B, 2003, SEMIN ONCOL, V30, P21, DOI 10.1053/sonc.2003.50021; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DEGREGORI J, 1994, GENE DEV, V8, P265, DOI 10.1101/gad.8.3.265; Feng WQ, 1999, J CELL SCI, V112, P339; GEHAN EA, 1965, BIOMETRIKA, V52, P650, DOI 10.1093/biomet/52.3-4.650; Goto H, 2005, J CANCER RES CLIN, V131, P73, DOI 10.1007/s00432-004-0600-9; Goto N, 2006, EUR J HAEMATOL, V77, P217, DOI 10.1111/j.1600-0609.2006.00702.x; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; HAGBERG H, 1983, CANCER, V51, P2220, DOI 10.1002/1097-0142(19830615)51:12<2220::AID-CNCR2820511212>3.0.CO;2-A; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kim JA, 2011, LEUKEMIA LYMPHOMA, V52, P205, DOI 10.3109/10428194.2010.542261; Konno R, 2000, CLIN CANCER RES, V6, P3576; Krejsek J, 1997, CLIN RHEUMATOL, V16, P149, DOI 10.1007/BF02247843; Maresca TJ, 2009, CURR BIOL, V19, P1210, DOI 10.1016/j.cub.2009.05.061; MCADAM B, 1993, MED ONCOL TUMOR PHAR, V10, P95; Mulaomerovic A, 2007, CANCER LETT, V248, P192, DOI 10.1016/j.canlet.2006.07.004; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Niitsu N, 1999, LEUKEMIA, V13, P1434, DOI 10.1038/sj.leu.2401502; Niitsu N, 2001, BLOOD, V97, P1202, DOI 10.1182/blood.V97.5.1202; Niitsu N, 2002, LEUKEMIA RES, V26, P241, DOI 10.1016/S0145-2126(01)00122-9; Oussenko IA, 2011, CANCER RES, V71, P4968, DOI 10.1158/0008-5472.CAN-10-1603; Paulli M, 1999, HUM PATHOL, V30, P178, DOI 10.1016/S0046-8177(99)90273-3; Pham LV, 2008, J BIOL CHEM, V283, P5081, DOI 10.1074/jbc.M706307200; Rentzos M, 2005, J NEUROL SCI, V228, P129, DOI 10.1016/j.jns.2004.11.001; Rodrigo-Peiris T, 2011, J EXP BOT, V62, P2705, DOI 10.1093/jxb/erq448; Sanchez-Beato M, 2003, BLOOD, V101, P1220, DOI 10.1182/blood-2002-07-2009; SARRIS AH, 1995, LEUKEMIA LYMPHOMA, V17, P473, DOI 10.3109/10428199509056860; SCHNEIDER RJ, 1980, CANCER, V46, P139, DOI 10.1002/1097-0142(19800701)46:1<139::AID-CNCR2820460122>3.0.CO;2-8; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Swerdlow SH, 2008, WHO CLASSIFICATION T; Terol MJ, 2003, ANN ONCOL, V14, P467, DOI 10.1093/annonc/mdg057; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Tsou JH, 2011, J PATHOL, V225, P243, DOI 10.1002/path.2934; Yeh YM, 2010, HISTOPATHOLOGY, V57, P785, DOI 10.1111/j.1365-2559.2010.03709.x	51	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79863	10.1371/journal.pone.0079863	http://dx.doi.org/10.1371/journal.pone.0079863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223200	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200093
J	Coovadia, YM; Mahomed, S; Pillay, M; Werner, L; Mlisana, K				Coovadia, Yacoob Mahomed; Mahomed, Sharana; Pillay, Melendhran; Werner, Lise; Mlisana, Koleka			Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a High Prevalence TB-HIV Region	PLOS ONE			English	Article							LINE PROBE ASSAY; RISK-FACTORS; MONORESISTANT TUBERCULOSIS; DRUG-RESISTANCE; UNITED-KINGDOM; WESTERN CAPE; MUTATIONS	Setting: The dual epidemics of HIV-TB including MDR-TB are major contributors to high morbidity and mortality rates in South Africa. Rifampicin (RIF) resistance is regarded as a proxy for MDR-TB. Currently available molecular assays have the advantage of rapidly detecting resistant strains of MTB, but the GeneXpert does not detect isoniazid (INH) resistance and the GenoTypeMTBDRplus(LPA) assay may underestimate resistance to INH. Increasing proportions of rifampicin mono-resistance resistance (RMR) have recently been reported from South Africa and other countries. Objective: This laboratory based study was conducted at NHLS TB Laboratory, Durban, which is the reference laboratory for culture and susceptibility testing in KwaZulu-Natal. We retrospectively determined, for the period 2007 to 2009, the proportion of RMR amongst Mycobacterium tuberculosis (MTB) isolates, that were tested for both RIF and INH, using the gold standard of culture based phenotypic drug susceptibility testing (DST). Gender and age were also analysed to identify possible risk factors for RMR. Design: MTB culture positive sputum samples from 16,748 patients were analysed for susceptibility to RIF and INH during the period 2007 to 2009. RMR was defined as MTB resistant to RIF and susceptible to INH. For the purposes of this study, only the first specimen from each patient was included in the analysis. Results: RMR was observed throughout the study period. The proportion of RMR varied from a low of 7.3% to a high of 10.0% [overall 8.8%]. Overall, males had a 42% increased odds of being RMR as compared to females. In comparison to the 50 plus age group, RMR was 37% more likely to occur in the 25-29 year age category. Conclusion: We report higher proportions of RMR ranging from 7.3% to 10% [overall 8.8%] than previously reported in the literature. To avoid misclassification of RMR, detected by the GeneXpert, as MDR-TB, culture based phenotypic DST must be performed on a second specimen, as recommended by the SA NDOH TB guidelines as well as WHO. We suggest that two sputum samples should be obtained at the first visit. The second sputum sample should be stored at 4 degrees C. The latter sample is then readily available for performing additional DST (phenotypic or genotypic) for 2nd lines drugs, resulting in a decreased waiting period for DST results to become available.	[Coovadia, Yacoob Mahomed; Mahomed, Sharana; Pillay, Melendhran; Mlisana, Koleka] Univ KwaZulu Natal, Natl Hlth Lab Serv, Durban, South Africa; [Coovadia, Yacoob Mahomed; Mahomed, Sharana; Mlisana, Koleka] Univ KwaZulu Natal, Dept Med Microbiol, Durban, South Africa; [Werner, Lise] UKZN, CAPRISA, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Coovadia, YM (corresponding author), Univ KwaZulu Natal, Natl Hlth Lab Serv, Durban, South Africa.	coovadia@ukzn.ac.za	Mlisana, Koleka/N-6204-2013	Mlisana, Koleka/0000-0002-8436-3268				Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; Austin JF, 2004, INT J TUBERC LUNG D, V8, P435; AZIZ MA, 2004, ANTITUBERCULOSIS DRU; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Bishai WR, 1996, NEW ENGL J MED, V334, P1573, DOI 10.1056/NEJM199606133342404; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; Dramowski A, 2012, INT J TUBERC LUNG D, V16, P76, DOI 10.5588/ijtld.11.0360; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Jaramillo E., 2008, GUIDELINES PROGRAMMA; Jarrin I, GUIDELINES PROGRAMMA; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; NOLAN CM, 1995, AM J RESP CRIT CARE, V152, P1067, DOI 10.1164/ajrccm.152.3.7663785; Organization WH, 2008, MOL LINE PROBE ASSAY; Organization WH, 2012, GLOBAL TUBERCULOSIS; ORMEROD LP, 1990, THORAX, V45, P403, DOI 10.1136/thx.45.5.403; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Pietzka AT, 2009, J ANTIMICROB CHEMOTH, V63, P1121, DOI 10.1093/jac/dkp124; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ridzon R, 1998, AM J RESP CRIT CARE, V157, P1881, DOI 10.1164/ajrccm.157.6.9712009; Sam IC, 2006, EMERG INFECT DIS, V12, P752, DOI 10.3201/eid1205.041339; Sanders M, 2006, INT J TUBERC LUNG D, V10, P178; Sandman L, 1999, AM J RESP CRIT CARE, V159, P468, DOI 10.1164/ajrccm.159.2.9805097; South African Department of Health, 2011, MAN DRUG RES TUB POL; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Traore H, 2000, INT J TUBERC LUNG D, V4, P481; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; WELTMAN AC, 1995, LANCET, V345, P1513, DOI 10.1016/S0140-6736(95)91074-3; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	33	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77712	10.1371/journal.pone.0077712	http://dx.doi.org/10.1371/journal.pone.0077712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223122	Green Published, gold			2022-12-27	WOS:000326656200014
J	Glusman, G; Caballero, J; Robinson, M; Kutlu, B; Hood, L				Glusman, Gustavo; Caballero, Juan; Robinson, Max; Kutlu, Burak; Hood, Leroy			Optimal Scaling of Digital Transcriptomes	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; DIFFERENTIAL EXPRESSION; NORMALIZATION; QUANTILE; MPSS	Deep sequencing of transcriptomes has become an indispensable tool for biology, enabling expression levels for thousands of genes to be compared across multiple samples. Since transcript counts scale with sequencing depth, counts from different samples must be normalized to a common scale prior to comparison. We analyzed fifteen existing and novel algorithms for normalizing transcript counts, and evaluated the effectiveness of the resulting normalizations. For this purpose we defined two novel and mutually independent metrics: (1) the number of "uniform'' genes (genes whose normalized expression levels have a sufficiently low coefficient of variation), and (2) low Spearman correlation between normalized expression profiles of gene pairs. We also define four novel algorithms, one of which explicitly maximizes the number of uniform genes, and compared the performance of all fifteen algorithms. The two most commonly used methods (scaling to a fixed total value, or equalizing the expression of certain 'housekeeping' genes) yielded particularly poor results, surpassed even by normalization based on randomly selected gene sets. Conversely, seven of the algorithms approached what appears to be optimal normalization. Three of these algorithms rely on the identification of "ubiquitous'' genes: genes expressed in all the samples studied, but never at very high or very low levels. We demonstrate that these include a "core'' of genes expressed in many tissues in a mutually consistent pattern, which is suitable for use as an internal normalization guide. The new methods yield robustly normalized expression values, which is a prerequisite for the identification of differentially expressed and tissue-specific genes as potential biomarkers.	[Glusman, Gustavo; Robinson, Max; Kutlu, Burak; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Caballero, Juan] Univ Autonoma Queretaro, Fac Ingn, Queretaro, Mexico	Institute for Systems Biology (ISB); Universidad Autonoma de Queretaro	Glusman, G (corresponding author), Inst Syst Biol, Seattle, WA USA.	Gustavo@SystemsBiology.org	Robinson, Max/AAS-5856-2021	Robinson, Max/0000-0003-0878-114X; Glusman, Gustavo/0000-0001-8060-5955; Caballero Perez, Juan/0000-0002-6160-3644	Edgewood Contracting Division, US Army [W911SR-09-C-0062]	Edgewood Contracting Division, US Army	This work was supported by contract W911SR-09-C-0062 from Edgewood Contracting Division, US Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dillies MA, 2012, BRIEF BIOINFORM; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hartemink AJ, 2001, SPIE BIOS 2001 SAN J; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kadota K, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-5; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qiu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-124; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; Sirbu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013822; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; Wu ZJ, 2010, GENOME RES, V20, P1730, DOI 10.1101/gr.108217.110; Yang L, 2009, BIOINFORMATICS, V25, P2244, DOI 10.1093/bioinformatics/btp369; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290; Zhou LH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-75; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77885	10.1371/journal.pone.0077885	http://dx.doi.org/10.1371/journal.pone.0077885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223126	gold, Green Published			2022-12-27	WOS:000326656200018
J	Hashiba, M; Ono, M; Hyogo, H; Ikeda, Y; Masuda, K; Yoshioka, R; Ishikawa, Y; Nagata, Y; Munekage, K; Ochi, T; Hirose, A; Nozaki-Fujimura, Y; Noguchi, S; Okamoto, N; Chayama, K; Suganuma, N; Saibara, T				Hashiba, Motoi; Ono, Masafumi; Hyogo, Hideyuki; Ikeda, Yukio; Masuda, Kosei; Yoshioka, Reiko; Ishikawa, Yoichi; Nagata, Yuri; Munekage, Kensuke; Ochi, Tsunehiro; Hirose, Akira; Nozaki-Fujimura, Yasuko; Noguchi, Shuhei; Okamoto, Nobuto; Chayama, Kazuaki; Suganuma, Narufumi; Saibara, Toshiji			Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE VARIABILITY; MONOCYTE ADHESION; OXIDATIVE STRESS; STEATOHEPATITIS; RISK; HYPERINSULINEMIA; HYPERGLYCEMIA; PROGRESSION; SEVERITY	Patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) often have metabolic disorders including insulin resistance and type 2 diabetes mellitus (T2DM). We clarified the predictive factors in glucose metabolism for progression of hepatic fibrosis in patients with NAFLD by the 75-g oral glucose tolerance test (75gOGTT) and a continuous glucose monitoring system (CGMS). One hundred sixty-nine patients (68 female and 101 male patients) with biopsy-proven NAFLD with performance with 75gOGTT were enrolled and divided into four groups according to the stage of hepatic fibrosis (F0-3). The proportion of patients with T2DM significantly gradually increased, HbA1c and the homeostasis model assessment of insulin resistance were significantly elevated, and 1,5-anhydroglucitol (1,5-AG) was remarkably decreased with the progression of fibrosis. In the 75gOGTT, both plasma glucose and insulin secretion were remarkably increased with the progression of fibrosis. The only factor significantly associated with advanced fibrosis was 1,5-AG (P = 0.008) as determined by multivariate logistic regression analysis. We next evaluated the changes in blood glucose during 24 hours by monitoring with the CGMS to confirm the relationship between glycemic variability and progression of fibrosis. Variability of median glucose, standard deviation of median glucose (P = 0.0022), maximum blood glucose (P = 0.0019), and Delta Min-max blood glucose (P = 0.0029) were remarkably higher in severe fibrosis than in mild fibrosis. Conclusion: Hyperinsulinemia and hyperglycemia, especially glycemic variability, are important predictive factors in glucose impairment for the progression of hepatic fibrosis in NAFLD.	[Hashiba, Motoi; Ono, Masafumi; Masuda, Kosei; Yoshioka, Reiko; Ishikawa, Yoichi; Nagata, Yuri; Munekage, Kensuke; Ochi, Tsunehiro; Hirose, Akira; Nozaki-Fujimura, Yasuko; Okamoto, Nobuto; Saibara, Toshiji] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Hyogo, Hideyuki; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima, Japan; [Ikeda, Yukio] Kochi Mem Hosp, Ctr Diabet, Kochi, Japan; [Noguchi, Shuhei; Suganuma, Narufumi] Kochi Med Sch, Dept Environm Med, Kochi, Japan	Kochi University; Hiroshima University; Kochi University	Ono, M (corresponding author), Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan.	onom@kochi-u.ac.jp	Suganuma, Narufumi/E-4805-2012	Suganuma, Narufumi/0000-0003-1610-6216; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Education, Culture, Sports, Science and Technology, Japan [23590979]; Grants-in-Aid for Scientific Research [25670369] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) 2011 Grant # 23590979, Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2007, NUTR REV, V65, pS57, DOI [10.1111/j.1753-4887.2007.tb00329.x, 10.1301/nr.2007.jun.S57-S63]; Bialasiewicz P, 2009, DIABETIC MED, V26, P339, DOI 10.1111/j.1464-5491.2009.02684.x; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hirsch IB, 2005, J DIABETES COMPLICAT, V19, P178, DOI 10.1016/j.jdiacomp.2004.10.001; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Jin WL, 2011, DIABETOLOGIA, V54, P1921, DOI 10.1007/s00125-011-2141-5; Kaji K, 2008, INT J MOL MED, V22, P801, DOI 10.3892/ijmm_00000088; Kilpatrick ES, 2010, DIABETIC MED, V27, P868, DOI 10.1111/j.1464-5491.2010.02929.x; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Kimura Y, 2011, J GASTROEN HEPATOL, V26, P517, DOI 10.1111/j.1440-1746.2010.06567.x; Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; Koschinsky T, 2001, DIABETES-METAB RES, V17, P113, DOI 10.1002/dmrr.188; Manchanayake J, 2011, J GASTROEN HEPATOL, V26, P510, DOI 10.1111/j.1440-1746.2010.06528.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Monnier L, 2008, DIABETES CARE, V31, pS150, DOI 10.2337/dc08-s241; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Node K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-23; Ono M, 2006, J GASTROENTEROL, V41, P725, DOI 10.1007/s00535-006-1876-0; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Pisarchik AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046582; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Reddy SK, 2012, HEPATOLOGY, V55, P1809, DOI 10.1002/hep.25536; Sonsuz A, 2002, AM J GASTROENTEROL, V97, P495; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Watada H, 2007, DIABETES RES CLIN PR, V77, pS58, DOI 10.1016/j.diabres.2007.01.034; WHALAN DJ, 1975, MED J AUSTRALIA, V1, P491, DOI 10.5694/j.1326-5377.1975.tb111524.x; Yoneda M, 2011, J GASTROENTEROL, V46, P1300, DOI 10.1007/s00535-011-0436-4	37	35	38	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e76161	10.1371/journal.pone.0076161	http://dx.doi.org/10.1371/journal.pone.0076161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223115	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200007
J	van Nierop, M; Janssens, M; Bruggeman, R; Cahn, W; de Haan, L; Kahn, RS; Meijer, CJ; Myin-Germeys, I; van Os, J; Wiersma, D				van Nierop, Martine; Janssens, Mayke; Bruggeman, Richard; Cahn, Wiepke; de Haan, Lieuwe; Kahn, Rene S.; Meijer, Carin J.; Myin-Germeys, Inez; van Os, Jim; Wiersma, Durk		Genetic Risk OUtcome Psychosis GRP	Evidence That Transition from Health to Psychotic Disorder Can Be Traced to Semi-Ubiquitous Environmental Effects Operating against Background Genetic Risk	PLOS ONE			English	Article							FAMILIAL LIABILITY; CHILDHOOD TRAUMA; PREMORBID ADJUSTMENT; NEGATIVE SYMPTOMS; CANNABIS USE; SCHIZOPHRENIA; METAANALYSIS; URBANICITY; EXPERIENCES; POPULATION	Background: In order to assess the importance of environmental and genetic risk on transition from health to psychotic disorder, a prospective study of individuals at average (n=462) and high genetic risk (n=810) was conducted. Method: A three-year cohort study examined the rate of transition to psychotic disorder. Binary measures indexing environmental exposure (combining urban birth, cannabis use, ethnicity and childhood trauma) and proxy genetic risk (high-risk sibling status) were used to model transition. Results: The majority of high-risk siblings (68%) and healthy comparison subjects (60%) had been exposed to one or more environmental risks. The risk of transition in siblings (n=9, 1.1%) was higher than the risk in healthy comparison subjects (n=2, 0.4%; ORadj=2.2,95% CI: 5-10.3). All transitions (100%) were associated with environmental exposure, compared to 65% of non-transitions (p=0.014), with the greatest effects for childhood trauma (ORadj=34.4,95% CI: 4.4-267.4), cannabis use (OR=4.1,95% CI: 1.1, 15.4), minority ethnic group (OR=3.8,95% CI: 1.2,12.8) and urban birth (OR=3.7,95% CI: 0.9,15.4). The proportion of transitions in the population attributable to environmental and genetic risk ranged from 28% for minority ethnic group, 45% for urban birth, 57% for cannabis use, 86% for childhood trauma, and 50% for high-risk sibling status. Nine out of 11 transitions (82%) were exposed to both genetic and environmental risk, compared to only 43% of non-transitions (p=0.03). Conclusion: Environmental risk associated with transition to psychotic disorder is semi-ubiquitous regardless of genetic high risk status. Careful prospective documentation suggests most transitions can be attributed to powerful environmental effects that become detectable when analysed against elevated background genetic risk, indicating gene-environment interaction.	[van Nierop, Martine; Janssens, Mayke; Myin-Germeys, Inez; van Os, Jim] Maastricht Univ Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands; [Bruggeman, Richard; Wiersma, Durk] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Cahn, Wiepke; Kahn, Rene S.] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [de Haan, Lieuwe; Meijer, Carin J.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England	Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands.	j.vanos@maastrichtuniversity.nl	van Os, Jim/C-2113-2014; Myin-Germeys, Inez/L-5106-2014; van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Myin Germeys, Inez/HIR-3364-2022	van Os, Jim/0000-0002-7245-1586; Myin Germeys, Inez/0000-0002-3731-4930; van Nierop, Martine/0000-0003-2734-0550; Bruggeman, Richard/0000-0002-3238-8471	Dutch Health Research Council (ZON-MW) [10-000-1002]; Site Amsterdam: Academic Psychiatric Centre AMC; Site Amsterdam: Ingeest; Site Amsterdam: Arkin; Site Amsterdam: Dijk en Duin; Site Amsterdam: Rivierduinen; Site Amsterdam: Erasmus MC; Site Amsterdam: GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht; Site Utrecht: Altrecht; Site Utrecht: Symfora; Site Utrecht: Meerkanten; Site Utrecht: Riagg Amersfoort; Site Utrecht: Delta; Site Groningen: University Medical Centre Groningen; Site Groningen: Lentis; Site Groningen: GGZ Friesland; Site Groningen: GGZ Drenthe; Site Groningen: Dimence; Site Groningen: Mediant; Site Groningen: GGZ De Grote Rivieren; Site Groningen: Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Centre; Site Maastricht: GGZ Eindhoven; Site Maastricht: GGZ Midden-Brabant; Site Maastricht: GGZ Oost-Brabant; Site Maastricht: GGZ Noord- Midden Limburg; Site Maastricht: Mondriaan Zorggroep; Site Maastricht: Prins Clauscentrum Sittard; Site Maastricht: RIAGG Roermond; Site Maastricht: Universitair Centrum Sint-Jozef Kortenberg; Site Maastricht: CAPRI University of Antwerp; Site Maastricht: PC Ziekeren Sint-Truiden; Site Maastricht: PZ Sancta Maria Sint-Truiden; Site Maastricht: GGZ Overpelt; Site Maastricht: OPZ Rekem; Jansen-Cilag; Eli Lilly and Company; Astra-Zeneca; Lundbeck; European Community [HEALTH-F2-2009-241909]	Dutch Health Research Council (ZON-MW)(Netherlands Organization for Health Research and Development); Site Amsterdam: Academic Psychiatric Centre AMC; Site Amsterdam: Ingeest; Site Amsterdam: Arkin; Site Amsterdam: Dijk en Duin; Site Amsterdam: Rivierduinen; Site Amsterdam: Erasmus MC; Site Amsterdam: GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht; Site Utrecht: Altrecht; Site Utrecht: Symfora; Site Utrecht: Meerkanten; Site Utrecht: Riagg Amersfoort; Site Utrecht: Delta; Site Groningen: University Medical Centre Groningen; Site Groningen: Lentis; Site Groningen: GGZ Friesland; Site Groningen: GGZ Drenthe; Site Groningen: Dimence; Site Groningen: Mediant; Site Groningen: GGZ De Grote Rivieren; Site Groningen: Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Centre; Site Maastricht: GGZ Eindhoven; Site Maastricht: GGZ Midden-Brabant; Site Maastricht: GGZ Oost-Brabant; Site Maastricht: GGZ Noord- Midden Limburg; Site Maastricht: Mondriaan Zorggroep; Site Maastricht: Prins Clauscentrum Sittard; Site Maastricht: RIAGG Roermond; Site Maastricht: Universitair Centrum Sint-Jozef Kortenberg; Site Maastricht: CAPRI University of Antwerp; Site Maastricht: PC Ziekeren Sint-Truiden; Site Maastricht: PZ Sancta Maria Sint-Truiden; Site Maastricht: GGZ Overpelt; Site Maastricht: OPZ Rekem; Jansen-Cilag; Eli Lilly and Company(Eli Lilly); Astra-Zeneca(AstraZeneca); Lundbeck(Lundbeck Corporation); European Community(European Commission)	This work was supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002) and matching funds from participating universities and mental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk en Duin, Rivierduinen, Erasmus MC, GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical Centre Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Centre, GGZ Eindhoven, GGZ Midden-Brabant, GGZ Oost-Brabant, GGZ Noord- Midden Limburg, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem). The analyses were supported by unrestricted grants from Jansen-Cilag, Eli Lilly and Company, Astra-Zeneca and Lundbeck. The research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Brill N, 2008, SCHIZOPHRENIA BULL, V34, P981, DOI 10.1093/schbul/sbm128; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Cutajar MC, 2010, ARCH GEN PSYCHIAT, V67, P1114, DOI 10.1001/archgenpsychiatry.2010.147; Elklit A, 2011, SCHIZOPHRENIA BULL, V37, P1305, DOI 10.1093/schbul/sbq048; Fusar-Poli P, 2013, ACTA PSYCHIAT SCAND, V127, P248, DOI 10.1111/acps.12028; Fusar-Poli P, 2014, SCHIZOPHRENIA BULL, V40, P120, DOI 10.1093/schbul/sbs136; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Johnstone EC, 2005, BRIT J PSYCHIAT, V186, P18, DOI 10.1192/bjp.186.1.18; Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132; Kahn RS, JAMA IN PRESS; Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911; Kirkbride JB, 2012, EPIGENOMICS-UK, V4, P303, DOI [10.2217/EPI.12.20, 10.2217/epi.12.20]; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Marcelis M, 1999, PSYCHOL MED, V29, P1197, DOI 10.1017/S0033291799008983; Matheson SL, 2011, SCHIZOPHR RES, V133, P133, DOI 10.1016/j.schres.2011.09.020; McGorry P, 2013, LANCET, V381, P343, DOI 10.1016/S0140-6736(12)61268-9; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; Musshoff F, 2006, THER DRUG MONIT, V28, P155, DOI 10.1097/01.ftd.0000197091.07807.22; NIMH Genetics Initiative, 1992, FAM INT GEN STUD FIG; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Purcell SM, 2009, NATURE; Read J, 2012, BRIT J PSYCHIAT, V200, P89, DOI 10.1192/bjp.bp.111.096727; Russell AJ, 1997, AM J PSYCHIAT, V154, P635; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; SELTEN JPCJ, 1993, COMPR PSYCHIAT, V34, P192, DOI 10.1016/0010-440X(93)90047-8; SMALL NE, 1984, BIOL PSYCHIAT, V19, P203; StataCorp, 2011, STAT STAT SOFTW REL, P173; The WHOQOL Group, 1998, PSYCHOL MED, V28, P551; van Nierop M, 2012, SCHIZOPHRENIA BULL, V38, P231, DOI 10.1093/schbul/sbr129; van Os J, 2003, AM J PSYCHIAT, V160, P477, DOI 10.1176/appi.ajp.160.3.477; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vassos E, 2012, SCHIZOPHRENIA BULL, V38, P1118, DOI 10.1093/schbul/sbs096; Velthorst E, 2012, COGN NEUROPSYCHIATRY; Weiser M, 2007, BRIT J PSYCHIAT, V191, P320, DOI 10.1192/bjp.bp.106.031328; Welch KA, 2011, BRIT J PSYCHIAT, V199, P386, DOI 10.1192/bjp.bp.110.090175; Wicks S, 2005, AM J PSYCHIAT, V162, P1652, DOI 10.1176/appi.ajp.162.9.1652; Wing J. K. C., 1974, MEASUREMENT CLASSIFI; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; World Health Organization, 1990, COMP INT DIAGN INT C	56	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e76690	10.1371/journal.pone.0076690	http://dx.doi.org/10.1371/journal.pone.0076690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223116	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200008
J	Welvaert, M; Rosseel, Y				Welvaert, Marijke; Rosseel, Yves			On the Definition of Signal-To-Noise Ratio and Contrast-To-Noise Ratio for fMRI Data	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; HEMODYNAMIC-RESPONSE FUNCTION; PHYSIOLOGICAL NOISE; FUNCTIONAL CONNECTIVITY; SPATIAL ICA; RESOLUTION; MOTION; MRI; SENSITIVITY; ENTROPY	Signal-to-noise ratio, the ratio between signal and noise, is a quantity that has been well established for MRI data but is still subject of ongoing debate and confusion when it comes to fMRI data. fMRI data are characterised by small activation fluctuations in a background of noise. Depending on how the signal of interest and the noise are identified, signal-to-noise ratio for fMRI data is reported by using many different definitions. Since each definition comes with a different scale, interpreting and comparing signal-to-noise ratio values for fMRI data can be a very challenging job. In this paper, we provide an overview of existing definitions. Further, the relationship with activation detection power is investigated. Reference tables and conversion formulae are provided to facilitate comparability between fMRI studies.	[Welvaert, Marijke; Rosseel, Yves] Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium	Ghent University	Welvaert, M (corresponding author), Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium.	Marijke.Welvaert@Ugent.be	Welvaert, Marijke/GOE-6151-2022; Welvaert, Marijke/K-8486-2013	Welvaert, Marijke/0000-0002-0802-8134; Rosseel, Yves/0000-0002-4129-4477				[Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Beckett A, 2012, NEUROIMAGE, V63, P1623, DOI 10.1016/j.neuroimage.2012.07.066; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bungert A, 2012, NEUROIMAGE, V59, P2167, DOI 10.1016/j.neuroimage.2011.10.013; Cabella BCT, 2009, PHYSICA A, V388, P41, DOI 10.1016/j.physa.2008.09.029; Calhoun VD, 2005, NEUROIMAGE, V25, P527, DOI 10.1016/j.neuroimage.2004.12.012; Casanova R, 2008, NEUROIMAGE, V40, P1606, DOI 10.1016/j.neuroimage.2008.01.011; Chen HF, 2004, MAGN RESON IMAGING, V22, P827, DOI 10.1016/j.mri.2003.12.003; Churchill NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031147; Conijn MMA, 2012, NEUROIMAGE, V59, P950, DOI 10.1016/j.neuroimage.2011.08.059; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; De Maziere PA, 2007, J MAGN RESON, V185, P138, DOI 10.1016/j.jmr.2006.12.001; den Dekker AJ, 2009, IEEE T MED IMAGING, V28, P287, DOI 10.1109/TMI.2008.2004427; Driver ID, 2012, NEUROIMAGE, V63, P1178, DOI 10.1016/j.neuroimage.2012.08.045; Duyn JH, 2012, NEUROIMAGE, V62, P1241, DOI 10.1016/j.neuroimage.2011.10.065; EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hahn AD, 2012, NEUROIMAGE, V59, P2231, DOI 10.1016/j.neuroimage.2011.09.082; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Hughes BL, 2012, NEUROIMAGE, V61, P889, DOI 10.1016/j.neuroimage.2012.03.011; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; Ing A, 2012, NEUROIMAGE, V63, P1487, DOI 10.1016/j.neuroimage.2012.07.042; Janssens T, 2012, NEUROIMAGE, V62, P1529, DOI 10.1016/j.neuroimage.2012.05.028; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Koush Y, 2012, NEUROIMAGE, V59, P478, DOI 10.1016/j.neuroimage.2011.07.076; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Lee S, 2011, J AM STAT ASSOC, V106, P1009, DOI 10.1198/jasa.2011.tm10332; Lin QH, 2010, HUM BRAIN MAPP, V31, P1076, DOI 10.1002/hbm.20919; Lindquist MA, 2008, HUM BRAIN MAPP, V29, P1276, DOI 10.1002/hbm.20475; Lopes R, 2012, NEUROIMAGE, V60, P1867, DOI 10.1016/j.neuroimage.2011.12.083; Marrelec G, 2003, HUM BRAIN MAPP, V19, P1, DOI 10.1002/hbm.10100; Nan FY, 1999, IEEE T MED IMAGING, V18, P320, DOI 10.1109/42.768841; Newton AT, 2012, NEUROIMAGE, V59, P2511, DOI 10.1016/j.neuroimage.2011.08.096; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Penny WD, 2012, NEUROIMAGE, V59, P319, DOI 10.1016/j.neuroimage.2011.07.039; Posse S, 2012, NEUROIMAGE, V61, P115, DOI 10.1016/j.neuroimage.2012.02.059; Redpath TW, 1998, BRIT J RADIOL, V71, P704, DOI 10.1259/bjr.71.847.9771379; Ryali S, 2011, NEUROIMAGE, V54, P807, DOI 10.1016/j.neuroimage.2010.09.052; Sarkka S, 2012, NEUROIMAGE, V60, P1517, DOI 10.1016/j.neuroimage.2012.01.067; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Scholvinck ML, 2012, NEUROIMAGE, V59, P2700, DOI 10.1016/j.neuroimage.2011.10.066; Shen YJ, 2012, NEUROIMAGE, V59, P3450, DOI 10.1016/j.neuroimage.2011.10.097; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Sturzbecher MJ, 2009, PHYS MED BIOL, V54, P161, DOI 10.1088/0031-9155/54/1/011; Suckling J, 2004, HUM BRAIN MAPP, V22, P193, DOI 10.1002/hbm.20027; Tabelow K, 2009, J NEUROSCI METH, V178, P357, DOI 10.1016/j.jneumeth.2008.12.011; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Valente G, 2009, MAGN RESON IMAGING, V27, P1110, DOI 10.1016/j.mri.2009.05.036; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent T, 2010, IEEE T MED IMAGING, V29, P1059, DOI 10.1109/TMI.2010.2042064; Wald LL, 2012, NEUROIMAGE, V62, P1221, DOI 10.1016/j.neuroimage.2012.02.077; Yang Z, 2012, NEUROIMAGE, V63, P403, DOI 10.1016/j.neuroimage.2012.06.060; Zhang CM, 2010, J MULTIVARIATE ANAL, V101, P1574, DOI 10.1016/j.jmva.2010.02.009; Zotev V, 2012, NEUROIMAGE, V63, P698, DOI 10.1016/j.neuroimage.2012.07.031	61	254	255	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77089	10.1371/journal.pone.0077089	http://dx.doi.org/10.1371/journal.pone.0077089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223118	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200010
J	Guo, XG; Ding, J; Qi, Y; Jia, N; Chu, SL; Lin, JX; Su, JZ; Peng, F; Niu, WQ				Guo, Xiaogang; Ding, Jie; Qi, Yue; Jia, Nan; Chu, Shaoli; Lin, Jinxiu; Su, Jinzi; Peng, Feng; Niu, Wenquan			Left Radial Access Is Preferable to Right Radial Access for the Diagnostic or Interventional Coronary Procedures: A Meta-Analysis Involving 22 Randomized Clinical Trials and 10287 Patients	PLOS ONE			English	Article							TRANSRADIAL APPROACH; CATHETERIZATION; ANGIOGRAPHY	Objective: The transradial approach has been used extensively for both diagnostic and interventional coronary procedures; however, there is no universal consensus hitherto on the optimal choice of radial access from either the left or the right artery. We therefore sought to meta-analyze available randomized clinical trials to compare the left with the right radial access for the diagnostic or interventional coronary procedures. Methods and Results: Four electronic databases including the PubMed, EMBASE, Wanfang, and CNKI were searched up to April 2013. In total, there were 22 qualified randomized trials involving 5317 and 4970 patients assigned to the left and the right radial accesses, respectively. Data were extracted independently by two investigators. Analyses of the full data set indicated significant reductions in fluoroscopy time (seconds) (weighted mean difference; 95% confidence interval; P: -36.18; -53.28 to -218.53; <0.0005) and contrast use (mL) (-2.88; -5.41 to -0.34; 0.026) in patients with the left radial access compared to those with the right radial access, and there was strong evidence of heterogeneity but low probability of publication bias. The failure rate of radial access from the left was relatively lower than that from the right (odds ratio: 0.83; 95% confidence interval: 0.68-1.01; P = 0.064). Further in meta-regression analyses, body mass index was found to be a potential source of heterogeneity for both fluoroscopy time (regression coefficient: 35.85; P = 0.025) and catheter number (regression coefficient: 0.35; P = 0.018). Conclusions: Our findings demonstrate that left radial access is preferable to right radial access in terms of fluoroscopy time and contrast use for the diagnostic or interventional coronary procedures. The import of this study lies in its great shock to the concept of convenient radial access from the right artery.	[Guo, Xiaogang; Ding, Jie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Qi, Yue] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing An Zhen Hosp, Beijing, Peoples R China; [Jia, Nan; Chu, Shaoli] Shanghai Jiao Tong Univ, Dept Hypertens, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Jia, Nan; Chu, Shaoli; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China; [Lin, Jinxiu; Su, Jinzi; Peng, Feng] Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Zhejiang University; Capital Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fujian Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Su, JZ (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Peoples R China.	sujinzi1@163.com; pengfeng@medmail.com.cn; niuwenquan_shcn@163.com	Qi, Yue/HGT-8175-2022	Su, Jinzi/0000-0003-4103-9174	Shanghai Rising Star Program [11QA1405500]; Beijing New Star Program [Z111107054511072]; Science Fund of Shanghai Jiao Tong University School of Medicine [11XJ21034]; National Natural Science Foundation of China [81000109]	Shanghai Rising Star Program; Beijing New Star Program; Science Fund of Shanghai Jiao Tong University School of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Rising Star Program (11QA1405500), the Beijing New Star Program (Z111107054511072), the Science Fund of Shanghai Jiao Tong University School of Medicine (11XJ21034), and the National Natural Science Foundation of China (81000109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondi-Zoccai G, 2013, INT J CARDIOL, V166, P621, DOI 10.1016/j.ijcard.2011.11.100; Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41; Chen C, 2007, CHINESE J INTERVENTI, V4, P460; Chen L, 2008, CHINESE J POSTGRADUA, V31, P10; Cox N, 2004, AM J CARDIOL, V94, P1174, DOI 10.1016/j.amjcard.2004.07.088; Dehghani P, 2009, JACC-CARDIOVASC INTE, V2, P1057, DOI 10.1016/j.jcin.2009.07.014; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dominici M, 2013, HEART, V99, P480, DOI 10.1136/heartjnl-2012-302895; Dominici M, 2012, J INTERV CARDIOL, V25, P203, DOI 10.1111/j.1540-8183.2011.00689.x; Fernandez-Portales J, 2006, REV ESP CARDIOL, V59, P1071, DOI 10.1157/13093986; Freixa X, 2012, CATHETER CARDIO INTE, V80, P267, DOI 10.1002/ccd.23474; He J, 2010, CHINESE J COAL IND M, V13, P1103; Jiang S, 2011, CHINESE J INTERVENTI, V19, P83; Kanei Y, 2011, AM J CARDIOL, V107, P195, DOI 10.1016/j.amjcard.2010.08.065; Kawashima O, 2004, CATHETER CARDIO INTE, V61, P333, DOI 10.1002/ccd.10769; Li XM, 2012, CARDIOVASC THER, V30, P273, DOI 10.1111/j.1755-5922.2011.00299.x; Louvard Y, 2001, CATHETER CARDIO INTE, V52, P181, DOI 10.1002/1522-726X(200102)52:2<181::AID-CCD1044>3.0.CO;2-G; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nie B, 2012, CHINA MED, V7, P913; Norgaz T, 2012, CATHETER CARDIO INTE, V80, P260, DOI 10.1002/ccd.23463; Pacchioni A, 2012, INTO JO CARDIOL; Pan Y, 2006, ZHEJIANG PRACTICAL M, V11, P243; Pelliccia F, 2012, AM J CARDIOL, V110, P771, DOI 10.1016/j.amjcard.2012.05.005; Piccini JP, 2009, EUR HEART J, V30, P1245, DOI 10.1093/eurheartj/ehp100; Santas E, 2009, REV ESP CARDIOL, V62, P482, DOI 10.1016/S0300-8932(09)71028-0; Sciahbasi A, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.003; [夏福纯 Xia Fuchun], 2010, [中国循环杂志, Chinese Circulation Journal], V25, P416; Yao ZhuHua, 2008, Zhongguo Shiyong Neike Zazhi / Chinese Journal of Practical Internal Medicine, V28, P571; Zhou Y, 2012, J ELECTROCARDIOL, V31, P427; 吴万里, 2010, [广东医学, Guangdong Medical Journal], V31, P1320	30	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78499	10.1371/journal.pone.0078499	http://dx.doi.org/10.1371/journal.pone.0078499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223815	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400030
J	Gotthard, G; Hiblot, J; Gonzalez, D; Elias, M; Chabriere, E				Gotthard, Guillaume; Hiblot, Julien; Gonzalez, Daniel; Elias, Mikael; Chabriere, Eric			Structural and Enzymatic Characterization of the Phosphotriesterase OPHC2 from Pseudomonas pseudoalcaligenes	PLOS ONE			English	Article							ORGANOPHOSPHORUS HYDROLASE OPHC2; METHYL PARATHION HYDROLASE; CATALYTIC-ACTIVITY; EVOLUTION; MECHANISMS; PESTICIDES; SYSTEM; FISH; SITE	Background: Organophosphates (OPs) are neurotoxic compounds for which current methods of elimination are unsatisfactory; thus bio-remediation is considered as a promising alternative. Here we provide the structural and enzymatic characterization of the recently identified enzyme isolated from Pseudomonas pseudoalcaligenes dubbed OPHC2. OPHC2 belongs to the metallo-beta-lactamase superfamily and exhibits an unusual thermal resistance and some OP degrading abilities. Principal findings: The X-ray structure of OPHC2 has been solved at 2.1 A resolution. The enzyme is roughly globular exhibiting a alpha beta/beta alpha topology typical of the metallo-beta-lactamase superfamily. Several structural determinants, such as an extended dimerization surface and an intramolecular disulfide bridge, common features in thermostable enzymes, are consistent with its high T-m (97.8 degrees C). Additionally, we provide the enzymatic characterization of OPHC2 against a wide range of OPs, esters and lactones. Significance: OPHC2 possesses a broad substrate activity spectrum, since it hydrolyzes various phosphotriesters, esters, and a lactone. Because of its organophosphorus hydrolase activity, and given its intrinsic thermostability, OPHC2 is an interesting candidate for the development of an OPs bio-decontaminant. Its X-ray structure shed light on its active site, and provides key information for the understanding of the substrate binding mode and catalysis.	[Gotthard, Guillaume; Hiblot, Julien; Gonzalez, Daniel; Chabriere, Eric] Univ Mediterranee, URMITE UMR CNRS IRD 6236, IFR48, Fac Med & Pharm, Marseille, France; [Elias, Mikael] Weizmann Inst Sci, IL-76100 Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Weizmann Institute of Science	Elias, M (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.	mikael.elias@weizmann.ac.il; eric.chabriere@univmed.fr	Hiblot, Julien/AAA-4452-2020; Elias, Mikael/AAH-9385-2021	Hiblot, Julien/0000-0002-7883-8079; Elias, Mikael/0000-0003-0406-7539	DGA, France [REI. 2009 34 0045]; DGA; APHM; IEF Marie Curie program [252836]	DGA, France; DGA; APHM; IEF Marie Curie program	This work was granted by DGA, France (REI. 2009 34 0045. J.H. and G.G. are PhD students granted by DGA. D.G. is a PhD student granted by APHM. M.E. is a fellow supported by the IEF Marie Curie program (grant No. 252836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Afriat-Jurnou L, 2012, BIOCHEMISTRY-US, V51, P6047, DOI 10.1021/bi300694t; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Aravind L, 1999, In Silico Biol, V1, P69; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Bigley AN, 2012, BIOCH BIOPHYS ACTA; Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004; Cheng TC, 1999, CHEM-BIOL INTERACT, V119, P455, DOI 10.1016/S0009-2797(99)00058-7; Chu XY, 2006, PROTEIN EXPRES PURIF, V49, P9, DOI 10.1016/j.pep.2006.03.013; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Del Vecchio P, 2009, EXTREMOPHILES, V13, P461, DOI 10.1007/s00792-009-0231-9; DELLUSGUR E, 2013, J MOL BIOL; Dong YJ, 2005, J MOL BIOL, V353, P655, DOI 10.1016/j.jmb.2005.08.057; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goldsmith M, 2012, CHEM BIOL, V19, P456, DOI 10.1016/j.chembiol.2012.01.017; Gotthard G, 2013, ACTA CRYSTALLOGR F, V69, P73, DOI 10.1107/S174430911205049X; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gupta RC, 2009, HANDBOOK OF TOXICOLOGY OF CHEMICAL WARFARE AGENTS, P1; Hiblot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047028; Hiblot J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00779; Jackson CJ, 2006, BIOCHEM J, V397, P501, DOI 10.1042/BJ20060276; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim MH, 2005, P NATL ACAD SCI USA, V102, P17606, DOI 10.1073/pnas.0504996102; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LeJeune KE, 1998, NATURE, V395, P27, DOI 10.1038/25634; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Monias BL, 1928, J INFECT DIS, V43, P330, DOI 10.1093/infdis/43.4.330; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OMBURO GA, 1992, J BIOL CHEM, V267, P13278; Pakala SB, 2007, APPL MICROBIOL BIOT, V73, P1452, DOI 10.1007/s00253-006-0595-z; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Raushel FM, 2002, CURR OPIN MICROBIOL, V5, P288, DOI 10.1016/S1369-5274(02)00314-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sapozhnikova Y, 2005, CHEMOSPHERE, V60, P196, DOI 10.1016/j.chemosphere.2004.12.061; Sapozhnikova Y, 2004, CHEMOSPHERE, V55, P797, DOI 10.1016/j.chemosphere.2003.12.009; Schrodinger L., 2020, PYMOL; Shen YJ, 2010, BIODEGRADATION, V21, P785, DOI 10.1007/s10532-010-9343-2; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Su YD, 2011, APPL BIOCHEM BIOTECH, V165, P989, DOI 10.1007/s12010-011-9314-z; Toth-Petroczy A, 2013, MOL BIOL EVOL, V30, P761, DOI 10.1093/molbev/mst003; Velankar S, 2012, NUCLEIC ACIDS RES, V40, pD445, DOI 10.1093/nar/gkr998; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vyas NK, 2010, BIOCHEMISTRY-US, V49, P547, DOI 10.1021/bi9011989; Wilkins MR, 1999, METH MOL B, V112, P531	54	35	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77995	10.1371/journal.pone.0077995	http://dx.doi.org/10.1371/journal.pone.0077995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223749	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400026
J	Huang, KH; Wang, CH; Lee, KY; Lin, SM; Lin, CH; Kuo, HP				Huang, Kuo-Hsiung; Wang, Chun-Hua; Lee, Kang-Yun; Lin, Shu-Min; Lin, Chien-Huang; Kuo, Han-Pin			NF-kappa B Repressing Factor Inhibits Chemokine Synthesis by Peripheral Blood Mononuclear Cells and Alveolar Macrophages in Active Pulmonary Tuberculosis	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; MYCOBACTERIUM-TUBERCULOSIS; CXC CHEMOKINES; IFN-GAMMA; BASAL REPRESSION; NITRIC-OXIDE; IP-10; IL-8; SECRETION; INFLAMMATION	NF-kappa B repressing factor (NRF) is a transcriptional silencer implicated in the basal silencing of specific NF-kappa B targeting genes, including iNOS, IFN-beta and IL-8/CXCL8. IP-10/CXCL10 and IL-8/CXCL8 are involved in neutrophil and lymphocyte recruitment against M. tuberculosis (MTb) and disease progression of pulmonary tuberculosis (TB). Alveolar macrophages (AM) and peripheral blood mononuclear cells (PBMC) were used to study the regulatory role of NRF in pulmonary TB. AM and PBMC were purified from 19 TB patients and 15 normal subjects. To study the underlying mechanism, PBMC were exposed to heated TB bacilli. The regulation role of NRF in IP-10/CXCL10 and IL-8/CXCL8 was determined by NRF knock-down or overexpression. NRF binding capabilities in promoter sites were measured by chromatin immunoprecipitation (ChIP) assay. The levels of IP-10/CXCL10, IL-8/CXCL8 and NRF were significantly higher in AM and PBMC in patients with active TB. NRF played an inhibitory role in IP-10/CXCL10 and IL-8/CXCL8 inductions. We delineate the role of NRF in pulmonary TB, which inhibits the expressions of IP-10/CXCL10 and IL-8/CXCL8 in AM and PBMC of patients with high bacterial load. NRF may serve as an endogenous repressor to prevent robust increase in IP-10/CXCL10 and IL-8/CXCL8 when TB bacterial load is high.	[Huang, Kuo-Hsiung; Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Chun-Hua; Lee, Kang-Yun; Lin, Shu-Min; Kuo, Han-Pin] Chang Gung Mem Hosp, Pulm Med Res Ctr, Taipei 10591, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital	Lin, CH (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	chlin@tmu.edu.tw; q8828@ms11.hinet.net	Wang, Chun-Hua/C-1488-2016; Wang, Chun-Hua/V-9861-2019	Wang, Chun-Hua/0000-0002-3514-9353; Lin, Chien-Huang/0000-0002-0916-8737	National Science Council, Taiwan [NSC97-2314-B-182A-095]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Taiwan (NSC97-2314-B-182A-095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; Chou PC, 2012, INT J TUBERC LUNG D, V16, P1674, DOI 10.5588/ijtld.11.0672; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; FRIEDLAND JS, 1992, EUR J IMMUNOL, V22, P1373, DOI 10.1002/eji.1830220607; Gangur V, 1998, FASEB J, V12, P705, DOI 10.1096/fasebj.12.9.705; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gupta R, 2004, SEMIN RESP CRIT CARE, V25, P245, DOI 10.1055/s-2004-829520; Ho SC, 2009, J IMMUNOL, V183, P411, DOI 10.4049/jimmunol.0803729; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; Keane MP, 1997, J IMMUNOL, V159, P1437; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1474, DOI 10.1164/ajrccm.155.4.9105097; LARSEN CG, 1995, J IMMUNOL, V155, P2151; Law KF, 1996, AM J RESP CRIT CARE, V153, P1377, DOI 10.1164/ajrccm.153.4.8616569; Lee KY, 2012, EUR RESPIR J, V40, P863, DOI 10.1183/09031936.00146811; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Matsuoka S, 2004, CLIN IMAG, V28, P119, DOI 10.1016/S0899-7071(03)00148-7; Murray JF, 2004, AM J RESP CRIT CARE, V169, P1181, DOI 10.1164/rccm.200402-140OE; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Nolan A, 2013, INT J TUBERC LUNG D, V17, P922, DOI 10.5588/ijtld.12.0610; Nourbakhsh M, 1999, EMBO J, V18, P6415, DOI 10.1093/emboj/18.22.6415; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; O'Kane CM, 2007, J IMMUNOL, V178, P3767, DOI 10.4049/jimmunol.178.6.3767; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; Riedel DD, 1997, INFECT IMMUN, V65, P4620, DOI 10.1128/IAI.65.11.4620-4623.1997; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Sauty A, 1999, J IMMUNOL, V162, P3549; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Tang NLS, 2009, CLIN CHIM ACTA, V406, P98, DOI 10.1016/j.cca.2009.06.006; Toossi Z, 1997, J IMMUNOL, V159, P4109; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Wang CH, 1998, EUR RESPIR J, V11, P809, DOI 10.1183/09031936.98.11040809; Wang XW, 2006, P NATL ACAD SCI USA, V103, P4204, DOI 10.1073/pnas.0507044103; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702	48	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77789	10.1371/journal.pone.0077789	http://dx.doi.org/10.1371/journal.pone.0077789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223729	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400016
J	Moriya, K; Nagatoshi, K; Noriyasu, Y; Okamura, T; Takamitsu, E; Suzuki, T; Utsumi, T				Moriya, Koko; Nagatoshi, Kei; Noriyasu, Yoshimi; Okamura, Tsuyoshi; Takamitsu, Emi; Suzuki, Takashi; Utsumi, Toshihiko			Protein N-Myristoylation Plays a Critical Role in the Endoplasmic Reticulum Morphological Change Induced by Overexpression of Protein Lunapark, an Integral Membrane Protein of the Endoplasmic Reticulum	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CYTOCHROME B(5) REDUCTASE; MYRISTIC ACID; OUTER MITOCHONDRIAL; ER; IDENTIFICATION; REQUIRES; MYRISTYLATION; TERMINUS; SEQUENCE	N-myristoylation of eukaryotic cellular proteins has been recognized as a modification that occurs mainly on cytoplasmic proteins. In this study, we examined the membrane localization, membrane integration, and intracellular localization of four recently identified human N-myristoylated proteins with predicted transmembrane domains. As a result, it was found that protein Lunapark, the human ortholog of yeast protein Lnp1p that has recently been found to be involved in network formation of the endoplasmic reticulum (ER), is an N-myristoylated polytopic integral membrane protein. Analysis of tumor necrosis factor-fusion proteins with each of the two putative transmembrane domains and their flanking regions of protein Lunapark revealed that transmembrane domain 1 and 2 functioned as type II signal anchor sequence and stop transfer sequence, respectively, and together generated a double-spanning integral membrane protein with an N-/C-terminal cytoplasmic orientation. Immunofluorescence staining of HEK293T cells transfected with a cDNA encoding protein Lunapark tagged with FLAG-tag at its C-terminus revealed that overexpressed protein Lunapark localized mainly to the peripheral ER and induced the formation of large polygonal tubular structures. Morphological changes in the ER induced by overexpressed protein Lunapark were significantly inhibited by the inhibition of protein N-myristoylation by means of replacing Gly2 with Ala. These results indicated that protein N-myristoylation plays a critical role in the ER morphological change induced by overexpression of protein Lunapark.	[Moriya, Koko; Nagatoshi, Kei; Noriyasu, Yoshimi; Okamura, Tsuyoshi; Takamitsu, Emi; Utsumi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Utsumi, Toshihiko] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan; [Suzuki, Takashi] Shimadzu Co Ltd, Clin & Biotechnol Business Unit, Kyoto, Japan	Yamaguchi University; Yamaguchi University; Shimadzu Corporation	Utsumi, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan.	utsumi@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23580136]; YU "Pump-Priming Program'' for Fostering Research Activities) from Yamaguchi University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); YU "Pump-Priming Program'' for Fostering Research Activities) from Yamaguchi University	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 23580136) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to TU). This work was also supported in part by a research grant (The YU "Pump-Priming Program'' for Fostering Research Activities) from Yamaguchi University (to TU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Beauchamp E, 2007, BIOCHIMIE, V89, P1553, DOI 10.1016/j.biochi.2007.07.001; Beauchamp E, 2009, BIOCHIMIE, V91, P1411, DOI 10.1016/j.biochi.2009.07.014; Bitar M, 2013, J MOL GRAPH MODEL, V39, P29, DOI 10.1016/j.jmgm.2012.10.004; BORGESE N, 1990, BIOCHEM J, V266, P341, DOI 10.1042/bj2660341; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Burnaevskiy N, 2013, NATURE, V496, P106, DOI 10.1038/nature12004; Chen S, 2013, CURR OPIN CELL BIOL, V25, P1; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Colombo S, 2005, J CELL BIOL, V168, P735, DOI 10.1083/jcb.200407082; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Ezanno H, 2012, LIPIDS, V47, P117, DOI 10.1007/s11745-011-3638-x; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; GRIPON P, 1995, VIROLOGY, V213, P292, DOI 10.1006/viro.1995.0002; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Ishisaka R, 1999, J BIOCHEM-TOKYO, V126, P413, DOI 10.1093/oxfordjournals.jbchem.a022466; Lambert C, 2001, J BIOL CHEM, V276, P22265, DOI 10.1074/jbc.M100956200; Le Seyec J, 1999, J VIROL, V73, P2052, DOI 10.1128/JVI.73.3.2052-2057.1999; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; OSTAPCHUK P, 1994, EMBO J, V13, P1048, DOI 10.1002/j.1460-2075.1994.tb06353.x; OZOLS J, 1984, J BIOL CHEM, V259, P3349; PERSING DH, 1987, J VIROL, V61, P1672, DOI 10.1128/JVI.61.5.1672-1677.1987; PRANGE R, 1991, J VIROL, V65, P3919, DOI 10.1128/JVI.65.7.3919-3923.1991; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Sakurai N, 2007, ANAL BIOCHEM, V362, P236, DOI 10.1016/j.ab.2006.12.030; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; SPIEGEL AM, 1991, TRENDS BIOCHEM SCI, V16, P338, DOI 10.1016/0968-0004(91)90139-M; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Suzuki T, 2006, PROTEOMICS, V6, P4486, DOI 10.1002/pmic.200600126; Suzuki T, 2010, PROTEOMICS, V10, P1780, DOI 10.1002/pmic.200900783; Utsumi T, 2005, FEBS J, V272, P472, DOI 10.1111/j.1742-4658.2004.04487.x; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wright Megan H, 2010, J Chem Biol, V3, P19, DOI 10.1007/s12154-009-0032-8; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	50	40	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78235	10.1371/journal.pone.0078235	http://dx.doi.org/10.1371/journal.pone.0078235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223779	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400042
J	Shehzad, SA; Alsaedi, A; Hayat, T; Alhuthali, MS				Shehzad, Sabir Ali; Alsaedi, Ahmed; Hayat, Tasawar; Alhuthali, M. Shahab			Three-Dimensional Flow of an Oldroyd-B Fluid with Variable Thermal Conductivity and Heat Generation/Absorption	PLOS ONE			English	Article							STAGNATION-POINT FLOW; BOUNDARY-LAYER-FLOW; STRETCHING SHEET; MICROPOLAR FLUID; MIXED CONVECTION; HELICAL FLOWS; POROUS-MEDIUM; RADIATION	This paper looks at the series solutions of three dimensional boundary layer flow. An Oldroyd-B fluid with variable thermal conductivity is considered. The flow is induced due to stretching of a surface. Analysis has been carried out in the presence of heat generation/absorption. Homotopy analysis is implemented in developing the series solutions to the governing flow and energy equations. Graphs are presented and discussed for various parameters of interest. Comparison of present study with the existing limiting solution is shown and examined.	[Shehzad, Sabir Ali; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Alsaedi, Ahmed; Hayat, Tasawar; Alhuthali, M. Shahab] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21413, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Shehzad, SA (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	ali_qau@yahoo.com	Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Shehzad, Sabir Ali/J-3885-2014; Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013	Alsaedi, Ahmed/0000-0003-3452-8922	Deanship of Scientific Research (DSR); King Abdulaziz University; Jeddah [10-130/1433HiCi]	Deanship of Scientific Research (DSR); King Abdulaziz University; Jeddah	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah under grant no. (10-130/1433HiCi). The authors, therefore, acknowledge with thanks DSR technical and financial support. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel PD, 2007, COMPUT MATH APPL, V54, P920, DOI 10.1016/j.camwa.2006.12.066; Bararnia H, 2012, CURR SCI INDIA, V103, P169; Bhattacharyya K, 2011, INT COMMUN HEAT MASS, V38, P917, DOI 10.1016/j.icheatmasstransfer.2011.04.020; Bhattacharyya K, 2011, INT J HEAT MASS TRAN, V54, P308, DOI 10.1016/j.ijheatmasstransfer.2010.09.041; Chen CH, 2010, INT J HEAT MASS TRAN, V53, P4264, DOI 10.1016/j.ijheatmasstransfer.2010.05.053; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Hayat T, 2012, NUCL ENG DES, V243, P15, DOI 10.1016/j.nucengdes.2011.11.005; Hayat T, 2011, ARAB J SCI ENG, V36, P1113, DOI 10.1007/s13369-011-0066-4; Hayat T, 2011, INT J NUMER METH FL, V67, P1418, DOI 10.1002/fld.2424; Hayat T, 2012, INT J CHEM REACT ENG, V10, DOI 10.1515/1542-6580.2655; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Jamil M, 2012, THEOR APPL MECH LETT, V2, DOI 10.1063/2.1201201; Kazem S, 2012, COMMUN NUMER ANAL, V2012; Li CR, 2012, COMMUN NONLINEAR SCI, V17, P5026, DOI 10.1016/j.cnsns.2012.04.012; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Liu YQ, 2011, COMPUT MATH APPL, V61, P443, DOI 10.1016/j.camwa.2010.11.021; Makinde OD, 2010, INT J THERM SCI, V49, P1813, DOI 10.1016/j.ijthermalsci.2010.05.015; Mukhopadhyay S, 2009, INT J HEAT MASS TRAN, V52, P3261, DOI 10.1016/j.ijheatmasstransfer.2008.12.029; Nofal T.A., 2011, APPL MATH SCI, V5, P2603; Qi D, 2009, CHINESE PHYS LETT, V26; Qi HT, 2009, APPL MATH MODEL, V33, P4184, DOI 10.1016/j.apm.2009.03.002; Rashidi MM, 2010, NONLINEAR ANAL-MODEL, V15, P83, DOI 10.15388/NA.2010.15.1.14366; Sahoo B, 2011, COMPUT MATH APPL, V61, P1442, DOI 10.1016/j.camwa.2011.01.017; Sajid M, 2010, CAN J PHYS, V88, P635, DOI 10.1139/P10-049; Si XY, 2011, APPL MATH MECH-ENGL, V32, P859, DOI 10.1007/s10483-011-1465-6; Tong DK, 2009, J NON-NEWTON FLUID, V156, P75, DOI 10.1016/j.jnnfm.2008.07.004; Vosughi H, 2011, MATH METHOD APPL SCI, V34, P1243, DOI 10.1002/mma.1436; Yao BH, 2009, COMMUN NONLINEAR SCI, V14, P3320, DOI 10.1016/j.cnsns.2009.01.014; Zheng LC, 2012, NONLINEAR ANAL-REAL, V13, P513, DOI 10.1016/j.nonrwa.2011.02.016; Zheng LC, 2011, COMMUN NONLINEAR SCI, V16, P731, DOI 10.1016/j.cnsns.2010.05.022	30	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78240	10.1371/journal.pone.0078240	http://dx.doi.org/10.1371/journal.pone.0078240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223780	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400043
J	Cha, JH; Bae, SH; Kim, HL; Park, NR; Choi, ES; Jung, ES; Choi, JY; Yoon, SK				Cha, Jung Hoon; Bae, Si Hyun; Kim, Hye Lim; Park, Na Ri; Choi, Eun Suk; Jung, Eun Sun; Choi, Jong Young; Yoon, Seung Kew			Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis	PLOS ONE			English	Article							HEPATIC-FIBROSIS; C57BL/KSJ-DB/DB MICE; INSULIN-RESISTANCE; COLON-CANCER; FACTOR-BETA; SUPPLEMENTATION; ANGIOGENESIS; ASSOCIATION; DISEASE; RISK	Purpose: Recent studies have revealed that branched-chain amino acids (BCAA) reduce the development of hepatocellular carcinoma (HCC) in patients with obesity and hepatitis C virus infection by improving insulin resistance (IR). The aim of this study was to examine the anti-cancer and anti-fibrotic effects of BCAA on the development of diethylnitrosamine (DEN)induced HCC and liver cirrhosis in a rat model. Methods: Male SD rats received weekly intraperitoneal injections of DEN (50 mg/kg of body weight) for 16 weeks to induce HCC. They were fed a diet containing 3% casein, 3% or 6% BCAA for 13 weeks beginning 6 weeks after DEN administration. DEN was used to induce HCC through stepwise development from cirrhosis to HCC. The effect of BCAA was evaluated in tumor tissues by histopathologic analyses, reverse transcription-polymerase chain reaction, and Western blotting. Results: The mean area and number of dysplastic nodules (DNs) and tumors in the casein group tended to be larger than those in the BCAA group 16 weeks after DEN administration. The mean fibrotic area in the BCAA group was smaller than that in the casein group. The BCAA group showed decreased mRNA levels for markers of fibrosis, angiogenesis, and apoptosis inhibition. Compared with the casein group, the BCAA group had lower levels of a-smooth muscle actin, vascular endothelial growth factor, p-b-catenin, p-p38 mitogen-activated protein kinase, proliferating cell nuclear antigen, and caspase-3 protein expression, as well as a higher level of cleaved caspase-3 protein expression. Conclusions: BCAA supplementation of the diet ameliorated liver fibrosis and HCC development in a DEN-induced rat model of HCC with liver cirrhosis, but not in the IR model. These results provide a rationale for anti-fibrosis and chemoprevention using BCAA treatment for HCC with liver cirrhosis, as well as decreasing the ammonia level.	[Cha, Jung Hoon; Bae, Si Hyun; Kim, Hye Lim; Park, Na Ri; Choi, Eun Suk; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Catholic Univ Liver Res Ctr, Seoul, South Korea; [Cha, Jung Hoon; Bae, Si Hyun; Kim, Hye Lim; Park, Na Ri; Choi, Eun Suk; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Jung, Eun Sun] Catholic Univ Korea, Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Bae, SH (corresponding author), Catholic Univ Korea, Catholic Univ Liver Res Ctr, Seoul, South Korea.	baesh@catholic.ac.kr			Samil Pharm. Co., Ltd., Korea	Samil Pharm. Co., Ltd., Korea	This study was supported by research funds from the Samil Pharm. Co., Ltd., Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; BUTTERWORTH RF, 1987, NEUROCHEM PATHOL, V6, P1, DOI 10.1007/BF02833598; CZAJA MJ, 1989, J CELL BIOL, V108, P2477, DOI 10.1083/jcb.108.6.2477; Donadon V, 2008, WORLD J GASTROENTERO, V14, P5695, DOI 10.3748/wjg.14.5695; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Giavazzi R, 1999, Forum (Genova), V9, P261; Hagiwara A, 2011, J CELL PHYSL; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heindryckx F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-219; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holecek M, 2010, NUTRITION, V26, P482, DOI 10.1016/j.nut.2009.06.027; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Iwasa J, 2010, CANCER SCI, V101, P460, DOI 10.1111/j.1349-7006.2009.01402.x; Kawaguchi T, 2008, INT J MOL MED, V22, P105; Kawaguchi T, 2007, LIVER INT, V27, P1287, DOI 10.1111/j.1478-3231.2007.01559.x; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Lai MS, 2006, HEPATOLOGY, V43, P1295, DOI 10.1002/hep.21208; Marchesini G, 2003, GASTROENTEROLOGY, V124, P1792, DOI 10.1016/S0016-5085(03)00323-8; Moriwaki H, 2004, BIOCHEM BIOPH RES CO, V313, P405, DOI 10.1016/j.bbrc.2003.07.016; Murata K, 2007, CANCER RES, V67, P3263, DOI 10.1158/0008-5472.CAN-06-3739; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Nair S, 2002, HEPATOLOGY, V36, P150, DOI 10.1053/jhep.2002.33713; Nakanishi C, 2010, TOHOKU J EXP MED, V221, P151, DOI 10.1620/tjem.221.151; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Nie QH, 2002, WORLD J GASTROENTERO, V8, P282; Park ST, 2010, CANCER CHEMOTH PHARM, V65, P1029, DOI 10.1007/s00280-009-1108-4; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schiel R, 2006, METHOD FIND EXP CLIN, V28, P169, DOI 10.1358/mf.2006.28.3.985230; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; Shimizu M, 2009, CLIN CANCER RES, V15, P3068, DOI 10.1158/1078-0432.CCR-08-2093; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Yoshiji H, 2009, J GASTROENTEROL, V44, P483, DOI 10.1007/s00535-009-0031-0; Zhou XW, 1996, INT J BIOCHEM CELL B, V28, P787, DOI 10.1016/1357-2725(96)00019-2	42	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77899	10.1371/journal.pone.0077899	http://dx.doi.org/10.1371/journal.pone.0077899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223741	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300014
J	Cordina-Duverger, E; Truong, T; Anger, A; Sanchez, M; Arveux, P; Kerbrat, P; Guenel, P				Cordina-Duverger, Emilie; Truong, Therese; Anger, Antoinette; Sanchez, Marie; Arveux, Patrick; Kerbrat, Pierre; Guenel, Pascal			Risk of Breast Cancer by Type of Menopausal Hormone Therapy: a Case-Control Study among Post-Menopausal Women in France	PLOS ONE			English	Article							REPLACEMENT THERAPY; ENDOMETRIAL CARCINOMA; DIFFERENT REGIMENS; ESTROGEN; PROGESTINS; PROGESTERONE; MORTALITY	Background: There is extensive epidemiological evidence that menopausal hormone therapy (MHT) increases breast cancer risk, particularly combinations of estrogen and progestagen (EP). We investigated the effects of the specific formulations and types of therapies used by French women. Progestagen constituents, regimen (continuous or sequential treatment by the progestagen), and time interval between onset of menopause and start of MHT were examined. Methods: We conducted a population-based case-control study in France in 1555 menopausal women (739 cases and 816 controls). Detailed information on MHT use was obtained during in-person interviews. Odds ratios and 95% confidence interval adjusted for breast cancer risk factors were calculated. Results: We found that breast cancer risk differed by type of progestagen among current users of EP therapies. No increased risk was apparent among EP therapy users treated with natural micronized progesterone. Among users of EP therapy containing a synthetic progestin, the odds ratio was 1.57 (0.99-2.49) for progesterone-derived and 3.35 (1.07-10.4) for testosterone-derived progestagen. Women with continuous regimen were at greater risk than women treated sequentially, but regimen and type of progestagen could not be investigated independently, as almost all EP combinations containing a testosterone-derivative were administered continuously and vice-versa. Tibolone was also associated with an increased risk of breast cancer. Early users of MHT after onset of menopause were at greater risk than users who delayed treatment. Conclusion: This study confirms differential effects on breast cancer risk of progestagens and regimens specifically used in France. Formulation of EP therapies containing natural progesterone, frequently prescribed in France, was not associated with increased risk of breast cancer but may poorly protect against endometrial cancer.	[Cordina-Duverger, Emilie; Truong, Therese; Anger, Antoinette; Sanchez, Marie; Guenel, Pascal] Ctr Rech Epidemiol & Sante Populat, CESP, INSERM, U1018, Villejuif, France; [Cordina-Duverger, Emilie; Truong, Therese; Anger, Antoinette; Sanchez, Marie; Guenel, Pascal] Univ Paris 11, UMRS 1018, Villejuif, France; [Arveux, Patrick] Breast Canc Registry Cote dOr, Ctr Georges Francois Leclerc, Dijon, France; [Kerbrat, Pierre] Ctr Eugene Marquis, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Centre Georges-Francois Leclerc; UNICANCER; Centre Eugene Marquis	Guenel, P (corresponding author), Ctr Rech Epidemiol & Sante Populat, CESP, INSERM, U1018, Villejuif, France.	pascal.guenel@inserm.fr	Guenel, Pascal/AAS-7688-2021; truong, therese/A-2837-2013; Guenel, Pascal/H-3728-2018	Guenel, Pascal/0000-0002-8359-518X; truong, therese/0000-0002-2943-6786; Guenel, Pascal/0000-0002-8359-518X	French National Institute of Cancer (INCa); Fondation de France; French Agency for Environmental and Occupational Health Safety (ANSES - ex-AFSSET); French National Research Agency (ANR); League against Cancer (Grand Ouest)	French National Institute of Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation de France(Fondation de France); French Agency for Environmental and Occupational Health Safety (ANSES - ex-AFSSET); French National Research Agency (ANR)(French National Research Agency (ANR)); League against Cancer (Grand Ouest)	The CECILE study was supported by grants from the French National Institute of Cancer (INCa), Fondation de France, the French Agency for Environmental and Occupational Health Safety (ANSES - ex-AFSSET), the French National Research Agency (ANR), the League against Cancer (Grand Ouest). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2010, AM J EPIDEMIOL, V172, P1394, DOI 10.1093/aje/kwq300; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Bakken K, 2011, INT J CANCER, V128, P144, DOI 10.1002/ijc.25314; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 2011, JNCI-J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Campagnoli C, 2005, J STEROID BIOCHEM, V96, P95, DOI 10.1016/j.jsbmb.2005.02.014; Campagnoli C, 2005, J STEROID BIOCHEM, V97, P441, DOI 10.1016/j.jsbmb.2005.08.015; Daubisse-Marliac L, 2011, ANN ONCOL, V22, P329, DOI 10.1093/annonc/mdq396; Dinger Juergen C, 2006, BMC Womens Health, V6, P13, DOI 10.1186/1472-6874-6-13; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Fournier A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710; Fournier A, 2008, J CLIN ONCOL, V26, P1260, DOI 10.1200/JCO.2007.13.4338; Fournier A, 2008, BREAST CANCER RES TR, V107, P103, DOI 10.1007/s10549-007-9523-x; Fournier A, 2011, MENOPAUSE, V18, P219, DOI 10.1097/gme.0b013e3181ecf3ec; Fournier A, 2009, J CLIN ONCOL, V27, P5138, DOI 10.1200/JCO.2008.21.6432; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; IARC (International Agency for Research on Cancer), 2012, IARC MON, V100F; Kuhl H, 2005, MATURITAS, V51, P83, DOI 10.1016/j.maturitas.2005.02.018; Lee SA, 2005, BRIT J CANCER, V92, P2049, DOI 10.1038/sj.bjc.6602617; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P3254, DOI 10.1001/jama.289.24.3254; Lyytinen HK, 2010, INT J CANCER, V126, P483, DOI 10.1002/ijc.24738; Milanese TR, 2006, J NATL CANCER I, V98, P1600, DOI 10.1093/jnci/djj439; Opatrny L, 2008, BJOG-INT J OBSTET GY, V115, P169, DOI 10.1111/j.1471-0528.2007.01520.x; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schindler AE, 2008, MATURITAS, V61, P171, DOI 10.1016/j.maturitas.2008.11.013; SMITH DC, 1975, NEW ENGL J MED, V293, P1164, DOI 10.1056/NEJM197512042932302; Stahlberg C, 2004, INT J CANCER, V109, P721, DOI 10.1002/ijc.20016; THOM MH, 1979, LANCET, V2, P455; von Euler-Chelpin M, 2010, CANCER CAUSE CONTROL; WHITEHEAD MI, 1981, NEW ENGL J MED, V305, P1599, DOI 10.1056/NEJM198112313052701; ZIEL HK, 1975, NEW ENGL J MED, V293, P1167, DOI 10.1056/NEJM197512042932303	36	87	91	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78016	10.1371/journal.pone.0078016	http://dx.doi.org/10.1371/journal.pone.0078016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223752	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300017
J	Ku, WL; Girvan, M; Yuan, GC; Sorrentino, F; Ott, E				Ku, Wai Lim; Girvan, Michelle; Yuan, Guo-Cheng; Sorrentino, Francesco; Ott, Edward			Modeling the Dynamics of Bivalent Histone Modifications	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENOME; MEMORY; DIFFERENTIATION; DEMETHYLASES; PLURIPOTENT; PROPAGATION; METHYLATION; INHERITANCE; ACTIVATION	Epigenetic modifications to histones may promote either activation or repression of the transcription of nearby genes. Recent experimental studies show that the promoters of many lineage-control genes in stem cells have "bivalent domains" in which the nucleosomes contain both active (H3K4me3) and repressive (H3K27me3) marks. It is generally agreed that bivalent domains play an important role in stem cell differentiation, but the underlying mechanisms remain unclear. Here we formulate a mathematical model to investigate the dynamic properties of histone modification patterns. We then illustrate that our modeling framework can be used to capture key features of experimentally observed combinatorial chromatin states.	[Ku, Wai Lim; Girvan, Michelle; Ott, Edward] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Ku, Wai Lim; Girvan, Michelle; Ott, Edward] Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA; [Girvan, Michelle] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Sorrentino, Francesco] Univ New Mexico, Dept Mech Engn, Albuquerque, NM 87131 USA; [Ott, Edward] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; University of New Mexico; University System of Maryland; University of Maryland College Park	Ku, WL (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	wlku@umd.edu	Ott, Edward/F-5609-2017; Ku, Wai Lim/R-7170-2016; Girvan, Michelle/E-3982-2016; O, E/F-1630-2015	Ott, Edward/0000-0002-9395-5062; Ku, Wai Lim/0000-0002-8859-6771; Girvan, Michelle/0000-0003-0299-0784; Girvan, Michelle/0000-0001-7519-2842	Office of Naval Research [N000140710734]; United States National Institutes of Health [HG005085]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by Office of Naval Research grant N000140710734 and United States National Institutes of Health grant HG005085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Binder H, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026006; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Chakravarthy H, 2011, FASEB J, V25, P206, DOI 10.1096/fj.10-166926; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; David-Rus D, 2009, J THEOR BIOL, V258, P112, DOI 10.1016/j.jtbi.2008.12.021; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hodges C, 2012, P NATL ACAD SCI USA, V109, P13296, DOI 10.1073/pnas.1211172109; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orlando DA, 2012, GENOMICS, V100, P320, DOI 10.1016/j.ygeno.2012.07.006; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Sedighi M, 2007, PHYS BIOL, V4, P246, DOI 10.1088/1478-3975/4/4/002; Sneppen K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002643; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yuan GC, 2012, WIRES SYST BIOL MED, V4, P297, DOI 10.1002/wsbm.1165; Zee BM, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-22; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	38	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77944	10.1371/journal.pone.0077944	http://dx.doi.org/10.1371/journal.pone.0077944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223747	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300016
J	Chu, MJJ; Phillips, ARJ; Hosking, AWG; MacDonald, JR; Bartlett, ASJR; Hickey, AJR				Chu, Michael J. J.; Phillips, Anthony R. J.; Hosking, Alexander W. G.; MacDonald, Julia R.; Bartlett, Adam S. J. R.; Hickey, Anthony J. R.			Hepatic Mitochondrial Function Analysis Using Needle Liver Biopsy Samples	PLOS ONE			English	Article							PRESERVATION; SURGERY	Backgrounds and Aim: Current assessment of pre-operative liver function relies upon biochemical blood tests and histology but these only indirectly measure liver function. Mitochondrial function (MF) analysis allows direct measurement of cellular metabolic function and may provide an additional index of hepatic health. Conventional MF analysis requires substantial tissue samples (>100 mg) obtained at open surgery. Here we report a method to assess MF using <3 mg of tissue obtained by a Tru-cut (R) biopsy needle making it suitable for percutaneous application. Methods: An 18G Bard (R) Max-core (R) biopsy instrument was used to collect samples. The optimal Tru-cut (R) sample weight, stability in ice-cold University of Wisconsin solution, reproducibility and protocol utility was initially evaluated in Wistar rat livers then confirmed in human samples. MF was measured in saponin-permeabilized samples using high-resolution respirometry. Results: The average mass of a single rat and human liver Tru-cut (R) biopsy was 5.60 +/- 0.30 and 5.16 +/- 0.15 mg, respectively (mean; standard error of mean). Two milligram of sample was found the lowest feasible mass for the MF assay. Tissue MF declined after 1 hour of cold storage. Six replicate measurements within rats and humans (n = 6 each) showed low coefficient of variation (<10%) in measurements of State-III respiration, electron transport chain (ETC) capacity and respiratory control ratio (RCR). Ischemic rat and human liver samples consistently showed lower State-III respiration, ETC capacity and RCR, compared to normal perfused liver samples. Conclusion: Consistent measurement of liver MF and detection of derangement in a disease state was successfully demonstrated using less than half the tissue from a single Tru-cut (R) biopsy. Using this technique outpatient assessment of liver MF is now feasible, providing a new assay for the evaluation of hepatic function.	[Chu, Michael J. J.; Phillips, Anthony R. J.; Bartlett, Adam S. J. R.] Univ Auckland, Dept Surg, Auckland 1, New Zealand; [Phillips, Anthony R. J.; MacDonald, Julia R.; Hickey, Anthony J. R.] Univ Auckland, Sch Biol Sci, Appl Surg & Metab Lab, Auckland 1, New Zealand; [Phillips, Anthony R. J.; Bartlett, Adam S. J. R.; Hickey, Anthony J. R.] Univ Auckland, Maurice Wilkins Ctr Biodiscovery, Auckland 1, New Zealand; [Hosking, Alexander W. G.; Bartlett, Adam S. J. R.] Univ Auckland, Sch Med, Auckland, New Zealand; [Phillips, Anthony R. J.; Bartlett, Adam S. J. R.] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland; Auckland City Hospital	Chu, MJJ (corresponding author), Univ Auckland, Dept Surg, Auckland 1, New Zealand.	michaeljjc@gmail.com		Chu, Michael Jen Jie/0000-0002-9892-7394	University of Auckland Faculty Research Development Fund [3626261]; Maurice & Phyllis Paykel Trust [8.1.29]	University of Auckland Faculty Research Development Fund; Maurice & Phyllis Paykel Trust	This work was supported by the University of Auckland Faculty Research Development Fund (Grant number 3626261) and the Maurice & Phyllis Paykel Trust (Grant number 8.1.29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Caraceni P, 2004, J HEPATOL, V41, P82, DOI 10.1016/j.jhep.2004.03.022; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Dare AJ, 2009, FREE RADICAL BIO MED, V47, P1517, DOI 10.1016/j.freeradbiomed.2009.08.019; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Gnaiger E., 2008, MITOCHONDRIAL DYSFUN, P327; GOO S, 2012, AUSTR PHYSL SOC P, V43, pP168; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Lacher DA, 2010, NATL HLTH STAT REPOR, V21, P1; Mendes-Braz M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/298657; Tevar AD, 2010, J AM COLL SURGEONS, V210, P515, DOI 10.1016/j.jamcollsurg.2010.01.020; TODO S, 1989, JAMA-J AM MED ASSOC, V261, P711, DOI 10.1001/jama.261.5.711; Velasco C.D., 2012, MITOCHONDRIAL PHYSL, V17, P1; Wians EH, 2009, LABMEDICINE, V40, P105, DOI 10.1309/KN404L0HHUTWWUDD	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79097	10.1371/journal.pone.0079097	http://dx.doi.org/10.1371/journal.pone.0079097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205366	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700102
J	Kumari, S; Ware, D				Kumari, Sunita; Ware, Doreen			Genome-Wide Computational Prediction and Analysis of Core Promoter Elements across Plant Monocots and Dicots	PLOS ONE			English	Article							POLYMERASE-II TRANSCRIPTION; CIS-ACTING ELEMENTS; FACTOR-BINDING SITES; TATA-BOX; POL-II; GENE-EXPRESSION; IN-VIVO; PREINITIATION COMPLEX; DNA MOTIFS; START SITE	Transcription initiation, essential to gene expression regulation, involves recruitment of basal transcription factors to the core promoter elements (CPEs). The distribution of currently known CPEs across plant genomes is largely unknown. This is the first large scale genome-wide report on the computational prediction of CPEs across eight plant genomes to help better understand the transcription initiation complex assembly. The distribution of thirteen known CPEs across four monocots (Brachypodium distachyon, Oryza sativa ssp. japonica, Sorghum bicolor, Zea mays) and four dicots (Arabidopsis thaliana, Populus trichocarpa, Vitis vinifera, Glycine max) reveals the structural organization of the core promoter in relation to the TATA-box as well as with respect to other CPEs. The distribution of known CPE motifs with respect to transcription start site (TSS) exhibited positional conservation within monocots and dicots with slight differences across all eight genomes. Further, a more refined subset of annotated genes based on orthologs of the model monocot (O. sativa ssp. japonica) and dicot (A. thaliana) genomes supported the positional distribution of these thirteen known CPEs. DNA free energy profiles provided evidence that the structural properties of promoter regions are distinctly different from that of the non-regulatory genome sequence. It also showed that monocot core promoters have lower DNA free energy than dicot core promoters. The comparison of monocot and dicot promoter sequences highlights both the similarities and differences in the core promoter architecture irrespective of the species-specific nucleotide bias. This study will be useful for future work related to genome annotation projects and can inspire research efforts aimed to better understand regulatory mechanisms of transcription.	[Kumari, Sunita; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ware, Doreen] ARS, USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Cold Spring Harbor Laboratory; United States Department of Agriculture (USDA)	Ware, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	ware@cshl.edu			USDA [1907-21000-030]; Gramene [DBI 0703908]; Direct For Biological Sciences [1127112] Funding Source: National Science Foundation	USDA(United States Department of Agriculture (USDA)); Gramene; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is funded by USDA (1907-21000-030) and Gramene (DBI 0703908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Aerts S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-34; Ali M, 2003, GENE, V320, P145, DOI 10.1016/S0378-1119(03)00821-7; Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; ASO T, 1994, J BIOL CHEM, V269, P26575; AVRAHAM S, 1992, J BIOL CHEM, V267, P610; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Bernard V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-166; Bielinska B, 2005, GENETICS, V169, P161, DOI 10.1534/genetics.104.033118; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Bulyk ML, 2004, GENOME BIOL, V5; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cai YH, 2012, AMINO ACIDS, V43, P1141, DOI 10.1007/s00726-012-1377-9; Carmack CS, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-1; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; CARROLL SL, 1988, MOL CELL BIOL, V8, P241, DOI 10.1128/MCB.8.1.241; Casimiro AC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-89; CASSIDY B, 1987, BIOCHIM BIOPHYS ACTA, V909, P133, DOI 10.1016/0167-4781(87)90035-2; CHEN KH, 1995, GENE, V164, P323, DOI 10.1016/0378-1119(95)00498-U; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; CLOS J, 1986, NUCLEIC ACIDS RES, V14, P7581, DOI 10.1093/nar/14.19.7581; COLGAN J, 1995, P NATL ACAD SCI USA, V92, P1955, DOI 10.1073/pnas.92.6.1955; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Darvish H, 2011, GENE, V475, P79, DOI 10.1016/j.gene.2010.12.013; Deng W, 2006, BIOCHEM SOC T, V34, P1051, DOI 10.1042/BST0341051; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fessele S, 2002, TRENDS GENET, V18, P60, DOI 10.1016/S0168-9525(02)02591-X; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Florquin K, 2005, NUCLEIC ACIDS RES, V33, P4255, DOI 10.1093/nar/gki737; Fukue Y, 2005, NUCLEIC ACIDS RES, V33, P3821, DOI 10.1093/nar/gki700; GARG LC, 1989, J BIOL CHEM, V264, P220; Gordan Raluca, 2008, Pac Symp Biocomput, P453; Grishkevich V, 2011, GENOME RES, V21, P707, DOI 10.1101/gr.113381.110; Halle JP, 1997, MOL CELL BIOL, V17, P4220, DOI 10.1128/MCB.17.8.4220; HAM J, 1994, EMBO J, V13, P147, DOI 10.1002/j.1460-2075.1994.tb06244.x; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ince TA, 1995, J BIOL CHEM, V270, P30249, DOI 10.1074/jbc.270.51.30249; ISHIKAWA Y, 1991, J MOL BIOL, V218, P55, DOI 10.1016/0022-2836(91)90873-5; ITO T, 1995, PLANT CELL PHYSIOL, V36, P1281; Itoh A, 2004, BIOCHEM BIOPH RES CO, V313, P612, DOI 10.1016/j.bbrc.2003.11.152; JI Z, 1990, MOL CELL BIOL, V10, P5177, DOI 10.1128/MCB.10.10.5177; Jin VX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-114; JOSHI CP, 1987, NUCLEIC ACIDS RES, V15, P6643, DOI 10.1093/nar/15.16.6643; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KEHOE DM, 1994, PLANT CELL, V6, P1123, DOI 10.1105/tpc.6.8.1123; KHACHIGIAN LM, 1994, J BIOL CHEM, V269, P22647; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; Klingenhoff A., 2002, In Silico Biology, V2, pS17; Kobayashi T, 1997, MAMM GENOME, V8, P554, DOI 10.1007/s003359900502; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Kuhlman TC, 1999, MOL CELL BIOL, V19, P2130; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Li N, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-8; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martinez E, 1998, MOL CELL BIOL, V18, P6571, DOI 10.1128/MCB.18.11.6571; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Megraw M, 2006, RNA, V12, P1612, DOI 10.1261/rna.130506; Molina C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-25; Morey C, 2011, PLANT PHYSIOL, V156, P1300, DOI 10.1104/pp.110.167809; Nakamura M, 2002, PLANT J, V29, P1, DOI 10.1046/j.0960-7412.2001.01188.x; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Niu Huifeng, 1995, Gene Expression, V4, P111; Ohler U, 2002, GENOME BIOL, V3, P87, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0087; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Pandey SP, 2006, BIOSYSTEMS, V83, P38, DOI 10.1016/j.biosystems.2005.09.001; Pedersen AG, 1998, J MOL BIOL, V281, P663, DOI 10.1006/jmbi.1998.1972; Perier RC, 1999, NUCLEIC ACIDS RES, V27, P307, DOI 10.1093/nar/27.1.307; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Rangannan V, 2009, MOL BIOSYST, V5, P1758, DOI [10.1039/B906535K, 10.1039/b906535k]; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rombauts S, 2003, PLANT PHYSIOL, V132, P1162, DOI 10.1104/pp.102.017715; Sakata-Takatani K, 2004, MATRIX BIOL, V23, P87, DOI 10.1016/j.matbio.2004.03.003; Sakurai H, 1996, FEBS LETT, V398, P113, DOI 10.1016/S0014-5793(96)01219-7; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Santel A, 2000, NUCLEIC ACIDS RES, V28, P1439, DOI 10.1093/nar/28.6.1439; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Shahmuradov IA, 2003, NUCLEIC ACIDS RES, V31, P114, DOI 10.1093/nar/gkg041; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2003, BIOINFORMATICS, V19, pi283, DOI 10.1093/bioinformatics/btg1039; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Solecki D, 1999, J BIOL CHEM, V274, P1791, DOI 10.1074/jbc.274.3.1791; Somboonthum P, 2005, NUCLEIC ACIDS RES, V33, P3401, DOI 10.1093/nar/gki652; Spooner W, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar056; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun H, 2011, NUCLEIC ACIDS RES, V39, P190, DOI 10.1093/nar/gkq775; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; TAMURA T, 1990, EMBO J, V9, P3101, DOI 10.1002/j.1460-2075.1990.tb07507.x; TAMURA TA, 1991, BIOCHIM BIOPHYS ACTA, V1129, P83, DOI 10.1016/0167-4781(91)90215-8; TASANEN K, 1992, J BIOL CHEM, V267, P11513; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; WARIISHI S, 1995, BIOCHEM BIOPH RES CO, V216, P729, DOI 10.1006/bbrc.1995.2682; Wu CH, 2001, MOL CELL BIOL, V21, P1593, DOI 10.1128/MCB.21.5.1593-1602.2001; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YAMAMOTO Y, 1993, PLANT MOL BIOL, V22, P985, DOI 10.1007/BF00028971; Yamamoto YY, 2008, NUCLEIC ACIDS RES, V36, pD977, DOI 10.1093/nar/gkm785; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yamamoto YY, 2007, NUCLEIC ACIDS RES, V35, P6219, DOI 10.1093/nar/gkm685; Yamamoto YY, 2011, DNA RES, V18, P333, DOI 10.1093/dnares/dsr020; Yamamoto YY, 2009, PLANT J, V60, P350, DOI 10.1111/j.1365-313X.2009.03958.x; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yang MQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S3; Zhao BW, 2001, MOL CARCINOGEN, V32, P92, DOI 10.1002/mc.1068; Zhou Qianjin, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P336; Zhou Q, 2008, NUCLEIC ACIDS RES, V36, P4137, DOI 10.1093/nar/gkn361; Zhou TY, 2002, NUCLEIC ACIDS RES, V30, P4145, DOI 10.1093/nar/gkf537	148	30	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e79011	10.1371/journal.pone.0079011	http://dx.doi.org/10.1371/journal.pone.0079011			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205361	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000326270700101
J	Kang, KT; Chou, CH; Weng, WC; Lee, PL; Hsu, WC				Kang, Kun-Tai; Chou, Chen-Han; Weng, Wen-Chin; Lee, Pei-Lin; Hsu, Wei-Chung			Associations between Adenotonsillar Hypertrophy, Age, and Obesity in Children with Obstructive Sleep Apnea	PLOS ONE			English	Article							PEDIATRIC TONSIL SIZE; ADENOID HYPERTROPHY; RADIOGRAPHIC EVALUATION; BODY-WEIGHT; AIRWAY; CHILDHOOD; DIAGNOSIS; SEVERITY; POLYSOMNOGRAM; ADOLESCENTS	Objective: To investigate the contributions of adenoid and tonsil size to childhood obstructive sleep apnea (OSA) and the interactions between adenotonsillar hypertrophy, age, and obesity in children with OSA. Methods: In total, 495 symptomatic patients were recruited. The patients were assigned to four groups according to age: toddler (age 1-3, n=42), preschool (age 3-6, n=164), school (age 6-12, n=200), and adolescence (age 12-18, n=89). All subjects had tonsil size graded by otolaryngologists, adenoid size determined on lateral radiographs (Fujioka method), and a full-night polysomnography. The apnea-hypopnea index (AHI), adenoid size, and tonsil size were compared in obese and non-obese children in the four age groups. Adjusted odds ratios (ORs) and 95% confidence interval (CI) of adenotonsillar hypertrophy and OSA risk were estimated by multi-logistic regression. Results: The AHI was positively related to tonsil grade (r=0.33, p <0.001) and adenoid size (r=0.24, p <0.01) in all patients. Tonsil grade was positively related to AHI in all four age groups. Adenoid size was positively related to AHI in the toddler, preschool, school groups, but not in the adolescent group (r=0.11, p=0.37). Tonsil grade and adenoid size were both positively related to AHI in obese and non-obese children. In the regression model, obesity (OR=2.89; 95% CI 1.47-5.68), tonsillar hypertrophy (OR=3.15; 95% CI 2.04-4.88), and adenoidal hypertrophy (OR=1.89; 95% CI 1.19-3.00) significantly increased OSA risk. Conclusions: Adenotonsillar hypertrophy and obesity are the major determinants of OSA in children. However, the influence of adenoid size decreases in adolescence.	[Kang, Kun-Tai; Chou, Chen-Han; Hsu, Wei-Chung] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Kang, Kun-Tai] Minist Hlth & Welf, Taipei Hosp, Dept Otolaryngol, New Taipei City, Taiwan; [Kang, Kun-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Weng, Wen-Chin; Lee, Pei-Lin; Hsu, Wei-Chung] Natl Taiwan Univ Hosp, Sleep Ctr, Taipei, Taiwan; [Weng, Wen-Chin] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Lee, Pei-Lin] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsu, WC (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.	hsuwc@ntu.edu.tw	Lee, Pei-Lin/L-5564-2019	Lee, Pei-Lin/0000-0002-6883-9502; Hsu, Wei-Chung/0000-0001-8583-8459; weng, wen-chin/0000-0002-6923-9138	National Taiwan University Hospital [NTUH 102-S2193]	National Taiwan University Hospital(National Taiwan University)	This study was supported partially by grand NTUH 102-S2193 from National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abramson Z, 2010, J ORAL MAXIL SURG, V68, P354, DOI 10.1016/j.joms.2009.09.087; Bhattacharjee R, 2010, AM J RESP CRIT CARE, V182, P676, DOI 10.1164/rccm.200912-1930OC; BRODSKY L, 1987, INT J PEDIATR OTORHI, V13, P149, DOI 10.1016/0165-5876(87)90091-7; Brooks LJ, 1998, J PEDIATR-US, V132, P682, DOI 10.1016/S0022-3476(98)70360-9; Cahali MB, 2011, CLINICS, V66, P1347, DOI 10.1590/S1807-59322011000800007; Cappabianca S, 2013, INT J PEDIATR OTORHI, V77, P69, DOI 10.1016/j.ijporl.2012.09.035; Caylakli F, 2009, INT J PEDIATR OTORHI, V73, P1532, DOI 10.1016/j.ijporl.2009.07.018; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Cho JH, 1999, J LARYNGOL OTOL, V113, P899, DOI 10.1017/S0022215100145530; Chou CH, 2013, INT J OBES LOND, DOI [10.1038/ijo.2013.184, DOI 10.1038/IJ0.2013.184]; COHEN D, 1985, CLIN OTOLARYNGOL, V10, P73, DOI 10.1111/j.1365-2273.1985.tb01170.x; CREPEAU J, 1982, OTOLARYNG HEAD NECK, V90, P548, DOI 10.1177/019459988209000505; Davis MM, 2007, PEDIATRICS, V120, pS229, DOI 10.1542/peds.2007-2329E; Dayyat E, 2009, CHEST, V136, P137, DOI 10.1378/chest.08-2568; Friedman M, 2009, OTOLARYNG HEAD NECK, V140, P800, DOI 10.1016/j.otohns.2009.01.043; FUJIOKA M, 1979, AM J ROENTGENOL, V133, P401, DOI 10.2214/ajr.133.3.401; GISLASON T, 1995, CHEST, V107, P963, DOI 10.1378/chest.107.4.963; Gozal D, 2007, CURR OPIN PULM MED, V13, P505, DOI 10.1097/MCP.0b013e3282ef6880; HIBBERT J, 1979, CLIN OTOLARYNGOL, V4, P321, DOI 10.1111/j.1365-2273.1979.tb01760.x; Howard NS, 2009, OTOLARYNG HEAD NECK, V140, P675, DOI 10.1016/j.otohns.2009.01.008; Hsu WC, 2013, INT J OBESITY, V37, P527, DOI 10.1038/ijo.2012.194; Iber C., 2007, AASM MANUAL SCORING; JOHANNES.S, 1968, ACTA RADIOL DIAGN, V7, P299, DOI 10.1177/028418516800700402; Kaditis AG, 2009, PEDIATR PULM, V44, P1216, DOI 10.1002/ppul.21126; Kang KT, 2012, INT J OBESITY, V36, P920, DOI 10.1038/ijo.2012.5; Kang KT, 2014, J FORMOS MED ASSOC, V113, P454, DOI 10.1016/j.jfma.2012.10.002; Katz ES, 2012, AM J RESP CRIT CARE, V185, P805, DOI 10.1164/rccm.201108-1455CI; Kindermann CA, 2008, INT J PEDIATR OTORHI, V72, P63, DOI 10.1016/j.ijporl.2007.09.013; Kohler MJ, 2008, SLEEP MED REV, V12, P347, DOI 10.1016/j.smrv.2008.04.008; Kolo ES, 2011, EUR J RADIOL, V79, pE38, DOI 10.1016/j.ejrad.2010.09.027; Kolo ES, 2010, INT J PEDIATR OTORHI, V74, P532, DOI 10.1016/j.ijporl.2010.02.015; Lam YY, 2006, CHEST, V130, P1751, DOI 10.1378/chest.130.6.1751; Lertsburapa K, 2010, INT J PEDIATR OTORHI, V74, P1281, DOI 10.1016/j.ijporl.2010.08.005; Li AM, 2008, THORAX, V63, P803, DOI 10.1136/thx.2007.091132; Loughlin GM, 1996, AM J RESP CRIT CARE, V153, P866; Major MP, 2006, AM J ORTHOD DENTOFAC, V130, P700, DOI 10.1016/j.ajodo.2005.05.050; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; Montgomery-Downs HE, 2006, PEDIATRICS, V117, P741, DOI 10.1542/peds.2005-1067; Feres MFN, 2012, BRAZ J OTORHINOLAR, V78, P80, DOI 10.1590/S1808-86942012000400016; Feres MFN, 2011, INT J PEDIATR OTORHI, V75, P1, DOI 10.1016/j.ijporl.2010.11.002; Nolan J, 2011, OTOLARYNG HEAD NECK, V144, P844, DOI 10.1177/0194599811400683; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Parikh SR, 2006, OTOLARYNG HEAD NECK, V135, P684, DOI 10.1016/j.otohns.2006.05.003; Ronen O, 2007, PEDIATRICS, V120, pE1028, DOI 10.1542/peds.2006-3433; Shine NP, 2005, INT J PEDIATR OTORHI, V69, P1475, DOI 10.1016/j.ijporl.2005.08.008; Tagaya M, 2012, INT J PEDIATR OTORHI, V76, P1827, DOI 10.1016/j.ijporl.2012.09.010; Uliel S, 2004, CHEST, V125, P872, DOI 10.1378/chest.125.3.872; Valera FCP, 2005, OTOLARYNG HEAD NECK, V132, P268, DOI 10.1016/j.otohns.2004.09.033; Wang DY, 1997, CLIN OTOLARYNGOL, V22, P172, DOI 10.1046/j.1365-2273.1997.00002.x; Wing YK, 2003, ARCH DIS CHILD, V88, P1043, DOI 10.1136/adc.88.12.1043; Ysunza A, 2008, INT J PEDIATR OTORHI, V72, P1159, DOI 10.1016/j.ijporl.2008.03.022	51	116	117	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78666	10.1371/journal.pone.0078666	http://dx.doi.org/10.1371/journal.pone.0078666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205291	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400095
J	Padte, NN; Boente-Carrera, M; Andrews, CD; McManus, J; Grasperge, BF; Gettie, A; Coelho-dos-Reis, JG; Li, XM; Wu, D; Bruder, JT; Sedegah, M; Patterson, N; Richie, TL; Wong, CH; Ho, DD; Vasan, S; Tsuji, M				Padte, Neal N.; Boente-Carrera, Mar; Andrews, Chasity D.; McManus, Jenny; Grasperge, Brooke F.; Gettie, Agegnehu; Coelho-dos-Reis, Jordana G.; Li, Xiangming; Wu, Douglass; Bruder, Joseph T.; Sedegah, Martha; Patterson, Noelle; Richie, Thomas L.; Wong, Chi-Huey; Ho, David D.; Vasan, Sandhya; Tsuji, Moriya			A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates	PLOS ONE			English	Article							KILLER T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PHASE I/II TRIAL; ALPHA-GALACTOSYLCERAMIDE; DENDRITIC CELLS; NKT CELLS; IN-VIVO; CIRCUMSPOROZOITE PROTEIN; PROTECTIVE IMMUNITY; PERIPHERAL-BLOOD	A key strategy to a successful vaccine against malaria is to identify and develop new adjuvants that can enhance T-cell responses and improve protective immunity. Upon co-administration with a rodent malaria vaccine in mice, 7DW8-5, a recently identified novel analog of alpha-galactosylceramide (alpha-GalCer), enhances the level of malaria-specific protective immune responses more strongly than the parent compound. In this study, we sought to determine whether 7DW8-5 could provide a similar potent adjuvant effect on a candidate human malaria vaccine in the more relevant non-human primate (NHP) model, prior to committing to clinical development. The candidate human malaria vaccine, AdPfCA (NMRC-M3V-Ad-PfCA), consists of two non-replicating recombinant adenoviral (Ad) vectors, one expressing the circumsporozoite protein (CSP) and another expressing the apical membrane antigen-1 (AMA1) of Plasmodium falciparum. In several phase 1 clinical trials, AdPfCA was well tolerated and demonstrated immunogenicity for both humoral and cell-mediated responses. In the study described herein, 25 rhesus macaques received prime and boost intramuscular (IM) immunizations of AdPfCA alone or with an ascending dose of 7DW8-5. Our results indicate that 7DW8-5 is safe and well-tolerated and provides a significant enhancement (up to 9-fold) in malaria-specific CD8+ T-cell responses after both priming and boosting phases, supporting further clinical development.	[Padte, Neal N.; Boente-Carrera, Mar; Andrews, Chasity D.; McManus, Jenny; Coelho-dos-Reis, Jordana G.; Li, Xiangming; Ho, David D.; Vasan, Sandhya; Tsuji, Moriya] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Grasperge, Brooke F.; Gettie, Agegnehu] Tulane Univ, Med Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Wu, Douglass; Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Bruder, Joseph T.] GenVec Inc, Res, Gaithersburg, MD USA; [Sedegah, Martha; Patterson, Noelle; Richie, Thomas L.] Naval Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Patterson, Noelle] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA	Rockefeller University; Tulane University; Scripps Research Institute; Naval Medical Research Center (NMRC); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Vasan, S (corresponding author), Henry M Jackson Fdn, Armed Forces Res Inst Med Sci, US Mil HIV Res Program, Bangkok, Thailand.	sandhya.vasan@afrims.org; mtsuji@adarc.org	Coelho-dos-Reis, Jordana/HGU-6453-2022	Richie, Thomas/0000-0002-2946-5456; Tsuji, Moriya/0000-0001-8587-277X	NIH [AI070258]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [38648]; Irene Diamond Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070258, R56AI070258] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; Irene Diamond Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by a grant from NIH AI070258 (M. T.), the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (Grant Number 38648 to D. D. H), and the Irene Diamond Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett JD, 2011, EXPERT REV VACCINES, V10, P1307, DOI [10.1586/ERV.11.88, 10.1586/erv.11.88]; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bontkes HJ, 2010, CLIN IMMUNOL, V136, P364, DOI 10.1016/j.clim.2010.04.019; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Chackerian A, 2002, INFECT IMMUN, V70, P6302, DOI 10.1128/IAI.70.11.6302-6309.2002; Courtney AN, 2011, EUR J IMMUNOL, V41, P3312, DOI 10.1002/eji.201041359; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Fernandez CS, 2009, J VIROL, V83, P1617, DOI 10.1128/JVI.02138-08; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Gansuvd B, 2008, J MED PRIMATOL, V37, P1, DOI 10.1111/j.1600-0684.2007.00222.x; Gardiner DF, 2006, VACCINE, V24, P287, DOI 10.1016/j.vaccine.2005.07.075; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Ishikawa A, 2005, CLIN CANCER RES, V11, P1910, DOI 10.1158/1078-0432.CCR-04-1453; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawakami K, 2001, INFECT IMMUN, V69, P6643, DOI 10.1128/IAI.69.11.6643-6650.2001; Kawakami K, 2001, INFECT IMMUN, V69, P213, DOI 10.1128/IAI.69.1.213-220.2001; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Mitchell D, 2011, HUM VACCINES, V7, P85, DOI 10.4161/hv.7.0.14567; Motsinger A, 2003, J VIROL, V77, P8153, DOI 10.1128/JVI.77.14.8153-8158.2003; Nieda M, 2004, BLOOD, V103, P383, DOI 10.1182/blood-2003-04-1155; Padte NN, 2011, CLIN IMMUNOL, V140, P142, DOI 10.1016/j.clim.2010.11.009; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Rout N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009787; Schneiders FL, 2011, CLIN IMMUNOL, V140, P130, DOI 10.1016/j.clim.2010.11.010; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Veldt BJ, 2007, J HEPATOL, V47, P356, DOI 10.1016/j.jhep.2007.04.018; Venkataswamy MM, 2009, J IMMUNOL, V183, P1644, DOI 10.4049/jimmunol.0900858; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Warshakoon HJ, 2009, HUM VACCINES, V5, P381, DOI 10.4161/hv.5.6.8175; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Woltman AM, 2009, ANTIVIR THER, V14, P809, DOI 10.3851/IMP1295	57	34	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78407	10.1371/journal.pone.0078407	http://dx.doi.org/10.1371/journal.pone.0078407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205224	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400081
J	Rivest, JB; Jemel, B; Bertone, A; McKerral, M; Mottron, L				Rivest, Jessica B.; Jemel, Boutheina; Bertone, Armando; McKerral, Michelle; Mottron, Laurent			Luminance- and Texture-Defined Information Processing in School-Aged Children with Autism	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MOTION PERCEPTION; 2ND-ORDER MOTION; SELECTIVE IMPAIRMENT; CONTRAST MODULATIONS; VISUAL-PERCEPTION; 1ST-ORDER MOTION; INDIVIDUALS; SEGREGATION; MECHANISMS	According to the complexity-specific hypothesis, the efficacy with which individuals with autism spectrum disorder (ASD) process visual information varies according to the extensiveness of the neural network required to process stimuli. Specifically, adults with ASD are less sensitive to texture-defined (or second-order) information, which necessitates the implication of several cortical visual areas. Conversely, the sensitivity to simple, luminance-defined (or first-order) information, which mainly relies on primary visual cortex (V1) activity, has been found to be either superior (static material) or intact (dynamic material) in ASD. It is currently unknown if these autistic perceptual alterations are present in childhood. In the present study, behavioural (threshold) and electrophysiological measures were obtained for static luminance-and texture-defined gratings presented to school-aged children with ASD and compared to those of typically developing children. Our behavioural and electrophysiological (P140) results indicate that luminance processing is likely unremarkable in autistic children. With respect to texture processing, there was no significant threshold difference between groups. However, unlike typical children, autistic children did not show reliable enhancements of brain activity (N230 and P340) in response to texture-defined gratings relative to luminance-defined gratings. This suggests reduced efficiency of neuro-integrative mechanisms operating at a perceptual level in autism. These results are in line with the idea that visual atypicalities mediated by intermediate-scale neural networks emerge before or during the school-age period in autism.	[Rivest, Jessica B.; Bertone, Armando; Mottron, Laurent] Univ Montreal, Ctr Excellence Pervas Dev Disorders CETEDUM, Montreal, PQ, Canada; [Rivest, Jessica B.; McKerral, Michelle] Univ Montreal, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Rivest, Jessica B.; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Jemel, Boutheina] Univ Montreal, Riviere des Prairies Hosp, Res Lab Neurosci & Cognit Electrophysiol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Mottron, L (corresponding author), Univ Montreal, Ctr Excellence Pervas Dev Disorders CETEDUM, Montreal, PQ, Canada.	Laurent.mottron@gmail.com		Mottron, Laurent/0000-0001-5668-5422; Jemel, Boutheina/0000-0003-3125-5914	Canadian Institutes of Health Research (CIHR) [200703MOP-171795-BSB-CFCA-4239]; Natural Sciences and Engineering Research Council of Canada (NSERC) [327504-2006 RGPIN]; NSCERC; Autism Research Training (ART) program in Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSCERC; Autism Research Training (ART) program in Canada	This work was supported by a grant to LM from the Canadian Institutes of Health Research (CIHR) (grant number 200703MOP-171795-BSB-CFCA-4239), by a grant to MM from the Natural Sciences and Engineering Research Council of Canada (NSERC) (grant number 327504-2006 RGPIN), as well as scholarships to JBR from NSCERC and the Autism Research Training (ART) program in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcand C, 2007, EXP BRAIN RES, V180, P263, DOI 10.1007/s00221-007-0854-y; Armstrong V, 2009, VISION RES, V49, P2774, DOI 10.1016/j.visres.2009.08.016; Ashida H, 2007, J NEUROPHYSIOL, V97, P1319, DOI 10.1152/jn.00723.2006; Baker CL, 2001, PROG BRAIN RES, V134, P171; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bertone A, 2006, J AUTISM DEV DISORD, V36, P55, DOI 10.1007/s10803-005-0042-5; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Bertone A, 2003, J COGNITIVE NEUROSCI, V15, P218, DOI 10.1162/089892903321208150; Bertone A, 2008, NEUROREPORT, V19, P225, DOI 10.1097/WNR.0b013e3282f48401; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Boeschoten MA, 2007, CLIN NEUROPHYSIOL, V118, P2076, DOI 10.1016/j.clinph.2007.05.004; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Calvert J, 2005, VISION RES, V45, P2218, DOI 10.1016/j.visres.2005.02.012; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Davis RAO, 2006, J AUTISM DEV DISORD, V36, P199, DOI 10.1007/s10803-005-0055-0; Del Viva MM, 2006, VISION RES, V46, P1242, DOI 10.1016/j.visres.2005.10.018; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Di Russo F, 2001, VISION RES, V41, P2435, DOI 10.1016/S0042-6989(01)00134-1; Dumoulin SO, 2003, CEREB CORTEX, V13, P1375, DOI 10.1093/cercor/bhg085; Dunn L.M., 2007, PEABODY PICTURE VOCA; Ellemberg D, 2003, VISION RES, V43, P651, DOI 10.1016/S0042-6989(03)00006-3; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greenaway R, 2013, NEUROPSYCHOLOGIA, V51, P592, DOI 10.1016/j.neuropsychologia.2013.01.005; Habak C, 2000, VISION RES, V40, P943, DOI 10.1016/S0042-6989(99)00235-7; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HYVARINEN L, 1980, ACTA OPHTHALMOL, V58, P507; Jarrold C, 2005, DEVELOPMENTAL SCI, V8, P344, DOI 10.1111/j.1467-7687.2005.00422.x; Jemel B, 2010, J VISION, V10, DOI 10.1167/10.6.13; Jolij J, 2007, NEUROREPORT, V18, P39, DOI 10.1097/01.wnr.0000236863.46952.a6; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kaldy Z, 2011, DEVELOPMENTAL SCI, V14, P980, DOI 10.1111/j.1467-7687.2011.01053.x; Kayser J., 2009, CURRENT SOURCE DENSI; Keita L, 2011, BIOL PSYCHIAT, V70, P806, DOI 10.1016/j.biopsych.2011.07.031; Kemner C, 2007, NEUROPSYCHOLOGIA, V45, P1293, DOI 10.1016/j.neuropsychologia.2006.09.016; Kogan CS, 2004, NEUROLOGY, V63, P1634, DOI 10.1212/01.WNL.0000142987.44035.3B; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Landy M., 2004, VISUAL NEUROSCIENCES, P1106; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Lewis TL, 2007, J VISION, V7, DOI 10.1167/7.4.9; Liu YN, 2011, NEUROPSYCHOLOGIA, V49, P2105, DOI 10.1016/j.neuropsychologia.2011.04.005; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luck S.J., 2005, INTRO EVENT RELATED; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; Milne E, 2009, BIOL PSYCHIAT, V65, P22, DOI 10.1016/j.biopsych.2008.07.017; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2013, NEUROSCI BIOBEHAV R, V37, P209, DOI 10.1016/j.neubiorev.2012.11.016; Nunez P.L, 1981, ELECT FIELDS BRAIN N; O'Riordan M, 2001, Q J EXP PSYCHOL-A, V54, P961, DOI 10.1080/02724980042000543; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Raven J., 1998, STANDARD ADV PROGR M, V1998; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith AT, 1998, J NEUROSCI, V18, P3816; Spencer JV, 2006, PERCEPTION, V35, P1047, DOI 10.1068/p5328; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Tsermentseli S, 2008, J AUTISM DEV DISORD, V38, P1201, DOI 10.1007/s10803-007-0500-3; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Vaina LM, 1996, P ROY SOC B-BIOL SCI, V263, P1225, DOI 10.1098/rspb.1996.0180; Vaina LM, 1998, VISUAL NEUROSCI, V15, P333, DOI 10.1017/S0952523898152082; Vandenbroucke MWG, 2008, J AUTISM DEV DISORD, V38, P941, DOI 10.1007/s10803-007-0467-0; Vandenbroucke MWG, 2008, BRAIN, V131, P1013, DOI 10.1093/brain/awm321; Wang LX, 2007, COGN NEUROPSYCHOL, V24, P550, DOI 10.1080/13546800701417096; ZHOU YX, 1994, J NEUROPHYSIOL, V72, P2134, DOI 10.1152/jn.1994.72.5.2134	73	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78978	10.1371/journal.pone.0078978	http://dx.doi.org/10.1371/journal.pone.0078978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205355	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300087
J	Metlapally, R; Gonzalez, P; Hawthorne, FA; Tran-Viet, KN; Wildsoet, CF; Young, TL				Metlapally, Ravikanth; Gonzalez, Pedro; Hawthorne, Felicia A.; Khanh-Nhat Tran-Viet; Wildsoet, Christine F.; Young, Terri L.			Scleral Micro-RNA Signatures in Adult and Fetal Eyes	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; SEED REGION; EXPRESSION; MIR-29B; GROWTH; FIBROBLASTS; BIOGENESIS; CELLS; PI3K	Introduction: In human eyes, ocular enlargement/ growth reflects active extracellular matrix remodeling of the outer scleral shell. Micro-RNAs are small non-coding RNAs that regulate gene expression by base pairing with target sequences. They serve as nodes of signaling networks. We hypothesized that the sclera, like most tissues, expresses micro-RNAs, some of which modulate genes regulating ocular growth. In this study, the scleral micro-RNA expression profile of rapidly growing human fetal eyes was compared with that of stable adult donor eyes using highthroughput microarray and quantitative PCR analyses. Methods: Scleral samples from normal human fetal (24 wk) and normal adult donor eyes were obtained (n=4 to 6, each group), and RNA extracted. Genome-wide micro-RNA profiling was performed using the Agilent micro-RNA microarray platform. Micro-RNA target predictions were obtained using Microcosm, TargetScan and PicTar algorithms. TaqMan r micro-RNA assays targeting micro-RNAs showing either highest significance, detection, or fold differences, and collagen specificity, were applied to scleral samples from posterior and peripheral ocular regions (n=7, each group). Microarray data were analyzed using R, and quantitative PCR data with 2(Lambda)-deltaCt methods. Results: Human sclera was found to express micro-RNAs, and comparison of microarray results for adult and fetal samples revealed many to be differentially expressed (p<0.01, min p=6.5x1011). Specifically, fetal sclera showed increased expression of mir-214, let-7c, let-7e, mir-103, mir-107, and mir-98 (1.5 to 4 fold changes, p< 0.01). However, no significant regionally specific differences. i. e., posterior vs. peripheral sclera, were observed for either adult or fetal samples. Conclusion: For the first time, micro-RNA expression has been catalogued in human sclera. Some micro-RNAs show age-related differential regulation, higher in the sclera of rapidly growing fetal eyes, consistent with a role in ocular growth regulation. Thus micro-RNAs represent potential targets for ocular growth manipulation, related to myopia and/ or other disorders such as scleral ectasia.	[Metlapally, Ravikanth; Wildsoet, Christine F.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Gonzalez, Pedro; Young, Terri L.] Duke Univ Hlth Syst, Duke Eye Ctr, Durham, NC USA; [Hawthorne, Felicia A.; Khanh-Nhat Tran-Viet; Young, Terri L.] Duke Univ, Ctr Human Genet, Durham, NC USA	University of California System; University of California Berkeley; Duke University; Duke University	Metlapally, R (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	metlapally@berkeley.edu			Research to Prevent Blindness Inc. through the Duke Eye Center; NIH/NEI [K12EY017269, 1K08EY022670, R01EY023287, R01 EY012392, 1R01EY018246]; NATIONAL EYE INSTITUTE [K08EY022670] Funding Source: NIH RePORTER	Research to Prevent Blindness Inc. through the Duke Eye Center; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by funds from Research to Prevent Blindness Inc. Small Grant through the Duke Eye Center, NIH/NEI K12EY017269 (Berkeley Clinical Scientist Development Program), and NIH/NEI 1K08EY022670 to RM; NIH/NEI R01EY023287 to PG; NIH/NEI R01 EY012392 to CFW; NIH/NEI 1R01EY018246 and Research To Prevent Blindness Inc grant to TLY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, ONTROLLING FALSE DIS, P289; BRON AJ, 1997, WOLFFS ANATOMY EYE O, P233; CHEN KC, INVEST OPHTHALMOL VI; CHRISTENSEN AM, 1991, INVEST OPHTH VIS SCI, V32, P2143; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Fledelius HC, 1996, BRIT J OPHTHALMOL, V80, P918, DOI 10.1136/bjo.80.10.918; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r42; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Iliff BW, 2012, INVEST OPHTH VIS SCI, V53, P348, DOI 10.1167/iovs.11-8783; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Luna C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051688; Luna C, 2009, MOL VIS, V15, P2488; Mancini M, 2012, AGING-US, V4, P843, DOI 10.18632/aging.100508; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Ogawa T, 2010, BIOCHEM BIOPH RES CO, V391, P316, DOI 10.1016/j.bbrc.2009.11.056; Orenes-Pinero E, 2013, INT J CARDIOL, V167, P1651, DOI 10.1016/j.ijcard.2012.09.120; Pattanayak Debasis, 2005, Indian Journal of Experimental Biology, V43, P7; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELLHEYER K, 1988, GRAEF ARCH CLIN EXP, V226, P89, DOI 10.1007/BF02172725; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Smith EL, 2007, INVEST OPHTH VIS SCI, V48, P3914, DOI 10.1167/iovs.06-1264; Smith EL, 2005, INVEST OPHTH VIS SCI, V46, P3965, DOI 10.1167/iovs.05-0445; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; VANDERWERF F, 1992, DOC OPHTHALMOL, V81, P357, DOI 10.1007/BF00169097; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Xu SB, 2009, PROG RETIN EYE RES, V28, P87, DOI 10.1016/j.preteyeres.2008.11.003; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	42	18	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78984	10.1371/journal.pone.0078984	http://dx.doi.org/10.1371/journal.pone.0078984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205357	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600116
J	Zhu, DC; Tanabe, SH; Yang, C; Zhang, WM; Sun, JZ				Zhu, Daochen; Tanabe, Shoko-Hosoi; Yang, Chong; Zhang, Weimin; Sun, Jianzhong			Bacterial Community Composition of South China Sea Sediments through Pyrosequencing-Based Analysis of 16S rRNA Genes	PLOS ONE			English	Article							EASTERN MEDITERRANEAN SEA; PHYLOGENETIC DIVERSITY; MICROBIAL DIVERSITY; BIOMASS PRODUCTION; SURFACE SEDIMENT; RARE BIOSPHERE; ARCTIC-OCEAN; DEEP-SEA; MICROORGANISMS; BIOGEOGRAPHY	Background: Subseafloor sediments accumulate large amounts of organic and inorganic materials that contain a highly diverse microbial ecosystem. The aim of this study was to survey the bacterial community of subseafloor sediments from the South China Sea. Methodology/Principal Findings: Pyrosequencing of over 265,000 amplicons of the V3 hypervariable region of the 16S ribosomal RNA gene was performed on 16 sediment samples collected from multiple locations in the northern region of the South China Sea from depths ranging from 35 to 4000 m. A total of 9,726 operational taxonomic units (OTUs; between 695 and 2819 unique OTUs per sample) at 97% sequence similarity level were generated. In total, 40 bacterial phyla including 22 formally described phyla and 18 candidate phyla, with Proteobacteria, Firmicutes, Planctomycetes, Actinobacteria and Chloroflexi being most diverse, were identified. The most abundant phylotype, accounting for 42.6% of all sequences, belonged to Gammaproteobacteria, which possessed absolute predominance in the samples analyzed. Among the 18 candidate phyla, 12 were found for the first time in the South China Sea. Conclusions: This study provided a novel insight into the composition of bacterial communities of the South China Sea subseafloor. Furthermore, abundances and community similarity analysis showed that the compositions of the bacterial communities are very similar at phylum level at different depths from 35-4000 m.	[Zhu, Daochen; Sun, Jianzhong] Jiangsu Univ, Sch Environm Engn, Zhenjiang, Jiangsu, Peoples R China; [Zhu, Daochen; Zhang, Weimin] Guangdong Inst Microbiol, Minist Guangdong Prov Jointly Breeding Base, State Key Lab Appl Microbiol South China, Guangzhou, Guangdong, Peoples R China; [Tanabe, Shoko-Hosoi] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga, Japan; [Yang, Chong] Zhenjiang Bioinnova Biotech Co Ltd, Dept R&D, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; University Shiga Prefecture	Zhu, DC (corresponding author), Jiangsu Univ, Sch Environm Engn, Zhenjiang, Jiangsu, Peoples R China.	dczhucn@hotmail.com; wmzhang58@qq.com	Zhu, Daochen/O-1941-2016	Zhu, Daochen/0000-0001-9646-9556	Natural Science Foundation of Jiangsu Province, China [BK2012695]; National High Technology Research and Development Program of China (863 Program) [2012AA092104]; Project Startup Foundation for Distinguished Scholars of Jiangsu University [10JDG084]; Chinese Academy of Sciences for Key Topics in Innovation Engineering [KSCX2-EW-G-12]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Project Startup Foundation for Distinguished Scholars of Jiangsu University; Chinese Academy of Sciences for Key Topics in Innovation Engineering(Chinese Academy of Sciences); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by a grant (Code: BK2012695) from the Natural Science Foundation of Jiangsu Province, China and by the grants from the National High Technology Research and Development Program of China (863 Program, 2012AA092104), as well as by the Project Startup Foundation for Distinguished Scholars of Jiangsu University (Code: 10JDG084), the Chinese Academy of Sciences for Key Topics in Innovation Engineering (KSCX2-EW-G-12) and Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Cao HL, 2011, ANTON LEEUW INT J G, V100, P545, DOI 10.1007/s10482-011-9610-1; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Galli I, 2008, MEAT SCI, V79, P521, DOI 10.1016/j.meatsci.2007.10.007; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Graham DE, 2012, ISME J, V6, P709, DOI 10.1038/ismej.2011.163; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Klotz MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00241; Kobayashi T, 2008, EXTREMOPHILES, V12, P519, DOI 10.1007/s00792-008-0157-7; Kouridaki I, 2010, INT MICROBIOL, V13, P143, DOI 10.2436/20.1501.01.119; Liao L, 2009, J ZHEJIANG UNIV-SC B, V10, P890, DOI 10.1631/jzus.B0920181; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pester M, 2010, ISME J, V4, P1591, DOI 10.1038/ismej.2010.75; Polymenakou PN, 2005, MICROB ECOL, V50, P447, DOI 10.1007/s00248-005-0005-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sapp M, 2010, FEMS MICROBIOL ECOL, V74, P410, DOI 10.1111/j.1574-6941.2010.00957.x; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sievert SM, 2007, OCEANOGRAPHY, V20, P117, DOI 10.5670/oceanog.2007.55; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamburini F, 2003, MAR GEOL, V201, P147, DOI 10.1016/S0025-3227(03)00214-7; Teira E, 2007, ENVIRON MICROBIOL, V9, P2551, DOI 10.1111/j.1462-2920.2007.01373.x; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Wang GH, 2010, ACTA OCEANOL SIN, V29, P98, DOI 10.1007/s13131-010-0054-7; Wang SH, 2012, CHINESE SCI BULL, V57, P1325, DOI 10.1007/s11434-012-4990-9; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Zhang Y, 2006, AQUAT MICROB ECOL, V43, P233, DOI 10.3354/ame043233; Zhang Y, 2011, RES MICROBIOL, V162, P320, DOI 10.1016/j.resmic.2010.12.006; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	39	69	79	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78501	10.1371/journal.pone.0078501	http://dx.doi.org/10.1371/journal.pone.0078501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205246	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600104
J	Mesa-Torres, N; Fabelo-Rosa, I; Riverol, D; Yunta, C; Albert, A; Salido, E; Pey, AL				Mesa-Torres, Noel; Fabelo-Rosa, Israel; Riverol, Debora; Yunta, Cristina; Albert, Armando; Salido, Eduardo; Pey, Angel L.			The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type I	PLOS ONE			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; ALANINEGLYOXYLATE AMINOTRANSFERASE; KINETIC STABILITY; MUTATION ANALYSIS; DISEASE; PROTEOSTASIS; DIAGNOSIS; STATES	Primary hyperoxaluria type I (PH1) is a conformational disease which result in the loss of alanine: glyoxylate aminotransferase (AGT) function. The study of AGT has important implications for protein folding and trafficking because PH1 mutants may cause protein aggregation and mitochondrial mistargeting. We herein describe a multidisciplinary study aimed to understand the molecular basis of protein aggregation and mistargeting in PH1 by studying twelve AGT variants. Expression studies in cell cultures reveal strong protein folding defects in PH1 causing mutants leading to enhanced aggregation, and in two cases, mitochondrial mistargeting. Immunoprecipitation studies in a cell-free system reveal that most mutants enhance the interactions with Hsc70 chaperones along their folding process, while in vitro binding experiments show no changes in the interaction of folded AGT dimers with the peroxisomal receptor Pex5p. Thermal denaturation studies by calorimetry support that PH1 causing mutants often kinetically destabilize the folded apo-protein through significant changes in the denaturation free energy barrier, whereas coenzyme binding overcomes this destabilization. Modeling of the mutations on a 1.9 angstrom crystal structure suggests that PH1 causing mutants perturb locally the native structure. Our work support that a misbalance between denaturation energetics and interactions with chaperones underlie aggregation and mistargeting in PH1, suggesting that native state stabilizers and protein homeostasis modulators are potential drugs to restore the complex and delicate balance of AGT protein homeostasis in PH1.	[Mesa-Torres, Noel; Pey, Angel L.] Univ Granada, Fac Sci, Dept Phys Chem, Granada, Spain; [Fabelo-Rosa, Israel; Riverol, Debora; Salido, Eduardo] Univ La Laguna, Inst Tecnol Biomed, Ctr Biomed Res Rare Dis, Tenerife, Spain; [Yunta, Cristina; Albert, Armando] CSIC, Inst Quim Fis Rocasolano, Dept Crystallog & Struct Biol, Madrid, Spain	University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Salido, E (corresponding author), Univ La Laguna, Inst Tecnol Biomed, Ctr Biomed Res Rare Dis, Tenerife, Spain.	esalido@ull.es; angelpey@ugr.es	Albert, Armando/J-2373-2012; Salido, Eduardo C/I-2232-2015	Albert, Armando/0000-0002-0026-6816; Salido, Eduardo C/0000-0001-9599-9854; Mesa-Torres, Noel/0000-0001-6653-6260; Pey, Angel Luis/0000-0001-7706-3243	Spanish ministry of Science and Innovation [RYC2009-04147, CSD2009-00088, SAF2011-23933, CSD2006-00015, S2010/BMD-2457, BFU2011-25384]; Junta de Andalucia [P11CTS-7187 ALP]; FPI predoctoral fellowships from the Spanish ministry of Science and Innovation	Spanish ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); FPI predoctoral fellowships from the Spanish ministry of Science and Innovation	This work was supported by the Spanish ministry of Science and Innovation (RYC2009-04147 and CSD2009-00088 to ALP, SAF2011-23933 to ES, and CSD2006-00015, S2010/BMD-2457 and BFU2011-25384 to AA) and Junta de Andalucia (P11CTS-7187 ALP); FPI predoctoral fellowships from the Spanish ministry of Science and Innovation to IF-R and NM-T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albert A, 2010, J BIOL CHEM, V285, P6371, DOI 10.1074/jbc.M109.062471; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; Cellini B, 2011, BBA-PROTEINS PROTEOM, V1814, P1577, DOI 10.1016/j.bbapap.2010.12.005; Cellini B, 2010, BIOCHIMIE, V92, P1801, DOI 10.1016/j.biochi.2010.08.005; Cellini B, 2010, P NATL ACAD SCI USA, V107, P2896, DOI 10.1073/pnas.0908565107; Cellini B, 2009, J BIOL CHEM, V284, P8349, DOI 10.1074/jbc.M808965200; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cochat P, 2012, NEPHROL DIAL TRANSPL, V27, P1729, DOI 10.1093/ndt/gfs078; Costas M, 2009, J MOL BIOL, V385, P924, DOI 10.1016/j.jmb.2008.10.056; Coulter-Mackie MB, 2006, MOL GENET METAB, V89, P349, DOI 10.1016/j.ymgme.2006.07.013; Danpure CJ, 2006, BBA-MOL CELL RES, V1763, P1776, DOI 10.1016/j.bbamcr.2006.08.021; Danpure CJ, 2001, PRIMARY HYPEROXALURI; DeLano W, 2002, PYMOL 0 99; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; Djordjevic S, 2010, ACTA CRYSTALLOGR F, V66, P233, DOI 10.1107/S1744309109054645; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fargue S, 2013, BIOCH BIOPHYS ACTA; Fargue S, 2013, J BIOL CHEM, V288, P2475, DOI 10.1074/jbc.M112.432617; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Gomes CM, 2012, CURR TOP MED CHEM, V12, P2460; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; Martin W, 2010, PHILOS T R SOC B, V365, P847, DOI 10.1098/rstb.2009.0252; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monico CG, 2005, KIDNEY INT, V67, P1704, DOI 10.1111/j.1523-1755.2005.00267.x; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pey AL, 2013, BIOCHEMISTRY-US, V52, P1160, DOI 10.1021/bi301565m; Pey AL, 2011, AMINO ACIDS, V41, P1233, DOI 10.1007/s00726-010-0801-2; Pittman AMC, 2012, GENETICS, V192, P831, DOI 10.1534/genetics.112.143750; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rumsby G, 1997, ANN CLIN BIOCHEM, V34, P400, DOI 10.1177/000456329703400411; Salido E, 2012, BBA-MOL BASIS DIS, V1822, P1453, DOI 10.1016/j.bbadis.2012.03.004; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; van Woerden CS, 2004, KIDNEY INT, V66, P746, DOI 10.1111/j.1523-1755.2004.00796.x; Williams EL, 2009, HUM MUTAT, V30, P910, DOI 10.1002/humu.21021; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	47	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71963	10.1371/journal.pone.0071963	http://dx.doi.org/10.1371/journal.pone.0071963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24205397	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200023
J	Donadio, E; Giusti, L; Seccia, V; Ciregia, F; da Valle, Y; Dallan, I; Ventroni, T; Giannaccini, G; Sellari-Franceschini, S; Lucacchini, A				Donadio, Elena; Giusti, Laura; Seccia, Veronica; Ciregia, Federica; da Valle, Ylenia; Dallan, Iacopo; Ventroni, Tiziana; Giannaccini, Gino; Sellari-Franceschini, Stefano; Lucacchini, Antonio			New Insight into Benign Tumours of Major Salivary Glands by Proteomic Approach	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; MACROPHAGE-CAPPING PROTEIN; WARTHINS TUMOR; PAROTID-GLAND; WHOLE SALIVA; IDENTIFICATION; CYTOLOGY; MANAGEMENT; CARCINOMA; DIAGNOSIS	Major salivary gland tumours are uncommon neoplasms of the head and neck. The increase of precise pre-operative diagnosis is crucial for their correct management and the identification of molecular markers would surely improve the required accuracy. In this study we performed a comparative proteomic analysis of fine needle aspiration fluids of the most frequent benign neoplasms of major salivary glands, namely pleomorphic adenoma and Warthin's tumour, in order to draw their proteomic profiles and to point out their significant features. Thirty-five patients submitted to parotidectomy were included in the study, 22 were identified to have pleomorphic adenoma and 14 Warthin's tumour. Fine needle aspiration samples were processed using a two-dimensional electrophoresis/mass spectrometry-based approach. A total of 26 differentially expressed proteins were identified. Ingenuity software was used to search the biological processes to which these proteins belong and to construct potential networks. Intriguingly, all Warthin's tumour up-regulated proteins such as Ig gamma-1 chain C region, Ig kappa chain C region and Ig alpha-1 chain C region and S100A9 were correlated to immunological and inflammatory diseases, while pleomorphic adenomas such as annexin A1, annexin A4, macrophage-capping protein, apolipoprotein E and alpha crystalline B chain were associated with cell death, apoptosis and tumorigenesis, showing different features of two benign tumours. Overall, our results shed new light on the potential usefulness of a proteomic approach to study parotid tumours and in particular up regulated proteins are able to discriminate two types of benign parotid lesions.	[Donadio, Elena; Giusti, Laura; Ciregia, Federica; da Valle, Ylenia; Ventroni, Tiziana; Giannaccini, Gino; Lucacchini, Antonio] Univ Pisa, Dept Pharm, Pisa, Italy; [Seccia, Veronica; Dallan, Iacopo; Sellari-Franceschini, Stefano] Azienda Osped Univ Pisana, Ear Nose Throat Unit 1, Pisa, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Lucacchini, A (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	lucas@farm.unipi.it	Seccia, Veronica/AAN-9738-2020; Ciregia, Federica/K-6612-2016	Ciregia, Federica/0000-0002-5851-9249; LUCACCHINI, ANTONIO/0000-0002-0917-4491; Giusti, Laura/0000-0001-7366-1932; Giannaccini, Gino/0000-0001-6436-8187				Aude-Garcia C, 2011, PROTEOMICS, V11, P324, DOI 10.1002/pmic.201000370; Baldini C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-188; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Daguci L, 2011, ROM J MORPHOL EMBRYO, V52, P1319; Eveson J., 2005, PATHOLOGY GENETICS H, P209; EVESON JW, 1985, J ORAL PATHOL MED, V14, P500, DOI 10.1111/j.1600-0714.1985.tb00522.x; Fakhry N, 2012, EUR ANN OTORHINOLARY, V129, P131, DOI 10.1016/j.anorl.2011.10.008; Giusti L, 2007, J ENDOCRINOL INVEST, V30, P865, DOI 10.1007/BF03349229; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Giusti L, 2007, J RHEUMATOL, V34, P2063; Giusti L, 2007, PROTEOMICS, V7, P1634, DOI 10.1002/pmic.200600783; Giusti L, 2011, MOL BIOSYST, V7, P687, DOI 10.1039/c0mb00191k; Giusti L, 2010, PROTEOM CLIN APPL, V4, P315, DOI 10.1002/prca.200900082; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Ha ES, 2013, CLIN BIOCHEM, V46, P369, DOI 10.1016/j.clinbiochem.2012.11.014; HELLER KS, 1992, AM J SURG, V164, P667, DOI 10.1016/S0002-9610(05)80731-7; Kimura K, 2013, J PROTEOMICS, V78, P362, DOI 10.1016/j.jprot.2012.10.004; Li MX, 2010, MED ONCOL, V27, P134, DOI 10.1007/s12032-009-9184-1; Morofuji N, 2012, J PROTEOMICS, V75, P1577, DOI 10.1016/j.jprot.2011.11.030; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Nagel H, 1999, DIAGN CYTOPATHOL, V20, P358, DOI 10.1002/(SICI)1097-0339(199906)20:6<358::AID-DC6>3.0.CO;2-X; Nomura H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-39; Partheen K, 2008, INT J CANCER, V123, P2130, DOI 10.1002/ijc.23758; Ralhan R, 2011, PROTEOMICS, V11, P2363, DOI 10.1002/pmic.201000186; Renz M, 2008, INT J CANCER, V122, P1476, DOI 10.1002/ijc.23215; Soggiu A, 2012, ACTA DIABETOL, V49, P453, DOI 10.1007/s00592-012-0407-0; Stewart CJR, 2000, DIAGN CYTOPATHOL, V22, P139; Teymoortash A, 2011, HISTOPATHOLOGY, V59, P143, DOI 10.1111/j.1365-2559.2011.03891.x; Thompson CC, 2007, GUT, V56, P95, DOI 10.1136/gut.2005.083691; Tripathi SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019213; Tripathi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011939; Tryggvason G, 2013, LARYNGOSCOPE, V123, P158, DOI 10.1002/lary.23613; Viguer JM, 2010, CYTOPATHOLOGY, V21, P164, DOI 10.1111/j.1365-2303.2009.00667.x; Volkmann J, 2013, INT J CANCER, V132, P2820, DOI 10.1002/ijc.27975; Wu JH, 2011, HEPATO-GASTROENTEROL, V58, P1182, DOI 10.5754/hge11380; Yaranal PJ, 2013, J CLIN DIAGN RES, V7, P163, DOI 10.7860/JCDR/2012/4683.2697	36	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71874	10.1371/journal.pone.0071874	http://dx.doi.org/10.1371/journal.pone.0071874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	24205396	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800023
J	Crivat, G; Lizunov, VA; Li, CR; Stenkula, KG; Zimmerberg, J; Cushman, SW; Pick, L				Crivat, Georgeta; Lizunov, Vladimir A.; Li, Caroline R.; Stenkula, Karin G.; Zimmerberg, Joshua; Cushman, Samuel W.; Pick, Leslie			Insulin Stimulates Translocation of Human GLUT4 to the Membrane in Fat Bodies of Transgenic Drosophila melanogaster	PLOS ONE			English	Article							GLUCOSE-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE; RAT ADIPOCYTES; ADIPOSE-CELLS; GROWTH; TRAFFICKING; RECEPTOR; PROTEIN; KINASE; GLUCOSE-TRANSPORTER-4	The fruit fly Drosophila melanogaster is an excellent model system for studies of genes controlling development and disease. However, its applicability to physiological systems is less clear because of metabolic differences between insects and mammals. Insulin signaling has been studied in mammals because of relevance to diabetes and other diseases but there are many parallels between mammalian and insect pathways. For example, deletion of Drosophila Insulin-Like Peptides resulted in 'diabetic' flies with elevated circulating sugar levels. Whether this situation reflects failure of sugar uptake into peripheral tissues as seen in mammals is unclear and depends upon whether flies harbor the machinery to mount mammalian-like insulin-dependent sugar uptake responses. Here we asked whether Drosophila fat cells are competent to respond to insulin with mammalian-like regulated trafficking of sugar transporters. Transgenic Drosophila expressing human glucose transporter-4 (GLUT4), the sugar transporter expressed primarily in insulin-responsive tissues, were generated. After expression in fat bodies, GLUT4 intracellular trafficking and localization were monitored by confocal and total internal reflection fluorescence microscopy (TIRFM). We found that fat body cells responded to insulin with increased GLUT4 trafficking and translocation to the plasma membrane. While the amplitude of these responses was relatively weak in animals reared on a standard diet, it was greatly enhanced in animals reared on sugar-restricted diets, suggesting that flies fed standard diets are insulin resistant. Our findings demonstrate that flies are competent to mobilize translocation of sugar transporters to the cell surface in response to insulin. They suggest that Drosophila fat cells are primed for a response to insulin and that these pathways are down-regulated when animals are exposed to constant, high levels of sugar. Finally, these studies are the first to use TIRFM to monitor insulin-signaling pathways in Drosophila, demonstrating the utility of TIRFM of tagged sugar transporters to monitor signaling pathways in insects.	[Crivat, Georgeta; Li, Caroline R.; Pick, Leslie] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Lizunov, Vladimir A.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Stenkula, Karin G.; Cushman, Samuel W.] NIDDK, Expt Diabet Metab & Nutr Sect, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Pick, L (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	lpick@umd.edu	Crivat, Georgeta/AAJ-5714-2020; Tsai, Yu-Chen/B-5852-2008; Bai, Li/N-8311-2013	Stenkula, Karin/0000-0002-0739-1150	March of Dimes Birth Defects Foundation [1-FY-10-368]; NICHD; NIDDK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the March of Dimes Birth Defects Foundation (grant # 1-FY-10-368 to L. P., http://www.marchofdimes.com/research/research-grants.aspx) and Intramural Research Programs of NICHD and NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani H, 1999, FEBS LETT, V460, P338, DOI 10.1016/S0014-5793(99)01369-1; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DAHLMAN DL, 1973, ANN ENTOMOL SOC AM, V66, P1023, DOI 10.1093/aesa/66.5.1023; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Escher SA, 1999, HEREDITAS, V130, P95, DOI 10.1111/j.1601-5223.1999.00095.x; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; GARVEY WT, 1987, J BIOL CHEM, V262, P189; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Henquin JC, 2005, JOSLINS DIABETES MEL; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Lee W, 1999, J BIOL CHEM, V274, P37755, DOI 10.1074/jbc.274.53.37755; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; OHARAIMAIZUMI M, 1992, BIOCHEM BIOPH RES CO, V185, P1016, DOI 10.1016/0006-291X(92)91728-9; OKADA T, 1994, J BIOL CHEM, V269, P3568; Oldham S, 2002, DEVELOPMENT, V129, P4103; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; PETRUZZELLI L, 1986, P NATL ACAD SCI USA, V83, P4710, DOI 10.1073/pnas.83.13.4710; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; Powis KV, 2011, CELL SIGNAL, V23, P1153, DOI 10.1016/j.cellsig.2011.02.010; Renstrom F, 2007, METABOLISM, V56, P190, DOI 10.1016/j.metabol.2006.09.012; RICORT JM, 1995, DIABETOLOGIA, V38, P1148, DOI 10.1007/s001250050406; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sajid W, 2011, J BIOL CHEM, V286, P661, DOI 10.1074/jbc.M110.156018; Sano H, 2005, BIOCHEM BIOPH RES CO, V332, P880, DOI 10.1016/j.bbrc.2005.05.027; SATOH S, 1993, J BIOL CHEM, V268, P17820; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Suga J, 1997, DIABETES, V46, P735, DOI 10.2337/diabetes.46.5.735; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; Thompson SN, 1997, BIOCHEM BIOPH RES CO, V237, P702, DOI 10.1006/bbrc.1997.7211; Thompson SN, 2003, J COMP PHYSIOL B, V173, P149, DOI 10.1007/s00360-002-0322-8; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Werner Haim, 2008, Archives of Physiology and Biochemistry, V114, P17, DOI [10.1080/13813450801900694, 10.1080/13813450801900694 ]; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; WOODRING J, 1993, J INSECT PHYSIOL, V39, P89, DOI 10.1016/0022-1910(93)90022-J; Wyatt G.R., 1967, ADV INSECT PHYSIOL, V4, P287, DOI DOI 10.1016/S0065-2806(08)60210-6; WYATT GR, 1957, J GEN PHYSIOL, V40, P833, DOI 10.1085/jgp.40.6.833; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106; Zhang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002429	67	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77953	10.1371/journal.pone.0077953	http://dx.doi.org/10.1371/journal.pone.0077953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223128	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200020
J	Lee, RB; Maria, MS; Estanislao, S; Rodriguez, C				Lee, Romeo B.; Maria, Madelene Sta.; Estanislao, Susana; Rodriguez, Cristina			Factors Associated with Depressive Symptoms among Filipino University Students	PLOS ONE			English	Article							GENDER-DIFFERENCES; FAMILY; PREVALENCE; ALCOHOL; ADOLESCENTS; BEHAVIOR	Depression can be prevented if its symptoms are addressed early and effectively. Prevention against depression among university students is rare in the Philippines, but is urgent because of the rising rates of suicide among the group. Evidence is needed to systematically identify and assist students with higher levels of depressive symptoms. We carried out a survey to determine the social and demographic factors associated with higher levels of depressive symptoms among 2,436 Filipino university students. The University Students Depression Inventory with measures on lethargy, cognition-emotion, and academic motivation, was used. Six of the 11 factors analyzed were found to be statistically significantly associated with more intense levels of depressive symptoms. These factors were: frequency of smoking, frequency of drinking, not living with biological parents, dissatisfaction with one's financial condition, level of closeness with parents, and level of closeness with peers. Sex, age category, course category, year level and religion were not significantly related. In identifying students with greater risk for depression, characteristics related to lifestyle, financial condition, parents and peers are crucial. There is a need to carry out more surveys to develop the pool of local knowledge on student depression.	[Lee, Romeo B.; Rodriguez, Cristina] De La Salle Univ, Dept Behav Sci, Manila 1004, Philippines; De La Salle Univ, Dept Psychol, Manila 1004, Philippines; [Estanislao, Susana] De La Salle Univ, Off Counselling & Career Serv, Manila 1004, Philippines	De La Salle University; De La Salle University; De La Salle University	Lee, RB (corresponding author), De La Salle Univ, Dept Behav Sci, Manila 1004, Philippines.	romeo.lee@dlsu.edu.ph	LEE, ROMEO B./R-3120-2019					Abel WD, 2012, W INDIAN MED J, V61, P494, DOI 10.7727/wimj.2012.179; Al-Busaidi Zakiya, 2011, Oman Med J, V26, P235, DOI 10.5001/omj.2011.58; AVISON WR, 1992, J HEALTH SOC BEHAV, V33, P77, DOI 10.2307/2137248; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Bostanci M, 2005, CROAT MED J, V46, P96; Bushnik T., 2005, CHILDREN YOUTH RES P; Catholic Bishops Conference of the Philippines, 2002, NAT FIL CATH YOUTH S; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Chen L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058379, DOI 10.1371/JOURNAL.PONE.0058379]; Commission on Higher Education, 2010, HIGH ED ENR GRAD SEC; Connell AM, 2006, DEV PSYCHOPATHOL, V18, P139, DOI 10.1017/S0954579406060081; DEYKIN EY, 1987, AM J PUBLIC HEALTH, V77, P178, DOI 10.2105/AJPH.77.2.178; Eisenberg D, 2007, AM J ORTHOPSYCHIAT, V77, P534, DOI 10.1037/0002-9432.77.4.534; Han M, 2011, J COLL STUDENT DEV, V52, P154, DOI 10.1353/csd.2011.0032; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Harrington R, 2001, BRIT MED BULL, V57, P47, DOI 10.1093/bmb/57.1.47; Hughes JL, 2011, PSYCHIAT ANN, V41, P235, DOI 10.3928/00485713-20110325-07; Hutcherson MS, 2011, THESIS TEXAS TU TEXA; Jewell J. D., 2003, J CHILD FAM STUD, V12, P77, DOI [DOI 10.1023/A:1021310226400, 10.1023/A:1021310226400]; Kamkar K., 2012, INT J PSYCHOL STUD, V4, P3, DOI [10.5539/ijps.v4n2p3, DOI 10.5539/IJPS.V4N2P3]; Khawaja N. G., 2008, AUSTR J GUIDANCE COU, V18, P1, DOI DOI 10.1375/AJGC.18.1.1; Knobloch LK, 2010, J SOC PERS RELAT, V27, P137, DOI 10.1177/0265407509348809; Lee Ridner S, 2005, J Sch Nurs, V21, P229, DOI 10.1622/1059-8405(2005)021[0229:SADSIA]2.0.CO;2; McCullough M E, 1999, Twin Res, V2, P126, DOI 10.1375/136905299320565997; Mikolajczyk RT, 2008, SOC PSYCH PSYCH EPID, V43, P105, DOI 10.1007/s00127-007-0282-0; NOLENHOEKSEMA S, 1994, J RES ADOLESCENCE, V4, P519, DOI 10.1207/s15327795jra0404_5; Patel V, 2007, BRIT MED BULL, V81-82, P81, DOI 10.1093/bmb/ldm010; Patten CA, 1997, J ADOLESCENT HEALTH, V20, P271, DOI 10.1016/S1054-139X(96)00170-X; Pearce MJ, 2003, J CLIN CHILD ADOLESC, V32, P267, DOI 10.1207/S15374424JCCP3202_12; Pedrelli P, 2011, PSYCHOPATHOLOGY, V44, P27, DOI 10.1159/000315358; Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298; Phillips R, 2006, INT SOC SCI REV, V81, P166; Roberts R, 1999, J AM COLL HEALTH, V48, P103, DOI 10.1080/07448489909595681; Rudolph KD, 2006, BEHAV EMOTIONAL DISO; Schutte KK, 1997, J CONSULT CLIN PSYCH, V65, P392, DOI 10.1037/0022-006X.65.3.392; Sheeber L, 2001, CLIN CHILD FAM PSYCH, V4, P19, DOI 10.1023/A:1009524626436; University of the Philippines Population Institute, 2002, FIL YOUTH 2002 YAFS; World Federation for Mental Health, 2012, DEPR GLOB CRIS; World Health Organization, 2007, RES CAP MENT HLTH LO; Yazici H, 2008, SOC BEHAV PERSONAL, V36, P799, DOI 10.2224/sbp.2008.36.6.799; Zawawi JA, 2009, EUR J PSYCHOL, V5, P71	41	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79825	10.1371/journal.pone.0079825	http://dx.doi.org/10.1371/journal.pone.0079825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223198	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200091
J	Ohara, S; Sato, S; Tsutsui, KI; Witter, MP; Iijima, T				Ohara, Shinya; Sato, Sho; Tsutsui, Ken-Ichiro; Witter, Menno P.; Iijima, Toshio			Organization of Multisynaptic Inputs to the Dorsal and Ventral Dentate Gyrus: Retrograde Trans-Synaptic Tracing with Rabies Virus Vector in the Rat	PLOS ONE			English	Article							MEDIAL ENTORHINAL CORTEX; HIPPOCAMPAL FIELD CA1; DIAGONAL BAND COMPLEX; PARAHIPPOCAMPAL REGION; INTERPEDUNCULAR NUCLEUS; LAMINAR ORGANIZATION; PRINCIPAL NEURONS; TOPOGRAPHIC ORGANIZATION; SUPRAMAMMILLARY NUCLEUS; RECIPROCAL CONNECTIONS	Behavioral, anatomical, and gene expression studies have shown functional dissociations between the dorsal and ventral hippocampus with regard to their involvement in spatial cognition, emotion, and stress. In this study we examined the difference of the multisynaptic inputs to the dorsal and ventral dentate gyrus (DG) in the rat by using retrograde trans-synaptic tracing of recombinant rabies virus vectors. Three days after the vectors were injected into the dorsal or ventral DG, monosynaptic neuronal labeling was present in the entorhinal cortex, medial septum, diagonal band, and supramammillary nucleus, each of which is known to project to the DG directly. As in previous tracing studies, topographical patterns related to the dorsal and ventral DG were seen in these regions. Five days after infection, more of the neurons in these regions were labeled and labeled neurons were also seen in cortical and subcortical regions, including the piriform and medial prefrontal cortices, the endopiriform nucleus, the claustrum, the cortical amygdala, the medial raphe nucleus, the medial habenular nucleus, the interpeduncular nucleus, and the lateral septum. As in the monosynaptically labeled regions, a topographical distribution of labeled neurons was evident in most of these disynaptically labeled regions. These data indicate that the cortical and subcortical inputs to the dorsal and ventral DG are conveyed through parallel disynaptic pathways. This second-order input difference in the dorsal and ventral DG is likely to contribute to the functional differentiation of the hippocampus along the dorsoventral axis.	[Ohara, Shinya; Sato, Sho; Tsutsui, Ken-Ichiro; Iijima, Toshio] Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan; [Witter, Menno P.] Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway; [Witter, Menno P.] Norwegian Univ Sci & Technol NTNU, Ctr Neural Computat, Trondheim, Norway	Tohoku University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Iijima, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan.	t-iijima@m.tohoku.ac.jp	Tsutsui, Ken-Ichiro/B-4378-2008; Ohara, Shinya/AAW-9705-2021	Tsutsui, Ken-Ichiro/0000-0001-5781-2948; Ohara, Shinya/0000-0003-0681-5086	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by the Kavli Foundation and the Norwegian Research Council to MPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARNISALO AA, 1995, NEUROSCIENCE, V65, P175, DOI 10.1016/0306-4522(94)00459-I; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bast T, 2001, EXP BRAIN RES, V139, P39, DOI 10.1007/s002210100746; Behan M, 1999, J COMP NEUROL, V408, P532; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; CABALLEROBLEDA M, 1993, J COMP NEUROL, V328, P115, DOI 10.1002/cne.903280109; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; Canto CB, 2012, J NEUROSCI, V32, P17620, DOI 10.1523/JNEUROSCI.3526-12.2012; Canto CB, 2012, HIPPOCAMPUS, V22, P1256, DOI 10.1002/hipo.20997; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; CULLINAN WE, 1991, J COMP NEUROL, V306, P631, DOI 10.1002/cne.903060408; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; Eichenbaum H, 2013, J COGNITIVE NEUROSCI, V25, P14, DOI 10.1162/jocn_a_00285; Eid T, 1996, EXP BRAIN RES, V109, P209; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; GAYKEMA RPA, 1990, J COMP NEUROL, V293, P103, DOI 10.1002/cne.902930109; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GROENEWEGEN HJ, 1986, J COMP NEUROL, V249, P65, DOI 10.1002/cne.902490107; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; HAYAKAWA T, 1993, ANAT EMBRYOL, V188, P139; Inoue K, 2004, SOC NEUR ABSTR, V124, P12; JACKSON AC, 1989, ACTA NEUROPATHOL, V78, P159, DOI 10.1007/BF00688204; Jinno S, 1998, BRAIN RES, V814, P55, DOI 10.1016/S0006-8993(98)01075-0; Jinno S, 2010, HIPPOCAMPUS, V20, P829, DOI 10.1002/hipo.20685; Jones BF, 2007, HIPPOCAMPUS, V17, P957, DOI 10.1002/hipo.20330; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kloosterman F, 2003, J COMP NEUROL, V455, P156, DOI 10.1002/cne.10472; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; KUYPERS HGJM, 1990, TRENDS NEUROSCI, V13, P71, DOI 10.1016/0166-2236(90)90071-H; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; LUSKIN MB, 1983, J COMP NEUROL, V216, P292, DOI 10.1002/cne.902160306; Majak K, 2004, J COMP NEUROL, V476, P414, DOI 10.1002/cne.20233; MONTONE KT, 1988, BRAIN RES BULL, V20, P233, DOI 10.1016/0361-9230(88)90183-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Naber PA, 1997, NEUROREPORT, V8, P2617, DOI 10.1097/00001756-199707280-00039; NADEL L, 1968, PHYSIOL BEHAV, V3, P891, DOI 10.1016/0031-9384(68)90174-1; NYAKAS C, 1987, BRAIN RES BULL, V18, P533, DOI 10.1016/0361-9230(87)90117-1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Reilly KC, 2012, SOC NEUR ABSTR, V702.02; Ohara S, 2009, FRONT NEUROSCI-SWITZ, V3, P344, DOI 10.3389/neuro.01.032.2009; Ohara S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.001.2009; Pan WX, 2004, PROG NEUROBIOL, V74, P127, DOI 10.1016/j.pneurobio.2004.09.003; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Prasad JA, 2013, J NEUROSCI, V33, P8494, DOI 10.1523/JNEUROSCI.5072-12.2013; Risold P.Y., 2004, RAT NERVOUS SYSTEM, P605, DOI DOI 10.1016/B978-012547638-6/50021-3; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Robertson DAF, 2005, EUR J NEUROSCI, V21, P1511, DOI 10.1111/j.1460-9568.2005.03990.x; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; SAPER CB, 1976, J COMP NEUROL, V169, P409, DOI 10.1002/cne.901690403; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEGAL M, 1974, BRAIN RES, V82, P263, DOI 10.1016/0006-8993(74)90603-9; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Soussi R, 2010, EUR J NEUROSCI, V32, P771, DOI 10.1111/j.1460-9568.2010.07329.x; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; VERTES RP, 1992, J COMP NEUROL, V326, P595, DOI 10.1002/cne.903260408; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1988, EXP BRAIN RES, V73, P23, DOI 10.1007/BF00279657; Watson C, 2006, RAT BRAIN STEREOTAXI; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Witter MP, 2007, LEARN MEMORY, V14, P705, DOI 10.1101/lm.725207; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; WITTER MP, 1988, NEUROSCIENCE, V24, P519, DOI 10.1016/0306-4522(88)90347-8; WITTER MP, 1992, NEUROSCI LETT, V148, P164, DOI 10.1016/0304-3940(92)90830-Z; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Witter MP, 1989, HIPPOCAMPUS NEW VIST, P53; Witter MP, 1988, NEUROSCI RES COMMUN, V2, P61; WYSS JM, 1979, NEUROSCIENCE, V4, P463, DOI 10.1016/0306-4522(79)90124-6; YOSHIDA K, 1995, NEUROSCI RES, V21, P199, DOI 10.1016/0168-0102(94)00852-7	87	28	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78928	10.1371/journal.pone.0078928	http://dx.doi.org/10.1371/journal.pone.0078928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223172	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200064
J	Rousseau, S; Iannuccelli, N; Mercat, MJ; Naylies, C; Thouly, JC; Servin, B; Milan, D; Pailhoux, E; Riquet, J				Rousseau, Sarah; Iannuccelli, Nathalie; Mercat, Marie-Jose; Naylies, Claire; Thouly, Jean-Claude; Servin, Bertrand; Milan, Denis; Pailhoux, Eric; Riquet, Juliette			A Genome-Wide Association Study Points out the Causal Implication of SOX9 in the Sex-Reversal Phenotype in XX Pigs	PLOS ONE			English	Article							COPY NUMBER VARIATION; CAMPOMELIC DYSPLASIA; GONADAL DIFFERENTIATION; SRY; GENE; INTERSEXUALITY; EXPRESSION; TRANSLOCATION; DUPLICATION; DISORDERS	Among farm animals, pigs are known to show XX sex-reversal. In such cases the individuals are genetically female but exhibit a hermaphroditism, or a male phenotype. While the frequency of this congenital disease is quite low (less than 1%), the economic losses are significant for pig breeders. These losses result from sterility, urogenital infections and the carcasses being downgraded because of the risk of boar taint. It has been clearly demonstrated that the SRY gene is not involved in most cases of sex-reversal in pigs, and that autosomal recessive mutations remain to be discovered. A whole-genome scan analysis was performed in the French Large-White population to identify candidate genes: 38 families comprising the two non-affected parents and 1 to 11 sex-reversed full-sib piglets were genotyped with the PorcineSNP60 BeadChip. A Transmission Disequilibrium Test revealed a highly significant candidate region on SSC12 (most significant p-value<4.65.10(-10)) containing the SOX9 gene. SOX9, one of the master genes involved in testis differentiation, was sequenced together with one of its main regulatory region Tesco. However, no causal mutations could be identified in either of the two sequenced regions. Further haplotype analyses did not identify a shared homozygous segment between the affected pigs, suggesting either a lack of power due to the SNP properties of the chip, or a second causative locus. Together with information from humans and mice, this study in pigs adds to the field of knowledge, which will lead to characterization of novel molecular mechanisms regulating sexual differentiation and dysregulation in cases of sex reversal.	[Rousseau, Sarah; Iannuccelli, Nathalie; Naylies, Claire; Servin, Bertrand; Milan, Denis; Riquet, Juliette] INRA, LGC UMR444, F-31326 Castanet Tolosan, France; [Mercat, Marie-Jose] IFIP, Pole Genet Motte Vicomte, Le Rheu, France; [Thouly, Jean-Claude] INRA, UE Domaine Galles 0332, F-31326 Castanet Tolosan, France; [Pailhoux, Eric] INRA, BDR UMR1198, Jouy En Josas, France	INRAE; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Riquet, J (corresponding author), INRA, LGC UMR444, F-31326 Castanet Tolosan, France.	juliette.riquet@toulouse.inra.fr	Servin, Bertrand/B-2206-2008	Servin, Bertrand/0000-0001-5141-0913; Iannuccelli, Nathalie/0000-0002-7822-3250	French National Research Agency (Agence Nationale de la Recherche) [ANR-08-GENM-040 SwAn]; BIOPORC; LABOGENA; Research Ministry (CIFFRE grant)	French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); BIOPORC; LABOGENA; Research Ministry (CIFFRE grant)	The project was supported by the French National Research Agency (Agence Nationale de la Recherche, ANR-08-GENM-040 SwAn project) and by BIOPORC. SR PhD is funded by LABOGENA and the Research Ministry (CIFFRE grant). The ANR and LABOGENA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BIOPORC has contributed to the construction of the collection used for the design; BIOPORC had no role in the analysis and the preparation of the manuscript.	Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Bagheri-Fam S, 2012, CHROMOSOME RES, V20, P191, DOI 10.1007/s10577-011-9269-5; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Dupuis MC, 2011, MAMM GENOME, V22, P613, DOI 10.1007/s00335-011-9337-3; Eggers S, 2012, CHROMOSOME RES, V20, P215, DOI 10.1007/s10577-012-9274-3; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hughes IA., 2006, J PEDIATR UROL, V2, P148, DOI [DOI 10.1016/J.JPUROL.2006.03.004, 10.1101/gr.247007.118]; Hunter RHF, 1996, MOL REPROD DEV, V45, P392, DOI 10.1002/(SICI)1098-2795(199611)45:3<392::AID-MRD17>3.0.CO;2-0; Jakubiczka S, 2010, SEX DEV, V4, P143, DOI 10.1159/000302403; JIMENEZ R, 1993, DEVELOPMENT, V118, P1303; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LARZUL C, 2008, 40 JOURN RECH PORC P, V40, P141; Lavery R, 2011, DEV BIOL, V354, P111, DOI 10.1016/j.ydbio.2011.03.029; Lear TL, 2012, SEX DEV, V6, P61, DOI 10.1159/000334048; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Meyers-Wallen VN, 2012, SEX DEV, V6, P46, DOI 10.1159/000332740; Meyers-Wallen VN, 1999, MOL REPROD DEV, V53, P266, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;266::AID-MRD2&gt;3.0.CO;2-6; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Pailhoux E, 1997, THERIOGENOLOGY, V47, P93, DOI 10.1016/S0093-691X(96)00343-3; Pailhoux E, 2001, J REP FER S, P65; Pailhoux E, 2001, J EXP ZOOL, V290, P700, DOI 10.1002/jez.1120; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier M, 2012, SEX DEV, V6, P33, DOI 10.1159/000334056; Parma P, 1999, BIOL REPROD, V61, P741, DOI 10.1095/biolreprod61.3.741; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Vetro A, 2011, J MED GENET, V48, P710, DOI 10.1136/jmedgenet-2011-100036; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; White S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017793; Whitworth DJ, 1996, DEVELOPMENT, V122, P4057	49	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79882	10.1371/journal.pone.0079882	http://dx.doi.org/10.1371/journal.pone.0079882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223201	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200094
J	Trucco, MM; Awad, O; Wilky, BA; Goldstein, SD; Huang, RL; Walker, RL; Shah, P; Katuri, V; Gul, N; Zhu, YLJ; McCarthy, EF; Paz-Priel, I; Meltzer, PS; Austin, CP; Xia, MH; Loeb, DM				Trucco, Matteo M.; Awad, Ola; Wilky, Breelyn A.; Goldstein, Seth D.; Huang, Ruili; Walker, Robert L.; Shah, Preeti; Katuri, Varalakshmi; Gul, Naheed; Zhu, Yuelin J.; McCarthy, Edward F.; Paz-Priel, Ido; Meltzer, Paul S.; Austin, Christopher P.; Xia, Menghang; Loeb, David M.			A Novel Chordoma Xenograft Allows In Vivo Drug Testing and Reveals the Importance of NF-kappa B Signaling in Chordoma Biology	PLOS ONE			English	Article							CELL-LINE; GENE-EXPRESSION; PHASE-II; BRACHYURY; IDENTIFICATION; ESTABLISHMENT; ACTIVATION; INDUCTION	Chordoma is a rare primary bone malignancy that arises in the skull base, spine and sacrum and originates from remnants of the notochord. These tumors are typically resistant to conventional chemotherapy, and to date there are no FDA-approved agents to treat chordoma. The lack of in vivo models of chordoma has impeded the development of new therapies for this tumor. Primary tumor from a sacral chordoma was xenografted into NOD/SCID/IL-2R gamma-null mice. The xenograft is serially transplantable and was characterized by both gene expression analysis and whole genome SNP genotyping. The NIH Chemical Genomics Center performed high-throughput screening of 2,816 compounds using two established chordoma cell lines, U-CH1 and U-CH2B. The screen yielded several compounds that showed activity and two, sunitinib and bortezomib, were tested in the xenograft. Both agents slowed the growth of the xenograft tumor. Sensitivity to an inhibitor of I kappa B, as well as inhibition of an NF-kappa B gene expression signature demonstrated the importance of NF-kappa B signaling for chordoma growth. This serially transplantable chordoma xenograft is thus a practical model to study chordomas and perform in vivo preclinical drug testing.	[Trucco, Matteo M.; Awad, Ola; Wilky, Breelyn A.; Goldstein, Seth D.; Shah, Preeti; Katuri, Varalakshmi; Gul, Naheed; Paz-Priel, Ido; Loeb, David M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Huang, Ruili; Austin, Christopher P.; Xia, Menghang] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Walker, Robert L.; Zhu, Yuelin J.; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [McCarthy, Edward F.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University	Loeb, DM (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	loebda@jhmi.edu	Zhu, Yuelin/ABD-5743-2021	Zhu, Yuelin/0000-0003-2762-0755; Walker, Robert/0000-0001-8235-4686; Wilky, Breelyn/0000-0001-5080-497X; Goldstein, Seth/0000-0001-7806-4109	The Chordoma Foundation; Sarcoma Foundation of America; NATIONAL CANCER INSTITUTE [P30CA006973, ZIABC010759, T32CA009071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	The Chordoma Foundation; Sarcoma Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was funded by grants from The Chordoma Foundation and from Sarcoma Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Dewaele B, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-4; George S, 2009, J CLIN ONCOL, V27, P3154, DOI 10.1200/JCO.2008.20.9890; Hallor KH, 2008, BRIT J CANCER, V98, P434, DOI 10.1038/sj.bjc.6604130; Hsu W, 2011, J NEUROSURG, V115, P760, DOI 10.3171/2011.5.JNS11185; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Jambhekar NA, 2010, ARCH PATHOL LAB MED, V134, P1181, DOI 10.1043/2009-0476-OA.1; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Liu XZ, 2012, J ORTHOP RES, V30, P1666, DOI 10.1002/jor.22113; Lo PK, 2013, EXP MOL PATHOL, V94, P262, DOI 10.1016/j.yexmp.2012.10.014; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Morel JCM, 2001, LAB INVEST, V81, P1371, DOI 10.1038/labinvest.3780351; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Rinner B, 2012, INT J ONCOL, V40, P443, DOI 10.3892/ijo.2011.1235; Siu IM, 2012, J NEUROSURG, V116, P801, DOI 10.3171/2011.12.JNS111123; Stacchiotti S, 2012, J CLIN ONCOL, V30, P914, DOI 10.1200/JCO.2011.35.3656; Stacchiotti S, 2011, CURR ONCOL REP, V13, P323, DOI 10.1007/s11912-011-0176-x; Sugita S, 2002, J IMMUNOL, V168, P5621, DOI 10.4049/jimmunol.168.11.5621; Tamborini E, 2010, NEURO-ONCOLOGY, V12, P776, DOI 10.1093/neuonc/noq003; Tanaka A, 2006, CANCER RES, V66, P419, DOI 10.1158/0008-5472.CAN-05-0741; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Xia MH, 2013, CANCER BIOL THER, V14, P638, DOI 10.4161/cbt.24596; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454	29	17	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79950	10.1371/journal.pone.0079950	http://dx.doi.org/10.1371/journal.pone.0079950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223206	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200099
J	van der Graaf, AM; Wiegman, MJ; Plosch, T; Zeeman, GG; van Buiten, A; Henning, RH; Buikema, H; Faas, MM				van der Graaf, Anne Marijn; Wiegman, Marjon J.; Plosch, Torsten; Zeeman, Gerda G.; van Buiten, Azuwerus; Henning, Robert H.; Buikema, Hendrik; Faas, Marijke M.			Endothelium-Dependent Relaxation and Angiotensin II Sensitivity in Experimental Preeclampsia	PLOS ONE			English	Article							LOW-DOSE-ENDOTOXIN; ACETYLCHOLINE-INDUCED RELAXATION; NITRIC-OXIDE; HYPERPOLARIZING FACTOR; VASCULAR REACTIVITY; MESENTERIC-ARTERIES; PREGNANT RATS; URINARY-EXCRETION; ANIMAL-MODEL; RECEPTOR	Objective: We investigated endothelial dysfunction and the role of angiotensin (Ang)-II type I (AT1-R) and type II (AT2-R) receptor in the changes in the Ang-II sensitivity in experimental preeclampsia in the rat. Methods: Aortic rings were isolated from low dose lipopolysaccharide (LPS) infused pregnant rats (experimental preeclampsia; n=9), saline-infused pregnant rats (n=8), and saline (n=8) and LPS (n=8) infused non-pregnant rats. Endothelium-dependent acetylcholine--mediated relaxation was studied in phenylephrine-preconstricted aortic rings in the presence of vehicle, N-G-nitro-L-arginine methyl ester and/or indomethacin. To evaluate the role for AT1-R and AT2-R in Ang-II sensitivity, full concentration response curves were obtained for Ang-II in the presence of losartan or PD123319. mRNA expression of the AT1-R and AT2-R, eNOS and iNOS, COX1 and COX2 in aorta were evaluated using real-time RT-PCR. Results: The role of vasodilator prostaglandins in the aorta was increased and the role of endothelium-derived hyperpolarizing factor and response of the AT1-R and AT2-R to Ang-II was decreased in pregnant saline infused rats as compared with non-pregnant rats. These changes were not observed during preeclampsia. Conclusion: Pregnancy induced adaptations in endothelial function, which were not observed in the rat model for preeclampsia. This role of lack of pregnancy induced endothelial adaptation in the pathophysiology of experimental preeclampsia needs further investigation.	[van der Graaf, Anne Marijn; Wiegman, Marjon J.; Zeeman, Gerda G.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Plosch, Torsten] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab, Groningen, Netherlands; [van Buiten, Azuwerus; Henning, Robert H.; Buikema, Hendrik] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [van der Graaf, Anne Marijn; Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van der Graaf, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands.	a.m.van.der.graaf@umcg.nl	Plösch, Torsten/X-6808-2019; Henning, Robert H/AAY-5222-2020	Plösch, Torsten/0000-0002-9305-4045; Henning, Robert/0000-0002-5135-4621				AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; ALOAMAKA CP, 1993, EXP PHYSIOL, V78, P403, DOI 10.1113/expphysiol.1993.sp003694; ALOAMAKA CP, 1993, RES EXP MED, V193, P407, DOI 10.1007/BF02576249; Anderson CM, 2006, EXP BIOL MED, V231, P1398, DOI 10.1177/153537020623100813; Anton L, 2009, ENDOCRINOLOGY, V150, P4316, DOI 10.1210/en.2009-0076; Ballejo G, 2002, LIFE SCI, V70, P3131, DOI 10.1016/S0024-3205(02)01576-X; BENJAMIN N, 1991, BRIT J CLIN PHARMACO, V32, P523, DOI 10.1111/j.1365-2125.1991.tb03944.x; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Bobadilla RA, 2005, CLIN EXP PHARMACOL P, V32, P202, DOI 10.1111/j.1440-1681.2005.04172.x; Bobadilla RA, 1997, HYPERTENSION, V30, P596, DOI 10.1161/01.HYP.30.3.596; Bobadilla RA, 2001, HYPERTENS PREGNANCY, V20, P143, DOI 10.1081/PRG-100106964; Brown MA, 1997, CLIN EXP HYPERTENS, V19, P713, DOI 10.3109/10641969709083181; Buikema H, 2000, BRIT J PHARMACOL, V130, P1999, DOI 10.1038/sj.bjp.0703498; BUIKEMA H, 1993, CARDIOVASC RES, V27, P2118, DOI 10.1093/cvr/27.12.2118; Buikema H, 1996, EUR HEART J, V17, P787; CHU ZM, 1993, BRIT J PHARMACOL, V109, P322, DOI 10.1111/j.1476-5381.1993.tb13573.x; Cockell AP, 1996, J PHYSIOL-LONDON, V495, P545, DOI 10.1113/jphysiol.1996.sp021614; Cockell AP, 1997, HYPERTENSION, V30, P247, DOI 10.1161/01.HYP.30.2.247; CONRAD KP, 1993, FASEB J, V7, P566, DOI 10.1096/fasebj.7.6.7682524; Cosentino F, 2005, AM J HYPERTENS, V18, P493, DOI 10.1016/j.amjhyper.2004.11.007; Davis JR, 2002, AM J PHYSIOL-REG I, V282, pR390, DOI 10.1152/ajpregu.00270.2001; Delemarre FMC, 2000, PROSTAG LEUKOTR ESS, V63, P209, DOI 10.1054/plef.2000.0211; Doering TP, 1998, AM J OBSTET GYNECOL, V178, P1307, DOI 10.1016/S0002-9378(98)70337-0; EASTERLING TR, 1990, OBSTET GYNECOL, V76, P1061; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Faas MM, 2004, AM J OBSTET GYNECOL, V191, P1192, DOI 10.1016/j.ajog.2004.03.041; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; FAAS MM, 1995, AM J PATHOL, V147, P1510; Faas MM, 2000, AM J OBSTET GYNECOL, V182, P351, DOI 10.1016/S0002-9378(00)70223-7; Faas MM, 1999, AM J REPROD IMMUNOL, V41, P224; Faas MM, 1997, J LAB CLIN MED, V130, P496, DOI 10.1016/S0022-2143(97)90126-8; Faas MM, 2000, AM J REPROD IMMUNOL, V44, P178, DOI 10.1111/j.8755-8920.2000.440308.x; Fraga-Silva RA, 2013, CURR HYPERTENS REP, V15, P31, DOI 10.1007/s11906-012-0324-1; FRIEDMAN SA, 1988, OBSTET GYNECOL, V71, P122; GANT NF, 1987, AM J KIDNEY DIS, V9, P303, DOI 10.1016/S0272-6386(87)80126-9; GANT NF, 1973, J CLIN INVEST, V52, P2682, DOI 10.1172/JCI107462; Gerber RT, 1998, BRIT J PHARMACOL, V125, P455, DOI 10.1038/sj.bjp.0702099; Gillham JC, 2003, EUR J OBSTET GYN R B, V109, P2, DOI 10.1016/S0301-2115(03)00044-7; GOETZ RM, 1994, BIOCHEM BIOPH RES CO, V205, P905, DOI 10.1006/bbrc.1994.2750; Irani RA, 2008, PLACENTA, V29, P763, DOI 10.1016/j.placenta.2008.06.011; JASPERS WJM, 1981, EUR J OBSTET GYN R B, V11, P379, DOI 10.1016/0028-2243(81)90087-3; JIRIK FR, 1989, J IMMUNOL, V142, P144; Kenny LC, 2002, CLIN SCI, V103, P67; KNOCK GA, 1994, J PHARMACOL EXP THER, V271, P1007; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Laskowska M, 2003, GYNECOL OBSTET INVES, V56, P55, DOI 10.1159/000072704; Leung PS, 2001, MOL CELL ENDOCRINOL, V184, P95, DOI 10.1016/S0303-7207(01)00637-2; Lewis DF, 2010, AM J REPROD IMMUNOL, V64, P376, DOI 10.1111/j.1600-0897.2010.00861.x; Li CB, 2000, HYPERTENSION, V36, P159, DOI 10.1161/01.HYP.36.2.159; Lopez-Jaramillo Patricio, 2008, Ther Adv Cardiovasc Dis, V2, P261, DOI 10.1177/1753944708092277; Lubarsky SL, 1997, AM J OBSTET GYNECOL, V176, P1069, DOI 10.1016/S0002-9378(97)70404-6; Luksha L, 2008, AM J PHYSIOL-REG I, V294, pR510, DOI 10.1152/ajpregu.00458.2007; Malatyalioglu E, 2000, J Matern Fetal Med, V9, P173; Martinez-Orgado J, 2003, J SOC GYNECOL INVEST, V10, P74, DOI 10.1016/S1071-5576(02)00220-4; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Mills JL, 1999, JAMA-J AM MED ASSOC, V282, P356, DOI 10.1001/jama.282.4.356; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; NATHAN L, 1995, BRIT J PHARMACOL, V114, P955, DOI 10.1111/j.1476-5381.1995.tb13297.x; Nielsen AH, 2000, PLACENTA, V21, P468, DOI 10.1053/plac.2000.0535; Oosterga M, 2000, CARDIOVASC DRUG THER, V14, P55, DOI 10.1023/A:1007843205311; Orshal JM, 2004, HYPERTENSION, V43, P434, DOI 10.1161/01.HYP.0000113044.46326.98; Plosch T, 2010, PLACENTA, V31, P910, DOI 10.1016/j.placenta.2010.07.009; Ralevic V, 1996, BRIT J PHARMACOL, V117, P1463, DOI 10.1111/j.1476-5381.1996.tb15307.x; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Saito T, 2004, FASEB J, V18, pA935; Schaefer WR, 1996, PROSTAGLANDINS, V52, P1, DOI 10.1016/0090-6980(96)00049-4; SCHAFER W, 1993, PROSTAGLANDINS, V46, P167, DOI 10.1016/0090-6980(93)90042-6; Schmitt M, 2005, HYPERTENSION, V46, P227, DOI 10.1161/01.HYP.0000164581.39811.bd; Serreau R, 2005, BJOG-INT J OBSTET GY, V112, P710, DOI 10.1111/j.1471-0528.2004.00525.x; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stennett AK, 2009, AM J PHYSIOL-HEART C, V296, pH745, DOI 10.1152/ajpheart.00861.2008; STLOUIS J, 1992, AM J OBSTET GYNECOL, V166, P684, DOI 10.1016/0002-9378(92)91698-A; Takiuti N H, 1999, Sao Paulo Med J, V117, P197; Ulu N, 2008, NEPHROL DIAL TRANSPL, V23, P1854, DOI 10.1093/ndt/gfm911; Vainio M, 2004, ACTA OBSTET GYN SCAN, V83, P1119, DOI 10.1111/j.0001-6349.2004.00396.x; Valdes G, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-79; van Drongelen J, 2012, AM J PHYSIOL-HEART C, V303, pH639, DOI 10.1152/ajpheart.00617.2011; vanderWeiden RMF, 1996, AM J OBSTET GYNECOL, V174, P1614, DOI 10.1016/S0002-9378(96)70616-6; Voors AA, 2005, J RENIN-ANGIO-ALDO S, V6, P145, DOI 10.3317/jraas.2005.021; Wang XM, 2003, AM J PHYSIOL-RENAL, V285, pF540, DOI 10.1152/ajprenal.00127.2003; Wang ZJ, 2012, J MATERN-FETAL NEO M, V25, P855, DOI 10.3109/14767058.2011.599077; Wilkinson IB, 2004, HYPERTENSION, V44, P112, DOI 10.1161/01.HYP.0000138068.03893.40; Xu Y, 2007, LIFE SCI, V80, P1678, DOI 10.1016/j.lfs.2007.01.041	85	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79884	10.1371/journal.pone.0079884	http://dx.doi.org/10.1371/journal.pone.0079884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223202	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200095
J	Beauchesne, D; Jaeger, JAG; St-Laurent, MH				Beauchesne, David; Jaeger, Jochen A. G.; St-Laurent, Martin-Hugues			Disentangling Woodland Caribou Movements in Response to Clearcuts and Roads across Temporal Scales	PLOS ONE			English	Article							FOREST-DWELLING CARIBOU; CONDITIONAL LOGISTIC-REGRESSION; MOOSE HABITAT SELECTION; FUNCTIONAL-RESPONSES; THREATENED CARIBOU; LARGE HERBIVORES; MODEL SELECTION; TRADE-OFFS; BOREAL; CONSERVATION	Although prey species typically respond to the most limiting factors at coarse spatiotemporal scales while addressing biological requirements at finer scales, such behaviour may become challenging for species inhabiting human altered landscapes. We investigated how woodland caribou, a threatened species inhabiting North-American boreal forests, modified their fine-scale movements when confronted with forest management features (i.e. clearcuts and roads). We used GPS telemetry data collected between 2004 and 2010 on 49 female caribou in a managed area in Quebec, Canada. Movements were studied using a use - availability design contrasting observed steps (i.e. line connecting two consecutive locations) with random steps (i.e. proxy of immediate habitat availability). Although caribou mostly avoided disturbances, individuals nonetheless modulated their fine-scale response to disturbances on a daily and annual basis, potentially compromising between risk avoidance in periods of higher vulnerability (i.e. calving, early and late winter) during the day and foraging activities in periods of higher energy requirements (i.e. spring, summer and rut) during dusk/dawn and at night. The local context in which females moved was shown to influence their decision to cross clearcut edges and roads. Indeed, although females typically avoided crossing clearcut edges and roads at low densities, crossing rates were found to rapidly increase in greater disturbance densities. In some instance, however, females were less likely to cross edges and roads as densities increased. Females may then be trapped and forced to use disturbed habitats, known to be associated with higher predation risk. We believe that further increases in anthropogenic disturbances could exacerbate such behavioural responses and ultimately lead to population level consequences.	[Beauchesne, David; Jaeger, Jochen A. G.] Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ, Canada; [Beauchesne, David] Concordia Univ, Ctr Northern Studies, Montreal, PQ, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Northern Studies, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Forest Res, Rimouski, PQ G5L 3A1, Canada	Concordia University - Canada; Concordia University - Canada; University of Quebec; University of Quebec	St-Laurent, MH (corresponding author), Univ Quebec, Ctr Northern Studies, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	martin-hugues_st-laurent@uqar.ca		Beauchesne, David/0000-0002-3590-8161	AbitibiBowater Inc.; Canada Economic Development; Concordia University; Conseil de l'industrie forestiere du Quebec; Fondation de la faune du Quebec; Fonds quebecois de la recherche sur la nature et les technologies; Fonds de recherche forestiere du Saguenay-Lac-St-Jean; Ministere des Ressources naturelles et de la Faune; Natural Sciences and Engineering Research Council of Canada; Universite du Quebec a Rimouski; World Wildlife Fund for Nature	AbitibiBowater Inc.; Canada Economic Development; Concordia University; Conseil de l'industrie forestiere du Quebec; Fondation de la faune du Quebec; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Fonds de recherche forestiere du Saguenay-Lac-St-Jean; Ministere des Ressources naturelles et de la Faune; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Universite du Quebec a Rimouski; World Wildlife Fund for Nature	This project was funded by the following partners: AbitibiBowater Inc., Canada Economic Development, Concordia University, Conseil de l'industrie forestiere du Quebec, Fondation de la faune du Quebec, Fonds quebecois de la recherche sur la nature et les technologies, Fonds de recherche forestiere du Saguenay-Lac-St-Jean, Ministere des Ressources naturelles et de la Faune, Natural Sciences and Engineering Research Council of Canada (Discovery Grant to M.-H. St-Laurent), Universite du Quebec a Rimouski and World Wildlife Fund for Nature. The authors also thank the Essipit First Nation and A. Chabot for providing access to their caribou telemetry data, via the Aboriginal Funds for Species at Risk (Environment Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Avgar T, 2013, J ANIM ECOL, V82, P96, DOI 10.1111/j.1365-2656.2012.02035.x; Barten NL, 2001, J WILDLIFE MANAGE, V65, P77, DOI 10.2307/3803279; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; Bastille-Rousseau G, 2011, ECOGRAPHY, V34, P588, DOI 10.1111/j.1600-0587.2010.06517.x; BERGERUD AT, 1987, CAN J ZOOL, V65, P1597, DOI 10.1139/z87-249; Bergman EJ, 2006, ECOL APPL, V16, P273, DOI 10.1890/04-1532; Bjorneraas K, 2011, WILDLIFE BIOL, V17, P44, DOI 10.2981/10-073; Briand Y, 2009, ECOSCIENCE, V16, P330, DOI 10.2980/16-3-3248; Brodeur V, 2008, CAN J ZOOL, V86, P1307, DOI 10.1139/Z08-118; Burton PJ, 1999, FOREST CHRON, V75, P623, DOI 10.5558/tfc75623-4; COSEWIC, 2011, CAN WILDL SPEC RISK; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; Courtois R., 1998, ALCES, V34, P210; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; Cyr D, 2009, FRONT ECOL ENVIRON, V7, P519, DOI 10.1890/080088; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Dussault C, 2006, CAN J FOREST RES, V36, P1097, DOI 10.1139/X05-310; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Environment Canada, 2011, SCI ASS INF ID CRIT; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Faille G, 2010, BIOL CONSERV, V143, P2840, DOI 10.1016/j.biocon.2010.08.001; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Frid A, 2002, CONSERV ECOL, V6; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gurarie E, 2011, OECOLOGIA, V165, P891, DOI 10.1007/s00442-010-1883-y; Gustine DD, 2008, CAN J ZOOL, V86, P812, DOI 10.1139/Z08-047; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Herfindal I, 2009, ECOGRAPHY, V32, P849, DOI 10.1111/j.1600-0587.2009.05783.x; Hins C, 2009, FOREST ECOL MANAG, V257, P636, DOI 10.1016/j.foreco.2008.09.049; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; IMS RA, 1993, BIOL CONSERV, V63, P261, DOI 10.1016/0006-3207(93)90722-D; Johnson CJ, 2001, OECOLOGIA, V127, P590, DOI 10.1007/s004420000573; Leblond M, 2011, LANDSCAPE ECOL, V26, P1433, DOI 10.1007/s10980-011-9647-6; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; Lesmerises R, 2013, ECOL EVOL, V3, P2880, DOI 10.1002/ece3.695; Lykkja Odd N., 2009, Alces, V45, P109; Mabille G, 2012, OECOLOGIA, V170, P965, DOI 10.1007/s00442-012-2382-0; Moreau G, 2012, J APPL ECOL, V49, P611, DOI 10.1111/j.1365-2664.2012.02134.x; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Peterson Rolf O., 2003, P104; Pinard V, 2012, J WILDLIFE MANAGE, V76, P189, DOI 10.1002/jwmg.217; Post E, 2003, CAN J ZOOL, V81, P1709, DOI 10.1139/Z03-172; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Robitaille A., 1998, PAYSAGES REGIONAUX Q; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Schaefer JA, 2007, J WILDLIFE MANAGE, V71, P1753, DOI 10.2193/2005-479; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Skarin A, 2010, POLAR BIOL, V33, P1263, DOI 10.1007/s00300-010-0815-y; St-Laurent Martin-Hugues, 2012, Rangifer, V32, P127; TREMBLAYGENDRON S, 2012, THESIS U QUEBEC RIMO; Whittington J, 2011, J APPL ECOL, V48, P1535, DOI 10.1111/j.1365-2664.2011.02043.x; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.5061/DRYAD.N3C2F; [No title captured]	64	20	20	0	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77514	10.1371/journal.pone.0077514	http://dx.doi.org/10.1371/journal.pone.0077514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223713	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400007
J	Draeger, HT; Assassi, S; Sharif, R; Gonzalez, EB; Harper, BE; Arnett, FC; Manzoor, A; Lange, RA; Mayes, MD				Draeger, Hilda T.; Assassi, Shervin; Sharif, Roozbeh; Gonzalez, Emilio B.; Harper, Brock E.; Arnett, Frank C.; Manzoor, Ameena; Lange, Richard A.; Mayes, Maureen D.			Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis	PLOS ONE			English	Article							SCLERODERMA; ELECTROCARDIOGRAM; DIAGNOSIS; DISEASE	Objective: To evaluate the prognostic significance of baseline electrocardiogram (ECG) abnormalities in a multiethnic cohort of patients with early systemic sclerosis (SSc) and to determine the serological, clinical, and echocardiogram correlates of ECG findings. Methods: SSc patients with disease duration of <= 5 years were enrolled in the GENISOS (Genetics versus Environment in Scleroderma Outcome Study) cohort. At the first visit, a standard 12 lead ECG was obtained along with demographic information, clinical data, and autoantibodies. The results of echocardiograms were also recorded. All ECGs were interpreted by a cardiologist unaware of the patients' clinical data. Results: Of 265 SSc patients with average disease duration at enrollment of 2.5 years, 140 (52.8%) had abnormal ECG findings. These findings were not associated with SSc disease type or autoantibody profile but were associated with more severe heart and lung involvement. A total of 75 patients (28.3%) died over a follow up time of 9.9 years. Complete right bundle branch block (+/- left anterior hemiblock) on ECG, present in 7 (2.6%) patients, predicted a higher risk of mortality (HR: 5.3; 95% CI: 2.1 to 13.4; p<0.001). The predictive significance of right bundle branch block was independent of age at enrollment, gender, ethnicity and risk factors for coronary artery disease. Conclusion: ECG abnormalities are common in patients with early SSc and are associated with the severity of lung and heart involvement. Right bundle branch block is an independent predictor of mortality, and should be considered a marker of disease severity in SSc.	[Draeger, Hilda T.] Univ Texas Hlth Sci Ctr Houston, Div Rheumatol, Houston, TX 77030 USA; [Assassi, Shervin; Sharif, Roozbeh; Arnett, Frank C.; Manzoor, Ameena; Mayes, Maureen D.] Univ Texas Hlth Sci Ctr Houston, Div Rheumatol & Clin Immunogenet, Houston, TX 77030 USA; [Sharif, Roozbeh; Gonzalez, Emilio B.; Harper, Brock E.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, Div Cardiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health San Antonio	Assassi, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Rheumatol & Clin Immunogenet, Houston, TX 77030 USA.	shervin.assassi@uth.tmc.edu	Sharif, Roozbeh/AAE-7492-2020; Lange, Richard/AAM-9594-2021		National Institutes of Health (NIH/NIAMS) Center of Research Translation (CORT) in Scleroderma [P50AR054144]; Department of Defense [PR1206877];  [NIH-KL2RR024149];  [K23AR061436]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR061436, P50AR054144] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NIAMS) Center of Research Translation (CORT) in Scleroderma; Department of Defense(United States Department of Defense); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding by the National Institutes of Health (NIH/NIAMS) Center of Research Translation (CORT) in Scleroderma P50AR054144 (Mayes); NIH-KL2RR024149 and K23AR061436 (Assassi); Department of Defense PR1206877 (Mayes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Aro AL, 2011, CIRC-ARRHYTHMIA ELEC, V4, P704, DOI 10.1161/CIRCEP.111.963561; Assassi S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3125; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; BULKLEY BH, 1976, CIRCULATION, V53, P483, DOI 10.1161/01.CIR.53.3.483; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Desai CS, 2011, CURR OPIN RHEUMATOL, V23, P545, DOI 10.1097/BOR.0b013e32834b8975; FOLLANSBEE WP, 1985, AM J MED, V79, P183, DOI 10.1016/0002-9343(85)90008-7; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; Ioannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031; LEROY EC, 1988, J RHEUMATOL, V15, P202; Medsger TA, 1999, J RHEUMATOL, V26, P2159; MEDSGER TA, 1971, ANN INTERN MED, V75, P369, DOI 10.7326/0003-4819-75-3-369; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P46, DOI 10.1016/j.acvd.2009.06.009; Morelli S, 1996, INT J CARDIOL, V57, P151, DOI 10.1016/S0167-5273(96)02808-2; OKIN PM, 1995, J AM COLL CARDIOL, V25, P417, DOI 10.1016/0735-1097(94)00371-V; Prineas RJ, 2010, MINNESOTA CODE MANUA, P325; Reveille JD, 2001, SEMIN ARTHRITIS RHEU, V30, P332, DOI 10.1053/sarh.2001.20268; RIDOLFI RL, 1976, AM J MED, V61, P361, DOI 10.1016/0002-9343(76)90373-9; ROMHILT DW, 1968, AM HEART J, V75, P752, DOI 10.1016/0002-8703(68)90035-5; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1	21	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78808	10.1371/journal.pone.0078808	http://dx.doi.org/10.1371/journal.pone.0078808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205321	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800022
J	Ibanez-Gonzalez, DL; Norris, SA				Ibanez-Gonzalez, Daniel Lopes; Norris, Shane A.			Chronic Non-Communicable Disease and Healthcare Access in Middle-Aged and Older Women Living in Soweto, South Africa	PLOS ONE			English	Article							COSTS; BIRTH	The aim of the current study was to describe the healthcare access, beliefs, and practices of middle-aged and older women residing in Soweto. This is a cross-sectional study of the primary (female) caregivers of the Birth to Twenty Cohort, based in Soweto, South Africa. The study instrument was administered to 1 102 caregivers as part of routine annual data collection. Over half the respondents (50.7%) reported having at least one chronic non-communicable disease (CND), only a small portion (33.3%) of whom reported accessing a healthcare service in the last 6 months. Reported availability of private medical practice and government clinics was high (75.1% and 61.5% respectively). The low utilisation of healthcare services by women with CND is a concern in terms of healthcare management. There is a need to further investigate how healthcare beliefs are formed, as well as the feasibility of programmes to support the ongoing management of CND in Soweto.	[Ibanez-Gonzalez, Daniel Lopes; Norris, Shane A.] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, South Africa	University of Witwatersrand	Ibanez-Gonzalez, DL (corresponding author), Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	Daniel.LopesIbanez-Gonzalez@wits.ac.za	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788	Wellcome Trust; University of the Witwatersrand; SANPAD (South Africa Netherlands research Programme on Alternatives in Development); MRC (SA); MRC/DfID (UK; Africa Research Leader Award); Medical Research Council [G1001333] Funding Source: researchfish; MRC [G1001333] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); University of the Witwatersrand; SANPAD (South Africa Netherlands research Programme on Alternatives in Development); MRC (SA)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/DfID (UK; Africa Research Leader Award)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Wellcome Trust, the University of the Witwatersrand, SANPAD (South Africa Netherlands research Programme on Alternatives in Development), MRC (SA) and MRC/DfID (UK; Africa Research Leader Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African National Congress, 1994, NAT HLTH PLAN S AFR; Bam N, 2013, AFR J PRIM HEALTH CA, V5, DOI 10.4102/phcfm.v5i1.423; Bhatia M, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-13; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; De Maeseneer J, 2010, BRIT J GEN PRACT, V60, P286, DOI 10.3399/bjgp10X483977; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Goudge J, 2009, TROP MED INT HEALTH, V14, P458, DOI 10.1111/j.1365-3156.2009.02256.x; Green A, 2002, INT J HEALTH PLAN M, V17, P333, DOI 10.1002/hpm.685; Grobler C, 2007, S AFR J ECON, V75, P327, DOI 10.1111/j.1813-6982.2007.00124.x; Johnston S, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-65; Kautzky K, 2008, S AFR HLTH REV, V1, P17, DOI [10.10520/EJC35514, DOI 10.10520/EJC35514]; Madamombe I, 2006, AFRICA RENEWAL; Magawa R., 2012, PRIMARY HLTH CARE IM, P16; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Norman R, 2001, POVERTY CHRONIC DIS, P53; Nxumalo N, 2011, J PUBLIC HEALTH POL, V32, pS124, DOI 10.1057/jphp.2011.26; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Statistics South Africa, 2012, GEN HOUS SURV 2011; Truter I, 2007, SA PHARM J, V74, P56; Yach D, 1991, Paediatr Perinat Epidemiol, V5, P211, DOI 10.1111/j.1365-3016.1991.tb00702.x	21	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78800	10.1371/journal.pone.0078800	http://dx.doi.org/10.1371/journal.pone.0078800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205316	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700097
J	Biswas, N; Rodriguez-Garcia, M; Crist, SG; Shen, Z; Bodwell, JE; Fahey, JV; Wira, CR				Biswas, Nabanita; Rodriguez-Garcia, Marta; Crist, Sarah G.; Shen, Zheng; Bodwell, Jack E.; Fahey, John V.; Wira, Charles R.			Effect of Tenofovir on Nucleotidases and Cytokines in HIV-1 Target Cells	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DENDRITIC CELLS; IN-VITRO; ALPHA; 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE; ECTO-5-NUCLEOTIDASE; METABOLISM; ACTIVATION; EXPRESSION; INFECTION	Tenofovir (TFV) has been widely used for pre-exposure prophylaxis of HIV-1 infection with mixed results. While the use of TFV in uninfected individuals for prevention of HIV-1 acquisition is actively being investigated, the possible consequences of TFV exposure for the HIV-target cells and the mucosal microenvironment are unknown. In the current study, we evaluated the effects of TFV treatment on blood-derived CD4(+) T cells, monocyte-derived macrophages and dendritic cells (DC). Purified HIV-target cells were treated with different concentrations of TFV (0.001-1.0 mg/ml) for 2 to 24hr. RNA was isolated and RT-PCR was performed to compare the levels of mRNA expression of nucleotidases and pro-inflammatory cytokine genes (MIP3 alpha, IL-8 and TNF alpha) in the presence or absence of TFV. We found that TFV increases 5'-ecto-nucleotidase (NT5E) and inhibits mitochondrial nucleotidase (NT5M) gene expression and increases 5' nucleotidase activity in macrophages. We also observed that TFV stimulates the expression and secretion of IL-8 by macrophages, DC, and activated CD4(+) T cells and increases the expression and secretion of MIP3 alpha by macrophages. In contrast, TFV had no effect on TNF alpha secretion from macrophages, DC and CD4(+) T cells. Our results demonstrate that TFV alters innate immune responses in HIV-target cells with potential implications for increased inflammation at mucosal surfaces. As new preventive trials are designed, these findings should provide a foundation for understanding the effects of TFV on HIV-target cells in microbicide trials.	[Biswas, Nabanita; Rodriguez-Garcia, Marta; Crist, Sarah G.; Shen, Zheng; Bodwell, Jack E.; Fahey, John V.; Wira, Charles R.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA	Dartmouth College	Biswas, N (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA.	nabanita.biswas@gmail.com			National Institutes of Health [HHSN272201000001C]; Advanced BioScience Laboratories, Inc.; NIH [AI102838, AI071761, AI013541]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI013541, R55AI013541, R56AI071761, R01AI102838, R01AI071761, R01AI013541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced BioScience Laboratories, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health contract HHSN272201000001C, which was indirectly funded by Advanced BioScience Laboratories, Inc., and by NIH grants AI102838, AI071761 and AI013541 (CRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; ARMSTRONG MA, 1988, ANN NEUROL, V24, P12, DOI 10.1002/ana.410240104; BALZARINI J, 1991, P NATL ACAD SCI USA, V88, P1499, DOI 10.1073/pnas.88.4.1499; BALZARINI J, 1991, P NATL ACAD SCI USA, V88, P4961, DOI 10.1073/pnas.88.11.4961; BIANCHI V, 1986, P NATL ACAD SCI USA, V83, P986, DOI 10.1073/pnas.83.4.986; Christensen LD, 1996, APMIS, V104, P126, DOI 10.1111/j.1699-0463.1996.tb00697.x; CHRISTENSEN LD, 1992, SCAND J IMMUNOL, V35, P407, DOI 10.1111/j.1365-3083.1992.tb02875.x; De Clercq E, 2007, BIOCHEM PHARMACOL, V73, P911, DOI 10.1016/j.bcp.2006.09.014; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Escribese MM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-118; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Ghosh M, 2009, AM J REPROD IMMUNOL, V62, P60, DOI 10.1111/j.1600-0897.2009.00713.x; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Krishna S, 2006, NUCLEIC ACIDS RES, V34, P2455, DOI 10.1093/nar/gkl140; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Lafferty MK, 2010, BLOOD, V115, P1564, DOI 10.1182/blood-2009-06-226423; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Lane BR, 2001, J VIROL, V75, P8195, DOI 10.1128/JVI.75.17.8195-8202.2001; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Mane Viraj P, 2008, J Biomol Tech, V19, P342; Melchjorsen J, 2011, JAIDS-J ACQ IMM DEF, V57, P265, DOI 10.1097/QAI.0b013e3182185276; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; MTN, 2012, MTN MICROBICIDE TRIA; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Rampazzo C, 2002, GENE, V294, P109, DOI 10.1016/S0378-1119(02)00651-0; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; ROBBINS BL, 1995, ANTIMICROB AGENTS CH, V39, P2304, DOI 10.1128/AAC.39.10.2304; Rodriguez-Garcia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062069; Rodriguez-Garcia M, 2013, J REPROD IMMUNOL, V97, P74, DOI 10.1016/j.jri.2012.10.010; Rodriguez-Garcia M, 2011, J LEUKOCYTE BIOL, V89, P507, DOI 10.1189/jlb.0610327; Rodriguez-Garcia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009436; SAVIC V, 1990, IMMUNOLOGY, V70, P321; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069854; UNAIDS, 2012, GLOBAL REPORT UNAIDS; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Zidek Z, 2001, ANTIMICROB AGENTS CH, V45, P3381, DOI 10.1128/AAC.45.12.3381-3386.2001; Zidek Z, 2007, EUR J PHARMACOL, V574, P77, DOI 10.1016/j.ejphar.2007.07.024	45	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78814	10.1371/journal.pone.0078814	http://dx.doi.org/10.1371/journal.pone.0078814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205323	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400107
J	Dutta, S; Rani, TS; Podile, AR				Dutta, Swarnalee; Rani, T. Swaroopa; Podile, Appa Rao			Root Exudate-Induced Alterations in Bacillus cereus Cell Wall Contribute to Root Colonization and Plant Growth Promotion	PLOS ONE			English	Article							FTIR SPECTROSCOPIC CHARACTERIZATION; AZOSPIRILLUM-BRASILENSE; IR SPECTROSCOPY; ORGANIC-ACIDS; RHIZOSPHERE; BACTERIA; STRAINS; PROTEIN; WHEAT; IDENTIFICATION	The outcome of an interaction between plant growth promoting rhizobacteria and plants may depend on the chemical composition of root exudates (REs). We report the colonization of tobacco, and not groundnut, roots by a non-rhizospheric Bacillus cereus (MTCC 430). There was a differential alteration in the cell wall components of B. cereus in response to the REs from tobacco and groundnut. Attenuated total reflectance infrared spectroscopy revealed a split in amide I region of B. cereus cells exposed to tobacco-root exudates (TRE), compared to those exposed to groundnut-root exudates (GRE). In addition, changes in exopolysaccharides and lipid-packing were observed in B. cereus grown in TRE-amended minimal media that were not detectable in GRE-amended media. Cell-wall proteome analyses revealed upregulation of oxidative stress-related alkyl hydroperoxide reductase, and DNA-protecting protein chain (Dlp-2), in response to GRE and TRE, respectively. Metabolism-related enzymes like 2-amino-3-ketobutyrate coenzyme A ligase and 2-methylcitrate dehydratase and a 60 kDa chaperonin were up-regulated in response to TRE and GRE. In response to B. cereus, the plant roots altered their exudate-chemodiversity with respect to carbohydrates, organic acids, alkanes, and polyols. TRE-induced changes in surface components of B. cereus may contribute to successful root colonization and subsequent plant growth promotion.	[Dutta, Swarnalee; Rani, T. Swaroopa; Podile, Appa Rao] Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Podile, AR (corresponding author), Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	arpsl@uohyd.ernet.in	Podile, Appa Rao/W-5077-2018	Podile, Appa Rao/0000-0003-3208-765X	Department of Science and Technology Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions (DST-FIST); University Grants Commission Centre for Advanced Studies (UGC-CAS); Department of Biotechnology (DBT)-Research Associateship; DBT-Centre for Research and Education in Biology and Biotechnology (DBT-CREBB); DST-INSPIRE	Department of Science and Technology Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions (DST-FIST)(Department of Science & Technology (India)); University Grants Commission Centre for Advanced Studies (UGC-CAS)(University Grants Commission, India); Department of Biotechnology (DBT)-Research Associateship(Department of Biotechnology (DBT) India); DBT-Centre for Research and Education in Biology and Biotechnology (DBT-CREBB); DST-INSPIRE(Department of Science & Technology (India))	The authors gratefully acknowledge the financial support of the Department of Science and Technology Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions (DST-FIST) to the Department of Plant Sciences, and of the University Grants Commission Centre for Advanced Studies (UGC-CAS) to the School of Life Sciences. SD thanks the Department of Biotechnology (DBT)-Research Associateship. TSR thanks DBT-Centre for Research and Education in Biology and Biotechnology (DBT-CREBB) and DST-INSPIRE for research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacilio-Jimenez M, 2003, PLANT SOIL, V249, P271, DOI 10.1023/A:1022888900465; Benizri E, 2001, BIOCONTROL SCI TECHN, V11, P557, DOI 10.1080/09583150120076120; Bergmeyer HU, 1963, METHOD ENZYMAT AN; Buensanteai N., 2008, J AGR SCI TECH-IRAN, V41, P101; Burdman S, 2001, MOL PLANT MICROBE IN, V14, P555, DOI 10.1094/MPMI.2001.14.4.555; Cakmak G, 2006, AQUAT TOXICOL, V77, P53, DOI 10.1016/j.aquatox.2005.10.015; Carrillo AE, 2002, NATURWISSENSCHAFTEN, V89, P428, DOI 10.1007/s00114-002-0347-6; Che FS, 2000, J BIOL CHEM, V275, P32347, DOI 10.1074/jbc.M004796200; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chung JW, 2007, MICROBIOL-SGM, V153, P206, DOI 10.1099/mic.0.2006/000455-0; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Cole JN, 2007, PROTEOMICS, V7, P4488, DOI 10.1002/pmic.200700626; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Cyran MR, 2007, J AGR FOOD CHEM, V55, P2329, DOI 10.1021/jf062473g; Dardanelli MS, 2010, PLANT SOIL, V328, P483, DOI 10.1007/s11104-009-0127-6; Das SN, 2010, J PLANT GROWTH REGUL, V29, P409, DOI 10.1007/s00344-010-9152-1; Das SN, 2010, WORLD J MICROB BIOT, V26, P1875, DOI 10.1007/s11274-010-0369-8; Dogan A, 2007, FOOD CHEM, V100, P1106, DOI 10.1016/j.foodchem.2005.11.017; Dutta S, 2010, CRIT REV MICROBIOL, V36, P232, DOI 10.3109/10408411003766806; Filip Z, 2004, MICROBIOL RES, V159, P257, DOI 10.1016/j.micres.2004.05.002; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Garip S, 2009, FOOD CHEM, V113, P1301, DOI 10.1016/j.foodchem.2008.08.063; Gorgulu ST, 2007, APPL SPECTROSC, V61, P300, DOI 10.1366/000370207780220903; Haque MA, 2004, MICROBIOL-SGM, V150, P1397, DOI 10.1099/mic.0.26767-0; Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; HELM D, 1995, FEMS MICROBIOL LETT, V126, P75, DOI 10.1111/j.1574-6968.1995.tb07393.x; HEULIN T, 1987, BIOL FERT SOILS, V4, P9; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P1121, DOI 10.1094/MPMI-19-1121; Kamnev AA, 2001, J MOL STRUCT, V563, P199, DOI 10.1016/S0022-2860(00)00877-2; Kamnev AA, 1997, J MOL STRUCT, V408, P201, DOI 10.1016/S0022-2860(96)09532-4; Kamnev AA, 2008, MICROB ECOL, V56, P615, DOI 10.1007/s00248-008-9381-z; Kamnev AA, 2008, SPECTROSC-INT J, V22, P83, DOI 10.1155/2008/862085; Kishore GK, 2005, J PHYTOPATHOL, V153, P169, DOI 10.1111/j.1439-0434.2005.00951.x; Kishore GK, 2005, LETT APPL MICROBIOL, V40, P260, DOI 10.1111/j.1472-765X.2005.01664.x; Kloepper JW, 1996, BIOSCIENCE, V46, P406, DOI 10.2307/1312874; Kravchenko LV, 2003, MICROBIOLOGY+, V72, P37, DOI 10.1023/A:1022269821379; Mantelin S, 2006, PLANTA, V223, P591, DOI 10.1007/s00425-005-0106-y; Mazzola M, 2004, MICROB ECOL, V48, P338, DOI 10.1007/s00248-003-1067-y; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Mohamed W, 2010, INFECT IMMUN, V78, P3306, DOI 10.1128/IAI.00210-10; Mols M, 2010, ENVIRON MICROBIOL, V12, P873, DOI 10.1111/j.1462-2920.2009.02132.x; Nagahashi G, 2000, MYCOL RES, V104, P1453, DOI 10.1017/S0953756200002860; Okubara PA, 2004, BIOL CONTROL, V30, P392, DOI 10.1016/j.biocontrol.2003.11.003; Persello-Cartieaux F, 2001, PLANTA, V212, P190, DOI 10.1007/s004250000384; PHILLIPS DA, 1992, PLANT PHYSIOL, V99, P1526, DOI 10.1104/pp.99.4.1526; Podile AR, 2006, PLANT-ASSOCIATED BACTERIA, P195; Robert P, 2005, J AGR FOOD CHEM, V53, P7014, DOI 10.1021/jf051145y; ROMANTSCHUK M, 1992, ANNU REV PHYTOPATHOL, V30, P225, DOI 10.1146/annurev.py.30.090192.001301; Rubio C, 2006, J MICROBIOL METH, V64, P287, DOI 10.1016/j.mimet.2005.05.013; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Seul KJ, 2007, J MICROBIOL BIOTECHN, V17, P934; Shimizu R, 2003, MOL GENET GENOMICS, V269, P21, DOI 10.1007/s00438-003-0817-3; Slavov S, 2004, J PLANT PHYSIOL, V161, P847, DOI 10.1016/j.jplph.2003.11.007; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; Szeghalmi A, 2007, ANAL BIOANAL CHEM, V387, P1779, DOI 10.1007/s00216-006-0850-2; Takatsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020985; Walz Alexander, 2007, Proteome Sci, V5, P11, DOI 10.1186/1477-5956-5-11; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; Wasim M, 2009, MICROBIOL-SGM, V155, P1192, DOI 10.1099/mic.0.022541-0	64	43	44	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78369	10.1371/journal.pone.0078369	http://dx.doi.org/10.1371/journal.pone.0078369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205213	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300056
J	Schijffelen, M; Konstantinov, SR; Lina, G; Spiliopoulou, I; van Duijkeren, E; Brouwer, EC; Fluit, AC				Schijffelen, Maarten; Konstantinov, Sergey R.; Lina, Gerard; Spiliopoulou, Iris; van Duijkeren, Engeline; Brouwer, Ellen C.; Fluit, Ad C.			Whole Genome Analysis of Epidemiologically Closely Related Staphylococcus aureus Isolates	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; METHICILLIN-RESISTANT; NASAL CARRIAGE; VIRULENCE; SEQUENCE; CARRIERS	The change of the bacteria from colonizers to pathogens is accompanied by a drastic change in expression profiles. These changes may be due to environmental signals or to mutational changes. We therefore compared the whole genome sequences of four sets of S. aureus isolates. Three sets were from the same patients. The isolates of each pair (S1800/S1805, S2396/S2395, S2398/S2397, an isolate from colonization and an isolate from infection, respectively) were obtained within <30 days of each other and the isolate from infection caused skin infections. The isolates were then compared for differences in gene content and SNPs. In addition, a set of isolates from a colonized pig and a farmer from the same farm at the same time (S0462 and S0460) were analyzed. The isolates pair S1800/S1805 showed a difference in a prophage, but these are easily lost or acquired. However, S1805 contained an integrative conjugative element not present in S1800. In addition, 92 SNPs were present in a variety of genes and the isolates S1800 and S1805 were not considered a pair. Between S2395/S2396 two SNPs were present: one was in an intergenic region and one was a synonymous mutation in a putative membrane protein. Between S2397/S2398 only one synonymous mutation in a putative lipoprotein was found. The two farm isolates were very similar and showed 12 SNPs in genes that belong to a number of different functional categories. However, we cannot pinpoint any gene that explains the change from carrier status to infection. The data indicate that differences between the isolate from infection and the colonizing isolate for S2395/S2396 and S2397/S2398 exist as well as between isolates from different hosts, but S1800/S1805 are not clonal.	[Schijffelen, Maarten; Konstantinov, Sergey R.; Brouwer, Ellen C.; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Lina, Gerard] Univ Lyon 1, Lab Bacteriol, CNR Staphylocoques, F-69365 Lyon, France; [Spiliopoulou, Iris] Univ Patras, Sch Med, Dept Microbiol, GR-26110 Patras, Greece; [van Duijkeren, Engeline] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, NL-3508 TC Utrecht, Netherlands; [van Duijkeren, Engeline] Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Patras; Utrecht University	Fluit, AC (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	a.c.fluit@umcutrecht.nl	Lina, Gerard J/L-9352-2014	Lina, Gerard/0000-0002-9236-7998	European Union FP7-HEALTH project CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions (CONCORD) [222718]	European Union FP7-HEALTH project CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions (CONCORD)	The study was funded in part by the European Union FP7-HEALTH project CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions (CONCORD). Grant agreement number: 222718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloemendaal ALA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011841; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Carpaij N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016419; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; HU L, 1995, J MED MICROBIOL, V42, P127, DOI 10.1099/00222615-42-2-127; Kalmeijer MD, 2000, INFECT CONT HOSP EP, V21, P319, DOI 10.1086/501763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Ruef C, 1996, J THORAC CARDIOV SUR, V112, P681, DOI 10.1016/S0022-5223(96)70052-1; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Stegger M, 2012, J BACTERIOL, V194, P1625, DOI 10.1128/JB.06653-11; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109	27	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78340	10.1371/journal.pone.0078340	http://dx.doi.org/10.1371/journal.pone.0078340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205205	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600098
J	Casey, MF; Neidell, M				Casey, Martin F.; Neidell, Matthew			Disconcordance in Statistical Models of Bisphenol A and Chronic Disease Outcomes in NHANES 2003-08	PLOS ONE			English	Article							HUMAN EXPOSURE; ENDOCRINE DISRUPTORS; NATIONAL-HEALTH; US POPULATION; URINARY; ASSOCIATION; VARIABILITY; SAMPLES; ADULTS	Background: Bisphenol A (BPA), a high production chemical commonly found in plastics, has drawn great attention from researchers due to the substance's potential toxicity. Using data from three National Health and Nutrition Examination Survey (NHANES) cycles, we explored the consistency and robustness of BPA's reported effects on coronary heart disease and diabetes. Methods And Findings: We report the use of three different statistical models in the analysis of BPA: (1) logistic regression, (2) log-linear regression, and (3) dose-response logistic regression. In each variation, confounders were added in six blocks to account for demographics, urinary creatinine, source of BPA exposure, healthy behaviours, and phthalate exposure. Results were sensitive to the variations in functional form of our statistical models, but no single model yielded consistent results across NHANES cycles. Reported ORs were also found to be sensitive to inclusion/exclusion criteria. Further, observed effects, which were most pronounced in NHANES 2003-04, could not be explained away by confounding. Conclusions: Limitations in the NHANES data and a poor understanding of the mode of action of BPA have made it difficult to develop informative statistical models. Given the sensitivity of effect estimates to functional form, researchers should report results using multiple specifications with different assumptions about BPA measurement, thus allowing for the identification of potential discrepancies in the data.	[Casey, Martin F.; Neidell, Matthew] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA; [Casey, Martin F.] Icahn Sch Med Mt Sinai, New York, NY USA	Columbia University; Icahn School of Medicine at Mount Sinai	Casey, MF (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.	martin.casey@mssm.edu		Casey, Martin/0000-0002-5049-012X				Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; [Anonymous], 2008, NBC NEWS; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; BICK J, 2006, NY TIMES; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Bolt HM, 2011, ARCH TOXICOL, V85, P1491, DOI 10.1007/s00204-011-0785-z; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Calafat A. M., 2010, LAB PROCEDURE MANUAL; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Calafat AM, 2009, ENVIRON HEALTH PERSP, V117, P639, DOI 10.1289/ehp.0800265; *CDC, 2005, AN REP GUID NAT HLTH; CDC, 2011, NATL HLTH NUTR EXAMI; Cooper JE, 2011, CHEMOSPHERE, V85, P943, DOI 10.1016/j.chemosphere.2011.06.060; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Hu WY, 2012, MOL CELL ENDOCRINOL, V354, P63, DOI 10.1016/j.mce.2011.08.032; Kelland K., 2010, REUTERS; Koch HM, 2012, J EXPO SCI ENV EPID, V22, P610, DOI 10.1038/jes.2012.39; LaKind JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051086; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Mariscal-Arcas M, 2009, FOOD CHEM TOXICOL, V47, P506, DOI 10.1016/j.fct.2008.12.011; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; *NAT CTR HLTH STAT, 2009, DAT DOC COD FREQ UR, P2007; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Noonan GO, 2011, J AGR FOOD CHEM, V59, P7178, DOI 10.1021/jf201076f; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Saili KS, 2012, TOXICOLOGY, V291, P83, DOI 10.1016/j.tox.2011.11.001; SEABROOK A, 2007, IS CHEM PLASTIC BOTT; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Spivey A, 2009, ENVIRON HEALTH PERSP, V117, pA541, DOI 10.1289/ehp.117-a541; Steenland K, 2011, ENVIRON HEALTH PERSP, V119, P831, DOI 10.1289/ehp.1002521; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Teppala S, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/598180; Vaidya SV, 2012, J ASTHMA, V49, P800, DOI 10.3109/02770903.2012.721041; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Whitcomb BW, 2008, PAEDIATR PERINAT EP, V22, P597, DOI 10.1111/j.1365-3016.2008.00969.x; Yan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025455; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P7044, DOI 10.1021/es200976k; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565	50	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79944	10.1371/journal.pone.0079944	http://dx.doi.org/10.1371/journal.pone.0079944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223205	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200098
J	Wang, ZJ; Lakes, RS; Golob, M; Eickhoff, JC; Chesler, NC				Wang, Zhijie; Lakes, Roderic S.; Golob, Mark; Eickhoff, Jens C.; Chesler, Naomi C.			Changes in Large Pulmonary Arterial Viscoelasticity in Chronic Pulmonary Hypertension	PLOS ONE			English	Article							CHRONIC HYPOXIA; MECHANICAL-PROPERTIES; VENTRICULAR-FUNCTION; ELASTIC PROPERTIES; COLLAGEN-FIBERS; WAVE REFLECTION; CONSCIOUS DOGS; IN-VIVO; WALL; PRESSURE	Conduit pulmonary artery (PA) stiffening is characteristic of pulmonary arterial hypertension (PAH) and is an excellent predictor of mortality due to right ventricular (RV) overload. To better understand the impact of conduit PA stiffening on RV afterload, it is critical to examine the arterial viscoelastic properties, which require measurements of elasticity (energy storage behavior) and viscosity (energy dissipation behavior). Here we hypothesize that PAH leads to frequency-dependent changes in arterial stiffness (related to elasticity) and damping ratio (related to viscosity) in large PAs. To test our hypothesis, PAH was induced by the combination of chronic hypoxia and an antiangiogenic compound (SU5416) treatment in mice. Static and sinusoidal pressure-inflation tests were performed on isolated conduit PAs at various frequencies (0.01-20 Hz) to obtain the mechanical properties in the absence of smooth muscle contraction. Static mechanical tests showed significant stiffening of large PAs with PAH, as expected. In dynamic mechanical tests, structural stiffness (kappa) increased and damping ratio (D) decreased at a physiologically relevant frequency (10 Hz) in hypertensive PAs. The dynamic elastic modulus (E), a material stiffness, did not increase significantly with PAH. All dynamic mechanical properties were strong functions of frequency. In particular, kappa, E and D increased with increasing frequency in control PAs. While this behavior remained for D in hypertensive PAs, it reversed for kappa and E. Since these novel dynamic mechanical property changes were found in the absence of changes in smooth muscle cell content or contraction, changes in collagen and proteoglycans and their interactions are likely critical to arterial viscoelasticity in a way that has not been previously described. The impact of these changes in PA viscoelasticity on RV afterload in PAH awaits further investigation.	[Wang, Zhijie; Lakes, Roderic S.; Chesler, Naomi C.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA; [Lakes, Roderic S.] Univ Wisconsin, Dept Engn Phys, Madison, WI USA; [Lakes, Roderic S.; Golob, Mark] Univ Wisconsin, Dept Mat Sci, Madison, WI USA; [Eickhoff, Jens C.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chesler, NC (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA.	chesler@engr.wisc.edu	; Stefanadis, Christodoulos/ABH-2232-2020	Chesler, Naomi/0000-0002-7612-5796; Stefanadis, Christodoulos/0000-0001-5974-6454	NIH [R01 HL086939]; AHA Midwest Affiliate Postdoctoral Fellowship [10POST2640148]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Midwest Affiliate Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by NIH R01 HL086939 (NCC) and AHA Midwest Affiliate Postdoctoral Fellowship 10POST2640148 (ZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshima D, 2009, J PHARMACOL SCI, V110, P182, DOI 10.1254/jphs.09059FP; Armentano RL, 2007, IEEE ENG MED BIOL, V26, P62, DOI 10.1109/MEMB.2007.289123; Armentano RL, 2006, HYPERTENSION, V47, P384, DOI 10.1161/01.HYP.0000205915.15940.15; ARMENTANO RL, 1995, CIRC RES, V76, P468, DOI 10.1161/01.RES.76.3.468; Armentano RL, 1998, HYPERTENSION, V31, P534, DOI 10.1161/01.HYP.31.1.534; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P458, DOI 10.1113/jphysiol.1961.sp006687; BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686; Bhatia A, 2005, P ANN INT IEEE EMBS, P2979, DOI 10.1109/IEMBS.2005.1617099; BRODT M, 1995, REV SCI INSTRUM, V66, P5292, DOI 10.1063/1.1146101; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; COX RH, 1984, AM J PHYSIOL, V246, pH90, DOI 10.1152/ajpheart.1984.246.1.H90; Danpinid A, 2010, ULTRASONICS, V50, P654, DOI 10.1016/j.ultras.2010.01.003; Dourte LM, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006200; Elliott DM, 2003, ANN BIOMED ENG, V31, P599, DOI 10.1114/1.1567282; FOURIE PR, 1992, CARDIOVASC RES, V26, P839, DOI 10.1093/cvr/26.9.839; Gamero LG, 2001, EXP PHYSIOL, V86, P519, DOI 10.1113/eph8602172; Gan CTJ, 2007, CHEST, V132, P1906, DOI 10.1378/chest.07-1246; Gomez-Arroyo J, 2012, AM J PHYSIOL-LUNG C, V302, pL977, DOI 10.1152/ajplung.00362.2011; Grignola JC, 2007, INT J CARDIOL, V115, P171, DOI 10.1016/j.ijcard.2006.03.007; Hunter KS, 2010, J APPL PHYSIOL, V108, P968, DOI 10.1152/japplphysiol.01173.2009; Kass DA, 2005, HYPERTENSION, V46, P185, DOI 10.1161/01.HYP.0000168053.34306.d4; Kawut SM, 2005, AM J CARDIOL, V95, P199, DOI 10.1016/j.amjcard.2004.09.006; Kobs RW, 2005, AM J PHYSIOL-HEART C, V288, pH1209, DOI 10.1152/ajpheart.01129.2003; Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722; Lammers SR, 2008, AM J PHYSIOL-HEART C, V295, pH1451, DOI 10.1152/ajpheart.00127.2008; LEAROYD BM, 1966, CIRC RES, V18, P278, DOI 10.1161/01.RES.18.3.278; Lee T, 2000, REV SCI INSTRUM, V71, P2855, DOI 10.1063/1.1150703; Li LP, 2004, BIORHEOLOGY, V41, P181; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Lichtenstein O, 1998, HYPERTENSION, V32, P346, DOI 10.1161/01.HYP.32.2.346; Liu Q, 2012, J BIOMECH, V45, P1192, DOI 10.1016/j.jbiomech.2012.01.035; Lujan TJ, 2009, J APPL PHYSIOL, V106, P423, DOI 10.1152/japplphysiol.90748.2008; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; Mahapatra S, 2006, J AM SOC ECHOCARDIOG, V19, P1045, DOI 10.1016/j.echo.2006.03.008; Mam V, 2010, J PHARMACOL EXP THER, V332, P455, DOI 10.1124/jpet.109.160119; Mangoni AA, 1996, J HYPERTENS, V14, P897, DOI 10.1097/00004872-199607000-00013; Manisty C, 2010, J AM COLL CARDIOL, V56, P24, DOI 10.1016/j.jacc.2010.03.030; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Naeije R, 2007, REV MAL RESPIR, V24, P481, DOI 10.1016/S0761-8425(07)91571-5; Naeije Robert, 2005, Ital Heart J, V6, P784; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Ooi CY, 2010, AM J PHYSIOL-HEART C, V299, pH1823, DOI 10.1152/ajpheart.00493.2009; OROURKE MF, 1993, J HYPERTENS, V11, P327, DOI 10.1097/00004872-199304000-00001; Pagnamenta A, 2010, J APPL PHYSIOL, V109, P1080, DOI 10.1152/japplphysiol.00467.2010; Quarck R, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-27; Robinson PS, 2004, J BIOMECH ENG-T ASME, V126, P252, DOI 10.1115/1.1695570; Sakao S, 2011, RESPIRATION, V81, P253, DOI 10.1159/000322011; Santana DB, 2005, J APPL PHYSIOL, V98, P605, DOI 10.1152/japplphysiol.00361.2004; Silver FH, 2002, CONNECT TISSUE RES, V43, P569, DOI 10.1080/03008200290001302; Stefanadis C, 1997, CIRCULATION, V96, P1853, DOI 10.1161/01.CIR.96.6.1853; Tabima DM, 2012, J BIOMECH, V45, P799, DOI 10.1016/j.jbiomech.2011.11.020; Tabima DM, 2010, AM J PHYSIOL-HEART C, V299, pH2069, DOI 10.1152/ajpheart.00805.2010; Tabima DM, 2010, J BIOMECH, V43, P1864, DOI 10.1016/j.jbiomech.2010.03.033; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; TAYLOR MG, 1966, BIOPHYS J, V6, P697, DOI 10.1016/S0006-3495(66)86689-4; Tian L, 2012, ANN BIOMED ENG, V40, P1419, DOI 10.1007/s10439-012-0509-4; Tian L, 2011, AM J PHYSIOL-HEART C, V301, pH1810, DOI 10.1152/ajpheart.00025.2011; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Wang Z, 2012, EFFECTS COL IN PRESS; Wang ZJ, 2012, BIOMECH MODEL MECHAN, V11, P279, DOI 10.1007/s10237-011-0309-z; Wang Zhijie, 2011, Pulm Circ, V1, P212, DOI 10.4103/2045-8932.83453; YANAGISHITA M, 1993, ACTA PATHOL JAPON, V43, P283; Yuan XJ, 2011, TXB PULMONARY VASCUL; Zhao JB, 2002, AM J PHYSIOL-HEART C, V282, pH622, DOI 10.1152/ajpheart.00620.2000	66	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78569	10.1371/journal.pone.0078569	http://dx.doi.org/10.1371/journal.pone.0078569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223157	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200049
J	Xu, YF; Li, H; Chen, W; Yao, XM; Xing, Y; Wang, X; Zhong, J; Meng, GX				Xu, Yongfen; Li, Hua; Chen, Wei; Yao, Xiaomin; Xing, Yue; Wang, Xun; Zhong, Jin; Meng, Guangxun			Mycoplasma hyorhinis Activates the NLRP3 Inflammasome and Promotes Migration and Invasion of Gastric Cancer Cells	PLOS ONE			English	Article							MALIGNANT-TRANSFORMATION; MEMBRANE LIPOPROTEINS; INTERLEUKIN-18; P37; INFECTIONS; INVASIVENESS; METASTASIS; CARCINOMA; GROWTH; SERUM	Background: Mycoplasma hyorhinis (M.hyorhinis, M.hy) is associated with development of gastric and prostate cancers. The NLRP3 inflammasome, a protein complex controlling maturation of important pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18, is also involved in tumorigenesis and metastasis of various cancers. Methodology/Principal Findings: To clarify whether M.hy promoted tumor development via inflammasome activation, we analyzed monocytes for IL-1 beta and IL-18 production upon M.hy challenge. When exposed to M.hy, human monocytes exhibited rapid and robust IL-1 beta and IL-18 secretion. We further identified that lipid-associated membrane protein (LAMP) from M.hy was responsible for IL-1 beta induction. Applying competitive inhibitors, gene specific shRNA and gene targeted mice, we verified that M.hy induced IL-1 beta secretion was NLRP3-dependent in vitro and in vivo. Cathepsin B activity, K+ efflux, Ca2+ influx and ROS production were all required for the NLRP3 inflammasome activation by M.hy. Importantly, it is IL-1 beta but not IL-18 produced from macrophages challenged with M.hy promoted gastric cancer cell migration and invasion. Conclusions: Our data suggest that activation of the NLRP3 inflammasome by M.hy may be associated with its promotion of gastric cancer metastasis, and anti-M.hy therapy or limiting NLRP3 signaling could be effective approach for control of gastric cancer progress.	[Xu, Yongfen; Li, Hua; Chen, Wei; Yao, Xiaomin; Xing, Yue; Zhong, Jin; Meng, Guangxun] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wang, Xun] Shanghai Blood Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Zhong, J (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	jzhong@sibs.ac.cn; gxmeng@sibs.ac.cn	Xu, Yongfen/CAF-5582-2022; li, hua/I-1881-2016; Zhong, Jin/M-6859-2018	Xu, Yongfen/0000-0002-2845-7753; li, hua/0000-0001-6367-4764; xing, yue/0000-0001-5845-2286; Zhong, Jin/0000-0002-3554-1275	Chinese Academy of Sciences; Natural Science Foundation of China [91029707, 31170868]; Shanghai Natural Science foundation [11ZR1442600]; Novo Nordisk-CAS Research Foundation; SA-SIBS Scholarship Program; National Key Programs on Infectious Disease [2012ZX10002007-003]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science foundation(Natural Science Foundation of Shanghai); Novo Nordisk-CAS Research Foundation(Novo Nordisk Foundation); SA-SIBS Scholarship Program; National Key Programs on Infectious Disease	This work was supported by grants from 100 Talent Program of the Chinese Academy of Sciences, Natural Science Foundation of China (91029707, 31170868), Shanghai Natural Science foundation (11ZR1442600), Novo Nordisk-CAS Research Foundation, SA-SIBS Scholarship Program, as well as grants from the National Key Programs on Infectious Disease (2012ZX10002007-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chow MT, 2012, IMMUNOL CELL BIOL; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; He J, 2009, CLIN VACCINE IMMUNOL, V16, P1750, DOI 10.1128/CVI.00281-09; Hernandez L, 2009, METHODS MOL BIOL, V571, P227, DOI 10.1007/978-1-60761-198-1_15; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kang JS, 2009, CARCINOGENESIS, V30, P1987, DOI 10.1093/carcin/bgp158; Ketcham CM, 2005, MOL CANCER THER, V4, P1031, DOI 10.1158/1535-7163.MCT-05-0040; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim KE, 2007, ONCOGENE, V26, P1468, DOI 10.1038/sj.onc.1209926; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Kornspan JD, 2012, FEMS MICROBIOL LETT; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lebel-Binay S, 2000, EUR CYTOKINE NETW, V11, P15; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lei G, 2013, CELL RES; Liu WB, 2007, CAN J MICROBIOL, V53, P270, DOI 10.1139/W06-120; Lo SC, 1992, AM SOC MICROBIOL, P525; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; NOELLE RJ, 1992, ADV EXP MED BIOL, V323, P131; Osawa R, 2011, J INFECTION, V62, P119, DOI 10.1016/j.jinf.2010.10.002; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rawadi G, 1996, INFECT IMMUN, V64, P637, DOI 10.1128/IAI.64.2.637-643.1996; Rawadi G, 1998, J IMMUNOL, V160, P1330; ROBERTS ED, 1962, CORNELL VET, V52, P306; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sung HR, 2006, J MICROBIOL, V44, P42; Tanaka F, 2000, CANCER RES, V60, P4838; Thong-Ngam D, 2006, WORLD J GASTROENTERO, V12, P4473, DOI 10.3748/wjg.v12.i28.4473; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; WAITES KB, 1999, MANUAL CLIN MICROBIO, pCH56; Yamanaka N, 2004, CLIN CANCER RES, V10, P1853, DOI 10.1158/1078-0432.CCR-03-0300; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; Yang J, 2003, MICROB PATHOGENESIS, V34, P17, DOI 10.1016/S0882-4010(02)00190-0; Zhang B, 2004, LEUKEMIA RES, V28, P91, DOI 10.1016/S0145-2126(03)00121-8; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	62	58	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77955	10.1371/journal.pone.0077955	http://dx.doi.org/10.1371/journal.pone.0077955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223129	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200021
J	Chih, PC; Yang, YC; Wu, JS; Chang, YF; Lu, FH; Chang, CJ				Chih, Pei-Chi; Yang, Yi-Ching; Wu, Jin-Shang; Chang, Yin-Fan; Lu, Feng-Hwa; Chang, Chih-Jen			Overweight Associated with Increased Risk of Erosive Esophagitis in a Non-Obese Taiwanese Population	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; METABOLIC SYNDROME; ADIPOSE-TISSUE; ESOPHAGOGASTRIC JUNCTION; BARRETTS-ESOPHAGUS; HIATAL-HERNIA; LIFE-STYLE; OBESITY; EPIDEMIOLOGY	Objective: To investigate the relationship between overweight and erosive esophagitis (EE) in a non-obese Taiwanese population. Design and Methods: A total of 7,352 subjects (non-obese, 5,826; obese, 1,526) from a health examination center at National Cheng Kung University Hospital were enrolled. Central obesity was defined by a waist circumference (WC) >= 90 cm in male and 80 cm in female. Overweight was defined as body mass index (BMI) of 24-26.9 kg/m(2), and general obesity as BMI >= 27 kg/m(2). The Los Angeles classification was adopted to determine the presence of EE. Results: There were significant differences in the prevalence of central obesity and different BMI status between subjects with and without EE in total and non-obese population. In total population, multivariate analyses revealed central obesity (OR, 1.17, 95% CI, 1.02-1.34, p = 0.021) and being obese (OR, 1.28, 95% CI, 1.07-1.52, p = 0.007)/overweight (OR, 1.25, 95% CI, 1.08-1.45, p = 0.003) had positive associations with EE in different model, respectively. When considering the joint effect of central obesity and BMI status, overweight (OR, 1.22; 95% CI, 1.04-1.44; p = 0.016) remained as an independent associated factor of EE but central obesity (OR, 1.06; 95% CI, 0.89-1.26; p = 0.549)/being obese (OR, 1.22; 95% CI, 0.98-1.53; p = 0.082) did not. As for non-obese group, separate model showed central obesity (OR, 1.19, 95% CI, 1.00-1.40, p = 0.046) and overweight (OR, 1.24; 95% CI, 1.07-1.44, p = 0.005) was positively associated with EE, respectively. However, being overweight (OR, 1.20; 95% CI, 1.02-1.42, p = 0.030) but not central obesity (OR, 1.08; 95% CI, 0.90-1.31; p = 0.398) was positively related to EE with considering the effect of overweight and central obesity simultaneously. Conclusion: Overweight effect on EE was more detrimental than central obesity in non-obese subjects. In addition, male gender, hiatus hernia and alcohol use were also associated with increased risk of EE.	[Chih, Pei-Chi] Madou Sin Lau Hosp, Dept Family Med, Tainan, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Chang, Yin-Fan; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Wu, JS (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	z8508014@email.ncku.edu.tw; em75210@email.ncku.edu.tw	Yang, Yi-Ching/C-7033-2014	Yang, Yi-Ching/0000-0003-1391-8040	Department of Family Medicine, National Cheng-Kung University Hospital [NCKUHFM-101-005]	Department of Family Medicine, National Cheng-Kung University Hospital	This study was supported by the grants from the Department of Family Medicine, National Cheng-Kung University Hospital (NCKUHFM-101-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-58; Anderson LA, 2009, GASTROENTEROLOGY, V136, P799, DOI 10.1053/j.gastro.2008.12.005; Bertin E, 2000, DIABETES METAB, V26, P178; Boguradzka A, 2011, POL ARCH MED WEWN, V121, P230, DOI 10.20452/pamw.1063; Bor S, 1999, DIGEST DIS SCI, V44, P290, DOI 10.1023/A:1026646215879; Cai N, 2012, WORLD J GASTROENTERO, V18, P2545, DOI 10.3748/wjg.v18.i20.2545; Cao WB, 2004, AM J PHYSIOL-GASTR L, V287, pG1131, DOI 10.1152/ajpgi.00216.2004; Chang CY, 2011, J GASTROEN HEPATOL, V26, P240, DOI 10.1111/j.1440-1746.2010.06529.x; Chen TS, 2007, J CLIN GASTROENTEROL, V41, P819, DOI 10.1097/01.mcg.0000225658.30803.79; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collings KL, 2003, MED SCI SPORT EXER, V35, P730, DOI 10.1249/01.MSS.0000064937.99001.56; de Vries DR, 2008, AM J GASTROENTEROL, V103, P1349, DOI 10.1111/j.1572-0241.2008.01909.x; Du J, 2007, WORLD J GASTROENTERO, V13, P6009, DOI 10.3748/wjg.13.6009; El-Serag HB, 2008, GUT, V57, DOI 10.1136/gut.2007.127878; El-Serag HB, 2007, GUT, V56, P749, DOI 10.1136/gut.2006.100263; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Festi D, 2009, WORLD J GASTROENTERO, V15, P1690, DOI 10.3748/wjg.15.1690; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Genuth S, 2003, DIABETES CARE, V26, P3160; Goh KL, 2011, J GASTROEN HEPATOL, V26, P2, DOI 10.1111/j.1440-1746.2010.06534.x; Gudlaugsdottir Sunna, 2002, Eur J Intern Med, V13, P369, DOI 10.1016/S0953-6205(02)00090-0; Gunji T, 2011, J GASTROENTEROL, V46, P448, DOI 10.1007/s00535-010-0359-5; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Kang MS, 2007, J GASTROEN HEPATOL, V22, P1656, DOI 10.1111/j.1440-1746.2006.04518.x; Kato M, 2011, J GASTROENTEROL, V46, P1361, DOI 10.1007/s00535-011-0453-3; KEKKI M, 1982, SCAND J GASTROENTERO, V17, P737, DOI 10.3109/00365528209181087; Labenz J, 2004, AM J GASTROENTEROL, V99, P1652, DOI 10.1111/j.1572-0241.2004.30390.x; Lee HL, 2009, J CLIN GASTROENTEROL, V43, P240, DOI 10.1097/MCG.0b013e318167b88a; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Matsuki N, 2013, J GASTROENTEROL, V48, P340, DOI 10.1007/s00535-012-0649-1; Miles MP, 2012, MED SCI SPORT EXER, V44, P2290, DOI 10.1249/MSS.0b013e318267b209; Mittal RK, 1997, NEW ENGL J MED, V336, P924, DOI 10.1056/NEJM199703273361306; Moayyedi P, 2005, ALIMENT PHARM THER, V22, P11, DOI 10.1111/j.1365-2036.2005.02605.x; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; Moki F, 2007, ALIMENT PHARM THER, V26, P1069, DOI 10.1111/j.1365-2036.2007.03454.x; Nam SY, 2009, ALIMENT PHARM THER, V29, P1042, DOI 10.1111/j.1365-2036.2009.03965.x; Nam SY, 2010, GASTROENTEROLOGY, V139, P1902, DOI 10.1053/j.gastro.2010.08.019; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Orlando RC, 2011, ANN NY ACAD SCI, V1232, P369, DOI 10.1111/j.1749-6632.2011.06064.x; Ou JL, 2012, J CHIN MED ASSOC, V75, P60, DOI 10.1016/j.jcma.2011.12.008; Pan WH, 2008, OBES REV, V9, P22, DOI 10.1111/j.1467-789X.2007.00434.x; Pandolfino JE, 2006, GASTROENTEROLOGY, V130, P639, DOI 10.1053/j.gastro.2005.12.016; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Park JH, 2008, WORLD J GASTROENTERO, V14, P5442, DOI 10.3748/wjg.14.5442; Ronkainen J, 2011, AM J GASTROENTEROL, V106, P1946, DOI 10.1038/ajg.2011.326; Selthofer-Relatic K, 2012, MED GLAS, V9, P198; Sopasakis VR, 2005, INT J OBESITY, V29, P1144, DOI 10.1038/sj.ijo.0803002; Tilg H, 2010, GASTROENTEROLOGY, V139, P1823, DOI 10.1053/j.gastro.2010.10.038; Trellakis S, 2012, OBESITY FACTS, V5, P305, DOI 10.1159/000339452; Tseng PH, 2012, DIABETES CARE, V35, P1053, DOI 10.2337/dc11-1596; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wang FW, 2010, DIGEST DIS SCI, V55, P1320, DOI 10.1007/s10620-009-0888-z; Whaley M., 2006, ACSMS GUIDELINES EXE; Wilson LJ, 1999, AM J GASTROENTEROL, V94, P2840, DOI 10.1111/j.1572-0241.1999.01426.x; Wong BCY, 2006, CLIN GASTROENTEROL H, V4, P398, DOI 10.1016/j.cgh.2005.10.011; World Health Organization, 2000, AS PAC PERSP RED OB; Wu JCY, 2007, GASTROENTEROLOGY, V132, P883, DOI 10.1053/j.gastro.2006.12.032; Wu P, 2011, NEUROGASTROENT MOTIL, V23, P989, DOI 10.1111/j.1365-2982.2011.01786.x; You TJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE741, DOI 10.1152/ajpendo.00419.2004	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77932	10.1371/journal.pone.0077932	http://dx.doi.org/10.1371/journal.pone.0077932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223746	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300015
J	Humann, FC; Tiberio, GJ; Hartfelder, K				Humann, Fernanda C.; Tiberio, Gustavo J.; Hartfelder, Klaus			Sequence and Expression Characteristics of Long Noncoding RNAs in Honey Bee Caste Development - Potential Novel Regulators for Transgressive Ovary Size	PLOS ONE			English	Article							APIS-MELLIFERA; JUVENILE-HORMONE; OVARIOLE NUMBER; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; CELL-DEATH; EVOLUTION; LARVAL; IDENTIFICATION; TRANSCRIPTION	Division of labor in social insect colonies relies on a strong reproductive bias that favors queens. Although the ecological and evolutionary success attained through caste systems is well sketched out in terms of ultimate causes, the molecular and cellular underpinnings driving the development of caste phenotypes are still far from understood. Recent genomics approaches on honey bee developmental biology revealed a set of genes that are differentially expressed genes in larval ovaries and associated with transgressive ovary size in queens and massive cell death in workers. Amongst these, two contigs called special attention, both being over 200 bp in size and lacking apparent coding potential. Herein, we obtained their full cDNA sequences. These and their secondary structure characteristics placed in evidence that they are bona fide long noncoding RNAs (lncRNA) differentially expressed in larval ovaries, thus named lncov1 and lncov2. Genomically, both map within a previously identified QTL on chromosome 11, associated with transgressive ovary size in honey bee workers. As lncov1 was over-expressed in worker ovaries we focused on this gene. Real-time qPCR analysis on larval worker ovaries evidenced an expression peak coinciding with the onset of autophagic cell death. Cellular localization analysis through fluorescence in situ hybridization revealed perinuclear spots resembling omega speckles known to regulate trafficking of RNA-binding proteins. With only four lncRNAs known so far in honey bees, two expressed in the ovaries, these findings open a novel perspective on regulatory factors acting in the fine tuning of developmental processes underlying phenotypic plasticity related to social life histories.	[Humann, Fernanda C.; Tiberio, Gustavo J.; Hartfelder, Klaus] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Humann, FC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, SP, Brazil.	fchumann@gmail.com	Hartfelder, Klaus/L-2300-2019; Hartfelder, Klaus/A-4293-2009	Hartfelder, Klaus/0000-0001-7981-8427; Hartfelder, Klaus/0000-0001-7981-8427	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/03171-5, 2012/01808-9, FAPESP 2006/06521-9, FAPESP 2011/15810-2]; Departmento de Biologia Celular e Molecular e Bioagentes patogenicos of FMRP-USP [FAPESP 2004/08868-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Departmento de Biologia Celular e Molecular e Bioagentes patogenicos of FMRP-USP	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, projects 2011/03171-5, and 2012/01808-9), fellowships to FCH (FAPESP 2006/06521-9) and GJT (FAPESP 2011/15810-2), Departmento de Biologia Celular e Molecular e Bioagentes patogenicos of FMRP-USP for granting use of its confocal microcopy facility (FAPESP 2004/08868-0). The funders had no role in study design, data collection and analisys, decision to publish, or preparation of the manuscript.	ASENCOT M, 1985, COMP BIOCHEM PHYS A, V81, P203, DOI 10.1016/0300-9629(85)90289-0; Azevedo SV, 2011, J INSECT PHYSIOL, V57, P38, DOI 10.1016/j.jinsphys.2010.09.004; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Behura SK, 2010, INSECT MOL BIOL, V19, P431, DOI 10.1111/j.1365-2583.2010.01010.x; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Buning J., 1994, INSECT OVARY ULTRAST; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen X, 2010, INSECT MOL BIOL, V19, P799, DOI 10.1111/j.1365-2583.2010.01039.x; Colonello-Frattini NA, 2009, APIDOLOGIE, V40, P481, DOI 10.1051/apido/2009009; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Durham AM, 2005, BIOINFORMATICS, V21, P2812, DOI 10.1093/bioinformatics/bti424; Elsik CG, 2006, GENOME RES, V16, P1329, DOI 10.1101/gr.5580606; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; GODT D, 1995, DEVELOPMENT, V121, P173; Graham AM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-95; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hartfelder K, 1997, INVERTEBR REPROD DEV, V31, P237, DOI 10.1080/07924259.1997.9672582; Hodin J., 2009, PHENOTYPIC PLASTICIT, P423, DOI DOI 10.1201/B10201-12; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Humann FC, 2011, INSECT BIOCHEM MOLEC, V41, P602, DOI 10.1016/j.ibmb.2011.03.013; Jung CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-77; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kiya T, 2012, INT J MOL SCI, V13, P15496, DOI 10.3390/ijms131215496; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lakhotia SC, 2012, WIRES RNA, V3, P779, DOI 10.1002/wrna.1135; Leimar O, 2012, ECOL EVOL, V3, pe414; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Linksvayer TA, 2011, J EVOLUTION BIOL, V24, P1939, DOI 10.1111/j.1420-9101.2011.02331.x; Linksvayer TA, 2009, GENETICS, V183, P693, DOI 10.1534/genetics.109.105452; Liu F, 2011, J INSECT PHYSIOL, V57, P274, DOI 10.1016/j.jinsphys.2010.11.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Louro R, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-4; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Ma HD, 2012, SCI WORLD J, DOI 10.1100/2012/541786; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Makert GR, 2006, BEHAV ECOL SOCIOBIOL, V60, P815, DOI 10.1007/s00265-006-0225-x; Malecova B, 2010, CURR OPIN MOL THER, V12, P214; Mallik M, 2009, GENETICS, V183, P831, DOI 10.1534/genetics.109.108571; Mattick JS, 2011, BIOCHIMIE, V93, P8; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Onorati MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002096; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; RAO JP, 1988, BIOCHIM BIOPHYS ACTA, V950, P30, DOI 10.1016/0167-4781(88)90070-X; Reginato RD, 2002, CELL BIOL INT, V26, P243, DOI 10.1006/cbir.2001.0839; REMBOLD H, 1987, INSECT BIOCHEM, V17, P1003, DOI 10.1016/0020-1790(87)90110-7; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sarikaya DP, 2012, DEV BIOL, V363, P279, DOI 10.1016/j.ydbio.2011.12.017; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; Sawata M, 2004, RNA, V10, P1047, DOI 10.1261/rna.5231504; Sawata M, 2002, RNA, V8, P772, DOI 10.1017/S1355838202028790; Snodgras RE, 1956, ANATOMY HONEY BEE; Ulveling D, 2011, BIOCHIMIE, V93, P633, DOI 10.1016/j.biochi.2010.11.004; Wayne ML, 1997, EVOLUTION, V51, P1156, DOI 10.1111/j.1558-5646.1997.tb03963.x; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803; Zander E., 1916, Z ANGEW ENTOMOL, V3, P1, DOI DOI 10.1111/J.1439-0418.1916.TB00552.X	72	44	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78915	10.1371/journal.pone.0078915	http://dx.doi.org/10.1371/journal.pone.0078915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205350	Green Submitted, gold, Green Published			2022-12-27	WOS:000326373800025
J	Maika, A; Mittinty, MN; Brinkman, S; Harper, S; Satriawan, E; Lynch, JW				Maika, Amelia; Mittinty, Murthy N.; Brinkman, Sally; Harper, Sam; Satriawan, Elan; Lynch, John W.			Changes in Socioeconomic Inequality in Indonesian Children's Cognitive Function from 2000 to 2007: A Decomposition Analysis	PLOS ONE			English	Article							MATERNAL DEPRESSION; HEALTH; ACHIEVEMENT; GRADIENTS; MORTALITY; COUNTRIES; INTELLIGENCE; EDUCATION; POVERTY; FAMILY	Background: Measuring social inequalities in health is common; however, research examining inequalities in child cognitive function is more limited. We investigated household expenditure-related inequality in children's cognitive function in Indonesia in 2000 and 2007, the contributors to inequality in both time periods, and changes in the contributors to cognitive function inequalities between the periods. Methods: Data from the 2000 and 2007 round of the Indonesian Family Life Survey (IFLS) were used. Study participants were children aged 7-14 years (n = 6179 and n = 6680 in 2000 and 2007, respectively). The relative concentration index (RCI) was used to measure the magnitude of inequality. Contribution of various contributors to inequality was estimated by decomposing the concentration index in 2000 and 2007. Oaxaca-type decomposition was used to estimate changes in contributors to inequality between 2000 and 2007. Results: Expenditure inequality decreased by 45% from an RCI = 0.29 (95% CI 0.22 to 0.36) in 2000 to 0.16 (95% CI 0.13 to 0.20) in 2007 but the burden of poorer cognitive function was higher among the disadvantaged in both years. The largest contributors to inequality in child cognitive function were inequalities in per capita expenditure, use of improved sanitation and maternal high school attendance. Changes in maternal high school participation (27%), use of improved sanitation (25%) and per capita expenditures (18%) were largely responsible for the decreasing inequality in children's cognitive function between 2000 and 2007. Conclusions: Government policy to increase basic education coverage for women along with economic growth may have influenced gains in children's cognitive function and reductions in inequalities in Indonesia.	[Maika, Amelia; Mittinty, Murthy N.; Lynch, John W.] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia; [Brinkman, Sally] Telethon Inst Child Hlth Res, Adelaide Branch, Adelaide, SA, Australia; [Harper, Sam] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Satriawan, Elan] Gadjah Mada Univ, Fac Econ & Business, Yogyakarta, Indonesia; [Satriawan, Elan] Natl Team Accelerating Poverty Reduct TNP2K, Jakarta, Indonesia	University of Adelaide; Telethon Kids Institute; McGill University; Gadjah Mada University	Maika, A (corresponding author), Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia.	amelia.maika@adelaide.edu.au	Harper, Sam/A-3406-2008; Brinkman, Sally/GZL-4613-2022; Satriawan, Elan/GON-9304-2022; Lynch, John W/A-4797-2008	Harper, Sam/0000-0002-2767-1053; Brinkman, Sally/0000-0001-7538-4844; Lynch, John W/0000-0003-2781-7902	Commonwealth Government through Department of Education, Employment & Workplace Relations (DEEWR); National Health and Medical Research Council of Australia (NHMRC) [570120]; NHMRC	Commonwealth Government through Department of Education, Employment & Workplace Relations (DEEWR); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Commonwealth Government through the Department of Education, Employment & Workplace Relations (DEEWR) [the International Postgraduate Research Scholarships and the Australian Scholarship Award to AM], and the National Health and Medical Research Council of Australia (NHMRC) [570120 to JWL]. MNM is also supported by funds from the NHMRC awarded to JWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANAL HLTH EQUITY USI; Bangirana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007898; Bradley RH, 2012, CHILD DEV, V83, P76, DOI 10.1111/j.1467-8624.2011.01674.x; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; Brouwers SA, 2009, LEARN INDIVID DIFFER, V19, P330, DOI 10.1016/j.lindif.2008.10.006; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Chib S., 2001, HDB EC, V5, P3569, DOI DOI 10.1016/S1573-4412(01)05010-3; Conti G., 2012, IZA DISCUSSION PAPER; D'Angiulli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007692; Duflo E, 2001, AM ECON REV, V91, P795, DOI 10.1257/aer.91.4.795; Fernald LCH, 2011, DEVELOPMENTAL SCI, V14, P832, DOI 10.1111/j.1467-7687.2010.01032.x; Franz CE, 2011, AM J GERIAT PSYCHIAT, V19, P559, DOI 10.1097/JGP.0b013e3181ef79f1; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Goldberg WA, 2008, PSYCHOL BULL, V134, P77, DOI 10.1037/0033-2909.134.1.77; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Hasegawa T, 2001, CHALLENGING INEQUITI, P90; Henderson M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000777; Hosseinpoor AR, 2006, INT J EPIDEMIOL, V35, P1211, DOI 10.1093/ije/dyl164; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kerckhoff AC, 2001, SOCIOL EDUC, V74, P1, DOI 10.2307/2673142; Kiernan KE, 2008, BRIT J SOCIOL, V59, P783, DOI 10.1111/j.1468-4446.2008.00219.x; Lindelow M, 2006, HEALTH ECON, V15, P263, DOI 10.1002/hec.1058; Lynn R, 2011, PERS INDIV DIFFER, V51, P321, DOI 10.1016/j.paid.2011.02.028; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Martins L, 2010, ECON EDUC REV, V29, P1016, DOI 10.1016/j.econedurev.2010.05.001; Ministry of National Development Planning, 2012, REP ACH MILL DEV GOA; Montt G, 2013, ARE COUNTRIES MOVING; Petterson G, 2012, U SUSSEX DEP EC WORK; Petterson SM, 2001, CHILD DEV, V72, P1794, DOI 10.1111/1467-8624.00379; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Rubin DB, 2004, MULTIPLE IMPUTATION; Santos DN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-202; Sastry N, 2010, DEMOGRAPHY, V47, P777; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Siddiqi A, 2007, INT J HEALTH SERV, V37, P63, DOI 10.2190/JU86-457P-7656-W4W7; Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109; Statistics Indonesia, 2012, STAT YB IND; Strauss J., 2004, WR1441NIANICHD; Strauss J., 2009, 4 WAVE INDONESIA FAM; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Violato M, 2011, HEALTH ECON, V20, P1201, DOI 10.1002/hec.1665; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Wehby GL, 2013, SOC SCI MED, V78, P86, DOI 10.1016/j.socscimed.2012.11.038; Witoelar F., 2009, NOTE CONSTRUCTION IF; World Bank, 2013, COUNTR PARTN STRAT I, P76501; World Bank, 2012, IND EC Q POL FOC; World Bank, 1990, IND STRAT SUST RED P, P10009; Yang S, 2010, AM J PUBLIC HEALTH, V100, P896, DOI 10.2105/AJPH.2009.160341	54	12	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78809	10.1371/journal.pone.0078809	http://dx.doi.org/10.1371/journal.pone.0078809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205322	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500134
J	Sarsam, M; Parkes, LM; Roberts, N; Reid, GS; Kinderman, P				Sarsam, May; Parkes, Laura M.; Roberts, Neil; Reid, Graeme S.; Kinderman, Peter			The Queen and I: Neural Correlates of Altered Self-Related Cognitions in Major Depressive Episode	PLOS ONE			English	Article							BRAIN GLUCOSE-METABOLISM; PAROXETINE; THERAPY	Background: Pervasive negative thoughts about the self are central to the experience of depression. Brain imaging studies in the general population have localised self-related cognitive processing to areas of the medial pre-frontal cortex. Aims: To use fMRI to compare the neural correlates of self-referential processing in depressed and non-depressed participants. Method: Cross-sectional comparison of regional activation using Blood Oxygen Level Dependent (BOLD) fMRI in 13 non-medicated participants with major depressive episode and 14 comparison participants, whilst carrying out a self-referential cognitive task. Results: Both groups showed significant activation of the dorsomedial pre-frontal cortex and posterior cingulate cortex in the 'self-referent' condition. The depressed group showed significantly greater activation in the medial superior frontal cortex during the self-referent task. No difference was observed between groups in the 'other-referent' condition. Conclusions: Major depressive episode is associated with specific neurofunctional changes related to self-referential processing.	[Sarsam, May; Kinderman, Peter] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Parkes, Laura M.] Univ Manchester, Inst Populat Hlth, Ctr Imaging Sci, Manchester, Lancs, England; [Roberts, Neil] Univ Edinburgh, Clin Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Reid, Graeme S.] Univ Lancaster, Div Hlth Res, Lancaster, England	University of Liverpool; University of Manchester; University of Edinburgh; Lancaster University	Kinderman, P (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	p.kinderman@liverpool.ac.uk	Reid, Graeme Stewart/AAG-5241-2019	Reid, Graeme Stewart/0000-0002-2869-787X; Parkes, Laura/0000-0001-6488-507X	University of Liverpool	University of Liverpool	The project was fully funded by the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Beck AT, 1996, PSYCHOL ASSESS; Brewin CR, 1996, ANNU REV PSYCHOL, V47, P33, DOI 10.1146/annurev.psych.47.1.33; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Broome MR, 2009, BRIT J PSYCHIAT, V194, P25, DOI 10.1192/bjp.bp.107.046789; Colombo A, 2003, SOC SCI MED, V56, P1557, DOI 10.1016/S0277-9536(02)00156-9; Department of Health, 2005, NEW WAYS WORK PSYCH; First M. B., 1997, STRUCTURED CLIN INTE; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Gutchess AH, 2007, SOC NEUROSCI-UK, V2, P117, DOI 10.1080/17470910701399029; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Kinderman P, 2005, HARVARD REV PSYCHIAT, V13, P206, DOI 10.1080/10673220500243349; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Lemogne C, 2011, SOC COGN AFFECT NEUR, V6, P426, DOI 10.1093/scan/nsq049; Lemogne C, 2010, J AFFECT DISORDERS, V124, P196, DOI 10.1016/j.jad.2009.11.003; Lemogne C, 2009, SOC COGN AFFECT NEUR, V4, P305, DOI 10.1093/scan/nsp008; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Murphy FC, 2003, PSYCHOL MED, V33, P455, DOI 10.1017/S0033291702007018; Nelson HE., 1982, NATL ADULT READING T; Neurobehavioural Systems Inc, 2001, PRES VERS 9 5; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Yoshimura S, 2013, SOCIAL COGNITIVE AFF; Yoshimura S, 2010, J AFFECT DISORDERS, V122, P76, DOI 10.1016/j.jad.2009.06.017	32	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78844	10.1371/journal.pone.0078844	http://dx.doi.org/10.1371/journal.pone.0078844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205330	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500136
J	Bailis, JM; Gordon, ML; Gurgel, JL; Komor, AC; Barton, JK; Kirsch, IR				Bailis, Julie M.; Gordon, Marcia L.; Gurgel, Jesse L.; Komor, Alexis C.; Barton, Jacqueline K.; Kirsch, Ilan R.			An Inducible, Isogenic Cancer Cell Line System for Targeting the State of Mismatch Repair Deficiency	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; TUMOR-CELLS; RHODIUM METALLOINSERTORS; COLORECTAL-CANCER; EMBRYONIC FIBROBLASTS; SELECTIVELY LETHAL; DRUG-RESISTANCE; LUNG-CANCER; DNA-DAMAGE; MSH2	The DNA mismatch repair system (MMR) maintains genome stability through recognition and repair of single-base mismatches and small insertion-deletion loops. Inactivation of the MMR pathway causes microsatellite instability and the accumulation of genomic mutations that can cause or contribute to cancer. In fact, 10-20% of certain solid and hematologic cancers are MMR-deficient. MMR-deficient cancers do not respond to some standard of care chemotherapeutics because of presumed increased tolerance of DNA damage, highlighting the need for novel therapeutic drugs. Toward this goal, we generated isogenic cancer cell lines for direct comparison of MMR-proficient and MMR-deficient cells. We engineered NCI-H23 lung adenocarcinoma cells to contain a doxycycline-inducible shRNA designed to suppress the expression of the mismatch repair gene MLH1, and compared single cell subclones that were uninduced (MLH1-proficient) versus induced for the MLH1 shRNA (MLH1-deficient). Here we present the characterization of these MMR-inducible cell lines and validate a novel class of rhodium metalloinsertor compounds that differentially inhibit the proliferation of MMR-deficient cancer cells.	[Bailis, Julie M.] Amgen Inc, Oncol Res, San Francisco, CA USA; [Gordon, Marcia L.; Gurgel, Jesse L.; Kirsch, Ilan R.] Amgen Inc, Oncol Res, Seattle, WA USA; [Komor, Alexis C.; Barton, Jacqueline K.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Amgen; Amgen; California Institute of Technology	Bailis, JM (corresponding author), Amgen Inc, Oncol Res, San Francisco, CA USA.	jbailis@amgen.com		Komor, Alexis/0000-0001-5043-0998	NIH [GM33309]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033309, R01GM033309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the NIH (GM33309 to J.K.B.) and NSF (fellowship to A. C. K.) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AHK, 2011, MOL CARCINOGEN, V50, P89, DOI 10.1002/mc.20697; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Brennetot C, 2005, INT J CANCER, V113, P446, DOI 10.1002/ijc.20586; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; Campbell MR, 2006, ONCOGENE, V25, P2531, DOI 10.1038/sj.onc.1209277; Castagnaro A, 2007, EXP LUNG RES, V33, P289, DOI 10.1080/01902140701539687; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Davis TW, 1998, CANCER RES, V58, P767; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Ernst RJ, 2011, BIOCHEMISTRY-US, V50, P10919, DOI 10.1021/bi2015822; Ernst RJ, 2009, J AM CHEM SOC, V131, P2359, DOI 10.1021/ja8081044; Fink D, 1998, CLIN CANCER RES, V4, P1; Hart JR, 2006, P NATL ACAD SCI USA, V103, P15359, DOI 10.1073/pnas.0607576103; Hewish M, 2013, BRIT J CANCER, V108, P983, DOI 10.1038/bjc.2013.3; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kawaguchi M, 2009, INT J ONCOL, V35, P977, DOI 10.3892/ijo_00000411; KOI M, 1994, CANCER RES, V54, P4308; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Komor AC, 2013, CHEM COMMUN, V49, P3617, DOI 10.1039/c3cc00177f; Komor AC, 2012, J AM CHEM SOC, V134, P19223, DOI 10.1021/ja3090687; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lawes DA, 2003, EUR J SURG ONCOL, V29, P201, DOI 10.1053/ejso.2002.1399; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Martin SA, 2011, CANCER RES, V71, P1836, DOI 10.1158/0008-5472.CAN-10-2836; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Rabinovich B, 2006, IMMUNOGENETICS, V58, P81, DOI 10.1007/s00251-005-0078-x; Reitmair AH, 1997, CANCER RES, V57, P3765; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Roschke AV, 2005, P NATL ACAD SCI USA, V102, P2964, DOI 10.1073/pnas.0405578102; Simpson AJG, 1997, ADV CANCER RES, V71, P209, DOI 10.1016/S0065-230X(08)60100-1; Sinicrope FA, 2006, AM J GASTROENTEROL, V101, P2818, DOI 10.1111/j.1572-0241.2006.00845.x; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Taverna P, 2000, CANCER CHEMOTH PHARM, V46, P507, DOI 10.1007/s002800000186; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Umar A, 1997, CANCER RES, V57, P3949; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Vilar E, 2009, CLIN CANCER RES, V15, P2829, DOI 10.1158/1078-0432.CCR-08-2432; Yasin SL, 2011, INT J ONCOL, V39, P719, DOI 10.3892/ijo.2011.1065	45	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78726	10.1371/journal.pone.0078726	http://dx.doi.org/10.1371/journal.pone.0078726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205301	Green Published, Green Accepted, gold			2022-12-27	WOS:000326270700095
J	Serao, NVL; Gonzalez-Pena, D; Beever, JE; Bollero, GA; Southey, BR; Faulkner, DB; Rodriguez-Zas, SL				Serao, Nick V. L.; Gonzalez-Pena, Dianelys; Beever, Jonathan E.; Bollero, German A.; Southey, Bruce R.; Faulkner, Daniel B.; Rodriguez-Zas, Sandra L.			Bivariate Genome-Wide Association Analysis of the Growth and Intake Components of Feed Efficiency	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISMS; CARCASS TRAITS; BOVINE CHROMOSOME-5; COMMERCIAL LINES; HORMONE RECEPTOR; BODY-WEIGHT; GENE; IDENTIFICATION; MULTIVARIATE	Single nucleotide polymorphisms (SNPs) associated with average daily gain (ADG) and dry matter intake (DMI), two major components of feed efficiency in cattle, were identified in a genome-wide association study (GWAS). Uni- and multi-SNP models were used to describe feed efficiency in a training data set and the results were confirmed in a validation data set. Results from the univariate and bivariate analyses of ADG and DMI, adjusted by the feedlot beef steer maintenance requirements, were compared. The bivariate uni-SNP analysis identified (P-value <0.0001) 11 SNPs, meanwhile the univariate analyses of ADG and DMI identified 8 and 9 SNPs, respectively. Among the six SNPs confirmed in the validation data set, five SNPs were mapped to KDELC2, PHOX2A, and TMEM40. Findings from the uni-SNP models were used to develop highly accurate predictive multi-SNP models in the training data set. Despite the substantially smaller size of the validation data set, the training multi-SNP models had slightly lower predictive ability when applied to the validation data set. Six Gene Ontology molecular functions related to ion transport activity were enriched (P-value <0.001) among the genes associated with the detected SNPs. The findings from this study demonstrate the complementary value of the uni- and multi-SNP models, and univariate and bivariate GWAS analyses. The identified SNPs can be used for genome-enabled improvement of feed efficiency in feedlot beef cattle, and can aid in the design of empirical studies to further confirm the associations.	[Serao, Nick V. L.; Gonzalez-Pena, Dianelys; Beever, Jonathan E.; Southey, Bruce R.; Faulkner, Daniel B.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Bollero, German A.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.	rodrgzzs@illinois.edu	Serão, Nick/AAE-5868-2019; Peña, Dianelys Gonzalez/AAF-4021-2019	Serão, Nick/0000-0002-6758-208X; Peña, Dianelys Gonzalez/0000-0003-4846-7569; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Southey, Bruce/0000-0002-8959-7709	USDA NIFA [2010-85122-20620, 2013-68004-20361, 2012-38420-30209, 2009-35205-05310]; NIH/NIDA [R21 DA027548, P30 DA 018310]; David H. and Norraine Baker Graduate Fellowship in Animal Sciences; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548, P30DA018310] Funding Source: NIH RePORTER	USDA NIFA(United States Department of Agriculture (USDA)); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); David H. and Norraine Baker Graduate Fellowship in Animal Sciences; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors appreciate the support from USDA NIFA (2010-85122-20620; 2013-68004-20361; 2012-38420-30209; 2009-35205-05310), NIH/NIDA (R21 DA027548 and P30 DA 018310) and the David H. and Norraine Baker Graduate Fellowship in Animal Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396; Banos G, 2008, J DAIRY SCI, V91, P3190, DOI 10.3168/jds.2007-0930; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Bolormaa S, 2010, J DAIRY SCI, V93, P3818, DOI 10.3168/jds.2009-2980; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Casas E, 2001, J ANIM SCI, V79, P854; Dayton W R, 2008, J Anim Sci, V86, pE217, DOI 10.2527/jas.2007-0456; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; FASS, 2010, GUID CAR US AGR AN R, V3rd; FERRELL CL, 1985, J ANIM SCI, V61, P725, DOI 10.2527/jas1985.613725x; Ganong W. F., 2005, REV MED PHYSL, V21; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gutierrez-Gil B, 2009, J ANIM SCI, V87, P24, DOI 10.2527/jas.2008-0922; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YZ, 2010, ANIM BIOTECHNOL, V21, P170, DOI 10.1080/10495391003768813; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Knott SA, 2000, GENETICS, V156, P899; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Korol AB, 2001, GENETICS, V157, P1789; Kreimer A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks269; Lancaster PA, 2009, J ANIM SCI, V87, P3887, DOI 10.2527/jas.2009-2041; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li C, 2004, J ANIM SCI, V82, P1; Li C, 2002, J ANIM SCI, V80, P1187; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Lombard Z, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000873; Lowe M., 2009, VALUE CHAIN ANAL US; Lu AJ, 2011, MOL BIOL REP, V38, P261, DOI 10.1007/s11033-010-0103-5; Marquez GC, 2009, ANIM GENET, V40, P986, DOI 10.1111/j.1365-2052.2009.01946.x; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Martinez A, 2010, J ANIM SCI, V88, P1229, DOI 10.2527/jas.2009-2025; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mizoshita K, 2004, J ANIM SCI, V82, P3415; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Rincon G, 2009, ANIM GENET, V40, P878, DOI 10.1111/j.1365-2052.2009.01934.x; Rolf MM, 2012, ANIM GENET, V43, P367, DOI 10.1111/j.1365-2052.2011.02273.x; Sadeque A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-59; Sandhiya S, 2009, INDIAN J MED RES, V129, P223; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Sherman EL, 2008, ANIM GENET, V39, P225, DOI 10.1111/j.1365-2052.2008.01704.x; Sherman EL, 2008, J ANIM SCI, V86, P1, DOI 10.2527/jas.2006-799; Sherman EL, 2010, J ANIM SCI, V88, P16, DOI 10.2527/jas.2008-1759; Sherman EL, 2009, J ANIM SCI, V87, P37, DOI 10.2527/jas.2008-0876; Snelling WM, 2011, J ANIM SCI, V89, P1731, DOI 10.2527/jas.2010-3526; Southey BR, 2003, J ANIM SCI, V81, P1399; Stearns TM, 2005, J ANIM SCI, V83, P2471; Taylor JF, 1998, ANIM GENET, V29, P194, DOI 10.1111/j.1365-2052.1998.00317.x; Trejo C. O., 2010, Professional Animal Scientist, V26, P620; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Wang J, 2010, MOL BIOL REP, V37, P571, DOI 10.1007/s11033-009-9816-8; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weller JI, 1996, THEOR APPL GENET, V92, P998, DOI 10.1007/BF00224040	66	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78530	10.1371/journal.pone.0078530	http://dx.doi.org/10.1371/journal.pone.0078530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205251	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700091
J	Lai, KR; Cui, JT; Ni, S; Zhang, YD; He, JL; Yao, K				Lai, Kairan; Cui, Jiantao; Ni, Shuang; Zhang, Yidong; He, Jiliang; Yao, Ke			The Effects of Postmenopausal Hormone Use on Cataract: A Meta-Analysis	PLOS ONE			English	Article							FEMALE REPRODUCTIVE FACTORS; REPLACEMENT THERAPY; LENS OPACITIES; RISK-FACTORS; ESTROGEN-RECEPTOR; EYE DISEASE; AGE; POPULATION; WOMEN; PROGRESSION	Background: Cataract is the leading cause of blindness worldwide. Many observational studies assessed the relationship between postmenopausal hormone replacement therapy (HRT) and risk of cataract development, but the reported results were controversial. The aim of present meta-analysis was to evaluate the association of postmenopausal hormone replacement therapy with risk of cataract development. Methods: The eligible observational studies, including cross-sectional, case-control and cohort studies, were identified by searching PubMed and Embase during March of 2013. Either a fixed-or a random-effects model was used to calculate the pooled odds ratio (OR) with its 95% confidence interval (95% CI). Subgroup analysis on cataract types was performed. Results: A total of four cohort and five case-control or cross-sectional studies were finally included into this meta-analysis. Overall, a significant decreased risk of developing any type of cataract was found in ever HRT group as compared with non-HRT group among cohort studies (OR 0.83; 95% CI: 0.71,0.97) and case-control or cross-sectional studies (OR 0.74; 95% CI: 0.59,0.93). Subgroup analysis on cataract types determined that the significantly decreased risk of nuclear cataract in current HRT group (OR 0.72; 95% CI: 0.61,0.85) and also a critically reduced risk of nuclear cataract in ever HRT group (OR 0.80; 95% CI: 0.64,1.01) were found among case-control or cross-sectional studies, as compared with non-HRT group. No association of HRT with risk of cortical and posterior subcapsular cataract was observed. Conclusions: The results of present meta-analysis indicate that postmenopausal hormone use may play a protective role in cataract development.	[Lai, Kairan; Cui, Jiantao; Ni, Shuang; Zhang, Yidong; Yao, Ke] Zhejiang Univ, Sch Med, Ctr Eye, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [He, Jiliang] Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310003, Zhejiang, Peoples R China; [Yao, Ke] Zhejiang Prov Key Lab Ophthalmol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yao, K (corresponding author), Zhejiang Univ, Sch Med, Ctr Eye, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Yao, Ke/0000-0002-6764-7365	National Natural Science Foundation of China [81130018, 81371001]; National "Twelfth Five-Year" Plan for Science & Technology Support of China [2012BAI08B01]; Zhejiang Key Innovation Team Project of China [2009R50039]; Zhejiang Key Laboratory Fund of China [2011E10006]; Chinese Ministry of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science & Technology Support of China; Zhejiang Key Innovation Team Project of China; Zhejiang Key Laboratory Fund of China; Chinese Ministry of Health	The present study was supported by the Key Program of National Natural Science Foundation of China (Grant No. 81130018), Program of National Natural Science Foundation of China (No. 81371001), National "Twelfth Five-Year" Plan for Science & Technology Support of China (No. 2012BAI08B01), Zhejiang Key Innovation Team Project of China (2009R50039), Zhejiang Key Laboratory Fund of China (2011E10006) and Project of National Clinical Key Discipline of Chinese Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM S, 1995, MATURITAS, V21, P91, DOI 10.1016/0378-5122(94)00881-7; Aina FO, 2006, EYE, V20, P417, DOI 10.1038/sj.eye.6701877; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Bigsby RM, 1999, P NATL ACAD SCI USA, V96, P9328, DOI 10.1073/pnas.96.16.9328; Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; Cumming RG, 1997, AM J EPIDEMIOL, V145, P242; Davis VL, 2002, P NATL ACAD SCI USA, V99, P9427, DOI 10.1073/pnas.132247999; Defay R, 2003, ANN EPIDEMIOL, V13, P638, DOI 10.1016/S1047-2797(03)00058-9; delCastillo JMB, 1997, OPHTHALMOLOGY, V104, P970; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Durant JS, 2006, EYE, V20, P1254, DOI 10.1038/sj.eye.6702087; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freeman EE, 2004, EPIDEMIOLOGY, V15, P451, DOI 10.1097/01.ede.0000129517.92192.29; Freeman EE, 2001, ARCH OPHTHALMOL-CHIC, V119, P1687; Gray S, 2003, LANCET, V362, P1332, DOI 10.1016/S0140-6736(03)14598-9; Hales AM, 1997, J EXP MED, V185, P273, DOI 10.1084/jem.185.2.273; HALES AM, 1994, CURR EYE RES, V13, P885, DOI 10.3109/02713689409015091; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILLER R, 1986, AM J EPIDEMIOL, V124, P916, DOI 10.1093/oxfordjournals.aje.a114481; Kanthan GL, 2010, ACTA OPHTHALMOL, V88, P773, DOI 10.1111/j.1755-3768.2009.01565.x; Klein B E, 1993, Trans Am Ophthalmol Soc, V91, P517; Klein BEK, 2000, AM J OPHTHALMOL, V130, P322, DOI 10.1016/S0002-9394(00)00474-8; KLEIN BEK, 1994, ARCH OPHTHALMOL-CHIC, V112, P85, DOI 10.1001/archopht.1994.01090130095025; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; Leske MC, 2000, OPHTHALMOLOGY, V107, P1267, DOI 10.1016/S0161-6420(00)00155-X; Lindblad BE, 2010, OPHTHALMOLOGY, V117, P424, DOI 10.1016/j.ophtha.2009.07.046; McCarty CA, 1999, AM J OPHTHALMOL, V128, P446, DOI 10.1016/S0002-9394(99)00218-4; Mitchell P, 1997, OPHTHALMOLOGY, V104, P581, DOI 10.1016/S0161-6420(97)30266-8; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MOORADIAN AD, 1993, J STEROID BIOCHEM, V45, P509, DOI 10.1016/0960-0760(93)90166-T; Nirmalan PK, 2004, INVEST OPHTH VIS SCI, V45, P4273, DOI 10.1167/iovs.04-0285; Noran NH, 2007, ASIA-PAC J PUBLIC HE, V19, P23, DOI 10.1177/10105395070190020501; Ogueta SB, 1999, INVEST OPHTH VIS SCI, V40, P1906; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pelit A, 2007, TURK KLIN TIP BILIM, V27, P811; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Uncu G, 2006, GYNECOL ENDOCRINOL, V22, P501, DOI 10.1080/09513590600917919; Wang XF, 2003, INVEST OPHTH VIS SCI, V44, P2067, DOI 10.1167/iovs.02-0841; Weintraub JM, 2002, OPHTHALMIC EPIDEMIOL, V9, P179, DOI 10.1076/opep.9.3.179.1513; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Worzala K, 2001, ARCH INTERN MED, V161, P1448, DOI 10.1001/archinte.161.11.1448; Younan C, 2002, AM J EPIDEMIOL, V155, P997, DOI 10.1093/aje/155.11.997; ZHANG JJ, 1994, J CLIN INVEST, V94, P1690, DOI 10.1172/JCI117514	47	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78647	10.1371/journal.pone.0078647	http://dx.doi.org/10.1371/journal.pone.0078647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205286	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300076
J	Terashita, Y; Yamagata, K; Tokoro, M; Itoi, F; Wakayama, S; Li, C; Sato, E; Tanemura, K; Wakayama, T				Terashita, Yukari; Yamagata, Kazuo; Tokoro, Mikiko; Itoi, Fumiaki; Wakayama, Sayaka; Li, Chong; Sato, Eimei; Tanemura, Kentaro; Wakayama, Teruhiko			Latrunculin A Treatment Prevents Abnormal Chromosome Segregation for Successful Development of Cloned Embryos	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; BOVINE PREIMPLANTATION EMBRYOS; G9A HISTONE METHYLTRANSFERASE; FULL-TERM DEVELOPMENT; CUMULUS CELL-NUCLEI; MOUSE EMBRYOS; ACTIN POLYMERIZATION; CLONING EFFICIENCY; LYSINE 9; METHYLATION	Somatic cell nuclear transfer to an enucleated oocyte is used for reprogramming somatic cells with the aim of achieving totipotency, but most cloned embryos die in the uterus after transfer. While modifying epigenetic states of cloned embryos can improve their development, the production rate of cloned embryos can also be enhanced by changing other factors. It has already been shown that abnormal chromosome segregation (ACS) is a major cause of the developmental failure of cloned embryos and that Latrunculin A (LatA), an actin polymerization inhibitor, improves F-actin formation and birth rate of cloned embryos. Since F-actin is important for chromosome congression in embryos, here we examined the relation between ACS and F-actin in cloned embryos. Using LatA treatment, the occurrence of ACS decreased significantly whereas cloned embryo-specific epigenetic abnormalities such as dimethylation of histone H3 at lysine 9 (H3K9me2) could not be corrected. In contrast, when H3K9me2 was normalized using the G9a histone methyltransferase inhibitor BIX-01294, the Magea2 gene-essential for normal development but never before expressed in cloned embryos-was expressed. However, this did not increase the cloning success rate. Thus, non-epigenetic factors also play an important role in determining the efficiency of mouse cloning.	[Terashita, Yukari; Yamagata, Kazuo; Tokoro, Mikiko; Itoi, Fumiaki; Wakayama, Sayaka; Li, Chong; Wakayama, Teruhiko] RIKEN, Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo, Japan; [Terashita, Yukari; Sato, Eimei; Tanemura, Kentaro] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan; [Yamagata, Kazuo] Osaka Univ, Microbial Dis Res Inst, Ctr Genet Anal Biol Responses, Suita, Osaka 565, Japan; [Tokoro, Mikiko; Itoi, Fumiaki] Asada Ladies Clin, Asada Inst Reprod Med, Kasugai, Aichi, Japan; [Li, Chong] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Wakayama, Sayaka; Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Dept Biotechnol, Kofu, Yamanashi, Japan	RIKEN; Tohoku University; Osaka University; Tongji University; University of Yamanashi	Terashita, Y (corresponding author), RIKEN, Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo, Japan.	yterashita@cdb.riken.jp; twakayama@yamanashi.ac.jp	Itoi, Fumiaki/AAN-6110-2020	Tokoro, Mikiko/0000-0003-1589-0889; Itoi, Fumiaki/0000-0001-5915-5056	Japan Society for the Promotion of Science;  [20062015];  [23248048]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	Financial support for this research was provided by Research Fellow of the Japan Society for the Promotion of Science to YT and Grant-in-Aid for Scientific Research on Priority Areas (20062015) and Scientific Research (A) (23248048) to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbach ST, 2007, DEV BIOL, V308, P309, DOI 10.1016/j.ydbio.2007.05.034; Balbach ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035322; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Inoue Kimiko, 2002, Science (Washington D C), V295, P297, DOI 10.1126/science.295.5553.297; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P1207, DOI 10.1262/jrd.19067; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Miyamoto K, 2013, CELL MOL LIFE SCI, V70, P3289, DOI 10.1007/s00018-012-1235-7; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Mori M, 2011, CURR BIOL, V21, P606, DOI 10.1016/j.cub.2011.03.002; Nakagata N, 1996, LAB ANIM SCI, V46, P236; Nowak-Imialek M, 2008, MOL REPROD DEV, V75, P731, DOI 10.1002/mrd.20816; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ohgane J, 2001, GENESIS, V30, P45, DOI 10.1002/gene.1031; Ohgane J, 2004, GENES CELLS, V9, P253, DOI 10.1111/j.1356-9597.2004.00720.x; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Terashita Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098764; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama S, 2003, CLONING STEM CELLS, V5, P181, DOI 10.1089/153623003769645848; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, REPRODUCTION, V122, P49, DOI 10.1530/rep.0.1220049; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamagata K, 2010, METHODS, V52, P259, DOI 10.1016/j.ymeth.2010.04.008; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358	44	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78380	10.1371/journal.pone.0078380	http://dx.doi.org/10.1371/journal.pone.0078380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205216	gold, Green Submitted, Green Published			2022-12-27	WOS:000326152300057
J	Wang, YB; Vogelsang, M; Schafer, G; Matejcic, M; Parker, MI				Wang, Yabing; Vogelsang, Matjaz; Schaefer, Georgia; Matejcic, Marco; Parker, M. Iqbal			MicroRNA Polymorphisms and Environmental Smoke Exposure as Risk Factors for Oesophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENETIC-VARIATION; LUNG-CANCER; METASTASIS; DNA; DYSREGULATION; EPIDEMIOLOGY; ASSOCIATION; POLLUTION; MIRNAS	MicroRNAs (miRNAs) and related polymorphisms have been implicated in the susceptibility to oesophageal squamous cell carcinoma (OSCC). In our study, three miRNA-related SNPs: rs6505162 A>C (pre-miRNA of miR-423), rs213210 A>G (3'UTR of miR-219-1) and rs7372209 C>T (5'UTR of miR-26a-1) were investigated in the Black and Mixed Ancestry population groups in South Africa. The potential cumulative effects of these SNPs, as well as gene-environment interactions were also analysed. In Blacks, rs6505162 A>C was associated with OSCC under dominant, additive and recessive models with odds ratios (ORs) 1.353, 1.404, and 2.858, respectively. This locus showed very strong interactions with smoke inhalation from burning wood or charcoal used for heating and cooking in very poorly ventilated areas (OR(GE)=7.855, P-(GE)=9.17*10(-10) in the Black group). Furthermore, the miR-423-3p level was 1.39 fold up-regulated in tumour tissues compared to the adjacent normal tissue (paired t-test P value 0.0087). SNP-SNP interaction between rs2132210 and rs7372209 was found in both Black and Mixed Ancestry subjects. The AA(rs213210)-CTrs7372209 genotype had a protective effect on OSCC risk (in the Black, OR=0.229, P=0.012; and the Mixed Ancestry groups, OR=0.230, P=0.00014). This study is the first to link SNPs in miR-423 together with environmental smoke exposure to risk for developing OSCC.	[Wang, Yabing; Vogelsang, Matjaz; Schaefer, Georgia; Matejcic, Marco; Parker, M. Iqbal] Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa; [Wang, Yabing; Schaefer, Georgia; Matejcic, Marco; Parker, M. Iqbal] UCT Fac Hlth Sci, IIDMM, Cape Town, South Africa; [Wang, Yabing; Schaefer, Georgia; Matejcic, Marco; Parker, M. Iqbal] UCT Fac Hlth Sci, Div Med Biochem, Cape Town, South Africa; [Vogelsang, Matjaz] Natl Inst Chem, Ljubljana, Slovenia	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town; National Institute of Chemistry - Slovenia	Parker, MI (corresponding author), Int Ctr Genet Engn & Biotechnol, UCT Campus, Cape Town, South Africa.	Iqbal.Parker@icgeb.org			International Centre for Genetic Engineering and Biotechnology (ICGEB); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; South African Medical Research Council; University of Cape Town; PRF; MRC	International Centre for Genetic Engineering and Biotechnology (ICGEB); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town; PRF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is based upon research supported by the International Centre for Genetic Engineering and Biotechnology (ICGEB), South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation, the South African Medical Research Council and the University of Cape Town. GS was funded by a grant from the PRF and MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; Hendricks D, 2002, IUBMB LIFE, V53, P263, DOI 10.1080/15216540212643; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ibiebele TI, 2010, CANCER CAUSE CONTROL, V21, P1475, DOI 10.1007/s10552-010-9576-8; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kollarova Helena, 2007, Biomedical Papers (Olomouc), V151, P17; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Kurmi OP, 2012, EUR RESPIR J, V40, P239, DOI 10.1183/09031936.00190211; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Lissowska J, 2005, AM J EPIDEMIOL, V162, P326, DOI 10.1093/aje/kwi204; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Calle ML, 2010, BIOINFORMATICS, V26, P2198, DOI 10.1093/bioinformatics/btq352; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wheeler JB, 2012, SURG CLIN N AM, V92, P1077, DOI 10.1016/j.suc.2012.07.008; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yu X, 2010, ASIAN PAC J CANCER P, V11, P1827; Zhang S, 2013, ONCOGENE, V32, P242, DOI 10.1038/onc.2012.32	39	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78520	10.1371/journal.pone.0078520	http://dx.doi.org/10.1371/journal.pone.0078520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205249	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600106
J	Harper, DM; Verdenius, I; Ratnaraj, F; Arey, AM; Rosemergey, B; Malnar, GJ; Wall, J				Harper, Diane M.; Verdenius, Inge; Ratnaraj, Felicia; Arey, Anne M.; Rosemergey, Beth; Malnar, Gerard J.; Wall, Jeffrey			Quantifying Clinical HPV4 Dose Inefficiencies in a Safety Net Population	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; CERVICAL-CANCER PREVENTION; COST-EFFECTIVENESS; PATIENT ADHERENCE; YOUNG-WOMEN; COMPLETION; ADOLESCENTS; SERIES; IMMUNOGENICITY; INITIATION	Purpose: HPV4 is the most expensive vaccine requiring three appropriately timed doses to provide maximal efficacy against two oncogenic HPV types. The primary purpose of this study is to quantify the use of HPV4 vaccine in a safety net health care system in terms of its inefficiencies. Methods: A retrospective study of HPV4 dosing from 2006-2009, among females 10-26 years old who sought care in a safety net health care system was conducted to determine dose usage patterns among those at highest risk for cervical cancer. Dose descriptors abstracted from the electronic medical record (EMR) included timing and number in series as well as characteristics of the person to whom and visit at which the dose was given. Dose inefficiencies were separated into "less than three doses'' and "mistimed doses'' for analysis. Results: The majority (66%) of HPV4 doses administered were insufficient to induce the maximal immune response necessary for HPV infection prevention. Among on-time doses, 58% were singleton or doublet doses. Mistimed doses accounted for 19% of all doses administered with late intervals being more common than early intervals among those receiving more than one dose (9% vs. 4%, p<0.001). Third doses were mistimed twice as often as second doses (10% vs. 5%, p<0.001). Black women were more likely to have a mistimed second dose and Hispanic women more likely to have a mistimed third dose compared to white women (OR = 1.70 (95% CI: 1.11, 2.61 and 2.44 (1.19, 5.00), respectively). The HPV4-only visit type at which HPV4 was initiated was the most significant predictor of on-time doublet completion. Conclusions: In a safety net health care system the large inefficiencies associated with HPV4 vaccination must be addressed in order to maximize our patient's cervical cancer prevention.	[Harper, Diane M.] Univ Missouri, Sch Med, Ctr Excellence, Kansas City, MO 64108 USA; [Harper, Diane M.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Harper, Diane M.; Ratnaraj, Felicia; Malnar, Gerard J.; Wall, Jeffrey] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA; [Harper, Diane M.; Arey, Anne M.; Rosemergey, Beth] Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64108 USA; [Verdenius, Inge] Radboud Univ Nijmegen, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Radboud University Nijmegen	Harper, DM (corresponding author), Univ Missouri, Sch Med, Ctr Excellence, Kansas City, MO 64108 USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				[Anonymous], 2008, FDA NEWS; Brisson M, 2011, SEX TRANSM INFECT, V87, P41, DOI 10.1136/sti.2010.044412; CDC, 2013, VACC PRIC LIST; Chao C, 2009, MAYO CLIN PROC, V84, P864, DOI 10.1016/S0025-6196(11)60503-X; Chou B, 2011, OBSTET GYNECOL, V118, P14, DOI 10.1097/AOG.0b013e318220ebf3; Cook RL, 2010, J ADOLESCENT HEALTH, V47, P596, DOI 10.1016/j.jadohealth.2010.09.015; Dempsey A, 2011, VACCINE, V29, P528, DOI 10.1016/j.vaccine.2010.10.051; Dempsey A, 2010, VACCINE, V28, P989, DOI 10.1016/j.vaccine.2009.10.133; *DEP HLTH HUM SERV, 2009, ADV COMM IMM PRACT A; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Dorell CG, 2011, PEDIATRICS, V128, P830, DOI 10.1542/peds.2011-0950; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; FDA Approval Letter, 2006, FDA APPROVAL LETT; Freeman HP, 2005, NIH PUB; French KM, 2007, BRIT J CANCER, V96, P514, DOI 10.1038/sj.bjc.6603575; Gold R, 2011, PREV MED, V52, P456, DOI 10.1016/j.ypmed.2011.04.010; Goldie SJ, 2008, VACCINE, V26, pM17, DOI 10.1016/j.vaccine.2008.06.018; Goldie SJ, 2008, REPROD HEALTH MATTER, V16, P86, DOI 10.1016/S0968-8080(08)32409-4; Gorin SNS, 2011, ADV THER, V28, P615, DOI 10.1007/s12325-011-0045-x; Grant D, 2012, VACCINES CHILDREN PR; Harper D. M., 2010, J VACCINES VACCIN, V1, P107, DOI [10.4172/2157-7560.1000107, DOI 10.4172/2157-7560.1000107]; Harper DM, 2010, DISCOV MED, V10, P7; Harper Diane M, 2011, ISRN Obstet Gynecol, V2011, P457204, DOI 10.5402/2011/457204; Hirth JM, 2012, CANCER-AM CANCER SOC, V118, P5623, DOI 10.1002/cncr.27598; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V306, P1643, DOI 10.1001/jama.2011.1480; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Nelson JC, 2009, AM J PUBLIC HEALTH, V99, pS389, DOI 10.2105/AJPH.2008.151332; Neubrand TPL, 2009, CLIN PEDIATR, V48, P966, DOI 10.1177/0009922809337534; Neuzil KM, 2011, JAMA-J AM MED ASSOC, V305, P1424, DOI 10.1001/jama.2011.407; Niccolai LM, 2011, AM J PREV MED, V41, P428, DOI 10.1016/j.amepre.2011.06.032; Perkins RB, 2012, J WOMENS HEALTH, V21, P813, DOI 10.1089/jwh.2011.3364; Romanowski B, 2011, HUM VACCINES, V7, P1374, DOI 10.4161/hv.7.12.18322; Rosen AB, 2009, AM J MANAG CARE, V15, P626; Rouzier R, 2010, J ADOLESCENT HEALTH, V47, P237, DOI 10.1016/j.jadohealth.2010.04.006; Rubin RF, 2012, J COMMUN HEALTH, V37, P1145, DOI 10.1007/s10900-012-9581-9; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Schluterman NH, 2011, VACCINE, V29, P3767, DOI 10.1016/j.vaccine.2011.03.032; Setia S, 2002, VACCINE, V20, P1148, DOI 10.1016/S0264-410X(01)00433-9; Smith LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-645; Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051; StatSoft Inc, 2010, STATISTICA DAT AN SO; Tan WY, 2011, VACCINE, V29, P2548, DOI 10.1016/j.vaccine.2011.01.066; Tiro JA, 2012, VACCINE, V30, P2368, DOI 10.1016/j.vaccine.2011.11.031; United States Securities and Exchange Commission, 2011, MERCK CO STRAT NAT S; United States Securities and Exchange Commission, 2012, MERCK CO INC ANN SEC, P51; United States Securities and Exchange Commission, 2012, MERCK CO INC Q SEC R, P47; Verdenius I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071295; Widdice LE, 2011, PEDIATRICS, V127, P77, DOI 10.1542/peds.2010-0812; Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258; Zimmerman RK, 2010, J WOMENS HEALTH, V19, P1441, DOI 10.1089/jwh.2009.1753	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77961	10.1371/journal.pone.0077961	http://dx.doi.org/10.1371/journal.pone.0077961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223131	gold, Green Submitted, Green Published			2022-12-27	WOS:000326656200023
J	Heenan, A; Williams, ID				Heenan, Adel; Williams, Ivor D.			Monitoring Herbivorous Fishes as Indicators of Coral Reef Resilience in American Samoa	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ACANTHURUS-NIGROFUSCUS; COMMUNITY STRUCTURE; MACROALGAL COVER; TROPHIC STATUS; PHASE-SHIFTS; SCALE; BIOMASS; ALGAL; DEPTH	Resilience-based management aims to promote or protect processes and species that underpin an ecosystem's capacity to withstand and recover from disturbance. The management of ecological processes is a developing field that requires reliable indicators that can be monitored over time. Herbivory is a key ecological process on coral reefs, and pooling herbivorous fishes into functional groups based on their feeding mode is increasingly used as it may quantify herbivory in ways that indicate resilience. Here we evaluate whether the biomass estimates of these herbivore functional groups are good predictors of reef benthic assemblages, using data from 240 sites from five island groups in American Samoa. Using an information theoretic approach, we assembled a candidate set of linear and nonlinear models to identify the relations between benthic cover and total herbivore and non-herbivore biomass and the biomass of the aforementioned functional groups. For each benthic substrate type considered (encrusting algae, fleshy macroalgae, hard coral and turf algae), the biomass of herbivorous fishes were important explanatory variables in predicting benthic cover, whereas biomass of all fishes combined generally was not. Also, in all four cases, variation in cover was best explained by the biomass of specific functional groups rather than by all herbivores combined. Specifically: 1) macroalgal and turf algal cover decreased with increasing biomass of 'grazers/detritivores'; and 2) cover of encrusting algae increased with increasing biomass of 'grazers/detritivores' and browsers. Furthermore, hard coral cover increased with the biomass of large excavators/bio-eroders (made up of large-bodied parrotfishes). Collectively, these findings emphasize the link between herbivorous fishes and the benthic community and demonstrate support for the use of functional groups of herbivores as indicators for resilience-based monitoring.	[Heenan, Adel] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Williams, Ivor D.] Pacific Islands Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa	Heenan, A (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	adel.heenan@gmail.com		Williams, Ivor/0000-0002-9444-1020; Heenan, Adel/0000-0002-8307-5352	United States National Oceanic Atmospheric Administration (NOAA) Coral Reef Conservation Program; Pacific Islands Fisheries Science Center	United States National Oceanic Atmospheric Administration (NOAA) Coral Reef Conservation Program; Pacific Islands Fisheries Science Center	Financial support was provided by the United States National Oceanic Atmospheric Administration (NOAA) Coral Reef Conservation Program (http://coralreef.noaa.gov/) and the Pacific Islands Fisheries Science Center (http://www.pifsc.noaa.gov/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Ayotte P., 2011, H1108 NOAA PAC ISL F, P24; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bonaldo RM, 2011, CORAL REEFS, V30, P259, DOI 10.1007/s00338-010-0669-3; Bunnefeld N, 2012, ECOGRAPHY, V35, P15, DOI 10.1111/j.1600-0587.2011.07078.x; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Chateau O, 2009, ICES J MAR SCI, V66, P50, DOI 10.1093/icesjms/fsn165; Cheal A, 2012, MAR BIOL, V159, P1143, DOI 10.1007/s00227-012-1893-x; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Choat JH, 2003, MONITORING CORAL REE, P68; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Froese R., 2014, FISHBASE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goatley CHR, 2010, MAR ECOL PROG SER, V415, P237, DOI 10.3354/meps08761; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Green A.L., 2009, MONITORING FUNCTIONA; Gust N, 2002, ENVIRON BIOL FISH, V64, P353, DOI 10.1023/A:1016112312009; Hart AM, 1996, MAR ECOL PROG SER, V132, P11, DOI 10.3354/meps132011; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 2005, CYBIUM, V29, P235; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Littler MM, 1985, P 5 INT COR REEF S T, V4, P3539; MacNeil MA, 2008, J FISH BIOL, V73, P1748, DOI 10.1111/j.1095-8649.2008.02067.x; Marshell A, 2012, CORAL REEFS, V31, P1093, DOI 10.1007/s00338-012-0931-y; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V209, P103, DOI 10.1016/S0022-0981(96)02663-9; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; O'Leary JK, 2012, CORAL REEFS, V31, P547, DOI 10.1007/s00338-012-0872-5; Ohman MC, 1998, ENVIRON BIOL FISH, V53, P19, DOI 10.1023/A:1007445226928; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Sabater MG, 2007, PAC SCI, V61, P503, DOI 10.2984/1534-6188(2007)61[503:SABCEO]2.0.CO;2; Steneck R.S, 1988, HERBIVORY CORAL REEF; Tolimieri N, 1998, MAR ECOL PROG SER, V167, P227, DOI 10.3354/meps167227; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; Travers MJ, 2010, J BIOGEOGR, V37, P148, DOI 10.1111/j.1365-2699.2009.02183.x; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams ID, 2006, MAR ECOL PROG SER, V310, P185, DOI 10.3354/meps310185; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Willliams I, 2011, J MARINE BIOL, V2011; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Zuur Alain F., 2009, P1	70	38	39	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79604	10.1371/journal.pone.0079604	http://dx.doi.org/10.1371/journal.pone.0079604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223183	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200076
J	O'Hanlon, DE; Moench, TR; Cone, RA				O'Hanlon, Deirdre E.; Moench, Thomas R.; Cone, Richard A.			Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; SIMPLEX-VIRUS TYPE-2; FEMALE GENITAL-TRACT; BACTERIAL VAGINOSIS; HYDROGEN-PEROXIDE; H2O2-PRODUCING LACTOBACILLI; NEISSERIA-GONORRHOEAE; IN-VITRO; OXYGEN; WOMEN	Lactic acid at sufficiently acidic pH is a potent microbicide, and lactic acid produced by vaginal lactobacilli may help protect against reproductive tract infections. However, previous observations likely underestimated healthy vaginal acidity and total lactate concentration since they failed to exclude women without a lactobacillus-dominated vaginal microbiota, and also did not account for the high carbon dioxide, low oxygen environment of the vagina. Fifty-six women with low (0-3) Nugent scores (indicating a lactobacillus-dominated vaginal microbiota) and no symptoms of reproductive tract disease or infection, provided a total of 64 cervicovaginal fluid samples using a collection method that avoided the need for sample dilution and rigorously minimized aerobic exposure. The pH of samples was measured by microelectrode immediately after collection and under a physiological vaginal concentration of CO2. Commercial enzymatic assays of total lactate and total acetate concentrations were validated for use in CVF, and compared to the more usual HPLC method. The average pH of the CVF samples was 3.5 +/- 0.3 (mean +/- SD), range 2.8-4.2, and the average total lactate was 1.0% +/- 0.2% w/v; this is a five-fold higher average hydrogen ion concentration (lower pH) and a fivefold higher total lactate concentration than in the prior literature. The microbicidal form of lactic acid (protonated lactic acid) was therefore eleven-fold more concentrated, and a markedly more potent microbicide, than indicated by prior research. This suggests that when lactobacilli dominate the vaginal microbiota, women have significantly more lactic acid-mediated protection against infections than currently believed. Our results invite further evaluations of the prophylactic and therapeutic actions of vaginal lactic acid, whether provided in situ by endogenous lactobacilli, by probiotic lactobacilli, or by products that reinforce vaginal lactic acid.	[O'Hanlon, Deirdre E.; Cone, Richard A.] Johns Hopkins Univ, Thomas C Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Moench, Thomas R.; Cone, Richard A.] ReProtect Inc, Baltimore, MD USA	Johns Hopkins University	O'Hanlon, DE (corresponding author), Johns Hopkins Univ, Thomas C Jenkins Dept Biophys, Baltimore, MD 21218 USA.	eohanlon@jhu.edu			National Institutes of Health [AI45967, AI60598, AI66726, AI096398]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI060598, P01AI045967, U01AI066726, U19AI096398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institutes of Health [grants number AI45967, AI60598, AI66726, and AI096398]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldunate M, 2013, J ANTIMICROB CHEMOTH; Allsworth JE, 2001, AM J OBSTET GYNECOL, V205, P113; Atassi F, 2010, FEMS MICROBIOL LETT, V304, P29, DOI 10.1111/j.1574-6968.2009.01887.x; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Connor RI, 2006, JAIDS-J ACQ IMM DEF, V43, P499, DOI 10.1097/01.qai.0000243048.50451.18; Conti C, 2009, J PHYSIOL PHARMACOL, V60, P19; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; Graver MA, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-8; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Hill DR, 2005, J APPL PHYSIOL, V99, P1582, DOI 10.1152/japplphysiol.01422.2004; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; HILLIER SL, 1992, OBSTET GYNECOL, V79, P369, DOI 10.1097/00006250-199203000-00008; HUNTER CA, 1958, AM J OBSTET GYNECOL, V75, P872, DOI 10.1016/0002-9378(58)90669-0; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lusk MJ, 2008, CURR OPIN INFECT DIS, V21, P49, DOI 10.1097/QCO.0b013e3282f3d988; Mane A, 2013, DIAGN MICR INFEC DIS, V75, P112, DOI 10.1016/j.diagmicrobio.2012.09.009; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Martin R, 2010, APPL ENVIRON MICROB, V76, P400, DOI 10.1128/AEM.01631-09; Mijac VD, 2006, EUR J OBSTET GYN R B, V129, P69, DOI 10.1016/j.ejogrb.2005.11.036; MURPHY MG, 1985, ARCH MICROBIOL, V141, P75, DOI 10.1007/BF00446743; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; O'Hanlon DE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-120; Ocana VS, 1999, FEMS IMMUNOL MED MIC, V23, P87, DOI 10.1016/S0928-8244(98)00116-3; OCONNOR TJ, 1995, INT J STD AIDS, V6, P267, DOI 10.1177/095646249500600409; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pastorek JG, 1996, CLIN INFECT DIS, V23, P1075, DOI 10.1093/clinids/23.5.1075; Pavletic Adriana J, 2004, Infect Dis Obstet Gynecol, V12, P63, DOI 10.1080/10647440400009839; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sewankambo N, 1997, LANCET, V350, P1036; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; SOBEL JD, 1990, BRIT J CLIN PRACT, V44, P65; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; STANEK R, 1992, BIOMED CHROMATOGR, V6, P231, DOI 10.1002/bmc.1130060506; Strus M, 2006, FEMS IMMUNOL MED MIC, V48, P56, DOI 10.1111/j.1574-695X.2006.00120.x; Tanton C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017480; Tomas MSJ, 2003, J MED MICROBIOL, V52, P1117, DOI 10.1099/jmm.0.05155-0; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; WAGNER G, 1984, AM J OBSTET GYNECOL, V148, P147, DOI 10.1016/S0002-9378(84)80165-9; WAGNER G, 1988, AM J OBSTET GYNECOL, V158, P1040, DOI 10.1016/0002-9378(88)90214-1; WAGNER G, 1978, FERTIL STERIL, V30, P50; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x; Zuck TT, 1939, AM J OBSTET GYNECOL, V38, P310, DOI 10.1016/S0002-9378(39)90833-1	53	243	256	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80074	10.1371/journal.pone.0080074	http://dx.doi.org/10.1371/journal.pone.0080074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223212	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200105
J	Thomson, ELS; Dennis, JJ				Thomson, Euan L. S.; Dennis, Jonathan J.			Common Duckweed (Lemna minor) Is a Versatile High-Throughput Infection Model For the Burkholderia cepacia Complex and Other Pathogenic Bacteria	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; GALLERIA-MELLONELLA; COLONY MORPHOLOGY; BIOFILM FORMATION; CENOCEPACIA; VIRULENCE; PLANT; GENES; SECRETION	Members of the Burkholderia cepacia complex (Bcc) have emerged in recent decades as problematic pulmonary pathogens of cystic fibrosis (CF) patients, with severe infections progressing to acute necrotizing pneumonia and sepsis. This study presents evidence that Lemna minor (Common duckweed) is useful as a plant model for the Bcc infectious process, and has potential as a model system for bacterial pathogenesis in general. To investigate the relationship between Bcc virulence in duckweed and Galleria mellonella (Greater wax moth) larvae, a previously established Bcc infection model, a duckweed survival assay was developed and used to determine LD50 values. A strong correlation (R-2 = 0.81) was found between the strains' virulence ranks in the two infection models, suggesting conserved pathways in these vastly different hosts. To broaden the application of the duckweed model, enteropathogenic Escherichia coli (EPEC) and five isogenic mutants with previously established LD50 values in the larval model were tested against duckweed, and a strong correlation (R-2 = 0.93) was found between their raw LD50 values. Potential virulence factors in B. cenocepacia K56-2 were identified using a high-throughput screen against single duckweed plants. In addition to the previously characterized antifungal compound (AFC) cluster genes, several uncharacterized genes were discovered including a novel lysR regulator, a histidine biosynthesis gene hisG, and a gene located near the gene encoding the recently characterized virulence factor SuhB(Bc). Finally, to demonstrate the utility of this model in therapeutic applications, duckweed was rescued from Bcc infection by treating with bacteriophage at 6-h intervals. It was observed that phage application became ineffective at a timepoint that coincided with a sharp increase in bacterial invasion of plant tissue. These results indicate that common duckweed can serve as an effective infection model for the investigation of bacterial virulence factors and therapeutic strategies to combat them.	[Thomson, Euan L. S.; Dennis, Jonathan J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Dennis, JJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	jon.dennis@ualberta.ca	Dennis, Jonathan/E-8515-2014	Dennis, Jonathan/0000-0001-9288-6555; Dennis, Jonathan/0000-0002-3925-9533	Natural Sciences and Engineering Council of Canada; Cystic Fibrosis Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The Natural Sciences and Engineering Council of Canada, Cystic Fibrosis Canada, and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Bernier SP, 2008, INFECT IMMUN, V76, P38, DOI 10.1128/IAI.00874-07; BURKHOLDER WALTER H., 1950, PHYTOPATH, V40, P115; Burns JL, 1996, ANTIMICROB AGENTS CH, V40, P307, DOI 10.1128/AAC.40.2.307; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Castonguay-Vanier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011467; Champion OL, 2010, J INFECT DIS, V201, P776, DOI 10.1086/650494; Chiu CH, 2001, J MED MICROBIOL, V50, P594, DOI 10.1099/0022-1317-50-7-594; Chu KK, 2004, INFECT IMMUN, V72, P6142, DOI 10.1128/IAI.72.10.6142-6147.2004; Clarke SC, 2003, CLIN MICROBIOL REV, V16, P365, DOI 10.1128/CMR.16.3.365-378.2003; Dennis JJ, 2008, APPL ENVIRON MICROB, V64, P2710; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Iriti M, 2007, MYCOPATHOLOGIA, V164, P57, DOI 10.1007/s11046-007-9026-7; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Kang YW, 1998, APPL ENVIRON MICROB, V64, P3939; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Lee YH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-28; Leuko S, 2012, INFECT IMMUN, V80, P3077, DOI 10.1128/IAI.00081-12; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; McCarthy Y, 2010, MOL MICROBIOL, V77, P1220, DOI 10.1111/j.1365-2958.2010.07285.x; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; O'Grady EP, 2011, J BACTERIOL, V193, P163, DOI 10.1128/JB.00852-10; O'Sullivan LA, 2007, ENVIRON MICROBIOL, V9, P1017, DOI 10.1111/j.1462-2920.2006.01228.x; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Randhawa Muhammad Akram, 2009, J Ayub Med Coll Abbottabad, V21, P184; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Rosales-Reyes R, 2012, MICROBIOL-SGM, V158, P2315, DOI 10.1099/mic.0.060988-0; Schikora A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024112; Schikora M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-171; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Seed KD, 2009, ANTIMICROB AGENTS CH, V53, P2205, DOI 10.1128/AAC.01166-08; Sokol PA, 2003, MICROBIOL-SGM, V149, P3649, DOI 10.1099/mic.0.26540-0; Stotz HU, 2013, ANTIMICROBIAL PEPTID; Subramoni S, 2013, MICROBIOL-SGM, V159, P603, DOI 10.1099/mic.0.064683-0; Subramoni S, 2011, INFECT IMMUN, V79, P2984, DOI 10.1128/IAI.00170-11; Thomson ELS, 2012, VIRULENCE, V3, P286, DOI 10.4161/viru.19355; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Yohalem DS, 1997, ANN APPL BIOL, V130, P467, DOI 10.1111/j.1744-7348.1997.tb07675.x; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559	51	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80102	10.1371/journal.pone.0080102	http://dx.doi.org/10.1371/journal.pone.0080102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223216	Green Submitted, Green Published, gold			2022-12-27	WOS:000326656200109
J	Malhotra, U; Zaidi, AH; Kosovec, JE; Kasi, PM; Komatsu, Y; Rotoloni, CL; Davison, JM; Irvin, CR; Hoppo, T; Nason, KS; Kelly, LA; Gibson, MK; Jobe, BA				Malhotra, Usha; Zaidi, Ali H.; Kosovec, Juliann E.; Kasi, Pashtoon M.; Komatsu, Yoshihiro; Rotoloni, Christina L.; Davison, Jon M.; Irvin, Clint R.; Hoppo, Toshitaka; Nason, Katie S.; Kelly, Lori A.; Gibson, Michael K.; Jobe, Blair A.			Prognostic Value and Targeted Inhibition of Survivin Expression in Esophageal Adenocarcinoma and Cancer-Adjacent Squamous Epithelium	PLOS ONE			English	Article							CELL CARCINOMA; APOPTOSIS; GENE; PREDICTORS; BLOOD; P53	Background: Survivin is an inhibitor of apoptosis and its over expression is associated with poor prognosis in several malignancies. While several studies have analyzed survivin expression in esophageal squamous cell carcinoma, few have focused on esophageal adenocarcinoma (EAC) and/or cancer-adjacent squamous epithelium (CASE). The purpose of this study was 1) to determine the degree of survivin up regulation in samples of EAC and CASE, 2) to evaluate if survivin expression in EAC and CASE correlates with recurrence and/or death, and 3) to examine the effect of survivin inhibition on apoptosis in EAC cells. Methods: Fresh frozen samples of EAC and CASE from the same patient were used for qRT-PCR and Western blot analysis, and formalin-fixed, paraffin-embedded tissue was used for immunohistochemistry. EAC cell lines, OE19 and OE33, were transfected with small interfering RNAs (siRNAs) to knockdown survivin expression. This was confirmed by qRT-PCR for survivin expression and Western blot analysis of cleaved PARP, cleaved caspase 3 and survivin. Survivin expression data was correlated with clinical outcome. Results: Survivin expression was significantly higher in EAC tumor samples compared to the CASE from the same patient. Patients with high expression of survivin in EAC tumor had an increased risk of death. Survivin expression was also noted in CASE and correlated with increased risk of distant recurrence. Cell line evaluation demonstrated that inhibition of survivin resulted in an increase in apoptosis. Conclusion: Higher expression of survivin in tumor tissue was associated with increased risk of death; while survivin expression in CASE was a superior predictor of recurrence. Inhibition of survivin in EAC cell lines further showed increased apoptosis, supporting the potential benefits of therapeutic strategies targeted to this marker.	[Malhotra, Usha] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Kasi, Pashtoon M.; Gibson, Michael K.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Zaidi, Ali H.; Kosovec, Juliann E.; Komatsu, Yoshihiro; Rotoloni, Christina L.; Irvin, Clint R.; Kelly, Lori A.] Allegheny Hlth Network, Allegheny Singer Res Inst, Pittsburgh, PA USA; [Davison, Jon M.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Hoppo, Toshitaka; Jobe, Blair A.] Allegheny Hlth Network, Dept Surg, Pittsburgh, PA USA; [Nason, Katie S.] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA	Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jobe, BA (corresponding author), Allegheny Hlth Network, Dept Surg, Pittsburgh, PA USA.	bjobe1@wpahs.org	Kasi, Pashtoon Murtaza/M-2569-2019	Kasi, Pashtoon Murtaza/0000-0002-5169-7085	NCI NIH HHS [K07 CA151613] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA151613] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Beardsmore DA, 2003, J GASTROINTEST SURG, V7, P77, DOI 10.1016/S1091-255X(02)00141-5; Cao M, 2009, CLIN EXP METASTAS, V26, P751, DOI 10.1007/s10585-009-9274-7; Chang E, 2010, J THORAC CARDIOV SUR, V140, P225, DOI 10.1016/j.jtcvs.2009.11.038; Chiou SK, 2003, BIOCHEM BIOPH RES CO, V305, P374, DOI 10.1016/S0006-291X(03)00724-1; Dhir R, 2008, CANCER-AM CANCER SOC, V113, P1705, DOI 10.1002/cncr.23768; Fukuda S, 2001, BLOOD, V98, P2091, DOI 10.1182/blood.V98.7.2091; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grimminger P, 2009, J SURG ONCOL, V100, P447, DOI 10.1002/jso.21355; Hamoui N, 2004, ARCH SURG-CHICAGO, V139, P712, DOI 10.1001/archsurg.139.7.712; Hoffmann AC, 2010, PHARMACOGENOMICS, V11, P341, DOI [10.2217/pgs.09.164, 10.2217/PGS.09.164]; Kato J, 2001, INT J CANCER, V95, P92; Kaur P, 2004, ARCH PATHOL LAB MED, V128, P39; Kelly RJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-35; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Ngan CY, 2008, CANCER SCI, V99, P129, DOI 10.1111/j.1349-7006.2007.00637.x; Ogawa R, 2009, MED MOL MORPHOL, V42, P102, DOI 10.1007/s00795-009-0443-1; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Reid BJ, 2001, AM J GASTROENTEROL, V96, P2839; Rosato A, 2006, INT J CANCER, V119, P1717, DOI 10.1002/ijc.21923; Shen X, 2012, AM J MED SCI, V344, P52, DOI 10.1097/MAJ.0b013e318239c4ee; Tamm I, 1998, CANCER RES, V58, P5315; Upadhyay R, 2011, ANN SURG ONCOL, V18, P880, DOI 10.1245/s10434-010-1371-y; Vallbohmer D, 2005, SURGERY, V138, P701, DOI 10.1016/j.surg.2005.06.051; Vetter CS, 2005, ARCH DERMATOL RES, V297, P26, DOI 10.1007/s00403-005-0572-x; Wani S, 2011, CLIN GASTROENTEROL H, V9, P220, DOI 10.1016/j.cgh.2010.11.008; Zhu HX, 2011, TUMOR BIOL, V32, P1147, DOI 10.1007/s13277-011-0217-y	30	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78343	10.1371/journal.pone.0078343	http://dx.doi.org/10.1371/journal.pone.0078343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223792	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326503400052
J	Szkandera, J; Stotz, M; Eisner, F; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; AlZoughbi, W; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M				Szkandera, Joanna; Stotz, Michael; Eisner, Florian; Absenger, Gudrun; Stojakovic, Tatjana; Samonigg, Hellmut; Kornprat, Peter; Schaberl-Moser, Renate; AlZoughbi, Wael; Ress, Anna Lena; Seggewies, Friederike Sophia; Gerger, Armin; Hoefler, Gerald; Pichler, Martin			External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients	PLOS ONE			English	Article							PRETREATMENT NEUTROPHIL; CIRCULATING NUMBERS; HEAD; INFLAMMATION; FOLFIRINOX; CARCINOMA; SURVIVAL; INVASION; TUMORS	Background: With growing evidence on the role of inflammation in cancer biology, the presence of a systemic inflammatory response has been postulated as having prognostic significance in a wide range of cancer types. The derived neutrophil to lymphocyte ratio (dNLR), which represents an easily determinable potential prognostic marker in daily practise and clinical trials, has never been externally validated in pancreatic cancer (PC) patients. Methods: Data from 474 consecutive PC patients, treated between 2004 and 2012 at a single centre, were evaluated retrospectively. Cancer-specific survival (CSS) was assessed using the Kaplan-Meier method. To evaluate the prognostic relevance of dNLR, univariate and multivariate Cox regression models were applied. Results: We calculated by ROC analysis a cut-off value of 2.3 for the dNLR to be ideal to discriminate between patients' survival in the whole cohort. Kaplan-Meier curve reveals a dNLR >= 2.3 as a factor for decreased CSS in PC patients (p<0.001, log-rank test). An independent significant association between high dNLR >= 2.3 and poor clinical outcome in multivariate analysis (HR = 1.24, CI95% = 1.01-1.51, p = 0.041) was identified. Conclusion: In the present study we confirmed elevated pre-treatment dNLR as an independent prognostic factor for clinical outcome in PC patients. Our data encourage independent replication in other series and settings of this easily available parameter as well as stratified analysis according to tumor resectability.	[Szkandera, Joanna; Stotz, Michael; Eisner, Florian; Absenger, Gudrun; Samonigg, Hellmut; Schaberl-Moser, Renate; Ress, Anna Lena; Seggewies, Friederike Sophia; Gerger, Armin; Pichler, Martin] Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria; [Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Kornprat, Peter] Med Univ Graz, Dept Surg, Div Gen Surg, Graz, Austria; [AlZoughbi, Wael; Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Pichler, M (corresponding author), Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria.	martin.pichler@medunigraz.at	, Kornprat/AAH-6353-2019; Hoefler, Gerald/H-1796-2016	Szkandera, Joanna/0000-0002-2217-893X; Hoefler, Gerald/0000-0002-9056-3063; Pichler, Martin/0000-0002-8701-9462	Oesterreichische Nationalbank'' (Anniversary Fund) [14320]	Oesterreichische Nationalbank'' (Anniversary Fund)	This study was supported by funds of the "Oesterreichische Nationalbank'' (Anniversary Fund, project number: 14320 to Gerald Hoefler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absenger G, 2013, BRIT J CANCER, V109, P395, DOI 10.1038/bjc.2013.346; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; CUBILLA AL, 1978, CANCER, V41, P880, DOI 10.1002/1097-0142(197803)41:3<880::AID-CNCR2820410315>3.0.CO;2-J; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Fortner JG, 1996, ANN SURG, V223, P147, DOI 10.1097/00000658-199602000-00006; GRIFFANTIBARTOLI F, 1994, ANTICANCER RES, V14, P657; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoffmann TK, 2002, CLIN CANCER RES, V8, P2553; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; NAGAKAWA T, 1991, INT J PANCREATOL, V10, P113; Ozaki H, 1999, SURG TODAY, V29, P16; PETRIE HT, 1985, J IMMUNOL, V134, P230; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; RABINOWICH H, 1987, CANCER RES, V47, P173; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; SHAU H, 1988, J IMMUNOL, V141, P4395; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Stotz M, 2013, J CLIN PATH IN PRESS; Szkandera J, 2013, BRIT J CANCER, V108, P1677, DOI 10.1038/bjc.2013.135; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Tinchon C, 2013, ACTA ONCOL, V52, P1231, DOI 10.3109/0284186X.2013.771821; ULICH TR, 1987, J IMMUNOL, V139, P3406; ULICH TR, 1989, BLOOD, V73, P108; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wang DS, 2012, MED ONCOL, V29, P3092, DOI 10.1007/s12032-012-0226-8; Yao YW, 2013, CANCER IMMUNOL IMMUN, V62, P471, DOI 10.1007/s00262-012-1347-9; Zikos TA, 2011, CANCER IMMUNOL IMMUN, V60, P819, DOI 10.1007/s00262-011-0996-4	36	78	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78225	10.1371/journal.pone.0078225	http://dx.doi.org/10.1371/journal.pone.0078225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223776	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400039
J	Rolls, DA; Sacks-Davis, R; Jenkinson, R; McBryde, E; Pattison, P; Robins, G; Hellard, M				Rolls, David A.; Sacks-Davis, Rachel; Jenkinson, Rebecca; McBryde, Emma; Pattison, Philippa; Robins, Garry; Hellard, Margaret			Hepatitis C Transmission and Treatment in Contact Networks of People Who Inject Drugs	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; SPONTANEOUS VIRAL CLEARANCE; P-ASTERISK MODELS; VIRUS-INFECTION; COST-EFFECTIVENESS; PLUS RIBAVIRIN; SOCIAL NETWORK; REINFECTION; USERS; HIV	Hepatitis C virus (HCV) chronically infects over 180 million people worldwide, with over 350,000 estimated deaths attributed yearly to HCV-related liver diseases. It disproportionally affects people who inject drugs (PWID). Currently there is no preventative vaccine and interventions feature long treatment durations with severe side-effects. Upcoming treatments will improve this situation, making possible large-scale treatment interventions. How these strategies should target HCV-infected PWID remains an important unanswered question. Previous models of HCV have lacked empirically grounded contact models of PWID. Here we report results on HCV transmission and treatment using simulated contact networks generated from an empirically grounded network model using recently developed statistical approaches in social network analysis. Our HCV transmission model is a detailed, stochastic, individual-based model including spontaneously clearing nodes. On transmission we investigate the role of number of contacts and injecting frequency on time to primary infection and the role of spontaneously clearing nodes on incidence rates. On treatment we investigate the effect of nine network-based treatment strategies on chronic prevalence and incidence rates of primary infection and re-infection. Both numbers of contacts and injecting frequency play key roles in reducing time to primary infection. The change from "less-" to "more-frequent" injector is roughly similar to having one additional network contact. Nodes that spontaneously clear their HCV infection have a local effect on infection risk and the total number of such nodes (but not their locations) has a network wide effect on the incidence of both primary and re-infection with HCV. Re-infection plays a large role in the effectiveness of treatment interventions. Strategies that choose PWID and treat all their contacts (analogous to ring vaccination) are most effective in reducing the incidence rates of re-infection and combined infection. A strategy targeting infected PWID with the most contacts (analogous to targeted vaccination) is the least effective.	[Rolls, David A.; Pattison, Philippa; Robins, Garry] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Jenkinson, Rebecca; Hellard, Margaret] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Sacks-Davis, Rachel; Jenkinson, Rebecca; Hellard, Margaret] Burnet Inst, Ctr Res Excellence Injecting Drug Use, Melbourne, Vic, Australia; [McBryde, Emma] Univ Melbourne, Dept Med RMH, Melbourne, Vic, Australia	University of Melbourne; Burnet Institute; Monash University; Burnet Institute; University of Melbourne	Rolls, DA (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	drolls@unimelb.edu.au	Sacks-Davis, Rachel/H-3277-2019; Rolls, David/C-2886-2012; McBryde, Emma/D-2220-2018	Rolls, David/0000-0003-0397-9923; Sacks-Davis, Rachel/0000-0003-0860-2762; McBryde, Emma/0000-0002-9570-9172; Pattison, Philippa/0000-0001-9626-2897; Robins, Garry/0000-0001-7538-5804	Australian Research Council [0987730]; Australian National Health and Medical Research Council [331312]; Victorian Medical Research Operational Infrastructure Program	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Medical Research Operational Infrastructure Program	This work was supported in part by the Australian Research Council (Discovery project grant 0987730, http://www.arc.gov.au/ncgp/dp/dp_default.htm), the Australian National Health and Medical Research Council (project grant 331312, postgraduate scholarship to RSD, Senior Research Fellowship to MH, http://www.nhmrc.gov.au/) and funding from the Victorian Medical Research Operational Infrastructure Program (http://www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructure-program) to the Burnet Institute (http://www.burnet.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Aitken CK, 2004, J INFECT DIS, V190, P1586, DOI 10.1086/424678; ANDERSON R M, 1991; [Anonymous], 2012, MATLAB VERS 7 14 0 R; [Anonymous], 2008, STUDY CHARACTERIZE E; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Backmund M, 2004, CLIN INFECT DIS, V39, P1540, DOI 10.1086/425361; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V, 2011, PAJEK PROGRAM LARGE; Bate JP, 2010, J GASTROEN HEPATOL, V25, P1276, DOI 10.1111/j.1440-1746.2010.06295.x; Brewer DD, 2006, J INFECT DIS, V194, P764, DOI 10.1086/505585; Caruntu Florin Alexandru, 2006, J Gastrointestin Liver Dis, V15, P249; Centers for Disease Control and Prevention, 2003, GUID SMALL IN PRESS; Chowell G, 2004, EMERG INFECT DIS, V10, P1258, DOI 10.3201/eid1007.030647; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Currie SL, 2008, DRUG ALCOHOL DEPEN, V93, P148, DOI 10.1016/j.drugalcdep.2007.09.011; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; De P, 2007, JAIDS-J ACQ IMM DEF, V46, P355, DOI 10.1097/QAI.0b013e3181565dde; Doyle JS, 2013, BRIT J CLIN PHARMACO, V75, P931, DOI 10.1111/j.1365-2125.2012.04419.x; Esposito N, 2004, MATH BIOSCI, V188, P29, DOI 10.1016/j.mbs.2003.11.001; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Friedman SR, 1998, ADDICTION, V93, P1403, DOI 10.1046/j.1360-0443.1998.939140311.x; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Grady BPX, 2012, EUR J GASTROEN HEPAT, V24, P1302, DOI 10.1097/MEG.0b013e32835702a8; Grebely J, 2012, HEPATOLOGY, V55, P1058, DOI 10.1002/hep.24754; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hahn JA, 2009, EPIDEMICS-NETH, V1, P47, DOI 10.1016/j.epidem.2008.10.002; Hartvigsen G, 2007, J THEOR BIOL, V246, P205, DOI 10.1016/j.jtbi.2006.12.027; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Hofer H, 2003, HEPATOLOGY, V37, P60, DOI 10.1053/jhep.2003.50019; Hutchinson SJ, 2006, INT J DRUG POLICY, V17, P211, DOI 10.1016/j.drugpo.2006.02.008; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Khan B, 2012, MODELING DYNAMIC RIS; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; Mather D, 1999, EUR J EPIDEMIOL, V15, P5, DOI 10.1023/A:1007548307196; McDonald SA, 2012, INT J DRUG POLICY, V23, P353, DOI 10.1016/j.drugpo.2012.02.003; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Micallef JM, 2007, J VIRAL HEPATITIS, V14, P413, DOI 10.1111/j.1365-2893.2006.00812.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miller ER, 2009, J INFECTION, V58, P375, DOI 10.1016/j.jinf.2009.02.014; Murray JM, 2003, INT J EPIDEMIOL, V32, P708, DOI 10.1093/ije/dyg102; National Centre in HIV Epidemiology and Clinical Research (NCHECR), 2006, HEP C VIR PROJ WORK; NCHECR, 2009, RET INV 2 EV COST EF; Neaigus A, 1995, NIDA Res Monogr, V151, P20; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pattison PE, 2013, J MATH PSYC IN PRESS; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Pollack HA, 2001, MED DECIS MAKING, V21, P357, DOI 10.1177/02729890122062659; Porco TC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-34; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Rolls DA, 2012, J THEOR BIOL, V297, P73, DOI 10.1016/j.jtbi.2011.12.008; Rolls DA, 2013, SOC NETWORK IN PRESS; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; Vickerman P, 2007, INT J EPIDEMIOL, V36, P396, DOI 10.1093/ije/dyl276; Vickerman P, 2009, SEX TRANSM INFECT, V85, P23, DOI 10.1136/sti.2008.034660; Vickerman P, 2012, J INFECT DIS, V205, P1342, DOI 10.1093/infdis/jis213; Vidondo B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-51; Wang P., 2006, PNET PROGRAM SIMULAT; Wasley A, 2008, MMWR SURVEILL SUMM, V57, P124; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Watanabe H, 2003, J MED VIROL, V71, P56, DOI 10.1002/jmv.10448; Welch D, 2011, EPIDEMICS-NETH, V3, P38, DOI 10.1016/j.epidem.2011.01.002; World Health Organization, 2012, PREV CONTR VIR HEP I; Wylie JL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-229	81	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78286	10.1371/journal.pone.0078286	http://dx.doi.org/10.1371/journal.pone.0078286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223787	gold, Green Published, Green Accepted			2022-12-27	WOS:000326499300027
J	Escudero, LV; Casamayor, EO; Chong, G; Pedros-Alio, C; Demergasso, C				Escudero, Lorena V.; Casamayor, Emilio O.; Chong, Guillermo; Pedros-Alio, Carles; Demergasso, Cecilia			Distribution of Microbial Arsenic Reduction, Oxidation and Extrusion Genes along a Wide Range of Environmental Arsenic Concentrations	PLOS ONE			English	Article							DISSIMILATORY ARSENATE; SULFATE REDUCTION; RESISTANCE GENES; OXIDASE GENES; BACTERIA; IDENTIFICATION; DETOXIFICATION; RESPIRATION; EXPRESSION; DIVERSITY	The presence of the arsenic oxidation, reduction, and extrusion genes arsC, arrA, aioA, and acr3 was explored in a range of natural environments in northern Chile, with arsenic concentrations spanning six orders of magnitude. A combination of primers from the literature and newly designed primers were used to explore the presence of the arsC gene, coding for the reduction of As (V) to As (III) in one of the most common detoxification mechanisms. Enterobacterial related arsC genes appeared only in the environments with the lowest As concentration, while Firmicutes-like genes were present throughout the range of As concentrations. The arrA gene, involved in anaerobic respiration using As (V) as electron acceptor, was found in all the systems studied. The As (III) oxidation gene aioA and the As (III) transport gene acr3 were tracked with two primer sets each and they were also found to be spread through the As concentration gradient. Sediment samples had a higher number of arsenic related genes than water samples. Considering the results of the bacterial community composition available for these samples, the higher microbial phylogenetic diversity of microbes inhabiting the sediments may explain the increased number of genetic resources found to cope with arsenic. Overall, the environmental distribution of arsenic related genes suggests that the occurrence of different ArsC families provides different degrees of protection against arsenic as previously described in laboratory strains, and that the glutaredoxin (Grx)-linked arsenate reductases related to Enterobacteria do not confer enough arsenic resistance to live above certain levels of As concentrations.	[Escudero, Lorena V.; Demergasso, Cecilia] Univ Catolica Norte, Ctr Invest Cient Tecnol Mineria CICITEM, Antofagasta, Chile; [Escudero, Lorena V.; Demergasso, Cecilia] Univ Catolica Norte, Ctr Biotecnol, Antofagasta, Chile; [Chong, Guillermo] Univ Catolica Norte, Dept Ciencias Geol, Antofagasta, Chile; [Casamayor, Emilio O.] CEAB CSIC, Ctr Estudis Avancats Blanes, Biogeodynam & Biodivers Grp, Blanes, Spain; [Pedros-Alio, Carles] CSIC, Inst Ciencias Mar, Barcelona, Spain	Universidad Catolica del Norte; Universidad Catolica del Norte; Universidad Catolica del Norte; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Demergasso, C (corresponding author), Univ Catolica Norte, Ctr Invest Cient Tecnol Mineria CICITEM, Antofagasta, Chile.	cdemerga@ucn.cl	Pedrós-Alió, Carlos/H-1222-2011; Casamayor, Emilio/A-3676-2010; Demergasso, Cecilia/A-7392-2013	Pedrós-Alió, Carlos/0000-0003-1009-4277; Casamayor, Emilio/0000-0001-7074-3318; Demergasso, Cecilia/0000-0003-4563-3066	BIOARSENICO from Fundacion BBVA, Spain; Chilean government through FONDECYT from the Science and Technology Chilean Commission (CONICYT) [1100795]; CICITEM, Antofagasta, Chile; EOC by DARKNESS from the Spanish MINECO [CGL2012-32747]	BIOARSENICO from Fundacion BBVA, Spain(BBVA Foundation); Chilean government through FONDECYT from the Science and Technology Chilean Commission (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CICITEM, Antofagasta, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CICITEM); EOC by DARKNESS from the Spanish MINECO	This research was funded by grant BIOARSENICO from Fundacion BBVA, Spain, and the Chilean government through FONDECYT Project 1100795 from the Science and Technology Chilean Commission (CONICYT). LVE was supported by a fellowship from CICITEM, Antofagasta, Chile, and EOC by DARKNESS CGL2012-32747, from the Spanish MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, DIVERSITY ARSENITE T; Achour-Rokbani A, 2010, APPL ENVIRON MICROB, V76, P948, DOI 10.1128/AEM.01738-09; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ball P, 2005, NATURE, V436, P313, DOI 10.1038/436313a; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Campos VL, 2011, ARCH ENVIRON CON TOX, V61, P185, DOI 10.1007/s00244-010-9601-7; Croal LR, 2004, ANNU REV GENET, V38, P175, DOI 10.1146/annurev.genet.38.072902.091138; Cuebas M, 2011, MICROBIOL-SGM, V157, P2004, DOI 10.1099/mic.0.048678-0; Demergasso C, 2008, EXTREMOPHILES, V12, P491, DOI 10.1007/s00792-008-0153-y; Demergasso CS, 2007, GEOMICROBIOL J, V24, P111, DOI 10.1080/01490450701266605; Dorador CI, 2007, THESIS; Dorador C, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000837; Escudero LV, 2009, THESIS U AUTONOMA BA; Giloteaux L, 2013, ISME J, V7, P370, DOI 10.1038/ismej.2012.109; Hamamura N, 2009, ENVIRON MICROBIOL, V11, P421, DOI 10.1111/j.1462-2920.2008.01781.x; Handley KM, 2009, ENVIRON MICROBIOL, V11, P1601, DOI 10.1111/j.1462-2920.2009.01890.x; Hollibaugh JT, 2006, APPL ENVIRON MICROB, V72, P2043, DOI 10.1128/AEM.72.3.2043-2049.2006; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Jackson CR, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-18; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kulp TR, 2006, APPL ENVIRON MICROB, V72, P6514, DOI 10.1128/AEM.01066-06; Lara J, 2012, EXTREMOPHILES, V16, P523, DOI 10.1007/s00792-012-0452-1; Lear G, 2007, APPL ENVIRON MICROB, V73, P1041, DOI 10.1128/AEM.01654-06; Lett MC, 2012, J BACTERIOL, V194, P207, DOI 10.1128/JB.06391-11; Li XK, 2007, J BACTERIOL, V189, P3705, DOI 10.1128/JB.01913-06; Macur RE, 2004, ENVIRON SCI TECHNOL, V38, P104, DOI 10.1021/es034455a; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Mardones-Perez L, 1997, THESIS U PARSIS SUD; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Newman DK, 1997, ARCH MICROBIOL, V168, P380, DOI 10.1007/s002030050512; Newman DK, 1997, APPL ENVIRON MICROB, V63, P2022, DOI 10.1128/AEM.63.5.2022-2028.1997; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Quemeneur M, 2010, APPL ENVIRON MICROB, V76, P4566, DOI 10.1128/AEM.03104-09; Rhine ED, 2007, BIOCHEM BIOPH RES CO, V354, P662, DOI 10.1016/j.bbrc.2007.01.004; Richey C, 2009, BIOCHEM BIOPH RES CO, V382, P298, DOI 10.1016/j.bbrc.2009.03.045; Risacher F., 1999, GEOQUIMICA AGUAS CUE; Saltikov CW, 2005, J BACTERIOL, V187, P7390, DOI 10.1128/JB.187.21.7390-7396.2005; Saltikov CW, 2003, APPL ENVIRON MICROB, V69, P2800, DOI 10.1128/AEM.69.5.2800-2809.2003; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Silver S, 2011, FEMS MICROBIOL LETT, V315, P79, DOI 10.1111/j.1574-6968.2010.02202.x; Slyemi D, 2012, PROKARYOTES DEAL; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Smith AH, 2000, ENVIRON HEALTH PERSP, V108, P617, DOI 10.2307/3434881; Song B, 2009, FEMS MICROBIOL ECOL, V68, P108, DOI 10.1111/j.1574-6941.2009.00657.x; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Sun YM, 2004, J MICROBIOL METH, V58, P335, DOI 10.1016/j.mimet.2004.04.015; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Villadangos AF, 2011, MOL MICROBIOL, V82, P998, DOI 10.1111/j.1365-2958.2011.07882.x; Villegas-Torres MF, 2011, INT BIODETER BIODEGR, V65, P147, DOI 10.1016/j.ibiod.2010.10.007; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Zargar K, 2012, ENVIRON MICROBIOL, V14, P1635, DOI 10.1111/j.1462-2920.2012.02722.x; Zargar K, 2010, J BACTERIOL, V192, P3755, DOI 10.1128/JB.00244-10; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843	62	58	60	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78890	10.1371/journal.pone.0078890	http://dx.doi.org/10.1371/journal.pone.0078890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205341	gold, Green Submitted, Green Published			2022-12-27	WOS:000326373800023
J	Medina, KL; Tangen, SN; Seaburg, LM; Thapa, P; Gwin, KA; Shapiro, VS				Medina, Kay L.; Tangen, Sarah N.; Seaburg, Lauren M.; Thapa, Puspa; Gwin, Kimberly A.; Shapiro, Virginia Smith			Separation of Plasmacytoid Dendritic Cells from B-Cell-Biased Lymphoid Progenitor (BLP) and Pre-Pro B Cells Using PDCA-1	PLOS ONE			English	Article							MURINE BONE-MARROW; RECEPTOR-DEFICIENT MICE; IL-7 RECEPTOR; LINEAGE DIFFERENTIATION; RAG1 LOCUS; PRECURSORS; MOUSE; GENE; EXPRESSION; LACKING	B-cell-biased lymphoid progenitors (BLPs) and Pre-pro B cells lie at a critical juncture between B cell specification and commitment. However, both of these populations are heterogenous, which hampers investigation into the molecular changes that occur as lymphoid progenitors commit to the B cell lineage. Here, we demonstrate that there are PDCA-1(+)Siglec H+ plasmacytoid dendritic cells (pDCs) that co-purify with BLPs and Pre-pro B cells, which express little or no CD11c or Ly6C. Removal of PDCA-1(+) pDCs separates B cell progenitors that express high levels of a Rag1-GFP reporter from Rag1-GFP(low/neg) pDCs within the BLP and Pre-pro B populations. Analysis of Flt3-ligand knockout and IL-7R alpha knockout mice revealed that there is a block in B cell development at the all-lymphoid progenitor (ALP) stage, as the majority of cells within the BLP or Pre-pro B gates were PDCA-1+ pDCs. Thus, removal of PDCA-1+ pDCs is critical for analysis of BLP and Pre-pro B cell populations. Analysis of B cell potential within the B220(+)CD19(-) fraction demonstrated that AA4.1(+)Ly6D(+)PDCA-1(-) Prepro B cells gave rise to CD19(+) B cells at high frequency, while PDCA-1+ pDCs in this fraction did not. Interestingly, the presence of PDCA-1(+) pDCs within CLPs may help to explain the conflicting results regarding the origin of these cells.	[Medina, Kay L.; Tangen, Sarah N.; Seaburg, Lauren M.; Thapa, Puspa; Gwin, Kimberly A.; Shapiro, Virginia Smith] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	Shapiro, VS (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	shapiro.virginia1@mayo.edu			NIH [R01 HL096108, R01 AI083279]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 HL096108 to K. L. M. and NIH R01 AI083279 to V. S. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Choi J, 2012, J IMMUNOL, V188, P3791, DOI 10.4049/jimmunol.1103390; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Dolence JJ, 2011, EUR J IMMUNOL, V41, P324, DOI 10.1002/eji.201040710; Esashi E, 2012, EUR J IMMUNOL, V42, P573, DOI 10.1002/eji.201142045; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Gwin K, 2010, J IMMUNOL, V185, P6572, DOI 10.4049/jimmunol.0904203; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kuwata N, 1999, J IMMUNOL, V163, P6355; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2010, J EXP MED, V207, P1359, DOI 10.1084/jem.20100147; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; Martensson IL, 1997, J EXP MED, V185, P653, DOI 10.1084/jem.185.4.653; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354; Wang YH, 2004, IMMUNITY, V21, P1, DOI 10.1016/j.immuni.2004.07.003; Welner RS, 2008, BLOOD, V112, P3753, DOI 10.1182/blood-2008-04-151506; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	40	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78408	10.1371/journal.pone.0078408	http://dx.doi.org/10.1371/journal.pone.0078408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205225	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500116
J	van Dam, LCJ; Ernst, MO				van Dam, Loes C. J.; Ernst, Marc O.			Knowing Each Random Error of Our Ways, but Hardly Correcting for It: An Instance of Optimal Performance	PLOS ONE			English	Article							INFORMATION; INTEGRATION; PERCEPTION; NOISE; MODEL	Random errors are omnipresent in sensorimotor tasks due to perceptual and motor noise. The question is, are humans aware of their random errors on an instance-by-instance basis? The appealing answer would be 'no' because it seems intuitive that humans would otherwise immediately correct for the errors online, thereby increasing sensorimotor precision. However, here we show the opposite. Participants pointed to visual targets with varying degree of feedback. After movement completion participants indicated whether they believed they landed left or right of target. Surprisingly, participants' left/right-discriminability was well above chance, even without visual feedback. Only when forced to correct for the error after movement completion did participants loose knowledge about the remaining error, indicating that random errors can only be accessed offline. When correcting, participants applied the optimal correction gain, a weighting factor between perceptual and motor noise, minimizing end-point variance. Together these results show that humans optimally combine direct information about sensorimotor noise in the system (the current random error), with indirect knowledge about the variance of the perceptual and motor noise distributions. Yet, they only appear to do so offline after movement completion, not while the movement is still in progress, suggesting that during movement proprioceptive information is less precise.	[van Dam, Loes C. J.; Ernst, Marc O.] Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany; [van Dam, Loes C. J.; Ernst, Marc O.] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany; [Ernst, Marc O.] Bernstein Ctr Computat Neurosci, Tubingen, Germany	University of Bielefeld; University of Bielefeld	van Dam, LCJ (corresponding author), Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany.	Loes.van_Dam@uni-bielefeld.de	van Dam, Loes C.J./I-5141-2015	van Dam, Loes C.J./0000-0003-0590-9347; Ernst, Marc/0000-0003-4197-8569	Bernstein Centre for Computational Neuroscience, Tubingen (BMBF) [FKZ: 01GO1002]; EU [248587]	Bernstein Centre for Computational Neuroscience, Tubingen (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	This research was supported by the Bernstein Centre for Computational Neuroscience, Tubingen (BMBF; FKZ: 01GO1002) and EU grant 248587 "THE.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley RJ, 2003, J NEUROSCI, V23, P3066; BLAKE A, 1993, VISION RES, V33, P1723, DOI 10.1016/0042-6989(93)90037-W; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; Cheron G, 2000, J CLIN NEUROPHYSIOL, V17, P280, DOI 10.1097/00004691-200005000-00006; Collins DF, 2005, J NEUROPHYSIOL, V94, P1699, DOI 10.1152/jn.00191.2005; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Goble DJ, 2010, NEUROSCI LETT, V481, P54, DOI 10.1016/j.neulet.2010.06.053; Hamilton AFD, 2002, J NEUROPHYSIOL, V87, P2434, DOI 10.1152/jn.00875.2001; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Korenberg AT, 2002, CAH PSYCHOL COGN, V21, P537; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; POST LJ, 1994, EXP BRAIN RES, V100, P107; Sabes PN, 1997, J NEUROSCI, V17, P7119; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Vitello MP, 2012, IMMERSIVE MULTIMODAL, P7, DOI DOI 10.1007/978-1-4471-2754-3; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78757	10.1371/journal.pone.0078757	http://dx.doi.org/10.1371/journal.pone.0078757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205308	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000326334500132
J	Colombatti, R; De Bon, E; Bertomoro, A; Casonato, A; Pontara, E; Omenetto, E; Saggiorato, G; Steffan, A; Damian, T; Cella, G; Teso, S; Manara, R; Rampazzo, P; Meneghetti, G; Basso, G; Sartori, MT; Sainati, L				Colombatti, Raffaella; De Bon, Emiliano; Bertomoro, Antonella; Casonato, Alessandra; Pontara, Elena; Omenetto, Elisabetta; Saggiorato, Graziella; Steffan, Agostino; Damian, Tamara; Cella, Giuseppe; Teso, Simone; Manara, Renzo; Rampazzo, Patrizia; Meneghetti, Giorgio; Basso, Giuseppe; Sartori, Maria Teresa; Sainati, Laura			Coagulation Activation in Children with Sickle Cell Disease Is Associated with Cerebral Small Vessel Vasculopathy	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PULMONARY-HYPERTENSION; PLASMA-LEVELS; TISSUE FACTOR; RISK; HYPERCOAGULABILITY; HYDROXYCARBAMIDE; ADAMTS-13; ADHESION; ANEMIA	Background: Thrombotic complications in Sickle Cell Disease (SCD) arise since infancy, but the role of the coagulation system in children has been poorly explored. To determine its role in the development of clinical complications in childhood we measured coagulation and endothelial parameters in children with SCD at steady state. Methods: Markers of thrombin generation, fibrin dissolution and endothelial activation were evaluated in 38 children with SS-S beta degrees, 6 with SC disease and 50 age and blood group matched controls. Coagulation variables were correlated with markers of hemolysis and inflammation, with the presence of cerebral and lung vasculopathy and with the frequency of clinical complications. Results: SS-S beta degrees patients presented higher levels of factor VIII, von Willebrand factor antigen (VWF:Ag) and collagen binding activity, tissue plasminogen activator antigen (t-PA:Ag), D-dimer, p-selectin, prothrombin fragment1+2 (F1+2) and lower ADAMTS-13: activity/VWF: Ag (p<0.05) compared to controls and SC patients. In SS-S beta degrees patients coagulation variables correlated positively with markers of inflammation, hemolysis, and negatively with HbF (p<0.05). Patients with cerebral silent infarcts showed significant decrease in t-PA: Ag and ADAMTS-13 Antigen and a tendency toward higher D-dimer, F1+2, TAT compared to patients without them. D-dimer was associated with a six fold increased risk of cerebral silent infarcts. No correlation was found between coagulation activation and large vessel vasculopathy or other clinical events except for decreased t-PA: Ag in patients with tricuspid Rigurgitant Velocity >2.5m/sec. Conclusions: SS-S beta degrees disease is associated with extensive activation of the coagulation system at steady state since young age. ADAMTS-13 and t-PA: Ag are involved in the development of cerebral silent infarcts.	[Colombatti, Raffaella; Basso, Giuseppe; Sainati, Laura] Univ Padua, Dept Pediat, Clin Pediat Hematol Oncol, Azienda Osped, Padua, Italy; [De Bon, Emiliano; Bertomoro, Antonella; Casonato, Alessandra; Pontara, Elena; Omenetto, Elisabetta; Saggiorato, Graziella; Cella, Giuseppe; Sartori, Maria Teresa] Univ Padua, Dept Cardiol Thorac & Vasc Sci, Azienda Osped, Padua, Italy; [Steffan, Agostino; Damian, Tamara] Ctr Riferimento Oncol, Dept Diagnost Lab & Cellular Therapy, I-33081 Aviano, Italy; [Teso, Simone] Univ Padua, Padua, Italy; [Manara, Renzo] Univ Padua, Neuroradiol Unit, Azienda Osped, Padua, Italy; [Rampazzo, Patrizia; Meneghetti, Giorgio] Univ Padua, Dept Neurol Sci, Neurosonol Unit, Azienda Osped, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; IRCCS Aviano (CRO); University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova	Colombatti, R (corresponding author), Univ Padua, Dept Pediat, Clin Pediat Hematol Oncol, Azienda Osped, Padua, Italy.	rcolombatti@gmail.com	Steffan, Agostino/ABE-5972-2020; Colombatti, Raffaella/D-2910-2017; Teso, Simone/F-3585-2015	Steffan, Agostino/0000-0002-6320-3054; Colombatti, Raffaella/0000-0001-9797-0457; Teso, Simone/0000-0002-6914-7567; Manara, Renzo/0000-0002-5130-3971; BASSO, GIUSEPPE/0000-0002-2634-9302	Fondazione Citta della Speranza [11/04]	Fondazione Citta della Speranza	The Research was performed at the Azienda Ospedaliera-Universita di Padova, with a Grant from the Fondazione Citta della Speranza 11/04. http://www.cittadellasperanza.org/web/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029786; Ataga KI, 2009, HAEMATOL-HEMATOL J, V94, P1481, DOI 10.3324/haematol.2009.013672; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Ballas SK, 2010, AM J HEMATOL, V85, P6, DOI 10.1002/ajh.21550; Colella MP, 2012, J THROMB HAEMOST, V10, P1967, DOI 10.1111/j.1538-7836.2012.04861.x; Colombatti R, 2012, PEDIATR BLOOD CANCER, V59, P1275, DOI 10.1002/pbc.24110; Colombatti R, 2010, BRIT J HAEMATOL, V150, P601, DOI 10.1111/j.1365-2141.2010.08269.x; Connes P, 2013, BRIT J HAEMATOL, V161, P484, DOI 10.1111/bjh.12300; De Franceschi L, 2011, SEMIN THROMB HEMOST, V37, P226, DOI 10.1055/s-0031-1273087; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; FAMODU AA, 1987, J CLIN PATHOL, V40, P1487, DOI 10.1136/jcp.40.12.1487; Fujioka M, 2010, BLOOD, V115, P1650, DOI 10.1182/blood-2009-06-230110; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Gavins F, 2007, MICROCIRCULATION, V14, P667, DOI 10.1080/10739680701404903; Gordeuk VR, 2011, HAEMATOL-HEMATOL J, V96, P33, DOI 10.3324/haematol.2010.030767; Hoppe C, 2004, BLOOD, V103, P2391, DOI 10.1182/blood-2003-09-3015; Kassim AA, 2013, ANNU REV MED, V64, P451, DOI 10.1146/annurev-med-120611-143127; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; KAUL DK, 1993, BLOOD, V81, P2429; Klarmann D, 2010, TRANSFUSION, V50, P1571, DOI 10.1111/j.1537-2995.2010.02604.x; Krishnan S, 2008, THROMB RES, V122, P455, DOI 10.1016/j.thromres.2007.12.004; Laurance S, 2011, HAEMATOL-HEMATOL J, V96, P534, DOI 10.3324/haematol.2010.026740; Lee MT, 2009, BRIT J HAEMATOL, V146, P437, DOI 10.1111/j.1365-2141.2009.07779.x; LESLIE J, 1975, BRIT J HAEMATOL, V30, P159, DOI 10.1111/j.1365-2141.1975.tb00530.x; Liesner R, 1998, BRIT J HAEMATOL, V103, P1037; Lipp G, 2007, SEMIN THROMB HEMOST, V33, P816, DOI 10.1055/s-2007-1000373; Mohan JS, 2005, BLOOD COAGUL FIBRIN, V16, P209, DOI 10.1097/01.mbc.0000164431.98169.8f; Monagle P, 2010, BLOOD REV, V24, P63, DOI 10.1016/j.blre.2009.12.001; Montanaro M, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-36; Morris CR, 2011, HAEMATOL-HEMATOL J, V96, P1, DOI 10.3324/haematol.2010.035097; Noubouossie DCF, 2012, THROMB RES, V130, P259, DOI 10.1016/j.thromres.2011.10.016; Noubouossie DF, 2012, AM J HEMATOL, V87, P145, DOI 10.1002/ajh.22206; Nsiri B, 1996, HEMATOL CELL THER, V38, P279, DOI 10.1007/s00282-996-0279-2; PHILLIPS G, 1988, AM J HEMATOL, V29, P52, DOI 10.1002/ajh.2830290113; Schnog JJB, 2006, AM J HEMATOL, V81, P492, DOI 10.1002/ajh.20653; Setty BNY, 2012, BRIT J HAEMATOL, V157, P370, DOI 10.1111/j.1365-2141.2012.09065.x; Setty BNY, 2001, BLOOD, V98, P3228, DOI 10.1182/blood.V98.12.3228; Shenkman B, 2006, THROMB HAEMOSTASIS, V96, P160, DOI 10.1160/TH06-01-0019; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Zhou Z, 2012, CURR VASC PHARMACOL, V10, P756, DOI 10.2174/157016112803520738; Zhou Z, 2009, THROMB HAEMOSTASIS, V101, P1070, DOI 10.1160/TH08-10-0677	44	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78801	10.1371/journal.pone.0078801	http://dx.doi.org/10.1371/journal.pone.0078801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205317	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400105
J	Setty-Shah, N; Maranda, L; Candela, N; Fong, J; Dahod, I; Rogol, AD; Nwosu, BU				Setty-Shah, Nithya; Maranda, Louise; Candela, Ninfa; Fong, Jay; Dahod, Idris; Rogol, Alan D.; Nwosu, Benjamin Udoka			Lactose Intolerance: Lack of Evidence for Short Stature or Vitamin D Deficiency in Prepubertal Children	PLOS ONE			English	Article							DIETARY CALCIUM INTAKE; GROWTH-FACTOR-I; MILK CONSUMPTION; BONE MASS; COWS MILK; FOLLOW-UP; HEIGHT; LEPTIN; RISK; ADIPOSITY	Background: The health consequences of lactose intolerance (LI) are unclear. Aims: To investigate the effects of LI on stature and vitamin D status. Hypotheses: LI subjects will have similar heights and vitamin D status as controls. Subjects and Methods: Prepubertal children of ages 3-12 years with LI (n=38, age 8.61 +/- 3.08y, male/female 19/19) were compared to healthy, age-and gender-matched controls (n=49, age 7.95 +/- 2.64, male/female 28/21). Inclusion criteria: prepubertal status (boys: testicular volume <3cc; girls: Tanner 1 breasts), diagnosis of LI by hydrogen breath test, and no history of calcium or vitamin D supplementation. Vitamin D deficiency was defined as 25-hydroxyvitamin D [25(OH) D] <50 nmol/L. Gender-adjusted midparental target height (MPTH) z-score was calculated using NCHS data for 18 year-old adults. Data were expressed as mean +/- SD. Results: There was no significant difference in 25(OH) D between the LI and non-LI subjects (60.1 +/- 21.1, vs. 65.4 +/- 26.1 nmol/L, p = 0.29). Upon stratification into normal weight (BMI <85th percentile) vs. overweight/obese (BMI >= 85th percentile), the normal weight controls had significantly higher 25(OH) D level than both the normal weight LI children (78.3 +/- 32.6 vs. 62.9 +/- 23.2, p = 0.025), and the overweight/obese LI children (78.3 +/- 32.6 vs. 55.3 +/- 16.5, p = 0.004). Secondly, there was no overall difference in height z-score between the LI children and controls. The normal weight LI patients had similar height as normal controls (-0.46 +/- 0.89 vs. -0.71 +/- 1.67, p = 0.53), while the overweight/obese LI group was taller than the normal weight controls (0.36 +/- 1.41 vs. -0.71 +/- 1.67, p = 0.049), and of similar height as the overweight/obese controls (0.36 +/- 1.41 vs. 0.87 +/- 1.45, p = 0.28). MPTH z-score was similar between the groups. Conclusion: Short stature and vitamin D deficiency are not features of LI in prepubertal children.	[Setty-Shah, Nithya; Candela, Ninfa; Fong, Jay; Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; [Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Dahod, Idris] St Vincent Hosp, Dept Pediat, Worcester, MA 01604 USA; [Rogol, Alan D.] Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Virginia	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA.	Benjamin.Nwosu@umassmemorial.org	Rogol, A.D./H-5871-2019	Rogol, A.D./0000-0002-7526-3142	Department of Pediatrics; Faculty Scholars Diversity Program, University of Massachusetts Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Department of Pediatrics; Faculty Scholars Diversity Program, University of Massachusetts Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by Department of Pediatrics, and the Faculty Scholars Diversity Program, University of Massachusetts Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biason-Lauber A, 2000, ENDOCRINOLOGY, V141, P1446, DOI 10.1210/en.141.4.1446; Black L. J., 2013, PUBLIC HEALTH NUTR, P1; Black RE, 2002, AM J CLIN NUTR, V76, P675, DOI 10.1093/ajcn/76.3.675; Bonjour JP, 1997, J CLIN INVEST, V99, P1287, DOI 10.1172/JCI119287; Boyd J, 1928, BRIT MED J, V1928, P140, DOI 10.1136/bmj.1.3499.140; Collett-Solberg PF, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/919405; Medeiros LCD, 2012, J PEDIATR GASTR NUTR, V54, P204, DOI 10.1097/MPG.0b013e3182380604; de Beer H, 2012, ECON HUM BIOL, V10, P299, DOI 10.1016/j.ehb.2011.08.003; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Hattori K, 2002, AM J HUM BIOL, V14, P275, DOI 10.1002/ajhb.10037; HENDERSON RC, 1994, BONE MINER, V27, P1, DOI 10.1016/S0169-6009(08)80181-X; HIMES JH, 1986, HUM BIOL, V58, P737; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P852; Hoppe C, 2006, ANNU REV NUTR, V26, P131, DOI 10.1146/annurev.nutr.26.010506.103757; Infante D, 2000, J PEDIATR GASTR NUTR, V30, P310, DOI 10.1097/00005176-200003000-00018; Isolauri E, 1998, J PEDIATR-US, V132, P1004, DOI 10.1016/S0022-3476(98)70399-3; Jin L, 1999, J CLIN ENDOCR METAB, V84, P2903, DOI 10.1210/jc.84.8.2903; KILLEEN J, 1978, J CHRON DIS, V31, P529, DOI 10.1016/0021-9681(78)90040-1; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lazarus R, 1996, INT J OBESITY, V20, P406; Lebrethon MC, 2000, ENDOCRINOLOGY, V141, P1464, DOI 10.1210/en.141.4.1464; Lehtimaki T, 2006, PEDIATRICS, V118, P1553, DOI 10.1542/peds.2006-0542; Leighton G, 1929, BRIT MED J, V1929, P23, DOI 10.1136/bmj.1.3548.23; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Lomer MCE, 2008, ALIMENT PHARM THER, V27, P93, DOI 10.1111/j.1365-2036.2007.03557.x; Lustig RH, 2008, PEDIAT ENDOCRINOLOGY; Maor G, 2002, J BONE MINER RES, V17, P1034, DOI 10.1359/jbmr.2002.17.6.1034; Mattar R, 2012, CLIN EXP GASTROENTER, V5, P113, DOI 10.2147/CEG.S32368; Nwosu BU, 2008, AM FAM PHYSICIAN, V78, P597; Nwosu BU, 2004, HORM RES, V62, P97, DOI 10.1159/000079711; Nwosu BU, 2013, J PEDIAT ENDOCRINOL, V26, P1; PAGANUS A, 1992, ACTA PAEDIATR, V81, P518, DOI 10.1111/j.1651-2227.1992.tb12286.x; Pettifor JM, 1997, J BONE MINER RES, V12, P1824, DOI 10.1359/jbmr.1997.12.11.1824; Rogers I, 2006, PUBLIC HEALTH NUTR, V9, P359, DOI 10.1079/PHN2006853; Rosenfeld RG, 2003, NEW ENGL J MED, V349, P2184, DOI 10.1056/NEJMp038156; Sacheck J, 2011, J PEDIATR-US, V159, P945, DOI 10.1016/j.jpeds.2011.06.001; STALLINGS VA, 1994, J PEDIATR GASTR NUTR, V18, P440, DOI 10.1097/00005176-199405000-00006; Suchy Frederick J, 2010, NIH Consens State Sci Statements, V27, P1; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wales JKH, 2002, PEDIAT ENDOCRINOLOGY; Wiley AS, 2012, AM J HUM BIOL, V24, P130, DOI 10.1002/ajhb.22201; Wiley AS, 2005, AM J HUM BIOL, V17, P425, DOI 10.1002/ajhb.20411; Wilt Timothy J, 2010, Evid Rep Technol Assess (Full Rep), P1; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yang JF, 2013, CLIN GASTROENTEROL H, V11, P262, DOI 10.1016/j.cgh.2012.11.034; Yu WH, 1997, P NATL ACAD SCI USA, V94, P1023, DOI 10.1073/pnas.94.3.1023	47	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78653	10.1371/journal.pone.0078653	http://dx.doi.org/10.1371/journal.pone.0078653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205288	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400094
J	Takada, S				Takada, Shinobu			Post-Embryonic Induction of ATML1-SRDX Alters the Morphology of Seedlings	PLOS ONE			English	Article							LAYER-SPECIFIC GENE; EPIDERMAL-CELL DIFFERENTIATION; ABC TRANSPORTER; ARABIDOPSIS; EXPRESSION; IDENTIFICATION; FIDDLEHEAD; RECEPTOR; SECRETION; PROTEINS	Arabidopsis thaliana MERISTEM LAYER 1 (ATML1), an HD-ZIP class IV homeobox gene, is one of the key regulators promoting epidermal cell differentiation in Arabidopsis thaliana. We recently showed that ATML1 was able to confer an ectopic shoot epidermis cell fate to non-epidermal tissues of seedlings, suggesting that ATML1 is a master regulator of epidermal cell fate. To further assess the roles of ATML1 and its homologs in epidermal cell differentiation, I generated transgenic plants expressing ATML1 fused with a transcriptional repressor sequence (ATML1-SRDX). Estradiol-induced expression of ATML1-SRDX in the seedlings decreased transcript levels of several epidermis-related genes. Moreover, these transgenic plants exhibited phenotypes such as increased permeability to a hydrophilic dye and fusion of leaves and cotyledons, which are reminiscent of epidermis and/or cuticle-deficient mutants. Epidermal cell morphology was severely affected in the strong lines: filamentous protrusions were formed on the surface of the cotyledons. Marker gene analyses showed that these protrusions did not have epidermis, mesophyll, root hair, or trichome cell identity, suggesting that post-embryonic expression of ATML1-SRDX was sufficient to alter cell identity in pre-existing protodermal cells of the cotyledons. Taken together, these results suggest that ATML1 and/or its target genes are not only necessary for the initial specification of epidermal cell fate but also may be necessary for the maintenance of epidermal cells in later stages.	Osaka Univ, Dept Biol Sci, Grad Sch Sci, Toyonaka, Osaka 560, Japan	Osaka University	Takada, S (corresponding author), Osaka Univ, Dept Biol Sci, Grad Sch Sci, Toyonaka, Osaka 560, Japan.	shinobu_takada@bio.sci.osaka-u.ac.jp	Takada, Shinobu/AAI-1590-2020	Takada, Shinobu/0000-0001-6587-2166	Japan Society for the Promotion of Science (JSPS) [20657012, 23657036, 22687003]; Grants-in-Aid for Scientific Research [23657036] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Challenging Exploratory Research (No. 20657012 and No. 23657036 to S. T.) from the Japan Society for the Promotion of Science (JSPS) and by a grant-in-aid for Young Scientists (No. 22687003 to S. T.) from JSPS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1999, PLANT CELL PHYSIOL, V40, P571, DOI 10.1093/oxfordjournals.pcp.a029579; Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Abe M, 2001, PLANT J, V26, P487, DOI 10.1046/j.1365-313x.2001.01047.x; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Goh T, 2012, DEVELOPMENT, V139, P883, DOI 10.1242/dev.071928; Heyl A, 2008, PLANT PHYSIOL, V147, P1380, DOI 10.1104/pp.107.115436; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Iwase A, 2011, CURR BIOL, V21, P508, DOI 10.1016/j.cub.2011.02.020; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; LARKIN JC, 1993, PLANT CELL, V5, P1739, DOI 10.1105/tpc.5.12.1739; LOLLE SJ, 1992, DEV BIOL, V152, P383, DOI 10.1016/0012-1606(92)90145-7; Lu PZ, 1996, PLANT CELL, V8, P2155, DOI 10.1105/tpc.8.12.2155; Lynn K, 1999, DEVELOPMENT, V126, P469; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Takada S, 2007, DEVELOPMENT, V134, P1141, DOI 10.1242/dev.02803; Takada S, 2013, DEVELOPMENT, V140, P1919, DOI 10.1242/dev.094417; Tanaka H, 2007, DEVELOPMENT, V134, P1643, DOI 10.1242/dev.003533; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; Weijers D, 2001, DEVELOPMENT, V128, P4289; Yephremov A, 1999, PLANT CELL, V11, P2187, DOI 10.1105/tpc.11.11.2187; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	32	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79312	10.1371/journal.pone.0079312	http://dx.doi.org/10.1371/journal.pone.0079312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205380	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400115
J	Barbero, A; Astiz, S; Lopez-Bote, CJ; Perez-Solana, ML; Ayuso, M; Garcia-Real, I; Gonzalez-Bulnes, A				Barbero, Alicia; Astiz, Susana; Lopez-Bote, Clemente J.; Perez-Solana, Maria L.; Ayuso, Miriam; Garcia-Real, Isabel; Gonzalez-Bulnes, Antonio			Maternal Malnutrition and Offspring Sex Determine Juvenile Obesity and Metabolic Disorders in a Swine Model of Leptin Resistance	PLOS ONE			English	Article							BETA-CELL FUNCTION; STEAROYL-COA DESATURASE; NATIONAL-BIRTH-COHORT; INSULIN-RESISTANCE; GROWTH-RETARDATION; GLUCOSE-TOLERANCE; PRETERM BIRTH; IBERIAN PIGS; FETAL-GROWTH; ACID CONTENT	The present study aimed to determine, in a swine model of leptin resistance, the effects of type and timing of maternal malnutrition on growth patterns, adiposity and metabolic features of the progeny when exposed to an obesogenic diet during their juvenile development and possible concomitant effects of the offspring sex. Thus, four groups were considered. A CONTROL group involved pigs born from sows fed with a diet fulfilling their daily maintenance requirements for pregnancy. The treated groups involved the progeny of females fed with the same diet but fulfilling either 160% or 50% of pregnancy requirements during the entire gestation (OVERFED and UNDERFED, respectively) or 100% of requirements until Day 35 of pregnancy and 50% of such amount from Day 36 onwards (LATE-UNDERFED). OVERFED and UNDERFED offspring were more prone to higher corpulence and fat deposition from early postnatal stages, during breast-feeding; adiposity increased significantly when exposed to obesogenic diets, especially in females. The effects of sex were even more remarkable in LATE-UNDERFED offspring, which had similar corpulence to CONTROL piglets; however, females showed a clear predisposition to obesity. Furthermore, the three groups of pigs with maternal malnutrition showed evidences of metabolic syndrome and, in the case of individuals born from OVERFED sows, even of insulin resistance and the prodrome of type-2 diabetes. These findings support the main role of early nutritional programming in the current rise of obesity and associated diseases in ethnics with leptin resistance.	[Barbero, Alicia; Lopez-Bote, Clemente J.; Ayuso, Miriam; Garcia-Real, Isabel] UCM, Fac Vet, Madrid, Spain; [Astiz, Susana; Perez-Solana, Maria L.; Gonzalez-Bulnes, Antonio] INIA, Madrid, Spain	Complutense University of Madrid	Gonzalez-Bulnes, A (corresponding author), INIA, Madrid, Spain.	bulnes@inia.es	ayuso, miriam/GPX-8386-2022; Astiz, Susana/AAN-8769-2021; Hernando, Miriam Ayuso/AAY-3751-2020; Gonzalez-Bulnes, Antonio/K-7691-2015; bote, clemente lopez/AAQ-6503-2021; REAL, MARIA ISABEL GARCIA/AAC-3654-2020; Lopez-Bote, Clemente/F-5103-2014	ayuso, miriam/0000-0001-6045-394X; Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Lopez-Bote, Clemente/0000-0002-6839-8057; Garcia Real, Maria Isabel/0000-0002-8886-3956; BARBERO, ALICIA/0000-0003-0213-6932	Spanish Ministry of Economy and Competitiveness [AGL2010-21991-C03-03]; FEDER	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission)	The experimental work was supported by funds from the Spanish Ministry of Economy and Competitiveness (project AGL2010-21991-C03-03), co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2011, J PEDIATR ENDOCR MET, V24, P427, DOI 10.1515/JPEM.2011.246; Al-Shoumer KA, 2008, ANN SAUDI MED, V28, P367; Aschner P, 2010, EXPERT REV CARDIOVAS, V8, P407, DOI [10.1586/erc.10.13, 10.1586/ERC.10.13]; Ashworth CJ, 2001, J REP FER S, P233; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Bauer R, 2003, EUR J OBSTET GYN R B, V110, pS40, DOI 10.1016/S0301-2115(03)00171-4; BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Bee G, 2004, J ANIM SCI, V82, P826; Berard J, 2010, MEAT SCI, V86, P845, DOI 10.1016/j.meatsci.2010.07.007; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Caron-Jobin M, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2011.19; Chandler-Laney PC, 2010, OBESITY, V18, P2086, DOI 10.1038/oby.2010.44; Chang J, 2011, J VET SCI, V12, P91, DOI 10.4142/jvs.2011.12.1.91; Church TS, 2009, DIABETES CARE, V32, P1289, DOI 10.2337/dc08-1871; DOUGLAS WR, 1972, SPACE LIFE SCI, V3, P226, DOI 10.1007/BF00928167; Elder DA, 2006, J CLIN ENDOCR METAB, V91, P185, DOI 10.1210/jc.2005-0853; FISHER DA, 1972, CALIF MED, V117, P34; Ford SP, 2007, J ANIM SCI, V85, P1285, DOI 10.2527/jas.2005-624; Foxcroft G R, 2006, J Anim Sci, V84 Suppl, pE105; Foxcroft G R, 2009, Soc Reprod Fertil Suppl, V66, P213; Gherlan Iuliana, 2012, Maedica (Bucur), V7, P205; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gonzalez-Bulnes A, 2012, CURR DIABETES REV, V8, P144, DOI 10.2174/157339912799424537; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hanson M, 2011, PROG BIOPHYS MOL BIO, V106, P272, DOI 10.1016/j.pbiomolbio.2010.12.008; HAUSMAN DB, 1991, BIOL NEONATE, V59, P257, DOI 10.1159/000243359; HOUPT KA, 1979, YALE J BIOL MED, V52, P307; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Koyama K, 1997, AM J PHYSIOL-ENDOC M, V273, pE708, DOI 10.1152/ajpendo.1997.273.4.E708; Kwiterovich Peter O, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P727; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; MARMER WN, 1981, LIPIDS, V16, P365, DOI 10.1007/BF02534964; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metges CC, 2005, J ANIM FEED SCI, V14, P15; Mitchell AD, 2001, J ANIM SCI, V79, P1800; Nieto R, 2002, BRIT J NUTR, V88, P39, DOI 10.1079/BJN2002591; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x; Ollivier L, 2009, ANIMAL, V3, P915, DOI 10.1017/S1751731109004297; Olufadi R, 2008, J CLIN PATHOL, V61, P697, DOI 10.1136/jcp.2007.048363; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Poudyal Hemant, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P217; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rey AI, 1997, ANIM SCI, V65, P515, DOI 10.1017/S1357729800008729; Rhodes P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007393; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; RUWE PJ, 1991, J ANIM SCI, V69, P1935, DOI 10.2527/1991.6951935x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scheen AJ, 2010, DIABETES METAB, V36, pS31, DOI 10.1016/S1262-3636(10)70464-X; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Slyper AH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e4; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Torres-Rovira L, 2013, ENDOCRINOL METAB IMM; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yajnik C S, 2002, Obes Rev, V3, P217, DOI 10.1046/j.1467-789X.2002.00072.x; Yee JK, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-19; YEN JT, 1982, J ANIM SCI, V54, P796, DOI 10.2527/jas1982.544796x	69	29	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78424	10.1371/journal.pone.0078424	http://dx.doi.org/10.1371/journal.pone.0078424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205230	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300059
J	Chua, ACG; Klopcic, BRS; Ho, DS; Fu, K; Forrest, CH; Croft, KD; Olynyk, JK; Lawrance, IC; Trinder, D				Chua, Anita C. G.; Klopcic, Borut R. S.; Ho, Desiree S.; Fu, Kristine; Forrest, Cynthia H.; Croft, Kevin D.; Olynyk, John K.; Lawrance, Ian C.; Trinder, Debbie			Dietary Iron Enhances Colonic Inflammation and IL-6/IL-11-Stat3 Signaling Promoting Colonic Tumor Development in Mice	PLOS ONE			English	Article							SODIUM-INDUCED COLITIS; CELL-CYCLE PROGRESSION; MUTANT MOUSE MODEL; NF-KAPPA-B; ULCERATIVE-COLITIS; BOWEL-DISEASE; INTESTINAL INFLAMMATION; OXIDATIVE STRESS; EPITHELIAL-CELLS; CROHNS-DISEASE	Chronic intestinal inflammation and high dietary iron are associated with colorectal cancer development. The role of Stat3 activation in iron-induced colonic inflammation and tumorigenesis was investigated in a mouse model of inflammation-associated colorectal cancer. Mice, fed either an iron-supplemented or control diet, were treated with azoxymethane and dextran sodium sulfate (DSS). Intestinal inflammation and tumor development were assessed by endoscopy and histology, gene expression by real-time PCR, Stat3 phosphorylation by immunoblot, cytokines by ELISA and apoptosis by TUNEL assay. Colonic inflammation was more severe in mice fed an iron-supplemented compared with a control diet one week post-DSS treatment, with enhanced colonic IL-6 and IL-11 release and Stat3 phosphorylation. Both IL-6 and ferritin, the iron storage protein, co-localized with macrophages suggesting iron may act directly on IL-6 producing-macrophages. Iron increased DSS-induced colonic epithelial cell proliferation and apoptosis consistent with enhanced mucosal damage. DSS-treated mice developed anemia that was not alleviated by dietary iron supplementation. Six weeks post-DSS treatment, iron-supplemented mice developed more and larger colonic tumors compared with control mice. Intratumoral IL-6 and IL-11 expression increased in DSS-treated mice and IL-6, and possibly IL-11, were enhanced by dietary iron. Gene expression of iron importers, divalent metal transporter 1 and transferrin receptor 1, increased and iron exporter, ferroportin, decreased in colonic tumors suggesting increased iron uptake. Dietary iron and colonic inflammation synergistically activated colonic IL-6/IL-11-Stat3 signaling promoting tumorigenesis. Oral iron therapy may be detrimental in inflammatory bowel disease since it may exacerbate colonic inflammation and increase colorectal cancer risk.	[Chua, Anita C. G.; Klopcic, Borut R. S.; Ho, Desiree S.; Fu, Kristine; Lawrance, Ian C.; Trinder, Debbie] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia; [Chua, Anita C. G.; Ho, Desiree S.; Trinder, Debbie] Western Australian Inst Med Res, Perth, WA, Australia; [Klopcic, Borut R. S.; Fu, Kristine] Fremantle Hosp, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia; [Forrest, Cynthia H.] Fremantle Hosp, Dept Histopathol, Fremantle, WA, Australia; [Forrest, Cynthia H.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Croft, Kevin D.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Olynyk, John K.] Fremantle Hosp, Dept Gastroenterol, Fremantle, WA, Australia; [Olynyk, John K.] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Olynyk, John K.] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Murdoch University; Curtin University	Chua, ACG (corresponding author), Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia.	anita.chua@uwa.edu.au	Chua, Anita CG/D-3718-2016; Lawrance, Ian C/H-5252-2014	Chua, Anita CG/0000-0003-1075-5901; Croft, Kevin/0000-0003-1596-4913; Olynyk, John/0000-0003-0417-3411	National Health and Medical Research Council, Australia (NHMRC) [APP1007769]; Cancer Council of Western Australia; Fremantle Hospital Medical Research Foundation; Raine Medical Research Foundation; Gastroenterological Society of Australia; NHMRC [APP1042370, APP1020437]	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia); Fremantle Hospital Medical Research Foundation; Raine Medical Research Foundation; Gastroenterological Society of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council, Australia (NHMRC; APP1007769 to DT, JKO, ACGC, ICL), Cancer Council of Western Australia (to DT, JKO, ICL, ACGC, BRSK), Fremantle Hospital Medical Research Foundation (to ACGC, BRSK, ICL, DSH) and Raine Medical Research Foundation (to ACGC). ACGC is a recipient of a Bushell Postdoctoral Fellowship from the Gastroenterological Society of Australia. DT is a recipient of a Senior Research Fellowship (APP1020437) and JKO is a recipient of a Practitioner Fellowship (APP1042370) from NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Carrier J, 2002, J NUTR, V132, P3146, DOI 10.1093/jn/131.10.3146; Carrier J, 2001, ALIMENT PHARM THER, V15, P1989, DOI 10.1046/j.1365-2036.2001.01113.x; Carrier JC, 2006, INT J COLORECTAL DIS, V21, P381, DOI 10.1007/s00384-005-0011-7; Chua ACG, 2010, J HEPATOL, V52, P425, DOI 10.1016/j.jhep.2009.12.010; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Drake SF, 2007, AM J PHYSIOL-GASTR L, V292, pG323, DOI 10.1152/ajpgi.00278.2006; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; GASCHE C, 1994, DIGEST DIS SCI, V39, P1930, DOI 10.1007/BF02088127; Gasche C, 2004, GUT, V53, P1190, DOI 10.1136/gut.2003.035758; Gearry RB, 2006, INFLAMM BOWEL DIS, V12, P936, DOI 10.1097/01.mib.0000231572.88806.b9; Gerlach K, 2012, CANCER RES, V72, P4340, DOI 10.1158/0008-5472.CAN-11-4155; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hagiwara C, 2002, J GASTROEN HEPATOL, V17, P758, DOI 10.1046/j.1440-1746.2002.02791.x; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Iwamoto M, 1996, J PATHOL, V180, P152; KESHAVARZIAN A, 1992, DIGEST DIS SCI, V37, P1866; KESHAVARZIAN A, 1990, GUT, V31, P786, DOI 10.1136/gut.31.7.786; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Kulnigg S, 2006, ALIMENT PHARM THER, V24, P1507, DOI 10.1111/j.1365-2036.2006.03146.x; Lakatos L, 2003, WORLD J GASTROENTERO, V9, P2300; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; LihBrody L, 1996, DIGEST DIS SCI, V41, P2078, DOI 10.1007/BF02093613; Millar AD, 2000, ALIMENT PHARM THERAP, V14, P1163; Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037; NELSON RL, 1994, JNCI-J NATL CANCER I, V86, P455, DOI 10.1093/jnci/86.6.455; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Neufert C, 2010, CELL CYCLE, V9, P652, DOI 10.4161/cc.9.4.10615; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Pillai RB, 1999, DIGEST DIS SCI, V44, P1565, DOI 10.1023/A:1026654725101; Pinnix ZK, 2010, SCI TRANSL MED, V2; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Seril DN, 2002, DIGEST DIS SCI, V47, P1266, DOI 10.1023/A:1015362228659; Seril DN, 2005, DIGEST DIS SCI, V50, P696, DOI 10.1007/s10620-005-2560-6; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wurzelmann JI, 1996, CANCER EPIDEM BIOMAR, V5, P503; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zacharski LR, 2008, JNCI-J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209	61	49	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78850	10.1371/journal.pone.0078850	http://dx.doi.org/10.1371/journal.pone.0078850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223168	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200060
J	Han, YY; Zhang, X; Wang, YF; Ming, F				Han, Yingying; Zhang, Xuan; Wang, Yaofeng; Ming, Feng			The Suppression of WRKY44 by GIGANTEA-miR172 Pathway Is Involved in Drought Response of Arabidopsis thaliana	PLOS ONE			English	Article							FLOWERING-TIME; GENE-EXPRESSION; PLANT DEVELOPMENT; CIRCADIAN CLOCK; ACID CONTENT; STRESS; SUGAR; IDENTIFICATION; SENSITIVITY; MODULATION	Water availability is an important environmental factor that controls flowering time. Many plants accelerate flowering under drought conditions, a phenomenon called drought escape. Four pathways are involved in controlling flowering time, but which ones participate in drought escape is not yet known. In this study, plants with loss-of-function mutations of GIGANTEA (GI) and CONSTANS (CO) exhibited abnormal drought-escape phenotypes. The peak mRNA levels of GI and FKF1 (Flavin-binding Kelch domain F box protein 1) and the mRNA levels of CO and FT (Flowering locus T) changed under drought stress. The microRNA factor miRNA172E was up-regulated by drought stress, and its up-regulation was dependent on GI, while other miRNA172s were not. Water-loss analyses indicated that gi mutants were more sensitive while miRNA172 over-expressing (miRNA172-OX) plants were less so to drought stress than wild-type plants. Digital gene expression and real-time PCR analyses showed that WRKY44 was down-regulated by GI and miRNA172. The WRKY44 protein could interact with TOE1 (a target of miRNA172) in a yeast two-hybrid system. We proposed that GI-miRNA172-WRKY44 may regulate drought escape and drought tolerance by affecting sugar signaling in Arabidopsis.	[Han, Yingying; Zhang, Xuan; Wang, Yaofeng; Ming, Feng] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Han, Yingying; Zhang, Xuan; Wang, Yaofeng; Ming, Feng] Fudan Univ, Sch Life Sci, Inst Plant Biol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ming, F (corresponding author), Fudan Univ, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	fming@fudan.edu.cn			National Natural Science Foundation of China [30900782]; Ministry of Agriculture of China [2008ZX08009-001-008]; Natural Science Foundation of Shanghai [12ZR1402300square]; Foundation of Chinese Post-doctor [20080440580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Foundation of Chinese Post-doctor	This work was supported by grants from National Natural Science Foundation of China (No. 30900782), the Ministry of Agriculture of China (2008ZX08009-001-008, Natural Science Foundation of Shanghai (No. 12ZR1402300 square), Foundation of Chinese Post-doctor (No. 20080440580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; BYRNE PF, 1995, CROP SCI, V35, P63, DOI 10.2135/cropsci1995.0011183X003500010011x; Cao SQ, 2007, BIOL PLANTARUM, V51, P359, DOI 10.1007/s10535-007-0073-1; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Crouin C, 2001, FEBS LETT, V495, P148, DOI 10.1016/S0014-5793(01)02373-0; Dejardin A, 1999, BIOCHEM J, V344, P503, DOI 10.1042/0264-6021:3440503; EIMERT K, 1995, PLANT CELL, V7, P1703, DOI 10.1105/tpc.7.10.1703; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Galvez DA, 2011, TREE PHYSIOL, V31, P250, DOI 10.1093/treephys/tpr012; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Hwang EW, 2011, GENES GENOM, V33, P105, DOI 10.1007/s13258-010-0135-1; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; KATO K, 1992, THEOR APPL GENET, V84, P259, DOI 10.1007/BF00229480; Kong Y. Q. M., 2010, American Journal of Plant Sciences, V1, P69, DOI 10.4236/ajps.2010.12009; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; LEONARD M, 1981, PLANT PHYSIOL, V67, P1245, DOI 10.1104/pp.67.6.1245; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Mangelsen E, 2010, PLANT PHYSIOL, V153, P14, DOI 10.1104/pp.110.154856; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Martin-Tryon EL, 2007, PLANT PHYSIOL, V143, P473, DOI 10.1104/pp.106.088757; McLaughlin JE, 2004, ANN BOT-LONDON, V94, P675, DOI 10.1093/aob/mch193; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Reeves PH, 2000, CURR OPIN PLANT BIOL, V3, P37, DOI 10.1016/S1369-5266(99)00041-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Seo PJ, 2011, PLANT J, V65, P418, DOI 10.1111/j.1365-313X.2010.04432.x; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas B., 1997, PHOTOPERIODISM PLANT; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; ZEEVAART JA, 1971, PLANT PHYSIOL, V48, P86, DOI 10.1104/pp.48.1.86; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	62	59	74	7	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e73541	10.1371/journal.pone.0073541	http://dx.doi.org/10.1371/journal.pone.0073541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223111	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200003
J	Ma, JD; Jiang, Z; He, S; Liu, YK; Chen, L; Long, KR; Jin, L; Jiang, AA; Zhu, L; Wang, JY; Li, MZ; Li, XW				Ma, Jideng; Jiang, Zhi; He, Shen; Liu, Yingkai; Chen, Lei; Long, Keren; Jin, Long; Jiang, An'an; Zhu, Li; Wang, Jinyong; Li, Mingzhou; Li, Xuewei			Intrinsic Features in MicroRNA Transcriptomes Link Porcine Visceral Rather than Subcutaneous Adipose Tissues to Metabolic Risk	PLOS ONE			English	Article							DOWN-REGULATION; INFLAMMATION; EXPRESSION; OBESITY; ADIPOGENESIS; INVASION; PROFILE; GENES; MACROPHAGES; ACTIVATION	MicroRNAs (miRNAs) are non-coding small RNA similar to 22 nucleotides in length that can regulate the expression of a wide range of coding genes at the post-transcriptional level. Visceral adipose tissues (VATs) and subcutaneous adipose tissues (SATs), the two main fat compartments in mammals, are anatomically, physiologically, metabolically, and clinically distinct. Various studies of adipose tissues have focused mainly on DNA methylation, and mRNA and protein expression, nonetheless little research sheds directly light on the miRNA transcriptome differences between these two distinct adipose tissue types. Here, we present a comprehensive investigation of miRNA transcriptomes across six variant porcine adipose tissues by small RNA-sequencing. We identified 219 known porcine miRNAs, 97 novel miRNA*s, and 124 miRNAs that are conserved to other mammals. A set of universally abundant miRNAs (i.e., miR-148a-3p, miR-143-3p, miR-27b-3p, miR-let-7a-1-5p, and miR-let-7f-5p) across the distinct adipose tissues was found. This set of miRNAs may play important housekeeping roles that are involved in adipogenesis. Clustering analysis indicated significant variations in miRNA expression between the VATs and SATs, and highlighted the role of the greater omentum in responding to potential metabolic risk because of the observed enrichment in this tissue of the immune-and inflammation-related miRNAs, such as the members of miR-17-92 cluster and miR-181 family. Differential expression of the miRNAs between the VATs and SATs, and miRNA target prediction analysis revealed that the VATs-specific enriched miRNAs were associated mainly with immune and inflammation responses. In summary, the differences of miRNA expression between the VATs and SATs revealed some of their intrinsic differences and indicated that the VATs might be closely associated with increased risk of metabolic disorders.	[Ma, Jideng; He, Shen; Liu, Yingkai; Long, Keren; Jin, Long; Jiang, An'an; Zhu, Li; Li, Mingzhou; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Jiang, Zhi] Novogene Bioinformat Inst, Beijing, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China	Sichuan Agricultural University	Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	mingzhou.li@163.com; xuewei.li@sicau.edu.cn		Li, Mingzhou/0000-0001-8681-7684	National High Technology Research and Development Program of China (863 Program) [2013AA102502]; Specialized Research Fund of Ministry of Agriculture of China [NYCYTX-009]; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province [2011YZGG15]; National Special Foundation for Transgenic Species of China [2011ZX08006-003]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Specialized Research Fund of Ministry of Agriculture of China; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province; National Special Foundation for Transgenic Species of China	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (2013AA102502) to M. L., the Specialized Research Fund of Ministry of Agriculture of China (NYCYTX-009), the Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province (2011YZGG15), and the National Special Foundation for Transgenic Species of China (2011ZX08006-003) to X. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen DC, 2010, EXP CELL RES, V316, P1681, DOI 10.1016/j.yexcr.2010.04.002; Arner P, 2005, CURR MOL MED, V5, P333, DOI 10.2174/1566524053766022; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Carlow DA, 2009, J IMMUNOL, V183, P1155, DOI 10.4049/jimmunol.0900409; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Clement K, 2007, J INTERN MED, V262, P422, DOI 10.1111/j.1365-2796.2007.01851.x; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Dogru T, 2007, DIABETES RES CLIN PR, V76, P24, DOI 10.1016/j.diabres.2006.07.031; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Ikeoka D, 2010, REV ASSOC MED BRAS, V56, P116, DOI 10.1590/S0104-42302010000100026; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Lafontan M, 2013, DIFFERENCES SUBCUTAN, P329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Pan S., 2012, BOUND VALUE PROBL, V1, P1; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P94, DOI 10.1002/ibd.21742; Piche ME, 2008, METABOLISM, V57, P1101, DOI 10.1016/j.metabol.2008.03.015; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sam S, 2008, DIABETES, V57, P2022, DOI 10.2337/db08-0157; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang T, 2013, INT J BIOL SCI, V9, P550, DOI 10.7150/ijbs.6257; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yildirim A, 2010, ROM J MORPHOL EMBRYO, V51, P759; Zhou CW, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-75; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	73	9	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80041	10.1371/journal.pone.0080041	http://dx.doi.org/10.1371/journal.pone.0080041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223210	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200103
J	Barak, MM; Lieberman, DE; Raichlen, D; Pontzer, H; Warrener, AG; Hublin, JJ				Barak, Meir M.; Lieberman, Daniel E.; Raichlen, David; Pontzer, Herman; Warrener, Anna G.; Hublin, Jean-Jacques			Trabecular Evidence for a Human-Like Gait in Australopithecus africanus	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; BENT-KNEE WALKING; CANCELLOUS BONE; ARDIPITHECUS-RAMIDUS; LAETOLI FOOTPRINTS; HUMAN BIPEDALISM; EARLY HOMININS; FEMORAL-HEAD; AFARENSIS; EVOLUTION	Although the earliest known hominins were apparently upright bipeds, there has been mixed evidence whether particular species of hominins including those in the genus Australopithecus walked with relatively extended hips, knees and ankles like modern humans, or with more flexed lower limb joints like apes when bipedal. Here we demonstrate in chimpanzees and humans a highly predictable and sensitive relationship between the orientation of the ankle joint during loading and the principal orientation of trabecular bone struts in the distal tibia that function to withstand compressive forces within the joint. Analyses of the orientation of these struts using microCT scans in a sample of fossil tibiae from the site of Sterkfontein, of which two are assigned to Australopithecus africanus, indicate that these hominins primarily loaded their ankles in a relatively extended posture like modern humans and unlike chimpanzees. In other respects, however, trabecular properties in Au africanus are distinctive, with values that mostly fall between those of chimpanzees and humans. These results indicate that Au. africanus, like Homo, walked with an efficient, extended lower limb.	[Barak, Meir M.; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Barak, Meir M.; Lieberman, Daniel E.; Warrener, Anna G.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Raichlen, David] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Pontzer, Herman] Hunter Coll, Dept Anthropol, New York, NY USA	Max Planck Society; Harvard University; University of Arizona; City University of New York (CUNY) System; Hunter College (CUNY)	Barak, MM (corresponding author), Winthrop Univ, Dept Biol, Rock Hill, SC 29733 USA.	barakm@winthrop.edu; danlieb@fas.harvard.edu	Barak, Meir/C-9957-2010; Warrener, Anna/AAC-5225-2020	Barak, Meir/0000-0003-4953-4380; Pontzer, Herman/0000-0003-2397-6543	American School of Prehistoric Research (Harvard University); Hintze Family Charitable Foundation; Minerva Stiftung Gesellschaft fur die Forschung mbH; LSB Leakey Foundation; National Science Foundation [ECS-0335765]	American School of Prehistoric Research (Harvard University); Hintze Family Charitable Foundation; Minerva Stiftung Gesellschaft fur die Forschung mbH; LSB Leakey Foundation; National Science Foundation(National Science Foundation (NSF))	For funding, the authors thank the American School of Prehistoric Research (Harvard University), the Hintze Family Charitable Foundation, the Minerva Stiftung Gesellschaft fur die Forschung mbH, and the LSB Leakey Foundation. The human and chimpanzee microCT scans were performed in the Center for Nanoscale Systems, Harvard University, a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MORPH PAR MEAS SKYSC; Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; Berger LR, 1996, J HUM EVOL, V30, P343, DOI 10.1006/jhev.1996.0027; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Carey TS, 2005, J HUM EVOL, V48, P25, DOI 10.1016/j.jhevol.2004.10.001; Christen P, 2012, BIOMECH MODEL MECHAN, V11, P483, DOI 10.1007/s10237-011-0327-x; Crompton RH, 1998, J HUM EVOL, V35, P55, DOI 10.1006/jhev.1998.0222; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; D'Aout K, 2002, AM J PHYS ANTHROPOL, V119, P37, DOI 10.1002/ajpa.10112; Darwin Charles, 1871, DESCENT MAN; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; DeSilva JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014432; DeSilva JM, 2009, P NATL ACAD SCI USA, V106, P6567, DOI 10.1073/pnas.0900270106; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Haraguchi N, 2009, FOOT ANKLE INT, V30, P177, DOI 10.3113/FAI.2009.0177; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HARRIGAN TP, 1988, J BIOMECH, V21, P269, DOI 10.1016/0021-9290(88)90257-6; HUNT KD, 1992, AM J PHYS ANTHROPOL, V87, P83, DOI 10.1002/ajpa.1330870108; Kabel J, 1999, BONE, V24, P115, DOI 10.1016/S8756-3282(98)00164-1; KIMIZUKA M, 1980, ARCH ORTHOP TRAUM SU, V96, P45, DOI 10.1007/BF01246141; Kobayashi S, 2003, BONE, V32, P163, DOI 10.1016/S8756-3282(02)00947-X; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; LANYON LE, 1974, J BONE JOINT SURG BR, VB 56, P160; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Lovejoy CO, 2010, PHILOS T R SOC B, V365, P3289, DOI 10.1098/rstb.2010.0112; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MacLatchy L, 2002, J HUM EVOL, V43, P89, DOI 10.1006/jhev.2002.0559; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; Pontzer H, 2004, J HUM EVOL, V46, P317, DOI 10.1016/j.jhevol.2003.12.006; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Raichlen DA, 2008, J HUM EVOL, V54, P112, DOI 10.1016/j.jhevol.2007.07.005; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Rook L, 1999, P NATL ACAD SCI USA, V96, P8795, DOI 10.1073/pnas.96.15.8795; Ryan TM, 2010, ANAT REC, V293, P719, DOI 10.1002/ar.21139; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Saparin P, 2011, ANAT REC, V294, P55, DOI 10.1002/ar.21285; Scherf H, 2009, AM J PHYS ANTHROPOL, V140, P39, DOI 10.1002/ajpa.21033; Schiff A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P224; Schmitt D, 2003, J EXP BIOL, V206, P1437, DOI 10.1242/jeb.00279; Sellers WI, 2005, J R SOC INTERFACE, V2, P431, DOI 10.1098/rsif.2005.0060; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Su A, 2013, J HUM EVOL, V64, P667, DOI 10.1016/j.jhevol.2013.03.003; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; TARDIEU C, 1994, AM J PHYS ANTHROPOL, V95, P183, DOI 10.1002/ajpa.1330950206; van der Meulen MCH, 2006, BONE, V38, P871, DOI 10.1016/j.bone.2005.11.026; Volpato V, 2008, PRIMATES, V49, P16, DOI 10.1007/s10329-007-0053-2; Wang WJ, 2003, J HUM EVOL, V44, P563, DOI 10.1016/S0047-2484(03)00045-9; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wolff J, 1892, GESETZ TRANSFORMATIO; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	65	67	67	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77687	10.1371/journal.pone.0077687	http://dx.doi.org/10.1371/journal.pone.0077687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223719	Green Published, gold			2022-12-27	WOS:000326597400010
J	Lee, KB; Park, KE; Kwon, IK; Tripurani, SK; Kim, KJ; Lee, JH; Niwa, K; Kim, MK				Lee, Kyung-Bon; Park, Ki-Eun; Kwon, In-Kiu; Tripurani, Swamy K.; Kim, Keun Jung; Lee, Ji Hye; Niwa, Koji; Kim, Min Kyu			Develop to Term Rat Oocytes Injected with Heat-Dried Sperm Heads	PLOS ONE			English	Article							DEVELOPMENT IN-VITRO; INTRACYTOPLASMIC INJECTION; MOUSE SPERMATOZOA; DESICCATION TOLERANCE; PRONUCLEAR FORMATION; HAMSTER OOCYTES; PLASMA-MEMBRANE; FERTILIZATION; ACTIVATION; MICROINJECTION	This study investigated the development of rat oocytes in vitro and in vivo following intracytoplasmic injection of heads from spermatozoa heat-dried at 50 degrees C for 8 h and stored at 4 degrees C in different gas phases. Sperm membrane and chromosome are damaged by the process of heat-drying. Oocyte activation and cleavage of oocytes were worse in oocytes injected with spermatozoa heat-dried and stored for 1 week than unheated, fresh spermatozoa, but in heat-dried spermatozoa, there were no differences in these abilities of oocytes between the samples stored in nitrogen gas and in air. The oocytes injected with heat-dried spermatozoa stored for 1 week could develop to the morula and blastocyst stages without difference between the samples stored in nitrogen gas and in air after artificial stimulation. Cleavage of oocytes and development of cleaved embryos were higher when heat-dried spermatozoa were stored for 3 and 6 months in nitrogen gas than in air. However, the ability of injected oocytes to develop to the morula and blastocyst stages was not inhibited even when heat-dried spermatozoa stored in both atmosphere conditions for as long as 6 months were used. When 2-cell embryos derived from oocytes injected with heads from spermatozoa heat-dried and stored for 1 week and 1 month were transferred, each 1 of 4 recipients was conceived, and the conceived recipients delivered 1 live young each. These results demonstrate that rat oocytes can be fertilized with heat-dried spermatozoa and that the fertilized oocytes can develop to term.	[Lee, Kyung-Bon; Park, Ki-Eun; Kwon, In-Kiu; Niwa, Koji] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Tripurani, Swamy K.] W Virginia Univ, Div Anim & Nutr Sci, Lab Anim Biotechnol & Genom, Morgantown, WV 26506 USA; [Kim, Keun Jung; Lee, Ji Hye; Kim, Min Kyu] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Anim Sci & Biotechnol, Taejon, South Korea	Okayama University; West Virginia University; Chungnam National University	Lee, KB (corresponding author), Chungnam Natl Univ, Inst Agr Sci, Taejon, South Korea.	kblee20@cnu.ac.kr; kminkyu@cnu.ac.kr		Kim, Keun Jung/0000-0003-2340-8319; KIM, MINKYU/0000-0001-7099-9735	Japan Society for the Promotion of Science [13GS0008]; Next-Generation BioGreen 21 program [PJ008148]; Rural Development Administration, Korea	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Next-Generation BioGreen 21 program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported in part by a grant-in Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (13GS0008) and by a grant from the Next-Generation BioGreen 21 program (No. PJ008148), Rural Development Administration, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi A, 1999, ARCH ANDROLOGY, V42, P1; Akutsu H, 2001, BIOL REPROD, V64, P249, DOI 10.1095/biolreprod64.1.249; Bhowmick S, 2003, BIOL REPROD, V68, P1779, DOI 10.1095/biolreprod.102.009407; Cozzi J, 2001, BIOL REPROD, V65, P1518, DOI 10.1095/biolreprod65.5.1518; Dozortsev D, 1998, ZYGOTE, V6, P143, DOI 10.1017/S0967199498000069; Elmoazzen HY, 2009, CRYOBIOLOGY, V59, P113, DOI 10.1016/j.cryobiol.2009.03.005; Hamano K, 1999, BIOL REPROD, V60, P1194, DOI 10.1095/biolreprod60.5.1194; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Hirabayashi M, 2002, TRANSGENIC RES, V11, P221, DOI 10.1023/A:1015210604906; Hochi S, 2008, MOL REPROD DEV, V75, P890, DOI 10.1002/mrd.20825; HOSHI K, 1992, ARCH ANDROLOGY, V29, P233, DOI 10.3109/01485019208987730; Jiang JY, 2002, MOL REPROD DEV, V61, P120, DOI 10.1002/mrd.1138; Kaneko T, 2003, BIOL REPROD, V69, P1859, DOI 10.1095/biolreprod.103.019729; Kasai T, 1999, ZYGOTE, V7, P187, DOI 10.1017/S0967199499000568; KEEFER CL, 1982, J EXP ZOOL, V224, P371, DOI 10.1002/jez.1402240310; Keskintepe L, 2002, BIOL REPROD, V67, P409, DOI 10.1095/biolreprod67.2.409; Kimura Y, 1998, BIOL REPROD, V58, P1407, DOI 10.1095/biolreprod58.6.1407; Kusakabe H, 2001, P NATL ACAD SCI USA, V98, P13501, DOI 10.1073/pnas.241517598; Kwon IK, 2004, BIOL REPROD, V71, P1430, DOI 10.1095/biolreprod.104.031260; Lee JW, 2004, MOL REPROD DEV, V68, P96, DOI 10.1002/mrd.20044; Lee KB, 2006, BIOL REPROD, V74, P146, DOI 10.1095/biolreprod.105.044743; Li MW, 2007, REPRODUCTION, V133, P919, DOI 10.1530/REP-06-0096; Liu JL, 2004, BIOL REPROD, V70, P1776, DOI 10.1095/biolreprod.103.025957; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Morozumi K, 2006, P NATL ACAD SCI USA, V103, P17661, DOI 10.1073/pnas.0608183103; Nakai M, 2003, BIOL REPROD, V68, P1003, DOI 10.1095/biolreprod.102.009506; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Said S, 2003, THERIOGENOLOGY, V60, P359, DOI 10.1016/S0093-691X(03)00028-1; Seita Y, 2009, J REPROD DEVELOP, V55, P475, DOI 10.1262/jrd.20216; Sutovsky P, 1996, HUM REPROD, V11, P1703; THADANI VM, 1980, J EXP ZOOL, V212, P435, DOI 10.1002/jez.1402120316; THADANI VM, 1979, J EXP ZOOL, V210, P161, DOI 10.1002/jez.1402100118; Wakayama T, 1998, J REPROD FERTIL, V112, P11, DOI 10.1530/jrf.0.1120011; Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639; Ward MA, 2003, BIOL REPROD, V69, P2100, DOI 10.1095/biolreprod.103.020529; Yamauchi Y, 2002, BIOL REPROD, V67, P534, DOI 10.1095/biolreprod67.2.534; YANAGIDA K, 1991, BIOL REPROD, V44, P440, DOI 10.1095/biolreprod44.3.440; Yanagimachi R, 1998, HUM REPROD, V13, P87, DOI 10.1093/humrep/13.suppl_1.87	38	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78260	10.1371/journal.pone.0078260	http://dx.doi.org/10.1371/journal.pone.0078260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223784	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400046
J	Sumiyoshi, M; Nakamura, A; Nakamura, H; Hakata, M; Ichikawa, H; Hirochika, H; Ishii, T; Satoh, S; Iwai, H				Sumiyoshi, Minako; Nakamura, Atsuko; Nakamura, Hidemitsu; Hakata, Makoto; Ichikawa, Hiroaki; Hirochika, Hirohiko; Ishii, Tadashi; Satoh, Shinobu; Iwai, Hiroaki			Increase in Cellulose Accumulation and Improvement of Saccharification by Overexpression of Arabinofuranosidase in Rice	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; CELL-WALL; D-XYLOSIDASE; HETEROLOGOUS EXPRESSION; PECTIC POLYSACCHARIDES; SIDE-CHAINS; BARLEY; PURIFICATION; SPECIFICITY; PLANTS	Cellulosic biomass is available for the production of biofuel, with saccharification of the cell wall being a key process. We investigated whether alteration of arabinoxylan, a major hemicellulose in monocots, causes an increase in saccharification efficiency. Arabinoxylans have beta-1,4-D-xylopyranosyl backbones and 1,3- or 1,4-alpha-L-arabinofuranosyl residues linked to O-2 and/or O-3 of xylopyranosyl residues as side chains. Arabinose side chains interrupt the hydrogen bond between arabinoxylan and cellulose and carry an ester- linked feruloyl substituent. Arabinose side chains are the base point for diferuloyl cross- links and lignification. We analyzed rice plants overexpressing arabinofuranosidase (ARAF) to study the role of arabinose residues in the cell wall and their effects on saccharification. Arabinose content in the cell wall of transgenic rice plants overexpressing individual ARAF full- length cDNA (OsARAF1-FOX and OsARAF3-FOX) decreased 25% and 20% compared to the control and the amount of glucose increased by 28.2% and 34.2%, respectively. We studied modifications of cell wall polysaccharides at the cellular level by comparing histochemical cellulose staining patterns and immunolocalization patterns using antibodies raised against alpha-(1,5)-linked L-Ara (LM6) and beta-(1,4)-linked D-Xyl (LM10 and LM11) residues. However, they showed no visible phenotype. Our results suggest that the balance between arabinoxylan and cellulose might maintain the cell wall network. Moreover, ARAF overexpression in rice effectively leads to an increase in cellulose accumulation and saccharification efficiency, which can be used to produce bioethanol.	[Sumiyoshi, Minako; Nakamura, Atsuko; Ishii, Tadashi; Satoh, Shinobu; Iwai, Hiroaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Hidemitsu; Hakata, Makoto; Ichikawa, Hiroaki; Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Institute of Agrobiological Sciences - Japan	Iwai, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	iwai.hiroaki.gb@u.tsukuba.ac.jp	Iwai, Hiroaki/B-3171-2014; Ichikawa, Hiroaki/AAB-3127-2019	Ichikawa, Hiroaki/0000-0002-1898-8235	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [GMA0007];  [18075004];  [24114006];  [AMR0001];  [EF1004]	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); ; ; ; 	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (18075004 to H. Iwai), a Grant-in-Aid for Scientific Research on Innovative Areas (24114006 to S. Satoh and H. Iwai) and grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, GMA0007 to S. Satoh) and AMR0001 to H. Ichikawa, and Green Technology Project, EF1004 to H. Ichikawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba K, 2009, MOL PLANT, V2, P893, DOI 10.1093/mp/ssp054; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brendel O, 2000, PHYTOCHEM ANALYSIS, V11, P7, DOI 10.1002/(SICI)1099-1565(200001/02)11:1&lt;7::AID-PCA488&gt;3.0.CO;2-U; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1984, PLANT PHYSIOL, V76, P205, DOI 10.1104/pp.76.1.205; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chen XY, 2009, PLANT SIGNAL BEHAV, V4, P489, DOI 10.4161/psb.4.6.8359; Coutinho PM, 1999, ROY SOC CH, P3; Drakakaki G, 2006, PLANT PHYSIOL, V142, P1480, DOI 10.1104/pp.106.086363; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Fulton LM, 2003, J EXP BOT, V54, P2467, DOI 10.1093/jxb/erg269; Gibeaut DM, 2005, PLANTA, V221, P729, DOI 10.1007/s00425-005-1481-0; Hakata M, 2010, BREEDING SCI, V60, P575, DOI 10.1270/jsbbs.60.575; Hoije A, 2008, BIOMACROMOLECULES, V9, P2042, DOI 10.1021/bm800290m; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; ISHII T, 1991, CARBOHYD RES, V219, P15, DOI 10.1016/0008-6215(91)89039-I; Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1; Iwai H, 2001, PLANTA, V213, P907, DOI 10.1007/s004250100559; Konishi T, 2011, PHYTOCHEMISTRY, V72, P1962, DOI 10.1016/j.phytochem.2011.07.012; Kotake T, 2006, J EXP BOT, V57, P2353, DOI 10.1093/jxb/erj206; Laidlaw HKC, 2012, J EXP BOT, V63, P3031, DOI 10.1093/jxb/ers019; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Lee RC, 2001, BIOCHEM J, V356, P181, DOI 10.1042/0264-6021:3560181; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; MAEDA H, 1967, J BIOCHEM-TOKYO, V62, P276, DOI 10.1093/oxfordjournals.jbchem.a128660; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Minic Z, 2004, PLANT PHYSIOL, V135, P867, DOI 10.1104/pp.104.041269; Minic Z, 2006, J EXP BOT, V57, P2339, DOI 10.1093/jxb/erj205; Montes RAC, 2008, PLANT PHYSIOL, V147, P63, DOI 10.1104/pp.107.110023; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Nakamura H, 2007, PLANT MOL BIOL, V65, P357, DOI 10.1007/s11103-007-9243-y; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Suzuki S, 2009, PLANT BIOTECHNOL-NAR, V26, P337, DOI 10.5511/plantbiotechnology.26.337; Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002; Willats WGT, 1999, PLANT J, V20, P619, DOI 10.1046/j.1365-313X.1999.00629.x; WOOD PJ, 1983, J CEREAL SCI, V1, P95, DOI 10.1016/S0733-5210(83)80027-7; Xiong JS, 2007, J EXP BOT, V58, P2799, DOI 10.1093/jxb/erm133; Yazaki J, 2004, NUCLEIC ACIDS RES, V32, pD383, DOI 10.1093/nar/gkh001	44	36	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78269	10.1371/journal.pone.0078269	http://dx.doi.org/10.1371/journal.pone.0078269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223786	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400048
J	Van Herck, P; Annemans, L; Sermeus, W; Ramaekers, D				Van Herck, Pieter; Annemans, Lieven; Sermeus, Walter; Ramaekers, Dirk			Evidence-Based Health Care Policy in Reimbursement Decisions: Lessons from a Series of Six Equivocal Case-Studies	PLOS ONE			English	Article							OSELTAMIVIR TREATMENT; TRASTUZUMAB; MANAGEMENT; INFLUENZA	Context: Health care technological evolution through new drugs, implants and other interventions is a key driver of healthcare spending. Policy makers are currently challenged to strengthen the evidence for and cost-effectiveness of reimbursement decisions, while not reducing the capacity for real innovations. This article examines six cases of reimbursement decision making at the national health insurance authority in Belgium, with outcomes that were contested from an evidence-based perspective in scientific or public media. Methods: In depth interviews with key stakeholders based on the adapted framework of Davies allowed us to identify the relative impact of clinical and health economic evidence; experience, expertise & judgment; financial impact & resources; values, ideology & political beliefs; habit & tradition; lobbyists & pressure groups; pragmatics & contingencies; media attention; and adoption from other payers & countries. Findings: Evidence was not the sole criterion on which reimbursement decisions were based. Across six equivocal cases numerous other criteria were perceived to influence reimbursement policy. These included other considerations that stakeholders deemed crucial in this area, such as taking into account the cost to the patient, and managing crisis scenarios. However, negative impacts were also reported, in the form of bypassing regular procedures unnecessarily, dominance of an opinion leader, using information selectively, and influential conflicts of interest. Conclusions: 'Evidence' and 'negotiation' are both essential inputs of reimbursement policy. Yet, purposely selected equivocal cases in Belgium provide a rich source to learn from and to improve the interaction between both. We formulated policy recommendations to reconcile the impact of all factors identified. A more systematic approach to reimburse new care may be one of many instruments to resolve the budgetary crisis in health care in other countries as well, by separating what is truly innovative and value for money from additional 'waste'.	[Van Herck, Pieter; Sermeus, Walter; Ramaekers, Dirk] Univ Louvain, Ctr Hlth Serv & Nursing Res, Louvain, Belgium; [Annemans, Lieven] Univ Ghent, Dept Publ Hlth, I CHER, B-9000 Ghent, Belgium	Ghent University	Van Herck, P (corresponding author), Univ Louvain, Ctr Hlth Serv & Nursing Res, Louvain, Belgium.	Pieter.vanherck@med.kuleuven.be	Sermeus, Walter/J-4290-2017	Sermeus, Walter/0000-0002-5915-1845	IFB (Belgian institute for pharmaceutical Business administration); UNAMEC (Belgian professional organization of medical devices); Pfizer; Roche; Edwards Life Sciences; Johnson Johnson	IFB (Belgian institute for pharmaceutical Business administration); UNAMEC (Belgian professional organization of medical devices); Pfizer(Pfizer); Roche(Roche Holding); Edwards Life Sciences; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	The authors have read the journal's policy and have the following conflicts: Pieter Van herck: None Declared. Lieven Annemans: Lieven Annemans received hospitality or fees for lectures on health economics from IFB (Belgian institute for pharmaceutical Business administration), UNAMEC (Belgian professional organization of medical devices), Pfizer, Roche and Edwards Life Sciences. Walter Sermeus: None Declared. Dirk Ramaekers: Dirk Ramaekers received hospitality or fees for speaking about and for teaching evidence-based health care from IFB (Belgian institute for pharmaceutical Business administration), UNAMEC (Belgian professional organisation of medical devices), Pfizer and Johnson & Johnson. He previously worked for the KCE, a governmentally funded HTA agency in Belgium, and is currently CMO of a hospital network buying and applying several of the drugs and devices discussed in this article. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bodenheimer T, 2005, ANN INTERN MED, V142, P932, DOI 10.7326/0003-4819-142-11-200506070-00012; Bonneux L, 2005, ELECTIVE ENDOVASCU A, V23 A; Chenail R. J, 2009, QUAL REP, V13, P14; Cole A, 2005, BRIT MED J, V331, P1041, DOI 10.1136/bmj.331.7524.1041; Creswell J.W, 2007, QUALITATIVE ENQUIRY; Davies P, 2004, 4 ANN CAMPB COLL C W; Dinh P, 2008, NAT CLIN PRACT ONCOL, V5, P645, DOI 10.1038/ncponc1219; EVAR trial participants, 2005, LANCET, V365, P2179; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hulstaert F, 2009, PHARM NONPHARMACEU C, V111 C; Huybrechts M, 2007, HADRON THERAPY REP A, V67 A; Huybrechts M, 2006, HLTH TECHNOLOGY AS A, V34 A; Intermutualistisch Agentschap, 2010, PROGR BORSTK VERG CE; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kaissi AA, 2008, HEALTH CARE MANAGE R, V33, P94, DOI 10.1097/01.HMR.0000304498.97308.40; Lebovic GS, 2010, BREAST, V19, P260, DOI 10.1016/j.breast.2010.03.013; Lodge M, 2007, RADIOTHER ONCOL, V83, P110, DOI 10.1016/j.radonc.2007.04.007; Organization for Economic Co-operation and Development, 2011, TOT EXP HLTH PERC GR; Paulus D, 2005, BREAST CANC SCREEN A, V11 A; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Smith JR, 2005, BRIT MED J, V331, P1203, DOI 10.1136/bmj.331.7526.1203-b; Van Damme H, 2009, ACTA CHIR BELG, V109, P436; Walshe K, 2001, MILBANK Q, V79, P429, DOI 10.1111/1468-0009.00214; World Health Organization, 2011, HLTH SYSTEMS TRANSIT	28	5	5	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78662	10.1371/journal.pone.0078662	http://dx.doi.org/10.1371/journal.pone.0078662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205290	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500128
J	Chang, WP; Liu, ME; Chang, WC; Yang, AC; Ku, YC; Pai, JT; Huang, HL; Tsai, SJ				Chang, Wei-Pin; Liu, Mu-En; Chang, Wei-Chiao; Yang, Albert C.; Ku, Yan-Chiou; Pai, Jei-Tsung; Huang, Hsiao-Ling; Tsai, Shih-Jen			Sleep Apnea and the Risk of Dementia: A Population-Based 5-Year Follow-Up Study in Taiwan	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; ALZHEIMERS-DISEASE; WOMEN; MEMORY; ASSOCIATION; PERFORMANCE; CORTEX; RAT; AGE	Background: Sleep apnea (SA) has been associated with cognitive impairment. However, no data regarding the risk of dementia in patients with SA has been reported in the general population. This retrospective matched-control cohort study was designed to estimate and compare the risk of dementia in SA and non-SA patients among persons aged 40 and above over a 5-year period follow-up. Methods: We conducted a nationwide 5-year population-based study using data retrieved from the Longitudinal Health Insurance Database 2005 (LHID2005) in Taiwan. The study cohort comprised 1414 patients with SA aged 40 years who had at least 1 inpatient service claim or 1 ambulatory care claim. The comparison cohort comprised 7070 randomly selected patients who were matched with the study group according to sex, age, and index year. We performed Cox proportional-hazards regressions to compute the 5-year dementia-free survival rates after adjusting for potentially confounding factors. Results: The SA patients in this study had a 1.70-times greater risk of developing dementia within 5 years of diagnosis compared to non-SA age-and sex-matched patients, after adjusting for other risk factors (95% confidence interval (CI) = 1.26-2.31; P < .01). For the gender-dependent effect, only females with SA were more likely to develop dementia (adjust HR: 2.38, 95% CI = 1.51-3.74; P < .001). For the age-dependent effect of different genders, males with SA aged 50-59 years had a 6.08 times greater risk for developing dementia (95% CI = 1.96-18.90), and females with SA aged >= 70 years had a 3.20 times greater risk of developing dementia (95% CI = 1.71-6.00). For the time-dependent effect, dementia may be most likely to occur in the first 2.5 years of follow-up (adjusted HR: 2.04, 95% CI = 1.35-3.07). Conclusions: SA may be a gender-dependent, age-dependent, and time-dependent risk factor for dementia.	[Chang, Wei-Pin; Pai, Jei-Tsung; Huang, Hsiao-Ling] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Liu, Mu-En] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Natl Yang Ming Univ, Div Psychiat, Sch Med, Taipei 112, Taiwan; [Ku, Yan-Chiou] Kaohsiung Vet Gen Hosp, Dept Nursing, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Taipei Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital	Tsai, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Yang, Albert Chih-Chieh/0000-0003-2794-9649; Chang, Wei-Chiao/0000-0002-8573-5924				Alchanatis M, 2008, SLEEP BREATH, V12, P17, DOI 10.1007/s11325-007-0133-y; ANCOLIISRAEL S, 1991, J AM GERIATR SOC, V39, P258, DOI 10.1111/j.1532-5415.1991.tb01647.x; Ayalon L, 2010, AM J RESP CRIT CARE, V182, P413, DOI 10.1164/rccm.200912-1805OC; Bliwise DL, 2002, J PSYCHOSOM RES, V53, P539, DOI 10.1016/S0022-3999(02)00436-1; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; KALES A, 1985, J CHRON DIS, V38, P427, DOI 10.1016/0021-9681(85)90138-9; Kheirandish L, 2005, PEDIATR RES, V58, P594, DOI 10.1203/01.pdr.0000176915.19287.e2; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Macey PM, 2012, SLEEP, V35, P1603, DOI 10.5665/sleep.2228; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; O'Hara R, 2005, NEUROLOGY, V65, P642, DOI 10.1212/01.wnl.0000173055.75950.bf; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; PICKETT CK, 1989, J APPL PHYSIOL, V66, P1656, DOI 10.1152/jappl.1989.66.4.1656; Popovic RM, 1998, J APPL PHYSIOL, V84, P1055, DOI 10.1152/jappl.1998.84.3.1055; Quintana-Gallego E, 2004, RESP MED, V98, P984, DOI 10.1016/j.rmed.2004.03.002; REGENSTEINER JG, 1989, J APPL PHYSIOL, V66, P808, DOI 10.1152/jappl.1989.66.2.808; Saaresranta T, 2006, MATURITAS, V55, P255, DOI 10.1016/j.maturitas.2006.03.007; Schwartz DJ, 2007, J CLIN SLEEP MED, V3, P631; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; Valipour A, 2012, Pneumologie, V66, P584, DOI 10.1055/s-0032-1325664; Wallace A, 2013, SLEEP, V36, P203, DOI 10.5665/sleep.2374; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Zeng YM, 2009, CHINESE MED J-PEKING, V122, P68, DOI 10.3760/cma.j.issn.0366-6999.2009.01.013	29	81	87	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78655	10.1371/journal.pone.0078655	http://dx.doi.org/10.1371/journal.pone.0078655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24205289	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300078
J	van der Wal, JEM; Dorenbosch, M; Immers, AK; Forteza, CV; Geurts, JJM; Peeters, ETHM; Koese, B; Bakker, ES				van der Wal, Jessica E. M.; Dorenbosch, Martijn; Immers, Anne K.; Forteza, Constanza Vidal; Geurts, Jeroen J. M.; Peeters, Edwin T. H. M.; Koese, Bram; Bakker, Elisabeth S.			Invasive Crayfish Threaten the Development of Submerged Macrophytes in Lake Restoration	PLOS ONE			English	Article							SEDIMENT PHOSPHORUS RELEASE; OF-THE-ART; PROCAMBARUS-CLARKII; EUTROPHIC LAKES; SHALLOW; IMPACT; WATERFOWL; FISH; DIVERSITY; HERBIVORY	Submerged macrophytes enhance water transparency and aquatic biodiversity in shallow water ecosystems. Therefore, the return of submerged macrophytes is the target of many lake restoration projects. However, at present, north-western European aquatic ecosystems are increasingly invaded by omnivorous exotic crayfish. We hypothesize that invasive crayfish pose a novel constraint on the regeneration of submerged macrophytes in restored lakes and may jeopardize restoration efforts. We experimentally investigated whether the invasive crayfish (Procambarus clarkii Girard) affects submerged macrophyte development in a Dutch peat lake where these crayfish are expanding rapidly. Seemingly favourable abiotic conditions for macrophyte growth existed in two 0.5 ha lake enclosures, which provided shelter and reduced turbidity, and in one lake enclosure iron was added to reduce internal nutrient loading, but macrophytes did not emerge. We transplanted three submerged macrophyte species in a full factorial exclosure experiment, where we separated the effect of crayfish from large vertebrates using different mesh sizes combined with a caging treatment stocked with crayfish only. The three transplanted macrophytes grew rapidly when protected from grazing in both lake enclosures, demonstrating that abiotic conditions for growth were suitable. Crayfish strongly reduced biomass and survival of all three macrophyte species while waterfowl and fish had no additive effects. Gut contents showed that crayfish were mostly carnivorous, but also consumed macrophytes. We show that P. clarkii strongly inhibit macrophyte development once favourable abiotic conditions for macrophyte growth are restored. Therefore, expansion of invasive crayfish poses a novel threat to the restoration of shallow water bodies in north-western Europe. Prevention of introduction and spread of crayfish is urgent, as management of invasive crayfish populations is very difficult.	[van der Wal, Jessica E. M.; Dorenbosch, Martijn; Immers, Anne K.; Forteza, Constanza Vidal; Bakker, Elisabeth S.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Geurts, Jeroen J. M.] Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; [Peeters, Edwin T. H. M.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands; [Koese, Bram] European Invertebrate Survey Netherlands, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Radboud University Nijmegen; Wageningen University & Research	Bakker, ES (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands.	l.bakker@nioo.knaw.nl	Bakker, Elisabeth S/B-7185-2008; KNAW, NIOO-KNAW/A-4320-2012	Bakker, Elisabeth S/0000-0002-5900-9136; van der Wal, Jessica Eva Megan/0000-0002-6441-3598; KNAW, NIOO-KNAW/0000-0002-3835-159X; Peeters, Edwin T.H.M./0000-0003-2541-1829	Agentschap NL Innovation Programme Water Framework Directive from the Dutch Ministry of Economic Affairs, Agriculture and Innovation [KRW08079]	Agentschap NL Innovation Programme Water Framework Directive from the Dutch Ministry of Economic Affairs, Agriculture and Innovation	AI was funded by the Agentschap NL Innovation Programme Water Framework Directive (KRW08079) from the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastacio PM, 2005, ARCH HYDROBIOL, V162, P37, DOI 10.1127/0003-9136/2005/0162-0037; Bakker ES, 2013, HYDROBIOLOGIA, V710, P23, DOI 10.1007/s10750-012-1142-9; Bates D., 2011, PACKAGE LME4 LINEAR; BOERS P, 1994, ARCH HYDROBIOL, V129, P339; Burley KL, 2001, FRESHWATER BIOL, V46, P1061, DOI 10.1046/j.1365-2427.2001.00789.x; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; CHAMBERS PA, 1990, FRESHWATER BIOL, V24, P81, DOI 10.1111/j.1365-2427.1990.tb00309.x; Correia AM, 2002, ACTA OECOL, V23, P421, DOI 10.1016/S1146-609X(02)01166-9; Crawley M.J., 2007, R BOOK; Cronin G, 2002, J CRUSTACEAN BIOL, V22, P708, DOI 10.1651/0278-0372(2002)022[0708:CFPFFM]2.0.CO;2; Dorenbosch M, 2012, FRESHWATER BIOL, V57, P1360, DOI 10.1111/j.1365-2427.2012.02790.x; Dorenbosch M, 2011, FRESHWATER BIOL, V56, P1783, DOI 10.1111/j.1365-2427.2011.02618.x; Geiger W, 2005, BIOL INVASIONS, V7, P49, DOI 10.1007/s10530-004-9635-8; Gherardi F, 2007, FRESHWATER BIOL, V52, P1249, DOI 10.1111/j.1365-2427.2007.01760.x; Gherardi F, 2006, MAR FRESHW BEHAV PHY, V39, P175, DOI 10.1080/10236240600869702; Gherardi F, 2011, AQUAT SCI, V73, P185, DOI 10.1007/s00027-011-0181-z; Giling D, 2009, J N AM BENTHOL SOC, V28, P626, DOI 10.1899/09-015.1; Grey J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042575; Gulati RD, 2008, LIMNOLOGICA, V38, P233, DOI 10.1016/j.limno.2008.05.008; Gulati RD, 2002, HYDROBIOLOGIA, V478, P73, DOI 10.1023/A:1021092427559; Hickey CW, 2009, NEW ZEAL J MAR FRESH, V43, P819, DOI 10.1080/00288330909510043; Hilt S, 2006, LIMNOLOGICA, V36, P155, DOI 10.1016/j.limno.2006.06.001; Hilt S, 2006, HYDROBIOLOGIA, V570, P95, DOI 10.1007/s10750-006-0167-3; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Irfanullah HM, 2004, AQUAT BOT, V80, P177, DOI 10.1016/j/aquabot.2004.07.010; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Jeppesen E, 1998, ECOSYSTEMS, V1, P250, DOI 10.1007/s100219900020; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Koese B., 2011, NEDERLANDSE RIVIERKR, V6; Korner S, 2003, HYDROBIOLOGIA, V506, P497, DOI 10.1023/B:HYDR.0000008561.67513.ec; Lake MD, 2002, HYDROBIOLOGIA, V470, P13, DOI 10.1023/A:1015689432289; Lamers LPM, 2002, HYDROBIOLOGIA, V478, P107, DOI 10.1023/A:1021022529475; Lauridsen TL, 2003, HYDROBIOLOGIA, V506, P641, DOI 10.1023/B:HYDR.0000008633.17385.70; LAURIDSEN TL, 1993, AQUAT BOT, V46, P1, DOI 10.1016/0304-3770(93)90061-Z; Lauridsen Torben L., 2003, Lakes & Reservoirs Research and Management, V8, P177, DOI 10.1111/j.1440-1770.2003.00224.x; LODGE DM, 1987, CAN J FISH AQUAT SCI, V44, P591, DOI 10.1139/f87-072; Marklund O, 2002, FRESHWATER BIOL, V47, P2049, DOI 10.1046/j.1365-2427.2002.00949.x; Matsuzaki SS, 2009, OECOLOGIA, V158, P673, DOI 10.1007/s00442-008-1180-1; Middelboe AL, 1997, FRESHWATER BIOL, V37, P553, DOI 10.1046/j.1365-2427.1997.00183.x; Momot Walter T., 1995, Reviews in Fisheries Science, V3, P33; Moss B., 1989, MORE EXACT ECOLOGY, P401; Nurminen L, 2003, HYDROBIOLOGIA, V506, P511, DOI 10.1023/B:HYDR.0000008577.16934.a9; Nystrom P, 1999, OIKOS, V85, P545, DOI 10.2307/3546704; Nystrom P, 1996, FRESHWATER BIOL, V36, P673, DOI 10.1046/j.1365-2427.1996.d01-508.x; Perrow MR, 1997, HYDROBIOLOGIA, V342, P241, DOI 10.1023/A:1017007911190; PHILLIPS G, 1994, HYDROBIOLOGIA, V275, P445, DOI 10.1007/BF00026733; R Development Core Team, 2011, R LANG ENV STAT COMP; Rodriguez CF, 2003, HYDROBIOLOGIA, V506, P421, DOI 10.1023/B:HYDR.0000008626.07042.87; Scheffer M., 2001, ECOLOGY SHALLOW LAKE; SMOLDERS A, 1995, ARCH HYDROBIOL, V133, P349; Sondergaard M, 1996, AQUAT BOT, V53, P73, DOI 10.1016/0304-3770(95)01013-0; Sondergaard M, 2003, HYDROBIOLOGIA, V506, P135, DOI 10.1023/B:HYDR.0000008611.12704.dd; Sondergaard M, 2007, J APPL ECOL, V44, P1095, DOI 10.1111/j.1365-2664.2007.01363.x; Souty-Grosset C, 2006, ATLAS CRAYFISH EUROP; Strand JA, 2001, FRESHWATER BIOL, V46, P1397, DOI 10.1046/j.1365-2427.2001.00746.x; ter Heerdt G, 2007, HYDROBIOLOGIA, V584, P305, DOI 10.1007/s10750-007-0594-9; van de Haterd RJW, 2007, HYDROBIOLOGIA, V584, P277, DOI 10.1007/s10750-007-0593-x; Van Giels J, 2011, 2009023602 ATKB; VanDonk E, 1996, HYDROBIOLOGIA, V340, P285, DOI 10.1007/BF00012769	59	33	35	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78579	10.1371/journal.pone.0078579	http://dx.doi.org/10.1371/journal.pone.0078579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205271	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300069
J	Heilig, Y; Schmitt, K; Seiler, S				Heilig, Yvonne; Schmitt, Kerstin; Seiler, Stephan			Phospho-Regulation of the Neurospora crassa Septation Initiation Network	PLOS ONE			English	Article							NDR-PROTEIN-KINASE; ASPERGILLUS-NIDULANS; SEPTUM FORMATION; CYTOKINESIS; SIN; PHOSPHORYLATION; GTPASE; YEAST; RING; MORPHOGENESIS	Proper cell division is essential for growth and development of uni- and multicellular organisms. The fungal septation initiation network (SIN) functions as kinase cascade that connects cell cycle progression with the initiation of cytokinesis. Miss-regulation of the homologous Hippo pathway in animals results in excessive cell proliferation and formation of tumors, underscoring the conservation of both pathways. How SIN proteins interact and transmit signals through the cascade is only beginning to be understood. Moreover, our understanding of septum formation and its regulation in filamentous fungi, which represent the vast majority of the fungal kingdom, is highly fragmentary. We determined that a tripartite kinase cascade, consisting of CDC-7, SID-1 and DBF-2, together with their regulatory subunits CDC-14 and MOB-1, is important for septum formation in the model mold Neurospora crassa. DBF-2 activity and septum formation requires auto-phosphorylation at Ser499 within the activation segment and phosphorylation of Thr671 in the hydrophobic motif by SID-1. Moreover, SID-1-stimulated DBF-2 activity is further enhanced by CDC-7, supporting a stepwise activation mechanism of the tripartite SIN kinase cascade in fungi. However, in contrast to the situation described for unicellular yeasts, the localization of the entire SIN cascade to spindle pole bodies is constitutive and cell cycle independent. Moreover, all SIN proteins except CDC-7 form cortical rings prior to septum initiation and localize to constricting septa. Thus, SIN localization and activity regulation significantly differs in unicellular versus syncytial ascomycete fungi.	[Heilig, Yvonne; Seiler, Stephan] Univ Freiburg, Inst Biol Mol Plant Physiol 2, D-79106 Freiburg, Germany; [Seiler, Stephan] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Schmitt, Kerstin] Univ Goettingen, Inst Microbiol & Genet, Gottingen, Germany	University of Freiburg; University of Freiburg; University of Gottingen	Seiler, S (corresponding author), Univ Freiburg, Inst Biol Mol Plant Physiol 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	Stephan.Seiler@biologie.uni-freiburg.de			DFG [SE1054/6-1, SE1054/3-2, SE1054/7-1]; Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB) (DFG) [GSC 226/1]; Neurospora program [PO1 GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB) (DFG)(German Research Foundation (DFG)); Neurospora program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research project was financially supported through the DFG Heisenberg fellowship SE1054/6-1, the DFG grants SE1054/3-2 and SE1054/7-1 and by the Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB) (DFG grant GSC 226/1). The authors acknowledge the Fungal Genetics Stock Center and the Neurospora program grant PO1 GM068087 for continuous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo-Palomares CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027148; Attner MA, 2012, MOL BIOL CELL, V23, P3122, DOI 10.1091/mbc.E12-03-0235; Baker SE, 2012, NEUR C 2012; Bruno KS, 2001, MOL MICROBIOL, V42, P3, DOI 10.1046/j.1365-2958.2001.02605.x; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Dettmann A, 2013, MOL MICROBIOL, V90, P796, DOI 10.1111/mmi.12399; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Dvash E, 2010, EUKARYOT CELL, V9, P502, DOI 10.1128/EC.00230-09; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gull K, 1978, FILAMENTOUS FUNGI DE, P78; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Harris SD, 2011, FUNGAL BIOL-UK, V115, P475, DOI 10.1016/j.funbio.2011.02.002; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2012, SEMIN CELL DEV BIOL, V23, P794, DOI 10.1016/j.semcdb.2012.04.001; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Hou MC, 2004, MOL CELL BIOL, V24, P3262, DOI 10.1128/MCB.24.8.3262-3276.2004; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; Johnson AE, 2012, CYTOSKELETON, V69, P686, DOI 10.1002/cm.21044; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Katayama S, 2012, J BIOCHEM, V152, P347, DOI 10.1093/jb/mvs075; Kawabata T, 2007, FUNGAL GENET NEWSL, V54, P5, DOI [10.4148/1941-4765.1096, DOI 10.4148/1941-4765.1096]; Kawabata T, 2007, CURR GENET, V52, P125, DOI 10.1007/s00294-007-0146-x; Kim JM, 2006, GENETICS, V173, P685, DOI 10.1534/genetics.105.054304; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Krapp A, 2006, J CELL SCI, V119, P2882, DOI 10.1242/jcs.03025; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037221; Maerz S, 2012, MOL CELL BIOL, V32, P2083, DOI 10.1128/MCB.06263-11; Maerz S, 2010, CURR OPIN MICROBIOL, V13, P663, DOI 10.1016/j.mib.2010.08.010; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Maerz S, 2009, MOL MICROBIOL, V74, P707, DOI 10.1111/j.1365-2958.2009.06896.x; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Mazanek M, 2010, J CHROMATOGR B, V878, P515, DOI 10.1016/j.jchromb.2009.12.017; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Meitinger F, 2012, CELL CYCLE, V11, P219, DOI 10.4161/cc.11.2.18857; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; Minke PF, 1999, FUNGAL GENET BIOL, V28, P55, DOI 10.1006/fgbi.1999.1160; Mourino-Perez RR, 2013, FUNGAL BIOL REV, V27, P1, DOI 10.1016/j.fbr.2013.02.002; RAJU NB, 1977, EXP MYCOL, V1, P152, DOI 10.1016/S0147-5975(77)80040-6; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; Richthammer C, 2012, MOL MICROBIOL, V85, P716, DOI 10.1111/j.1365-2958.2012.08133.x; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Roberts-Galbraith RH, 2008, GENE DEV, V22, P3082, DOI 10.1101/gad.1748908; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Wolkow TD, 1996, J CELL SCI, V109, P2179; Ziv C, 2009, MOL MICROBIOL, V74, P974, DOI 10.1111/j.1365-2958.2009.06911.x	55	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e79464	10.1371/journal.pone.0079464	http://dx.doi.org/10.1371/journal.pone.0079464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205386	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600120
J	Gall, MG; Chen, YQ; de Ribeiro, AJV; Zhang, H; Bailey, CG; Spielman, DS; Yu, DMT; Gorrell, MD				Gall, Margaret G.; Chen, Yiqian; de Ribeiro, Ana Julia Vieira; Zhang, Hui; Bailey, Charles G.; Spielman, Derek S.; Yu, Denise M. T.; Gorrell, Mark D.			Targeted Inactivation of Dipeptidyl Peptidase 9 Enzymatic Activity Causes Mouse Neonate Lethality	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; CELL-ADHESION; SUBSTANCE-P; DPP-IV; EXPRESSION; MICE; INHIBITION; GENE; LOCALIZATION; APOPTOSIS	Dipeptidyl Peptidase (DPP) 4 and related dipeptidyl peptidases are emerging as current and potential therapeutic targets. DPP9 is an intracellular protease that is regulated by redox status and by SUMO1. DPP9 can influence antigen processing, epidermal growth factor (EGF)-mediated signaling and tumor biology. We made the first gene knock-in (gki) mouse with a serine to alanine point mutation at the DPP9 active site (S729A). Weaned heterozygote DPP9(wt/S729A) pups from 110 intercrosses were indistinguishable from wild-type littermates. No homozygote DPP9(S729A/S729A) weaned mice were detected. DPP9(S729A/S729A) homozygote embryos, which were morphologically indistinguishable from their wild-type littermate embryos at embryonic day (ED) 12.5 to ED 17.5, were born live but these neonates died within 8 to 24 hours of birth. All neonates suckled and contained milk spots and were of similar body weight. No gender differences were seen. No histological or DPP9 immunostaining pattern differences were seen between genotypes in embryos and neonates. Mouse embryonic fibroblasts (MEFs) from DPP9(S729A/S729A) ED13.5 embryos and neonate DPP9(S729A/S729A) mouse livers collected within 6 hours after birth had levels of DPP9 protein and DPP9-related proteases that were similar to wild-type but had less DPP9/DPP8-derived activity. These data confirmed the absence of DPP9 enzymatic activity due to the presence of the serine to alanine mutation and no compensation from related proteases. These novel findings suggest that DPP9 enzymatic activity is essential for early neonatal survival in mice.	[Gall, Margaret G.; Chen, Yiqian; de Ribeiro, Ana Julia Vieira; Zhang, Hui; Bailey, Charles G.; Yu, Denise M. T.; Gorrell, Mark D.] Centenary Inst, Camperdown, NSW, Australia; [Gall, Margaret G.; Chen, Yiqian; de Ribeiro, Ana Julia Vieira; Zhang, Hui; Bailey, Charles G.; Yu, Denise M. T.; Gorrell, Mark D.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Spielman, Derek S.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney	Gorrell, MD (corresponding author), Centenary Inst, Camperdown, NSW, Australia.	m.gorrell@centenary.usyd.edu.au	Zhang, Hui Emma/J-6888-2019; Gorrell, Mark Douglas/H-7231-2019; Gorrell, Mark/AAX-6394-2021	Zhang, Hui Emma/0000-0002-4699-4237; Gorrell, Mark Douglas/0000-0002-0528-2604; Bailey, Charles/0000-0002-4725-7829	National Health and Medical Research Council of Australia [512218]; Rebecca L. Cooper Foundation; Sydney Medical School Foundation/Francis M. Hooper Scholarship for Medical Research through the University of Sydney; University of Sydney; Australian Postgraduate Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Foundation; Sydney Medical School Foundation/Francis M. Hooper Scholarship for Medical Research through the University of Sydney; University of Sydney(University of Sydney); Australian Postgraduate Award(Australian Government)	This work was funded by National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/grants/types-funding) grant 512218 and Rebecca L. Cooper Foundation (http://www.cooperfoundation.org.au/funding.html) grants to MDG. MGG holds a Sydney Medical School Foundation/Francis M. Hooper Scholarship for Medical Research through the University of Sydney (http://sydney.edu.au/medicine/scholawards/postgrad/research.php#francishooper). YC holds a University of Sydney international student scholarship (http://sydney.edu.au/scholarships/prospective/international_postgraduate_scholarships.shtml#usi). HZ holds an Australian Postgraduate Award (http://sydney.edu.au/scholarships/research/postgraduate_awards.shtml#APAUPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Abbott CA, 1999, FEBS LETT, V458, P278, DOI 10.1016/S0014-5793(99)01166-7; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Ajami K, 2003, BIOCHEMISTRY-US, V42, P694, DOI 10.1021/bi026846s; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Burkey BF, 2008, DIABETES OBES METAB, V10, P1057, DOI 10.1111/j.1463-1326.2008.00860.x; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chowdhury S, 2013, WORLD J GASTROENTERO, V19, P2883, DOI 10.3748/wjg.v19.i19.2883; Christiansen VJ, 2013, NEOPLASIA, V15, P348, DOI 10.1593/neo.121850; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Dubois V, 2010, BBA-PROTEINS PROTEOM, V1804, P781, DOI 10.1016/j.bbapap.2009.11.022; Dubois V, 2009, J HISTOCHEM CYTOCHEM, V57, P531, DOI 10.1369/jhc.2009.952739; ERICKSON RH, 1992, J BIOL CHEM, V267, P21623; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Hardy ICW, 1997, APPL ANIM BEHAV SCI, V51, P217, DOI 10.1016/S0168-1591(96)01106-9; Harstad EB, 2013, REGUL PEPTIDES, V186, P26, DOI 10.1016/j.regpep.2013.07.003; HEYMANN E, 1978, FEBS LETT, V91, P360, DOI 10.1016/0014-5793(78)81210-1; Keane F. M., 2012, PROTEINASES DRUG TAR, P119; Keane FM, 2011, FEBS J, V278, P1316, DOI 10.1111/j.1742-4658.2011.08051.x; Kirby M, 2010, CLIN SCI, V118, P31, DOI 10.1042/CS20090047; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lu C, 2011, CANC RES, V187; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; Niedermeyer J, 2001, INT J DEV BIOL, V45, P445; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Park J., 2008, OPEN ENZYM INHIB J, V1, P52, DOI [10.2174/1874940200801010052, DOI 10.2174/1874940200801010052]; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Pilla E, 2012, J BIOL CHEM, V287, P44320, DOI 10.1074/jbc.M112.397224; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reinhold D, 2009, CLIN CHEM LAB MED, V47, P268, DOI 10.1515/CCLM.2009.062; RUGH R, 1968, MOUSE ITS REPROD DEV; Rummey C, 2007, PROTEINS, V66, P160, DOI 10.1002/prot.21138; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SCHLAGER G, 1968, J HERED, V59, P363, DOI 10.1093/oxfordjournals.jhered.a107747; Spagnuolo PA, 2013, LEUKEMIA, V27, P1236, DOI 10.1038/leu.2013.9; Stremenova J, 2010, INT J ONCOL, V36, P351, DOI 10.3892/ijo_00000506; Tang HK, 2011, FEBS LETT, V585, P3409, DOI 10.1016/j.febslet.2011.10.009; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Van Goethem S, 2011, J MED CHEM, V54, P5737, DOI 10.1021/jm200383j; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Walsh MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058860; Wang Aiying, 2012, BMC Pharmacology, V12, P2, DOI 10.1186/1471-2210-12-2; Wang XM, 2007, HEPATOLOGY, V46, p299A; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Wilson CH, 2013, J BIOL CHEM, V288, P13936, DOI 10.1074/jbc.M112.445841; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Wu WG, 2012, BIOORG MED CHEM LETT, V22, P5536, DOI 10.1016/j.bmcl.2012.07.033; Xu J, 2005, CURRENT PROTOCOLS S, V70; Yao TW, 2011, MOL CANCER RES, V9, P948, DOI 10.1158/1541-7786.MCR-10-0272; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760; Zhang H, 2013, MOL CANC RE IN PRESS	57	34	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78378	10.1371/journal.pone.0078378	http://dx.doi.org/10.1371/journal.pone.0078378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223149	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200041
J	Goff, PH; Eggink, D; Seibert, CW; Hai, R; Martinez-Gil, L; Krammer, F; Palese, P				Goff, Peter H.; Eggink, Dirk; Seibert, Christopher W.; Hai, Rong; Martinez-Gil, Luis; Krammer, Florian; Palese, Peter			Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies	PLOS ONE			English	Article							VIRAL-INFECTION; VACCINE; IGA; MECHANISM; RESPONSES; IMMUNITY	The global population remains vulnerable in the face of the next pandemic influenza virus outbreak, and reformulated vaccinations are administered annually to manage seasonal epidemics. Therefore, development of a new generation of vaccines is needed to generate broad and persistent immunity to influenza viruses. Here, we describe three adjuvants that enhance the induction of stalk-directed antibodies against heterologous and heterosubtypic influenza viruses when administered with chimeric HA proteins. Addavax, an MF59-like nanoemulsion, poly(I: C), and an RNA hairpin derived from Sendai virus (SeV) Cantell were efficacious intramuscularly. The SeV RNA and poly(I: C) also proved to be effective respiratory mucosal adjuvants. Although the quantity and quality of antibodies induced by the adjuvants varied, immunized mice demonstrated comparable levels of protection against challenge with influenza A viruses on the basis of HA stalk reactivity. Finally, we present that intranasally, but not intramuscularly, administered chimeric HA proteins induce mucosal IgA antibodies directed at the HA stalk.	[Goff, Peter H.; Eggink, Dirk; Seibert, Christopher W.; Hai, Rong; Martinez-Gil, Luis; Krammer, Florian; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA; [Goff, Peter H.; Seibert, Christopher W.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA; [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Palese, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA.	peter.palese@mssm.edu	Martinez-Gil, Luis/M-7422-2014; Krammer, Florian/H-3237-2019	Martinez-Gil, Luis/0000-0002-9076-7760; Krammer, Florian/0000-0003-4121-776X; Palese, Peter/0000-0002-0337-5823; Eggink, Dirk/0000-0002-4248-6008; Goff, Peter/0000-0002-3488-4997	National Institutes of Health [HHSN272200900032C, 1P01AI097092-353 01A1]; Austrian Science Fund (FWF) [J 3232]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by a National Institutes of Health adjuvant development contract (HHSN272200900032C) and grant (1P01AI097092-353 01A1). Florian Krammer was supported by an Erwin Schrodinger fellowship (J 3232) from the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Cox RJ, 2013, HUM VACC IMMUNOTHER, V9, P405, DOI 10.4161/hv.22908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Martinez-Gil L, 2013, J VIROL, V87, P1290, DOI 10.1128/JVI.02338-12; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; Miller MS, 2013, J INFECT DIS, V207, P98, DOI 10.1093/infdis/jis652; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Palese P, 2006, FIELDS VIROLOGY; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; RENEGAR KB, 1991, J IMMUNOL, V146, P1972; Schaffner W, 2006, US INFFECT DIS, P28; Seibert CW, 2013, J VIROL, V87, P7793, DOI 10.1128/JVI.00979-13; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	25	50	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79194	10.1371/journal.pone.0079194	http://dx.doi.org/10.1371/journal.pone.0079194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223176	Green Published, Green Submitted, gold			2022-12-27	WOS:000326656200068
J	Jung, SK; Kim, MK; Lee, YH; Shin, DH; Shin, MH; Chun, BY; Choi, BY				Jung, Su Kyoung; Kim, Mi-Kyung; Lee, Young-Hoon; Shin, Dong Hoon; Shin, Min-Ho; Chun, Byung-Yeol; Choi, Bo Youl			Lower Zinc Bioavailability May Be Related to Higher Risk of Subclinical Atherosclerosis in Korean Adults	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; PHYTATE INTAKE; MOLAR RATIOS; HUMAN HEALTH; DIETARY; MICRONUTRIENT; THICKNESS; ARTERY; REPRODUCIBILITY; NUTRITION	Background: There is a proposed link between dietary zinc intake and atherosclerosis, but this relationship remains unclear. Phytate may contribute to this relationship by influencing zinc bioavailability. Objective: The aim of this study is to examine the relationship between zinc bioavailability and subclinical atherosclerosis in healthy Korean adults. Materials and Methods: The present cross-sectional analysis used baseline data from the Korean multi-Rural Communities Cohort Study (MRCohort), which is a part of The Korean Genome Epidemiology Study (KoGES). A total of 5,532 subjects (2,116 men and 3,416 women) aged 40 years and older were recruited from rural communities in South Korea between 2005 and 2010. Phytate: zinc molar ratio, estimated from a food-based food frequency questionnaire (FFQ) of 106 food items, was used to determine zinc bioavailability, and carotid intima media thickness (cIMT) and pulse wave velocity (PWV) were measured to calculate the subclinical atherosclerotic index. Results: We found that phytate: zinc molar ratio is positively related to cIMT in men. A higher phytate: zinc molar ratio was significantly related to an increased risk of atherosclerosis in men, defined as the 80th percentile value of cIMT (5th vs. 1st quintile, OR = 2.11, 95% CI 1.42-3.15, P for trend = 0.0009), and especially in elderly men (5th vs. 1st quintile, OR = 2.58, 95% CI 1.52-4.37, P for trend = 0.0021). We found a positive relationship between phytate: zinc molar ratio and atherosclerosis risk among women aged 65 years or younger. Phytate: zinc molar ratio was not found to be related to PWV. Conclusions: Lower zinc bioavailability may be related to higher atherosclerosis risk.	[Jung, Su Kyoung; Kim, Mi-Kyung; Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Jung, Su Kyoung; Kim, Mi-Kyung; Choi, Bo Youl] Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Coll Med, Dept Prevent Med, Iksan, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Coll Med, Inst Wonkwang Med Sci, Iksan, South Korea; [Shin, Dong Hoon] Keimyung Univ, Sch Med, Dept Prevent Med, Daegu, South Korea; [Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Gwangju, South Korea; [Chun, Byung-Yeol] Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Daegu, South Korea; [Chun, Byung-Yeol] Kyungpook Natl Univ, Hlth Promot Res Ctr, Daegu, South Korea	Hanyang University; Hanyang University; Wonkwang University; Wonkwang University; Keimyung University; Chonnam National University; Kyungpook National University; Kyungpook National University	Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea.	kmkkim@hanyang.ac.kr		Jung, Sukyoung/0000-0001-9200-2158; Shin, Min-Ho/0000-0002-2217-5624	National Research Foundation of Korea [NRF-2012R1A1A2001930]; Korea Centers for Disease Control and Prevention [2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Centers for Disease Control and Prevention	This study was supported by the National Research Foundation of Korea (grant NRF-2012R1A1A2001930) and partially supported by the Korea Centers for Disease Control and Prevention (grants 2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, and 2009-E71006-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Amirabdollahian F, 2010, PUBLIC HEALTH NUTR, V13, P1380, DOI 10.1017/S1368980010000704; Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS37, DOI 10.1038/sj.ejcn.1602296; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Foster M, 2012, NUTRIENTS, V4, P676, DOI 10.3390/nu4070676; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hambidge KM, 2010, AM J CLIN NUTR, V91, p1430S, DOI 10.3945/ajcn.2010.28674B; Harland B F, 1987, World Rev Nutr Diet, V52, P235; He K, 2008, AM J CLIN NUTR, V88, P1111, DOI 10.1093/ajcn/88.4.1111; Health Canada, 2010, DIETARY REFERENCE IN; Hess SY, 2009, FOOD NUTR BULL, V30, pS5, DOI 10.1177/15648265090301S102; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Ikonomidis I, 2008, ATHEROSCLEROSIS, V199, P3, DOI 10.1016/j.atherosclerosis.2008.02.019; IQBAL TH, 1994, GUT, V35, P1233, DOI 10.1136/gut.35.9.1233; Joung H, 2004, J FOOD COMPOS ANAL, V17, P713, DOI 10.1016/j.jfca.2003.10.002; Kobayashi K, 2004, ATHEROSCLEROSIS, V173, P13, DOI 10.1016/j.atherosclerosis.2003.10.013; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; Kwun IS, 2000, BIOL TRACE ELEM RES, V75, P29, DOI 10.1385/BTER:75:1-3:29; 신진호, 2005, Korean Circulation Journal, V35, P683; Little PJ, 2010, NUTRITION, V26, P1050, DOI 10.1016/j.nut.2010.03.007; Ma G, 2007, EUR J CLIN NUTR, V61, P368, DOI 10.1038/sj.ejcn.1602513; MACKEY RH, 2007, CALCIFICATIONS ARTER, P75212; MILLS C, 1996, TRACE ELEMENTS HUMAN; Mitani S, 2012, BLOOD PRESSURE, V21, P338, DOI 10.3109/08037051.2012.686176; Mohommad MK, 2012, NUTR CLIN PRACT, V27, P8, DOI 10.1177/0884533611433534; MORRIS ER, 1989, BIOL TRACE ELEM RES, V19, P107, DOI 10.1007/BF02925452; Otto MCCD, 2011, J NUTR, V141, P1508, DOI 10.3945/jn.111.138115; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Ouyang P, 2009, ATHEROSCLEROSIS, V204, P255, DOI 10.1016/j.atherosclerosis.2008.08.037; Perez-Lopez FR, 2010, REPROD SCI, V17, P511, DOI 10.1177/1933719110367829; Persson H, 1998, J AGR FOOD CHEM, V46, P3194, DOI 10.1021/jf971055w; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2009, J AM COLL NUTR, V28, P257, DOI 10.1080/07315724.2009.10719780; Prasad AS, 2009, NUTR CANCER, V61, P879, DOI 10.1080/01635580903285122; Roohani N, 2013, J RES MED SCI, V18, P144; Salgueiro MJ, 2000, NUTR RES, V20, P737, DOI 10.1016/S0271-5317(00)00163-9; Stensland-Bugge E, 2001, ATHEROSCLEROSIS, V154, P437, DOI 10.1016/S0021-9150(00)00486-X; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; The Korean Nutrition Society, 2000, RECOMMENDED DIETARY, V7th; Willett W., 2012, NUTR EPIDEMIOLOGY; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yang YJ, 2010, BRIT J NUTR, V104, P1202, DOI 10.1017/S0007114510001893	43	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80115	10.1371/journal.pone.0080115	http://dx.doi.org/10.1371/journal.pone.0080115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223217	Green Submitted, gold, Green Published			2022-12-27	WOS:000326656200110
J	Vaughan, G; Xia, GL; Forbi, JC; Purdy, MA; Rossi, LMG; Spradling, PR; Khudyakov, YE				Vaughan, Gilberto; Xia, Guoliang; Forbi, Joseph C.; Purdy, Michael A.; Rossi, Livia Maria Goncalves; Spradling, Philip R.; Khudyakov, Yury E.			Genetic Relatedness among Hepatitis A Virus Strains Associated with Food-Borne Outbreaks	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; UNITED-STATES; C VIRUS; INFECTION; SOFTWARE; DNA	The genetic characterization of hepatitis A virus (HAV) strains is commonly accomplished by sequencing subgenomic regions, such as the VP1/P2B junction. HAV genome is not extensively variable, thus presenting opportunity for sharing sequences of subgenomic regions among genetically unrelated isolates. The degree of misrepresentation of phylogenetic relationships by subgenomic regions is especially important for tracking transmissions. Here, we analyzed whole-genome (WG) sequences of 101 HAV strains identified from 4 major multi-state, food-borne outbreaks of hepatitis A in the Unites States and from 14 non-outbreak-related HAV strains that shared identical VP1/P2B sequences with the outbreak strains. Although HAV strains with an identical VP1/P2B sequence were specific to each outbreak, WG were different, with genetic diversity reaching 0.31% (mean 0.09%). Evaluation of different subgenomic regions did not identify any other section of the HAV genome that could accurately represent phylogenetic relationships observed using WG sequences. The identification of 2-3 dominant HAV strains in 3 out of 4 outbreaks indicates contamination of the implicated food items with a heterogeneous HAV population. However, analysis of intra-host HAV variants from eight patients involved in one outbreak showed that only a single sequence variant established infection in each patient. Four non-outbreak strains were found closely related to strains from 2 outbreaks, whereas ten were genetically different from the outbreak strains. Thus, accurate tracking of HAV strains can be accomplished using HAV WG sequences, while short subgenomic regions are useful for identification of transmissions only among cases with known epidemiological association.	[Vaughan, Gilberto; Xia, Guoliang; Forbi, Joseph C.; Purdy, Michael A.; Rossi, Livia Maria Goncalves; Spradling, Philip R.; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Vaughan, G (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30329 USA.	GVaughan@cdc.gov			Division of Viral Hepatitis	Division of Viral Hepatitis	This work was supported by Division of Viral Hepatitis Intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon JJ, 2005, J INFECT DIS, V192, P1323, DOI 10.1086/462425; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bialek SR, 2007, CLIN INFECT DIS, V44, P838, DOI 10.1086/511874; Costa-Mattioli M, 2002, J VIROL, V76, P9516, DOI 10.1128/JVI.76.18.9516-9525.2002; Craig AS, 2007, AM J MED SCI, V334, P180, DOI 10.1097/MAJ.0b013e3181425411; Cuthbert JA, 2001, CLIN MICROBIOL REV, V14, P38, DOI 10.1128/CMR.14.1.38-58.2001; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Fujiwara K, 2001, J HEPATOL, V35, P112, DOI 10.1016/S0168-8278(01)00074-5; Hollinger FB., 2001, FIELDS VIROLOGY, P799; JANSEN RW, 1990, P NATL ACAD SCI USA, V87, P2867, DOI 10.1073/pnas.87.8.2867; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Laird DT, 2011, FOOD MICROBIOL, V28, P998, DOI 10.1016/j.fm.2011.01.011; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Nainan OV, 2006, CLIN MICROBIOL REV, V19, P63, DOI 10.1128/CMR.19.1.63-79.2006; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; NAINAN OV, 1991, J GEN VIROL, V72, P1685, DOI 10.1099/0022-1317-72-7-1685; Purcell RH, 2002, J INFECT DIS, V185, P1668, DOI 10.1086/340520; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Rivera-Osorio P, 2011, J CLIN MICROBIOLOGY; ROBERTSON BH, 1991, J INFECT DIS, V163, P286, DOI 10.1093/infdis/163.2.286; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Russi JC, 2003, AM J TROP MED HYG, V68, P716, DOI 10.4269/ajtmh.2003.68.716; Sanchez G, 2003, VIROLOGY, V315, P34, DOI 10.1016/S0042-6822(03)00483-5; Schiodt FV, 1999, LIVER TRANSPLANT SUR, V5, P29, DOI 10.1002/lt.500050102; Shieh YC, 2007, J FOOD PROTECT, V70, P145, DOI 10.4315/0362-028X-70.1.145; Shieh YC, 2009, J FOOD PROTECT, V72, P2390, DOI 10.4315/0362-028X-72.11.2390; Takahashi Y, 1993, Indian J Gastroenterol, V12 Suppl 3, P19; Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855	29	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e74546	10.1371/journal.pone.0074546	http://dx.doi.org/10.1371/journal.pone.0074546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223112	gold, Green Published, Green Submitted			2022-12-27	WOS:000326656200004
J	Cheng, DY; Hao, YW; Zhou, WL; Ma, YR				Cheng, Daye; Hao, Yiwen; Zhou, Wenling; Ma, Yiran			Vascular Endothelial Growth Factor+936C/T,-634G/C, 2578C/A, and-1154G/A Polymorphisms with Risk of Preeclampsia: A Meta-Analysis	PLOS ONE			English	Article							MATERNAL PLASMA-LEVELS; GENETIC POLYMORPHISMS; PLACENTAL GROWTH; NO ASSOCIATION; NITRIC-OXIDE; SERUM-LEVELS; PREGNANCIES; VEGF; DIMETHYLARGININE	Background: Emerging evidence showed that VEGF gene polymorphisms are involved in the regulation of VEGF protein expression, thus increasing an individual's susceptibility to preeclampsia (PE); but individually published results are inconclusive. The aim of this meta-analysis was to investigate the associations between VEGF gene polymorphisms and PE risk. Methods: A systematic literature search of MEDLINE, Embase, Web of Science, and CNKI (Chinese National Knowledge Infrastructure) databases was conducted. Statistical analyses were performed using STATA 12.0 software and Review manager 5.1. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. Results: According to the inclusion criteria, 11 case-control studies were finally included in this meta-analysis. A total of 1,069 PE cases and 1,315 controls were included in this study. Our meta-analysis indicated that VEGF +936C/T (T vs. C, OR = 1.52, 95%CI = 1.08-2.12) or -634G/C polymorphism (C vs. G, OR = 1.24, 95%CI = 1.03-1.50) was associated with the risk of PE, whereas there was no association between -2578C/A (A vs. C, OR = 0.98, 95%CI = 0.82-1.16) or -1154G/A (A vs. G, OR = 1.30, 95%CI = 0.94-1.78) polymorphism and PE risk in our study. Conclusion: Our meta-analysis suggested that VEGF -2578C/A or -1154G/A polymorphism had no association with PE risk in all examined patients, whereas there was an association between VEGF +936C/T or -634G/C polymorphism and risk of PE.	[Cheng, Daye; Hao, Yiwen; Zhou, Wenling; Ma, Yiran] China Med Univ, Hosp 1, Dept Transfus, Shenyang, Peoples R China	China Medical University	Cheng, DY (corresponding author), China Med Univ, Hosp 1, Dept Transfus, Shenyang, Peoples R China.	dayecheng_cmu@163.com			Liaoning Natural Science Fund, Liaoning Province, China [201102257]	Liaoning Natural Science Fund, Liaoning Province, China	This study was supported by Liaoning Natural Science Fund, Liaoning Province, China (Topic No: 201102257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Andraweera PH, 2013, J MATERN-FETAL NEO M, V26, P532, DOI 10.3109/14767058.2012.743520; Anthony FW, 1997, ANN CLIN BIOCHEM, V34, P276, DOI 10.1177/000456329703400309; Atis A, 2012, INT J IMMUNOGENET, V39, P241, DOI 10.1111/j.1744-313X.2011.01082.x; BAKER PN, 1995, OBSTET GYNECOL, V86, P815, DOI 10.1016/0029-7844(95)00259-T; Banyasz I, 2006, MOL HUM REPROD, V12, P233, DOI 10.1093/molehr/gal024; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bosio PM, 2001, AM J OBSTET GYNECOL, V184, P146, DOI 10.1067/mob.2001.108342; Brockelsby J, 1999, LAB INVEST, V79, P1101; Brownbill P, 2008, PLACENTA, V29, P950, DOI 10.1016/j.placenta.2008.08.020; Chedraui P, 2013, J MATERN-FETAL NEO M, V26, P226, DOI 10.3109/14767058.2012.733760; Cunha VMD, 2011, REV BRAS GINECOL OBS, V33, P158, DOI 10.1590/S0100-72032011000700007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eiland E, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/586578; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Foidart JM, 2009, J REPROD IMMUNOL, V82, P106, DOI 10.1016/j.jri.2009.09.001; Garza-Veloz I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-35; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Huang Y., 2009, MATERN CHILD HLTH J, V24, P2712; Hunter A, 2000, HYPERTENSION, V36, P965, DOI 10.1161/01.HYP.36.6.965; Jain L, 2009, MOL CANCER THER, V8, P2496, DOI 10.1158/1535-7163.MCT-09-0302; Kim YJ, 2008, TWIN RES HUM GENET, V11, P77, DOI 10.1375/twin.11.1.77; Livingston JC, 2000, AM J OBSTET GYNECOL, V183, P1554, DOI 10.1067/mob.2000.108022; Lyall F, 1997, BRIT J OBSTET GYNAEC, V104, P223, DOI 10.1111/j.1471-0528.1997.tb11050.x; Madazli R, 2003, ACTA OBSTET GYN SCAN, V82, P797, DOI 10.1034/j.1600-0412.2003.00206.x; Moodley J, 2004, HYPERTENS PREGNANCY, V23, P247, DOI 10.1081/PRG-200030301; Ong S, 2000, BEST PRACT RES CL OB, V14, P969, DOI 10.1053/beog.2000.0138; Papazoglou D, 2004, MOL HUM REPROD, V10, P321, DOI 10.1093/molehr/gah048; Pasqualetti G, 2007, PHARMACOGENOMICS, V8, P49, DOI 10.2217/14622416.8.1.49; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Sandrim VC, 2009, MOL HUM REPROD, V15, P115, DOI 10.1093/molehr/gan076; Sharkey AM, 1996, EUR J CLIN INVEST, V26, P1182, DOI 10.1046/j.1365-2362.1996.830605.x; Shim JY, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.045; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Stevens A, 2003, CANCER RES, V63, P812; Yun H., 2011, STUDY ASS VEGF GENE	37	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78173	10.1371/journal.pone.0078173	http://dx.doi.org/10.1371/journal.pone.0078173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223772	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400036
J	Trape, JF; Diatta, G; Arnathau, C; Bitam, I; Sarih, M; Belghyti, D; Bouattour, A; Elguero, E; Vial, L; Mane, Y; Balde, C; Pugnolle, F; Chauvancy, G; Mahe, G; Granjon, L; Duplantier, JM; Durand, P; Renaud, F				Trape, Jean-Francois; Diatta, Georges; Arnathau, Celine; Bitam, Idir; Sarih, M'hammed; Belghyti, Driss; Bouattour, Ali; Elguero, Eric; Vial, Laurence; Mane, Youssouph; Balde, Cellou; Pugnolle, Franck; Chauvancy, Gilles; Mahe, Gil; Granjon, Laurent; Duplantier, Jean-Marc; Durand, Patrick; Renaud, Francois			The Epidemiology and Geographic Distribution of Relapsing Fever Borreliosis in West and North Africa, with a Review of the Ornithodoros erraticus Complex (Acari: Ixodida)	PLOS ONE			English	Article							TICK-BORNE BORRELIOSIS; RODENTS; MALARIA; PART	Background: Relapsing fever is the most frequent bacterial disease in Africa. Four main vector / pathogen complexes are classically recognized, with the louse Pediculus humanus acting as vector for B. recurrentis and the soft ticks Ornithodoros sonrai, O. erraticus and O. moubata acting as vectors for Borrelia crocidurae, B. hispanica and B. duttonii, respectively. Our aim was to investigate the epidemiology of the disease in West, North and Central Africa. Methods And Findings: From 2002 to 2012, we conducted field surveys in 17 African countries and in Spain. We investigated the occurrence of Ornithodoros ticks in rodent burrows in 282 study sites. We collected 1,629 small mammals that may act as reservoir for Borrelia infections. Using molecular methods we studied genetic diversity among Ornithodoros ticks and Borrelia infections in ticks and small mammals. Of 9,870 burrows investigated, 1,196 (12.1%) were inhabited by Ornithodoros ticks. In West Africa, the southern and eastern limits of the vectors and Borrelia infections in ticks and small mammals were 13 degrees N and 01 degrees E, respectively. Molecular studies revealed the occurrence of nine different Ornithodoros species, including five species new for science, with six of them harboring Borrelia infections. Only B. crocidurae was found in West Africa and three Borrelia species were identified in North Africa: B. crocidurae, B. hispanica, and B. merionesi. Conclusions: Borrelia Spirochetes responsible for relapsing fever in humans are highly prevalent both in Ornithodoros ticks and small mammals in North and West Africa but Ornithodoros ticks seem absent south of 13 degrees N and small mammals are not infected in these regions. The number of Ornithodoros species acting as vector of relapsing fever is much higher than previously known.	[Trape, Jean-Francois; Diatta, Georges; Vial, Laurence; Mane, Youssouph; Chauvancy, Gilles] Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal; [Arnathau, Celine; Elguero, Eric; Vial, Laurence; Pugnolle, Franck; Durand, Patrick; Renaud, Francois] CNRS, Inst Rech Dev, IRD, MIVEGEC,UMR, Montpellier, France; [Bitam, Idir] Inst Pasteur, Lab Ecol Syst Vectoriels, Algiers, Algeria; [Sarih, M'hammed] Inst Pasteur, Lab Malad Vectorielles, Casablanca, Morocco; [Belghyti, Driss] Univ Ibn Tofail, Dept Biol, Fac Sci, Kenitra, Morocco; [Bouattour, Ali] Inst Pasteur, Serv Entomol Med, Tunis, Tunisia; [Balde, Cellou] Inst Pasteur, Lab Entomol Med & Venimol, Kindia, Guinea; [Mahe, Gil] Inst Rech Dev, UMR Hydrosci, Montpellier, France; [Granjon, Laurent; Duplantier, Jean-Marc] Ctr Biol & Gest Populat, Inst Rech Dev, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ibn Tofail University of Kenitra; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Trape, JF (corresponding author), Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal.	jean-francois.trape@ird.fr	Granjon, Laurent/K-2111-2016; Driss, BELGHYTI/E-6963-2014; BELGHYTI, Driss/AAK-8888-2020; Mahe, Gil/AAY-9002-2021	Granjon, Laurent/0000-0003-1182-3793; Driss, BELGHYTI/0000-0002-2465-8742; Mahe, Gil/0000-0002-0081-750X; Prugnolle, Franck/0000-0001-8519-1253	GICC programme of the French Ministry of Ecology [CV02000201]; Agence Nationale de la Recherche [3215AO-3R077-STEV]; IRD special programme "Evolution Climatique et Sante" [IRD-ATI-ECS]	GICC programme of the French Ministry of Ecology; Agence Nationale de la Recherche(French National Research Agency (ANR)); IRD special programme "Evolution Climatique et Sante"	The study received grants from the GICC programme of the French Ministry of Ecology (ref: CV02000201), the programmes "Sante-Environnement" and "Sante-Travail" of the Agence Nationale de la Recherche (ref: 3215AO-3R077-STEV), and the IRD special programme "Evolution Climatique et Sante" (ref: IRD-ATI-ECS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 1935, ARCH I PASTEUR TUNIS, V22, P350; Baltazard M., 1950, Bulletin de la Societe de Pathologie Exotique Paris, V43, P595; BARCLAY AJG, 1990, T ROY SOC TROP MED H, V84, P852, DOI 10.1016/0035-9203(90)90106-O; BERGERET C., 1946, Bulletin Medical de l'Afrique-Occidentale Francaise, V3, P29; BLANC G., 1948, BULL SOC PATH EXOT, V41, P139; BOIRON H., 1949, BULL SOC PATH EXOT, V42, P62; Bouattour A, 2010, VECTOR-BORNE ZOONOT, V10, P825, DOI 10.1089/vbz.2009.0151; BRYCESON AD, 1970, Q J MED, V39, P129; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Cadavid D, 1998, CLIN INFECT DIS, V26, P151, DOI 10.1086/516276; Camicas JL, 1998, PARIS ORSTOM, P233; CHABAUD ALAIN, 1954, ANN PARASITOL HUMAINE ET COMP, V29, P89; Chausov E.V., 2010, ENTOMOL REV, V90, P240, DOI DOI 10.1134/S0013873810020090; Colangelo P, 2007, MOL PHYLOGENET EVOL, V42, P797, DOI 10.1016/j.ympev.2006.10.001; Colas Belcour J, 1930, ARCH I PASTEUR TUNIS, V19, P1; Cutler SJ, 2009, CLIN MICROBIOL INFEC, V15, P400, DOI 10.1111/j.1469-0691.2009.02819.x; Cutler SJ, 2006, EMERG INFECT DIS, V12, P369, DOI 10.3201/eid1203.050899; de BUEN SADI, 1926, ANN PARASITOL HUM ET COMP, V4, P185; DIATTA G, 1994, T ROY SOC TROP MED H, V88, P423, DOI 10.1016/0035-9203(94)90412-X; Diatta G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001810; Dobigny G, 2005, HEREDITY, V95, P358, DOI 10.1038/sj.hdy.6800730; Dobigny G, 2011, MAMM BIOL, V76, P417, DOI 10.1016/j.mambio.2010.10.002; Dutton JE, 1905, BRIT MED J, V1905, P1259; Eguale Tewdros., 2002, ETHIOP J HLTH SCI, V12, P103; Fukunaga M, 2001, VECTOR-BORNE ZOONOT, V1, P331, DOI 10.1089/15303660160025949; GARNHAM PCC, 1947, T ROY SOC TROP MED H, V41, P141, DOI 10.1016/S0035-9203(47)90209-5; Gaud M, 1947, B ORG MOND SANTE, V1, P75; Gaud M, 1947, B ORG MOND SANTE, V1, P99; GOUBAU PF, 1984, ANN SOC BELG MED TR, V64, P335; GOUBAU PFJ, 1983, ANN SOC BELG MED TR, V63, P347; Granjon L, 2003, MAMMAL REV, V33, P77, DOI 10.1046/j.1365-2907.2003.00007.x; Granjon L, 2009, RONGEURS AFRIQUE SAH, P215; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoogstraal H, 1956, 0050502907 NM, P113; Hornus P, 1928, NOTE SUJET FIEVRE RE, V17, P327; Kisinza WN, 2003, LANCET, V362, P1283, DOI 10.1016/S0140-6736(03)14609-0; Larrouse F., 1923, Annales de Parasitologie Paris, V1, P170; Lecompte F, 2005, MOL PHYLOGENET EVOL, V37, P899, DOI 10.1016/j.ympev.2005.06.018; LEESON HS, 1952, B ENTOMOL RES, V43, P407, DOI 10.1017/S000748530004058X; LEESON HS, 1953, B ENTOMOL RES, V44, P517, DOI 10.1017/S0007485300025591; Lucas H, 1849, EXPLORATION SCI ALGE, P316; Mackie FP, 1907, BRIT MED J, V1907, P1706, DOI 10.1136/bmj.2.2450.1706; Mahe G, 2012, CARTE PLUIES ANN AF; Mathis C., 1934, Ann Inst Pasteur Paris T, V52, P166; Mathis C, 1932, B SOC PATHOL EXOT, V21, P472; Mathis Constant, 1946, OEUVRE PASTORIENS AF; Morel P. C., 1959, Revue d'Elevage, V12, P53; Morel P.-C., 2003, B ACAD VET FR, DOI DOI 10.4267/2042/66807; Neumann G, 1896, MEM SOC ZOOL FRANCE, V9, P25; Nicolle C, 1928, PRESENCE MAROC SPIRO, V17, P83; Nordstrand A, 2007, EMERG INFECT DIS, V13, P117, DOI 10.3201/eid1301.060670; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramos JM, 2008, ANN TROP MED PARASIT, V102, P467, DOI 10.1179/136485908X300887; RODHAIN F, 1976, B I PASTEUR, V74, P173; Ross PH, 1904, BRIT MED J, V1904, P1453, DOI 10.1136/bmj.2.2291.1453; Sarih M, 2009, EMERG INFECT DIS, V15, P1626, DOI 10.3201/eid1510.090403; SAUTET J., 1944, BULL SOC PATH EXOT, V37, P182; Schwan TG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001924; SERGENT A., 1933, Bulletin de la Societe de Pathologie Exotique, V26, P906; Sergent Edm., 1908, Bulletin de la Societe de Pathologie Exotique Paris, V1; SOUTHERN PM, 1969, MEDICINE, V48, P129, DOI 10.1097/00005792-196903000-00002; SPARROW H, 1958, Bull World Health Organ, V19, P673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; Trape JF, 1996, AM J TROP MED HYG, V54, P289, DOI 10.4269/ajtmh.1996.54.289; TRAPE JF, 1991, LANCET, V337, P473, DOI 10.1016/0140-6736(91)93404-W; VELU H., 1919, Bulletin de la Societe de Pathologie Exotique, V12, P99; Venzal JM, 2008, J MED ENTOMOL, V45, P832, DOI 10.1603/0022-2585(2008)45[832:TOATSG]2.0.CO;2; Vial L, 2006, LANCET, V368, P37, DOI 10.1016/S0140-6736(06)68968-X; Vitorino L, 2007, MICROBIOL-SGM, V153, P160, DOI 10.1099/mic.0.2006/001149-0; WALTON GERALD A., 1962, SYMPOSIA ZOOL SOC LONDON, V6, P83; Weldon ED, 1955, WORLD DISTRIBUTION S, V2; Wilson DE, 2005, MAMMALS WORLD TAXONI, V1	77	83	86	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78473	10.1371/journal.pone.0078473	http://dx.doi.org/10.1371/journal.pone.0078473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223812	Green Published, gold			2022-12-27	WOS:000326503400065
J	Wang, MC; Hashimoto, M; Hashidoko, Y				Wang, Mengcen; Hashimoto, Makoto; Hashidoko, Yasuyuki			Repression of Tropolone Production and Induction of a Burkholderia plantarii Pseudo-Biofilm by Carot-4-en-9, 10-diol, a Cell-to-Cell Signaling Disrupter Produced by Trichoderma virens	PLOS ONE			English	Article							SECONDARY METABOLITES; CAROTANE SESQUITERPENE; GENE-EXPRESSION; QUORUM; BACTERIA; PROTEIN; BIOSYNTHESIS; SUBSTANCES; AERUGINOSA; BEHAVIORS	Background: The tropolone-tolerant Trichoderma virens PS1-7 is a biocontrol agent against Burkholderia plantarii, causative of rice seedling blight. When exposed to catechol, this fungus dose-dependently produced carot-4-en-9,10-diol,a sesquiterpene-type autoregulatory signal molecule that promotes self-conidiation of T. virens PS1-7 mycelia. It was, however, uncertain why T. virens PS1-7 attenuates the symptom development of the rice seedlings infested with B. plantarii. Methodology/Principal Findings: To reveal the antagonism by T. virens PS1-7 against B. plantarii leading to repression of tropolone production in a coculture system, bioassay-guided screening for active compounds from a 3-d culture of T. virens PS1-7 was conducted. As a result, carot-4-en-9,10-diol was identified and found to repress tropolone production of B. plantarii from 10 to 200 mu M in a dose-dependent manner as well as attenuate virulence of B. plantarii on rice seedlings. Quantitative RT-PCR analysis revealed that transcriptional suppression of N-acyl-L-homoserine lactone synthase plaI in B. plantarii was the main mode of action by which carot-4-en-9,10-diol mediated the quorum quenching responsible for repression of tropolone production. In addition, the unique response of B. plantarii to carot-4-en-9,10-diol in the biofilm formed in the static culture system was also found. Although the initial stage of B. plantarii biofilm formation was induced by both tropolone and carot-4-en-9,10-diol, it was induced in different states. Moreover, the B. plantarii biofilm that was induced by carot-4-en-9,10-diol at the late stage showed defects not only in matrix structure but also cell viability. Conclusions/Significance: Our findings demonstrate that carot-4-en-9,10-diol released by T. virens PS1-7 acts as an interkingdom cell-to-cell signaling molecule against B. plantarii to repress tropolone production and induces pseudo-biofilm to the cells. This observation also led to another discovery that tropolone is an autoregulatory cell-to-cell signaling molecule of B. plantarii that induces a functional biofilm other than a simple B. plantarii virulence factor.	[Hashidoko, Yasuyuki] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Hashidoko, Y (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	yasu-h@abs.agr.hokudai.ac.jp	Hashimoto, Makoto/B-7837-2012; Wang, Mengcen/AAP-6051-2021; Wang, Mengcen/AAN-3975-2021	Hashimoto, Makoto/0000-0002-5526-8835; Wang, Mengcen/0000-0001-7169-6779	Ministry of Economy, Trade and Industry, Japan for the METI Project; Chinese Scholarship Council for the Scholarship [CSC 2010632028];  [485 20240833]	Ministry of Economy, Trade and Industry, Japan for the METI Project; Chinese Scholarship Council for the Scholarship; 	The authors are grateful to the Ministry of Economy, Trade and Industry, Japan for the METI Project (Highly efficient gene design for microbial production of innovative biomaterials to Y.H.) and Chinese Scholarship Council for the Scholarship (CSC 2010632028 to M.W.). This research work was also financially supported by a Grant-in-aid for Scientific Research A (no. 485 20240833 to Y.H.). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha R, 2005, J BASIC MICROB, V45, P12, DOI 10.1002/jobm.200410451; AZEGAMI K, 1985, Annals of the Phytopathological Society of Japan, V51, P315, DOI 10.3186/jjphytopath.51.315; AZEGAMI K, 1988, APPL ENVIRON MICROB, V54, P844, DOI 10.1128/AEM.54.3.844-847.1988; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Barnard AML, 2007, PHILOS T R SOC B, V362, P1165, DOI 10.1098/rstb.2007.2042; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Cataldi TRI, 2013, ANAL BIOANAL CHEM, V405, P493, DOI 10.1007/s00216-012-6371-2; Chernin L, 2011, ENV MICROBIOL REP, V3, P698, DOI 10.1111/j.1758-2229.2011.00284.x; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Dandurishvili N, 2011, J APPL MICROBIOL, V110, P341, DOI 10.1111/j.1365-2672.2010.04891.x; Defoirdt T, 2007, ENVIRON MICROBIOL, V9, P2486, DOI 10.1111/j.1462-2920.2007.01367.x; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Dufour N, 2011, FEMS MICROBIOL LETT, V314, P10, DOI 10.1111/j.1574-6968.2010.02154.x; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gao MS, 2003, MOL PLANT MICROBE IN, V16, P827, DOI 10.1094/MPMI.2003.16.9.827; Geng HF, 2010, J BACTERIOL, V192, P4377, DOI 10.1128/JB.00410-10; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Gram L, 1996, APPL ENVIRON MICROB, V62, P4284, DOI 10.1128/AEM.62.11.4284-4287.1996; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Howell CR, 2004, PHYTOPATHOLOGY, V94, pS138; Jarosz LM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002312; Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Koh CL, 2013, SENSORS-BASEL, V13, P6217, DOI 10.3390/s130506217; Lee SH, 1995, J NAT PROD, V58, P1822, DOI 10.1021/np50126a004; Lemos JA, 2010, METHODS MOL BIOL, V666, P87, DOI 10.1007/978-1-60761-820-1_7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mukherjee PK, 2012, MICROBIOL-SGM, V158, P35, DOI 10.1099/mic.0.053629-0; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Okajima Y, 2006, INVEST OPHTH VIS SCI, V47, P2971, DOI 10.1167/iovs.05-1172; Okegbe C, 2012, ANTIOXID REDOX SIGN, V16, P658, DOI 10.1089/ars.2011.4249; ONDEYKA JG, 1995, BIOORG MED CHEM LETT, V5, P733, DOI 10.1016/0960-894X(95)00104-2; Pacheco AR, 2009, CURR OPIN MICROBIOL, V12, P192, DOI 10.1016/j.mib.2009.01.006; Ponnusamy K, 2010, BRAZ J MICROBIOL, V41, P227, DOI 10.1590/S1517-838220100001000032; Popat R, 2008, BRIT MED BULL, V87, P63, DOI 10.1093/bmb/ldn030; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Shinohara M, 2008, J PESTIC SCI, V33, P90, DOI 10.1584/jpestics.33.90; Solis R, 2006, FEMS MICROBIOL LETT, V259, P106, DOI 10.1111/j.1574-6968.2006.00254.x; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Teplitski M, 2000, MOL PLANT MICROBE IN, V13, P637, DOI 10.1094/MPMI.2000.13.6.637; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wang MC, 2013, APPL ENVIRON MICROB, V79, P1906, DOI 10.1128/AEM.03531-12; WATANABE N, 1990, J NAT PROD, V53, P1176, DOI 10.1021/np50071a006; Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h; Zhu H, 2011, LETT APPL MICROBIOL, V52, P269, DOI 10.1111/j.1472-765X.2010.02993.x	59	12	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78024	10.1371/journal.pone.0078024	http://dx.doi.org/10.1371/journal.pone.0078024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223754	Green Published, gold			2022-12-27	WOS:000326503400029
J	Ross, AB; DeStigter, KK; Rielly, M; Souza, S; Morey, GE; Nelson, M; Silfen, EZ; Garra, B; Matovu, A; Kawooya, MG				Ross, Andrew B.; DeStigter, Kristen K.; Rielly, Matthew; Souza, Sonia; Morey, Gabriel Eli; Nelson, Melissa; Silfen, Eric Z.; Garra, Brian; Matovu, Alphonsus; Kawooya, Michael Grace			A Low-Cost Ultrasound Program Leads to Increased Antenatal Clinic Visits and Attended Deliveries at a Health Care Clinic in Rural Uganda	PLOS ONE			English	Article							MATERNAL MORTALITY; PREGNANCY	Background: In June of 2010, an antenatal ultrasound program to perform basic screening for high-risk pregnancies was introduced at a community health care center in rural Uganda. Whether the addition of ultrasound scanning to antenatal visits at the health center would encourage or discourage potential patients was unknown. Our study sought to evaluate trends in the numbers of antenatal visits and deliveries at the clinic, pre- and post-introduction of antenatal ultrasound to determine what effect the presence of ultrasound at the clinic had on these metrics. Methods and Findings: Records at Nawanyago clinic were reviewed to obtain the number of antenatal visits and deliveries for the 42 months preceding the introduction of ultrasound and the 23 months following. The monthly mean deliveries and antenatal visits by category (first visit through fourth return visit) were compared pre- and post-ultrasound using a Kruskal-Wallis one-way ANOVA. Following the introduction of ultrasound, significant increases were seen in the number of mean monthly deliveries and antenatal visits. The mean number of monthly deliveries at the clinic increased by 17.0 (13.3-20.6, 95% CI) from a pre-ultrasound average of 28.4 to a post-ultrasound monthly average of 45.4. The number of deliveries at a comparison clinic remained flat over this same time period. The monthly mean number of antenatal visits increased by 97.4 (83.3-111.5, 95% CI) from a baseline monthly average of 133.5 to a post-ultrasound monthly mean of 231.0, with increases seen in all categories of antenatal visits. Conclusions: The availability of a low-cost antenatal ultrasound program may assist progress towards Millennium Development Goal 5 by encouraging women in a rural environment to come to a health care facility for skilled antenatal care and delivery assistance instead of utilizing more traditional methods.	[Ross, Andrew B.; DeStigter, Kristen K.] Univ Vermont, Coll Med, Dept Radiol, Fletcher Allen Hlth Care, Burlington, VT USA; [Rielly, Matthew] Philips Healthcare, Ultrasound Res & Dev, Bangalore, Karnataka, India; [Souza, Sonia; Nelson, Melissa] Philips Healthcare, Div Res, Bothell, WA USA; [Morey, Gabriel Eli] Univ Vermont, Coll Med, Fletcher Allen Hlth Care, Burlington, VT USA; [Silfen, Eric Z.] Philips Hlth Care, Andover, MA USA; [Garra, Brian] Vet Affairs Hosp, Dept Radiol, Washington, DC USA; [Matovu, Alphonsus] Kamuli Mission Hosp, Dept Surg, Kamuli, Uganda; [Kawooya, Michael Grace] Mengo Hosp, Ernest Cook Ultrasound Res & Educ Inst, Kampala, Uganda	University of Vermont; University of Vermont Medical Center; Philips; Philips Healthcare; Philips; Philips Healthcare; University of Vermont; University of Vermont Medical Center; Philips; Philips Healthcare	Ross, AB (corresponding author), Univ Vermont, Coll Med, Dept Radiol, Fletcher Allen Hlth Care, Burlington, VT USA.	Andrew.ross@vtmednet.org		Morey, Gabriel Eli/0000-0001-7411-0489; Ross, Andrew/0000-0002-4866-6923	Imaging the World; Fineberg Foundation; Bill and Melinda Gates Foundation; Philips Health Care; McKesson Corporation; Peervue Corporation; Alpha Omega Alpha postgraduate award	Imaging the World; Fineberg Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Philips Health Care; McKesson Corporation; Peervue Corporation; Alpha Omega Alpha postgraduate award	Funding for this study was provided by Imaging the World which received funding from the Fineberg Foundation, the Bill and Melinda Gates Foundation, Philips Health Care, McKesson Corporation, and Peervue Corporation. This research was also supported (in part) by an Alpha Omega Alpha postgraduate award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale JR, 2003, IMPROVING BIRTH OUTC, P372; Bashour H, 2005, REPROD HEALTH MATTER, V13, P147, DOI 10.1016/S0968-8080(05)25164-9; Daar AS, 2002, NAT GENET, V32, P229, DOI 10.1038/ng1002-229; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; DeStigter K. K., 2011, 2011 IEEE Global Humanitarian Technology Conference, P290, DOI 10.1109/GHTC.2011.39; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Gammeltoft T, 2007, REPROD HEALTH MATTER, V15, P163, DOI 10.1016/S0968-8080(06)29280-2; Garra BS, 2008, OFFICIAL P AM I ULTR; Geerts LTGM, 1996, BRIT J OBSTET GYNAEC, V103, P501, DOI 10.1111/j.1471-0528.1996.tb09796.x; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Group C2W, 2012, BUILD FUT WOM CHILDR; Haines A, 2004, BMJ-BRIT MED J, V329, P394, DOI 10.1136/bmj.329.7462.394; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; McDonagh M, 1996, HEALTH POLICY PLANN, V11, P1, DOI 10.1093/heapol/11.1.1; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034018; Ronsmans C, 2003, TROP MED INT HEALTH, V8, P940, DOI 10.1046/j.1365-3156.2003.01111.x; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Sibley L, 2004, MIDWIFERY, V20, P51, DOI 10.1016/S0266-6138(03)00053-6; van Dyk B, 2007, INT J GYNECOL OBSTET, V98, P257, DOI 10.1016/j.ijgo.2007.03.034; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	21	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78450	10.1371/journal.pone.0078450	http://dx.doi.org/10.1371/journal.pone.0078450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205234	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500120
J	Witsenburg, JJ; Glauner, H; Muller, JP; Groenewoud, JMM; Roth, G; Bohmer, FD; Adjobo-Hermans, MJW; Brock, R				Witsenburg, J. Joris; Glauner, Heike; Mueller, Joerg P.; Groenewoud, Johannes M. M.; Roth, Guenter; Boehmer, Frank-Dietmar; Adjobo-Hermans, Merel J. W.; Brock, Roland			A Quantitative Assessment of Costimulation and Phosphatase Activity on Microclusters in Early T Cell Signaling	PLOS ONE			English	Article							RECEPTOR MICROCLUSTERS; ANTIGEN-RECEPTOR; CO-STIMULATION; IMMUNOLOGICAL SYNAPSE; ACTIVATION; CD28; PROTEIN; KINASE; TCR; CLUSTERS	T cell signaling is triggered through stimulation of the T cell receptor and costimulatory receptors. Receptor activation leads to the formation of membrane-proximal protein microclusters. These clusters undergo tyrosine phosphorylation and organize multiprotein complexes thereby acting as molecular signaling platforms. Little is known about how the quantity and phosphorylation levels of microclusters are affected by costimulatory signals and the activity of specific signaling proteins. We combined micrometer-sized, microcontact printed, striped patterns of different stimuli and simultaneous analysis of different cell strains with image processing protocols to address this problem. First, we validated the stimulation protocol by showing that high expression levels CD28 result in increased cell spreading. Subsequently, we addressed the role of costimulation and a specific phosphotyrosine phosphatase in cluster formation by including a SHP2 knock-down strain in our system. Distinguishing cell strains using carboxyfluorescein succinimidyl ester enabled a comparison within single samples. SHP2 exerted its effect by lowering phosphorylation levels of individual clusters while CD28 costimulation mainly increased the number of signaling clusters and cell spreading. These effects were observed for general tyrosine phosphorylation of clusters and for phosphorylated PLC gamma 1. Our analysis enables a clear distinction between factors determining the number of microclusters and those that act on these signaling platforms.	[Witsenburg, J. Joris; Glauner, Heike; Adjobo-Hermans, Merel J. W.; Brock, Roland] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Mueller, Joerg P.; Boehmer, Frank-Dietmar] Jena Univ Hosp, Inst Mol Cell Biol, Jena, Germany; [Groenewoud, Johannes M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Roth, Guenter] Univ Freiburg, Dept Microsyst Engn IMTEK, Lab MEMS Applicat, D-79106 Freiburg, Germany; [Roth, Guenter] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	Radboud University Nijmegen; Friedrich Schiller University of Jena; Radboud University Nijmegen; University of Freiburg; University of Freiburg	Brock, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands.	R.Brock@ncmls.ru.nl	Brock, Roland/O-9411-2019; Adjobo-Hermans, Merel/AAN-5989-2020; Groenewoud, Hans JMM/R-3588-2017; Adjobo-Hermans, M.J.W./L-4170-2015; Brock, Roland/K-2590-2012	Adjobo-Hermans, Merel/0000-0002-5947-2876; Groenewoud, Hans JMM/0000-0002-4974-150X; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Brock, Roland/0000-0003-1395-6127	Volkswagen Foundation [I/7 7 472]	Volkswagen Foundation(Volkswagen)	This work has been supported by the Volkswagen Foundation (http://www.volkswagenstiftung.de/" Nachwuchsgruppen an Universitaten'', I/7 7 472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.3.CO;2-D; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cantrell DA, 2001, J CELL SCI, V114, P1439; Culley FJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000159; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Hashimoto-Tane A, 2010, MOL CELL BIOL, V30, P3421, DOI 10.1128/MCB.00160-10; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.0.CO;2-U; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lichtenfels R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032994; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Newman DK, 2001, BLOOD, V97, P2351, DOI 10.1182/blood.V97.8.2351; Nguyen TV, 2006, J IMMUNOL, V177, P5990, DOI 10.4049/jimmunol.177.9.5990; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Osborn M, 1982, METHODS CELL BIOL CY, V97; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Perez-Villar JJ, 1999, J IMMUNOL, V163, P6435; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Saito T, 2010, FEBS LETT, V584, P4865, DOI 10.1016/j.febslet.2010.11.036; Salazar-Fontana LI, 2001, CLIN IMMUNOL, V99, P253, DOI 10.1006/clim.2001.5003; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Song JX, 2008, CELL MOL IMMUNOL, V5, P239, DOI 10.1038/cmi.2008.30; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Thiel M, 2010, IMMUNOLOGY, V129, P28, DOI 10.1111/j.1365-2567.2009.03155.x; UEDA Y, 1995, INT IMMUNOL, V7, P957, DOI 10.1093/intimm/7.6.957; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Wange R L, 2000, Sci STKE, V2000, pre1; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741	65	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e79277	10.1371/journal.pone.0079277	http://dx.doi.org/10.1371/journal.pone.0079277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205378	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500147
J	Mellor, RM; Greenfield, SM; Dowswell, G; Sheppard, JP; Quinn, T; McManus, RJ				Mellor, Ruth M.; Greenfield, Sheila M.; Dowswell, George; Sheppard, James P.; Quinn, Tom; McManus, Richard J.			Health Care Professionals' Views on Discussing Sexual Wellbeing with Patients Who Have Had a Stroke: A Qualitative Study	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; NATIONAL-SURVEY; OVARIAN-CANCER; ISSUES; REHABILITATION; CONSEQUENCES; INTIMACY; LIFE; MEN; COMMUNICATION	Objectives: To examine the experiences of health care professionals discussing sexual wellbeing with patients who have had a stroke. Design: In-depth qualitative interview study with purposive sampling and thematic analysis. Participants: 30 health care professionals purposively recruited to include different roles and settings along the stroke patient pathway in secondary and primary care. Setting: Two hospitals and three general practices in the West Midlands, UK. Results: Sexual wellbeing was a topic that participants did not raise with patients and was infrequently raised by patients. Barriers to raising discussion were on four levels: structural, health care professional, patient, and professional-patient interface. Barriers within these levels included: sexual wellbeing not present within hospital stroke policy; the perception that sexual wellbeing was not within participants' role; participants' concern that raising the issue could cause harm to the patient; and the views that discussion would be inappropriate with older people or unimportant to women. Resources exist to aid discussion but many participants were unaware of them, and most of those that were, did not use them routinely. Conclusions: Participants lacked motivation, ownership, and the confidence and skills to raise sexual wellbeing routinely after stroke. Similar findings have been reported in cancer care and other taboo subjects such as incontinence potentially resulting in a sub-optimal experience for patients. Normalisation of the inclusion of sensitive topics in discussions post-stroke does not seem to need significant structural intervention and simple changes such as information provision and legitimisation through consideration of the issue in standard care policies may be all that is required. The experiences recounted by professionals in this study suggest that such changes are needed now.	[Mellor, Ruth M.; Greenfield, Sheila M.; Dowswell, George] Univ Birmingham, Birmingham, W Midlands, England; [Sheppard, James P.; McManus, Richard J.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Quinn, Tom] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Birmingham; University of Oxford; University of Surrey	Greenfield, SM (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	s.m.greenfield@bham.ac.uk	Sheppard, James/AAR-6793-2021	Sheppard, James/0000-0002-4461-8756; Quinn, Tom/0000-0002-5116-0034	National Institute for Health Research (NIHR); National Institute for Health Research (NIHR) through the Collaboration for Leadership in Applied Health Research and Care for the Birmingham and Black Country (CLAHRC-BBC) programme; NIHR Career Development Fellowship; National Institute for Health Research [NIHR-RP-02-12-015, CDF/01/017] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) through the Collaboration for Leadership in Applied Health Research and Care for the Birmingham and Black Country (CLAHRC-BBC) programme; NIHR Career Development Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. All authors were funded by the National Institute for Health Research (NIHR) through the Collaboration for Leadership in Applied Health Research and Care for the Birmingham and Black Country (CLAHRC-BBC) programme. RJM was funded by an NIHR Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom B, 2010, SCAND J CARING SCI, V24, P116, DOI 10.1111/j.1471-6712.2009.00694.x; Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Bener A, 2008, INT UROL NEPHROL, V40, P701, DOI 10.1007/s11255-008-9334-y; Boosman H, 2011, CLIN REHABIL, V25, P460, DOI 10.1177/0269215510388314; Brown SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001757.pub3; Byrne M, 2013, EUR J CARDIOVASC NUR, V12, P558, DOI 10.1177/1474515113477273; Byrne M, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-40; Cheung RTF, 2008, EUR J NEUROL, V15, P641, DOI 10.1111/j.1468-1331.2008.02177.x; Currie L, 1998, Nurs Stand, V12, P35; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.535088, 10.1161/STROKEAHA.108.534487]; Department of Health, 2007, NAT STROK STRAT; Dowswell G, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5824; Finch H., 2003, QUALITATIVE RES PRAC, P170, DOI https://doi.org/10.4135/9781452230108; Forbat L, 2012, BJU INT, V109, P98, DOI 10.1111/j.1464-410X.2011.10257.x; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Gott M, 2003, FAM PRACT, V20, P690, DOI 10.1093/fampra/cmg612; HAWTON K, 1984, J PSYCHOSOM RES, V28, P243, DOI 10.1016/0022-3999(84)90026-6; Higgins A, 2008, J ADV NURS, V62, P307, DOI 10.1111/j.1365-2648.2007.04586.x; Hinchliff S, 2005, HEALTH SOC CARE COMM, V13, P345, DOI 10.1111/j.1365-2524.2005.00566.x; Hinchliff S, 2011, J SEX RES, V48, P106, DOI 10.1080/00224499.2010.548610; Hordern A, 2008, CANCER NURS, V31, pE9, DOI 10.1097/01.NCC.0000305695.12873.d5; Hordern AJ, 2007, MED J AUSTRALIA, V186, P224, DOI 10.5694/j.1326-5377.2007.tb00877.x; Hughes MK, 2000, CANCER NURS, V23, P477, DOI 10.1097/00002820-200012000-00011; Jaarsma T, 2010, EUR J CARDIOVASC NUR, V9, P24, DOI 10.1016/j.ejcnurse.2009.11.003; Jung JH, 2008, UROLOGY, V71, P99, DOI 10.1016/j.urology.2007.08.045; Kautz DD, 2007, REHABIL NURS, V32, P95, DOI 10.1002/j.2048-7940.2007.tb00160.x; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Kim JR, 2008, J PSYCHOSOM RES, V65, P565, DOI 10.1016/j.jpsychores.2008.06.005; Kimura M, 2001, COMPR PSYCHIAT, V42, P217, DOI 10.1053/comp.2001.23141; Korpelainen JT, 1999, STROKE, V30, P715, DOI 10.1161/01.STR.30.4.715; Lennon S, 2013, CLIN REHABIL, V27, P867, DOI 10.1177/0269215513481045; Lindau ST, 2012, AM J CARDIOL, V109, P1439, DOI 10.1016/j.amjcard.2012.01.355; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; McLaughlin J, 2005, SEX DISABIL, V23, P213, DOI 10.1007/s11195-005-8929-9; Milne JL, 2008, INT J NURS STUD, V45, P765, DOI 10.1016/j.ijnurstu.2007.01.006; Mirone V, 2002, INT J IMPOT RES, V14, P256, DOI 10.1038/sj.ijir.3900879; MONGA TN, 1986, ARCH PHYS MED REHAB, V67, P415; Monz B, 2005, MATURITAS, V52, pS3, DOI 10.1016/j.maturitas.2005.09.007; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; QSR International, 1999, NVIVO QUAL DAT AN SO; Ritchie J, 2003, QUALITATIVE RES PRAC, P77; Sarkadi A, 2001, FAM PRACT, V18, P161, DOI 10.1093/fampra/18.2.161; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Schmitz MA, 2010, TOP STROKE REHABIL, V17, P204, DOI 10.1310/tsr1703-204; Shell J A, 1994, Oncol Nurs Forum, V21, P553; Sheppard JP, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001430; Sinclair Emma, 2014, Disabil Rehabil, V36, P409, DOI 10.3109/09638288.2013.793410; Stead ML, 2001, BRIT MED J, V323, P836, DOI 10.1136/bmj.323.7317.836; Stead ML, 2003, BRIT J CANCER, V88, P666, DOI 10.1038/sj.bjc.6600799; Steinke E, 1996, Clin Nurs Res, V5, P462, DOI 10.1177/105477389600500408; Strauss A., 2008, BASICS QUALITATIVE R, V3rd, P65, DOI [10.4135/9781452230153qu, DOI 10.4135/9781452230153]; Strauss A., 1998, BASICS QUALITATIVE R; Stroke Association, 2012, SEX STROK, P2; Sundquist Kendra, 2003, Aust Fam Physician, V32, P19; Swanson JG, 2002, CAN FAM PHYSICIAN, V48, P86; Thompson HS, 2009, J CLIN NURS, V18, P1803, DOI 10.1111/j.1365-2702.2008.02694.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Whitehead WE, 2005, GASTROENTEROLOGY, V129, P6, DOI 10.1053/j.gastro.2005.05.043; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1; Yar Mohammed, 2006, Health Stat Q, P44; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	63	42	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78802	10.1371/journal.pone.0078802	http://dx.doi.org/10.1371/journal.pone.0078802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24205318	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000326270700098
J	Karakawa, A; Murata, H; Hirasawa, H; Mayama, C; Asaoka, R				Karakawa, Ayako; Murata, Hiroshi; Hirasawa, Hiroyo; Mayama, Chihiro; Asaoka, Ryo			Detection of Progression of Glaucomatous Visual Field Damage Using the Point-Wise Method with the Binomial Test	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; LINEAR-REGRESSION; SENSITIVITY; PREDICTION; AGREEMENT; PERIMETRY; DESIGN; INDEX; RATES; DECAY	Purpose: To compare the performance of newly proposed point-wise linear regression (PLR) with the binomial test (binomial PLR) against mean deviation (MD) trend analysis and permutation analyses of PLR (PoPLR), in detecting global visual field (VF) progression in glaucoma. Methods: 15 VFs (Humphrey Field Analyzer, SITA standard, 24-2) were collected from 96 eyes of 59 open angle glaucoma patients (6.0 +/- 1.5 [mean +/- standard deviation] years). Using the total deviation of each point on the 2nd to 16th VFs (VF2-16), linear regression analysis was carried out. The numbers of VF test points with a significant trend at various probability levels (p<0.025, 0.05, 0.075 and 0.1) were investigated with the binomial test (one-side). A VF series was defined as "significant" if the median p-value from the binomial test was <0.025. Similarly, the progression analysis was carried out using only second to sixth VFs (VF2-6). The performance of each method was evaluated using the 'consistency measures'; proportion both significant (PBS): both VF series (VF2-6 and VF2-16) were "significant", proportion both were not significant (PBNS): both were "not significant", proportion inconsistently significant (PIS): VF2-16 was "not significant" but VF2-6 was "significant". A similar analysis was carried out using VF2-7 and VF2-15 series, and the performance was compared with MD trend analysis and PoPLR. Results: The PBS of the binomial PLR method (0.14 to 0.86) was significantly higher than MD trend analysis (0.04 to 0.89) and PoPLR (0.09 to 0.93). The PIS of the proposed method (0.0 to 0.17) was significantly lower than the MD approach (0.0 to 0.67) and PoPLR (0.07 to 0.33). The PBNS of the three approaches were not significantly different. Conclusions: The binomial BLR method gives more consistent results than MD trend analysis and PoPLR, hence it will be helpful as a tool to 'flag' possible VF deterioration.	[Karakawa, Ayako; Murata, Hiroshi; Hirasawa, Hiroyo; Mayama, Chihiro; Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan	University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25861618, 60645000, 50570701]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This was supported in part by Grant 25861618 (HM), 60645000 (HH), 50570701 (CM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang GS, 2011, J GLAUCOMA, V20, P223, DOI 10.1097/IJG.0b013e3181e08137; Anton A, 2012, EUR J OPHTHALMOL, P187; Anton A, 2013, EUR J OPHTHALMOL, V23, P187, DOI 10.5301/ejo.5000193; Artes PH, 2011, INVEST OPHTH VIS SCI, V52, P4030, DOI 10.1167/iovs.10-6905; Asaoka R, 2013, GRAEF ARCH CLIN EXP, V251, P1335, DOI 10.1007/s00417-012-2214-2; Azarbod P, 2012, INVEST OPHTH VIS SCI, V53, P5403, DOI 10.1167/iovs.12-9930; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Bengtsson B, 2009, ARCH OPHTHALMOL-CHIC, V127, P1610, DOI 10.1001/archophthalmol.2009.297; BIRCH MK, 1995, PERIMETRY UPDATE 1994/1995, P31; Caprioli J, 2011, INVEST OPHTH VIS SCI, V52, P4765, DOI 10.1167/iovs.10-6414; Casas-Llera P, 2009, BRIT J OPHTHALMOL, V93, P1576, DOI 10.1136/bjo.2009.158097; CHAUHAN BC, 1990, INVEST OPHTH VIS SCI, V31, P512; Crabb DP, 2012, INVEST OPHTH VIS SCI, V53, P2770, DOI 10.1167/iovs.12-9476; Fisher R. A., 1992, STAT METHODS RES WOR; Fitzke FW, 1996, BRIT J OPHTHALMOL, V80, P40, DOI 10.1136/bjo.80.1.40; Heijl A, 1991, EXTENDED EMPIRICAL S; HOLMIN C, 1982, ACTA OPHTHALMOL, V60, P267; Katz J, 1997, OPHTHALMOLOGY, V104, P1017, DOI 10.1016/S0161-6420(97)30192-4; KRAKAU CET, 1985, ACTA OPHTHALMOL, V63, P19; Leske MC, 1999, OPHTHALMOLOGY, V106, P2144, DOI 10.1016/S0161-6420(99)90497-9; MCNAUGHT AI, 1995, GRAEF ARCH CLIN EXP, V233, P750, DOI 10.1007/BF00184085; McNaught AI, 1996, GRAEF ARCH CLIN EXP, V234, P411, DOI 10.1007/BF02539406; Medeiros FA, 2010, OPHTHALMOLOGY, V117, P2061, DOI 10.1016/j.ophtha.2010.02.015; MIKELBERG FS, 1986, AM J OPHTHALMOL, V101, P1; Musch DC, 1999, OPHTHALMOLOGY, V106, P653, DOI 10.1016/S0161-6420(99)90147-1; Nouri-Mahdavi K, 2007, ARCH OPHTHALMOL-CHIC, V125, P1176, DOI 10.1001/archopht.125.9.1176; NouriMahdavi K, 1997, OPHTHALMOLOGY, V104, P1228, DOI 10.1016/S0161-6420(97)30153-5; O'Brien C, 1992, POINT POINT LINEAR R; O'Leary N, 2012, INVEST OPHTH VIS SCI, V53, P6776, DOI 10.1167/iovs.12-10049; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao HL, 2013, INVEST OPHTH VIS SCI, V54, P307, DOI 10.1167/iovs.12-10836; Rao HL, 2011, OPHTHALMOLOGY, V118, P249, DOI 10.1016/j.ophtha.2010.05.027; Rao HL, 2012, INVEST OPHTH VIS SCI, V54, P307; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P5985, DOI 10.1167/iovs.12-10428; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P2760, DOI 10.1167/iovs.11-7976; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; SPENCELEY SE, 1994, OPHTHAL PHYSL OPT, V14, P239, DOI 10.1111/j.1475-1313.1994.tb00004.x; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; Team RDC, 2010, R LANG ENV STAT COMP; van de Wiel MA, 2009, BIOSTATISTICS, V10, P550, DOI 10.1093/biostatistics/kxp011; Viswanathan AC, 1997, BRIT J OPHTHALMOL, V81, P1037, DOI 10.1136/bjo.81.12.1037; Viswanathan AC, 2003, BRIT J OPHTHALMOL, V87, P726, DOI 10.1136/bjo.87.6.726; WILD JM, 1993, INVEST OPHTH VIS SCI, V34, P1907	43	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78630	10.1371/journal.pone.0078630	http://dx.doi.org/10.1371/journal.pone.0078630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205283	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400092
J	Romania, P; Castellano, A; Surace, C; Citti, A; De Ioris, MA; Sirleto, P; De Mariano, M; Longo, L; Boldrini, R; Angioni, A; Locatelli, F; Fruci, D				Romania, Paolo; Castellano, Aurora; Surace, Cecilia; Citti, Arianna; De Ioris, Maria Antonietta; Sirleto, Pietro; De Mariano, Marilena; Longo, Luca; Boldrini, Renata; Angioni, Adriano; Locatelli, Franco; Fruci, Doriana			High-Resolution Array CGH Profiling Identifies Na/K Transporting ATPase Interacting 2 (NKAIN2) as a Predisposing Candidate Gene in Neuroblastoma	PLOS ONE			English	Article							CELL-LINES; ACTIVATING MUTATIONS; GERMLINE MUTATIONS; PHOX2B MUTATIONS; ALK KINASE; EXPRESSION; PHENOTYPE; TUMORS; MYCN; CLASSIFICATION	Neuroblastoma (NB), the most common solid cancer in early childhood, usually occurs sporadically but also its familial occurance is known in 1-2% of NB patients. Germline mutations in the ALK and PHOX2B genes have been found in a subset of familial NBs. However, because some individuals harbouring mutations in these genes do not develop this tumor, additional genetic alterations appear to be required for NB pathogenesis. Herein, we studied an Italian family with three NB patients, two siblings and a first cousin, carrying an ALK germline-activating mutation R1192P, that was inherited from their unaffected mothers and with no mutations in the PHOX2B gene. A comparison between somatic and germline DNA copy number changes in the two affected siblings by a high resolution array-based Comparative Genomic Hybridization (CGH) analysis revealed a germline gain at NKAIN2 (Na/K transporting ATPase interacting 2) locus in one of the sibling, that was inherited from the parent who does not carry the ALK mutation. Surprisingly, NKAIN2 was expressed at high levels also in the affected sibling that lacks the genomic gain at this locus, clearly suggesting the existance of other regulatory mechanisms. High levels of NKAIN2 were detected in the MYCN-amplified NB cell lines and in the most aggressive NB lesions as well as in the peripheral blood of a large cohort of NB patients. Consistent with a role of NKAIN2 in NB development, NKAIN2 was down-regulated during all-trans retinoic acid differentiation in two NB cell lines. Taken together, these data indicate a potential role of NKAIN2 gene in NB growth and differentiation.	[Romania, Paolo; Castellano, Aurora; De Ioris, Maria Antonietta; Locatelli, Franco; Fruci, Doriana] IRCCS, Bambino Gesu Childrens Hosp, Paediat Haematol Oncol Dept, Rome, Italy; [Surace, Cecilia; Sirleto, Pietro; Angioni, Adriano] IRCCS, Bambino Gesu Childrens Hosp, Cytogenet & Mol Genet Unit, Rome, Italy; [Citti, Arianna; Boldrini, Renata] IRCCS, Bambino Gesu Childrens Hosp, Dept Pathol, Rome, Italy; [De Mariano, Marilena; Longo, Luca] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, I-16132 Genoa, Italy; [Locatelli, Franco] Univ Pavia, Dept Pediat, I-27100 Pavia, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Genoa; IRCCS AOU San Martino IST; University of Pavia	Fruci, D (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Paediat Haematol Oncol Dept, Rome, Italy.	doriana.fruci@opbg.net	angioni, adriano/G-1160-2014; sirleto, pietro/G-3902-2014; Longo, Luca/K-6156-2018; Surace, Cecilia/AAA-8657-2020; DE IORIS, MARIA ANTONIETTA/AAA-9588-2022; Romania, Paolo/K-3839-2018; Surace, Cecilia/AAA-9163-2020; castellano, aurora/AAA-6535-2020; Fruci, Doriana/AAA-8218-2019	angioni, adriano/0000-0003-0862-2456; sirleto, pietro/0000-0001-5292-3315; Longo, Luca/0000-0002-5153-4243; DE IORIS, MARIA ANTONIETTA/0000-0002-2113-4505; Romania, Paolo/0000-0001-6855-1464; Surace, Cecilia/0000-0003-2344-6948; castellano, aurora/0000-0002-2316-4927; Fruci, Doriana/0000-0003-3388-7296; Sirleto, Pietro/0000-0002-3569-4829	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy); Italian Neuroblastoma foundation; AIRC special grant "5 x 1000''; Italian Ministry of Health [GR-2010-2311890]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Italian Neuroblastoma foundation; AIRC special grant "5 x 1000''; Italian Ministry of Health(Ministry of Health, Italy)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy) to D. F., the Italian Neuroblastoma foundation to L. L., and the AIRC special grant "5 x 1000'' to F. L. L. Longo is the recipient of the pYoung Investigatorsq grant GR-2010-2311890 from the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Bocciardi R, 2005, HUM MUTAT, V26, P426, DOI 10.1002/humu.20235; Bourdeaut F, 2012, EUR J HUM GENET, V20, P291, DOI 10.1038/ejhg.2011.195; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Carr J, 2007, CANCER GENET CYTOGEN, V172, P127, DOI 10.1016/j.cancergencyto.2006.08.012; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Forloni M, 2010, CANCER RES, V70, P916, DOI 10.1158/0008-5472.CAN-09-2582; GARAVENTA A, 1993, J CLIN ONCOL, V11, P1770, DOI 10.1200/JCO.1993.11.9.1770; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gigliotti AR, 2009, EUR J CANCER, V45, P3220, DOI 10.1016/j.ejca.2009.08.020; Gorokhova S, 2007, HUM MOL GENET, V16, P2394, DOI 10.1093/hmg/ddm167; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Krona C, 2008, INT J ONCOL, V32, P575; Kryh H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matera I, 2004, J MED GENET, V41, P373, DOI 10.1136/jmg.2003.015412; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; McConville C, 2006, AM J MED GENET A, V140A, P1297, DOI 10.1002/ajmg.a.31278; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Reynolds C P, 1994, Prog Clin Biol Res, V385, P237; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Yue Y, 2006, J MED GENET, V43, P143, DOI 10.1136/jmg.2004.029660	36	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78481	10.1371/journal.pone.0078481	http://dx.doi.org/10.1371/journal.pone.0078481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205241	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400082
J	Sun, CX; Forster, C; Nakamura, F; Glogauer, M				Sun, Chunxiang; Forster, Carol; Nakamura, Fumihiko; Glogauer, Michael			Filamin-A Regulates Neutrophil Uropod Retraction through RhoA during Chemotaxis	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; CDC42 GTPASES; MICE; PHOSPHORYLATION; MYOSIN; RAC1; MALFORMATIONS; CYTOSKELETON; MACROPHAGES; ACTIVATION	Filamin-A (FLNa) has been shown to be a key cross-linker of actin filaments in the leading edge of a motile melanoma cell line, however its role in neutrophils undergoing chemotaxis is unknown. Using a murine transgenic model in which FLNa is selectively deleted in granulocytes, we report that, while neutrophils lacking FLNa show normal polarization and pseudopod extension, they exhibit obvious defects in uropod retraction. This uropod retraction defect was found to be a direct result of reduced FLNa mediated activation of the small GTPase RhoA and myosin mediated actin contraction in the FLNa null cells. This results in a neutrophil recruitment defect in FLNa null mice. The compensatory increase in FLNb levels that was observed in the FLNa null neutrophils may be sufficient to compensate for the lack of FLNa at the leading edge allowing for normal polarization, however this compensation is unable to regulate RhoA activated tail retraction at the rear of the cell.	[Sun, Chunxiang; Forster, Carol; Glogauer, Michael] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Nakamura, Fumihiko] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA	University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Glogauer, M (corresponding author), Univ Toronto, Fac Dent, Toronto, ON, Canada.	Michael.Gloaguer@utoronto.ca	Glogauer, Michael/D-2504-2011; Nakamura, Fumihiko/N-5476-2016	Glogauer, Michael/0000-0002-6248-5977; Nakamura, Fumihiko/0000-0002-6872-4246	Canadian Institute of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019429] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Canadian Institute of Health Research funded this work with an operating grant to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSTEIN RS, 1983, J CLIN INVEST, V72, P1863, DOI 10.1172/JCI111148; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Benard V, 2002, METHOD ENZYMOL, V345, P349; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fenteany G, 2004, CURR OPIN HEMATOL, V11, P15, DOI 10.1097/00062752-200401000-00004; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Hixenbaugh EA, 1997, AM J PHYSIOL-HEART C, V273, pH981, DOI 10.1152/ajpheart.1997.273.2.H981; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pestonjamasp KN, 2006, BLOOD, V108, P2814, DOI 10.1182/blood-2006-01-010363; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; WEIHING RR, 1985, CAN J BIOCHEM CELL B, V63, P397, DOI 10.1139/o85-059; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	31	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e79009	10.1371/journal.pone.0079009	http://dx.doi.org/10.1371/journal.pone.0079009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205360	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400113
J	Mesa-Pereira, B; Medina, C; Camacho, EM; Flores, A; Santero, E				Mesa-Pereira, Beatriz; Medina, Carlos; Maria Camacho, Eva; Flores, Amando; Santero, Eduardo			Novel Tools to Analyze the Function of Salmonella Effectors Show That SvpB Ectopic Expression Induces Cell Cycle Arrest in Tumor Cells	PLOS ONE			English	Article							ADP-RIBOSYLATES ACTIN; VIRULENCE PLASMID; GENE-EXPRESSION; MEDIATED APOPTOSIS; SECRETION SYSTEM; DELAYS ENTRY; SPV GENES; IN-VITRO; TYPHIMURIUM; PROTEIN	In order to further characterize its role in pathogenesis and to establish whether its overproduction can lead to eukaryotic tumor cell death, Salmonella strains able to express its virulence factor SpvB (an ADP-ribosyl transferase enzyme) in a salicylate-inducible way have been constructed and analyzed in different eukaryotic tumor cell lines. To do so, the bacterial strains bearing the expression system have been constructed in a Delta purD background, which allows control of bacterial proliferation inside the eukaryotic cell. In the absence of bacterial proliferation, salicylate-induced SpvB production resulted in activation of caspases 3 and 7 and apoptotic cell death. The results clearly indicated that controlled SpvB production leads to F-actin depolimerization and either G1/S or G2/M phase arrest in all cell lines tested, thus shedding light on the function of SpvB in Salmonella pathogenesis. In the first place, the combined control of protein production by salicylate regulated vectors and bacterial growth by adenine concentration offers the possibility to study the role of Salmonella effectors during eukaryotic cells infection. In the second place, the salicylate-controlled expression of SpvB by the bacterium provides a way to evaluate the potential of other homologous or heterologous proteins as antitumor agents, and, eventually to construct novel potential tools for cancer therapy, given that Salmonella preferentially proliferates in tumors.	[Mesa-Pereira, Beatriz; Medina, Carlos; Maria Camacho, Eva; Flores, Amando; Santero, Eduardo] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Dept Biol Mol & Ingn Bioquim,Junta Andalucia, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Flores, A (corresponding author), Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Dept Biol Mol & Ingn Bioquim,Junta Andalucia, Seville, Spain.	aflodia@upo.es	Camacho, Eva/K-9839-2014; Santero, Eduardo/K-6510-2014; Mesa, Beatriz/O-9895-2019; Flores, Amando/K-9283-2017; Medina Morillas, Carlos/L-1773-2014	Camacho, Eva/0000-0002-6465-7381; Flores, Amando/0000-0002-1887-0659; Medina Morillas, Carlos/0000-0003-0069-7330; Santero, Eduardo/0000-0002-6111-7160	Andalusian government [P07-CVI02518]	Andalusian government	This work was supported by the grant "Proyecto de Excelencia P07-CVI02518" from the Andalusian government and by a fellowship from the Andalusian government to BMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor TA, 2011, CELL MICROBIOL, V13, P1858, DOI 10.1111/j.1462-5822.2011.01701.x; Andersson M, 2003, EXP EYE RES, V76, P175, DOI 10.1016/S0014-4835(02)00283-X; Barnett SJ, 2005, J PEDIATR SURG, V40, P993, DOI 10.1016/j.jpedsurg.2005.03.015; Barth H, 1999, INFECT IMMUN, V67, P5083, DOI 10.1128/IAI.67.10.5083-5090.1999; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; Browne SH, 2002, INFECT IMMUN, V70, P7126, DOI 10.1128/IAI.70.12.7126-7135.2002; Cebolla A, 2002, APPL ENVIRON MICROB, V68, P5034, DOI 10.1128/AEM.68.10.5034-5041.2002; Cebolla A, 2001, NUCLEIC ACIDS RES, V29, P759, DOI 10.1093/nar/29.3.759; Chae HD, 2005, ONCOGENE, V24, P4813, DOI 10.1038/sj.onc.1208640; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cummings BS, 2004, J PHARMACOL EXP THER, V310, P126, DOI 10.1124/jpet.104.065862; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FIERER J, 1992, J INFECT DIS, V166, P639, DOI 10.1093/infdis/166.3.639; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; GARZON A, 1995, GENETICS, V140, P427; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; GUINEY DG, 1994, FEMS MICROBIOL LETT, V124, P1, DOI 10.1016/0378-1097(94)90324-7; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Hochmann H, 2006, BIOCHEMISTRY-US, V45, P1271, DOI 10.1021/bi051810w; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kim GY, 2011, MAR DRUGS, V9, P2176, DOI 10.3390/md9112176; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kim MO, 2008, CANCER LETT, V271, P25, DOI 10.1016/j.canlet.2008.05.034; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Lee KG, 2007, CELL CYCLE, V6, P1487; Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Libby SJ, 2000, CELL MICROBIOL, V2, P49, DOI 10.1046/j.1462-5822.2000.00030.x; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; Medina C, 2012, J BIOTECHNOL, V157, P413, DOI 10.1016/j.jbiotec.2011.11.022; Medina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023055; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Moon DO, 2008, BIOCHEM PHARMACOL, V76, P312, DOI 10.1016/j.bcp.2008.05.006; Moss DK, 2006, J CELL SCI, V119, P2362, DOI 10.1242/jcs.02959; Nemunaitis J, 2003, CANCER GENE THER, V10, P737, DOI 10.1038/sj.cgt.7700634; Aguilera MO, 2012, AUTOPHAGY, V8, P1590, DOI 10.4161/auto.21459; Paesold G, 2002, CELL MICROBIOL, V4, P771, DOI 10.1046/j.1462-5822.2002.00233.x; Pawelek JM, 1997, CANCER RES, V57, P4537; Royo JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni168; Royo JL, 2007, NAT METHODS, V4, P937, DOI 10.1038/NMETH1107; Ryan RM, 2006, BIOESSAYS, V28, P84, DOI 10.1002/bies.20336; Saltzman DA, 1996, CANCER BIOTHER RADIO, V11, P145, DOI 10.1089/cbr.1996.11.145; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Senatus PB, 2006, MOL CANCER THER, V5, P20, DOI 10.1158/1535-7163.MCT-05-0181; SENDEROWICZ AMJ, 1995, J NATL CANCER I, V87, P46, DOI 10.1093/jnci/87.1.46; Srivastava P, 2012, CARCINOGENESIS, V33, P2199, DOI 10.1093/carcin/bgs269; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tezcan-Merdol D, 2005, INT J MED MICROBIOL, V295, P201, DOI 10.1016/j.ijmm.2005.04.008; Tezcan-Merdol D, 2001, MOL MICROBIOL, V39, P606, DOI 10.1046/j.1365-2958.2001.02258.x; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Udagawa T, 2000, J PHARMACOL EXP THER, V294, P421; Valle E, 2005, INFECT IMMUN, V73, P2835, DOI 10.1128/IAI.73.5.2835-2840.2005; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716	63	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78458	10.1371/journal.pone.0078458	http://dx.doi.org/10.1371/journal.pone.0078458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205236	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600102
J	Zhao, HS; Chen, DL; Peng, ZH; Wang, LL; Gao, ZM				Zhao, Hansheng; Chen, Dongliang; Peng, Zhenhua; Wang, Lili; Gao, Zhimin			Identification and Characterization of MicroRNAs in the Leaf of Ma Bamboo (Dendrocalamus latiflorus) by Deep Sequencing	PLOS ONE			English	Article							SMALL RNAS; TRANSCRIPTION FACTOR; TARGET GENES; CONSERVED MICRORNAS; REGULATED MICRORNAS; EXPRESSION ANALYSIS; RT-PCR; ARABIDOPSIS; CLONING; STRESS	MicroRNAs (miRNAs), a class of non-coding small endogenous RNAs of approximately 22 nucleotides, regulate gene expression at the post-transcriptional levels by targeting mRNAs for degradation or by inhibiting protein translation. Thousands of miRNAs have been identified in many species. However, there is no information available concerning miRNAs in ma bamboo (Dendrocalamus latiflorus), one of the most important non-timber forest products, which has essential ecological roles in forests. To identify miRNAs in D. latiflorus, a small RNA library was constructed from leaf tissues. Using next generation high-throughput sequencing technology and bioinformatics analysis, we obtained 11,513,607 raw sequence reads and identified 84 conserved miRNAs (54 mature miRNAs and 30 star miRNAs) belonging to 17 families, and 81 novel miRNAs (76 mature miRNAs and five star miRNAs) in D. latiflorus. One hundred and sixty-two potential targets were identified for the 81 novel bamboo miRNAs. Several targets for the novel miRNAs are transcription factors that play important roles in plant development. Among the novel miRNAs, 30 were selected and their expression profiles in response to different light conditions were validated by qRT-PCR. This study provides the first large-scale cloning and characterization of miRNAs in D. latiflorus. Eighty-four conserved and 81 novel miRNAs were identified in D. latiflorus. Our results present a broad survey of bamboo miRNAs based on experimental and bioinformatics analysis. Although it will be necessary to validate the functions of miRNAs by further experimental research, these results represent a starting point for future research on D. latiflorus and related species.	[Zhao, Hansheng; Chen, Dongliang; Peng, Zhenhua; Wang, Lili; Gao, Zhimin] Int Ctr Bamboo, Key Open Lab Sci & Technol Bamboo & Rattan, State Forestry Adm, Beijing, Peoples R China; [Peng, Zhenhua] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	International Centre for Bamboo & Rattan; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Peng, ZH (corresponding author), Int Ctr Bamboo, Key Open Lab Sci & Technol Bamboo & Rattan, State Forestry Adm, Beijing, Peoples R China.	pengzh@icbr.ac.cn; gaozhimin@icbr.ac.cn	wang, lili/HDL-7210-2022; zhao, hansheng/GRS-2764-2022		State Forestry Administration of China [2011-4-55]; special funds for scientific research on forestry public causes [200704001]; Fundamental Research Funds for ICBR [1632013009]	State Forestry Administration of China; special funds for scientific research on forestry public causes; Fundamental Research Funds for ICBR	This work was financially supported under the introduction project of "948" by the State Forestry Administration of China (No. 2011-4-55), the special funds for scientific research on forestry public causes (No. 200704001) and Fundamental Research Funds for ICBR (No. 1632013009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Backman TWH, 2008, NUCLEIC ACIDS RES, V36, pD982, DOI 10.1093/nar/gkm997; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carra A, 2009, PLANT J, V59, P750, DOI 10.1111/j.1365-313X.2009.03906.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Dhondt S, 2010, PLANT PHYSIOL, V154, P1183, DOI 10.1104/pp.110.158857; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Fu XY, 2007, BIOTECHNOL LETT, V29, P1293, DOI 10.1007/s10529-007-9370-1; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046443; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lertpanyasampatha M, 2012, PLANTA, V236, P437, DOI 10.1007/s00425-012-1622-1; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; LIN CS, 2007, NEW FORESTS, V9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; Mica E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-109; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Singh SR, 2013, PHYSIOL MOL BIOL PLA, V19, P21, DOI 10.1007/s12298-012-0147-1; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Thomas MF, 2010, METHODS MOL BIOL, V667, P93, DOI 10.1007/978-1-60761-811-9_7; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wollmann H, 2010, EUR J CELL BIOL, V89, P250, DOI 10.1016/j.ejcb.2009.11.004; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057863; Yin ZJ, 2010, GENET MOL RES, V9, P1186, DOI 10.4238/vol9-2gmr805; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064642; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083	84	19	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78755	10.1371/journal.pone.0078755	http://dx.doi.org/10.1371/journal.pone.0078755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205306	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600109
J	Wang, FM; Xu, X; Zou, B; Guo, ZH; Li, ZA; Zhu, WX				Wang, Faming; Xu, Xin; Zou, Bi; Guo, Zhihua; Li, Zhian; Zhu, Weixing			Biomass Accumulation and Carbon Sequestration in Four Different Aged Casuarina equisetifolia Coastal Shelterbelt Plantations in South China	PLOS ONE			English	Article							FINE-ROOT BIOMASS; SOIL CARBON; SECONDARY FORESTS; STAND DEVELOPMENT; DRY TROPICS; NITROGEN; DYNAMICS; CHRONOSEQUENCE; EUCALYPTUS; FIXATION	Thousands of kilometers of shelterbelt plantations of Casuarina equisetifolia have been planted to protect the southeast coastline of China. These plantations also play an important role in the regional carbon (C) cycling. In this study, we examined plant biomass increment and C accumulation in four different aged C. equisetifolia plantations in sandy beaches in South China. The C accumulated in the C. equisetifolia plant biomass increased markedly with stand age. The annual rate of C accumulation in the C. equisetifolia plant biomass during 0-3, 3-6, 6-13 and 13-18 years stage was 2.9, 8.2, 4.2 and 1.0 Mg C ha(-1) yr(-1), respectively. Soil organic C (SOC) at the top 1 m soil layer in these plantations was 17.74, 5.14, 6.93, and 11.87 Mg C ha(-1), respectively, with SOC density decreasing with increasing soil depth. Total C storage in the plantation ecosystem averaged 26.57, 38.50, 69.78, and 79.79 Mg C ha(-1) in the 3, 6, 13 and 18-yrs plantation, with most of the C accumulated in the aboveground biomass rather than in the belowground root biomass and soil organic C. Though our results suggest that C. equisetifolia plantations have the characteristics of fast growth, high biomass accumulation, and the potential of high C sequestration despite planting in poor soil conditions, the interactive effects of soil condition, natural disturbance, and human policies on the ecosystem health of the plantation need to be further studied to fully realize the ecological and social benefits of the C equisetifolia shelterbelt forests in South China.	[Wang, Faming; Xu, Xin; Zou, Bi; Li, Zhian; Zhu, Weixing] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Guo, Zhihua] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Zhu, Weixing] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Forestry; Institute of Wetland Research, CAF; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Li, ZA (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	lizan@scbg.ac.cn; wxzhu@binghamton.edu	Wang, Faming/J-9342-2014	Wang, Faming/0000-0002-7543-6779; Zhu, Weixing/0000-0002-4274-6973	National Basic Research Program of China [2011CB403200]; NSFC [U1131001]; Natural Science Foundation of China [31300419]; Chinese Academy of Sciences [KSCX2-EW-J-28, XDA05070307]; National Science and Technology Pillar program [2009BAD2B0604]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Pillar program	This work was funded by National Basic Research Program of China (2011CB403200), NSFC-Guangdong Joint Project (U1131001), Natural Science Foundation of China (31300419), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-28), the "Strategic Priority Research Program - Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (XDA05070307) and the key projects in the National Science and Technology Pillar program (2009BAD2B0604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Borja I, 2008, TREE PHYSIOL, V28, P773, DOI 10.1093/treephys/28.5.773; Campo J, 2001, BIOGEOCHEMISTRY, V53, P161, DOI 10.1023/A:1010663516029; Chen DM, 2011, AGR FOREST METEOROL, V151, P1214, DOI 10.1016/j.agrformet.2011.04.011; Clements F.E., 1916, PLANT SUCCESSION ANA; Davis MR, 2003, FOREST ECOL MANAG, V177, P313, DOI 10.1016/S0378-1127(02)00333-X; El-Lankany M, 1990, ADV CASUARINA RES UT; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fonseca W, 2011, FOREST ECOL MANAG, V262, P1400, DOI 10.1016/j.foreco.2011.06.036; GAUTHIER D, 1985, SOIL BIOL BIOCHEM, V17, P375, DOI 10.1016/0038-0717(85)90076-8; Goulden ML, 2011, GLOBAL CHANGE BIOL, V17, P855, DOI 10.1111/j.1365-2486.2010.02274.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hardman CJ, 2012, ORYX, V46, P204, DOI 10.1017/S0030605311000251; Harmand JM, 2004, FOREST ECOL MANAG, V188, P249, DOI 10.1016/j.foreco.2003.07.026; HARRISON AF, 1995, FORESTRY, V68, P335, DOI 10.1093/forestry/68.4.335; Hong YuanCheng, 2010, Journal of Zhejiang Forestry Science and Technology, V30, P66; Hughes RF, 1999, ECOLOGY, V80, P1892; Johnston MH, 1996, FOREST ECOL MANAG, V83, P17, DOI 10.1016/0378-1127(96)03704-8; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Usuga JCL, 2010, FOREST ECOL MANAG, V260, P1906, DOI 10.1016/j.foreco.2010.08.040; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; Mascarenhas A, 2008, J ENVIRON MANAGE, V89, P24, DOI 10.1016/j.jenvman.2007.01.053; Mather A, 2003, LAND USE POLICY, V20, P195, DOI 10.1016/S0264-8377(03)00003-6; Miao S.Y., 1998, GUIHAIA, V18, P16; Mo HM, 2003, FOREST ECOL MANAG, V175, P573; Muthukumar T, 2010, NEW FOREST, V40, P101, DOI 10.1007/s11056-009-9186-z; Parrotta JA, 1996, CAN J FOREST RES, V26, P1684, DOI 10.1139/x26-190; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Rokityanskiy D, 2007, TECHNOL FORECAST SOC, V74, P1057, DOI 10.1016/j.techfore.2006.05.022; Sartori F, 2007, AGR ECOSYST ENVIRON, V122, P325, DOI 10.1016/j.agee.2007.01.026; Schedlbauer JL, 2008, FOREST ECOL MANAG, V255, P1326, DOI 10.1016/j.foreco.2007.10.039; Schlamadinger B, 1996, BIOMASS BIOENERG, V10, P275, DOI 10.1016/0961-9534(95)00113-1; Srivastava AK, 1995, BIOMASS BIOENERG, V9, P465, DOI 10.1016/0961-9534(95)00048-8; State Forestry Administration (SFA), 2009, CHIN FOR STAT YB 200; TROUVE C, 1994, SOIL BIOL BIOCHEM, V26, P287, DOI 10.1016/0038-0717(94)90169-4; WILDE SERGIUS A., 1964, SOIL SCI, V97, P276, DOI 10.1097/00010694-196404000-00009; WILLIAMSLINERA G, 1983, BIOTROPICA, V15, P275, DOI 10.2307/2387652; [杨昆 YANG Kun], 2006, [生态环境, Ecology and Environment], V15, P84; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; Zhang H.L., 1996, CHINESE ECOSYSTEM RE, P1; Zhong C., 2003, CHINA FOREST SCI TEC, V17, P3, DOI DOI 10.3969/J.ISSN.1000-8101.2003.02.001; Zhong CL, 2010, SYMBIOSIS, V50, P107, DOI 10.1007/s13199-009-0039-5; Zoysa M. de, 2008, Small-scale Forestry, V7, P17, DOI 10.1007/s11842-008-9038-2	46	18	20	8	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77449	10.1371/journal.pone.0077449	http://dx.doi.org/10.1371/journal.pone.0077449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143236	Green Published, Green Submitted, gold			2022-12-27	WOS:000325894100073
J	Abada, YSK; Nguyen, HP; Schreiber, R; Ellenbroek, B				Abada, Yah-se K.; Nguyen, Huu Phuc; Schreiber, Rudy; Ellenbroek, Bart			Assessment of Motor Function, Sensory Motor Gating and Recognition Memory in a Novel BACHD Transgenic Rat Model for Huntington Disease	PLOS ONE			English	Article							YAC128 MOUSE MODEL; COGNITIVE DEFICITS; NEUROPATHOLOGICAL FEATURES; PREPULSE INHIBITION; MUTANT HUNTINGTIN; GENE; SYMPTOMS; MICE; HD; ABNORMALITIES	Rationale: Huntington disease (HD) is frequently first diagnosed by the appearance of motor symptoms; the diagnosis is subsequently confirmed by the presence of expanded CAG repeats (> 35) in the HUNTINGTIN (HTT) gene. A BACHD rat model for HD carrying the human full length mutated HTT with 97 CAG-CAA repeats has been established recently. Behavioral phenotyping of BACHD rats will help to determine the validity of this model and its potential use in preclinical drug discovery studies. Objectives: The present study seeks to characterize the progressive emergence of motor, sensorimotor and cognitive deficits in BACHD rats. Materials and Methods: Wild type and transgenic rats were tested from 1 till 12 months of age. Motor tests were selected to measure spontaneous locomotor activity (open field) and gait coordination. Sensorimotor gating was assessed in acoustic startle response paradigms and recognition memory was evaluated in an object recognition test. Results: Transgenic rats showed hyperactivity at 1 month and hypoactivity starting at 4 months of age. Motor coordination imbalance in a Rotarod test was present at 2 months and gait abnormalities were seen in a Catwalk test at 12 months. Subtle sensorimotor changes were observed, whereas object recognition was unimpaired in BACHD rats up to 12 months of age. Conclusion: The current BACHD rat model recapitulates certain symptoms from HD patients, especially the marked motor deficits. A subtle neuropsychological phenotype was found and further studies are needed to fully address the sensorimotor phenotype and the potential use of BACHD rats for drug discovery purposes.	[Abada, Yah-se K.] EVOTEC AG, Neuropharmacol, Hamburg, Germany; [Abada, Yah-se K.] Univ Bremen, Brain Res Inst, Dept Neuropharmacol, D-28359 Bremen, Germany; [Nguyen, Huu Phuc] Univ Tubingen, Inst Med Genet & Appl Gen, Tubingen, Germany; [Schreiber, Rudy] Univ Groningen, Groningen, Netherlands; [Ellenbroek, Bart] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand	Evotec; University of Bremen; Eberhard Karls University of Tubingen; University of Groningen; Victoria University Wellington	Abada, YSK (corresponding author), EVOTEC AG, Neuropharmacol, Hamburg, Germany.	yah-se.abada@evotec.com	Nguyen, Huu Phuc/F-5390-2015; Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Nguyen, Huu Phuc/0000-0001-6139-788X; Ellenbroek, Bart/0000-0003-1996-4873; abada, komla yah-se/0000-0003-0085-8747	Neuromodel, an Initial Training Network through the people programme FP7 of the European Union [215618-2]	Neuromodel, an Initial Training Network through the people programme FP7 of the European Union	This work was supported by grant no. 215618-2 from Neuromodel, an Initial Training Network funded through the people programme FP7 of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, BEHAV BRAIN RES, V238, P243, DOI 10.1016/j.bbr.2012.10.039; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bowles KR, 2012, BRAIN RES BULL, V88, P276, DOI 10.1016/j.brainresbull.2011.07.021; Brooks S, 2009, BRAIN RES BULL, V79, P310, DOI 10.1016/j.brainresbull.2009.03.003; Carter RJ, 1999, J NEUROSCI, V19, P3248; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; CHABOT CC, 1992, BEHAV NEUROSCI, V106, P846, DOI 10.1037/0735-7044.106.5.846; Cisbani G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.121; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; DIMAIO L, 1993, J MED GENET, V30, P289, DOI 10.1136/jmg.30.4.289; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Ellenbroek BA, 2004, BIOL PSYCHIAT, V55, P701, DOI 10.1016/j.biopsych.2003.10.024; ESTEBAN A, 1981, J NEUROL NEUROSUR PS, V44, P43, DOI 10.1136/jnnp.44.1.43; Fink KD, 2012, BEHAV NEUROSCI, V126, P479, DOI 10.1037/a0028028; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Hahn-Barma V, 1998, J NEUROL NEUROSUR PS, V64, P172, DOI 10.1136/jnnp.64.2.172; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Huntington G., 1872, MED SURG REP, V26, P320; Jones L, 2011, INT REV NEUROBIOL, V98, P373, DOI 10.1016/B978-0-12-381328-2.00015-8; Kirch RD, 2013, BEHAV BRAIN RES, V239, P15, DOI 10.1016/j.bbr.2012.10.048; Kodsi MH, 1997, BRAIN RES, V773, P45, DOI 10.1016/S0006-8993(97)00869-X; KOLLER WC, 1985, NEUROLOGY, V35, P1450, DOI 10.1212/WNL.35.10.1450; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lawrence AD, 2000, BRAIN, V123, P1349, DOI 10.1093/brain/123.7.1349; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Montoya A, 2006, NEUROPSYCHOLOGIA, V44, P1984, DOI 10.1016/j.neuropsychologia.2006.01.015; MYERS RH, 1985, J NEUROL NEUROSUR PS, V48, P530, DOI 10.1136/jnnp.48.6.530; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; ROSENBERG NK, 1995, J MED GENET, V32, P600, DOI 10.1136/jmg.32.8.600; Seaman RL, 2000, NEUROSCI LETT, V280, P183, DOI 10.1016/S0304-3940(00)00790-4; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; SWERDLOW NR, 1992, PSYCHOPHARMACOLOGY, V108, P189, DOI 10.1007/BF02245306; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zeef DH, 2012, BEHAV BRAIN RES, V227, P194, DOI 10.1016/j.bbr.2011.11.009; Zeef DH, 2012, BEHAV BRAIN RES, V226, P435, DOI 10.1016/j.bbr.2011.09.041; Zheng ZQ, 2012, PROG MOL BIOL TRANSL, V107, P189, DOI 10.1016/B978-0-12-385883-2.00010-2	58	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68584	10.1371/journal.pone.0068584	http://dx.doi.org/10.1371/journal.pone.0068584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874679	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800037
J	Shi, ZJ; Cao, Z; Qin, D; Zhu, WT; Wang, Q; Li, MS; Wang, GJ				Shi, Zunji; Cao, Zhan; Qin, Dong; Zhu, Wentao; Wang, Qian; Li, Mingshun; Wang, Gejiao			Correlation Models between Environmental Factors and Bacterial Resistance to Antimony and Copper	PLOS ONE			English	Article							ARSENATE-REDUCING BACTERIA; SOIL; DIVERSITY; ARSENITE; GENES; CONTAMINATION; OXIDATION; SEQUENCE	Antimony (Sb) and copper (Cu) are toxic heavy metals that are associated with a wide variety of minerals. Sb(III)-oxidizing bacteria that convert the toxic Sb(III) to the less toxic Sb(V) are potentially useful for environmental Sb bioremediation. A total of 125 culturable Sb(III)/Cu(II)-resistant bacteria from 11 different types of mining soils were isolated. Four strains identified as Arthrobacter, Acinetobacter and Janibacter exhibited notably high minimum inhibitory concentrations (MICs) for Sb(III) (>10 mM), making them the most highly Sb(III)-resistant bacteria to date. Thirty-six strains were able to oxidize Sb(III), including Pseudomonas-, Comamonas-, Acinetobacter-, Sphingopyxis-, Paracoccus-Aminobacter-, Arthrobacter-, Bacillus-, Janibacter-and Variovorax-like isolates. Canonical correspondence analysis (CCA) revealed that the soil concentrations of Sb and Cu were the most obvious environmental factors affecting the culturable bacterial population structures. Stepwise linear regression was used to create two predictive models for the correlation between soil characteristics and the bacterial Sb(III) or Cu(II) resistance. The concentrations of Sb and Cu in the soil was the significant factors affecting the bacterial Sb(III) resistance, whereas the concentrations of S and P in the soil greatly affected the bacterial Cu(II) resistance. The two stepwise linear regression models that we derived are as follows. MICSb(III) = 606.605+0.14533 x C-Sb +0.24128 x C-Cu and MICCu(II) = 58. 3844+0.02119 x C-S + 0.00199 + C-P [where the MICSb(III) and MICCu(II) represent the average bacterial MIC for the metal of each soil (mu M), and the C-Sb, C-Cu, C-S and C-P represent concentrations for Sb, Cu, S and P (mg/kg) in soil, respectively, p<0.01]. The stepwise linear regression models we developed suggest that metals as well as other soil physicochemical parameters can contribute to bacterial resistance to metals.	[Shi, Zunji; Cao, Zhan; Qin, Dong; Zhu, Wentao; Wang, Qian; Li, Mingshun; Wang, Gejiao] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Wang, GJ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	gejiao@mail.hzau.edu.cn	Wang, Qian/AAC-9717-2021	Wang, Qian/0000-0003-4507-0523; Shi, Zunji/0000-0002-1276-6762	Major International Joint Research Project, National Natural Science Foundation of China [31010103903]; Chinese 863 project [2012AA101402-3]	Major International Joint Research Project, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 project(National High Technology Research and Development Program of China)	This work was supported by a Major International Joint Research Project, National Natural Science Foundation of China (31010103903) and by the Chinese 863 project (2012AA101402-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Anderson CR, 2004, CURR MICROBIOL, V48, P341, DOI 10.1007/s00284-003-4205-3; Angers B, 1999, MOL ECOL, V8, P1043, DOI 10.1046/j.1365-294x.1999.00669.x; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Brochu C, 2003, ANTIMICROB AGENTS CH, V47, P3073, DOI 10.1128/AAC.47.10.3073-3079.2003; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Fan H, 2008, J APPL MICROBIOL, V105, P529, DOI 10.1111/j.1365-2672.2008.03790.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Filella M, 2007, EARTH-SCI REV, V80, P195, DOI 10.1016/j.earscirev.2006.09.003; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Green H. H., 1918, S AFR J SCI, V14, P465; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamamura N, 2013, MICROBES ENVIRON, V28, P257, DOI 10.1264/jsme2.ME12217; Hao XL, 2012, J BACTERIOL, V194, P903, DOI 10.1128/JB.06585-11; [何孟常 He Mengchang], 2002, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University], V38, P417; Hong YG, 2009, INT BIODETER BIODEGR, V63, P973, DOI 10.1016/j.ibiod.2009.08.001; Jackson CR, 2005, SOIL BIOL BIOCHEM, V37, P2319, DOI 10.1016/j.soilbio.2005.04.010; Jenkins RO, 2002, TRENDS ORGANOMET CHE, V4, P109; JOHNSTON SE, 1979, SOIL SCI SOC AM J, V43, P304, DOI 10.2136/sssaj1979.03615995004300020013x; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lehr CR, 2007, APPL ENVIRON MICROB, V73, P2386, DOI 10.1128/AEM.02789-06; Li J, 2013, INT BIODETER BIODEGR, V76, P76, DOI 10.1016/j.ibiod.2012.06.009; Lialikova N N, 1974, Mikrobiologiia, V43, P941; Liao SJ, 2013, GEOMICROBIOL J, V30, P150, DOI 10.1080/01490451.2011.654379; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liu FY, 2010, ENVIRON GEOCHEM HLTH, V32, P401, DOI 10.1007/s10653-010-9284-z; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Montgomery D.C., 2012, INTRO LINEAR REGRESS; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Okkenhaug G, 2011, ENVIRON POLLUT, V159, P2427, DOI 10.1016/j.envpol.2011.06.028; Palacios C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003853; Pepi M, 2007, J APPL MICROBIOL, V103, P2299, DOI 10.1111/j.1365-2672.2007.03471.x; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; Quemeneur M, 2008, APPL ENVIRON MICROB, V74, P4567, DOI 10.1128/AEM.02851-07; Rensing C, 2013, METAL IONS LIFE SCI, V12, P417, DOI 10.1007/978-94-007-5561-1_12; Smichowski P, 2008, TALANTA, V75, P2, DOI 10.1016/j.talanta.2007.11.005; Statistix, 2003, STAT 8 0 US MAN; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang QY, 2007, FIELD CROP RES, V102, P219, DOI 10.1016/j.fcr.2007.04.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turpeinen R, 2004, FEMS MICROBIOL ECOL, V47, P39, DOI 10.1016/S0168-6496(03)00232-0; Valverde A, 2011, CHEMOSPHERE, V85, P129, DOI 10.1016/j.chemosphere.2011.06.025; Wang Q, 2011, J APPL MICROBIOL, V111, P1065, DOI 10.1111/j.1365-2672.2011.05142.x; Weeger W, 1999, BIOMETALS, V12, P141, DOI 10.1023/A:1009255012328; WHITE C, 1995, INT BIODETER BIODEGR, V35, P17, DOI 10.1016/0964-8305(95)00036-5; WHITESIDE LS, 1986, CAN MINERAL, V24, P247; Xiong J, 2012, PLOS ONE; Xiong JB, 2010, APPL ENVIRON MICROB, V76, P7277, DOI 10.1128/AEM.00500-10; Zao LH, 2001, APPL ENVIRON MICROB, V67, P2129, DOI 10.1128/AEM.67.5.2129-2135.2001; Zhang DY, 2010, J APPL PHYCOL, V22, P479, DOI 10.1007/s10811-009-9482-1; [张晓军 Zhang Xiaojun], 2005, [环境科学与技术, Enuivonmental science and technology], V28, P40	54	122	127	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78533	10.1371/journal.pone.0078533	http://dx.doi.org/10.1371/journal.pone.0078533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	23671712	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700092
J	Zhang, XY; Nie, ZH; Wang, WJ; Leung, DWM; Xu, DG; Chen, BL; Chen, Z; Zeng, LX; Liu, EE				Zhang, Xian Yong; Nie, Zhuan Hua; Wang, Wen Juan; Leung, David W. M.; Xu, Da Gao; Chen, Bai Ling; Chen, Zhe; Zeng, Lie Xian; Liu, E. E.			Relationship between Disease Resistance and Rice Oxalate Oxidases in Transgenic Rice	PLOS ONE			English	Article							GERMIN-LIKE PROTEINS; SCLEROTINIA-SCLEROTIORUM; BRASSICA-NAPUS; GENE; WHEAT; ASSOCIATION; DEFENSE; BARLEY; FAMILY; SENSITIVITY	Differential expression of rice oxalate oxidase genes (OsOxO1-4) in rice leaves (Oryza sativa L.) in response to biotic stress was assayed using RT-PCR. OsOxO4 was induced transiently at 12 h in plants inoculated with the pathogens of bacterial blight and that of the wounding control. Inoculation with the rice blast pathogen induced OsOxO2 expression compared to the mock spray control. Overexpressing OsOxO1 or OsOxO4 in rice resulted in elevated transcript levels of the respective transgene as well as OsOxO3 in leaves compared to that in untransformed wild type (WT). In a line of RNA-i transgenic rice plants (i-12), expression of all four OsOxO genes except that of OsOxO2 was severely inhibited. Oxalate oxidase (OxO, EC 1.2.3.4) activity in plants overexpressing OsOxO1 or OsOxO4 was substantially higher than that in WT and the RNA-i lines. It was found that transgenic rice plants with substantially higher OxO activity were not more resistant to rice blast and bacterial blight than WT. In contrast, some RNA-i lines with less OxO activity seemed to be more resistant to rice blast while some overexpressing lines were more susceptible to rice blast than WT. Therefore, OxO might not be a disease resistance factor in rice.	[Zhang, Xian Yong; Nie, Zhuan Hua; Chen, Bai Ling; Chen, Zhe; Liu, E. E.] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Wen Juan; Zeng, Lie Xian] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China; [Leung, David W. M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Xu, Da Gao] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences; University of Canterbury; South China Agricultural University	Liu, EE (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	eeliu70@163.com			National Natural Science Foundation of China [31071345]; Guangdong Province Science and technology plan project [2010B020301007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and technology plan project	This work was supported by the National Natural Science Foundation of China (31071345) and Guangdong Province Science and technology plan project (2010B020301007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee J, 2010, BIOCHEM BIOPH RES CO, V402, P637, DOI 10.1016/j.bbrc.2010.10.073; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Carrillo MGC, 2009, RICE, V2, P67, DOI 10.1007/s12284-009-9024-0; Chipps TJ, 2005, PHYTOPATHOLOGY, V95, P292, DOI 10.1094/PHYTO-95-0292; Davidson RM, 2010, RICE, V3, P43, DOI 10.1007/s12284-010-9038-7; Donaldson PA, 2001, PHYSIOL MOL PLANT P, V59, P297, DOI 10.1006/pmpp.2001.0369; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Feng Jie, 2004, Journal of Agricultural Biotechnology, V12, P312; Godfrey D, 2007, MOL PLANT MICROBE IN, V20, P1112, DOI 10.1094/MPMI-20-9-1112; GRZELCZAK ZF, 1984, CAN J BIOCHEM CELL B, V62, P1351, DOI 10.1139/o84-172; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Hurkman WJ, 1996, PLANT PHYSIOL, V111, P735, DOI 10.1104/pp.111.3.735; Kim ST, 2009, PROTEOMICS, V9, P1302, DOI 10.1002/pmic.200800589; LANE BG, 1993, J BIOL CHEM, V268, P12239; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; Liang HY, 2001, PLANT MOL BIOL, V45, P619, DOI 10.1023/A:1010631318831; Lou YG, 2006, PLANT PHYSIOL, V140, P1126, DOI 10.1104/PP.105.073700; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Rietz S, 2012, J EXP BOT, V63, P5507, DOI 10.1093/jxb/ers203; THOMPSON EW, 1980, J BIOL CHEM, V255, P5965; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Wu JL, 2004, THEOR APPL GENET, V108, P1024, DOI 10.1007/s00122-003-1528-1; Xin GL, 1987, CHINESE J RICE SCI, V1, P118; Yadav S, 2012, WORLD J MICROB BIOT, V28, P3197, DOI 10.1007/s11274-012-1130-2; Yang JY, 2008, RICE SCI, V15, P311, DOI 10.1016/S1672-6308(09)60009-3; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang ZG, 1996, PLANT MOL BIOL REP, V14, P266, DOI 10.1007/BF02671662; Zhou FS, 1998, PLANT PHYSIOL, V117, P33, DOI 10.1104/pp.117.1.33; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	33	53	54	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78348	10.1371/journal.pone.0078348	http://dx.doi.org/10.1371/journal.pone.0078348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205207	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300052
J	Krementsov, DN; Wall, EH; Martin, RA; Subramanian, M; Noubade, R; Del Rio, R; Mawe, GM; Bond, JP; Poynter, ME; Blankenhorn, EP; Teuscher, C				Krementsov, Dimitry N.; Wall, Emma H.; Martin, Rebecca A.; Subramanian, Meenakumari; Noubade, Rajkumar; Del Rio, Roxana; Mawe, Gary M.; Bond, Jeffrey P.; Poynter, Matthew E.; Blankenhorn, Elizabeth P.; Teuscher, Cory			Histamine H-3 Receptor Integrates Peripheral Inflammatory Signals in the Neurogenic Control of Immune Responses and Autoimmune Disease Susceptibility	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SUBCAPSULAR SINUS MACROPHAGES; REGULATE ACTH RELEASE; DRAINING LYMPH-NODES; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; B-CELLS; T-CELL; ANTAGONISTS/INVERSE AGONISTS; NEURAL REFLEXES	Histamine H-3 receptor (Hrh3/H3R) is primarily expressed by neurons in the central nervous system (CNS) where it functions as a presynaptic inhibitory autoreceptor and heteroreceptor. Previously, we identified an H3R-mediated central component in susceptibility to experimental allergic encephalomyelitis (EAE), the principal autoimmune model of multiple sclerosis (MS), related to neurogenic control of blood brain barrier permeability and peripheral T cell effector responses. Furthermore, we identified Hrh3 as a positional candidate for the EAE susceptibility locus Eae8. Here, we characterize Hrh3 polymorphisms between EAE-susceptible and resistant SJL and B10.S mice, respectively, and show that Hrh3 isoform expression in the CNS is differentially regulated by acute peripheral inflammatory stimuli in an allele-specific fashion. Next, we show that Hrh3 is not expressed in any subpopulations of the immune compartment, and that secondary lymphoid tissue is anatomically poised to be regulated by central H3R signaling. Accordingly, using transcriptome analysis, we show that, inflammatory stimuli elicit unique transcriptional profiles in the lymph nodes of H3RKO mice compared to WT mice, which is indicative of negative regulation of peripheral immune responses by central H3R signaling. These results further support a functional link between the neurogenic control of T cell responses and susceptibility to CNS autoimmune disease coincident with acute and/or chronic peripheral inflammation. Pharmacological targeting of H3R may therefore be useful in preventing the development and formation of new lesions in MS, thereby limiting disease progression.	[Krementsov, Dimitry N.; Wall, Emma H.; Martin, Rebecca A.; Subramanian, Meenakumari; Noubade, Rajkumar; Del Rio, Roxana; Mawe, Gary M.; Bond, Jeffrey P.; Poynter, Matthew E.; Teuscher, Cory] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Blankenhorn, Elizabeth P.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Teuscher, Cory] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	University of Vermont; Drexel University; University of Vermont	Teuscher, C (corresponding author), Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA.	C.Teuscher@uvm.edu	Krementsov, Dimitry/Y-8288-2019; Gonzalez, Victor M/F-7396-2010	Krementsov, Dimitry/0000-0003-2709-7466; Poynter, Matthew/0000-0002-7578-4570; Gonzalez, Victor M/0000-0001-7538-0552; del Rio-Guerra, Roxana/0000-0001-6871-3259	National Institute of Health [AI041747, NS036526, NS060901]; National Multiple Sclerosis Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036526, R01NS060901] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants AI041747, NS036526, and NS060901 to CT. This work was also supported in part by a postdoctoral fellowship from the National Multiple Sclerosis Society to DNK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Affymetrix, 2005, GENECHIP EXPR AN TEC; Aicher SA, 2004, PAIN, V110, P560, DOI 10.1016/j.pain.2004.03.025; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Antel J, 2012, ACTA NEUROPATHOL, V123, P627, DOI 10.1007/s00401-012-0953-0; Bakker RA, 2006, MOL PHARMACOL, V69, P1194, DOI 10.1124/mol.105.019299; Bakker RA, 2004, INFLAMM RES, V53, P509, DOI 10.1007/s00011-004-1286-9; Bannerman DD, 1999, LAB INVEST, V79, P1181; Beghdadi W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006004; Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI 10.2307/2346101; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bongers G, 2007, J PHARMACOL EXP THER, V323, P888, DOI 10.1124/jpet.107.127639; Brooks TA, 2006, BRAIN RES, V1120, P172, DOI 10.1016/j.brainres.2006.08.085; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen JC, 2003, EUR J PHARMACOL, V467, P57, DOI 10.1016/S0014-2999(03)01635-2; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; CLARK MA, 1992, EUR J PHARMACOL, V210, P31, DOI 10.1016/0014-2999(92)90648-N; Coge F, 2001, BIOCHEM J, V355, P279, DOI 10.1042/0264-6021:3550279; Courtney AM, 2009, MED CLIN N AM, V93, P451, DOI 10.1016/j.mcna.2008.09.014; DeLuca J, 2011, NEUROREHABILITATION, V29, P197, DOI 10.3233/NRE-2011-0695; Drutel G, 2001, MOL PHARMACOL, V59, P1; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Encinas JA, 2001, INT IMMUNOL, V13, P257, DOI 10.1093/intimm/13.3.257; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; FELTEN DL, 1985, J IMMUNOL, V135, pS755; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Hancock AA, 2005, EXPERT OPIN INV DRUG, V14, P223, DOI 10.1517/13543784.14.3.223; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Lassmann H, 2011, NEUROPATH APPL NEURO, V37, P698, DOI 10.1111/j.1365-2990.2011.01189.x; Lebois EP, 2011, CURR TOP MED CHEM, V11, P648; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Lu CM, 2008, J NEUROSCI RES, V86, P2624, DOI 10.1002/jnr.21716; Lynch JL, 2008, PAIN, V136, P293, DOI 10.1016/j.pain.2007.07.007; Ma RLZ, 2002, SCIENCE, V297, P620, DOI 10.1126/science.1072810; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Matarese G, 2010, NAT REV NEUROL, V6, P455, DOI 10.1038/nrneurol.2010.89; Matthews PM, 2001, CURR OPIN NEUROL, V14, P279, DOI 10.1097/00019052-200106000-00004; Meng J, 2008, EUR J PHARMACOL, V587, P336, DOI 10.1016/j.ejphar.2008.03.019; Millan-Guerrero RO, 2011, ARCH MED RES, V42, P44, DOI 10.1016/j.arcmed.2011.01.009; Minagar A, 2006, NEUROL RES, V28, P230, DOI 10.1179/016164106X98080; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Noubade R, 2008, J IMMUNOL, V180, P7471, DOI 10.4049/jimmunol.180.11.7471; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Prat A, 2005, CURR OPIN NEUROL, V18, P225, DOI 10.1097/01.wco.0000169737.99040.31; Ramagopalan SV, 2008, J NEUROIMMUNOL, V201, P183, DOI 10.1016/j.jneuroim.2008.02.016; Ramagopalan SV, 2008, TRENDS NEUROSCI, V31, P645, DOI 10.1016/j.tins.2008.09.001; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Rovaris M, 2009, NEUROLOGY, V72, P1693, DOI 10.1212/WNL.0b013e3181a55feb; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; SHEPPARD MN, 1983, THORAX, V38, P333, DOI 10.1136/thx.38.5.333; Solaro C, 2011, NAT REV NEUROL, V7, P519, DOI 10.1038/nrneurol.2011.120; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Takahashi K, 2002, J CLIN INVEST, V110, P1791, DOI 10.1172/JCI200215784; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wellendorph P, 2002, NEUROPHARMACOLOGY, V42, P929, DOI 10.1016/S0028-3908(02)00041-2; WEST RE, 1994, EUR J PHARM-MOLEC PH, V267, P343, DOI 10.1016/0922-4106(94)90160-0; Wiedemann P, 2002, J NEURAL TRANSM, V109, P443, DOI 10.1007/s007020200036; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	83	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e62743	10.1371/journal.pone.0062743	http://dx.doi.org/10.1371/journal.pone.0062743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894272	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100001
J	Shi, ZH; Long, W; Zhao, C; Guo, XR; Shen, R; Ding, HJ				Shi, Zhonghua; Long, Wei; Zhao, Chun; Guo, Xirong; Shen, Rong; Ding, Hongjuan			Comparative Proteomics Analysis Suggests that Placental Mitochondria are Involved in the Development of Pre-Eclampsia	PLOS ONE			English	Article							FATTY-ACID OXIDATION; PROSTATE-CANCER; ITRAQ; STRESS; EXPRESSION; DISORDERS; APOPTOSIS; PROTEINS	Introduction: Pre-eclampsia (PE), a severe pregnancy-specific disease characterized by the new onset of hypertension, proteinuria, edema, and a series of other systematic disorders, is a state of widespread mitochondrial dysfunction of the placenta. Methods: We compared the morphology of mitochondria in pre-eclamptic and normotensive placentae using electron microscopy. To reveal the systematic protein expression changes of placental mitochondria that might explain the pathogenesis of PE, we performed iTRAQ analysis combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) on differentially expressed placental mitochondria proteins from 4 normotensive and 4 pre-eclamptic pregnancies. Bioinformatics analysis was used to find the relative processes that these differentially expressed proteins were involved in. Three differentially expressed proteins were chosen to confirm by Western blotting and immunohistochemistry. Results: Morphological data demonstrated degenerative and apoptotic changes in the mitochondria of pre-eclamptic placentae. We found four proteins were upregulated and 22 proteins were downregulated in pre-eclamptic placentae compared with normotensive placentae. Bioinformatics analysis showed that these proteins were involved in many critical processes in the development of pre-eclampsia such as apoptosis, fatty acid oxidation, the respiratory chain, reactive oxygen species generation, the tricarboxylic acid cycle and oxidative stress. Conclusions: This preliminary work provides a better understanding of the proteomic alterations of mitochondria from pre-eclamptic placentae and may aid in our understanding of the importance of mitochondria in the development of pre-eclampsia.	[Shi, Zhonghua; Long, Wei; Zhao, Chun; Guo, Xirong; Shen, Rong; Ding, Hongjuan] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Shen, R (corresponding author), Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	shenr_njfy@163.com; dinghj_njfy@163.com	Wang, Qian/AAC-9717-2021	Wang, Qian/0000-0003-4507-0523; Shi, Zunji/0000-0002-1276-6762	Nanjing Medical Science and Technique Development Foundation; Medical Science and Technology Development Foundation of Nanjing Department of Health [YKK12099]	Nanjing Medical Science and Technique Development Foundation; Medical Science and Technology Development Foundation of Nanjing Department of Health	This work was financially supported by the Nanjing Medical Science and Technique Development Foundation and the Medical Science and Technology Development Foundation of Nanjing Department of Health (YKK12099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha JL, 2012, PLACENTA, V33, P132, DOI 10.1016/j.placenta.2011.11.027; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Cunningham G.F., 2005, WILLIAMS OBSTET, V22nd ed., DOI [10.1097/00001888-193609000-00027, DOI 10.1097/00001888-193609000-00027]; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Glen A, 2010, PROSTATE, V70, P1313, DOI 10.1002/pros.21167; Haggarty P, 2002, PLACENTA, V23, P86, DOI 10.1053/plac.2001.0743; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Illsinger S, 2010, REPROD SCI, V17, P219, DOI 10.1177/1933719109351597; Jiang Y, 2012, J HEMATOL ONCOL, V18, P11; Khatun R, 2003, PLACENTA, V24, P870, DOI 10.1016/S0143-4004(03)00138-3; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Padmini E, 2009, CLIN CHEM LAB MED, V47, P1073, DOI 10.1515/CCLM.2009.247; Pollard HB, 2006, MOL CELL PROTEOMICS, V5, P1628, DOI 10.1074/mcp.M600091-MCP200; Rakheja D, 2002, PLACENTA, V23, P447, DOI 10.1053/plac.2002.0808; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; ROBERTS JM, 2004, MATERNAL FETAL MED P, P859; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Shekhawat P, 2003, AM J PHYSIOL-ENDOC M, V284, pE1098, DOI 10.1152/ajpendo.00481.2002; Shekhawat PS, 2005, PEDIATR RES, V57, p78R, DOI 10.1203/01.PDR.0000159631.63843.3E; Shibata E, 2003, PLACENTA, V24, P698, DOI 10.1016/S0143-4004(03)00083-3; Sun CY, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-22; TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Watson AL, 1998, J CLIN ENDOCR METAB, V83, P1697, DOI 10.1210/jc.83.5.1697; Widschwendter M, 1998, MOL MED TODAY, V4, P286, DOI 10.1016/S1357-4310(98)01293-3; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Young NK, 2007, PROTEOM CLIN APPL, V1, P1625	35	122	127	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64351	10.1371/journal.pone.0064351	http://dx.doi.org/10.1371/journal.pone.0064351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671712	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700070
J	Yu, QF; Ye, W; Wang, W; Chen, HF				Yu, Qingfen; Ye, Wei; Wang, Wei; Chen, Hai-Feng			Global Conformational Selection and Local Induced Fit for the Recognition between Intrinsic Disordered p53 and CBP	PLOS ONE			English	Article							DYNAMIC ENERGY LANDSCAPE; CREB-BINDING-PROTEIN; TRANSITION-STATE; MOLECULAR-DYNAMICS; TRANSCRIPTIONAL ACTIVATION; CHYMOTRYPSIN INHIBITOR-2; TRANSACTIVATION DOMAIN; COUPLED BINDING; MECHANISM; COACTIVATOR	The transactivation domain (TAD) of tumor suppressor p53 can bind with the nuclear coactivator binding domain (NCBD) of cyclic-AMP response element binding protein (CBP) and activate transcription. NMR experiments demonstrate that both apo-NCBD and TAD are intrinsic disordered and bound NCBD/TAD undergoes a transition to well folded. The recognition mechanism between intrinsic disordered proteins is still hotly debated. Molecular dynamics (MD) simulations in explicit solvent are used to study the recognition mechanism between intrinsic disordered TAD and NCBD. The average RMSD values between bound and corresponding apo states and Kolmogorov-Smirnov P test analysis indicate that TAD and NCBD may follow an induced fit mechanism. Quantitative analysis indicates there is also a global conformational selection. In summary, the recognition of TAD and NCBD might obey a local induced fit and global conformational selection. These conclusions are further supported by high-temperature unbinding kinetics and room temperature landscape analysis. These methods can be used to study the recognition mechanism of other intrinsic disordered proteins.	[Yu, Qingfen; Ye, Wei; Wang, Wei; Chen, Hai-Feng] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	Chen, HF (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	haifengchen@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020	Li, Haizhou/0000-0001-9158-9401	Ministry of Science and Technology China [2012CB721003]; National High-tech Research & Development Program of China (863 Program) [2012AA020403]; National Natural Science Foundation of China [31271403]; Shanghai Education Committee [12ZZ023]; Shanghai Pujiang Program [10PJD010]; Natural Science Foundation of Shanghai from China [10ZR1414500]; Medical Engineering Cross Fund of Shanghai Jiaotong University [YG2010MS67]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National High-tech Research & Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Education Committee; Shanghai Pujiang Program(Shanghai Pujiang Program); Natural Science Foundation of Shanghai from China; Medical Engineering Cross Fund of Shanghai Jiaotong University	This work was sponsored by grants from Ministry of Science and Technology China(2012CB721003), by National High-tech Research & Development Program of China (863 Program)(2012AA020403), by National Natural Science Foundation of China (31271403), by Innovation Program of Shanghai Education Committee (Grants No. 12ZZ023), by Shanghai Pujiang Program (10PJD010), by the Natural Science Foundation of Shanghai from China (Grants No. 10ZR1414500), and by Medical Engineering Cross Fund of Shanghai Jiaotong University (YG2010MS67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agakishiev G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.072302; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; CAFLISCH A, 1994, P NATL ACAD SCI USA, V91, P1746, DOI 10.1073/pnas.91.5.1746; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Case D.A., 2022, AMBER 2020; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2005, P NATL ACAD SCI USA, V102, P13445, DOI 10.1073/pnas.0501773102; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Fernandez-Escamilla AM, 2004, P NATL ACAD SCI USA, V101, P2834, DOI 10.1073/pnas.0304180101; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gsponer J, 2002, P NATL ACAD SCI USA, V99, P6719, DOI 10.1073/pnas.092686399; Henkels CH, 2006, J AM CHEM SOC, V128, P7772, DOI 10.1021/ja057279+; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kuo SW, 2012, BIOMATERIALS, V33, P5013, DOI 10.1016/j.biomaterials.2012.03.080; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; LEVITT M, 1983, J MOL BIOL, V168, P621, DOI 10.1016/S0022-2836(83)80306-4; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; Livengood JA, 2002, J BIOL CHEM, V277, P9054, DOI 10.1074/jbc.M108870200; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422; Petsko GA, 2003, CURR PROTOC BIOINFOR; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Ritort F, 2002, P NATL ACAD SCI USA, V99, P13544, DOI 10.1073/pnas.172525099; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Sun Y, 2012, DIABETES CARE, V35, P1047, DOI 10.2337/dc11-1511; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Ye W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043788; Ye W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036382	64	87	90	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59627	10.1371/journal.pone.0059627	http://dx.doi.org/10.1371/journal.pone.0059627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	24223789	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500067
J	Chen, YX; Zhu, LQ; Chen, Z				Chen, Yongxiang; Zhu, Liqi; Chen, Zhe			Family Income Affects Children's Altruistic Behavior in the Dictator Game	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; CATEGORIZATION; EVOLUTION	This study aimed to examine how family income and social distance influence young rural Chinese children's altruistic behavior in the dictator game (DG). A total of 469 four-year-old children from eight rural areas in China, including many children left behind by parents who had migrated to urban areas for work, played the DG. Stickers comprised the resource, while recipients in the game were assumed to be either their friends or strangers, with the social distance (i.e., strangers compared to friends) as a between-subjects variable. Children donated significantly more stickers to their friends than to strangers. Moreover, children from lower income families donated more stickers than children from higher income families. However, no gender and parental migrant status differences in children's prosocial behaviors were evident in this sample. Findings of this study suggest that children's altruistic behaviours to peers are influenced by family characteristics since preschool age. The probable influence of local socialization practices on development and the possible adaptive significance were discussed.	[Chen, Yongxiang; Zhu, Liqi] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Yongxiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Zhe] Univ Calif Davis, Dept Human & Community Dev, Davis, CA 95616 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Zhu, LQ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zhulq@psych.ac.cn		Liu, Zhi hao/0000-0002-1583-5057; Migliaccio, Antimo/0000-0002-4197-2055; mo, zengnan/0000-0002-3047-3138	Chinese Academy of Sciences [KJZD-EW-L04, Y1CX012Y01]; 973 program [2010CB8339004]; National Science Foundation of China [30970911]	Chinese Academy of Sciences(Chinese Academy of Sciences); 973 program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Sciences (KJZD-EW-L04 and Y1CX012Y01), the 973 program(2010CB8339004) and National Science Foundation of China (30970911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN VL, 1975, J PERS SOC PSYCHOL, V32, P971, DOI 10.1037/0022-3514.32.6.971; Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Asis, 2006, ASIAN POPULATION STU, V2, P45, DOI [10.1080/17441730600700556, DOI 10.1080/17441730600700556]; Ben-Ner A, 2009, J ECON BEHAV ORGAN, V72, P153, DOI 10.1016/j.jebo.2009.05.007; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Chu SM, 2012, PERS INDIV DIFFER, V52, P691, DOI 10.1016/j.paid.2011.12.029; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; ENGEL C, 2010, WORKING PAPER SERIES, P1; *FED CWS, 2008, NAT SURV LEFT BEH CH; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Friesen J, 2012, J ECON PSYCHOL, V33, P1156, DOI 10.1016/j.joep.2012.08.003; Froiland JM, 2013, SCHOOL PSYCHOL INT, V34, P33, DOI 10.1177/0143034312454361; Fujisawa KK, 2008, INT J BEHAV DEV, V32, P89, DOI 10.1177/0165025407084055; Gueguen N, 2012, SWISS J PSYCHOL, V71, P157, DOI 10.1024/1421-0185/a000083; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Harbaugh WT, 2007, J ECON PSYCHOL, V28, P127, DOI 10.1016/j.joep.2006.03.005; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hesketh T, 2011, SOC PSYCH PSYCH EPID, V46, P733, DOI 10.1007/s00127-010-0240-0; HOFFMAN ML, 1975, J PERS SOC PSYCHOL, V31, P937, DOI 10.1037/h0076825; JIAO SL, 1986, CHILD DEV, V57, P357, DOI 10.2307/1130591; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Kwan YK, 2009, CHILD INDIC RES, V2, P375, DOI 10.1007/s12187-009-9041-y; LI JL, 1995, POPUL DEV REV, V21, P563, DOI 10.2307/2137750; Milonoff M, 2012, ANN ZOOL FENN, V49, P378, DOI 10.5735/086.049.0512; Ng R, 2011, DEV PSYCHOL, V47, P1230, DOI 10.1037/a0024923; Okasha S, 2010, NATURE, V467, P653, DOI 10.1038/467653a; Rachlin H, 2008, BEHAV PROCESS, V79, P120, DOI 10.1016/j.beproc.2008.06.002; Rao LL, 2011, EVOL HUM BEHAV, V32, P63, DOI 10.1016/j.evolhumbehav.2010.07.002; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Rutte C, 2009, CURR SCI INDIA, V97, P1573; Shen JP, 1999, J PSYCHOL, V133, P115, DOI 10.1080/00223989909599726; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang Y, 2009, J AM ACAD CHILD PSY, V48, P1137, DOI 10.1097/CHI.0b013e3181bc72f8; Wen M, 2012, CHILD DEV, V83, P120, DOI 10.1111/j.1467-8624.2011.01698.x; YU J, 2010, DEV CHILDRENS FAIR B; Zheng HM, 2010, NEUROPSYCHOLOGIA, V48, P3198, DOI 10.1016/j.neuropsychologia.2010.06.031; Zhou F., 2006, POPULATION J, V3, P60	41	92	96	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80419	10.1371/journal.pone.0080419	http://dx.doi.org/10.1371/journal.pone.0080419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255PK	24260499	Green Published, gold, Green Submitted			2022-12-27	WOS:000327252100156
J	Chen, Y; Xin, XX; Li, J; Xu, JF; Yu, XX; Li, TY; Mo, ZN; Hu, YL				Chen, Yang; Xin, Xianxiang; Li, Jie; Xu, Jianfeng; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan; Hu, Yanling			RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer	PLOS ONE			English	Article							FOCAL ADHESION KINASE; POSITIVE SELECTION; ACQUIRED-RESISTANCE; CELL-MIGRATION; GENOME; STATISTICS; PROTEIN; MUTATIONS; GENES; EGFR	Prostate cancer (PCa) is a global disease causing large numbers of deaths every year. Recent studies have indicated the RTK/ERK pathway might be a key pathway in the development of PCa. However, the exact association and evolution-based mechanism remain unclear. This study was conducted by combining genotypic and phenotypic data from the Chinese Consortium for Prostate Cancer Genetics (ChinaPCa) with related databases such as the HapMap Project and Genevar. In this analysis, expression of quantitative trait loci (eQTLs) analysis, natural selection and gene-based pathway analysis were involved. The pathway analysis confirmed the positive relationship between PCa risk and several key genes. In addition, combined with the natural selection, it seems that 4 genes (EGFR, ERBB2, PTK2, and RAF1) with five SNPs (rs11238349, rs17172438, rs984654, rs11773818, and rs17172432) especially rs17172432, might be pivotal factors in the development of PCa. The results indicate that the RTK/ERK pathway under natural selection is a key link in PCa risk. The joint effect of the genes and loci with positive selection might be one reason for the development of PCa. Dealing with all the factors simultaneously might give insight into prevention and aid in predicting the success of potential therapies for PCa.	[Chen, Yang; Xin, Xianxiang; Li, Jie; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan; Hu, Yanling] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Xin, Xianxiang; Hu, Yanling] Guangxi Med Univ, Med Res Ctr, Nanning, Guangxi, Peoples R China; [Chen, Yang; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol & Nephrol, Nanning, Peoples R China; [Yu, Xiaoxiang] 303rd Hosp Chinese Peoples Liberat Army, Dept Urol, Nanning, Guangxi Zhuang, Peoples R China; [Li, Jie] Guangxi Med Univ, Affiliated Hosp 1, Res Ctr Guangxi Reprod Med, Nanning, Guangxi Zhuang, Peoples R China; [Xu, Jianfeng] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, Fudan Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University; Fudan University; Fudan University; Wake Forest University; Wake Forest Baptist Medical Center	Mo, ZN (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com; ylhupost@163.com		Liu, Zhi hao/0000-0002-1583-5057; Migliaccio, Antimo/0000-0002-4197-2055; mo, zengnan/0000-0002-3047-3138	National Program on Key Basic Research Project (973 Program) [2012CB518303]; National Natural Science Foundation of China [81060213, 81272853]; Guangxi Natural Science Foundation [2011GXNSFB018100]; Postdoctoral Sustentation Fund of China [2012M511886]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Postdoctoral Sustentation Fund of China	This study was supported by grants from National Program on Key Basic Research Project (973 Program) (2012CB518303), the National Natural Science Foundation of China (81060213, 81272853), Guangxi Natural Science Foundation (2011GXNSFB018100) and Postdoctoral Sustentation Fund of China (2012M511886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arteaga CL, 2002, SEMIN ONCOL, V29, P4, DOI 10.1053/sonc.2002.34047; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Caraglia M, 2007, J CELL PHYSIOL, V211, P533, DOI 10.1002/jcp.20960; Chen LQ, 2011, CLIN CANCER RES, V17, P6218, DOI 10.1158/1078-0432.CCR-11-1548; Choi BK, 2012, CANCER MED-US, V1, P28, DOI 10.1002/cam4.10; Dong LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004895; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Escara-Wilke J, 2012, CANCER METAST REV, V31, P615, DOI 10.1007/s10555-012-9365-9; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hong YS, 2009, CANCER EPIDEM BIOMAR, V18, P680, DOI 10.1158/1055-9965.EPI-08-0961; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung HY, 2012, CANCER RES TREAT, V44, P251, DOI 10.4143/crt.2012.44.4.251; Keller Evan T, 2011, For Immunopathol Dis Therap, V2, P89; Kelley JL, 2009, HUM MOL GENET, V18, P779, DOI 10.1093/hmg/ddn399; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Lacoste J, 2005, MOL CELL ENDOCRINOL, V235, P51, DOI 10.1016/j.mce.2004.06.014; Lamy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053240; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Milone MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.165; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Ning QY, 2011, GENET MOL RES, V10, P3855, DOI 10.4238/2011.December.14.10; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Peng L, 2013, CURR MOL MED, V13, P333; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Ren GP, 2012, GENE CHROMOSOME CANC, V51, P1014, DOI 10.1002/gcc.21984; Rezaiemanesh Alireza, 2010, Human Antibodies, V19, P63, DOI 10.3233/HAB-2010-0229; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; STORM SM, 1993, TOXICOL LETT, V67, P201, DOI 10.1016/0378-4274(93)90056-4; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; Tan M, 2007, ADV EXP MED BIOL, V608, P119; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055298; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906	52	92	96	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78254	10.1371/journal.pone.0078254	http://dx.doi.org/10.1371/journal.pone.0078254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24260499	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400044
J	Li, M; Zhang, YM; Zhang, ZY; Ji, XH; Zhang, R; Liu, DL; Gao, LP; Zhang, J; Wang, BA; Wu, YS; Wu, SJ; Chen, XL; Feng, SQ; Chen, XS				Li, Min; Zhang, Yanmin; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wang, Biao; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen			Hypersensitive Ethylene Signaling and ZMdPG1 Expression Lead to Fruit Softening and Dehiscence	PLOS ONE			English	Article							DNA-BINDING PROTEINS; GOLDEN-DELICIOUS APPLES; GCC-BOX; TOMATO FRUIT; ARABIDOPSIS-THALIANA; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; CIS-ELEMENTS	Taishanzaoxia' fruit rapid softening and dehiscence during ripening stage and this process is very sensitive to endogenous ethylene. In this study, we cloned five ethylene signal transcription factors (ZMdEIL1, ZMdEIL2, ZMdEIL3, ZMdERF1 and ZMdERF2) and one functional gene, ZMdPG1, encoding polygalacturonase that could loose the cell connection which associated with fruit firmness decrease and fruit dehiscence to illustrate the reasons for this specific fruit phenotypic and physiological changes. Expression analysis showed that ZMdERF1 and ZMdEIL2 transcription were more abundant in 'Taishanzaoxia' softening fruit and dehiscent fruit and their expression was inhibited by an ethylene inhibitor 1-methylcyclopropene. Therefore, ZMdERF1 and ZMdEIL2 expression were responses to endogenous ethylene and associated with fruit softening and dehiscence. ZMdPG1 expression was induced when fruit softening and dehiscence but this induction can be blocked by 1-MCP, indicating that ZMdPG1 was essential for fruit softening and dehiscence and its expression was mediated by the endogenously occurred ethylene. ZMdPG1 overexpression in Arabidopsis led to silique early dehiscence while suppressing ZMdPG1 expression by antisense ZMdPG1 prevented silique naturally opening. The result also suggested that ZMdPG1 related with the connection between cells that contributed to fruit softening and dehiscence. ZMdERF1 was more closely related with ethylene signaling but it was not directly regulated the ZMdPG1, which might be regulated by the synergic pattern of ethylene transcription factors because of both the ZMdERF1 and ZMdERF2 could interact with ZMdEIL2.	[Li, Min; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Yanmin] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Wang, Biao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Key Basic Research Program of China [2011CB100606]; National Natural Science Foundation of China [31171932, 31272132]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2011CB100606 and the National Natural Science Foundation of China (31171932 and 31272132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Atkinson R.G., 2008, New Zealand Patent, Patent No. [NZ570886, 570886]; ATKINSON RG, 1994, PLANT PHYSIOL, V105, P1437, DOI 10.1104/pp.105.4.1437; Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Camps C, 2005, J TEXTURE STUD, V36, P387, DOI 10.1111/j.1745-4603.2005.00023.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELLAPENNA D, 1986, P NATL ACAD SCI USA, V83, P6420, DOI 10.1073/pnas.83.17.6420; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liu ChaoChao, 2011, Acta Horticulturae Sinica, V38, P133; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Mir NA, 2001, J AM SOC HORTIC SCI, V126, P618, DOI 10.21273/JASHS.126.5.618; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Rieu I, 2003, J EXP BOT, V54, P2239, DOI 10.1093/jxb/erg240; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Saftner RA, 2003, J AM SOC HORTIC SCI, V128, P120, DOI 10.21273/JASHS.128.1.0120; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Schupp JR, 2004, HORTSCIENCE, V39, P1030, DOI 10.21273/HORTSCI.39.5.1030; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; SPEIRS J, 1990, J PLANT PHYSIOL, V135, P576, DOI 10.1016/S0176-1617(11)80639-5; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Toivonen PMA, 2005, J HORTIC SCI BIOTECH, V80, P439, DOI 10.1080/14620316.2005.11511957; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang ZY, 2000, PLANT MOL BIOL, V42, P317, DOI 10.1023/A:1006309529922; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XueRen, 2009, Acta Horticulturae Sinica, V36, P133; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101	57	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58745	10.1371/journal.pone.0058745	http://dx.doi.org/10.1371/journal.pone.0058745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527016	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600038
J	Li, X; Yao, XP; Wang, YB; Hu, FL; Wang, F; Jiang, LY; Liu, YP; Wang, D; Sun, GZ; Zhao, YS				Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Wang, Da; Sun, Guizhi; Zhao, Yashuang			MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features	PLOS ONE			English	Article							REVISED BETHESDA GUIDELINES; MICROSATELLITE INSTABILITY; HMLH1 PROMOTER; LYNCH-SYNDROME; COLON-CANCER; INSTITUTE WORKSHOP; GENE METHYLATION; BRAF MUTATION; HEREDITARY; HYPERMETHYLATION	Purpose: To describe the frequency of MLH1 promoter methylation in colorectal cancer (CRC); to explore the associations between MLH1 promoter methylation and clinicopathological and molecular factors using a systematic review and meta-analysis. Methods: A literature search of the PubMed and Embase databases was conducted to identify relevant articles published up to September 7, 2012 that described the frequency of MLH1 promoter methylation or its associations with clinicopathological and molecular factors in CRC. The pooled frequency, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. Results: The pooled frequency of MLH1 promoter methylation in unselected CRC was 20.3% (95% CI: 16.8-24.1%). They were 18.7% (95% CI: 14.7-23.6%) and 16.4% (95% CI: 11.9-22.0%) in sporadic and Lynch syndrome (LS) CRC, respectively. Significant associations were observed between MLH1 promoter methylation and gender (pooled OR = 1.641, 95% CI: 1.215-2.215; P = 0.001), tumor location (pooled OR = 3.804, 95% CI: 2.715-5.329; P<0.001), tumor differentiation (pooled OR = 2.131, 95% CI: 1.464-3.102; P<0.001), MSI (OR: 27.096, 95% CI: 13.717-53.526; P<0.001). Significant associations were also observed between MLH1 promoter methylation and MLH1 protein expression, BRAF mutation (OR = 14.919 (95% CI: 6.427-34.631; P<0.001) and 9.419 (95% CI: 2.613-33.953; P = 0.001), respectively). Conclusion: The frequency of MLH1 promoter methylation in unselected CRC was 20.3%. They were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively. MLH1 promoter methylation may be significantly associated with gender, tumor location, tumor differentiation, MSI, MLH1 protein expression, and BRAF mutation.	[Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Da] Harbin Med Univ, Dept Sci & Technol Adm, Harbin, Heilongjiang Pr, Peoples R China; [Sun, Guizhi] Harbin Med Univ, Canc Hosp, Dept Surg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.	zhao_yashuang@263.net	Wang, Fan/I-6099-2019; Zhao, Yashuang/I-6145-2019; li, xia/HHZ-7468-2022; Li, Xiaobing/B-1267-2019; Liu, YuPeng/P-3181-2018	Wang, Fan/0000-0002-9869-9504; Liu, Guowen/0000-0002-2672-6104; Li, Xiaobing/0000-0001-9105-6365; Liu, YuPeng/0000-0002-8652-1987	National Natural Science Foundation of China for Priority Areas [NSFC 30972538]; Education Bureau of Heilongjiang Province [11531100]; Graduate Foundation; Scientific Research of Heilongjiang Province [YJSCX2009-224HLJ]; Harbin Medical University [HCXB2009009]	National Natural Science Foundation of China for Priority Areas; Education Bureau of Heilongjiang Province; Graduate Foundation; Scientific Research of Heilongjiang Province; Harbin Medical University	This study was supported by grants from National Natural Science Foundation of China for Priority Areas (NSFC 30972538), Education Bureau of Heilongjiang Province (11531100), and the Graduate Foundation, supported by the Scientific Research of Heilongjiang Province (YJSCX2009-224HLJ) and Harbin Medical University (HCXB2009009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502; Arnold CN, 2004, CANCER BIOL THER, V3, P73, DOI 10.4161/cbt.3.1.590; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495; Bettstetter M, 2007, CLIN CANCER RES, V13, P3221, DOI 10.1158/1078-0432.CCR-06-3064; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boland CR, 1998, CANCER RES, V58, P5248; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Cunningham JM, 1998, CANCER RES, V58, P3455; de Vogel S, 2009, ANN ONCOL, V20, P1216, DOI 10.1093/annonc/mdn782; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Deng GR, 1999, CANCER RES, V59, P2029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dykes SL, 2003, CANCER-AM CANCER SOC, V98, P48, DOI 10.1002/cncr.11445; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fox EJ, 2006, J MOL DIAGN, V8, P68, DOI 10.2353/jmoldx.2006.050084; Garagnani P, 2012, CURR PHARM DES; Gay LJ, 2011, NUTR CANCER, V63, P1000, DOI 10.1080/01635581.2011.596987; Gazzoli I, 2002, CANCER RES, V62, P3925; GLOBOCAN, 2008, CANC FACT SHEET; Grady WM, 2001, CANCER RES, V61, P900; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Q, 2012, DIAGN MOL PATHOL, V21, P24, DOI 10.1097/PDM.0b013e318230effd; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Jass JR, 2002, EUR J CANCER, V38, P858, DOI 10.1016/S0959-8049(02)00041-2; Julie C, 2008, AM J GASTROENTEROL, V103, P2825, DOI 10.1111/j.1572-0241.2008.02084.x; Kane MF, 1997, CANCER RES, V57, P808; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Lee KH, 2011, LANGENBECK ARCH SURG, V396, P1017, DOI 10.1007/s00423-011-0812-9; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Mathers JC, ADV GENET, V71, P3; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154; Mirchev M, 2007, J IMAB ANN P SCI PAP, P95; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nakagawa H, 2001, CANCER RES, V61, P6991; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Park IJ, 2007, J KOREAN MED SCI, V22, pS91, DOI 10.3346/jkms.2007.22.S.S91; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Potocnik U, 2001, CANCER GENET CYTOGEN, V126, P85, DOI 10.1016/S0165-4608(00)00399-X; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Raedle J, 2001, ANN INTERN MED, V135, P566, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00007; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shannon BA, 2001, CANCER LETT, V167, P91, DOI 10.1016/S0304-3835(01)00431-1; Shi XZ, 2006, BIOMED CHROMATOGR, V20, P815, DOI 10.1002/bmc.606; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Strazzullo M, 2003, CANCER-AM CANCER SOC, V98, P1540, DOI 10.1002/cncr.11651; Tannergard P, 1997, HUM GENET, V101, P51, DOI 10.1007/s004390050585; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Velayos FS, 2005, J GASTROINTEST SURG, V9, P329, DOI 10.1016/j.gassur.2004.05.007; Vilkin A, 2009, CANCER-AM CANCER SOC, V115, P760, DOI 10.1002/cncr.24019; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Ward R, 2001, GUT, V48, P821, DOI 10.1136/gut.48.6.821; Ward RL, 2005, J PATHOL, V207, P377, DOI 10.1002/path.1851; Yamamoto H, 2002, GENE CHROMOSOME CANC, V33, P322, DOI 10.1002/gcc.10010; Yiu R, 2005, DIS COLON RECTUM, V48, P2061, DOI 10.1007/s10350-005-0171-0; Zhou HH, 2008, WORLD J GASTROENTERO, V14, P7329, DOI 10.3748/wjg.14.7329	78	84	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59064	10.1371/journal.pone.0059064	http://dx.doi.org/10.1371/journal.pone.0059064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23861826	gold, Green Published, Green Submitted			2022-12-27	WOS:000317263900009
J	Li, M; Zhang, QP; Liu, LN; Lu, WP; Wei, H; Li, RW; Lu, S				Li, Mei; Zhang, Qiuping; Liu, Lina; Lu, Weipeng; Wei, Hong; Li, Rachel W.; Lu, Shen			Expression of the Mismatch Repair Gene hMLH1 Is Enhanced in Non-Small Cell Lung Cancer with EGFR Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CLINICAL-SIGNIFICANCE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; CARCINOMAS; PROTEINS; HMSH2	Mismatch repair (MMR) plays a pivotal role in keeping the genome stable. MMR dysfunction can lead to carcinogenesis by gene mutation accumulation. HMSH2 and hMLH1 are two key components of MMR. High or low expression of them often mark the status of MMR function. Mutations (EGFR, KRAS, etc) are common in non-small cell lung cancer (NSCLC). However, it is not clear what role MMR plays in NSCLC gene mutations. The expression of MMR proteins hMSH2 and hMLH1, and the proliferation markers PCNA and Ki67 were measured by immunohistochemistry in 181 NSCLCs. EGFR and KRAS mutations were identified by high resolution melting analysis. Stronger hMLH1 expression correlated to a higher frequency of EGFR mutations in exon 19 and 21 (p<0.0005). Overexpression of hMLH1 and the adenocarcinoma subtype were both independent factors that related to EGFR mutations in NSCLCs (p=0.013 and p<0.0005). The expression of hMLH1, hMSH2 and PCNA increased, while Ki67 expression significantly decreased (p=0.030) in NSCLCs with EGFR mutations. Overexpression of hMLH1 could be a new molecular marker to predict the response to EGFR-TKIs in NSCLCs. Furthermore, EGFR mutations might be an early event of NSCLC that occur before MMR dysfunction.	[Li, Mei; Lu, Weipeng; Wei, Hong; Lu, Shen] Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China; [Zhang, Qiuping] Dalian Med Univ, Hosp 1, Dept Pathol, Dalian, Peoples R China; [Liu, Lina] Dalian Med Univ, Hosp 1, Dept Internal Med, Dalian, Peoples R China; [Li, Rachel W.] Australian Med Univ, Sch Med, Canberra, ACT, Australia	Dalian Medical University; Dalian Medical University; Dalian Medical University	Lu, S (corresponding author), Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China.	lvshen1956@126.com	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Nature Science Funds in China [81071805]; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	National Nature Science Funds in China; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	This work was supported by the National Nature Science Funds in China (Fund No. 81071805; URL: http://isisn.nsfc.gov.cn/egrantweb/), and Dalian Merricon Gene Diagnosis Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Betz BL, 2011, AM J CLIN PATHOL, V136, P564, DOI 10.1309/AJCP84TUTQOSUONG; Bischoff J, 2012, CLIN EXP METASTAS, V29, P889, DOI 10.1007/s10585-012-9478-0; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Donehower LA, 2013, J PATHOL, V229, P99, DOI 10.1002/path.4087; Kawaguchi M, 2009, INT J ONCOL, V34, P1541, DOI 10.3892/ijo_00000283; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Li M, 2008, ONCOL REP, V19, P401; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Romeo F, 2011, INT J BIOCHEM CELL B, V43, P1754, DOI 10.1016/j.biocel.2011.08.011; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saletta F, 2007, CANCER RES, V67, P7088, DOI 10.1158/0008-5472.CAN-06-4420; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Sholl LM, 2010, AM J CLIN PATHOL, V133, P922, DOI 10.1309/AJCPST1CTHZS3PSZ; Stoehr C, 2012, PATHOBIOLOGY, V79, P162, DOI 10.1159/000335642; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Vageli D, 2009, LUNG CANCER, V64, P282, DOI 10.1016/j.lungcan.2008.09.018; Vageli DP, 2012, INT J BIOL MARKER, V27, pE400, DOI 10.5301/JBM.2012.9420; van Puijenbroek M, 2008, FAM CANCER, V7, P319, DOI 10.1007/s10689-008-9194-8; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang Y, 2000, GENE DEV, V14, P927; Wang YC, 2003, J CLIN INVEST, V111, P887, DOI 10.1172/JCI200315475; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xinarianos G, 2000, CANCER RES, V60, P4216; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014	47	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78500	10.1371/journal.pone.0078500	http://dx.doi.org/10.1371/journal.pone.0078500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	23527016	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300065
J	Zhang, GL; Huang, SQ; Duan, QH; Shu, W; Hou, YC; Zhu, SY; Miao, XP; Nie, SF; Wei, S; Guo, N; Shan, H; Xu, YH				Zhang, Guoliang; Huang, Shuqiong; Duan, Qionghong; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Guo, Nan; Shan, Hua; Xu, Yihua			Application of a Hybrid Model for Predicting the Incidence of Tuberculosis in Hubei, China	PLOS ONE			English	Article							TIME-SERIES; HEALTH SYSTEM; SEASONALITY; TRANSMISSION	Background: A prediction model for tuberculosis incidence is needed in China which may be used as a decision-supportive tool for planning health interventions and allocating health resources. Methods: The autoregressive integrated moving average (ARIMA) model was first constructed with the data of tuberculosis report rate in Hubei Province from Jan 2004 to Dec 2011. The data from Jan 2012 to Jun 2012 were used to validate the model. Then the generalized regression neural network (GRNN)-ARIMA combination model was established based on the constructed ARIMA model. Finally, the fitting and prediction accuracy of the two models was evaluated. Results: A total of 465,960 cases were reported between Jan 2004 and Dec 2011 in Hubei Province. The report rate of tuberculosis was highest in 2005 (119.932 per 100,000 population) and lowest in 2010 (84.724 per 100,000 population). The time series of tuberculosis report rate show a gradual secular decline and a striking seasonal variation. The ARIMA (2, 1, 0) x (0, 1, 1) 12 model was selected from several plausible ARIMA models. The residual mean square error of the GRNN-ARIMA model and ARIMA model were 0.4467 and 0.6521 in training part, and 0.0958 and 0.1133 in validation part, respectively. The mean absolute error and mean absolute percentage error of the hybrid model were also less than the ARIMA model. Discussion and Conclusions: The gradual decline in tuberculosis report rate may be attributed to the effect of intensive measures on tuberculosis. The striking seasonal variation may have resulted from several factors. We suppose that a delay in the surveillance system may also have contributed to the variation. According to the fitting and prediction accuracy, the hybrid model outperforms the traditional ARIMA model, which may facilitate the allocation of health resources in China.	[Zhang, Guoliang; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Xu, Yihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Shuqiong] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Duan, Qionghong] TB Inst TB Control & Prevent Wuhan City, Wuhan, Peoples R China; [Guo, Nan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shan, Hua] Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Xu, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	xuyihua_6@hotmail.com	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Chen XY, 2004, LANCET, V364, P417; Cheng G, 2005, T ROY SOC TROP MED H, V99, P355, DOI 10.1016/j.trstmh.2004.07.005; Debanne SM, 2000, EMERG INFECT DIS, V6, P148, DOI 10.3201/eid0602.000207; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hu WB, 2004, AM J TROP MED HYG, V71, P129, DOI 10.4269/ajtmh.2004.71.129; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Leung MT, 2000, COMPUT OPER RES, V27, P1093, DOI 10.1016/S0305-0548(99)00144-6; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Medeiros MC, 2000, IEEE T NEURAL NETWOR, V11, P1402, DOI 10.1109/72.883463; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076	31	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80969	10.1371/journal.pone.0080969	http://dx.doi.org/10.1371/journal.pone.0080969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223232	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200125
J	Zhang, A; Qi, QW; Jiang, LL; Zhou, F; Wang, JF				Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng			Population Exposure to PM2.5 in the Urban Area of Beijing	PLOS ONE			English	Article							COARSE PARTICLES; FINE PARTICLES; AIR-QUALITY	The air quality in Beijing, especially its PM2.5 level, has become of increasing public concern because of its importance and sensitivity related to health risks. A set of monitored PM2.5 data from 31 stations, released for the first time by the Beijing Environmental Protection Bureau, covering 37 days during autumn 2012, was processed using spatial interpolation and overlay analysis. Following analyses of these data, a distribution map of cumulative exceedance days of PM2.5 and a temporal variation map of PM2.5 for Beijing have been drawn. Computational and analytical results show periodic and directional trends of PM2.5 spreading and congregating in space, which reveals the regulation of PM2.5 overexposure on a discontinuous medium-term scale. With regard to the cumulative effect of PM2.5 on the human body, the harm from lower intensity overexposure in the medium term, and higher overexposure in the short term, are both obvious. Therefore, data of population distribution were integrated into the aforementioned PM2.5 spatial spectrum map. A spatial statistical analysis revealed the patterns of PM2.5 gross exposure and exposure probability of residents in the Beijing urban area. The methods and conclusions of this research reveal relationships between long-term overexposure to PM2.5 and people living in high-exposure areas of Beijing, during the autumn of 2012.	[Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Qi, QW (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	qiqw@igsnrr.ac.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	National Natural Science Foundation of China [41201412]; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Natural Science Foundation of China (41201412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar H, 2005, STOCH ENV RES RISK A, V19, P301, DOI 10.1007/s00477-005-0234-8; Bureau BCA Mapping BIoSa, 2005, BEIJ ADM DISTR ATL; Bureau BCA Mapping BIoSa, 2007, BEIJ ADM DISTR TUZH; China's Ministry of Environmental Protection, 2012, AMB AIR QUAL STAND; Du XA, 2010, J ENVIRON SCI-CHINA, V22, P1757, DOI 10.1016/S1001-0742(09)60316-8; Fann N, 2011, RISK ANAL, DOI DOI 10.1111/J.1539-6924.2011.01630.X; Gavett SH, 2001, INT ARCH ALLERGY IMM, V124, P109, DOI 10.1159/000053685; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Hao YP, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-3; Jorgensen NW, 2012, J AM COLL CARDIOL, V60; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kunii O, 2002, ARCH ENVIRON HEALTH, V57, P16, DOI 10.1080/00039890209602912; Li P, 2012, PLOS ONE; Lippmann M, 1998, ISSUES ENV SCI TECHN, V10, P75; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Municipality OftSPCoB Statistics BMBo Beijing SOotNBoSi, 2012, TAB 2010 POP CENS BE; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Qiu F, 2012, GISCI REMOTE SENS, V49, P644, DOI 10.2747/1548-1603.49.5.644; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Urbat M, 2004, ATMOS ENVIRON, V38, P3781, DOI 10.1016/j.atmosenv.2004.03.061; Vallejo M, 2006, J EXPO SCI ENV EPID, V16, P125, DOI 10.1038/sj.jea.7500447; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; [袁杨森 YUAN Yangsen], 2007, [生态环境, Ecology and Environment], V16, P18; Zhao W, 2012, GEOGRAPHICAL RES, V417-428	25	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63486	10.1371/journal.pone.0063486	http://dx.doi.org/10.1371/journal.pone.0063486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	24223232	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500073
J	Zhang, YB; Wei, C; Jiang, WD; Wang, L; Li, CR; Wang, YY; Dow, JM; Sun, WX				Zhang, Yuanbao; Wei, Chao; Jiang, Wendi; Wang, Lei; Li, Churui; Wang, Yunyue; Dow, John Maxwell; Sun, Wenxian			The HD-GYP Domain Protein RpfG of Xanthomonas oryzae pv. oryzicola Regulates Synthesis of Extracellular Polysaccharides that Contribute to Biofilm Formation and Virulence on Rice	PLOS ONE			English	Article							DIFFUSIBLE SIGNAL FACTOR; 2-COMPONENT SYSTEM; GENE-EXPRESSION; CAMPESTRIS; VESICATORIA; PHOSPHODIESTERASE; SEQUENCES; ACTIVATOR; BACTERIA; CLUSTER	Bacterial leaf streak caused by Xanthomonas oryzae pv. oryzicola (Xoc) is one of the most important diseases in rice. However, little is known about the pathogenicity mechanisms of Xoc. Here we have investigated the function of three HD-GYP domain regulatory proteins in biofilm formation, the synthesis of virulence factors and virulence of Xoc. Deletion of rpfG resulted in altered production of extracellular polysaccharides (EPS), abolished virulence on rice and enhanced biofilm formation, but had little effect on the secretion of proteases and motility. In contrast, mutational analysis showed that the other two HD-GYP domain proteins had no effect on virulence factor synthesis and tested phenotypes. Mutation of rpfG led to up-regulation of the type III secretion system and altered expression of three putative glycosyltransferase genes gumD, pgaC and xagB, which are part of operons directing the synthesis of different extracellular polysaccharides. The pgaABCD and xagABCD operons were greatly up-regulated in the Xoc Delta rpfG mutant, whereas the expression of the gum genes was unaltered or slightly enhanced. The elevated biofilm formation of the Xoc Delta rpfG mutant was dramatically reduced upon deletion of gumD, xagA and xagB, but not when pgaA and pgaC were deleted. Interestingly, only the Delta gumD mutant, among these single gene mutants, exhibits multiple phenotype alterations including reduced biofilm and EPS production and attenuated virulence on rice. These data indicate that RpfG is a global regulator that controls biofilm formation, EPS production and bacterial virulence in Xoc and that both gumD- and xagB-dependent EPS contribute to biofilm formation under different conditions.	[Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wei, Chao; Wang, Yunyue] Yunnan Agr Univ, Minist Educ, Key Lab Agr Biodivers & Plant Dis Management, Kunming, Peoples R China; [Dow, John Maxwell] Univ Coll Cork, Biosci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University; University College Cork	Zhang, YB (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wxs@cau.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	973 program [2011CB100700]; National Natural Science Foundation of China (NSFC) [31272007]; PCSIRT Program [IRT1042, NCET-09-0736]; Ph.D. Programs Foundation of Ministry of Education of China; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	973 program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); PCSIRT Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the 973 program 2011CB100700, National Natural Science Foundation of China (NSFC) grant 31272007, PCSIRT Program IRT1042, NCET-09-0736 and Ph.D. Programs Foundation of Ministry of Education of China to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; AWODERU VA, 1991, TROP PEST MANAGE, V37, P356, DOI 10.1080/09670879109371614; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; BOYER MH, 1984, J BIOTECHNOL, V1, P241, DOI 10.1016/0168-1656(84)90009-9; CANNON FC, 1979, MOL GEN GENET, V174, P59, DOI 10.1007/BF00433306; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe23; Feng JX, 2009, MICROBIOL-SGM, V155, P3033, DOI 10.1099/mic.0.028910-0; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guo YP, 2012, MOL PLANT MICROBE IN, V25, P165, DOI 10.1094/MPMI-07-11-0184; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JIANG J, 2009, ACTA MICROBIOL SIN, V49, P1018; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Meng FH, 2011, J BACTERIOL, V193, P2477, DOI 10.1128/JB.01360-10; MOFFETT ML, 1983, PLANT BACTERIAL DIS, P393; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; OU SH, 1985, ROCE DIS; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Rai R, 2012, MOL PLANT MICROBE IN, V25, P789, DOI 10.1094/MPMI-11-11-0285-R; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Yang FH, 2012, MOL PLANT MICROBE IN, V25, P1361, DOI 10.1094/MPMI-01-12-0014-R; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	73	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59428	10.1371/journal.pone.0059428	http://dx.doi.org/10.1371/journal.pone.0059428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	24223232	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700121
